TTDDRUGID	LNM	Indication	ICD9	ICD10
DAP000001	Quetiapine	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DAP000001	Quetiapine	Schizophrenia	295	F20
DAP000002	Theophylline	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP000003	Risperidone	Schizophrenia	295	F20
DAP000004	Dasatinib	Chronic myelogenous leukemia	205.1	C92.1
DAP000004	Dasatinib	Solid tumours; Multiple myeloma	140-199, 203.0, 210-229	C00-C75, C7A, C7B, C90.0, D10-D36, D3A
DAP000005	Sunitinib	Advanced renal cell carcinoma	189	C64
DAP000005	Sunitinib	Gastrointestinal cancer	.	C15-C26
DAP000006	Sorafenib	Advanced renal cell carcinoma	189	C64
DAP000006	Sorafenib	Hepatocellular carcinoma; NSCLC; Melanoma	155, 162, 172	C22.0, C33, C34, C43
DAP000006	Sorafenib	Myelodysplastic syndromes; AML; Head and neck cancer; Breast cancer; Pancreatic cancer	140-149, 140-229, 157, 183, 205.0	C00-C96, C07-C14, C25, C32, C33, C56, C92.0
DAP000007	Dexamethasone	Rheumatold arthritis	714	M05-M06
DAP000008	Eletriptan	Migraine	346	G43
DAP000009	Isotretinoin	Acne vulgaris	706.1	L70.0
DAP000010	Mirtazapine	Depression	311	F32
DAP000010	Mirtazapine	Fibromyalgia	729.1	M79.7
DAP000011	Isoniazid	Tuberculosis	010-018	A15-A19
DAP000012	Disulfiram	Alcohol use disorders	303	F10.2
DAP000012	Disulfiram	Non-small-cell lung cancer	162	C33, C34
DAP000013	Dipyridamole	Hypertension	401	I10, I11, I12, I13, I15
DAP000014	Cyclosporine	Psoriasis	696	L40
DAP000015	L-Glutamic Acid	Indigestion	.	K30
DAP000015	L-Glutamic Acid	Schizophrenia	295	F20
DAP000016	Norepinephrine	Cardiac arrest	.	I46
DAP000016	Norepinephrine	Septic shock; Neurogenic shock	785, 785.52	R57.8, R65.21
DAP000017	Dextropropoxyphene	Pain	338,780	R52, G89
DAP000018	Vasopressin	Enuresis; Polyuria; Diabetes insipidus	250, 253.5, 307.6, 588.1, 788.30, 788.42	E08-E13, E23.2, F98.0, N25.1, R32, R35
DAP000019	Pramipexole	Parkinson's disease	332	F02.3, G20
DAP000020	Leuprolide	Prostate cancer	185	C61
DAP000021	Diazepam	Pain; Anesthesia; Anxiety	300, 338,780	F40-F42, R52, G89
DAP000022	Olanzapine	Schizophrenia	295	F20
DAP000023	Goserelin	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
DAP000024	Methylphenidate	Attention deficit hyperactivity disorder	314	F90
DAP000024	Methylphenidate	Traumatic brain injury	800, 801, 803, 804, 850-854	S06
DAP000025	Pindolol	Cachexia	799.4	R64
DAP000025	Pindolol	Hypertension; Angina	401, 413	I10, I11, I12, I13, I15, I20
DAP000026	Flupenthixol	Cocaine addiction	304.2	F14.2
DAP000026	Flupenthixol	Schizophrenia	295	F20
DAP000027	Mecamylamine	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DAP000027	Mecamylamine	Hypertension	401	I10, I11, I12, I13, I15
DAP000028	Becaplermin	Diabetes mellitus	250	E08-E13
DAP000029	Clozapine	Schizophrenia	295	F20
DAP000030	Bosentan	Pulmonary arterial hypertension	416	I27.0, I27.2
DAP000031	Buspirone	Anxiety disorder	300	F40-F42
DAP000032	Tetracycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000033	Mitotane	Adrenocortical carcinoma	194	C74.0
DAP000033	Mitotane	Cushing's disease	.	E24.9
DAP000034	Trifluoperazine	Anxiety disorder	300	F40-F42
DAP000034	Trifluoperazine	Schizophrenia	295	F20
DAP000035	Trichlormethiazide	Edema	.	R60.9
DAP000035	Trichlormethiazide	Oedema and hypertension	401, 782.3	I10, I11, I12, I13, I15, R60.9
DAP000036	Neomycin	Acute hepatic failure and alcoholic cirrhosis of the liver	570, 571.1	K71, K72
DAP000037	Glibenclamide	Diabetes mellitus	250	E08-E13
DAP000038	Labetalol	Hypertension	401	I10, I11, I12, I13, I15
DAP000039	Lamotrigine	Epilepsy	345	G40
DAP000039	Lamotrigine	Epilepsy; Bipolar disorder	296, 345	F31, G40
DAP000040	Verapamil	Hypertension; Angina	401, 413	I10, I11, I12, I13, I15, I20
DAP000041	Carmustine	Brain cancer	191	C71
DAP000042	Nefazodone	Anxiety disorder	300	F40-F42
DAP000042	Nefazodone	Depression	311	F32
DAP000043	Furosemide	Edema	.	R60.9
DAP000043	Furosemide	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
DAP000044	Dutasteride	Benign prostatic hyperplasia	600	N40
DAP000044	Dutasteride	Prostate cancer	185	C61
DAP000045	Finasteride	Benign prostatic hyperplasia	600	N40
DAP000046	Amsacrine	Acute lymphoblastic leukemia	204	C91.0
DAP000047	Bethanidine	Heart arrhythmia	.	I47-I49
DAP000047	Bethanidine	Hypertension	401	I10, I11, I12, I13, I15
DAP000048	Pentoxifylline	Intermittent claudication	440.21	I73.9
DAP000049	Pemetrexed	Malignant pleural mesothelioma	163	C45
DAP000049	Pemetrexed	Pleural mesothelioma	163	C45
DAP000050	Idarubicin	Acute myeloid leukemia	205	C92.0
DAP000051	Sertraline	Depression	311	F32
DAP000052	Bupropion	Depression	311	F32
DAP000053	Orlistat	Obesity	278	E66
DAP000054	Venlafaxine	Depression	311	F32
DAP000055	Ethambutol	Mycobacterium tuberculosis infection	.	A15-A19
DAP000055	Ethambutol	Tuberculosis	010-018	A15-A19
DAP000056	Foscarnet	Herpes viruses	053, 054	B00, B02
DAP000057	Mitoxantrone	Cancers	140-229	C00-C96
DAP000058	Terlipressin	Bleeding	.	R58
DAP000058	Terlipressin	Hypertension	401	I10, I11, I12, I13, I15
DAP000059	Guanadrel Sulfate	Hypertension	401	I10, I11, I12, I13, I15
DAP000060	Adefovir Dipivoxil	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DAP000061	Phenobarbital	Anxiety disorder	300	F40-F42
DAP000061	Phenobarbital	Seizures	345.9, 780.3	G40, P90, R56
DAP000062	Oxaliplatin	Colorectal cancer	153, 154	C18-C21
DAP000063	Frovatriptan	Migraine headaches	346	G43
DAP000064	Lofexidine	Drug withdrawal syndrome	.	P96.1
DAP000064	Lofexidine	Heroin and opiate withdrawal	304	F10-F19
DAP000065	Carteolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000066	Epinephrine	Allergy	995.3	T78.4
DAP000066	Epinephrine	Sepsis	995.0, 995.91	A40, A41, T78.2
DAP000068	Ropinirole	Parkinson's disease	332	F02.3, G20
DAP000069	Pergolide	Parkinson's disease	332	F02.3, G20
DAP000070	Ramelteon	Circadian rhythm sleep disorder	327.3, 780.55	G47.2
DAP000070	Ramelteon	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000071	Morphine	Opioid addiction and dependence	.	F11.2
DAP000071	Morphine	Pain	338,780	R52, G89
DAP000072	Fentanyl	Anesthesia	338	R52
DAP000072	Fentanyl	Cancer pain	338,780	R52, G89
DAP000073	Buprenorphine	Pain	338,780	R52, G89
DAP000074	Desmopressin	Factor VIII deficiency	.	D66
DAP000074	Desmopressin	Primary nocturnal enuresis	307.6, 788.36	F98.0, R32
DAP000075	Cevimeline	Sjogren's syndrome	710.2	M35.0
DAP000076	Aripiprazole	Schizophrenia	295	F20
DAP000077	Zolmitriptan	Migraine	346	G43
DAP000078	Dihydroergotamine	Migraine headaches	346	G43
DAP000079	Ziprasidone	Schizophrenia	295	F20
DAP000080	Isoproterenol	Bradycardia; Heart block	116.0, 426.9	B40, I44-I45
DAP000081	Tranylcypromine	Depression	311	F32
DAP000082	Liothyronine	Hypothyroidism	244	E03
DAP000083	Levothyroxine	Hypothyroidism	244	E03
DAP000084	Chlordiazepoxide	Anxiety disorder	300	F40-F42
DAP000085	Eplerenone	Heart failure	428	I50
DAP000086	Tamsulosin	Benign prostatic hyperplasia	600	N40
DAP000087	Yohimbine	Male impotence	302.72, 607.84	F52.2, N48.4
DAP000088	Timolol	Glaucoma	365	H40-H42
DAP000088	Timolol	High blood pressure	401	I10, I11, I12, I13, I15
DAP000089	Propranolol	Angina	413	I20
DAP000089	Propranolol	Migraine	346	G43
DAP000090	Mifepristone	Medical abortion	779.6	O04
DAP000091	Zafirlukast	Asthma	493	J45
DAP000092	Bicalutamide	Advanced prostatic cancer	185	C61
DAP000093	Felbamate	Epilepsy	345	G40
DAP000094	Abarelix	Advanced prostate cancer	185	C61
DAP000095	Anakinra	Rheumatold arthritis	714	M05-M06
DAP000096	Cetrorelix	Controlled ovarian stimulation	183	C56
DAP000097	Naloxone	Narcotic depression	304.9, 311	F19.20, F32
DAP000098	Conivaptan	Euvolemic hyponatremia	276.1	E87.1
DAP000099	Caffeine	Fatigue; Orthostatic hypotension	458.0, 780.7	I95.1, R53
DAP000099	Caffeine	Headache	339, 784.0	G43-G44, R51
DAP000100	Perphenazine	Emesis	787	R11
DAP000100	Perphenazine	Schizophrenia; Bipolar disorder	295, 296	F20, F31
DAP000101	Loratadine	Allergy	995.3	T78.4
DAP000102	Terfenadine	Allergy	995.3	T78.4
DAP000103	Cyproheptadine	Allergy	995.3	T78.4
DAP000104	Trazodone	Depression	311	F32
DAP000105	Atracurium	Anesthesia	338	R52
DAP000105	Atracurium	General anesthesia	338	R52
DAP000106	Etanercept	Rheumatold arthritis	714	M05-M06
DAP000107	Infliximab	Asthma	493	J45
DAP000107	Infliximab	Psoriasis; Crohn's disease; Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis	555, 556, 556.9, 696, 696.0, 710-719, 714, 720.0	K50, K50-K52, K51, L40, L40.5, M00-M25, M05-M06, M07, M08.1, M45
DAP000108	Tamoxifen	Breast cancer	174, 175	C50
DAP000108	Tamoxifen	Cancer	.	C00-C97
DAP000109	Telithromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000109	Telithromycin	Respiratory infections	.	J06.9
DAP000110	Tobramycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000111	Erythromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000112	Zolpidem	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000113	Filgrastim	Neutropenia	288	D70
DAP000114	Vincristine	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
DAP000114	Vincristine	Lung cancer	.	C33-C34
DAP000115	Adapalene	Acne vulgaris	706.1	L70.0
DAP000116	Gentamicin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000117	Aztreonam	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000118	Citalopram	Depression	311	F32
DAP000119	Acetyldigitoxin	Congestive heart failure	428	I50
DAP000120	Digitoxin	Cardiovascular disease	.	I51.6
DAP000120	Digitoxin	Congestive cardiac insufficiency; Arrhythmias; Heart failure	427, 428	I47-I49, I50
DAP000121	Lidocaine	Anesthesia	338	R52
DAP000122	Nadolol	High blood pressure; Angina	401, 413	I10, I11, I12, I13, I15, I20
DAP000123	Pancuronium	Anesthesia	338	R52
DAP000124	Guanethidine	Hypertension	401	I10, I11, I12, I13, I15
DAP000125	Debrisoquin	Hypertension	401	I10, I11, I12, I13, I15
DAP000128	Sodium bicarbonate	Acidosis	.	E87.2
DAP000128	Sodium bicarbonate	Metabolic acidosis	276.2	E87.2
DAP000129	Carbamazepine	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DAP000129	Carbamazepine	Epilepsy; Bipolar disorder	296, 345	F31, G40
DAP000130	Phenytoin	Seizures	.	G40,R56
DAP000130	Phenytoin	Seizures	345.9, 780.3	G40, P90, R56
DAP000131	Chloroprocaine	Anesthesia	338	R52
DAP000131	Chloroprocaine	Pain	338,780	R52, G89
DAP000132	Glimepiride	Diabetes mellitus	250	E08-E13
DAP000132	Glimepiride	Non-insulin dependent diabetes	.	E11.9
DAP000133	Repaglinide	Diabetes mellitus	250	E08-E13
DAP000133	Repaglinide	Non-insulin dependent diabetes	.	E11.9
DAP000134	Isradipine	Hypertension	401	I10, I11, I12, I13, I15
DAP000135	Carvedilol	Congestive heart failure	428	I50
DAP000136	Tolbutamide	Diabetes mellitus	250	E08-E13
DAP000137	Topiramate	Alcohol use disorders	303	F10.2
DAP000137	Topiramate	Epilepsy	345	G40
DAP000138	Clotrimazole	Fungal infection	110-118	B35-B49
DAP000139	Amlodipine	Hypertension; Angina	401, 413	I10, I11, I12, I13, I15, I20
DAP000140	Tramadol	Pain	338,780	R52, G89
DAP000141	Ergotamine	Headache	339, 784.0	G43-G44, R51
DAP000141	Ergotamine	Migraine	346	G43
DAP000142	Flunarizine	Migraine	346	G43
DAP000143	Minoxidil	Hypertension	401	I10, I11, I12, I13, I15
DAP000144	Streptomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000144	Streptomycin	Endocarditis	421	I33
DAP000145	Ceftriaxone	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000146	Cefotaxime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000146	Cefotaxime	Infectious disease	001-139	A00-B99
DAP000147	Mercaptopurine	Acute lymphoblastic leukemia	204	C91.0
DAP000147	Mercaptopurine	Acute lymphocytic leukemia	204	C91.0
DAP000148	Trilostane	Cushing's disease	255	E24
DAP000149	Rivastigmine	Alzheimer's disease	331	G30
DAP000150	Milrinone	Congestive heart failure	428	I50
DAP000151	Drotrecogin alfa	Cerebrovascular ischaemia	.	G45.9,I67.8
DAP000151	Drotrecogin alfa	Severe sepsis	995.91	A40-A41
DAP000152	Diflunisal	Dysmenorrhea	.	N94.4-N94.6
DAP000152	Diflunisal	Pain	338,780	R52, G89
DAP000153	Sulfasalazine	Inflammatory bowel dieasea; Rheumatoid arthritis	555, 556, 714	K50, K51, M05-M06
DAP000153	Sulfasalazine	Inflammatory bowel disease	555, 556	K50, K51
DAP000154	Miconazole	Fungal infection	110-118	B35-B49
DAP000155	Cefalotin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000155	Cefalotin	Urinary tract infections	599	N39.0
DAP000156	Atovaquone	Fungal infection	110-118	B35-B49
DAP000156	Atovaquone	Pneumocystis carinii infection	.	B59
DAP000157	Enfuvirtide	HIV infections	42	B20
DAP000158	Moxifloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000159	Gatifloxacin	Respiratory tract infections	460-519	J00-J99
DAP000160	Levofloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000161	Sparfloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000162	Tacrolimus	Ocular allergy	360-379	H00-H59
DAP000162	Tacrolimus	Organ transplant rejection	279.5, 996	D89.8, T86
DAP000163	Ethchlorvynol	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000164	Tiagabine	Anxiety disorder	300	F40-F42
DAP000164	Tiagabine	Anxiety disorder; Insomnia	300, 307.4, 327.0	F40-F42, F51.0, G47.0
DAP000164	Tiagabine	Panic disorder; Epilepsy	300.01, 300.21, 345	F41.0, G40
DAP000165	Chloroquine	Malaria	84	B50-B54
DAP000166	Lithium	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DAP000167	Lamivudine	HIV infections; Chronic hepatitis B	042, 070.2-070.3	B16, B18.0, B18.1, B20
DAP000168	Indinavir	HIV infections	42	B20
DAP000169	Ritonavir	HIV infections	42	B20
DAP000170	Amprenavir	HIV infections	42	B20
DAP000171	Saquinavir	HIV infections	42	B20
DAP000172	Stavudine	HIV infections	42	B20
DAP000173	Ribavirin	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DAP000173	Ribavirin	Hepatitis C virus infection	070.4, 070.5, 070.70, 460-519	B17.1, B18.2, J00-J99
DAP000174	Acarbose	Cardiovascular disease	390-459	I00-I99
DAP000174	Acarbose	Diabetes mellitus	250	E08-E13
DAP000175	Nicotine	Nicotine dependence	305.1	F17
DAP000176	Sibutramine	Obesity	278	E66
DAP000177	Doxepin	Depression	311	F32
DAP000178	Clopidogrel	Coronary artery disease	410-414, 429.2	I20-I25
DAP000178	Clopidogrel	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DAP000179	Imatinib	Chronic myelogenous leukemia	205.1	C92.1
DAP000179	Imatinib	Glioma; Lung cancer; Prostate cancer; Solid tumours	140-199, 191, 210-229	C00-C75, C71, C7A, C7B, D10-D36, D3A
DAP000179	Imatinib	Intestinal cancer; Myeloid leukemia	152, 153, 205	C17, C18, C92
DAP000180	Omeprazole	Gastroesophageal reflux disease	530	K21
DAP000181	Piroxicam	Pain	338,780	R52, G89
DAP000182	Alendronate	Osteoporosis; Paget's disease	731.0, 733.0	M80-M81, M88
DAP000183	Delavirdine	HIV infections	42	B20
DAP000184	Nevirapine	HIV infections	42	B20
DAP000185	Aprotinin	Bleeding	.	R58
DAP000185	Aprotinin	Perioperative blood loss	459	R58
DAP000186	Fluoxetine	Depression	311	F32
DAP000187	Amiloride	Congestive heart failure; Hypertension	428	I50
DAP000188	Bendroflumethiazide	Edema	.	R60.9
DAP000188	Bendroflumethiazide	High blood pressure	401	I10, I11, I12, I13, I15
DAP000189	Heparin	Acute coronary syndrome	411.1	I20.0
DAP000190	Ciprofloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000191	Cilostazol	Intermittent claudication	440.21	I73.9
DAP000192	Doxorubicin	Cancers	140-229	C00-C96
DAP000193	Epirubicin	Cancers	140-229	C00-C96
DAP000194	Thioguanine	Acute myeloid leukemia	205	C92.0
DAP000195	Pseudoephedrine	Allergic rhinitis	477	J30
DAP000195	Pseudoephedrine	Nasal congestion	478.19	J34.89
DAP000196	Cisatracurium Besylate	Anesthesia	338	R52
DAP000196	Cisatracurium Besylate	General anesthesia	338	R52
DAP000197	Rifampin	Tuberculosis	010-018	A15-A19
DAP000198	L-Proline	Dietary supplement	260-269	E40-E46
DAP000199	Tranexamic Acid	Excessive bleeding	459	R58
DAP000200	Aminocaproic Acid	Excessive postoperative bleeding	459	R58
DAP000201	Magnesium Sulfate	Acute pain	338,780	R52, G89
DAP000202	Epoetin alfa	Anemia	280-285	D50-D64
DAP000203	Alteplase	Pulmonary embolism	415.1	I26
DAP000204	Tenecteplase	Myocardial infarction	410	I21, I22
DAP000205	Metformin	Diabetes mellitus	250	E08-E13
DAP000206	Phenformin	Diabetes mellitus	250	E08-E13
DAP000206	Phenformin	Non-insulin dependent diabetes	.	E11.9
DAP000207	Marinol	Anorexia	307.1	F50.0-F50.1
DAP000208	Lubiprostone	Chronic idiopathic constipation	564	K59.0
DAP000208	Lubiprostone	Constipation	564	K59.0
DAP000209	Levodopa	Parkinson's disease	.	G20
DAP000209	Levodopa	Parkinson's disease	332	F02.3, G20
DAP000210	Gemfibrozil	Hyperlipidemia	272.0-272.4	E78
DAP000211	Paricalcitol	Hyperparathyroidism	252	E21
DAP000212	Dopamine	Hypotension	458, 796.3	I95
DAP000212	Dopamine	Parkinson's disease	332	F02.3, G20
DAP000213	Codeine	Cough	786.2	R05
DAP000213	Codeine	Pain	338,780	R52, G89
DAP000214	Butorphanol	Migraine	346	G43
DAP000214	Butorphanol	Pain	338,780	R52, G89
DAP000215	Cisplatin	Cancers	140-229	C00-C96
DAP000216	Primaquine	Malaria	84	B50-B54
DAP000217	Felypressin	Localisation	.	.
DAP000218	Almotriptan	Acute migraine	346	G43
DAP000219	Sumatriptan	Migraine headaches	346	G43
DAP000220	Rizatriptan	Acute migraine	346	G43
DAP000221	Ondansetron	Alcohol use disorders	303	F10.2
DAP000221	Ondansetron	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DAP000222	Cisapride	Gastroesophageal reflux disease	530	K21
DAP000223	Adenosine	Paroxysmal supraventricular tachycardia	427	I47.1
DAP000224	Phenylephrine	Anesthesia	338	R52
DAP000224	Phenylephrine	Ophthalmic disorders	360-379	H00-H59
DAP000225	Metaraminol	Hypotension	458, 796.3	I95
DAP000226	Methyldopa	Hypertension	401	I10, I11, I12, I13, I15
DAP000227	Ergonovine	Postpartum haemorrhage	666	O72
DAP000228	Ephedrine	Asthma	493	J45
DAP000228	Ephedrine	Asthma; Bronchitis	466, 490, 491, 493	J20-J21, J42, J45
DAP000229	Midodrine	Hypotension	458, 796.3	I95
DAP000229	Midodrine	Orthostatic hypotension	458	I95.1
DAP000230	Meperidine	Anesthesia	338	R52
DAP000230	Meperidine	Pain	338,780	R52, G89
DAP000231	Clonidine	Hypertension	401	I10, I11, I12, I13, I15
DAP000232	Guanabenz	High blood pressure	401	I10, I11, I12, I13, I15
DAP000232	Guanabenz	Hypertension	401	I10, I11, I12, I13, I15
DAP000233	Dexmedetomidine	Anesthesia	338	R52
DAP000233	Dexmedetomidine	Sedation	338	R52
DAP000234	Tizanidine	Muscle hypertonia	.	M62
DAP000234	Tizanidine	Spasms; Pain	338,780	R52, G89
DAP000235	Oxymetazoline	Nasal congestion	478.19	J34.89
DAP000235	Oxymetazoline	Ocular disease	.	H00-H59
DAP000236	Apraclonidine	Additional intra ocular pressure reduction	.	H40-H42
DAP000236	Apraclonidine	Glaucoma	365	H40-H42
DAP000237	Lorazepam	Anxiety disorder	300	F40-F42
DAP000238	Temazepam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000239	Alprazolam	Anxiety disorder	300	F40-F42
DAP000240	Clorazepate	Anxiety disorder; Insomnia	300, 307.4	F40-F42, F51.0, G47.0
DAP000241	Midazolam	Sedation	338	R52
DAP000242	Flurazepam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000243	Oxazepam	Anxiety disorder	300	F40-F42
DAP000244	Triazolam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000245	Dobutamine	Heart failure; Cardiogenic shock	428.0, 785.51	I50, R57.0
DAP000246	Terbutaline	Asthma	493	J45
DAP000247	Formoterol	Asthma	493	J45
DAP000248	Salbutamol	Acute asthma	493	J45
DAP000249	Pirbuterol	Asthma	493	J45
DAP000250	Bambuterol	Asthma	493	J45
DAP000251	Cabergoline	Hyperprolactinaemia	253.1	E22.1
DAP000252	Mesoridazine	Alcohol use disorders	303	F10.2
DAP000252	Mesoridazine	Schizophrenia	295	F20
DAP000253	Hydrocodone	Pain	338,780	R52, G89
DAP000254	Fenoldopam	Hypertension	401	I10, I11, I12, I13, I15
DAP000255	Lisuride	Parkinson's disease	332	F02.3, G20
DAP000256	Cinacalcet	Cardiovascular disease; Kidney disease	390-459, 580-589	I00-I99, N00-N29
DAP000256	Cinacalcet	Hyperparathyroidism	252	E21
DAP000257	Baclofen	Multiple sclerosis	340	G35
DAP000258	Progabide	Depression	311	F32
DAP000258	Progabide	Muscle hypertonia	.	M62
DAP000259	Clonazepam	Epilepsy	345	G40
DAP000259	Clonazepam	Seizures	.	G40
DAP000260	Pentagastrin	Diagnosis	.	I73.9
DAP000261	Ivermectin	Intestinal strongyloidiasis due to nematode parasite	127.2	B78
DAP000261	Ivermectin	Nematode infection	.	B80
DAP000262	Clofibrate	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
DAP000262	Clofibrate	Dysbetalipoproteinemia	272.2	E78.2
DAP000263	Bethanechol	Urinary dysfunction	.	N39.3-N39.4
DAP000263	Bethanechol	Urinary retention	788.2	R33
DAP000264	Remifentanil	General anesthesia	338	R52
DAP000265	Varenicline	Smoking cessation	292	F17.2
DAP000266	Zaleplon	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000267	Methadone	Cough	786.2	R05
DAP000267	Methadone	Opiate dependence	304	F11
DAP000268	Levorphanol	Pain	338,780	R52, G89
DAP000269	Carbetocin	Autism	299	F84.0
DAP000269	Carbetocin	Postpartum haemorrhage	666	O72
DAP000270	Fenofibrate	High cholesterol levels; High triglyceride levels	272.0, 272.1	E78.0, E78.1, E78.2, E78.3
DAP000271	Rosiglitazone	Diabetes mellitus	250	E08-E13
DAP000272	Pioglitazone	Diabetes mellitus	250	E08-E13
DAP000273	Iloprost	Pulmonary arterial hypertension	416	I27.0, I27.2
DAP000274	Travoprost	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
DAP000275	Alitretinoin	Kaposi's sarcoma	176	C46
DAP000276	Bexarotene	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DAP000277	Dextromethorphan	Cough; Pain	338, 786.2,780	R05, R52, G89
DAP000277	Dextromethorphan	Pain	338,780	R52, G89
DAP000278	Imiquimod	Skin cancers	172, 173	C43, C44
DAP000279	Ibutilide	Atrial fibrillation	427.31	I48
DAP000280	Brimonidine	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
DAP000281	Apomorphine	Parkinson's disease	.	G20
DAP000281	Apomorphine	Parkinson's disease	332	F02.3, G20
DAP000282	Bromocriptine	Parkinson's disease	332	F02.3, G20
DAP000283	Oxycodone	Pain	338,780	R52, G89
DAP000284	Cosyntropin	Adrenocortical insufficiency	255.4	E27.1-E27.4
DAP000285	Eptifibatide	Acute cardiac ischemic events	410	I21, I22
DAP000286	Pegvisomant	Acromegaly	253	E22.0
DAP000287	Mecasermin	Growth failure	.	R62.8
DAP000287	Mecasermin	IGF-1 deficiency	259.4	E34.3
DAP000288	Glycine	Dietary shortage	260-269	E40-E46
DAP000288	Glycine	Neuropathic pain	338,780	R52, G89
DAP000289	Calcitriol	Vitamin D deficiency	268	E55
DAP000290	Calcidiol	Vitamin D deficiency	268	E55
DAP000291	Ergocalciferol	Hypoparathyroidism	252.1	E20, E89.2, P71.4
DAP000292	Calcipotriol	Psoriasis	696	L40
DAP000293	Mianserin	Depression	311	F32
DAP000293	Mianserin	Major depressive disorder	296.2, 296.3	F32, F33
DAP000294	Triflupromazine	Emesis	787	R11
DAP000294	Triflupromazine	Psychoses	290-299	F20-F29
DAP000295	Granisetron	Nausea; Vomiting	787, 787.0	R11
DAP000296	Procaine	Anesthesia	338	R52
DAP000296	Procaine	HIV infections	42	B20
DAP000297	Spironolactone	Congestive heart failure	428	I50
DAP000298	Dapiprazole	Drug dependence	303-304	F10.2-F19.2
DAP000298	Dapiprazole	Mydriasis	379.43	H57.0
DAP000299	Phentolamine	Dermal necrosis	.	K05
DAP000299	Phentolamine	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DAP000300	Prazosin	Hypertension	401	I10, I11, I12, I13, I15
DAP000300	Prazosin	Prostate hyperplasia	.	N40
DAP000301	Flutamide	Prostate cancer	185	C61
DAP000302	Nilutamide	Prostate cancer	185	C61
DAP000303	Levobunolol	Glaucoma	365	H40-H42
DAP000303	Levobunolol	Open-angle glaucoma	365	H40-H42
DAP000304	Esmolol	Acute supraventricular tachycardia	427.0, 427.89	I47.1
DAP000304	Esmolol	Heart arrhythmia	.	I47-I49
DAP000305	Betaxolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000306	Nimodipine	Cerebral vasospasm	443.9	I73.9
DAP000307	Rimonabant	Obesity	278	E66
DAP000308	Maraviroc	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP000308	Maraviroc	HIV infections	42	B20
DAP000308	Maraviroc	Human immunodeficiency virus infection	.	B20
DAP000309	Montelukast	Asthma	493	J45
DAP000310	Sulpiride	Schizophrenia	295	F20
DAP000311	Loxapine	Major depressive disorder	296.2, 296.3	F32, F33
DAP000311	Loxapine	Psychotic disorders	290-299	F20-F29
DAP000312	Remoxipride	Schizophrenia	295	F20
DAP000313	Haloperidol	Schizophrenia	295	F20
DAP000314	Aminolevulinic acid	Photodynamic therapy	706.1	L70.0
DAP000315	Thiethylperazine	Emesis	787	R11
DAP000315	Thiethylperazine	Nausea; Vomiting	787, 787.0	R11
DAP000316	Pimozide	Anxiety disorder	300	F40-F42
DAP000316	Pimozide	Schizophrenia	295	F20
DAP000317	Domperidone	Dyspepsia	536.8	K30
DAP000317	Domperidone	Gastrointestinal problems	536, 750	K30-K31, Q40-Q41
DAP000318	Thiothixene	Anxiety disorder	300	F40-F42
DAP000318	Thiothixene	Schizophrenia	295	F20
DAP000319	Fulvestrant	Breast cancer	174, 175	C50
DAP000319	Fulvestrant	Breast cancer	174, 175, 217	C50, D24
DAP000320	Budesonide	Asthma; Non-infectious rhinitis	472.0, 477, 493	J00, J30, J31.0, J45
DAP000321	Amlexanox	Aphthous ulcers	528.2	K12.0
DAP000321	Amlexanox	Respiratory tract inflammation	.	J00-J99
DAP000322	Clemastine	Allergic rhinitis	477	J30
DAP000323	Cetirizine	Allergic rhinitis	477	J30
DAP000324	Hydroxyzine	Anxiety disorder	300	F40-F42
DAP000325	Cinnarizine	Vertigo meniere's disease	386.0, 438.85, 780.4	H81, H81.0, R42
DAP000326	Astemizole	Allergic rhinitis	.	J30
DAP000326	Astemizole	Allergic rhinitis	477	J30
DAP000327	Propiomazine	Anxiety disorder	300	F40-F42
DAP000327	Propiomazine	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000328	Tripelennamine	Allergic rhinitis	477	J30
DAP000328	Tripelennamine	Asthma	493	J45
DAP000329	Ketotifen	Allergic conjunctivitis	372.14	H10.45
DAP000330	Fexofenadine	Allergic rhinitis	477	J30
DAP000331	Desloratadine	Allergic rhinitis	477	J30
DAP000332	Azelastine	Allergic conjunctivitis	372.14	H10.45
DAP000333	Dimenhydrinate	Emesis	787	R11
DAP000333	Dimenhydrinate	Nausea; Vomiting	787, 787.0	R11
DAP000334	Promethazine	Allergic disorders; Itching; Nausea and vomiting	698, 787, 787.0, 995.3	L29, R11, T78.4
DAP000335	Levocabastine	Allergic conjunctivitis	372.14	H10.45
DAP000336	Chlorpheniramine	Allergic rhinitis; Urticaria	477, 708	J30, L50
DAP000337	Cyclizine	Motion sickness	994.6	T75.3
DAP000337	Cyclizine	Nausea; Vomiting	787, 787.0	R11
DAP000338	Cimetidine	Acid-reflux disorders	530.81	K21
DAP000339	Nizatidine	Acid-reflux disorders	530.81	K21
DAP000340	Ranitidine	Peptic ulcer disease	531-534	K25-K27
DAP000341	Famotidine	Peptic ulcer disease	531-534	K25-K27
DAP000342	Trospium	Overactive bladder disorder	596.51	N32.81
DAP000342	Trospium	Spasm	728.85	R25.2
DAP000343	Scopolamine	Amnesia	.	F04
DAP000343	Scopolamine	Nausea; Addiction	303-305, 787.0	F10-F19, R11
DAP000344	Tiotropium	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP000345	Tropicamide	Diagnosis of mydriasis	379.43	H57.0
DAP000345	Tropicamide	Salivary gland disease	.	K11
DAP000346	Metixene	Parkinson's disease	332	F02.3, G20
DAP000347	Carbachol	Glaucoma	365	H40-H42
DAP000348	Levallorphan	Narcotic depression	304.9, 311	F19.20, F32
DAP000349	Rocuronium	Anesthesia	338	R52
DAP000349	Rocuronium	General anesthesia	338	R52
DAP000350	Doxacurium chloride	Anesthesia	338	R52
DAP000350	Doxacurium chloride	General anesthesia	338	R52
DAP000351	Tubocurarine	Anesthesia	338	R52
DAP000351	Tubocurarine	Smoking withdrawl syndrom	292	F17.2
DAP000352	Metocurine	Anesthesia	338	R52
DAP000353	Pipecuronium	Anesthesia	338	R52
DAP000353	Pipecuronium	Spasms; Pain	338,780	R52, G89
DAP000354	Vecuronium	Spasms; Pain	338,780	R52, G89
DAP000355	Doxacurium	Spasms; Pain	338,780	R52, G89
DAP000356	Pentazocine	Anesthesia	338	R52
DAP000357	Sufentanil	Anesthesia	338	R52
DAP000358	Misoprostol	Medical abortion	779.6	O04
DAP000358	Misoprostol	Planned abortion	.	Z31
DAP000359	Alprostadil	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DAP000360	Dinoprostone	Medical abortion	779.6	O04
DAP000361	Bumetanide	Edema	.	R60.9
DAP000361	Bumetanide	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
DAP000362	Aprepitant	Nausea; Vomiting	787, 787.0	R11
DAP000363	Valsartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000364	Irbesartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000365	Dihydrotachysterol	Hypocalcemia; Hypoparathyroidism	252.0, 275.41	E21, E83.51
DAP000365	Dihydrotachysterol	Hypoparathyroidism	252.1	E20, E89.2, P71.4
DAP000366	Methysergide	Migraine	346	G43
DAP000366	Methysergide	Migraine headaches	346	G43
DAP000367	Palonosetron	Nausea; Vomiting	787, 787.0	R11
DAP000368	Dolasetron	Nausea; Vomiting	787, 787.0	R11
DAP000369	Alosetron	Irritable bowel syndrome	564.1	K58
DAP000370	Alfuzosin	Benign prostatic hyperplasia	600	N40
DAP000371	Terazosin	Benign prostatic hyperplasia	600	N40
DAP000371	Terazosin	Hypertension	401	I10, I11, I12, I13, I15
DAP000372	Sotalol	Maintenance of normal sinus rhythm	427	I46-I49
DAP000373	Prochlorperazine	Nausea; Vomiting	787, 787.0	R11
DAP000374	Chlorpromazine	Emesis	787	R11
DAP000374	Chlorpromazine	Schizophrenia	295	F20
DAP000375	Fluphenazine	Psychotic disorders	290-299	F20-F29
DAP000376	Tolterodine	Overactive bladder disorder	596.51	N32.81
DAP000376	Tolterodine	Urinary incontinence	788.3	N39.3, N39.4, R32
DAP000377	Atropine	Organophosphate poisoning	989.3	T60.0
DAP000377	Atropine	Poison intoxication	.	T36-T50
DAP000378	Decamethonium	Muscle Relaxant	.	N39.3,N39.4,R32
DAP000379	Naltrexone	Alcohol use disorders	303	F10.2
DAP000379	Naltrexone	Opiate dependence	304	F11
DAP000380	Nalbuphine	Pain	338,780	R52, G89
DAP000381	Doxazosin	Hypertension	401	I10, I11, I12, I13, I15
DAP000382	Rituximab	Hematologic malignancies	200-209	C81-C96
DAP000382	Rituximab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DAP000383	Ibritumomab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DAP000384	Tositumomab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DAP000385	Alemtuzumab	Chronic lymphocytic leukaemia	204.1	C91.1
DAP000385	Alemtuzumab	Multiple sclerosis	.	G35
DAP000386	Palivizumab	Respiratory syncytial virus 	79.6	B97.4
DAP000387	Omalizumab	Asthma	493	J45
DAP000387	Omalizumab	Chronic idiopathic urticaria	708	L50
DAP000388	Basiliximab	Organ transplant rejection	279.5, 996	D89.8, T86
DAP000389	Daclizumab	Organ transplant rejection	279.5, 996	D89.8, T86
DAP000390	Gemtuzumab ozogamicin	Acute myeloid leukemia	205	C92.0
DAP000391	Trastuzumab	Asthma	.	J45
DAP000391	Trastuzumab	Breast cancer	174, 175	C50
DAP000392	Adalimumab	Rheumatold arthritis	714	M05-M06
DAP000393	Bevacizumab	Colorectal cancer	153, 154	C18-C21
DAP000393	Bevacizumab	Ovarian cancer; Breast cancer; Non-small cell lung cancer; Colon cancer; Gastric cancerand prostate cancer	140-229, 151, 153, 154, 162, 174, 175, 183, 185, 204.0	C00-C96, C16, C18-C21, C33, C33-C34, C34, C50, C56, C61, C91.0
DAP000393	Bevacizumab	Relapsed/refractory multiple myeloma; Extensive small-cell lung cancer	140-229, 162, 203.0	C00-C96, C33-C34, C90.0
DAP000394	Cetuximab	Colorectal cancer	153, 154	C18-C21
DAP000395	Pegfilgrastim	Non-myeloid cancer	140-199	C00-C75, C7A, C7B
DAP000396	Teriparatide	Osteogenesis imperfecta	756.51	Q78.0
DAP000397	Octreotide	Acromegaly	253	E22.0
DAP000398	Linezolid	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000400	Amikacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000401	Oxytetracycline	Acne vulgaris	706.1	L70.0
DAP000401	Oxytetracycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000402	Demeclocycline	Acne vulgaris	706.1	L70.0
DAP000402	Demeclocycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000403	Spectinomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000403	Spectinomycin	Neisseria gonorrhoeae infection	.	A87
DAP000404	Netilmicin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000404	Netilmicin	Staphylococcus aureus infection	.	A41.0
DAP000405	Minocycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000406	Kanamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000407	Paromomycin	Acute and chronic intestinal amebiasis	6	A06
DAP000408	Azithromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000409	Clindamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000410	Clarithromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000411	Troleandomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000412	Droperidol	Emesis	787	R11
DAP000412	Droperidol	Nausea; Vomiting	787, 787.0	R11
DAP000413	Propericiazine	Psychiatric disorders	.	F99
DAP000413	Propericiazine	Psychotic disorders	290-299	F20-F29
DAP000414	Vardenafil	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DAP000415	Alclometasone	Inflammatory diseases	.	.
DAP000416	Beclomethasone	Asthma; Allergic rhinitis	477, 493	J30, J45
DAP000417	Triamcinolone	Allergy	995.3	T78.4
DAP000418	Flurandrenolide	Inflammatory diseases	.	.
DAP000419	Prednisolone	Asthma; Rheumatoid arthritis	493, 714	J45, M05-M06
DAP000420	Rimexolone	Eye Inflammation	360-379	H00-H59
DAP000421	Fluocinonide	Inflammatory diseases	.	.
DAP000422	Paramethasone	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DAP000422	Paramethasone	Inflammatory diseases	.	.
DAP000423	Ciclesonide	Asthma	493	J45
DAP000423	Ciclesonide	Obstructive airway diseases	490-492, 494-496	J40-J44, J47
DAP000424	Metyrapone	Cushing's disease	.	E24.9
DAP000424	Metyrapone	Cushing's disease	255	E24
DAP000425	Loperamide	Acute diarrhea	787.91	A09, K59.1
DAP000426	Rifapentine	Mycobacterium tuberculosis infection	.	A15-A19
DAP000426	Rifapentine	Tuberculosis	010-018	A15-A19
DAP000427	Zopiclone	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000428	Ardeparin	Deep vein thrombosis	453.4	I80.2
DAP000429	Melatonin	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000429	Melatonin	Sleep disorders	307.4, 327, 780.5	F51, G47
DAP000430	Promazine	Emesis	787	R11
DAP000430	Promazine	Psychomotor agitation	308.2	F43.0
DAP000431	Ertapenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000432	Ampicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000433	Ceftazidime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000433	Ceftazidime	Infectious disease	001-139	A00-B99
DAP000434	Loracarbef	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000434	Loracarbef	Otitis media	.	H65-H67
DAP000435	Dicloxacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000435	Dicloxacillin	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DAP000436	Cefdinir	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000437	Cephalexin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000437	Cephalexin	Urinary tract infections	599	N39.0
DAP000438	Carbenicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000439	Cefixime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000439	Cefixime	Escherichia coli infection	.	A00-B99
DAP000440	Oxacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000440	Oxacillin	Bacterial respiratory tract infection	.	J13,J15
DAP000441	Meropenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000442	Cefaclor	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000443	Amoxicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000444	Cefditoren	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000445	Cefuroxime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000445	Cefuroxime	Infectious disease	001-139	A00-B99
DAP000446	Cefadroxil	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000447	Cefprozil	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000448	Cefamandole	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000449	Cefazolin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000450	Cefoperazone	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000450	Cefoperazone	Endometriosis	617	N80
DAP000451	Cefotetan	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000452	Cefoxitin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000452	Cefoxitin	Bacteroides fragilis infection	.	B96.6
DAP000453	Ceftizoxime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000454	Cefradine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000454	Cefradine	Otitis media	.	H65-H67
DAP000455	Cefepime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000456	Ceftibuten	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000457	Cefpodoxime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000458	Ticarcillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000458	Ticarcillin	Escherichia coli infection	.	A00-B99
DAP000459	Imipenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000460	Chloramphenicol	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000461	Tamibarotene	Leukemia	208.9	C91-C95
DAP000462	Tazarotene	Acne vulgaris	706.1	L70.0
DAP000462	Tazarotene	Psoriasis	696	L40
DAP000463	Paroxetine	Depression	311	F32
DAP000464	Deslanoside	Congestive cardiac insufficiency; Arrhythmias; Heart failure	427, 428	I47-I49, I50
DAP000464	Deslanoside	Congestive heart failure	428	I50
DAP000465	Ouabain	Atrial fibrillation; Heart failure	427.31, 428.0	I48, I50
DAP000466	Ciclopirox	Fungal infection	110-118	B35-B49
DAP000467	Aluminium	Atopic dermatitis	691.8	L20
DAP000467	Aluminium	Hyperhidrosis	780.8	R61
DAP000468	Almitrine	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP000469	Ridogrel	Acute myocardial infarction	410	I21-I22
DAP000469	Ridogrel	Arterial thrombosis	.	I80-I82
DAP000470	Paclitaxel	Cancers	140-229	C00-C96
DAP000471	Metyrosine	Pheochromocytoma	194.0, 227.0, 255.6	C74.1, D35.0
DAP000472	Hydromorphone	HIV-1 infections	42	B20
DAP000472	Hydromorphone	Pain	338,780	R52, G89
DAP000473	Abciximab	Angina	413	I20
DAP000474	Adenosine triphosphate	Dietary shortage	260-269	E40-E46
DAP000475	Minaprine	Cerebral infarction	.	I63
DAP000475	Minaprine	Depression	311	F32
DAP000476	Thioridazine	Brain diseases	.	G00-G99
DAP000476	Thioridazine	Schizophrenia	295	F20
DAP000477	Tolazoline	Peripheral vasoconstriction	443	I73
DAP000477	Tolazoline	Pulmonary hypertension	416	I27.0, I27.2
DAP000478	Phenoxybenzamine	Hypertension	401	I10, I11, I12, I13, I15
DAP000479	Cryptenamine	Hypertension	401	I10, I11, I12, I13, I15
DAP000480	Metipranolol	Angina	413	I20
DAP000480	Metipranolol	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
DAP000481	Metoprolol	Angina	413	I20
DAP000481	Metoprolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000482	Atenolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000483	Bisoprolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000484	Acebutolol	Angina	413	I20
DAP000484	Acebutolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000485	Oxprenolol	Angina	413	I20
DAP000485	Oxprenolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000486	Nicardipine	High blood pressure; Angina	401, 413	I10, I11, I12, I13, I15, I20
DAP000487	Felodipine	Hypertension	401	I10, I11, I12, I13, I15
DAP000488	Penciclovir	HIV infections	42	B20
DAP000488	Penciclovir	Viral infections	042-075	A80-A99, B00-B34
DAP000489	Famciclovir	Hepatitis B virus infection	.	B16
DAP000489	Famciclovir	Viral infections	042-075	A80-A99, B00-B34
DAP000490	Diphenhydramine	Allergic rhinitis	477	J30
DAP000490	Diphenhydramine	Vertigo meniere's disease	386.0, 438.85, 780.4	H81, H81.0, R42
DAP000491	Quinine	Malaria	84	B50-B54
DAP000492	Pirenzepine	Duodenal ulcer	.	K25-K27
DAP000492	Pirenzepine	Peptic ulcer disease	531-534	K25-K27
DAP000493	Memantine	Alzheimer's disease	331	G30
DAP000493	Memantine	Autism	299	F84.0
DAP000493	Memantine	Neuropathic pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
DAP000493	Memantine	Parkinson's disease	332	F02.3, G20
DAP000494	Duloxetine	Depression	311	F32
DAP000495	Dofetilide	Maintenance of normal sinus rhythm	427	I46-I49
DAP000496	Amiodarone	Tachyarrhythmias	427, 785.0	I47-I49, R00.0
DAP000497	Propafenone	Tachyarrhythmias	427, 785.0	I47-I49, R00.0
DAP000498	Indapamide	Edema	.	R60.9
DAP000498	Indapamide	Hypertension	401	I10, I11, I12, I13, I15
DAP000499	Dantrolene	Malignant hyperthermia	995.86	T88.3
DAP000500	Zonisamide	Epilepsy	345	G40
DAP000500	Zonisamide	Seizures	.	G40
DAP000501	Phenacemide	Epilepsy	345	G40
DAP000502	Levetiracetam	Epilepsy	345	G40
DAP000503	Indecainide	Dysrhythmias	427	I47-I49
DAP000503	Indecainide	Heart arrhythmia	.	I47-I49
DAP000504	Disopyramide	Urinary incontinence	788.3	N39.3, N39.4, R32
DAP000504	Disopyramide	Ventricular arrhythmias	427.1	I47.2
DAP000505	Mexiletine	Ventricular arrhythmias	427.1	I47.2
DAP000506	Hexylcaine	Anesthesia	338	R52
DAP000507	Dibucaine	Anesthesia	338	R52
DAP000507	Dibucaine	Hemorrhoids	.	I84
DAP000508	Mephenytoin	Epilepsy	345	G40
DAP000509	Dyclonine	Anesthesia	338	R52
DAP000509	Dyclonine	Pain	.	G89
DAP000510	Moricizine	Heart arrhythmia	.	I47-I49
DAP000510	Moricizine	Irregular heartbeats	427	I47-I49
DAP000511	Prilocaine	Anesthesia	338	R52
DAP000511	Prilocaine	Pain	.	G89
DAP000512	Ethotoin	Complex partial seizures	345.4	G40.2
DAP000512	Ethotoin	Epilepsy	345	G40
DAP000513	Proparacaine	Anesthesia	338	R52
DAP000514	Benzonatate	Cough	786.2	R05
DAP000515	Quinidine	Ventricular arrhythmias	427.1	I47.2
DAP000516	Procainamide	Ventricular arrhythmias	427.1	I47.2
DAP000517	Tocainide	Ventricular arrhythmias	427.1	I47.2
DAP000518	Flecainide	Tachyarrhythmias	427, 785.0	I47-I49, R00.0
DAP000519	Encainide	Heart arrhythmia	.	I47-I49
DAP000519	Encainide	Irregular heartbeats	427	I47-I49
DAP000520	Fosphenytoin	Cerebrovascular ischaemia	.	G45.9,I67.8
DAP000520	Fosphenytoin	Seizures	345.9, 780.3	G40, P90, R56
DAP000521	Chlorthalidone	Edema	.	R60.9
DAP000521	Chlorthalidone	Hypertension	401	I10, I11, I12, I13, I15
DAP000522	Gliclazide	Diabetes mellitus	250	E08-E13
DAP000523	Losartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000524	Candesartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000525	Bepridil	Chronic stable angina	413	I20
DAP000526	Ethosuximide	Epilepsy	345	G40
DAP000526	Ethosuximide	Seizures	.	G40,R56
DAP000527	Riluzole	Amyotrophic lateral sclerosis	335.2	G12.2
DAP000528	Oxcarbazepine	Epilepsy	345	G40
DAP000529	Nifedipine	Angina pectoris	413	I20
DAP000530	Metoclopramide	Emesis	787	R11
DAP000530	Metoclopramide	Nausea; Vomiting	787, 787.0	R11
DAP000531	Bleomycin	Cancer	140-229	C00-C96
DAP000531	Bleomycin	Hodgkin's lymphoma	201	C81
DAP000532	Cyclophosphamide	Cancers	140-229	C00-C96
DAP000533	Dacarbazine	Cancer	.	C00-C97
DAP000533	Dacarbazine	Malignant melanoma	172	C43
DAP000534	Metronidazole	Amebiasis	6	A06
DAP000535	Carboplatin	Ovarian carcinoma	183	C56
DAP000536	Dactinomycin	Cancer	140-229	C00-C96
DAP000536	Dactinomycin	Cancers	140-229	C00-C96
DAP000537	Ifosfamide	Cancers	140-229	C00-C96
DAP000538	Tetrahydrobiopterin	Dietary supplement	260-269	E40-E46
DAP000539	Griseofulvin	Dermatological disease	.	L00-L99
DAP000539	Griseofulvin	Ringworm infections	110	B35, B36
DAP000540	Alefacept	Pain	338,780	R52, G89
DAP000541	Lepirudin	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DAP000542	Bivalirudin	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DAP000543	Pyruvic acid	Burns and burn infection	.	A00-B99
DAP000543	Pyruvic acid	Dietary shortage	260-269	E40-E46
DAP000544	Menadione	Vitamin K deficiency	269	E56.1
DAP000545	Succinic acid	Dietary shortage	260-269	E40-E46
DAP000546	Anidulafungin	Convulsions	.	R56.0
DAP000546	Anidulafungin	Fungal infection	110-118	B35-B49
DAP000547	Caspofungin	Fungal infection	110-118	B35-B49
DAP000548	Micafungin	Candidiasis infection	.	B37
DAP000548	Micafungin	Fungal infection	110-118	B35-B49
DAP000549	Progesterone	Infertility	628	N97.0
DAP000550	Pravastatin	Hypercholesterolemia	272	E78.0
DAP000551	Lovastatin	Hypercholesterolemia	272	E78.0
DAP000552	Simvastatin	Hypercholesterolemia	272	E78.0
DAP000553	Atorvastatin	Hypercholesterolemia	272	E78.0
DAP000554	Fluvastatin	Hypercholesterolemia	272	E78.0
DAP000555	Rosuvastatin	Elevated CRP	.	E78.0
DAP000555	Rosuvastatin	Hypercholesterolemia	272	E78.0
DAP000556	Divalproex sodium	Seizures	345.9, 780.3	G40, P90, R56
DAP000557	Vigabatrin	Epilepsy; Infantile spasms; Complex partial seizures	345, 345.4, 345.5, 345.9, 728.85, 780.3	G40, G40, G40.0, G40.2, P90, R25.2, R56
DAP000558	Tacrine	Alzheimer's disease	331	G30
DAP000559	Galantamine	Alzheimer's disease	331	G30
DAP000560	Donepezil	Alzheimer's disease	331	G30
DAP000561	Physostigmine	Glaucoma	365	H40-H42
DAP000562	Edrophonium	Diagnosis of myasthenia gravis	358	G70.0
DAP000563	Neostigmine	Myasthenia gravis	358	G70.0
DAP000564	Clodronate	Hypercalcemia	275.42	E83.5
DAP000565	Cladribine	Hairy cell leukemia	202.4	C91.4
DAP000566	Pentostatin	Hairy cell leukemia	202.4	C91.4
DAP000567	Fludarabine	Hematological malignancies	200-209	C81-C96
DAP000568	Fomepizole	Athylene glycol or methanol poisoning	980.1, 982	T51.1, T52.3
DAP000569	Sulindac	Ankylosing spondylitis	720	M08.1, M45
DAP000569	Sulindac	Rheumatold arthritis	714	M05-M06
DAP000570	Levamisole	Allergic rhinitis	477	J30
DAP000570	Levamisole	Colon cancer	153, 154	C18-C21
DAP000571	Lisdexamfetamine	Attention deficit hyperactivity disorder	314	F90
DAP000572	Dextroamphetamine	Attention deficit hyperactivity disorder	314	F90
DAP000573	Methamphetamine	Attention deficit hyperactivity disorder	314	F90
DAP000574	Phendimetrazine	Obesity	278	E66
DAP000575	Triamterene	Congestive heart failure	428	I50
DAP000575	Triamterene	Hypertension; Edema	401, 782.3	I10, I11, I12, I13, I15, R60.9
DAP000576	Moclobemide	Depression	311	F32
DAP000577	Isocarboxazid	Depression	311	F32
DAP000577	Isocarboxazid	Major depressive disorder	296.2, 296.3	F32, F33
DAP000578	Phenelzine	Anxiety disorder	300	F40-F42
DAP000578	Phenelzine	Depression	311	F32
DAP000579	Selegiline	Parkinson's disease	332	F02.3, G20
DAP000580	Pargyline	Hypertension	401	I10, I11, I12, I13, I15
DAP000581	Ramipril	Congestive heart failure; Hypertension	428	I50
DAP000582	Fosinopril	Hypertension	401	I10, I11, I12, I13, I15
DAP000583	Trandolapril	Hypertension	401	I10, I11, I12, I13, I15
DAP000584	Benazepril	Hypertension	401	I10, I11, I12, I13, I15
DAP000585	Enalapril	Hypertension	401	I10, I11, I12, I13, I15
DAP000586	Moexipril	Hypertension	401	I10, I11, I12, I13, I15
DAP000587	Lisinopril	Hypertension	401	I10, I11, I12, I13, I15
DAP000588	Quinapril	Hypertension	401	I10, I11, I12, I13, I15
DAP000589	Captopril	Hypertension	401	I10, I11, I12, I13, I15
DAP000590	Docetaxel	Cancers	140-229	C00-C96
DAP000591	Zileuton	Asthma	493	J45
DAP000592	Carbidopa	Parkinson's disease	.	G20
DAP000592	Carbidopa	Parkinson's disease	332	F02.3, G20
DAP000593	Dipivefrin	Glaucoma	365	H40-H42
DAP000593	Dipivefrin	Open-angle glaucoma	365	H40-H42
DAP000594	Pimecrolimus	Atopic dermatitis	691.8	L20
DAP000595	Nisoldipine	Hypertension	401	I10, I11, I12, I13, I15
DAP000596	Dyphylline	Acute bronchial asthma	493	J45
DAP000596	Dyphylline	Asthma	493	J45
DAP000597	Enprofylline	Asthma	493	J45
DAP000598	Ethoxzolamide	Glaucoma; Duodenal ulcers	365, 531-534	H40-H42, K25-K27
DAP000599	Methazolamide	Chronic and acute open-angle glaucoma	365	H40-H42
DAP000600	Acetazolamide	Glaucoma	365	H40-H42
DAP000601	Dichlorphenamide	Chronic glaucoma	365	H40-H42
DAP000602	Brinzolamide	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
DAP000603	Benzthiazide	Edema	.	R60.9
DAP000603	Benzthiazide	High blood pressure	401	I10, I11, I12, I13, I15
DAP000604	Cyclothiazide	Edema	.	R60.9
DAP000604	Cyclothiazide	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
DAP000605	Chlorothiazide	Congestive heart failure	428	I50
DAP000605	Chlorothiazide	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
DAP000606	Ethinamate	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000607	Tolcapone	Parkinson's disease	332	F02.3, G20
DAP000608	Entacapone	Parkinson's disease	332	F02.3, G20
DAP000609	Miglustat	Type 1 Gaucher disease	272.7	E75.22
DAP000610	Amrinone	Congestive heart failure	428	I50
DAP000610	Amrinone	Hypertension	401	I10, I11, I12, I13, I15
DAP000611	Enoximone	Congestive heart failure	428	I50
DAP000612	Anagrelide	Thrombocythemia	289.9	D75.8
DAP000613	Aminophylline	Asthma	493	J45
DAP000613	Aminophylline	Bronchial asthma	493	J45
DAP000614	Sildenafil	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DAP000615	Tadalafil	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DAP000616	Enoxaparin	Venous thrombosis	453	I80-I82
DAP000617	Indomethacin	Patent ductus arteriosus	747	Q25.0
DAP000618	Ketorolac	Pain	338,780	R52, G89
DAP000619	Fenoprofen	Ankylosing spondylitis	720	M08.1, M45
DAP000619	Fenoprofen	Rheumatold arthritis	714	M05-M06
DAP000620	Diclofenac	Rheumatold arthritis	714	M05-M06
DAP000621	Flurbiprofen	Rheumatold arthritis	714	M05-M06
DAP000622	Oxaprozin	Inflammatory diseases	.	.
DAP000622	Oxaprozin	Osteoarthritis	715	M15-M19, M47
DAP000623	Ketoprofen	Rheumatold arthritis; Pain	338, 714,780	M05-M06, R52, G89
DAP000624	Testolactone	Advanced breast cancer	174, 175	C50
DAP000625	Exemestane	Hormonally-responsive breast cancer	174, 175	C50
DAP000626	Letrozole	Hormonally-responsive breast cancer	174, 175	C50
DAP000627	Anastrozole	Breast cancer	174, 175	C50
DAP000628	Fluconazole	Fungal infection	110-118	B35-B49
DAP000629	Terconazole	Candida infection	.	B37.0
DAP000629	Terconazole	Fungal infection	110-118	B35-B49
DAP000630	Ketoconazole	Fungal infection	.	B35-B49
DAP000630	Ketoconazole	Fungal infection	110-118	B35-B49
DAP000631	Itraconazole	Fungal infection	110-118	B35-B49
DAP000632	Cilastatin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000633	Pyrimethamine	Acute malaria	84	B50-B54
DAP000634	Proguanil	Malaria	84	B50-B54
DAP000635	Trimetrexate	Pneumocystis pneumonia	136.3	B20.6
DAP000636	Leflunomide	Active rheumatoid arthritis	714	M05, M06
DAP000636	Leflunomide	Multiple sclerosis	.	G35
DAP000637	Dapsone	Pneumocystis carinii pneumonia	136.3	B20.6
DAP000638	Sulfadoxine	Malaria	84	B50-B54
DAP000639	Sitagliptin	Diabetes mellitus	250	E08-E13
DAP000639	Sitagliptin	Diabetes mellitus type 2	.	E11
DAP000640	Azacitidine	Myelodysplastic syndromes	238.7	D46
DAP000641	Decitabine	Myelodysplastic syndromes	238.7	D46
DAP000642	Vidarabine	Herpes simplex virus infection	54	B00
DAP000643	Valaciclovir	Cytomegalovirus infection	.	B25
DAP000643	Valaciclovir	Viral infections	042-075	A80-A99, B00-B34
DAP000644	Cytarabine	Acute lymphoblastic leukemia	204	C91.0
DAP000644	Cytarabine	Hematological malignancies	200-209	C81-C96
DAP000645	Ganciclovir	CMV retinitis	78.5	B25.8, H30.9
DAP000645	Ganciclovir	Viral infections	042-075	A80-A99, B00-B34
DAP000646	Valganciclovir	CMV retinitis	78.5	B25.8, H30.9
DAP000646	Valganciclovir	Viral infections	042-075	A80-A99, B00-B34
DAP000647	Irinotecan	Colorectal cancer	153, 154	C18-C21
DAP000648	Topotecan	Ovarian cancer	183	C56
DAP000649	Dexrazoxane	Breast cancer	174, 175	C50
DAP000650	Valrubicin	Bladder cancer	188	C67
DAP000650	Valrubicin	Psoriasis	696	L40
DAP000651	Teniposide	Acute lymphoblastic leukemia	204	C91.0
DAP000652	Trovafloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000653	Lomefloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000654	Norfloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000655	Ofloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000656	Rifabutin	Tuberculosis; Mycobacterium avium complex disease	010-018, 031	A15-A19, A31
DAP000657	Gefitinib	Cancers	140-229	C00-C96
DAP000657	Gefitinib	Head and neck cancer	140-149	C07-C14, C32, C33
DAP000657	Gefitinib	Urethral cancer; Bladder cancer; Ovarian cancer; Prostate cancer; Breast cancer	140-229, 174, 175, 183, 188	C00-C96, C50, C56, C67
DAP000658	Risedronate	Osteopetrosis	.	Q78.2?
DAP000658	Risedronate	Paget's disease	731	M88
DAP000659	Cerulenin	Dramatic weight loss	783.21	R63.4
DAP000660	Pyrazinamide	Mycobacterium tuberculosis infection	.	A15-A19
DAP000660	Pyrazinamide	Tuberculosis	010-018	A15-A19
DAP000661	Thiopental	Anesthesia	338	R52
DAP000661	Thiopental	Seizures	.	G40,R56
DAP000662	Propofol	Anesthesia	338	R52
DAP000663	Sirolimus	Dutch elm disease	.	B81-B83
DAP000663	Sirolimus	Organ rejection	279.5, 996	D89.8, T86
DAP000664	Thiabendazole	Dutch elm disease	.	B81-B83
DAP000664	Thiabendazole	Helminth infection	.	B81-B83
DAP000665	Gabapentin	Cancers	.	.
DAP000665	Gabapentin	Partial seizures	345.4, 345.5	G40.0, G40.2
DAP000666	Piperazine	Ascariasis; Enterobiasis	127.0, 127.4	B77, B80
DAP000666	Piperazine	Worm infections	.	B80
DAP000667	Butabarbital	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000668	Butalbital	Anxiety disorder	300	F40-F42
DAP000668	Butalbital	Headache	339, 784.0	G43-G44, R51
DAP000669	Etomidate	Anesthesia	338	R52
DAP000670	Talbutal	Sedation	338	R52
DAP000671	Pentobarbital	Anxiety disorder	300	F40-F42
DAP000671	Pentobarbital	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000672	Clobazam	Epilepsy; Anxiety disorder	300, 345	F40-F42, G40
DAP000672	Clobazam	Seizures associated with LennoxCGastaut syndrome	.	R56.9
DAP000673	Meprobamate	Anxiety disorder	300	F40-F42
DAP000674	Secobarbital	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000675	Metharbital	Epilepsy	345	G40
DAP000676	Picrotoxin	Respiratory distress	518.5, 518.82	J80
DAP000677	Methohexital	Anesthesia	338	R52
DAP000678	Primidone	Epilepsy	345	G40
DAP000678	Primidone	Seizures	.	G40,R56
DAP000679	Halazepam	Anxiety disorder	300	F40-F42
DAP000680	Methylphenobarbital	Anxiety disorder	300	F40-F42
DAP000681	Ethanol	Cystitis	.	N30
DAP000681	Ethanol	Intractable chronic pain	338,780	R52, G89
DAP000682	Methoxyflurane	Anesthesia	338	R52
DAP000683	Methyprylon	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000684	Thiamylal	Anesthesia	338	R52
DAP000685	Flumazenil	General anesthesia	338	R52
DAP000686	Amobarbital	Anxiety disorder	300	F40-F42
DAP000686	Amobarbital	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000687	Butethal	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000688	Hexobarbital	Anesthesia	338	R52
DAP000689	Prazepam	Anxiety disorder	300	F40-F42
DAP000690	Quazepam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000691	Nitrazepam	Epilepsy	345	G40
DAP000691	Nitrazepam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000692	Halothane	Anesthesia	338	R52
DAP000693	Desflurane	Anesthesia	338	R52
DAP000694	Sevoflurane	Anesthesia	338	R52
DAP000695	Praziquantel	Flatworms infection	120-129	B65-B83
DAP000695	Praziquantel	Schistosomiasis	120	B65
DAP000696	Tirofiban	Acute coronary syndrome	411.1	I20.0
DAP000697	Entecavir	Hepatitis B virus infection	.	B16
DAP000697	Entecavir	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
DAP000698	Telbivudine	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
DAP000699	Amodiaquine	Malaria	84	B50-B54
DAP000700	Tenofovir	HIV infections	42	B20
DAP000701	Zidovudine	HIV infections	42	B20
DAP000702	Didanosine	HIV infections	42	B20
DAP000703	Zalcitabine	HIV infections	42	B20
DAP000704	Abacavir	HIV infections	42	B20
DAP000705	Nelfinavir	HIV infections	42	B20
DAP000706	Atazanavir	HIV infections	42	B20
DAP000707	Fosamprenavir	HIV infections	42	B20
DAP000708	Lopinavir	Clostridium difficile infection	.	A04.7,A41.4,A48.0
DAP000708	Lopinavir	HIV infections	42	B20
DAP000709	Efavirenz	HIV infections	42	B20
DAP000710	Bacitracin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000710	Bacitracin	Skin infections	.	L00-L08
DAP000711	Mupirocin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000712	Miglitol	Diabetes mellitus	250	E08-E13
DAP000713	Benzquinamide	Emesis	787	R11
DAP000713	Benzquinamide	Nausea; Vomiting	787, 787.0	R11
DAP000714	Oseltamivir	Influenza virus infections	487	J10, J11
DAP000715	Zanamivir	Influenza virus infections	487	J10, J11
DAP000716	Mivacurium	Anesthesia	338	R52
DAP000716	Mivacurium	General anesthesia	338	R52
DAP000717	Ezetimibe	Hypercholesterolemia	272	E78.0
DAP000718	Hydrocortisone	Inflammatory diseases	.	.
DAP000719	Phentermine	Obesity	278	E66
DAP000720	Reboxetine	Depression	311	F32
DAP000721	Atomoxetine	Attention deficit hyperactivity disorder	314	F90
DAP000722	Mazindol	Obesity	278	E66
DAP000723	Ticlopidine	Stroke	434.91	I61-I63
DAP000724	Pantoprazole	Gastroesophageal reflux disease	530	K21
DAP000725	Lansoprazole	NSAID-related gastric ulcer	531	K25
DAP000725	Lansoprazole	Peptic ulcer disease	531-534	K25-K27
DAP000726	Esomeprazole	Peptic ulcer disease	531-534	K25-K27
DAP000727	Rabeprazole	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000728	Hydralazine	Hypertension	401	I10, I11, I12, I13, I15
DAP000729	Mesalazine	Ulcerative colitis	556	K51
DAP000730	Suprofen	Dysmenorrhea	.	N94.4-N94.6
DAP000730	Suprofen	Miosis during ocular surgery	379.42	H57.03
DAP000731	Salicyclic acid	Acne vulgaris	706.1	L70.0
DAP000731	Salicyclic acid	Dermatitis	692.9	L20-L30
DAP000732	Bromfenac	Inflammatory diseases	.	.
DAP000732	Bromfenac	Postoperative inflammation	998	T81
DAP000733	Balsalazide	Inflammatory bowel disease	555, 556	K50, K51
DAP000734	Salsalate	Osteoarthritis	715	M15-M19, M47
DAP000734	Salsalate	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000735	Nabumetone	Migraine	346	G43
DAP000735	Nabumetone	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000736	Tenoxicam	Arthropathy	.	M00-M14
DAP000736	Tenoxicam	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000737	Celecoxib	Pain	338,780	R52, G89
DAP000737	Celecoxib	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000738	Etoricoxib	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000739	Hydroxyurea	Chronic myelogenous leukemia	205.1	C92.1
DAP000740	Fluvoxamine	Depression	311	F32
DAP000741	Escitalopram	Depression	311	F32
DAP000742	Clomipramine	Depression	311	F32
DAP000742	Clomipramine	Major depressive disorder	296.2, 296.3	F32, F33
DAP000743	Acitretin	Psoriasis	696	L40
DAP000744	Digoxin	Congestive cardiac insufficiency; Arrhythmias; Heart failure	427, 428	I47-I49, I50
DAP000745	Torasemide	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
DAP000746	Methyclothiazide	Edema	.	R60.9
DAP000746	Methyclothiazide	Hypertension	401	I10, I11, I12, I13, I15
DAP000747	Hydroflumethiazide	Edema	.	R60.9
DAP000747	Hydroflumethiazide	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
DAP000748	Ethacrynic acid	Glaucoma	365	H40-H42
DAP000748	Ethacrynic acid	High blood pressure	401	I10, I11, I12, I13, I15
DAP000749	Metolazone	Edema	.	R60.9
DAP000749	Metolazone	Hypertension	401	I10, I11, I12, I13, I15
DAP000750	Hydrochlorothiazide	Luid retention	782.3	R60.9
DAP000751	Polythiazide	Edema	.	R60.9
DAP000751	Polythiazide	Hypertension	401	I10, I11, I12, I13, I15
DAP000752	Naftifine	Dermatomycosis	.	B36.0
DAP000752	Naftifine	Fungal infection	110-118	B35-B49
DAP000753	Terbinafine	Fungal infection	110-118	B35-B49
DAP000754	Chlormerodrin	Diagnosis	.	.
DAP000755	Reserpine	Hypertension	401	I10, I11, I12, I13, I15
DAP000756	Tetrabenazine	Huntington's disease	.	F02.2,G10
DAP000756	Tetrabenazine	Hyperkinetic movement disorder	333	G20-G26
DAP000757	Auranofin	Inflammatory arthritis	710-719	M00-M25
DAP000758	Argatroban	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DAP000759	Raltitrexed	Colon cancer; Rectal cancer	153, 154	C18-C21
DAP000760	Trifluridine	Viral infections	042-075	A80-A99, B00-B34
DAP000761	Capecitabine	Breast cancer	174, 175	C50
DAP000761	Capecitabine	Colorectal cancer	153, 154	C18-C21
DAP000762	Carbimazole	Hyperthyroidism	242	E05
DAP000763	Methimazole	Hyperthyroidism	242	E05
DAP000764	Pentamidine	Fungal infection	110-118	B35-B49
DAP000764	Pentamidine	HIV infections	42	B20
DAP000765	Vinorelbine	Cancers	140-229	C00-C96
DAP000765	Vinorelbine	Lung cancer	162	C33-C34
DAP000766	Telmisartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000767	Fosfomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000768	Dicumarol	Bleeding	444, 453	I74, I80-I82
DAP000768	Dicumarol	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DAP000769	Phenindione	Blood clotting disorder	286	D65-D69
DAP000769	Phenindione	Pulmonary embolism	415.1	I26
DAP000770	Warfarin	Atrial fibrillation	427.31	I48
DAP000771	Phenprocoumon	Blood clotting disorder	286	D65-D69
DAP000771	Phenprocoumon	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DAP000772	Acenocoumarol	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DAP000773	Allopurinol	Hyperuricemia	790.6	E79.0
DAP000774	Nitisinone	Hereditary tyrosinemia type 1	270.2	E70.2
DAP000775	Dorzolamide	Open-angle glaucoma	365	H40-H42
DAP000776	Acetaminophen	Inflammatory diseases	.	.
DAP000776	Acetaminophen	Pain	338,780	R52, G89
DAP000777	Tolmetin	Osteoarthritis	715	M15-M19, M47
DAP000777	Tolmetin	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000778	Etodolac	Pain	338,780	R52, G89
DAP000779	Mefenamic acid	Dysmenorrhea	.	N94.4-N94.6
DAP000779	Mefenamic acid	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
DAP000780	Ibuprofen	Pain	338,780	R52, G89
DAP000781	Amantadine	Influenza virus A infection	487	J10, J11
DAP000782	Azathioprine	Crohn's disease	.	K50
DAP000782	Azathioprine	Organ transplant rejection	279.5, 996	D89.8, T86
DAP000783	Mycophenolate mofetil	Autoimmune diseases	279.4	D84.9, M35.9
DAP000783	Mycophenolate mofetil	Organ transplant rejection	279.5, 996	D89.8, T86
DAP000783	Mycophenolate mofetil	Pemphigus vulgaris	694.4	L10.0
DAP000784	Mycophenolic acid	Organ transplant rejection	279.5, 996	D89.8, T86
DAP000785	Vinblastine	Cancer	140-229	C00-C96
DAP000785	Vinblastine	Cancers	140-229	C00-C96
DAP000786	Etoposide	Cancers	140-229	C00-C96
DAP000786	Etoposide	Lung cancer	.	C33-C34
DAP000787	Chlorambucil	Breast cancer	174, 175, 217	C50, D24
DAP000787	Chlorambucil	Chronic lymphocytic leukaemia	204.1	C91.1
DAP000788	Daunorubicin	Acute myeloid leukemia	205	C92.0
DAP000789	Clofazimine	Crohn's disease	555	K50
DAP000790	Mechlorethamine	Hodgkin's lymphoma	.	C81.9
DAP000790	Mechlorethamine	Prostate cancer	185	C61
DAP000791	Melphalan	Multiple myeloma	203	C90.0
DAP000792	Raloxifene	Breast cancer	174, 175, 217	C50, D24
DAP000792	Raloxifene	Osteoporosis in post-menopausal women	733	M80-M81
DAP000793	Toremifene	Breast cancer	174, 175	C50
DAP000793	Toremifene	Breast cancer	174, 175, 217	C50, D24
DAP000794	Sulfinpyrazone	Arthritis	710-719	M00-M25
DAP000794	Sulfinpyrazone	Gout	274.00274.1274.8274.9	M10
DAP000795	Meclizine	Motion sickness	994.6	T75.3
DAP000795	Meclizine	Nausea; Vomiting	787, 787.0	R11
DAP000796	Methoxamine	Hypertension	401	I10, I11, I12, I13, I15
DAP000797	Levosimendan	Congestive heart failure	428	I50
DAP000798	Dihydroxyaluminium	Skin irritations	709.8	L98.8
DAP000799	Enflurane	Anesthesia	338	R52
DAP000800	Darbepoetin alfa	Anemia	280-285	D50-D64
DAP000801	Interferon Alfa-2a, Recombinant	Chronic hepatitis C	070.4, 070.5, 070.70	B17.1, B18.2
DAP000802	Insulin recombinant	Diabetes mellitus	250	E08-E13
DAP000803	Insulin Lyspro recombinant	Diabetes mellitus	250	E08-E13
DAP000804	Pyridoxal Phosphate	Coronary artery disease	410-414, 429.2	I20-I25
DAP000804	Pyridoxal Phosphate	Dietary shortage	260-269	E40-E46
DAP000805	L-Alanine	Dietary shortage	260-269	E40-E46
DAP000805	L-Alanine	Glioma	191	C71
DAP000806	Gamma-Homolinolenic acid	Dietary shortage	260-269	E40-E46
DAP000807	L-Phenylalanine	Dietary shortage	260-269	E40-E46
DAP000808	L-Tyrosine	Dietary shortage	260-269	E40-E46
DAP000809	Pyridostigmine	Myasthenia gravis	358	G70.0
DAP000810	Perindopril	Hypertension	401	I10, I11, I12, I13, I15
DAP000811	Orciprenaline	Asthma	493	J45
DAP000812	Fondaparinux sodium	Venous thrombosis	453	I80-I82
DAP000813	Fluocinolone Acetonide	Inflammatory diseases	.	.
DAP000814	Flumethasone Pivalate	Contact dermatitis	692	L23, L24, L25
DAP000815	Meclofenamic acid	Ankylosing spondylitis	720	M08.1, M45
DAP000815	Meclofenamic acid	Joint and muscular pain	719.4, 729.1,338,780	M25.5, M79.1, G89, R52
DAP000816	Aciclovir	Viral infections	042-075	A80-A99, B00-B34
DAP000817	Nalidixic Acid	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000817	Nalidixic Acid	Fungal urinary tract infection	.	N39.0
DAP000818	Conjugated Estrogens	Cardiovascular disease	390-459	I00-I99
DAP000818	Conjugated Estrogens	Vasomotor symptoms	627.2	N95.1
DAP000819	Cromoglicate	Allergic rhinitis	477	J30
DAP000820	Histamine Phosphate	Diagnosis	.	I73.9
DAP000821	Penicillamine	Rheumatold arthritis	714	M05-M06
DAP000822	Insulin-lispro	Diabetes mellitus	250	E08-E13
DAP000823	Homatropine Methylbromide	Peptic ulcer disease	531-534	K25-K27
DAP000823	Homatropine Methylbromide	Uveitis	364	H20
DAP000824	Metocurine Iodide	Anesthesia	338	R52
DAP000825	Quinacrine	Female infertility	628	N97.0
DAP000825	Quinacrine	Giardiasis; Cutaneous leishmaniasis	007.1, 085.1-085.4	A07.1, B55.1
DAP000826	Dinoprost Tromethamine	Aborting second-trimester pregnancy (between 12th to 18th week of gestation)	779.6	O04
DAP000827	Etidronic acid	Paget's disease	731	M88
DAP000828	Potassium Chloride	Hypokalemia	276.8	E87.6
DAP000829	Fluorouracil	Cancers	140-229	C00-C96
DAP000830	Monobenzone	Vitiligo	709.01	L80
DAP000831	Valproic Acid	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DAP000831	Valproic Acid	Epilepsy	290-319, 345	F01-F99, G40
DAP000832	Sertindole	Schizophrenia	295	F20
DAP000833	Chlorprothixene	Psychotic disorders	.	F20-F29
DAP000833	Chlorprothixene	Psychotic disorders	290-299	F20-F29
DAP000834	Cocaine	Anesthesia	338	R52
DAP000834	Cocaine	Ocular disease	.	H00-H59
DAP000835	Oxyphencyclimine	Gastrointestinal disorders	530-558	K20-K64
DAP000835	Oxyphencyclimine	Peptic ulcer	531-534	K25-K27
DAP000836	Tridihexethyl	Acquired nystagmus	379.5	H55
DAP000837	Anisotropine Methylbromide	Peptic ulcer	531-534	K25-K27
DAP000837	Anisotropine Methylbromide	Peptic ulcer disease	531-534	K25-K27
DAP000838	Framycetin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000839	Lincomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000839	Lincomycin	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000840	Dromostanolone	Female androgenresponsive recurrent mammary cancer	174, 175	C50
DAP000841	Testosterone	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
DAP000842	Aminoglutethimide	Breast cancer	174, 175, 217	C50, D24
DAP000842	Aminoglutethimide	Cushing's disease; Metastatic breast cancer	174, 175, 255.0	C50, E24
DAP000843	Aspirin	Cardiovascular disease	390-459	I00-I99
DAP000843	Aspirin	Pain	338,780	R52, G89
DAP000844	Acetophenazine	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DAP000844	Acetophenazine	False perceptions	297, 780.1	F22, R44
DAP000845	Zuclopenthixol	Schizophrenia	295	F20
DAP000846	Carphenazine	Schizophrenia	295	F20
DAP000847	Paliperidone	Schizophrenia	295	F20
DAP000848	Amisulpride	Schizophrenia	295	F20
DAP000849	Clofarabine	Acute lymphoblastic leukemia	204	C91.0
DAP000849	Clofarabine	Myelodysplastic syndromes	238.7	D46
DAP000850	Hydroxystilbamidine Isethionate	Blastomycosis	116	B40
DAP000851	Gemifloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000852	Dihydroergotoxine	Alzheimer's disease	331	G30
DAP000853	Lapatinib	Breast cancer	174, 175	C50
DAP000853	Lapatinib	Lymphoma	.	C81-C96
DAP000854	Estradiol	Breast cancer	174, 175, 217	C50, D24
DAP000854	Estradiol	Hormone replacement therapy	V07.4	Z79.890
DAP000855	Etonogestrel	Female contraceptive	.	Z30
DAP000856	Ethynodiol Diacetate	Hormonal contraceptives	.	Z30
DAP000857	Acamprosate	Alcohol use disorders	303	F10.2
DAP000858	Orphenadrine	Pain	338,780	R52, G89
DAP000858	Orphenadrine	Parkinson's disease	332	F02.3, G20
DAP000859	Doxylamine	Anxiety disorder; Morning sickness	300, 643.0	F40-F42, O21.0
DAP000860	Phenmetrazine	Obesity	278	E66
DAP000861	Megestrol	Advanced breast and endometrium carcinoma	174, 175, 182.0	C50, C54.1
DAP000862	Diethylpropion	Migraine; Obisity	278, 346	E66, G43
DAP000863	Protriptyline	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DAP000863	Protriptyline	Depression	311	F32
DAP000864	Amitriptyline	Depression; Chronic pain	311, 338,780	F32, R52, G89
DAP000864	Amitriptyline	Major depressive disorder	296.2, 296.3	F32, F33
DAP000865	Thalidomide	Multiple myeloma	203	C90.0
DAP000866	Sulodexide	Central or sensorineural tinnitus	388.3	H93.1
DAP000867	Abatacept	Rheumatold arthritis	.	M05-M06
DAP000867	Abatacept	Rheumatold arthritis	714	M05-M06
DAP000868	Oxtriphylline	Cough	786.2	R05
DAP000869	Vitamin B6	Vitamin B6 deficiency	266.1	E53.1
DAP000869	Vitamin B6	Vitamin deficiency	.	E56.9
DAP000870	Vitamin B1	Thiamine deficiency	.	E51
DAP000870	Vitamin B1	Vitamin B1 deficiency	265.0, 265.1	E51
DAP000872	N-Acetyl-D-glucosamine	Autoimmune diseases	279.4	D84.9, M35.9
DAP000872	N-Acetyl-D-glucosamine	Myopathy	.	M60-M63
DAP000873	Ursodeoxycholic acid	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DAP000873	Ursodeoxycholic acid	Primary biliary cirrhosis	571.6	K74.3
DAP000874	Mannitol	Bronchiectasis	494, 748.61	J47, Q33.4
DAP000874	Mannitol	Renal failure	584, 585	N17, N18, N19
DAP000875	Ranolazine	Chronic angina	413	I20
DAP000876	Menthol	Pain	338,780	R52, G89
DAP000876	Menthol	Throat irritation	478.29	J39.2
DAP000877	Bifonazole	Fungal infection	.	B35-B49
DAP000877	Bifonazole	Fungal infection	110-118	B35-B49
DAP000878	Hydroxychloroquine	Malaria	84	B50-B54
DAP000879	Nystatin	Fungal infection	110-118	B35-B49
DAP000880	Tigecycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000880	Tigecycline	Skin infections	.	L00-L99
DAP000881	Lymecycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000882	Clomocycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000883	Methacycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000884	Rolitetracycline	Acne vulgaris	706.1	L70.0
DAP000884	Rolitetracycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000885	Roxithromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000886	Retapamulin	Impetigo	684	L01
DAP000887	Josamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000888	Dirithromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000889	Azelaic Acid	Acne vulgaris	706.1	L70.0
DAP000890	Naratriptan	Migraine headaches	346	G43
DAP000891	Cyclobenzaprine	Depression	311	F32
DAP000892	Capreomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000892	Capreomycin	Mycobacterium tuberculosis infection	.	A15-A19
DAP000893	Ambenonium	Myasthenia gravis	358	G70.0
DAP000894	Demecarium bromide	Anxiety disorder	300	F40-F42
DAP000894	Demecarium bromide	Open-angle glaucoma	365	H40-H42
DAP000895	Malathion	Pediculus humanus capitis	132	B85.0
DAP000896	Isoflurophate	Glaucoma	365	H40-H42
DAP000897	Bevantolol	Angina	413	I20
DAP000897	Bevantolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000898	Mephentermine	Hypotension	458, 796.3	I95
DAP000899	Phenylpropanolamine	Obesity	278	E66
DAP000900	Guanfacine	Hypertension	401	I10, I11, I12, I13, I15
DAP000901	Ergoloid mesylate	Alzheimer's disease	331	G30
DAP000902	Nicergoline	Brain ischaemia	435, 437	G45.9, I67.8
DAP000902	Nicergoline	Senile dementia	290-294	F01-F07
DAP000903	Nandrolone	Osteoporosis in post-menopausal women	733	M80-M81
DAP000904	Fluoxymesterone	Breast cancer	174, 175, 217	C50, D24
DAP000904	Fluoxymesterone	Male hypogonadism	257.2	E23.0, E28.3, E29.1
DAP000905	Oxandrolone	Alcoholic hepatitis	571.1	K70.1
DAP000906	Cyproterone	Hyperandrogenism	.	E25.9
DAP000906	Cyproterone	Prostate cancer	185	C61
DAP000907	Olmesartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000908	Eprosartan	Hypertension	401	I10, I11, I12, I13, I15
DAP000909	Deserpidine	Hypertension	401	I10, I11, I12, I13, I15
DAP000910	Rescinnamine	Hypertension	401	I10, I11, I12, I13, I15
DAP000911	Spirapril	Hypertension	401	I10, I11, I12, I13, I15
DAP000912	Cilazapril	Congestive heart failure	428	I50
DAP000913	Masoprocol	Prostate cancer	185	C61
DAP000914	Diethylcarbamazine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000914	Diethylcarbamazine	Lymphatic filariasis	125	B74
DAP000915	Quinidine barbiturate	Cardiac arrhythmias	427	I47-I49
DAP000916	Probucol	Coronary artery disease	410-414, 429.2	I20-I25
DAP000917	Mitiglinide	Diabetes mellitus	250	E08-E13
DAP000918	Nateglinide	Diabetes mellitus	250	E08-E13
DAP000919	Tolazamide	Diabetes mellitus	250	E08-E13
DAP000920	Glipizide	Diabetes mellitus	250	E08-E13
DAP000921	Glycodiazine	Diabetes mellitus	250	E08-E13
DAP000922	Acetohexamide	Diabetes mellitus	250	E08-E13
DAP000923	Chlorpropamide	Diabetes mellitus	250	E08-E13
DAP000923	Chlorpropamide	Non-insulin dependent diabetes	.	E11.9
DAP000924	Gliquidone	Diabetes mellitus	250	E08-E13
DAP000925	Glisoxepide	Diabetes mellitus	250	E08-E13
DAP000925	Glisoxepide	Non-insulin dependent diabetes	.	E11.9
DAP000926	Tazobactam	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000927	Trimethoprim	Urinary tract infections	599	N39.0
DAP000928	Fleroxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000929	Rosoxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000930	Estazolam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000931	Flunitrazepam	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000932	Clotiazepam	Anxiety disorder	300	F40-F42
DAP000933	Eszopiclone	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP000934	Fludiazepam	Anxiety disorder	300	F40-F42
DAP000935	Isoetharine	Asthma	493	J45
DAP000936	Arbutamine	Coronary artery disease	410-414, 429.2	I20-I25
DAP000937	Ritodrine	Premature labour	644, 765	O60.1, P07.3
DAP000938	Penbutolol	Angina	413	I20
DAP000938	Penbutolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000939	Bretylium	Atrioventricular heart block	426.0, 426.1	I44.0-I44.3
DAP000940	Practolol	Cardiac arrhythmias	427	I47-I49
DAP000941	Alprenolol	Angina	413	I20
DAP000941	Alprenolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000942	Nebivolol	Hypertension	401	I10, I11, I12, I13, I15
DAP000943	Arformoterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP000944	Procaterol	Asthma	493	J45
DAP000945	Clenbuterol	Chronic breathing disorders	490-496	J44-J47
DAP000946	Fenoterol	Asthma	493	J45
DAP000947	Salmeterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP000948	Clavulanate	Anxiety disorder	.	F40-F42
DAP000948	Clavulanate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000949	Vindesine	Acute lymphoblastic leukemia	204	C91.0
DAP000949	Vindesine	Cancers	140-229	C00-C96
DAP000950	Mebendazole	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DAP000950	Mebendazole	Worm infections	120-129	B65-B83
DAP000951	Albendazole	Microsporidial infection	.	B60.8
DAP000951	Albendazole	Worm infections	120-129	B65-B83
DAP000952	Chlorzoxazone	Acute pain	338,780	R52, G89
DAP000952	Chlorzoxazone	Musculoskeletal disease	.	M00-M99
DAP000953	Halofantrine	Malaria	84	B50-B54
DAP000954	Aprindine	Cardiac arrhythmias	427	I47-I49
DAP000955	Quinethazone	Congestive heart failure	428	I50
DAP000955	Quinethazone	Hypertension	401	I10, I11, I12, I13, I15
DAP000956	Diazoxide	Hypertension	401	I10, I11, I12, I13, I15
DAP000957	Perhexiline	Angina pectoris	413	I20
DAP000958	L-Carnitine	Nutritional deficiency	260-269	E40-E64
DAP000959	Papaverine	Spasm	728.85	R25.2
DAP000960	Udenafil	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DAP000961	Ceruletide	Cancer	140-229	C00-C96
DAP000961	Ceruletide	Pancreatic malfunction	577	K85, K86
DAP000962	Echothiophate Iodide	Chronic glaucoma	365	H40-H42
DAP000963	Hexafluronium bromide	Anesthesia	338	R52
DAP000963	Hexafluronium bromide	Spasms; Pain	338,780	R52, G89
DAP000964	Coagulation Factor IX	Christmas disease	286.1	D67
DAP000964	Coagulation Factor IX	Haemophilia B	286.1	D67
DAP000965	Collagenase	Dermal ulcers; Skin burns	707.00, 940-949	L88, L89, T20-T31
DAP000965	Collagenase	Skin burns	940-949	T20-T31
DAP000966	Vitamin C	Urinary tract infections	599	N39.0
DAP000966	Vitamin C	Vitamin C deficiency	267	E54
DAP000967	Eculizumab	Paroxysmal nocturnal hemoglobinuria	.	D59.5
DAP000967	Eculizumab	Paroxysmal nocturnal hemoglobinuria	283.2	D59.5
DAP000968	Naproxen	Ankylosing spondylitis	720	M08.1, M45
DAP000968	Naproxen	Pain; Rheumatoid arthritis	338, 714,780	M05-M06, R52, G89
DAP000969	Icosapent	Hyperglyceridemic	790.29	R73.9
DAP000970	Lumiracoxib	Knee osteoarthritis	715	M15-M19, M47
DAP000971	Meloxicam	Arthritis	710-719	M00-M25
DAP000972	Niflumic Acid	Dysmenorrhea	.	N94.4-N94.6
DAP000972	Niflumic Acid	Rheumatold arthritis	714	M05-M06
DAP000973	Tiaprofenic acid	Osteoarthritis	715	M15-M19, M47
DAP000973	Tiaprofenic acid	Pain	338,780	R52, G89
DAP000974	Phenylbutazone	Ankylosing spondylitis	720	M08.1, M45
DAP000974	Phenylbutazone	Chronic pain	338.2,780	R52.1-R52.2, G89
DAP000975	Carprofen	Osteoarthritis	715	M15-M19, M47
DAP000975	Carprofen	Pain	338,780	R52, G89
DAP000976	Cinalukast	Asthma	.	J45
DAP000976	Cinalukast	Asthma	493	J45
DAP000977	Pranlukast	Asthma; Prophylaxis	493	J45
DAP000978	Methylergonovine	Bleeding	.	R58
DAP000978	Methylergonovine	Excessive bleeding	459	R58
DAP000979	Molindone	Schizophrenia	295	F20
DAP000980	Fluspirilene	Anxiety disorder	300	F40-F42
DAP000980	Fluspirilene	Schizophrenia	295	F20
DAP000981	Dornase Alfa	Asthma	493	J45
DAP000981	Dornase Alfa	Cystic fibrosis	277	E84
DAP000982	Adenine	Dietary shortage	260-269	E40-E46
DAP000983	Busulfan	Myeloproliferative disease	205.1, 238.4, 289.89, 289.9	D47.1
DAP000984	Streptozocin	Metastatic islet cell carcinoma	157.4	C25.4
DAP000984	Streptozocin	Pancreatic cancer	.	C25
DAP000985	Nelarabine	Leukaemia	204	C91.0
DAP000985	Nelarabine	Leukemia	208.9	C91-C95
DAP000986	Procarbazine	Brain cancer	191	C71
DAP000986	Procarbazine	Hodgkin's lymphoma	201	C81
DAP000987	Temozolomide	Grade IV astrocytoma	191	C71
DAP000988	Pipobroman	Chronic myelogenous leukemia	205.1	C92.1
DAP000988	Pipobroman	Refractory chronic myeloid leukaemia	205.1	C92.1
DAP000989	Altretamine	Ovarian cancer	.	C56
DAP000989	Altretamine	Ovarian cancer	183	C56
DAP000990	Uracil mustard	Acute myeloid leukemia	205	C92.0
DAP000990	Uracil mustard	Lymphatic malignancies	202	C81-C96
DAP000991	Lomustine	Brain cancer	191, 225.0	C71, D33
DAP000991	Lomustine	Glioma	191	C71
DAP000992	Oxamniquine	Schistosomiasis	120	B65
DAP000993	Furazolidone	Diarrhea	787.91	A09, K59.1
DAP000994	Mitomycin	Cancer	140-229	C00-C96
DAP000994	Mitomycin	Gastro-intestinal cancer; Breast cancer	150-159, 174, 175	C15-C26, C50
DAP000995	Proflavine	Sepsis	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000996	Methoxsalen	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DAP000996	Methoxsalen	Psoriasis	696	L40
DAP000997	Idoxuridine	Herpes simplex virus infection	54	B00
DAP000998	Nitrofurantoin	Urinary tract infections	599	N39.0
DAP000999	Cinoxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP000999	Cinoxacin	Urinary tract infections	599	N39.0
DAP001000	Enoxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001000	Enoxacin	Urinary tract infections	599	N39.0
DAP001001	Pefloxacin	Gonococcal urethritis	98	A54
DAP001002	Novobiocin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001002	Novobiocin	Staphylococcus aureus infection	.	A41.0
DAP001003	Lucanthone	Cancer	.	C00-C97
DAP001003	Lucanthone	Cancer	140-229	C00-C96
DAP001005	Grepafloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001005	Grepafloxacin	Bacterial pneumonia infection	.	J13,J15
DAP001006	Rifaximin	Diarrhea	787.91	A09, K59.1
DAP001007	Fencamfamine	Depressive fatigue	780.71	R53.82
DAP001008	Fusidic Acid	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001008	Fusidic Acid	Staphylococcus aureus infection	.	A41.0
DAP001009	Panitumumab	Colorectal cancer	.	C18-C20,C21
DAP001009	Panitumumab	Colorectal cancer	153, 154	C18-C21
DAP001009	Panitumumab	Locally advanced head and neck cancer	140-149	C07-C14, C32, C33
DAP001010	Erlotinib	Colon cancer; Glioma; Breast cancer; Head and neck cancer	140-149, 140-229, 183, 191	C00-C96, C07-C14, C32, C33, C56, C71
DAP001010	Erlotinib	Non-small cell lung cancer	162	C33, C34
DAP001010	Erlotinib	Non-small-cell lung cancer	162	C33, C34
DAP001010	Erlotinib	Pancreatic cancer	157	C25
DAP001011	Diethylstilbestrol	Cancer	.	C00-C97
DAP001011	Diethylstilbestrol	Gonorrheal vaginitis	98	A54
DAP001012	Chlorotrianisene	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DAP001012	Chlorotrianisene	Menopause	627.2	N95.0
DAP001013	Clomifene	Female infertility	628	N97.0
DAP001013	Clomifene	Hormone deficiency	.	E00-E90
DAP001014	Mestranol	Oral contraceptives	.	Z30
DAP001015	Dienestrol	Atrophic vaginitis	627.3	N95.2
DAP001015	Dienestrol	Female genital tract inflammation	.	N73.9
DAP001016	Quinestrol	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
DAP001016	Quinestrol	Female infertility	628	N97.0
DAP001017	Danazol	Breast cancer	174, 175, 217	C50, D24
DAP001017	Danazol	Menorrhagia	627	N92.0
DAP001018	Ethinyl Estradiol	Estrogen deficiency	.	E28.39
DAP001018	Ethinyl Estradiol	Female hypogonadism	253, 256	E23, E28
DAP001019	Estriol	Hormone deficiency	.	E00-E90
DAP001019	Estriol	Multiple sclerosis	340	G35
DAP001020	Estrone	Menopausal and postmenopausal disorders	627	N95
DAP001021	Pamidronate	Hypercalcemia	275.42	E83.5
DAP001022	Ibandronate	Osteoporosis in post-menopausal women	733	M80-M81
DAP001023	Zoledronate	Hypercalcemia	275.42	E83.5
DAP001024	Methyl aminolevulinate	Acne vulgaris	706.1	L70.0
DAP001024	Methyl aminolevulinate	Photodynamic therapy	706.1	L70.0
DAP001025	Pentosan Polysulfate	Interstitial cystitis; Painful bladder syndrome	595.1,338,780	N30.1, G89, R52
DAP001026	Palifermin	Oral mucositis	528	K12.3
DAP001027	Menotropins	Female infertility	628	N97.0
DAP001028	Follitropin beta	Female infertility	628	N97.0
DAP001029	Urofollitropin	Female infertility	628	N97.0
DAP001030	Choriogonadotropin alfa	Female infertility	628	N97.0
DAP001031	Suramin	African trypanosomiasis	86.5	B56
DAP001031	Suramin	Prostate tumor	185	C61
DAP001032	Heptabarbital	Anesthesia	338	R52
DAP001033	Isoflurane	Anesthesia	338	R52
DAP001034	Aprobarbital	Anesthesia	338	R52
DAP001034	Aprobarbital	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP001035	Bromazepam	Anxiety disorder; Panic attacks	300	F40-F42
DAP001036	Lindane	Infestations of lice and scabies	132.0, 133.0	B85.0, B86
DAP001036	Lindane	Pediculus capitis infestation	.	B85.0
DAP001037	Glucagon recombinant	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
DAP001038	Exenatide	Diabetes mellitus	250	E08-E13
DAP001038	Exenatide	Diabetes mellitus type 2	.	E11
DAP001039	Fluticasone Propionate	Asthma	493	J45
DAP001039	Fluticasone Propionate	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DAP001040	Methylprednisolone	Rheumatold arthritis	714	M05-M06
DAP001041	Prednisone	Inflammatory diseases	.	.
DAP001042	Mometasone	Skin allergies	995.3	T78.4
DAP001043	Betamethasone	Inflammatory diseases	.	.
DAP001044	Amcinonide	Inflammatory diseases	.	.
DAP001045	Loteprednol Etabonate	Eye Inflammation	360-379	H00-H59
DAP001046	Flunisolide	Allergic rhinitis	477	J30
DAP001047	Fluorometholone	Inflammatory diseases	.	.
DAP001048	Medrysone	Eye Inflammation	360-379	H00-H59
DAP001049	Capromab	Diagnosis of prostate cancer	185	C61
DAP001049	Capromab	Prostate tumor	185	C61
DAP001050	Hexachlorophene	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001051	Nafarelin	Endometriosis	617	N80
DAP001052	Gonadorelin	Hypothalamic hypogonadism	257.2	E23.0, E28.3, E29.1
DAP001053	Sargramostim	Bone marrow transplantation	279.5, 996	D89.8, T86
DAP001054	Somatropin recombinant	Growth hormone deficiency	253.3	E23.0
DAP001055	Sermorelin	Growth disorder	.	E23.0
DAP001055	Sermorelin	Growth hormone deficiency	253.3	E23.0
DAP001056	Nitric Oxide	Cancer	.	C00-C97
DAP001056	Nitric Oxide	Respiratory failure	518.81	J96
DAP001057	Isosorbide Dinitrate	Anal fissure	.	K60.0-K60.2
DAP001057	Isosorbide Dinitrate	Angina pectoris; Anal fissure	413, 565.0	I20, K60.0-K60.2
DAP001058	Isosorbide Mononitrate	Angina	413	I20
DAP001058	Isosorbide Mononitrate	Angina pectoris	413	I20
DAP001059	Nitroglycerin	Angina pectoris	413	I20
DAP001060	Erythrityl Tetranitrate	Angina	413	I20
DAP001061	Bepotastine	Allergic rhinitis; Urticaria; Pruritus	477, 708	J30, L50
DAP001062	Olopatadine	Allergic conjunctivitis	372.14	H10.45
DAP001062	Olopatadine	Ocular allergy	360-379	H00-H59
DAP001063	Pheniramine	Hay fever	477	J30
DAP001064	Pemirolast	Allergic conjunctivitis	372.14	H10.45
DAP001064	Pemirolast	Allergic rhinitis	477	J30
DAP001065	Triprolidine	Hay fever	477	J30
DAP001066	Brompheniramine	Allergic rhinitis	477	J30
DAP001067	Emedastine	Allergic conjunctivitis	372.14	H10.45
DAP001068	Dexbrompheniramine	Allergic rhinitis	477	J30
DAP001068	Dexbrompheniramine	Hay fever	477	J30
DAP001069	Carbinoxamine	Allergic rhinitis	477	J30
DAP001070	Methdilazine	Allergic rhinitis	477	J30
DAP001071	Diphenylpyraline	Allergic rhinitis	477	J30
DAP001072	Bromodiphenhydramine	Cough	786.2	R05
DAP001072	Bromodiphenhydramine	Hay fever	477	J30
DAP001073	Phenindamine	Common cold; Allergies	460, 995.3	J00, T78.4
DAP001074	Epinastine	Allergic conjunctivitis	372.14	H10.45
DAP001075	Aceprometazine	Sleep disorders	307.4, 327, 780.5	F51, G47
DAP001076	Buclizine	Emesis	787	R11
DAP001076	Buclizine	Nausea; Vomiting	787, 787.0	R11
DAP001077	Trimeprazine	Allergic rhinitis	477	J30
DAP001078	Mequitazine	Allergic rhinitis	477	J30
DAP001079	Azatadine	Allergic rhinitis	477	J30
DAP001079	Azatadine	Allergy	995.3	T78.4
DAP001080	Chlophedianol	Anesthesia	338	R52
DAP001081	Betazole	Gastric secretory disorders	536.8	K30
DAP001082	Vorinostat	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DAP001083	Cidofovir	Cytomegalovirus	78.5	B25.8, H30.9
DAP001084	Emtricitabine	HIV infections	42	B20
DAP001084	Emtricitabine	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DAP001084	Emtricitabine	Hepatitis virus infection	.	K75.9
DAP001085	Tipranavir	HIV infections	42	B20
DAP001086	Darunavir	HIV infections	42	B20
DAP001087	Rimantadine	Influenza virus A infection	487	J10, J11
DAP001088	Insulin Glargine recombinant	Diabetes mellitus	250	E08-E13
DAP001089	Insulin, porcine	Diabetes mellitus	250	E08-E13
DAP001090	Insulin-detemir	Diabetes mellitus	250	E08-E13
DAP001090	Insulin-detemir	Type 1/2 diabetes	250	E08-E13
DAP001091	Insulin-glargine	Diabetes mellitus	250	E08-E13
DAP001092	Insulin-aspart	Diabetes mellitus	250	E08-E13
DAP001093	Insulin-glulisine	Diabetes mellitus	250	E08-E13
DAP001094	Natalizumab	Multiple sclerosis	340	G35
DAP001095	Efalizumab	Psoriasis	696	L40
DAP001095	Efalizumab	Renal Transplantation	279.5, 996	D89.8, T86
DAP001096	Gallium nitrate	Hypercalcemia	275.42	E83.5
DAP001097	Glucosamine	Osteoarthritis	715	M15-M19, M47
DAP001098	Denileukin diftitox	Advanced non-Small cell lung cancer	162	C33, C34
DAP001098	Denileukin diftitox	Leukemias; Lymphomas	202.8, 204-208	C81-C96, C91-C95
DAP001099	Aldesleukin	Metastatic renal cell carcer	189	C64
DAP001099	Aldesleukin	Non-Hodgkin's lymphoma	200, 202	C82-C85
DAP001100	Dezocine	Pain	338,780	R52, G89
DAP001101	Posaconazole	Aspergillosis	.	B44
DAP001101	Posaconazole	Fungal infection	110-118	B35-B49
DAP001102	Alpha-1-proteinase inhibitor	Emphysema	.	J43
DAP001102	Alpha-1-proteinase inhibitor	Panacinar emphysema	492	J43
DAP001103	Lutropin alfa	Female infertility	628	N97.0
DAP001104	Voglibose	Diabetes mellitus	250	E08-E13
DAP001105	Fludrocortisone	Cerebral salt-wasting syndrome	.	E87.1
DAP001106	Desoxycorticosterone Pivalate	Addison's disease	255.4	E27.1-E27.2
DAP001107	Rasagiline	Parkinson's disease	.	G20
DAP001107	Rasagiline	Parkinson's disease	332	F02.3, G20
DAP001108	Hyoscyamine	Gastrointestinal disorders	530-558	K20-K64
DAP001109	Methantheline	Bladder disease	.	N30-N32
DAP001109	Methantheline	Irritable bowel syndrome	564.1	K58
DAP001110	Procyclidine	Parkinson's disease	.	G20
DAP001110	Procyclidine	Parkinson's disease	332	F02.3, G20
DAP001111	Cyclopentolate	Ocular disease	.	H00-H59
DAP001111	Cyclopentolate	Pediatric eye examinations	.	H00-H59
DAP001112	Ipratropium	Obstructive lung diseases	490-492, 494-496	J40-J44, J47
DAP001113	Pilocarpine	Glaucoma	365	H40-H42
DAP001113	Pilocarpine	Xerostomia	527.7	K11.7, R68.2
DAP001114	Flavoxate	Muscle Relaxant	.	N39.3,N39.4,R32
DAP001114	Flavoxate	Urinary incontinence	788.3	N39.3, N39.4, R32
DAP001115	Mepenzolate	Gastrointestinal disease	.	K00-K93
DAP001115	Mepenzolate	Peptic ulcer disease	531-534	K25-K27
DAP001116	Glycopyrrolate	Anesthesia	338	R52
DAP001117	Clidinium	Abdominal stomach pain	789.0,338,780	R10, G89, R52
DAP001117	Clidinium	Irritable bowel syndrome	564.1	K58
DAP001118	Dicyclomine	Dyspepsia	536.8	K30
DAP001118	Dicyclomine	Irritable bowel syndrome	564.1	K58
DAP001119	Ethopropazine	Parkinson's disease	332	F02.3, G20
DAP001120	Cycrimine	Parkinson's disease	332	F02.3, G20
DAP001121	Benztropine	Parkinson's disease	.	G20
DAP001121	Benztropine	Parkinson's disease	332	F02.3, G20
DAP001122	Trihexyphenidyl	Dystonia	.	G24
DAP001122	Trihexyphenidyl	Parkinson's disease	332	F02.3, G20
DAP001123	Propantheline	Excessive sweating	780.8	R61
DAP001123	Propantheline	Stomach ulcer	.	K25-K27
DAP001124	Oxyphenonium	Spasm	728.85	R25.2
DAP001125	Biperiden	Parkinson's disease	.	G20
DAP001125	Biperiden	Parkinson's disease	332	F02.3, G20
DAP001126	Methylscopolamine	Gastrointestinal disease	.	K00-K93
DAP001126	Methylscopolamine	Peptic ulcer disease	531-534	K25-K27
DAP001127	Gallamine Triethiodide	Stabilize muscle contractions	.	M00-M99
DAP001128	Oxybutynin	Urinary and bladder difficulties	788	R33
DAP001128	Oxybutynin	Urinary incontinence	788.3	N39.3, N39.4, R32
DAP001129	Solifenacin	Overactive bladder disorder	596.51	N32.81
DAP001130	Diphemanil Methylsulfate	Peptic ulcer disease	531-534	K25-K27
DAP001131	Darifenacin	Overactive bladder disorder	596.51	N32.81
DAP001131	Darifenacin	Urinary incontinence	788.3	N39.3, N39.4, R32
DAP001132	Succinylcholine	Anesthesia	338	R52
DAP001132	Succinylcholine	Spasms; Pain	338,780	R52, G89
DAP001133	Diphenidol	Emesis	787	R11
DAP001133	Diphenidol	Nausea; Vomiting	787, 787.0	R11
DAP001134	Alfentanil	Anesthesia	338	R52
DAP001135	Anileridine	Pain	338,780	R52, G89
DAP001136	Diphenoxylate	Diarrhea	787.91	A09, K59.1
DAP001137	Methadyl Acetate	Opiate dependence	304	F11
DAP001138	Oxymorphone	Pain	338,780	R52, G89
DAP001139	Levomethadyl Acetate	Opiate dependence	304	F11
DAP001140	Alvimopan	Gastrointestinal disease	.	K00-K93
DAP001140	Alvimopan	Pain	338,780	R52, G89
DAP001141	Ethionamide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001141	Ethionamide	Tuberculosis	010-018	A15-A19
DAP001142	Prothionamide	Tuberculosis	010-018	A15-A19
DAP001143	Trimethaphan	Aneurysm	.	I72
DAP001143	Trimethaphan	Hypertensive emergencies	401-405	I10
DAP001144	Pentolinium	Hypotension	458, 796.3	I95
DAP001145	Candoxatril	Cardiotonic	.	I50
DAP001145	Candoxatril	Hypertension	401	I10, I11, I12, I13, I15
DAP001146	Amphetamine	Attention deficit hyperactivity disorder	314	F90
DAP001147	Benzphetamine	Obesity	278	E66
DAP001148	Ketamine	Anesthesia	338	R52
DAP001148	Ketamine	Cancer pain	338,780	R52, G89
DAP001149	Amoxapine	Depression	311	F32
DAP001149	Amoxapine	Major depressive disorder	296.2, 296.3	F32, F33
DAP001150	Maprotiline	Depression	311	F32
DAP001150	Maprotiline	Major depressive disorder	296.2, 296.3	F32, F33
DAP001151	Desipramine	Attention deficit hyperactivity disorder	314	F90
DAP001151	Desipramine	Depression	311	F32
DAP001152	Nortriptyline	Depression	311	F32
DAP001153	Trimipramine	Depression	311	F32
DAP001154	Imipramine	Anxiety disorder	300	F40-F42
DAP001154	Imipramine	Depression	311	F32
DAP001155	Milnacipran	Depression	311	F32
DAP001156	Oxytocin	Induced labour	.	O00-O99
DAP001157	Cefpiramide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001158	Cephaloglycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001159	Cyclacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001159	Cyclacillin	Lung infection	162	C33-C34
DAP001160	Cephapirin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001160	Cephapirin	Sepsis	.	A40-A41
DAP001161	Cloxacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001161	Cloxacillin	Osteoarthritis	.	M19.90
DAP001162	Bacampicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001163	Flucloxacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001164	Piperacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001164	Piperacillin	Infectious disease	001-139	A00-B99
DAP001165	Penicillin V	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001166	Nafcillin	Arthritis	710-719	M00-M25
DAP001166	Nafcillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001167	Hetacillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001168	Penicillin G	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001168	Penicillin G	Otitis media	.	H65-H67
DAP001169	Azlocillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001170	Meticillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001170	Meticillin	Neurological disease	.	G00-G99
DAP001171	Pivampicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001172	Cefacetrile	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001173	Cefonicid	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001174	Pivmecillinam	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001174	Pivmecillinam	Urinary tract infections	599	N39.0
DAP001175	Ceforanide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001176	Amdinocillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001176	Amdinocillin	Urinary tract infections	599	N39.0
DAP001177	Cefotiam	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001177	Cefotiam	Bacterial respiratory tract infection	.	J13,J15
DAP001178	Cefmenoxime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001179	Cefmetazole	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001180	Mezlocillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001180	Mezlocillin	Urinary tract infections	599	N39.0
DAP001181	Latamoxef	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001182	Bezafibrate	Hyperlipidaemia	272.0-272.4	E78
DAP001183	Clobetasol	Inflammation and itching	698	L29
DAP001184	Diflorasone	Skin allergies	995.3	T78.4
DAP001185	Desoximetasone	Inflammatory diseases	.	.
DAP001186	Halobetasol Propionate	Inflammatory diseases	.	.
DAP001187	Hydrocortamate	Inflammatory diseases	.	.
DAP001188	Desonide	Atopic dermatitis	691.8	L20
DAP001189	Prednicarbate	Inflammatory diseases	.	.
DAP001190	Clocortolone	Inflammatory skin conditions	.	L00-L99
DAP001191	Sulfacetamide	Acne vulgaris	706.1	L70.0
DAP001191	Sulfacetamide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001192	Sulfoxone	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001193	Sulfanilamide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001194	Urokinase	Deep venous thrombosis; Pulmonary embolism; Myocardial infarction	410, 415.1, 437.6, 444.9, 453, 453.40, 671.5, 671.9	I21, I22, I26, I74, I80-I82, I80.2, I82, O88, T79.0-T79.1
DAP001195	Reteplase	Heart attack	410	I21, I22
DAP001195	Reteplase	Myocardial infarction	410	I21, I22
DAP001197	Anistreplase	Acute Coronary thrombosis	414.8	I24.0
DAP001197	Anistreplase	Myocardial infarction	410	I21, I22
DAP001198	Streptokinase	Cerebrovascular ischaemia	.	G45.9,I67.8
DAP001198	Streptokinase	Pulmonary embolism	415.1	I26
DAP001199	Sulfametopyrazine	Urinary tract infections	599	N39.0
DAP001200	Sulfapyridine	Dermatitis	692.9	L20-L30
DAP001200	Sulfapyridine	Dermatitis herpetiformis	694	L12.2, L13
DAP001201	Sulfacytine	Cystitis	.	N30
DAP001201	Sulfacytine	Urinary tract infections	599	N39.0
DAP001202	Sulfamethizole	Urinary tract infections	599	N39.0
DAP001203	Sulfisoxazole	Otitis media	.	H65-H67
DAP001203	Sulfisoxazole	Urinary tract infections	599	N39.0
DAP001204	Oxiconazole	Fungal infection	110-118	B35-B49
DAP001204	Oxiconazole	Tinea pedis	.	B35.6
DAP001205	Dydrogesterone	Menstrual disorders	626	N91-N95
DAP001206	Drospirenone	Oral contraceptive	.	Z30
DAP001207	Levonorgestrel	Hormonal contraceptives	.	Z30
DAP001208	Norgestrel	Contraception	.	Z30
DAP001208	Norgestrel	Hormonal contraceptives	.	Z30
DAP001209	Desogestrel	Hormonal contraceptives	.	Z30
DAP001210	Norgestimate	Hormonal contraceptives	.	Z30
DAP001211	Medroxyprogesterone	Hormonal contraceptives	.	Z30
DAP001212	Norethindrone	Oral contraceptive	.	Z30
DAP001213	Epoprostenol	Pulmonary hypertension	416	I27.0, I27.2
DAP001214	Treprostinil	Pulmonary arterial hypertension	416	I27.0, I27.2
DAP001215	Carboprost Tromethamine	Aborting pregnancy between the 13th and 20th weeks of gestation	779.6	O04
DAP001216	Latanoprost	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
DAP001217	Bimatoprost	Glaucoma	365	H40-H42
DAP001217	Bimatoprost	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
DAP001218	Ximelagatran	Coagulation	.	I80-I82
DAP001219	Aliskiren	Hypertension	401	I10, I11, I12, I13, I15
DAP001219	Aliskiren	Hypotension	.	I95
DAP001220	Remikiren	Hypertension	.	I10-I15
DAP001220	Remikiren	Hypertension	401	I10, I11, I12, I13, I15
DAP001221	Tretinoin	Acne vulgaris	706.1	L70.0
DAP001221	Tretinoin	Acute promyelocytic leukemia	205	C92.4
DAP001222	Temsirolimus	Renal cell carcinoma	189	C64
DAP001223	Everolimus	Advanced kidney cancer	189	C64
DAP001223	Everolimus	Renal cell carcinoma	189	C64
DAP001224	Dexfenfluramine	Drug dependence	303-304	F10.2-F19.2
DAP001224	Dexfenfluramine	Obesity	278	E66
DAP001225	Gadobenate Dimeglumine	Central nervous system disease	.	G00-G99
DAP001225	Gadobenate Dimeglumine	Visualizing lesions with abnormal blood brain barrier	437.9	I67.9
DAP001226	Iodipamide	Cholecystography	574, 575	K81, K82
DAP001226	Iodipamide	Gallbladder disease	.	K80-K82
DAP001227	Sodium lauryl sulfate	Constipation	564	K59.0
DAP001228	Bismuth	Diarrhea	.	A09,K59.1
DAP001228	Bismuth	Diarrhea	787.91	A09, K59.1
DAP001229	Bupivacaine	Anesthesia	338	R52
DAP001230	Ropivacaine	Anesthesia	338	R52
DAP001231	Oxybuprocaine	Anesthesia	338	R52
DAP001232	Mepivacaine	Anesthesia	338	R52
DAP001232	Mepivacaine	Pain	338,780	R52, G89
DAP001233	Levobupivacaine	Anesthesia	338	R52
DAP001234	Benzocaine	Anesthesia	338	R52
DAP001235	Permethrin	Infections with sarcoptes scabiei	133	B86
DAP001235	Permethrin	Pediculus capitis infestation	.	B85.0
DAP001236	Butenafine	Dermatologic infections	680-686	L00-L08
DAP001237	Tolnaftate	Jock itch; Athlete's foot	110.3, 110.4	B35.3, B35.6
DAP001237	Tolnaftate	Tinea pedis	.	B35.6
DAP001238	Sulfadiazine	Infectious disease	001-139	A00-B99
DAP001238	Sulfadiazine	Urinary tract infections	599	N39.0
DAP001239	Sulfamethoxazole	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001239	Sulfamethoxazole	Infectious disease	001-139	A00-B99
DAP001240	Sulfamerazine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001241	Sulfamethazine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001243	Alseroxylon	Hypertension	401	I10, I11, I12, I13, I15
DAP001244	Leucovorin/5-fluorouracil	Colon cancer	153, 154	C18-C21
DAP001245	Floxuridine/5-fluorouracil	Colorectal cancer	153, 154	C18-C21
DAP001246	Gemcitabine	Cancers	140-229	C00-C96
DAP001247	Propylthiouracil	Alcoholic hepatitis	571.1	K70.1
DAP001247	Propylthiouracil	Hyperthyroidism	242	E05
DAP001248	Thyrotropin Alfa	Diagnosis of thyroid cancer	193	C73
DAP001248	Thyrotropin Alfa	Toxic nodular goiter	.	E05.1,E05.2
DAP001249	Docosanol	Herpes simplex virus infection	54	B00
DAP001250	Cinolazepam	Muscle Relaxant	.	N39.3,N39.4,R32
DAP001251	Adinazolam	Anxiety disorder; Status epilepticus	300, 345.3	F40-F42, G40
DAP001252	Chlormezanone	Anxiety disorder	300	F40-F42
DAP001252	Chlormezanone	Spasms; Pain	338,780	R52, G89
DAP001253	Methsuximide	Epilepsy	345	G40
DAP001253	Methsuximide	Epileptic seizures	345.9, 780.3	G40, P90, R56
DAP001254	Colchicine	Acute gouty arthritis	274	M10
DAP001254	Colchicine	Gout	274.00274.1274.8274.9	M10
DAP001255	Lenalidomide	Anaemia	280-285	D50-D64
DAP001255	Lenalidomide	Multiple myeloma	203	C90.0
DAP001256	Forasartan	Hypertension	.	I10-I15
DAP001256	Forasartan	Hypertension	401	I10, I11, I12, I13, I15
DAP001257	Saprisartan	Cognitive impairment	.	F06.7
DAP001257	Saprisartan	Hypertension	401	I10, I11, I12, I13, I15
DAP001258	Tasosartan	Hypertension	401	I10, I11, I12, I13, I15
DAP001259	Pegaptanib	Age-related macular degeneration	362.5	H35.3
DAP001259	Pegaptanib	Neovascular age-related macular degeneration	362.5	H35.3
DAP001260	Ranibizumab	Age-related macular degeneration	362.5	H35.3
DAP001260	Ranibizumab	Diabetic macular edema; Retinal vein occlusion	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DAP001260	Ranibizumab	Macular degeneration	.	H35.3
DAP001261	Lercanidipine	Hypertension	401	I10, I11, I12, I13, I15
DAP001262	Diltiazem	Hypertension	401	I10, I11, I12, I13, I15
DAP001263	Nitrendipine	Hypertension	401	I10, I11, I12, I13, I15
DAP001264	Pregabalin	Diabetic nephropathy	.	E11.40
DAP001264	Pregabalin	Neuropathic pain	338,780	R52, G89
DAP001265	Trimethadione	Epileptic conditions	345	G40
DAP001265	Trimethadione	Pancreatic cancer	.	C25
DAP001266	Paramethadione	Paramethadione syndrome	741, 744, 745, 746, 751, 753	Q05, Q17, Q20-Q28, Q60, Q79
DAP001266	Paramethadione	Seizures	.	G40,R56
DAP001267	Butoconazole	Candida infection	.	B37.0
DAP001267	Butoconazole	Fungal infection	110-118	B35-B49
DAP001268	Tioconazole	Fungal infection	110-118	B35-B49
DAP001268	Tioconazole	Onychomycosis	.	B35.1
DAP001269	Econazole	Fungal infection	110-118	B35-B49
DAP001269	Econazole	Tinea pedis	.	B35.3
DAP001270	Sertaconazole	Fungal infection	.	B35-B49
DAP001270	Sertaconazole	Fungal infection	110-118	B35-B49
DAP001271	Voriconazole	Invasive aspergillosis	117.3	B44
DAP001272	Botulinum Toxin Type B	Cervical dystonia	333.83	G24.3
DAP001272	Botulinum Toxin Type B	Parkinson's disease	332	F02.3, G20
DAP001273	Cholecalciferol	Vitamin D deficiency	268	E55
DAP001274	Anisindione	Coagulation	.	I80-I82
DAP001275	Phytonadione	Bleeding	.	R58
DAP001275	Phytonadione	Vitamin K deficiency	269	E56.1
DAP001276	Sodium Tetradecyl Sulfate	Hemangioma	.	D18.00
DAP001276	Sodium Tetradecyl Sulfate	Varicose and spider veins of the leg	454-456, 671	I83, I85, I86
DAP001277	Acetohydroxamic Acid	Urinary tract infections	599	N39.0
DAP001278	Peginterferon alfa-2a	Hairy cell leukemia	202.4	C91.4
DAP001279	Peginterferon alfa-2b	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DAP001280	Interferon alfa-n1	Chronic myelogenous leukemia	205.1	C92.1
DAP001280	Interferon alfa-n1	Hairy cell leukemia, Malignant melanoma	172, 202.4, 208.9	C43, C91-C95, C91.4
DAP001281	Interferon alfa-n3	Papillomavirus infections	.	B97.7
DAP001281	Interferon alfa-n3	Venereal or genital warts	78.11	A63.0
DAP001282	Interferon beta-1a	Multiple sclerosis	340	G35
DAP001283	Interferon beta-1b	Multiple sclerosis	340	G35
DAP001284	Interferon alfacon-1	Hairy cell leukemia	202.4	C91.4
DAP001284	Interferon alfacon-1	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DAP001285	Interferon Alfa-2b, Recombinant	Hairy cell leukemia	202.4	C91.4
DAP001286	Interferon gamma-1b	Chronic granulomatous disease	288.1	D71
DAP001287	Oprelvekin	Severe thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DAP001288	Quinupristin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001289	Alglucosidase alfa	Pompe's disease	.	E74.0
DAP001289	Alglucosidase alfa	Type II glycogen storage disease	271	E74.0
DAP001290	Galsulfase	Mucopolysaccharidosis VI	277.5	E76.2
DAP001291	NADH	Parkinson's disease	332	F02.3, G20
DAP001292	Probenecid	Gout	274.00274.1274.8274.9	M10
DAP001292	Probenecid	Gout; hyperuricemia	274, 790.6	E79.0, M10
DAP001293	Nitazoxanide	Diarrhea	787.91	A09, K59.1
DAP001294	Dalfopristin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001295	Doxapram	Respiratory disease	.	J00-J99
DAP001295	Doxapram	Respiratory disorder	518.81	J96
DAP001296	Secretin	Diagnosis of pancreatic exocrine dysfunction and gastrinoma	157.4, 577.8	C25.4, K86.8
DAP001296	Secretin	Gastrinoma	.	D37.9
DAP001297	Cysteamine	Radiation sickness	990	T66
DAP001298	Botulinum Toxin Type A	Strabismus; Blepharospasm	333.81, 378	G24.5, H49-H50
DAP001299	Satumomab Pendetide	Breast cancer	174, 175, 217	C50, D24
DAP001299	Satumomab Pendetide	Diagnosis of cancer	140-229	C00-C96
DAP001300	Antithymocyte globulin	Aplastic anemia	284	D60-D61
DAP001301	Muromonab	Organ rejection	279.5, 996	D89.8, T86
DAP001302	Salmon Calcitonin	Osteoporosis	733	M80-M81
DAP001303	Arcitumomab	Breast cancer	174, 175, 217	C50, D24
DAP001303	Arcitumomab	Cancer	140-229	C00-C96
DAP001304	Inulin	Measure kidney function	.	.
DAP001305	Glutethimide	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP001306	Hesperetin	High Cholesterol levels	272	E78.0
DAP001307	Estramustine	Cancer	140-229	C00-C96
DAP001307	Estramustine	Prostate cancer	185	C61
DAP001308	Tetrahydrofolic acid	Dietary shortage	260-269	E40-E46
DAP001309	Folic Acid	Folate deficiency	266.2	D52, E53.8
DAP001309	Folic Acid	Vitamin deficiency	.	E56.9
DAP001310	Mefloquine	Malaria	84	B50-B54
DAP001310	Mefloquine	Plasmodium falciparum infection	.	B54
DAP001311	Gamma Hydroxybutyric Acid	Anesthetic narcolepsy	338, 347	G47.4, R52
DAP001312	Iron Dextran	Iron deficiency	280.9	E61.1
DAP001312	Iron Dextran	Iron deficiency anaemia	.	D50
DAP001313	Iron	Iron deficiency anaemia	.	D50
DAP001313	Iron	Iron-deficiency anemia	280	D50
DAP001314	Benzylpenicilloyl Polylysine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001314	Benzylpenicilloyl Polylysine	Risk of administering penicillin	.	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001315	Glatiramer Acetate	Multiple sclerosis	340	G35
DAP001316	L-Tryptophan	Depression	311	F32
DAP001317	Nitroprusside	Hypertension	401	I10, I11, I12, I13, I15
DAP001318	Bortezomib	Multiple myeloma	203	C90.0
DAP001318	Bortezomib	NHL; MCL	200, 200.4, 202	C82-C85, C85.7
DAP001319	Adenosine monophosphate	Dietary shortage	260-269	E40-E46
DAP001320	Nesiritide	Congestive heart failure	428	I50
DAP001321	Silver sulfadiazine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001321	Silver sulfadiazine	Skin burns	940-949	T20-T31
DAP001322	Amphotericin B	Fungal infection	110-118	B35-B49
DAP001323	Polymyxin B Sulfate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001323	Polymyxin B Sulfate	Pseudomonas aeruginosa infection	001-139	A00-B99
DAP001324	Colistin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001324	Colistin	Pseudomonas aeruginosa infection	001-139	A00-B99
DAP001325	Candicidin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001326	Chlorhexidine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001326	Chlorhexidine	Periodontal disease	.	K05
DAP001327	Gramicidin D	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001328	Daptomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001329	Colistimethate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001329	Colistimethate	Bacterial respiratory tract infection	.	J13,J15
DAP001330	Vancomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001331	Natamycin	Conjunctivitis	372	H10
DAP001331	Natamycin	Fungal infection	110-118	B35-B49
DAP001332	Haloprogin	Athlete's foot	110.4	B35.3
DAP001332	Haloprogin	Candida infection	.	B37.0
DAP001333	Arsenic trioxide	Acute lymphoblastic leukemia	204	C91.0
DAP001333	Arsenic trioxide	Leukemia	208.9	C91-C95
DAP001334	OspA lipoprotein	Lyme disease	88.81	A69.2
DAP001335	Cycloserine	Dementia	290-294	F01-F07
DAP001335	Cycloserine	Tuberculosis	010-018	A15-A19
DAP001336	Hydroxocobalamin	Lung injury	.	S00-T98
DAP001336	Hydroxocobalamin	Vitamin B12 deficiency	266.2	E53.8
DAP001337	Troglitazone	Diabetes mellitus	.	E10-E14
DAP001337	Troglitazone	Diabetes mellitus	250	E08-E13
DAP001338	Rofecoxib	Alzheimer's disease	.	G30,F00
DAP001338	Rofecoxib	Osteoarthritis	715	M15-M19, M47
DAP001339	(+)-Irinotecan	Colon cancer	153, 154	C18-C21
DAP001339	(+)-Irinotecan	Solid tumours	.	C00-C75,C7A,C7B
DAP001340	(S)-(+)-Dimethindene maleate	Pruritus	698	L29
DAP001341	(S)-Duloxetine	Back pain	724.5,338,780	M54, G89, R52
DAP001341	(S)-Duloxetine	Smoking cessation	292	F17.2
DAP001342	Aclarubicin	Acute myeloid leukemia	205	C92.0
DAP001342	Aclarubicin	Cancer	140-229	C00-C96
DAP001343	Acrivastine	Allergic rhinitis	477	J30
DAP001344	Aldosterone	Hypertension	401	I10, I11, I12, I13, I15
DAP001345	Almogran	Migraine	346	G43
DAP001346	Aminopterin	Acute lymphoblastic leukemia	.	C91.0
DAP001346	Aminopterin	Leukemia	208.9	C91-C95
DAP001347	Antazoline	Nasal congestion	478.19	J34.89
DAP001348	Dhaq diacetate	Cancer	140-229	C00-C96
DAP001349	Eflornithine	African trypanosomiasis	86.5	B56
DAP001350	Barbital	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP001351	Barbituric acid	Depression	311	F32
DAP001352	Biricodar	Ovarian cancer	183	C56
DAP001352	Biricodar	Solid tumours	.	C00-C75,C7A,C7B
DAP001353	Buprenex	Pain	338,780	R52, G89
DAP001354	Cephalosporin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001355	Charybdotoxin	Scorpion envenoming syndrome	989.5	T63.2
DAP001356	Chlornitromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001356	Chlornitromycin	Infections	001-139	A00-B99
DAP001357	Chloroquinium	Malaria	84	B50-B54
DAP001359	Ciprofibrate	Atherosclerosis	414.0, 440	I70
DAP001359	Ciprofibrate	Hyperlipoproteinemia	272.0-272.4	E78
DAP001360	Ciprofloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001361	Clorgyline	Major depressive disorder	296.2, 296.3	F32, F33
DAP001361	Clorgyline	Parkinson's disease	332	F02.3, G20
DAP001362	Connexyn	Attention deficit hyperactivity disorder	314	F90
DAP001363	Danaparoid	Deep venous clots	453.4	I80.2
DAP001364	Dapotum D	Ascariasis; Enterobiasis	127.0, 127.4	B77, B80
DAP001365	Antazoline hydrochloride	Ocular allergies	360-379	H00-H59
DAP001366	Dimethindene	Allergic rhinitis	477	J30
DAP001366	Dimethindene	Respiratory allergies	460-519	J00-J99
DAP001367	Eprosartan mesylate	High blood pressure	401	I10, I11, I12, I13, I15
DAP001368	Domperidone maleate	Upper gastrointestinal motility disorders	536.8	K30
DAP001372	Ebselen	Hearing loss	389	H90-H91
DAP001372	Ebselen	Reperfusion injury and stroke	410, 434.91	I21, I22, I61-I63
DAP001373	Antazoline phosphate	Ocular allergies	360-379	H00-H59
DAP001374	Enalaprilat	Hypertension	401	I10, I11, I12, I13, I15
DAP001375	Enprofylline paradox	Asthma	493	J45
DAP001376	Epalrestat	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DAP001378	Dimethindene maleate	Respiratory allergies	460-519	J00-J99
DAP001379	Ergotidine	Cancer	.	C00-C97
DAP001379	Ergotidine	Respiratory allergies	460-519	J00-J99
DAP001380	Fluticasone	Inflammatory diseases	.	.
DAP001383	Foscavir	Cytomegalovirus retinitis	78.5	B25.8, H30.9
DAP001384	Fosmidomycin	Malaria	84	B50-B54
DAP001385	Gaboxadol	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP001386	Ganirelix	Ovulation	256	E28
DAP001387	Gatifloxacin	Respiratory tract infections	460-519	J00-J99
DAP001388	Gentamicine sulfate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001389	Guggulsterone	Osteoarthritis	715	M15-M19, M47
DAP001390	Herbimycin A	Cancer	140-229	C00-C96
DAP001391	Hydroxyflutamide	Prostate cancer	185	C61
DAP001392	Inamrinone	Heart disease	390-429	I00-I52
DAP001393	Isovanillin	Cancer	140-229	C00-C96
DAP001394	Ketanserin	Hypertension	401	I10, I11, I12, I13, I15
DAP001395	Lestaurtinib	Acute myeloid leukemia	205	C92.0
DAP001395	Lestaurtinib	Acute myeloid leukemia; Prostate cancer; Pancreatic cancer	140-199, 140-229, 157, 205.0, 210-229	C00-C75, C00-C96, C25, C7A, C7B, C92.0, D10-D36, D3A
DAP001395	Lestaurtinib	Myeloid leukemia	205	C92
DAP001395	Lestaurtinib	Psoriasis	.	L40
DAP001396	Levobetaxolol	Glaucoma	365	H40-H42
DAP001397	Levocetirizine dihydrochloride	Allergic rhinitis	477	J30
DAP001398	Meclocycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001399	Mepyramine	Allergy	995.3	T78.4
DAP001400	Mepyramine maleate	Allergy	995.3	T78.4
DAP001401	Mitomycin A	Cancers	140-229	C00-C96
DAP001402	Mitomycin C	Cancers	140-229	C00-C96
DAP001403	Mizolastine	Allergic rhinitis	477	J30
DAP001404	Mizoribine	Hyperuricemia	790.6	E79.0
DAP001404	Mizoribine	Transplant rejection	.	T86
DAP001405	Morantel tartrate	Mature gastrointestinal nematode infections	127	B77-B81
DAP001406	Motexafin gadolinium	Brain cancer	191	C71
DAP001406	Motexafin gadolinium	Human immunodeficiency virus infection	.	B20
DAP001407	Nalmefene	Alcohol use disorders	303	F10.2
DAP001408	Naphazoline	Minor eye irritations	360-379	H00-H59
DAP001408	Naphazoline	Otitis media	.	H65-H67
DAP001409	Nicorandil	Angina	413	I20
DAP001410	Nicotinamide	Inflammatory skin conditions	.	L00-L99
DAP001412	Olmesartan medoxomil	High blood pressure	401	I10, I11, I12, I13, I15
DAP001413	Oxantel pamoate	Trichuris trichiura infection	127.3	B79
DAP001414	Oxatomide	Hay fever	477	J30
DAP001416	Pamidronate disodium	Bone disease	.	M00-M99
DAP001416	Pamidronate disodium	Osteoporosis	733	M80-M81
DAP001417	Pinacidil	High blood pressure	401	I10, I11, I12, I13, I15
DAP001418	Prolixin decanoate	Chronic schizophrenics	295	F20
DAP001419	Quercetin	Obesity	278	E66
DAP001420	Quinagolide	Hyperprolactinaemia	253.1	E22.1
DAP001421	Quinagolide hydrochloride	High prolactin levels	253.1	E22.1
DAP001422	Retigabine	Epilepsy	.	G40
DAP001422	Retigabine	Epilepsy	345	G40
DAP001424	Salbutamol sulphate	Acute asthma	493	J45
DAP001424	Salbutamol sulphate	Asthma	493	J45
DAP001426	Salmeterol xinafoate	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DAP001426	Salmeterol xinafoate	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DAP001427	Sarpogrelate	Diabetes mellitus	250	E08-E13
DAP001428	Seroxat	Depression	311	F32
DAP001429	Sulindac sulfide	Rheumatold arthritis	714	M05-M06
DAP001430	Tenofovir disoproxil	HIV infections	42	B20
DAP001430	Tenofovir disoproxil	Hepatitis virus infection	.	K75.9
DAP001431	Tetracaine	Pain	.	G89
DAP001431	Tetracaine	Spinal anesthesia	338	R52
DAP001432	Tetrodotoxin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001432	Tetrodotoxin	Substance dependence	.	F10-F19
DAP001433	Tiazofurin	Cancer	140-229	C00-C96
DAP001434	Tinzaparin	Deep vein thrombosis; Pulmonary embolism	415.1, 453.40	I26, I80.2
DAP001435	Triclosan	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001436	Ultracet	Pain	338,780	R52, G89
DAP001437	Vinpocetine	Acute ischemic stroke	434.91	I61-I63
DAP001439	Zemaira	Emphysema	492	J43
DAP001440	AD-4833	Diabetes mellitus	250	E08-E13
DAP001441	Ambrisentan	Pulmonary arterial hypertension	416	I27.0, I27.2
DAP001442	Candesartan cilexetil	Cerebrovascular ischaemia	.	G45.9,I67.8
DAP001442	Candesartan cilexetil	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DAP001442	Candesartan cilexetil	Hypertension	401	I10, I11, I12, I13, I15
DAP001443	Dexlansoprazole	Erosive esophagitis; Non-erosive gastro-esophageal reflux disease	530	K20, K21
DAP001444	Febuxostat	Hyperuricaemia in gout	274, 790.6	E79.0, M10
DAP001445	Lasofoxifene	Osteoporosis	733	M80-M81
DAP001445	Lasofoxifene	Postmenopausal osteoporosis	733	M80-M81
DAP001446	Leuprorelin acetate	Contraception	.	Z30
DAP001446	Leuprorelin acetate	Prostate cancer	185	C61
DAP001447	Revolade/Promacta	Chronic liver disease; Hepatitis C induced thrombocytopaenia	287.3, 287.4, 287.5	D69.6, P61.0
DAP001447	Revolade/Promacta	Idiopathic thrombocytopenic purpura	287.31	D69.3
DAP001447	Revolade/Promacta	Oncology-related thrombocytopaenia	287.3, 287.4, 287.5	D69.6, P61.0
DAP001448	Tocilizumab	Juvenile idiopathic arthritis	714.3	M08.0
DAP001448	Tocilizumab	Rheumatold arthritis	714	M05-M06
DAP001449	Topetecan	Small-cell lung cancer	140-229, 162, 162.9, 204.0	C00-C96, C33-C34, C34.90, C91.0
DAP001450	Treximet	Migraine	346	G43
DAP001451	Tyverb/Tykerb	Gastric cancer	151	C16
DAP001451	Tyverb/Tykerb	Head and neck squamous cell carcinoma	199	C44
DAP001451	Tyverb/Tykerb	Refractory breast cancer	174, 175	C50
DAP001452	Amfepramone	Obesity	278	E66
DAP001453	Artemether	Malaria	84	B50-B54
DAP001453	Artemether	Plasmodium infection	.	B54
DAP001454	Artemisinin	Malaria	84	B50-B54
DAP001455	Artemisinin SP	Malaria	84	B50-B54
DAP001456	Artesunate	Malaria	84	B50-B54
DAP001456	Artesunate	Plasmodium infection	.	B54
DAP001457	Asasantin	Cerebrovascular ischaemia	434.91	I61-I63
DAP001458	Balofloxacin	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001459	Barbiturate	Anaesthesia	338	R52
DAP001460	Benztropine mesylate	Parkinson's disease	332	F02.3, G20
DAP001461	B-Lactams	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001462	Bromocryptine mesylate	Parkinson's disease	332	F02.3, G20
DAP001463	Cefozopran	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001464	Chlorproguanil	Malaria	84	B50-B54
DAP001465	Ciprofloxacin XR	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001466	CT-102	Diabetic foot ulcer	707	L88-L89
DAP001468	D-cycloserine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001468	D-cycloserine	Obsessive-compulsive disorder	300.3	F42
DAP001469	Desvenalfaxine succinate	Fibromyalgia	729.1	M79.7
DAP001470	Dexamfetamine	Attention deficit hyperactivity disorder	314	F90
DAP001471	Dihydroartemisinin	Malaria	84	B50-B54
DAP001472	DWP-401	Diabetic foot ulcer	707	L88-L89
DAP001476	Etravirine	HIV infections	42	B20
DAP001476	Etravirine	HIV-1 infections	42	B20
DAP001477	Faropenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001477	Faropenem	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001478	Fenfluramine	Obesity	278	E66
DAP001479	Fluoroquinolone	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001480	GMA-161	Idiopathic thrombocytopenic purpura	287.31	D69.3
DAP001481	Guanfacine extended release	Attention deficit hyperactivity disorder	314	F90
DAP001482	HEGF	Diabetic foot ulcer	707	L88-L89
DAP001483	Ibutamoren	Fibromyalgia	729.1	M79.7
DAP001483	Ibutamoren	Growth hormone deficiency	.	E23.0
DAP001484	Indiplon	Fibromyalgia; Insomnia	307.4, 327.0, 729.1	F51.0, G47.0, M79.7
DAP001484	Indiplon	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DAP001485	Isoxyl	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001486	Ispaghula	Irritable bowel syndrome	564.1	K58
DAP001488	Lanreotide Autogel	Acromegaly	253	E22.0
DAP001489	Levetriacetam	Fibromyalgia	729.1	M79.7
DAP001490	Lipo-alprostadil	Diabetic foot ulcer	707	L88-L89
DAP001491	Lumefantrine	Malaria	84	B50-B54
DAP001491	Lumefantrine	Plasmodium infection	.	B54
DAP001492	Macrolides	Asthma	493	J45
DAP001492	Macrolides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001493	MCB-3837	Malaria; Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 084, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, B50-B54
DAP001494	Mebeverine	Irritable bowel syndrome	564.1	K58
DAP001495	Meglitinides	Hyperglycaemia in type 2 diabetes mellitus	250, 790.29	E11, R73.9
DAP001496	Methamfetamine	Pain; Inflammatory diseases	338,780	R52, G89
DAP001497	Nemonapride	Schizophrenia	295	F20
DAP001499	Nitrous oxide	Anaesthesia	338	R52
DAP001499	Nitrous oxide	Anxiety disorder	300	F40-F42
DAP001500	Novobiocine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001502	OZ277	Malaria	.	B50-B54
DAP001502	OZ277	Malaria	84	B50-B54
DAP001503	PD-172760	Schizophrenia	295	F20
DAP001504	Piperaquine	Malaria	84	B50-B54
DAP001506	Pravigard	Myocardial infarction; Cerebrovascular ischaemia	410, 434.91	I21, I22, I61-I63
DAP001507	Proquanil	Anxiety disorder	300	F40-F42
DAP001507	Proquanil	Malaria	84	B50-B54
DAP001508	Pyronaridine	Malaria	84	B50-B54
DAP001508	Pyronaridine	Plasmodium infection	.	B54
DAP001509	Quinolones	Plasmodium falciparum infection	.	B54
DAP001509	Quinolones	Tuberculosis	010-018	A15-A19
DAP001510	Raltegravir	HIV infections	42	B20
DAP001512	Rifampicin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001512	Rifampicin	Fungal infection	.	B35-B49
DAP001515	Ropinirole HCl	Parkinson's disease	332	F02.3, G20
DAP001516	Rufinamide	Epilepsy	345	G40
DAP001516	Rufinamide	Seizures associated with LennoxCGastaut syndrome	.	R56.9
DAP001519	Simvistatin	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DAP001519	Simvistatin	Hyperlipidemia	272.0-272.4	E78
DAP001520	Sitaxsentan	Pulmonary arterial hypertension	416	I27.0, I27.2
DAP001521	SM-101	Autoimmune diseases	279.4	D84.9, M35.9
DAP001521	SM-101	Idiopathic thrombocytopenic purpura	287.31	D69.3
DAP001522	Sodium oxybate	Fibromyalgia	729.1	M79.7
DAP001523	Sulfonamides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001524	Sulphadoxine	Malaria	84	B50-B54
DAP001525	TC-5280	Schizophrenia	295	F20
DAP001526	Tegaserod	Dyspepsia	536.8	K30
DAP001526	Tegaserod	Gastro-oesophageal reflux	530	K21
DAP001526	Tegaserod	Irritable bowel syndrome	564.1	K58
DAP001527	Tetracyclines	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DAP001527	Tetracyclines	Multiple sclerosis	340	G35
DAP001528	Tianeptine	Depression	311	F32
DAP001528	Tianeptine	Major depressive disorder	296.2, 296.3	F32, F33
DAP001530	Tolvaptan	Heart failure	428	I50
DAP001530	Tolvaptan	Hypervolaemic hyponatraemia; Euvolaemic hyponatraemia	276.1	E87.1
DAP001530	Tolvaptan	Hyponatremia	.	E87.1
DAP001531	Tranilast	Ocular allergy	360-379	H00-H59
DAP001532	Trihexyphenidyl HCl	Parkinson's disease	332	F02.3, G20
DAP001533	Trimipramine	Anxiety disorder	300	F40-F42
DAP001533	Trimipramine	Depression	311	F32
DAP001534	Tropisetron	Fibromyalgia	729.1	M79.7
DAP001535	Varenicline tartrate	Tobacco dependence	305.1	F17
DAP001537	Ximelegatran	Atrial fibrillation; Venous thromboembolism; Myocardial infarction	410, 427.31, 453	I21, I22, I48, I80-I82
DAP001538	Fomivirsen sodium	CMV retinitis	78.5	B25.8, H30.9
DAP001539	Zoledronic acid	Postmenopausal osteoporosis	733	M80-M81
DAP001540	Ziconotide	Pain	.	G89
DAP001540	Ziconotide	Pain	338,780	R52, G89
DAP001540	Ziconotide	Traumatic brain injury	800, 801, 803, 804, 850-854	S06
DAP001541	Valdecoxib	Osteoarthritis; Rheumatoid arthritis	714, 715	M05-M06, M15-M19, M47
DAP001542	Flucytosine	Endocarditis	421	I33
DAP001542	Flucytosine	Fungal infection	110-118	B35-B49
DAP001543	Vitamin A	Night blindness	368.6	H53.6
DAP001544	Vildagliptin	Type 2 diabetes	250.00, 250.02	E11
DAP001545	Cinryze	Hereditary angioedema	277.6	D84.1
DAP001546	Vitamin B3	Lipid disorders; Cardiovascular disease	272, 390-459	E78, I00-I99
DAP001546	Vitamin B3	Niacin deficiency	.	E52
DAP001547	Milnacipran HCl	Fibromyalgia	729.1	M79.7
DAP001548	Prasugrel	Acute coronary syndrome undergoing percutaneous coronary intervention	444	I74
DAP001549	Pralatrexate	Breast cancer	174, 175	C50
DAP001549	Pralatrexate	Peripheral T cell lymphoma	202.7	C84.4
DAP001550	Pazopanib HCl	Renal cell carcinoma	189	C64
DAP001551	Dalfampridine	Improving walking in patients with multiple sclerosis	340	G35
DAP001552	Carglumic acid	Acute hyperammonaemia	270.6	E72.2
DAP001553	Alcaftadine	Allergic conjunctivitis	372.14	H10.45
DAP001554	Ulipristal	Contraception	.	Z30
DAP001555	Dabigatran	Stroke in atrial fibrillation	434.91	I61-I63
DAP001556	Tesamorelin	HIV lipodystrophy	272.6	E88.1
DAP001557	Eribulin	Breast cancer	174, 175	C50
DAP001558	Meningococcal groups A, C, Y and W-135 conjugate vaccine	Meningococcal disease	.	A39.0
DAP001558	Meningococcal groups A, C, Y and W-135 conjugate vaccine	Meningococcal disease caused by Neisseria meningitidis A C Y and W-135	.	A39.0
DAP001559	Pneumococcal 13-valent conjugate vaccine	Streptococcus pneumoniae infection	.	J13
DAP001559	Pneumococcal 13-valent conjugate vaccine	Streptococcus pneumoniae infection	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
DAP001560	Alpha1-proteinase inhibitor	Emphysema	492	J43
DAP001561	Ipilimumab	Late-stage melanoma	172	C43
DAP001561	Ipilimumab	Prostate cancer	.	C61
DAP001562	Ixabepilone	Advanced breast cancer	174, 175	C50
DAP001562	Ixabepilone	Breast cancer	174, 175	C50
DAP100399	Doxycycline	Advanced gum disease; chronic periodontitis	523.4, 523.5	K05.3, K05.4
DCL000001	Sodium stibogluconate	Cancers	140-229	C00-C96
DCL000001	Sodium stibogluconate	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000002	PG-530742	Osteoarthritis; Myocardial infarction	410, 715	I21, I22, M15-M19, M47
DCL000003	BMS 275291	NSCLC; Hormone-refractory prostate cancer; Kaposi's Sarcoma	140-229, 162, 176, 185, 204.0	C00-C96, C33, C33-C34, C34, C46, C61, C91.0
DCL000003	BMS 275291	Solid tumours	.	C00-C75,C7A,C7B
DCL000004	Prinomastat	Brain cancer	191	C71
DCL000004	Prinomastat	Lung cancer; Prostate cancer	140-229, 162, 185	C00-C96, C33-C34, C61
DCL000005	Marimastat	Pancreatic cancer	.	C25
DCL000005	Marimastat	Pancreatic cancer; Lung cancer	140-229, 157, 162	C00-C96, C25, C33-C34
DCL000006	SNS-314	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000007	SNS-032	B-lymphoid malignancies; Advanced solid tumours	140-199, 202.8	C00-C75, C7A, C7B, C85.1
DCL000007	SNS-032	Solid tumours	.	C00-C75,C7A,C7B
DCL000008	Neovastat	Cancer; Psoriasis	140-229, 696	C00-C96, L40
DCL000008	Neovastat	Lung cancer	.	C33-C34
DCL000008	Neovastat	Non-small Cell Lung cancer; Renal cell carcinoma	140-229, 162, 162.9, 189, 204.0	C00-C96, C33, C33-C34, C34, C34.90, C64, C91.0
DCL000009	XL418	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000010	CYC116	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000011	XL999	Advanced malignancies	140-229	C00-C96
DCL000011	XL999	Solid tumours	.	C00-C75,C7A,C7B
DCL000012	JSM 6427	Macular degeneration	362.5	H35.3
DCL000013	R1295	Rheumatold arthritis	714	M05-M06
DCL000014	BB-3644	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000014	BB-3644	Cancer	140-229	C00-C96
DCL000015	Curaxin CBLC102	Prostate cancer; Kidney cancer	140-229, 185	C00-C96, C61
DCL000016	UCN-01	Non-small-cell lung cancer	162	C33, C34
DCL000017	XL844	Advanced solid tumours; Advanced lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DCL000017	XL844	Solid tumours	.	C00-C75,C7A,C7B
DCL000018	CAP-232	Pain	.	G89
DCL000018	CAP-232	Refractory renal cell carcinoma	189	C64
DCL000018	CAP-232	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000019	Dermolastin	Atopic Dermatitis	273.4, 691.8, 692.9	E88.0, L20, L20-L30
DCL000019	Dermolastin	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000019	Dermolastin	Emphysema	492	J43
DCL000020	CPG 52364	Systemic lupus erythematosus	710	M32
DCL000021	PRLX 93936	Myeloma	203	C90.0
DCL000021	PRLX 93936	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000022	GSK 659032	Cardiovascular disease	390-459	I00-I99
DCL000023	SB681323	Chronic rheumatoid Arthritis	714	M05-M06
DCL000023	SB681323	Rheumatold arthritis; Coronary artery disease	320-359, 338, 338.2, 410-414, 429.2, 710-719, 714,780	G00-G99, I20-I25, M00-M25, M05-M06, R52, R52.1-R52.2, G89
DCL000024	GSK 796406	Hypertension	401	I10, I11, I12, I13, I15
DCL000025	A-425619	Pain	338,780	R52, G89
DCL000026	A-993610	Pain	338,780	R52, G89
DCL000027	ABT-102	Chronic pathological pain	338,780	R52, G89
DCL000028	ABT-239	Alzheimer's disease; Schizophrenia	295, 331.0	F20, G30
DCL000028	ABT-239	Cognitive impairment	.	F06.7
DCL000029	ABT-869	Advanced colorectal cancer	153, 154	C18-C21
DCL000029	ABT-869	Liver cancer; Digestive system diseases; Adenocarcinoma	140-199, 140-239, 150-159, 155, 210, 211, 570-574	C00-C75, C00-C96, C00-D48, C15-C26, C22.0, C7A, C7B, D12-D13, K70-K77
DCL000029	ABT-869	Solid tumours	.	C00-C75,C7A,C7B
DCL000030	ACCLAIM	Angina	413	I20
DCL000030	ACCLAIM	Angina; Coronary artery disease	410-414, 413, 429.2	I20, I20-I25
DCL000031	ADX10059	Anxiety disorder	.	F40-F42
DCL000031	ADX10059	Anxiety disorder	300	F40-F42
DCL000031	ADX10059	Migraine; Cluster headaches; Gastroesophageal reflux disease	, 339, 339.00, 339.01, 339.02, 346, 530, 784.0	G43, G43-G44, G44.0, K21, R51
DCL000032	ADX-48621	Depression	311	F32
DCL000032	ADX-48621	Mood disorder	.	F30-F39
DCL000033	Aerovant	Asthma	493	J45
DCL000034	Almorexant	Sleep disorders	307.4, 327, 780.5	F51, G47
DCL000034	Almorexant	Sleep disorders; Insomnia	307.4, 307.41, 307.42, 327, 327.0, 780.5, 780.51, 780.52	F51, F51.0, G47, G47.0
DCL000035	Alvespimycin hydrochloride	Ovarian cancer; Refractory hematological malignancies	140-229, 140-239, 183, 200-209	C00-C96, C00-C96, C56, C81-C96
DCL000035	Alvespimycin hydrochloride	Refractory acute myelogenous leukemia; HER2-positive metastatic breast cancer and leukaemia	140-229, 174, 175, 205.0, 208.9	C00-C96, C50, C91-C95, C92.0
DCL000036	ALX-0081	Thrombocytopenia	.	D69.6
DCL000036	ALX-0081	Thrombosis; Cardiovascular disorders	390-459, 437.6, 453, 671.5, 671.9	I00-I99, I80-I82
DCL000037	AM103	Cardiovascular disease	.	I00-I99
DCL000037	AM103	Cardiovascular disease	390-459	I00-I99
DCL000038	AM-111	Hearing loss	389	H90-H91
DCL000038	AM-111	Neurological disease	.	G00-G99
DCL000039	AM803	Asthma	493	J45
DCL000039	AM803	Inflammatory disorders	.	.
DCL000040	AMD-070	HIV infections	42	B20
DCL000041	AMD-3100	Chronic lymphocytic leukaemia; Small lymphocytic lymphoma	202.8, 204.0, 204.1, 204.1V10.60, 208.9	C81-C96, C91-C95, C91.0, C91.1
DCL000041	AMD-3100	HIV infections	42	B20
DCL000042	Amelubant	Chronic obstructive pulmonary disease; Cystic fibrosis; Asthma	277.0, 460-519, 490-492, 493, 494-496, 709.2	E84, J00-J99, J40-J44, J45, J47, L90.5
DCL000042	Amelubant	Cystic fibrosis	277	E84
DCL000042	Amelubant	Rheumatold arthritis	714	M05-M06
DCL000043	AMG 076	Obesity	278	E66
DCL000044	AMG-517	Chronic pathological pain	338,780	R52, G89
DCL000045	AMG-8562	Pain	338,780	R52, G89
DCL000046	AMG-8563	Pain	338,780	R52, G89
DCL000047	AN0128	Atopic Dermatitis	691.8, 692.9	L20, L20-L30
DCL000047	AN0128	Atopic dermatitis	691.8	L20
DCL000047	AN0128	Psoriatic disorders	696	L40
DCL000047	AN0128	Psoriatic disorders; Acne	696	L40
DCL000048	Anacetrapib	Atherosclerosis	414.0, 440	I70
DCL000048	Anacetrapib	Hyperlipidemia	.	E78.5
DCL000048	Anacetrapib	Hyperlipidemia	272.0-272.4	E78
DCL000049	Anamorelin	Cachexia; Anorexia	307.1, 799.4	F50.0-F50.1, R64
DCL000049	Anamorelin	Carbohydrate metabolism disorder	.	E73-E74
DCL000050	Anatibant	Traumatic brain injury	800, 801, 803, 804, 850-854	S06
DCL000051	APD668	Diabetes mellitus type 2	250	E11
DCL000052	ARQ 197	Solid tumours; Pancreatic cancer	140-199, 140-229, 157, 210-229	C00-C75, C00-C96, C25, C7A, C7B, D10-D36, D3A
DCL000053	ARRY-520	Cancer	.	C00-C97
DCL000053	ARRY-520	Cancer	140-229	C00-C96
DCL000054	ARRY-797	Cancer; Inflammatory disorders	140-229	C00-C96
DCL000054	ARRY-797	Oral facial pain	338,780	R52, G89
DCL000054	ARRY-797	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
DCL000055	AS1409	Kidney cancer; Melanoma	140-229, 172	C00-C96, C43
DCL000055	AS1409	Melanoma	.	C43
DCL000056	AT-101	Lymphoid leukemia; Non-Hodgkin's lymphoma; Prostate cancer	140-229, 185, 200, 202, 202.8, 208.9	C00-C96, C61, C81-C96, C82-C85, C91-C95
DCL000056	AT-101	Prostate cancer	.	C61
DCL000057	AT13387	Cancer	140-229	C00-C96
DCL000057	AT13387	Melanoma	172	C43
DCL000058	AT7519	Non-Hodgkin's lymphoma	200, 202	C82-C85
DCL000058	AT7519	Solid tumours	.	C00-C75,C7A,C7B
DCL000058	AT7519	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000059	AT9283	Leukemia; Myeloid	208.9	C91-C95
DCL000059	AT9283	Solid tumours	.	C00-C75,C7A,C7B
DCL000060	AVT-02 UE	Skin infections	.	L00-L99
DCL000060	AVT-02 UE	Skin infections	001-139, 680-709	A00-B99, L00-L99
DCL000061	AZD3409	Solid tumours	.	C00-C75,C7A,C7B
DCL000061	AZD3409	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000062	AZD-9684	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DCL000063	BCTC	Pain	338,780	R52, G89
DCL000064	BCX-34	Lymphoma	.	C81-C96
DCL000064	BCX-34	Psoriasis; Cutaneous T-cell lymphoma	202.1, 202.2, 202.8, 696	C81-C96, C84.0, C84.1, L40
DCL000065	BCX-4208	Gout	274.00274.1274.8274.9	M10
DCL000065	BCX-4208	Moderate to Severe Plaque Psoriasis	696	L40
DCL000066	BF-Derm1	Skin infections	.	L00-L99
DCL000066	BF-Derm1	Skin infections	680-709	L00-L99
DCL000067	BI 2536	Acute myeloid leukemia	.	C92.0
DCL000067	BI 2536	Advanced or metastatic non-small cell lung cancer	162	C33-C34
DCL000067	BI 2536	Metastatic hormone-refractory prostate cancer	185	C61
DCL000068	BI 6727	Acute myeloid leukemia	205	C92.0
DCL000069	Bimosiamose	Asthma	.	J45
DCL000069	Bimosiamose	Asthma	493	J45
DCL000069	Bimosiamose	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000069	Bimosiamose	Inflammatory disorders	.	.
DCL000069	Bimosiamose	Psoriatic disorders; Atopic dermatitis	691.8, 692.9, 696	L20, L20-L30, L40
DCL000070	Biomed 101	Renal cell carcinoma	189	C64
DCL000071	BIRB 796	Inflammatory bowel disease	555, 556	K50, K51
DCL000071	BIRB 796	Psoriatic disorders	696	L40
DCL000072	BMS-201038	Familial hypercholesterolemia	.	E78.0
DCL000072	BMS-201038	Familial hypercholesterolemia	272	E78.0
DCL000073	BMS214662	Cancer	140-229	C00-C96
DCL000073	BMS214662	Non-small cell lung cancer	.	C33-C34
DCL000074	Bremelanotide	Erectile dysfunction	.	F52.2,N48.4
DCL000074	Bremelanotide	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DCL000074	Bremelanotide	Sexual dysfunction	302.7	F52
DCL000075	C1-INH	Hereditary angioedema	277.6	D84.1
DCL000076	C326	Crohn's disease	.	K50
DCL000076	C326	Inflammatory disorders	.	.
DCL000077	Capridine-beta	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL000077	Capridine-beta	Psoriasis	.	L40
DCL000077	Capridine-beta	Psoriatic disorders	696	L40
DCL000079	CC-401	Cancer	.	C00-C97
DCL000079	CC-401	Myeloid leukemia	205	C92
DCL000080	CCX915	Multiple sclerosis	340	G35
DCL000080	CCX915	Neurological disease	.	G00-G99
DCL000081	CD-NP	Myocardial infarction; Heart disease	390-429, 410	I00-I52, I21, I22
DCL000082	Celgosivir	Hepatitis C virus infection	.	B17.1,B18.2
DCL000082	Celgosivir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000083	CGP71683A	Obesity	278	E66
DCL000084	CGX-1160	Acute or chronic pain	338,780	R52, G89
DCL000084	CGX-1160	Pain	.	G89
DCL000085	CHR-2797	Acute myeloid leukemia	205	C92.0
DCL000085	CHR-2797	Myeloid leukemia	205	C92
DCL000085	CHR-2797	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000086	CI-1033	Lymphoma	.	C81-C96
DCL000086	CI-1033	NSCLC; Colorectal cancer; Head and neck cancer; Thyroid cancer; Breast cancer; Mesothelioma; Melanoma	140-229, 162, 163, 172	C00-C96, C33, C34, C43, C45
DCL000087	Cilansetron	Irritable Bowel Syndrome	564.1, 787.91	A09, K58, K59.1
DCL000087	Cilansetron	Irritable bowel syndrome	.	K58
DCL000088	Cipralisant	Attention deficit hyperactivity disorder	314	F90
DCL000088	Cipralisant	Sleep disorders	.	F51,G47
DCL000089	CNF1010	Solid tumours; Chronic myelogenous leukemia	140-199, 205.1, 208.9, 210-229	C00-C75, C7A, C7B, C91-C95, C92.1, D10-D36, D3A
DCL000090	COR100140	Atherosclerosis	414.0, 440	I70
DCL000090	COR100140	Inflammatory diseases	.	.
DCL000091	CP-609,754	Bladder cancer	188	C67
DCL000092	CP-690,550	Kidney transplant rejection	996.81	T86.1
DCL000092	CP-690,550	Rheumatoid arthritis	710-719, 714	M00-M25, M05, M05-M06, M06
DCL000092	CP-690,550	Rheumatold arthritis	714	M05-M06
DCL000093	CRA-028129	Psoriatic disorders	696	L40
DCL000094	CRF-1 antagonist	Anxiety disorder; Irritable bowel syndrome	300, 564.1	F40-F42, K58
DCL000094	CRF-1 antagonist	Depression	311	F32
DCL000094	CRF-1 antagonist	Mood disorder	.	F30-F39
DCL000095	CRx-191	Psoriatic disorders	696	L40
DCL000096	CT-322	Cancer	140-229	C00-C96
DCL000096	CT-322	Macular degeneration	362.5	H35.3
DCL000097	CTS-21166	Alzheimer's disease	.	G30,F00
DCL000097	CTS-21166	Alzheimer's disease	331	G30
DCL000098	CYC-800	Cancer	140-229	C00-C96
DCL000099	CYT 99007	Acquired immunodeficiency syndrome	.	B20-B24
DCL000099	CYT 99007	Cancer; Immunodeficiency	042, 140-229, 279.3	B20, C00-C96, D84.9
DCL000100	DAP-81	Cancer	140-229	C00-C96
DCL000101	Dapagliflozin	Diabetes mellitus type 2	250	E11
DCL000101	Dapagliflozin	Type 2 diabetes	250.00, 250.02	E11
DCL000102	Darapladib	Arteriosclerosis	.	I70
DCL000102	Darapladib	Atherosclerosis	414.0, 440	I70
DCL000103	Dexloxiglumide	Irritable Bowel Syndrome; Gastroesophageal reflux disease	530, 564.1	K21, K58
DCL000103	Dexloxiglumide	Irritable bowel syndrome	.	K58
DCL000104	DG031	Asthma	.	J45
DCL000104	DG031	Coronary Artery disease; Heart attack	410, 410-414, 429.2	I20-I25, I21-I22
DCL000105	DG041	Peripheral vascular disease	443.9	I73.9
DCL000106	DG051	Myocardial infarction	.	I21-I22
DCL000106	DG051	Myocardial infarction	410	I21, I22
DCL000107	E2012	Alzheimer's disease	331	G30
DCL000108	Ecallantide	Hereditary angioedema	277.6	D84.1
DCL000109	Enzastaurin	Brain cancer; Central nervous system tumors	191	C71
DCL000109	Enzastaurin	Glioblastoma multiforme	191	C71
DCL000109	Enzastaurin	Non-Hodgkin's lymphoma	200, 202	C82-C85
DCL000109	Enzastaurin	Solid tumours	.	C00-C75,C7A,C7B
DCL000110	Exherin	Cancer	.	C00-C97
DCL000110	Exherin	Ovarian cancer; Breast cancer; Melanoma	140-229, 172, 174, 175, 183	C00-C96, C43, C50, C56
DCL000110	Exherin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000111	FG-2216	Anemia	.	D50-D64
DCL000111	FG-2216	Anemia; Kidney disease	280-285, 580-589	D50-D64, N00-N29
DCL000112	FG-4592	Anemia; Kidney disease	280-285, 580-589	D50-D64, N00-N29
DCL000113	FGF-1	Peripheral vascular disease; Ulcers	325, 430-459, 443.9	G45-G46, I60-I95, I73.9
DCL000113	FGF-1	Severe coronary heart disease	414	I25.1
DCL000114	Fibrostat	Burns and burn infection; Scar Tissue	001-139	A00-B99
DCL000115	FK-228	Cutaneous T-Cell Lymphoma; Lymphoma; Renal Cell Carcinoma; Prostate cancer	140-229, 185, 189, 202.1, 202.2, 202.8	C00-C96, C61, C64, C81-C96, C84.0, C84.1
DCL000115	FK-228	Lymphoid leukemia; Myeloid leukemia	205, 208.9	C91-C95, C92
DCL000115	FK-228	Pancreatic cancer; Solid tumors; Multiple myeloma	140-199, 140-229, 157, 203.0, 210-229	C00-C75, C00-C96, C25, C7A, C7B, C90.0, D10-D36, D3A
DCL000116	Flavopiridol	Chronic lymphocytic leukaemia	204.1	C91.1
DCL000116	Flavopiridol	Graft-versus-host disease	.	D89.811
DCL000116	Flavopiridol	Hepatocellular carcinoma	155	C22.0
DCL000116	Flavopiridol	Lymphoma	202.8	C81-C96
DCL000117	Forodesine	Refractory cutaneous T-cell lymphoma; B-cell acute lymphoblastic leukemia	202.1, 202.2, 202.8, 204.0, 208.9	C81-C96, C84.0, C84.1, C91-C95, C91.0
DCL000118	GHRH analog	Growth hormone deficiency; Lipodystrophy; Chronic renal failure	272.6, 584, 585, 585.9585.1-585.5403	E88.1, N17, N18, N19
DCL000118	GHRH analog	Hormone deficiency	.	E00-E90
DCL000119	GI 181771	Obesity	.	E66
DCL000119	GI 181771	Obesity	278	E66
DCL000120	GMX1777	Lymphoma; Solid tumors	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, D10-D36, D3A
DCL000120	GMX1777	Solid tumours	.	C00-C75,C7A,C7B
DCL000121	GRC-6211	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
DCL000122	GRN163L	Breast cancer; Lymphoid leukemia; Multiple Myeloma	140-229, 174, 175, 203.0, 208.9	C00-C96, C50, C90.0, C91-C95
DCL000122	GRN163L	Solid tumours	.	C00-C75,C7A,C7B
DCL000122	GRN163L	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000123	GSK461364	Advanced solid tumours; Non-Hodgkin's Lymphoma	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C82-C85, D10-D36, D3A
DCL000124	GSK-923295	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000125	Guanilib	Crohn's disease	.	K50
DCL000125	Guanilib	Crohn's disease; Ulcerative colitis; Inflammatory bowel disease	555, 556, 556.9	K50, K50-K52, K51
DCL000126	GW 468816	Tobacco dependence	305.1	F17
DCL000127	HIF-1alpha	Solid tumours	.	C00-C75,C7A,C7B
DCL000127	HIF-1alpha	Solid tumours; Lymphoma	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, D10-D36, D3A
DCL000128	HMN-214	Pancreatic and prostate cancers	157, 185	C25, C61
DCL000128	HMN-214	Solid tumours	.	C00-C75,C7A,C7B
DCL000129	HspE7 (TLR3 agonist adjuvant)	Anal intraepithelial neoplasia	154	C21
DCL000129	HspE7 (TLR3 agonist adjuvant)	Human papillomavirus infections	078.1079.4	B97.7
DCL000130	ICA-105665	Epilepsy	.	G40
DCL000130	ICA-105665	Epilepsy	345	G40
DCL000131	Icatibant	Hereditary angioedema	277.6	D84.1
DCL000131	Icatibant	Liver disease	570-574	K70-K77
DCL000132	Ilepatril	Hypertension	401	I10, I11, I12, I13, I15
DCL000132	Ilepatril	Hypertension; Renal failure; Heart failure; Diabetic nephropathy	250, 401, 428, 580-599, 584, 585	E08-E13, I10, I11, I12, I13, I15, I50, N00-N29, N17, N18, N19
DCL000133	Implitapide	Hyperlipidemia	.	E78.5
DCL000133	Implitapide	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DCL000134	INCB13739	Diabetes mellitus	.	E10-E14
DCL000134	INCB13739	Diabetes mellitus type 1	250	E10
DCL000134	INCB13739	Diabetes mellitus type 2	250	E11
DCL000135	INCB3284	Obese insulin-resistant disorders	250	E11
DCL000135	INCB3284	Rheumatold arthritis	714	M05-M06
DCL000136	INO-1001	Brain cancer	.	C71
DCL000136	INO-1001	Brain cancer	191	C71
DCL000136	INO-1001	Myocardial infarction; Cardiovascular disorders	390-459, 410	I00-I99, I21, I22
DCL000137	IPI-504	Gastrointestinal stromal tumors	150-159	C15-C26
DCL000137	IPI-504	Non-small cell lung cancer	162	C33, C34
DCL000137	IPI-504	Prostate cancer	185	C61
DCL000137	IPI-504	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000138	Isofagomine tartrate	Metabolic disease	270-279	E70-E89
DCL000139	Ispinesib	Head and neck cancer; Renal cell carcinoma; Ovarian cancer; Solid tumors	140-149, 140-199, 140-229, 183, 189, 210-229	C00-C75, C00-C96, C07-C14, C32-C33, C56, C64, C7A, C7B, D10-D36, D3A
DCL000139	Ispinesib	Lung cancer	162	C33-C34
DCL000139	Ispinesib	Pediatric cancer	.	.
DCL000139	Ispinesib	Solid tumours	.	C00-C75,C7A,C7B
DCL000140	KAI-1455	Ischemic reperfusion injury	.	.
DCL000141	KAI-9803	Myocardial infarction	410	I21, I22
DCL000141	KAI-9803	Reperfusion injury and heart attacks; Acute myocardial infarction	410	I21, I21-I22, I22
DCL000142	KC706	Cardiovascular disease	390-459	I00-I99
DCL000142	KC706	Inflammatory bowel disease; Rheumatoid arthritis; Cardiovascular disorders; Psoriasis	390-459, 555, 556, 696, 710-719, 714	I00-I99, K50, K51, L40, M00-M25, M05-M06
DCL000143	KD3010	Metabolic disease; Obesity	270-279, 278	E66, E70-E89
DCL000143	KD3010	Obesity	.	E66
DCL000144	KOS-2187	Gastrointestinal disease	.	K00-K93
DCL000144	KOS-2187	Gastrointestinal disorders; Gastroesophageal reflux disease	530, 530-558	K20-K64, K21
DCL000145	KU-0059436	Gastric cancer; Breast cancer; Ovarian cancer	140-229, 151, 174, 175, 183	C00-C96, C16, C50, C56
DCL000145	KU-0059436	Neoplasm metastasis; Solid tumors	140-199, 140-239, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000146	Labradimil	Brain cancer	140-229, 191	C00-C96, C71
DCL000147	Lapaquistat acetate	Hyperlipidemia	272.0-272.4	E78
DCL000148	LC-445	Cancer	140-229	C00-C96
DCL000149	Lintitript	Pancreatic cancer	.	C25
DCL000149	Lintitript	Pancreatic cancer; Obesity	140-229, 157, 278	C00-C96, C25, E66
DCL000150	L-NAME	Hypertension; Angina	401, 413	I10, I11, I12, I13, I15, I20
DCL000151	L-NMMA	Angina	413	I20
DCL000151	L-NMMA	Cardiovascular disease	.	I51.6
DCL000152	Lonafarnib	Non-small cell lung cancer	162	C33, C34
DCL000153	Lonidamine	Benign Prostatic hyperplasia; Prostate disorders	600	N40
DCL000154	LR3001	Cancer	.	C00-C97
DCL000154	LR3001	Myeloid leukemia	205	C92
DCL000155	LTB 019	Asthma	.	J45
DCL000155	LTB 019	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000156	LY293111	Pancreatic cancer	157	C25
DCL000157	LY335979	Acute myeloid leukemia	205	C92.0
DCL000157	LY335979	Cancer	140-229	C00-C96
DCL000158	LY354740	Anxiety disorder	.	F40-F42
DCL000158	LY354740	Psychosis; Schizophrenia; Schizoaffective Disorder	290-299, 295, 295.70	F20, F20-F29, F25
DCL000159	LY404039	Psychosis; Schizophrenia; Schizoaffective Disorder	290-299, 295, 295.70	F20, F20-F29, F25
DCL000159	LY404039	Schizophrenia	295	F20
DCL000160	M-100240	Hypertension	401	I10, I11, I12, I13, I15
DCL000160	M-100240	Hypotension	.	I95
DCL000161	MB07803	Diabetes mellitus type 2	.	E11
DCL000161	MB07803	Diabetes mellitus type 2	250	E11
DCL000162	MBX-8025	Dyslipidemia	272	E78
DCL000162	MBX-8025	Hyperlipidemia; Obesity	272.0-272.4, 278	E66, E78
DCL000163	Meclinertant	Colorectal cancer; Prostate cancer; Schizophrenia; Psychosis; Depression; Lung cancer	140-229, 153, 154, 162, 185, 290-299, 295, 295.70, 311	C00-C96, C18-C21, C33-C34, C61, F20, F20-F29, F25, F32
DCL000163	Meclinertant	Inflammatory bowel disease	.	K50,K51
DCL000164	Medusa IL-2	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000164	Medusa IL-2	Cancer	140-229	C00-C96
DCL000165	Midostaurin	Breast cancer; Colorectal cancer	153, 154, 174, 175	C18-C21, C50
DCL000165	Midostaurin	Colon cancer; Breast cancer; CLL; AML; GIST	140-199, 150-159, 200, 202, 202.8, 204.1, 205.0, 210-229	C00-C75, C15-C26, C7A, C7B, C81-C96, C82-C85, C91.1, C92.0, D10-D36, D3A
DCL000166	Migalastat	Fabry disease	272.7	E75.2
DCL000167	Mitemcinal	Gastroparesis	536.3	K31.8
DCL000167	Mitemcinal	Irritable bowel syndrome	564.1	K58
DCL000168	MIV-701	Osteoporosis	733	M80-M81
DCL000169	MLN8054	Advanced malignancies	140-229	C00-C96
DCL000169	MLN8054	Solid tumours	.	C00-C75,C7A,C7B
DCL000169	MLN8054	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000170	MLN8237	Acute myeloid leukemia; Myelodysplastic syndrome; Ovarian cancer	140-229, 183, 205.0, 208.9, 238.7	C00-C96, C56, C91-C95, C92.0, D46
DCL000170	MLN8237	Cancer	.	C00-C97
DCL000170	MLN8237	Haematological malignancies	140-229	C00-C96
DCL000170	MLN8237	Paediatric solid tumours or ALL	140-199	C00-C75, C7A, C7B
DCL000171	MP470	Solid tumours	.	C00-C75,C7A,C7B
DCL000171	MP470	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000172	MS-275	Melanoma; Prostate cancer; Lung cancer; Colorectal cancer	140-229, 153, 154, 172	C00-C96, C18-C21, C43
DCL000172	MS-275	Psychotic disorders	.	F20-F29
DCL000173	MSX-122	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DCL000173	MSX-122	Solid tumours	.	C00-C75,C7A,C7B
DCL000174	NBI-34041	Anxiety disorder; Depression; Irritable bowel syndrome	300, 311, 564.1	F32, F40-F42, K58
DCL000175	NBI-37582	Anxiety disorder; Depression	300, 311	F32, F40-F42
DCL000176	ND1251	Depression	311	F32
DCL000177	NGD-4715	Obesity	278	E66
DCL000178	NGD-8243	Acute or chronic pain	338,780	R52, G89
DCL000178	NGD-8243	Pain	.	G89
DCL000178	NGD-8243	Urinary incontinence	788.3	N39.3, N39.4, R32
DCL000179	NM-702	Angina	.	I20
DCL000179	NM-702	Peripheral vascular disease	443.9	I73.9
DCL000180	NMS-1	Cancer	140-229	C00-C96
DCL000181	NV-52	Inflammatory bowel disease	555, 556	K50, K51
DCL000182	NXN-188	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
DCL000184	Octopamine	Thromboembolic disorders	437.6, 453, 671.5, 671.9	I80-I82
DCL000185	Odanacatib	Osteoporosis	.	M80-M81
DCL000185	Odanacatib	Postmenopausal Women with Osteoporosis	733	M80-M81
DCL000186	OGX-011	Prostate cancer; Breast cancer; Lung cancer	140-229, 162, 174, 175, 185	C00-C96, C33-C34, C50, C61
DCL000187	Olcegepant	Migraine	.	G43
DCL000187	Olcegepant	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
DCL000188	Omapatrilat	Hypertension	.	I10-I15
DCL000188	Omapatrilat	Hypertension	401	I10, I11, I12, I13, I15
DCL000189	ON 019190.Na	Cancer	140-229	C00-C96
DCL000190	ONO-4819	Fracture	.	M48.5
DCL000190	ONO-4819	Ulcerative colitis	556	K51
DCL000191	Osanetant	Depression	311	F32
DCL000191	Osanetant	Schizophrenia	.	F20
DCL000191	Osanetant	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DCL000192	Ostabolin-C	Osteoporosis	.	M80-M81
DCL000192	Ostabolin-C	Osteoporosis; Menopause	627.2, 733.0	M80-M81, N95.0
DCL000193	Pasireotide	Cushing's disease	.	E24.0
DCL000193	Pasireotide	Neuroendocrine tumors; Carcinoid tumor; Pancreatic neuroendocrine tumor	140-199, 157.4, 209, 209.4, 209.5, 209.6, 210-229	C00-C75, C25.4, C75, C7A, C7B, D10-D36, D3A, E34.0
DCL000193	Pasireotide	Pancreatic cancer	157	C25
DCL000194	Perifosine	Non-small cell lung cancer	162	C33, C34
DCL000194	Perifosine	Refractory multiple myeloma; Recurrent malignant glioma; Rare sarcoma's refractory	191, 203.0	C71, C90.0
DCL000194	Perifosine	Solid tumours	.	C00-C75,C7A,C7B
DCL000195	PG-490-88	Cancer	140-229	C00-C96
DCL000196	Phenoxodiol	Late-stage ovarian cancer	183	C56
DCL000196	Phenoxodiol	Lymphoma	.	C81-C96
DCL000196	Phenoxodiol	Prostate cancer	185	C61
DCL000197	PI-88	Hepatocellular carcinoma	155	C22.0
DCL000197	PI-88	Liver cancer	.	C22
DCL000197	PI-88	Prostate cancer; Lung cancer	140-229, 162, 185	C00-C96, C33-C34, C61
DCL000198	Prolarix	Cancer	140-229	C00-C96
DCL000199	PRX-321	Brain cancer; Kidney cancer; Lung cancer	140-229, 162, 191	C00-C96, C33-C34, C71
DCL000199	PRX-321	Cancer	.	C00-C97
DCL000199	PRX-321	Cancer	140-229	C00-C96
DCL000200	PS-938285	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000201	PSN-101	Diabetes mellitus	250	E08-E13
DCL000202	PSN357	Diabetes mellitus type 2	250	E11
DCL000203	PTC299	Solid tumours	.	C00-C75,C7A,C7B
DCL000203	PTC299	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000204	PTH 1-34	Osteoporosis	733	M80-M81
DCL000204	PTH 1-34	Psoriatic disorders	696	L40
DCL000205	PX-12	Cancer	.	C00-C97
DCL000205	PX-12	Gastric cancer	151	C16
DCL000205	PX-12	Pancreatic cancer	157	C25
DCL000206	PX-478	Cancer	140-229	C00-C96
DCL000207	PXD101	Bladder cancer; Ovarian cancer; Cutaneous T-cell lymphoma	140-229, 163, 183, 188, 202.1, 202.2, 202.8	C00-C96, C45, C56, C67, C81-C96, C84.0, C84.1
DCL000207	PXD101	Colorectal cancer	153, 154	C18-C21
DCL000207	PXD101	Myelodysplastic syndromes; Solid Tumors	140-199, 210-229, 238.7	C00-C75, C7A, C7B, D10-D36, D3A, D46
DCL000207	PXD101	Myeloid leukemia; Liver cancer; Sarcoma	140-229, 155, 205, 208.9	C00-C96, C22.0, C91-C95, C92
DCL000207	PXD101	Non-small cell lung cancer	162	C33, C34
DCL000208	R343	Allergic asthma	493	J45
DCL000208	R343	Allergic reaction; Asthma	493, 995.3	J45, T78.4
DCL000209	R411	Asthma	493	J45
DCL000210	R763	Cancer	140-229	C00-C96
DCL000210	R763	Haematological malignancies	200-209	C81-C96
DCL000211	R788	Lymphoma	.	C81-C96
DCL000211	R788	Rheumatold arthritis; Thrombocytopenia; Non-Hodgkin's Lymphoma	200, 202, 202.8, 287.3, 287.4, 287.5, 710-719, 714	C81-C96, C82-C85, D69.6, M00-M25, M05-M06, P61.0
DCL000212	RB-006	Thrombosis; Coronary artery disease; Vascular diseases	325, 410-414, 429.2, 430-459, 437.6, 453, 671.5, 671.9	G45-G46, I20-I25, I60-I95, I80-I82
DCL000213	RDP58	Diarrhea	.	A09,K59.1
DCL000213	RDP58	Ulcerative colitis; Crohn's disease	555, 556, 556.9	K50, K50-K52, K51
DCL000214	Relacatib	Bone metastases	198.5	C79.51
DCL000214	Relacatib	Osteoporosis	.	M80-M81
DCL000214	Relacatib	Osteoporosis	733	M80-M81
DCL000215	Resiquimod	Genital warts; Genital herpes	054.1, 078.11	A60, A63.0
DCL000215	Resiquimod	Herpes simplex virus infection	.	A60,B00
DCL000216	RhuDex	Rheumatold arthritis	.	M05-M06
DCL000216	RhuDex	Rheumatold arthritis	714	M05-M06
DCL000217	RTA 402	Multiple Myeloma; Solid Tumors; Lymphoma	140-199, 202.8, 203.0, 210-229	C00-C75, C7A, C7B, C81-C96, C90.0, D10-D36, D3A
DCL000217	RTA 402	Solid tumours	.	C00-C75,C7A,C7B
DCL000218	RX-0201	Metastatic pancreatic cancer	157	C25
DCL000218	RX-0201	Solid tumours	.	C00-C75,C7A,C7B
DCL000219	SAR3419	Lymphoma	.	C81-C96
DCL000219	SAR3419	Non-Hodgkin's lymphoma	200, 202	C82-C85
DCL000220	Saredutant	Anxiety disorder	.	F40-F42
DCL000220	Saredutant	Depression; Anxiety disorders	300, 300.02, 311	F32, F40-F42, F41.1
DCL000221	SB222200	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DCL000222	SB-559448	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DCL000223	SB-705498	Acute migraine	346	G43
DCL000224	SB-743921	Cancer	.	C00-C97
DCL000224	SB-743921	Non-Hodgkin's Lymphoma	140-229, 200, 202, 202.8	C00-C96, C81-C96, C82-C85
DCL000225	SCH-530348	Ischemic stroke; Acute coronary syndrome	390-459, 411.1, 434.91	I00-I99, I20.0, I61-I63
DCL000225	SCH-530348	Myocardial infarction	.	I21-I22
DCL000226	SCIO-469	Acute or chronic pain	338,780	R52, G89
DCL000226	SCIO-469	Pain	.	G89
DCL000226	SCIO-469	Rheumatold arthritis	714	M05-M06
DCL000227	Seliciclib	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL000227	Seliciclib	Breast cancer; NSCLC; Lymphoid leukemia; Glomerulonephritis; Multiple myeloma	162, 203.0, 208.9, 580-582	C33, C34, C90.0, C91-C95, N00, N01, N03, N18
DCL000228	SF1126	Solid tumours	.	C00-C75,C7A,C7B
DCL000228	SF1126	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000229	SGX523	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000230	SLV 306	Acute decompensated heart failure; Renal dysfunction	428, 428.0, 584, 585	I50, N17-N19
DCL000230	SLV 306	Hypotension	.	I95
DCL000231	SNX-5422	Cancer	140-229	C00-C96
DCL000231	SNX-5422	Hematological malignancies	200-209	C81-C96
DCL000232	SR 144190	Anxiety disorder	.	F40-F42
DCL000232	SR 144190	Depression; Acute or chronic pain; Anxiety disorders; Urinary incontinence	300, 311, 338, 338.2, 787.6, 788.3,780	F32, F40-F42, N39.3, N39.3-N39.4, N39.4, R15, R32, R52, R52.1-R52.2, G89
DCL000233	SR-123781A	Acute coronary syndrome	411.1	I20.0
DCL000233	SR-123781A	Thrombosis	.	I80-I82
DCL000233	SR-123781A	Venous thrombosis	453	I80-I82
DCL000234	SRT501	Colorectal cancer	153, 154	C18-C21
DCL000234	SRT501	Multiple myeloma	203	C90.0
DCL000235	STA-5326	Crohn's disease	555	K50
DCL000235	STA-5326	Moderate to Severe rheumatoid arthritis	714	M05-M06
DCL000236	STA-9090	Leukemia	.	C91-C95
DCL000236	STA-9090	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000237	Stannsoporfin	Hyperbilirubinemia	.	E80.6
DCL000237	Stannsoporfin	Neonatal hyperbilirubinemia; Jaundice	773, 774, 782.4	P58, P59, R17
DCL000238	STX 64	Prostate cancer	185	C61
DCL000239	T487	Inflammatory disorders	.	.
DCL000239	T487	Psoriatic disorders	696	L40
DCL000240	T-5224	Rheumatold arthritis	714	M05-M06
DCL000241	Talnetant	Irritable bowel syndrome	564.1	K58
DCL000241	Talnetant	Psychotic disorders	.	F20-F29
DCL000241	Talnetant	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DCL000242	Tanespimycin	Breast cancer; Melanoma	140-229, 172, 174, 175	C00-C96, C43, C50
DCL000242	Tanespimycin	Multiple myeloma	203	C90.0
DCL000243	Tanomastat	Pancreatic cancer; Lung cancer; Ovarian cancer; Osteoarthritis	140-229, 157, 162, 183, 715	C00-C96, C25, C33-C34, C56, M15-M19, M47
DCL000244	Tarazepide	Gastrointestinal disease	.	K00-K93
DCL000244	Tarazepide	Gastrointestinal disorders	530-558	K20-K64
DCL000245	Telcagepant	Cluster Headaches; Migraine	339, 339.00, 339.01, 339.02, 346, 784.0	G43, G43-G44, G44.0, R51
DCL000245	Telcagepant	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
DCL000246	TG100-115	Angioedema	.	D84.1
DCL000246	TG100-115	Angioedema; Myocardial infarction	277.6, 410, 995.1	D84.1, I21, I22, T78.3
DCL000247	Thrombopoietin	Thrombocytopenia	.	D69.6
DCL000247	Thrombopoietin	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DCL000248	TKI258	Advanced or metastatic renal cell cancer	189	C64
DCL000248	TKI258	Solid tumours	.	C00-C75,C7A,C7B
DCL000249	TLR9 agonist	Colorectal cancer	153, 154	C18-C21
DCL000250	TM30338	Obesity	.	E66
DCL000250	TM30338	Obesity	278	E66
DCL000251	TM30339	Schizophrenia	.	F20
DCL000251	TM30339	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DCL000252	Torcetrapib	Hyperlipidemia	.	E78.5
DCL000252	Torcetrapib	Peripheral vascular disease; Hyperlipidemia	272.0-272.4, 325, 430-459, 443.9	E78, G45-G46, I60-I95, I73.9
DCL000253	TTP889	Blood forming organ disorders	.	D75.9
DCL000253	TTP889	Venous thromboembolism	453	I80-I82
DCL000254	Tyloxapol	Cystic fibrosis	277	E84
DCL000254	Tyloxapol	Pediatric cystic fibrosis	277.0, 709.2	E84, L90.5
DCL000255	TZP-101	Gastrointestinal disease	.	K00-K93
DCL000255	TZP-101	Ileus; Gastroparesis; Miscellaneous gastrointestinal disorders	530-558, 536.3, 537.2, 560.1, 560.31, 777.1, 777.4	K20-K64, K31.5, K31.8, K56.0, K56.3, K56.7, P76.1
DCL000256	Urocortin 2	Congestive heart failure	428	I50
DCL000258	Varespladib	Coronary Artery disease; Atherosclerosis	410-414, 414.0, 429.2, 440	I20-I25, I70
DCL000259	VX-680	Chronic myelogenous Leukemia; Acute lymphoblastic leukemia	205.1, 208.9	C91-C95, C92.1
DCL000259	VX-680	Leukemia	208.9	C91-C95
DCL000259	VX-680	Solid tumours	.	C00-C75,C7A,C7B
DCL000260	VX-702	Coronary artery disease	.	I20-I25
DCL000260	VX-702	Inflammatory disorders	.	.
DCL000260	VX-702	Rheumatold arthritis; Coronary artery disease	410-414, 429.2, 710-719, 714	I20-I25, M00-M25, M05-M06
DCL000261	VX-745	Myelodysplastic syndromes	.	D46
DCL000261	VX-745	Rheumatold arthritis	714	M05-M06
DCL000262	XL147	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000262	XL147	Endometrial cancer	182	C54.1
DCL000263	XL647	Cancer	140-229	C00-C96
DCL000263	XL647	Carcinoma; Non-small-cell lung cancer	162	C33, C34
DCL000263	XL647	Solid tumours	.	C00-C75,C7A,C7B
DCL000264	XL765	Solid tumours; Non-small-cell lung cancer; Malignant gliomas	140-199, 140-229, 162, 191, 210-229	C00-C75, C00-C96, C33, C33-C34, C34, C71, C7A, C7B, D10-D36, D3A
DCL000265	XL880	Gastric cancer; Renal cell carcinoma; Squamous cell cancer of head and neck	140-229, 151, 189	C00-C96, C16, C64
DCL000265	XL880	Solid tumours	.	C00-C75,C7A,C7B
DCL000265	XL880	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000266	Zarnestra	Acute myeloid leukemia	205	C92.0
DCL000266	Zarnestra	Pancreatic cancer; Colorectal cancer	140-229, 153, 154, 157	C00-C96, C18-C21, C25
DCL000267	ZK-thiazolidinone	Cancer	140-229	C00-C96
DCL000268	Talsaclidine isomer	Alzheimer's disease	331	G30
DCL000269	Linazolast	Inflammatory disorders	.	.
DCL000270	Sorbinil	Diabetes mellitus	250	E08-E13
DCL000270	Sorbinil	Diabetic cataract	.	E10.36,E11.36
DCL000271	Arbidol	Influenza virus infections	487	J10, J11
DCL000271	Arbidol	Viral infections	042-075	A80-A99, B00-B34
DCL000272	Brequinar sodium	Advanced gastrointestinal cancer	150-159	C15-C26
DCL000272	Brequinar sodium	Cancer	.	C00-C97
DCL000273	Lonapalene	Psoriasis	696	L40
DCL000274	Vicriviroc	HIV infections	42	B20
DCL000275	Ifetroban sodium	Cardiovascular disease	390-459	I00-I99
DCL000275	Ifetroban sodium	Thrombosis	.	I80-I82
DCL000276	ICA-17043	Exercise induced Asthma	493	J45
DCL000276	ICA-17043	Hematopoietic	.	D50-D89
DCL000276	ICA-17043	Sickle-cell disease	282.6	D57
DCL000277	LG100268	Acquired immune deficiency syndrome	.	B20
DCL000277	LG100268	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000278	Viramidine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL000278	Viramidine	Viral infections	042-075	A80-A99, B00-B34
DCL000279	Sabcomeline hydrochloride	Cardiovascular disease	390-459	I00-I99
DCL000279	Sabcomeline hydrochloride	Parkinson's disease	.	G20
DCL000280	Evernimicin	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DCL000280	Evernimicin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000281	Sch-351125	HIV infections	42	B20
DCL000281	Sch-351125	Human immunodeficiency virus infection	.	B20
DCL000282	E2101	Cervical dystonia	333.83	G24.3
DCL000282	E2101	Spasm	.	R25.2
DCL000283	Zenarestat	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DCL000283	Zenarestat	Neuropathy	.	G64,G90.0
DCL000284	RPR 200765A	Rheumatold arthritis	714	M05-M06
DCL000285	CVT-124	Atrial fibrillation; Congestive heart failure	427.31, 428, 428.0	I48, I50
DCL000285	CVT-124	Autoimmune diseases	.	D84.9
DCL000286	Peramivir	Influenza virus infections	.	J10-J11
DCL000286	Peramivir	Influenza virus infections	487	J10, J11
DCL000287	ATL-146e	Diagnosis of coronary disorders	410-414, 429.2	I20-I25
DCL000287	ATL-146e	Gastric diseases	536, 750	K30-K31, Q40-Q41
DCL000288	Cilnidipine	High blood pressure	401	I10, I11, I12, I13, I15
DCL000289	Plevitrexed (R)-isomer	Advanced gastric cancer	151	C16
DCL000290	TOP-53	Lung metastatic tumors	162	C33, C34
DCL000290	TOP-53	Solid tumours	.	C00-C75,C7A,C7B
DCL000291	T-705	Influenza virus infections	.	J10-J11
DCL000291	T-705	Influenza virus infections	487	J10, J11
DCL000292	SU5614	Airway inflammation	460-519	J00-J99
DCL000293	Xanthine	Apnea	786.03	R06.81
DCL000294	Cetilistat	Diabetes mellitus; Obesity	250, 270-279, 278	E08-E13, E66, E70-E89
DCL000294	Cetilistat	Obesity	278	E66
DCL000295	Tariquidar	Adrenocortical carcinoma	194	C74.0
DCL000295	Tariquidar	Solid tumours	.	C00-C75,C7A,C7B
DCL000296	Atrasentan	Hormone-refractory prostate cancer	185	C61
DCL000297	CS-8958	Influenza virus infections	487	J10, J11
DCL000298	Valspodar	Acute myeloid leukemia	205	C92.0
DCL000298	Valspodar	Leukemia; Epithelial ovarian cancer; Primary peritoneal cancer	140-229, 158, 183, 208.9	C00-C96, C48.1, C48.1-C48.2, C48.2, C56, C91-C95
DCL000299	PS433540	Hypertension	401	I10, I11, I12, I13, I15
DCL000300	INCB9471	Human immunodeficiency virus infection	.	B20
DCL000300	INCB9471	Infections	001-139	A00-B99
DCL000301	Linetastine	Inflammatory diseases	.	.
DCL000301	Linetastine	Rhinitis	.	J00,J30,J31.0
DCL000302	Licofelone	Osteoarthritis	715	M15-M19, M47
DCL000303	Talsaclidine fumarate	Alzheimer's disease	.	G30,F00
DCL000303	Talsaclidine fumarate	Alzheimer's disease	331	G30
DCL000304	Metoprine	Advanced cancers	140-229	C00-C96
DCL000305	GW873140	HIV-1 infections	42	B20
DCL000306	Benzbromarone	Gout	274.00274.1274.8274.9	M10
DCL000306	Benzbromarone	Hyperuricaemia; Gout	274, 790.6	E79.0, M10
DCL000307	MK-591	Asthma	.	J45
DCL000307	MK-591	Ulcerative colitis	556	K51
DCL000308	Lobucavir	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DCL000308	Lobucavir	Viral infections	042-075	A80-A99, B00-B34
DCL000309	Glucobay	Diabetes mellitus type 2	250	E11
DCL000310	TAK-491	Hypertension	401	I10, I11, I12, I13, I15
DCL000311	Fidarestat	Diabetes mellitus	250	E08-E13
DCL000312	KW-6002	Parkinson's disease	332	F02.3, G20
DCL000313	Tecadenoson	Atrial fibrillation	427.31	I48
DCL000313	Tecadenoson	Cardiac arrhythmias	.	I47-I49
DCL000314	Teriflunomide	Multiple sclerosis	.	G35
DCL000314	Teriflunomide	Rheumatold arthritis	714	M05-M06
DCL000315	ABT-761	Asthma	.	J45
DCL000315	ABT-761	Asthma	493	J45
DCL000316	BIBV 308	Angina	413	I20
DCL000316	BIBV 308	Peripheral vascular disease	.	I73.9
DCL000317	Romidepsin	Cutaneous T cell lymphoma	202.1, 202.2	C84.0, C84.1
DCL000317	Romidepsin	Peripheral T-cell lymphoma	202.7	C84.4
DCL000317	Romidepsin	Renal cell carcinoma; Hormone refractory prostate cancer	140-229, 185, 189, 203.0, 205.0	C00-C96, C61, C64, C90.0, C92.0
DCL000317	Romidepsin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000318	Ramatroban	Perennial allergic rhinitis	477	J30
DCL000319	Hematide	Anemia	280-285	D50-D64
DCL000320	LY231514	Non-squamous non-small Cell Lung cancer	162	C33, C34
DCL000321	Brasofensine	Parkinson's disease	.	G20
DCL000321	Brasofensine	Parkinson's disease	332	F02.3, G20
DCL000322	GT-389255	Obesity	278	E66
DCL000323	Isatoribine	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000323	Isatoribine	Hepatitis C virus infection	.	B17.1,B18.2
DCL000324	LY-156735	Anxiety disorder	.	F40-F42
DCL000324	LY-156735	Circadian rhythm sleep disorder	327.3, 780.55	G47.2
DCL000325	Geldanamycin	Kidney cancer; Peripheral nerve damage	140-229, 356.0, 356.8	C00-C96, G64, G90.0
DCL000326	Seratrodast	Allergic asthma	493	J45
DCL000327	Taranabant	Obesity	278	E66
DCL000328	Xanomeline tartrate	Alzheimer's disease	331	G30
DCL000328	Xanomeline tartrate	Parkinson's disease	.	G20
DCL000329	VEC-162	Sleep disorders	.	F51,G47
DCL000329	VEC-162	Transient insomnia	307.41	F51.02
DCL000330	Genistein	Pancreatic cancer	.	C25
DCL000330	Genistein	Prostate cancer	185	C61
DCL000331	Cilofungin	Candida infection	112	B37
DCL000331	Cilofungin	Fungal infection	.	B35-B49
DCL000332	Salvicine	Cancer	140-229	C00-C96
DCL000332	Salvicine	Cancers	140-229	C00-C96
DCL000333	Tasidotin hydrochloride	Cancer	140-229	C00-C96
DCL000333	Tasidotin hydrochloride	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000334	Garenoxacin	Endocarditis	421	I33
DCL000335	Agomelatine	Major depressive disorder	296.2, 296.3	F32, F33
DCL000336	AR-C69931 MX	Atherosclerosis; Percutaneous coronary intervention	390-459, 411.1, 414.0, 440	I00-I99, I20.0, I25.1, I70
DCL000337	Plevitrexed	Advanced gastric cancer	151	C16
DCL000337	Plevitrexed	Solid tumours	.	C00-C75,C7A,C7B
DCL000338	Benoxaprofen	Inflammatory diseases	.	.
DCL000339	Nomifensine	Breast cancer	174, 175, 217	C50, D24
DCL000339	Nomifensine	Endogenous depression	311	F32
DCL000340	Amineptine	Major depressive disorder	296.2, 296.3	F32, F33
DCL000340	Amineptine	Severe depressive episodes	296.2	F32.2, F32.3
DCL000341	Mibefradil	Angina	.	I20
DCL000341	Mibefradil	Hypertension	401	I10, I11, I12, I13, I15
DCL000342	SU-6668	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL000343	BMS-599626	Cancers	140-229	C00-C96
DCL000343	BMS-599626	Solid tumours	.	C00-C75,C7A,C7B
DCL000344	Tykerb	Bladder cancer; NSCLC; Brain cancer	140-229, 162, 188, 191	C00-C96, C33, C34, C67, C71
DCL000344	Tykerb	Refractory metastatic breast cancer; Renal cell carcinoma	140-229, 174, 175	C00-C96, C50
DCL000345	CP-724714	Cancers	140-229	C00-C96
DCL000345	CP-724714	Lymphoma	.	C81-C96
DCL000346	HKI-272	Advanced solid tumors; Breast cancer	140-199, 140-229, 174, 175, 210-229	C00-C75, C00-C96, C50, C7A, C7B, D10-D36, D3A
DCL000346	HKI-272	Breast cancer	174, 175	C50
DCL000347	TAK165	Cancers	140-229	C00-C96
DCL000348	PTK787/ZK 222584	Acute myeloid leukemia; Ovarian cancer; Prostate cancer	140-229, 183, 185, 205.0, 238.7	C00-C96, C56, C61, C92.0, D46
DCL000348	PTK787/ZK 222584	Colorectal cancer; Renal cancer; Brain cancer; Breast cancer; Ovarian cancer; NSCLC; Age-related wet degeneration	140-229, 183, 204.0, 362.50	C00-C96, C56, C91.0, H35.3
DCL000348	PTK787/ZK 222584	Glioma; Solid tumours; NSCLC	140-199, 162, 191, 210-229	C00-C75, C33, C34, C71, C7A, C7B, D10-D36, D3A
DCL000349	CP-547632	Cancer	140-229	C00-C96
DCL000349	CP-547632	NSCLC; Ovarian cancer; Solid tumours	140-199, 140-229, 162, 183, 210-229	C00-C75, C00-C96, C33, C34, C56, C7A, C7B, D10-D36, D3A
DCL000350	Vandetanib	Breast cancer; Thyroid tumours; Multiple myeloma cancer; Brain cancer; Head and neck cancer	140-149, 140-199, 140-229, 203.0, 210-229	C00-C75, C00-C96, C07-C14, C32, C33, C7A, C7B, C90.0, D10-D36, D3A
DCL000350	Vandetanib	Solid tumours	.	C00-C75,C7A,C7B
DCL000350	Vandetanib	Solid tumours; Non-small-cell lung cancer	140-199, 162, 210-229	C00-C75, C33, C34, C7A, C7B, D10-D36, D3A
DCL000351	Pazopanib	Advanced metastatic renal cancer	189	C64
DCL000351	Pazopanib	Solid tumours; Non-small-cell lung cancer	140-199, 162, 210-229	C00-C75, C33, C34, C7A, C7B, D10-D36, D3A
DCL000352	OSI-930	Cancers	140-229	C00-C96
DCL000352	OSI-930	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000353	Axitinib	Advanced renal cell carcinoma	189	C64
DCL000353	Axitinib	Lung cancer; Thyroid cancer	140-229, 162, 193	C00-C96, C33-C34, C73
DCL000353	Axitinib	Renal cell carcinoma	189	C64
DCL000354	Cediranib	Advanced breast cancer	174, 175	C50
DCL000354	Cediranib	Colorectal cancer	153, 154	C18-C21
DCL000354	Cediranib	Fallopian tube cancer; Ovarian cancer; Peritoneal cavity cancer	140-229, 158, 183, 183.2, 221.0	C00-C96, C48.1, C48.2, C56, C57, D28
DCL000354	Cediranib	Solid tumours	.	C00-C75,C7A,C7B
DCL000355	KRN633	Glioma; Solid tumours	140-199, 191	C00-C75, C71, C7A, C7B
DCL000356	BAY-57-9352	Cancers	140-229	C00-C96
DCL000356	BAY-57-9352	Solid tumours	.	C00-C75,C7A,C7B
DCL000357	SU-14813	Breast cancer	174, 175, 217	C50, D24
DCL000357	SU-14813	Metastatic breast cancer	174, 175	C50
DCL000357	SU-14813	cancers	140-229	C00-C96
DCL000358	BMS-582664	Hepatocellular carcinoma	155	C22.0
DCL000359	CP-868596	Gastrointestinal cancer	.	C15-C26
DCL000359	CP-868596	cancers	140-229	C00-C96
DCL000360	Nilotinib	Acute lymphoblastic leukemia; Chronic myelogenous leukemia	150-159, 204.0, 205.1	C15-C26, C91.0, C92.1
DCL000360	Nilotinib	Chronic myelogenous leukemia	.	C92.1
DCL000360	Nilotinib	Leukemia	208.9	C91-C95
DCL000361	AEE-788	Solid tumours	.	C00-C75,C7A,C7B
DCL000361	AEE-788	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000362	CEP-7055	Pancreastic cancer; Prostate cancer; solid tumours	140-199, 140-229, 185, 210-229	C00-C75, C00-C96, C61, C7A, C7B, D10-D36, D3A
DCL000363	PD-0325901	Breast cancer; Colon tumor; NSCLC	.	C50,C18-C21,C33-C34
DCL000363	PD-0325901	NSCLC; Melanoma; Breast cancer; Colon cancer	140-229, 153, 154, 162, 172	C00-C96, C18-C21, C33, C34, C43
DCL000363	PD-0325901	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000364	AEW-541	Multiple myeloma	140-229, 203.0	C00-C96, C90.0
DCL000365	PD-332991	Cancers	140-229	C00-C96
DCL000366	Ro 31-7453	Ovarian cancer; Endometrial cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
DCL000366	Ro 31-7453	Solid tumours	.	C00-C75,C7A,C7B
DCL000367	Tandutinib	Acute myeloid leukemia	205	C92.0
DCL000367	Tandutinib	Glioblatoma; Gliosarcoma; Anaplastic mixed oligoastrocytoma	191	C71
DCL000368	AZD0530	Colorectal cancer	.	C18-C20,C21
DCL000368	AZD0530	Osteosarcoma; Hematological malignancies; Solid tumours	140-199, 140-239, 170, 200-209, 210-229	C00-C75, C00-C96, C40-C41, C7A, C7B, C81-C96, D10-D36, D3A
DCL000369	Bosutinib	Advanced breast cancer	174, 175	C50
DCL000370	GSK159802	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DCL000371	GSK163090	Anxiety disorder	300	F40-F42
DCL000371	GSK163090	Major depressive disorder; Major depressive; Episode; Anxiety	296.2, 296.3, 300	F32, F32.2, F32.3, F33, F40-F42
DCL000372	GSK184072	Colon cancer; Hematologic cancers; Type 2 diabetes	140-229, 250, 250.00, 250.02	C00-C96, E08-E13, E11
DCL000372	GSK184072	Colorectal cancer	.	C18-C20,C21
DCL000373	GSK221149	Threatened pre-term labour	.	O60.1,P07.3
DCL000374	GSK239512	Alzheimer's disease	.	G30,F00
DCL000374	GSK239512	Mild to moderate alzheimer's disease; Dementia	290-294, 331.0	F01-F07, G30
DCL000375	GSK256066	Asthma	.	J45
DCL000375	GSK256066	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DCL000376	GSK256073	Diabetes mellitus type 2	.	E11
DCL000376	GSK256073	Dyslipidaemia	272	E78
DCL000377	GSK424887	Depression; Anxiety	300, 311	F32, F40-F42
DCL000378	GSK461364	Advanced solid tumours; Non-Hodgkin's Lymphoma	140-199, 140-229, 200, 202, 202.8, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, C82-C85, D10-D36, D3A
DCL000378	GSK461364	Solid tumours	.	C00-C75,C7A,C7B
DCL000379	GW468816	Smoking cessation	292	F17.2
DCL000380	GSK561679	Alcohol use disorders	.	F10
DCL000380	GSK561679	Major depressive disorder	296.2, 296.3, 300	F32, F33, F40-F42
DCL000381	GSK573719	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000382	GSK586529	Anxiety disorder	.	F40-F42
DCL000382	GSK586529	Depression; Anxiety	300, 311	F32, F40-F42
DCL000383	GSK598809	Drug dependence	303-305	F10-F19
DCL000384	GSK618334	Drug dependence	303-304	F10.2-F19.2
DCL000384	GSK618334	Drug dependence	303-305	F10-F19
DCL000385	GW642444	Asthma	.	J45
DCL000385	GW642444	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DCL000386	SB-649868	Sleep disorders; Insomnia	307.4, 307.41, 307.42, 327, 327.0, 780.5, 780.51, 780.52	F51, F51.0, G47, G47.0
DCL000386	SB-649868	Substance dependence	.	F10-F19
DCL000387	SB-656933	Cystic fibrosis; Chronic obstructive pulmonary disease	277.0, 490-492, 494-496	E84, J40-J44, J47
DCL000388	GW685698X	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DCL000389	SB-705498	Acute migraine; Non-allergic rhinitis	346, 472.0, 477, 995.3	G43, J00, J30, J31.0, T78.4
DCL000389	SB-705498	Rhinitis	.	J00,J30,J31.0
DCL000390	GSK729327	Schizophrenia	295	F20
DCL000391	SB-742457	Alzheimer's disease	331	G30
DCL000391	SB-742457	Alzheimer's disease; Dementia	290-294, 331.0	F01-F07, G30
DCL000392	SB-756050	Type 2 diabetes	250.00, 250.02	E11
DCL000393	GSK835726	Allergic rhinitis	477	J30
DCL000394	GW870086X	Asthma	493	J45
DCL000395	GSK923295	Refractory cancer	140-239	C00-C96
DCL000395	GSK923295	Solid tumours	.	C00-C75,C7A,C7B
DCL000396	GSK945237	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000397	GSK961081	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000398	GSK962040	Delayed gastric emptying	536.3	K31.8
DCL000399	GSK1004723	Allergic rhinitis	477	J30
DCL000400	GSK1014802	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DCL000401	GSK1018921	Schizophrenia	295	F20
DCL000402	GSK1034702	Schizophrenia; Dementia	290-294, 295	F01-F07, F20
DCL000403	GSK1120212	Solid tumours; Lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DCL000404	GSK1144814	Schizophrenia	295	F20
DCL000405	GSK1265744	HIV infections	42	B20
DCL000406	GSK1278863	Anaemia	280-285	D50-D64
DCL000406	GSK1278863	Autism	299	F84.0
DCL000407	GSK1292263	Gastric cancer	151	C16
DCL000407	GSK1292263	Type 2 diabetes	250.00, 250.02	E11
DCL000408	GSK1349572	HIV infections	42	B20
DCL000410	GSK1482160	Pain	338,780	R52, G89
DCL000411	GSK1521498	Alcohol use disorders	.	F10
DCL000411	GSK1521498	Obesity	278	E66
DCL000412	GSK1614235	Diabetes mellitus type 2	.	E11
DCL000412	GSK1614235	Type 2 diabetes	250.00, 250.02	E11
DCL000413	GSK2190915	Asthma	493	J45
DCL000414	GSK2245840	Chronic obstructive pulmonary disease	.	J40-J44,J47
DCL000414	GSK2245840	Type 2 diabetes; Chronic obstructive pulmonary disease	250, 250.00, 250.02, 490-492, 494-496	E08-E13, E11, J40-J44, J47
DCL000415	ABT-263	Advanced SCLC; Relapsed or refractory CLL; Lymphoid malignancies	140-229, 140-239, 162, 162.9, 202, 204.0, 204.1, 208.9	C00-C96, C00-C96, C33-C34, C34.90, C81-C96, C91-C95, C91.0, C91.1
DCL000415	ABT-263	Chronic lymphocytic leukemia	204.1	C91.1
DCL000416	AG-14699	Cancer	140-229	C00-C96
DCL000416	AG-14699	Hypoxia	.	R09.02
DCL000417	Agatolimod	Esophageal cancer; Melanoma	140-229, 150, 162, 172	C00-C96, C15, C33-C34, C43
DCL000417	Agatolimod	Lung cancer	.	C33-C34
DCL000418	Albiglutide	Type 2 diabetes	250.00, 250.02	E11
DCL000419	Aleglitazar	Diabetes mellitus type 2	.	E11
DCL000419	Aleglitazar	Diabetes mellitus type 2	250	E08-E13
DCL000420	Alicaforsen	Crohn's disease; Ulcerative colitis	555, 556, 556.9	K50, K50-K52, K51
DCL000421	Alogliptin	Diabetes mellitus	250	E08-E13
DCL000421	Alogliptin	Diabetes mellitus type 2	.	E11
DCL000422	Alvocidib	Chronic lymphocytic leukemia	204.1	C91.1
DCL000423	AMG 108	Rheumatold arthritis	.	M05-M06
DCL000423	AMG 108	Rheumatold arthritis	714	M05-M06
DCL000424	AMG 317	Asthma	493	J45
DCL000425	AMG 386	Breast cancer	.	C50
DCL000425	AMG 386	Cancers	140-229	C00-C96
DCL000426	AMG 479	Breast cancer	.	C50
DCL000426	AMG 479	Cancers	140-229	C00-C96
DCL000427	AMG 761	Asthma	493	J45
DCL000427	AMG 761	T-cell Acute lymphocytic leukemia	.	C91.5
DCL000428	Anti-Abeta	Alzheimer's disease	331	G30
DCL000429	Anti-CD4	Rheumatold arthritis	714	M05-M06
DCL000430	Anti-cMet	Cancer	140-229	C00-C96
DCL000431	Anti-EGFL7	Solid tumours; Non-small cell lung cancer; Metastatic colorectal cancer	140-199, 140-229, 153, 154, 162, 204.0, 210-229	C00-C75, C00-C96, C18-C21, C33, C33-C34, C34, C7A, C7B, C91.0, D10-D36, D3A
DCL000432	Anti-IFN alfa	Systemic lupus erythematosus	710	M32
DCL000433	Anti-IL13	Asthma	493	J45
DCL000434	Anti-Mek	Cancer	140-229	C00-C96
DCL000435	Anti-NRP1	Cancer	140-229	C00-C96
DCL000435	Anti-NRP1	Solid tumours	.	C00-C75,C7A,C7B
DCL000436	Anti-oxLDL	Atherosclerosis	414.0, 440	I70
DCL000436	Anti-oxLDL	Cardiovascular disease	444	I74
DCL000437	Apaziquone	Non-invasive bladder cancer	188	C67
DCL000437	Apaziquone	Solid tumours	.	C00-C75,C7A,C7B
DCL000438	Apixaban	Atrial fibrillation	427.31	I48
DCL000438	Apixaban	Thrombosis	.	I80-I82
DCL000439	Apomab	Colorectal cancer	153, 154	C18-C21
DCL000439	Apomab	NSCLC; non-Hodgkin's lymphoma	162, 200, 202	C33, C34, C82-C85
DCL000440	Ataciguat	Neuropathic pain	338,780	R52, G89
DCL000441	ATL/TV1102	Multiple sclerosis; Inflammation	.	G35
DCL000442	ATL1103	Acromegally	253	E22.0
DCL000442	ATL1103	Acromegaly	.	E22.0
DCL000443	Avastin+/-Tarceva	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
DCL000444	AVE0010	Type 2 diabetes	250	E11
DCL000445	AVE0118	Obstructive sleep apnea	327.23, 780.57	G47.3
DCL000446	AVE0675	Asthma	493	J45
DCL000447	AVE0897	Diabetes mellitus type 2	.	E11
DCL000447	AVE0897	Type 2 diabetes	250.00, 250.02	E11
DCL000448	AVE1625	Psychotic disorders	.	F20-F29
DCL000448	AVE1625	Schizophrenia	295	F20
DCL000449	AVE5026	Venous thromboembolism in cancer	140-229	C00-C96
DCL000450	AZD0328	Alzheimer's disease	.	G30,F00
DCL000450	AZD0328	Alzheimer's disease; Schizophrenia	295, 331.0	F20, G30
DCL000451	AZD0837	Nonvalvular atrial fibrillation; Thrombosis	427.31, 437.6, 453, 671.5, 671.9	I48, I80-I82
DCL000451	AZD0837	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DCL000452	AZD1152	Acute myeloid leukemia	.	C92.0
DCL000452	AZD1152	Acute myeloid leukemia; Haematological malignancies	140-239, 200-209, 205, 205.0, 208.9	C00-C96, C81-C96, C91-C95, C92, C92.0
DCL000452	AZD1152	Myeloid leukemia	205	C92
DCL000453	AZD1175	Diabetes mellitus	.	E10-E14
DCL000453	AZD1175	Hypertension; Diabetes and obesity	250, 278, 401	E08-E13, E66, I10, I11, I12, I13, I15
DCL000454	AZD1236	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000455	AZD1386	Esophagus sensitivity	530	K20-K22
DCL000455	AZD1386	Gastroesophageal reflux disease	.	K21
DCL000455	AZD1386	Pain	338,780	R52, G89
DCL000456	AZD1446	Alzheimer's disease	140-229, 331.0	C00-C96, G30
DCL000456	AZD1446	Alzheimer's disease	331	G30
DCL000457	AZD1656	Diabetes mellitus	.	E10-E14
DCL000457	AZD1656	Type 2 diabetes	250	E11
DCL000458	AZD1704	Pain	338,780	R52, G89
DCL000459	AZD1940	Pain	338	R52
DCL000459	AZD1940	Pain	338,780	R52, G89
DCL000460	AZD1981	Asthma	.	J45
DCL000460	AZD1981	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DCL000461	AZD2066	Diabetic neuropathy	.	E10.4,E11.4,E13.4
DCL000461	AZD2066	Major depressive disorder; GERD; Chronic neuropathic pain	296.2, 296.3, 338, 356.0, 356.8, 530,780	F32, F33, G64, G90.0, K21, R52, G89
DCL000462	AZD2207	Diabetes mellitus	.	E10-E14
DCL000462	AZD2207	Diabetes mellitus; Obesity	250, 278	E08-E13, E66
DCL000463	AZD2516	Chronic neuropathic pain	338, 356.0, 356.8, 530,780	G64, G90.0, K21, R52, G89
DCL000463	AZD2516	Gastroesophageal reflux disease	.	K21
DCL000464	AZD2624	Schizophrenia	295	F20
DCL000465	AZD3241	Parkinson's disease	.	G20
DCL000465	AZD3241	Parkinson's disease	332	F02.3, G20
DCL000466	AZD3355	Gastroesophageal reflux disease	530	K21
DCL000467	AZD4017	Diabetes Mellitus Type 2; Obesity	250, 278	E11, E66
DCL000468	AZD4769	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000468	AZD4769	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000469	AZD4818	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000470	AZD5672	Rheumatold arthritis	714	M05-M06
DCL000471	AZD5904	Chronic obstructive pulmonary disease	.	J40-J44,J47
DCL000471	AZD5904	Multiple sclerosis	340	G35
DCL000472	AZD5985	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DCL000472	AZD5985	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DCL000473	AZD6244	Cancer	.	C00-C97
DCL000473	AZD6244	Non-small cell lung cancer; Melanoma	162, 172	C33, C34, C43
DCL000474	AZD6280	Anxiety disorder	300	F40-F42
DCL000474	AZD6280	Anxiety disorder; Schizophrenia	295, 300	F20, F40-F42
DCL000475	AZD6370	Diabetes mellitus type 2	.	E11
DCL000475	AZD6370	Type 2 diabetes	250.00, 250.02	E11
DCL000476	AZD6482	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DCL000477	AZD6765	Major depressive disorder	296.2, 296.3	F32, F33
DCL000478	AZD6918	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000478	AZD6918	Solid tumours; Advanced solid malignancies	140-199, 140-239, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000479	AZD7325	Anxiety disorder	300	F40-F42
DCL000479	AZD7325	Generalized anxiety disorder	300.02	F41.1
DCL000480	AZD7762	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000480	AZD7762	Solid tumours; Advanced solid malignancies	140-199, 140-239, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000481	AZD8055	Cancer	140-229	C00-C96
DCL000481	AZD8055	Endometrial carcinoma; Lymphoma	140-199, 182.0, 202.8, 210-229	C00-C75, C54.1, C7A, C7B, C81-C96, D10-D36, D3A
DCL000482	AZD8075	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DCL000482	AZD8075	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DCL000483	AZD8330	Solid tumours	.	C00-C75,C7A,C7B
DCL000483	AZD8330	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000484	AZD8529	Schizophrenia	295	F20
DCL000485	AZD8566	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DCL000486	AZD8931	Breast cancer	.	C50
DCL000486	AZD8931	Breast cancer	140-229, 140-239, 174, 175, 610-611	C00-C96, C00-C96, C00-D48, C50, N60-N64
DCL000487	AZD9056	Chronic obstructive pulmonary disease	.	J40-J44,J47
DCL000487	AZD9056	Rheumatold arthritis	714	M05-M06
DCL000488	AZD9639	Respiratory syncytial virus infection	79.6	B97.4
DCL000488	AZD9639	Viral infections	.	B34
DCL000489	AZD9668	Bronchiectasis	.	J47
DCL000489	AZD9668	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000490	Azilsartan	Hypertension	401	I10, I11, I12, I13, I15
DCL000491	Azilsartan medoxomil	Hypertension	401	I10, I11, I12, I13, I15
DCL000492	Azithromycin/chloroquine	Bacterial infection	84	B50-B54
DCL000493	Belimumab	Systemic lupus erythematosus	710	M32
DCL000494	Beta-Lapachone	Cancer	140-229	C00-C96
DCL000494	Beta-Lapachone	Solid tumours	.	C00-C75,C7A,C7B
DCL000495	Bevacizumab+Erlotinib	Non-small-cell lung carcinoma	162	C33, C34
DCL000496	Bevacizumab+Rituximab	Lymphoma; Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
DCL000497	Bevacizumab+Trastuzumab	Metastatic breast cancer	174, 175	C50
DCL000498	BIBW 2992	Non-small cell lung cancer	162	C33, C34
DCL000498	BIBW 2992	Non-small-cell lung carcinoma	162	C33, C34
DCL000499	Brilinta	Arterial thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DCL000499	Brilinta	Thrombosis	.	I80-I82
DCL000500	BSI-201	Solid tumours	.	C00-C75,C7A,C7B
DCL000500	BSI-201	Triple-negative breast cancer	174, 175	C50
DCL000501	Budesonide & formoterol fumarate dihydrate	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DCL000502	Cabazitaxel	Breast cancer	174, 175, 217	C50, D24
DCL000502	Cabazitaxel	Prostate cancer	185	C61
DCL000502	Cabazitaxel	Solid cancer	140-199	C00-C75, C7A, C7B
DCL000503	CAT-354	Asthma	493	J45
DCL000504	Conatumumab	Cancers	140-229	C00-C96
DCL000504	Conatumumab	Colorectal cancer	.	C18-C20,C21
DCL000504	Conatumumab	Progressive cancer	140-229	C00-C96
DCL000505	CP-533536	Bone healing	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DCL000505	CP-533536	Osteoporosis	.	M80-M81
DCL000506	CP-675206	Genitourinary; Gastrointestinal cancers; Colorectal cancer; Melanoma	140-229, 150-159, 153, 154, 172	C00-C96, C15-C26, C18-C21, C43
DCL000507	CP-800569	Atherosclerosis	414.0, 440	I70
DCL000508	CP-945598	Obesity	278	E66
DCL000509	Crestor/TriLipix	Dyslipidaemia	272	E78
DCL000510	CytoFab	Sepsis	.	A40-A41
DCL000510	CytoFab	Severe sepsis; Septic Shock	785.52, 995.91	A40-A41, R65.21
DCL000511	Dacetuzumab	Large B-Cell lymphoma; Non-Hodgkin's lymphoma	202.8	C81-C96
DCL000512	Dalbavancin	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DCL000512	Dalbavancin	Infectious diseases	001-139	A00-B99
DCL000513	Dalcetrapib	Dyslipidemia	272	E78
DCL000513	Dalcetrapib	Hyperlipidemia	.	E78.5
DCL000514	Darotropium	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000515	Darotropium + 642444	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000516	Denosumab	Bone metastases in prostate cancer	185	C61
DCL000516	Denosumab	Postmenopausal osteoporosis	733	M80-M81
DCL000516	Denosumab	Rheumatold arthritis	714	M05-M06
DCL000517	Dilmapimod	Acute lung injury; Acute respiratory distress syndrome	518, 518.5, 518.82	J80
DCL000518	Dulanermin	Indolent relapsed non-Hodgkin's lymphoma; Metastatic non-small cell lung cancer	140-229, 162, 200, 202, 202.8, 204.0	C00-C96, C33, C33-C34, C34, C81-C96, C82-C85, C91.0
DCL000518	Dulanermin	Metastatic colorectal cancer	153, 154	C18-C21
DCL000519	Dutasteride & tamsulosin	Prostate cancer; Benign prostatic hyperplasia	140-229, 185, 600	C00-C96, C61, N40
DCL000520	DwLIP-GCGRrx	Diabetes mellitus	250	E08-E13
DCL000521	Elsamitrucin	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DCL000521	Elsamitrucin	Mantle cell lymphoma; Chronic lymphocytic leukemia; Advanced solid tumors	140-199, 200.4, 202.8, 204.0, 204.1, 208.9, 210-229	C00-C75, C7A, C7B, C81-C96, C85.7, C91-C95, C91.0, C91.1, D10-D36, D3A
DCL000522	Eraxis/Vfend	Fungal infections	.	.
DCL000523	Erlotinib+Bevacizumab	Non-small-cell lung carcinoma	162	C33, C34
DCL000524	Esomeprazole magnesium	Heartburn; Gastroesophageal reflux disease; Extra-oesophageal reflux disease	530, 787.1	K21, R12
DCL000524	Esomeprazole magnesium	Peptic ulcer bleeding	531-534	K25-K27
DCL000525	Esomeprazole magnesium+Aspirin	Low dose aspirin associated peptic ulcer	531-534	K25-K27
DCL000526	Esreboxetine	Fibromyalgia	729.1	M79.7
DCL000527	Figitumumab	Gastrointestinal cancer; Genitourinary; Ewing's Sarcoma; Small cell lung cancer	140-229, 150-159, 162, 162.9, 170, 174, 175, 204.0	C00-C96, C15-C26, C33-C34, C34.90, C41, C50, C91.0
DCL000527	Figitumumab	Malignant adrenal gland cancer	.	C74.0
DCL000527	Figitumumab	Non-small cell lung cancer	162	C33, C34
DCL000528	Firategrast	Multiple sclerosis	.	G35
DCL000528	Firategrast	Relapsing forms of multiple sclerosis	340	G35
DCL000529	GA101	Non-Hodgkin's lymphoma	200, 202	C82-C85
DCL000530	Gabapentin enacarbil	Migraine prophylaxis; Neuropathic pain	338, 346,780	G43, R52, G89
DCL000530	Gabapentin enacarbil	Moderate-to-severe restless legs syndrome	.	G25.81
DCL000531	GSK610677	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000532	HuMAb OX40L	Allergic rhinitis	.	J30
DCL000532	HuMAb OX40L	Asthma	493	J45
DCL000533	IAP Antagonist	Cancer	140-229	C00-C96
DCL000534	Iboctadekin & rituximab	Non-Hodgkin's lymphoma; Follicular lymphoma	200, 202, 202.0, 202.8	C81-C96, C82, C82-C85
DCL000535	Iboctadekin + Doxil	Ovarian cancer	183	C56
DCL000537	Idraparinux	Heart disease	.	I00-I52
DCL000537	Idraparinux	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DCL000538	IDX136	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL000538	IDX136	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000539	IDX375	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL000539	IDX375	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000540	IDX899	HIV infections	42	B20
DCL000541	INCB15050	HIV infections	42	B20
DCL000542	INCB18424	Myelofibrosis; Psoriasis; Rheumatoid arthritis; Multiple myeloma; Prostate cancer	140-229, 185, 203.0, 289.83, 696, 710-719, 714	C00-C96, C61, C90.0, C94.4, D47.1, L40, M00-M25, M05-M06
DCL000543	INCB19602	Metabolic disorders	.	E70-E90
DCL000543	INCB19602	Type 2 diabetes	250.00, 250.02	E11
DCL000544	INCB24360	Cancer	.	C00-C97
DCL000544	INCB24360	Cancers	140-229	C00-C96
DCL000545	INCB28050	Rheumatold arthritis	.	M05-M06
DCL000545	INCB28050	Rheumatold arthritis	714	M05-M06
DCL000546	INCB8696	Multiple scierosis	340	G35
DCL000547	IPI-493	Gastric cancer	151	C16
DCL000547	IPI-493	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000548	ISIS 113715	Diabetes mellitus	250	E08-E13
DCL000548	ISIS 113715	Diabetes mellitus type 2	250	E11
DCL000549	ISIS-5GLT2rx	Diabetes mellitus	250	E08-E13
DCL000550	ISIS-CRP	Cardiovascular disease; Inflammatory disorders	390-459	I00-I99
DCL000550	ISIS-CRP	Diarrhea	.	A09,K59.1
DCL000551	Ispronicline	Alzheimer's disease; Schizophrenia	295, 331.0	F20, G30
DCL000551	Ispronicline	Schizophrenia; Alzheimer's disease	295, 331.0	F20, G30
DCL000552	Larotaxel	Cancer	140-229	C00-C96
DCL000552	Larotaxel	Pancreatic cancer; Bladder cancer	188	C67
DCL000553	Linagliptin	Diabetes mellitus type 2	250	E11
DCL000554	Losmapimod	Cardiovascular disease; COPD; Depression	311, 390-459, 490-492, 494-496	F32, I00-I99, J40-J44, J47
DCL000554	Losmapimod	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000555	Lu AA21004	Mood and anxiety disorders	296, 300	F30-F39, F40-F42
DCL000557	LY2275796	Advanced cancers	140-229	C00-C96
DCL000558	MEDI-528	Asthma	493	J45
DCL000559	MEDI-561	Breast cancer	174, 175, 217	C50, D24
DCL000559	MEDI-561	Gastrointestinal stromal tumor; Solid tumours	140-199, 150-159	C00-C75, C15-C26, C7A, C7B
DCL000560	MEDI-563	Asthma	.	J45
DCL000560	MEDI-563	Asthma	493	J45
DCL000561	Mepolizumab	Asthma	.	J45
DCL000561	Mepolizumab	Severe asthma; nasal polyposis	471, 493	J33, J45
DCL000562	MetMAb	Metastatic non-small cell lung cancer	162	C33, C34
DCL000563	Milveterol	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DCL000564	Mitemcinal fumarate	Gastroparesis; Irritable bowel syndrome	536.3, 564.1	K31.8, K58
DCL000564	Mitemcinal fumarate	Pain	.	G89
DCL000565	MK-0524B	Atherosclerosis	414.0, 440	I70
DCL000566	MK-0646	Cancer	140-229	C00-C96
DCL000567	MK-0752	Alzheimer's disease	.	G30,F00
DCL000567	MK-0752	Pancreatic cancer	157	C25
DCL000568	MK-0822	Ostereoporosis	733	M80-M81
DCL000569	MK-1775	Cervical cancer	180	C53
DCL000569	MK-1775	Ovarian cancer	.	C56
DCL000570	MK-2206	Cancer	140-229	C00-C96
DCL000570	MK-2206	Colon cancer; Rectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DCL000571	MK-4827	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000571	MK-4827	Ovarian cancer	.	C56
DCL000572	MK-5108	Cancer	140-199, 140-229, 140-239, 210-229	C00-C75, C00-C96, C00-C96, C00-D48, C7A, C7B, D10-D36, D3A
DCL000573	MK-7418	Heart failure	.	I50
DCL000573	MK-7418	Heart failure; Congestive	428	I50
DCL000574	MK-8033	Advanced cancers	140-229	C00-C96
DCL000574	MK-8033	Solid tumours	.	C00-C75,C7A,C7B
DCL000575	MLN0415	Arthritis	.	M00-M25
DCL000575	MLN0415	Inflammatory diseases	.	.
DCL000576	MLN4924	Advanced malignancies	140-229	C00-C96
DCL000576	MLN4924	Cancer	.	C00-C97
DCL000577	Motavizumab	Respiratory syncytial virus 	79.6	B97.4
DCL000577	Motavizumab	Respiratory syncytial virus infection	79.6	B97.4
DCL000578	Motesanib	Breast cancer	174, 175	C50
DCL000578	Motesanib	Non-small cell lung cancer	162	C33, C34
DCL000579	Motesanib diphosphate	Progressive non-small cell lung cancer	162	C33, C34
DCL000579	Motesanib diphosphate	Solid tumours	.	C00-C75,C7A,C7B
DCL000580	Nerispirdine	Multiple sclerosis	340	G35
DCL000580	Nerispirdine	Pain	.	G89
DCL000581	Ocrelizumab	Multiple Sclerosis; Primary progressive	340	G35
DCL000581	Ocrelizumab	Multiple sclerosis	340	G35
DCL000582	Ofatumumab	Chronic lymphocytic leukaemia	204.1	C91.1
DCL000582	Ofatumumab	Diffuse large B cell lymphoma; Multiple sclerosis	202.8, 340	C85.1, G35
DCL000582	Ofatumumab	Rheumatold arthritis; Follicular lymphoma	202.0, 714	C82, M05-M06
DCL000583	Olaparib	Breast cancer; Ovarian cancer	174, 175, 183	C50, C56
DCL000584	Ortataxel	Cancer	140-229	C00-C96
DCL000584	Ortataxel	Carcinoma; Renal cell solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000585	Orvepitant	Anxiety disorder	.	F40-F42
DCL000585	Orvepitant	Depression; Anxiety	300, 311	F32, F40-F42
DCL000586	Otamixaban	Angina	.	I20
DCL000586	Otamixaban	Coronary disease	411.1, 414.0	I20.0, I25.1
DCL000587	Otelixizumab	Type 1 diabetes	250.01	E10
DCL000588	Ozarelix	Endometriosis	617	N80
DCL000588	Ozarelix	Hormone-dependent prostate cancer; Benign prostatic hypertrophy	185, 600	C61, N40
DCL000588	Ozarelix	Prostate disorder	.	N40-N42
DCL000589	Pazopanib + Tyverb/Tykerb	Inflammatory breast cancer	174, 175	C50
DCL000590	PD-200390	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DCL000591	PD-348292	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DCL000592	Pertuzumab	Breast cancer	174, 175	C50
DCL000592	Pertuzumab	Pancreatic cancer	157	C25
DCL000593	PF-1228305	Pulmonary hypertension	416	I27.0, I27.2
DCL000594	PF-1913539	Alzheimer's disease	.	G30,F00
DCL000594	PF-1913539	Alzheimer's disease	331	G30
DCL000594	PF-1913539	Huntington's disease	294.1, 333.4	F02.2, G10
DCL000595	PF-217830	Bipolar disorder	.	F31
DCL000595	PF-217830	Schizophrenia	295	F20
DCL000596	PF-299804	Cancer	140-229	C00-C96
DCL000596	PF-299804	Glioblastoma	.	C71
DCL000597	PF-3185043	Atherosclerosis	414.0, 440	I70
DCL000598	PF-4383119	Broad chronic pain	338,780	R52, G89
DCL000598	PF-4383119	Hepatocellular carcinoma	.	C22.0
DCL000598	PF-4383119	Osteoarthritis symptoms	715	M15-M19, M47
DCL000599	PF-4523655	Diabetic macular degeneration; Age-related macular degeneration	250, 362.01, 362.50, 362.53	E08-E13, H35.3, H35.8
DCL000600	LY294002	Cancer	140-229	C00-C96
DCL000601	PI3K alpha	Cancer	140-229	C00-C96
DCL000602	R1450	Alzheimer's disease	331	G30
DCL000603	R1507	NSCLC; Ewing's sarcoma; Metastatic breast cancer	140-229, 162, 170, 174, 175	C00-C96, C33, C34, C41, C50
DCL000603	R1507	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000604	R1678	Schizophrenia	.	F20
DCL000604	R1678	Schizophrenia	295	F20
DCL000605	R3477	Autoimmune diseases	.	D84.9
DCL000605	R3477	Autoimmune diseases	279.4	D84.9, M35.9
DCL000606	R3487	Alzheimer's disease; Schizophrenia	295, 331.0	F20, G30
DCL000607	R4733	Breast cancer	174, 175, 217	C50, D24
DCL000607	R4733	Solid tumours	140-199	C00-C75, C7A, C7B
DCL000608	R4930	Asthma	493	J45
DCL000609	R4996	Alzheimer's disease	331	G30
DCL000609	R4996	Neurological disease	.	G00-G99
DCL000611	R7112	Cancer	140-229	C00-C96
DCL000612	R7128	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000613	R7159	Non-Hodgkin's lymphoma	200, 202	C82-C85
DCL000614	R7201	Type 2 diabetes	250.00, 250.02	E11
DCL000615	R7204	Malignant melanoma	172	C43
DCL000615	R7204	Metastatic melanoma	172	C43
DCL000616	R7227	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000617	R7232	Dyslipidemia	272	E78
DCL000617	R7232	Lipid metabolism disorder	.	E75-E78
DCL000618	R7334	Macular degeneration	.	H35.3
DCL000618	R7334	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000619	Remogliflozin etabonate	Type 1/2 diabetes	250	E08-E13
DCL000620	Resatorvid	Sepsis	.	A40-A41
DCL000620	Resatorvid	Severe sepsis	995.91	A40-A41
DCL000621	RhApo2L/TRAIL	Cancers	140-229	C00-C96
DCL000622	RhuMAb Beta7	Ulcerative colitis	556	K51
DCL000623	RhuMAb IFN alpha	Systemic lupus erythematosus	710	M32
DCL000624	Ridaforolimus	Sarcoma	140-229	C00-C96
DCL000625	Rilapladib	Arteriosclerosis	.	I70
DCL000625	Rilapladib	Atherosclerosis	414.0, 440	I70
DCL000626	Rilotumumab	Grade IV malignant glioma; Glioblastoma multiforme	191	C71
DCL000627	Rituxan Hemotalogy/oncology	Non-Hodgkin's lymphoma	202	C82
DCL000628	Rituxan Immunology	Pemphigus disease	694.4	L10
DCL000629	Romiplostim	Chemotherapy-induced thrombocytopenia; Myelodysplastic syndromes	238.7, 287.3, 287.4, 287.5	D46, D69.6, P61.0
DCL000629	Romiplostim	Thrombocytopenia	.	D69.6
DCL000630	Ronacaleret	Osteoporosis	.	M80-M81
DCL000630	Ronacaleret	Osteoporosis; Fracture healing	733	M80-M81
DCL000631	Rosiglitazone & metformin	Diabetes mellitus	250	E08-E13
DCL000632	Rosiglitazone & simvastatin	Type 2 diabetes	250.00, 250.02	E11
DCL000633	Rosiglitazone XR	Alzheimer's disease	331	G30
DCL000634	SAR110894	Alzheimer's disease	.	G30,F00
DCL000634	SAR110894	Alzheimer's disease	331	G30
DCL000635	SAR153191	Ankylosing spondylitis	.	M08.1,M45
DCL000635	SAR153191	Rheumatold arthritis	714	M05-M06
DCL000636	SAR164877	Osteoarthritis	.	M15-M19,M47
DCL000636	SAR164877	Pain	338,780	R52, G89
DCL000637	SAR351034	Lipid metabolism disorder	.	E75-E78
DCL000637	SAR351034	Type 2 diabetes; Dyslipidemia	250, 250.00, 250.02, 272	E08-E13, E11, E78
DCL000638	SAR407899	Erectile dysfunction; Neuropathic pain	302.72, 338, 356.0, 356.8, 607.84,780	F52.2, G64, G90.0, N48.4, R52, G89
DCL000638	SAR407899	Pulmonary hypertension	416	I27.0, I27.2
DCL000639	Saxagliptin	Type 2 diabetes	250.00, 250.02	E11
DCL000640	Sifalimumab	Advanced renal cell carcinoma	189	C64
DCL000640	Sifalimumab	Systemic lupus erythematosus; Myositis	695, 710.0, 729.1	L51-L54, M32, M60
DCL000641	SPI-1620	Cancer	.	C00-C97
DCL000641	SPI-1620	Carcinoma	230-234	D00-D09
DCL000642	SSR125543	Anxiety disorder	.	F40-F42
DCL000642	SSR125543	Depression; Posttraumatic stress disorder	309.81, 311	F32, F43.1
DCL000643	SSR411298	Anxiety disorder	300	F40-F42
DCL000643	SSR411298	Major depressive disorder	296.2, 296.3, 311	F32, F33
DCL000644	Sulopenem	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DCL000644	Sulopenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000645	Sulopenem IV	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000646	Sunitinib malate	Metastatic renal cell carcer; Gastrointestinal stromal tumors	140-199, 150-159, 189, 210-229	C00-C75, C15-C26, C64, C7A, C7B, D10-D36, D3A
DCL000646	Sunitinib malate	Soft tissue sarcoma	171	C49
DCL000647	SYR-472	Diabetes mellitus	250	E08-E13
DCL000647	SYR-472	Metabolic disorders	.	E70-E90
DCL000648	TAK-100	Diabetes mellitus	250	E08-E13
DCL000649	TAK-285	Cancer	140-229	C00-C96
DCL000649	TAK-285	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000650	TAK-385	Endometriosis	.	N80
DCL000650	TAK-385	Endometriosis; Uterus myoma	218.9, 617	D25, N80
DCL000651	TAK-442	Thrombosis	.	I80-I82
DCL000651	TAK-442	Venous arterial thromboembolism	444, 453	I74, I80-I82
DCL000652	TAK-448	Prostate cancer	185	C61
DCL000652	TAK-448	Prostate tumor	185	C61
DCL000653	TAK-591	Hypertension	401	I10, I11, I12, I13, I15
DCL000654	TAK-593	Cancer	140-229	C00-C96
DCL000654	TAK-593	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000655	TAK-683	Prostate cancer	185	C61
DCL000655	TAK-683	Prostate tumor	185	C61
DCL000656	TAK-701	Advanced malignancies	140-229	C00-C96
DCL000656	TAK-701	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL000657	TAK-901	Advanced malignancies	140-229	C00-C96
DCL000657	TAK-901	Hematological malignancies	200-209	C81-C96
DCL000658	TC-5619	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DCL000658	TC-5619	Neurological disease	.	G00-G99
DCL000659	Totrombopag	Thrombocytopenia	.	D69.6
DCL000659	Totrombopag	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DCL000660	Trastuzumab-DM1	Breast cancer	174, 175	C50
DCL000661	UK-369003	Benign prostatic hyperplasia	600	N40
DCL000661	UK-369003	Erectile dysfunction	.	F52.2,N48.4
DCL000662	Vedolizmab	Ulcerative colitis; Crohn's disease	555, 556, 556.9	K50, K50-K52, K51
DCL000663	Xaliproden	Alzheimer's disease; Peripheral sensory neuropathies	331.0, 356.0, 356.8	G30, G64, G90.0
DCL000663	Xaliproden	Lateral sclerosis	.	G12.2
DCL000664	Xatral	Benign prostatic hyperplasia	600	N40
DCL000665	Zibotentan	Hormone resistant prostate cancer	185	C61
DCL000665	Zibotentan	Solid tumours	.	C00-C75,C7A,C7B
DCL000666	Zunrisa/Rezonic	Chemotherapy-induced nausea and vomiting	787	R11
DCL000667	GSK 679769	Incontinence; Anxiety disorder; Chemotherapyinduced emesis; Major depressive disorder	296.2, 296.3, 300, 787, 787.6, 788.3	F32, F33, F40-F42, N39.3-N39.4, R11, R15, R32
DCL000668	(-)-3PPP, Maryland	Schizophrenia	295	F20
DCL000669	Reboxetine	Cerebral stroke	434.91	I61-I63
DCL000669	Reboxetine	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DCL000670	2-Methoxyestradiol	Carcinoid tumor; Endometriosis	140-199, 209.4, 209.5, 209.6, 210-229, 617	C00-C75, C75, C7A, C7B, D10-D36, D3A, E34.0, N80
DCL000670	2-Methoxyestradiol	Pulmonary arterial hypertension	.	I27.0,I27.2
DCL000671	4-Aminopyridine	Improving walking in patients with multiple sclerosis	340	G35
DCL000671	4-Aminopyridine	Spinal cord injuries	952	S14, S24, S34
DCL000672	5-HT4/D2 antagonists	Schizophrenia	295	F20
DCL000673	Abaperidone hydrochloride	Schizophrenia	295	F20
DCL000674	Abetimus sodium	Lupus nephritis	583.81	M32.1, N08.5
DCL000674	Abetimus sodium	Systemic lupus erythematosus	710	M32
DCL000675	ABT-089	ADHD; Schizophrenia; Anxiety; dementia	290-294, 295, 300, 314.0	F01-F07, F20, F40-F42, F90
DCL000675	ABT-089	Psychotic disorders	.	F20-F29
DCL000676	ABT-874	Autoimmune diseases	.	D84.9
DCL000676	ABT-874	Crohn's disease	555	K50
DCL000676	ABT-874	Moderate to Severe Plaque Psoriasis	696	L40
DCL000676	ABT-874	Rheumatold arthritis	714	M05-M06
DCL000677	Aclidinium bromide	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000678	ACV-1	Neuropathic pain	338,780	R52, G89
DCL000678	ACV-1	Pain	.	G89
DCL000679	AD-337	Fibromyalgia	.	M79.7
DCL000679	AD-337	Fibromyalgia; Myalgia; Chemotherapyinduced emesis	729.1, 787	M79.1, M79.7, R11
DCL000680	Adatanserin	Anxiety disorder	.	F40-F42
DCL000680	Adatanserin	Severe mood disorders	296	F30-F39
DCL000681	AdPEDR	Exudative age-related macular degeneration	362.5	H35.3
DCL000682	AEB07	Transplant rejection	279.5, 996	D89.8, T86
DCL000683	Aflibercept	Ovarian cancer	183	C56
DCL000684	AGN-199981	Neuropathic pain	338,780	R52, G89
DCL000685	AIN457	Ankylosing spondylitis	720	M08.1, M45
DCL000685	AIN457	Uveitis	364	H20
DCL000686	AKR-501	Idiopathic thrombocytopenic purpura	287.31	D69.3
DCL000687	Albuterol sulfate	Acute lung injury	518	J80
DCL000688	Alfa-interferon	Endometriosis	617	N80
DCL000689	Alphagen	Chronic obstructive pulmonary disease; Cystic fibrosis	277.0, 460-519, 490-492, 494-496, 709.2	E84, J00-J99, J40-J44, J47, L90.5
DCL000690	ALX-5407	Schizophrenia	295	F20
DCL000691	Amediplase	Myocardial infarction	.	I21-I22
DCL000691	Amediplase	Thrombolysis	410, 415.1, 434.91, 459.9	I21-I22, I26, I61-I63, I99.9
DCL000692	AMG 623	Idiopathic thrombocytopenic purpura	287.31	D69.3
DCL000692	AMG 623	Systemic lupus erythematosus	710	M32
DCL000693	AMG108	Rheumatold arthritis	714	M05-M06
DCL000694	AMG-714	Rheumatold arthritis	714	M05-M06
DCL000695	Amibegron	Major depressive disorder	.	F32,F33
DCL000695	Amibegron	Major depressive disorders; Obesity; Type 2 diabetes	250, 250.00, 250.02, 278, 296, 296.2, 296.3	E08-E13, E11, E66, F30-F39, F32, F33
DCL000695	Amibegron	Major depressive disorders; Severe mood disorders	296, 296.2, 296.3	F30-F39, F32, F33
DCL000696	Amitriptyline+ketamine	Neuropathic pain	338,780	R52, G89
DCL000697	AOD-9604	Growth hormone deficiency	.	E23.0
DCL000697	AOD-9604	Obesity	278	E66
DCL000698	Aplindore fumarate	Psychotic disorders	.	F20-F29
DCL000698	Aplindore fumarate	Schizophrenia	295	F20
DCL000699	Apremilast	Psoriasis	696	L40
DCL000700	Arofylline	Asthma	.	J45
DCL000700	Arofylline	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000701	ART621	Autoimmune diseases	.	D84.9
DCL000701	ART621	Rheumatoid Arthritis; Psoriasis	696, 710-719, 714	L40, M00-M25, M05-M06
DCL000702	Arverapamil	Irritable bowel syndrome	564.1	K58
DCL000702	Arverapamil	Irritable bowel syndrome with diarrhoea	.	K58.0
DCL000703	Asenapine	Schizophrenia; Bipolar disorder	295, 296	F20, F31
DCL000704	Asimadoline	Diarrhea-predominant IBS	564.1	K58.0
DCL000704	Asimadoline	Pain	.	G89
DCL000705	Asoprisnil	Contraception	.	Z30
DCL000705	Asoprisnil	Endometriosis	617	N80
DCL000706	Atacicept	Graft rejection in heart transplantation; Idiopathic thrombocytopenic purpura	287.31, 996	D69.3, T86
DCL000706	Atacicept	Lymphoma	.	C81-C96
DCL000706	Atacicept	Rheumatold arthritis; Multiple Sclerosis	340, 710-719, 714	G35, M00-M25, M05-M06
DCL000707	Atiprimod	Inflammatory bowel disease	.	K50,K51
DCL000707	Atiprimod	Multiple myeloma	203	C90.0
DCL000708	AVE1701	Rheumatold arthritis	714	M05-M06
DCL000709	AVE-5997EF	Schizophrenia	295	F20
DCL000710	Avosentan	Diabetic kidney disease	.	E11.22
DCL000710	Avosentan	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DCL000711	Axovan-3	Eating disorder; Obesity	278, 307.5	E66, F50
DCL000712	AZD-9272	Gastroesophageal reflux disease	.	K21
DCL000712	AZD-9272	Neuropathic pain	338,780	R52, G89
DCL000713	Azimilide	Arrhythmia	.	I47-I49
DCL000713	Azimilide	Atrial fibrillation	427.31	I48
DCL000714	Balicatib	Osteoporosis	.	M80-M81
DCL000714	Balicatib	Osteoporosis	733	M80-M81
DCL000715	Becampanel	Convulsions	.	R56.0
DCL000715	Becampanel	Epilepsy	345	G40
DCL000716	Belatacept	Heart transplant rejection	996	T86
DCL000716	Belatacept	Kidney transplant rejection	.	Z48.22
DCL000717	Benzydamine	Chemotherapy or radiotherapy-induced mucositis	338, 528.0,780	K12.3, R52, G89
DCL000718	Benzylamine derivative	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10, I11, I12, I13, I15, I50
DCL000719	Bepotastine besilate	Allergic conjunctivitis	372.14	H10.45
DCL000719	Bepotastine besilate	Ocular allergy	360-379	H00-H59
DCL000720	Bertilimumab	Allergic rhinitis	.	J30
DCL000720	Bertilimumab	Ocular allergy	360-379	H00-H59
DCL000721	Beta3-adrenoceptor agonist	Eating disorder; Obesity	278, 307.5	E66, F50
DCL000722	BG-9928	Acute and chronic heart failure	428	I50
DCL000722	BG-9928	Congestive heart failure	428	I50
DCL000723	Bicifadine	Chronic low back pain; Neuropathic pain	338, 356.0, 356.8, 724.2, 724.5,780	G64, G90.0, M54, M54.5, R52, G89
DCL000723	Bicifadine	Pain	.	G89
DCL000724	Bifeprunox	Schizophrenia	295	F20
DCL000725	BIIB014	Parkinson's disease	332	F02.3, G20
DCL000726	BIM23A760	Acromegaly	253	E22.0
DCL000726	BIM23A760	Carcinoid syndrome	.	E34.0
DCL000727	Blonanserin	Psychotic disorders	.	F20-F29
DCL000727	Blonanserin	Schizophrenia	295	F20
DCL000728	BP4.879a	Schizophrenia	295	F20
DCL000729	BR3-Fc	Autoimmune diseases	.	D84.9
DCL000729	BR3-Fc	Rheumatold arthritis; Idiopathic thrombocytopenic purpura	287.31, 710-719, 714	D69.3, M00-M25, M05-M06
DCL000730	Brivaracetam	Epilepsy	345	G40
DCL000730	Brivaracetam	Pain	.	G89
DCL000731	BSF-78438	Schizophrenia	295	F20
DCL000732	BTS-79018	Schizophrenia	295	F20
DCL000733	Bupropion+naltrexone	Obesity	278	E66
DCL000734	Buproprion+zonisamide	Obesity	278	E66
DCL000735	Canakinumab	Cryopyrin-associated periodic syndromes	277.31, 322.2, 339.8, 708.2, 708.8, 714.3	E85.0, G03.1, G44.8, L50.2, L50.8, M08.9
DCL000735	Canakinumab	Rheumatold arthritis	.	M05-M06
DCL000735	Canakinumab	Urticaria; Vasculitis	446, 447.6, 708	I77.6, I80, L50, L95, M30-M31
DCL000736	Cand 5	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DCL000736	Cand 5	Exudative age-related macular degeneration	362.5	H35.3
DCL000737	Capsaicin	Neuropathic pain	338,780	R52, G89
DCL000738	Carebastine	Ocular allergy	360-379	H00-H59
DCL000739	Carisbamate	Epilepsy; Focal; Seizure disorder	345, 345.4, 345.5, 345.9, 780.3	G40, G40, G40.0, G40.2, P90, R56
DCL000739	Carisbamate	Neuropathic pain	338,780	R52, G89
DCL000740	Carmoterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000741	Casopitant	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DCL000742	CBD cannabis derivative	Schizophrenia	295	F20
DCL000743	CDP323	Multiple Sclerosis; Rheumatoid arthritis	340, 710-719, 714	G35, M00-M25, M05-M06
DCL000743	CDP323	Multiple sclerosis	340	G35
DCL000744	Ceftobiprole	Intensive care unit; Bacterial infections	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000745	Certolizumab	Rheumatold arthritis	714	M05-M06
DCL000746	Certolizumab pegol	Crohn's disease	555	K50
DCL000746	Certolizumab pegol	Inflammatory bowel disease	555, 556	K50, K51
DCL000746	Certolizumab pegol	Psoriasis	696	L40
DCL000747	Cethrin	Spinal cord injuries	.	G95.9
DCL000747	Cethrin	Spinal cord injuries	952	S14, S24, S34
DCL000748	Cethromycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000748	Cethromycin	Pneumonia; Bacterial infections	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104, 480-486, 770.0	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, J12, J13 , J14, J15, J16, J17, J18, P23
DCL000749	CF101	Psoriasis	696	L40
DCL000749	CF101	Rheumatold arthritis	714	M05-M06
DCL000750	CHF 5407	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000751	CHF-3381	Neuropathic pain	338,780	R52, G89
DCL000751	CHF-3381	Pain	.	G89
DCL000752	Cilomilast	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DCL000752	Cilomilast	Emphysema; Bronchitis; Chronic obstructive pulmonary disease	460-519, 466, 490, 490-492, 491, 492, 494-496	J00-J99, J20-J21, J40-J44, J42, J43, J47
DCL000753	Cizolirtine	Neuropathic pain	338,780	R52, G89
DCL000753	Cizolirtine	Pain	.	G89
DCL000754	CJ-13610	Asthma	.	J45
DCL000754	CJ-13610	Asthma	493	J45
DCL000755	CNS-5161	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
DCL000755	CNS-5161	Neuropathic pain	338,780	R52, G89
DCL000756	CNTF	Diabetes mellitus type 2	.	E11
DCL000756	CNTF	Obesity	278	E66
DCL000757	CP-316,311	Major depressive disorder; Severe mood disorder	296, 296.2, 296.3	F30-F39, F32, F33
DCL000758	CRF-R2 antagonists	Eating disorders stimulate food consumption anxiety	307.5	F50
DCL000759	CS-003	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DCL000759	CS-003	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000760	CX-516	Psychotic disorders	.	F20-F29
DCL000760	CX-516	Schizophrenia; Pervasive developmental disorder	295, 299	F20, F84
DCL000761	CX717	ADHD; Sleep disorders; Alzheimer's disease	307.4, 314.0, 327, 331.0, 710.0, 780.5	F51, F90, G30, G47, M32
DCL000761	CX717	Sleep disorders	.	F51,G47
DCL000762	Cyclosporin A	Ocular allergy	360-379	H00-H59
DCL000763	DA-5018	Diabetic neuropathy; Postherpetic neuralgia	053.19, 250, 250.6, 356.0, 356.8	B02.2, E08-E13, E10.4, E11.4, E13.4, G44.847, G53.0, G64, G90.0
DCL000763	DA-5018	Pain	.	G89
DCL000764	DA-7101	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000765	Dapivirine	HIV infections	42	B20
DCL000766	DDP-225	Chronic functional vomiting	536.2	R11.10
DCL000766	DDP-225	Irritable bowel syndrome	564.1	K58
DCL000766	DDP-225	Pain	.	G89
DCL000767	Deforolimus	Multiple myeloma	203	C90.0
DCL000768	Desvenlafaxine	Major depressive disorder	296.2, 296.3	F32, F33
DCL000768	Desvenlafaxine	Major depressive disorder; Menopausal staging; Vasomotor symptoms	296, 296.2, 296.3, 627.2	F30-F39, F32, F33, N95.0, N95.1
DCL000769	Desvenlafaxine SR	Depressive disorder; Painful diabetic neuropathy	250, 250.6, 296.2, 296.3, 338, 356.0, 356.8,780	E08-E13, E10.4, E11.4, E13.4, F32, F33, G64, G90.0, R52, G89
DCL000770	Dexanabinol	Cognition disorders	.	F06.7
DCL000770	Dexanabinol	Traumatic brain injury	800, 801, 803, 804, 850-854	S06
DCL000771	Dexefaroxan	Parkinson's disease	332	G20
DCL000771	Dexefaroxan	Schizophrenia	295	F20
DCL000772	Dextofisopam	Anxiety disorder	300	F40-F42
DCL000772	Dextofisopam	Irritable bowel syndrome	564.1	K58
DCL000773	Dextromethorphan+quinidine	Painful diabetic neuropathy	250.6,338,780	E10.4, E11.4, E13.4, G89, R52
DCL000774	Diquafosol	Dry eye disease	370.33	H16.229
DCL000775	Divers drug	Cancer pain	338,780	R52, G89
DCL000776	DNK-333	Asthma	.	J45
DCL000776	DNK-333	Irritable bowel syndrome with diarrhoea	493, 564.1, 787.91	A09, J45, K58, K59.1
DCL000777	Dopamine antags	Schizophrenia	295	F20
DCL000778	Doripenem	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000778	Doripenem	Urinary tract infections	599	N39.0
DCL000779	DOV 21947	Severe mood disorders	296	F30-F39
DCL000780	DOV-216303	Severe mood disorders	296	F30-F39
DCL000781	DOV-21947	Severe mood disorders	296	F30-F39
DCL000782	Doxercalciferol	Chronic Kidney disease; Kidney transplantation	403, 580-589, 585.1-585.5, 585.9, 996	N00-N29, N18, T86
DCL000782	Doxercalciferol	Hyperparathyroidism	252.02, 588.81	E21.1
DCL000783	Dronedarone	Angina	413	I20
DCL000783	Dronedarone	Atrial fibrillation	427.31	I48
DCL000784	D-serine	Schizophrenia	295	F20
DCL000785	DU-127090	Parkinson's disease	332	F02.3, G20
DCL000785	DU-127090	Psychotic disorders	.	F20-F29
DCL000786	E 7080	Ovarian cancer	183	C56
DCL000787	E 7974	Ovarian cancer	183	C56
DCL000788	E-2007	Diabetic neuropathy	.	E10.4,E11.4,E13.4
DCL000788	E-2007	Parkinson's disease	332	F02.3, G20
DCL000789	E-5842	Psychotic disorders	.	F20-F29
DCL000789	E-5842	Schizophrenia	295	F20
DCL000790	EAA-090	Painful diabetic neuropathy	250.6,338,780	E10.4, E11.4, E13.4, G89, R52
DCL000791	Eslicarbazepine acetate	Epilepsy	345	G40
DCL000792	Eltrombopag	Idiopathic thrombocytopenic purpura	287.31	D69.3
DCL000792	Eltrombopag	Thrombocytopenia	.	D69.6
DCL000793	Elzasonan hydrochloride	Mood disorder	.	F30-F39
DCL000793	Elzasonan hydrochloride	Severe mood disorders	296	F30-F39
DCL000794	Emapunil	Anxiety disorder	.	F40-F42
DCL000794	Emapunil	Severe mood disorders	296	F30-F39
DCL000795	Entacapone+levodopa+carbidopa	Parkinson's disease; Restless legs syndrome	332, 333.94	F02.3, G20, G25.8
DCL000796	EP-51216	Eating disorder	307.5	F50
DCL000797	EP-51389	Eating disorder	307.5	F50
DCL000798	Epothilon	Breast cancer; Ovarian cancer	140-229, 174, 175, 183	C00-C96, C50, C56
DCL000799	Epratuzumab	Lymphoma	.	C81-C96
DCL000799	Epratuzumab	Systemic lupus erythematosus; Graft rejection in heart transplantation	695, 710.0, 996	L51-L54, M32, T86
DCL000800	Ezlopitant	Emesis	.	R11
DCL000800	Ezlopitant	Emesis; Irritable bowel syndrome	564.1, 787	K58, R11
DCL000801	Farampator	Major depressive disorder	.	F32,F33
DCL000801	Farampator	Schizophrenia	295	F20
DCL000802	Farletuzumab	Ovarian cancer	.	C56
DCL000802	Farletuzumab	Ovarian cancer	183	C56
DCL000803	FG-3019	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DCL000803	FG-3019	Pancreatic cancer	.	C25
DCL000803	FG-3019	Type 2 diabetes; Idiopathic pulmonary fibrosis	250, 250.00, 250.02, 515, 516.3, 709.2	E08-E13, E11, J84.1, L90.5
DCL000804	Fingolimod	Multiple sclerosis	340	G35
DCL000804	Fingolimod	Primary progressive multiple sclerosis	340	G35
DCL000805	Flibanserin	Female sexual dysfunction	302.7	F52, R37
DCL000805	Flibanserin	Mood disorder	.	F30-F39
DCL000806	Fluphenazine Decanoate	Psoriasis	696	L40
DCL000807	Fontolizumab	Inflammatory bowel disease; Rheumatoid arthritis	555, 556, 710-719, 714	K50, K51, M00-M25, M05-M06
DCL000807	Fontolizumab	Psoriatic disorders	696	L40
DCL000808	FTY720	Multiple sclerosis	340	G35
DCL000809	Fumaric acid	Pustular palmoplantar psoriasis; Multiple sclerosis	340, 696, 696.1	G35, L40, L40.3
DCL000810	Gabapentin ER	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
DCL000811	Ganaxolone	Epilepsy	.	G40
DCL000811	Ganaxolone	Epilepsy	345	G40
DCL000812	GC-1008	Idiopathic pulmonary fibrosis	516.3	J84.1
DCL000813	Gepirone ER	Depression	311	F32
DCL000813	Gepirone ER	Mood disorder	.	F30-F39
DCL000814	GI-181771	Obesity	278	E66
DCL000815	Gliatech	Schizophrenia	295	F20
DCL000816	Glufosfamide	Ovarian cancer	183	C56
DCL000816	Glufosfamide	Solid tumours	.	C00-C75,C7A,C7B
DCL000817	GMC-283	Schizophrenia	295	F20
DCL000818	Golimumab	Inflammatory bowel disease	555, 556	K50, K51
DCL000818	Golimumab	Psoriasis	.	L40
DCL000818	Golimumab	Rheumatold arthritis; Psoriatic arthritis; Ankylosing spondylitis	696.0, 710-719, 714, 720.0	L40.5, M00-M25, M05-M06, M07, M08.1, M45
DCL000819	GPI-1485	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DCL000819	GPI-1485	Parkinson's disease	332	F02.3, G20
DCL000820	GPI-16072	Neuropathic pain	338,780	R52, G89
DCL000821	GRN163	Multiple myeloma	203	C90.0
DCL000822	GSK-159797	Chronic obstructive pulmonary disease	.	J40-J44,J47
DCL000822	GSK-159797	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000823	GSK233705	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000824	GSK372475	ADHD; Severe mood disorders	296, 314.00, 314.01	F30-F39, F90
DCL000825	GSK642444	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000826	GSK-644784	Neuropathic pain	338,780	R52, G89
DCL000827	GSK-677954	Non-alcoholic fatty liver disease	571.8	K76.0
DCL000828	GSK-681323	Rheumatold arthritis; Chronic obstructive pulmonary disease	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DCL000829	GTP-010	Dyspepsia	.	K30
DCL000829	GTP-010	Irritable bowel syndrome; Dyspepsia	536.8, 564.1	K30, K58
DCL000830	GW-406381	Osteoarthritis; Neuropathic pain	338, 356.0, 356.8, 715,780	G64, G90.0, M15-M19, M47, R52, G89
DCL000830	GW-406381	Pain	.	G89
DCL000831	GW-427353	Irritable Bowel Syndrome	250, 250.00, 250.02, 278, 564.1	E08-E13, E11, E66, K58
DCL000831	GW-427353	Urinary incontinence	.	N39.3-N39.4
DCL000832	GW-493838	Neuropathic pain	338,780	R52, G89
DCL000832	GW-493838	Pain	.	G89
DCL000833	GW842470X	Atopic dermatitis	691.8	L20
DCL000834	GW876008	Irritable bowel syndrome	300, 311, 564.1	F32, F40-F42, K58
DCL000835	HCV-796	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL000835	HCV-796	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL000836	HMR-2934	Schizophrenia	295	F20
DCL000837	HP-184	Multiple sclerosis	340	G35
DCL000838	Ibudilast	Allergic conjunctivitis	372.14	H10.45
DCL000838	Ibudilast	Opioid-related disorders; Diabetic neuropathy	250, 250.6, 292, 304.0, 305.50, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, F11, G64, G90.0
DCL000839	IC-485	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000840	Iclaprim	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DCL000840	Iclaprim	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000841	Idazoxan	Major depressive disorder; Parkinson's disease	296.2, 296.3, 332	F02.3, F32, F33, G20
DCL000842	IL-18BP	B-cell Non-hodgkin's Lymphoma; Rheumatoid arthritis	200, 202, 202.8, 710-719, 714	C81-C96, C82-C85, M00-M25, M05-M06
DCL000843	Iloperidone	Schizophrenia	295	F20
DCL000844	INCB018424	Myelofibrosis	.	C94.4,D47.1
DCL000844	INCB018424	Myelofibrosis; Polycythemia vera	289.0, 289.83, 776.4	C94.4, D47.1, D75.1, P61.1
DCL000845	INCB-3284	Metabolic disorders	.	E70-E90
DCL000845	INCB-3284	Rheumatold arthritis	714	M05-M06
DCL000846	Indacaterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000847	Inolimomab	Graft-versus host disease	.	T86.0
DCL000847	Inolimomab	Heart transplant rejection	996	T86
DCL000848	INS-37217	Cystic fibrosis	.	E84
DCL000848	INS-37217	Cystic fibrosis	277	E84
DCL000849	IP-751	Cystitis	.	N30
DCL000849	IP-751	Neuropathic pain	338,780	R52, G89
DCL000850	Ipamorelin	Growth hormone deficiency	.	E23.0
DCL000850	Ipamorelin	Postoperative ileus	537.2, 560.1, 560.31, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, P76.1
DCL000851	ISIS 301012	Dyslipidemia	272	E78
DCL000852	ITF2357	Acute myeloid leukemia	205	C92.0
DCL000852	ITF2357	Myelofibrosis; Essential thrombocythemia; Polycythemia vera	238.71, 289.0, 289.83, 289.9, 776.4	C94.4, D47.1, D47.3, D75.1, D75.2, D75.8, P61.1
DCL000853	K-832	Rheumatold arthritis	714	M05-M06
DCL000854	KB-6806	Chemotherapy-induced emesis	787	R11
DCL000855	KDS-2000	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
DCL000856	KW-3902	Acute and chronic heart failure	428	I50
DCL000857	L-759274	Anxiety disorder	300	F40-F42
DCL000857	L-759274	Severe mood disorders; Depression	296, 311	F30-F39, F32
DCL000858	Lacosamide	Convulsions	.	R56.0
DCL000858	Lacosamide	Epilepsy	345	G40
DCL000858	Lacosamide	Painful diabetic neuropathy	250.6,338,780	E10.4, E11.4, E13.4, G89, R52
DCL000859	Lamectacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000860	Laquinamod	Multiple sclerosis	340	G35
DCL000861	LAS-34273	Chronic obstructive pulmonary disease	.	J40-J44,J47
DCL000861	LAS-34273	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000862	LE-300	Schizophrenia	295	F20
DCL000863	Leptin	Lipodystrophy	.	E88.1
DCL000863	Leptin	Prader-Willi syndrome; Raynauds disease; Alzheimers disease; Cardiovascular disease	331.0, 390-459, 443.0, 759.81	G30, I00-I99, I73.0, Q87.1
DCL000864	Lerisetron	Nausea	.	R11
DCL000864	Lerisetron	Nausea; Vomiting; Testicular germ cell tumor; Emesis	140-199, 183, 186, 210-229, 220, 222.0, 787, 787.0	C00-C75, C56, C62, C7A, C7B, D10-D36, D27, D29.2, D3A, R11
DCL000865	Leukotriene antagonist	Idiopathic pulmonary fibrosis	516.3	J84.1
DCL000866	LGD-4665	Immune thrombocytopenic purpura; Idiopathic thrombocytopenic purpura	287.31	D69.3
DCL000866	LGD-4665	Thrombocytopenia	.	D69.6
DCL000867	Licarbazepine	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DCL000867	Licarbazepine	Epilepsy	345	G40
DCL000868	Linaclotide	Constipation; Postoperative ileus	537.2, 560.1, 560.31, 564.0, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, K59.0, P76.1
DCL000869	Liraglutide	Diabetes mellitus type 2	.	E11
DCL000869	Liraglutide	Obesity	278	E66
DCL000869	Liraglutide	Type 2 diabetes	250.00, 250.02	E11
DCL000870	Lixivaptan	Congestive heart failure	428	I50
DCL000870	Lixivaptan	Euvolemic hyponatremia; Hypervolemic hyponatremia	276.1	E87.1
DCL000870	Lixivaptan	Hyponatremia	.	E87.1
DCL000871	LJP-1082	Hughes syndrome	289.81	D68.8
DCL000872	Lorcaserin	Drug abuse	303, 304, 305	F10-F19
DCL000872	Lorcaserin	Obesity	278	E66
DCL000873	Lurasidone hydrochloride	Schizophrenia	295	F20
DCL000874	LY-293111	Inflammatory bowel disease	555, 556	K50, K51
DCL000874	LY-293111	Pancreatic cancer	157	C25
DCL000875	LymphoStat B	Rheumatold arthritis	.	M05-M06
DCL000875	LymphoStat B	Systemic lupus erythematosus	710	M32
DCL000876	Magnesium	Acute ischemic stroke	434.91	I61-I63
DCL000876	Magnesium	Asthma	493	J45
DCL000877	MCI-186	Amyotrophic Lateral Sclerosis	335.20, 434.91	G12.2, I61-I63
DCL000877	MCI-186	Cerebral infarction	.	I63
DCL000878	MD-1100	Constipation	.	K59.0
DCL000878	MD-1100	Irritable bowel syndrome	564.1	K58
DCL000879	MEM-1003	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DCL000879	MEM-1003	Dementia	.	F01-F07
DCL000880	MEM-3454	Schizophrenia	.	F20
DCL000880	MEM-3454	Schizophrenia	295	F20
DCL000881	Methylnaltrexone	Constipation; Postoperative ileus	537.2, 560.1, 560.31, 564.0, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, K59.0, P76.1
DCL000882	Milveterol+Fluticasone	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DCL000883	MLN1202	Cardiovascular disease	.	I00-I99
DCL000883	MLN1202	Metastatic cancer; Unspecified adult solid tumor	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL000883	MLN1202	Multiple sclerosis	340	G35
DCL000884	MLN3897	Rheumatold arthritis	714	M05-M06
DCL000885	MN-305	Anxiety disorder	.	F40-F42
DCL000885	MN-305	Severe mood disorders	296	F30-F39
DCL000887	MRE-0094	Diabetic foot ulcer	707	L88-L89
DCL000887	MRE-0094	Wound healing	.	T14.0-T14.1
DCL000888	MS-377	Psychotic disorders	.	F20-F29
DCL000888	MS-377	Schizophrenia	295	F20
DCL000889	N-0923	Parkinson's disease	.	G20
DCL000889	N-0923	Parkinson's disease	332	F02.3, G20
DCL000890	N-5984	Obesity	.	E66
DCL000890	N-5984	Obesity; Type 2 diabetes	250, 250.00, 250.02, 278	E08-E13, E11, E66
DCL000892	NCX-4016	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DCL000892	NCX-4016	Type 2 diabetes; Early nephropathy; Claudication	250, 250.00, 250.02, 250.4, 338, 437.6, 443.9, 453, 580-599, 671.5, 671.9,780	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DCL000893	NE-100	Psychotic disorders	.	F20-F29
DCL000893	NE-100	Schizophrenia	295	F20
DCL000894	Nepadutant	Infantile colics; Postoperative ileus	537.2, 560.1, 560.31, 777.1, 777.4, 789.7	K31.5, K56.0, K56.3, K56.7, P76.1, R10.4
DCL000894	Nepadutant	Irritable bowel syndrome	.	K58
DCL000895	Neramexane	Alcohol use disorders	303	F10.2
DCL000895	Neramexane	Cancer pain	338,780	R52, G89
DCL000896	NERI IV	Mood disorder	.	F30-F39
DCL000896	NERI IV	Severe mood disorders	296	F30-F39
DCL000897	Netoglitazone	Diabetes mellitus type 1	.	E10
DCL000897	Netoglitazone	Non-alcoholic fatty liver disease	571.8	K76.0
DCL000898	NGD 94-1	Psychotic disorders	.	F20-F29
DCL000898	NGD 94-1	Schizophrenia	295	F20
DCL000899	NS 1209	Epilepsy	345	G40
DCL000899	NS 1209	Neuropathic pain	338,780	R52, G89
DCL000899	NS 1209	Pain	.	G89
DCL000900	NS 2359	ADHD; Depression; Cocaine addiction	303-304, 304.2, 311, 314.00, 314.01	F10-F19, F14.2, F32, F90
DCL000900	NS 2359	Substance dependence	.	F10-F19
DCL000901	NVA237	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000901	NVA237	Peptic ulcer	531-534	K25-K27
DCL000902	NVP-LAQ824	General leukaemia cancer	204-208	C91-C95
DCL000902	NVP-LAQ824	Leukemia	.	C91-C95
DCL000902	NVP-LAQ824	Severe mood disorders	296	F30-F39
DCL000903	Oblimersen	Advanced Melanoma; Multiple myeloma	172, 203.0	C43, C90.0
DCL000903	Oblimersen	Cancer	.	C00-C97
DCL000904	Ocaperidone	Schizophrenia	295	F20
DCL000904	Ocaperidone	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DCL000905	ONO-2506	Cerebral ischemia	459.89	I99.8
DCL000905	ONO-2506	Stroke	434.91	I61-I63
DCL000906	ONO-6126	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DCL000906	ONO-6126	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000907	OPC-14523	Bulimia nervosa; Severe mood disorders	296, 307.51	F30-F39, F50.2
DCL000907	OPC-14523	Female sexual dysfunction	302.7	F52, R37
DCL000907	OPC-14523	Mood disorder	.	F30-F39
DCL000908	Oravescent fentanyl	Neuropathic pain	338,780	R52, G89
DCL000909	Orexin-1 antagonist	Heart transplant rejection	996	T86
DCL000910	ORG 34517/34850	Severe mood disorders	296	F30-F39
DCL000911	Org-23366	Schizophrenia	295	F20
DCL000912	Oritavancin	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DCL000912	Oritavancin	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL000913	OrM3	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000914	Panobinostat	Primary myelofibrosis; Post-polycythemia vera; Post-essential thrombocytopenia; Cutaneous T cell-lymphomas	203.0, 287.3, 287.4, 287.5, 289.0, 289.83, 776.4	C90.0, C94.4, D47.1, D69.6, D75.1, P61.0, P61.1
DCL000914	Panobinostat	Type 2 diabetes	250.00, 250.02	E11
DCL000915	Pardoprunox	Advanced Stage Parkinson's Disease	332	F02.3, G20
DCL000916	PD-157533	Schizophrenia	295	F20
DCL000917	PD-157695	Schizophrenia	295	F20
DCL000918	PD-158771	Schizophrenia	295	F20
DCL000919	PD-165167	Schizophrenia	295	F20
DCL000921	PegCNTF	Obesity	278	E66
DCL000922	Plerixafor	Human immunodeficiency virus infection	.	B20
DCL000922	Plerixafor	Non-Hodgkin's Lymphoma; Late-stage Solid Tumors	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C82-C85, D10-D36, D3A
DCL000923	Pexacerfont	Anxiety disorder	.	F40-F42
DCL000923	Pexacerfont	Severe mood disorders	296	F30-F39
DCL000924	PF-00547659	Crohn's disease	.	K50
DCL000924	PF-00547659	Ulcerative colitis; Inflammatory bowel disease	555, 556, 556.9	K50, K50-K52, K51
DCL000925	Pfizer 10	Female sexual dysfunction	302.7	F52, R37
DCL000926	Pfizer 4	Female sexual dysfunction	302.7	F52, R37
DCL000927	PG-116800	Acute and chronic heart failure	428	I50
DCL000927	PG-116800	Osteoarthritis	715	M15-M19, M47
DCL000928	Phentermine+topiramate	Obesity	278	E66
DCL000929	Phenylbutyrate	Urea cycle disorders	270.6	E72.2
DCL000930	Pimavanserin	Parkinson's disease; Psychosis	290-299, 332	F02.3, F20-F29, G20
DCL000930	Pimavanserin	Schizophrenia	.	F20
DCL000931	Pinaverium bromide	Irritable bowel syndrome	564.1	K58
DCL000932	Pirfenidone	Idiopathic pulmonary fibrosis	.	J84.1
DCL000932	Pirfenidone	Idiopathic pulmonary fibrosis	516.3	J84.1
DCL000933	Pitavastatin	Hyperlipidaemia; Mixed dyslipidaemia	272, 272.0-272.4	E78
DCL000933	Pitavastatin	Hyperlipidemia	272.0-272.4	E78
DCL000934	PNU-177864	Schizophrenia	295	F20
DCL000935	PNU-282987	Schizophrenia	295	F20
DCL000936	Pramlintide	Type 1/2 diabetes	250	E08-E13
DCL000936	Pramlintide	Type 1/2 diabetes	250, 278	E08-E13, E66
DCL000937	PRX-00023	Mood disorder	.	F30-F39
DCL000937	PRX-00023	Severe mood disorders	296	F30-F39
DCL000938	PRX-08066	Pulmonary arterial hypertension	416	I27.0, I27.2
DCL000939	Pumosetrag	Gastro-oesophageal reflux	530	K21
DCL000939	Pumosetrag	Gastrointestinal disease	.	K00-K93
DCL000939	Pumosetrag	Irritable bowel syndrome	564.1	K58
DCL000940	PYY3-36	Obesity	278	E66
DCL000941	Quetiapine SR	Panic disorder; Severe mood disorders; Schizophrenia	295, 296, 300.01, 300.21	F20, F30-F39, F41.0
DCL000942	QVA-149	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000943	R 673	Anxiety disorder	.	F40-F42
DCL000943	R 673	Depression	311	F32
DCL000944	R1503	Rheumatold arthritis	714	M05-M06
DCL000945	R348	Autoimmune diseases	.	D84.9
DCL000945	R348	Psoriasis	696	L40
DCL000946	R-788	Rheumatold arthritis	714	M05-M06
DCL000947	Radafaxine	Major depressive disorder	296.0, 296.1, 296.2, 296.3, 296.4, 296.5, 296.6, 296.7, 296.8	F31, F32, F33
DCL000948	Radaxafine HCl	Neuropathic pain	338,780	R52, G89
DCL000949	Ralfinamide	Neuropathic pain	338,780	R52, G89
DCL000949	Ralfinamide	Pain	.	G89
DCL000950	Rambazole	Psoriasis	.	L40
DCL000950	Rambazole	Psoriasis	696	L40
DCL000951	RDEA 594	Gout	.	M10
DCL000951	RDEA 594	Gout	274.00274.1274.8274.9	M10
DCL000952	RDP-58	Ulcerative colitis; Crohn's disease; Psoriasis; Eczema; Multiple sclerosis; Barrett's esophagus	340, 530.85, 555, 556.9, 692, 696	G35, K22.7, K50, K50-K52, L20-L30, L40
DCL000953	Recombinant human C1 inhibitor	Hereditary angioedema	.	D84.1
DCL000953	Recombinant human C1 inhibitor	Painful diabetic neuropathy	250.6,338,780	E10.4, E11.4, E13.4, G89, R52
DCL000954	Renzapride	Irritable bowel syndrome	.	K58
DCL000954	Renzapride	Irritable bowel syndrome	564.1	K58
DCL000955	Reparixin	Ischemia-reperfusion injury; Lung transplantation; Graft rejection in heart transplantation	996, 996.84	T86, T86.81
DCL000955	Reparixin	Rheumatold arthritis	.	M05-M06
DCL000956	Resiniferatoxin	Interstitial cystitis	.	N30.1
DCL000956	Resiniferatoxin	Neuropathic pain	338,780	R52, G89
DCL000957	Revatropate	Chronic obstructive pulmonary disease	.	J40-J44,J47
DCL000957	Revatropate	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000958	RGH-896	Diabetic peripheral neuropathic pain	250.6, 338,780	E10.4, E11.4, E13.4, R52, G89
DCL000958	RGH-896	Neuropathic pain	338,780	R52, G89
DCL000959	Rho-kinase inhibitor	Glaucoma	365	H40-H42
DCL000959	Rho-kinase inhibitor	Pulmonary arterial hypertension	416	I27.0, I27.2
DCL000960	RhTPO	Sarcoma; Idiopathic thrombocytopenic purpura	287.31	D69.3
DCL000961	Rilonacept	Acute gout glare	274	M10
DCL000961	Rilonacept	Arthritis	.	M00-M25
DCL000962	Rimonbant	Obesity	278	E66
DCL000963	Risperidone Consta	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DCL000964	Roflumilast	Asthma	.	J45
DCL000964	Roflumilast	Atopic dermatitis	691.8	L20
DCL000964	Roflumilast	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000965	Rolofylline	Heart failure	428	I50
DCL000966	Rotigotine patch	Restless legs syndrome; Parkinson's disease	332, 333.94	F02.3, G20, G25.8
DCL000967	RPSGL-Ig	Delayed graft function; Heart transplantation	996	T86
DCL000968	R-sibutramine metabolite	Depression; Attention deficit hyperactivity disorder	311, 314.00, 314.01	F32, F90
DCL000968	R-sibutramine metabolite	Mood disorder	.	F30-F39
DCL000969	RTI-336	Cocaine addiction	304.2	F14.2
DCL000970	Ruboxistaurin	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DCL000971	S-777469	Atopic dermatitis	.	L20
DCL000971	S-777469	Atopic dermatitis	691.8	L20
DCL000972	Safinamide	Idiopathic parkinson's disease	332	F02.3, G20
DCL000972	Safinamide	Parkinson's disease	332	F02.3, G20
DCL000973	Sarizotan	Parkinson's disease	332	F02.3, G20
DCL000973	Sarizotan	Psychotic disorders	.	F20-F29
DCL000974	Satavaptan	Acute and chronic heart failure	428	I50
DCL000974	Satavaptan	Cardiovascular disease	390-459	I00-I99
DCL000975	SB-265610	Asthma	.	J45
DCL000975	SB-265610	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000976	SB-277011	Schizophrenia	295	F20
DCL000976	SB-277011	Substance dependence	.	F10-F19
DCL000977	SB-656933	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000978	SB-683699	Multiple sclerosis	340	G35
DCL000979	SCH 420814	Parkinson's disease	332	F02.3, G20
DCL000980	SCH-527123	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000981	SDZ-MAR-327	Psychotic disorders	.	F20-F29
DCL000981	SDZ-MAR-327	Schizophrenia	295	F20
DCL000982	Seletracetam	Epilepsy	345	G40
DCL000983	Sibenadet	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL000984	Sigma antagonist	Schizophrenia	295	F20
DCL000985	Siplizumab	Cancer; Psoriasis	140-229, 696	C00-C96, L40
DCL000985	Siplizumab	Lymphoma	.	C81-C96
DCL000986	Sivelestat sodium hydrate	Acute lung injury; Acute respiratory distress syndrome	518.5, 518.82	J80
DCL000987	SLV-308	Parkinson's disease	.	G20
DCL000987	SLV-308	Parkinson's disease	332	F02.3, G20
DCL000988	SLV-310	Psychotic disorders	.	F20-F29
DCL000988	SLV-310	Schizophrenia	295	F20
DCL000989	SLV-313	Psychotic disorders	.	F20-F29
DCL000989	SLV-313	Schizophrenia	295	F20
DCL000990	SLV-317	Inflammatory bowel disease	555, 556	K50, K51
DCL000990	SLV-317	Irritable bowel syndrome	564.1	K58
DCL000991	SLV-319	Obesity; Psychosis	278, 290-299	E66, F20-F29
DCL000991	SLV-319	Psychotic disorders	.	F20-F29
DCL000992	SLV320	Heart failure	428	I50
DCL000993	SLV-323	Irritable bowel syndrome; Chemo therapy induced emesis; Gastric motility disorder	536.8, 564.1, 787	K30, K58, R11
DCL000994	SNDX-275	Hodgkin's lymphoma; Multiple myeloma	201, 202.8, 203.0	C81, C81-C96, C90.0
DCL000995	SNS-595	Ovarian cancer	183	C56
DCL000995	SNS-595	Solid tumours	.	C00-C75,C7A,C7B
DCL000996	Sotrastaurin acetate	Renal Transplantation	.	Z48.22
DCL000997	SPI-376	Psychotic disorders	.	F20-F29
DCL000997	SPI-376	Schizophrenia	295	F20
DCL000998	SPI-860	Neuropathic pain	338,780	R52, G89
DCL000999	SR46349B	Anxiety disorder	.	F40-F42
DCL000999	SR46349B	Sleep initiation and maintenance disorders; Primary Insomnia; Schizophrenia	295, 307.41, 307.42, 327.0, 780.51, 780.52	F20, F51.0, G47.0
DCL001000	SSR-125047	Schizophrenia	295	F20
DCL001001	SSR149415	Anxiety disorder	.	F40-F42
DCL001001	SSR149415	Major depressive disorder; Anxiety	300	F40-F42
DCL001002	SSR-181507	Psychotic disorders	.	F20-F29
DCL001002	SSR-181507	Schizophrenia	295	F20
DCL001003	Statins	Multiple myeloma	203	C90.0
DCL001004	SU5416	Multiple myeloma; HIV Infections	001-139, 042, 203.0	A00-B99, B20, C90.0
DCL001004	SU5416	Solid tumours	.	C00-C75,C7A,C7B
DCL001005	Sulfasalizine	Rheumatold arthritis	714	M05-M06
DCL001006	Sumanirole	Parkinson's disease	.	G20
DCL001006	Sumanirole	Parkinson's disease	332	F02.3, G20
DCL001007	SUN-11031	Anorexia	.	F50.0-F50.1
DCL001007	SUN-11031	Anorexia nervosa cachexia	307.1, 799.4	F50.0-F50.1, R64
DCL001008	SUN13834	Atopic dermatitis	691.8	L20
DCL001008	SUN13834	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DCL001009	T-62	Neuropathic pain	338,780	R52, G89
DCL001010	TA-2005	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DCL001011	TAK-637	Depression	311	F32
DCL001011	TAK-637	Mood disorder	.	F30-F39
DCL001012	Talactoferrin Alfa	Severe Sepsis; Diabetic foot ulcers	250, 707, 995.91	A40, A40-A41, A41, E08-E13, L88-L89
DCL001013	Talampanel	Convulsions	.	R56.0
DCL001013	Talampanel	Epilepsy; Parkinson's disease	332, 345	F02.3, G20, G40
DCL001014	TC-1698	Alzheimer's disease	331	G30
DCL001014	TC-1698	Schizophrenia	295	F20
DCL001015	Tebipenem	Nicotine dependence; Obesity	278, 305.1	E66, F17
DCL001016	Telbermin	Diabetic foot ulcer	.	E08-E13
DCL001016	Telbermin	Diabetic foot ulcer	707	L88-L89
DCL001017	TG101348	Myelofibrosis	.	C94.4,D47.1
DCL001017	TG101348	Myelofibrosis	289.83	C94.4, D47.1
DCL001018	TgAAC-94	Psoriatic arthritis; Rheumatoid arthritis	696.0, 710-719, 714	L40.5, M00-M25, M05-M06, M07
DCL001019	TGBA01AD	Major depressive disorder	296.2, 296.3	F32, F33
DCL001019	TGBA01AD	Severe mood disorders	296	F30-F39
DCL001020	Trafermin	Periodontitis	523.5	K05.4
DCL001021	Tramadol ER	Neuropathic pain; Postherpetic neuralgia	053.19, 338, 356.0, 356.8,780	B02.2, G44.847, G53.0, G64, G90.0, R52, G89
DCL001022	Traxoprodil	Parkinson's disease	332	F02.3, G20
DCL001022	Traxoprodil	Severe mood disorders	296	F30-F39
DCL001023	Trazodone CR	Fibromyalgia; Major depressive disorder; Severe mood disorders	296, 296.2, 296.3, 729.1	F30-F39, F32, F33, M79.7
DCL001024	TRIDMAC	Severe mood disorders	296	F30-F39
DCL001025	TRO-19622	Chemotherapy-induced peripheral neuropathy	356.0, 356.8	G64, G90.0
DCL001025	TRO-19622	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DCL001026	TRX4	Rheumatold arthritis	714	M05-M06
DCL001026	TRX4	Type 1 diabetes; Psoriasis	250, 250.01, 696	E08-E13, E10, L40
DCL001027	TV-4710	Systemic lupus erythematosus	710	M32
DCL001028	U-99194A	Schizophrenia	295	F20
DCL001029	U-99363E	Schizophrenia	295	F20
DCL001030	Ustekinumab	Crohn's disease; Inflammatory bowel disease	555, 556	K50, K51
DCL001030	Ustekinumab	Moderate-to-severe plaque psoriasis	696	L40
DCL001030	Ustekinumab	Psoriasis	696	L40
DCL001031	Valproate	Alcohol use disorders	303	F10.2
DCL001032	Vanoxerine	Atrial fibrillation	427.31	I48
DCL001032	Vanoxerine	Cocaine addiction	304.2	F14.2
DCL001033	Vasoactive intestinal peptide	Chronic obstructive pulmonary disease; Pulmonary arterial hypertension	401, 416.0, 490-492, 494-496	I10, I11, I12, I13, I15, I27.0, I27.2, J40-J44, J47
DCL001034	VEGF Trap	Exudative age-related macular degeneration	362.5	H35.3
DCL001035	Vestipitant	Anxiety disorder; Chemotherapyinduced emesis; Dyspepsia; Major depressive disorder	296.2, 296.3, 300, 536.8, 787	F32, F33, F40-F42, K30, R11
DCL001036	Vilazodone	Major depressive disorder	296.2, 296.3	F32, F33
DCL001037	Voclosporin	Kidney diseases; Heart transplantation	996	T86
DCL001037	Voclosporin	Psoriasis	696	L40
DCL001038	XL019	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL001038	XL019	Polycythemia vera	238.4	D45
DCL001039	XL784	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL001039	XL784	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DCL001040	XTL-2125	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001040	XTL-2125	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001041	Y-931	Schizophrenia	295	F20
DCL001042	ZD-3638	Psychotic disorders	.	F20-F29
DCL001042	ZD-3638	Schizophrenia	295	F20
DCL001044	ABT-894	Neuropathic pain	338,780	R52, G89
DCL001045	ISIS 104838	Crohn's disease	.	K50
DCL001045	ISIS 104838	Rheumatold arthritis	714	M05-M06
DCL001046	OGX-427	Breast cancer; Ovarian cancer; Bladder cancer; Prostate cancer; Lung cancer	140-229, 162, 183, 188	C00-C96, C33-C34, C56, C67
DCL001046	OGX-427	Cancer	.	C00-C97
DCL001047	MBI 1121	Cancer	140-229	C00-C96
DCL001047	MBI 1121	Condyloma	.	A51.3
DCL001048	TPI ASM8	Asthma	493	J45
DCL001049	HGTV43	Acquired immune deficiency syndrome	42	B20
DCL001049	HGTV43	HIV infections	42	B20
DCL001051	AVI-4065	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001051	AVI-4065	Hepatitis virus infection	573.3	K75.9
DCL001052	Merck drug	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001053	Mipomersen	Atherosclerosis	414.0, 440	I70
DCL001053	Mipomersen	Familial hypercholesterolemia	.	E78.0
DCL001054	VRX496	Acquired immune deficiency syndrome	42	B20
DCL001055	Antisense TAR and RevM10	Acquired immune deficiency syndrome	42	B20
DCL001056	ISIS 14803	Hepatitis C virus infection	.	B17.1,B18.2
DCL001056	ISIS 14803	Hepatitis C virus infection	001-139, 070.4, 070.5, 070.70, 573.3	A00-B99, B17.1, B18.2, K75.9
DCL001057	AVI4126	Cancer	.	C00-C97
DCL001057	AVI4126	Coronary Artery disease; Coronary Restenosis; Cardiovascular restenosis	410-414, 429.2, 429.89	I20-I25, I51.89
DCL001058	AP12009	Colorectal cancer	.	C18-C20,C21
DCL001058	AP12009	Glioblastoma; Anaplastic Astrocytoma; Malignant brain tumors	140-199, 191, 210-229, 225.0	C00-C75, C71, C7A, C7B, D10-D36, D33, D3A
DCL001059	ICo-007	Diabetic macular edema; Diabetic retinopathy	250, 250.5, 362.0-362.2, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35-H35.2, H35.8, H36, E10.3, E11.3, E13.3, R60.9
DCL001059	ICo-007	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DCL001060	TV-1102	Multiple sclerosis	340	G35
DCL001061	LY2181308	Non-small cell lung cancer	162	C33, C34
DCL001062	ISIS 325568	Diabetes mellitus type 2	250	E11
DCL001062	ISIS 325568	Type 2 diabetes	250.00, 250.02	E11
DCL001063	Affinitak	Lung cancer; Breast cancer; Colorectal cancer; Ovarian cancer; Melanoma	140-229, 162, 162.9, 172, 183, 200, 202, 204.0	C00-C96, C33, C33-C34, C34, C34.90, C43, C56, C82-C85, C91.0
DCL001064	7-hydroxystaurosporine	Leukaemia; Myelodysplastic Syndrome; Solid tumours; Lymphoma	140-199, 202.8, 208.9, 210-229, 758.33	C00-C75, C7A, C7B, C81-C96, C91-C95, D10-D36, D3A, Q93.88
DCL001064	7-hydroxystaurosporine	Renal cell carcinoma; Melanoma and lymphoma; Small cell lung cancer	162, 172, 189, 202.8	C33, C34, C43, C64, C81-C96
DCL001065	AEG35156	Cancer	.	C00-C97
DCL001065	AEG35156	Relapsed/refractory chronic lymphocytic leukaemia; Advanced non-small-cell lung cancer; Advanced pancreatic cancer	140-229, 157, 162, 202.0, 202.8, 204.0, 204.1, 204.1V10.60, 208.9	C00-C96, C25, C33, C33-C34, C34, C81-C96, C82, C91-C95, C91.0, C91.1
DCL001066	AGN211745	Choroidal neovascularization; Age-related macular degeneration	362.5	H35.3
DCL001067	ALN-RSV01	Respiratory syncytial virus infection	79.6	B97.4
DCL001067	ALN-RSV01	Viral infections	042-075	A80-A99, B00-B34
DCL001068	AT-9283	Solid tumours; AML; ALL; CML; MDS; Myelofibrosis	140-199, 200, 202, 204.0, 205.0, 205.1, 210-229, 289.83, 758.33	C00-C75, C7A, C7B, C82-C85, C91.0, C92.0, C92.1, C94.4, D10-D36, D3A, D47.1, Q93.88
DCL001069	Bevasiranib	Exudative age-related macular degeneration	362.5	H35.3
DCL001070	CYC-116	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001070	CYC-116	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001071	ENMD-2076	Acute myeloid leukemia	.	C92.0
DCL001071	ENMD-2076	Ovarian cancer; Fallopian cancer; Peritoneal cancer	140-229, 158, 183, 183.2, 221.0	C00-C96, C48.1-C48.2, C56, C57, D28
DCL001072	GSK1070916	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001073	P1446A-05	Advanced refractory solid; Haematological tumours	140-229	C00-C96
DCL001073	P1446A-05	Cancer	140-229	C00-C96
DCL001074	P276-00	Mantle cell lymphoma	200.4	C85.7
DCL001074	P276-00	Multiple myeloma; Mantle cell lymphoma; Head and neck cancers; Cyclin D1-positive melanoma	140-149, 140-229, 172, 200.4, 202.8, 203.0	C00-C96, C07-C14, C32-C33, C43, C81-C96, C85.7, C90.0
DCL001075	PD-0332991	Breast cancer	174, 175	C50
DCL001075	PD-0332991	Mantle-cell lymphoma	202.8	C81-C96
DCL001076	PF-03814735	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001076	PF-03814735	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001077	PF-477736	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001077	PF-477736	Solid tumours	.	C00-C75,C7A,C7B
DCL001078	PHA-739358	Prostate cancer	185	C61
DCL001079	R547	Advanced solid tumours	140-199, 140-239, 210-229	C00-C75, C00-D48, C7A, C7B, D10-D36, D3A
DCL001080	R-roscovitine	Cancer	.	C00-C97
DCL001080	R-roscovitine	Non-small cell lung cancer	162	C33, C34
DCL001081	SCH 727965	Acute lymphoblastic leukemia	.	C91.0
DCL001081	SCH 727965	Advanced NHL; Advanced multiple myeloma; Advanced CLL	140-199, 200, 202, 203.0, 204.1, 210-229	C00-C75, C7A, C7B, C82-C85, C90.0, C91.1, D10-D36, D3A
DCL001081	SCH 727965	Advanced breast cancer; NSCLC; Acute leukaemia	140-229, 162, 174, 175, 202.8, 208.9	C00-C96, C33, C34, C50, C81-C96, C91-C95
DCL001082	Terameprocol	Leukaemia; Refractory solid tumours; Lymphoma	140-199, 202.8, 208.9, 210-229	C00-C75, C7A, C7B, C81-C96, C91-C95, D10-D36, D3A
DCL001082	Terameprocol	Solid tumours	.	C00-C75,C7A,C7B
DCL001083	VX-689	Cancer	140-199, 140-229, 140-239, 210-229	C00-C75, C00-C96, C00-C96, C00-D48, C7A, C7B, D10-D36, D3A
DCL001083	VX-689	Solid tumours	.	C00-C75,C7A,C7B
DCL001084	ZK 304709	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001085	BEZ235	Advanced solid tumours; Advanced breast cancer	140-199, 140-229, 174, 175, 210-229	C00-C75, C00-C96, C50, C7A, C7B, D10-D36, D3A
DCL001085	BEZ235	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001086	BGT226	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001086	BGT226	Solid tumours; Advanced breast cancer; Cowden's syndrome	140-199, 140-229, 174, 175, 210-229, 759.6	C00-C75, C00-C96, C50, C7A, C7B, D10-D36, D3A, Q85.8
DCL001087	BKM120	Breast cancer	.	C50
DCL001087	BKM120	Metastatic breast cancer	174, 175	C50
DCL001088	GDC0941	Advanced solid tumours; Non-Hodgkin's lymphoma	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C82-C85, D10-D36, D3A
DCL001089	GSK1059615	Metastatic breast cancer; Endometrial cancer; Lymphoma	140-199, 140-229, 174, 175, 182.0, 202.8, 210-229	C00-C75, C00-C96, C50, C54.1, C7A, C7B, C81-C96, D10-D36, D3A
DCL001090	PX-866	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001090	PX-866	Cancer	.	C00-C97
DCL001091	CAL-101	Chronic lymphocytic leukaemia; Acute myeloid leukaemia; Non-Hodgkin's lymphoma	200, 202, 202.8, 204.1, 205.0, 208.9	C81-C96, C82-C85, C91-C95, C91.1, C92.0
DCL001092	MK2206	Colon cancer; Rectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DCL001093	VQD-002	Haematological malignancies; Leukaemia; Non-small-cell lung cancer	140-229, 140-239, 162, 200-209, 208.9	C00-C96, C00-C96, C33, C33-C34, C34, C81-C96, C91-C95
DCL001094	AP23573	Metastatic soft-tissue sarcomas; Metastatic bone sarcomas	.	I51.89
DCL001094	AP23573	Restenosis	.	I51.89
DCL001095	OSI-027	Renal cancer	.	C64
DCL001095	OSI-027	Solid tumours; Lymphoma	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, D10-D36, D3A
DCL001096	SCH-D	HIV infections	42	B20
DCL001096	SCH-D	Human immunodeficiency virus infection	.	B20
DCL001097	PRO 140	HIV infections	42	B20
DCL001097	PRO 140	Human immunodeficiency virus infection	.	B20
DCL001098	SGS-742	Alzheimer's disease	331	G30
DCL001098	SGS-742	Cognitive impairment	.	F06.7
DCL001099	LY293558	Acute migraine; Neuropathic pain; Dental pain	338, 346,780	G43, R52, G89
DCL001099	LY293558	Pain	.	G89
DCL001100	Sodium butyrate	Acute myeloid leukemia	205	C92.0
DCL001100	Sodium butyrate	Refractory sickle cell ulcers	282.5, 282.6	D57
DCL001101	ABT-279	Type 2 diabetes	250.00, 250.02	E11
DCL001102	AG140699	Malignant melanoma	172	C43
DCL001103	AN-9	Malignant melanoma	172	C43
DCL001103	AN-9	Melanoma	.	C43
DCL001104	Besonprodil	Parkinson's disease	332	F02.3, G20
DCL001105	BMS-488043	HIV infections	42	B20
DCL001106	CBT-1	Non-small cell lung cancer	.	C33-C34
DCL001106	CBT-1	Non-small cell lung cancer	162	C33, C34
DCL001107	Curcumin I	Cancer	140-229	C00-C96
DCL001107	Curcumin I	Irritable bowel syndrome	564.1	K58
DCL001108	ELB-139	Anxiety disorder	300	F40-F42
DCL001108	ELB-139	Schizophrenia	295	F20
DCL001109	EVT-101	Neurological disease	.	G00-G99
DCL001109	EVT-101	Neuropathic pain	356.0, 356.8	G64, G90.0
DCL001109	EVT-101	Parkinson's disease	332	F02.3, G20
DCL001110	IDDBCP161883	Diabetes mellitus type 2	.	E11
DCL001110	IDDBCP161883	Type 2 diabetes	250.00, 250.02	E11
DCL001111	LAQ824	General leukaemia cancer	204-208	C91-C95
DCL001112	LY-544344	Anxiety disorder	.	F40-F42
DCL001112	LY-544344	Anxiety disorder	300	F40-F42
DCL001113	Melogliptin	Diabetes mellitus type 2	.	E11
DCL001113	Melogliptin	Type 2 diabetes	250.00, 250.02	E11
DCL001114	MGCD-0103	Acute myeloid leukemia	205	C92.0
DCL001114	MGCD-0103	Solid tumours	.	C00-C75,C7A,C7B
DCL001115	NVP-AUY922	Cancers	140-229	C00-C96
DCL001116	Ocinaplon	Generalized anxiety disorder	300.02	F41.1
DCL001117	PDX-101	Cancers	140-229	C00-C96
DCL001118	Pro 542	HIV infections	42	B20
DCL001118	Pro 542	Human immunodeficiency virus infection	.	B20
DCL001119	Pyroxamide	Cancer	140-229	C00-C96
DCL001119	Pyroxamide	Cancers	140-229	C00-C96
DCL001120	S-18986	Alzheimer's disease	331	G30
DCL001120	S-18986	Cognition disorders	.	F06.7
DCL001121	SSR-162369	Type 2 diabetes	250.00, 250.02	E11
DCL001122	Tacedinaline	Cancers	140-229	C00-C96
DCL001123	TNX-355	HIV infections	42	B20
DCL001125	CB1954/EP-0152R, NQO2 prodrug therapy	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DCL001125	CB1954/EP-0152R, NQO2 prodrug therapy	Cancer	140-229	C00-C96
DCL001126	V85546	Inflammatory diseases	.	.
DCL001127	Gilenia	Multiple sclerosis	340	G35
DCL001128	4SC-203	Acute myeloid leukemia	.	C92.0
DCL001128	4SC-203	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001129	4SC-205	Lymphoma	.	C81-C96
DCL001129	4SC-205	Solid tumours; Malignant lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DCL001130	ABT-072	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001130	ABT-072	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001131	ABT-333	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001131	ABT-333	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001132	ABT-450	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001132	ABT-450	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001133	ACE-011	Anemia	280-285	D50-D64
DCL001134	ACE-041	Advanced cancers; Age-related macular degeneration	140-229, 362.50	C00-C96, H35.3
DCL001134	ACE-041	Macular degeneration	.	H35.3
DCL001135	ACH-1625	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001135	ACH-1625	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001136	ADX415	Hypertension	401	I10, I11, I12, I13, I15
DCL001137	ALB-127158(a)	Obesity	278	E66
DCL001138	ALN-TTR01	Amyloidosis	.	E85
DCL001138	ALN-TTR01	Amyloidosis	277.3	E85
DCL001139	ALN-VSP	Liver cancer	.	C22
DCL001139	ALN-VSP	Liver cancer	155.2	C22.9
DCL001140	ANA773	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001140	ANA773	Hepatitis C virus infection	.	B17.1,B18.2
DCL001141	ANAVEX 2-73	Alzheimer's disease	331	G30
DCL001141	ANAVEX 2-73	Breast cancer	.	C50
DCL001142	Anti-CD22	Hematologic malignancies	200-209	C81-C96
DCL001143	Anti-Factor D	Geographic atrophy associated with AMD	362.5	H35.3
DCL001144	Anti-FGFR3	Multiple myeloma	203	C90.0
DCL001145	Anti-HER3/EGFR DAF	Metastatic epithelial tumors	140-199	C00-C75, C7A, C7B
DCL001146	Anti-LT alpha	Rheumatold arthritis	714	M05-M06
DCL001147	Anti-M1 prime	Asthma	493	J45
DCL001148	APC-100	Castration-resistant prostate cancer	185	C61
DCL001148	APC-100	Prostate cancer	185	C61
DCL001149	ARI-3037MO	Dyslipidemia	272	E78
DCL001149	ARI-3037MO	Lipid metabolism disorder	.	E75-E78
DCL001150	ASG-22ME	Solid tumours	.	C00-C75,C7A,C7B
DCL001150	ASG-22ME	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001151	ASG-5ME	Pancreatic cancer	157	C25
DCL001151	ASG-5ME	Pancreatic cancer; Prostate cancer	140-229, 157, 185	C00-C96, C25, C61
DCL001152	AT001/r84	Cancers	140-229	C00-C96
DCL001153	ATL1102	Multiple sclerosis	340	G35
DCL001154	AZD5658	Diabetes mellitus type 2	.	E11
DCL001154	AZD5658	Obesity; Diabetes	250, 278	E08-E13, E66
DCL001155	AZD7687	Diabetes mellitus	.	E10-E14
DCL001155	AZD7687	Obesity; Diabetes	250, 278	E08-E13, E66
DCL001156	AZD8329	Diabetes mellitus	.	E10-E14
DCL001156	AZD8329	Diabetes mellitus; Obesity	250, 278	E08-E13, E66
DCL001157	BI 201335	Gastric cancer	151	C16
DCL001157	BI 201335	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001158	BI 207127	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001159	BIT225	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001159	BIT225	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001160	BMS 650032	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001160	BMS 650032	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
DCL001161	BMS 790052	Hepatitis C virus infection	.	B17.1,B18.2
DCL001161	BMS 790052	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001162	BMS 791325	Hepatitis C virus infection	.	B17.1,B18.2
DCL001162	BMS 791325	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001163	BMS-824383	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001164	BMS-830216	Obesity	.	E66
DCL001164	BMS-830216	Obesity	278	E66
DCL001165	BMS-833923	Cancers	140-229	C00-C96
DCL001165	BMS-833923	Chronic myelogenous leukemia	.	C92.1
DCL001166	BMS-908662	Cancers	140-229	C00-C96
DCL001166	BMS-908662	Solid tumours	.	C00-C75,C7A,C7B
DCL001167	BNC105	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DCL001167	BNC105	Ovarian cancer	.	C56
DCL001168	Cabozantinib	Gastric cancer; Hepatocellular carcinoma; Melanoma; Prostate cancer; NSCLC	140-229, 155, 157, 162, 172, 174, 175, 183, 185, 204.0	C00-C96, C22.0, C25, C33, C33-C34, C34, C43, C50, C56, C61, C91.0
DCL001168	Cabozantinib	Medullary thyroid cancer	193	C73
DCL001168	Cabozantinib	Metastatic castration-resistant prostate cancer; Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
DCL001168	Cabozantinib	Solid tumours	.	C00-C75,C7A,C7B
DCL001168	Cabozantinib	Thyroid cancer; Renal cell carcinoma	140-229, 189, 193	C00-C96, C64, C73
DCL001169	Canagliflozin	Diabetes mellitus type 2	.	E11
DCL001169	Canagliflozin	Type 2 diabetes	250.00, 250.02	E11
DCL001170	Cenderitide	Heart disease	.	I00-I52
DCL001170	Cenderitide	Heart failure	428	I50
DCL001171	CF102	Hepatocellular carcinoma; Hepatitis C infection	001-139, 070.4, 070.5, 070.70, 155, 573.3	A00-B99, B17.1, B18.2, C22.0, K75.9
DCL001172	Clemizole	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001172	Clemizole	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001173	Clevudine	Hepatitis B virus infection	.	B16
DCL001173	Clevudine	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DCL001174	CM2489	Autoimmune diseases	.	D84.9
DCL001174	CM2489	Psoriasis	696	L40
DCL001175	CVX-060	Renal cancer	.	C64
DCL001175	CVX-060	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001176	Danoprevir	Hepatitis C virus infection	.	B17.1,B18.2
DCL001176	Danoprevir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001177	Debio 025	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001178	Debio 0827	Chronic pain	338.2,780	R52.1-R52.2, G89
DCL001178	Debio 0827	Pain	.	G89
DCL001179	Debio 0932	Cancer	.	C00-C97
DCL001179	Debio 0932	Cancers	140-229	C00-C96
DCL001180	DPX-Survivac	Ovarian cancer	183	C56
DCL001180	DPX-Survivac	Solid tumours	.	C00-C75,C7A,C7B
DCL001181	EXC 001	Fibrosis	.	L90.5
DCL001181	EXC 001	Fibrosis	709.2	L90.5
DCL001182	EZN-2968	Solid tumours	.	C00-C75,C7A,C7B
DCL001182	EZN-2968	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001183	EZN-3042	Cancer	140-229	C00-C96
DCL001183	EZN-3042	Solid tumours	.	C00-C75,C7A,C7B
DCL001184	EZN-4176	Prostate cancer	185	C61
DCL001185	Filibuvir	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001185	Filibuvir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001186	GDC-0068	Solid tumours	.	C00-C75,C7A,C7B
DCL001186	GDC-0068	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001187	GDC-0623	Metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001187	GDC-0623	Solid tumours	140-199	C00-C75, C7A, C7B
DCL001188	GDC-0973	Cancer	.	C00-C97
DCL001188	GDC-0973	Solid tumours	140-199	C00-C75, C7A, C7B
DCL001189	GDC-0980	Advanced solid tumours; Non-Hodgkin's lymphoma	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C82-C85, D10-D36, D3A
DCL001190	GS-9256	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001190	GS-9256	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001191	GSK2118436	Metastatic melanoma; Solid tumors	140-199, 172, 210-229	C00-C75, C43, C7A, C7B, D10-D36, D3A
DCL001192	HPP404	Allergic rhinitis	477	J30
DCL001192	HPP404	Diabetes mellitus	250	E08-E13
DCL001193	IDX-189	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001194	IMO-2055	Renal cell carcinoma; Solid Tumours	140-199, 189, 210-229	C00-C75, C64, C7A, C7B, D10-D36, D3A
DCL001194	IMO-2055	Solid tumours	.	C00-C75,C7A,C7B
DCL001195	IMO-2125	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001195	IMO-2125	Hepatitis C virus infection	.	B17.1,B18.2
DCL001196	IMO-3100	Autoimmune diseases	.	D84.9
DCL001196	IMO-3100	Autoimmune diseases	279.4	D84.9, M35.9
DCL001197	Indibulin	Advanced sarcomar	.	C96.4
DCL001197	Indibulin	Breast cancer	174, 175, 217	C50, D24
DCL001198	INK128	Multiple myeloma	.	C90.0
DCL001198	INK128	Multiple myeloma	203	C90.0
DCL001199	ISIS-APOCIII	Hypertriglyceridemia	.	E78.1,E78.2,E78.3
DCL001199	ISIS-APOCIII	Inflammation; High triglycerides; Atherosclerosis; Metabolic syndrome	277.7, 414.0, 440	E88.81, I70
DCL001200	ISIS-EIF4E	Cancers	140-229	C00-C96
DCL001201	ISIS-FXI	Blood coagulation disorders	.	D65-D68
DCL001201	ISIS-FXI	Clotting disorders	286	D65-D69
DCL001202	ISIS-SGLT2	Type 2 diabetes	250.00, 250.02	E11
DCL001203	ISIS-SOD1	Amyotrophic lateral sclerosis	335.2	G12.2
DCL001204	ISIS-TTR	Amyloidosis	277.3	E85
DCL001205	LB80380	Hepatitis B virus infection	.	B16
DCL001205	LB80380	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DCL001206	LFA102	Breast cancer	.	C50
DCL001206	LFA102	Breast cancer; Prostate cancer	140-229, 174, 175, 185	C00-C96, C50, C61
DCL001207	Mavrilimumab	Rheumatold arthritis	.	M05-M06
DCL001207	Mavrilimumab	Rheumatold arthritis	714	M05-M06
DCL001208	MEDI3617	Cancers	140-229	C00-C96
DCL001208	MEDI3617	Solid tumours	140-199	C00-C75, C7A, C7B
DCL001209	MEDI-551	B-cell lymphoma	.	C85.1
DCL001209	MEDI-551	Lymphoma; Chronic lymphocytic leukemia; Multiple myeloma	202.8, 203.0, 204.1, 208.9	C81-C96, C90.0, C91-C95, C91.1
DCL001210	MEDI-573	Solid tumours	.	C00-C75,C7A,C7B
DCL001210	MEDI-573	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001211	MEDI-575	Glioblastoma	.	C71
DCL001211	MEDI-575	Glioblastoma	191	C71
DCL001212	MEDI-578	Osteoarthritic pain	338,780	R52, G89
DCL001212	MEDI-578	Pain	338,780	R52, G89
DCL001213	Miravirsen	Hepatitis C virus infection	.	B17.1,B18.2
DCL001213	Miravirsen	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001214	MIV-210	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DCL001214	MIV-210	Human immunodeficiency virus infection	.	B20
DCL001215	MK-3281	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001215	MK-3281	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001216	MK-5172	Hepatitis C virus infection	.	B17.1,B18.2
DCL001216	MK-5172	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001217	Moxetumomab Pasudotox	Chronic lymphocytic leukaemia	.	C91.1
DCL001217	Moxetumomab Pasudotox	Leukemia	208.9	C91-C95
DCL001218	OPI-1002	Delayed graft function; Acute kidney injury	584	N17
DCL001219	Ospemifene	Dyspareunia	.	N94.1
DCL001219	Ospemifene	Post-menopausal vaginal atrophy	627.3	N95.2
DCL001220	PF-03882845	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DCL001221	PF-04620110	Diabetes mellitus type 2	.	E11
DCL001221	PF-04620110	Diabetes mellitus type 2	250	E11
DCL001222	PPI-461	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001222	PPI-461	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001223	PRX00933	Obesity; Diabetes	250, 278	E08-E13, E66
DCL001224	PSI-7977	Hepatitis C virus infection	.	B17.1,B18.2
DCL001224	PSI-7977	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001225	PSI-938	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001225	PSI-938	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001226	PSN821	Diabetes mellitus type 2	.	E11
DCL001226	PSN821	Type 2 diabetes	250.00, 250.02	E11
DCL001227	Resminostat	Cancer	.	C00-C97
DCL001227	Resminostat	Hepatocellular carcinoma	155	C22.0
DCL001228	RG3039	Spinal muscular atrophy	.	G12.0-G12.1
DCL001228	RG3039	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DCL001229	RG7128	Hepatitis C virus infection	.	B17.1,B18.2
DCL001229	RG7128	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001230	Rontalizumab	Systemic lupus erythematosus	710	M32
DCL001231	S-222611	Malignant tumor	140-199	C00-C75, C7A, C7B
DCL001231	S-222611	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DCL001232	S-234462	Obesity	278	E66
DCL001233	S-265744 LAP	HIV infections	42	B20
DCL001234	S-297995	Constipation	564	K59.0
DCL001234	S-297995	Opioid induced adverse effect	304	F11
DCL001235	S-349572	HIV infections	42	B20
DCL001236	S-474474	Metabolic syndrome X	277.7	E88.81
DCL001237	S-555739	Allergy	.	T78.4
DCL001237	S-555739	Allergy	995.3	T78.4
DCL001238	SCY-635	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001239	SelG1	Anemia	.	D50-D64
DCL001239	SelG1	Vaso-occlusive crisis	282.62	D57.00
DCL001240	Setrobuvir	Hepatitis C virus infection	.	B17.1,B18.2
DCL001240	Setrobuvir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001241	SGN-70	Autoimmune diseases	.	D84.9
DCL001241	SGN-70	Autoimmune diseases	279.4	D84.9, M35.9
DCL001242	SGN-75	Non-Hodgkin's lymphoma	.	C85.9
DCL001242	SGN-75	Renal cell carcinoma; non-Hodgkin's lymphoma	189, 200, 202, 202.8	C64, C81-C96, C82-C85
DCL001243	SPC4955	High cholesterol levels	272	E78.0
DCL001243	SPC4955	Hyperlipidemia	272.0-272.4	E78
DCL001244	SPC5001	Hypercholesterolemia	272	E78.0
DCL001244	SPC5001	Hyperlipidemia	272.0-272.4	E78
DCL001245	Tegobuvir	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001245	Tegobuvir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001246	TM38837	Diabetes mellitus type 2	.	E11
DCL001246	TM38837	Obesity; Metabolic disorders	270-279, 278	E66, E70-E89
DCL001247	TMC435	Hepatitis C virus infection	.	B17.1,B18.2
DCL001247	TMC435	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001248	TMC649128	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001248	TMC649128	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001249	TTP435	Obesity	.	E66
DCL001249	TTP435	Obesity	278	E66
DCL001250	Vaniprevir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001251	Velneperit	Obesity	278	E66
DCL001252	Vidofludimus	Multiple sclerosis	.	G35
DCL001252	Vidofludimus	Rheumatold arthritis; Inflammatory bowel disease	555, 556, 710-719, 714	K50, K51, M00-M25, M05-M06
DCL001253	VX-222	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001254	VX-500	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DCL001254	VX-500	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001255	VX-759	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001256	VX-916	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DCL001257	XL550	Cardiovascular disease	.	I00-I99
DCL001257	XL550	Type 2 diabetes	250, 250.00, 250.02, 401, 580-599	E08-E13, E11, I10, I11, I12, I13, I15, N00-N29
DCL001258	XL652/XL014	Cardiovascular disease; Metabolic disorders	270-279, 390-459	E70-E89, I00-I99
DCL001259	ZGN-433	Obesity	.	E66
DCL001259	ZGN-433	Obesity	278	E66
DCL001260	ZY01	Obesity; Diabetes	250, 278	E08-E13, E66
DCL001261	ZYOG1	Diabetes mellitus	.	E10-E14
DCL001261	ZYOG1	Diabetes mellitus	250	E08-E13
DIB000001	Org-34092	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB000002	AZD-6495	Cancer	140-229	C00-C96
DIB000003	STF-31	Cancer	140-229	C00-C96
DIB000004	Salmonella Typhi Vi antigen-dominant negative inhibitor protein capsular matrix vaccine	Salmonella infection	.	A02.9
DIB000005	ZD-2767	Solid tumours	.	C00-C75,C7A,C7B
DIB000006	LG-1550	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB000007	AE-443p	Influenza virus infections	487	J10, J11
DIB000008	BAY-793	HIV infections	42	B20
DIB000009	Soluble epoxide hydrolase inhibitors	Cardiovascular disease	390-459	I00-I99
DIB000010	IFN-beta	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000011	Pim1 inhibitors	Cancer	140-229	C00-C96
DIB000012	TRX-518	Melanoma	.	C43
DIB000013	Micacocidin A	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000014	Antivaginolysin mAbs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000015	ABT-414	Glioblastoma	.	C71
DIB000016	VLD-517	Plasmodium infection	.	B54
DIB000017	INC-106	Restenosis	.	I51.89
DIB000018	QBM076	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB000019	HOE-065	Cognition disorders	.	F06.7
DIB000020	D-7193	Immuno-modulator	.	D80-D89
DIB000021	Liposomal lurtotecan	Lung cancer	.	C33-C34
DIB000022	Mesenchymal precursor cells	Osteoarthritis	715	M15-M19, M47
DIB000023	TAK-810	Prostate cancer	185	C61
DIB000024	Migraine therapy	Migraine	346	G43
DIB000025	ALO-1567	Glaucoma	.	H40-H42
DIB000026	OncoVAX	Melanoma	.	C43
DIB000027	Iopamidol	Cardiovascular disease	390-459	I00-I99
DIB000028	CD4-BFFI	HIV-1 infections	42	B20
DIB000029	FPA-008	Autoimmune diseases	.	D84.9
DIB000030	MX-895	Breast cancer	174, 175, 217	C50, D24
DIB000031	RS-1439	Alzheimer's disease	.	G30,F00
DIB000032	MDX-066	Diarrhea	787.91	A09, K59.1
DIB000033	BC-22	Major depressive disorder	296.2, 296.3	F32, F33
DIB000034	DRL-17822	Arteriosclerosis	.	I70
DIB000035	18F-AV-45 dimer	Cerebral amyloid angiopathy	.	I68.0
DIB000036	AG-SCT101	Hypertension	401	I10, I11, I12, I13, I15
DIB000037	TAK-802	Urinary dysfunction	.	N39.3-N39.4
DIB000038	AT-007	Autoimmune diseases	279.4	D84.9, M35.9
DIB000039	NM-2023	Discovery agent	.	.
DIB000040	GX-E2	Anemia	280-285	D50-D64
DIB000041	Tr-2	Cancer	140-229	C00-C96
DIB000042	NP-432	Bacterial respiratory tract infection	.	J13,J15
DIB000043	Epanova	Hypertriglyceridemia	.	E78.1
DIB000044	Flulaval QIV	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB000045	RepliVec	Cancer	140-229	C00-C96
DIB000046	Cx-621	Ischemic stroke	434.91	I61-I63
DIB000047	DT-330	Cancer	140-229	C00-C96
DIB000048	NNI-351	Major depressive disorder	296.2, 296.3	F32, F33
DIB000049	CCX-025	Crohn's disease	.	K50
DIB000050	Small molecule therapeutic	Infectious disease	001-139	A00-B99
DIB000051	P52-/p36- GAP vaccine	Plasmodium falciparum infection	.	B54
DIB000052	IC-47	Streptococcus pneumoniae infection	.	A00-B99
DIB000053	TGN-208	Cancer	.	C00-C97
DIB000054	LY-2584702	Cancer	140-229	C00-C96
DIB000055	Marburg virus vaccine	Marburg virus infection	.	A98.3
DIB000056	PI3k/AKT/mTOR inhibitor	Hepatocellular carcinoma	155	C22.0
DIB000057	TES-23-NCS	Cancer	140-229	C00-C96
DIB000058	BEPH	Cancer	140-229	C00-C96
DIB000059	Gene discovery	Osteoporosis	733	M80-M81
DIB000060	Claudiximab	Esophageal cancer	.	C15
DIB000061	AP-101	Ischemia	459.89	I99.8
DIB000062	Beta secretase inhibitor	Alzheimer's disease	.	G30,F00
DIB000063	WCK-2349	MRSA infection	41.12	A49.02
DIB000064	Rheumatolin regulator	Rheumatold arthritis	714	M05-M06
DIB000065	BCH-150	Gastrointestinal disease	.	K00-K93
DIB000066	MD-921	Wound healing	.	S91.3
DIB000067	CDD-0235-J	Alzheimer's disease	.	G30,F00
DIB000068	ACP-106	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000069	AZM-1	Neuropathic pain	338,780	R52, G89
DIB000070	ONO-8815Ly	Miscarriage	.	O03
DIB000071	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB000072	OP-145	Bronchitis	.	J20-J21,J42
DIB000073	ABX-0401	Inflammatory bowel disease	.	K50,K51
DIB000074	Estrogen receptor beta agonists	Cancer	140-229	C00-C96
DIB000075	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB000076	MEN-10880	HIV-1 infections	42	B20
DIB000077	GW-215864	Rhinitis	.	J00,J30,J31.0
DIB000078	ICI-245991	Atherosclerosis	414.0, 440	I70
DIB000079	IP-1200	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB000080	ARGENT	Prostate tumor	185	C61
DIB000081	Toll-like receptor modulators	Inflammatory diseases	.	.
DIB000082	HT-0712	Cognitive impairment	.	F06.7
DIB000083	Anticonvulsants	Epilepsy	345	G40
DIB000084	Alpha-1 proteinase inhibitor	Alpha-1 antitrypsin deficiency	.	E88.0
DIB000085	ABL 001	Leukemia	208.9	C91-C95
DIB000086	Dust mite allergen immunotherapy	Perennial allergic rhinitis	477	J30
DIB000087	MTC-220	Cancer	140-229	C00-C96
DIB000088	NCX 1022	Atopic dermatitis	691.8	L20
DIB000089	HCMV therapeutics	Cytomegalovirus infection	.	B25
DIB000090	Zona pellucida contraceptive vaccine	Female contraception	.	Z30.013
DIB000091	GLP-1 receptor modulator	Diabetes mellitus	250	E08-E13
DIB000092	FAN6 Vaccine	Hepatocellular carcinoma	.	C22.0
DIB000093	GS-168	Renal cancer	.	C64
DIB000094	HRG-214	HIV infections	42	B20
DIB000095	Befloxatone	Major depressive disorder	.	F32,F33
DIB000096	RX-1792	Cancer	140-229	C00-C96
DIB000097	Full-length Factor VIII molecule	Hemophilia	286	D66-D68
DIB000098	Phytosel	Cancer	140-229	C00-C96
DIB000099	CALDARET HYDRATE	Cardiovascular disease	.	I00-I99
DIB000100	RX-01-423	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB000101	Anti-CD20 engineered toxin bodies	Lymphoma	202.8	C81-C96
DIB000102	TDI-0018	Motor neurone disease	335.2	G12.2
DIB000103	AE-AI vaccine	Avian flu	.	J09.X2
DIB000104	MCPP	Mood disorder	.	F30-F39
DIB000105	HB-1345	Acne vulgaris	706.1	L70.0
DIB000106	Acteoside	Nephritis	.	N00-N19,N25-N29
DIB000107	Adenosine 5'-triphosphate	Bradycardia	427.81, 659.7, 779.81, 785.9	R00.1
DIB000108	IR-103	HIV infections	42	B20
DIB000109	Sodium iodide symporter adenoviral gene therapy	Prostate cancer	.	C61
DIB000110	Myomap	Cardiovascular disease	390-459	I00-I99
DIB000111	AM-3301	Allergic rhinitis	477	J30
DIB000112	BIBN-140	Alzheimer's disease	.	G30,F00
DIB000113	SDZ-87-469	Coronary artery disease	.	I20-I25
DIB000114	SF-107	Allergy	995.3	T78.4
DIB000115	SDZ-GPI-562	Thrombosis	.	I80-I82
DIB000116	Prevecon	Contraception	.	Z30
DIB000117	Inactivated viral vaccine	Flavivirus infection	.	A86
DIB000118	CP-663427	Cancer	140-229	C00-C96
DIB000119	99mTc-MIP-1407	Neuroendocrine cancer	.	C7A
DIB000120	Antisense ICAM-1-TCS	Transplant rejection	.	T86
DIB000121	Anti-MRSA	Fungal infection	.	B35-B49
DIB000122	BAY 10-00394	Small-cell lung cancer	162	C33, C34
DIB000123	AZ-05	Cancer	140-229	C00-C96
DIB000124	Corticosteroid	Gastrointestinal disease	.	K00-K93
DIB000125	PanCyte	Anemia	.	D50-D64
DIB000126	SiRNA therapeutics	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000127	Glycoferon	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000128	CDD-190	Alzheimer's disease	.	G30,F00
DIB000129	Cannabinoids	Schizophrenia	295	F20
DIB000130	NOPPI	Cancer	140-229	C00-C96
DIB000131	Lurtotecan	Ovarian cancer	.	C56
DIB000132	Iodinated glycerol	Asthma	493	J45
DIB000133	PKM2 inhibitors	Cancer	140-229	C00-C96
DIB000134	Gene therapy	Prostate tumor	185	C61
DIB000135	PJ-016	Psychotic disorders	.	F20-F29
DIB000136	Fat-derived stem cell-based therapy	HIV infections	42	B20
DIB000137	CCR5 mAb	HIV infections	42	B20
DIB000138	TM-400	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB000139	SKF-96067	Peptic ulcer	.	K25-K27
DIB000140	SPV-30	Chronic fatigue syndrome	.	G93.3
DIB000141	RP-66055	Cerebral infarction	.	I63
DIB000142	LXR-0151	Diarrhea	787.91	A09, K59.1
DIB000143	DNA gyrase B inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000144	ImmuCyst	Hepatocellular carcinoma	155	C22.0
DIB000145	MDDR 347017	Viral infections	042-075	A80-A99, B00-B34
DIB000146	ProTarg	Prostate tumor	185	C61
DIB000147	SMAT therapy	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000148	R-84	Cancer	140-229	C00-C96
DIB000149	IMUC vaccine	Brain cancer	191	C71
DIB000150	PF-2575799	Diabetes mellitus	250	E08-E13
DIB000151	CH-4938056	Cancer	140-229	C00-C96
DIB000152	SOM-0856	Viral infections	042-075	A80-A99, B00-B34
DIB000153	F-9TG	Factor IX deficiency	.	D67
DIB000154	BN-80245	Cancer	140-229	C00-C96
DIB000155	ES-1	Osteoporosis	733	M80-M81
DIB000156	Creaferon	Hepatitis virus infection	.	B15-B19
DIB000157	Cetraxal Otic	Otitis externa	.	H60
DIB000158	Parietaria Judaica-containing vaccine	Allergic conjunctivitis	372.14	H10.45
DIB000159	HL-018	Diabetes mellitus	.	E10-E14
DIB000160	Glial cell line-derived neurotrophic factor protein	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000161	COX-2 inhibitors	Cancer	140-229	C00-C96
DIB000162	GMDP analogues	Immune disorder	.	D80-D89
DIB000163	FOLIGO 002	Ovarian cancer	.	C56
DIB000164	DNA vaccine	HIV infections	42	B20
DIB000165	Regulatory T-cells	Autoimmune diseases	279.4	D84.9, M35.9
DIB000166	APR-246	Cancer	140-229	C00-C96
DIB000167	Monoclonal antibody	Non-insulin dependent diabetes	.	E11.9
DIB000168	AWD-72-011	Allergy	995.3	T78.4
DIB000169	ITE	Cancer	140-229	C00-C96
DIB000170	ASC-JMZ1	Bladder cancer	188	C67
DIB000171	RVP-500-01	Colorectal cancer	.	C18-C20,C21
DIB000172	TO-195	Nephritis	.	N00-N19,N25-N29
DIB000173	SP-10	HIV infections	42	B20
DIB000174	Tienoxolol	Hypertension	401	I10, I11, I12, I13, I15
DIB000175	SX-PCK9	Hypercholesterolemia	272	E78.0
DIB000176	UCB-35440	Rhinitis	.	J00,J30,J31.0
DIB000177	MOR-104	Inflammatory diseases	.	.
DIB000178	TG-6002	Cancer	140-229	C00-C96
DIB000179	SR-58878	Irritable bowel syndrome	.	K58
DIB000180	AVE-9940	Rheumatold arthritis	714	M05-M06
DIB000181	Intravenous immunostimulant	Colorectal cancer	153, 154	C18-C21
DIB000182	Meninge B	Meningitis	320-322	G00-G03
DIB000183	HAP aniline mustard	Cancer	140-229	C00-C96
DIB000184	E-5110	Inflammatory diseases	.	.
DIB000185	HD-101	Asthma	493	J45
DIB000186	OC104-26	Cancer	.	C00-C97
DIB000187	Ibuprofenamine	Osteoarthritis	.	M19.90
DIB000188	FX-107	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB000189	BI 860585	Solid tumours	.	C00-C75,C7A,C7B
DIB000190	CX-7000	Cancer	140-229	C00-C96
DIB000191	OP-05 program	Liver cancer	155	C22.0
DIB000192	KW-2581	Breast cancer	174, 175, 217	C50, D24
DIB000193	AB-0532-targeting monoclonal antibodies	Ovarian cancer	.	C56
DIB000194	Phleum pratense-containing vaccine	Allergic conjunctivitis	372.14	H10.45
DIB000195	Protexia	Alzheimer's disease	.	G30,F00
DIB000196	Sporeamicins	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000197	PG-201	Arthralgia	.	M25.5
DIB000198	P2Y1 antagonists	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB000199	CT84.66	Breast cancer	.	C50
DIB000200	HIV integrase inhibitors	Human immunodeficiency virus infection	.	B20
DIB000201	NS5B HCV RNA polymerase nucleoside inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000202	WC-3027	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB000203	EC-0531	Cancer	140-229	C00-C96
DIB000204	T-2	Plasmodium infection	.	B54
DIB000205	CAL-102-R	Herpes simplex virus infection	.	A60,B00
DIB000206	TAN-950A	Fungal infection	.	B35-B49
DIB000207	Vaccine	HIV infections	42	B20
DIB000208	DP-VPA	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB000209	PF-06342674	Type 1 diabetes	250.01	E10
DIB000210	DasKloster 0274-01	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB000211	F-351	Liver disease	570-574	K70-K77
DIB000212	F-50040	Melanoma	172	C43
DIB000213	OPN-305	Myelodysplastic syndromes	.	D46
DIB000214	NCT-400	Major depressive disorder	296.2, 296.3	F32, F33
DIB000215	Guar gum	Hypercholesterolemia	272	E78.0
DIB000216	Warburg effect inhibitors	Cancer	140-229	C00-C96
DIB000217	VVP-100X	Non-insulin dependent diabetes	.	E11.9
DIB000218	PUR-118	Respiratory disease	.	J00-J99
DIB000219	PKR-activating lentiviral-based antisense RNA therapy	Cancer	140-229	C00-C96
DIB000220	WL-276	Cancer	140-229	C00-C96
DIB000221	Dermatological agents	Dermatological disease	.	L00-L99
DIB000222	KD-901	Alzheimer's disease	331	G30
DIB000223	CAI orotate	Cancer	140-229	C00-C96
DIB000224	SB-206343	HIV-1 infections	42	B20
DIB000225	Entelon	Lymphatic disease	.	I89.8
DIB000226	Fluarix	Influenza virus infections	487	J10, J11
DIB000227	Rh-GDNF	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000228	E-0116	Psoriasis	696	L40
DIB000229	BPM 31510 intravenous	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB000230	MystiTears	Xerophthalmia	.	E50.6-E50.7
DIB000231	DOX-PSASP-BBN-RGD prodrugs	Prostate tumor	185	C61
DIB000232	AMPK stimulators	Non-insulin dependent diabetes	.	E11.9
DIB000233	CY-301	Herpes simplex virus infection	54	B00
DIB000234	Recombinant glucocerebrosidase enzyme	Gaucher disease	272.7	E75.2
DIB000235	GlyT1 PET radiotracers	Schizophrenia	295	F20
DIB000236	HIV-ribonucleoprotein complex modulators	HIV-1 infections	42	B20
DIB000237	PS-388023	Ocular disease	.	H00-H59
DIB000238	KP-27	Cancer	140-229	C00-C96
DIB000239	SCH-48461	Hyperlipidemia	.	E78.5
DIB000240	NaAPR1M-74	Hookworm infection	.	B76.9
DIB000241	SBC-106	Lysosomal storage disease	.	E75-E77
DIB000242	SMT-D003	Glaucoma	365	H40-H42
DIB000243	OHR/AVR118	Cachexia	.	R64
DIB000244	LPO-1010CA	Cataract	366	H25-H26, H28, Q12.0
DIB000245	MDR inhibitors	Cancer	140-229	C00-C96
DIB000246	CSA-13	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000247	Ektomun	Melanoma	172	C43
DIB000248	MRX-4	Allergic rhinitis	477	J30
DIB000249	PF-4480682	Neuropathic pain	338,780	R52, G89
DIB000250	Temsirolimus	Renal cell carcinoma	189	C64
DIB000251	BB-2275	Human immunodeficiency virus infection	.	B20
DIB000252	MTL-004	Cancer	140-229	C00-C96
DIB000253	Alizapride	Emesis	787	R11
DIB000254	ALERT	Cancer	140-229	C00-C96
DIB000255	PF-572778	Generalized anxiety disorder	300.02	F41.1
DIB000256	Iomeprol	Brain diseases	.	G00-G99
DIB000257	Samatasvir	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB000258	P-1104	Multiple sclerosis	340	G35
DIB000259	Epoxyeicosatrienoic acid mimetics	Pain	338,780	R52, G89
DIB000260	APC-8020	Amyloidosis	277.3	E85
DIB000261	MEDI0680	Solid tumours	.	C00-C75,C7A,C7B
DIB000262	Rilmakalim	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB000263	GSK-2197870A	Hepatitis B virus infection	.	B16
DIB000264	XL-499	Cancer	.	C00-C97
DIB000265	AKP-020	Diabetes mellitus type 2	250	E11
DIB000266	STD-052	Constipation	564	K59.0
DIB000267	NLC-002	Obesity	278	E66
DIB000268	MTL-102	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000269	RNAi therapy	Huntington's disease	.	F02.2,G10
DIB000270	Anticancer human antibody	Multiple myeloma	203	C90.0
DIB000271	Bapineuzumab	Alzheimer's disease	.	G30,F00
DIB000272	Lycobetaine analogs	Cancer	140-229	C00-C96
DIB000273	Human herpesvirus 6 (HHV-6) U94/REP protein-based therapy	Angiogenesis disorder	.	I00-I99
DIB000274	TREFENTANIL HYDROCHLORIDE	Pain	.	G89
DIB000275	IMX-942	Mucositis	.	K92.81
DIB000276	TTH 03-001	Pain	338,780	R52, G89
DIB000277	Hemozoin formation inhibitors	Plasmodium infection	.	B54
DIB000278	DPI-3290	Pain	.	G89
DIB000279	CDRI-97/78	Plasmodium falciparum infection	.	B54
DIB000280	68Ga-based PET tracer (cancer imaging), Novo	Cancer	140-229	C00-C96
DIB000281	RO-5267683	Discovery agent	.	.
DIB000282	Endothelin antagonists	Hypertension	.	I10-I15
DIB000283	S. pneumoniae paediatric next generation vaccine	Steptococcus pneumoniae disease	.	J13
DIB000284	UPA-targeted oncolytic Sendai virus	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000285	PRE-084	Aging skin	.	L00-L99
DIB000286	CiPSC therapy	Hematological disease	.	D50-D89
DIB000287	NIP-004	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB000288	XomaZyme-Mel	Melanoma	.	C43
DIB000289	Tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB000290	Incobotulinum toxin A	Cervical cancer	.	C53
DIB000291	KT-1	Cardiovascular disease	390-459	I00-I99
DIB000292	NGM 282	Type 2 diabetes	250.00, 250.02	E11
DIB000293	ASIC3 inhibitors	Pain	338,780	R52, G89
DIB000294	RNA polymerase inhibitor	Picornavirus infection	.	A00-B99
DIB000295	L-651582	Solid tumours	.	C00-C75,C7A,C7B
DIB000296	Staphylococcus epidermidis GP-1 vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000297	HCV prophylactic vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000298	XTL-Pseudomonas-MAb	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB000299	Ramoplanin oral	Clostridium difficile infection	001-139	A00-B99
DIB000300	FCE-24265	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB000301	Oralgen Tree Pollen	Allergy	995.3	T78.4
DIB000302	ACAM-1000	Virus infection	.	B03
DIB000303	Recombinant IgG birch allergen vaccine	Allergy	995.3	T78.4
DIB000304	Abobotulinum toxin A	Cervical cancer	.	C53
DIB000305	PW-4156	Muscle hypertonia	.	M62
DIB000306	AZD-9343	Gastroesophageal reflux disease	.	K21
DIB000307	TGF-beta elevating agent	Atherosclerosis	414.0, 440	I70
DIB000308	TGC-9	Cancer	140-229	C00-C96
DIB000309	Selective androgen receptor degraders	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB000310	ARO 087	Cancer	.	.
DIB000311	Tabimorelin	Growth hormone deficiency	.	E23.0
DIB000312	JNJ-39393406	Cognitive impairment	.	F06.7
DIB000313	AXP-107-16	Gynecological disorder	.	N70-N98
DIB000314	TIPLASININ	Thrombosis	.	I80-I82
DIB000315	Fibrimage	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB000316	BL-1832	Pain	338,780	R52, G89
DIB000317	ALT-022	Glaucoma	365	H40-H42
DIB000318	Minopafant	Septic shock	.	A41.9
DIB000319	Mdm2-p53 inhibitors	Cancer	140-229	C00-C96
DIB000320	SAF-312	Pain	338,780	R52, G89
DIB000321	Protectaid	Contraception	.	Z30
DIB000322	AP-1531	Migraine	346	G43
DIB000323	SB-209670	Arrhythmia	.	I47-I49
DIB000324	Vaccine	Lyme disease	88.81	A69.2
DIB000325	CH-3697	Asthma	493	J45
DIB000326	CAL-201	Metapneumovirus infection	.	J12.3
DIB000327	Anti-inflammatory program	Inflammatory diseases	.	.
DIB000328	Omigapil	Lateral sclerosis	.	G12.2
DIB000329	MP-0270	Autoimmune diseases	279.4	D84.9, M35.9
DIB000330	DTwP-HepB-Hib prophylactic vaccine	Hepatitis B virus infection	.	B16
DIB000331	TL1 inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB000332	M2 proton channel inhibitors	Influenza virus infections	487	J10, J11
DIB000333	Physostigmine	Xerostomia	527.7	K11.7, R68.2
DIB000334	AVI-6006	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB000335	LAS-30538	Hyperinsulinemia	.	E16.1
DIB000336	Premarin/Trimegestone	Menopause	627.2	N95.0
DIB000337	Gyrase B inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB000338	Typhoid vaccine	Salmonella infection	.	A02.9
DIB000339	ASP-3258	Respiratory tract inflammation	.	J00-J99
DIB000340	AVR-168	Cancer	140-229	C00-C96
DIB000341	BAY-1006451	Atherosclerosis	414.0, 440	I70
DIB000342	AAV2-hRPE65v2	Ocular disease	.	H00-H59
DIB000343	GM-CSF/B7-2 gene therapy and vaccine	Brain cancer	.	C71
DIB000344	Epileptic therapeutics	Epilepsy	345	G40
DIB000345	CEP-37249	Cancer	140-229	C00-C96
DIB000346	MGN-1374	Myocardial infarction	410	I21, I22
DIB000347	Org-9935	Asthma	.	J45
DIB000348	BI 655066	Ankylosing spondylitis	.	M08.1,M45
DIB000349	PNU-142721	Human immunodeficiency virus infection	.	B20
DIB000350	Male erectile dysfunction therapy	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB000351	PT-401	Anemia	.	D50-D64
DIB000352	HIV-PV Vaccine I	HIV infections	42	B20
DIB000353	AP-300	Bladder cancer	188	C67
DIB000354	GSK-2485852	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000355	UR-12510	Allergy	.	T78.4
DIB000356	Dehydroquinate synthase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000357	Lysin therapy	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000358	RO-4929097	Breast cancer	.	C50
DIB000359	ATX-3105	Inflammatory diseases	.	.
DIB000360	AZD-8309	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DIB000361	SOTB07	Asthma	493	J45
DIB000362	Rheumatoid arthritis and allergy therapeutics	Allergy	995.3	T78.4
DIB000363	Tetramune	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000364	Bruton's tyrosine kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB000365	Faropenem medoxomil	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB000366	SLV-307	Parkinson's disease	.	G20
DIB000367	IMMU-114	Leukemia	208.9	C91-C95
DIB000368	DC-756	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000369	Triplex-forming oligonucleotides	Cancer	140-229	C00-C96
DIB000370	CCR4 antagonist	Atopic dermatitis	691.8	L20
DIB000371	ANA-06	Discovery agent	.	.
DIB000372	DB-900	Diabetes mellitus type 2	.	E11
DIB000373	Antimalarials	Plasmodium falciparum infection	.	B54
DIB000374	SPL-2101	Cancer	140-229	C00-C96
DIB000375	DMP-961	Human immunodeficiency virus infection	.	B20
DIB000376	Dextrin-2-sulphate (D2S) intravaginal gel	HIV infections	42	B20
DIB000377	U-89854	Anxiety disorder	.	F40-F42
DIB000378	Neisseria/HSV vaccine	Cytomegalovirus infections	001-139, 078.5	A00-B99, B25
DIB000379	APG-2305	Autoimmune diseases	279.4	D84.9, M35.9
DIB000380	Dabuzalgron	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB000381	Interferon alpha-2b	Hepatitis C virus infection	.	B17.1,B18.2
DIB000382	Cytokine modulators	Inflammatory diseases	.	.
DIB000383	Antimalarial fatty acids	Plasmodium infection	.	B54
DIB000384	PF-06260414	Cachexia	799.4	R64
DIB000385	Cyclofenil	Infertility	.	N46,N97.0
DIB000386	Diphtheria, tetanus, acellular pertussis vaccine	Bordetella pertussis infection	.	A37.0
DIB000387	Zomepirac	Pain	338,780	R52, G89
DIB000388	Human acetyl-CoA carboxylase inhibitors	Obesity	278	E66
DIB000389	CAF-01	Vaccination	.	.
DIB000390	S-8184	Ovarian cancer	183	C56
DIB000391	ASC-201	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB000392	AC-3174	Non-alcoholic steatohepatitis	.	K75.81
DIB000393	ZYI-1	Inflammatory diseases	.	.
DIB000394	Osutidine	Duodenal ulcer	.	K25-K27
DIB000395	BE-14106 analogs	Cancer	140-229	C00-C96
DIB000396	ACK-1 inhibitors	Cancer	140-229	C00-C96
DIB000397	Reformulated raltegravir	Human immunodeficiency virus infection	.	B20
DIB000398	HuM-195-Bi-213	Acute myeloid leukemia	205	C92.0
DIB000399	TA-CIN	Cervical cancer	.	C53
DIB000400	Monoclonal antibody therapeutics	Bone disease	.	M00-M99
DIB000401	OPC-22575	Ulcerative colitis	.	K51
DIB000402	SF-108	Glaucoma	365	H40-H42
DIB000403	Japanese cedar peptide allergy desensitization agent	Allergy	995.3	T78.4
DIB000404	Glycolysis inhibitor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000405	CAT-3000 series	Cardiovascular disease	390-459	I00-I99
DIB000406	TNF alpha release inhibitors	Inflammatory diseases	.	.
DIB000407	Nemonaxacin	Methicillin-resistant staphylococcus aureus	.	B95.62
DIB000408	MCP-203	Major depressive disorder	296.2, 296.3	F32, F33
DIB000409	PF-4308515	Inflammatory diseases	.	.
DIB000410	ZAMI-633	Urinary tract disease	.	N00-N99
DIB000411	TA-5538	Overactive bladder disorder	596.51	N32.81
DIB000412	MCC-257	Cognition disorders	.	F06.7
DIB000413	Megalin antagonists	Nephrotoxicity	.	N14.2
DIB000414	MK-434	Prostate disorder	.	N40-N42
DIB000415	Tetracycline-based compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000416	NNC-14-0185	Epilepsy	345	G40
DIB000417	SKL-PD	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000418	Terbinafine hydrochloride	Onychomycosis	.	B35.1
DIB000419	CCR5 targeting monoclonal antibody	Ulcerative colitis	556	K51
DIB000420	Interleukin-1 inhibitors	Arthritis	710-719	M00-M25
DIB000421	TAK-778	Osteoporosis	.	M80-M81
DIB000422	ALS 2-0426	Diabetes mellitus type 2	250	E11
DIB000423	Empagli ozin	Type 2 diabetes	250.00, 250.02	E11
DIB000424	Selenium sulfide	Erythema	.	L51.9
DIB000425	BRIFENTANIL	Pain	338	R52
DIB000426	Citicoline	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB000427	BCX-5191	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000428	Concatameric CD2Ig	Discovery agent	.	.
DIB000429	MediPhage MRPA	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB000430	NS3 helicase protein-targeting agents	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000431	E-2078	Pain	.	G89
DIB000432	CFG920	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
DIB000433	QAN-747	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB000434	IL-8	Psoriasis	696	L40
DIB000435	Synthetic carbohydrate-based vaccine	Anemia	.	D50-D64
DIB000436	QLT-091001	Restless legs syndrome	.	G25.81
DIB000437	Gold sodium thiomalate	Rheumatold arthritis	714	M05-M06
DIB000438	MT-112	Solid tumours	.	C00-C75,C7A,C7B
DIB000439	BT-063	Autoimmune diseases	279.4	D84.9, M35.9
DIB000440	BDNA-002	Influenza virus infections	487	J10, J11
DIB000441	AF-243	Deafness	.	H90-H91
DIB000442	RNA vaccine	Allergy	995.3	T78.4
DIB000443	VX-970	Solid tumours	.	C00-C75,C7A,C7B
DIB000444	RPR-107836	Anxiety disorder	.	F40-F42
DIB000445	VLP vaccine	Plasmodium infection	.	B54
DIB000446	TRM-88	Wound healing	.	S91.3
DIB000447	NPS 1776	Epilepsy	345	G40
DIB000448	Debio-1141	Bladder cancer	188	C67
DIB000449	HIV vaccines	HIV-1 infections	42	B20
DIB000450	Tyrosine kinase inhibitor conjugated RAP-based peptide	Hepatocellular carcinoma	155	C22.0
DIB000451	ZP-10395	Cancer	.	C00-C97
DIB000452	AG-TMB711	Gastric motility disorder	.	K22.4
DIB000453	Estrogen-related receptor alpha modulators	Non-insulin dependent diabetes	.	E11.9
DIB000454	SE-ET-TP020d	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB000455	ICT-037	Cancer	140-229	C00-C96
DIB000456	Lip1/ApoB siRNA	Hepatocellular carcinoma	155	C22.0
DIB000457	Estrogen receptor beta-selective phytoestrogenic formulation	Menopause	627.2	N95.0
DIB000458	CCX-168	Vasculitis	.	I77.6,I80
DIB000459	SORETOLIDE	Convulsions	.	R56.0
DIB000460	Deuterated sigma-1 agonists	Brain injury	.	S09.90
DIB000461	CNS-1169	Schizophrenia	295	F20
DIB000462	Alkaloidal immunosuppresants	Transplant rejection	.	T86
DIB000463	NAI-acne	Acne vulgaris	706.1	L70.0
DIB000464	TRF-1101	Sickle-cell anemia	280-285	D50-D64
DIB000465	CCR2 antagonists	Arteriosclerosis	.	I70
DIB000466	DWJ-207	Neuropathic pain	338,780	R52, G89
DIB000467	Bacteriophage	Staphylococcus aureus infection	001-139	A00-B99
DIB000468	Endothelin-1 antagonists	Heart disease	390-429	I00-I52
DIB000469	RAD-100	Pain	.	G89
DIB000470	BECATECARIN	Solid tumours	.	C00-C75,C7A,C7B
DIB000471	MEHD-7945A	Solid tumours	.	C00-C75,C7A,C7B
DIB000472	IPFK2 inhibitors	Cancer	140-229	C00-C96
DIB000473	West Nile Vaccine	Infectious and parasitic disease	.	A00-B99
DIB000474	Dihydralazine	Hypertension	401	I10, I11, I12, I13, I15
DIB000475	BM-162115	Inflammatory diseases	.	.
DIB000476	8H9	Cancer	140-229	C00-C96
DIB000477	E-0722	Diabetic cataract	.	E10.36,E11.36
DIB000478	DS-AH-14	Asthma	493	J45
DIB000479	HIF-PH inhibitors	Anemia	280-285	D50-D64
DIB000480	Sphingosine kinase inhibitor	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB000481	AL-408	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000482	GSK2838497A	Hemophilus influenza	.	B96.3
DIB000483	AMT-030	Hyperoxaluria	.	E74.8
DIB000484	Non-steroidal glucocorticoid agonists	Inflammatory diseases	.	.
DIB000485	Probiotic therapy	Gastrointestinal disease	.	K00-K93
DIB000486	Bistacrine derivatives	Alzheimer's disease	331	G30
DIB000487	Pim-1 kinase inhibitors	Cancer	140-229	C00-C96
DIB000488	HE-2000	Cystic fibrosis	.	E84
DIB000489	Iseganan	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000490	PF-05335810	Hypercholesterolemia	272	E78.0
DIB000491	Hepatitis A vaccine (inactivated)	Hepatitis A virus infection	.	B15.9
DIB000492	Pro-apoptotic DNA vaccine	Insulin dependent diabetes	.	E10
DIB000493	Glycosidase inhibitors	Viral infections	042-075	A80-A99, B00-B34
DIB000494	AKN-028	Acute myeloid leukemia	205	C92.0
DIB000495	Anti-miR-146a antisense oligonucleotide	Inflammatory diseases	.	.
DIB000496	Lofepramine	Major depressive disorder	296.2, 296.3	F32, F33
DIB000497	Oxysterol-based Liver X receptor modulator	Obesity	278	E66
DIB000498	BW-858C	Asthma	.	J45
DIB000499	SC-72393	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB000500	RX-77368	Dementia	.	F01-F07
DIB000501	LL-Z-1640-2	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000502	AMT-060	Factor IX deficiency	.	D67
DIB000503	Fradafiban	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB000504	HP-831-064	Wound healing	.	S91.3
DIB000505	PDE 9 inhibitors	Neurological disease	.	G00-G99
DIB000506	Z-321	Parkinson's disease	.	G20
DIB000507	Ioxaglate	Cardiovascular disease	390-459	I00-I99
DIB000508	ACN-1052	Glaucoma	365	H40-H42
DIB000509	E-6087	Pain	.	G89
DIB000510	Helicobacter project	Helicobacter pylori infection	41.86	B96.81
DIB000511	P53-MDM2 binding inhibitors	Cancer	140-229	C00-C96
DIB000512	Lavoltidine	Gastroesophageal reflux disease	.	K21
DIB000513	EPB-600	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000514	RM-6427	Cryptosporidium infection	.	A07.2
DIB000515	Anti-hepcidin antibodies	Anemia	280-285	D50-D64
DIB000516	Alpha-sarcoglycan gene-containing recombinant AAV1 vector based therapy	Muscular dystrophy	.	G71.0
DIB000517	GLP1R agonists	Discovery agent	.	.
DIB000518	Anti-fibrin mAb	Diagnosis of deep vein	.	I82.210?
DIB000519	Allogenic adipose-derived stem cell therapy	Anal fistula	.	K60.3
DIB000520	MTB72F vaccine	Influenza A virus H1N1 infections	.	J11.1
DIB000521	OGT-719	Liver cancer	155	C22.0
DIB000522	TDI-0105	Motor neurone disease	335.2	G12.2
DIB000523	CyMVectin	Cytomegalovirus infection	.	B25
DIB000524	Short-acting etomidate analogue	General anesthesia	338	R52
DIB000525	HGT-1410	Sanfilippo syndrome	.	E76.2
DIB000526	V-950	Alzheimer's disease	.	G30,F00
DIB000527	DPS-102	Psoriasis	.	L40
DIB000528	AnergiX-IDDM	Insulin dependent diabetes	.	E10
DIB000529	AKP-320	Diabetes mellitus type 2	.	E11
DIB000530	G-series prophage vaccine	Glioblastoma	.	C71
DIB000531	SMP-028	Asthma	493	J45
DIB000532	Z-360	Ulcerative colitis	.	K51
DIB000533	Trimazosin	Congestive heart failure	428	I50
DIB000534	Ro-40-0655	Colorectal cancer	.	C18-C20,C21
DIB000535	Seasonal influenza vaccine	Colorectal cancer	.	C18-C20,C21
DIB000536	CNJ-H01	Hepatitis virus infection	573.3	K75.9
DIB000537	Anti-CD97 monoclonal antibody	Rheumatold arthritis	714	M05-M06
DIB000538	P38-alpha inhibitors	Inflammatory diseases	.	.
DIB000539	Rhenex	Cancer	.	C00-C97
DIB000540	RHuA1AT	Alpha-1 antitrypsin deficiency	.	E88.0
DIB000541	P54	Cancer	.	C00-C97
DIB000542	HIV vaccine	HIV infections	42	B20
DIB000543	AS04	Discovery agent	.	.
DIB000544	Antimicrobial therapeutics	Infectious disease	001-139	A00-B99
DIB000545	HSV DNA vaccine	Herpes simplex virus infection	.	B00
DIB000546	EDG-007	Estrogen deficiency	.	E28.39
DIB000547	GPR119 agonists	Non-insulin dependent diabetes	.	E11.9
DIB000548	IkappaB kinase beta (IKKbeta) inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB000549	QR-334	Salivary gland dysfunction	.	K11.7
DIB000550	Antifungal agents	Fungal infection	.	B35-B49
DIB000551	TA-381	Cerebral infarction	.	I63
DIB000552	Tazofelone	Inflammatory bowel disease	555, 556	K50, K51
DIB000553	Lung inflammation therapy	Lung inflammation	.	D86
DIB000554	Acel-Immune	Bordetella pertussis infection	.	A37.0
DIB000555	PF-807925	Atherosclerosis	414.0, 440	I70
DIB000556	Thrombopoietin antagonist	Thrombotic stroke	410, 434.91	I21, I22, I61-I63
DIB000557	Alvameline tartrate	Cognitive impairment	.	F06.7
DIB000558	Dopamine D3 antagonists	Psychotic disorders	.	F20-F29
DIB000559	Androgen receptor modulators	Osteoporosis	733	M80-M81
DIB000560	MMB-4	Poison intoxication	.	T36-T50
DIB000561	JNJ-38224342	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DIB000562	Cystine analogs	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB000563	PBOX apoptosis inducers	Cancer	.	C00-C97
DIB000564	Nephesh-1000	Lung cancer	162	C33-C34
DIB000565	PF-3932295	Obesity	278	E66
DIB000566	IL-15 inhibitors	Cancer	140-229	C00-C96
DIB000567	Cutamesine	Major depressive disorder	.	F32,F33
DIB000568	SOM-1025	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000569	MT-061 lead series	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000570	S-20928	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB000571	U-104841	Anxiety disorder	300	F40-F42
DIB000572	Parathyroid hormone analog	Osteoporosis	733	M80-M81
DIB000573	Pyrazinamide analogs	Mycobacterium tuberculosis infection	.	A15-A19
DIB000574	FAP-alpha -targeting BiTE antibody	Cancer	140-229	C00-C96
DIB000575	Anticachexia therapy	Cachexia	799.4	R64
DIB000576	EG-Vac	Cancer	.	C00-C97
DIB000577	CGS-18102A	Anxiety disorder	300	F40-F42
DIB000578	JNJ-26483327	Cancer	140-229	C00-C96
DIB000579	NMS-E628	Cancer	140-229	C00-C96
DIB000580	L-695256	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000581	Lanperisone	Nervous and musculoskeletal disorders	.	R25-R29
DIB000582	SKF-105809	Pain	.	G89
DIB000583	ERA-923	Breast cancer	174, 175	C50
DIB000584	MK-8150	Hypertension	401	I10, I11, I12, I13, I15
DIB000585	SRX-251	Dysmenorrhea	.	N94.4-N94.6
DIB000586	Oncoprev	Cancer	140-229	C00-C96
DIB000587	VPZ-758	Raynaud's disease	.	I73.01
DIB000588	IS-0402	Autoimmune diseases	279.4	D84.9, M35.9
DIB000589	Tridihexethyl chloride	Peptic ulcer	531-534	K25-K27
DIB000590	ACE C-terminal site inhibitors	Cardiovascular disease	390-459	I00-I99
DIB000591	Prostate cancer vaccine	Prostate tumor	185	C61
DIB000592	RAS-111	Sepsis	995.91	A40, A41
DIB000593	Melanoma vaccine	Melanoma	172	C43
DIB000594	Sexual dysfunction therapeutics	Male sexual dysfunction	.	N52.9
DIB000595	AZD-2858	Alzheimer's disease	331	G30
DIB000596	DA-3607	Brain cancer	.	C71
DIB000597	Gp100:209-217(210M) peptide vaccine	Melanoma	172	C43
DIB000598	SYM-005	Cancer	140-229	C00-C96
DIB000599	WT1-targeted autologous dendritic cell vaccine	Acute myeloid leukemia	.	C92.0
DIB000600	Insulin receptor activators	Diabetes mellitus	250	E08-E13
DIB000601	BPX-201	Prostate cancer	185	C61
DIB000602	ABS-401	Amnesia	.	F04
DIB000603	VLI-01B	Cancer	.	C00-C97
DIB000604	COL-1777	Uterine fibroids	.	D25
DIB000605	SB-612111	Inflammatory diseases	.	.
DIB000606	SERMs	Cancer	140-229	C00-C96
DIB000607	TRK-851	Cough	786.2	R05
DIB000608	Carmoxirole	Hypertension	401	I10, I11, I12, I13, I15
DIB000609	Crodox	Breast cancer	174, 175, 217	C50, D24
DIB000610	Attapulgite	Diarrhea	.	A09,K59.1
DIB000611	PLR-8	Asthma	493	J45
DIB000612	Her-2/neu vaccine	Ovarian cancer	183	C56
DIB000613	FE-203799	Gastrointestinal disease	.	K00-K93
DIB000614	LIM-0746	Cholesterol metabolism disorder	.	E70-E88
DIB000615	Ragweed allergy vaccine sublingual	Lymphoma	.	C81-C96
DIB000616	LPD-608	Hypercholesterolemia	272	E78.0
DIB000617	Migis-mIgA	Nephritis	.	N00-N19,N25-N29
DIB000618	INC-104	Pulmonary hypertension	416	I27.0, I27.2
DIB000619	Hydrogel (antimicrobial vaginal pessary)	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000620	Kibow Biotics	Kidney diseases	580-589	N00-N29
DIB000621	HRA-081035	Contraception	.	Z30
DIB000622	U-75875	HIV infections	42	B20
DIB000623	Nitroimidazoles	Mycobacterium tuberculosis infection	.	A15-A19
DIB000624	PR-5-I	Fertility	.	N00-N99
DIB000625	Anti-LIGHT humanized monoclonal antibody	Inflammatory diseases	.	.
DIB000626	VX-15	Multiple sclerosis	.	G35
DIB000627	Anti-Fas mAbs	Cancer	140-229	C00-C96
DIB000628	Istaroxime	Cardiotonic	.	I50
DIB000629	AP-022	Glaucoma	365	H40-H42
DIB000630	VTX-763	Autoimmune diseases	279.4	D84.9, M35.9
DIB000631	534U87	Epileptic seizure	.	G40,R56
DIB000632	NBI-6024	Diabetes mellitus type 1	.	E10
DIB000633	AG-041R	Ulcerative colitis	.	K51
DIB000634	Nocathiacin I analogs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000635	A-620223	Cancer	140-229	C00-C96
DIB000636	Ammoniated mercury	Psoriasis	696	L40
DIB000637	P38 kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB000638	TGX-6B4	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB000639	KP-9928	Hypercholesterolemia	272	E78.0
DIB000640	EVO-044	Cancer	140-229	C00-C96
DIB000641	Lincosamide antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000642	Human anti-rabies mAb	Rabies virus infection	001-139	A00-B99
DIB000643	Emeriamine	Diabetes mellitus	250	E08-E13
DIB000644	Chromic phosphate P 32	Cancer	140-229	C00-C96
DIB000645	KI-0802	Gastrointestinal ulcer	.	K28
DIB000646	VasoPET	Coronary artery disease	410-414, 429.2	I20-I25
DIB000647	PRO-289	Huntington's disease	.	F02.2,G10
DIB000648	Labyrinthin vaccine	Cancer	140-229	C00-C96
DIB000649	Sphingosine kinase inhibitors	Arteriosclerosis	.	I70
DIB000650	RG7410	Psychotic disorders	290-299	F20-F29
DIB000651	Org-231295	Anxiety disorder	300	F40-F42
DIB000652	CLVax 1.0	Influenza virus infections	487	J10, J11
DIB000653	H7N1 vaccine	Influenza virus infections	487, 488	J10, J11
DIB000654	GSK-732461	HIV infections	42	B20
DIB000655	Lu-02-750	Parkinson's disease	.	G20
DIB000656	FK-505	Hyperuricosuria	.	E79
DIB000657	AME-527	Rheumatold arthritis	714	M05-M06
DIB000658	CST-104	Cancer	140-229	C00-C96
DIB000659	Lobaplatin	Breast cancer	174, 175, 217	C50, D24
DIB000660	INOC-019	Prostate tumor	185	C61
DIB000661	RG7888	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000662	GPI-2138	Cocaine addiction	304.2	F14.2
DIB000663	IDRA-21	Alzheimer's disease	.	G30,F00
DIB000664	PNT-300	Cancer	140-229	C00-C96
DIB000665	ETX-9101	Asthma	493	J45
DIB000666	Beta-amyloid aggregation inhibitors	Alzheimer's disease	331	G30
DIB000667	4SC-301	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000668	ALN-HPN	Anemia	280-285	D50-D64
DIB000669	Pramiconazole	Dermatological disease	.	L00-L99
DIB000670	AD-412	Autoimmune diseases	279.4	D84.9, M35.9
DIB000671	S-14080	Inflammatory diseases	.	.
DIB000672	LSI-518P	Cardiovascular disease	390-459	I00-I99
DIB000673	MPGES-1 inhibitors	Cancer	.	C00-C97
DIB000674	Gene therapy	Ischemia	459.89	I99.8
DIB000675	AZD-8450	Lipid metabolism disorder	.	E75-E78
DIB000676	NasoVac	Influenza virus infections	487	J10, J11
DIB000677	ICI-D-6888	Hypertension	401	I10, I11, I12, I13, I15
DIB000678	MSB0010445	Melanoma	172	C43
DIB000679	Recombinant plague F1V vaccine	Yersinia infections	.	A20
DIB000680	ST-587	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB000681	GSK406725	Epilepsy	345	G40
DIB000682	Ciprofloxacin dry powder inhalation	Malignant melanoma	172	C43
DIB000683	Mibefradil	Ovarian cancer	.	C56
DIB000684	PDGFR inhibitors	Pulmonary hypertension	416	I27.0, I27.2
DIB000685	AGY-64873	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB000686	F-18 exendin-4 derivative PET tracers	Diabetes mellitus	250	E08-E13
DIB000687	NHS-IL2-LT	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000688	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB000689	Atu-111	Prostate tumor	185	C61
DIB000690	MDDR 287569	Urinary incontinence	.	N39.3-N39.4
DIB000691	Reversed chloroquines	Plasmodium infection	.	B54
DIB000692	Leber's congenital amaurosis gene therapy	Visual disturbances	.	H53
DIB000693	NM-9308	Age related macular degeneration	.	H35.30
DIB000694	DB-200 series	Psoriasis	696	L40
DIB000695	Lenti-D	Adrenoleukodystrophy	.	E71.529
DIB000696	Lipid transferase modulators	Cancer	140-229	C00-C96
DIB000697	DP-4088	Blood coagulation disorders	.	D65-D68
DIB000698	Undecaprenyl pyrophosphate synthase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000699	CS-461	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000700	TBC-256	Cardiovascular disease	.	I00-I99
DIB000701	ACE-435	Cachexia	799.4	R64
DIB000702	CX-1739	Attention deficit hyperactivity disorder	.	F90
DIB000703	SL-601	Bladder cancer	188	C67
DIB000704	TBC-395	Cardiovascular disease	390-459	I00-I99
DIB000705	Perfluorochemical emulsion	Myocardial infarction	410	I21, I22
DIB000706	Smallpox vaccine	Virus infection	.	B03
DIB000707	NRD-135S	Pain	338,780	R52, G89
DIB000708	OC42-92	Cancer	140-229	C00-C96
DIB000709	ACEA-1031	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB000710	IL-2/Superantigen B gene medicine	Melanoma	172	C43
DIB000711	Alpha 1 Antitrypsin	Bacillus anthracis infection	.	A22
DIB000712	CASTANOSPERMINE	Diabetes	250	E08-E13
DIB000713	SDZ-ICM-567	Anxiety disorder	.	F40-F42
DIB000714	External guide sequence oligozyme	Acute promyelocytic leukemia	205	C92.4
DIB000715	LF-13-0491c	Atherosclerosis	414.0, 440	I70
DIB000716	CCX-140	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DIB000717	PB1046	Hypertension	.	I10-I15
DIB000718	GDC-0084	Glioma	.	C71
DIB000719	HyVec-Angio	Cancer	140-229	C00-C96
DIB000720	ALKASAR-18	Cancer	140-229	C00-C96
DIB000721	TT-112	Bleeding	.	R58
DIB000722	HCV entry inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000723	IGN-311	Cancer	140-229	C00-C96
DIB000724	YM-440	Diabetes mellitus type 1	.	E10
DIB000725	MLN-3126	Sjogren's syndrome	710.2	M35.0
DIB000726	Genetically modified allogeneic sertoli cells	Brain injury	.	S09.90
DIB000727	SC-236	Cancer	140-229	C00-C96
DIB000728	Ubiquitin specific protease-2 inhibitors	Prostate tumor	185	C61
DIB000729	Marine natural products	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000730	EMA-401	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
DIB000731	MNLP-462a	Cancer	140-229	C00-C96
DIB000732	IPH-3201	Cancer	140-229	C00-C96
DIB000733	ElCams	Infectious disease	001-139	A00-B99
DIB000734	ARM036	Heart failure	.	I50
DIB000735	TDI-0048	Motor neurone disease	335.2	G12.2
DIB000736	15-lipoxygenase inhibitors (CIP modulators), Galileo	Diabetes mellitus	.	E10-E14
DIB000737	Haempatch	Bleeding	.	R58
DIB000738	Vaccine	Influenza virus infections	487	J10, J11
DIB000739	Nurr 1 activators	Parkinson's disease	.	G20
DIB000740	Ganglioside vaccine	Metastatic sarcoma	.	C49
DIB000741	Omiganan	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000742	RecA inhibitors	Escherichia coli infection	.	A00-B99
DIB000743	PYM-50018	Glaucoma	365	H40-H42
DIB000744	RG6013	Hemophilia A	286	D66
DIB000745	INOC-016	Breast cancer	174, 175, 217	C50, D24
DIB000746	TEI-5178	Nephritis	.	N00-N19,N25-N29
DIB000747	IPN-120	Influenza virus infections	487	J10, J11
DIB000748	ABI-010	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000749	CNTO-1959	Asthma	493	J45
DIB000750	AMRS-001	Brain injury	.	S09.90
DIB000751	Recombinant bacterial vector vaccine	Hepatitis B virus infection	.	B16
DIB000752	Extended-release opioid	Pain	338,780	R52, G89
DIB000753	PDS-0102	Melanoma	172	C43
DIB000754	R-1068	Emesis	787	R11
DIB000755	LPCN-1056	Asthma	493	J45
DIB000756	TVX-005	Influenza virus infections	487	J10, J11
DIB000757	OX 19	Urinary incontinence	.	N39.3-N39.4
DIB000758	Vaxfectin	Discovery agent	.	.
DIB000759	INGN-402	Cancer	140-229	C00-C96
DIB000760	AM-679	Ocular inflammation	.	H00-H59
DIB000761	ASP-0306	Urinary dysfunction	.	N39.3-N39.4
DIB000762	SPD-473	Mood disorder	.	F30-F39
DIB000763	NGN-9079	Alzheimer's disease	331	G30
DIB000764	CNT0-5	Inflammation	.	I20-I25
DIB000765	HumaSPECT	Prostate tumor	185	C61
DIB000766	Suramin sodium	Cancer	140-229	C00-C96
DIB000767	AIM-101	Asthma	493	J45
DIB000768	M-2001	Non-insulin dependent diabetes	.	E11.9
DIB000769	N-65 lacritin	Xerophthalmia	.	E50.6-E50.7
DIB000770	Cetefloxacin	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB000771	Z-300	Gastric ulcer	.	K25
DIB000772	AST-915	Movement disorder	.	R25
DIB000773	Diazonamide analogs	Cancer	140-229	C00-C96
DIB000774	NCX-125	Glaucoma	365	H40-H42
DIB000775	CD79-targeted immunotoxins	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB000776	ACTH receptor antagonists	Cushing's disease	.	E24.9
DIB000777	Glycoprotein viral vector vaccine	Marburg virus infection	.	A98.3
DIB000778	Kevetrin	Cancer	140-229	C00-C96
DIB000779	HPV vaccine	Papillomavirus infections	.	B97.7
DIB000780	AZD-5423	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB000781	PF-05	Constipation	564	K59.0
DIB000782	C-Ron targeting antibodies	Cancer	140-229	C00-C96
DIB000783	Polysaccharide conjugate synthetic vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB000784	E-EBU-dM	HIV-1 infections	42	B20
DIB000785	Hepatitis B virus infection therapy	Hepatitis B virus infection	.	B16
DIB000786	RO-5458640	Solid tumours	.	C00-C75,C7A,C7B
DIB000787	A-81988	Hypertension	401	I10, I11, I12, I13, I15
DIB000788	Recombinant Wolinella (rWS) asparaginase	Cancer	140-229	C00-C96
DIB000789	Artemisinin-peptide conjugates	Cancer	.	C00-C97
DIB000790	Next generation recombinant soluble Fc receptors	Autoimmune diseases	279.4	D84.9, M35.9
DIB000791	Peptide mammalian sterile 20-like kinase 1 inhibitors	Ischemic heart diseases	410-414	I20-I25
DIB000792	CVX-045	Solid tumours	.	C00-C75,C7A,C7B
DIB000793	Anti-aging glycopeptides	Inflammatory diseases	.	.
DIB000794	TAMOLARIZINE HYDROCHLORIDE	Cognitive impairment	.	F06.7
DIB000795	TRPV1 inhibitor	Pain	338,780	R52, G89
DIB000796	JTK-853	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000797	SYL-040003	Ocular hypertension	365.04	H40.0
DIB000798	Inactine	Anemia	.	D50-D64
DIB000799	VAS-203	Brain injury	.	S09.90
DIB000800	Ramorelix	Esophageal cancer	.	C15
DIB000801	FemiVac	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000802	GliPR inhibitors	Glioma	191	C71
DIB000803	NTC-121	Glioma	191	C71
DIB000804	TRPV3 modulators	Pain	338,780	R52, G89
DIB000805	MDDR 265009	Cancer immunotherapy	140-229	C00-C96
DIB000806	ORG-13011	Psychotic disorders	.	F20-F29
DIB000807	Plasmin	Occlusion	.	I66.9
DIB000808	VS-6063	Mesothelioma	.	C45
DIB000809	ATR-107	Crohn's disease	.	K50
DIB000810	CMP-3	Discovery agent	.	.
DIB000811	PF-251802	Rheumatold arthritis	714	M05-M06
DIB000812	SPD-418	Epilepsy	345	G40
DIB000813	209-342	Cancer	140-229	C00-C96
DIB000814	Cytomegalovirus vaccine	Cytomegalovirus infection	.	B25
DIB000815	WT-4869	Leukaemia	.	C91-C95
DIB000816	Gene therapy	Mucopolysaccharidosis type I	.	E76.3?
DIB000817	Male contraceptive	Male contraception	.	Z30.2
DIB000818	Choroid plexus cell-derived factors	Wound healing	.	S91.3
DIB000819	Glucokinase activators	Diabetes mellitus	250	E08-E13
DIB000820	RQ-00000007 (oral)	Pain	.	G89
DIB000821	CDD-34	Alzheimer's disease	.	G30,F00
DIB000822	CRD-007	Aortic aneurysm	.	I71
DIB000823	Thioureidobutyronitrile	Solid tumours	.	C00-C75,C7A,C7B
DIB000824	ADepVac	Alzheimer's disease	331	G30
DIB000825	Pomisartan	Hypertension	401	I10, I11, I12, I13, I15
DIB000826	E-4080	Angina	413	I20
DIB000827	Drotaverine	Irritable bowel syndrome	564.1	K58
DIB000828	Mebiphon	Bone metastases	198.5	C79.51
DIB000829	SAR408701	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000830	Celivarone fumarate	Cardiac arrhythmias	.	I47-I49
DIB000831	RO-17	Ulcer	531-534	K25-K27
DIB000832	Acetyl CoA carboxylase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000833	AI-1008	Chronic myelogenous leukemia	205.1	C92.1
DIB000834	DMDC	Cancer	140-229	C00-C96
DIB000835	2-NAP	Gastrointestinal disease	.	K00-K93
DIB000836	Etilevodopa	Parkinson's disease	.	G20
DIB000837	Kinase inhibitors	Discovery agent	.	.
DIB000838	ATRINOSITOL	Pain	338	R52
DIB000839	Anticancer compounds	Cancer	140-229	C00-C96
DIB000840	AZD4901	Multiple sclerosis	340	G35
DIB000841	ALL-3	Cancer	140-229	C00-C96
DIB000842	GPI-2A	HIV infections	42	B20
DIB000843	CEFCANEL DALOXATE HYDROCHLORIDE	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB000844	LAS-101057	Asthma	.	J45
DIB000845	MLN-1021	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB000846	AZD-5099	Infectious disease	001-139	A00-B99
DIB000847	Gene therapy	Cancer	140-229	C00-C96
DIB000848	OPN4 antagonists	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB000849	CIGB-428	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB000850	HGT-1111	Metachromatic leukodystrophy	.	E75.25
DIB000851	TGF alpha	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB000852	QG-AGC1	Cancer	140-229	C00-C96
DIB000853	T611	Viral infections	042-075	A80-A99, B00-B34
DIB000854	CZEN-001	Pruritus	698	L29
DIB000855	IPX-159	Restless legs syndrome	.	G25.81
DIB000856	APX-005	Chronic lymphocytic leukaemia	204.1	C91.1
DIB000857	Lifibrol	Atherosclerosis	414.0, 440	I70
DIB000858	Aimpila	Colorectal cancer	153, 154	C18-C21
DIB000859	GSK2654911A	Viral infections	.	B09
DIB000860	LIFARIZINE HYDROCHLORIDE	Nerve injury	.	T14.4
DIB000861	CP-79328	Cancer	140-229	C00-C96
DIB000862	Buflomedil	Peripheral vascular disease	443.9	I73.9
DIB000863	NNC-00-3094	Schizophrenia	295	F20
DIB000864	SNX-002	Neurodegenerative diseases	.	G30-G32
DIB000865	MKC-1106-MT	Melanoma	.	C43
DIB000866	Small molecule therapeutics	Cardiovascular disease	390-459	I00-I99
DIB000867	Aminocandin	Fungal infection	.	B35-B49
DIB000868	Immunomodulator	Pulmonary fibrosis	515, 516.3	J84.1
DIB000869	BFPET	Coronary artery disease	.	I20-I25
DIB000870	GlycoPEG-GCSF	Cancer	140-229	C00-C96
DIB000871	SERAZAPINE HYDROCHLORIDE	Anxiety disorder	.	F40-F42
DIB000872	CEA antibody program	Cancer	140-229	C00-C96
DIB000873	AZD-1678	Asthma	493	J45
DIB000874	IL-2 vaccine	Gastrointestinal cancer	.	C15-C26
DIB000875	GORALATIDE	Hematopoietic	.	D50-D89
DIB000876	P2X7 antagonists	Nervous system inflammation	.	G00-G09
DIB000877	Dexamethasone sodium phosphate	Ataxia telangiectasia	.	G11.3
DIB000878	Apogen MS	Multiple sclerosis	340	G35
DIB000879	ARX-Trail	Colon cancer	153, 154	C18-C21
DIB000880	IRAK4 inhibitors	Diffuse large b-cell lymphoma	200	C83.3
DIB000881	ABX-PTH	Parathyroid disease	.	E20-E21
DIB000882	AP-11014	Cancer	140-229	C00-C96
DIB000883	V-1810	Cancer	140-229	C00-C96
DIB000884	GRNOPC-1	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB000885	H pylori vaccine	Helicobacter pylori infection	41.86	B96.81
DIB000886	VEGF kinoid	Cancer	.	C00-C97
DIB000887	PP-9706642	Herpes simplex virus infection	.	B00
DIB000888	Parkinson's disease therapy	Parkinson's disease	.	G20
DIB000889	AIKb2	Alzheimer's disease	331	G30
DIB000890	Peptide-based viral entry inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB000891	Fibroblast growth factor	Ear disease	.	H83.9
DIB000892	PeproStat	Bleeding	.	R58
DIB000893	DA-9801	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB000894	Alpha 1 proteinase inhibitor	Alpha-1 antitrypsin deficiency	.	E88.0
DIB000895	IFN alpha kinoid	HIV infections	42	B20
DIB000896	Indocyanine green	Gastrointestinal disease	.	K00-K93
DIB000897	INOC-003	Cancer	.	C00-C97
DIB000898	Adenovirus 4-based vaccine	Papillomavirus infections	.	B97.7
DIB000899	CV-787	Prostate tumor	185	C61
DIB000900	TT-114	Blood clotting disorder	286	D65-D69
DIB000901	MN-7105	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB000902	Stem cell therapy	Cardiovascular disease	390-459	I00-I99
DIB000903	CKD-712	Cancer	.	C00-C97
DIB000904	Rh-MBL	HIV infections	42	B20
DIB000905	Delequamine hydrochloride	Male sexual disorders	.	F52
DIB000906	NK-1007	Atrial fibrillation	427.31	I48
DIB000907	TAK-218	Neurological disease	.	G00-G99
DIB000908	HDAC inhibitors	Cancer	140-229	C00-C96
DIB000909	HIF-1 alpha inhibitors	Cancer	140-229	C00-C96
DIB000910	Vaccine	Staphylococcus aureus infection	001-139	A00-B99
DIB000911	TAK-029	Thrombosis	.	I80-I82
DIB000912	D-04	Cardiovascular disease	390-459	I00-I99
DIB000913	CM-4612	Attention deficit hyperactivity disorder	314	F90
DIB000914	Koningic acid ester derivatives	Cancer	140-229	C00-C96
DIB000915	Munumbicins	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB000916	ABX-102	Cancer	140-229	C00-C96
DIB000917	CT-400	Cancer	140-229	C00-C96
DIB000918	Hydroxyethyl starch	Serious blood volume loss	.	R58
DIB000919	GW-559090	Allergic rhinitis	.	J30
DIB000920	Anti-FGFR1 mAb program	Cancer	.	C00-C97
DIB000921	Recombinant anti-IgE vaccine	Allergy	995.3	T78.4
DIB000922	S-1746	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB000923	Autologous Tr1 cell therapy	Asthma	493	J45
DIB000924	Antibody vaccine	Alzheimer's disease	331	G30
DIB000925	PVAC	Psoriasis	696	L40
DIB000926	MSH-1001	Ocular hypertension	.	H40.0
DIB000927	SINITRODIL	Angina	.	I20
DIB000928	BL-1050	HIV infections	42	B20
DIB000929	GSK-2256098	Cancer	.	C00-C97
DIB000930	MVA-BN DF	Flavivirus infection	.	A86
DIB000931	IQB-9302	Pain	.	G89
DIB000932	GPs-0193	HIV infections	42	B20
DIB000933	BPL-003 series	Pain	338,780	R52, G89
DIB000934	Histone methyltransferase inhibitors	Cancer	140-229	C00-C96
DIB000935	GKT-03 program	Hypertension	401	I10, I11, I12, I13, I15
DIB000936	VII-87-B	Hypertension	401	I10, I11, I12, I13, I15
DIB000937	Cytomegalovirus vaccine	Cytomegalovirus infection	.	B25
DIB000938	Cardiovascular therapeutics	Cardiovascular disease	390-459	I00-I99
DIB000939	Oshadi D	Cancer	.	C00-C97
DIB000940	RNAi therapy	Asthma	493	J45
DIB000941	GFP-bacterial methioninase/selenomethionine GDEPT	Cancer	140-229	C00-C96
DIB000942	Vitamin B12 monoclonal antibodies	Autoimmune diseases	279.4	D84.9, M35.9
DIB000943	CI-950	Rheumatold arthritis	714	M05-M06
DIB000944	YKP-1358	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DIB000945	West Nile virus vaccine	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB000946	FGF-R2 tyrosine kinase inhibitors	Cancer	140-229	C00-C96
DIB000947	Diatrizoate	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB000948	Antidiabetics	Non-insulin dependent diabetes	.	E11.9
DIB000949	MS-136	Breast cancer	174, 175, 217	C50, D24
DIB000950	BMY-30129	Pruritus	.	L29
DIB000951	Dengue virus vaccines	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB000952	Niclosamide	Cestode infection	.	B71.9
DIB000953	KH-164	HIV infections	42	B20
DIB000954	TTP-355	Diabetes mellitus	.	E10-E14
DIB000955	BlockAide/CR	HIV infections	42	B20
DIB000956	Alzheimer's disease therapeutic	Alzheimer's disease	331	G30
DIB000957	(S)-oxybutynin	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB000958	VZV vaccine	Adult varicella zoster virus infection	.	B02
DIB000959	Terflavoxate	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB000960	Gonadimmune	Prostate cancer	185	C61
DIB000961	PfCDPK1 inhibitors	Plasmodium falciparum infection	.	B54
DIB000962	Fibrin Sealant	Wound healing	.	S91.3
DIB000963	Oxygent	Respiratory failure	518.81	J96
DIB000964	CHB-111	Hepatitis B virus infection	.	B16
DIB000965	Carbetapentane	Cough	786.2	R05
DIB000966	Quick-acting insulin	Diabetes mellitus	250	E08-E13
DIB000967	Deligoparin sodium	Ulcerative colitis	556	K51
DIB000968	Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy	Immunodeficiency	.	D84.9
DIB000969	CMV glycoprotein B subunit vaccine	Cytomegalovirus infection	.	B25
DIB000970	HBP-347	Autoimmune diseases	279.4	D84.9, M35.9
DIB000971	Cell transplant	Age related macular degeneration	.	H35.30
DIB000972	Guanadrel	Hypertension	401	I10, I11, I12, I13, I15
DIB000973	Plasma derived human butyrylcholinesterase	Neurotoxicity drug-induced	.	T36-T50
DIB000974	Apratastat	Rheumatold arthritis	714	M05-M06
DIB000975	RP-54745	Rheumatold arthritis	714	M05-M06
DIB000976	HinsBet	Insulin dependent diabetes	.	E10
DIB000977	KD-501	Alzheimer's disease	331	G30
DIB000978	Cytoreg	Cancer	.	C00-C97
DIB000979	ABANOQUIL MESILATE	Cardiac arrhythmias	.	I47-I49
DIB000980	TBC-2019	Asthma	493	J45
DIB000981	Meningococcus CY vaccine	Neisseria meningitidis infection	.	A87
DIB000982	CL-277082	Arteriosclerosis	.	I70
DIB000983	Diacol	Gastrointestinal infection	.	A09.0
DIB000984	SARS vaccine	SARS coronavirus infection	.	J12.81
DIB000985	DIADENOSINE TETRAPHOSPHATE	Cardiac arrhythmias	.	I47-I49
DIB000986	MBX-2044	Diabetes mellitus type 2	.	E11
DIB000987	VALERGEN-DS (subcutaneous)	Asthma	493	J45
DIB000988	Pinazepam	Anxiety disorder	300	F40-F42
DIB000989	Synthetic long peptide based vaccines against antigen X/Y	Cancer	140-229	C00-C96
DIB000990	Depigoid birch pollen extract vaccine	Allergic conjunctivitis	372.14	H10.45
DIB000991	Recombinant human biglycan	Duchenne dystrophy	.	G71.0
DIB000992	DAV-132	Toxicity	.	T36-T50,T51-T65
DIB000993	DARGLITAZONE	Diabetes mellitus	.	E10-E14
DIB000994	Mesenchymal precursor cells	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB000995	P-1736	Diabetes mellitus	.	E10-E14
DIB000996	CMV DNA vaccine	Cytomegalovirus	78.5	B25.8, H30.9
DIB000997	XMetD	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
DIB000998	IL-2/gene-modified lymphocytes	Ovarian cancer	183	C56
DIB000999	Encapsulated cells	Breast cancer	.	C50
DIB001000	HNK-20	Respiratory syncytial virus 	79.6	B97.4
DIB001001	VRX-03011	Alzheimer's disease	.	G30,F00
DIB001002	NY-ESO-1 vaccine	Cancer	140-229	C00-C96
DIB001003	INDUSCA-1	Inflammatory bowel disease	555, 556	K50, K51
DIB001004	RG-7599	Cancer	140-229	C00-C96
DIB001005	IL-7/CD80-expressing allogeneic RCC-26 tumor cell vaccine	Renal cell carcinoma	189	C64
DIB001006	MGAWN-1	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB001007	VK-11	Alzheimer's disease	331	G30
DIB001008	DNA vaccine	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB001009	ARI-1778	Atherosclerosis	414.0, 440	I70
DIB001010	HIV replication inhibitors	HIV infections	42	B20
DIB001011	NB-003	Acne vulgaris	706.1	L70.0
DIB001012	BIA-10	Pain	338,780	R52, G89
DIB001013	Digibind	Eclampsia	.	O14
DIB001014	GTx-134	Cancer	140-229	C00-C96
DIB001015	Polyclonal antibodies	MRSA infection	.	B95.62
DIB001016	Tosagestin	Contraception	.	Z30
DIB001017	V-710	Staphylococcus aureus infection	001-139	A00-B99
DIB001018	Antimalarial agents	Plasmodium falciparum infection	.	B54
DIB001019	UCB-11056	Cognition disorders	.	F06.7
DIB001020	CBF-BS2	Rheumatold arthritis	714	M05-M06
DIB001021	Vaccine	Chlamydia infection	.	A74.9
DIB001022	CTCE-9908	Sarcoma	.	C00-C75
DIB001023	Human growth hormone gene therapy	Growth disorder	.	E23.0
DIB001024	SiRNA therapy	Bladder cancer	188	C67
DIB001025	CL-246738	Immuno-suppressant	.	T86.0
DIB001026	GLP-1 receptor PAM	Non-insulin dependent diabetes	.	E11.9
DIB001027	MBO7133	Liver cancer	155	C22.0
DIB001028	RO-5428029	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001029	SAR-152954	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB001030	MyoCell SDF-1	Heart failure	.	I50
DIB001031	FK-518	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001032	LIM-5310	Toxicity	.	T36-T50,T51-T65
DIB001033	Alpha 2A adrenoceptor antagonist	Sepsis	995.91	A40, A41
DIB001034	FR-128998	Thrombocytopenia	.	D69.6
DIB001035	RO-5212054	Cancer	140-229	C00-C96
DIB001036	ERB-196	Inflammatory bowel disease	.	K50,K51
DIB001037	ABT-080	Asthma	.	J45
DIB001038	AZD-5069	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001039	GR-270773	Sepsis	.	A40-A41
DIB001040	BI-11634	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB001041	OX-30	Pain	338,780	R52, G89
DIB001042	Recombinant Factor VIII	Factor VIII deficiency	.	D66
DIB001043	AbGn-107	Pancreatic cancer	.	C25
DIB001044	DiffGAM	Diarrhea	787.91	A09, K59.1
DIB001045	ITL-1636	Breast cancer	174, 175, 217	C50, D24
DIB001046	CAT-2200	Rheumatold arthritis	714	M05-M06
DIB001047	Riminophenazine	Mycobacterium tuberculosis infection	.	A15-A19
DIB001048	CNTO-3649	Diabetes mellitus type 2	.	E11
DIB001049	Monohydroxyethylrutoside	Cardiovascular disease	.	I00-I99
DIB001050	BAY-Q-1531	Allergy	995.3	T78.4
DIB001051	LAS-30813	Allergy	995.3	T78.4
DIB001052	BBS-1 BACE inhibitor mAb vaccine	Alzheimer's disease	331	G30
DIB001053	HDAC inhibitors	Cancer	140-229	C00-C96
DIB001054	Bioremineralization modulators II	Cardiovascular disease	390-459	I00-I99
DIB001055	Lintuzumab	Leukaemia	.	C91-C95
DIB001056	HG-1091	Immune disorder	.	D80-D89
DIB001057	VT-384	Inflammatory diseases	.	.
DIB001058	Postoperative pain prophylactic therapy	Pain	338,780	R52, G89
DIB001059	Anti-wolbachia therapy	Filariasis	.	B74.9
DIB001060	ROCK-1 inhibitors	Atherosclerosis	414.0, 440	I70
DIB001061	PF-275366	Acne vulgaris	706.1	L70.0
DIB001062	Oxabact	Hyperoxaluria	.	E74.8
DIB001063	FVh1 DNA-based influenza vaccine	Influenza A virus H1N1 infections	487, 488	J10, J11
DIB001064	KM-4056	Cancer	140-229	C00-C96
DIB001065	ACEA-1416	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001066	Anti-CD20 monoclonal antibodies	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB001067	TherMax	Inflammatory diseases	.	.
DIB001068	TAFA-93	Transplant rejection	.	T86
DIB001069	Toleragens	Autoimmune diseases	279.4	D84.9, M35.9
DIB001070	Diamyd	Diabetes mellitus type 1	.	E10
DIB001071	ATON-004	Heavy metal poisoning	.	X49
DIB001072	IG-RD-001	Respiratory disease	.	J00-J99
DIB001073	Immune globulin high dose	Alzheimer's disease	331	G30
DIB001074	CAM-2036	Non-insulin dependent diabetes	.	E11.9
DIB001075	Gamma-sarcoglycan gene-containing recombinant AAV1 vector based therapy	Duchenne muscular dystrophy	.	G71.0
DIB001076	HCV vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001077	NPC-15669	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB001078	SB-9200	Hepatitis B virus infection	.	B16
DIB001079	Oral anti-inflammatory agents	Inflammatory diseases	.	.
DIB001080	HL-004	Arteriosclerosis	.	I70
DIB001081	ONO-4641	Rheumatold arthritis	714	M05-M06
DIB001082	F1-ATP synthase antibody	Cancer	140-229	C00-C96
DIB001083	HGH	Cachexia	799.4	R64
DIB001084	PIBAXIZINE	Spasm	.	R25.2
DIB001085	HIV-1 integrase inhibitors	HIV-1 infections	42	B20
DIB001086	Obesity therapeutics	Obesity	278	E66
DIB001087	HPMA-gemcitabine conjugate	Cancer	140-229	C00-C96
DIB001088	Heat shock protein 90 inhibitors	Alzheimer's disease	331	G30
DIB001089	Cancer therapy	Cancer	140-229	C00-C96
DIB001090	CI-959	Asthma	.	J45
DIB001091	A-82186	Hypertension	401	I10, I11, I12, I13, I15
DIB001092	Edg5 antagonists	Hypertension	401	I10, I11, I12, I13, I15
DIB001093	FAAH inhibitor	Metabolic disorders	.	E70-E90
DIB001094	EGF-SLiP fusion protein	Breast cancer	174, 175, 217	C50, D24
DIB001095	LG-912	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001096	DNX-2401	Glioblastoma	.	C71
DIB001097	Prednisolone sodium metazoate	Inflammatory bowel disease	.	K50,K51
DIB001098	ZT-102	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001099	ZFP T-cell therapy	Cancer	140-229	C00-C96
DIB001100	Anti-Candida heteropolymer (HP) monoclonal antibody	Candida infection	.	B37.0
DIB001101	BPR-DC-2	Cancer	140-229	C00-C96
DIB001102	MicroRNA-targeting antisense oligonucleotide therapy	Liver cancer	155	C22.0
DIB001103	MEDl-570	Systemic lupus erythematosus	710	M32
DIB001104	Hypertension NCE	Hypertension	401	I10, I11, I12, I13, I15
DIB001105	TVX-008	Discovery agent	.	.
DIB001106	SCIB-1	Melanoma	172	C43
DIB001107	DARPins	Autoimmune diseases	279.4	D84.9, M35.9
DIB001108	Foxy-5	Breast cancer	174, 175, 217	C50, D24
DIB001109	SRX-246	Anxiety disorder	.	F40-F42
DIB001110	Lysine-specific demethylase 1 inhibitors	Cancer	140-229	C00-C96
DIB001111	Etilefrine	Cardiovascular disease	390-459	I00-I99
DIB001112	PF-06463922	Cancer	.	C00-C97
DIB001113	Gene therapy	Pain	338,780	R52, G89
DIB001114	Minnelide 001	Gastrointestinal cancer	.	C15-C26
DIB001115	SOR-C13	Ovarian cancer	.	C56
DIB001116	HG-1245	Cancer	140-229	C00-C96
DIB001117	VP-50406	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001118	MIS-416/immunogen	Bacillus anthracis infection	.	A22
DIB001119	ASP-2535	Schizophrenia	295	F20
DIB001120	Civacir	Pancreatic cancer	157	C25
DIB001121	FRG-8701	Stomach ulcer	.	K25-K27
DIB001122	NADPH oxidase inhibitors	Ocular disease	.	H00-H59
DIB001123	UP-5222-04	Pain	338	R52
DIB001124	Oxymetholone	Aplastic anemia	284	D60-D61
DIB001125	Nav1.8 blockers	Pain	338,780	R52, G89
DIB001126	VL-01	Cancer	.	C00-C97
DIB001127	Actacel	Bordetella pertussis infection	.	A37.0
DIB001128	NRNA program	Epstein Barr virus infection	.	B27
DIB001129	CFTR inhibitors	Diarrhea	787.91	A09, K59.1
DIB001130	Beta 2 adrenoceptor modulator	Asthma	493	J45
DIB001131	IC14	Sepsis	.	A40-A41
DIB001132	TPN-729	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB001133	ATX-MS-1467	Multiple sclerosis	340	G35
DIB001134	CG-0070	Bladder cancer	.	C67
DIB001135	Huntingtons disease therapy	Huntington's disease	.	F02.2,G10
DIB001136	PHY-906	Hepatocellular carcinoma	155	C22.0
DIB001137	SERM-3339	Osteoporosis	733	M80-M81
DIB001138	CMP-1	Allergic rhinitis	477	J30
DIB001139	HLA-B7.75-84	Immuno-suppressant	.	T86.0
DIB001140	VS1-011	Cancer	140-229	C00-C96
DIB001141	Simenepag isopropyl	Ocular hypertension	365.04	H40.0
DIB001142	Paroxetine HCl	Premature ejaculation	302.75	F52.4
DIB001143	Anti-L1 monoclonal antibodies	Cancer	140-229	C00-C96
DIB001144	H2N3 MO 2003/AA	Influenza virus infections	487	J10, J11
DIB001145	SLP-0901	Escherichia coli infection	.	A00-B99
DIB001146	Renin inhibitors	Hypertension	401	I10, I11, I12, I13, I15
DIB001147	AAV2-hFIX16	Factor IX deficiency	.	D67
DIB001148	H-103	Metastasis	.	C00-C97
DIB001149	8H9 mAb	Brain cancer	191	C71
DIB001150	ARX-201	Growth disorder	.	E23.0
DIB001151	JTT-851	Diabetes mellitus type 2	.	E11
DIB001152	Telinavir	Human immunodeficiency virus infection	.	B20
DIB001153	PAZINACLONE	Anxiety disorder	300	F40-F42
DIB001154	Pantothenic acid	Vitamin deficiency	.	E56.9
DIB001155	Paquinimod	Lupus	.	M32
DIB001156	Cx-611	Rheumatold arthritis	714	M05-M06
DIB001157	OP-03 program	Melanoma	172	C43
DIB001158	Angiomate I	Cancer	140-229	C00-C96
DIB001159	KBSA-301	Staphylococcus aureus infection	001-139	A00-B99
DIB001160	PT-200	Atrophy	.	M62.571
DIB001161	CPSI-306	Discovery agent	.	.
DIB001162	RG-7356	Hematological malignancies	.	C81-C96
DIB001163	Recombinant botulinum toxin vaccine	Yersinia infections	.	A04.6
DIB001164	MEDI-542	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB001165	AGN-208397	Retinal venous occlusion	.	H34.8
DIB001166	MGL-3196	Hyperlipidemia	.	E78.5
DIB001167	SNX-9 class compounds	Cancer	140-229	C00-C96
DIB001168	VBY-129	Autoimmune diseases	279.4	D84.9, M35.9
DIB001169	Astenose	Atherosclerosis	414.0, 440	I70
DIB001170	5-lipoxygenase inhibitors (pain, cardiovascular disease), Amira Pharmaceuticals	Cardiovascular disease	390-459	I00-I99
DIB001171	DNA-HIV-C/NYVAC-HIV-C	HIV infections	42	B20
DIB001172	CLR-900	Neurological disease	.	G00-G99
DIB001173	Falcipain protease inhibitor	Plasmodium infection	.	B54
DIB001174	T-0632	Pancreatic disease	.	K85-K86
DIB001175	MBP(82-98)	Multiple sclerosis	340	G35
DIB001176	Clothiapine	Schizophrenia	295	F20
DIB001177	Non-sulfonylurea P2Y12 antagonists	Cardiovascular disease	390-459	I00-I99
DIB001178	MNT-03-01	Fungal infection	.	B35-B49
DIB001179	GPCR antagonists	Alzheimer's disease	331	G30
DIB001180	Bornaprine	Parkinson's disease	.	G20
DIB001181	Synthetic peptide H1N1/H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB001182	CCD-3693	Anxiety disorder	.	F40-F42
DIB001183	Protein kinase inhibitors	Cancer	140-229	C00-C96
DIB001184	Interferon alfa-n3	HIV infections	42	B20
DIB001185	GSK3117391	Rheumatold arthritis	714	M05-M06
DIB001186	Anti-CD46 mAb	Breast cancer	.	C50
DIB001187	14C-urea	Helicobacter pylori infection	41.86	B96.81
DIB001188	CHF-1255	Cardiotonic	.	I50
DIB001189	SSR-128428	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB001190	U-104842	Anxiety disorder	300	F40-F42
DIB001191	MILFASARTAN	Hypertension	.	I10-I15
DIB001192	Ro-327315	Rheumatold arthritis	714	M05-M06
DIB001193	SPD-756	Human immunodeficiency virus infection	.	B20
DIB001194	RDEA-436	Cancer	.	C00-C97
DIB001195	Grp78 nucleoside inhibitors	Cancer	140-229	C00-C96
DIB001196	RO-5095932	Non-insulin dependent diabetes	.	E11.9
DIB001197	CM-2501	Poison intoxication	.	T36-T50
DIB001198	Inflammasome modulator	Inflammatory diseases	.	.
DIB001199	SYN-114	Cognitive impairment	.	F06.7
DIB001200	Genital herpes therapy	Herpes simplex virus infection	54	B00
DIB001201	GR-131663	Anxiety disorder	300	F40-F42
DIB001202	Streptococcus vaccines	Streptococcus pneumoniae infection	.	A00-B99
DIB001203	CMI-206	Inflammatory diseases	.	.
DIB001204	GFT-505	Diabetes mellitus type 2	.	E11
DIB001205	AntiHer2-XTEN-Docetaxel	Breast cancer	174, 175, 217	C50, D24
DIB001206	TN-871	Cognition disorders	.	F06.7
DIB001207	Anthrax vaccine	Bacillus anthracis infection	.	A22
DIB001208	MNT-02-07	Clostridium botulinum infection	.	A05.1
DIB001209	Esterase-sensitive motif compounds	Arthritis	710-719	M00-M25
DIB001210	BO-653	Restenosis	.	I51.89
DIB001211	Glycolipids	Parkinson's disease	.	G20
DIB001212	FK-584	Central and peripheral nervous diseases	.	G96.9
DIB001213	Apoptosis stimulator	Leukemia	208.9	C91-C95
DIB001214	TG-100-344	Ocular disease	.	H00-H59
DIB001215	5-HT 6 antagonists (CIAS), Galenea	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB001216	JR-032	Hunter syndrome	.	E76.1
DIB001217	Chloral hydrate	Alcohol use disorders	303	F10.2
DIB001218	Pirazolac	Inflammatory diseases	.	.
DIB001219	SR-59230A	Irritable bowel syndrome	564.1	K58
DIB001220	PBI-230	Intoxication	.	T36-T50
DIB001221	CXCR3 antagonists	Inflammatory diseases	.	.
DIB001222	Antiviral iminosugars	Viral infections	042-075	A80-A99, B00-B34
DIB001223	BMS-824393	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001224	ONX-0912	Solid tumours	.	C00-C75,C7A,C7B
DIB001225	Ypeginterferon alfa-2a (chronic hepatitis B/C) Amoytop	Hepatitis B virus infection	.	B16
DIB001226	Neurodegenerative disease therapy	Neurodegenerative diseases	.	G30-G32
DIB001227	LLL-12	Cancer	140-229	C00-C96
DIB001228	G-619	Thrombosis	.	I80-I82
DIB001229	BC-6213	Osteoporosis	733	M80-M81
DIB001230	AGT-182	Hunter syndrome	.	E76.1
DIB001231	GPR119 agonists	Non-insulin dependent diabetes	.	E11.9
DIB001232	ADD-17014	Epileptic seizure	.	G40,R56
DIB001233	Bunazosin	Glaucoma	365	H40-H42
DIB001234	SGS742	Schizophrenia	.	F20
DIB001235	Olanzapine/fluoxetine combination	Depression	311	F32
DIB001236	PFT-X-beta	Toxicity	.	T36-T50,T51-T65
DIB001237	Ciprofloxacin	Otitis media	.	H65-H67
DIB001238	SRSS-021	Emesis	.	R11
DIB001239	P-2745	Chronic myelogenous leukemia	205.1	C92.1
DIB001240	RG7716	Macular degeneration	.	H35.3
DIB001241	PDL-241	Immune disorder	.	D80-D89
DIB001242	NOLOMIROLE HYDROCHLORIDE	Heart failure	.	I50
DIB001243	Monoclonal antibody	Cancer	140-229	C00-C96
DIB001244	Eloctate	Haemophilia A	286	D66
DIB001245	L-697639	Human immunodeficiency virus infection	.	B20
DIB001246	Metabotropic glutamate receptor 5 antagonists	Neurological disease	.	G00-G99
DIB001247	FOSOPAMINE	Hypertension	401	I10, I11, I12, I13, I15
DIB001248	Buprenorphine prodrugs	Opiate dependence	304	F11
DIB001249	Fenspiride hydrochloride	Asthma	493	J45
DIB001250	TDI-0046	Motor neurone disease	335.2	G12.2
DIB001251	Tiamenidine	Hypertension	401	I10, I11, I12, I13, I15
DIB001252	SKF-97574	Peptic ulcer	.	K25-K27
DIB001253	AVP-5	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB001254	MCT-175	Multiple sclerosis	340	G35
DIB001255	TH-1011	Cancer	140-229	C00-C96
DIB001256	TAK-661	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB001257	H1N1 influenza A inactivated split virion vaccine	Influenza virus infections	487	J10, J11
DIB001258	Partial hGK activators	Non-insulin dependent diabetes	.	E11.9
DIB001259	T-type calcium channel antagonist	Pain	338,780	R52, G89
DIB001260	SSR-69071	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001261	BP-9906	Cancer	140-229	C00-C96
DIB001262	V-073	Enterovirus infection	001-139	A00-B99
DIB001263	Recoflavone eye drops	Inflammatory bowel disease	.	K50,K51
DIB001264	Ad-p53	Cancer	140-229	C00-C96
DIB001265	HCGRP8-37	Pain	338,780	R52, G89
DIB001266	Melatonin receptor ligands	Discovery agent	.	.
DIB001267	Ad5-ENVA-48	HIV-1 infections	42	B20
DIB001268	Ronomilast	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB001269	Oligonucleotide decoys (NFkappaB)	Atopic dermatitis	.	L20
DIB001270	Therapy	Pre-eclampsia	642.4-642.7	O11, O14
DIB001271	DE-098	Rheumatold arthritis	.	M05-M06
DIB001272	LXR agonists	Cardiovascular disease	390-459	I00-I99
DIB001273	BNV-222	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB001274	Ceronapril	Major depressive disorder	.	F32,F33
DIB001275	VK-12	Cancer	.	C00-C97
DIB001276	R-71762	HIV-1 infections	42	B20
DIB001277	EFEGATRAN SULFATE HYDRATE	Myocardial infarction	.	I21-I22
DIB001278	Malaria vaccine	Plasmodium falciparum infection	.	B54
DIB001279	AEP-924	Major depressive disorder	296.2, 296.3	F32, F33
DIB001280	RotaTeq	Rotavirus infections	001-139	A00-B99
DIB001281	Hexavalent conjugate vaccine	Bordetella pertussis infection	.	A37.0
DIB001282	KB-5246	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB001283	Small molecule program targeting Th17 cells	Autoimmune diseases	279.4	D84.9, M35.9
DIB001284	FX-125L	Scar tissue	.	L00-L99
DIB001285	LY-2300559	Migraine	.	G43
DIB001286	MC-116	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB001287	Non-nucleoside reverse transcriptase inhibitors	HIV infections	42	B20
DIB001288	BIOO-6	Cancer	140-229	C00-C96
DIB001289	PM-181104	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001290	Lixte-1.2	Neurological disease	.	G00-G99
DIB001291	KI-0904	Cancer	140-229	C00-C96
DIB001292	F18-ML-10	Brain cancer	191	C71
DIB001293	Anti-HIV therapeutics	HIV infections	42	B20
DIB001294	Therapeutic program (Alzheimer's disease) B&C Biopharm/Equispharm	Alzheimer's disease	331	G30
DIB001295	DR-3001	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB001296	Therapeutic DNA vaccine	Hepatitis B virus infection	.	B16
DIB001297	Glycogen synthase kinase-3 inhibitors	Diabetes mellitus type 2	.	E11
DIB001298	Plasmodium falciparum vaccines	Plasmodium falciparum infection	.	B54
DIB001299	Brassinosteroid analogs	Herpes simplex virus infection	.	A60,B00
DIB001300	Bacteriophage	MRSA infection	.	B95.62
DIB001301	HPV vaccine	Papillomavirus infections	.	B97.7
DIB001302	Malaria vaccine	Plasmodium falciparum infection	.	B54
DIB001303	APS-001	Cancer	.	C00-C97
DIB001304	SYM-004	Head and neck cancer	.	C07-C14,C32-C33
DIB001305	4SC-207	Cancer	140-229	C00-C96
DIB001306	GN-1140	Liver cancer	155	C22.0
DIB001307	RLY-106	Cardiovascular disease	390-459	I00-I99
DIB001308	NTO-1151	Cervical cancer	180	C53
DIB001309	Genz-644470	Hyperphosphatemia	.	E83
DIB001310	SU-740	Stomach ulcer	.	K25-K27
DIB001311	Fab inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001312	Cannabinoids	Inflammatory diseases	.	.
DIB001313	LGD2941	Osteoporosis	733	M80-M81
DIB001314	SEN-196	Huntington's disease	.	F02.2,G10
DIB001315	ABS-103	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB001316	IVN-birch	Allergic rhinitis	477	J30
DIB001317	Cericlamine	Anxiety disorder	300	F40-F42
DIB001318	TGF-BR2 mAb	Cancer	.	C00-C97
DIB001319	Zinc salts	Arthritis	710-719	M00-M25
DIB001320	Viperfav	Poison intoxication	.	T36-T50
DIB001321	Rh-Apo2L	Solid tumours	.	C00-C75,C7A,C7B
DIB001322	NMDA receptor antagonists	Atherosclerosis	414.0, 440	I70
DIB001323	44-Bu	Heart arrhythmia	.	I47-I49
DIB001324	Anti-human transferrin receptor dimeric immunoglobulinA antibody	Multiple myeloma	203	C90.0
DIB001325	Interferon alfa-n3	HIV infections	42	B20
DIB001326	Denibulin	Cancer	.	C00-C97
DIB001327	Cognition enhancer	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB001328	Protein kinase inhibitors	Cancer	140-229	C00-C96
DIB001329	SP-333	Ulcerative colitis	556	K51
DIB001330	TRK-130	Overactive bladder disorder	596.51	N32.81
DIB001331	NK-3 antagonists	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB001332	SAR-260093	Diabetes mellitus type 2	.	E11
DIB001333	Laxatives stimulant	Constipation	564	K59.0
DIB001334	CR-2991	Hypertension	401	I10, I11, I12, I13, I15
DIB001335	AWD-160-275	Cardiovascular disease	390-459	I00-I99
DIB001336	ARC-2022	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
DIB001337	COR-1	Heart failure	.	I50
DIB001338	OCM-127	Leukemia	208.9	C91-C95
DIB001339	Folate biosynthesis inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB001340	TCR-less T-cell therapy	Cancer	140-229	C00-C96
DIB001341	BLV-0704	Pain	338,780	R52, G89
DIB001342	ASP-7035	Nocturia	.	R35
DIB001343	Undisclosed protein	Cancer	140-229	C00-C96
DIB001344	CTL-301-targeted CB-1954 GDEPT	Colorectal cancer	153, 154	C18-C21
DIB001345	Bcl-xL modulators	Cancer	140-229	C00-C96
DIB001346	AZD-9742	MRSA infection	.	B95.62
DIB001347	Sigma-1 antagonist	Cognitive impairment	.	F06.7
DIB001348	AZD-5455	Anxiety disorder	300	F40-F42
DIB001349	HIF-1 alpha inhibitors	Cancer	140-229	C00-C96
DIB001350	Ipecac	Poison intoxication	.	T36-T50
DIB001351	SORAPRAZAN	Peptic ulcer	.	K25-K27
DIB001352	CBLB-502	Acute radiation syndrome	.	T66
DIB001353	N-1177-inh	Lymphoma	.	C81-C96
DIB001354	Triiodobenzene contrast agents	Gastrointestinal disease	.	K00-K93
DIB001355	GNI-104	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001356	OTSGC-A24	Colorectal cancer	.	C18-C20,C21
DIB001357	GW-813893	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB001358	Antibody therapeutics	Macular degeneration	.	H35.3
DIB001359	PR1 peptide antigen vaccine	Acute myeloid leukemia	205	C92.0
DIB001360	MGN-6114	Peripheral vascular disease	443.9	I73.9
DIB001361	P38-alpha kinase inhibitor	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB001362	Rhenium-188-LL2	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB001363	CC-100	Motor neurone disease	335.2	G12.2
DIB001364	LT gene	Cancer	140-229	C00-C96
DIB001365	TDI-0102	Motor neurone disease	335.2	G12.2
DIB001366	RO-6036	Obesity	278	E66
DIB001367	Small molecule therapeutics	Diabetes mellitus	250	E08-E13
DIB001368	AstraStim	Cancer	140-229	C00-C96
DIB001369	Anti-MIF antibodies	Autoimmune diseases	.	D84.9
DIB001370	Sonophotodynamic therapy	Cancer	140-229	C00-C96
DIB001371	BMS-936557	Immune disorder	.	D80-D89
DIB001372	Natriuretic peptides	Congestive heart failure	428	I50
DIB001373	TBC-Thai	HIV infections	42	B20
DIB001374	ND-07	Inflammatory diseases	.	.
DIB001375	Mentat	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB001376	Potassium channel blockers	Autoimmune diseases	279.4	D84.9, M35.9
DIB001377	L-696229	Human immunodeficiency virus infection	.	B20
DIB001378	NMI-1182	Inflammatory diseases	.	.
DIB001379	ALS therapy	Motor neurone disease	335.2	G12.2
DIB001380	RXR activators	Non-insulin dependent diabetes	.	E11.9
DIB001381	FCE-25148A	Viral infections	042-075	A80-A99, B00-B34
DIB001382	F-15845	Angina	.	I20
DIB001383	GW-250495	Asthma	.	J45
DIB001384	LOSIGAMONE	Epileptic seizure	.	G40,R56
DIB001385	MIV-170	HIV infections	42	B20
DIB001386	PEV-7	Candida infection	.	B37.0
DIB001387	AST-120	Irritable bowel syndrome	564.1	K58
DIB001388	VLIM-88	Acute myeloid leukemia	205	C92.0
DIB001389	EDG-004	Generalized anxiety disorder	300.02	F41.1
DIB001390	Gram positive antibacterials	MRSA infection	.	B95.62
DIB001391	Vasonex CR	Congestive heart failure	428	I50
DIB001392	Talotrexin	Solid tumours	.	C00-C75,C7A,C7B
DIB001393	Hl-con1	Macular degeneration	.	H35.3
DIB001394	FCE-28161	Cancer	140-229	C00-C96
DIB001395	EDP-13	Cancer	140-229	C00-C96
DIB001396	SAFINGOL	Psoriasis	696	L40
DIB001397	Lanoconazole	Dermatological disease	.	L00-L99
DIB001398	Ertumaxomab	Breast cancer	174, 175, 217	C50, D24
DIB001399	Aponidin	Autoimmune diseases	279.4	D84.9, M35.9
DIB001400	Spheramine	Parkinson's disease	332	F02.3, G20
DIB001401	AC-0523	Huntington's disease	.	F02.2,G10
DIB001402	AC-170	Allergic conjunctivitis	372.14	H10.45
DIB001403	INO-8875	Glaucoma	365	H40-H42
DIB001404	Undisclosed compounds	Metabolic disorders	.	E70-E90
DIB001405	PF-04895162	Epilepsy	345	G40
DIB001406	Adaphostin	Chronic myelogenous leukemia	205.1	C92.1
DIB001407	Qb-Feld 1	Allergy	995.3	T78.4
DIB001408	AWD-140-190	Epileptic seizure	.	G40,R56
DIB001409	SEL-120	Cancer	140-229	C00-C96
DIB001410	GR-45809	Pain	338,780	R52, G89
DIB001411	SL-90.0571	Epilepsy	345	G40
DIB001412	Gamma-glutamyl transpeptidase inhibitors	Discovery agent	.	.
DIB001413	ENDG-6010	Dementia	290-294	F01-F07
DIB001414	GR-1655 complex	Fungal infection	.	B35-B49
DIB001415	ZYGK-1	Diabetes mellitus	250	E08-E13
DIB001416	XG-5XX	Viral infections	042-075	A80-A99, B00-B34
DIB001417	TDI-0010	Motor neurone disease	335.2	G12.2
DIB001418	SX-HIV1	Retrovirus infection	.	B33.3
DIB001419	LEE011	Cancer	.	C00-C97
DIB001420	N-substituted amino-benzamides	Epilepsy	345	G40
DIB001421	LT-ZP001	Obesity	278	E66
DIB001422	SB-1	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB001423	DNA vaccine	Prostate tumor	185	C61
DIB001424	SV-BR-1-GM	Cancer	140-229	C00-C96
DIB001425	Double mutant heat-labile toxin	Escherichia coli infection	.	A00-B99
DIB001426	HGH	Growth disorder	.	E23.0
DIB001427	XN-05	Cancer	140-229	C00-C96
DIB001428	Integrin-linked kinase inhibitors	Cancer	.	C00-C97
DIB001429	Non-nucleoside compounds	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001430	Hepatitis B gene therapy	Hepatitis B virus infection	.	B16
DIB001431	C-Vaxin	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001432	IMGN-009	Cancer	140-229	C00-C96
DIB001433	Thioredoxin reductase inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB001434	Merozoite surface protein 3 long synthetic peptide vaccine	Plasmodium infection	.	B54
DIB001435	THRX-198321	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001436	Enterotoxigenic E coli vaccine	Diarrhea	.	A09,K59.1
DIB001437	MPC-0767	Cancer	140-229	C00-C96
DIB001438	Flobufen	Rheumatold arthritis	.	M05-M06
DIB001439	Protein kinase inhibitors	Alzheimer's disease	331	G30
DIB001440	PYM-60001	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB001441	ET-005	Acquired hemolytic anemia	.	D59.9
DIB001442	NSC-631570	Cancer	.	C00-C97
DIB001443	New biologic entity	Cancer	.	C00-C97
DIB001444	BCH-371	HIV infections	42	B20
DIB001445	S-1033	Glaucoma	365	H40-H42
DIB001446	Neridronate	Bone disease	.	M00-M99
DIB001447	Z-6568	Hypertension	401	I10, I11, I12, I13, I15
DIB001448	Morniflumate	Otitis media	.	H65-H67
DIB001449	GIDAZEPAM	Anxiety disorder	300	F40-F42
DIB001450	Pancrecarb	Pancreatic disease	.	K85-K86
DIB001451	FP-21399	HIV infections	42	B20
DIB001452	Aurora A kinase inhibitors	Cancer	140-229	C00-C96
DIB001453	Unsaturated long chain fatty acids	Multiple sclerosis	340	G35
DIB001454	Cyclocreatine	Viral infections	042-075	A80-A99, B00-B34
DIB001455	STAMP	Dental caries	521	K02
DIB001456	Pentaerythritol tetranitrate	Angina	413	I20
DIB001457	Non-nucleoside HIV-1 reverse transcriptase inhibitors,	HIV infections	42	B20
DIB001458	FR-104	Autoimmune diseases	279.4	D84.9, M35.9
DIB001459	ACP-319	Chronic lymphocytic leukemia	204.1	C91.1
DIB001460	PV903	Infertility	.	N46,N97.0
DIB001461	Molsidomine	Angina	413	I20
DIB001462	EX-1314	Cachexia	799.4	R64
DIB001463	RBx-2258	Prostate hyperplasia	.	N40
DIB001464	TAK-003	Dengue	61	A90
DIB001465	AD-p53 gene therapy	Colorectal cancer	.	C18-C20,C21
DIB001466	SC-51316	Hypertension	401	I10, I11, I12, I13, I15
DIB001467	SP-SAP	Cancer pain	338,780	R52, G89
DIB001468	EVT-501	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB001469	Cystatin C	Alzheimer's disease	331	G30
DIB001470	Alpha selective PI3K inhibitors	Cancer	140-229	C00-C96
DIB001471	MRKAd5/ALVAC	HIV infections	42	B20
DIB001472	Recombinant L-asparaginase	Acute lymphoblastic leukemia	204	C91.0
DIB001473	Zohydro ER	Pain	.	G89
DIB001474	Norwalk EPVaccine	Norwalk virus infection	.	A08
DIB001475	Anti-WT-1 cancer vaccine	Leukemia	.	C91-C95
DIB001476	Strontium-89	Pain	338,780	R52, G89
DIB001477	SOM-0004	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001478	Minokine	Neurodegenerative diseases	.	G30-G32
DIB001479	BAY-Z-4305	HIV-1 infections	42	B20
DIB001480	Alpha-synuclein modulator	Parkinson's disease	.	G20
DIB001481	CRS-100	Liver cancer	155	C22.0
DIB001482	FX-141L	Inflammatory diseases	.	.
DIB001483	Anti-TSLP mAb	Asthma	493	J45
DIB001484	MDL-27192	Epileptic seizure	.	G40,R56
DIB001485	Farnesyl transferase inhibitors	Cancer	140-229	C00-C96
DIB001486	Sch-45752	Asthma	493	J45
DIB001487	MGN-8107	Motor neurone disease	335.2	G12.2
DIB001488	AA-204	Renal disease	.	N00-N29
DIB001489	ALX-25	Asthma	.	J45
DIB001490	Recombinant T-cell receptor ligand	Rheumatold arthritis	714	M05-M06
DIB001491	Neo-GAA	Pompe's disease	.	E74.02
DIB001492	Recombinant pollen hypoallergenic vaccine	Allergic rhinitis	477	J30
DIB001493	DWP-05195	Neuropathic pain	338,780	R52, G89
DIB001494	Histamine H3 antagonists	Obesity	278	E66
DIB001495	Fsn-0306	Cancer	.	C00-C97
DIB001496	LY-518674	Diabetes mellitus	.	E10-E14
DIB001497	IMM-101	Cancer	.	C00-C97
DIB001498	Clp protease inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001499	DNA alkylating agents	Cancer	140-229	C00-C96
DIB001500	Herpes simplex virus therapy	Herpes simplex virus infection	54	B00
DIB001501	7U85	Solid tumours	.	C00-C75,C7A,C7B
DIB001502	Calcium-activated small conductance potassium channel blockers	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB001503	Farnesoid X receptor antagonists	Liver disease	570-574	K70-K77
DIB001504	NGN-9076	Parkinson's disease	.	G20
DIB001505	Granzyme B inhibitors (aneurysm & dermatological disorders) viDA Therapeutics	Aneurysm	.	I72
DIB001506	AG-SFT103	Hypertension	401	I10, I11, I12, I13, I15
DIB001507	NF-kB pathway inhibitors	Cancer	140-229	C00-C96
DIB001508	Pumactant	Asthma	493	J45
DIB001509	Human recombinant protein	Wound healing	.	S91.3
DIB001510	AN-019	Chronic myelogenous leukemia	.	C92.1
DIB001511	NSD-551	Brain cancer	.	C71
DIB001512	AC-150	Allergic conjunctivitis	372.14	H10.45
DIB001513	Non-nucleoside reverse transcriptase inhibitors	HIV infections	42	B20
DIB001514	DNA vaccine	Colorectal cancer	.	C18-C20,C21
DIB001515	Immunosuppressant drug	Discovery agent	.	.
DIB001516	Edaglitazone	Diabetes mellitus type 2	.	E11
DIB001517	NAAG peptidase inhibitors	Brain injury	.	S09.90
DIB001518	Huntingtons disease therapy	Huntington's disease	.	F02.2,G10
DIB001519	LAM-111	Muscular dystrophy	.	G71.0
DIB001520	NVC-704	Conjunctivitis	372	H10
DIB001521	SGN-40	Lymphoma	.	C81-C96
DIB001522	DISC-CMV	Cytomegalovirus infection	.	B25
DIB001523	NI-1201	Autoimmune diseases	279.4	D84.9, M35.9
DIB001524	PF-4878691	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001525	IN0-3106	Squamous cell carcinoma of the head and neck	199	C44
DIB001526	Poly-ICR vaccine adjuvant	Keratosis	.	L57.0
DIB001527	BIWA 4	Cancer	.	C00-C97
DIB001528	TCN-202	Cytomegalovirus infection 	.	B25.9
DIB001529	Recombinant human lubricin	Osteoarthritis	715	M15-M19, M47
DIB001530	CD33-targeting BiTE antibodies	Myeloid leukemia	205	C92
DIB001531	Naveglitazar	Diabetes mellitus	.	E10-E14
DIB001532	Kv1.5 modulators	Atrial fibrillation	427.31	I48
DIB001533	LU-53439	Major depressive disorder	.	F32,F33
DIB001534	MAbs targeting PAR-1	Cancer	140-229	C00-C96
DIB001535	BFH-772	Psoriasis	696	L40
DIB001536	Hairpin RNA	Psoriasis	696	L40
DIB001537	KI-0502	Cancer	140-229	C00-C96
DIB001538	KN-203	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB001539	HIV-neutralizing VRC-01 mAb-stimulating vaccine	HIV infections	42	B20
DIB001540	Migis-mIgG	Autoimmune diseases	279.4	D84.9, M35.9
DIB001541	Melphalan flufenamide	Ovarian cancer	.	C56
DIB001542	PF-06480605	Crohn's disease	.	K50
DIB001543	SDZ-NKT-343	Pain	.	G89
DIB001544	TGF beta 2 receptor peptantagonists	Wound healing	.	S91.3
DIB001545	ViperaTAb	Poison intoxication	.	T36-T50
DIB001546	Glucocorticoid mimetics	Inflammatory diseases	.	.
DIB001547	PF-4447943	Alzheimer's disease	.	G30,F00
DIB001548	C-Cure	Neuroblastoma	.	C74
DIB001549	Lu-AA21004	Mood disorder	.	F30-F39
DIB001550	Lm-Malaria	Plasmodium infection	.	B54
DIB001551	Raf protein kinase inhibitor	Polycystic kidney disease	753.1	Q61
DIB001552	Gene therapy	Cystic fibrosis	.	E84
DIB001553	Gene therapy	Transplant rejection	.	T86
DIB001554	Diclofenac	Pain	338,780	R52, G89
DIB001555	SLV-334	Brain injury	.	S09.90
DIB001556	Antroquinonol	Non-small-cell lung carcinoma	162	C33, C34
DIB001557	PI-166	Liver cancer	155	C22.0
DIB001558	Meningococcus B vaccine	Neisseria meningitidis infection	.	A87
DIB001559	CX-1942	Sleep apnea	.	G47.3
DIB001560	DS-1150b	Type 2 diabetes	250.00, 250.02	E11
DIB001561	AP-301-IH	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB001562	ARI-3037M0	Dyslipidemia	272	E78
DIB001563	DIFLOMOTECAN	Solid tumours	.	C00-C75,C7A,C7B
DIB001564	NB-001	Multile sclerosis	.	G35
DIB001565	PI3Kdelta inhibitors	Cancer	.	C00-C97
DIB001566	P22-VLP	HIV infections	42	B20
DIB001567	AZD7624	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001568	DMD-02	Duchenne dystrophy	.	G71.0
DIB001569	Non-functioning P2X7 receptor antibodies	Skin cancers	.	C43-C44
DIB001570	Carbonic anhydrase activators	Attention deficit hyperactivity disorder	314	F90
DIB001571	BAY1125976	Cancer	.	C00-C97
DIB001572	SiRNA therapy	Age related macular degeneration	.	H35.30
DIB001573	JTT-811	Diabetic complication	.	E08-E13
DIB001574	EXISULIND	Colorectal cancer	.	C18-C20,C21
DIB001575	ICI-D-8731	Hypertension	401	I10, I11, I12, I13, I15
DIB001576	Elpamotide	Biliary cancer	.	C22,C24
DIB001577	Prophylactic Japanese encephalitis vaccine	Japanese encephalitis virus infection	.	A83.0
DIB001578	Fluorovinyloxyacetamide anti-inflammatory drugs	Neurodegenerative diseases	.	G30-G32
DIB001579	H1N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB001580	PDM-08	Cancer	.	C00-C97
DIB001581	SLIT TR-03	Lung cancer	162	C33-C34
DIB001582	MKT-077	Solid tumours	.	C00-C75,C7A,C7B
DIB001583	CG-400549	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB001584	BetaGRAFT	Diabetes mellitus	250	E08-E13
DIB001585	Human liver-engrafting cells	Liver disease	570-574	K70-K77
DIB001586	Tyrosine kinase receptor modulator	Rheumatold arthritis	714	M05-M06
DIB001587	SBP-002	Melanoma	.	C43
DIB001588	SQ-28603	Hypertension	401	I10, I11, I12, I13, I15
DIB001589	RED-183003	Cancer	140-229	C00-C96
DIB001590	Liposomal disintergrin	Cancer	140-229	C00-C96
DIB001591	FO-152	Cancer	140-229	C00-C96
DIB001592	Dimerescent receptors	Hematological disease	.	D50-D89
DIB001593	TRV027	Heart failure	.	I50
DIB001594	Pramiracetam	Brain diseases	.	G00-G99
DIB001595	S-9788	Cancer	140-229	C00-C96
DIB001596	Sepsis therapy	Sepsis	995.91	A40, A41
DIB001597	Recombinant human alkaline phosphatase	Ulcerative colitis	556	K51
DIB001598	Aom-0925	Diabetes mellitus	250	E08-E13
DIB001599	T-588	Amyotrophic lateral sclerosis	335.2	G12.2
DIB001600	YD-101	Arthritis	710-719	M00-M25
DIB001601	Cyclosporin A analogs	Asthma	493	J45
DIB001602	CVBT-141B	Wound healing	.	T14.0-T14.1
DIB001603	AZETIRELIN	Pain	.	G89
DIB001604	KBSA-302	Staphylococcus aureus infection	001-139	A00-B99
DIB001605	Anti-HBs human mAb	Hepatitis B virus infection	.	B16
DIB001606	Bone marrow stem cell therapy	Ischemic heart diseases	410-414	I20-I25
DIB001607	Bcl-2 protein modulators	Cancer	140-229	C00-C96
DIB001608	DC-SIGN antagonists	Infectious disease	001-139	A00-B99
DIB001609	IL-2/CD80 expressing autologous whole cell vaccine	Leukemia	208.9	C91-C95
DIB001610	MK-6105	Allergy	995.3	T78.4
DIB001611	Hematological disease agents	Hematological disease	.	D50-D89
DIB001612	JDP-201	Allergy	995.3	T78.4
DIB001613	3C23K	Cancer	140-229	C00-C96
DIB001614	Jak2 inhibitors	Cancer	140-229	C00-C96
DIB001615	UMN-03	Metabolic disorders	.	E70-E90
DIB001616	Anti-VEGFR 1 mAb	Discovery agent	.	.
DIB001617	Tricyclic broad-spectrum metallo-beta-lactamase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001618	NPC-16570	Allergy	995.3	T78.4
DIB001619	NOX-D14	Inflammatory diseases	.	.
DIB001620	Asfotase alfa	Genetic disorder	.	Q00-Q99
DIB001621	PJJ-34	Cancer	140-229	C00-C96
DIB001622	2LM20-4	Autoimmune diseases	279.4	D84.9, M35.9
DIB001623	PF-06650833	Lupus	710	M32
DIB001624	D-20133	Cancer	140-229	C00-C96
DIB001625	OB-cadherin antagonists	Metastasis	.	C00-C97
DIB001626	TBC-11040	Hypertension	401	I10, I11, I12, I13, I15
DIB001627	Recombinant acidic fibroblast growth factor	Skin burns	940-949	T20-T31
DIB001628	Lysosomal acid lipase	Atherosclerosis	414.0, 440	I70
DIB001629	PND-1186	Cancer	140-229	C00-C96
DIB001630	DE-074	Corneal disease	.	H15-H22
DIB001631	VSN-16R	Muscle spasm	.	M62.838
DIB001632	ASB formulation	Cocaine addiction	304.2	F14.2
DIB001633	Tetrahydrouridine	Solid tumours	.	C00-C75,C7A,C7B
DIB001634	CX-1030	Immune disorder	.	D80-D89
DIB001635	THF carbapenems	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001636	JZP-3	Anxiety disorder	300	F40-F42
DIB001637	PPRT-321	Prostate hyperplasia	.	N40
DIB001638	OP-2507	Hypertension	401	I10, I11, I12, I13, I15
DIB001639	KAR-1880	Dermatitis	692.9	L20-L30
DIB001640	HGS-TR2J	Cancer	140-229	C00-C96
DIB001641	AZD-3342	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001642	Aleplasinin	Alzheimer's disease	331	G30
DIB001643	HYG-202	Discovery agent	.	.
DIB001644	DNA intercalators	Cancer	140-229	C00-C96
DIB001645	NC-2500	Hyperuricemia	790.6	E79.0
DIB001646	Ghrelin antagonists	Metabolic disorders	.	E70-E90
DIB001647	NGP-X004	Leukopenia	.	D72.819
DIB001648	KD020	Kidney disorders	.	N00-N39
DIB001649	Zemab	Cancer	140-229	C00-C96
DIB001650	VTN-706	Cancer	140-229	C00-C96
DIB001651	1-TDC	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001652	DORANIDAZOLE	Cancer	140-229	C00-C96
DIB001653	FK-888	Migraine	.	G43
DIB001654	TP-834	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001655	GPCR modulators	Discovery agent	.	.
DIB001656	ADCON(R)	Wound healing	.	S91.3
DIB001657	P21-activated kinase inhibitors	Cancer	.	C00-C97
DIB001658	Parkinson's disease therapy	Parkinson's disease	.	G20
DIB001659	Orexin analog	Eating disorder	307.5	F50
DIB001660	DE-117	Glaucoma	365	H40-H42
DIB001661	Bicyclolide antibiotics	Bacterial respiratory tract infection	.	J13,J15
DIB001662	Vericigiuat	Heart failure	.	I50
DIB001663	AZD-4121	Lipid metabolism disorder	.	E75-E78
DIB001664	PRS-211375 iv	Pain	.	G89
DIB001665	VGX-200	Cancer	140-229	C00-C96
DIB001666	111In-OC-125 F(ab1/2)-DTPA	Ovarian cancer	.	C56
DIB001667	Ypeginterferon alfa-2b	Hepatitis B virus infection	.	B16
DIB001668	Anti-inflammatories	Inflammatory diseases	.	.
DIB001669	Antibody	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB001670	SR-26831	Rheumatold arthritis	714	M05-M06
DIB001671	Polysaccharide A	Inflammation	.	I20-I25
DIB001672	Antivirals	Respiratory syncytial virus 	79.6	B97.4
DIB001673	MEDI4920	Sjogren's syndrome	.	M35.0
DIB001674	CB2 activator	Osteoporosis	733	M80-M81
DIB001675	76Br-16alpha,17alpha-dioxolane progestin analogs (breast cancer), Washington University/University of Illinois	Breast cancer	174, 175, 217	C50, D24
DIB001676	OT-010	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB001677	Oral controlled-release therapy	Drug delivery platform	.	.
DIB001678	BCL-5	Diabetes mellitus	250	E08-E13
DIB001679	TJ-8023	Pain	338,780	R52, G89
DIB001680	AlleVax	Allergy	995.3	T78.4
DIB001681	AL-60371	Small-cell lung cancer	.	C34.90
DIB001682	Tasisulam	Acute myeloid leukemia	205	C92.0
DIB001683	PRS-050	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB001684	DRL-21994	Lipid metabolism disorder	.	E75-E78
DIB001685	99mTc-fanolesomab	Appendicitis	.	K35
DIB001686	P53-MDM2 protein interaction inhibitors	Cancer	140-229	C00-C96
DIB001687	Tolterodine tartrate	Overactive bladder disorder	596.51	N32.81
DIB001688	SL-11093	Cancer	140-229	C00-C96
DIB001689	Polatuzumab vedotin	Diffuse large b-cell lymphoma	.	C83.3
DIB001690	PV-707	Skin burns	940-949	T20-T31
DIB001691	Peanut allergy desensitization vaccine	Hypersensitivity	.	T78.4
DIB001692	EPC-K1	Nerve injury	.	T14.4
DIB001693	Antisense oligonucleotides	Huntington's disease	.	F02.2,G10
DIB001694	Tau protein modulator	Neurodegenerative diseases	.	G30-G32
DIB001695	Ethiodized oil	Lymphatic disease	.	I89.8
DIB001696	Biodefense vaccine	Infectious disease	001-139	A00-B99
DIB001697	Phosphopantethiene adenyltransferase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001698	NS5B inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001699	Antral	Hepatitis virus infection	573.3	K75.9
DIB001700	Vaccine	Flavivirus infection	.	A86
DIB001701	G-CSF	Leukemia	208.9	C91-C95
DIB001702	InterveXin-PCP	Drug dependence	303-304	F10.2-F19.2
DIB001703	2-MOE phosphorothioate gapmers (myotonic dystrophy), Genzyme/Isis Pharmaceuticals	Myotonic dystrophy	.	G71.1
DIB001704	Demobesin	Breast cancer	174, 175, 217	C50, D24
DIB001705	XB-947	Solid tumours	.	C00-C75,C7A,C7B
DIB001706	Beraprost 314d	Epilepsy	345	G40
DIB001707	NPC-17923	Rheumatold arthritis	714	M05-M06
DIB001708	NMDA NR1 vaccine	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001709	Selective mTOR inhibitors	Cancer	140-229	C00-C96
DIB001710	Tolonium chloride	Cancer	.	C00-C97
DIB001711	PEK fusion protein vaccine	Cervical cancer	.	C53
DIB001712	NS-9	Liver cancer	155	C22.0
DIB001713	DES-6	Cytomegalovirus infection	.	B25
DIB001714	ELND-007	Alzheimer's disease	.	G30,F00
DIB001715	NVB-302	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB001716	AE-IG	Genetic disease	.	Z15
DIB001717	Anti-ALK antibody	Cancer	140-229	C00-C96
DIB001718	Chemopreventive	Bladder cancer	188	C67
DIB001719	GPD-1116	Asthma	.	J45
DIB001720	Mesenchymal precursor cell product	Type 2 diabetes	250.00, 250.02	E11
DIB001721	Staphguard	Staphylococcus aureus infection	001-139	A00-B99
DIB001722	VEGF121-rGel	Cancer	140-229	C00-C96
DIB001723	NOX-A12	Macular degeneration	.	H35.3
DIB001724	AKB-4924	MRSA infection	.	B95.62
DIB001725	HTU-PA	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001726	VP-20621	Multiple sclerosis	340	G35
DIB001727	PDE10 inhibitors	Schizophrenia	295	F20
DIB001728	Fully human monoclonal antibody 5-B1	Cancer	140-229	C00-C96
DIB001729	Latrunculin B	Glaucoma	365	H40-H42
DIB001730	TAN-876A	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001731	Anti-IL-23 immunotherapy	Inflammatory diseases	.	.
DIB001732	RNF43-721	Colorectal cancer	.	C18-C20,C21
DIB001733	97-139	Cerebrovascular disorders	.	I60-I69
DIB001734	Flosequinan	Cardiovascular disease	390-459	I00-I99
DIB001735	ICAM-5 modulator	Neurological disease	.	G00-G99
DIB001736	CD-349	Hypertension	401	I10, I11, I12, I13, I15
DIB001737	Formoterol Modulite	Asthma	493	J45
DIB001738	CPG-603	Atherosclerosis	414.0, 440	I70
DIB001739	FP-187	Autoimmune diseases	279.4	D84.9, M35.9
DIB001740	Nerve growth factor	Alzheimer's disease	.	G30,F00
DIB001741	TG-3030	Nicotine dependence	305.1	F17
DIB001742	ADE-CRAN	Wound healing	.	S91.3
DIB001743	CXCR4 receptor antagonists	HIV-1 infections	42	B20
DIB001744	RLP-068	Fungal infection	.	B35-B49
DIB001745	Antimalarials	Plasmodium infection	.	B54
DIB001746	SGN-30	Cancer	.	C00-C97
DIB001747	Ezatiostat analogs	Leukemia	.	C91-C95
DIB001748	MAR-701	Diabetes mellitus type 2	.	E11
DIB001749	AG-120	Hematological malignancies	.	C81-C96
DIB001750	VDA-1124	Aortic aneurysm	.	I71
DIB001751	T-115 analogs	Cancer	140-229	C00-C96
DIB001752	Metabolic disease program	Metabolic disorders	.	E70-E90
DIB001753	Anti-estrogens	Breast cancer	174, 175, 217	C50, D24
DIB001754	AMR-103	Parkinson's disease	.	G20
DIB001755	SYT inhibitors	Inflammatory diseases	.	.
DIB001756	T-25 series	Inflammatory diseases	.	.
DIB001757	DM-107	Atopic dermatitis	691.8	L20
DIB001758	Adva-33c	Cancer	140-229	C00-C96
DIB001759	Autologous dendritic cell vaccine	Glioblastoma	.	C71
DIB001760	ChimeriVax-West Nile	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB001761	NPB-2	Cancer	140-229	C00-C96
DIB001762	SX-MTR1	Bladder cancer	188	C67
DIB001763	Binodenoson	Hypertension	.	I10-I15
DIB001764	INP-01	Pain	338,780	R52, G89
DIB001765	Ragweed pollen extract	Allergic reaction	995.3	T78.4
DIB001766	SRI-7755	HIV infections	42	B20
DIB001767	PF-06273588	Discovery agent	.	.
DIB001768	Erythropoietin	Anemia	280-285	D50-D64
DIB001769	Gene therapy	Hearing disorder	.	H90.5
DIB001770	IN0-3112	Cervical cancer	.	C53
DIB001771	Herpes simplex virus therapy	Herpes simplex virus infection	54	B00
DIB001772	Cyclosporine A	Transplant rejection	.	T86
DIB001773	BMY-30123	Acne vulgaris	706.1	L70.0
DIB001774	E-1210	Fungal infection	.	B35-B49
DIB001775	Cell transplant	Muscular dystrophy	.	G71.0
DIB001776	HuCAL-derived fully human antibodies	Cancer	.	C00-C97
DIB001777	Modified CCR5-transduced autologous hematopoietic stem cells	HIV infections	42	B20
DIB001778	GPIba targeting mAbs	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001779	HCV protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB001780	TAK-233	Pheumatoid arthritis	.	.
DIB001781	TV-45070	Osteoarthritis	.	M19.90
DIB001782	Eperisone	Muscle spasm	.	M62.838
DIB001783	FIDUXOSIN HYDROCHLORIDE	Prostate disease	.	N42.9
DIB001784	Stroke therapy	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001785	Lexacalcitol	Cancer	.	C00-C97
DIB001786	CD-554	Atopic dermatitis	.	L20
DIB001787	ZK-235253	Breast cancer	174, 175, 217	C50, D24
DIB001788	Ozenoxacin	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB001789	BIBX-1382	Chronic lymphocytic leukaemia	.	C91.1
DIB001790	MyeloXen	Multiple sclerosis	340	G35
DIB001791	AZD1979	Obesity	278	E66
DIB001792	AL-6802	Cancer	140-229	C00-C96
DIB001793	Brain-derived neurotrophic factor peptidomimetics	Rett syndrome	.	F84.2
DIB001794	Prostat	Prostate hyperplasia	.	N40
DIB001795	11C-AZD-2184	Alzheimer's disease	.	G30,F00
DIB001796	DA-8031	Premature ejaculation	302.75	F52.4
DIB001797	Dual Jak2/Hexim1 kinase inhibitors	HIV infections	42	B20
DIB001798	DasKloster 0028-01	Pulmonary fibrosis	515, 516.3	J84.1
DIB001799	SGB-1534	Hypotension	458, 796.3	I95
DIB001800	HBN-2	Neurological disease	.	G00-G99
DIB001801	ETX-1153b	MRSA infection	.	B95.62
DIB001802	AZD-5122	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001803	Pyrimidinone antibiotic	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001804	Trka antagonists	Neuropathic pain	338,780	R52, G89
DIB001805	Anticalin	Alzheimer's disease	331	G30
DIB001806	PD-143188	Psychotic disorders	.	F20-F29
DIB001807	AN-808	Alzheimer's disease	331	G30
DIB001808	CP-334479	Hypercholesterolemia	272	E78.0
DIB001809	Silicon-modified indomethacin	Arthritis	710-719	M00-M25
DIB001810	MicroRNA antagonists	Cancer	.	C00-C97
DIB001811	Recombinant human keratinocyte growth factor-2	Wound healing	.	T14.0-T14.1
DIB001812	UR-8267	Hypertension	401	I10, I11, I12, I13, I15
DIB001813	PRTT-200	Fibromyalgia	729.1	M79.7
DIB001814	MAb based Smo modulators	Cancer	140-229	C00-C96
DIB001815	F-2833	Atherosclerosis	414.0, 440	I70
DIB001816	BMS-183920	Hypertension	401	I10, I11, I12, I13, I15
DIB001817	ZD-7944	Asthma	493	J45
DIB001818	HC-PTP inhibitors	Wound healing	.	T14.0-T14.1
DIB001819	MDX-1140	Cancer	140-229	C00-C96
DIB001820	GM-602	Alzheimer's disease	331	G30
DIB001821	5-HT 2c receptor agonists (obesity/schizophrenia), Galenea	Obesity	278	E66
DIB001822	EM-703	Inflammatory diseases	.	.
DIB001823	GSK-1437173A	Malaria	84	B50-B54
DIB001824	2PX	Pain	.	G89
DIB001825	Anthrax monoclonal antibody therapy	Bacillus anthracis infection	.	A22
DIB001826	NC-190	Solid tumours	.	C00-C75,C7A,C7B
DIB001827	Filgrastim-SNDZ	Neutropenia	.	D70
DIB001828	Human and mouse gp100 DNA plasmid vaccines	Cancer	.	C00-C97
DIB001829	TNFcept	Rheumatold arthritis	714	M05-M06
DIB001830	Insulin-like growth factor 1 receptor modulator	Hepatocellular carcinoma	155	C22.0
DIB001831	Natural killer cell therapy	Multiple myeloma	203	C90.0
DIB001832	SRSS-022	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB001833	Menactra	Neisseria meningitidis infection	.	A87
DIB001834	PNU-142633	Migraine	346	G43
DIB001835	AD-177	Psoriasis	696	L40
DIB001836	SR-59026	Male sexual disorders	.	F52
DIB001837	SCH-42495	Hypotension	.	I95
DIB001838	MORAb-28	Cancer	.	C00-C97
DIB001839	PF-14	Pain	338,780	R52, G89
DIB001840	Pentacel	Bordetella pertussis infection	.	A37.0
DIB001841	S-3578	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001842	Hemoximer	Hypotension	.	I95
DIB001843	KW-6055	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB001844	AD-03	Alzheimer's disease	.	G30,F00
DIB001845	TGSC01AA(4)	Anxiety disorder	300	F40-F42
DIB001846	Fovepta	Infectious disease	001-139	A00-B99
DIB001847	SA3C	Cancer	140-229	C00-C96
DIB001848	BHQ-880	Multiple myeloma	.	C90.0
DIB001849	IL-21 receptor-targeted human monoclonal antibodies	Inflammatory diseases	.	.
DIB001850	Rofleponide	Allergic rhinitis	.	J30
DIB001851	JTV-803	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB001852	IRX-4310	Psoriasis	696	L40
DIB001853	R-102557	Fungal infection	.	B35-B49
DIB001854	Sustained release incrementally modified drug	Stomach ulcer	.	K25-K27
DIB001855	HPIV-1 vaccine	Parainfluenza virus infection	.	J12.2
DIB001856	AIC-292	HIV infections	42	B20
DIB001857	Microfibrillar collagen hemostat	Bleeding	.	R58
DIB001858	CreaVax-HCC	Hepatocellular carcinoma	155	C22.0
DIB001859	IGF-1 analogs	Diabetes mellitus	250	E08-E13
DIB001860	Small-molecule BNO69 inhibitors	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB001861	Thymocartin	Hodgkin's lymphoma	.	C81.9
DIB001862	SER-101	Congestive heart failure	428	I50
DIB001863	P38-alpha inhibitors	Inflammatory diseases	.	.
DIB001864	CAT-2003	Hypertriglyceridemia	.	E78.1,E78.2,E78.3
DIB001865	XEN-600 series	Iron overload	.	R79.0
DIB001866	PF-05105679	Pain	338,780	R52, G89
DIB001867	CKD-403	Cancer	140-229	C00-C96
DIB001868	EHT/AGN-0003	Neurodegenerative diseases	.	G30-G32
DIB001869	Genetically-engineered autologous hematopoietic stem cell therapy	Hurler syndrome	.	E76.01
DIB001870	MDX-1097	Hematological malignancies	.	C81-C96
DIB001871	Cholera EPVaccine	Vibrio cholerae infection	.	A00.0
DIB001872	Avian influenza vaccine	Influenza virus infections	487	J10, J11
DIB001873	Choline analogs	Neurological disease	.	G00-G99
DIB001874	BVF-247	Cardiovascular disease	390-459	I00-I99
DIB001875	CV-9201	Non-small-cell lung cancer	162	C33, C34
DIB001876	SRSA-360	Neuropathic pain	338,780	R52, G89
DIB001877	AEZS-131	Cancer	140-229	C00-C96
DIB001878	BOF-4272	Gout	.	M10
DIB001879	Integrin antagonists	Inflammatory diseases	.	.
DIB001880	House dust mite allergy vaccine	Allergic reaction	995.3	T78.4
DIB001881	Adenovirus 4-based vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB001882	Argyrin B	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001883	Live attenuated recombinant vaccine	Chikungunya virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
DIB001884	MDDR 323756	Cancer	140-229	C00-C96
DIB001885	AMPK activators	Diabetes mellitus	250	E08-E13
DIB001886	RhoA inhibitors	Bone disease	.	M00-M99
DIB001887	Anti-CD19 chimeric antigen receptor-expressing autologous T lymphocytes	Cancer	.	C00-C97
DIB001888	Diphtheria, tetanus, whole-cell pertussis vaccine	Bordetella pertussis infection	.	A37.0
DIB001889	Small molecule inhibitors	Metabolic syndrome X	277.7	E88.81
DIB001890	Recombinant anti-human-CD25 monoclonal antibody	Transplant rejection	.	T86
DIB001891	Human Alpha Antitrypsin	Genetic disorder	.	Q00-Q99
DIB001892	Hydrocodone bitartrate	Type 1 diabetes	250.01	E10
DIB001893	Resultz	Head lice	.	B85.0
DIB001894	PFKFB3 inhibitors	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB001895	CCR5 antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB001896	Nifurtimox	Trypanosomiasis	086.5-086	B56-B57
DIB001897	PMX-53	Atopic dermatitis	.	L20
DIB001898	Polyclonal antibodies	Mycobacterium tuberculosis infection	.	A15-A19
DIB001899	Interleukin-2 inducible tyrosine kinase inhibitors	Lymphoma	202.8	C81-C96
DIB001900	Influenza therapy	Influenza virus infections	487	J10, J11
DIB001901	GKT-04 program	Angiogenesis disorder	.	I00-I99
DIB001902	Targeted intracellular photodynamic therapy	Cancer	140-229	C00-C96
DIB001903	Comvac4-HB	Hepatitis B virus infection	.	B16
DIB001904	EP-5001	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB001905	OXY-111A	Cardiovascular disease	.	I00-I99
DIB001906	INA-115E	Cytomegalovirus infection	.	B25
DIB001907	PTSD therapy	Post traumatic stress disorder	.	F43.1
DIB001908	Rifaximin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001909	Gadodiamide	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB001910	OCM-7342	Breast cancer	174, 175, 217	C50, D24
DIB001911	SB-41947	Cancer	140-229	C00-C96
DIB001912	GW-695634	Human immunodeficiency virus infection	.	B20
DIB001913	ALD-401	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB001914	CY-1503	Hypertension	.	I10-I15
DIB001915	Org-9616	Anesthesia	338	R52
DIB001916	RX-5902	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB001917	Hsp 90 inhibitors	Cancer	140-229	C00-C96
DIB001918	ICI-198615	Asthma	493	J45
DIB001919	Anti-VEGFR2 CD8 cell therapy	Cancer	.	C00-C97
DIB001920	AGE inhibitors	Diabetic complication	.	E08-E13
DIB001921	Metallo-SAHA	Cancer	140-229	C00-C96
DIB001922	Sulukast	Asthma	.	J45
DIB001923	LTB4	Human immunodeficiency virus infection	.	B20
DIB001924	Nuvanil	Pain	.	G89
DIB001925	BMN-110	Morquio syndrome	.	E76.2
DIB001926	WIB-901H	Hyperlipidemia	272.0-272.4	E78
DIB001927	T-9001	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB001928	TG-0054	Macular degeneration	.	H35.3
DIB001929	WC-3018	Acne vulgaris	706.1	L70.0
DIB001930	SST-0001	Cancer	140-229	C00-C96
DIB001931	H-PGDS inhibitors	Allergy	995.3	T78.4
DIB001932	Antifungals	Fungal infection	.	B35-B49
DIB001933	FK-906	Hypertension	.	I10-I15
DIB001934	ZK-157348	Infertility	.	N46,N97.0
DIB001935	SQ-33600	Hyperlipidemia	.	E78.5
DIB001936	PIBROZELESIN HYDROCHLORIDE	Solid tumours	.	C00-C75,C7A,C7B
DIB001937	Vax-SPIRAL	Leptospiraceae infection	.	A69.20
DIB001938	F-1013	Cancer	.	C00-C97
DIB001939	XEN-D0104	Atrial fibrillation	427.31	I48
DIB001940	Recombinant hypoallergenic vaccine	Allergic rhinitis	477	J30
DIB001941	MVA3000	Viral infections	042-075	A80-A99, B00-B34
DIB001942	JCV-specific TCR a chains-CD3zeta fusion protein	Progressive multifocal leukoencephalopathy	.	A81.2
DIB001943	18F-fluoromethylallylcholine	Cancer	140-229	C00-C96
DIB001944	CP-126998	Alzheimer's disease	.	G30,F00
DIB001945	Inno-LC-01	Glioblastoma	191	C71
DIB001946	VR096	Inflammation	.	.
DIB001947	NN-1218	Diabetes mellitus	250	E08-E13
DIB001948	Cyt-1010	Pain	338,780	R52, G89
DIB001949	SB-366791	Pain	338,780	R52, G89
DIB001950	Mitonafide	Solid tumours	.	C00-C75,C7A,C7B
DIB001951	MK-3614	Hypertension	401	I10, I11, I12, I13, I15
DIB001952	Antivirals	HIV infections	42	B20
DIB001953	Modified PT1.2	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001954	Yeast-based malaria treatment	Plasmodium infection	.	B54
DIB001955	DTaP-Polio vaccine	Bordetella pertussis infection	.	A37.0
DIB001956	ZP-004	Cough	786.2	R05
DIB001957	CT-750 series	Pain	338,780	R52, G89
DIB001958	IPN-100	Respiratory syncytial virus 	79.6	B97.4
DIB001959	CZ-ON002 series	Cancer	140-229	C00-C96
DIB001960	CT-400P	Bone metastases	.	C79.51
DIB001961	Pleodrug	Peripheral neuropathy	.	G64
DIB001962	Alpha-glucosidase	Muscle disease	.	M60-M63
DIB001963	TGR-1202	Hematological malignancies	200-209	C81-C96
DIB001964	EG-016	Peripheral vascular disease	443.9	I73.9
DIB001965	X-072-NAB	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB001966	JNJ-42165279	Anxiety disorder	300	F40-F42
DIB001967	JBD-411	Plasmodium infection	.	B54
DIB001968	GT102-279	Hypercholesterolemia	272	E78.0
DIB001969	Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy	Cancer	140-229	C00-C96
DIB001970	Src kinase inhibitor	Colon cancer	153, 154	C18-C21
DIB001971	F-200	Ocular disease	.	H00-H59
DIB001972	HPPH photodynamic therapy	Cancer	.	C00-C97
DIB001973	Amyloid beta-protein inhibitors	Alzheimer's disease	331	G30
DIB001974	AMA1 binding peptide-based malaria vaccine	Plasmodium infection	.	B54
DIB001975	MIF antagonists	Cancer	.	C00-C97
DIB001976	SBC-014	Neutropenia	288	D70
DIB001977	Fullerene-encapsulated MRI imaging agents	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB001978	Talc	Pleural disease	.	J90
DIB001979	BAY-417307	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB001980	Neo-Kidney Augment	Type 2 diabetes	250.00, 250.02	E11
DIB001981	PPA-904	Acne vulgaris	706.1	L70.0
DIB001982	Beta cell-targeting mTCR program	Insulin dependent diabetes	.	E10
DIB001983	HKI-46F08	Cancer	140-229	C00-C96
DIB001984	C-102	Myasthenia gravis	358	G70.0
DIB001985	Trioxsalen	Vitiligo	709.01	L80
DIB001986	TILNOPROFEN ARBAMEL	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB001987	NV-04	Cardiovascular disease	390-459	I00-I99
DIB001988	SWC-312	Pulmonary hypertension	416	I27.0, I27.2
DIB001989	PRT-062607	Chronic lymphocytic leukaemia	.	C91.1
DIB001990	Lm Ft	Tularemia	.	A21.9
DIB001991	Micrurus fulvius antivenin	Poison intoxication	.	T36-T50
DIB001992	CM3.1-AC100	Diabetes mellitus	.	E10-E14
DIB001993	BU-32	Cancer	140-229	C00-C96
DIB001994	Tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB001995	SCP-1	Pain	338,780	R52, G89
DIB001996	AJI-9561	Cancer	140-229	C00-C96
DIB001997	PfPK7 inhibitors	Plasmodium falciparum infection	.	B54
DIB001998	99mTc-Demogastrin 2 (medullary thyroid cancer), Biomedica Life Sciences	Medullary thyroid cancer	193	C73
DIB001999	Human Factor XIII	Blood forming organ disorders	.	D75.9
DIB002000	NT-KO-003	Motor neurone disease	335.2	G12.2
DIB002001	L-DOS47	Lung cancer	162	C33-C34
DIB002002	TJ-960	Epilepsy	345	G40
DIB002003	PLECONARIL	Viral infections	042-075	A80-A99, B00-B34
DIB002004	SR-2566	Eczema	.	L20-L30
DIB002005	SPI-017	Alzheimer's disease	331	G30
DIB002006	SB-203347	Sepsis	.	A40-A41
DIB002007	HM-61713B	Cancer	140-229	C00-C96
DIB002008	Gene therapy	HIV infections	42	B20
DIB002009	MK-0963	Prostate disorder	.	N40-N42
DIB002010	CpG-10101	Hepatitis C virus infection	.	B17.1,B18.2
DIB002011	PI3K alpha inhibitors	Cancer	140-229	C00-C96
DIB002012	Pleodrug	Alzheimer's disease	331	G30
DIB002013	Rifalazil derivatives	Respiratory tract infections	460-519	J00-J99
DIB002014	Zabiciprilat	Hypertension	.	I10-I15
DIB002015	Bone marrow-derived stem cell therapy	Arthropathy	.	M00-M14
DIB002016	CP-778875	Lipid metabolism disorder	.	E75-E78
DIB002017	LADIRUBICIN	Breast cancer	.	C50
DIB002018	T2c-002	Peripheral arterial occlusive disease	.	I73.9
DIB002019	AFG-495	Osteoporosis	733	M80-M81
DIB002020	BiTe antibodies	Cancer	140-229	C00-C96
DIB002021	LECOZOTAN HYDROCHLORIDE	Cognitive impairment	.	F06.7
DIB002022	EF-13	Cancer	140-229	C00-C96
DIB002023	NEP inhibitors	Pain	338,780	R52, G89
DIB002024	RWJ-676070	Congestive heart failure	428, 428.0	I50
DIB002025	Matripase inhibitors	Metastasis	.	C00-C97
DIB002026	HP-011-101	Ulcer	531-534	K25-K27
DIB002027	BK-218	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB002028	PEG-Infergen	Hepatitis virus infection	573.3	K75.9
DIB002029	EC-2 peptide gene therapy	Cancer	140-229	C00-C96
DIB002030	Small molecule compounds	Cachexia	799.4	R64
DIB002031	Roclatan	Glaucoma	.	H40-H42
DIB002032	PRO-105	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DIB002033	Capsid assembly inhibitor	HIV-1 infections	42	B20
DIB002034	PSD-506	Overactive bladder disorder	596.51	N32.81
DIB002035	GSK-2251052	Urinary tract infections	.	N39.0
DIB002036	Tamiphosphor	Influenza virus infections	487	J10, J11
DIB002037	Vaccines	Cancer	.	C00-C97
DIB002038	PEV-8	Influenza virus infections	487	J10, J11
DIB002039	NS-2710	Anxiety disorder	.	F40-F42
DIB002040	Nicotinic acetylcholine receptor inhibitors	Nicotine dependence	305.1	F17
DIB002041	ZK-136796	Cancer	.	C00-C97
DIB002042	RWJ-58259	Restenosis	.	I51.89
DIB002043	Stem cell therapy	Metabolic disorders	.	E70-E90
DIB002044	BAY-Y-5959	Cardiovascular disease	.	I00-I99
DIB002045	Fibrinogen antagonists	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002046	PGX-5188	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB002047	INGN-234	Oral cavity cancer	.	C00-C08
DIB002048	CT-2657	HIV infections	42	B20
DIB002049	P1A	Toxicity	.	T36-T50,T51-T65
DIB002050	Vaccinia virus therapy	Melanoma	.	C43
DIB002051	TP-104	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002052	CDK inhibitors	Cancer	140-229	C00-C96
DIB002053	Helivax	Helicobacter pylori infection	.	B98
DIB002054	RTL-342m	Optic neuritis	.	H46
DIB002055	PARP inhibitor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002056	J5dLPS/OMP	Sepsis	.	A40-A41
DIB002057	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB002058	RG-12718	Gastric motility disorder	.	K22.4
DIB002059	Sodium taurocholate	Diabetes mellitus type 2	.	E11
DIB002060	IGN-101	Colorectal cancer	.	C18-C20,C21
DIB002061	4030W92	Pain	338	R52
DIB002062	AD5-10	Cancer	140-229	C00-C96
DIB002063	ImMucin	Multiple myeloma	.	C90.0
DIB002064	DX-2500	Ischemic heart diseases	.	I20-I25
DIB002065	Debio-0721	Discovery agent	.	.
DIB002066	RASV-Sp	Streptococcus pneumoniae infection	.	A00-B99
DIB002067	Trypanosomal cysteinyl protease inhibitors	Plasmodium falciparum infection	.	B54
DIB002068	BBT-015	Neutropenia	288	D70
DIB002069	Bimakalim	Angina	.	I20
DIB002070	LY-2409021	Diabetes mellitus type 2	.	E11
DIB002071	DIMS-0150	Ulcerative colitis	.	K51
DIB002072	AZD-7928	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB002073	TV1-Kidney-1	Renal cancer	189	C64
DIB002074	Sulindac derivatives	Cancer	.	C00-C97
DIB002075	L-ornithine phenylacetate	Acute liver failure	.	K72
DIB002076	PF-05241328	Pain	338,780	R52, G89
DIB002077	Novovac-M1	Melanoma	172	C43
DIB002078	Erythropoietin gene therapy	Anemia	280-285	D50-D64
DIB002079	PDE 4 inhibitors	Inflammatory diseases	.	.
DIB002080	MMR vaccine	Measles virus infection	.	B06.9
DIB002081	Goserelin acetate	Breast cancer	.	C50
DIB002082	Acetyl-CoA carboxylase inhibitors	Fungal infection	.	B35-B49
DIB002083	11C-MK-8278	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB002084	Olea europaea-containing vaccine	Allergic conjunctivitis	372.14	H10.45
DIB002085	NasoVAX	Bacillus anthracis infection	.	A22
DIB002086	MeningiVax	Neisseria meningitidis infection	.	A87
DIB002087	RG7882	Ovarian cancer	.	C56
DIB002088	VG-101	Menopause	.	N95.0
DIB002089	DeImmunized Abs	Colon cancer	153, 154	C18-C21
DIB002090	Ro-46-2005	Hypertension	401	I10, I11, I12, I13, I15
DIB002091	ALK inhibitors	Lymphoma	202.8	C81-C96
DIB002092	RWJ-46458	Hypertension	401	I10, I11, I12, I13, I15
DIB002093	ADC-1001	Inflammatory diseases	.	.
DIB002094	OX-NLA	Allergic rhinitis	477	J30
DIB002095	L-E	Acquired immune deficiency syndrome	.	B20
DIB002096	SDZ-267-489	Atherosclerosis	414.0, 440	I70
DIB002097	Docusate calcium	Constipation	564	K59.0
DIB002098	IDD-5	Colorectal cancer	153, 154	C18-C21
DIB002099	A-216546	Solid tumours	.	C00-C75,C7A,C7B
DIB002100	Adenosine A3 receptor modulators	Inflammatory diseases	.	.
DIB002101	GLUDOPA	Diuretic	.	Y54.5
DIB002102	Small-molecule anticancer compounds	Cancer	140-229	C00-C96
DIB002103	RP-49356	Hypertension	.	I10-I15
DIB002104	JTP-4761	Hypertension	401	I10, I11, I12, I13, I15
DIB002105	TRNA synthetase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002106	LY-210073	Asthma	.	J45
DIB002107	GX-110E	Hepatitis B virus infection	.	B16
DIB002108	DWE-01	Ulcer	531-534	K25-K27
DIB002109	MIF antagonists	Cancer	.	C00-C97
DIB002110	ZP-003	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB002111	Quinoline piperidines	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002112	17beta-Hydroxysteroid Dehydrogenase 1 inhibitors (breast cancer), ElexoPharma	Breast cancer	174, 175, 217	C50, D24
DIB002113	IPLl576092	Asthma	493	J45
DIB002114	Multivalent adenoviral vaccine	Yersinia infections	.	A20
DIB002115	Edotecarin	Gastric cancer	.	C16
DIB002116	Anti-MT1-MMP antibody	Age related macular degeneration	.	H35.30
DIB002117	2CVV	Cystic fibrosis	277	E84
DIB002118	T-2307	Mycoses	.	B49
DIB002119	GKT-137831	Fibrosis	.	L90.5
DIB002120	Prophylactic vaccine	Herpes simplex virus infection	54	B00
DIB002121	H-NOX proteins	Hypoxia	799.02	R09.02
DIB002122	Cathepsin F modulators	Autoimmune diseases	.	D84.9
DIB002123	CNS-3040	Schizophrenia	295	F20
DIB002124	A-74273	Hypertension	.	I10-I15
DIB002125	DLYE-5953A	Refractory solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002126	NO-containing nanoparticles	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB002127	PA-1806	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB002128	HIV-1 integrase inhibitors	HIV infections	42	B20
DIB002129	Anti-uPAR antibodies	Pancreatic cancer	.	C25
DIB002130	Aggrecanase-2 inhibitors	Osteoarthritis	715	M15-M19, M47
DIB002131	NNC-22-0031	Psychotic disorders	.	F20-F29
DIB002132	Shikimate kinase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002133	ABN-912	Asthma	.	J45
DIB002134	Drug 2862277	Acute lung injury	518	J80
DIB002135	Akt1 inhibitors	Cancer	140-229	C00-C96
DIB002136	Polymerized vaccine	Allergy	995.3	T78.4
DIB002137	SLV-322	Heart arrhythmia	.	I47-I49
DIB002138	HIV therapeutics	HIV infections	42	B20
DIB002139	Metoprolol succinate	Angina	413	I20
DIB002140	Anti-CD20 antibody	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB002141	HIF-1 inhibitors	Cancer	140-229	C00-C96
DIB002142	SCH-602539	Atherosclerosis	414.0, 440	I70
DIB002143	PRT-105	Poison intoxication	.	.
DIB002144	GW-278884	Colorectal cancer	153, 154	C18-C21
DIB002145	R-1065	Obesity	278	E66
DIB002146	31.1Chi	Cancer	140-229	C00-C96
DIB002147	CRTX-072	Cough	786.2	R05
DIB002148	FGI-106 series	Viral infections	042-075	A80-A99, B00-B34
DIB002149	Tiropramide	Pain	338,780	R52, G89
DIB002150	NC-4016	Cancer	.	C00-C97
DIB002151	New generation S pneumoniae vaccine	Meningitis	320-322	G00-G03
DIB002152	PG-102	Autoimmune diseases	.	D84.9
DIB002153	UTP compounds	Diagnosis	.	Y57.6
DIB002154	TTAC-0001	Cancer	140-229	C00-C96
DIB002155	SYM-006	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002156	YM-022	Gastrointestinal disease	.	K00-K93
DIB002157	SUN-0597	Allergic rhinitis	477	J30
DIB002158	KP-736	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB002159	GM-7050	Inflammatory diseases	.	.
DIB002160	LZ-8	Autoimmune diseases	279.4	D84.9, M35.9
DIB002161	AS-601811	Acne vulgaris	.	L70.0
DIB002162	Oncolysin S	Nervous system cancer	.	C72.9
DIB002163	CHR-5154	Inflammatory diseases	.	.
DIB002164	99mTc-Hynic-Annexin V	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB002165	Ad-4 vectored vaccine	HIV infections	42	B20
DIB002166	GP-3269	Convulsions	.	R56.0
DIB002167	AugmAb	Cancer	140-229	C00-C96
DIB002168	REV-576	Autoimmune diseases	.	D84.9
DIB002169	HPV E7/calreticulin DNA vaccine	Cancer	140-229	C00-C96
DIB002170	Chronic HBV infection therapy	Hepatitis B virus infection	.	B16
DIB002171	LB-10522	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002172	VEGF-2 gene therapy	Coronary artery disease	410-414, 429.2	I20-I25
DIB002173	ATL-104	Cancer	140-229	C00-C96
DIB002174	LED-209	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002175	Anti-PrP mAbs	Cancer	140-229	C00-C96
DIB002176	DRP-049	Fibrosis	709.2	L90.5
DIB002177	SQ-31727	Hypertension	.	I10-I15
DIB002178	Nu-2	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002179	GMI-1070	Asthma	.	J45
DIB002180	V930	Cancer	140-229	C00-C96
DIB002181	BRL-52656	Pain	.	G89
DIB002182	Antiparasitic agents	Plasmodium infection	.	B54
DIB002183	XR-3005	Colorectal cancer	.	C18-C20,C21
DIB002184	ACT-280778	Essential hypertension	401	I10, I11, I12, I13, I15
DIB002185	BIBX-79	Arteriosclerosis	.	I70
DIB002186	MIVOBULIN ISETHIONATE	Cancer	140-229	C00-C96
DIB002187	BCT-197	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB002188	CCR5 gene-disrupted autologous stem cell therapy	Lymphoma	202.8	C81-C96
DIB002189	Gastrin synthetic peptide antigen vaccine	Pancreatic cancer	.	C25
DIB002190	MEN-10207	Pain	338,780	R52, G89
DIB002191	SDZ-62-434	Solid tumours	.	C00-C75,C7A,C7B
DIB002192	TROP-2-targeted anti-CD74 siRNA	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002193	CNTO-3157	Asthma	493	J45
DIB002194	NKP-14	Cancer	140-229	C00-C96
DIB002195	Spirogermanium hydrochloride	Cancer	.	C00-C97
DIB002196	GS-497C	Lung cancer	162	C33-C34
DIB002197	RLIP76 protein	Sunburn	.	L55.9
DIB002198	Mesenchymal stem cell therapies	Osteoarthritis	715	M15-M19, M47
DIB002199	IGF-1R inhibitors	Cancer	140-229	C00-C96
DIB002200	Protein kinase inhibitor	Cancer	140-229	C00-C96
DIB002201	CYT003	Asthma	.	J45
DIB002202	NX-210	Spinal cord injuries	952	S14, S24, S34
DIB002203	Fas delta therapy	Transplant rejection	.	T86
DIB002204	NS1 gene-silencing siRNA nanoparticles	Respiratory syncytial virus 	79.6	B97.4
DIB002205	AGN-150998	Macular degeneration	.	H35.3
DIB002206	Transient receptor potential ion channel modulators	Hypertension	401	I10, I11, I12, I13, I15
DIB002207	Chemopreventive	Cancer	.	C00-C97
DIB002208	UFT	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002209	Mequitamium iodide	Asthma	493	J45
DIB002210	Antisense oligonucleotides	Cancer	140-229	C00-C96
DIB002211	Prostate cancer vaccine	Prostate tumor	185	C61
DIB002212	CBL0137	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DIB002213	KLS-0611	Xerophthalmia	.	E50.6-E50.7
DIB002214	RG-7594	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002215	Metabolic modulators	Metabolic disorders	.	E70-E90
DIB002216	CEP-427	Alzheimer's disease	.	G30,F00
DIB002217	Stem cell therapy	Spinal cord injuries	952	S14, S24, S34
DIB002218	CEP-32496	Cancer	.	C00-C97
DIB002219	Vaccine	Prostate tumor	185	C61
DIB002220	MK-3118	Fungal infection	.	B35-B49
DIB002221	OPN-501	Inflammatory bowel disease	555, 556	K50, K51
DIB002222	KR-33889	Myocardial infarction	410	I21, I22
DIB002223	Croconazole	Dermatological disease	.	L00-L99
DIB002224	MG-1104	Factor IX deficiency	.	D67
DIB002225	NT-CC-017	Neurodegenerative diseases	.	G30-G32
DIB002226	Anti-interleukin 3 antibody	Rheumatold arthritis	714	M05-M06
DIB002227	LB-102	Memory loss	.	F03
DIB002228	Ragweed allergy vaccine	Allergic rhinitis	477	J30
DIB002229	PDGF	Wound healing	.	T14.0-T14.1
DIB002230	Anti-Staphylococcus enterotoxin B hyperimmune globulin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002231	Recombinant human hepatocyte growth factor	Renal failure	.	N17-N19
DIB002232	BAY-39-9624	Osteoporosis	733	M80-M81
DIB002233	P53-HDM2 protein interaction inhibitors	Cancer	.	C00-C97
DIB002234	Abeta retroparticles	Alzheimer's disease	331	G30
DIB002235	RQ-00317076	Pain	338,780	R52, G89
DIB002236	HIV DNA vaccine	HIV infections	42	B20
DIB002237	Panavir I	HIV-1 infections	42	B20
DIB002238	Transglutaminase 2 inhibitors	Huntington's disease	.	F02.2,G10
DIB002239	Beta-Gly	Multiple sclerosis	340	G35
DIB002240	Mapracorat	Ocular disease	.	H00-H59
DIB002241	Protein-protein inhibitors	Alzheimer's disease	331	G30
DIB002242	Diphtheria/tetanus/pertussis vaccine	Bordetella pertussis infection	.	A37.0
DIB002243	Anti-inflammatory therapy	Inflammatory diseases	.	.
DIB002244	Peanut allergen therapeutic vaccine	Allergy	995.3	T78.4
DIB002245	Interferon alpha (topical)	Viral infections	042-075	A80-A99, B00-B34
DIB002246	HPP-851	Metabolic disorders	.	E70-E90
DIB002247	Very low dose (VLD) cyclobenzaprine	Fibromyalgia	729.1	M79.7
DIB002248	Gram positive antibacterials	Mycobacterium tuberculosis infection	.	A15-A19
DIB002249	VT-224	Inflammatory diseases	.	.
DIB002250	Alprazolam lingual spray	Anxiety disorder	300	F40-F42
DIB002251	ORG-34517	Depression	311	F32
DIB002252	Acipimox	Atherosclerosis	414.0, 440	I70
DIB002253	CR-002	Cystic fibrosis	277	E84
DIB002254	AVX-601	Cytomegalovirus infection	.	B25
DIB002255	Simotinib	Cancer	140-229	C00-C96
DIB002256	Iobitridol	Cancer	140-229	C00-C96
DIB002257	NTC-100	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002258	Antineoplaston-A5	Cancer	140-229	C00-C96
DIB002259	Anti-inflammatories	Mucositis	.	K00-K95
DIB002260	AZD-2098	Asthma	493	J45
DIB002261	FT-071	Fibrosis	709.2	L90.5
DIB002262	Aptamer therapeutics (systemic	Ocular disease	.	H00-H59
DIB002263	Tumor metabolism modulator	Cancer	140-229	C00-C96
DIB002264	PC-DAC:Insulin	Diabetes mellitus type 1	.	E10
DIB002265	Ormaplatin	Leukemia	.	C91-C95
DIB002266	Antibacterial compounds	Shigella infections	.	A03.9
DIB002267	Human placental growth factor 1-CVX-2000 monoclonal antibody conjugated therapeutic	Cancer	140-229	C00-C96
DIB002268	AZD-4992	Breast cancer	174, 175, 217	C50, D24
DIB002269	ASM-024	Asthma	493	J45
DIB002270	HF-0699	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002271	CS-0230 series	Cancer	140-229	C00-C96
DIB002272	MNX-100	Cancer	.	C00-C97
DIB002273	EncorStat	Corneal abrasion	.	S05.0
DIB002274	Kv1.1 potassium channel blockers	Neuropathy	.	G64,G90.0
DIB002275	MCP-1 antagonists	Inflammatory diseases	.	.
DIB002276	S0109	Mycobacterium tuberculosis infection	.	A15-A19
DIB002277	AMPE4L	Diabetes mellitus	250	E08-E13
DIB002278	Palinavir	HIV infections	42	B20
DIB002279	BCH-671	Cancer	140-229	C00-C96
DIB002280	C-RAF1 inhibitor	Cancer	140-229	C00-C96
DIB002281	V81444	Parkinson's disease	332	F02.3, G20
DIB002282	NSD-644	Neurological disease	320-359	G00-G99
DIB002283	MGX-006	Emesis	787	R11
DIB002284	DMP-811	Hypertension	401	I10, I11, I12, I13, I15
DIB002285	ON-01500 series	Cancer	.	C00-C97
DIB002286	NY-ESO-1/LAGE-1-specific T-cells	Sarcoma	.	C00-C75
DIB002287	Bradykinin B1 receptor antagonists	Pain	.	G89
DIB002288	LAF-389	Cancer	.	C00-C97
DIB002289	CJ-50300	Virus infection	.	B03
DIB002290	ME1100	Bacterial pneumonia infection	.	J13,J15
DIB002291	CEP-37251	Bone metastases	.	C79.51
DIB002292	VLP vaccines	Ebola virus infection	.	A98
DIB002293	AC-625	Hypertension	.	I10-I15
DIB002294	EOS-013	Retinitis pigmentosa	.	H35.5
DIB002295	PAN-22	Hepatocellular carcinoma	155	C22.0
DIB002296	Pyrazole series (malaria) DrexelMed/University of Washington/Medicines for Malaria Venture	Plasmodium falciparum infection	.	B54
DIB002297	AM-101	Tinnitus	.	H93.1
DIB002298	IGN523	Acute myeloid leukemia	205	C92.0
DIB002299	Topical etoricoxib	Osteoarthritis	715	M15-M19, M47
DIB002300	PI3K inhibitor	Cancer	140-229	C00-C96
DIB002301	SX5	Staphylococcus aureus infection	001-139	A00-B99
DIB002302	Aceclofenac	Inflammatory diseases	.	.
DIB002303	AMPA receptor modulator	Neurological disease	.	G00-G99
DIB002304	Allosteric GABA B receptor modulators	Anxiety disorder	300	F40-F42
DIB002305	Short ragweed pollen extracts	Allergic reaction	995.3	T78.4
DIB002306	Atiratecan	Colorectal cancer	.	C18-C20,C21
DIB002307	H3 receptor inverse agonists	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB002308	Anti-phosphatidylserine antibody	Viral infections	042-075	A80-A99, B00-B34
DIB002309	HDAC4 inhibtors	Huntington's disease	.	F02.2,G10
DIB002310	Lantibiotic-based recombinant protein	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002311	BCH-2687	Pain	.	G89
DIB002312	NS-1619	Asthma	.	J45
DIB002313	TULOPAFANT	Cardiac arrhythmias	.	I47-I49
DIB002314	DNA synthesis inhibitors	Plasmodium infection	.	B54
DIB002315	DWJ-205	Fungal infection	.	B35-B49
DIB002316	ITV-3	HIV infections	42	B20
DIB002317	Prussian blue	Metal intoxication	.	T56
DIB002318	Tifacogin	Sepsis	.	A40-A41
DIB002319	SSR-240612	Rheumatold arthritis	.	M05-M06
DIB002320	Low molecular weight heparin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB002321	BLX-155	Deep vein thrombosis	453.4	I80.2
DIB002322	Anticachexia therapeutic	Cachexia	799.4	R64
DIB002323	CDRI-99/411	Plasmodium infection	.	B54
DIB002324	AT13148	Solid tumours	.	C00-C75,C7A,C7B
DIB002325	PT-107	Sarcoma	.	C00-C75
DIB002326	Tilidine	Pain	338,780	R52, G89
DIB002327	CETP inhibitors	Atherosclerosis	414.0, 440	I70
DIB002328	Anthrax immune globulin therapy	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB002329	HGS-1029	Hematological malignancies	.	C81-C96
DIB002330	Vaxfectin plasmid DNA pandemic influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB002331	Nitrofurazone	Skin burns	940-949	T20-T31
DIB002332	MGB-101	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002333	NU-100	Multiple sclerosis	.	G35
DIB002334	CGP-57701	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002335	DM-204	Cancer	.	C00-C97
DIB002336	Burkholderia pseudomallei therapeutics	Melioidosis	.	A24.9
DIB002337	ANG-4011	Fibrosis	709.2	L90.5
DIB002338	Lentiviral gene therapy	Parkinson's disease	.	G20
DIB002339	RIG-200	Hypertension	.	I10-I15
DIB002340	ASP-3291	Ulcerative colitis	556	K51
DIB002341	GA-hGH	Cachexia	.	R64
DIB002342	HP-290	Parkinson's disease	.	G20
DIB002343	AF-802	Non-small cell lung cancer	.	C33-C34
DIB002344	CRAM 1-2	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB002345	BAY-X-7195	Asthma	.	J45
DIB002346	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB002347	Nox4 inhibitors	Cardiovascular disease	390-459	I00-I99
DIB002348	VP8 subunit rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB002349	TG4040 (MVA-HCV)	Hepatitis virus infection	573.3	K75.9
DIB002350	MK-6349	Non-insulin dependent diabetes	.	E11.9
DIB002351	Cx-602	Ischemic stroke	434.91	I61-I63
DIB002352	Oleylphosphocholine	Leishmania infection	.	B55.0
DIB002353	SARIPIDEM	Anxiety disorder	300	F40-F42
DIB002354	Metamizole	Fever	.	R50.9
DIB002355	Y-20024	Psychotic disorders	.	F20-F29
DIB002356	212-Pb-TCMC-trastuzumab	Cancer	140-229	C00-C96
DIB002357	SER-201	Cancer	140-229	C00-C96
DIB002358	SDZ-249482	Pain	338,780	R52, G89
DIB002359	Anti-N3pG-Abeta antibody	Alzheimer's disease	331	G30
DIB002360	Plasmid DNA vaccine	Chikungunya virus infection	.	A92.0
DIB002361	Org-9768	Depression	311	F32
DIB002362	SRSC-355	Neuropathic pain	338,780	R52, G89
DIB002363	Pseudomonas aeruginosa vaccine	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB002364	Oxidosqualene inhibitor	Hyperlipidemia	272.0-272.4	E78
DIB002365	ARX-618	Metabolic disorders	.	E70-E90
DIB002366	Imaging agent	Pancreatic cancer	.	C25
DIB002367	DX-619	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB002368	Respiratory disease program	Respiratory disease	.	J00-J99
DIB002369	Ad-5 vaccine	Herpes simplex virus infection	.	B00
DIB002370	HBF-0259	Hepatitis B virus infection	.	B16
DIB002371	Alpha synuclein inhibitors	Parkinson's disease	.	G20
DIB002372	ERC-1671	Lymphoma	.	C81-C96
DIB002373	MesoTarg	Pancreatic cancer	.	C25
DIB002374	KB-5359	Lipid metabolism disorder	.	E75-E78
DIB002375	Ropidoxuridine	Cancer	.	C00-C97
DIB002376	Rho kinase inhibitors	Cancer	.	C00-C97
DIB002377	KI-1003	Eating disorder	307.5	F50
DIB002378	VP20629	Friedreich's ataxia	334	G11.1
DIB002379	MPI-461359	HIV infections	42	B20
DIB002380	Folate binding protein-E39	Endometrial cancer	182	C54.1
DIB002381	Anti-allergy peptides	Allergy	995.3	T78.4
DIB002382	PH-80	Premenstrual syndrome	.	N94.3
DIB002383	GTx-822	Ocular disease	.	H00-H59
DIB002384	PMA-BB10	Cancer	.	C00-C97
DIB002385	Peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002386	ThermoStem	Metabolic disorders	.	E70-E90
DIB002387	NK-109	Solid tumours	.	C00-C75,C7A,C7B
DIB002388	RO-5126766	Cancer	.	C00-C97
DIB002389	Vasonex	Myocardial infarction	410	I21, I22
DIB002390	AGTC-0106	Alpha-1 antitrypsin deficiency	.	E88.0
DIB002391	ABP 501	Rheumatold arthritis	.	M05-M06
DIB002392	Tuberculosis therapeutics	Mycobacterium tuberculosis infection	.	A15-A19
DIB002393	Calcium channel blocker	Schistosomiasis	120	B65
DIB002394	Ultrase	Pancreatic disorders	.	K86.9
DIB002395	TgAAV-TNFR:Fc	Inflammatory disorders	.	.
DIB002396	Lentiviral RNAi therapy	HIV-1 infections	42	B20
DIB002397	DW-816	Hyperlipidemia	272.0-272.4	E78
DIB002398	DPI-201-106	Cardiovascular disease	390-459	I00-I99
DIB002399	Stapled peptides	Autoimmune diseases	279.4	D84.9, M35.9
DIB002400	UMN-01	Cancer	140-229	C00-C96
DIB002401	R-765	Non-insulin dependent diabetes	.	E11.9
DIB002402	AS-1402	Breast cancer	174, 175	C50
DIB002403	Trifenagrel	Inflammatory diseases	.	.
DIB002404	SLX-1016	Breast cancer	174, 175, 217	C50, D24
DIB002405	Diphtheria toxoid adsorbed	Corynebacterium diphtheriae infection	.	A36.9
DIB002406	UNI-rhIL-11	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB002407	Recombinant hypoallergenic vaccine	Allergy	995.3	T78.4
DIB002408	ReN-1820	Cystitis	.	N30
DIB002409	VLA-4 inhibitors	Asthma	493	J45
DIB002410	TR-4	Cancer	140-229	C00-C96
DIB002411	JX-2011	Prostate tumor	185	C61
DIB002412	MDDR 178925	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB002413	VAR-10300	Neurodegenerative diseases	.	G30-G32
DIB002414	Measles vaccine	Measles virus infection	.	B06.9
DIB002415	Isosteviol	Non-insulin dependent diabetes	.	E11.9
DIB002416	E-3309	Helicobacter pylori infection	41.86	B96.81
DIB002417	Parkinsons disease cell therapy	Parkinson's disease	.	G20
DIB002418	PHY-626	Cancer	.	C00-C97
DIB002419	Phylomers	Brain injury	.	S09.90
DIB002420	ABT-510	Solid tumours	.	C00-C75,C7A,C7B
DIB002421	Cat peptide allergy desensitization agent	Allergy	995.3	T78.4
DIB002422	PXL-01	Scar tissue	.	L00-L99
DIB002423	RP-66266	Angina	.	I20
DIB002424	CP-230821	Atherosclerosis	414.0, 440	I70
DIB002425	Co-60549	Anxiety disorder	300	F40-F42
DIB002426	TT-124	Blood clotting disorder	286	D65-D69
DIB002427	HL-022	Cancer	.	C00-C97
DIB002428	PG2-2000	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB002429	BC-7013	Skin infections	.	L00-L99
DIB002430	Ipoxyn	Ischemia	459.89	I99.8
DIB002431	Isoquinoline alkaloids	Cancer	140-229	C00-C96
DIB002432	SCIO-323	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002433	TARP peptide vaccines	Prostate tumor	185	C61
DIB002434	Ragweed pollen allergen sublingual immunotherapy	Allergy	995.3	T78.4
DIB002435	Insulin DNA therapeutic	Diabetes mellitus	250	E08-E13
DIB002436	RhMBL	Infectious disease	001-139	A00-B99
DIB002437	Camptothecin analogs	Cancer	140-229	C00-C96
DIB002438	RO-09-4889	Cancer	.	C00-C97
DIB002439	Delta selective PI3K inhibitors	Cancer	.	C00-C97
DIB002440	Malaria vaccine	Plasmodium falciparum infection	.	B54
DIB002441	Org-30850	Contraception	.	Z30
DIB002442	A-68930	Hypertension	.	I10-I15
DIB002443	SAR-106881	Peripheral arterial occlusive disease	.	I73.9
DIB002444	SAR-1118	Allergic conjunctivitis	.	H10.0
DIB002445	GPR182 antagonists	Pancreatic cancer	.	C25
DIB002446	Memory disorder therapy	Amnesia	.	F04
DIB002447	D-5519	Asthma	.	J45
DIB002448	Recombinant fusion protein TB vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB002449	Vaccine Immunomedics	Breast cancer	174, 175, 217	C50, D24
DIB002450	HMPL-002	Cancer	.	C00-C97
DIB002451	VLA-4 inhibitor	Inflammatory disorders	.	.
DIB002452	SSR-146977	Psychotic disorders	.	F20-F29
DIB002453	Very small embryonic-like stem cells	Glaucoma	365	H40-H42
DIB002454	R112	Allergic rhinitis	477	J30
DIB002455	GGTase inhibitors	Fungal infection	.	B35-B49
DIB002456	PV-701	Cancer	.	C00-C97
DIB002457	PL-225B	Cancer	140-229	C00-C96
DIB002458	Beta LT	Lymphoma	.	C81-C96
DIB002459	SUVN-507	Neurological disease	.	G00-G99
DIB002460	FR-149581	Hypertension	401	I10, I11, I12, I13, I15
DIB002461	Helicobacter pylori therapeutics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002462	Steroid hormone conjugates	Cachexia	.	R64
DIB002463	LA-419	Cardiovascular disease	390-459	I00-I99
DIB002464	ENDG-4010	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002465	Leukozene	Chronic lymphocytic leukaemia	204.1	C91.1
DIB002466	SAR-1118	Allergic conjunctivitis	.	H10.0
DIB002467	Oligonucleotides	HIV infections	42	B20
DIB002468	FGFR4 antisense oligonucleotides	Obesity	278	E66
DIB002469	SeV-amyloid beta RNA vaccine	Alzheimer's disease	331	G30
DIB002470	Anti-Factor VII siRNA	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB002471	Bucelipase alfa	Exocrine pancreatic insufficiency	.	K86.8
DIB002472	Neutrophil elastase inhibitors	Pulmonary disease	460-519	J00-J99
DIB002473	KM-391	Autism	299	F84.0
DIB002474	PF-610355	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB002475	CGM097	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB002476	MVA-BN	Ebola virus infection	.	A98
DIB002477	SD-560	Pulmonary fibrosis	515, 516.3	J84.1
DIB002478	Recombinant B-cell peptide vaccine	Allergy	995.3	T78.4
DIB002479	Cell cycle inhibitors	Cancer	140-229	C00-C96
DIB002480	Topical antimicrobial	Acne vulgaris	706.1	L70.0
DIB002481	HGT-2610	Leukodystrophy	.	E75.25
DIB002482	Pyriplatin	Cancer	140-229	C00-C96
DIB002483	PandyFlu	Influenza virus infections	487	J10, J11
DIB002484	WAY-123223	Heart arrhythmia	.	I47-I49
DIB002485	NK-611	Solid tumours	.	C00-C75,C7A,C7B
DIB002486	Encapsulated human islet allografts	Diabetes mellitus type 1	250	E10
DIB002487	Fusolin	Hepatitis B virus infection	.	B16
DIB002488	Yellow fever vaccine	Yellow fever virus infection	.	A95
DIB002489	JKB-122	Hepatitis virus infection	573.3	K75.9
DIB002490	Autologous fat-derived stem cell therapy	Cancer	.	C00-C97
DIB002491	AF-3473	Neuropathic pain	338,780	R52, G89
DIB002492	SWC-158	Neuropathic pain	338,780	R52, G89
DIB002493	S-1389	Heart arrhythmia	.	I47-I49
DIB002494	PD-AAV9	Parkinson's disease	.	G20
DIB002495	SRD-326	Raynaud's disease	.	I73.01
DIB002496	KP-303	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB002497	Bentazepam	Anxiety disorder	300	F40-F42
DIB002498	Antibacterial peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002499	HALOFUGINONE HYDROBROMIDE	Duchenne muscular dystrophy	.	G71.0
DIB002500	PDC-31	Dysmenorrhea	.	N94.4-N94.6
DIB002501	OPT-102	Cancer	140-229	C00-C96
DIB002502	R-803	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB002503	Dopamine receptor antagonist	Schizophrenia	295	F20
DIB002504	Pazopanib	Solid tumours	.	C00-C75,C7A,C7B
DIB002505	EBC-46	Cancer	.	C00-C97
DIB002506	EXP-991	Dementia	290-294	F01-F07
DIB002507	DS-1971	Pain	.	G89
DIB002508	CaMKII inhibitors	Inflammatory diseases	.	.
DIB002509	MK-0731	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002510	E-2609	Alzheimer's disease	.	G30,F00
DIB002511	MIF antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB002512	UTL-5g	Toxicity	.	T36-T50,T51-T65
DIB002513	Casein kinase I inhibitors	Cancer	140-229	C00-C96
DIB002514	Safflower seed-derived apolipoprotein A1	Cardiovascular disease	390-459	I00-I99
DIB002515	ARX-AHD	Breast cancer	174, 175, 217	C50, D24
DIB002516	HPMA-docetaxel conjugate	Cancer	140-229	C00-C96
DIB002517	Hyaluronan	Pancytopenia	.	D61.81
DIB002518	CTLA-4-XTEN	Rheumatold arthritis	714	M05-M06
DIB002519	Carmeseal	Fibrosis	709.2	L90.5
DIB002520	Leptin	Alzheimer's disease	331	G30
DIB002521	SARMs	Cancer	140-229	C00-C96
DIB002522	MBS-101C	Infectious disease	001-139	A00-B99
DIB002523	AS-013	Thrombosis	.	I80-I82
DIB002524	CPZEN-45	Mycobacterium tuberculosis infection	.	A15-A19
DIB002525	GR-194444	Sepsis	995.91	A40, A41
DIB002526	Ambasilide	Cardiac arrhythmias	.	I47-I49
DIB002527	Placental expanded stem cell therapy	Peripheral vascular disorders	.	I73.9
DIB002528	GCOL-201 series	Cancer	.	.
DIB002529	Carbol-fuchsin topical solution	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002530	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB002531	CP-118	Allergic rhinitis	477	J30
DIB002532	UCB-1277763	Inflammatory diseases	.	.
DIB002533	SD-101	Hepatitis C virus infection	.	B17.1,B18.2
DIB002534	S-2474	Rheumatold arthritis	.	M05-M06
DIB002535	PF-755616	Rheumatold arthritis	714	M05-M06
DIB002536	Centanamycin	Cancer	.	C00-C97
DIB002537	CSC-700008	Anxiety disorder	300	F40-F42
DIB002538	Antihistamine	Allergy	995.3	T78.4
DIB002539	Mesenchymal precursor cells	Inflammatory diseases	.	.
DIB002540	NPB-01	Pemphigoid	.	L12.0
DIB002541	A-3309	Lipid metabolism disorder	.	E75-E78
DIB002542	TPR-100-Rx	Pain	338,780	R52, G89
DIB002543	Nanoemulsion	Molluscum contagiosum infection	.	B08.1
DIB002544	M2eA universal influenza vaccine	Influenza virus infections	487	J10, J11
DIB002545	RDX-008	Hypernatremia	.	E87.0
DIB002546	CDX-1307	Bladder cancer	.	C67
DIB002547	Semparatide	Osteoporosis	.	M80-M81
DIB002548	R-1164	Osteoporosis	733	M80-M81
DIB002549	Sildenafil citrate	Erectile dysfunction	.	F52.2,N48.4
DIB002550	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB002551	JPH-101	Hyperphosphatemia	.	E83
DIB002552	EVax	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002553	BMS-986202	Idiopathic pulmonary fibrosis	.	J84.1
DIB002554	ZT-52537	Cognitive impairment	.	F06.7
DIB002555	MPL-containing Pollinex allergy desensitization vaccine	Malignant melanoma	172	C43
DIB002556	4'-GALACTOSYLLACTOSE	Hyperlipidemia	.	E78.5
DIB002557	Broad-spectrum antiviral	Rhinovirus infection	.	J20.6?
DIB002558	Recombinant house dust mite allergy desensitization injection	Allergy	995.3	T78.4
DIB002559	JTH-601	Prostate disease	.	N42.9
DIB002560	SSR-125180	Obesity	278	E66
DIB002561	PP2A stimulator	Alzheimer's disease	.	G30,F00
DIB002562	JNJ-40411813	Anxiety disorder	.	F40-F42
DIB002563	842166X	Pain	.	G89
DIB002564	Kv1.3 potassium channel inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB002565	CSL-412	Influenza virus infections	487	J10, J11
DIB002566	Amosulalol	Hypertension	401	I10, I11, I12, I13, I15
DIB002567	Alpha-C-galactosyl ceramide	Cancer	.	C00-C97
DIB002568	SR-146131	Obesity	278	E66
DIB002569	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB002570	EBV-related Hodgkin's disease vaccine	Hodgkin's lymphoma	.	C81.9
DIB002571	Platinum compounds	Cancer	140-229	C00-C96
DIB002572	Cancer-specific osteopontin-targeted monoclonal antibodies	Cancer	140-229	C00-C96
DIB002573	ASP-4058	Multiple sclerosis	340	G35
DIB002574	PT003 GFF	Crohn's disease	.	K50
DIB002575	Trodusquemine	Obesity	278	E66
DIB002576	SDZ-GLI-328	Genetic disorder	.	Q00-Q99
DIB002577	AT-101	Hemorrhagic dhock	.	R57.1
DIB002578	Aurograb	Staphylococcus aureus infection	001-139	A00-B99
DIB002579	Polo-like kinase 1 inhibitors	Cancer	140-229	C00-C96
DIB002580	Malaria vaccine	Plasmodium infection	.	B54
DIB002581	Vaccine	Hepatitis A virus infection	.	B15.9
DIB002582	PTI-421	Discovery agent	.	.
DIB002583	Tresperimus	Autoimmune diseases	279.4	D84.9, M35.9
DIB002584	CB-30865	Cancer	140-229	C00-C96
DIB002585	ST-669	Viral infections	042-075	A80-A99, B00-B34
DIB002586	ASP-2002	Ulcerative colitis	556	K51
DIB002587	Multi-targeted therapeutics	Cancer	140-229	C00-C96
DIB002588	Phosphate	Constipation	564	K59.0
DIB002589	Ad-OC-hsvTK/valacyclovir	Prostate tumor	185	C61
DIB002590	LPO-1010DR	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB002591	MGN-9103	Cardiac failure	.	I50
DIB002592	RNA-dependent protein kinase inhibitors	Metabolic disorders	.	E70-E90
DIB002593	Grass pollen-derived peptides	Allergic conjunctivitis	372.14	H10.45
DIB002594	FLU-v	Influenza virus infections	487	J10, J11
DIB002595	Adamantane analogs	HIV-1 infections	42	B20
DIB002596	RG7745	Infections disease	.	A00-B99
DIB002597	GM-CSF therapy	Cystic fibrosis	277	E84
DIB002598	NG-2	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB002599	GT-3021	Herpes simplex virus infection	.	B00
DIB002600	FR-121196	Alzheimer's disease	.	G30,F00
DIB002601	Recombinant human lymphotoxin alpha derivatives	Cancer	140-229	C00-C96
DIB002602	MG-111	Stomach ulcer	.	K25-K27
DIB002603	QBP1 mimetics	Huntington's disease	.	F02.2,G10
DIB002604	BRL-36378	Hypertension	.	I10-I15
DIB002605	Netupitant	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DIB002606	Gold-based cancer therapy	Cancer	140-229	C00-C96
DIB002607	Tyrophostins	Cancer	140-229	C00-C96
DIB002608	DX-2712	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB002609	DNA binding agents	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002610	NP-17	Alzheimer's disease	331	G30
DIB002611	Acetyl CoA carboxylase inhibitors	Obesity	278	E66
DIB002612	SAR-103168	Acute myeloid leukemia	205	C92.0
DIB002613	ABH001	Liver cancer	.	C22
DIB002614	Antibacterial DNA ligase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002615	DLO6002	Parkinson's disease	332	F02.3, G20
DIB002616	SiRNA inhibitors/polymeric nanoparticles	Prostate tumor	185	C61
DIB002617	Aviscumine	Cancer	.	C00-C97
DIB002618	HuMax-CD74	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002619	ACE-920	Escherichia coli infection	.	A00-B99
DIB002620	CXB-909	Neurodegenerative diseases	.	G30-G32
DIB002621	Anti-CEA designer T cell therapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002622	GSK-2302025A	Melanoma	172	C43
DIB002623	NS3 protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB002624	Gene therapy	Cancer	140-229	C00-C96
DIB002625	Drug delivery system	Gastrointestinal infection	.	A09.0
DIB002626	CD4/CD2 inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB002627	Oncolysin B	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB002628	Aganirsen	Genitourinary tract cancer	.	C67.9
DIB002629	SentoClone	Melanoma	172	C43
DIB002630	Gene therapy (BRCA 1) Megabios/Lilly	Breast cancer	174, 175, 217	C50, D24
DIB002631	Ketobemidone	Pain	338,780	R52, G89
DIB002632	BHT-3034	Myasthenia gravis	358	G70.0
DIB002633	Osteoblast cell therapy	Osteonecrosis	733.4	M87
DIB002634	Perillyl alcohol	Cancer	140-229	C00-C96
DIB002635	Y-27152	Angina	.	I20
DIB002636	Tramiprosate	Alzheimer's disease	.	G30,F00
DIB002637	AVI-6003	Marburg virus disease	78.89	A98.3
DIB002638	XM-323	Human immunodeficiency virus infection	.	B20
DIB002639	GS-9148	HIV infections	42	B20
DIB002640	TMC-310911	HIV disease immunotherapy	42	B20
DIB002641	RS-23597-190	Gastric motility disorder	.	K22.4
DIB002642	AS-1949490	Non-insulin dependent diabetes	.	E11.9
DIB002643	DE-105	Corneal disease	.	H15-H22
DIB002644	ICI-219623	Hypertension	401	I10, I11, I12, I13, I15
DIB002645	FM-303	Inflammatory bowel disease	555, 556	K50, K51
DIB002646	Surrobodies	Breast cancer	174, 175, 217	C50, D24
DIB002647	Anti-obesity program	Obesity	278	E66
DIB002648	Imagabalin	Generalized anxiety disorder	300.02	F41.1
DIB002649	INO-4885	Asthma	493	J45
DIB002650	Coal tar	Psoriasis	696	L40
DIB002651	Hepatitis C vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB002652	Milatuzumab-Fab-CEA-loaded dendritic cell vaccine	Cancer	140-229	C00-C96
DIB002653	Small molecule NSAIDs	Autoimmune diseases	279.4	D84.9, M35.9
DIB002654	GNE-652	Multiple myeloma	203	C90.0
DIB002655	PMX-30063 topical oral rinse	Oral mucositis	528	K12.3
DIB002656	Lilly-15	Cancer	140-229	C00-C96
DIB002657	Docusate	Constipation	564	K59.0
DIB002658	Endogenous human peptide LL-37	Wound healing	.	S91.3
DIB002659	Drug 1940029	Acne vulgaris	.	L70.0
DIB002660	TGF-alpha	Human immunodeficiency virus infection	.	B20
DIB002661	Beta-blocker	Glaucoma	365	H40-H42
DIB002662	Anti-CGEN-991 antibody	Ovarian cancer	.	C56
DIB002663	YF-476	Stomach ulcer	.	K25-K27
DIB002664	KT-362	Heart arrhythmia	.	I47-I49
DIB002665	GR-127607	Migraine	346	G43
DIB002666	Calcium dobesilate	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB002667	RG-7166	Major depressive disorder	296.2, 296.3	F32, F33
DIB002668	Varicella vaccine	Varicella zoster virus infections	.	B01,B02
DIB002669	FP-1302	Inflammatory diseases	.	.
DIB002670	KB-2683	Arthritic	710-719	M00-M25
DIB002671	Adult mesenchymal precursor stem cell therapy	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB002672	Ketoprofen transdermal patch	Pain	.	G89
DIB002673	Salmonella typhi vaccine	Salmonella infection	.	A02.9
DIB002674	Brain tumor vaccine	Brain cancer	191	C71
DIB002675	DT-310	Cancer	140-229	C00-C96
DIB002676	BIA-12	Cardiovascular disease	390-459	I00-I99
DIB002677	Human sulfur free MTAP inhibitors	Cancer	140-229	C00-C96
DIB002678	PMX-10098	Fungal infection	.	B35-B49
DIB002679	AZM-016	Diabetes mellitus type 2	.	E11
DIB002680	R-102444	Pancreatitis	.	K85,K86.0,K86.1
DIB002681	Peptide vaccines	Cancer	140-229	C00-C96
DIB002682	Levotofisopam	Anxiety disorder	300	F40-F42
DIB002683	Dermatological agents	Dermatitis	692.9	L20-L30
DIB002684	Tie-2 inhibitors	Cancer	140-229	C00-C96
DIB002685	SP-1000	Hypercholesterolemia	272	E78.0
DIB002686	18F-FEDAA-1106	Alzheimer's disease	.	G30,F00
DIB002687	RhH1.3	Acute myeloid leukemia	.	C92.0
DIB002688	Glutathionarsenoxide	HIV infections	42	B20
DIB002689	LM-CD45	Transplant rejection	.	T86
DIB002690	GC-2107	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB002691	Oligonucleotides	Hypertension	401	I10, I11, I12, I13, I15
DIB002692	P53 fusion protein	Liver cancer	155	C22.0
DIB002693	Glucokinase activators	Diabetes mellitus	250	E08-E13
DIB002694	Baminercept	Rheumatold arthritis	714	M05-M06
DIB002695	CARM1 inhibitors	Cancer	140-229	C00-C96
DIB002696	Concatameric TFNR1Ig therapy program	Discovery agent	.	.
DIB002697	Sabeluzole	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002698	Daunorubicin citrate liposome injection	Kaposi's sarcoma	.	C46.1
DIB002699	RPL-554	Allergic rhinitis	.	J30
DIB002700	ERK inhibitors	Cancer	140-229	C00-C96
DIB002701	Caracemide	Cancer	140-229	C00-C96
DIB002702	Dengue virus vaccine	Dengue	61	A90
DIB002703	Interleukin-2	Cancer	140-229	C00-C96
DIB002704	P2B-004	Cancer	140-229	C00-C96
DIB002705	TRPV1 siRNA	Ocular inflammation	.	H00-H59
DIB002706	SQ-34990	Cytomegalovirus infection	.	B25
DIB002707	SIV Factor IX gene therapy	Factor IX deficiency	.	D67
DIB002708	Cannabinoid receptor-1 antagonists	Liver disease	570-574	K70-K77
DIB002709	NCX-701	Pain	338,780	R52, G89
DIB002710	Immune globulin	Bacillus anthracis infection	.	A22
DIB002711	PNT-500	Cancer	140-229	C00-C96
DIB002712	FIV vectors	Factor VIII deficiency	.	D66
DIB002713	CEP-37250	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DIB002714	FluPro	Influenza virus infections	487	J10, J11
DIB002715	Isoxicam	Osteoarthritis	715	M15-M19, M47
DIB002716	MEN-B	Neisseria meningitidis infection	.	A87
DIB002717	IRX-02	Leukemia	208.9	C91-C95
DIB002718	111In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide (melanoma), NuView/University of New Mexico	Melanoma	172	C43
DIB002719	KUR-111	Bone disease	.	M00-M99
DIB002720	KK-505	Asthma	493	J45
DIB002721	Progenitor cell therapy	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB002722	TRM-115	Gastric ulcer	.	K25
DIB002723	Smallpox vaccine	Virus infection	.	B03
DIB002724	SUVN-504	Emesis	787	R11
DIB002725	Somatropin intranasal rhGH	Growth hormone deficiency	.	E23.0
DIB002726	HIV vaccine	HIV infections	42	B20
DIB002727	BMS-954561	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB002728	EMITEFUR	Solid tumours	.	C00-C75,C7A,C7B
DIB002729	TAK-259	Overactive bladder disorder	596.51	N32.81
DIB002730	HF-0420	Dementia	290-294	F01-F07
DIB002731	PTI-DX304	Discovery agent	.	.
DIB002732	SAR-650984	Hematological malignancies	.	C81-C96
DIB002733	WY-46016	Allergy	.	T78.4
DIB002734	Flurbiprofen sodium	Ocular inflammation	.	H00-H59
DIB002735	ADE-APTO	Wound healing	.	S91.3
DIB002736	Azaribine	Psoriasis	696	L40
DIB002737	SMND-309	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002738	Anthrax DNA vaccine	Anthrax	22	A22
DIB002739	R-7025	Hepatitis B virus infection	.	B16
DIB002740	Glycoprotein conjugated vaccine (meningococcal group B meningitis)	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002741	RGLP-1	Diabetes mellitus type 2	250	E11
DIB002742	PARP inhibitors	Cancer	.	C00-C97
DIB002743	OBI-1	Factor VIII deficiency	.	D66
DIB002744	N,N`-diacetyl-L-cystine	Immuno-modulator	.	D80-D89
DIB002745	BAOGONGTENG A	Glaucoma	365	H40-H42
DIB002746	HIV integrase inhibitors	HIV infections	42	B20
DIB002747	ATP-exclusionary kinase inhibitors	Cancer	140-229	C00-C96
DIB002748	PA-517	Autoimmune diseases	279.4	D84.9, M35.9
DIB002749	CLT-002	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB002750	PRO-055	Duchenne dystrophy	.	G71.0
DIB002751	UNBS-1450	Cancer	140-229	C00-C96
DIB002752	NP-003	Parkinson's disease	.	G20
DIB002753	Antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002754	ACI-24	Alzheimer's disease	.	G30,F00
DIB002755	Pegsunercept	Rheumatold arthritis	714	M05-M06
DIB002756	HG-1109	Cancer	.	C00-C97
DIB002757	B7-2/GM-CSF cancer gene therapy vaccine	Cancer	140-229	C00-C96
DIB002758	INTEGRA Artificial Skin	Skin burns	940-949	T20-T31
DIB002759	Cell-based TIV	Influenza virus infections	487	J10, J11
DIB002760	Altiratinib	Solid tumours	.	C00-C75,C7A,C7B
DIB002761	Bitolterol	Asthma	493	J45
DIB002762	Clomet	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002763	G-301	Prostate tumor	185	C61
DIB002764	E-1454	Gastrointestinal disease	.	K00-K93
DIB002765	GLP-1 analog	Non-insulin dependent diabetes	.	E11.9
DIB002766	CT-200	Cancer	140-229	C00-C96
DIB002767	HG-1141	Cancer	140-229	C00-C96
DIB002768	DNA vaccine	Marburg virus disease	78.89	A98.3
DIB002769	Enoticumab	Solid malignancies	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002770	SonoLysis Prolyse	Cerebral ischemia	459.89	I99.8
DIB002771	CLX-0900	Hyperlipidemia	.	E78.5
DIB002772	Ubiquitin conjugating enzyme (UBC) inhibitors	Cancer	.	C00-C97
DIB002773	L-N2	Acquired immune deficiency syndrome	.	B20
DIB002774	HL-038	Angina	413	I20
DIB002775	BIIB059	Lupus	.	M32
DIB002776	Rawsonol	Arteriosclerosis	.	I70
DIB002777	MOR-206	Cancer	140-229	C00-C96
DIB002778	MurD ligase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002779	MTOR inhibitors	Cancer	140-229	C00-C96
DIB002780	BL-1889	Pruritus	698	L29
DIB002781	CH-3442	Asthma	493	J45
DIB002782	Needle-free ETEC vaccine	Diarrhea	.	A09,K59.1
DIB002783	Cell therapies	Cancer	140-229	C00-C96
DIB002784	DNA vaccine	HIV infections	42	B20
DIB002785	Recombinant hypoallergenic vaccine	Allergy	995.3	T78.4
DIB002786	Eptacog alfa intravenous	Hemophilia	286	D66-D68
DIB002787	PL-6983	Female sexual dysfunction	302.7	F52, R37
DIB002788	Cyclolignan picropodophyllin	Colorectal cancer	.	C18-C20,C21
DIB002789	NV-196	Cancer	.	C00-C97
DIB002790	IPI-616	Hypertension	401	I10, I11, I12, I13, I15
DIB002791	ASP-9521	Prostate tumor	185	C61
DIB002792	Tetrahydrozoline	Ocular disease	.	H00-H59
DIB002793	Pyridocarbazole series	Cancer	140-229	C00-C96
DIB002794	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB002795	RG-7449	Allergic rhinitis	477	J30
DIB002796	CD5 monoclonals/RIPs	Autoimmune diseases	279.4	D84.9, M35.9
DIB002797	BiTE molecules	Renal cancer	.	C64
DIB002798	NIS215	Diabetes mellitus type 2	250	E11
DIB002799	SP-1031C	Cancer	140-229	C00-C96
DIB002800	RNAi therapy	Respiratory syncytial virus 	79.6	B97.4
DIB002801	Exeporfinium chloride topical	Staphylococcus aureus infection	.	A41.0
DIB002802	Ipodate	Gallbladder disease	.	K80-K82
DIB002803	RSOD variants	Autoimmune diseases	.	D84.9
DIB002804	Pl-3K delta inhibitor	Cancer	140-229	C00-C96
DIB002805	DTaP-HepB prophylactic vaccine	Hepatitis B virus infection	.	B16
DIB002806	API-31510	Cancer	140-229	C00-C96
DIB002807	Cytokine combination	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002808	Non-egg animal cell culture-based vaccine	Influenza virus infections	487	J10, J11
DIB002809	BTK inhibitor	Rheumatold arthritis	714	M05-M06
DIB002810	Small molecule therapeutics	Alzheimer's disease	331	G30
DIB002811	Cyclic pyranopterin monophosphate	Encephalopathy	.	G93.4
DIB002812	PGF2ALPHA-IE	Glaucoma	.	H40-H42
DIB002813	Hepatitis A vaccine	Hepatitis A virus infection	.	B15.9
DIB002814	NSC-281612	Cancer	140-229	C00-C96
DIB002815	PKX-462	Migraine	346	G43
DIB002816	NPS-846	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002817	Seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB002818	TNF-targeting small molecule therapeutic	Autoimmune diseases	279.4	D84.9, M35.9
DIB002819	ZD-7155	Hypertension	401	I10, I11, I12, I13, I15
DIB002820	Fasiglifam hemihydrate	Diabetes mellitus type 2	.	E11
DIB002821	A-74932	Lung cancer	.	C33-C34
DIB002822	RecQ-siRNA	Cancer	140-229	C00-C96
DIB002823	PNB-05	Obsessive-compulsive disorder	.	F42
DIB002824	Amtolmetin guacil	Inflammatory diseases	.	.
DIB002825	J-995	Estrogen deficiency	.	E28.39
DIB002826	Isopropamide iodide	Allergic rhinitis	477	J30
DIB002827	Vaccine	Shigella infections	.	A03.9
DIB002828	Concatameric TNFR2 therapy program	Discovery agent	.	.
DIB002829	NMDA/glycine antagonists	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB002830	FFC-15	Bladder cancer	.	C67
DIB002831	QLT-091568	Glaucoma	365	H40-H42
DIB002832	RH-1	Solid tumours	.	C00-C75,C7A,C7B
DIB002833	Unfractionated heparin tablets	Thrombosis	.	I80-I82
DIB002834	NPSP-795	Osteoporosis	733	M80-M81
DIB002835	Autologous stem cell therapy	Spinal cord injuries	952	S14, S24, S34
DIB002836	Pyrroles	Cancer	140-229	C00-C96
DIB002837	Oglemilast	Asthma	.	J45
DIB002838	Dual norepinephrine reuptake inhibitors/5-HT1A partial agonists	Psychiatric disorders	.	F99
DIB002839	Benzodiazepine derivatives	Neuropathic pain	338,780	R52, G89
DIB002840	NKM	Influenza virus infections	487	J10, J11
DIB002841	Amyloid-beta synthesis inhibitor	Alzheimer's disease	331	G30
DIB002842	TAP-1 gene therapy	Cancer	140-229	C00-C96
DIB002843	RESEQUINIL	Epilepsy	.	G40
DIB002844	GD-1	Cancer	140-229	C00-C96
DIB002845	GSK2398852	Amyloidosis	.	E85
DIB002846	AllerT	Allergy	995.3	T78.4
DIB002847	Trecetilide fumarate	Cardiac arrhythmias	.	I47-I49
DIB002848	AE-08	Melanoma	.	C43
DIB002849	Somatropin	Growth hormone deficiency	253.3	E23.0
DIB002850	DW-800	Mucositis	.	K00-K95
DIB002851	Etozolin	Congestive heart failure	428	I50
DIB002852	Nacolomab tafenatox	Colorectal cancer	153, 154	C18-C21
DIB002853	ONT-093/OC144-093	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB002854	XGP-310	Migraine	346	G43
DIB002855	TGP-580	Neurodegenerative diseases	.	G30-G32
DIB002856	5-HT2c agonists (metabolic disorders), Boehringer	Metabolic disorders	.	E70-E90
DIB002857	Gene-based dengue fever therapeutics	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB002858	RhASM enzyme replacement therapy (acid sphingomyelinase deficiency)	Niemann-Pick disease	.	E75.249
DIB002859	Inhibitor of Neutr. Elastase	Bronchiectasis	494, 748.61	J47, Q33.4
DIB002860	Polysaccharide vaccine	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB002861	Delphinidin	Cardiovascular disease	.	I00-I99
DIB002862	GAG/carbohydrate compounds	Alzheimer's disease	331	G30
DIB002863	Andolast	Rhinitis	.	J00,J30,J31.0
DIB002864	Adeno-virus based RNAi therapy	Huntington's disease	.	F02.2,G10
DIB002865	AK-106-001616	Rheumatold arthritis	714	M05-M06
DIB002866	OBP-AI1	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB002867	5-HT 2c agonists (neurological/psychiatric disease), Pfizer	Neurological disease	.	G00-G99
DIB002868	EF-27	Radiation sickness	990	T66
DIB002869	Lecimibide	Hyperlipidemia	.	E78.5
DIB002870	Methamphetamine intravenous	Stroke	.	I61-I63
DIB002871	ABT-267	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB002872	BHT-3201	Type 1 diabetes	250.01	E10
DIB002873	Brodimoprim	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002874	HG-1300	Cancer	140-229	C00-C96
DIB002875	BMS-200980	Myocardial infarction	410	I21, I22
DIB002876	MSC2156119	Cancer	.	C00-C97
DIB002877	Undisclosed compound	Hearing disorder	.	H90.5
DIB002878	Propylhexedrine	Obesity	278	E66
DIB002879	NF-AT proteins	Autoimmune diseases	279.4	D84.9, M35.9
DIB002880	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB002881	RG-2833	Friedreich's ataxia	.	G11.1
DIB002882	IDEC-131	Thrombocytopenia	.	D69.6
DIB002883	PAN-90716-DES	Ocular disease	.	H00-H59
DIB002884	NoroVAXX	Norwalk virus infection	.	A08
DIB002885	SC-103b	Diabetic complication	.	E08-E13
DIB002886	COX-2 inhibitors	Inflammatory diseases	.	.
DIB002887	VII-7-B	Anxiety disorder	300	F40-F42
DIB002888	MC-02002	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002889	NNC-55-0118	Insulin dependent diabetes	.	E10
DIB002890	AMD-AAV7	Age related macular degeneration	.	H35.30
DIB002891	Terodiline	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB002892	SL-25.1039	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB002893	Stearoyl-CoA desaturase-1 inhibitors	Obesity	278	E66
DIB002894	MDL-29311	Atherosclerosis	414.0, 440	I70
DIB002895	BTA-188	Rhinovirus infection	.	J20.6?
DIB002896	AGN-2979	Psychotic disorders	.	F20-F29
DIB002897	Prognox	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB002898	H1N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB002899	LEMINOPRAZOLE	Ulcerative colitis	.	K51
DIB002900	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB002901	Sapropterin dihydrochloride	Hyperphenylalaninemia	.	E70.1
DIB002902	PF-04995274	Alzheimer's disease	.	G30,F00
DIB002903	ErythroMax	Hypoxia	799.02	R09.02
DIB002904	BB-476	Atherosclerosis	414.0, 440	I70
DIB002905	ABX-MA1	Melanoma	172	C43
DIB002906	RPR-109891	Angina	.	I20
DIB002907	HG-1224	Immune disorder	.	D80-D89
DIB002908	BB-PTH 1-84	Osteoporosis	733	M80-M81
DIB002909	NGD-93-1	Psychotic disorders	.	F20-F29
DIB002910	West Nile virus vaccine	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB002911	PolyQ modulator	Huntington's disease	.	F02.2,G10
DIB002912	Nexopamil	Hypertension	.	I10-I15
DIB002913	EGP 2 specific single chain antibody plus GO enzyme based immunotoxin	Cancer	140-229	C00-C96
DIB002914	Type II collagen	Rheumatold arthritis	714	M05-M06
DIB002915	Myelopid	Immune disorder	.	D80-D89
DIB002916	Moxisylyte	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB002917	SKLB-010	Inflammatory diseases	.	.
DIB002918	Selective estrogen receptor degraders	Breast cancer	174, 175, 217	C50, D24
DIB002919	APN-201	Dermatitis	.	L20-L30
DIB002920	APC therapy	Adult respiratory distress syndrome	518.5, 518.82	J80
DIB002921	NDV-4	Staphylococcus aureus infection	.	A41.0
DIB002922	AVX901	Breast cancer	.	C50
DIB002923	Cancer cell-produced immune cell-repellent protein inhibitors	Cancer	140-229	C00-C96
DIB002924	Recombinant follicle stimulating hormone	Female infertility	628	N97.0
DIB002925	Hormone-independent vaccine	Prostate hyperplasia	.	N40
DIB002926	Antimetastasis agent	Metastasis	.	C00-C97
DIB002927	BRAF kinase inhibitor	Cancer	140-229	C00-C96
DIB002928	TBC-1336	Inflammatory diseases	.	.
DIB002929	SL-052	Cancer	.	C00-C97
DIB002930	Pivagabine	Depressive disorders	296, 300	F30-F39, F40-F42
DIB002931	NT-502	Age related macular degeneration	.	H35.30
DIB002932	Recombinant human iduronate-2-sulfatase	Hunter syndrome	.	E76.1
DIB002933	CIGB-228	Papillomavirus infections	.	A00-B99
DIB002934	HSV therapy	Cancer	140-229	C00-C96
DIB002935	ABS-300 series	Alzheimer's disease	331	G30
DIB002936	ALT 005	Ophthalmic infection	.	H00-H59
DIB002937	VG-106	Cancer	140-229	C00-C96
DIB002938	PF-232798	HIV infections	42	B20
DIB002939	Keratinocyte modulator	Psoriasis	696	L40
DIB002940	LETRAZURIL	Isosporiasis	.	A07.3
DIB002941	[18F]DCFPyL	Prostate tumor	185	C61
DIB002942	Tubulin antagonists	Cancer	140-229	C00-C96
DIB002943	CB-182804	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB002944	PMI-008	Obesity	278	E66
DIB002945	Angiostatin/with radiation therapy	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB002946	TAN-876B	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB002947	UX-005	Lysosomal storage disease	.	E75-E77
DIB002948	Anti-inflammatory therapeutics	Respiratory tract inflammation	.	J00-J99
DIB002949	LA-N8	Factor VIII deficiency	.	D66
DIB002950	Rivastigmine	Discovery agent	.	.
DIB002951	PUMAPRAZOLE	Duodenal ulcer	.	K25-K27
DIB002952	ZP-3022	Diabetes mellitus	250	E08-E13
DIB002953	EMP-123	Peanut hypersensitivity	995.61, V15.01	T78.4
DIB002954	AlleKine	Arthritis	710-719	M00-M25
DIB002955	Beta-amyloid precursor protein modulators	Alzheimer's disease	331	G30
DIB002956	Piracetam	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB002957	SR-59062A	Gastrointestinal disease	.	K00-K93
DIB002958	Org-43902	Infertility	.	N46,N97.0
DIB002959	TSS-HIG	Endotoxic shock	.	R57.8
DIB002960	SCP-123 analogs	Pain	338,780	R52, G89
DIB002961	HO/03/03	Diabetic foot ulcer	.	E08-E13
DIB002962	MEDI-491	Viral infections	042-075	A80-A99, B00-B34
DIB002963	Targeted gold nanoparticle	Mycobacterium tuberculosis infection	.	A15-A19
DIB002964	Influenza A and B virus targeting compounds	Influenza virus infections	487	J10, J11
DIB002965	Antipsychotics	Schizophrenia	295	F20
DIB002966	MN-462	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB002967	RAP-310	Alzheimer's disease	331	G30
DIB002968	AT-3375	Parkinson's disease	.	G20
DIB002969	NCX-1047	Dermatitis	692.9	L20-L30
DIB002970	TAN-1518A	Carcinoma	.	D07.30
DIB002971	Tarvacin Anti-Viral	Hepatitis virus infection	573.3	K75.9
DIB002972	HAp-IFN	Hepatitis C virus infection	.	B17.1,B18.2
DIB002973	KW-3433	Hypertension	401	I10, I11, I12, I13, I15
DIB002974	LMS-611 inhalant	Asthma	493	J45
DIB002975	NBM-HD-1	Cancer	.	C00-C97
DIB002976	Recombinant H5N1 pandemic influenza antigen vaccine	Influenza virus infections	487	J10, J11
DIB002977	Pancreatic stem cell therapy	Diabetes mellitus	250	E08-E13
DIB002978	131I-labeled scFv antibody F-16 (solid tumor/hematological malignancy), Philogen	Hematological malignancies	.	C81-C96
DIB002979	Humanized mAb program	Lung cancer	162	C33-C34
DIB002980	NI-0801	Autoimmune diseases	.	D84.9
DIB002981	C-Met kinase inhibitors	Cancer	140-229	C00-C96
DIB002982	Semaphorin-3E anti-platelet agent	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB002983	FK-960	Cognitive impairment	.	F06.7
DIB002984	Farnesoid X receptor agonists	Diabetes mellitus	250	E08-E13
DIB002985	GM608	Parkinson's disease	.	G20
DIB002986	Ty800	Infectious and parasitic disease	.	A00-B99
DIB002987	Glypromate	Neurological disease	320-359	G00-G99
DIB002988	MOZENAVIR MESILATE	Human immunodeficiency virus infection	.	B20
DIB002989	Dual antigen anthrax vaccine	Bacillus anthracis infection	.	A22
DIB002990	3E10-MBNL1 protein therapy (iv, myotonic dystrophy type 1), 4s3 Bioscience	Myotonic dystrophy type 1	.	G71.1
DIB002991	Benzoyl peroxide	Acne vulgaris	706.1	L70.0
DIB002992	PEGylated recombinant IFN-alpha2b	Cancer	.	C00-C97
DIB002993	LErafAON	Solid tumours	.	C00-C75,C7A,C7B
DIB002994	Insulin sensitizers	Non-insulin dependent diabetes	.	E11.9
DIB002995	PRB-01022	Atherosclerosis	414.0, 440	I70
DIB002996	HG-1246	Cancer	140-229	C00-C96
DIB002997	VE-cadherin antagonists	Cancer	140-229	C00-C96
DIB002998	Neurotrophic factor-producing stem cells	Multiple sclerosis	340	G35
DIB002999	RU-5135	Anxiety disorder	300	F40-F42
DIB003000	Dual-specific monoclonal antibodies	Cancer	140-229	C00-C96
DIB003001	LOR-220	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003002	P-6915	Cancer	140-229	C00-C96
DIB003003	Drug screening	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB003004	HRGP	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003005	NI-1401	Autoimmune diseases	279.4	D84.9, M35.9
DIB003006	AMXT-1501	Head and neck cancer	140-149	C07-C14, C32-C33
DIB003007	BAL-8557	Fungal infections	110-118	B35-B49
DIB003008	BRS-3 agonists	Obesity	278	E66
DIB003009	Elosulfase alfa	Mucopolysaccharidosis	.	E76
DIB003010	Inflammatory bowel disease therapy	Inflammatory bowel disease	555, 556	K50, K51
DIB003011	EM-1126	Prostate tumor	185	C61
DIB003012	OX-CLI	Respiratory tract inflammation	.	J00-J99
DIB003013	BMS-663068	Human immunodeficiency virus infection	.	B20
DIB003014	LASSBio-881	Pain	338,780	R52, G89
DIB003015	XB-05	Cancer	140-229	C00-C96
DIB003016	Encapsulated cells	Parkinson's disease	.	G20
DIB003017	Vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB003018	OX-641	Migraine	346	G43
DIB003019	CRILVASTATIN	Hyperlipidemia	.	E78.5
DIB003020	Anti-miR-122 antisense oligonucleotide	Fatty liver disease	.	K70,K76.0
DIB003021	Anthranilimide-based glycogen phosphorylase inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB003022	CC-90001	Fibrosis	709.2	L90.5
DIB003023	MED-27	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB003024	JMV-980	Asthma	493	J45
DIB003025	Alatrofloxacin mesylate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003026	Gene therapy	Head and neck cancer	140-149	C07-C14, C32-C33
DIB003027	GYKI-12743	Hypertension	401	I10, I11, I12, I13, I15
DIB003028	Triferic	Iron deficiency anaemia	.	D50
DIB003029	CXD-101	Cancer	140-229	C00-C96
DIB003030	R-61837	Viral infections	042-075	A80-A99, B00-B34
DIB003031	R-1435	Deep vein thrombosis	453.4	I80.2
DIB003032	NU-400	Multiple sclerosis	340	G35
DIB003033	SWT-05105	Vitiligo	709.01	L80
DIB003034	GW-2331	Atherosclerosis	414.0, 440	I70
DIB003035	EP-94	Ischemic heart diseases	410-414	I20-I25
DIB003036	Pidotimod	Urinary tract infections	599	N39.0
DIB003037	VLP vaccine	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB003038	Gene therapy	Factor IX deficiency	.	D67
DIB003039	CMLVAX100	Leukemia	.	C91-C95
DIB003040	Xipamide	Hypertension	401	I10, I11, I12, I13, I15
DIB003041	ME-1128	Metabolic disorders	.	E70-E90
DIB003042	AZD-7268	Anxiety disorder	300	F40-F42
DIB003043	CGS-24565	Atherosclerosis	414.0, 440	I70
DIB003044	WASP gene therapy	WiskottCAldrich syndrome	.	D82.0
DIB003045	PA-161	HIV infections	42	B20
DIB003046	CEFTRAZONAL BOPENTIL	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB003047	GS-9160	HIV infections	42	B20
DIB003048	GSK-2392102A	Staphylococcal infections	.	A49.0
DIB003049	M-518101	Psoriasis	696	L40
DIB003050	Usp14 inhibitors	Neurodegenerative diseases	.	G30-G32
DIB003051	NPS-3	Dermatitis	692.9	L20-L30
DIB003052	Immunotherapy	Aplastic anemia	284	D60-D61
DIB003053	T-cell therapy	Cancer	140-229	C00-C96
DIB003054	Kv1.3 potassium channel blockers	Autoimmune diseases	.	D84.9
DIB003055	L-97-1 intravenous	Sepsis	.	A40-A41
DIB003056	ThromboMer	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB003057	CB-1922	HIV infections	42	B20
DIB003058	PPD-10558	Lipid metabolism disorder	.	E75-E78
DIB003059	RG-7010	Motor neurone disease	335.2	G12.2
DIB003060	BPI-3006	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
DIB003061	AS-101	Acute myeloid leukemia	205	C92.0
DIB003062	Amifostine	Mucositis	.	K00-K95
DIB003063	HIV vaccine	HIV infections	42	B20
DIB003064	Z-207	Allergic rhinitis	477	J30
DIB003065	SC-108	Cardiovascular disease	390-459	I00-I99
DIB003066	RQ-00000010	Gastric motility disorder	.	K22.4
DIB003067	Antibacterial protease inhibitors	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003068	Omri-Hep-B	Hepatitis B virus infection	.	B16
DIB003069	CEMADOTIN HYDROCHLORIDE	Cancer	140-229	C00-C96
DIB003070	Bone disease therapy	Bone disease	.	M00-M99
DIB003071	Peg. Adrenomedullin	Lung disease	.	J00-J99
DIB003072	Dual Pgp/MRP1 inhibitors	Cancer	140-229	C00-C96
DIB003073	AZD-6942	Rheumatold arthritis	714	M05-M06
DIB003074	BFPT-12603	Asthma	493	J45
DIB003075	TCMP-80	Immuno-modulator	.	D80-D89
DIB003076	ACI-518	Alzheimer's disease	331	G30
DIB003077	ICI-170777	Cardiotonic	.	I50
DIB003078	APD-405	Emesis	787	R11
DIB003079	Topoisomerase inhibitors	Cancer	140-229	C00-C96
DIB003080	P-7	Eczema	.	L20-L30
DIB003081	SWT-01113	Atopic dermatitis	691.8	L20
DIB003082	Monoclonal antibodies	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003083	FR-144420	Angina	413	I20
DIB003084	NGD-91-1	Anxiety disorder	300	F40-F42
DIB003085	MEDl-550	Influenza A virus infections	.	J10-J11
DIB003086	Rx-04	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003087	MG-4101	Cancer	.	C00-C97
DIB003088	TRPV1 antagonists	Pain	338,780	R52, G89
DIB003089	TTH 02-001	Neurodegenerative diseases	.	G30-G32
DIB003090	BGC-20-0166	Obstructive sleep apnea	327.23, 780.57	G47.3
DIB003091	ABI-200	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003092	OxycoDex	Pain	.	G89
DIB003093	Nicotine vaccine	Nicotine dependence	305.1	F17
DIB003094	TV-1380	Cocaine dependence	.	F14.2
DIB003095	INGN-241	Solid tumours	.	C00-C75,C7A,C7B
DIB003096	Group B meningococcal NOMV vaccine series	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003097	CD37 antibodies	Cancer	140-229	C00-C96
DIB003098	Recombinant trichosanthin mutant	HIV infections	42	B20
DIB003099	Insulin-like growth factor-I (IGF-I)	Osteoarthritis	715	M15-M19, M47
DIB003100	PF-431499	Obesity	278	E66
DIB003101	AGS-348	Hereditary angioedema	277.6	D84.1
DIB003102	NM-9505	Discovery agent	.	.
DIB003103	WIN-64733	Bronchitis	.	J20-J21,J42
DIB003104	Anti-Neu5Gc mAbs	Cancer	140-229	C00-C96
DIB003105	NAMI-A	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003106	Musculoskeletal disorder/metabolic disease therapy	Metabolic disorders	.	E70-E90
DIB003107	AKL-0707	Lipodystrophy	.	E88.1
DIB003108	ARM-AK-105	Hyperlipidemia	272.0-272.4	E78
DIB003109	LY-2456302	Alcohol use disorders	303	F10.2
DIB003110	NanoBarium	Gastrointestinal disease	.	K00-K93
DIB003111	ARGENT/RAPID regulated Factors VIII and IX	Factor IX deficiency	.	D67
DIB003112	Analgesics	Migraine	346	G43
DIB003113	HYG-440	Dermatological disease	.	L00-L99
DIB003114	ONX-0914	Autoimmune diseases	279.4	D84.9, M35.9
DIB003115	RNA vaccine	Allergy	995.3	T78.4
DIB003116	Q-101	HIV infections	42	B20
DIB003117	PF-738502	Fibromyalgia	729.1	M79.7
DIB003118	Multiple sclerosis therapy	Multiple sclerosis	340	G35
DIB003119	Navuridine	Human immunodeficiency virus infection	.	B20
DIB003120	GT-16-239	Arteriosclerosis	440	I70
DIB003121	S-110	Acute myeloid leukemia	.	C92.0
DIB003122	Albaconazole	Fungal infection	110-118	B35-B49
DIB003123	ARH-1029	Helicobacter pylori infection	41.86	B96.81
DIB003124	SEP-363856	Major depressive disorder	296.2, 296.3	F32, F33
DIB003125	LASSBio-1524	Inflammatory diseases	.	.
DIB003126	NI-101	Alzheimer's disease	.	G30,F00
DIB003127	Imepitoin	Convulsions	.	R56.0
DIB003128	Capsid assembly inhibitor	HIV-1 infections	42	B20
DIB003129	SKL-PSY	Psychiatric disorders	.	F99
DIB003130	Cancer therapy	Cancer	140-229	C00-C96
DIB003131	Cotrimazine	Urinary tract infections	599	N39.0
DIB003132	Podofilox-based mitosis inhibitors	Cancer	140-229	C00-C96
DIB003133	M-PGES-1 inhibitors	Inflammatory diseases	.	.
DIB003134	Atu-027	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003135	PBSVax	HIV infections	42	B20
DIB003136	CereCRIB	Pain	338,780	R52, G89
DIB003137	CNSB-004	Pain	338,780	R52, G89
DIB003138	SiRNA	Uterine cervix cancer	.	C53
DIB003139	CYSTEMUSTINE	Solid tumours	.	C00-C75,C7A,C7B
DIB003140	R-665	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB003141	Vif inhibitors	HIV infections	42	B20
DIB003142	BAY-W-9279	Fungal infection	.	B35-B49
DIB003143	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB003144	Nanofibers	Myocardial infarction	410	I21, I22
DIB003145	Beclanorsen	Leukaemia	.	C91-C95
DIB003146	Albutropin	Growth disorder	.	E23.0
DIB003147	Cripto-1 mAbs	Cancer	140-229	C00-C96
DIB003148	NY-ESO-1 vaccine	Melanoma	.	C43
DIB003149	PINS	Breast cancer	174, 175, 217	C50, D24
DIB003150	CJ-30002	Non-insulin dependent diabetes	.	E11.9
DIB003151	Lu-AA37096	Anxiety disorder	300	F40-F42
DIB003152	Sodium stibogluconate	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003153	Gene therapy	Factor IX deficiency	.	D67
DIB003154	Cyclin-dependent kinase inhibitors	Glomerulonephritis	580-582	N00, N01, N03, N18
DIB003155	K-201	Atopic dermatitis	691.8	L20
DIB003156	KLS-HPV	Uterine cervix cancer	.	C53
DIB003157	MINAMESTANE	Bladder cancer	.	C67
DIB003158	ISIS-AR	Prostate cancer	185	C61
DIB003159	Vero-cell H5N1 vaccine	Influenza virus infections	487, 488	J10, J11
DIB003160	A-86719.1	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB003161	Perflubutane lipid microsphere-encapsulated	Heart disease	390-429	I00-I52
DIB003162	Th17 modulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB003163	GS-2992	HIV infections	42	B20
DIB003164	SPP-676	Hypertension	401	I10, I11, I12, I13, I15
DIB003165	CNTO-2476	Retinitis pigmentosa	.	H35.5
DIB003166	ALT-803	Cancer	.	C00-C97
DIB003167	CNX-1351	Cancer	140-229	C00-C96
DIB003168	Zolasartan	Hypotension	.	I95
DIB003169	Glystatins	Epilepsy	345	G40
DIB003170	Virexxa	Endometrial cancer	.	C54.1
DIB003171	HS-131	Opiate dependence	304	F11
DIB003172	HSD-1 inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB003173	Vaccine	Female contraception	.	Z30.013
DIB003174	Plant-derived alkaloid analogs	Acute myeloid leukemia	205	C92.0
DIB003175	Thymoctonan	Immuno-stimulant	.	.
DIB003176	DG-17	Human immunodeficiency virus infection	.	B20
DIB003177	RG7775	Acute myeloid leukemia	.	C92.0
DIB003178	AMP protein kinase agonist	Diabetes mellitus type 2	.	E11
DIB003179	DS-3032	Solid tumours	.	C00-C75,C7A,C7B
DIB003180	LY-2066948	Hot flashes	.	N95.1
DIB003181	ARRY-575	Cancer	140-229	C00-C96
DIB003182	CI-922	Allergy	.	T78.4
DIB003183	MBC-31	Osteoporosis	733	M80-M81
DIB003184	Hi-8 PrimeBoost therapeutic melanoma vaccine	Melanoma	172	C43
DIB003185	Febarbamate	Aggressive non-Hodgkin's lymphoma	.	F63
DIB003186	CEB-925	Hypercholesterolemia	272	E78.0
DIB003187	HuMax-VEGF	Cancer	140-229	C00-C96
DIB003188	Org-20599	Anesthesia	338	R52
DIB003189	Beta-2 microglobulin mutants	Autoimmune diseases	279.4	D84.9, M35.9
DIB003190	CSP-9222	Cancer	140-229	C00-C96
DIB003191	AI-128	Asthma	493	J45
DIB003192	KW-2170	Breast cancer	.	C50
DIB003193	West Nile virus vaccine	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB003194	Gene therapy	Duchenne muscular dystrophy	.	G71.0
DIB003195	Monoclonal antibody cocktail	Virus infection	.	B03
DIB003196	TachoComb	Wound healing	.	S91.3
DIB003197	HIV vaccine	HIV infections	42	B20
DIB003198	SMART derivatives	Melanoma	172	C43
DIB003199	Glucocorticoid receptor ligands	Inflammatory diseases	.	.
DIB003200	ZD-6804	Pain	338,780	R52, G89
DIB003201	FT-1050-treated bone marrow stem cell therapy	Cancer	140-229	C00-C96
DIB003202	99mTc-EC-0652	Prostate tumor	185	C61
DIB003203	SQ-30741	Thrombosis	.	I80-I82
DIB003204	HD-201	Cancer	140-229	C00-C96
DIB003205	NT-3	Constipation	.	K59.0
DIB003206	Relaxin	Cardiac failure	.	I50
DIB003207	FURPROFEN	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB003208	Oligonucleotides	Alopecia	.	L65.9
DIB003209	AWD-131-139	Epilepsy	345	G40
DIB003210	NeisVac-C	Neisseria meningitidis infection	.	A87
DIB003211	NsG-0202	Alzheimer's disease	.	G30,F00
DIB003212	PknB inhibitor	Mycobacterium tuberculosis infection	.	A15-A19
DIB003213	Gene therapy	Head and neck cancer	140-149	C07-C14, C32-C33
DIB003214	NPS-1	Cancer	140-229	C00-C96
DIB003215	Thermostable vaccines	Measles virus infection	.	B06.9
DIB003216	Stem cell therapy	Neurological disease	.	G00-G99
DIB003217	Antibacterial therapeutics	Infectious disease	001-139	A00-B99
DIB003218	Human papillomavirus vaccine	Papillomavirus infections	.	B97.7
DIB003219	Anti-VEGFR 3 mAb	Discovery agent	.	.
DIB003220	S-288310	Bladder cancer	188	C67
DIB003221	RO-23-7553	Prostate disorder	.	N40-N42
DIB003222	NKP-3752	Cancer	140-229	C00-C96
DIB003223	OctreoScan	Cancer	140-229	C00-C96
DIB003224	NVX-207	Cancer	.	C00-C97
DIB003225	IVN-mite	Allergy	995.3	T78.4
DIB003226	MK-0719	Pain	338,780	R52, G89
DIB003227	ACAM-FLU-A	Influenza virus infections	487, 488	J10, J11
DIB003228	IMA-910	Colorectal cancer	153, 154	C18-C21
DIB003229	CVS-1578	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB003230	O-Vax	Ovarian cancer	.	C56
DIB003231	TVX-003	Influenza virus infections	487	J10, J11
DIB003232	Alpha amino acids	Cancer	.	C00-C97
DIB003233	Doxorubicin-peptide-PEG conjugate	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB003234	Sordaricin analogs	Fungal infection	.	B35-B49
DIB003235	IGN-312	Cancer	140-229	C00-C96
DIB003236	Ambroxol	Bronchitis	.	J20-J21,J42
DIB003237	SJ-BRV	Obesity	278	E66
DIB003238	Sci-DaPT-Vac	Bordetella pertussis infection	.	A37.0
DIB003239	HG-1177	Cancer	140-229	C00-C96
DIB003240	A-Fizz	Anal fissure	.	K60.0-K60.2
DIB003241	RPAF-AH	Sepsis	.	A40-A41
DIB003242	AS-1892802	Pain	338,780	R52, G89
DIB003243	B-Raf kinase inhibitors	Cancer	140-229	C00-C96
DIB003244	Saruplase	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB003245	EDP-24	Cancer	140-229	C00-C96
DIB003246	TDM-621	Bleeding	.	R58
DIB003247	Polycythemia vera therapy	Polycythemia vera	.	D45
DIB003248	NS3 protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003249	EP HIV-1090 vaccine	HIV infections	42	B20
DIB003250	CP-409092	Anxiety disorder	300	F40-F42
DIB003251	KP-624	Hyperuricemia	790.6	E79.0
DIB003252	StarGen Stargardt's disease gene therapy	Stargardt disease	.	H35.5
DIB003253	ZK-91296	Alzheimer's disease	.	G30,F00
DIB003254	EGS-21	Crohn's disease	.	K50
DIB003255	Muscarinic M1 agonists	Schizophrenia	295	F20
DIB003256	Clostridium butyricum MIYAIRI 588	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003257	NHT-0112	Alzheimer's disease	.	G30,F00
DIB003258	R-1315	Alzheimer's disease	331	G30
DIB003259	Acamprosate prodrugs	Alcohol use disorders	303	F10.2
DIB003260	ERYTHROMYCIN SALNACEDIN	Dermatological disease	.	L00-L99
DIB003261	Seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB003262	PAR-401	Influenza virus infections	487	J10, J11
DIB003263	PD-3766	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB003264	GW-660511	Hypertension	.	I10-I15
DIB003265	Recombinant mAb-biocide fusion proteins	Cryptosporidium infection	.	A07.2
DIB003266	RSD-931	Pain	338,780	R52, G89
DIB003267	Acecainide	Solid tumours	.	C00-C75,C7A,C7B
DIB003268	Quinoline methanols	Plasmodium falciparum infection	.	B54
DIB003269	FK-011	Asthma	.	J45
DIB003270	Salicylamide	Pain	338,780	R52, G89
DIB003271	Atypical antipsychotics	Schizophrenia	295	F20
DIB003272	COG-112	Cancer	.	C00-C97
DIB003273	Bervastatin	Thrombosis	.	I80-I82
DIB003274	Prophylactic vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003275	Adacel	Bordetella pertussis infection	.	A37.0
DIB003276	CNS-5788	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB003277	AHR-14042	Anxiety disorder	300	F40-F42
DIB003278	Virion project	Coronavirus infection	.	B34.2
DIB003279	LpxA inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003280	Diphenylfuran derivatives	Arthritis	710-719	M00-M25
DIB003281	DCC-2909	Metastasis	.	C00-C97
DIB003282	SR-33805	Angina	.	I20
DIB003283	PMA-411R	Autoimmune diseases	279.4	D84.9, M35.9
DIB003284	Tonabersat	Epilepsy	345	G40
DIB003285	CNS-1237	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB003286	LCP-3301	Autoimmune diseases	279.4	D84.9, M35.9
DIB003287	Cetrimide	Skin infections	.	L00-L08
DIB003288	MIQ-003	Multiple sclerosis	340	G35
DIB003289	Diftalone	Inflammatory diseases	.	.
DIB003290	Varicella-zoster vaccine (Varivax/Zostavax)	Adult varicella zoster virus infection	.	B02
DIB003291	TRI-102	Type 2 diabetes	250.00, 250.02	E11
DIB003292	18F labeled ethanolamine derivatives (cancer imaging), Bayer Schering	Cancer	140-229	C00-C96
DIB003293	Nepafenac	Osteoarthritis	.	M19.90
DIB003294	JAK3 inhibitor	Discoid lupus erythematosus	.	L93.0
DIB003295	PRO-GR-300	Fibrosis	709.2	L90.5
DIB003296	ALS-L1023	Obesity	278	E66
DIB003297	Tyrosine kinase inhibitors	Cancer	140-229	C00-C96
DIB003298	CPI-003	Myocardial infarction	.	I21-I22
DIB003299	CS0240-0600 program	Immune disorder	.	D80-D89
DIB003300	CreaVax-RCC	Renal cell carcinoma	189	C64
DIB003301	90Y-anti-cadherin 3 antibody (cancer), Perseus	Cancer	140-229	C00-C96
DIB003302	TVX-004	Influenza virus infections	487	J10, J11
DIB003303	Recombinant von Willebrand factor/recombinant Factor VIII complex	Von willebrand disease	.	D68.0
DIB003304	Poly-ICR	Keratosis	.	L57.0
DIB003305	Methanesulfonyl fluoride	Alzheimer's disease	.	G30,F00
DIB003306	MB-11319	Allergy	995.3	T78.4
DIB003307	AVIHEME	Sickle-cell anemia	280-285	D50-D64
DIB003308	Non-peptide TPO mimics	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB003309	RANBEZOLID HYDROCHLORIDE	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB003310	BGC-20-0582	Pediculus capitis infestation	.	B85.0
DIB003311	TGFTX-1	Atherosclerosis	414.0, 440	I70
DIB003312	KH-902	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DIB003313	TC-2696	Pain	.	G89
DIB003314	ST-0701	Cardiovascular disease	390-459	I00-I99
DIB003315	HBP-347	Cancer	.	C00-C97
DIB003316	P450RAI inhibitors	Breast cancer	.	C50
DIB003317	Alloferon	Cancer	.	C00-C97
DIB003318	CDP-484	Immune disorder	.	D80-D89
DIB003319	ABS-200 series	Cancer	.	C00-C97
DIB003320	GR-144053	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB003321	RBT-05	HIV infections	42	B20
DIB003322	Anti-allergens	Allergy	995.3	T78.4
DIB003323	Anti-complement therapy	Inflammatory diseases	.	.
DIB003324	Lenercept	Asthma	.	J45
DIB003325	LY-2979165	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB003326	Protein kinase C iota inhibitors	Cancer	140-229	C00-C96
DIB003327	Capuramycin derivative translocase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003328	AlloMune	Transplant rejection	.	T86
DIB003329	Anti-angiomotin antibodies	Cancer	.	C00-C97
DIB003330	Targeted tyrosine kinase program	Cancer	140-229	C00-C96
DIB003331	Trombodipine	Platelet aggregatory	.	D69.1
DIB003332	Antimalarials	Plasmodium infection	.	B54
DIB003333	Adenosine kinase inhibitors	Epileptic seizure	.	G40,R56
DIB003334	Antibacterial antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003335	MDY-1001	Gastrointestinal disease	.	K00-K93
DIB003336	MOR-202	Multiple myeloma	203	C90.0
DIB003337	NR-584	Asthma	493	J45
DIB003338	MPL-S	Endotoxic shock	.	R57.8
DIB003339	Therapeutic agents	Genetic disorder	.	Q00-Q99
DIB003340	Thrombin inhibitor	Thrombosis	.	I80-I82
DIB003341	B-220	Autoimmune diseases	279.4	D84.9, M35.9
DIB003342	SB-273005	Osteoporosis	.	M80-M81
DIB003343	ETS-6103	Major depressive disorder	296.2, 296.3	F32, F33
DIB003344	FT-101	Heart disease	390-429	I00-I52
DIB003345	CEL-1000 peptide vaccine	Cancer	.	C00-C97
DIB003346	Ro-25-0534	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003347	OPC-12182	Ulcer	531-534	K25-K27
DIB003348	HG-1072	Cancer	140-229	C00-C96
DIB003349	Ro-25-8138	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003350	Obtustatin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB003351	Recombinant Clostridium botulinum A/B vaccine	Clostridium botulinum infection	.	A05.1
DIB003352	EMD-503982	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB003353	IDEC-151	Rheumatold arthritis	714	M05-M06
DIB003354	Dornase alpha	Cystic fibrosis	277	E84
DIB003355	AZD-5745	Gastrointestinal disease	.	K00-K93
DIB003356	IRX-4	Prostate tumor	185	C61
DIB003357	T-cell receptor	Arthritis	710-719	M00-M25
DIB003358	V-934/V-935	Cancer	140-229	C00-C96
DIB003359	L-glutamine	Short bowel syndrome	579.3	K91.8
DIB003360	Nav 1.6 channel modulator	Multiple sclerosis	340	G35
DIB003361	DPI-221	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB003362	Small molecule therapeutics	Neurodegenerative diseases	.	G30-G32
DIB003363	QAL964	Rheumatold arthritis	714	M05-M06
DIB003364	APG-201	Cancer	140-229	C00-C96
DIB003365	PF-277343	Alopecia	.	L65.9
DIB003366	PBI-1393	Cancer	.	C00-C97
DIB003367	ST-06	Injury	.	S00-T88
DIB003368	Vivia-1615	Cancer	140-229	C00-C96
DIB003369	Therapeutic program	Cardiovascular disease	390-459	I00-I99
DIB003370	Grippol TC	Influenza virus infections	487	J10, J11
DIB003371	Alinidine	Angina	.	I20
DIB003372	CYT-006-AngQb	Hypertension	401	I10, I11, I12, I13, I15
DIB003373	OT-121	Asthma	493	J45
DIB003374	Iodixanol	Cardiovascular disease	390-459	I00-I99
DIB003375	KF-17515	Inflammatory diseases	.	.
DIB003376	Crotamiton	Pruritus	698	L29
DIB003377	OPC 108459	Atrial fibrillation	.	I48
DIB003378	AZD6738	Chronic lymphocytic leukaemia	.	C91.1
DIB003379	Syk tyrosine kinase inhibitors	Allergy	.	T78.4
DIB003380	Patisiran	Amyloidosis	.	E85
DIB003381	KPI-022	Cardiovascular disease	390-459	I00-I99
DIB003382	VA-118020	Respiratory disorder	.	J98.9
DIB003383	GVX-3322	Cytomegalovirus infection	.	B25
DIB003384	Gene-activated beta-interferon	Multiple sclerosis	340	G35
DIB003385	Rad51	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB003386	Antibacterial peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003387	ATN-658	Cancer	140-229	C00-C96
DIB003388	L-740141	Emesis	.	R11
DIB003389	Cartistem-adipo	Arthropathy	.	M00-M14
DIB003390	Masilukast	Asthma	.	J45
DIB003391	NO-COX-2	Pain	.	G89
DIB003392	RNA vaccine	Allergy	995.3	T78.4
DIB003393	TSRI-265	Cancer	140-229	C00-C96
DIB003394	BMY-30047	Acne vulgaris	706.1	L70.0
DIB003395	DMPDDF	Cancer	140-229	C00-C96
DIB003396	RG6061	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003397	Tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB003398	G-256	Cardiac arrhythmias	.	I47-I49
DIB003399	C10-1040	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003400	Talizumab	Allergic reaction	995.3	T78.4
DIB003401	Tissue kallikrein inhibitors	Inflammatory diseases	.	.
DIB003402	Dendritic cell vaccine	Head and neck cancer	140-149	C07-C14, C32-C33
DIB003403	Peniel 1000	Osteoarthritis	715	M15-M19, M47
DIB003404	Adiptin	Obesity	278	E66
DIB003405	KW-4490	Asthma	493	J45
DIB003406	BST-204	Cancer	140-229	C00-C96
DIB003407	RUS 3108	Atherosclerosis	414.0, 440	I70
DIB003408	APT3111	Blood forming organ disorders	.	D75.9
DIB003409	VIA-3196	Hypercholesterolaemia	.	E78.0
DIB003410	CD-832.HCL	Angina	.	I20
DIB003411	INT-0022	Psychotic disorders	.	F20-F29
DIB003412	HLA-A, B7.1-transfected adenocarcinoma vaccine	Cancer	.	C00-C97
DIB003413	11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD-1) inhibitors (diabetes), Poxel	Diabetes mellitus	250	E08-E13
DIB003414	NaV1.7 inhibitors	Pain	338,780	R52, G89
DIB003415	SAVOXEPIN MESYLATE	Psychotic disorders	.	F20-F29
DIB003416	HLA-DQ2/DQ8 inhibitors	Celiac disease	579	K90.0
DIB003417	FLM-5011	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB003418	424C79	Pain	338,780	R52, G89
DIB003419	TDI-0065	Motor neurone disease	335.2	G12.2
DIB003420	FHT-1206	Discovery agent	.	.
DIB003421	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB003422	RP-66784	Angina	.	I20
DIB003423	Ditragal	Psoriasis	696	L40
DIB003424	Nidulalin A derivatives	Cancer	140-229	C00-C96
DIB003425	Butylscopolamine	Dysmenorrhea	.	N94.4-N94.6
DIB003426	ELS-120	Herpes simplex virus infection	54	B00
DIB003427	JTP-2942	Cognitive impairment	.	F06.7
DIB003428	Adenovirus gene therapy (Maroteux-Lamy syndrome)	Maroteaux-Lamy syndrome	.	E76.29
DIB003429	Idoxifene	Breast cancer	174, 175, 217	C50, D24
DIB003430	Aviase	HIV infections	42	B20
DIB003431	Valomaciclovir stearate	Adult varicella zoster virus infection	.	B02
DIB003432	P-glycoprotein inhibitors	Cancer	140-229	C00-C96
DIB003433	EF-12	Coronary artery disease	410-414, 429.2	I20-I25
DIB003434	AA-2379	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB003435	BC-PN-02	Neuropathy	356.0, 356.8	G64, G90.0
DIB003436	Itrocinonide	Asthma	493	J45
DIB003437	Anti-M-CSF antibodies	Bone metastases	198.5	C79.51
DIB003438	Viral RNA amplification inhibitors	Influenza virus infections	487	J10, J11
DIB003439	Benzodiazepine	Anxiety disorder	300	F40-F42
DIB003440	ARGENT/RAPID regulated sTNFR and IL-1RA	Osteoarthritis	.	M15-M19,M47
DIB003441	NB-004	Herpes simplex virus infection	54	B00
DIB003442	PB-127	Cardiovascular disease	390-459	I00-I99
DIB003443	VLI-03A	Hepatitis virus infection	.	B15-B19
DIB003444	H1N1 vaccine	Influenza virus infections	487	J10, J11
DIB003445	QAX-028	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB003446	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB003447	AGN-190383	Inflammatory diseases	.	.
DIB003448	CPD-VO	Cancer	140-229	C00-C96
DIB003449	IRX-5183	Solid tumours	.	C00-C75,C7A,C7B
DIB003450	FP-0220	Cardiovascular disease	390-459	I00-I99
DIB003451	MEDl-551	Scleroderma	701.0710.1	L94.0-L94.1, M34
DIB003452	Buccal SMT-D001	Hypersalivation	.	K11.7
DIB003453	Neo-Urinary Conduit	Bladder cancer	188	C67
DIB003454	Ad5Ag85A	Mycobacterium tuberculosis infection	.	A15-A19
DIB003455	Prophylactic/therapeutic anti-HCV vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003456	Epstein-Barr vaccine	Viral infections	042-075	A80-A99, B00-B34
DIB003457	MEDI8111	Bleeding	.	R58
DIB003458	Rycals	Heart failure	.	I50
DIB003459	Vaccines targeting beta amyloid	Alzheimer's disease	.	G30,F00
DIB003460	BCP-1071	Upper respiratory infection	.	J00-06,J30-39
DIB003461	ME-3407	Duodenal ulcer	.	K25-K27
DIB003462	INM-176	Alzheimer's disease	.	G30,F00
DIB003463	Factor-VIIa-XTEN	Hemophilia	286	D66-D68
DIB003464	HO/04/08	Dermatological disease	.	L00-L99
DIB003465	Alendronate sodium hydrate	Hypercalcemia	275.42	E83.5
DIB003466	INP-341	Skin burns	940-949	T20-T31
DIB003467	ZD-0490	Colorectal cancer	153, 154	C18-C21
DIB003468	LP-30171	Cancer	.	C00-C97
DIB003469	EDG-006	Major depressive disorder	296.2, 296.3	F32, F33
DIB003470	MK-0343	Anxiety disorder	300	F40-F42
DIB003471	Trastuzumab biosimilar	Cervical cancer	.	C53
DIB003472	Bropirimine	Viral infections	042-075	A80-A99, B00-B34
DIB003473	A-134974	Epilepsy	.	G40
DIB003474	HI-557 vaccines	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003475	Prodrug	Pain	338,780	R52, G89
DIB003476	AN-1792	Alzheimer's disease	331	G30
DIB003477	Cytorex-EBV	Cancer	140-229	C00-C96
DIB003478	RWJ-387273	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB003479	SDZ-NVI-085	Major depressive disorder	.	F32,F33
DIB003480	Nucleoside hydrolase inhibitors	Leishmania infection	.	B55.0
DIB003481	NLP-83	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003482	NU300	Influenza virus infections	.	J11.1
DIB003483	CNTO-0007	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB003484	Radiolabeled anti-CEACAM6 antibodies	Pancreatic cancer	.	C25
DIB003485	LG-1041	Hunter syndrome	.	E76.1
DIB003486	AC-8632	Parkinson's disease	.	G20
DIB003487	MPC-2130	Cancer	140-229	C00-C96
DIB003488	Recombinant Factor X	Hemophilia	286	D66-D68
DIB003489	VESTIPITANT MESYLATE	Major depressive disorder	.	F32,F33
DIB003490	Azosemide	Edema	.	R60.9
DIB003491	IB-08A099	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003492	Sarecycline	Acne vulgaris	706.1	L70.0
DIB003493	Steroid mimics	Breast cancer	174, 175, 217	C50, D24
DIB003494	Travoprost punctal plug	Glaucoma	365	H40-H42
DIB003495	LY-444711	Growth hormone deficiency	.	E23.0
DIB003496	Datelliptium chloride	Breast cancer	.	C50
DIB003497	JNJ-54861911	Alzheimer's disease	331	G30
DIB003498	EV-086 oral/intravenous formulation	Fungal infection	.	B35-B49
DIB003499	R-type pyocins	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB003500	ISF-402	Diabetes mellitus type 2	250	E11
DIB003501	Ticrynafen	Congestive heart failure	428	I50
DIB003502	DIMETHYNUR	Solid tumours	.	C00-C75,C7A,C7B
DIB003503	Anti-HCV program	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003504	Q-301	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003505	Zeamatin	Fungal infection	.	B35-B49
DIB003506	Gaegurin derivatives	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003507	DCVax-Ovarian	Pain	.	G89
DIB003508	CHS-0214	Ischemic heart disorders	.	I20-I25
DIB003509	B-850040	Solid tumours	.	C00-C75,C7A,C7B
DIB003510	NGD 96-3	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB003511	GT-1106	Chronic myelogenous leukemia	205.1	C92.1
DIB003512	Myocardial infarction therapy	Myocardial infarction	410	I21, I22
DIB003513	NP-213	Onychomycosis	.	B35.1
DIB003514	KRG-3332	Glaucoma	.	H40-H42
DIB003515	Memantine	Alzheimer's disease	331	G30
DIB003516	RS-93522	Hypertension	.	I10-I15
DIB003517	FSH superagonists	Infertility	.	N46,N97.0
DIB003518	ANG-2004	Obesity	278	E66
DIB003519	BetaRx	Diabetes mellitus type 1	250	E10
DIB003520	Analgesic peptides	Temporomandibular joint syndrome	.	M26
DIB003521	NB-325	HIV infections	42	B20
DIB003522	CIGB-552	Cancer	.	C00-C97
DIB003523	Gene therapy	Cancer	140-229	C00-C96
DIB003524	Poly-microbial agents	Infectious disease	001-139	A00-B99
DIB003525	PTP1b inhibitors	Diabetes mellitus type 2	.	E11
DIB003526	E047/1	Cardiac arrhythmias	.	I47-I49
DIB003527	CL-275838	Depression	311	F32
DIB003528	RP-73163	Arteriosclerosis	.	I70
DIB003529	TA-270	Asthma	.	J45
DIB003530	WX-04554	Bone disease	.	M00-M99
DIB003531	BZYX	Neurodegenerative diseases	.	G30-G32
DIB003532	177Lu-DOTATATE	Hepatitis C virus infection	.	B17.1,B18.2
DIB003533	Ii-key/MHC class II epitope hybrid peptides	Allergy	995.3	T78.4
DIB003534	Streptokinase rectal suppository	Hemorrhoids	.	I84
DIB003535	Thrombin inhibitors	Blood coagulation disorders	.	D65-D68
DIB003536	RT-001	Acne vulgaris	.	L70.0
DIB003537	Humanized mAb program	Ovarian cancer	.	C56
DIB003538	Pilsicainide	Heart arrhythmia	.	I47-I49
DIB003539	Adenosine A2b antagonists	Asthma	493	J45
DIB003540	UK-74505	Septic shock	.	A41.9
DIB003541	Hepatitis C virus therapy	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003542	PD-158473	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB003543	Lomeguatrib	Cancer	.	C00-C97
DIB003544	LAI338	Type 1 diabetes	250.01	E10
DIB003545	Tegafur	Cancer	140-229	C00-C96
DIB003546	Vivaglobin	Neuropathy	356.0, 356.8	G64, G90.0
DIB003547	BIZELESIN	Skin disease	.	L00-L99
DIB003548	LY03004	Schizophrenia	295	F20
DIB003549	HCV polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003550	ATL-313	Arteriosclerosis	.	I70
DIB003551	SM-19712	Hypertension	.	I10-I15
DIB003552	Tocofersolan	Vitamin E deficiency	.	E56.0
DIB003553	RF-1051	Genetic disorder	.	Q00-Q99
DIB003554	Human monoclonal antibodies	Cancer	140-229	C00-C96
DIB003555	Palladium Pd 103	Melanoma	.	C43
DIB003556	ADX-63365	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB003557	TAZOMELINE	Cognitive impairment	.	F06.7
DIB003558	Matrix M	Vaccination	.	.
DIB003559	NAChR alpha 7 APLs	Alzheimer's disease	331	G30
DIB003560	INV-155	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB003561	Avaxim	Hepatitis A virus infection	.	B15.9
DIB003562	Extrothyroxine	Hyperlipoproteinemia	.	E78
DIB003563	LACTIN-V	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003564	Monoclonal antibodies	Pancreatic cancer	.	C25
DIB003565	IGN301	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB003566	TAN-1496	Cancer	140-229	C00-C96
DIB003567	Dupilumab	Asthma	.	J45
DIB003568	MBP(75-95)	Multiple sclerosis	.	G35
DIB003569	MK-4815	Plasmodium falciparum infection	.	B54
DIB003570	Growth factor modulators	Cancer	140-229	C00-C96
DIB003571	GPX-150D	Breast cancer	.	C50
DIB003572	Astaxanthin derivative	Cardiovascular disease	390-459	I00-I99
DIB003573	AVE-1642	Breast cancer	.	C50
DIB003574	Anti-CD44vRA monoclonal antibody	Inflammatory diseases	.	.
DIB003575	Universal influenza A and B vaccine	Influenza virus infections	487	J10, J11
DIB003576	CC49 radioimmunoconjugates	Cancer	.	C00-C97
DIB003577	Nuleusin	Melanoma	.	C43
DIB003578	BIOO-2	Cancer	140-229	C00-C96
DIB003579	DEBIO-9902 SR	Alzheimer's disease	331	G30
DIB003580	Mycobacterium tuberculosis therapeutics	Mycobacterium tuberculosis infection	.	A15-A19
DIB003581	PS-178990	Muscle atrophy	.	M62.5
DIB003582	EPO	Discovery agent	.	.
DIB003583	Nicotinic ACh agonists	Alzheimer's disease	331	G30
DIB003584	AMG0714	Rheumatold arthritis	714	M05-M06
DIB003585	I-131 Na-I	Metastasis	.	C00-C97
DIB003586	IW-9179	Dyspepsia	536.8	K30
DIB003587	ROCK I/II inhibitors	Inflammatory diseases	.	.
DIB003588	Androgen restored contraceptive	Contraception	.	Z30
DIB003589	FP-85A	Mycobacterium tuberculosis infection	.	A15-A19
DIB003590	O-GlcNAcase (OGA)-targeting agents	Alzheimer's disease	331	G30
DIB003591	Sporidin-G	Diarrhea	.	A09,K59.1
DIB003592	LEO-29102	Atopic dermatitis	691.8	L20
DIB003593	GSK-2584786A	Influenza virus infections	487	J10, J11
DIB003594	EP-1300	Malaria	84	B50-B54
DIB003595	MOR-203	Cancer	140-229	C00-C96
DIB003596	MSP-2017	Cardiovascular disease	390-459	I00-I99
DIB003597	Omni-Raf inhibitors	Cancer	140-229	C00-C96
DIB003598	SOM-0720	Blood clotting disorder	286	D65-D69
DIB003599	RET tyrosine kinase inhibitors	Thyroid cancer	193	C73
DIB003600	BI-187004 CL	Type 2 diabetes	250.00, 250.02	E11
DIB003601	ANX-510	Pancreatic cancer	157	C25
DIB003602	AMI-HS	Liver disease	570-574	K70-K77
DIB003603	ACP-196	Chronic lymphocytic leukaemia	.	C91.1
DIB003604	KI-1001	Cancer	140-229	C00-C96
DIB003605	ADOZELESIN	Solid tumours	.	C00-C75,C7A,C7B
DIB003606	GSK-2231395A	Streptococcus pneumoniae infection	.	A00-B99
DIB003607	Org-20781	Heart arrhythmia	.	I47-I49
DIB003608	MK-287	Septic shock	.	A41.9
DIB003609	WIT-301	Insulin dependent diabetes	.	E10
DIB003610	Platinum drugs	Cancer	140-229	C00-C96
DIB003611	ME-3221	Hypertension	401	I10, I11, I12, I13, I15
DIB003612	Benperidol	Schizophrenia	295	F20
DIB003613	Choroid plexus cell therapy	Neurodegenerative diseases	.	G30-G32
DIB003614	REGN-421	Solid tumours	.	C00-C75,C7A,C7B
DIB003615	PV-801	Injury	.	S00-T88
DIB003616	Anti HB-EGF monoclonal antibodies	Cancer	140-229	C00-C96
DIB003617	EthR inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB003618	FSH	Discovery agent	.	.
DIB003619	Succimer	Metal intoxication	.	T56
DIB003620	TRP antagonists	Overactive bladder disorder	596.51	N32.81
DIB003621	Irreversible alpha selective PI3K inhibitors	Cancer	140-229	C00-C96
DIB003622	SDZ-SER-082	Neurological disease	.	G00-G99
DIB003623	TP-801	Cancer	140-229	C00-C96
DIB003624	Anti-CD-103 monoclonal antibodies	Immune disorder	.	D80-D89
DIB003625	PRS-060	Asthma	493	J45
DIB003626	KUC-7483	Overactive bladder disorder	.	N32.81
DIB003627	Voltage-gated ion channel modulators	Noise induced hearing loss	.	H90-H95
DIB003628	CC-220	Sarcoidosis	135	D86
DIB003629	PKC alpha inhibitor	Ovarian cancer	.	C56
DIB003630	111In-labeled LFA-1 targeted imaging agent (lymphoma/leukemia), NuView/University of New Mexico	Leukemia	.	C91-C95
DIB003631	Umbilical cord stem cell based HPV vaccine	Papillomavirus infections	.	B97.7
DIB003632	Girisopam	Anxiety disorder	300	F40-F42
DIB003633	RTI-113	Cocaine addiction	304.2	F14.2
DIB003634	GNI-103	Hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DIB003635	Interleukin-6	Hematological disease	.	D50-D89
DIB003636	Plasmodium vivax vaccine	Plasmodium vivax infection	.	B54
DIB003637	Betaine	Inborn error of metabolism	.	E88.9
DIB003638	HIV entry inhibitors	HIV infections	42	B20
DIB003639	PfENR inhibitors	Plasmodium falciparum infection	.	B54
DIB003640	PF-06427878	Hyperlipidemia	272.0-272.4	E78
DIB003641	PM-181108	Infectious disease	001-139	A00-B99
DIB003642	Antineoplaston A-10	Glioblastoma	.	C71
DIB003643	RAVAX	Psoriasis	696	L40
DIB003644	HG-1343	Cancer	140-229	C00-C96
DIB003645	MTD-102	Cancer	140-229	C00-C96
DIB003646	Hemoxin (Niprisan)	Anemia	.	D50-D64
DIB003647	VGV-1	HIV infections	42	B20
DIB003648	APG-101.10	Gout	274.00274.1274.8274.9	M10
DIB003649	MEDI-500	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB003650	GL-0NC1	Peritoneal cancer	.	C48.1-C48.2
DIB003651	HF-0220	Alzheimer's disease	.	G30,F00
DIB003652	VEGF superagonists	Cancer	140-229	C00-C96
DIB003653	CB-183872	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003654	ZD-3980	Prostate hyperplasia	.	N40
DIB003655	IL-15 plasmid gene therapy	Cancer	140-229	C00-C96
DIB003656	BM-212	Asthma	.	J45
DIB003657	Rubella virus vaccine live	Rubella virus infection	.	B06.9?
DIB003658	SLV-311	Gastrointestinal disease	.	K00-K93
DIB003659	CWF-0808	Transplant rejection	.	T86
DIB003660	Drug conjugate program	Cancer	140-229	C00-C96
DIB003661	IMM-308	Multiple sclerosis	340	G35
DIB003662	CS-92	Acquired immune deficiency syndrome	.	B20
DIB003663	LA-8045	Acute coronary syndrome	411.1	I20.0
DIB003664	NBI-98854	Movement disorder	.	R25
DIB003665	KB-9520	Cancer	.	C00-C97
DIB003666	RG7813	Solid tumours	.	C00-C75,C7A,C7B
DIB003667	Sodium pyruvate	Asthma	493	J45
DIB003668	BCX-1470	Bleeding	.	R58
DIB003669	Riboflavin	Acne vulgaris	706.1	L70.0
DIB003670	ME-1036	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003671	Encepur	Pediatric cancer	.	.
DIB003672	Arthritis therapies	Arthritis	710-719	M00-M25
DIB003673	NLG919	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB003674	Recombinant batroxobin	Blood forming organ disorders	.	D75.9
DIB003675	MAT-302	Ocular disease	.	H00-H59
DIB003676	CR-3294	Diarrhea	.	A09,K59.1
DIB003677	FM-TP5000 series	Diabetes mellitus type 2	.	E11
DIB003678	TTI-1612 intravesicular	Interstitial cystitis	.	N30.1
DIB003679	Anti-DLL4 antibodies	Cancer	140-229	C00-C96
DIB003680	Platelet activating factor receptor inhibitors	Pain	338,780	R52, G89
DIB003681	GSK-2239633	Asthma	493	J45
DIB003682	HBV vaccine	Hepatitis B virus infection	.	B16
DIB003683	LymphoRad-131	Lymphoma	.	C81-C96
DIB003684	Golotimod	Immuno-modulator	.	D80-D89
DIB003685	INV-21	Hand, foot and mouth disease	.	B08.4
DIB003686	BAY-27-9955	Diabetes mellitus type 2	.	E11
DIB003687	AG-13925	Cancer	140-229	C00-C96
DIB003688	Kidney disease medicine	Kidney failure	.	N17-N19
DIB003689	BM-17.0505	Diabetes mellitus	250	E08-E13
DIB003690	RNA polymerase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003691	Adoptive T-cell therapy	Melanoma	.	C43
DIB003692	LM-1376	Asthma	.	J45
DIB003693	PT001 GP	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB003694	DACOPAFANT	Septic shock	.	A41.9
DIB003695	SMOi2-17	Cancer	140-229	C00-C96
DIB003696	ICI-198583	Cancer	140-229	C00-C96
DIB003697	Etanercept	Sciatica	.	M54.3-M54.4
DIB003698	Dicycloplatin	Prostate cancer	.	C61
DIB003699	Adenovirus type 4 and 7 vaccine	Respiratory disease	.	J00-J99
DIB003700	Solulin	Thrombosis	.	I80-I82
DIB003701	OPC-18750	Cardiotonic	.	I50
DIB003702	LY-2623091	Chronic kidney disease	.	N18
DIB003703	RPR-101821	Arteriosclerosis	.	I70
DIB003704	Vibrilase	Burns and burn infection	001-139	A00-B99
DIB003705	HG-1387	Discovery agent	.	.
DIB003706	SC-106	Rheumatold arthritis	.	M05-M06
DIB003707	GTx-230	Cancer	140-229	C00-C96
DIB003708	MP-100	Anxiety disorder	300	F40-F42
DIB003709	SHAPE	Lymphoma	202.8	C81-C96
DIB003710	UltraCD40L	Systemic lupus erythematosus	710	M32
DIB003711	Non-nucleoside reverse transcriptase inhibitors	HIV infections	42	B20
DIB003712	ProVax	HIV infections	42	B20
DIB003713	AZ-TAK1	Mantle cell lymphoma	200.4	C85.7
DIB003714	Basulin	Diabetes mellitus	250	E08-E13
DIB003715	DISC-PRO	Herpes simplex virus infection	54	B00
DIB003716	Melanin concentrating hormone receptor-1 antagonists	Obesity	278	E66
DIB003717	DS-4574	Asthma	.	J45
DIB003718	Opioid agonists	Pain	338,780	R52, G89
DIB003719	Fenretinide	Macular degeneration	362.5	H35.3
DIB003720	Metallo-levodopa	Parkinson's disease	.	G20
DIB003721	Molecularly imprinted polymers	Atherosclerosis	414.0, 440	I70
DIB003722	HRC-102	Reperfusion injury	.	I00-I99
DIB003723	Human interferon alpha oral	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB003724	JTP-4819	Cognitive impairment	.	F06.7
DIB003725	Asthma therapeutic	Asthma	493	J45
DIB003726	Autolymphocyte therapy	Hepatitis B virus infection	.	B16
DIB003727	DNA-Ad	Plasmodium malariae infection	.	B50
DIB003728	AP5280	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003729	Secreted/transmembrane receptor proteins	Cachexia	799.4	R64
DIB003730	TVX-009	Discovery agent	.	.
DIB003731	ADX40-TB	Mycobacterium tuberculosis infection	.	A15-A19
DIB003732	11beta-HSD1 inhibitors (type 2 diabetes), Connexios Life Sciences	Non-insulin dependent diabetes	.	E11.9
DIB003733	HIF inhibitor project	Renal cell carcinoma	189	C64
DIB003734	SAR-21609	Asthma	493	J45
DIB003735	PSP-D-BAFF	Discovery agent	.	.
DIB003736	Cis-urocanic acid	Atopic dermatitis	691.8	L20
DIB003737	Dendritic cell vaccine	Melanoma	172	C43
DIB003738	99mTc-sestamibi	Breast cancer	174, 175, 217	C50, D24
DIB003739	MitoAscorbate	Non-alcoholic steatohepatitis	.	K75.81
DIB003740	ARC-1905	Macular degeneration	.	H35.3
DIB003741	MT-110	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB003742	Alzheimer's disease therapy	Alzheimer's disease	331	G30
DIB003743	AAV1-FS344	Macular degeneration	.	H35.3
DIB003744	Eladem	Prostate cancer	185	C61
DIB003745	NP-619	Alopecia	.	L65.9
DIB003746	A-101	Cardiovascular disease	390-459	I00-I99
DIB003747	CIP-137401	Cancer	140-229	C00-C96
DIB003748	Gene therapy	Inborn error of metabolism	.	E88.9
DIB003749	LESOPITRON DIHYDROCHLORIDE	Mood disorder	.	F30-F39
DIB003750	DPC-1528	Acne vulgaris	706.1	L70.0
DIB003751	UR-8225	Asthma	.	J45
DIB003752	Small molecule compounds	Cardiovascular disease	390-459	I00-I99
DIB003753	Glucokinase activators	Diabetes mellitus	250	E08-E13
DIB003754	R-1067	Major depressive disorder	296.2, 296.3	F32, F33
DIB003755	Interleukin-7 receptor	Autoimmune diseases	.	D84.9
DIB003756	PI-200	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB003757	GMDP	Infectious disease	001-139	A00-B99
DIB003758	Mannose receptor blocker (inhaled/oral	Asthma	493	J45
DIB003759	MX-7220	Lung cancer	.	C33-C34
DIB003760	AMI-25	Liver disease	570-574	K70-K77
DIB003761	SPM-5185	Angina	413	I20
DIB003762	Meningitis B vaccine	Neisseria meningitidis infection	.	A87
DIB003763	CVT-1	Hypercholesterolemia	272	E78.0
DIB003764	LIPO-4	HIV infections	42	B20
DIB003765	PF-06438179	Rheumatold arthritis	.	M05-M06
DIB003766	ACT-2	Wound healing	.	S91.3
DIB003767	ENRASENTAN	Pulmonary arterial hypertension	.	I27.0,I27.2
DIB003768	APV-001	Viral infections	042-075	A80-A99, B00-B34
DIB003769	Hypoestoxide	Cancer	.	C00-C97
DIB003770	Ebola virus entry inhibitors	Ebola virus infection	.	A98
DIB003771	AstaFactor	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB003772	Muscular dystrophy therapy	Muscular dystrophy	.	G71.0
DIB003773	NsG-33	Motor neurone disease	335.2	G12.2
DIB003774	Fibrin sealant	Bleeding	.	R58
DIB003775	DSLIM	Cancer	.	C00-C97
DIB003776	SC-54750	Emesis	.	R11
DIB003777	SM-10661	Septic shock	.	A41.9
DIB003778	Human embryonic stem cell therapy	Diabetes mellitus	250	E08-E13
DIB003779	Org-30035	Psychotic disorders	.	F20-F29
DIB003780	Humanized SMART Anti-IL-12 Antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB003781	Picroliv	Liver disease	570-574	K70-K77
DIB003782	Dual PPAR alpha/gamma agonists	Diabetes mellitus type 2	.	E11
DIB003783	Obesity therapeutics	Obesity	278	E66
DIB003784	NRX-1074	Major depressive disorder	296.2, 296.3	F32, F33
DIB003785	Interferon-alpha dimers	Cancer	.	C00-C97
DIB003786	EG-Decorin	Ulcer	531-534	K25-K27
DIB003787	Smallpox vaccine	Virus infection	.	B03
DIB003788	EMD-94283	Cancer	140-229	C00-C96
DIB003789	GPG-290	Angina	413	I20
DIB003790	MGN-4893	Polycythemia vera	238.4	D45
DIB003791	VAL-001	Acne vulgaris	706.1	L70.0
DIB003792	AC-710	Autoimmune diseases	279.4	D84.9, M35.9
DIB003793	Idiotypic vaccines	Mantle cell lymphoma	202.8	C81-C96
DIB003794	HSV2 DNA vaccine	Genital herpes	.	A60.09
DIB003795	Sibutramine mesylate	Obesity	278	E66
DIB003796	SeV gene therapy	Rheumatold arthritis	714	M05-M06
DIB003797	NeurTriptin	Neurodegenerative diseases	.	G30-G32
DIB003798	SRD-174	Pruritus	698	L29
DIB003799	GS-14K4	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003800	NexVax2	Diabetes mellitus type 1	.	E10
DIB003801	Amitivir	Viral infections	042-075	A80-A99, B00-B34
DIB003802	CS-038	Diabetes mellitus type 2	.	E11
DIB003803	AB-1096-targeting monoclonal antibodies	Ovarian cancer	.	C56
DIB003804	ALX-0061	Autoimmune diseases	.	D84.9
DIB003805	RSV-604	Viral infections	.	B34
DIB003806	NKTR-194	Pain	338,780	R52, G89
DIB003807	HT-2678	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB003808	Melapuldencel-T	Malignant melanoma	172	C43
DIB003809	BAY-Y-1015	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB003810	AN-207	Cancer	140-229	C00-C96
DIB003811	Tavaborole	Onychomycosis	.	B35.1
DIB003812	Ruthenium complexes	Autoimmune diseases	279.4	D84.9, M35.9
DIB003813	ANA-02	Pain	338,780	R52, G89
DIB003814	Pneumococcal vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB003815	Du-123015	Anxiety disorder	.	F40-F42
DIB003816	AG-331	Solid tumours	.	C00-C75,C7A,C7B
DIB003817	AIDSVAX	HIV infections	42	B20
DIB003818	Beta-catenin/Tcf-4 pathway inhibitors	Colorectal cancer	153, 154	C18-C21
DIB003819	Streptococcus pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB003820	HepaVaxx C	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003821	Lymphocyte-specific tyrosine kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB003822	PGL-2	Endometriosis	.	N80
DIB003823	Oral contraceptive	Sexual dysfunction	.	F52
DIB003824	VR736	Influenza virus infections	487, 488	J10, J11
DIB003825	SEL-100130	Inflammatory diseases	.	.
DIB003826	Human mAbs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003827	Protein tyrosine phosphatase 1B inhibitors	Metabolic disorders	.	E70-E90
DIB003828	Epstein-barr virus-specific immunotherapy	Nasopharyngeal carcinoma	.	C11.9
DIB003829	S-2150	Angina	.	I20
DIB003830	LE-SN38	Colorectal cancer	153, 154	C18-C21
DIB003831	A-68552	Obesity	278	E66
DIB003832	MEN-11149	Asthma	.	J45
DIB003833	WSB-290	Autoimmune diseases	279.4	D84.9, M35.9
DIB003834	OTK18 TF mAbs	Viral encephalitis	.	A86
DIB003835	Anti-inflammatory agent	Inflammatory diseases	.	.
DIB003836	Chk-1 kinase inhibitors	Cancer	140-229	C00-C96
DIB003837	Polyclonal antibodies	Obesity	278	E66
DIB003838	API-003	Inflammatory diseases	.	.
DIB003839	DA-3031	Neutropenia	288	D70
DIB003840	Cepacidine A	Fungal infection	.	B35-B49
DIB003841	CNS-1505	Neuropathy	356.0, 356.8	G64, G90.0
DIB003842	Antiparasitic	Leishmania infection	.	B55.0
DIB003843	DuP-532	Hypertension	401	I10, I11, I12, I13, I15
DIB003844	131I-CLR-1404	Cancer	.	C00-C97
DIB003845	G1T28-1	Cancer	.	C00-C97
DIB003846	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB003847	PUP-1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB003848	Glycan G-family glycogene 4 inhibitors	Non-alcoholic steatohepatitis	.	K75.81
DIB003849	Prosaptide TX14(A)	Neuropathic pain	338,780	R52, G89
DIB003850	APC-300	Prostate tumor	185	C61
DIB003851	Antiangiogenic Surrobodies	Cancer	140-229	C00-C96
DIB003852	SQ-109	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB003853	Esterom	Pain	338,780	R52, G89
DIB003854	Notch pathway inhibitors	Neurodegenerative diseases	.	G30-G32
DIB003855	Cebaracetam	Cognition disorders	.	F06.7
DIB003856	SC-01	Allergy	995.3	T78.4
DIB003857	B-247	Wound healing	.	S91.3
DIB003858	Vaccine	HIV infections	42	B20
DIB003859	Toca 511 & Toca FC combination	Glioblastoma	.	C71
DIB003860	Estradiol acetate	Menopause	627.2	N95.0
DIB003861	HCV entry inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003862	R-954	Diabetic complication	.	E08-E13
DIB003863	MAPKAP kinase 2 inhibitors	Inflammatory diseases	.	.
DIB003864	Vaccine	Parasitic infection	.	B89
DIB003865	ONC1-13B	Metastatic prostate cancer	185	C61
DIB003866	PX-867	Cardiovascular disease	390-459	I00-I99
DIB003867	IMD-1622	Myocardial infarction	410	I21, I22
DIB003868	Anticancers	Cancer	140-229	C00-C96
DIB003869	BAY-35-3377	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003870	MB-11055	Fatty liver disease	.	K70,K76.0
DIB003871	NN344	Diabetes mellitus	250	E08-E13
DIB003872	Plasma kallikrein inhibitors	Hereditary angioedema	277.6	D84.1
DIB003873	Lazabemide	Cognitive impairment	.	F06.7
DIB003874	Cardiospheres	Cardiac failure	.	I50
DIB003875	P-13	Otitis media	.	H65-H67
DIB003876	ENDG-8010	Epilepsy	345	G40
DIB003877	Viral uptake inhibitors	Ebola virus infection	.	A98
DIB003878	Inflexal V	Influenza virus infections	487	J10, J11
DIB003879	ISV-215	Glaucoma	365	H40-H42
DIB003880	Muscarinic M3 antagonists	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB003881	DUP-860	Fungal infections	110-118	B35-B49
DIB003882	Timcodar dimesilate	Cancer	140-229	C00-C96
DIB003883	Estrogen inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB003884	Sustained release incrementally modified drug	Dyspepsia	536.8	K30
DIB003885	NmVac4	Meningococcal infections	.	A39
DIB003886	Alpha synuclein-modulators	Parkinson's disease	.	G20
DIB003887	Radiolabelled-huA33	Colorectal cancer	.	C18-C20,C21
DIB003888	KD018	Liver cancer	.	C22
DIB003889	(99M)-TC-CPI	Diagnosis	.	Y57.6
DIB003890	ARX-212	Neurological disease	.	G00-G99
DIB003891	NT-001	Neuropathic pain	338,780	R52, G89
DIB003892	TDI-0028	Motor neurone disease	335.2	G12.2
DIB003893	CEP-2563	Solid tumours	.	C00-C75,C7A,C7B
DIB003894	UR-12460	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB003895	DM-PIT-1	Cancer	140-229	C00-C96
DIB003896	Acadesine	Diabetes mellitus	.	E10-E14
DIB003897	MV-NIS	Head and neck cancer	140-149	C07-C14, C32-C33
DIB003898	KK-562	Asthma	493	J45
DIB003899	XR-1853	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB003900	C-5997	Rheumatold arthritis	714	M05-M06
DIB003901	GIPR PAM program	Non-insulin dependent diabetes	.	E11.9
DIB003902	Colostat-G	Diarrhea	787.91	A09, K59.1
DIB003903	Protease inhibitors	Viral infections	.	B34
DIB003904	Onychomycosis patch	Onychomycosis	.	B35.1
DIB003905	Human recombinant factor VIII	Factor VIII deficiency	.	D66
DIB003906	EM-2487	HIV infections	42	B20
DIB003907	Hsp90 inhibitors	Cancer	140-229	C00-C96
DIB003908	QR-333	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB003909	CG-1255	Acute myeloid leukemia	205	C92.0
DIB003910	MG-1109	Influenza virus infections	487	J10, J11
DIB003911	Arylpropenamides	Hepatitis B virus infection	.	B16
DIB003912	AP-1030	Metabolic disorders	.	E70-E90
DIB003913	VM-501	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB003914	CDP-1050	Heart failure	.	I50
DIB003915	TT-310	Cancer	.	C00-C97
DIB003916	Hookworm vaccine	Infectious and parasitic disease	.	A00-B99
DIB003917	ATX-MS2	Multiple sclerosis	340	G35
DIB003918	Syk tyrosine kinase inhibitors	Allergy	.	T78.4
DIB003919	MAb based glypican-3 modulators	Cancer	140-229	C00-C96
DIB003920	AG-014	Celiac disease	579	K90.0
DIB003921	Protease inhibitors	Discovery agent	.	.
DIB003922	ALD-601	Lysosomal storage disease	.	E75-E77
DIB003923	AP-501	Autoimmune diseases	279.4	D84.9, M35.9
DIB003924	Abafungin	Fungal infection	.	B35-B49
DIB003925	AS-03	Discovery agent	.	.
DIB003926	VAL-101	Cancer	140-229	C00-C96
DIB003927	Dust mite peptide allergy desensitization	Allergy	995.3	T78.4
DIB003928	Ad-14nr prototype vaccine	Infectious disease	001-139	A00-B99
DIB003929	BIOO-1	Cancer	140-229	C00-C96
DIB003930	SSR-182289	Myocardial infarction	.	I21-I22
DIB003931	Histidase-PEG-20	Cancer	140-229	C00-C96
DIB003932	NMDA NR2B antagonists	Brain injury	.	S09.90
DIB003933	CPI-005	Cardiac failure	.	I50
DIB003934	PB-6	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB003935	LUSAPERIDONE	Depression	311	F32
DIB003936	Rheumatoid arthritis therapy	Rheumatold arthritis	714	M05-M06
DIB003937	SNG-8033	Leukemia	208.9	C91-C95
DIB003938	GPCR modulators	Schizophrenia	295	F20
DIB003939	Tyk2 kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB003940	Levodropropizine	Cough	786.2	R05
DIB003941	Vaccine	Herpes simplex virus infection	.	B00
DIB003942	GI-197111	Alopecia	.	L65.9
DIB003943	CTA-192	Hyperparathyroidism	252.02, 588.81	E21.1
DIB003944	Selective estrogen receptor modulators	Osteoporosis	733	M80-M81
DIB003945	HM-5016504	Cancer	140-229	C00-C96
DIB003946	SB-559457	Acute myeloid leukemia	205	C92.0
DIB003947	Antimalarial DNA vaccine	Plasmodium falciparum infection	.	B54
DIB003948	Immunosuppressive antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB003949	Mouse astrocyte-derived pluripotent stem cell therapy	Parkinson's disease	.	G20
DIB003950	HP-802-247	Duchenne dystrophy	.	G71.0
DIB003951	Antiviral agents	Viral infections	042-075	A80-A99, B00-B34
DIB003952	H1N1 influenza A vaccine	Influenza virus infections	487	J10, J11
DIB003953	TriAb/TriGem	Lung cancer	162	C33-C34
DIB003954	Xylose	Gastrointestinal disease	.	K00-K93
DIB003955	Multi-epitope tyrosinase/gp100 vaccine	Melanoma	172	C43
DIB003956	Atrovent/Combivent	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB003957	SAR342434	Diabetes mellitus	250	E08-E13
DIB003958	BU-4514N	Alzheimer's disease	.	G30,F00
DIB003959	HO-4073	Cancer	140-229	C00-C96
DIB003960	Tumor-associated macrophage immunotherapy	Cancer	140-229	C00-C96
DIB003961	Betulinic acid derivative caspase inducers	Cancer	140-229	C00-C96
DIB003962	Insulin secretion modulators	Non-insulin dependent diabetes	.	E11.9
DIB003963	VEGF-2 gene therapy	Cardiovascular disease	390-459	I00-I99
DIB003964	QBX258	Asthma	493	J45
DIB003965	Corticotropin	Cushing's disease	.	E24.9
DIB003966	ZIFROSILONE	Cognitive impairment	.	F06.7
DIB003967	QRX-401	Hypercholesterolemia	272	E78.0
DIB003968	ALTU-236	Genetic disorder	.	Q00-Q99
DIB003969	Dicationic compounds	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB003970	Filorexant	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB003971	TDI-0015	Motor neurone disease	335.2	G12.2
DIB003972	Beifutai	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB003973	RG7935	Parkinson's disease	332	F02.3, G20
DIB003974	BRT-FC-83C	Atopic dermatitis	691.8	L20
DIB003975	Candistat-G	Candida albicans infection	.	B37.0
DIB003976	ALS-AAV9	Motor neurone disease	335.2	G12.2
DIB003977	YM-534	Cancer	140-229	C00-C96
DIB003978	AMP-110	Autoimmune diseases	279.4	D84.9, M35.9
DIB003979	MS therapy	Multiple sclerosis	340	G35
DIB003980	SRG	Neutropenia	288	D70
DIB003981	GR-86014	Cognitive impairment	.	F06.7
DIB003982	Antimalarials	Plasmodium falciparum infection	.	B54
DIB003983	PF-06282999	Acute coronary syndrome	411.1	I20.0
DIB003984	CYT004-MelQcG10	Melanoma	.	C43
DIB003985	SR-2640	Asthma	.	J45
DIB003986	PF-4603629	Diabetes mellitus type 2	.	E11
DIB003987	Oncofetal antigen vaccine	Cancer	140-229	C00-C96
DIB003988	OMV-based Neisseria lactamia meningitidis vaccine	Neisseria meningitidis infection	.	A87
DIB003989	SQ-33351	Hypertension	401	I10, I11, I12, I13, I15
DIB003990	S-16020-2	Solid tumours	.	C00-C75,C7A,C7B
DIB003991	DGAT-1 inhibitors	Obesity	278	E66
DIB003992	CA-50040	Colorectal cancer	153, 154	C18-C21
DIB003993	RG-1662	Alzheimer's disease	.	G30,F00
DIB003994	SABIPORIDE MESILATE	Angina pectoris	413	I20
DIB003995	EREMOMYCIN	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB003996	RPI-78M injectable	HIV infections	42	B20
DIB003997	Immunomodulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB003998	SSS-08	Uterine cervix cancer	.	C53
DIB003999	LY-377604	Obesity	278	E66
DIB004000	BE-16627B	Inflammatory diseases	.	.
DIB004001	GATA-3-specific DNAzyme	Asthma	493	J45
DIB004002	Aom-0871	Transplant rejection	.	T86
DIB004003	PUR-0110	Inflammatory diseases	.	.
DIB004004	APN-601	Pain	338,780	R52, G89
DIB004005	Recombinant T-cell receptor ligand	Celiac disease	579	K90.0
DIB004006	CCR2 antagonists	Inflammatory diseases	.	.
DIB004007	HMaxi-K	Overactive bladder disorder	596.51	N32.81
DIB004008	Debio-0826	Cancer	140-229	C00-C96
DIB004009	Recombinant RGD-hirudin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB004010	Rimiterol	Asthma	493	J45
DIB004011	TDI-0115	Motor neurone disease	335.2	G12.2
DIB004012	Textilinin	Bleeding	.	R58
DIB004013	CWF-0902	Migraine	346	G43
DIB004014	UP-275-22	Hypertension	401	I10, I11, I12, I13, I15
DIB004015	Zinc acetate vaginal gel	HIV infections	42	B20
DIB004016	Managlinat dialanetil	Diabetes mellitus type 2	250	E11
DIB004017	A-74187	Peripheral vascular disease	443.9	I73.9
DIB004018	Relenza IV	Erectile dysfunction	.	F52.2,N48.4
DIB004019	JG-365	HIV infections	42	B20
DIB004020	Bmx kinase inhibitors	Cancer	140-229	C00-C96
DIB004021	Avipro	Prostate tumor	185	C61
DIB004022	GDC-0834	Rheumatold arthritis	714	M05-M06
DIB004023	MB-11316	Injury	.	S00-T88
DIB004024	EVP-1001-1	Heart disease	390-429	I00-I52
DIB004025	Cureskin	Scar tissue	.	L00-L99
DIB004026	Branched-chained aminotransferase-1 inhibitors	Cancer	.	C00-C97
DIB004027	EPI-001	Prostate tumor	185	C61
DIB004028	Trivalent vaccine	Bacillus anthracis infection	.	A22
DIB004029	STAT3 inhibitors	Cancer	140-229	C00-C96
DIB004030	Orochol	Vibrio cholerae infection	.	A00.0
DIB004031	AA-29504	Major depressive disorder	296.2, 296.3	F32, F33
DIB004032	WBI-2000 series	Cancer	140-229	C00-C96
DIB004033	ALO-02 Oxycodone- naltrexone core	Pain	338,780	R52, G89
DIB004034	PMX-30024	Mycobacterium tuberculosis infection	.	A15-A19
DIB004035	PRO-044	Duchenne muscular dystrophy	.	G71.0
DIB004036	Epothilone-based compounds	Autism	299	F84.0
DIB004037	OsteoCel	Injury	.	S00-T88
DIB004038	MBX-500	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004039	Recombinant human beta defensin 2	Atopic dermatitis	691.8	L20
DIB004040	HT-61	Staphylococcus aureus infection	.	A41.0
DIB004041	Galanin antagonists	Pancreatitis	577.0-577.1	K85, K86.0K86.1
DIB004042	CDK inhibitors	Cancer	140-229	C00-C96
DIB004043	Chemokine antagonists	HIV infections	42	B20
DIB004044	ELND-002	Autoimmune diseases	.	D84.9
DIB004045	XB-387	Non-small-cell lung cancer	162	C33, C34
DIB004046	Amyotrophic lateral sclerosis therapy	Motor neurone disease	335.2	G12.2
DIB004047	VLI-04A	Bacillus anthracis infection	.	A22
DIB004048	RQ-00000008	Inflammatory diseases	.	.
DIB004049	RetinoStat	Macular degeneration	.	H35.3
DIB004050	OXi4503 v	Refractory acute myeloid leukemia	205	C92.0
DIB004051	Panaecin	Lung infection	162	C33-C34
DIB004052	CXCR2 antagonists	Inflammatory diseases	.	.
DIB004053	Oligotide	Renal disease	.	N00-N29
DIB004054	TG-44	Helicobacter pylori infection	41.86	B96.81
DIB004055	CGP-38560A	Hypertension	.	I10-I15
DIB004056	Janus kinase 3 inhibitors	Inflammatory diseases	.	.
DIB004057	Rotarix	Rotavirus infections	001-139	A00-B99
DIB004058	RG-4929	Metabolic disorders	.	E70-E90
DIB004059	HL-162	Hyperlipidemia	272.0-272.4	E78
DIB004060	Ribozymes	HIV infections	42	B20
DIB004061	ICI-D-1542	Cardiovascular disease	390-459	I00-I99
DIB004062	Cytoporins	Bacterial respiratory tract infection	.	J13,J15
DIB004063	Synthetic peptide series	Cancer	.	C00-C97
DIB004064	Monoxanes	Plasmodium infection	.	B54
DIB004065	Plant-derived antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004066	MV-9411	Keratosis	.	L57.0
DIB004067	E coli toxin-based adjuvants	Discovery agent	.	.
DIB004068	Debio-1142	Cancer	140-229	C00-C96
DIB004069	ADV-1002401	Diabetes mellitus type 2	.	E11
DIB004070	AA-10044	Diabetes mellitus	250	E08-E13
DIB004071	TT-115	Blood clotting disorder	286	D65-D69
DIB004072	CNS-1044	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004073	Lurosetron	Emesis	.	R11
DIB004074	TPO therapy program	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB004075	Edetate disodium	Heart arrhythmia	.	I47-I49
DIB004076	M-1001	Lipid metabolism disorder	.	E75-E78
DIB004077	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB004078	Irofulven/Taxotere	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB004079	CAL-103-R	Herpes simplex virus infection	.	A60,B00
DIB004080	Albinterferon alfa-2b	Hepatitis C virus infection	.	B17.1,B18.2
DIB004081	MLCV liposome vaccine	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB004082	HL-021	Cancer	.	C00-C97
DIB004083	HPPT vaccine	Influenza virus infections	487	J10, J11
DIB004084	SapC-DOPS	Cancer	140-229	C00-C96
DIB004085	Aviptadil	Acute lung injury	518	J80
DIB004086	PDE 7 inhibitors	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB004087	FCE-20696	Mycobacterium tuberculosis infection	.	A15-A19
DIB004088	SKF-105685	Autoimmune diseases	279.4	D84.9, M35.9
DIB004089	Urinary tract infections vaccine	Urinary tract infections	599	N39.0
DIB004090	RDEA-684	Gout	274.00274.1274.8274.9	M10
DIB004091	Leucine-rich repeat kinase 2 (LRRK2) inhibitors	Parkinson's disease	.	G20
DIB004092	Anti-chikungunya monoclonal antibodies	Chikungunya virus infection	.	A92.0
DIB004093	NCX1 activation inhibitor	Multiple sclerosis	340	G35
DIB004094	Therapeutic peptide program	Lipid metabolism disorder	.	E75-E78
DIB004095	20S proteasome inhibitors (cancer), Millennium Pharmaceuticals	Cancer	140-229	C00-C96
DIB004096	RG-14893	Asthma	493	J45
DIB004097	MGN-1703	Colorectal cancer	.	C18-C20,C21
DIB004098	Her2-targeted autologous T-cell therapy	Glioblastoma	.	C71
DIB004099	Ether lipid	Cancer	.	C00-C97
DIB004100	NBI-29	Prostate tumor	185	C61
DIB004101	VVZ-140	Pain	338,780	R52, G89
DIB004102	G009	Immuno-stimulant	.	.
DIB004103	AC-262271	Glaucoma	365	H40-H42
DIB004104	Influenza A virus H7N9 vaccine	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB004105	Endothelial nitric oxide synthase gene therapy	Ischemia	459.89	I99.8
DIB004106	Topical anticholinergics	Discovery agent	.	.
DIB004107	Peptide deformylase inhibitor	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004108	CXCR7 antagonists	Cancer	.	C00-C97
DIB004109	N-0861	Cardiac disease	.	I00-I99
DIB004110	Ilodecakin	Scar tissue	.	L00-L99
DIB004111	153Sm-EDTMP	Bone metastases	198.5	C79.51
DIB004112	Nabi-HB (intravenous)	Hepatitis B virus infection	070.2, 070.3, 573.3	B16, B18.0, B18.1, K75.9
DIB004113	FANDOFLOXACIN HYDROCHLORIDE	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB004114	HIV vaccine	HIV infections	42	B20
DIB004115	Amphotericin B inhalation powder	Fungal infection	.	B35-B49
DIB004116	S1P1 agonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB004117	L2 capsid protein-targeting monovalent vaccine	Papillomavirus infections	.	B97.7
DIB004118	Chondroitinase AC/B	Spinal cord injuries	952	S14, S24, S34
DIB004119	FG-3622	Fungal infection	.	B35-B49
DIB004120	Ampiroxicam	Inflammatory diseases	.	.
DIB004121	AN-3661	Plasmodium falciparum infection	.	B54
DIB004122	PRT-20	Duchenne dystrophy	.	G71.0
DIB004123	OG-19	Dementia	290-294	F01-F07
DIB004124	C-Cbl shRNA adenoviral gene therapy	Cancer	140-229	C00-C96
DIB004125	Suriclone	Anxiety disorder	300	F40-F42
DIB004126	TACE inhibitors	Inflammatory diseases	.	.
DIB004127	Enterococcus faecalis vaccine	Enterococcus faecalis infection	.	B95.2
DIB004128	Bee venom allergy vaccine	Allergy	995.3	T78.4
DIB004129	CorrolVec	Cancer	140-229	C00-C96
DIB004130	HRI kinase inhibitors	Anemia	280-285	D50-D64
DIB004131	NCX 950	Asthma	493	J45
DIB004132	Potassium iodide	Thyrotoxicosis	.	E05.90
DIB004133	Weight regulating human endocrine peptide	Obesity	278	E66
DIB004134	Anti-CD-20 mAb	Discovery agent	.	.
DIB004135	BZF961	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB004136	Lanosterol demethylase inhibitors	Leishmania infection	.	B55.0
DIB004137	LEO-90110	Psoriasis	696	L40
DIB004138	EC-0565	Cancer	.	C00-C97
DIB004139	Sharon-1000	Mycobacterium tuberculosis infection	.	A15-A19
DIB004140	PCNU	Brain cancer	191	C71
DIB004141	2-deoxyglucose	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB004142	AG-013958	Age related macular degeneration	.	H35.30
DIB004143	VA-DIFTET	Clostridium tetani infection	001-139	A00-B99
DIB004144	MCD-386	Alzheimer's disease	.	G30,F00
DIB004145	Modified BCG vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB004146	CSL-112	Atherosclerosis	414.0, 440	I70
DIB004147	BrevaRex	Multiple myeloma	.	C90.0
DIB004148	GR-DD1	Liver cancer	155	C22.0
DIB004149	CGP-48369	Hypertension	401	I10, I11, I12, I13, I15
DIB004150	Acellular pertussis vaccine	Allergy	995.3	T78.4
DIB004151	AZD-8165	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB004152	Lipoteichoic acid	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004153	58-1066	Cancer	140-229	C00-C96
DIB004154	NT-FV-007	Motor neurone disease	335.2	G12.2
DIB004155	FBPase inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB004156	Sutilains	Skin burns	940-949	T20-T31
DIB004157	ABT-116	Pain	338,780	R52, G89
DIB004158	Therapeutic peptide program	Obesity	278	E66
DIB004159	Enadoline	Pain	.	G89
DIB004160	Bubonic plague vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004161	JB991	Skin infections	680-709	L00-L99
DIB004162	Quorum sensing inhibitor	Staphylococcus aureus infection	.	A41.0
DIB004163	GS-4997	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DIB004164	MEDI8897	Respiratory syncytial virus 	.	J12.1
DIB004165	AVL-3288	Cognition disorders	.	F06.7
DIB004166	LipoTECA	Scar tissue	.	L00-L99
DIB004167	Parenteral Cephalosporin	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB004168	KC-11458	Gastric motility disorder	.	K22.4
DIB004169	11C-PBR-170	Discovery agent	.	.
DIB004170	DCB-WH1	Diabetic foot ulcer	.	E08-E13
DIB004171	Casein kinase 1 inhibitors	Cancer	.	C00-C97
DIB004172	CAMOR antagonists	Movement disorder	.	R25
DIB004173	SR-43845	Glaucoma	.	H40-H42
DIB004174	OX-914	Asthma	.	J45
DIB004175	Nebracetam	Parkinson's disease	.	G20
DIB004176	SPI-5557	Deafness	.	H90-H91
DIB004177	BMS-180560	Hypertension	401	I10, I11, I12, I13, I15
DIB004178	HG-1097	Cancer	140-229	C00-C96
DIB004179	DCVax-Liver	Liver cancer	155	C22.0
DIB004180	PSI-879	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004181	ASP-0265	Endometriosis	617	N80
DIB004182	ThermoProfen	Pain	.	G89
DIB004183	DTI-0026	Glomerulonephritis	580-582	N00, N01, N03, N18
DIB004184	JCAR017	Leukaemia	.	C91-C95
DIB004185	Laevo-Bambuterol	Asthma	493	J45
DIB004186	PRX-12205	Neurological disease	.	G00-G99
DIB004187	EDP-420	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB004188	L-670596	Asthma	493	J45
DIB004189	PC-1005	HIV infections	42	B20
DIB004190	BMS-816336	Lipid metabolism disorder	.	E75-E78
DIB004191	MGluR2 PAMs	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB004192	PT2.0	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB004193	Fluzone QIV ID	Ovarian cancer	183	C56
DIB004194	Hemoparatide	Metabolic disorders	.	E70-E90
DIB004195	SOM-0633	Fungal infection	.	B35-B49
DIB004196	Neorphine series	Pain	338,780	R52, G89
DIB004197	Recombinant adenovirus vector vaccine	Alzheimer's disease	331	G30
DIB004198	CRD-5	Hyperlipidemia	.	E78.5
DIB004199	GCAN 101	Melanoma	.	C43
DIB004200	Interferon alpha	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004201	ETI-204	Anthrax	22	A22
DIB004202	Calcium release-activated calcium channel (CRAC) inhibitor	Non-small-cell lung cancer	162	C33, C34
DIB004203	Synthetic carbohydrate-based vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004204	ET-009	Bladder cancer	188	C67
DIB004205	Repirinast	Asthma	493	J45
DIB004206	NSL-101	Oral facial pain	338,780	R52, G89
DIB004207	CNT0-5825	Allergic asthma	493	J45
DIB004208	SAR-407899	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DIB004209	OPC-28326	Peripheral vascular disease	443.9	I73.9
DIB004210	OBE-102	Weight loss	.	R63.4
DIB004211	AVI-4557	Anxiety disorder	.	F40-F42
DIB004212	SAR-113945	Osteoarthritis	715	M15-M19, M47
DIB004213	PPI-1301	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004214	EDI1200	Ectodermal dysplasia	.	Q82.4
DIB004215	CGEN-25068	Immune disorder	.	D80-D89
DIB004216	Tolecine	Herpesvirus infection	.	B00
DIB004217	JTV-806	Restenosis	.	I51.89
DIB004218	NanoEmulsion NSAID	Osteoarthritis	715	M15-M19, M47
DIB004219	FHT-1106	Ischemic heart diseases	410-414	I20-I25
DIB004220	R-TPR-013	Female infertility	628	N97.0
DIB004221	AS-01 adjuvant	Discovery agent	.	.
DIB004222	SAL-200	Staphylococcus aureus infection	001-139	A00-B99
DIB004223	SR-44163	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB004224	IMMLG-5521	Inflammatory diseases	.	.
DIB004225	BPI-713001	Diabetes mellitus	250	E08-E13
DIB004226	GTU-dengue vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB004227	Synthetic hypericin	Viral infections	042-075	A80-A99, B00-B34
DIB004228	Human monoclonal antibody	Influenza virus infections	487	J10, J11
DIB004229	SPX-601	Arthritis	710-719	M00-M25
DIB004230	TOPIXANTRONE HYDROCHLORIDE	Gastric cancer	.	C16
DIB004231	DTwP-HBV vaccine	Hepatitis B virus infection	.	B16
DIB004232	HIV integrase inhibitors	HIV infections	42	B20
DIB004233	SG-292	Cancer	140-229	C00-C96
DIB004234	IKACh channel inhibitors	Atrial fibrillation	427.31	I48
DIB004235	Neo-1507	Osteoarthritis	.	M19.90
DIB004236	HP-161	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004237	PS-873266	Inflammatory diseases	.	.
DIB004238	RXI-109	Fibrosis	.	L90.5
DIB004239	Recombinant TSH superagonists	Thyroid cancer	193	C73
DIB004240	JR-101	Gaucher disease	272.7	E75.2
DIB004241	CT-340	Arthritis	710-719	M00-M25
DIB004242	Nucleoside analogs	Cancer	140-229	C00-C96
DIB004243	Kaposi's sarcoma-associated herpesvirus inhibitors	Kaposi's sarcoma	.	C46.1
DIB004244	Ioflubenzamide (131I)	Melanoma	172	C43
DIB004245	Adenovirus/Semliki Forest virus hybrid vector delivered IL-12 immunotherapy	Hepatitis B virus infection	.	B16
DIB004246	Lantibiotic-based proteins	Influenza virus infections	487	J10, J11
DIB004247	MM-46115	Viral infections	042-075	A80-A99, B00-B34
DIB004248	PDGF	Gastrointestinal disease	.	K00-K93
DIB004249	GSK-114814	Alcohol use disorders	303	F10.2
DIB004250	Selegiline	Major depressive disorder	296.2, 296.3	F32, F33
DIB004251	Pretarget technology	Cancer	140-229	C00-C96
DIB004252	A-887755	Alzheimer's disease	331	G30
DIB004253	IKur antagonist	Atrial fibrillation	427.31	I48
DIB004254	EG-HPV	Papillomavirus infections	.	B97.7
DIB004255	AZM-121	Irritable bowel syndrome	564.1	K58
DIB004256	ISIS-SOD1Rx	Motor neurone disease	335.2	G12.2
DIB004257	Hsp 90 inhibitors	Cancer	140-229	C00-C96
DIB004258	Fentiazac	Dysmenorrhea	.	N94.4-N94.6
DIB004259	CT-3501	Coronary artery disease	410-414, 429.2	I20-I25
DIB004260	Prophylactic multivalent anthrax/plague vaccine	Bacillus anthracis infection	.	A22
DIB004261	18F-AV-1451	Alzheimer's disease	.	G30,F00
DIB004262	OX-008	Angina	413	I20
DIB004263	PHA-793887	Cancer	140-229	C00-C96
DIB004264	Hepatitis C immune globulin	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DIB004265	Cat-SPIRE	Cancer	140-229	C00-C96
DIB004266	Eptazocine patch	Pain	338,780	R52, G89
DIB004267	PB-108	Infectious disease	001-139	A00-B99
DIB004268	MDX-1411	Cancer	.	C00-C97
DIB004269	CAT-1904	Non-insulin dependent diabetes	.	E11.9
DIB004270	Anti-Let-7 microRNA therapy	Diabetes mellitus	250	E08-E13
DIB004271	EDP-23	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004272	DPV-001	Non-small-cell lung carcinoma	162	C33, C34
DIB004273	Dezinamide	Epileptic seizure	.	G40,R56
DIB004274	ADE-APTK	Scar tissue	.	L00-L99
DIB004275	KDT-600	Obesity	278	E66
DIB004276	E-4021	Cardiovascular disease	.	I00-I99
DIB004277	MDT-012	Autoimmune diseases	279.4	D84.9, M35.9
DIB004278	CYT-004-MelQbG10	Melanoma	.	C43
DIB004279	Ad2/HIF-1alpha/VP16	Peripheral vascular disease	443.9	I73.9
DIB004280	Erythromycin/sulfisoxazole	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004281	LN-020	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004282	PNU-109291	Migraine	346	G43
DIB004283	Inactivated virus vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB004284	GRNIC-1	Insulin dependent diabetes	.	E10
DIB004285	WY-50295-tromethamine	Asthma	.	J45
DIB004286	Neuroprotectant	Alzheimer's disease	331	G30
DIB004287	RSD-921	Anesthesia	338	R52
DIB004288	Carabersat	Epileptic seizure	.	G40,R56
DIB004289	Multiple selective kinase inhibitors	Leukemia	208.9	C91-C95
DIB004290	Activated adult marrow stromal cells	Immune disorder	.	D80-D89
DIB004291	Phosphonate	Leukemia	.	C91-C95
DIB004292	GLPG-0492	Cachexia	.	R64
DIB004293	Acne therapy	Acne vulgaris	706.1	L70.0
DIB004294	Gevotroline	Psychotic disorders	.	F20-F29
DIB004295	TPI-1020	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB004296	Hormone antagonists	Cancer	140-229	C00-C96
DIB004297	MIF modulators	Cancer	140-229	C00-C96
DIB004298	VSF-173	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB004299	MRX34	Liver cancer	.	C22
DIB004300	EPI-3905	Gastrointestinal disease	.	K00-K93
DIB004301	NN-8226	Psoriasis	.	L40
DIB004302	GSK-958108	Premature ejaculation	302.75	F52.4
DIB004303	Anti-NTB-A monoclonal antibodies	Cancer	140-229	C00-C96
DIB004304	C-Met antagonist monoclonal antibody	Cancer	140-229	C00-C96
DIB004305	ST-802	Ocular disease	.	H00-H59
DIB004306	MUC1 inhibitor	Cancer	140-229	C00-C96
DIB004307	Grass allergy vaccine	Allergic rhinitis	477	J30
DIB004308	BLI-1100	Acne vulgaris	706.1	L70.0
DIB004309	GP88 neutralizing monoclonal antibody	Cancer	140-229	C00-C96
DIB004310	ACH-2881	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004311	Small molecule analgesics	Pain	338,780	R52, G89
DIB004312	S1P1 agonists	Cardiovascular disease	390-459	I00-I99
DIB004313	KBAB-401	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004314	Botulinum toxin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004315	PH-284	Cachexia	799.4	R64
DIB004316	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB004317	Therapeutic vaccine	Colon cancer	153, 154	C18-C21
DIB004318	VCH-286	HIV infections	42	B20
DIB004319	Cordil	Heart arrhythmia	.	I47-I49
DIB004320	MILACAINIDE TARTRATE	Cardiac arrhythmias	.	I47-I49
DIB004321	Migrastatin analogs	Metastasis	.	C00-C97
DIB004322	AP-1101	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB004323	AVP-26452	Hyperlipidemia	272.0-272.4	E78
DIB004324	Histone deacetylase inhibitors	Immune disorder	.	D80-D89
DIB004325	Influenza A virus H3N2 vaccine	Influenza A virus H3N2 infections	.	J11.1
DIB004326	H-33525	Esophagitis	.	K20
DIB004327	Aposense probe-cytotoxic agent conjugates	Cancer	140-229	C00-C96
DIB004328	MIST-B03	Inflammatory diseases	.	.
DIB004329	Coprexa	Neurological disease	.	G00-G99
DIB004330	IPI-950	Renal failure	584, 585	N17, N18, N19
DIB004331	ZP-013	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB004332	Dengue fever vaccine	Dengue fever	061, 780.6	A90, R50
DIB004333	HIV protease inhibitors	HIV infections	42	B20
DIB004334	AZD-3778	Asthma	493	J45
DIB004335	PSI-6130	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004336	BL-5040	Cachexia	799.4	R64
DIB004337	Therapeutic program	Mycobacterium tuberculosis infection	.	A15-A19
DIB004338	DuP-991	Fungal infection	.	B35-B49
DIB004339	Albumin-binding paclitaxel prodrug	Prostate tumor	185	C61
DIB004340	Satigrel	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB004341	EVT-301	Alzheimer's disease	.	G30,F00
DIB004342	Tafluposide	Cancer	.	C00-C97
DIB004343	DTwP-HepB prophylactic vaccine	Hepatitis B virus infection	.	B16
DIB004344	H5N1 avian influenza subunit vaccines	Influenza virus infections	487	J10, J11
DIB004345	AAV-HIV vaccine	HIV infections	42	B20
DIB004346	CBLB-612	Radiation sickness	990	T66
DIB004347	AFCo1/recombinant MSP vaccine	Plasmodium infection	.	B54
DIB004348	ET-006	Ovarian cancer	.	C56
DIB004349	JNK inhibitors	Neurodegenerative diseases	.	G30-G32
DIB004350	Parvovirus H-1	Glioblastoma	191	C71
DIB004351	SFc	Autoimmune diseases	279.4	D84.9, M35.9
DIB004352	Small molecule therapeutics	Psychiatric disorders	.	F99
DIB004353	AMPPL	Diabetes mellitus	250	E08-E13
DIB004354	AP-401	Inflammatory diseases	.	.
DIB004355	IkT-001	Infectious disease	001-139	A00-B99
DIB004356	Small molecule compounds	Non-insulin dependent diabetes	.	E11.9
DIB004357	VLP vaccine	Influenza virus infections	487	J10, J11
DIB004358	LEX-028	Inflammatory diseases	.	.
DIB004359	DISC GM-CSF	Melanoma	.	C43
DIB004360	Nedaplatin	Non-small-cell lung cancer	162	C33, C34
DIB004361	Particle 3B	HIV infections	42	B20
DIB004362	MK-4214	Neutropenia	288	D70
DIB004363	Human liver progenitor cells	Liver cirrhosis	.	K70.3,K71.7,K74
DIB004364	ALB-137391(a)	Irritable bowel syndrome	564.1	K58
DIB004365	Viloxazine	Major depressive disorder	296.2, 296.3	F32, F33
DIB004366	MG-3	Plasmodium infection	.	B54
DIB004367	CAP-7.1	Cancer	140-229	C00-C96
DIB004368	RG7800	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DIB004369	ESN-YY	Inflammatory diseases	.	.
DIB004370	2085-P	Otitis media	.	H65-H67
DIB004371	BP-C2	Radiation sickness	990	T66
DIB004372	JTK-003	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004373	Hepatitis C virus E2 protein vaccines	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004374	EC-708	Prostate tumor	185	C61
DIB004375	Light-activated photodynamic compounds (PDC) photodynamic therapy	Cancer	140-229	C00-C96
DIB004376	PELITREXOL	Cancer	140-229	C00-C96
DIB004377	OM-174	Cancer	.	C00-C97
DIB004378	VAP-1	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB004379	LY-2940094	Major depressive disorder	.	F32,F33
DIB004380	OBP-401	Cancer	140-229	C00-C96
DIB004381	XR-368	Anxiety disorder	300	F40-F42
DIB004382	Sel-K1	Inflammatory bowel disease	555, 556	K50, K51
DIB004383	H2S-releasing derivatives of acetylsalicylic acid	Cardiovascular disease	390-459	I00-I99
DIB004384	Tetrabranched peptides	Multidrug resistant infection	.	A00-B99
DIB004385	Etretinate	Keratosis	.	L57.0
DIB004386	NGN-9077	Multiple system atrophy	.	G90.3
DIB004387	EphB4 neutralizing antibody	Cancer	140-229	C00-C96
DIB004388	APT070	Kidney diseases	580-589	N00-N29
DIB004389	DK-507k	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004390	Luzindole	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB004391	Undisclosed compounds	Pain	338,780	R52, G89
DIB004392	CFC-240	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004393	S-17092-1	Cognitive impairment	.	F06.7
DIB004394	Anti-PECAM-1 mAb	Cancer	140-229	C00-C96
DIB004395	AD-5467	Diabetes mellitus	.	E10-E14
DIB004396	LK-903	Atherosclerosis	414.0, 440	I70
DIB004397	ODSH	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB004398	BLY719	Solid tumours	.	C00-C75,C7A,C7B
DIB004399	Dendritic cell electrofusion cancer vaccine	Kidney cancer	140-229	C00-C96
DIB004400	DU-6681	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB004401	SprayGel	Laparoscopic; Open pelvic; Abdominal surgical procedure	.	.
DIB004402	Anti-CD47 mAb	Ischemia	459.89	I99.8
DIB004403	NKTT-320	Cancer	.	C00-C97
DIB004404	Pyrimethamine/sulfadoxine	Pneumocystis carinii infection	.	B59
DIB004405	Nuclear importation inhibition compounds	HIV-1 infections	42	B20
DIB004406	Humanized monoclonal antibodies	Thyroid associated ophthalmopathy	.	H06.2
DIB004407	Alpha-MSH peptide derivatives	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004408	DP-3005	Angina	413	I20
DIB004409	Polyoxidonium	Infectious disease	001-139	A00-B99
DIB004410	Lirequinil	Anxiety disorder	.	F40-F42
DIB004411	Hepatect CP	Hepatitis B virus infection	.	B16
DIB004412	MK-7622	Alzheimer's disease	331	G30
DIB004413	CP-870893	Cancer	140-229	C00-C96
DIB004414	SEL-103	Alzheimer's disease	331	G30
DIB004415	AL-59412C	Ocular hypertension	365.04	H40.0
DIB004416	CK-2066260	Neuromuscular disease	.	N31.9
DIB004417	OTX-015	Myelodysplastic syndromes	.	D46
DIB004418	Histone deacetylase inhibitors	Cancer	.	C00-C97
DIB004419	GABA-B receptor PAM	Anxiety disorder	300	F40-F42
DIB004420	FAS inhibitors	Cancer	140-229	C00-C96
DIB004421	Ear disorder therapeutics	Ear disease	.	H83.9
DIB004422	Pramoxine	Anal fissure	.	K60.0-K60.2
DIB004423	AZD-9335	Gastroesophageal reflux disease	.	K21
DIB004424	JNJ-38877605	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004425	SWT-02.100	Wound healing	.	S91.3
DIB004426	UX-004	Lysosomal storage disease	.	E75-E77
DIB004427	MEDI7510	Respiratory syncytial virus 	001-139, 079.6	A00-B99, B97.4
DIB004428	PV-802	Gastrointestinal disease	.	K00-K93
DIB004429	Bromperidol	Schizophrenia	295	F20
DIB004430	PAV-617	Ebola virus infection	.	A98
DIB004431	MER-3001	Diabetes mellitus type 1	.	E10
DIB004432	Fexinidazole	Trypanosomiasis	086.5-086	B56-B57
DIB004433	ETN-001	Alzheimer's disease	331	G30
DIB004434	VT-1	Breast cancer	174, 175, 217	C50, D24
DIB004435	NS5A inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004436	PPLs	Neurodegenerative diseases	.	G30-G32
DIB004437	CO-12	Mycobacterium tuberculosis infection	.	A15-A19
DIB004438	Decorin-like collagen-binding peptidoglycan	Scar tissue	.	L00-L99
DIB004439	NW-1772	Neurodegenerative diseases	.	G30-G32
DIB004440	ELAD	Heart failure	.	I50
DIB004441	CNTO-5825	Allergic asthma	493	J45
DIB004442	Panamesine	Psychotic disorders	.	F20-F29
DIB004443	Antiangiogenesis gene therapy	Cancer	140-229	C00-C96
DIB004444	P113D	Cystic fibrosis	277	E84
DIB004445	Gastrointestinal therapy	Gastric motility disorder	.	K22.4
DIB004446	FR-900482	Leukemia	.	C91-C95
DIB004447	AZD-8418	Schizophrenia	295	F20
DIB004448	Recombinant pox virus vaccine	Melanoma	172	C43
DIB004449	FGFR2-ADC	Cancer	140-229	C00-C96
DIB004450	Prohibitin targeting peptide-1	Obesity	.	E66
DIB004451	HI-con1	Cancer	.	C00-C97
DIB004452	C-met kinase inhibitor	Cancer	140-229	C00-C96
DIB004453	Cefpiroxime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004454	Tiapamil	Cardiovascular disease	390-459	I00-I99
DIB004455	DHAC	Mesothelioma	.	C45
DIB004456	BI-661051	Cancer	.	.
DIB004457	HM-78136B	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004458	HBI-3000	Heart arrhythmia	.	I47-I49
DIB004459	IL-2 antibody	Cancer	140-229	C00-C96
DIB004460	NWP-09	Attention deficit hyperactivity disorder	314	F90
DIB004461	HIV vaccine	HIV infections	42	B20
DIB004462	Pentetate calcium trisodium	Acute radiation syndrome	.	T66
DIB004463	GS-438	Cancer	.	C00-C97
DIB004464	ISIS-1082	Viral infections	042-075	A80-A99, B00-B34
DIB004465	5-LO (pain/neuro-inflammation), St Charles Pharmaceuticals	Nervous system inflammation	.	G00-G09
DIB004466	Recombinant protein subunit vaccine	Influenza virus infections	487	J10, J11
DIB004467	B-B4-DC1	B-cell lymphoma	202.8	C85.1
DIB004468	Protein-protein interaction inhibitors	Cancer	140-229	C00-C96
DIB004469	50-235	Hypertension	.	I10-I15
DIB004470	Clofoctol	Bronchitis	.	J20-J21,J42
DIB004471	CROMOGLYCATE LISETIL HYDROCHLORIDE	Asthma	.	J45
DIB004472	SEGLITIDE	Pain	.	G89
DIB004473	HiviCides I and II	HIV infections	42	B20
DIB004474	S-38093	Alzheimer's disease	.	G30,F00
DIB004475	BBT-018	Neutropenia	288	D70
DIB004476	Isomazole	Asthma	493	J45
DIB004477	IMP-111	Cancer	140-229	C00-C96
DIB004478	PT-630	Diabetes mellitus type 2	.	E11
DIB004479	TDI-0020	Motor neurone disease	335.2	G12.2
DIB004480	RLIP76 protein	Dermatological disease	.	L00-L99
DIB004481	11-beta hydroxysteroid dehydrogenase inhibitors (metabolic disorder), Ipsen	Metabolic disorders	.	E70-E90
DIB004482	ImCOOH	Acne vulgaris	706.1	L70.0
DIB004483	CI-933	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB004484	INO-5150	Prostate tumor	185	C61
DIB004485	Tromethamine	Acidosis	.	E87.2
DIB004486	IB-09A149	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004487	Desirudin IV	Coronary arteries 	.	I25
DIB004488	KIN-3031	Pain	338,780	R52, G89
DIB004489	RG-7432	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004490	EXP-6803	Hypertension	401	I10, I11, I12, I13, I15
DIB004491	TAS-114	Cancer	.	C00-C97
DIB004492	Glisolamide	Diabetes mellitus	250	E08-E13
DIB004493	MAPKAP kinase 2 inhibitors	Inflammatory diseases	.	.
DIB004494	ON-09250	Central nervous system disease	.	G00-G99
DIB004495	MDX-1203	Cancer	.	C00-C97
DIB004496	Hemagglutinin inhibitors	Influenza virus infections	487	J10, J11
DIB004497	SWT-05141	Atopic dermatitis	691.8	L20
DIB004498	Third-generation recombinant protective antigen program	Bacillus anthracis infection	.	A22
DIB004499	EDN-OL1	Alzheimer's disease	331	G30
DIB004500	IL-8 antagonists	Angiogenesis disorder	.	I00-I99
DIB004501	Prinoxodan	Cardiac failure	.	I50
DIB004502	M-114	Viral infections	042-075	A80-A99, B00-B34
DIB004503	ABT-RTA-408	Non-small cell lung cancer	.	C33-C34
DIB004504	Trospectomycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004505	Kv4.3 voltage-dependent potassium channel antagonists	Heart arrhythmia	.	I47-I49
DIB004506	KI-0803	Cancer	140-229	C00-C96
DIB004507	Fascin inhibitor	Cancer	140-229	C00-C96
DIB004508	NS5B HCV polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004509	FCE-26752	Carcinoma	.	D07.30
DIB004510	Anti-DEC-205 antibody vaccine	HIV infections	42	B20
DIB004511	MTHF	Cognition disorders	.	F06.7
DIB004512	VR-461	Fungal infection	.	B35-B49
DIB004513	HEMOxygenation	Cardiovascular disease	390-459	I00-I99
DIB004514	AMPA receptor positive modulator	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB004515	STP-432	Crohn's disease	.	K50
DIB004516	Bridged beta lactamase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004517	Sharon-2000	Dental caries	521	K02
DIB004518	Veronate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004519	Gene therapy	Anemia	280-285	D50-D64
DIB004520	Latranal	Pain	338,780	R52, G89
DIB004521	Topoisomerase I inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB004522	LL-3858	Mycobacterium tuberculosis infection	.	A15-A19
DIB004523	SB-9000	Hepatitis B virus infection	.	B16
DIB004524	E-4177	Hypertension	401	I10, I11, I12, I13, I15
DIB004525	Borocaptate sodium B 10	Brain cancer	191	C71
DIB004526	Lymphotoxin beta receptor-specific antibodies	Cancer	140-229	C00-C96
DIB004527	Alibra	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB004528	Galactofucan sulphate fraction	HIV infections	42	B20
DIB004529	ALZ-801	Alzheimer's disease	.	G30,F00
DIB004530	RhLCAT therapy	Acute coronary syndrome	.	I24.9
DIB004531	Seasonal influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB004532	GT 1061	Alzheimer's disease	331	G30
DIB004533	AN-10	Alopecia	.	L65.9
DIB004534	Bimatoprost sustained release	Glaucoma	365	H40-H42
DIB004535	Interleukin-2	Infectious disease	001-139	A00-B99
DIB004536	AmZaar	Hypertension	401	I10, I11, I12, I13, I15
DIB004537	PF-06252616	Muscular dystrophy	.	G71.0
DIB004538	HCV replication inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004539	PPAR gamma agonists	Osteosarcoma	170	C40-C41
DIB004540	FFC-14A	Solid tumours	.	C00-C75,C7A,C7B
DIB004541	Onco-D	Cancer	140-229	C00-C96
DIB004542	Oxiracetam	Dementia	290-294	F01-F07
DIB004543	EPTALOPROST	Solid tumours	.	C00-C75,C7A,C7B
DIB004544	Next generation dengue fever vaccines	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB004545	HL-1172	Cancer	140-229	C00-C96
DIB004546	GTU-based DNA vaccine	HIV infections	42	B20
DIB004547	Sabarubicin	Solid tumours	.	C00-C75,C7A,C7B
DIB004548	Omega interferon	Hepatitis C virus infection	.	B17.1,B18.2
DIB004549	Thermostable prophylactic shigella vaccine	Shigella infections	.	A03.9
DIB004550	MSI-469	Periodontal disease	.	K05
DIB004551	B-cell depleting anti-CD22 monoclonal antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB004552	RNA vaccine	Allergy	995.3	T78.4
DIB004553	OPT-104	Cancer	140-229	C00-C96
DIB004554	RG-7446	Cancer	140-229	C00-C96
DIB004555	LY-314657	Neurological disease	.	G00-G99
DIB004556	NAV5001	Dementia	.	F01-F07
DIB004557	ETHOXY-IDAZOXAN	Poison intoxication	.	S00-T88
DIB004558	Prevnar	Otitis media	.	H65-H67
DIB004559	BP-16	Breast cancer	.	C50
DIB004560	PF-04965842	Lupus	710	M32
DIB004561	Benfluorex	Hyperlipidemia	272.0-272.4	E78
DIB004562	PRO-140	HIV infections	42	B20
DIB004563	MC4 receptor agonists	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB004564	18F-LMI-1195	Heart failure	.	I50
DIB004565	MBHT	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004566	AL-59640	Xerophthalmia	.	E50.6-E50.7
DIB004567	BDM-I	Fungal infection	.	B35-B49
DIB004568	NARDETEROL	Depression	311	F32
DIB004569	Small-molecule TRPm5 modulators	Diabetes mellitus	250	E08-E13
DIB004570	Heat shock protein	Rheumatold arthritis	714	M05-M06
DIB004571	SDZ-OG-37-325	Autoimmune diseases	279.4	D84.9, M35.9
DIB004572	MEN-10979	HIV-1 infections	42	B20
DIB004573	AN-2718	Fungal infection	.	B35-B49
DIB004574	PolongaTab	Poison intoxication	.	T36-T50
DIB004575	XEL-002BG	Pain	338,780	R52, G89
DIB004576	EPO peptide mimetics	Anemia	280-285	D50-D64
DIB004577	MTOR pathway inhibitors	Cancer	140-229	C00-C96
DIB004578	HMR-1426	Obesity	.	E66
DIB004579	AGN-190604	Dermatitis	692.9	L20-L30
DIB004580	Histamine-3 antagonists	Metabolic disorders	.	E70-E90
DIB004581	L-742728	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004582	NV-07a	Inflammatory bowel disease	555, 556	K50, K51
DIB004583	EK-399	Inflammatory diseases	.	.
DIB004584	PF-2391677	Gastroesophageal reflux disease	.	K21
DIB004585	RAAV-LK gene therapy	Hepatocellular carcinoma	155	C22.0
DIB004586	Rapamycin analog	Tuberous sclerosis	.	Q85.1
DIB004587	CX-717	Alzheimer's disease	.	G30,F00
DIB004588	EXO-226	Diabetic kidney disease	.	E11.22
DIB004589	Cyclandelate	Dementia	290-294	F01-F07
DIB004590	AZD-3514	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB004591	GLY-220	Diabetic angiopathy	250.7	E10.5, E11.5, E13.5
DIB004592	Samarium-153-DOTMP	Bone cancer	.	C41.0
DIB004593	2-hydroxyoleic acid	Hypertension	.	I10-I15
DIB004594	Afeletecan	Breast cancer	.	C50
DIB004595	Improved influenza vaccine	Influenza virus infections	487	J10, J11
DIB004596	L-701376	Neurological disease	.	G00-G99
DIB004597	AZ-01, PEGylated interferon-beta	Multiple sclerosis	340	G35
DIB004598	Discodermolide	Immuno-suppressant	.	T86.0
DIB004599	HIV capsid assembly inhibitors	HIV infections	42	B20
DIB004600	LB-101	Memory loss	.	F03
DIB004601	RMH-41	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004602	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB004603	KPE-02004	Helicobacter pylori infection	41.86	B96.81
DIB004604	SLV319	Obesity	278	E66
DIB004605	OM-89	Rheumatold arthritis	714	M05-M06
DIB004606	NS-257	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004607	Motexafin lutetium	Restenosis	.	I51.89
DIB004608	GED-0301	Crohn's disease	555	K50
DIB004609	IL-17A inhibitor	Autoimmune diseases	279.4	D84.9, M35.9
DIB004610	Clostridium difficile vaccine	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB004611	LBVH-0101	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004612	HIV monoclonals	HIV infections	42	B20
DIB004613	TROXACITABINE	Solid tumours	.	C00-C75,C7A,C7B
DIB004614	PF-4554878	Cancer	140-229	C00-C96
DIB004615	EVO-022	Breast cancer	174, 175, 217	C50, D24
DIB004616	Gene therapy product	Factor VIII deficiency	.	D66
DIB004617	Thrombin-JMI	Bleeding	.	R58
DIB004618	GR-89696	Neurodegenerative diseases	.	G30-G32
DIB004619	NN-4201	Non-insulin dependent diabetes	.	E11.9
DIB004620	Second-generation kallikrein inhibitors	Dermatological disease	.	L00-L99
DIB004621	LB-2.1	Fungal infection	.	B35-B49
DIB004622	Flavonoid derivatives	Cancer	140-229	C00-C96
DIB004623	EC-2208	Allergy	995.3	T78.4
DIB004624	HL-2353	Hemophilia	286	D66-D68
DIB004625	Napitane mesilate	Major depressive disorder	.	F32,F33
DIB004626	Thiopilocarpine	Cognitive impairment	.	F06.7
DIB004627	Corticosteroids	Acne vulgaris	706.1	L70.0
DIB004628	KMS-88 series	Alzheimer's disease	331	G30
DIB004629	MOD-7023	Anemia	280-285	D50-D64
DIB004630	TARP peptide-pulsed autologous dendritic cell vaccine	Prostate tumor	185	C61
DIB004631	RR-1	Cancer	.	C00-C97
DIB004632	Grazax	Allergic rhinitis	.	J30
DIB004633	NVC-422 nasal	Infectious disease	001-139	A00-B99
DIB004634	ETV-002	HIV infections	42	B20
DIB004635	TDI-0114	Motor neurone disease	335.2	G12.2
DIB004636	Pyruvate kinase inhibitor	MRSA infection	.	B95.62
DIB004637	PAT-SM3	Cancer	140-229	C00-C96
DIB004638	WT2725	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB004639	Ranpirnase-antibody conjugates	Cancer	140-229	C00-C96
DIB004640	LA22-radioimmunoconjugates	Cancer	140-229	C00-C96
DIB004641	SDZ-ENX-792	Alzheimer's disease	.	G30,F00
DIB004642	Flurbiprofen nitroxybutyl ester	Osteoporosis	.	M80-M81
DIB004643	Protein kinase C inhibitors	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB004644	Papillomavirus vaccine	Papillomavirus infections	.	B97.7
DIB004645	PF-3463275	Schizophrenia	295	F20
DIB004646	90Y-labeled humanized anti-Tac mAb (anticancer), NCI	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB004647	Anti-VPAC1 antibodies	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB004648	RBx-10017609	Respiratory disease	.	J00-J99
DIB004649	Angeloxin	Cancer	140-229	C00-C96
DIB004650	Inhibitor of p70S6 Kinase/AKT	Cancer	.	C00-C97
DIB004651	SPIO-Stasix nanoparticles	Prostate tumor	185	C61
DIB004652	HLA-DR1/DR4 inhibitors	Rheumatold arthritis	714	M05-M06
DIB004653	Mixed Factor VIIa/Xa inhibitors	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB004654	G-protein modulators	Dermatological disease	.	L00-L99
DIB004655	WF-10917	Autoimmune diseases	279.4	D84.9, M35.9
DIB004656	3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor (hypercholesterolemia), Biopharm technologies	Hypercholesterolemia	272	E78.0
DIB004657	Banoxantrone	Acute lymphoblastic leukemia	.	C91.0
DIB004658	WA-8242-A1	Inflammatory diseases	.	.
DIB004659	AgaDerm	Dermatomycosis	.	B36.0
DIB004660	F-11105	Asthma	493	J45
DIB004661	Recombinant hypoallergenic vaccine	Allergy	995.3	T78.4
DIB004662	VA-119930	Inflammatory bowel disease	555, 556	K50, K51
DIB004663	Non-steroidal anti-inflammatory drug	Discovery agent	.	.
DIB004664	P2X7 receptor inhibitors	Cancer	140-229	C00-C96
DIB004665	TMB-358	HIV infections	42	B20
DIB004666	AZD2184	Alzheimer's disease	331	G30
DIB004667	Plague vaccine	Yersinia infections	.	A20
DIB004668	Autologous melanoma cell vaccine	Cancer	.	C00-C97
DIB004669	Emepronium	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB004670	MTAN transition state analog inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004671	FSH patch	Infertility	.	N46,N97.0
DIB004672	CXB-724	Anxiety disorder	300	F40-F42
DIB004673	FR-229934	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB004674	IC31 seasonal influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB004675	KST-401	Cancer	.	C00-C97
DIB004676	Shigella prophylactic vaccine	Shigella infections	.	A03.9
DIB004677	AT-005	Inflammatory bowel disease	555, 556	K50, K51
DIB004678	Epoetin alfa biosimilar	Myasthenic syndrome	.	G73
DIB004679	BMS-820132	Diabetes mellitus type 2	.	E11
DIB004680	CXCR6 antagonist	Inflammatory diseases	.	.
DIB004681	Nikkomycin Z	Candidiasis infection	.	B37
DIB004682	TBC-M4	HIV infections	42	B20
DIB004683	124-iodine-labeled PSCA targeting minibody (prostate cancer), ImaginAb	Prostate tumor	185	C61
DIB004684	DK-0141	Acute lung injury	518	J80
DIB004685	Tetrazolast meglumine	Asthma	.	J45
DIB004686	D-24241	Allergy	995.3	T78.4
DIB004687	L-701273	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004688	DA-3811	Gaucher disease	272.7	E75.2
DIB004689	STP-601	Ocular disease	.	H00-H59
DIB004690	TrkA antagonists	Pain	338,780	R52, G89
DIB004691	TZ-101sm	Osteoporosis	733	M80-M81
DIB004692	PDE10 inhibitor	Schizophrenia	295	F20
DIB004693	H2S-releasing latanoprost	Ocular disease	.	H00-H59
DIB004694	Endothelial lipase inhibitors	Cardiovascular disease	390-459	I00-I99
DIB004695	APC-003	Cancer	140-229	C00-C96
DIB004696	Angiotensin II-targeting vaccine	Hypertension	401	I10, I11, I12, I13, I15
DIB004697	Sulotroban	Asthma	.	J45
DIB004698	Pemirolast potassium	Conjunctivitis	372	H10
DIB004699	TriGem	Melanoma	.	C43
DIB004700	Fatty acid biosynthesis inhibitors	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB004701	Cancer Vac	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB004702	MQX-3016	Keratosis	.	L57.0
DIB004703	Hepatitis C therapy	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004704	Sprodiamide	Diagnosis	.	Y57.6
DIB004705	NIP-151	Atrial fibrillation	427.31	I48
DIB004706	MAT-303	Autoimmune diseases	279.4	D84.9, M35.9
DIB004707	XEL-003FL	Onychomycosis	.	B35.1
DIB004708	Ro-44-3949	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004709	MAD-001	Cardiac failure	.	I50
DIB004710	Live attenuated influenza vaccine	Influenza virus infections	487	J10, J11
DIB004711	SL-65.4272	Cardiovascular disease	390-459	I00-I99
DIB004712	CGP-52411	Cancer	.	C00-C97
DIB004713	Gene therapy	Breast cancer	174, 175, 217	C50, D24
DIB004714	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB004715	Nitecapone	Pain	.	G89
DIB004716	Thyroglobulin	Hypothyroidism	244	E03
DIB004717	DPS-151	Psoriasis	696	L40
DIB004718	Alisporivir	Duchenne muscular dystrophy	359.1	G71.0
DIB004719	P-7	Inflammatory diseases	.	.
DIB004720	TT-105	Deep vein thrombosis	453.4	I80.2
DIB004721	SAV-001	HIV-1 infections	42	B20
DIB004722	Human growth hormone mimics	Growth disorder	.	E23.0
DIB004723	Cadrofloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004724	Recombinant misfolded truncated tau protein vaccine	Neurodegenerative diseases	.	G30-G32
DIB004725	Arthritis therapy	Arthritis	.	M00-M25
DIB004726	Flt 4 kinase inhibitors	Metastasis	.	C00-C97
DIB004727	GV-196771	Migraine	.	G43
DIB004728	Daxalipram	Multiple sclerosis	340	G35
DIB004729	AKT protein kinase inhibitors	Cancer	140-229	C00-C96
DIB004730	Male immunocontraception	Contraception	.	Z30
DIB004731	Etofenamate	Rheumatold arthritis	714	M05-M06
DIB004732	MG-1110	Cancer	140-229	C00-C96
DIB004733	VM-1500	HIV infections	42	B20
DIB004734	CAP-1002	Myocardial infarction	410	I21, I22
DIB004735	Drug combination	Cardiovascular disease	390-459	I00-I99
DIB004736	SSAO inhibitor	Cancer	140-229	C00-C96
DIB004737	Fenclofenac	Arthritis	710-719	M00-M25
DIB004738	Pneumococcal conjugate vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB004739	RS-1748	Asthma	493	J45
DIB004740	BVT-115959	Pain	.	G89
DIB004741	XGP-125	Arthritis	710-719	M00-M25
DIB004742	WinRho SDF	Autoimmune diseases	279.4	D84.9, M35.9
DIB004743	HuMax-Wnt	Cancer	140-229	C00-C96
DIB004744	TVB-2640	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DIB004745	IPS-01003	Cancer	140-229	C00-C96
DIB004746	CGP-62360	Melanoma	172	C43
DIB004747	Piperazinyloxoquinoline derivatives	HIV-1 infections	42	B20
DIB004748	Cloperastine	Cough	786.2	R05
DIB004749	PAR-1 antagonists	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DIB004750	AMR-SIX-1	Obesity	278	E66
DIB004751	Lisuride hydrogen maleate	Fibrosis	709.2	L90.5
DIB004752	BLV-0801	Cancer	.	C00-C97
DIB004753	MVA-BN HIV nef	HIV infections	42	B20
DIB004754	LDI-200	Leukaemia	.	C91-C95
DIB004755	Monoclonal antibodies	Colon cancer	153, 154	C18-C21
DIB004756	HuMax-CD32b	B-cell lymphoma	202.8	C85.1
DIB004757	CEFMATILEN HYDROCHLORIDE HYDRATE	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004758	VR-147	Migraine	346	G43
DIB004759	BmAb-200	Cancer	140-229	C00-C96
DIB004760	Typhim Vi	Salmonella infection	.	A02.9
DIB004761	Botulinum toxin vaccine	Yersinia infections	.	A04.6
DIB004762	SF-110	Inflammatory diseases	.	.
DIB004763	Dermatological agent	Acne vulgaris	706.1	L70.0
DIB004764	Alpha 1a-adrenergic receptor allosteric antagonists	Prostate hyperplasia	.	N40
DIB004765	NGN-9078	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004766	CBR-2198	Gastrointestinal infection	.	A09.0
DIB004767	GS-4977	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB004768	PN-200	Herpesvirus infection	.	B00
DIB004769	VA-045	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004770	N-251	Alzheimer's disease	331	G30
DIB004771	HBV capsid assembly inhibitors	Hepatitis B virus infection	.	B16
DIB004772	HS-210	Ovarian cancer	.	C56
DIB004773	CLX-090700	Diabetes mellitus	250	E08-E13
DIB004774	Glycan G-family 10 glycogene inhibitors	Renal disease	.	N00-N29
DIB004775	Testetrol	Hypogonadism	257.2	E23.0, E28.3, E29.1
DIB004776	Green soap	Acne vulgaris	706.1	L70.0
DIB004777	Dextran	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB004778	TB-101	Bleeding	.	R58
DIB004779	BL-1829	Natural health supplement	.	.
DIB004780	MDL-43291	Asthma	493	J45
DIB004781	EPI-2221	Cancer	140-229	C00-C96
DIB004782	T-1210	Allergic conjunctivitis	372.14	H10.45
DIB004783	SC-124a	Multiple sclerosis	340	G35
DIB004784	Plasmepsin V inhibitors	Plasmodium infection	.	B54
DIB004785	Anti-IL1RAP antibody	Leukemia	208.9	C91-C95
DIB004786	NAI-107	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004787	StaphTAME	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004788	ADE-APTW	Wound healing	.	S91.3
DIB004789	PF-2413873	Endometriosis	617	N80
DIB004790	DDB-S	Liver disease	.	K70-K77
DIB004791	Dopropidil	Angina	.	I20
DIB004792	UltraBAFF	Discovery agent	.	.
DIB004793	Perfluoropropane gas-filled nanobubbles	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB004794	GTU-influenza vaccine	Influenza virus infections	487	J10, J11
DIB004795	Protamine	Bleeding	.	R58
DIB004796	Histone acetyltransferase p300 inhibitors	Cancer	.	C00-C97
DIB004797	SC-112c	Attention deficit hyperactivity disorder	314	F90
DIB004798	BC-DU-04	Ulcer	531-534	K25-K27
DIB004799	Inhibitor of AKRC3	Endometriosis	617	N80
DIB004800	NX-001	Kidney transplant rejection	.	Z48.22
DIB004801	Gastrin 17C diphtheria toxoid conjugate	Pancreatic cancer	.	C25
DIB004802	BCL-003	Glioma	191	C71
DIB004803	Methotrimeprazine	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB004804	PRX-102	Fabry's disease	.	E75.2
DIB004805	DS-3801	Constipation	.	K59.0
DIB004806	Human heterologous liver cells	Urea cycle disorders	.	E72.20
DIB004807	BAL-0019764	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004808	AD-529	Neuropathic pain	338,780	R52, G89
DIB004809	Pandemic influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB004810	CGRP pepducins	Pain	338,780	R52, G89
DIB004811	Recombinant factor VIII	Factor VIII deficiency	.	D66
DIB004812	CGP-13774	Asthma	.	J45
DIB004813	Long-acting exenatide	Type 2 diabetes	250.00, 250.02	E11
DIB004814	RALURIDINE	Human immunodeficiency virus infection	.	B20
DIB004815	OX-51	Pain	338,780	R52, G89
DIB004816	KM-011	Atherosclerosis	414.0, 440	I70
DIB004817	Mitosis inhibitors/M phase cell apoptosis inducers	Cancer	140-229	C00-C96
DIB004818	Plasmin	Peripheral vascular disease	443.9	I73.9
DIB004819	Antibody therapeutics	Graft-versus host disease	.	T86.0
DIB004820	Hematopoietic stem cell gene therapy	WiskottCAldrich syndrome	.	D82.0
DIB004821	PET imaging agent	Cancer	140-229	C00-C96
DIB004822	MEN-10376	Anxiety disorder	300	F40-F42
DIB004823	Arenastatin A analogs	Cancer	140-229	C00-C96
DIB004824	Activin-like kinase 5 inhibitor	Scar tissue	.	L00-L99
DIB004825	Sunepitron hydrochloride	Anxiety disorder	.	F40-F42
DIB004826	VH-0445 based conjugated therapeutics	Pain	338,780	R52, G89
DIB004827	Ethamsylate	Menorrhagia	627	N92.0
DIB004828	Oral tryptase inhibitors	Asthma	493	J45
DIB004829	Antisense hnRNP A2/B1 RNA	Glioblastoma	191	C71
DIB004830	HIV-NeutraGAM	HIV infections	42	B20
DIB004831	Gene therapy	Restenosis	.	I51.89
DIB004832	GANTACURIUM CHLORIDE	Anesthesia	338	R52
DIB004833	M2 proton channel inhibitors	Influenza virus infections	487	J10, J11
DIB004834	Lnfluvac TC	Influenza virus infections	.	J11.1
DIB004835	GP-1001	Influenza virus infections	487	J10, J11
DIB004836	Cancer medicine	Cancer	.	C00-C97
DIB004837	H5N1 influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB004838	Paliperidone	Schizophrenia	295	F20
DIB004839	Plasmid IL-12 immunotherapy	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DIB004840	Nicotine and drugs abuse vaccine	Drug dependence	303-304	F10.2-F19.2
DIB004841	Box-5	Melanoma	.	C43
DIB004842	Octafluoropropane perflutren lipid microsphere	Heart disease	390-429	I00-I52
DIB004843	XL-388	Cancer	140-229	C00-C96
DIB004844	Adnectin program	Immune disorder	.	D80-D89
DIB004845	Activated recombinant FVII-albumin fusion protein	Hemophilia	.	D66-D68
DIB004846	ZP-001	Contracture	.	M24.5
DIB004847	OBR-5-340	Coxsackie virus infection	.	B97.11
DIB004848	Bisacodyl	Constipation	564	K59.0
DIB004849	Aptamer therapeutics	Inflammatory diseases	.	.
DIB004850	TRICAPRYLIN	Coagulation	.	I80-I82
DIB004851	ReN-1826	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB004852	Desoxypeganine	Alcohol use disorders	.	F10
DIB004853	ABBV-399	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB004854	PD-01	Parkinson's disease	.	G20
DIB004855	Stem cell therapy	Peripheral vascular disease	443.9	I73.9
DIB004856	DCVax-Pancreas	Pancreatic cancer	.	C25
DIB004857	Septic shock therapy	Septic shock	785.52	A41.9
DIB004858	Ecopipam (controlled-release	Lesch-nyhan syndrome	.	E79.1
DIB004859	SiRNA therapy	Acute lung injury	518	J80
DIB004860	ND-701	Mycobacterium tuberculosis infection	.	A15-A19
DIB004861	CTP-conjugated WT1 peptide	Cancer	140-229	C00-C96
DIB004862	NF-kB inhibitors	Rheumatold arthritis	714	M05-M06
DIB004863	NN-8828	Autoimmune diseases	.	D84.9
DIB004864	YM-934	Angina	.	I20
DIB004865	TKP-1001	Alzheimer's disease	331	G30
DIB004866	Clopidogrel intravenous	Coronary thrombosis	.	I24.0
DIB004867	BN-58705	Inflammatory diseases	.	.
DIB004868	NS3-NS4A inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004869	Q-Vax	Coxiella infection	.	A78
DIB004870	OMS824	Huntington's disease	.	F02.2,G10
DIB004871	Annexin-related peptide	Cardiovascular disease	390-459	I00-I99
DIB004872	CL-301 series	Neurological disease	.	G00-G99
DIB004873	ZD-1611	Hypotension	.	I95
DIB004874	SK&F-S-106203	Asthma	.	J45
DIB004875	Epigallocatechin gallate	Liver fibrosis	571	K70.3, K71.7, K74
DIB004876	Saccharomyces boulardii	Diarrhea	787.91	A09, K59.1
DIB004877	CDP-146	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB004878	Pancreatic enzyme	Nervous system disease	.	G00-G99
DIB004879	Multiple sclerosis therapy	Multiple sclerosis	340	G35
DIB004880	E2 inhibitor	Papillomavirus infections	.	B97.7
DIB004881	MVA HER-2 AutoVac	Breast cancer	174, 175, 217	C50, D24
DIB004882	Drug 2696275	WiskottCAldrich syndrome	.	D82.0
DIB004883	Plasminogen concentrate	Alzheimer's disease	331	G30
DIB004884	LP-02	Ulcerative colitis	556	K51
DIB004885	Tapet	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB004886	Rabies immune globulin	Rabies virus infection	001-139	A00-B99
DIB004887	Axomadol	Back pain	724.5,338,780	M54, G89, R52
DIB004888	Ch14.18,	Neuroblastoma	194	C74.9
DIB004889	Org-32782	Major depressive disorder	296.2, 296.3	F32, F33
DIB004890	BDF-9148	Cardiac failure	.	I50
DIB004891	ProSavin	Parkinson's disease	.	G20
DIB004892	D-22631	Cancer	140-229	C00-C96
DIB004893	U-97456	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004894	Replicase	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004895	MDX-018	Autoimmune diseases	.	D84.9
DIB004896	Varicella zoster virus vaccine live	Herpes zoster	53	B02
DIB004897	T1-1081	Macular degeneration	.	H35.3
DIB004898	KT6-971	Hypercholesterolemia	272	E78.0
DIB004899	KUR-211	Ulcer	531-534	K25-K27
DIB004900	CGP-57698	Asthma	.	J45
DIB004901	DWJ-208	Pain	338,780	R52, G89
DIB004902	AEG-33773	Diabetic neuropathy	.	E10.4,E11.4,E13.4
DIB004903	AZM-091	Ulcerative colitis	556	K51
DIB004904	Prostatix	Prostate tumor	185	C61
DIB004905	HemaMax	Myelodysplastic syndromes	.	D46
DIB004906	AGS-22ME	Solid tumours	.	C00-C97
DIB004907	Hypoglycemic agent	Non-insulin dependent diabetes	.	E11.9
DIB004908	MK-1972	HIV-1 infections	42	B20
DIB004909	HDAC 8 inhibitors	Cancer	.	C00-C97
DIB004910	Arthromir	Rheumatold arthritis	714	M05-M06
DIB004911	FC EPO	Anemia	280-285	D50-D64
DIB004912	NTHi-Pneumo vaccine	Hemophilus influenza	.	B96.3
DIB004913	Anti-CD44 mAb	Acute myeloid leukemia	205	C92.0
DIB004914	HL-1983	Hepatitis B virus infection	.	B16
DIB004915	62Cu-ATSM	Hypoxia	799.02	R09.02
DIB004916	98mTC-CIM-ANT	Neuroendocrine cancer	.	C7A
DIB004917	Immunotherapeutic	Cancer	140-229	C00-C96
DIB004918	AIKa1	Osteoarthritis	715	M15-M19, M47
DIB004919	DSP-0565	Epilepsy	.	G40
DIB004920	Pixykine	Human immunodeficiency virus infection	.	B20
DIB004921	AP-004	Proctitis	.	K51.2,K62.7,K62.8
DIB004922	Human Cytomegalovirus vaccine	Cytomegalovirus infection	.	B25
DIB004923	TRPV4 modulators (osteoporosis/pain). Hydra Biosciences	Osteoporosis	733	M80-M81
DIB004924	Dixyrazine	Anxiety disorder	300	F40-F42
DIB004925	CT-3537	HIV infections	42	B20
DIB004926	62Cu-ETS	Renal disease	.	N00-N29
DIB004927	TSR-011	Non-small-cell lung carcinoma	162	C33, C34
DIB004928	P2X7 antagonists	Inflammatory diseases	.	.
DIB004929	DOV-216419	Major depressive disorder	296.2, 296.3	F32, F33
DIB004930	SOM-0525	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB004931	AP-23588	Osteoporosis	733	M80-M81
DIB004932	SKF-88046	Asthma	493	J45
DIB004933	DPK-DTSM-02	Cancer	140-229	C00-C96
DIB004934	ACP-001	Growth hormone deficiency	253.3	E23.0
DIB004935	CDK9 inhibitor	Inflammatory diseases	.	.
DIB004936	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB004937	SL-18.1616	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB004938	CGP-25875	Asthma	.	J45
DIB004939	Plasma derived factor VIII PEGylated liposomal	Factor VIII deficiency	.	D66
DIB004940	Unithiol	Metal intoxication	.	T56
DIB004941	Evitar	Wound healing	.	S91.3
DIB004942	DKC-215	Hypertension	401	I10, I11, I12, I13, I15
DIB004943	Flesinoxan	Anxiety disorder	.	F40-F42
DIB004944	SYL-040012	Ocular hypertension	365.04	H40.0
DIB004945	NN9928	Type 2 diabetes	250.00, 250.02	E11
DIB004946	CGS-30440	Hypertension	401	I10, I11, I12, I13, I15
DIB004947	Nucleotide based program	Cancer	140-229	C00-C96
DIB004948	E7/HSP70 DNA vaccine	Head and neck cancer	140-149	C07-C14, C32-C33
DIB004949	Radavirsen	Influenza virus infections	.	J10-J11
DIB004950	SMT-15000	Infectious disease	001-139	A00-B99
DIB004951	90Y-cG250	Cancer	140-229	C00-C96
DIB004952	NOV-205	HIV infections	42	B20
DIB004953	Aldehyde dehydrogenase modulators	Discovery agent	.	.
DIB004954	CAMPESTANOL ASCORBYL PHOSPHATE	Hyperlipidemia	.	E78.5
DIB004955	Antibody-producing anti-HIV gene therapy	HIV infections	42	B20
DIB004956	EX-201	Mucositis	.	K00-K95
DIB004957	S-3536	Osteoarthritis	715	M15-M19, M47
DIB004958	RNA polymerase inhibitor	Discovery agent	.	.
DIB004959	MufroSyn	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004960	AVP-13358	Rhinitis	472.0, 477	J00, J30, J31.0
DIB004961	Anti-LAG3 antibody	Hematological malignancies	.	C81-C96
DIB004962	Aurora kinase inhibitors	Cancer	140-229	C00-C96
DIB004963	KA-10X	Cancer	140-229	C00-C96
DIB004964	Hepatitis B virus vaccine	Hepatitis B virus infection	.	B16
DIB004965	Gene therapy	Glioma	191	C71
DIB004966	WC-3048	Female sexual dysfunction	302.7	F52, R37
DIB004967	HCV NS5b polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004968	Anti-IL31	Immune disorder	.	D80-D89
DIB004969	DW-286	Bacterial respiratory tract infection	.	J13,J15
DIB004970	Artemisone	Plasmodium infection	.	B54
DIB004971	PHER-O2	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB004972	Hoe-33342	Cancer	140-229	C00-C96
DIB004973	LentiGlobin	Beta thalassemia	.	D56.1
DIB004974	Typhoid vaccine	Salmonella infection	.	A02.9
DIB004975	Lipobean	Lipid metabolism disorder	.	E75-E78
DIB004976	HIV vaccine	HIV infections	42	B20
DIB004977	CEL-2000	Rheumatold arthritis	714	M05-M06
DIB004978	NS3 protease inhibitors	Flavivirus infection	.	A86
DIB004979	Leridistim	Immune disorder	.	D80-D89
DIB004980	EDP-15	Myocardial infarction	410	I21, I22
DIB004981	MMP-12 inhibitors	Atherosclerosis	414.0, 440	I70
DIB004982	Dothiepin	Major depressive disorder	296.2, 296.3	F32, F33
DIB004983	Oxymorphone	Pain	338,780	R52, G89
DIB004984	Anti-CMV mAbs	Cytomegalovirus infection	.	B25
DIB004985	G0-203-2c	Acute myeloid leukemia	.	C92.0
DIB004986	DTI-0009 (oral)	Atrial fibrillation	427.31	I48
DIB004987	NV.AT.08	Ocular disease	.	H00-H59
DIB004988	L19-TNF-alpha	Colorectal cancer	.	C18-C20,C21
DIB004989	NHE-1 inhibitors	Myocardial infarction	410	I21, I22
DIB004990	RP-1000	Obesity	278	E66
DIB004991	CXCR3 antagonists	Inflammatory diseases	.	.
DIB004992	RFT-5.dgA	Human immunodeficiency virus infection	.	B20
DIB004993	Hairpin RNA IRES inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB004994	BXL-01-0029	Heart transplant rejection	.	T86.21
DIB004995	SDZ-62-826	Cancer	140-229	C00-C96
DIB004996	NE-2	Pain	338,780	R52, G89
DIB004997	Elastase inhibitors	Cystic fibrosis	277	E84
DIB004998	Lanthanum carbonate	Hyperphosphatemia	.	E83
DIB004999	HGH	Growth hormone deficiency	253.3	E23.0
DIB005000	Nicotinic acid receptor agonists	Cardiovascular disease	390-459	I00-I99
DIB005001	E-3620	Gastric motility disorder	.	K22.4
DIB005002	CAT-1902	Inflammatory bowel disease	555, 556	K50, K51
DIB005003	Symakalim	Hypertension	401	I10, I11, I12, I13, I15
DIB005004	HuMax-HepC	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005005	DMP-444	Coronary artery disease	.	I20-I25
DIB005006	AG-NPP709	Bronchitis	.	J20-J21,J42
DIB005007	Cation channel of sperm modulators	Contraception	.	Z30
DIB005008	CEP-4186	Acute myeloid leukemia	.	C92.0
DIB005009	CD-2475/101	Acne vulgaris	706.1	L70.0
DIB005010	XEN-D0501	Overactive bladder disorder	596.51	N32.81
DIB005011	Progesterone	Premature labour	.	O60.1,P07.3
DIB005012	CaroRx	Dental caries	521	K02
DIB005013	TJN-598	Glomerulonephritis	580-582	N00, N01, N03, N18
DIB005014	GDC-0994	Solid tumours	.	C00-C75,C7A,C7B
DIB005015	GT-038	Retinitis pigmentosa	.	H35.5
DIB005016	GFC-036	Leishmania donovani infection	.	B55.0
DIB005017	CNV-2197944	Pain	338,780	R52, G89
DIB005018	HSV-2 vaccine	Herpes simplex virus infection	.	B00
DIB005019	DHODH inhibitors	Plasmodium falciparum infection	.	B54
DIB005020	Amyotrophic lateral sclerosis therapeutics	Motor neurone disease	335.2	G12.2
DIB005021	Oral insulin	Diabetes mellitus type 1	.	E10
DIB005022	Avicine	Colorectal cancer	153, 154	C18-C21
DIB005023	CCR5 receptor inhibitors	HIV infections	42	B20
DIB005024	Therapeutic cancer vaccine	Papillomavirus infections	.	B97.7
DIB005025	RO5545965	Schizophrenia	295	F20
DIB005026	Bone morphogenetic protein-4	Glioblastoma	191	C71
DIB005027	Sch-46442	Atherosclerosis	414.0, 440	I70
DIB005028	E1/E4-deleted adenoviral therapy	Cystic fibrosis	277	E84
DIB005029	Pseudomonas aeruginosa MAb	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB005030	LBR-101	Migraine	.	G43
DIB005031	Autologous cell based gene therapy	Pulmonary hypertension	416	I27.0, I27.2
DIB005032	BMTP-11	Prostate cancer	.	C61
DIB005033	Personalized macrophage cell therapy	Neurological disease	.	G00-G99
DIB005034	H-102	Hepatocellular carcinoma	155	C22.0
DIB005035	Glycan G-family glycogene 1 inhibitors	Parkinson's disease	.	G20
DIB005036	ONO-1603	Cognitive impairment	.	F06.7
DIB005037	STAT-3 DECOY (NSC-741763)	Cancer	140-229	C00-C96
DIB005038	Tr-3	Cancer	140-229	C00-C96
DIB005039	Cytotect CP	Cytomegalovirus infection	.	B25
DIB005040	Morrhuate sodium	Hemorrhoids	.	I84
DIB005041	LEURUBICIN	Cancer	140-229	C00-C96
DIB005042	Anti-TGF-beta-R2 antibody	Cancer	140-229	C00-C96
DIB005043	Gaucher disease therapy	Gaucher disease	272.7	E75.2
DIB005044	LIM-0744	Toxicity	.	T36-T50,T51-T65
DIB005045	LC-9018	Cancer	.	C00-C97
DIB005046	Sorbitol	Constipation	564	K59.0
DIB005047	OB-28	Cancer	.	C00-C97
DIB005048	Anti-mIR-155 therapy	Immune disorder	.	D80-D89
DIB005049	BB-15600	Cancer	140-229	C00-C96
DIB005050	UNI-rE-4	Diabetes mellitus type 2	.	E11
DIB005051	Angiogenesis inhibitors	Cancer	140-229	C00-C96
DIB005052	HV-1	Blood clotting disorder	286	D65-D69
DIB005053	VG-FLU	Influenza virus infections	487	J10, J11
DIB005054	Lintuzumab Ac-226	Leukemia	208.9	C91-C95
DIB005055	GLP-1 analogs	Non-insulin dependent diabetes	.	E11.9
DIB005056	XE-9	Transplant rejection	.	T86
DIB005057	Glycoprotein conjugated vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005058	U-90042	Anxiety disorder	300	F40-F42
DIB005059	SEMORPHONE HYDROCHLORIDE	Pain	.	G89
DIB005060	FT-026	Fibrosis	709.2	L90.5
DIB005061	L-701315	Neurological disease	.	G00-G99
DIB005062	HIV integrase inhibitors	HIV infections	42	B20
DIB005063	OT-417	Cystic fibrosis	277	E84
DIB005064	BVT-3498	Metabolic disorders	.	E70-E90
DIB005065	GX-G3	Cancer	.	C00-C97
DIB005066	Quinotolast	Asthma	.	J45
DIB005067	R-4 based DNA vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB005068	NS3 targeting antibodies	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB005069	EU-C-003	Cancer	140-229	C00-C96
DIB005070	Anti-RON receptor mAbs	Cancer	140-229	C00-C96
DIB005071	CAP-22	Diabetic angiopathy	250.7	E10.5, E11.5, E13.5
DIB005072	AV-370	Cancer	140-229	C00-C96
DIB005073	FerriSeltz	Gastrointestinal disease	.	K00-K93
DIB005074	J-104135	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB005075	VP6 rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB005076	RP-64477	Hyperlipidemia	.	E78.5
DIB005077	Sodium nitrite	Myocardial infarction	410	I21, I22
DIB005078	MenBioVax	Neisseria meningitidis infection	.	A87
DIB005079	RO-16-8714	Diabetes	250	E08-E13
DIB005080	NS-1546	Major depressive disorder	.	F32,F33
DIB005081	SAVX-1	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB005082	Melitracen	Major depressive disorder	296.2, 296.3	F32, F33
DIB005083	ACAM529	Herpes simplex virus infection	.	B00
DIB005084	H1N1 vaccine	Influenza virus infections	487	J10, J11
DIB005085	LFF-269	Hypertension	.	I10-I15
DIB005086	Mu opioid agonists	Pain	338,780	R52, G89
DIB005087	Universal influenza vaccine	Influenza virus infections	487	J10, J11
DIB005088	Hdm2 inhibitors	Cancer	140-229	C00-C96
DIB005089	MVA-BN HIV Multiantigen	HIV infections	42	B20
DIB005090	Q-Derp1	Various major chronic diseases	.	.
DIB005091	NPC-01	Dysmenorrhea	.	N94.4-N94.6
DIB005092	CW-343	Gastroesophageal reflux disease	.	K21
DIB005093	Hepatitis A virus vaccine	Hepatitis A virus infection	.	B15.9
DIB005094	L-N1	Acquired immune deficiency syndrome	.	B20
DIB005095	B7/CD28 costimulatory proteins	Autoimmune diseases	279.4	D84.9, M35.9
DIB005096	MV-CEA	Glioblastoma	.	C71
DIB005097	Undisclosed compound	Pain	338,780	R52, G89
DIB005098	Anticancer therapeutics	Metastasis	.	C00-C97
DIB005099	Imaging agent	Infectious disease	001-139	A00-B99
DIB005100	L-691121	Cardiac arrhythmias	.	I47-I49
DIB005101	Glucagon-like-peptide 1 receptor modulators	Non-insulin dependent diabetes	.	E11.9
DIB005102	Cell-based therapy	Pulmonary hypertension	416	I27.0, I27.2
DIB005103	DscCfaE recombinant vaccine	Escherichia coli infection	.	A00-B99
DIB005104	Rimexolone	Arthritis	710-719	M00-M25
DIB005105	GPR142 agonists	Non-insulin dependent diabetes	.	E11.9
DIB005106	GS-9411	Pulmonary disease	460-519	J00-J99
DIB005107	Tyropanoate sodium	Gallbladder disease	.	K80-K82
DIB005108	Vaccine	Cancer	140-229	C00-C96
DIB005109	PF-06273340	Pain	.	G89
DIB005110	CP-331	Pain	.	G89
DIB005111	Stempeucel	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005112	APG-232	Cancer	140-229	C00-C96
DIB005113	Collagenase ABC	Diabetic foot ulcer	.	E08-E13
DIB005114	Genetically-engineered autologous hematopoietic stem cell therapy	Chronic granulomatous disease	.	D71
DIB005115	AX-12977	Influenza virus infections	487	J10, J11
DIB005116	Axitirome	Hyperlipidemia	.	E78.5
DIB005117	Metadoxine	Myeloma	203	C90.0
DIB005118	CL-186659	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005119	MOR-102	Psoriasis	.	L40
DIB005120	BILD-1263	Herpes simplex virus infection	.	A60,B00
DIB005121	XR-1500	Cancer	140-229	C00-C96
DIB005122	B-lymphocyte inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB005123	Single dose vaccine	Influenza virus infections	487	J10, J11
DIB005124	SC-112	Alcohol use disorders	303	F10.2
DIB005125	Clopidogrel	Thrombosis	.	I80-I82
DIB005126	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB005127	IL1R1 negative allosteric modulators	Gout	274.00274.1274.8274.9	M10
DIB005128	Anti-TAT HIV vaccine	HIV infections	42	B20
DIB005129	Sotirimod	Keratosis	.	L57.0
DIB005130	CS-765	Infectious disease	001-139	A00-B99
DIB005131	GRK-2 inhibitors	Congestive heart failure	428	I50
DIB005132	Rispenzepine	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB005133	MP-157	Hypertension	401	I10, I11, I12, I13, I15
DIB005134	SGC stimulators	Angina	413	I20
DIB005135	SWC-240	Mucositis	.	K00-K95
DIB005136	CGP-49823	Pain	.	G89
DIB005137	WNV DNA vaccine	Influenza virus infections	487, 488	J10, J11
DIB005138	SYN-1001	Pain	338,780	R52, G89
DIB005139	Humanized mAb program	Colorectal cancer	153, 154	C18-C21
DIB005140	Anti-angiogenic peptides	Cancer	140-229	C00-C96
DIB005141	CP-331684	Diabetes mellitus	.	E10-E14
DIB005142	KUR-114	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB005143	PRAME antigen-specific cancer	Malignant melanoma	172	C43
DIB005144	Oxybutynin	Interstitial cystitis	.	N30.1
DIB005145	Doreptide	Parkinson's disease	.	G20
DIB005146	6-azacytidine, National Academy of Sciences of Ukraine	Cancer	.	C00-C97
DIB005147	INV-400 series	Atherosclerosis	414.0, 440	I70
DIB005148	A-80987	Human immunodeficiency virus infection	.	B20
DIB005149	H1N1 vaccine	Influenza virus infections	487	J10, J11
DIB005150	CF-238	Infectious disease	001-139	A00-B99
DIB005151	N2 binding inhibitors	Reperfusion injury	.	I00-I99
DIB005152	TDI-0113	Motor neurone disease	335.2	G12.2
DIB005153	Anti-hantavirus monoclonal antibody	Hantavirus infection	.	B33.4
DIB005154	PG-760564	Rheumatold arthritis	714	M05-M06
DIB005155	CDD-0199-J	Alzheimer's disease	.	G30,F00
DIB005156	AR-H050642	Heart arrhythmia	.	I47-I49
DIB005157	MetAP2/SIRT1 dual inhibitors	Cancer	140-229	C00-C96
DIB005158	Tenecrin	Sepsis	995.91	A40, A41
DIB005159	LY-2875358	Cancer	.	C00-C97
DIB005160	Dalvastatin	Hyperlipidemia	.	E78.5
DIB005161	GS-8374	HIV infections	42	B20
DIB005162	TBC-10662	Cardiovascular disease	390-459	I00-I99
DIB005163	InhA inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB005164	GSK2981710	Alzheimer's disease	331	G30
DIB005165	Copper catalyst-based agent	Overactive bladder disorder	596.51	N32.81
DIB005166	Dermofural	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB005167	Selective glucocorticoid receptor agonists	Inflammatory diseases	.	.
DIB005168	CNSB-001	Neuropathic pain	338,780	R52, G89
DIB005169	Antineoplaston AS2-5	Cancer	140-229	C00-C96
DIB005170	DAS-431 IV	Dementia	.	F01-F07
DIB005171	SR-59104A	Gastrointestinal disease	.	K00-K93
DIB005172	Ragweed allergy immunotherapy vaccine	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DIB005173	YPEG-EPO	Anemia	280-285	D50-D64
DIB005174	HyperAcute vaccine	Melanoma	172	C43
DIB005175	Achromatopsia gene therapy	Achromatopsia	.	H53.51
DIB005176	GRC-17536	Pain	338,780	R52, G89
DIB005177	Beta cell replication-supporting therapy	Diabetes mellitus	250	E08-E13
DIB005178	HepaXen	Hepatitis B virus infection	.	B16
DIB005179	FabOvar	Ovarian cancer	.	C56
DIB005180	Antiparkinsonian agents	Parkinson's disease	.	G20
DIB005181	GSK2838232	HIV-1 infections	42	B20
DIB005182	Peptide YY 3-36	Obesity	278	E66
DIB005183	Stapled peptides	Infectious disease	001-139	A00-B99
DIB005184	Fosfluridine tidoxil	Keratosis	.	L57.0
DIB005185	ACE-06X	Metabolic disorders	.	E70-E90
DIB005186	A-252444.0	Inflammatory diseases	.	.
DIB005187	XEN-402	Pain	.	G89
DIB005188	MINT-1526A	Cancer	140-229	C00-C96
DIB005189	Technetium TC 99M votumumab	Colorectal cancer	153, 154	C18-C21
DIB005190	ACVR2B program	Muscle wasting disease	.	M62.50?
DIB005191	ME-1071	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005192	264W94	Hyperlipidemia	.	E78.5
DIB005193	HIV-LAMP-vax	HIV infections	42	B20
DIB005194	Bufexamac	Dermatitis	692.9	L20-L30
DIB005195	Ro-25-2016	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005196	NM-9405	Rheumatold arthritis	714	M05-M06
DIB005197	Atocalcitol	Psoriasis	696	L40
DIB005198	PYRAZOLOACRIDINE	Colorectal cancer	.	C18-C20,C21
DIB005199	EGFR-T790M kinase inhibitors	Lung cancer	162	C33-C34
DIB005200	Zutectra	Hepatitis B virus infection	.	B16
DIB005201	TTP-547	Diabetes mellitus	250	E08-E13
DIB005202	CL-284027	Cardiotonic	.	I50
DIB005203	Stem cell factor modulator	Atopic dermatitis	691.8	L20
DIB005204	AZD-3043	Anesthesia	338	R52
DIB005205	PI3K-alpha inhibitors	Cancer	140-229	C00-C96
DIB005206	TCK-1	Inflammatory diseases	.	.
DIB005207	VBP series	Asthma	493	J45
DIB005208	ETC-276	Ischemia	459.89	I99.8
DIB005209	ActoBiotic	Gastrointestinal infection	.	A09.0
DIB005210	Bis-stillbene analogs	Glioblastoma	191	C71
DIB005211	Hi8 melanoma vaccine	Melanoma	172	C43
DIB005212	CLR-901	Neurological disease	.	G00-G99
DIB005213	V-ATPase inhibitors	Osteoporosis	733	M80-M81
DIB005214	Beta-amyloid inhibitor	Alzheimer's disease	331	G30
DIB005215	Pirsidomine	Angina pectoris	413	I20
DIB005216	Western equine encephalitis virus vaccine	West Nile virus infection	.	A92
DIB005217	SP-D	Lung inflammation	.	D86
DIB005218	WSB-102 series	Autoimmune diseases	279.4	D84.9, M35.9
DIB005219	Angiogenic siRNA therapy	Osteoporosis	733	M80-M81
DIB005220	RV-568	Asthma	493	J45
DIB005221	Tc99-labeled 14F7 humanized mAb	Breast cancer	174, 175, 217	C50, D24
DIB005222	MAb based CD-133 modulators	Cancer	140-229	C00-C96
DIB005223	Recombinant botulinum toxin	Neurological disease	.	G00-G99
DIB005224	Urtoxazumab	Escherichia coli infection	.	A00-B99
DIB005225	TEM-8-Fc	Cancer	140-229	C00-C96
DIB005226	Rabies antibody	Parasitic infection	.	B89
DIB005227	Miboplatin	Prostate tumor	185	C61
DIB005228	Donitriptan	Migraine	.	G43
DIB005229	AVX-003	Glomerulonephritis	580-582	N00, N01, N03, N18
DIB005230	AVE-8134	Heart failure	.	I50
DIB005231	Cefodizime	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005232	AZD1419	Asthma	493	J45
DIB005233	DELTIBANT	Septic shock	.	A41.9
DIB005234	GPR139 antagonists	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB005235	Syn-1002	Pain	338,780	R52, G89
DIB005236	ALK inhibitors	Neuroblastoma	194	C74.9
DIB005237	PRC-4016	Dyslipidemia	272	E78
DIB005238	CR-5259 series	Osteoarthritis	715	M15-M19, M47
DIB005239	NH-02D	Brain injury	.	S09.90
DIB005240	Cocaine abuse therapy	Cocaine addiction	304.2	F14.2
DIB005241	PC-SOD	Interstitial lung disease	.	J84.9
DIB005242	Malaria vaccine	Plasmodium infection	.	B54
DIB005243	Gene therapy	Mesothelioma	163	C45
DIB005244	123I-MNI-330	Alzheimer's disease	331	G30
DIB005245	ABT-299	Septic shock	.	A41.9
DIB005246	BCT-100	Cancer	140-229	C00-C96
DIB005247	Carbapenem antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005248	HUMAN CORTICOTROPIN-RELEASING HORMONE	Leukemia	208.9	C91-C95
DIB005249	Metrizamide	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB005250	Podophyllum	Verruca vulgaris	.	B07.9
DIB005251	FR-111142	Arthritis	710-719	M00-M25
DIB005252	Cx-601	Perianal fistula	.	K60.3
DIB005253	BMS-180448	Angina	.	I20
DIB005254	Ghrelin analogs	Cachexia	799.4	R64
DIB005255	Ro-25-0993	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005256	9-AMINOCAMPTOTHECIN	Acquired immunodeficiency syndrome	.	B20-B24
DIB005257	AP-1510	Cancer	140-229	C00-C96
DIB005258	Tarafenacin	Overactive bladder disorder	596.51	N32.81
DIB005259	Vinorelbine Optisome	Small-cell lung cancer	.	C34.90
DIB005260	TOL-463	Vagina disease	.	N76.0
DIB005261	Varicella-zoster immune globulin	Varicella zoster virus infections	.	B01,B02
DIB005262	7-methylxanthine	Myopia	.	H52.1
DIB005263	FXI antisense oligonucleotides	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB005264	Zinc finger protein transcripition factors	Cancer	140-229	C00-C96
DIB005265	Recombinant opticin	Cancer	.	C00-C97
DIB005266	Anti-CXCR7 monoclonal antibody	Cancer	140-229	C00-C96
DIB005267	M-16209	Diabetes mellitus	.	E10-E14
DIB005268	62Cu-PTSM	Occlusive coronary artery disease	.	I25
DIB005269	Influenza B live attenuatedvirus vaccine	Influenza virus infections	487	J10, J11
DIB005270	VVZ-138	Arthritis	710-719	M00-M25
DIB005271	Small molecule therapeutics	Lipid metabolism disorder	.	E75-E78
DIB005272	Fullerene therapeutics	Age related macular degeneration	.	H35.30
DIB005273	MK-1903	Arteriosclerosis	.	I70
DIB005274	Vercirnon sodium	Crohn's disease	.	K50
DIB005275	ATGC-OP0359	Prostate tumor	185	C61
DIB005276	TRC-6XXX series	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005277	Vaccine	Candida albicans infection	.	B37.0
DIB005278	Antifungal potentiators	Fungal infection	.	B35-B49
DIB005279	Vaccine	Papillomavirus infections	.	B97.7
DIB005280	CP1	Cough	786.2	R05
DIB005281	IMO-14	Diabetes mellitus type 2	.	E11
DIB005282	HCV NS3/4A protease inhibitors	Hepatitis C virus infection	.	B17.1,B18.2
DIB005283	AIR-Epinephrine	Allergic reaction	995.3	T78.4
DIB005284	ME1111	Onychomycosis	.	B35.1
DIB005285	Multiclade DNA recombinant adenovirus-5 (rAd5) vaccine	HIV-1 infections	42	B20
DIB005286	Clonixin	Dysmenorrhea	.	N94.4-N94.6
DIB005287	Lancovutide inhaled	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB005288	Anticancer mAbs	Cancer	140-229	C00-C96
DIB005289	Theradigm-HIV	Viral infections	042-075	A80-A99, B00-B34
DIB005290	BK-4SP	Bordetella pertussis infection	.	A37.0
DIB005291	Cancer therapeutics	Cancer	140-229	C00-C96
DIB005292	CA-9-targeted autologous cell therapy	Cancer	140-229	C00-C96
DIB005293	ICX-RHY	Skin infections	680-709	L00-L99
DIB005294	MT-3995	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB005295	VLP-based cytomegalovirus vaccine	Cytomegalovirus infection	.	B25
DIB005296	Rabies vaccine	Rabies virus infection	001-139	A00-B99
DIB005297	Sophorolipid isoforms	Cancer	.	C00-C97
DIB005298	KamRAB	Leukemia	208.9	C91-C95
DIB005299	Anticancer compounds	Cancer	140-229	C00-C96
DIB005300	AWD-5239	Cognition disorders	.	F06.7
DIB005301	Orexin 2R NAM program	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB005302	Metastatic cancer therapy	Cancer	140-229	C00-C96
DIB005303	EUK-418	Radiation sickness	990	T66
DIB005304	TEI-7322	Respiratory disease	.	J00-J99
DIB005305	Pepticlere	Alzheimer's disease	331	G30
DIB005306	Theradigm-CEA	Colon cancer	153, 154	C18-C21
DIB005307	Met inhibitors	Cancer	140-229	C00-C96
DIB005308	Argotom-VAX	HIV infections	42	B20
DIB005309	Icodextrin	Kidney diseases	580-589	N00-N29
DIB005310	Glucagon antagonists	Diabetes mellitus type 2	.	E11
DIB005311	Immune globulin	Filoviridae	.	A99
DIB005312	Angiotensin II AT1 antagonists	Inflammatory bowel disease	555, 556	K50, K51
DIB005313	Benznidazole	Trypanosomiasis	086.5-086	B56-B57
DIB005314	BSP-C801 series	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005315	5-HT(2C) receptor agonists	Obesity	278	E66
DIB005316	JNK modulators	Obesity	278	E66
DIB005317	EMD-53998	Cardiovascular disease	.	I00-I99
DIB005318	CRTH2 antagonists	Allergy	995.3	T78.4
DIB005319	BBT-012	Cancer	.	C00-C97
DIB005320	Human prothrombin complex concentrate	Bleeding	.	R58
DIB005321	SDZ-280-636	Fungal infection	.	B35-B49
DIB005322	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB005323	SAR-389644	Allergic rhinitis	.	J30
DIB005324	LA-EP2006	Neutropenia	.	D70
DIB005325	Asthma therapeutics	Asthma	493	J45
DIB005326	Retinoid X receptor agonists	Diabetes mellitus	.	E10-E14
DIB005327	PEG-EPO	Anemia	280-285	D50-D64
DIB005328	BIO-500	Radiation sickness	990	T66
DIB005329	Anisperimus	Immuno-suppressant	.	T86.0
DIB005330	Anti-HIV peptides	HIV infections	42	B20
DIB005331	Beta amyloid modulators	Alzheimer's disease	331	G30
DIB005332	PF-708093	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005333	YJRN-0904	Hyperlipidemia	272.0-272.4	E78
DIB005334	Gp120 targeting chimeric monoclonal antibodies	HIV infections	42	B20
DIB005335	Lipovaxin-MM	Melanoma	172	C43
DIB005336	IMU-200 series	Epilepsy	345	G40
DIB005337	WY-47766	Osteoporosis	.	M80-M81
DIB005338	Pentraxin 2/analog	Fibrosis	709.2	L90.5
DIB005339	LG-911	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005340	Herzyme	Breast cancer	174, 175, 217	C50, D24
DIB005341	AS-02 adjuvant	Discovery agent	.	.
DIB005342	TLC-C-53	Respiratory distress syndrome	518.5, 518.82	J80
DIB005343	BYK-324677	Non-insulin dependent diabetes	.	E11.9
DIB005344	IMD-026259	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB005345	ND-AMB	Leishmania infection	.	B55.0
DIB005346	Hextend	Blood transfusion	.	D50-D89
DIB005347	TRK-170	Inflammatory bowel disease	555, 556	K50, K51
DIB005348	Anti-EGFR mAb	Discovery agent	.	.
DIB005349	Ushercell	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005350	Isbogrel	Angina	413	I20
DIB005351	BFPT-16864	Rheumatold arthritis	714	M05-M06
DIB005352	AAV-miApoB	Hypercholesterolemia	272	E78.0
DIB005353	Carimune NF	Immune disorder	.	D80-D89
DIB005354	S-1286	Cancer	.	C00-C97
DIB005355	BMS-182657	Cardiovascular disease	390-459	I00-I99
DIB005356	JAK3 kinase inhibitors	Inflammatory diseases	.	.
DIB005357	NSD-726	Autoimmune diseases	279.4	D84.9, M35.9
DIB005358	VRC-EBODNA023-00-VP	Ebola virus infection	.	A98
DIB005359	AG-NPN803	Nephritis	.	N00-N19,N25-N29
DIB005360	Recombinant hypoallergenic vaccine	Allergic rhinitis	477	J30
DIB005361	PAV-612	Rabies virus infection	001-139	A00-B99
DIB005362	Glycogen synthase inhibitor	Neurodegenerative diseases	.	G30-G32
DIB005363	R-99	Immune disorder	.	D80-D89
DIB005364	Opterone	Hormone deficiency	.	E00-E90
DIB005365	K-953	Cardiac arrhythmias	.	I47-I49
DIB005366	Aprotinin	Bleeding	.	R58
DIB005367	I i-key/MHC class II epitope hybrid peptide vaccines	HIV infections	42	B20
DIB005368	INT-0015/2008	Panic disorder	300.01, 300.21	F41.0
DIB005369	Hemophilus influenzae type b conjugated vaccine	Haemophilus influenzae infection	.	J11.1
DIB005370	Second-generation leptin	Obesity	278	E66
DIB005371	Fsn-0503	Cancer	.	C00-C97
DIB005372	Cathepsin V inhibitors	Colorectal cancer	.	C18-C20,C21
DIB005373	TBI-301	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005374	MK-6302	Neutropenia	288	D70
DIB005375	TriTAb	Poison intoxication	.	T36-T50
DIB005376	R-1578	Mood disorder	.	F30-F39
DIB005377	Interferon alpha 5	Infectious disease	001-139	A00-B99
DIB005378	SF-103	Glaucoma	365	H40-H42
DIB005379	VG-LC	Lung cancer	162	C33-C34
DIB005380	H3N2 live attenuated influenza virus vaccine	Influenza virus infections	487	J10, J11
DIB005381	ReN-005	Huntington's disease	.	F02.2,G10
DIB005382	Tritanrix HB	Hepatitis B virus infection	.	B16
DIB005383	NM-3	Cancer	140-229	C00-C96
DIB005384	Anti-FGFR2 antibody	Cancer	140-229	C00-C96
DIB005385	ACH-0137171	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005386	CI-986	Rheumatold arthritis	.	M05-M06
DIB005387	NV-18	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005388	YN-968D1	Breast cancer	.	C50
DIB005389	COP1-LNP	Hepatocellular carcinoma	155	C22.0
DIB005390	BMS-181168	Cognition disorders	.	F06.7
DIB005391	Oglufanide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005392	LCL-161	Cancer	.	C00-C97
DIB005393	TA-NIC	Nicotine dependence	305.1	F17
DIB005394	Fentanyl MDTS	Pain	.	G89
DIB005395	Oxygen carrier	Skin burns	940-949	T20-T31
DIB005396	Irinotecan liposomal	Cancer	.	C00-C97
DIB005397	Antifungals	Fungal infection	.	B35-B49
DIB005398	Jak2 inhibitors	Multiple sclerosis	340	G35
DIB005399	SPP-600	Hypertension	401	I10, I11, I12, I13, I15
DIB005400	Neisseria meningitidis B protein vaccine	Neisseria meningitidis infection	.	A87
DIB005401	TAK-058	Schizophrenia	.	F20
DIB005402	Vascular targeting technology	Cancer	140-229	C00-C96
DIB005403	HG-1182	Cancer	140-229	C00-C96
DIB005404	EGR-Xa	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB005405	PAT-SM5	Cancer	140-229	C00-C96
DIB005406	TY-11345	Peptic ulcer	.	K25-K27
DIB005407	IDM-2	Bladder cancer	188	C67
DIB005408	Triheptanoin	Fatty acid disorders	.	E71
DIB005409	Lymphozene	B-cell lymphoma	202.8	C85.1
DIB005410	M5	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005411	LC-150444	Diabetes mellitus type 2	.	E11
DIB005412	JTE-051	Allergy	.	T78.4
DIB005413	OB-14	Osteoporosis	733	M80-M81
DIB005414	GM-CSF	Neurological disease	.	G00-G99
DIB005415	Antivirulence WaaC inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005416	IMM-252	HIV infections	42	B20
DIB005417	MBX-700	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB005418	Vaccimel	Melanoma	172	C43
DIB005419	STD-06	Dermatological disease	.	L00-L99
DIB005420	Antiviral agent	Enterovirus infection	.	B34.1
DIB005421	Creatine analogs	Cancer	.	C00-C97
DIB005422	HybriCell	Melanoma	.	C43
DIB005423	KF-15766	Allergy	995.3	T78.4
DIB005424	Solubilized type 1 native bovine collagen	Scleroderma	701.0710.1	L94.0-L94.1, M34
DIB005425	Radiolabeled anti-RECAF antibodies	Cancer	140-229	C00-C96
DIB005426	K-828-AB	Dementia	290-294	F01-F07
DIB005427	H1N1 pandemic influenza A vaccine	Influenza virus infections	487	J10, J11
DIB005428	MST-188	Non-small-cell lung carcinoma	162	C33, C34
DIB005429	Allosteric GSK-3b inhibitors	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB005430	ANQ-9040	Paralysis	.	G72.3
DIB005431	Onyvax-105	Colorectal cancer	.	C18-C20,C21
DIB005432	Rebmab-100	Fallopian tube cancer	.	C57.0,D28.2
DIB005433	NICANARTINE	Atherosclerosis	414.0, 440	I70
DIB005434	AF-3485 program	Inflammatory diseases	.	.
DIB005435	SMT-D004	Age related macular degeneration	.	H35.30
DIB005436	Superoxide dismutase	Myocardial infarction	.	I21-I22
DIB005437	BAMLET	Bladder cancer	188	C67
DIB005438	APF-580	Pain	338,780	R52, G89
DIB005439	CIGB-200	HIV infections	42	B20
DIB005440	PG-140	Transplant rejection	.	T86
DIB005441	Ibopamine	Congestive heart failure	428	I50
DIB005442	REACTA	Cancer	140-229	C00-C96
DIB005443	Deleobuvir	Hepatitis C virus infection	.	B17.1,B18.2
DIB005444	THVD-201	Overactive bladder disorder	596.51	N32.81
DIB005445	Second-generation cannabinoids	Autoimmune diseases	279.4	D84.9, M35.9
DIB005446	Glycosaminoglycan modulators	Ocular disease	.	H00-H59
DIB005447	Ademetionine	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005448	Emdogain	Cancer	.	C00-C97
DIB005449	E-2011	Anxiety disorder	.	F40-F42
DIB005450	SGN LIV1A	Breast cancer	.	C50
DIB005451	Torbafylline	Peripheral vascular disease	443.9	I73.9
DIB005452	CFZ533	Rheumatold arthritis	714	M05-M06
DIB005453	FR-76830	Angina	413	I20
DIB005454	Isocitrate dehydrogenase inhibitors	Cancer	140-229	C00-C96
DIB005455	HN-10200	Cardiac failure	.	I50
DIB005456	IKK-epsilon/TBK 1 inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB005457	Zipeprol	Cough	786.2	R05
DIB005458	Chondroprotective agents	Articular cartilage disorders	.	M24.10
DIB005459	Budipine	Migraine	346	G43
DIB005460	SFLT-01	Macular degeneration	.	H35.3
DIB005461	YM-75466	Thrombosis	.	I80-I82
DIB005462	Hsp90 inhibitors	Cancer	140-229	C00-C96
DIB005463	ALT-020	Ocular infection	.	H00-H59
DIB005464	Small molecule CCR5 inhibitor	HIV infections	42	B20
DIB005465	Glucagon-like peptide-1 gene therapy	Diabetes mellitus	250	E08-E13
DIB005466	AMT-090	Huntington's disease	.	F02.2,G10
DIB005467	NMK-36	Cancer	.	C00-C97
DIB005468	TVX-010	Discovery agent	.	.
DIB005469	KPT-330	Solid tumours	.	C00-C75,C7A,C7B
DIB005470	FM-401	Inflammatory diseases	.	.
DIB005471	11C-PBR-28	Brain diseases	.	G00-G99
DIB005472	MEDR-440	Respiratory disease	.	J00-J99
DIB005473	Z-944	Neuropathic pain	338,780	R52, G89
DIB005474	PharmaPEG-interferon-alpha	Infectious disease	001-139	A00-B99
DIB005475	TDI-0032	Motor neurone disease	335.2	G12.2
DIB005476	NSI-566RSC	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005477	HX-01	Cancer	.	C00-C97
DIB005478	TB-antigen	Mycobacterium tuberculosis infection	.	A15-A19
DIB005479	AF-05	Anxiety disorder	300	F40-F42
DIB005480	Encenicline	Multiple myeloma	.	C90.0
DIB005481	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB005482	DFP	Pain	.	G89
DIB005483	Genz-682452	Fabry's disease	.	E75.2
DIB005484	Intranasal influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB005485	OT-551	Ocular inflammation	.	H00-H59
DIB005486	Myolimus-eluting stent	Coronary artery restenosis	.	I20-I25
DIB005487	WY-28342	Rheumatold arthritis	.	M05-M06
DIB005488	RGD-039	Thrombosis	.	I80-I82
DIB005489	Salmonella typhi vaccine	Salmonella infection	.	A02.9
DIB005490	Cathepsin K inhibitors	Osteoporosis	.	M80-M81
DIB005491	Omiganan	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005492	RP-66364	Inflammatory diseases	.	.
DIB005493	TTI-314	Autoimmune diseases	279.4	D84.9, M35.9
DIB005494	TNK-651	HIV infections	42	B20
DIB005495	Virulence blockers	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005496	VEGF-2 receptor modulator	Age related macular degeneration	.	H35.30
DIB005497	SER-207	Cancer	140-229	C00-C96
DIB005498	99mTc-MIP-1340	Prostate tumor	185	C61
DIB005499	BTA-798	Rhinovirus infection	.	J20.6?
DIB005500	V-503	Papillomavirus infections	.	B97.7
DIB005501	Factor IX gene therapy	Hemophilia	286	D66-D68
DIB005502	MesoStem	Insulin dependent diabetes	.	E10
DIB005503	B1-655075	Blood coagulation disorders	.	D65-D68
DIB005504	Ro-31-8830	Inflammatory diseases	.	.
DIB005505	FB-1811	Salmonella infection	.	A02.9
DIB005506	Mycobacterium tuberculosis infection targeting compounds	Mycobacterium tuberculosis infection	.	A15-A19
DIB005507	OSH-101	Alopecia	.	L65.9
DIB005508	131I-ImmuRAIT-HCG, Immunomedics	Cancer	140-229	C00-C96
DIB005509	SpirH	HIV infections	.	B20
DIB005510	XT-101	Neuropathic pain	338,780	R52, G89
DIB005511	NZ-107	Asthma	.	J45
DIB005512	Statin	Hypercholesterolemia	272	E78.0
DIB005513	PYN-22	Obesity	278	E66
DIB005514	CL-2000	Colon cancer	153, 154	C18-C21
DIB005515	S1P1 agonists	Cancer	.	C00-C97
DIB005516	C-0334578	Hepatitis virus infection	573.3	K75.9
DIB005517	UvrD helicase inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB005518	Afegostat plus enzyme replacement therapy	Gaucher disease	272.7	E75.2
DIB005519	M-410	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005520	TEW-7197	Solid tumours	.	C00-C75,C7A,C7B
DIB005521	Non-anticoagulation heparins	Cancer	140-229	C00-C96
DIB005522	KPE-02001003	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005523	Ultramorph	Pain	338,780	R52, G89
DIB005524	Esonarimod	Arthritic	710-719	M00-M25
DIB005525	FK-788	Hypertension	.	I10-I15
DIB005526	LY2944876	Diabetes mellitus	250	E08-E13
DIB005527	DP-6001	HIV infections	42	B20
DIB005528	Antivaginolysin single chain variable fragments	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005529	CRB-0022	Pain	338,780	R52, G89
DIB005530	AVP-7	Cancer	140-229	C00-C96
DIB005531	VNA-932	Urinary incontinence	.	N39.3-N39.4
DIB005532	Histone demethylase GASC-1 inhibitor	Cancer	140-229	C00-C96
DIB005533	AERAS-402	Mycobacterium tuberculosis infection	.	A15-A19
DIB005534	PMA-511R	Autoimmune diseases	279.4	D84.9, M35.9
DIB005535	KB-001	Infections disease	.	A00-B99
DIB005536	AVN-457	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB005537	Human neural stem cell therapy	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB005538	Actinomycetes metabolites	Mycobacterium tuberculosis infection	.	A15-A19
DIB005539	Protease inhibitors	HIV infections	42	B20
DIB005540	213-Bi DOTA-PESIN	Cancer	140-229	C00-C96
DIB005541	PfSUB-1 protease inhibitors	Plasmodium falciparum infection	.	B54
DIB005542	Apolipoprotein A-IV	Eating disorder	307.5	F50
DIB005543	ELOMOTECAN HYDROCHLORIDE	Solid tumours	.	C00-C75,C7A,C7B
DIB005544	AMESERGIDE	Mood disorder	.	F30-F39
DIB005545	OX-27	Cancer pain	338,780	R52, G89
DIB005546	RVX-408	Cardiovascular disease	390-459	I00-I99
DIB005547	Oncology therapeutics	Cancer	140-229	C00-C96
DIB005548	123I-MNI-168	Alzheimer's disease	331	G30
DIB005549	Opioid antagonist	Bulimia nervosa	.	F50.2
DIB005550	Group A streptococcal vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005551	BC-822	Cancer	140-229	C00-C96
DIB005552	MDC-1231	Colon cancer	153, 154	C18-C21
DIB005553	Stanozolol	Hereditary angioedema	277.6	D84.1
DIB005554	HL-024	Cancer	.	C00-C97
DIB005555	Omniferon	Cancer	.	C00-C97
DIB005556	CTL	Renal cancer	.	C64
DIB005557	LY3090106	Rheumatold arthritis	714	M05-M06
DIB005558	RP01	Allergic reaction	995.3	T78.4
DIB005559	Ondansetron pulsatile release	Substance dependence	.	F10-F19
DIB005560	SSR-126517E	Thrombosis	.	I80-I82
DIB005561	ETN-002	Motor neurone disease	335.2	G12.2
DIB005562	OSE-300	Parkinson's disease	.	G20
DIB005563	PENCLOMEDINE	Solid tumours	.	C00-C75,C7A,C7B
DIB005564	HBV vaccine	Hepatitis B virus infection	.	B16
DIB005565	Calpain inhibitors	Neurological disease	.	G00-G99
DIB005566	LIV-1205	Cancer	140-229	C00-C96
DIB005567	ATN-224	Solid tumours	.	C00-C75,C7A,C7B
DIB005568	Multimeric-001	Influenza virus infections	487	J10, J11
DIB005569	Her-2-Bi-armed ATC	Breast cancer	.	C50
DIB005570	Gadomelitol	Cardiovascular disease	390-459	I00-I99
DIB005571	CLT-009	Angiogenesis disorder	.	I00-I99
DIB005572	DF-1012	Cough	786.2	R05
DIB005573	Imaging-theranostic nanoemulsion agents	Ovarian cancer	.	C56
DIB005574	Metabolic disease program	Diabetes mellitus	250	E08-E13
DIB005575	Nh-125	Cancer	140-229	C00-C96
DIB005576	IDR-1018	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005577	Oligonucleotide	Herpes simplex virus infection	54	B00
DIB005578	Daniquidone	Lymphoma	.	C81-C96
DIB005579	Chickenpox vaccine	Varicella zoster virus infections	.	B01,B02
DIB005580	K-454	Cancer	140-229	C00-C96
DIB005581	Transdermal patch	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB005582	KRP-109	Discovery agent	.	.
DIB005583	OC-000459	Allergy	.	T78.4
DIB005584	Anti-HM1.24	Multiple myeloma	203	C90.0
DIB005585	AMX-256	Short bowel syndrome	579.3	K91.8
DIB005586	Fusion proteins	Influenza virus infections	487	J10, J11
DIB005587	OcuNex	Wound healing	.	S91.3
DIB005588	CL-H01	Migraine	346	G43
DIB005589	S-1360	HIV infections	42	B20
DIB005590	BP-C1	Breast cancer	174, 175, 217	C50, D24
DIB005591	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB005592	PV-921	Cancer	140-229	C00-C96
DIB005593	NAHE-001	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005594	CNT0-1959	Rheumatold arthritis	714	M05-M06
DIB005595	BPS-804	Metabolic bone disease	.	E50-E64,E70-E90
DIB005596	ALD-805	Cancer	140-229	C00-C96
DIB005597	AS-210	Psoriasis	696	L40
DIB005598	Valtorcitabine	Hepatitis virus infection	573.3	K75.9
DIB005599	ICA-69673	Pain	.	G89
DIB005600	Dasotraline	Mood disorder	.	F30-F39
DIB005601	BR-05001	Anemia	280-285	D50-D64
DIB005602	CC-0101	Cancer	140-229	C00-C96
DIB005603	BB-101	Pain	338,780	R52, G89
DIB005604	Sphingosine 1 phosphate-1 agonists	Psoriasis	696	L40
DIB005605	HuN901-DC1	Small-cell lung cancer	.	C34.90
DIB005606	SPD-557	Diabetic gastroparesis	.	E08-E13
DIB005607	Agriflu	Influenza virus infections	487	J10, J11
DIB005608	KRI-1314	Hypertension	401	I10, I11, I12, I13, I15
DIB005609	GI-10001	Chronic myelogenous leukemia	205.1	C92.1
DIB005610	Vaccine	Plasmodium infection	.	B54
DIB005611	NPT-1162	Non-insulin dependent diabetes	.	E11.9
DIB005612	ImmuRAIT-CEA-rhenium-188	Colon cancer	153, 154	C18-C21
DIB005613	CL-329753	Cancer	140-229	C00-C96
DIB005614	ScFv23/rGel	Breast cancer	174, 175, 217	C50, D24
DIB005615	ACI-91	Alzheimer's disease	.	G30,F00
DIB005616	Fatty acid-binding protein 4 inhibitors	Obesity	278	E66
DIB005617	Caspase activators	Cancer	140-229	C00-C96
DIB005618	111In-imciromab pentetate	Myocardial infarction	410	I21, I22
DIB005619	IkT-014	Polyomavirus infection	.	B97.89
DIB005620	Eculizumab	Age related macular degeneration	.	H35.30
DIB005621	CRIB	Neurodegenerative diseases	.	G30-G32
DIB005622	REC-15/3079	Urinary incontinence	.	N39.3-N39.4
DIB005623	Pretarget	Lymphoma	.	C81-C96
DIB005624	Physostigmine/scopolamine	Nicotine dependence	305.1	F17
DIB005625	ALORACETAM	Cognition disorders	.	F06.7
DIB005626	Sulfatinib	Cancer	140-229	C00-C96
DIB005627	Alzheimers disease therapy	Alzheimer's disease	331	G30
DIB005628	Viral capsid assembly inhibitors	HIV infections	42	B20
DIB005629	RP-57	Scar tissue	.	L00-L99
DIB005630	SOM-1000	Fungal infection	.	B35-B49
DIB005631	Indole-3-carbinol dimer analogs	Breast cancer	174, 175, 217	C50, D24
DIB005632	RHPIV1 84/del/170/942A	Parainfluenza virus infection	.	J12.2
DIB005633	Mammalian sterile 20-like kinase 1 gene eluting stent	Restenosis	.	I51.89
DIB005634	HuMax-CD38b	Cancer	140-229	C00-C96
DIB005635	Human recombinant polyclonal anitbodies	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB005636	Fusion toxin protein	Cancer	140-229	C00-C96
DIB005637	SND-121 prodrugs	Neuropathic pain	338,780	R52, G89
DIB005638	DNMT1 inhibitors	Cancer	140-229	C00-C96
DIB005639	CDK5/p25 inhibitor	Neurodegenerative diseases	.	G30-G32
DIB005640	CVS-1123	Myocardial infarction	.	I21-I22
DIB005641	Deuterium-enriched oxybutynin derivatives	Overactive bladder disorder	596.51	N32.81
DIB005642	Org-10490	Psychotic disorders	.	F20-F29
DIB005643	FR-180102	Helicobacter pylori infection	41.86	B96.81
DIB005644	Broxaterol	Asthma	493	J45
DIB005645	EG-P119	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DIB005646	ALT-804	Cancer	140-229	C00-C96
DIB005647	F-3796	Alzheimer's disease	.	G30,F00
DIB005648	Granulosin	Chronic granulomatous disease	.	D71
DIB005649	Comvac5	Hepatitis B virus infection	.	B16
DIB005650	PDE5 inhibitors	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB005651	SJ-3249	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005652	XP-20925	Migraine	346	G43
DIB005653	APN-501 series	Cancer	140-229	C00-C96
DIB005654	Specific HLA binding inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB005655	E coli vaccine	Diarrhea	787.91	A09, K59.1
DIB005656	GDNF-containing DNA nanoparticle therapy	Parkinson's disease	.	G20
DIB005657	JPD-105	Infectious disease	001-139	A00-B99
DIB005658	NPL-2003	Obsessive-compulsive disorder	.	F42
DIB005659	Naronapride	Gastroesophageal reflux disease	.	K21
DIB005660	PF-05186462	Pain	338,780	R52, G89
DIB005661	Inactivated parasite blood-stage malaria vaccine	Plasmodium infection	.	B54
DIB005662	Second generation Heptazyme	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005663	ADC-3680	Allergic rhinitis	.	J30
DIB005664	GIP program	Metabolic disorders	.	E70-E90
DIB005665	Yersinia pestis vaccine	Yersinia infections	.	A20
DIB005666	Indazole-based tubulin inhibitors	Cancer	140-229	C00-C96
DIB005667	BW-A137C	Inflammatory diseases	.	.
DIB005668	ER-34122	Inflammatory diseases	.	.
DIB005669	E-1413	Major depressive disorder	296.2, 296.3	F32, F33
DIB005670	MGluR7 NAM inhibitors	Major depressive disorder	296.2, 296.3	F32, F33
DIB005671	AAV-based vaccines	Cancer	.	C00-C97
DIB005672	AMT-021	Acute intermittent (hepatic) porphyria	.	E80.21
DIB005673	F-14413	Alzheimer's disease	331	G30
DIB005674	E-6080	Asthma	.	J45
DIB005675	CM-2359	Neuropathy	356.0, 356.8	G64, G90.0
DIB005676	Recombinant T-cell receptor ligand	Uveitis	364	H20
DIB005677	FPL-64170	Psoriasis	.	L40
DIB005678	AKB-6548	Anemia	.	D50-D64
DIB005679	Heat stable vaccine	Hepatitis B virus infection	.	B16
DIB005680	GZ402666	Pompe's disease	.	E74.0
DIB005681	Anti-inflammatory agents	Ocular inflammation	.	H00-H59
DIB005682	Gentian violet	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005683	LPO-1010UV	Uveitis	364	H20
DIB005684	Nav1.7 inhibitors	Pain	338,780	R52, G89
DIB005685	Galanin antagonists	Alzheimer's disease	331	G30
DIB005686	Epinastine HCl	Allergic conjunctivitis	372.14	H10.45
DIB005687	BG-777	HIV infections	42	B20
DIB005688	IRAK4 inhibitors	Inflammatory diseases	.	.
DIB005689	Alvameline	Alzheimer's disease	.	G30,F00
DIB005690	SARS virus vaccine	SARS coronavirus infection	.	J12.81
DIB005691	Modified GDNF	Parkinson's disease	.	G20
DIB005692	AA-123	Prostate tumor	185	C61
DIB005693	Shikimate kinase inhibitors	Mycobacterium infection	.	A31
DIB005694	AH-9700	Pollakiuria	.	R35
DIB005695	TAK-583	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB005696	Actinonin analogs	Cancer	140-229	C00-C96
DIB005697	Immunomodulators	Asthma	493	J45
DIB005698	PRLX93936	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005699	Kifunensine	Muscular dystrophy	.	G71.0
DIB005700	DC-9703	Non-insulin dependent diabetes	.	E11.9
DIB005701	EM-5618	Cancer	140-229	C00-C96
DIB005702	Seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB005703	Isoflavone-based compounds	Cancer	140-229	C00-C96
DIB005704	AR-D-111421	Asthma	493	J45
DIB005705	RO-5303253	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005706	CIGB-370	Cancer	140-229	C00-C96
DIB005707	S-18326	Myocardial infarction	.	I21-I22
DIB005708	Thalassemia therapeutics	Thalassemia	.	D56
DIB005709	MT-001	Hypercholesterolemia	272	E78.0
DIB005710	BUFLOMEDIL PYRIDOXALPHOSPHATE	Cardiovascular disease	.	I51.6
DIB005711	SP-650003	Inflammatory bowel disease	.	K50,K51
DIB005712	Second-generation HCV entry inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005713	BIOO-7	Discovery agent	.	.
DIB005714	AE-H vaccine	HIV infections	.	B20
DIB005715	D-4418	Cutaneous T-cell lymphoma	.	C84.0,C84.1
DIB005716	Efalith	Acne vulgaris	706.1	L70.0
DIB005717	GRN-529	Major depressive disorder	296.2, 296.3	F32, F33
DIB005718	Caspase-3 inhibitors	Alzheimer's disease	.	G30,F00
DIB005719	Aminopyridines	Plasmodium falciparum infection	.	B54
DIB005720	ONO-3307	Coagulation	.	I80-I82
DIB005721	Retinitis pigmentosa therapy	Retinitis pigmentosa	.	H35.5
DIB005722	GSK2618960	Multiple sclerosis	340	G35
DIB005723	Apoptosis-inducing peptide	Cancer	140-229	C00-C96
DIB005724	Liranaftate	Fungal infection	.	B35-B49
DIB005725	Mam-06.301	Allergy	995.3	T78.4
DIB005726	Oral delta opioid agonists	Premature ejaculation	302.75	F52.4
DIB005727	PN-403	Alzheimer's disease	331	G30
DIB005728	FHT-CT4	Asthma	493	J45
DIB005729	Factor VIII-transfected autologous cell therapy	Hemophilia	286	D66-D68
DIB005730	CBI-009	HIV infections	42	B20
DIB005731	RTL-1000	Multile sclerosis	.	G35
DIB005732	GnRH antagonists	Endocrine disease	.	E00-E35
DIB005733	KDT-500	Inflammatory diseases	.	.
DIB005734	JTT-651	Diabetes mellitus type 2	.	E11
DIB005735	Ketoprofen patch	Pain	.	G89
DIB005736	IN-001	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB005737	DPC-681	Human immunodeficiency virus infection	.	B20
DIB005738	Inhibitor of Chymse	Cardiovascular disease	.	I00-I99
DIB005739	Pyridone back-up compounds	Plasmodium falciparum infection	.	B54
DIB005740	Sulfur hexafluoride lipid-type a microspheres	Cardiovascular disease	.	I51.6
DIB005741	MX-76629	Cancer	140-229	C00-C96
DIB005742	IDX-719	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005743	Estetrol	Autoimmune diseases	279.4	D84.9, M35.9
DIB005744	GW-1536	Diabetes mellitus type 2	.	E11
DIB005745	AIK-21	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005746	Gene therapy	Cancer	.	C00-C97
DIB005747	GSK-1070806	Type 2 diabetes	250.00, 250.02	E11
DIB005748	DNA vaccine	Cancer	140-229	C00-C96
DIB005749	AM-643	Dermatological disease	.	L00-L99
DIB005750	YP-004	Cancer	140-229	C00-C96
DIB005751	Peptide program	Viral infections	042-075	A80-A99, B00-B34
DIB005752	CTA1-DD/M2e vaccine	Influenza virus infections	487	J10, J11
DIB005753	AEZS-120	Melanoma	.	C43
DIB005754	PF-3004459	Alopecia	.	L65.9
DIB005755	Dual acting Hsp90/TRAP1 inhibitors	Cancer	140-229	C00-C96
DIB005756	CMI-392	Psoriasis	.	L40
DIB005757	ABT-981	Osteoarthritis	.	M15-M19,M47
DIB005758	Intravenous minocycline	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005759	Adhesion kinase modulators	Cancer	140-229	C00-C96
DIB005760	ASCJ-M series	Prostate hyperplasia	.	N40
DIB005761	Granotapide	Hyperlipidemia	.	E78.5
DIB005762	Recombinant B-cell peptide vaccine	Allergic rhinitis	477	J30
DIB005763	Aganirsen ophthalmic formulation	Macular degeneration	.	H35.3
DIB005764	MV-6401	Restenosis	.	I51.89
DIB005765	Beta-lactam antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005766	HIE-124	General anesthesia	338	R52
DIB005767	Apogossypol	Cancer	140-229	C00-C96
DIB005768	Tridolgosir	Cancer	.	C00-C97
DIB005769	LJP-920	Transplant rejection	.	T86
DIB005770	ABJ-879	Cancer	140-229	C00-C96
DIB005771	Tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB005772	CEE-03-320	Substance dependence	.	F10-F19
DIB005773	LAS-Z019	Gastric motility disorder	.	K22.4
DIB005774	AF-219	Overactive bladder disorder	.	N32.81
DIB005775	XEN-402	Pain	.	G89
DIB005776	NE-0080	Helicobacter pylori infection	.	B98
DIB005777	DNA vaccine	Dengue fever	061, 780.6	A90, R50
DIB005778	Skeletal targeted radiotherapy	Multiple myeloma	203	C90.0
DIB005779	AZD-2563	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005780	RM-4864	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB005781	RO-26-9228	Urinary incontinence	.	N39.3-N39.4
DIB005782	SD-118	Inflammatory diseases	.	.
DIB005783	Antigen-pulsed dendritic cell vaccine	Melanoma	172	C43
DIB005784	Inhaled supergeneric	Cancer	.	C00-C97
DIB005785	Ro-25-4094	Inflammatory diseases	.	.
DIB005786	IZONSTERIDE	Hirsutism	.	L68.0
DIB005787	MDL-28133A	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB005788	Hematopoietic stem cell therapy	Beta thalassemia	.	D56.1
DIB005789	CT-100	Renal disease	.	N00-N29
DIB005790	BA-011	HIV infections	42	B20
DIB005791	AbGn-168	Allergy	.	T78.4
DIB005792	ML-03	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB005793	Haw-AD-14	Alzheimer's disease	331	G30
DIB005794	DEF-201	Ebola virus infection	.	A98
DIB005795	ASBT inhibitors	Hypercholesterolemia	272	E78.0
DIB005796	XEL-002LG	Pain	338,780	R52, G89
DIB005797	Cholazol	Atherosclerosis	414.0, 440	I70
DIB005798	Cardiogenic stem cell modulators	Congestive heart failure	428	I50
DIB005799	PM-102	Bleeding	.	R58
DIB005800	HN-1 Taxane	Squamous cell carcinoma	199	C44
DIB005801	GSK-256073	Hyperlipidemia	.	E78.5
DIB005802	PF-3557156	Pain	338,780	R52, G89
DIB005803	ALX-0141	Osteoporosis	.	M80-M81
DIB005804	LAS-31270	Cardiac failure	.	I50
DIB005805	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB005806	Fructose-1,6-bisphosphatase inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB005807	Electrophilic alkylating agents	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005808	Long-acting erythropoietin conjugate	Anemia	.	D50-D64
DIB005809	HuMax-Her2	Cancer	140-229	C00-C96
DIB005810	Protein tyrosine kinase inhibitors	Acute myeloid leukemia	205	C92.0
DIB005811	FR-194738	Hypercholesterolaemia	.	E78.0
DIB005812	Combretastatin-A4 analogs	Cancer	140-229	C00-C96
DIB005813	GZ402663	Macular degeneration	.	H35.3
DIB005814	Adipose-derived stem cell therapy	Cardiovascular disease	390-459	I00-I99
DIB005815	IPP-203101	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005816	ORG-33628	Contraception	.	Z30
DIB005817	Magnesium salicylate	Inflammatory diseases	.	.
DIB005818	Boostrix	Bordetella pertussis infection	.	A37.0
DIB005819	DPD-207	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005820	SPD-474	Parkinson's disease	.	G20
DIB005821	123I-MNI-420	Huntington's disease	.	F02.2,G10
DIB005822	P2X7 antagonists	Pain	338,780	R52, G89
DIB005823	AZD-9164	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB005824	Melatonin program	Discovery agent	.	.
DIB005825	RLP-073	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB005826	BMS-186318	HIV-1 infections	42	B20
DIB005827	SB-234551	Nerve injury	.	T14.4
DIB005828	KNI-102	HIV infections	42	B20
DIB005829	PDE 4 inhibitor	Inflammatory diseases	.	.
DIB005830	Isoindolinone derivatives	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005831	NO-COX-2 inhibitor	Pain	.	G89
DIB005832	Dengue virus methyltransferase inhibitors	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB005833	ABS-201	Psychotic disorders	.	F20-F29
DIB005834	TRN-157	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB005835	Flt 3 inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB005836	Anti-ADDL antibodies	Alzheimer's disease	331	G30
DIB005837	CCR5 targeting monoclonal antibody	Discovery agent	.	.
DIB005838	Proteolytic mAbs	Toxicity	.	T36-T50,T51-T65
DIB005839	BAY-1075553	Prostate tumor	185	C61
DIB005840	HIV vaccine	HIV infections	42	B20
DIB005841	BBI-608	Cancer	.	C00-C97
DIB005842	CJ-12255	Eczema	.	L20-L30
DIB005843	AG-350	Cancer	.	C00-C97
DIB005844	Peptide antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005845	C-met mAbs	Cancer	.	C00-C97
DIB005846	FRM-6308	Schizophrenia	295	F20
DIB005847	Epstein-Barr virus therapy	Cancer	140-229	C00-C96
DIB005848	F4co vaccine	HIV infections	42	B20
DIB005849	GP-1100	Neuropathic pain	338,780	R52, G89
DIB005850	Plk-1 inhibitors	Cancer	140-229	C00-C96
DIB005851	ZT-1	Parkinson's disease	.	G20
DIB005852	NPI-3304	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005853	A33-Ac-225	Colon cancer	153, 154	C18-C21
DIB005854	WC-3049	Congestive heart failure	428	I50
DIB005855	NNI-PD program	Parkinson's disease	.	G20
DIB005856	RP-67580	Pain	.	G89
DIB005857	SOM-0010	Viral infections	042-075	A80-A99, B00-B34
DIB005858	NPI-32101	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB005859	EphA2-targeting BiTE molecules	Cancer	140-229	C00-C96
DIB005860	Doxepin intranasal	Headache	.	G43-G44
DIB005861	Spike and nucleocapsid protein-targeting vaccine	SARS coronavirus infection	.	J12.81
DIB005862	SEP-227900	Cognitive impairment	.	F06.7
DIB005863	PTH(7-34) liposomal cream	Alopecia	.	L65.9
DIB005864	Zindoxifene	Breast cancer	174, 175, 217	C50, D24
DIB005865	CSL-627	Factor VIII deficiency	.	D66
DIB005866	Annual influenza vaccine	Influenza virus infections	487	J10, J11
DIB005867	LY-285434	Hypertension	401	I10, I11, I12, I13, I15
DIB005868	GSK-315234A	Rheumatold arthritis	714	M05-M06
DIB005869	Non-Hodgkin lymphoma vaccine	B-cell lymphoma	202.8	C85.1
DIB005870	Angiogenesis inhibitors	Cancer	140-229	C00-C96
DIB005871	PrLL-37	Wound healing	.	S91.3
DIB005872	Multiple sclerosis therapy	Multiple sclerosis	340	G35
DIB005873	GPCR40 agonists	Diabetes mellitus	250	E08-E13
DIB005874	BIM-23268	Acromegaly	.	E22.0
DIB005875	DW-941	SARS coronavirus infection	.	J12.81
DIB005876	Human therapeutic antibodies	Cancer	.	C00-C97
DIB005877	Anti-HIV compounds	HIV infections	42	B20
DIB005878	TJ-8117	Nephritis	.	N00-N19,N25-N29
DIB005879	FGI-103-723	Ebola virus infection	.	A98
DIB005880	F-2692	Anxiety disorder	300	F40-F42
DIB005881	YKP-GI	Constipation	.	K59.0
DIB005882	CV-6402.2HCL	Cardiac arrhythmias	.	I47-I49
DIB005883	T2c-003	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB005884	Bombesin BRS-3 receptor agonists	Congestive heart failure	428, 428.0	I50
DIB005885	T-115	Cancer	140-229	C00-C96
DIB005886	PT-00114	Anxiety disorder	300	F40-F42
DIB005887	Cancer therapy	Cancer	140-229	C00-C96
DIB005888	AS-1406	Cancer	.	C00-C97
DIB005889	HG-1154	Cardiovascular disease	390-459	I00-I99
DIB005890	BF/PC-13	Dermatitis	692.9	L20-L30
DIB005891	CGP-28014	Major depressive disorder	.	F32,F33
DIB005892	PYC-35B	Skin burns	940-949	T20-T31
DIB005893	MLN-2201	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005894	Hydriodic acid iodine-125	Asthma	493	J45
DIB005895	Befiperide	Anxiety disorder	300	F40-F42
DIB005896	EM-101	Cancer	140-229	C00-C96
DIB005897	KPS-0373	Parkinson's disease	.	G20
DIB005898	LD-02GIFRO	Gastroparesis	536.3	K31.8
DIB005899	PNB-03	Parkinson's disease	.	G20
DIB005900	Oxypurinol	Heart failure	.	I50
DIB005901	SB-209247	Psoriasis	.	L40
DIB005902	LEX-026	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB005903	AC-1204	Pancreatic cancer	157	C25
DIB005904	EC-301	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB005905	CGP-44826	Asthma	493	J45
DIB005906	PF-514273	Obesity	278	E66
DIB005907	Talabostat	Hematopoietic	.	D50-D89
DIB005908	Flufenoxina	Major depressive disorder	296.2, 296.3	F32, F33
DIB005909	Simotaxel	Cancer	140-229	C00-C96
DIB005910	G-protein modulators	Respiratory disorder	.	J98.9
DIB005911	Tetanus immune globulin	Clostridium tetani infection	001-139	A00-B99
DIB005912	Dual PI3K/mTOR inhibitors	Cancer	140-229	C00-C96
DIB005913	Interleukin-1 receptor gene therapy	Rheumatold arthritis	714	M05-M06
DIB005914	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB005915	PS948115	Respiratory failure	518.81	J96
DIB005916	Javelin	Melanoma	172	C43
DIB005917	SM-6586	Hypertension	.	I10-I15
DIB005918	TZ101	Hematological malignancies	200-209	C81-C96
DIB005919	GSK-523338	Non-insulin dependent diabetes	.	E11.9
DIB005920	TrasGEX	Cancer	140-229	C00-C96
DIB005921	MTI-SAM3	Melanoma	172	C43
DIB005922	Antibody-drug conjugate	Discovery agent	.	.
DIB005923	A-72055	Alzheimer's disease	331	G30
DIB005924	ONT-093	Solid tumours	.	C00-C75,C7A,C7B
DIB005925	Recombinant human CC10	Endometriosis	617	N80
DIB005926	TPIV100	Breast cancer	174, 175	C50
DIB005927	Recombinant Tat protein vaccine	HIV infections	42	B20
DIB005928	M-108101	Acne vulgaris	706.1	L70.0
DIB005929	Lexatumumab	Cancer	140-229	C00-C96
DIB005930	BF-389	Rheumatold arthritis	.	M05-M06
DIB005931	Bone morphogenetic receptor agonist	Obesity	278	E66
DIB005932	ADS-NPTMZ-1	Melanoma	172	C43
DIB005933	SQ-33961	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB005934	SR-95577A	Neurological disease	.	G00-G99
DIB005935	Dendritic cell vaccine	Ovarian cancer	.	C56
DIB005936	FP0011	Amyotrophic lateral sclerosis	335.2	G12.2
DIB005937	Anti-TB antibiotics	Mycobacterium tuberculosis infection	.	A15-A19
DIB005938	Luliconazole 1.3%	Tinea pedis	.	B35.3
DIB005939	Late sodium current modulators	Coronary artery disease	410-414, 429.2	I20-I25
DIB005940	Aldosterone synthase inhibitors	Cardiovascular disease	390-459	I00-I99
DIB005941	CGP-37849	Neurological disease	.	G00-G99
DIB005942	HIV integrase inhibitors	HIV infections	42	B20
DIB005943	HBN-3	Septic shock	785.52	A41.9
DIB005944	EPI-288	Cancer	140-229	C00-C96
DIB005945	New molecular entity	Infectious disease	001-139	A00-B99
DIB005946	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB005947	Modified SDF-1	Cardiovascular disease	390-459	I00-I99
DIB005948	Anti-CD40-XTEN	Rheumatold arthritis	714	M05-M06
DIB005949	LXR agonists	Atherosclerosis	414.0, 440	I70
DIB005950	Cyclodextrin	Osteoarthritis	715	M15-M19, M47
DIB005951	Infanrix-IPV	Bordetella pertussis infection	.	A37.0
DIB005952	Amyloid-derived diffusible ligands	Alzheimer's disease	331	G30
DIB005953	PD-0805	Parkinson's disease	.	G20
DIB005954	M-110101	Seborrhea	.	L21
DIB005955	Boric acid	Otitis media	.	H65-H67
DIB005956	AZM-140	Diabetes mellitus	.	E10-E14
DIB005957	LPCVD series	Cardiovascular disease	390-459	I00-I99
DIB005958	ND7001	Mood disorder	.	F30-F39
DIB005959	Busulfan Partaject	Meningitis	320-322	G00-G03
DIB005960	Psychiatric therapeutics	Psychiatric disorders	.	F99
DIB005961	5-HT 6 antagonists (cognitive disorder/pain), Biovitrum/Proximagen	Pain	338,780	R52, G89
DIB005962	HEV-239	Hepatitis E virus infection	.	B17.2
DIB005963	SMART ABL-364	Breast cancer	174, 175, 217	C50, D24
DIB005964	AJA-777	Dyspepsia	536.8	K30
DIB005965	Oxytocin receptor antagonists	Androgen decline	.	E20-E35
DIB005966	GPR-120 agonists	Metabolic disorders	.	E70-E90
DIB005967	MCP-205	Ischemic heart diseases	410-414	I20-I25
DIB005968	S. sonnei-rEPA	Shigella infections	.	A03.9
DIB005969	ING-1	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB005970	AVI-7012	Junin virus infection	.	A96
DIB005971	NS-072	Parkinson's disease	.	G20
DIB005972	GT-2104	Anxiety disorder	.	F40-F42
DIB005973	UX001 sialic acid	Hereditary inclusion body myositis	.	G72.41
DIB005974	S3	Infectious disease	001-139	A00-B99
DIB005975	LY3009120	Cancer	.	C00-C97
DIB005976	VGCC antagonists	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005977	Adipiplon	Sleep disorders	.	F51,G47
DIB005978	SDZ-CPI-975	Diabetes	250	E08-E13
DIB005979	Human monoclonal antibody-toxin conjugates	Myocardial infarction	410	I21, I22
DIB005980	Multiform PI3K inhibitors	Inflammatory diseases	.	.
DIB005981	LyphoDerm	Wound healing	.	S91.3
DIB005982	E-2001	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB005983	Keratinocyte growth factor (KGF)	Solid tumours	.	C00-C75,C7A,C7B
DIB005984	Anti-miR-296 antisense oligonucleotides	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB005985	11C-GSK-215083	Neurodegenerative diseases	.	G30-G32
DIB005986	PA-647	Mycobacterium tuberculosis infection	.	A15-A19
DIB005987	UltiMAb IgG1 antibody	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB005988	Ulodesine	Autoimmune diseases	.	D84.9
DIB005989	CHML	Cancer	140-229	C00-C96
DIB005990	CGP-50068	Cognition disorders	.	F06.7
DIB005991	CNTF	Motor neurone disease	335.2	G12.2
DIB005992	Tuberculosis DNA vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB005993	Cromafiban	Coronary artery disease	.	I20-I25
DIB005994	XEL-004FP	Pain	338,780	R52, G89
DIB005995	TDI-0067	Motor neurone disease	335.2	G12.2
DIB005996	Co-agonist peptide	Diabetes mellitus	250	E08-E13
DIB005997	ZT-386	Asthma	493	J45
DIB005998	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB005999	INC-101	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006000	Viral infection therapy	Viral infections	042-075	A80-A99, B00-B34
DIB006001	RO-14	Phlebothrombosis	.	I80-I82
DIB006002	Trivalent plasmid DNA vaccine	Herpes simplex virus infection	.	B00
DIB006003	Paraldehyde	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB006004	Haemophilus influenzae B (Hib) vaccine	Haemophilus influenzae infection	.	J11.1
DIB006005	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB006006	GYKI-16084	Prostate disorder	.	N40-N42
DIB006007	AdVac tuberculosis vaccine	Tuberculosis	010-018	A15-A19
DIB006008	LAS-41007	Keratosis	.	L57.0
DIB006009	LG-740	Leukemia	.	C91-C95
DIB006010	PEG-hGH	Dwarfism	.	E23.0,E34.2,E45.0,Q77.4
DIB006011	STX	Estrogen deficiency	.	E28.39
DIB006012	Edobacomab	Endotoxic shock	.	R57.8
DIB006013	CGS-23425	Atherosclerosis	414.0, 440	I70
DIB006014	EZN-3920	Cancer	140-229	C00-C96
DIB006015	Nefecon	IgA nephropathy	.	N02.8
DIB006016	KW-5092	Pain	.	G89
DIB006017	Nicotinic acid 1 receptor (GPR109A) agonists	Atherosclerosis	414.0, 440	I70
DIB006018	CPX	Cystic fibrosis	277	E84
DIB006019	ONO-4817	Inflammatory bowel disease	555, 556	K50, K51
DIB006020	AZD2995	Alzheimer's disease	331	G30
DIB006021	CEE-04-421	Pain	338,780	R52, G89
DIB006022	Peptide therapy	Autoimmune diseases	279.4	D84.9, M35.9
DIB006023	Cerdulatinib	Non-Hodgkin's lymphoma	.	C85.9
DIB006024	Human monoclonal antibodies	Inflammatory diseases	.	.
DIB006025	SKI-2019R	Cancer	.	C00-C97
DIB006026	Proteasome inhibitors	Cancer	140-229	C00-C96
DIB006027	Neuroprotectant program	Neurodegenerative diseases	.	G30-G32
DIB006028	Recombinant Factor VIII	Hemophilia	286	D66-D68
DIB006029	ENDG-3010	Pain	338,780	R52, G89
DIB006030	MiR-34a mimics	Liver cancer	155	C22.0
DIB006031	Rhenium-186 etidronate	Bone metastases	198.5	C79.51
DIB006032	Recombinant T-cell peptide vaccine	Allergy	995.3	T78.4
DIB006033	NFTC-103	Cardiovascular disease	390-459	I00-I99
DIB006034	INOS inhibitors	Inflammatory diseases	.	.
DIB006035	B-4474	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006036	BAY-94-9392	Cancer	140-229	C00-C96
DIB006037	HO/07/09	Wound healing	.	S91.3
DIB006038	Carbocyclic nucleoside based antiviral program	Viral infections	042-075	A80-A99, B00-B34
DIB006039	CROBENETINE HYDROCHLORIDE	Pain	338	R52
DIB006040	BCL-004	Renal cell carcinoma	189	C64
DIB006041	Theradigm-fungal infections	Fungal infection	.	B35-B49
DIB006042	GCSF	Leukopenia	.	D72.819
DIB006043	AR-12286	Glaucoma	.	H40-H42
DIB006044	18F-labeled glyburide analogs, University of Pennsylvania	Non-insulin dependent diabetes	.	E11.9
DIB006045	APG-101	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006046	DWP-418	Cancer	.	C00-C97
DIB006047	HB-AS02V	Hepatitis B virus infection	.	B16
DIB006048	KSB-307	Osteoarthritis	715	M15-M19, M47
DIB006049	Cinnamide-based NMDA antagonists	Head injury	.	S00.0,S09
DIB006050	Pneumococcal vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB006051	EVP-4473	Alzheimer's disease	331	G30
DIB006052	Abilify Maintena	Erythropoietic porphyria	.	E80.0
DIB006053	PYC-38	Respiratory distress syndrome	518.5, 518.82	J80
DIB006054	Macrolide antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006055	PRS-040	Ocular disease	.	H00-H59
DIB006056	Drug screening	HIV infections	42	B20
DIB006057	TDI-0059	Motor neurone disease	335.2	G12.2
DIB006058	BCT303	Hypothyroidism	244	E03
DIB006059	CX-1010	Epilepsy	345	G40
DIB006060	Ro-48-1220	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006061	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB006062	Drug 2838232	HIV infections	.	B20
DIB006063	AV-965	Alzheimer's disease	.	G30,F00
DIB006064	RJM-0035-K002	Hypertension	401	I10, I11, I12, I13, I15
DIB006065	HER2p63-71 peptide vaccine	Cancer	140-229	C00-C96
DIB006066	P-7435	Diabetes mellitus	250	E08-E13
DIB006067	Goat polyclonal antibodies	Motor neurone disease	335.2	G12.2
DIB006068	IS-159	Migraine	.	G43
DIB006069	PRO-135	Myotonic dystrophy	.	G71.1
DIB006070	Vasoflux	Myocardial infarction	.	I21-I22
DIB006071	APD	HIV-1 infections	42	B20
DIB006072	S-9977	Cognitive impairment	.	F06.7
DIB006073	Encepur (new formulation)	Flavivirus infection	.	A86
DIB006074	COL-2401	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006075	BC-ONY-01	Onychomycosis	.	B35.1
DIB006076	J-607Y	Allergy	995.3	T78.4
DIB006077	Birch peptide allergy desensitization agent	Allergy	995.3	T78.4
DIB006078	LORECLEZOLE	Epileptic seizure	.	G40,R56
DIB006079	Heparin	Deep vein thrombosis	.	I80.2
DIB006080	DPC-A78277	HIV infections	42	B20
DIB006081	Ro-09-1227	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006082	U-54494A	Epilepsy	345	G40
DIB006083	LCG-MAb	Lung cancer	162	C33-C34
DIB006084	Gene therapy	Alzheimer's disease	.	G30,F00
DIB006085	DGAT1 inhibitor	Cancer	.	C00-C97
DIB006086	PP-405	Cancer	140-229	C00-C96
DIB006087	TDI-0066	Motor neurone disease	335.2	G12.2
DIB006088	OntecizumabAmatuximab	Colorectal cancer	.	C18-C20,C21
DIB006089	Tetracycline derivatives	Asthma	493	J45
DIB006090	Lu-AA39959	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB006091	P53 modulators	Cancer	140-229	C00-C96
DIB006092	BCH-670	Cancer	140-229	C00-C96
DIB006093	WAY-121898	Atherosclerosis	414.0, 440	I70
DIB006094	HL-009	Atopic dermatitis	691.8	L20
DIB006095	2-quinolines series (Leishmaniasis), DNDi/CDRI/Advinus Therapeutics	Leishmania infection	.	B55.0
DIB006096	CR-3834	Hypertension	401	I10, I11, I12, I13, I15
DIB006097	AR-54	Cancer	.	C00-C97
DIB006098	AD-0027	Cancer	140-229	C00-C96
DIB006099	Cervarix	Papillomavirus infections	.	B97.7
DIB006100	CaspaCIDe DLI	Graft-versus-host disease	.	D89.811
DIB006101	CNS-1067	Epilepsy	345	G40
DIB006102	Enterococcus faecalis conjugate vaccine	Enterococcus faecalis infection	.	B95.2
DIB006103	Tetracycline derivatives	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006104	GABA B receptor agonists	Neuropathic pain	338,780	R52, G89
DIB006105	LC-01	Ocular inflammation	.	H00-H59
DIB006106	Ovastatin	Ovarian cancer	.	C56
DIB006107	Ophthalmological agents	Ocular disease	.	H00-H59
DIB006108	G-573	Cancer	140-229	C00-C96
DIB006109	ASP-4901	Genitourinary disorders	.	N00-N99
DIB006110	PSMA-VRP	Prostate cancer	185	C61
DIB006111	ZK-191703	Breast cancer	174, 175, 217	C50, D24
DIB006112	CPG23NEUR	Neurological disease	.	G00-G99
DIB006113	Recombinant human fibrinogen	Wound healing	.	S91.3
DIB006114	AJM-300	Crohn's disease	.	K50
DIB006115	99mTc-MIP-1404	Prostate tumor	185	C61
DIB006116	ZYH-1	Lipid metabolism disorder	.	E75-E78
DIB006117	Btk inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB006118	Deriglidole	Diabetes	250	E08-E13
DIB006119	Prophylactic DNA vaccine	Eastern equine encephalitis virus infection	.	A83.2
DIB006120	RP-AAV8	Retinitis pigmentosa	.	H35.5
DIB006121	ANG-2010	Pain	338,780	R52, G89
DIB006122	Diloxanide	Parasitic infection	.	B89
DIB006123	Bacteriophage vaccine	Lymphoma	202.8	C81-C96
DIB006124	CXB-029	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB006125	F-8-IL-10 fusion protein	Endometriosis	.	N80
DIB006126	Colestilan	Diabetes mellitus	250	E08-E13
DIB006127	DXL-625	Chronic lymphocytic leukaemia	204.1	C91.1
DIB006128	ImmuStem	Graft-versus host disease	.	T86.0
DIB006129	NPC-16377	Psychotic disorders	.	F20-F29
DIB006130	Iopanoic acid	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB006131	Vaccine	Cancer	.	C00-C97
DIB006132	SP-003	Asthma	493	J45
DIB006133	XEL-007DO	Cardiovascular disease	390-459	I00-I99
DIB006134	DNA vaccine	Influenza virus infections	487	J10, J11
DIB006135	MAT-401	Aspergillus infection	.	B44.9
DIB006136	Japanese encephalitis virus vaccine	Japanese encephalitis virus infection	.	A83.0
DIB006137	CP-640922	Dermatomycosis	.	B36.0
DIB006138	ALKS-37	Constipation	564	K59.0
DIB006139	Aurothioglucose	Arthritis	710-719	M00-M25
DIB006140	RAAV vaccine	Melanoma	.	C43
DIB006141	OBERADILOL MONOETHYL MALEATE	Hypertension	401	I10, I11, I12, I13, I15
DIB006142	XR-5000	Colorectal cancer	.	C18-C20,C21
DIB006143	AHCQ	Asthma	493	J45
DIB006144	SURADISTA	Solid tumours	.	C00-C75,C7A,C7B
DIB006145	Dengue virus targeting compounds	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB006146	RHb1.1	Anemia	.	D50-D64
DIB006147	MGN-4220	Fibrosis	709.2	L90.5
DIB006148	RAPID regulated insulin	Diabetes mellitus type 1	.	E10
DIB006149	Protein tyrosine phosphatase inhibitors	Diabetes mellitus type 2	.	E11
DIB006150	Tetanus vaccine	Clostridium tetani infection	001-139	A00-B99
DIB006151	HER-2/HER-1 vaccine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006152	AKT-10081	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB006153	SNO-Hb	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006154	11C-6-Me-BTA-1	Alzheimer's disease	.	G30,F00
DIB006155	BV-6481	Mycobacterium tuberculosis infection	.	A15-A19
DIB006156	H1N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB006157	DepoNSAID program	Pain	338,780	R52, G89
DIB006158	CYT-007-TNFQb	Allergic rhinitis	.	J30
DIB006159	Autologous myoblast and fibroblast cell therapy	Stress urinary incontinence	.	N39.3
DIB006160	RAV-12	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006161	Recombinant vaccine	Colon cancer	153, 154	C18-C21
DIB006162	MV-2101	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB006163	Malaria discovery program	Plasmodium falciparum infection	.	B54
DIB006164	NeoEA-1001	Alzheimer's disease	331	G30
DIB006165	Gardasil	Papillomavirus infections	.	B97.7
DIB006166	BAMLET	Keratosis	.	L57.0
DIB006167	Allotrap-2702	Transplant rejection	.	T86
DIB006168	Meridamycin analogs	Neurological disease	.	G00-G99
DIB006169	BLX-883	Hepatitis C virus infection	.	B17.1,B18.2
DIB006170	VBY-376	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006171	IQP-0410	HIV-1 infections	42	B20
DIB006172	LIMAZOCIC	Liver disease	.	K70-K77
DIB006173	Hematopoietic stem cells	Leukopenia	.	D72.819
DIB006174	Factor Xa inhibitors	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB006175	Urokinase inhibitors	Cancer	140-229	C00-C96
DIB006176	BAY-86-4884	Liver disease	570-574	K70-K77
DIB006177	Sm-p80-VR1020	Schistosomiasis	120	B65
DIB006178	ATP binding cassette transporter activator	Metabolic disorders	.	E70-E90
DIB006179	Pan-MLK inhibitors	Alzheimer's disease	331	G30
DIB006180	Alpha-type-1 polarized dendritic cells	Chronic lymphocytic leukaemia	204.1	C91.1
DIB006181	METH-mAb	Methamfetamine abuse	.	F19
DIB006182	Hemophilus influenzae type b (Hib) vaccine	Haemophilus influenzae infection	.	J11.1
DIB006183	Org-31433	Dementia	290-294	F01-F07
DIB006184	PSI-661	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006185	DIAPLASININ	Thrombolysis	.	I21-I22,I26,I61-I63,I99.9
DIB006186	Squalestatin 1	Arteriosclerosis	.	I70
DIB006187	Inactivated whole cell cholera vaccine	Vibrio cholerae infection	.	A00.0
DIB006188	SDZ-280-446	Cancer	140-229	C00-C96
DIB006189	BILD-598	Herpes simplex virus infection	.	A60,B00
DIB006190	NGN-9080	Spinal cord injuries	952	S14, S24, S34
DIB006191	ALGRX 2872	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
DIB006192	KI-0906	Arthritis	710-719	M00-M25
DIB006193	Bidisomide	Heart arrhythmia	.	I47-I49
DIB006194	Delucemine	Depression	311	F32
DIB006195	FAS-89B	Obesity	278	E66
DIB006196	MIRFENTANIL HYDROCHLORIDE	Pain	.	G89
DIB006197	F-50000	Autoimmune diseases	279.4	D84.9, M35.9
DIB006198	Dual attack synbiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006199	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB006200	Anti-S pneumoniae humanized monoclonal antibodies	Streptococcus pneumoniae infection	.	A00-B99
DIB006201	OCM-8054	Breast cancer	174, 175, 217	C50, D24
DIB006202	CERE-135	Motor neurone disease	335.2	G12.2
DIB006203	Org-33832	Planned abortion	.	Z31
DIB006204	ED-110	Cancer	140-229	C00-C96
DIB006205	Grass pollen immunotherapy	Allergic reaction	995.3	T78.4
DIB006206	Autologous myoblast cell therapy	Myocardial infarction	410	I21, I22
DIB006207	DasKloster 0501-01	Scleroderma	701.0710.1	L94.0-L94.1, M34
DIB006208	Opicapone	Parkinson's disease	.	G20
DIB006209	Lypressin	Amnesia	.	F04
DIB006210	MP-PN-1	Cancer	140-229	C00-C96
DIB006211	GR-82334	Emesis	.	R11
DIB006212	Anti-Notch-1 receptor mAbs	Cancer	140-229	C00-C96
DIB006213	Human monoclonal antibodies	Respiratory syncytial virus 	79.6	B97.4
DIB006214	Heparin-EGF-like factor	Gastrointestinal disease	.	K00-K93
DIB006215	MetPril	Hypertension	401	I10, I11, I12, I13, I15
DIB006216	Nucleoside analog/cell differentiation inducer	Acute myeloid leukemia	205	C92.0
DIB006217	Nova-EPO	Anemia	280-285	D50-D64
DIB006218	JTT-302	Lipid metabolism disorder	.	E75-E78
DIB006219	Naturally derived antibacterial agents	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006220	BJ-B11	Herpes simplex virus infection	54	B00
DIB006221	192C86	Thrombosis	.	I80-I82
DIB006222	HI-6	Poison intoxication	.	S00-T88
DIB006223	HDV-interferon	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006224	Pascolizumab	Asthma	493	J45
DIB006225	LGD-6972	Diabetes mellitus type 2	.	E11
DIB006226	DYN-15	Blindness	.	H53.6
DIB006227	M3 viral protein	Autoimmune diseases	279.4	D84.9, M35.9
DIB006228	AEM-28	Hyperlipidemia	272.0-272.4	E78
DIB006229	Aom-0785	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006230	Rocilinostat	Multiple myeloma	203	C90.0
DIB006231	PAN-622-toxin conjugate	Cholangiocarcinoma	.	C22.1
DIB006232	PRTT-100	Pain	338,780	R52, G89
DIB006233	G-115	Prostate tumor	185	C61
DIB006234	PDE 4 inhibitors	Atopic dermatitis	691.8	L20
DIB006235	RAP-103	Neuropathic pain	338,780	R52, G89
DIB006236	S1P1 modulators	Cardiovascular disease	390-459	I00-I99
DIB006237	RET tyrosine kinase inhibitors	Cancer	140-229	C00-C96
DIB006238	Ornidazole	Amoebiasis	.	A06
DIB006239	Antimalarial azalides	Plasmodium infection	.	B54
DIB006240	BMS-181100	Psychotic disorders	.	F20-F29
DIB006241	MUT-056399	Methicillin-resistant staphylococcus aureus	.	A49.0
DIB006242	NPC-342925	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006243	CRTX-070	Allergic rhinitis	477	J30
DIB006244	FluMist	Influenza virus infections	487	J10, J11
DIB006245	MDX-1342	Leukaemia	.	C91-C95
DIB006246	Lodoxamide	Asthma	493	J45
DIB006247	Hepapoietin	Liver disease	.	K70-K77
DIB006248	LY03005	Major depressive disorder	296.2, 296.3	F32, F33
DIB006249	Protein kinase therapeutic	Autoimmune diseases	279.4	D84.9, M35.9
DIB006250	CDP-492	Emesis	787	R11
DIB006251	Amphotericin B liposomal oral	Mycoses	.	B49
DIB006252	FAS-115	Obesity	278	E66
DIB006253	BL-4040	Renal injury	.	N17.9
DIB006254	Desmopressin	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
DIB006255	AMG-889436	Parkinson's disease	.	G20
DIB006256	IKur antagonists	Heart arrhythmia	.	I47-I49
DIB006257	TAK-659	Hematological malignancies	.	C81-C96
DIB006258	APD-597	Diabetes mellitus type 2	.	E11
DIB006259	PRX-111	Female infertility	628	N97.0
DIB006260	PAT-CM-1	Cancer	140-229	C00-C96
DIB006261	FR-900452	Asthma	493	J45
DIB006262	BMS-986046	Heart failure	428	I50
DIB006263	Adenovirus gene therapy	Bladder cancer	188	C67
DIB006264	Reniale	Renal cell carcinoma	189	C64
DIB006265	TDI-0053	Motor neurone disease	335.2	G12.2
DIB006266	Malaria vaccine	Plasmodium infection	.	B54
DIB006267	Tecovirimat	Virus infection	.	B03
DIB006268	Diclofenac potassium ophthalmic	Pain	.	G89
DIB006269	Arsenic-derived apoptosis stimulators	Cancer	140-229	C00-C96
DIB006270	B-581	Cancer	140-229	C00-C96
DIB006271	UTIBAPRIL	Hypertension	.	I10-I15
DIB006272	Trimesta	Multiple sclerosis	340	G35
DIB006273	Interferon alpha 2b,	Cervical intraepithelial neoplasia	.	D06,N87
DIB006274	Pranidipine	Angina	.	I20
DIB006275	TVX-002	Influenza virus infections	487	J10, J11
DIB006276	K-252c	Alzheimer's disease	331	G30
DIB006277	NT0102	Cardiovascular disease	.	I51.6
DIB006278	Imeglimin	Diabetes mellitus type 2	.	E11
DIB006279	PNT-600	Cancer	140-229	C00-C96
DIB006280	ENMD-1198	Solid tumours	.	C00-C75,C7A,C7B
DIB006281	Furnidipine	Nerve injury	.	T14.4
DIB006282	IGN-2098	Duodenal ulcer	.	K25-K27
DIB006283	Pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB006284	Virapt	HIV infections	42	B20
DIB006285	PSD-508	Dysmenorrhea	.	N94.4-N94.6
DIB006286	BBT-021	Anemia	280-285	D50-D64
DIB006287	Antifungal agents	Fungal infection	.	B35-B49
DIB006288	PRO-206	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006289	WEB-2347	Allergy	.	T78.4
DIB006290	SDZ-PGU-693	Non-insulin dependent diabetes	.	E11.9
DIB006291	DNA fusion vaccine	Cancer	140-229	C00-C96
DIB006292	Anti-VEGF165 siRNA	Age related macular degeneration	.	H35.30
DIB006293	E-3040	Thrombosis	.	I80-I82
DIB006294	Nefopam	Pain	338,780	R52, G89
DIB006295	Cancer gene therapy	Ankylosing spondylitis	720	M08.1, M45
DIB006296	HA20	Lymphoma	.	C81-C96
DIB006297	HIV DNA vaccine	HIV infections	42	B20
DIB006298	AZD-8294	Lipid metabolism disorder	.	E75-E78
DIB006299	Sortase A inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006300	Soluble ErbB3 theragnostics	Cancer	140-229	C00-C96
DIB006301	ANT-429	Cancer	140-229	C00-C96
DIB006302	AFT-EPO	Anemia	280-285	D50-D64
DIB006303	LXR-015-2	Ischemia	.	I99.8
DIB006304	KT-105	Cancer	140-229	C00-C96
DIB006305	Protein subunit vaccine	Lung cancer	162	C33-C34
DIB006306	Transdermal patch	Alzheimer's disease	331	G30
DIB006307	Labeled FSH superagonist	Ovarian cancer	.	C56
DIB006308	HIV vaccine	HIV infections	42	B20
DIB006309	BAY-Y-3118	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB006310	BC-3205	Bacterial respiratory tract infection	.	J13,J15
DIB006311	SOLPECAINOL HYDROCHLORIDE	Cardiac arrhythmias	.	I47-I49
DIB006312	Tesofensine	Pain	.	G89
DIB006313	BT-016	Rheumatold arthritis	714	M05-M06
DIB006314	Fenbunafide	Cancer	140-229	C00-C96
DIB006315	ZO-Y49	Gynecological disorder	.	N70-N98
DIB006316	Epigenetic target inhibitors	Cancer	140-229	C00-C96
DIB006317	GPCR modulators	Cardiovascular disease	390-459	I00-I99
DIB006318	Profezyme	Wound healing	.	S91.3
DIB006319	PET imaging agents	Cardiovascular disease	390-459	I00-I99
DIB006320	Macrophage migration inhibitory factor antagonists	Rheumatold arthritis	714	M05-M06
DIB006321	ADCON-T/N	Wound healing	.	S91.3
DIB006322	FM-VP4	Hyperlipidemia	272.0-272.4	E78
DIB006323	TNFmab	Rheumatold arthritis	714	M05-M06
DIB006324	FT-011	Fibrosis	709.2	L90.5
DIB006325	SMNH compounds	Viral infections	042-075	A80-A99, B00-B34
DIB006326	PMX-60056	Blood coagulation disorders	.	D65-D68
DIB006327	Infanrix-DTaP-IPV-Hep B	Hepatitis B virus infection	.	B16
DIB006328	Dermal anesthetics	Anesthesia	338	R52
DIB006329	RON8 mAb	Cancer	140-229	C00-C96
DIB006330	HIV-integrase inhibitors	HIV infections	42	B20
DIB006331	Recombinant human zinc alpha-2 glycoprotein (ZAG)	Diabetes mellitus	250	E08-E13
DIB006332	Fumagillin analogs	Cancer	140-229	C00-C96
DIB006333	CXCR-2 targeting mAbs	Cancer	140-229	C00-C96
DIB006334	NCX-226	Pulmonary fibrosis	515, 516.3	J84.1
DIB006335	TPM-1/Morphine	Pain	.	G89
DIB006336	Combination autologous stem cell therapy	Ischemia	.	I99.8
DIB006337	M tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB006338	KD-801	Colorectal cancer	153, 154	C18-C21
DIB006339	KD025	Rheumatold arthritis	.	M05-M06
DIB006340	SOM-0005	Viral infections	042-075	A80-A99, B00-B34
DIB006341	IB-09C190	Angiogenesis disorder	.	I00-I99
DIB006342	RVSVIN HIV-1 gag vaccine	HIV infections	42	B20
DIB006343	Cantuzumab mertansine	Non-small-cell lung cancer	162	C33, C34
DIB006344	Andos	Oxygen supply	.	.
DIB006345	AVI-7537	Ebola virus infection	.	A98
DIB006346	MP-0112	Macular degeneration	.	H35.3
DIB006347	Smallpox vaccine	Virus infection	.	B03
DIB006348	Peptide-conjugated phosphorodiamidate morpholino oligomers	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006349	Radiolabeled VEGF	Atherosclerosis	414.0, 440	I70
DIB006350	Tefinostat	Cancer	140-229	C00-C96
DIB006351	CSL-324	Inflammatory diseases	.	.
DIB006352	Influenza A virus H7N1 vaccine	Influenza A virus H7N1 infections	.	J11.1
DIB006353	PEP-6409	HIV infections	42	B20
DIB006354	Monocyte depleting antibody	Immune disorder	.	D80-D89
DIB006355	AEOL-10150	Multiple sclerosis	.	G35
DIB006356	TTP-054	Diabetes mellitus type 2	.	E11
DIB006357	JNJ-26113100	Atopic dermatitis	691.8	L20
DIB006358	Memex	Alzheimer's disease	331	G30
DIB006359	BBT-032	Multiple sclerosis	340	G35
DIB006360	E-101	Infections disease	.	A00-B99
DIB006361	Phytocannabinoids	Epilepsy	345	G40
DIB006362	JAK inhibitors	Ankylosing spondylitis	720	M08.1, M45
DIB006363	GPR85 antagonists	Obesity	278	E66
DIB006364	Utrophin modulators	Duchenne muscular dystrophy	.	G71.0
DIB006365	Anti-FGFR2 humanized mAb	Cancer	140-229	C00-C96
DIB006366	Proximab	Inflammatory bowel disease	555, 556	K50, K51
DIB006367	TDP-43 modulator	Motor neurone disease	335.2	G12.2
DIB006368	Remune	Hereditary angioedema	277.6	D84.1
DIB006369	WTC-01	Cancer	140-229	C00-C96
DIB006370	SIM-0702	Cancer	140-229	C00-C96
DIB006371	APS001F	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB006372	DARNA compounds	Prostate tumor	185	C61
DIB006373	AFM-21	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006374	IdB-1016	Liver disease	570-574	K70-K77
DIB006375	PACAP38	Nerve injury	.	T14.4
DIB006376	Pneumococcus vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB006377	Gene therapy	Cardiovascular disease	390-459	I00-I99
DIB006378	TUCARESOL	Immuno-stimulant	.	.
DIB006379	DX-9065	Blood coagulation disorders	.	D65-D68
DIB006380	ZD-9063P	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006381	DI-VAL-L-DC	Cancer	140-229	C00-C96
DIB006382	MXC-3255	Diabetes mellitus type 2	.	E11
DIB006383	Heart failure therapy	Cardiac failure	.	I50
DIB006384	H3N2 and B influenza vaccine	Influenza virus infections	487	J10, J11
DIB006385	MGlu2 receptor PET ligand	Psychiatric disorders	.	F99
DIB006386	HIV infection-resistant autologous hematopoietic stem cell therapy	HIV infections	42	B20
DIB006387	Epoetin zeta	Anemia	.	D50-D64
DIB006388	PF-06413367	Asthma	.	J45
DIB006389	FluNhance	Adenosine deaminase defciency	.	D81.3
DIB006390	CKD-404	Growth disorder	.	E23.0
DIB006391	PENNVAX-6	Human immunodeficiency virus infection	.	B20
DIB006392	ON-04 series	Breast cancer	174, 175, 217	C50, D24
DIB006393	SBIM therapeutics	Huntington's disease	.	F02.2,G10
DIB006394	Cytochrome P-450 24 (CYP24) inhibitors	Hyperparathyroidism	252.02, 588.81	E21.1
DIB006395	CI-966	Convulsions	.	R56.0
DIB006396	Anti-BCR mAbs	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB006397	BF/PC-21	Inflammatory diseases	.	.
DIB006398	Cipatinib	Cancer	140-229	C00-C96
DIB006399	KI-0901	Cancer	140-229	C00-C96
DIB006400	RTU-007	Diabetic cataract	.	E10.36,E11.36
DIB006401	AMT-070	Liver cirrhosis	.	K70.3,K71.7,K74
DIB006402	AK-2	Viral infections	042-075	A80-A99, B00-B34
DIB006403	Heberkinasa	Myocardial infarction	410	I21, I22
DIB006404	Cidofovir prodrugs	Viral infections	042-075	A80-A99, B00-B34
DIB006405	Priorix-Tetra	Varicella zoster virus infections	.	B01,B02
DIB006406	99mTc-biciromab	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB006407	Belladonna	Colitis	.	K50-K52
DIB006408	CKD-10101	Cancer	140-229	C00-C96
DIB006409	Acyclovir elaidate	Herpesvirus infection	.	B00
DIB006410	Leinamycin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006411	LEX-001	Inflammatory diseases	.	.
DIB006412	AA-10022	Pain	338,780	R52, G89
DIB006413	VaxiFlu-S	Influenza virus infections	487	J10, J11
DIB006414	Alpha-1 proteinase inhibitor	Alpha-1 antitrypsin deficiency	.	E88.0
DIB006415	AP-214	Candidiasis infection	.	B37.0
DIB006416	Herpes simplex vaccine	Herpes simplex virus infection	.	A60,B00
DIB006417	BW-42	Breast cancer	174, 175, 217	C50, D24
DIB006418	SR-80027A	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB006419	VLP vaccine	Influenza virus infections	487	J10, J11
DIB006420	PDE 10 inhibitors	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB006421	Nuclease modulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB006422	MK2 inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB006423	EGFR antisense DNA	Head and neck cancer	.	C07-C14,C32-C33
DIB006424	T-cell epitope-based DNA vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB006425	Rilmenidine	Hypertension	401	I10, I11, I12, I13, I15
DIB006426	AX-5847	Filoviridae	.	A99
DIB006427	NTP-6009	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB006428	HP-05	Fatigue	.	R53
DIB006429	Anti-CD44 monoclonal antibody	Rheumatold arthritis	714	M05-M06
DIB006430	SRM003	Peripheral vascular disorders	.	I73.9
DIB006431	CK-2127107	Muscular atrophy	.	M62.5
DIB006432	KC-399	Alopecia	.	L65.9
DIB006433	NRT-100	Pain	338,780	R52, G89
DIB006434	MKC-121	Hyperlipidemia	.	E78.5
DIB006435	99mTc-rBitistatin	Embolism	.	I74,I82
DIB006436	HIAPP aggregation inhibitor	Non-insulin dependent diabetes	.	E11.9
DIB006437	Apolipoprotein B-targeting Dicer substrate siRNA	Cancer	140-229	C00-C96
DIB006438	GP-1200	Ulcerative colitis	556	K51
DIB006439	Infusible platelet membrane	Bleeding	.	R58
DIB006440	BK-C-0701	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB006441	Domitroban	Thrombosis	.	I80-I82
DIB006442	DU-29894	Psychotic disorders	.	F20-F29
DIB006443	TLR-9 agonists	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006444	NAA-004	Inflammatory bowel disease	555, 556	K50, K51
DIB006445	ISCOMATRIX	Discovery agent	.	.
DIB006446	BVA-101	Multiple sclerosis	340	G35
DIB006447	Bradykinin B1 receptor antagonists	Inflammatory diseases	.	.
DIB006448	VEGF/rGel	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB006449	Endothelin type A receptor antagonist	Premature labour	.	O60.1,P07.3
DIB006450	SC-45694	Inflammatory diseases	.	.
DIB006451	Radiosensitizer gene therapy	Pancreatic cancer	.	C25
DIB006452	Vif dimerization antagonist	HIV-1 infections	42	B20
DIB006453	KLS-40	Autoimmune diseases	279.4	D84.9, M35.9
DIB006454	Verubulin	Solid tumours	.	C00-C75,C7A,C7B
DIB006455	MDDR 282232	Arthritic	710-719	M00-M25
DIB006456	Small molecule neutrophil elastase inhibitor/human surfactant peptide B conjugate	Emphysema	492	J43
DIB006457	ReN-004	Alzheimer's disease	331	G30
DIB006458	LI-301	Premature ejaculation	302.75	F52.4
DIB006459	Dual Rho-associated protein kinase 1/2 inhibitors	Immune disorder	.	D80-D89
DIB006460	ZD-7349	Multiple sclerosis	.	G35
DIB006461	BAY-86-9596	Cancer	140-229	C00-C96
DIB006462	Nanobody therapeutics	Immune disorder	.	D80-D89
DIB006463	FP-253-GDEPT	Prostate cancer	.	C61
DIB006464	EVade ribonuclease antibody conjugates	Cancer	140-229	C00-C96
DIB006465	PIC-060 analogs	Dermatitis	692.9	L20-L30
DIB006466	ER-21041	Pain	338,780	R52, G89
DIB006467	BI 695501	Rheumatold arthritis	714	M05-M06
DIB006468	BioBypass	Coronary artery disease	410-414, 429.2	I20-I25
DIB006469	KI-0805	Obesity	278	E66
DIB006470	TGL-749	Hyperlipidemia	272.0-272.4	E78
DIB006471	Vaccine	Yersinia infections	.	A20
DIB006472	Recombinant anti-IgE Fabs	Asthma	493	J45
DIB006473	GRT-3983Y	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB006474	Tralokinumab	Ulcerative colitis	556	K51
DIB006475	NanoDisks	Brain injury	.	S09.90
DIB006476	GSC-1	Hyperglycemia	790.29	R73.9
DIB006477	Dendritic cell vaccine	Melanoma	.	C43
DIB006478	NSP2 protease inhibitors	Chikungunya virus infection	.	A92.0
DIB006479	BL-1892	Skin cancers	.	C43-C44
DIB006480	DuP-128 analogs	Arteriosclerosis	.	I70
DIB006481	FK-962	Alzheimer's disease	.	G30,F00
DIB006482	LpxC membrane biosynthesis inhibitors	Multidrug resistant infection	.	A00-B99
DIB006483	Recombinant human interferon gamma receptor antagonists	Arteriosclerosis	440	I70
DIB006484	ADX-10061	Psychotic disorders	.	F20-F29
DIB006485	FX-006	Pain	.	G89
DIB006486	MK-51	Dermatological disease	.	L00-L99
DIB006487	Itriglumide	Anxiety disorder	.	F40-F42
DIB006488	Nanobody therapeutics	Cancer	140-229	C00-C96
DIB006489	INS365 respiratory	Bronchitis	.	J20-J21,J42
DIB006490	Gene therapy	Lysosomal storage disease	.	E75-E77
DIB006491	CP-122288	Migraine	.	G43
DIB006492	ICI-169369	Anxiety disorder	.	F40-F42
DIB006493	PEV3A	Malaria	.	B50-B54
DIB006494	HAV human antibody	Hepatitis A virus infection	.	B15.9
DIB006495	IDAZOXAN HYDROCHLORIDE	Neurological disease	.	G00-G99
DIB006496	Meluadrine	Premature ejaculation	.	F52.4
DIB006497	PMX-900	Cancer	140-229	C00-C96
DIB006498	SP-19501	Fungal infection	.	B35-B49
DIB006499	Antifibrinolytic agents	Bleeding	.	R58
DIB006500	Second-generation protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006501	Fluorofenidone	Fibrosis	709.2	L90.5
DIB006502	DAA-1097	Anxiety disorder	300	F40-F42
DIB006503	ST-05	Spinal disease	.	G95.9
DIB006504	MAb-216	Leukemia	208.9	C91-C95
DIB006505	KC-11425	Asthma	493	J45
DIB006506	Tedalinab	Pain	.	G89
DIB006507	Pro-Islet	Diabetes mellitus	250	E08-E13
DIB006508	PF-4455242	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB006509	Inhibitor of FGFR	Cancer	140-229	C00-C96
DIB006510	IPX203	Parkinson's disease	332	F02.3, G20
DIB006511	SRSC-371	Epilepsy	345	G40
DIB006512	PARCETASAL	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB006513	CODA-001	Cornea epithelial defects	.	H18.899
DIB006514	Cancer stem cell-targeting therapeutic	Cancer	140-229	C00-C96
DIB006515	BC-3781 intravenous	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006516	Topoisomerase I inhibitors	Cancer	140-229	C00-C96
DIB006517	Zilascorb (2H)	Cancer	140-229	C00-C96
DIB006518	Prophylactic protein vaccine	Schistosomiasis	120	B65
DIB006519	P45	Alopecia	.	L65.9
DIB006520	Asthma therapy	Asthma	493	J45
DIB006521	Kanglaite injection	Cachexia	799.4	R64
DIB006522	Antiviral drug program	Viral infections	042-075	A80-A99, B00-B34
DIB006523	Peptide-T	Neurodegenerative diseases	.	G30-G32
DIB006524	ADL 10-0101	Pain	.	G89
DIB006525	SNX-1012	Mucositis	.	K00-K95
DIB006526	K-103-PA	Pain	338,780	R52, G89
DIB006527	L-163017	Hypertension	401	I10, I11, I12, I13, I15
DIB006528	EP4-R antagonist	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
DIB006529	OCFENTANIL	Pain	338	R52
DIB006530	Fungal fatty acid synthase inhibitors	Fungal infection	.	B35-B49
DIB006531	Factor XII (FXII) antisense oligonucleotide	Blood clotting disorder	286	D65-D69
DIB006532	Juvenon Energy Formula	Cardiovascular disease	390-459	I00-I99
DIB006533	FR-901483	Graft-versus host disease	.	T86.0
DIB006534	Opioid prodrugs	Pain	338,780	R52, G89
DIB006535	FR-901469 analogs	Fungal infection	.	B35-B49
DIB006536	Necuparanib	Pancreatic cancer	157	C25
DIB006537	CMV-specific STAR fusions	Cytomegalovirus infection	.	B25
DIB006538	ITX-5061	HIV-1 infections	42	B20
DIB006539	MLI-1018	Otitis media	.	H65-H67
DIB006540	CER-227185	Acute myeloid leukemia	205	C92.0
DIB006541	CDK inhibitors	Cancer	140-229	C00-C96
DIB006542	JD-4000 series	Inflammatory bowel disease	555, 556	K50, K51
DIB006543	TK-DLI	Graft-versus host disease	.	T86.0
DIB006544	FAS-20013	Mycobacterium tuberculosis infection	.	A15-A19
DIB006545	R-545	Urinary dysfunction	.	N39.3-N39.4
DIB006546	ET-007	Small-cell lung cancer	.	C34.90
DIB006547	GC-1102	Hepatitis B virus infection	.	B16
DIB006548	LAMB3-transduced autologous epidermal stem cells	Epidermolysis bullosa	.	Q81
DIB006549	CDD-0097	Alzheimer's disease	.	G30,F00
DIB006550	Bis(olanzapine) pamoate monohydrate	Psychotic disorders	290-299	F20-F29
DIB006551	MIC-31	Gastrointestinal ulcer	.	K28
DIB006552	DPP-IV inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB006553	Adjustable basal insulin	Diabetes mellitus	250	E08-E13
DIB006554	PRO-2000	HIV infections	42	B20
DIB006555	MGluR5 antagonists	Anxiety disorder	300	F40-F42
DIB006556	KU-2285	Cancer	140-229	C00-C96
DIB006557	CDK2 inhibitors	Cancer	140-229	C00-C96
DIB006558	ONO-4053	Allergic rhinitis	.	J30
DIB006559	Sustained release incrementally modified drug	Alzheimer's disease	331	G30
DIB006560	TYT-1	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB006561	PK1	Solid tumours	.	C00-C75,C7A,C7B
DIB006562	Cefluprenam	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB006563	Tiqueside	Hyperlipidemia	.	E78.5
DIB006564	NK-3 antagonists	Asthma	493	J45
DIB006565	EDP-22	Glaucoma	365	H40-H42
DIB006566	BMN-111	Achondroplasia	.	Q77.4
DIB006567	ON-579	Asthma	.	J45
DIB006568	AC-03-636	Cancer	.	C00-C97
DIB006569	IFN beta	Viral infections	.	B34
DIB006570	AGN-190744	Dermatitis	692.9	L20-L30
DIB006571	TAK-715	Rheumatold arthritis	714	M05-M06
DIB006572	DWJ-425	Rheumatold arthritis	714	M05-M06
DIB006573	JIN-2019	Cancer	140-229	C00-C96
DIB006574	SILTENZEPINE	Stomach disease	.	K30-K31
DIB006575	Autologous VEGF-and angiopoietin-1-expressing endothelial and smooth muscle cell therapy	Cardiovascular disease	390-459	I00-I99
DIB006576	BM-20	Hypertension	401	I10, I11, I12, I13, I15
DIB006577	Bacteriophage mixture	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB006578	Menadiol sodium diphosphate	Blood clotting disorder	286	D65-D69
DIB006579	Antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006580	C4X-301	Cardiovascular disease	390-459	I00-I99
DIB006581	ONO-1404	Peripheral vascular disease	443.9	I73.9
DIB006582	NSI-566	Lateral sclerosis	.	G12.2
DIB006583	Small molecule therapeutics	Inflammatory diseases	.	.
DIB006584	CR-3465	Allergy	.	T78.4
DIB006585	MD-990 program	Respiratory disease	.	J00-J99
DIB006586	C-Met targeting antibodies	Cancer	140-229	C00-C96
DIB006587	Mutant B-Raf (V600E) kinase inhibitors	Cancer	140-229	C00-C96
DIB006588	Muscle wasting protein therapeutics	Muscle wasting disease	.	M62.50?
DIB006589	IPL 550,260	Inflammatory disorders	.	.
DIB006590	NAChR APLs	Alzheimer's disease	331	G30
DIB006591	LPG-1030S	Irritable bowel syndrome	564.1	K58
DIB006592	9cUAB-30	Cancer	140-229	C00-C96
DIB006593	FAD-104	Solid tumours	.	C00-C75,C7A,C7B
DIB006594	LPCN-1087	Cough	786.2	R05
DIB006595	AL-43546	Xerophthalmia	.	E50.6-E50.7
DIB006596	NN-1952	Insulin dependent diabetes	.	E10
DIB006597	Antimalarials	Plasmodium falciparum infection	.	B54
DIB006598	EC-145	Solid tumours	.	C00-C75,C7A,C7B
DIB006599	DW-953	Dyspepsia	536.8	K30
DIB006600	Esterified estrogens	Breast cancer	174, 175, 217	C50, D24
DIB006601	PFK-158	Solid tumours	.	C00-C75,C7A,C7B
DIB006602	RTA-801	Motor neurone disease	335.2	G12.2
DIB006603	PRT-300	Duchenne dystrophy	.	G71.0
DIB006604	VTX-1463	Allergic rhinitis	.	J30
DIB006605	Pfs48	Plasmodium falciparum infection	.	B54
DIB006606	EU-C-001	Brain injury	.	S09.90
DIB006607	NLCQ-1	Cancer	140-229	C00-C96
DIB006608	MT-176 lead series	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006609	PF-821385	HIV infections	42	B20
DIB006610	Myeloid progenitor cancer stem cells targeting antibodies	Cancer	140-229	C00-C96
DIB006611	ATF-HI-8	Cancer	140-229	C00-C96
DIB006612	C5aR pepducins	Inflammatory diseases	.	.
DIB006613	LIM-0723	Toxicity	.	T36-T50,T51-T65
DIB006614	ADE-LAM	Wound healing	.	S91.3
DIB006615	ZYT-1	Lipid metabolism disorder	.	E75-E78
DIB006616	NN-414	Diabetes mellitus type 1	.	E10
DIB006617	Org-20223	Psychotic disorders	.	F20-F29
DIB006618	VM-106	Chronic granulomatous disease	.	D71
DIB006619	GLY-205 series	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB006620	DW-167	Hepatocellular carcinoma	155	C22.0
DIB006621	UltraGITRL	Cancer	.	C00-C97
DIB006622	SynGEM	Respiratory syncytial virus 	79.6	B97.4
DIB006623	Hepatitis B immune globulin	Hepatitis B virus infection	.	B16
DIB006624	STD-07	Constipation	564	K59.0
DIB006625	LP-226A1	Cancer	.	C00-C97
DIB006626	QPI-1007	Glaucoma	.	H40-H42
DIB006627	Choline magnesium trisalicylate	Osteoarthritis	715	M15-M19, M47
DIB006628	I.V. carbamazepine	Type 1 diabetes	250.01	E10
DIB006629	Trumenba	Meningitis	.	G03.9
DIB006630	NALTIAZEM HYDROCHLORIDE	Angina	.	I20
DIB006631	VEGF-targeting gene therapy	Motor neurone disease	335.2	G12.2
DIB006632	CI-923	Bronchodilator	493	J45
DIB006633	NT-1635	Sarcopenia	.	M62.9
DIB006634	NNC-26-0194	Growth disorder	.	E23.0
DIB006635	Nelfinavir	SARS coronavirus infection	.	J12.81
DIB006636	HCV therapeutics	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006637	Liposome Encapsulated Mitoxantrone (LEM)	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB006638	Peptitrol delivery system	Diabetes mellitus	250	E08-E13
DIB006639	TETRAPLATIN TETRANITRATE	Cancer	.	C00-C97
DIB006640	BAY-50-9062	Osteoporosis	733	M80-M81
DIB006641	Retinoid-acid receptor-related orphan receptor gamma t inverse agonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB006642	M2del11 H1N1	Influenza virus infections	487	J10, J11
DIB006643	PROXODOLOL	Glaucoma	365	H40-H42
DIB006644	Beta-lactamase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006645	Therapeutic program	Diabetes mellitus	250	E08-E13
DIB006646	LAS-30563	Emesis	787	R11
DIB006647	NIC-002	Nicotine dependence	305.1	F17
DIB006648	RNAi therapeutic	Cholangiocarcinoma	.	C22.1
DIB006649	Vaccine	Shigella infections	.	A03.9
DIB006650	Vaccine	Influenza virus infections	487	J10, J11
DIB006651	CNSB-006	Arthralgia	.	M25.5
DIB006652	KSB-303	Colorectal cancer	.	C18-C20,C21
DIB006653	Eltoprazine	Aggressive non-Hodgkin's lymphoma	.	F63
DIB006654	CGRP	Asthma	493	J45
DIB006655	Insulin	Diabetes mellitus	250	E08-E13
DIB006656	Nell-1 protein therapeutic	Heart injury	.	S26
DIB006657	GRC-15300	Pain	.	G89
DIB006658	Proenzy	Multiple sclerosis	340	G35
DIB006659	DasKloster 0182-01	Sarcoidosis	135	D86
DIB006660	Opium (class)	Pain	338,780	R52, G89
DIB006661	Small molecule therapeutic	Alzheimer's disease	331	G30
DIB006662	Enzyme I inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006663	NS-220	Hyperlipidemia	.	E78.5
DIB006664	NLP-44	Acne vulgaris	706.1	L70.0
DIB006665	S. flexneri type 2a-rEPA Asucc	Shigella infections	.	A03.9
DIB006666	AVN-458	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB006667	Botulinum neurotoxin inhibitor	Clostridium botulinum infection	.	A05.1
DIB006668	Sci-DaPT/Hep B-Vac	Hepatitis B virus infection	.	B16
DIB006669	Nucleoside reverse transcriptase inhibitor	HIV-1 infections	42	B20
DIB006670	ABT-202	Pain	338,780	R52, G89
DIB006671	R-1458	Non-insulin dependent diabetes	.	E11.9
DIB006672	Cancer cell targeting peptides	Glioma	191	C71
DIB006673	A-003	Cardiovascular disease	390-459	I00-I99
DIB006674	TDI-0055	Motor neurone disease	335.2	G12.2
DIB006675	Cefatrizine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006676	Hib-MenCY-TT vaccine	Meningitis	320-322	G00-G03
DIB006677	Calcitriol	Congenital alopecia	.	Q84.0
DIB006678	Alpha-galactosidase A	Fabry disease	272.7	E75.2
DIB006679	Interleukin-2 gene therapy	Cancer	140-229	C00-C96
DIB006680	PEG-naloxol	Opioid-induced constipation	564	K59.0
DIB006681	NKP 608	Mood disorder	.	F30-F39
DIB006682	VEGF regulatory agent	Coronary artery disease	.	I20-I25
DIB006683	Antibody-peptide conjugate,	Cancer	140-229	C00-C96
DIB006684	ECFCs	Cardiovascular disease	390-459	I00-I99
DIB006685	BIBU-129	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB006686	Insulin long-acting iv	Type 2 diabetes	250.00, 250.02	E11
DIB006687	NXT-1021	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006688	Maclizumab	Inflammatory diseases	.	.
DIB006689	UP-116-77	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB006690	T-cell peptide	Autoimmune diseases	279.4	D84.9, M35.9
DIB006691	MBS-101	Infectious disease	001-139	A00-B99
DIB006692	CureXcell	Diabetic foot ulcer	.	E08-E13
DIB006693	JIN-2013	Cardiovascular disease	390-459	I00-I99
DIB006694	Dendritic cell vaccine	Melanoma	172	C43
DIB006695	EV71 vaccine	Enterovirus infection	001-139	A00-B99
DIB006696	GASTRAZOLE	Duodenal ulcer	.	K25-K27
DIB006697	Proteolysis inducing factor receptor antagonists	Cachexia	799.4	R64
DIB006698	Recombinant therapeutic proteins	Cancer	.	C00-C97
DIB006699	Fully-deleted adenoviral vector-based immunosuppressants	Factor VIII deficiency	.	D66
DIB006700	Inter alpha inhibitor proteins	Sepsis	995.91	A40, A41
DIB006701	ANA-011	Cancer	140-229	C00-C96
DIB006702	Loxoprofen gel	Inflammatory diseases	.	.
DIB006703	WSS-45	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB006704	Bacteriophage mixture	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB006705	Preeclampsia diagnostic/treatment	Pre-eclampsia	642.4-642.7	O11, O14
DIB006706	E2 protein vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006707	Adenosine modulators	Asthma	493	J45
DIB006708	PAK4 inhibitors	Cancer	140-229	C00-C96
DIB006709	Small molecule Id protein inhibitors	Cancer	140-229	C00-C96
DIB006710	MB-311	Cancer	140-229	C00-C96
DIB006711	Genetically modified autologous T-cell therapy	HIV infections	42	B20
DIB006712	PI3K delta inhibitors	Cancer	140-229	C00-C96
DIB006713	NO-antihypertensives	Hypertension	401	I10, I11, I12, I13, I15
DIB006714	Long-acting FSH conjugate	Female infertility	628	N97.0
DIB006715	T-cell gene therapy	HIV infections	42	B20
DIB006716	Efaproxyn	Lung cancer	.	C33-C34
DIB006717	OSL-95II	Viral infections	042-075	A80-A99, B00-B34
DIB006718	AbGn-150	Multiple myeloma	203	C90.0
DIB006719	KUR-521	Back pain	724.5,338,780	M54, G89, R52
DIB006720	CP-141	Asthma	493	J45
DIB006721	KI-0003	Cancer	140-229	C00-C96
DIB006722	MEN-10627	Asthma	.	J45
DIB006723	L-698544	Alzheimer's disease	.	G30,F00
DIB006724	Frakefamide	Pain	.	G89
DIB006725	PDC-748	Cough	786.2	R05
DIB006726	SA-237	Rheumatold arthritis	.	M05-M06
DIB006727	MAb combination therapy	Infectious disease	001-139	A00-B99
DIB006728	NHS-IL 12	Cancer	140-229	C00-C96
DIB006729	Nanoparticle vaccine	Insulin dependent diabetes	.	E10
DIB006730	LV305	Breast cancer; Malignant melanoma; NSCLC	.	C50,C43,C33-C34
DIB006731	Anti-PSMA antibody-drug conjugates	Prostate tumor	185	C61
DIB006732	HCV NS3 protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006733	Droxinavir hydrochloride	HIV infections	42	B20
DIB006734	FPL-62064	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB006735	Myrrhanol A	Inflammatory diseases	.	.
DIB006736	SOM-0003	Viral infections	042-075	A80-A99, B00-B34
DIB006737	UP-257-13	Hypertension	401	I10, I11, I12, I13, I15
DIB006738	BF-388	Inflammatory diseases	.	.
DIB006739	CD40 mRNA-targeting antisense oligonucleotides	Inflammatory diseases	.	.
DIB006740	Sodium ferric gluconate complex	Iron deficiency anaemia	.	D50
DIB006741	Monoclonal antibody therapy	Influenza virus infections	487	J10, J11
DIB006742	PET imaging agent	Melanoma	172	C43
DIB006743	CD-832	Angina	.	I20
DIB006744	Small molecule therapeutic	Cancer pain	338,780	R52, G89
DIB006745	PRX-12261	Neurological disease	.	G00-G99
DIB006746	Debrase	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB006747	INTERCEPT	Infectious and parasitic disease	.	A00-B99
DIB006748	Myristoyl transferase inhibitors	Trypanosomiasis	086.5-086	B56-B57
DIB006749	Tuberculin	Mycobacterium tuberculosis infection	.	A15-A19
DIB006750	TG-D	Bone disease	.	M00-M99
DIB006751	AZD-3161	Peripheral neuropathy	.	G64
DIB006752	Vaccine	Diarrhea	.	A09,K59.1
DIB006753	CMET Avimer polypeptides	Cancer	140-229	C00-C96
DIB006754	Bisbenzimidazole analogs	Cancer	140-229	C00-C96
DIB006755	Epstein Barr-based gene therapy	Cancer	140-229	C00-C96
DIB006756	Cu64-CNND1-L	Lung cancer	162	C33-C34
DIB006757	DDS-07M	Pain	338,780	R52, G89
DIB006758	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB006759	Ubiquitin pathway inhibitors	Cancer	140-229	C00-C96
DIB006760	HD-003	Renal disease	.	N00-N29
DIB006761	Altered cell metabolism energy production enzyme inhibitors	Cancer	.	C00-C97
DIB006762	ISIS-DMPK	Myotonic dystrophy	.	G71.1
DIB006763	Diltiazem cream	Anal fissure	.	K60.0-K60.2
DIB006764	Influsome-Vac	Influenza virus infections	487	J10, J11
DIB006765	SB-247853	Anxiety disorder	.	F40-F42
DIB006766	Antiparasitic diamidines	Trypanosomiasis	086.5-086	B56-B57
DIB006767	CERM-12816	Angina	.	I20
DIB006768	FOZIVUDINE TIDOXIL	Human immunodeficiency virus infection	.	B20
DIB006769	Aom-0821	Cardiovascular disease	390-459	I00-I99
DIB006770	Cell signaling modulators	Breast cancer	174, 175, 217	C50, D24
DIB006771	GPI-3000	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006772	BIA-13	Respiratory disorder	.	J98.9
DIB006773	IC-747	Psoriasis	696	L40
DIB006774	FCE-25876	Major depressive disorder	296.2, 296.3	F32, F33
DIB006775	EP-200	Cancer	140-229	C00-C96
DIB006776	Ipafricept	Ovarian cancer	.	C56
DIB006777	GOVX-B11	HIV infections	.	B20
DIB006778	APT-102	Cerebral infarction	.	I63
DIB006779	Celtura	Influenza virus infections	487	J10, J11
DIB006780	MGCD516	Solid tumours	.	C00-C75,C7A,C7B
DIB006781	HuM-195-Ac-225	Acute myeloid leukemia	205	C92.0
DIB006782	Anti-FAK oligonucleotides	Cancer	140-229	C00-C96
DIB006783	Cdk inhibitors	Cancer	140-229	C00-C96
DIB006784	Maxy-10	Autoimmune diseases	.	D84.9
DIB006785	Immunomodulators	Cancer	140-229	C00-C96
DIB006786	Small molecule therapeutics	Cancer	.	C00-C97
DIB006787	Allergy DNA vaccine	Allergy	995.3	T78.4
DIB006788	GM-CSF-expressing oncolytic adenovirus	Cancer	140-229	C00-C96
DIB006789	MK-4074	Diabetes mellitus	250	E08-E13
DIB006790	PC-213	HIV infections	42	B20
DIB006791	BVF-300	Gastrointestinal disease	.	K00-K93
DIB006792	BCL6 peptide inhibitor	Diffuse large b-cell lymphoma	200	C83.3
DIB006793	MJ-451	Asthma	.	J45
DIB006794	DAd5GNE vaccine	Cocaine addiction	304.2	F14.2
DIB006795	ONO-8130	Pollakiuria	.	R35
DIB006796	CB1 antagonists	Obesity	278	E66
DIB006797	Vitatropin	Growth disorder	.	E23.0
DIB006798	IKH-25	Cancer	140-229	C00-C96
DIB006799	Medi-NK	Lung cancer	162	C33-C34
DIB006800	XR-113	Cancer	140-229	C00-C96
DIB006801	Antibacterial compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006802	DC-159a	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006803	FM-101	Multiple myeloma	203	C90.0
DIB006804	CTCE-0324	Peripheral vascular disease	443.9	I73.9
DIB006805	BiTE antibodies	Multiple myeloma	203	C90.0
DIB006806	SRI-63-675	Endotoxic shock	.	R57.8
DIB006807	Alpha-synuclein aggregation inhibitor	Parkinson's disease	.	G20
DIB006808	MB-840	Liver cancer	155	C22.0
DIB006809	TSH-01	Hormone deficiency	.	E00-E90
DIB006810	Rev-RRE inhibitors	HIV infections	42	B20
DIB006811	HT-90B	Anxiety disorder	.	F40-F42
DIB006812	NRP290	Pain	338,780	R52, G89
DIB006813	Energy metabolism inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB006814	K-877	Lipid metabolism disorder	.	E75-E78
DIB006815	Chikungunya virus vaccine	Chikungunya virus infection	.	A92.0
DIB006816	EPD-clofarabine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006817	Antibodies	Prostate disease	.	N42.9
DIB006818	Bivigam	Immune disorder	.	D80-D89
DIB006819	MMP-13 inhibitors	Inflammatory diseases	.	.
DIB006820	ASP2215	Acute myeloid leukemia	205	C92.0
DIB006821	TIM ETEC vaccine	Diarrhea	.	A09,K59.1
DIB006822	Rhodamine-123	Prostate tumor	185	C61
DIB006823	AMT-050	Cholesterol metabolism disorder	.	E70-E88
DIB006824	DTP vaccine	Bordetella pertussis infection	.	A37.0
DIB006825	Caffeine citrate	Sleep apnea	.	G47.3
DIB006826	Berubicin	Cancer	.	C00-C97
DIB006827	S-12363	Cancer	140-229	C00-C96
DIB006828	AZD-7140	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DIB006829	LTA	Pain	338,780	R52, G89
DIB006830	CVT-E002	Viral infections	042-075	A80-A99, B00-B34
DIB006831	Amyloid beta oligomers	Alzheimer's disease	331	G30
DIB006832	ViaScint	Cardiovascular disease	390-459	I00-I99
DIB006833	Multivalent (HIVIS 07) DNA vaccine Derma Vax/ZetaJet	HIV infections	42	B20
DIB006834	NY-ESO-1 tumour vaccine	Lung cancer	162	C33-C34
DIB006835	Rubidium chloride Rb82	Coronary artery disease	410-414, 429.2	I20-I25
DIB006836	OCT-SG815	Arthritis	710-719	M00-M25
DIB006837	BIO-300	Cancers	.	.
DIB006838	HIV-1 integrase inhibitors	HIV infections	42	B20
DIB006839	Peptide IL-6 antagonist	Arthritis	710-719	M00-M25
DIB006840	ACY-001	Coronary ischemia	.	I25
DIB006841	Ro-41-4439	Cancer	140-229	C00-C96
DIB006842	MK-7246	Respiratory disease	.	J00-J99
DIB006843	Abeta amyloid agonist	Glioma	191	C71
DIB006844	Anti-HCV agent	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006845	Islet Neogenesis Therapy (I.N.T.)	Diabetes mellitus type 1	250	E10
DIB006846	Pumafentrine	Asthma	.	J45
DIB006847	Intanza	Influenza virus infections	487	J10, J11
DIB006848	Brain-derived stem cell therapy	Neurological disease	.	G00-G99
DIB006849	KLS-Npk	Parkinson's disease	.	G20
DIB006850	Adnectin IL-23 inhibitor	Immune disorder	.	D80-D89
DIB006851	F-50029	Hantavirus infection	.	B33.4
DIB006852	LI 401	Gingivitis	.	K05.0-K05.1
DIB006853	447C88	Hyperlipidemia	.	E78.5
DIB006854	Titanocene dichloride	Cancer	.	C00-C97
DIB006855	Cannabinoid 1 antagonists	Obesity	278	E66
DIB006856	Cancer therapy	Cancer	140-229	C00-C96
DIB006857	KPPF-1	Ulcerative colitis	556	K51
DIB006858	ABT-110	Chronic pain	338.2,780	R52.1-R52.2, G89
DIB006859	Enloplatin	Chronic lymphocytic leukaemia	204.1	C91.1
DIB006860	Meningococcus B vaccine	Neisseria meningitidis infection	.	A87
DIB006861	Sipoglitazar	Diabetes mellitus	250	E08-E13
DIB006862	Tesmilifene	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
DIB006863	Autologous bone marrow-derived mesenchymal stem cells	Lateral sclerosis	.	G12.2
DIB006864	IAP inhibitors	Cancer	140-229	C00-C96
DIB006865	OMS-302	Pain	338,780	R52, G89
DIB006866	CO-8	Diabetes mellitus	250	E08-E13
DIB006867	MKC-1106-PP	Cancer	.	C00-C97
DIB006868	Enteric-coated mycophenolate sodium	Transplant rejection	.	T86
DIB006869	CS-204	Metabolic disorders	.	E70-E90
DIB006870	AKP-501	Female infertility	628	N97.0
DIB006871	INCB40093	Lymphoma	.	C81-C96
DIB006872	PHY-808	Cancer	.	C00-C97
DIB006873	Alprostadil liposome	Respiratory distress syndrome	518.5, 518.82	J80
DIB006874	Dual Btk/Jak3 inhibitor	Rheumatold arthritis	714	M05-M06
DIB006875	Pandemic H1N1 live attenuated influenza virus vaccine	Influenza virus infections	487	J10, J11
DIB006876	CeaVac	Colorectal cancer	.	C18-C20,C21
DIB006877	SAR-104772	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB006878	KRP-101	Hyperlipidemia	.	E78.5
DIB006879	Monoclonal antibodies	Cancer	.	C00-C97
DIB006880	Long-acting oxyntomodulin	Obesity	278	E66
DIB006881	XR-9051	Cancer	140-229	C00-C96
DIB006882	ATI-1150	Cancer	140-229	C00-C96
DIB006883	JAK tyrosine kinase inhibitors	Inflammatory diseases	.	.
DIB006884	Suplatast tosilate	Allergy	995.3	T78.4
DIB006885	HIV maturation inhibitors	HIV infections	42	B20
DIB006886	Candida albicans vaccine	Candida albicans infection	.	B37.0
DIB006887	CT-2584	Solid tumours	.	C00-C75,C7A,C7B
DIB006888	5-HT2A receptor antagonists (undisclosed indication), Angelini Pharmaceuticals	Discovery agent	.	.
DIB006889	Recombinant human alkaline phosphatase	Inflammatory diseases	.	.
DIB006890	NPS-P156	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB006891	AZD4721	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB006892	SCIB-2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB006893	Sulochrin	Asthma	493	J45
DIB006894	Sucralfate	Acne vulgaris	706.1	L70.0
DIB006895	DAV-148	Enterobacteriaceae infection	.	A04.8
DIB006896	MX-35	Ovarian cancer	.	C56
DIB006897	Piroxicam betadex	Cancer	.	C00-C97
DIB006898	Penicillin G benzathine	Treponema pallidum infection	.	A53.9
DIB006899	LAS-41004	Atopic dermatitis	691.8	L20
DIB006900	FCP-3P1	Atherosclerosis	414.0, 440	I70
DIB006901	Cell cycle inhibitors	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB006902	PDK-1 inhibitors	Cancer	140-229	C00-C96
DIB006903	JAK3 inhibitor	Sjogren's syndrome 	.	M35.0
DIB006904	GX-137	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006905	PXS-25	Fibrosis	.	L90.5
DIB006906	AT-012	Cancer	140-229	C00-C96
DIB006907	Rabies vaccine	Rabies virus infection	001-139	A00-B99
DIB006908	CH-673	Asthma	493	J45
DIB006909	PMI-005	Osteoarthritis	.	M15-M19,M47
DIB006910	HPV 16/18 vaccine	Papillomavirus infections	.	B97.7
DIB006911	FluDrugStrategy	Influenza virus infections	487	J10, J11
DIB006912	Neutrophil-repellent biochemical compounds	Inflammatory diseases	.	.
DIB006913	DW-514	Dementia	290-294	F01-F07
DIB006914	Antivirals	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB006915	Engineered toxin bodies	Cancer	140-229	C00-C96
DIB006916	JAIVAC-1	Plasmodium falciparum infection	.	B54
DIB006917	Parkinsons therapeutic peptides	Parkinson's disease	.	G20
DIB006918	PPI-03306	Sleep apnea	.	G47.3
DIB006919	EB-1053	Osteoporosis	.	M80-M81
DIB006920	BOF-12013	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006921	Prifinium	Irritable bowel syndrome	564.1	K58
DIB006922	GNI-105	Papillomavirus infections	.	B97.7
DIB006923	CY-1788	Septic shock	785.52	A41.9
DIB006924	Segard	Sepsis	.	A40-A41
DIB006925	Anti-HERV-W humanized monoclonal antibodies	Schizophrenia	295	F20
DIB006926	SERM-beta compounds	Breast cancer	174, 175, 217	C50, D24
DIB006927	Tiprelestat	Pulmonary arterial hypertension	.	I27.0,I27.2
DIB006928	Prolanta	Breast cancer	174, 175, 217	C50, D24
DIB006929	RNAi therapeutics	Huntington's disease	.	F02.2,G10
DIB006930	MTI-723	Prostate tumor	185	C61
DIB006931	Cardiotrophin-1	Acute liver failure	.	K72
DIB006932	Male erectile dysfunction therapy	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB006933	Epithalon	Ocular inflammation	.	H00-H59
DIB006934	AZD-8677	Diabetes mellitus	250	E08-E13
DIB006935	Theradigm-prostate	Prostate tumor	185	C61
DIB006936	AZT-P-DDI	Human immunodeficiency virus infection	.	B20
DIB006937	P-216CM	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006938	Pokeweed antiviral protein	Systemic lupus erythematosus	710	M32
DIB006939	SOM-0420	Osteoporosis	733	M80-M81
DIB006940	RLIP76 protein	Radiation sickness	990	T66
DIB006941	Nisin combination	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006942	AM-220	Wound healing	.	S91.3
DIB006943	JB-004/A	Inner ear disease	.	H80-H83
DIB006944	Pyrrolo triazine-based aurora kinase inhibitors	Cancer	140-229	C00-C96
DIB006945	Antibacterial peptides	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006946	M-5200	Skin allergies	.	T78.4
DIB006947	Levodopa	Parkinson's disease	.	G20
DIB006948	Human monoclonal antibodies	Influenza virus infections	487	J10, J11
DIB006949	F-16242	Major depressive disorder	296.2, 296.3	F32, F33
DIB006950	XToll	Autoimmune diseases	.	D84.9
DIB006951	HS-113	Cancer	140-229	C00-C96
DIB006952	Labeled LH superagonist	Breast cancer	174, 175, 217	C50, D24
DIB006953	NT-69-L	Alcohol use disorders	303	F10.2
DIB006954	HBV vaccine	Hepatitis B virus infection	.	B16
DIB006955	Recombinant human TNF receptor	Arthritis	710-719	M00-M25
DIB006956	Polymer-tubulysin A prodrug conjugate	Cancer	140-229	C00-C96
DIB006957	YH-4808	Duodenal ulcer	.	K25-K27
DIB006958	AYX-1	Pain	.	G89
DIB006959	5-FP	Solid tumours	.	C00-C75,C7A,C7B
DIB006960	PEDF gene therapy	Macular degeneration	.	H35.3
DIB006961	N-acetyltransferase inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB006962	Bradykinin antagonists	Asthma	.	J45
DIB006963	ST-0703	Cardiovascular disease	390-459	I00-I99
DIB006964	TIBENELAST	Bronchodilator	493	J45
DIB006965	Diclofenac sodium patch	Pain	.	G89
DIB006966	Cyrtominetin	Mucolytic	.	J00-J99
DIB006967	DT-320	Cancer	140-229	C00-C96
DIB006968	TL-1836	Cancer	140-229	C00-C96
DIB006969	Remimazolam	Anesthesia	338	R52
DIB006970	Artemisinin derivatives	Cancer	.	C00-C97
DIB006971	ASP-7147	Irritable bowel syndrome	564.1	K58
DIB006972	DDG-39	Acquired immune deficiency syndrome	.	B20
DIB006973	MDT-006	Constipation	564	K59.0
DIB006974	5HT1A agonist series (anxiety/depression), Prosarix	Anxiety disorder	300	F40-F42
DIB006975	VGV-X	HIV infections	42	B20
DIB006976	BVT-74316	Obesity	278	E66
DIB006977	PF-5177624	Cancer	140-229	C00-C96
DIB006978	Myotubularin gene-containing AAV vector based therapy	Myopathy	.	M60-M63
DIB006979	Tat Oyi-Cys22	HIV infections	42	B20
DIB006980	Antiviral hyperactivation limiting therapeutics	HIV infections	42	B20
DIB006981	AP-414	Allergy	995.3	T78.4
DIB006982	CP-4200	Cancer	140-229	C00-C96
DIB006983	SAR-566658	Solid tumours	.	C00-C75,C7A,C7B
DIB006984	HSV vaccine	Herpes simplex virus infection	54	B00
DIB006985	Carbapenem derivative	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB006986	CHGN111	Skin infections	680-709	L00-L99
DIB006987	ITAMELINE	Cognitive impairment	.	F06.7
DIB006988	EP2 antagonists	Cancer	.	C00-C97
DIB006989	P2B-003	Cancer	140-229	C00-C96
DIB006990	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB006991	Alzheimer's disease therapy	Alzheimer's disease	331	G30
DIB006992	Lolium perenne/Cynodon dactylon-containing vaccine	Allergic rhinitis	477	J30
DIB006993	Interferon modulator	Autoimmune diseases	279.4	D84.9, M35.9
DIB006994	NS5a	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB006995	ISU-201	Autoimmune diseases	279.4	D84.9, M35.9
DIB006996	Oral HPV vaccine	Papillomavirus infections	.	B97.7
DIB006997	Colfosceril palmitate	Respiratory distress syndrome	518.5, 518.82	J80
DIB006998	Theradigm-Melanoma	Cancer	.	C00-C97
DIB006999	P2Y12 antagonists	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007000	Lactulose	Constipation	564	K59.0
DIB007001	TMA-230	Bacterial infection	.	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007002	REC-0436	Overactive bladder disorder	596.51	N32.81
DIB007003	S-47445	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB007004	Dual antigen vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007005	Selective Rac1/1b GTPase nucleotide binding inhibitors	Cancer	.	C00-C97
DIB007006	Nisin	Bacillus anthracis infection	.	A22
DIB007007	AZD8186	Solid tumours	140-199	C00-C75, C7A, C7B
DIB007008	RPGRIP1 AAV vector gene therapy	Ocular disease	.	H00-H59
DIB007009	SLV-337	Cardiovascular disease	390-459	I00-I99
DIB007010	BAX-499	Factor IX deficiency	.	D67
DIB007011	Org-25435	Epilepsy	.	G40
DIB007012	Ro-24-7341	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007013	Radio-labeled monoclonal antibody	Melanoma	172	C43
DIB007014	ET-003	Colon cancer	153, 154	C18-C21
DIB007015	PC-8608	Cancer	140-229	C00-C96
DIB007016	A-204176	Stress urinary incontinence	.	N39.3
DIB007017	DZ-13	Cancer	140-229	C00-C96
DIB007018	Nano-steroid	Rheumatold arthritis	714	M05-M06
DIB007019	TKP-1002	Schizophrenia	295	F20
DIB007020	EF-5	Rheumatold arthritis	714	M05-M06
DIB007021	Omadacycline intravenous	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007022	SRW-LAMP-vax	Allergy	995.3	T78.4
DIB007023	Recombinant PGF modulators	Wound healing	.	S91.3
DIB007024	REG-3	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007025	XP-28	Muscle weakness	.	M62.8
DIB007026	GMK	Melanoma	.	C43
DIB007027	AR-102	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB007028	A-841720	Pain	338,780	R52, G89
DIB007029	Tissuegene-Cs	Articular cartilage disorders	.	M24.10
DIB007030	TD-1770	Bladder cancer	188	C67
DIB007031	Xcellerated T cells	Cancer	.	C00-C97
DIB007032	NM-007-LENK	Pain	338,780	R52, G89
DIB007033	Angiogenesis promoters	Cardiovascular disease	390-459	I00-I99
DIB007034	RP-66153	Asthma	493	J45
DIB007035	FMP2.1/AS02A	Plasmodium falciparum infection	.	B54
DIB007036	MAb therapy	Cancer	140-229	C00-C96
DIB007037	Live attenuated Shigella sonnei vaccine	Shigella sonnei infection	.	A03.9
DIB007038	Live attenuated tularemia vaccine	Tularemia	.	A21.9
DIB007039	IGF-methotrexate conjugate	Cancer	140-229	C00-C96
DIB007040	PDC-41	Dysmenorrhea	.	N94.4-N94.6
DIB007041	BDNF	Motor neurone disease	335.2	G12.2
DIB007042	DAS-181	Influenza virus infections	.	J10-J11
DIB007043	VTX-744	Discovery agent	.	.
DIB007044	Conjugated estrogens (Premarin)	Breast cancer	174, 175, 217	C50, D24
DIB007045	AG-1068	HIV infections	42	B20
DIB007046	KI-0907	Obesity	278	E66
DIB007047	NDC-KM	Cancer	140-229	C00-C96
DIB007048	PRINOMIDE TROMETHAMINE	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB007049	DTI-015	Liver cancer	.	C22
DIB007050	BAL-30072	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB007051	MAb program	Autoimmune diseases	279.4	D84.9, M35.9
DIB007052	ZATOSETRON MALEATE	Anxiety disorder	.	F40-F42
DIB007053	SC-45662	Asthma	.	J45
DIB007054	TKM-Ebola	Ebola virus infection	.	A98
DIB007055	DPP-4 inhibitors	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
DIB007056	Dismutase mimetics	Cancer	.	C00-C97
DIB007057	Activated charcoal	Poison intoxication	.	T36-T50
DIB007058	P2B-002	Cancer	140-229	C00-C96
DIB007059	KOS-2484	Cancer	140-229	C00-C96
DIB007060	LANEPITANT	Pain	.	G89
DIB007061	DISBA-01	Cancer	.	C00-C97
DIB007062	Lidamine	Irritable bowel syndrome	564.1	K58
DIB007063	HPP-376	Pain	338,780	R52, G89
DIB007064	U-96988	Human immunodeficiency virus infection	.	B20
DIB007065	SERCA 2a activators	Cardiac failure	.	I50
DIB007066	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB007067	ORG-25935	Psychotic disorders	.	F20-F29
DIB007068	Stamulumab	Duchenne muscular dystrophy	.	G71.0
DIB007069	First-generation influenza vaccine	Influenza virus infections	487	J10, J11
DIB007070	PSMA-targeted tubulysin B conjugates	Prostate cancer	185	C61
DIB007071	Antiarthritis compounds	Arthritis	710-719	M00-M25
DIB007072	Recombinant factor VIII	Factor VIII deficiency	.	D66
DIB007073	MOD-1002	Obesity	278	E66
DIB007074	Erythropoietin mimetics	Brain injury	.	S09.90
DIB007075	Antiparasitic	Trypanosomiasis	086.5-086	B56-B57
DIB007076	Bamifylline	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB007077	IL-6 inhibitors	Inflammatory diseases	.	.
DIB007078	APD-421	Emesis	.	R11
DIB007079	Recombinant human cartilage-derived retinoic acid-sensitive protein depot	Articular cartilage disorders	.	M24.10
DIB007080	Smac mimetics	Cancer	140-229	C00-C96
DIB007081	CNS-1118	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007082	TRK-710	Cancer	140-229	C00-C96
DIB007083	FR-901724	HIV infections	42	B20
DIB007084	Wnt pathway antagonists	Cancer	140-229	C00-C96
DIB007085	ORG-34167	Depression	311	F32
DIB007086	Re-188-P-2045	Lung cancer	.	C33-C34
DIB007087	NDC-1187	Cancer	140-229	C00-C96
DIB007088	Needle-free influenza vaccine patch	Influenza virus infections	487	J10, J11
DIB007089	Anticancer Bak program	Heart failure	.	I50
DIB007090	JIN-2011	Cancer	140-229	C00-C96
DIB007091	SR-59119A	Gastrointestinal disease	.	K00-K93
DIB007092	Snake venom antisera	Poison intoxication	.	T36-T50
DIB007093	TRPM 8 blocker	Pain	338,780	R52, G89
DIB007094	Neuropeptide Y2 agonists	Peripheral vascular disease	443.9	I73.9
DIB007095	CetuGEX	Cancer	140-229	C00-C96
DIB007096	Phenylalanine hydroxylase	Autoimmune diseases	.	D84.9
DIB007097	Capsid-modified Ad 5-based vaccine	Plasmodium infection	.	B54
DIB007098	Cryopreserved human liver cells	Liver disease	570-574	K70-K77
DIB007099	AZM-127	Diabetes mellitus	.	E10-E14
DIB007100	MUC1-Poly-ICLC	Colorectal cancer	.	C18-C20,C21
DIB007101	Anti-Notch-1 mAbs	Cancer	140-229	C00-C96
DIB007102	NanoJacketed cancer therapeutics	Cancer	140-229	C00-C96
DIB007103	CRIB	Alzheimer's disease	.	G30,F00
DIB007104	LY-2503029	Cancer	140-229	C00-C96
DIB007105	Antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007106	Orexin 1 antagonists	Discovery agent	.	.
DIB007107	Glycan modulators	Lysosomal storage disease	.	E75-E77
DIB007108	AR08	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DIB007109	PNH-192	Cancer	140-229	C00-C96
DIB007110	AZD-3839	Alzheimer's disease	.	G30,F00
DIB007111	Streptococcus pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB007112	SCD-1 inhibitors	Dermatological disease	.	L00-L99
DIB007113	6-mercaptopurine (oral delayed-release, Crohn's disease), Teva	Crohn's disease	.	K50
DIB007114	Antituberculosis agents	Mycobacterium tuberculosis infection	.	A15-A19
DIB007115	Echovist	Gynecological disorder	.	N70-N98
DIB007116	TPO gene plasmid	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB007117	TgAAC-09	HIV infections	42	B20
DIB007118	MLN-2704	Prostate cancer	185	C61
DIB007119	AZD-4750	Multiple sclerosis	340	G35
DIB007120	Atrimer program	Cancer	140-229	C00-C96
DIB007121	Cirrhosis	Liver disease	570-574	K70-K77
DIB007122	NM-4540	Discovery agent	.	.
DIB007123	SPD-704	Neisseria meningitidis infection	.	A87
DIB007124	KA-398	Asthma	.	J45
DIB007125	Amyloid oligomer antagonists	Alzheimer's disease	331	G30
DIB007126	TR-Flu	Influenza virus infections	487	J10, J11
DIB007127	HIV vaccine	HIV infections	42	B20
DIB007128	PT-00311	Neurological disease	.	G00-G99
DIB007129	Prophylatic hepatitis C virus vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007130	RemeStim-CEA	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007131	NN-2501	Diabetes mellitus type 2	.	E11
DIB007132	M-239144	Periodontal disease	.	K05
DIB007133	GABA mimetics	Neuropathic pain	338,780	R52, G89
DIB007134	NV.TLM.10	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB007135	HDAC inhibitors	Cancer	140-229	C00-C96
DIB007136	Pentetate zinc trisodium	Acute radiation syndrome	.	T66
DIB007137	PC-190723	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007138	ES-285	Solid tumours	.	C00-C75,C7A,C7B
DIB007139	AFM-15	Autoimmune diseases	279.4	D84.9, M35.9
DIB007140	Hsp90 inhibitors	Plasmodium falciparum infection	.	B54
DIB007141	Diabetes therapy	Diabetes mellitus	250	E08-E13
DIB007142	KRP-107	Autoimmune diseases	279.4	D84.9, M35.9
DIB007143	CSF-1R inhibitor	Bone cancer	.	C41.0
DIB007144	YM-43611	Psychotic disorders	.	F20-F29
DIB007145	Glycosylated antibodies	Discovery agent	.	.
DIB007146	CY-1747	Cardiovascular disease	390-459	I00-I99
DIB007147	NN-8630	Growth hormone deficiency	253.3	E23.0
DIB007148	Etamicastat	Heart failure	.	I50
DIB007149	KRN-5500	Peripheral neuropathy	.	G64
DIB007150	PD-360324	Rheumatold arthritis	.	M05-M06
DIB007151	Trk inhibitors	Cancer	140-229	C00-C96
DIB007152	Allox	Wound healing	.	S91.3
DIB007153	V-28-3B	Fungal infection	.	B35-B49
DIB007154	MDA-106	Neurodegenerative diseases	.	G30-G32
DIB007155	ICP0 modulators	Herpes simplex virus infection	54	B00
DIB007156	EPB-200	Viral infections	042-075	A80-A99, B00-B34
DIB007157	Systebryl	Amyloidosis	277.3	E85
DIB007158	DABO derivatives	HIV infections	42	B20
DIB007159	Modified vitamin A	Age related macular degeneration	.	H35.30
DIB007160	VLTS-589	Peripheral vascular disease	443.9	I73.9
DIB007161	IMX-TB2	Mycobacterium tuberculosis infection	.	A15-A19
DIB007162	SOM-0888	Plasmodium infection	.	B54
DIB007163	Cyclosporin A-based peptides	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007164	BMY-43748	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB007165	Analgesics	Pain	338,780	R52, G89
DIB007166	SMC-0006 prodrug	Cancer	140-229	C00-C96
DIB007167	GBL-100	Dermatological disease	.	L00-L99
DIB007168	AM-461	Respiratory disease	.	J00-J99
DIB007169	Viral capsid assembly inhibitors	Pox virus infection	.	B08.8
DIB007170	FibroStem	Scar tissue	.	L00-L99
DIB007171	Propoxycaine	Pain	.	G89
DIB007172	Lipopeptide program	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007173	Telomerase inhibitors	Cancer	140-229	C00-C96
DIB007174	Dichloroacetate sodium	Pulmonary hypertension	416	I27.0, I27.2
DIB007175	Respiratory syncytial virus vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB007176	DPP-IV inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB007177	Anti-IgE vaccine	Allergy	995.3	T78.4
DIB007178	Co-111732	Epilepsy	345	G40
DIB007179	VPM-4-001	Prostate tumor	185	C61
DIB007180	Ladostigil	Alzheimer's disease	.	G30,F00
DIB007181	BL-1021	Pain	.	G89
DIB007182	Yttrium (90Y) clivatuzumab tetraxetan	Pancreatic cancer	.	C25
DIB007183	Pleodrug	Polycystic kidney disease	753.1	Q61
DIB007184	M-402	Cancer	.	C00-C97
DIB007185	Radioimmunotherapy	Cancer	140-229	C00-C96
DIB007186	Erythromycin stinoprate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007187	Nelipepimut	Non-Hodgkin's lymphoma	.	C85.9
DIB007188	ATLIPROFEN METHYL ESTER	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB007189	ChronVac-C/TG-4040 prime-boost vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007190	Napsagatran	Myocardial infarction	.	I21-I22
DIB007191	NanoDTPA	Iron overload	.	R79.0
DIB007192	Sarcoma cancer vaccine	Sarcoma	.	C00-C75
DIB007193	Fungicide	Fungal infection	.	B35-B49
DIB007194	RPK-739	Cancer	140-229	C00-C96
DIB007195	HG-1068	Cancer	140-229	C00-C96
DIB007196	G protein beta gamma subunit inhibitors	Cardiac failure	.	I50
DIB007197	DANOFLOXACIN	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB007198	Plasma kallikrein inhibitors	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DIB007199	SARS coronavirus vaccine	SARS coronavirus infection	.	J12.81
DIB007200	Measles, mumps, rubella vaccine, live	Measles virus infection	.	B06.9
DIB007201	EGF816	Non-small-cell lung carcinoma	162	C33, C34
DIB007202	Therapeutic antibody program	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB007203	INO-3112	Head and neck cancer	140-149	C07-C14, C32-C33
DIB007204	Metronidazole 10% topical ointment	Crohn's disease	.	K50
DIB007205	Long-acting GCSF conjugate	Neutropenia	288	D70
DIB007206	Oralgen Pollen	Allergic rhinitis	477	J30
DIB007207	Bacterial infection/severe burns therapy	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007208	PRT-064445	Bleeding	.	R58
DIB007209	Molgramostim	Wound healing	.	T14.0-T14.1
DIB007210	11-beta-HSD1 inhibitors (metabolic disorder), Abbott	Metabolic disorders	.	E70-E90
DIB007211	Anti PSA antibody conjugates	Prostate tumor	185	C61
DIB007212	Norelin	Prostate cancer	185	C61
DIB007213	Fluorescein derivative contrast agent	Ocular disease	.	H00-H59
DIB007214	P2X7 purinoreceptor antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB007215	N-8295	Influenza virus infections	487	J10, J11
DIB007216	TS-032	Schizophrenia	295	F20
DIB007217	FolateImmune	Cancer	.	C00-C97
DIB007218	Interferon alpha	Chronic myelogenous leukemia	205.1	C92.1
DIB007219	Nucleozin	Influenza virus infections	487	J10, J11
DIB007220	SIV-Mac251	HIV infections	42	B20
DIB007221	AVE-0847	Hyperlipidemia	.	E78.5
DIB007222	SO-3	Scar tissue	.	L00-L99
DIB007223	VEGF gene therapy	Coronary artery disease	410-414, 429.2	I20-I25
DIB007224	Adipsin	Obesity	278	E66
DIB007225	Nanobody therapeutics	Cancer	140-229	C00-C96
DIB007226	Org-9731	Heart failure	.	I50
DIB007227	Small molecule therapeutics	Cardiovascular disease	390-459	I00-I99
DIB007228	C-KAD ophthalmic solution	Cataract	366	H25-H26, H28, Q12.0
DIB007229	HMAG-1 targeting GRSA	Breast cancer	174, 175, 217	C50, D24
DIB007230	Anti-infertility program	Infertility	.	N46,N97.0
DIB007231	E-2040	Schizophrenia	295	F20
DIB007232	ANTAGONIST-G	Cancer	140-229	C00-C96
DIB007233	Anthrax vaccine	Bacillus anthracis infection	.	A22
DIB007234	ACH-2892	Infectious disease	001-139	A00-B99
DIB007235	PD-159913	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007236	FR-183998	Hypertension	401	I10, I11, I12, I13, I15
DIB007237	A-007	Skin cancers	.	C43-C44
DIB007238	Adyvia	Diabetes mellitus type 2	.	E11
DIB007239	UC-38	HIV infections	42	B20
DIB007240	SSAO inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007241	Hsp70 inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007242	Artemisinin-based iron chelators	Cancer	.	C00-C97
DIB007243	BMS-633749	HIV-1 infections	42	B20
DIB007244	Pyrrole-imidazole polyamides	Papillomavirus infections	.	B97.7
DIB007245	TGF-beta Shield	Cancer	.	C00-C97
DIB007246	Genistein analogs	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007247	NT0202	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DIB007248	STP-702	Influenza virus infections	487	J10, J11
DIB007249	Ketolides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007250	SPPI-339	Attention deficit hyperactivity disorder	314	F90
DIB007251	VP004	Substance dependence	.	F10-F19
DIB007252	SAN-134	Osteoporosis	.	M80-M81
DIB007253	PBI-4419	Fibrosis	709.2	L90.5
DIB007254	Propofol lingual spray	Pain	.	G89
DIB007255	G-1128	Chronic myelogenous leukemia	205.1	C92.1
DIB007256	CR002	Nephropathy	.	N00-N29
DIB007257	Metformin arginine-hemisuccinimide	Diabetes mellitus type 2	.	E11
DIB007258	Humanized antibody	Cardiovascular disease	390-459	I00-I99
DIB007259	MVA-mBN85B	Measles virus infection	.	B06.9
DIB007260	Bifemelane	Alzheimer's disease	.	G30,F00
DIB007261	SCI program	Spinal cord injuries	952	S14, S24, S34
DIB007262	IPP-204106	Cancer	.	C00-C97
DIB007263	GenePro	HIV infections	42	B20
DIB007264	Bone disease therapy	Bone disease	.	M00-M99
DIB007265	Cardiotrophin-1	Liver disease	570-574	K70-K77
DIB007266	Bimatoprost	Alopecia	.	L65.9
DIB007267	Prophylactic DNA vaccine	Hepatitis B virus infection	.	B16
DIB007268	Sch-40338	Allergy	.	T78.4
DIB007269	T2c-001	Congestive heart failure	428	I50
DIB007270	CVP EPICOAT P aeruginosa vaccine	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB007271	TRU-015	Lymphoma	.	C81-C96
DIB007272	Neutrophil elastase inhibitors	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB007273	PNU-171990A	Irritable bowel syndrome	564.1	K58
DIB007274	Botulinum neurotoxin vaccine	Botulism	.	A05.1
DIB007275	Small molecule inhibitors	Cancer	140-229	C00-C96
DIB007276	AG-394	Cancer	.	C00-C97
DIB007277	AVI-5038	Duchenne dystrophy	.	G71.0
DIB007278	CEFETECOL	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB007279	MMP-12 inhibitors	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB007280	TAR-1	Cancer	140-229	C00-C96
DIB007281	AZD-0275	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DIB007282	Genital herpes treatment	Herpes simplex virus infection	.	A60,B00
DIB007283	GD-AAV8	Gaucher disease	272.7	E75.2
DIB007284	Rumbrin	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007285	Adenylyl cyclase 5 inhibitors	Cardiovascular disease	390-459	I00-I99
DIB007286	DR-5/DR-4 cross reactive mAbs	Cancer	140-229	C00-C96
DIB007287	LPO-1010CSR	Retinopathy	362.0-362.2	H35-H35.2
DIB007288	Growth hormone	Growth hormone deficiency	253.3	E23.0
DIB007289	Nociceptin receptor ligands	Anxiety disorder	300	F40-F42
DIB007290	PSX-4206	Pulmonary disease	460-519	J00-J99
DIB007291	BL-6020	Cachexia	799.4	R64
DIB007292	PRO-2844	Dermatitis	692.9	L20-L30
DIB007293	NTHI vaccine	Haemophilus influenzae prophylaxis	487, 488	J10, J11
DIB007294	NPS-2	Cancer	140-229	C00-C96
DIB007295	Polyglutamate camptothecin	Solid tumours	.	C00-C75,C7A,C7B
DIB007296	T-2000	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007297	PIRICAPIRON	Anxiety disorder	.	F40-F42
DIB007298	Opioid receptor-like 1 (ORL1) antagonists	Major depressive disorder	296.2, 296.3	F32, F33
DIB007299	Tpl2 kinase inhibitors	Rheumatold arthritis	714	M05-M06
DIB007300	SIM-0710	Cancer	140-229	C00-C96
DIB007301	Poliovirus vaccine	Poliovirus infection	.	A80.9
DIB007302	CPD-0905	Trypanosomiasis	086.5-086	B56-B57
DIB007303	ZK-93426	Alzheimer's disease	.	G30,F00
DIB007304	NLP-91	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007305	CKD-533	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB007306	Seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB007307	SC-41930	Inflammatory bowel disease	.	K50,K51
DIB007308	DM-83	Diabetes mellitus type 2	.	E11
DIB007309	MGI-805	Lyme disease	88.81	A69.2
DIB007310	AIT-034	Dementia	290-294	F01-F07
DIB007311	PRO-053	Duchenne dystrophy	.	G71.0
DIB007312	Seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB007313	HCV NS5A inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007314	APX-002	Diabetes mellitus	250	E08-E13
DIB007315	Cardioprotectants	Congestive heart failure	428	I50
DIB007316	124I-labeled 11-1F4	Amyloidosis	277.3	E85
DIB007317	ABS-212	Pain	338,780	R52, G89
DIB007318	HuCAL-derived monoclonal antibody	Ocular disease	.	H00-H59
DIB007319	Transcobalamin (vitamin B12) receptor-targeting mAbTCR23-saporin conjugate	Cancer	140-229	C00-C96
DIB007320	AV-2201	Pain	338,780	R52, G89
DIB007321	Methazolamide	Glaucoma	365	H40-H42
DIB007322	Hemomex I	Cancer	.	C00-C97
DIB007323	Stichodactyla helianthus-derived Kv1.3 potassium channel inhibitors	Psoriatic arthritis	696	L40.5, M07
DIB007324	LP-2307	Cancer	.	C00-C97
DIB007325	Flavonols	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007326	Stachyflin derivatives	Influenza virus infections	487	J10, J11
DIB007327	RecAAT	Alpha-1 antitrypsin deficiency	.	E88.0
DIB007328	AZM-122	Gastrointestinal disease	.	K00-K93
DIB007329	BIIC-402	Hypertension	.	I10-I15
DIB007330	Therapeutic peptide program	Osteoarthritis	715	M15-M19, M47
DIB007331	Proapoptotic Surrobodies	Cancer	140-229	C00-C96
DIB007332	ATI-0917	Human immunodeficiency virus infection	.	B20
DIB007333	Piritramide	Pain	338,780	R52, G89
DIB007334	AVR-147	Cancer	140-229	C00-C96
DIB007335	BMS-378806 analogs	HIV-1 infections	42	B20
DIB007336	CI-1012	Acquired immune deficiency syndrome	.	B20
DIB007337	Albuterpenoids	Adult varicella zoster virus infection	.	B02
DIB007338	BIBW-22	Cancer	140-229	C00-C96
DIB007339	SEH inhibitors	Hypertension	401	I10, I11, I12, I13, I15
DIB007340	Ezogabine extended release	Behcet's disease	.	M35.2
DIB007341	EDG-005	Major depressive disorder	296.2, 296.3	F32, F33
DIB007342	DNA vaccine	Melanoma	.	C43
DIB007343	TDI-0087	Motor neurone disease	335.2	G12.2
DIB007344	FSHR NAM	Contraception	.	Z30
DIB007345	Amsilarotene	Cancers	.	C00-D48
DIB007346	KX-03	Autoimmune diseases	279.4	D84.9, M35.9
DIB007347	NP-50201	Psoriasis	696	L40
DIB007348	Alpha 7 nicotinic acetylcholine receptor positive allosteric modulators	Alzheimer's disease	331	G30
DIB007349	Antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007350	GTx-027	Cancer	140-229	C00-C96
DIB007351	PYN-9	Ileus	537.2, 560.1, 560.31, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, P76.1
DIB007352	Cholera vaccine	Vibrio cholerae infection	.	A00.0
DIB007353	Miltirone	Anxiety disorder	300	F40-F42
DIB007354	WNK1 modulators	Hypertension	401	I10, I11, I12, I13, I15
DIB007355	M-512101	Acne vulgaris	706.1	L70.0
DIB007356	Salmonella enterica vaccine	Salmonella infection	.	A02.9
DIB007357	MN-8001	Autoimmune diseases	279.4	D84.9, M35.9
DIB007358	CMV trivalent vaccine	Cytomegalovirus	78.5	B25.8, H30.9
DIB007359	Estropipate	Hypogonadism	257.2	E23.0, E28.3, E29.1
DIB007360	CMX-001	Cancer	140-229	C00-C96
DIB007361	Vax-TET	Clostridium tetani infection	001-139	A00-B99
DIB007362	P70S6 kinase inhibitors	Cancer	.	C00-C97
DIB007363	GSK2849466	Heart failure	428	I50
DIB007364	BMS-903452	Diabetes mellitus type 2	.	E11
DIB007365	Mitoflaxone	Cancer	140-229	C00-C96
DIB007366	RK-28	Cancer	140-229	C00-C96
DIB007367	14F7 humanized mAb, The Center of Molecular Immunology	Cancer	140-229	C00-C96
DIB007368	LX-2932	Autoimmune diseases	279.4	D84.9, M35.9
DIB007369	PGGA-PTX	Cancer	140-229	C00-C96
DIB007370	OT-440	Glaucoma	365	H40-H42
DIB007371	Haemophilus influenzae vaccine	Haemophilus influenzae infection	.	J11.1
DIB007372	ASB-010	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB007373	STP-902	Respiratory syncytial virus 	79.6	B97.4
DIB007374	Second-generation tau aggregation inhibitor	Alzheimer's disease	.	G30,F00
DIB007375	CGP-40215A	Pneumocystis carinii infection	.	B59
DIB007376	NVP-AUY-922 follow-up compounds	Cancer	140-229	C00-C96
DIB007377	RX-10045	Ocular disease	.	H00-H59
DIB007378	L-690488	Major depressive disorder	296.2, 296.3	F32, F33
DIB007379	AL-309	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB007380	Antiparasitics	Cancer	.	C00-C97
DIB007381	Anticancer/antidiabetic protein	Cancer	.	C00-C97
DIB007382	TP-102	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007383	CelTOS antigen-GLA-SE adjuvant vaccine	Plasmodium infection	.	B54
DIB007384	HL-035	Syndrome X	.	E88.9
DIB007385	JCAR014	Non-Hodgkin's lymphoma	.	C85.9
DIB007386	IC31	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB007387	BC-19	Brain diseases	.	G00-G99
DIB007388	HMR-3004	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007389	LXT-101	Prostate cancer	.	C61
DIB007390	RiVax oral/intranasal	Poison intoxication	.	T36-T50
DIB007391	RG-7234	Diabetes mellitus type 2	.	E11
DIB007392	TVA-Brain-1	Nervous system disease	.	G00-G99
DIB007393	HIV integrase inhibitors	HIV infections	42	B20
DIB007394	FP-1096	Endometriosis	617	N80
DIB007395	ALGRX-1207	Pain	338,780	R52, G89
DIB007396	HepaStem	Liver failure	.	K72.9
DIB007397	DAU-6285	Emesis	.	R11
DIB007398	Monoclonal antibody	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB007399	E-0706	Fungal infection	.	B35-B49
DIB007400	LY3023414	Cancer	.	C00-C97
DIB007401	Pleurostatin	Lung cancer	162	C33-C34
DIB007402	HSV-2 vaccine	Herpes simplex virus infection	.	B00
DIB007403	IB-09A133	Angiogenesis disorder	.	I00-I99
DIB007404	Anti-Abeta monoclonal antibodies	Alzheimer's disease	331	G30
DIB007405	Radioprotectants	Cardiovascular disease	390-459	I00-I99
DIB007406	RG-7152	Asthma	.	J45
DIB007407	ATI-0409	Infectious disease	001-139	A00-B99
DIB007408	Aom-0755	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007409	Endothelial nitric oxide synthase (eNOS) gene therapy	Coronary artery disease	.	I20-I25
DIB007410	Endovion	Cancer	.	C00-C97
DIB007411	Desmosin	Periodontal disease	.	K05
DIB007412	L-G1	Acquired immune deficiency syndrome	.	B20
DIB007413	VI-0134	Premature ejaculation	302.75	F52.4
DIB007414	Radotinib	Leukemia	208.9	C91-C95
DIB007415	OPT-88	Osteoarthritis	715	M15-M19, M47
DIB007416	ASP-3652	Overactive bladder disorder	.	N32.81
DIB007417	MK-866	Inflammatory diseases	.	.
DIB007418	C-5304	Cancer	140-229	C00-C96
DIB007419	Neurosolve	Glaucoma	365	H40-H42
DIB007420	Latanoprost punctal plug	Glaucoma	365	H40-H42
DIB007421	SR-90067	Hormone deficiency	.	E00-E90
DIB007422	SPN-803	Parkinson's disease	.	G20
DIB007423	CR8020 mAb	Influenza virus infections	.	J10-J11
DIB007424	Methylenecyclopropane nucleoside analogs	Cytomegalovirus infection	.	B25
DIB007425	Interferon alpha	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007426	MetAP2 inhibitors	Cancer	140-229	C00-C96
DIB007427	SB-435495	Arteriosclerosis	.	I70
DIB007428	NPRx-30	Neurodegenerative diseases	.	G30-G32
DIB007429	Alk5 inhibitors	Pulmonary hypertension	416	I27.0, I27.2
DIB007430	Soluble FePPi	Anemia	.	D50-D64
DIB007431	Antiviral	Influenza virus infections	487	J10, J11
DIB007432	QAK-423	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB007433	Anti-emetics	Nausea	.	R11
DIB007434	N-type calcium channel blockers	Neuropathic pain	338,780	R52, G89
DIB007435	KD-IX-73-4	Inflammatory diseases	.	.
DIB007436	DCN01	Ocular infection	.	H00-H59
DIB007437	TBI-304	Anemia	280-285	D50-D64
DIB007438	CGRP-A2 radioligand agent	Migraine	346	G43
DIB007439	RSV vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB007440	Immune globulin intravenous	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB007441	NEO100	Glioblastoma	.	C71
DIB007442	SB-219825	Pain	338,780	R52, G89
DIB007443	RAGE-immunoglobulin fusion protein	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DIB007444	Theradigm-Her-2	Breast cancer	174, 175, 217	C50, D24
DIB007445	NP-50511	Cancer	140-229	C00-C96
DIB007446	Thiotepa	Breast cancer	174, 175, 217	C50, D24
DIB007447	PEGylated leptin	Obesity	278	E66
DIB007448	Interleukin-2	HIV infections	42	B20
DIB007449	Idrapril	Hypertension	.	I10-I15
DIB007450	SK channel modulators	Overactive bladder disorder	596.51	N32.81
DIB007451	PI-88/Taxotere	Cancer	.	C00-C97
DIB007452	BN-2629	Solid tumours	.	C00-C75,C7A,C7B
DIB007453	Dipeptidyl aminopeptidase I inhibitors	Plasmodium falciparum infection	.	B54
DIB007454	H2S-releasing L-dopa	Parkinson's disease	.	G20
DIB007455	RHIIP	Diabetes mellitus	250	E08-E13
DIB007456	GS-522	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB007457	Abeta aggregation inhibitors	Alzheimer's disease	331	G30
DIB007458	Levamlodipine	Hypertension	401	I10, I11, I12, I13, I15
DIB007459	NPB-3	Allergic rhinitis	477	J30
DIB007460	Metallo-zanamivir	Influenza virus infections	487	J10, J11
DIB007461	ZnT8 agonists	Non-insulin dependent diabetes	.	E11.9
DIB007462	LASINAVIR	Human immunodeficiency virus infection	.	B20
DIB007463	CytoCor	Wound healing	.	S91.3
DIB007464	Spinal cord injury therapy	Spinal cord injuries	952	S14, S24, S34
DIB007465	TA-102	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007466	26S proteasome inhibitors (cancer), Ergon	Cancer	140-229	C00-C96
DIB007467	AG-568	Cancer	140-229	C00-C96
DIB007468	Congenital hemophilia and inhibitors	Thrombogenesis	.	I80-I82
DIB007469	BM-17.0744	Diabetes mellitus type 1	.	E10
DIB007470	STAT-3 inhibitors	Cancer	140-229	C00-C96
DIB007471	TGF-beta	Pleural disease	.	J90
DIB007472	Beta-3 adrenoceptor agonists	Diabetes mellitus	250	E08-E13
DIB007473	MitoLinoleic	Non-alcoholic steatohepatitis	.	K75.81
DIB007474	CY-726	Inflammatory diseases	.	.
DIB007475	Melastatin	Skin cancers	.	C43-C44
DIB007476	RNA-144101	Age related macular degeneration	.	H35.30
DIB007477	LX-1033	Irritable bowel syndrome	.	K58
DIB007478	BSI-302	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007479	MLR-1326	Diabetes mellitus	250	E08-E13
DIB007480	SKF-96231	Asthma	.	J45
DIB007481	SNN-0029	Lateral sclerosis	.	G12.2
DIB007482	Cecropin B	Cancer	140-229	C00-C96
DIB007483	CGP-25454A	Major depressive disorder	296.2, 296.3	F32, F33
DIB007484	Antiarrhythmics	Heart arrhythmia	.	I47-I49
DIB007485	L-648051	Asthma	493	J45
DIB007486	PF-4522625	Influenza virus infections	487	J10, J11
DIB007487	Avrina	Skin infections	.	L00-L99
DIB007488	Vorsetuzumab mafodotin	Renal cancer	.	C64
DIB007489	AP-10295	Cancer	140-229	C00-C96
DIB007490	Org-9991	Muscle spasm	.	M62.838
DIB007491	AAV5-gene therapy	Sanfilippo syndrome	.	E76.2
DIB007492	CXCR7 pepducins	Cancer	140-229	C00-C96
DIB007493	Low toxic paclitaxel derivative	Cancer	140-229	C00-C96
DIB007494	Bacteriophages	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007495	HBV vaccine	Hepatitis B virus infection	.	B16
DIB007496	BCH-1788	Pain	338,780	R52, G89
DIB007497	ADL-5945	Constipation	.	K59.0
DIB007498	SiRNA micelle	Discovery agent	.	.
DIB007499	Long-acting Factor VII conjugate	Bleeding	.	R58
DIB007500	Pleodrug	Hyperlipidemia	272.0-272.4	E78
DIB007501	AEH-10p	Cancer	.	C00-C97
DIB007502	Anticancer agent	Cancer	140-229	C00-C96
DIB007503	PIM protein kinase inhibitors	Cancer	140-229	C00-C96
DIB007504	Anti-VLA-1 mAb	Rheumatold arthritis	.	M05-M06
DIB007505	AC-4402	Alzheimer's disease	331	G30
DIB007506	NM-2014	Rheumatold arthritis	714	M05-M06
DIB007507	Lactitol	Liver disease	570-574	K70-K77
DIB007508	TRAXOPRODIL MESYLATE	Neurological disease	.	G00-G99
DIB007509	PD-131628	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007510	AZD-5106	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB007511	CIGB-M3	Colorectal cancer	.	C18-C20,C21
DIB007512	GLi2 RNA antagonist	Cancer	140-229	C00-C96
DIB007513	Pim kinase inhibitors	Cancer	140-229	C00-C96
DIB007514	Iron proteinsuccinylate	Anemia	280-285	D50-D64
DIB007515	ALN-RSV01	Respiratory infections	.	J06.9
DIB007516	Taspoglutide	Diabetes mellitus type 1	.	E10
DIB007517	E coli vaccine	Escherichia coli infection	.	A00-B99
DIB007518	ET-642	Atherosclerosis	414.0, 440	I70
DIB007519	AGI-1067	Restenosis	.	I51.89
DIB007520	Sunscreens	Skin cancers	.	C43-C44
DIB007521	Stroke therapy	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007522	U-80816	Amnesia	.	F04
DIB007523	Allogeneic/autologous adult mesenchymal stem cell therapy	Ischemic heart diseases	.	I20-I25
DIB007524	GR-79236	Diabetes mellitus	.	E10-E14
DIB007525	LY-243062	Inflammatory diseases	.	.
DIB007526	MIPS program	Discovery agent	.	.
DIB007527	AL-0671	Arteriosclerosis	.	I70
DIB007528	ACH-3102	Hepatitis C virus infection	.	B17.1,B18.2
DIB007529	Formyl peptide receptor antagonists	Inflammatory diseases	.	.
DIB007530	Fialuridine	Hepatitis B virus infection	.	B16
DIB007531	PhageBioDerm	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007532	SUN-44	Neuropathy	356.0, 356.8	G64, G90.0
DIB007533	HLA-A*2402-restricted KIF20A and VEGFR-1 epitope peptide vaccine	Pancreatic cancer	.	C25
DIB007534	Bone synthesis-stimulating small molecule therapeutics	Osteoporosis	733	M80-M81
DIB007535	AZD9291	Melanoma	.	C43
DIB007536	QAV-680	Allergic rhinitis	.	J30
DIB007537	INK4a	Cancer	140-229	C00-C96
DIB007538	Hylenex	Cancer	140-229	C00-C96
DIB007539	RSV therapeutics	Respiratory syncytial virus 	79.6	B97.4
DIB007540	PS-015146	Discovery agent	.	.
DIB007541	BM-21.1298	HIV-1 infections	42	B20
DIB007542	BI 655064	Rheumatold arthritis	714	M05-M06
DIB007543	Spiros	Diabetes mellitus type 1	.	E10
DIB007544	PF-05150122	Pain	338,780	R52, G89
DIB007545	BISNAFIDE MESILATE	Solid tumours	.	C00-C75,C7A,C7B
DIB007546	Amezinium	Hypotension	458, 796.3	I95
DIB007547	TNF-related apoptosis-inducing ligand-expressing mesenchymal stem cell therapy	Cancer	140-229	C00-C96
DIB007548	U-93385	Anxiety disorder	.	F40-F42
DIB007549	Vaqta	Hepatitis A virus infection	.	B15.9
DIB007550	S-888711	Liver disease	.	K70-K77
DIB007551	BB-16000	Cancer	140-229	C00-C96
DIB007552	Vagonixen	Asthma	493	J45
DIB007553	131I-radretumab	Non-small cell lung cancer	.	C33-C34
DIB007554	KLH/IMG	Discovery agent	.	.
DIB007555	SN-28049	Cancer	140-229	C00-C96
DIB007556	Anti-CGEN-153 mAb	Ovarian cancer	.	C56
DIB007557	T89	Myeloma	203	C90.0
DIB007558	Erteberel	Prostate hyperplasia	.	N40
DIB007559	Incruse Ellipta	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB007560	EP-400	Cancer	140-229	C00-C96
DIB007561	Calcium polycarbophil	Irritable bowel syndrome	564.1	K58
DIB007562	ANG-2864	Cancer	.	C00-C97
DIB007563	EZN-2279	Immunodeficiency	.	D84.9
DIB007564	PF-4064900	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007565	S1P1 modulators	Autoimmune diseases	.	D84.9
DIB007566	STX-107	Autism	.	F84.0
DIB007567	NCP-004	Diabetes mellitus	250	E08-E13
DIB007568	Pseudomonas aeruginosa vaccine	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB007569	Alagebrium chloride	Hypotension	.	I95
DIB007570	GE-20372A	HIV infections	42	B20
DIB007571	P-1	Atopic dermatitis	.	L20
DIB007572	GL-2045	Autoimmune diseases	279.4	D84.9, M35.9
DIB007573	MDDR 184045	Mycobacterium tuberculosis infection	.	A15-A19
DIB007574	PAR-2 modulators	Inflammatory bowel disease	555, 556	K50, K51
DIB007575	JTK-656	HIV infections	42	B20
DIB007576	Aom-0763	Gout	274.00274.1274.8274.9	M10
DIB007577	TAK-783	Rheumatold arthritis	714	M05-M06
DIB007578	CZ-112	Solid tumours	.	C00-C75,C7A,C7B
DIB007579	Plasma kallikrein inhibitors	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DIB007580	Infanrix	Bordetella pertussis infection	.	A37.0
DIB007581	ETHIMIZOL	Cognition disorders	.	F06.7
DIB007582	HO/02/10	Dermatological disease	.	L00-L99
DIB007583	ABS-205	Neurodegenerative diseases	.	G30-G32
DIB007584	Ragwitek	Allergic rhinitis	.	J30
DIB007585	Carbonic anhydrase inhibitors	Cancer	.	C00-C97
DIB007586	ENT-103	Pain	338,780	R52, G89
DIB007587	CHGN-182	Fibrosis	709.2	L90.5
DIB007588	RAXOFELAST	Ischemia	.	I99.8
DIB007589	OCV-105	Pancreatic cancer	.	C25
DIB007590	CB-03-01	Acne vulgaris	.	L70.0
DIB007591	T-oligos	Cancer	140-229	C00-C96
DIB007592	HXTC-901	Bleeding	.	R58
DIB007593	COTI-219	Small-cell lung cancer	.	C34.90
DIB007594	Plasminogen activator inhibitors	Cancer	.	C00-C97
DIB007595	A-75729	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007596	HIV-specific STAR fusions	HIV infections	42	B20
DIB007597	Ro-25-1132	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB007598	PGL-1001	Female infertility	628	N97.0
DIB007599	Antimalarial compounds	Plasmodium infection	.	B54
DIB007600	OPA-6566	Glaucoma	365	H40-H42
DIB007601	MIN-117	Major depressive disorder	.	F32,F33
DIB007602	PDE1 inhibitors	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB007603	HI-1640V	Asthma	493	J45
DIB007604	IDP-115	Rosacea	.	L71
DIB007605	Merbarone	Pancreatic cancer	.	C25
DIB007606	S-903	Cardiac failure	.	I50
DIB007607	SDZ-MTH-958	Restenosis	.	I51.89
DIB007608	Endoxifen	Breast cancer	174, 175, 217	C50, D24
DIB007609	PC-22	Cancer	140-229	C00-C96
DIB007610	OT-4003	Asthma	.	J45
DIB007611	Neuroprotective thioderivatives	Epilepsy	345	G40
DIB007612	Ascrolimus	Psoriasis	696	L40
DIB007613	ALN-TTRsc	Cardiomyopathy	.	I42.0
DIB007614	IDN-13389	Cancer	140-229	C00-C96
DIB007615	WAY-125971	Heart arrhythmia	.	I47-I49
DIB007616	NIM-811	Cancer	.	C00-C97
DIB007617	CEP-431	Alzheimer's disease	331	G30
DIB007618	UC-32	HIV infections	42	B20
DIB007619	AL-02	Amyotrophic lateral sclerosis	335.2	G12.2
DIB007620	SPI-256	HIV infections	42	B20
DIB007621	Orphanin antagonists	Diarrhea	.	A09,K59.1
DIB007622	CTAP101 Capsules	Kidney diseases	580-589	N00-N29
DIB007623	Phosphate absorption inhibitor	Hyperphosphatemia	.	E83
DIB007624	SL-910102	Hypertension	401	I10, I11, I12, I13, I15
DIB007625	A-71623	Obesity	278	E66
DIB007626	KALA-617	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007627	T-686	Atherosclerosis	414.0, 440	I70
DIB007628	Rimacalib	Rheumatold arthritis	.	M05-M06
DIB007629	KMB-17	Enterovirus infection	.	B34.1
DIB007630	Hedgehog inhibitors	Cancer	140-229	C00-C96
DIB007631	Nanobody therapeutics	Inflammatory diseases	.	.
DIB007632	R-1	Irritable bowel syndrome	564.1	K58
DIB007633	GR-65630	Emesis	787	R11
DIB007634	MG-1105	Hepatitis B virus infection	.	B16
DIB007635	SC-52012	Thrombosis	.	I80-I82
DIB007636	PUR0200	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB007637	Metalloenzyme inhibitors	Onchocerciasis	.	B73
DIB007638	GSK2654909A	Viral infections	.	B09
DIB007639	TPM-02/Insulin	Diabetes mellitus	250	E08-E13
DIB007640	AZD-0303	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007641	HCV polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007642	CEL-011	Bladder cancer	188	C67
DIB007643	HER-2 Protein AutoVac	Breast cancer	.	C50
DIB007644	S-16961	Hyperlipidemia	.	E78.5
DIB007645	Agrippal S1/MF-59 influenza vaccine	Influenza virus infections	487	J10, J11
DIB007646	GR-159897	Anxiety disorder	.	F40-F42
DIB007647	ABC-7	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007648	EV71 vaccine program	Enterovirus infection	001-139	A00-B99
DIB007649	LPO-1010AM	Age related macular degeneration	.	H35.30
DIB007650	QA-241	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007651	CGX-1002	Pain	338,780	R52, G89
DIB007652	Ro-24-8138	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007653	Human M-SAA3 peptide	Gastrointestinal infection	.	A09.0
DIB007654	RG-83852	Cancer	140-229	C00-C96
DIB007655	F-16-IL-2 fusion protein	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007656	MX-4509	Neurological disease	.	G00-G99
DIB007657	ATX-F8 program	Factor VIII deficiency	.	D66
DIB007658	MNX-200	Cancer	140-229	C00-C96
DIB007659	SARMs	Testosterone deficiency	.	E29.1
DIB007660	MSX-3	Parkinson's disease	.	G20
DIB007661	Ro-25-6833	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB007662	Fibronectin extra domain A	Discovery agent	.	.
DIB007663	Hypothemycin	Cancer	140-229	C00-C96
DIB007664	DCB-AD1	Alzheimer's disease	331	G30
DIB007665	GR-95168	Viral infections	042-075	A80-A99, B00-B34
DIB007666	SILPERISONE HYDROCHLORIDE	Spasm	.	R25.2
DIB007667	Recombinant vaccine	Allergy	995.3	T78.4
DIB007668	Gamma chain-transduced hematopoietic stem cell therapy	Immune disorder	.	D80-D89
DIB007669	Rx-101	Radiation sickness	990	T66
DIB007670	KIM-127	Inflammatory diseases	.	.
DIB007671	Selective Chk1 inhibitors	Cancer	140-229	C00-C96
DIB007672	SK&F-104662	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007673	Cyclin-dependent protein kinase inhibitors	Polycystic kidney disease	753.1	Q61
DIB007674	Ciprokiren	Hypertension	401	I10, I11, I12, I13, I15
DIB007675	AFTVac	Glioblastoma	.	C71
DIB007676	Aptamer therapeutics (systemic	Infectious disease	001-139	A00-B99
DIB007677	CT-5357	Inflammatory diseases	.	.
DIB007678	Dermatrol delivery system	Anxiety disorder	300	F40-F42
DIB007679	Photodynamic therapy	Cancer	140-229	C00-C96
DIB007680	TJ-9	Asthma	493	J45
DIB007681	Enzyme mAbs	Inflammatory diseases	.	.
DIB007682	MKC-204	Autoimmune diseases	279.4	D84.9, M35.9
DIB007683	Gene therapy	Melanoma	.	C43
DIB007684	BGC-20-1531	Migraine	.	G43
DIB007685	EMD-56551	Anxiety disorder	.	F40-F42
DIB007686	WR-279396	Leishmania infection	.	B55.0
DIB007687	PMA-104R	Cancer	140-229	C00-C96
DIB007688	EZN-4150	Cancer	140-229	C00-C96
DIB007689	Ledgins	HIV infections	42	B20
DIB007690	ES-305	Hypertension	401	I10, I11, I12, I13, I15
DIB007691	Anipamil	Hypertension	401	I10, I11, I12, I13, I15
DIB007692	Vapitadine	Allergic skin disorders	.	L00-L99
DIB007693	Debio-0617	Cancer	140-229	C00-C96
DIB007694	Pimagedine HCl	Diabetic kidney disease	.	E11.22
DIB007695	Anti-MDR	Cancer	140-229	C00-C96
DIB007696	BP-Inter-014	Hepatitis B virus infection	.	B16
DIB007697	LT-ZMP001	Autoimmune diseases	.	D84.9
DIB007698	DWJ-424	Cancer	140-229	C00-C96
DIB007699	GM-CSF cancer vaccine	Cancer	140-229	C00-C96
DIB007700	Autoimmune disease therapy	Autoimmune diseases	279.4	D84.9, M35.9
DIB007701	PPI-668	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB007702	HPV vaccine	Papillomavirus infections	.	B97.7
DIB007703	Muscarinic antagonists	Neurodegenerative diseases	.	G30-G32
DIB007704	NSL-036	Neuropathic pain	338,780	R52, G89
DIB007705	PulmoXen	Cystic fibrosis	277	E84
DIB007706	LRN-281	Xerophthalmia	.	E50.6-E50.7
DIB007707	LF-7-0165c	Atherosclerosis	414.0, 440	I70
DIB007708	MEM-1414	Mood disorder	.	F30-F39
DIB007709	KBPA-103	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB007710	Alpha 4 beta 2 nAChR antagonist	Metabolic disorders	.	E70-E90
DIB007711	Cytoros	Cancer	140-229	C00-C96
DIB007712	IMGN289	Solid tumours	.	C00-C75,C7A,C7B
DIB007713	Fully human antibody	Cardiovascular disease	390-459	I00-I99
DIB007714	SB-1578	Cancer	.	C00-C97
DIB007715	Orphanin FQ receptor ligands	Drug dependence	303-304	F10.2-F19.2
DIB007716	Nifurzide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007717	RG2077	Graft-versus host disease	.	T86.0
DIB007718	TSP-50 targeting monoclonal antibodies	Bone disease	.	M00-M99
DIB007719	BAY1143572	Cancer	.	C00-C97
DIB007720	Fostrap	Hyperphosphatemia	.	E83
DIB007721	PBI-1402	Anemia	.	D50-D64
DIB007722	Progesterone receptor modulators	Uterine fibroids	.	D25
DIB007723	DV-0100	Systemic lupus erythematosus	710	M32
DIB007724	Clazakizumab	Crohn's disease	555	K50
DIB007725	Oligonucleotides	Psoriasis	696	L40
DIB007726	SDZ-SCV-106	Colorectal cancer	153, 154	C18-C21
DIB007727	L-694247	Migraine	346	G43
DIB007728	UshStat	Deafness	.	H90-H91
DIB007729	BMS-212122	Arteriosclerosis	.	I70
DIB007730	Rovelizumab	Cerebrovascular disorders	.	I60-I69
DIB007731	CX-1040	Immune disorder	.	D80-D89
DIB007732	BMS-181101	Mood disorder	.	F30-F39
DIB007733	BVX-20-CD20	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB007734	Cell therapy	Macular degeneration	.	H35.3
DIB007735	SiRNA therapy	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007736	AIM-501	Restenosis	.	I51.89
DIB007737	Epi-13	Insulin dependent diabetes	.	E10
DIB007738	RLP-035	Escherichia coli infection	.	A00-B99
DIB007739	BCG vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB007740	Anti-obesity therapy	Obesity	278	E66
DIB007741	MS-806	Diabetic complication	.	E08-E13
DIB007742	CZEN-002	Fungal infections	110-118	B35-B49
DIB007743	Dual PI3K/mTOR inhibitor	Cancer	140-229	C00-C96
DIB007744	Erythropoietin	Anemia	280-285	D50-D64
DIB007745	EDP-MRSA-1	MRSA infection	.	B95.62
DIB007746	PF-04776548	HIV infections	42	B20
DIB007747	PI-2301	Multiple sclerosis	340	G35
DIB007748	XR-5082	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007749	DMARDs	Rheumatold arthritis	714	M05-M06
DIB007750	ME-10393	Dermatitis	692.9	L20-L30
DIB007751	RGB-286638	Hematological malignancies	.	C81-C96
DIB007752	Pleuromutilins	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007753	DVD-Ig	Cancer	.	C00-C97
DIB007754	Human enterovirus 71 vaccine	Enterovirus infection	001-139	A00-B99
DIB007755	FR-152558	Alzheimer's disease	.	G30,F00
DIB007756	Prostanoid receptor ligands	Inflammatory diseases	.	.
DIB007757	Trimebutine	Irritable bowel syndrome	564.1	K58
DIB007758	Monoctanoin	Gallstone	.	K82.9
DIB007759	Dihydrofolate reductase inhibitors	Fungal infection	.	B35-B49
DIB007760	Ordopidine	Psychotic disorders	.	F20-F29
DIB007761	GLP-1 peptide analogs	Diabetes mellitus	250	E08-E13
DIB007762	AM0010	Solid tumours	.	C00-C75,C7A,C7B
DIB007763	IL-2 pDNA	Melanoma	172	C43
DIB007764	B-cell depleting anti-CD20 monoclonal antibody	Autoimmune diseases	.	D84.9
DIB007765	L-4-OXALYSINE	Cancer	140-229	C00-C96
DIB007766	DNCB	Immuno-modulator	.	D80-D89
DIB007767	Lefradafiban	Angina	.	I20
DIB007768	ATF-936	Osteoporosis	.	M80-M81
DIB007769	TOCA-511	Glioblastoma	.	C71
DIB007770	HCV therapeutics	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007771	Anti-Marburg virus mAbs	Marburg virus infection	.	A98.3
DIB007772	Leptin	Obesity	278	E66
DIB007773	Propofol phosphate	Anesthesia	338	R52
DIB007774	Zn-DPA-H	Ischemic heart diseases	410-414	I20-I25
DIB007775	Etrabamine	Parkinson's disease	.	G20
DIB007776	Cyclin dependent kinase inhibitors	Cancer	140-229	C00-C96
DIB007777	TH-GW pharmaccine	Genital herpes	.	A60.09
DIB007778	IG-AI-025	Rheumatold arthritis	714	M05-M06
DIB007779	TRPV1 agonist	Neuropathic pain	338,780	R52, G89
DIB007780	S-100	Obesity	278	E66
DIB007781	Dersalazine	Inflammatory bowel disease	.	K50,K51
DIB007782	Bi-51013	Transplant rejection	.	T86
DIB007783	WIN-66306	Inflammatory bowel disease	.	K50,K51
DIB007784	MMR vaccine	Measles virus infection	.	B06.9
DIB007785	PTI-221	Discovery agent	.	.
DIB007786	Streptococcus pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB007787	Topical p38 MAP kinase inhibitor	Psoriasis	696	L40
DIB007788	INDUS-82030	Influenza virus infections	487	J10, J11
DIB007789	VN-180	Herpesvirus infection	.	B00
DIB007790	SGI-1252	Cancer	140-229	C00-C96
DIB007791	NP-05	Osteoporosis	733	M80-M81
DIB007792	TAK-603	Inflammatory bowel disease	555, 556	K50, K51
DIB007793	JTP-2724	Hypertension	401	I10, I11, I12, I13, I15
DIB007794	Dibenzoylmethane	Cancer	.	C00-C97
DIB007795	Benzamides	Inflammatory diseases	.	.
DIB007796	HZ-08	Cancer	140-229	C00-C96
DIB007797	AUX-202	Bone metastases	198.5	C79.51
DIB007798	HDL cholesterol enhancers	Coronary artery disease	.	I20-I25
DIB007799	MK-944a	Human immunodeficiency virus infection	.	B20
DIB007800	IT-101	Solid tumours	.	C00-C75,C7A,C7B
DIB007801	HSP90 inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB007802	Monoclonal antibody vaccine	Rabies virus infection	001-139	A00-B99
DIB007803	BL-1040	Myocardial infarction	410	I21, I22
DIB007804	ABI-013	Cancer	140-229	C00-C96
DIB007805	Onyvax-CR	Colorectal cancer	153, 154	C18-C21
DIB007806	Anti-LG843 antibody	Lipid metabolism disorder	.	E75-E78
DIB007807	NCX-4215	Hypertension	401	I10, I11, I12, I13, I15
DIB007808	LY-545694	Neuropathic pain	338,780	R52, G89
DIB007809	Trappsol Cyclo	Niemann-Pick disease	.	E75.249
DIB007810	Human embryonic stem cell-derived osteoblasts	Osteoporosis	733	M80-M81
DIB007811	NV.XOD.09	Brain cancer	191	C71
DIB007812	BM-13.1188	Diabetes mellitus	250	E08-E13
DIB007813	IPC-003	Cancer	.	C00-C97
DIB007814	SC-50505	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB007815	Anti-IL-5 Receptor MAb	Asthma	493	J45
DIB007816	PDGF-BB	Diabetic foot ulcer	.	E08-E13
DIB007817	CMDA	Cancer	140-229	C00-C96
DIB007818	K-103-IP	Pain	.	G89
DIB007819	Low molecular weight dextran sulphate	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB007820	Ad-IFNg	Lymphoma	.	C81-C96
DIB007821	MVI-816	Prostate cancer	185	C61
DIB007822	BMP-7 bone morphogenetic protein	Renal disease	.	N00-N29
DIB007823	JX-1395	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007824	D-420720	Diabetes mellitus	250	E08-E13
DIB007825	LAS-186323	Multiple sclerosis	.	G35
DIB007826	Mu opioid receptor modulators	Pain	338,780	R52, G89
DIB007827	Vasopressin receptor antagonist	Heart failure	428	I50
DIB007828	Hsp90 inhibitors	Cancer	140-229	C00-C96
DIB007829	Ranagengliotucel-T	Brain cancer	.	C71
DIB007830	Anti-GM-CSF human mAbs	Autoimmune diseases	279.4	D84.9, M35.9
DIB007831	GPCR39 pepducins	Diabetes mellitus	250	E08-E13
DIB007832	Vaccine	Lyme disease	88.81	A69.2
DIB007833	Fatty acid amide hydrolase inhibitors	Inflammatory diseases	.	.
DIB007834	GW-805858	Asthma	493	J45
DIB007835	GI-129471	Inflammatory diseases	.	.
DIB007836	NOX-100	Hypotension	458, 796.3	I95
DIB007837	STAT-3 signal transduction inhibitors	Cancer	140-229	C00-C96
DIB007838	ASCJ-9 topical	Alopecia	.	L65.9
DIB007839	LMB-2	Chronic lymphocytic leukaemia	.	C91.1
DIB007840	CYC-103 cyclin groove inhibitors	Cancer	140-229	C00-C96
DIB007841	AMAP-102	Arthritis	710-719	M00-M25
DIB007842	Antifungals	Fungal infection	.	B35-B49
DIB007843	Probodies	Breast cancer	174, 175, 217	C50, D24
DIB007844	RX-20001	Ocular disease	.	H00-H59
DIB007845	GSK-650394	Prostate tumor	185	C61
DIB007846	VPC-8 series	Cancer	.	C00-C97
DIB007847	P-276	Breast cancer	.	C50
DIB007848	ATI-2341	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB007849	Anti-sclerostin antibody	Discovery agent	.	.
DIB007850	HPV vaccine	Papillomavirus infections	.	B97.7
DIB007851	Anticancer peptides	Cancer	140-229	C00-C96
DIB007852	DNA vaccines	Chronic lymphocytic leukaemia	204.1	C91.1
DIB007853	Urea	Dermatological disease	.	L00-L99
DIB007854	Mecobalamin	Anemia	.	D50-D64
DIB007855	Capravirine	HIV infections	42	B20
DIB007856	CTP-298	HIV infections	42	B20
DIB007857	LY-517717	Thrombosis	.	I80-I82
DIB007858	HL-130	Hypertension	401	I10, I11, I12, I13, I15
DIB007859	PFA prodrugs	Cytomegalovirus infection	.	B25
DIB007860	BN-50726	Nerve injury	.	T14.4
DIB007861	LM-1507.NA	Asthma	.	J45
DIB007862	TZ-93	Cancer	140-229	C00-C96
DIB007863	EBV-targeted autologous T-cell therapy	Lymphoma	202.8	C81-C96
DIB007864	Magnesium valproate	Acne vulgaris	706.1	L70.0
DIB007865	Antova	Thrombocytopenia	.	D69.6
DIB007866	Adipose-derived regenerative cell therapy	Chronic myocardial ischemia	.	I25.6
DIB007867	Odapipam	Psychotic disorders	.	F20-F29
DIB007868	ALS-2135	Viral infections	042-075	A80-A99, B00-B34
DIB007869	DHH-B	Anxiety disorder	300	F40-F42
DIB007870	HG-1164	Cancer	140-229	C00-C96
DIB007871	Anti-CSF1R antibody	Cancer	140-229	C00-C96
DIB007872	STX-140	Osteoporosis	.	M80-M81
DIB007873	Mirogabalin	Cardiovascular disease	.	I00-I99
DIB007874	CN-16	Septic shock	785.52	A41.9
DIB007875	CYT-013-IL1bQb	Inflammatory diseases	.	.
DIB007876	DasKloster 0247-01	Pulmonary hypertension	416	I27.0, I27.2
DIB007877	BMS-753493	Cancer	140-229	C00-C96
DIB007878	Nesosteine	Asthma	493	J45
DIB007879	JNJ-10229570	Acne vulgaris	.	L70.0
DIB007880	SUVN-502	Neurological disease	320-359	G00-G99
DIB007881	EUK-189	Skin burns	940-949	T20-T31
DIB007882	Monosialoganglioside	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007883	PAF program	Nervous system inflammation	.	G00-G09
DIB007884	SKF-105494	Diuretic	.	Y54.5
DIB007885	Prodigiosin	Pancreatic cancer	.	C25
DIB007886	PharmaPEG-interferon-beta	Neurological disease	.	G00-G99
DIB007887	Stem cell inhibitors	Cancer	140-229	C00-C96
DIB007888	SNS-314 prodrugs	Cancer	140-229	C00-C96
DIB007889	PPMX-2017	Cancer	140-229	C00-C96
DIB007890	KHK-6188	Neuropathic pain	338,780	R52, G89
DIB007891	IL-5 antagonists	Allergy	.	T78.4
DIB007892	Fadolmidine	Pain	338	R52
DIB007893	A-76341	Diabetes mellitus	250	E08-E13
DIB007894	Piroximone	Cardiac failure	.	I50
DIB007895	Cobacan	Peritoneal cancer	.	C48.1-C48.2
DIB007896	R-343	Asthma	493	J45
DIB007897	Adiponectin mimetics	Atherosclerosis	414.0, 440	I70
DIB007898	Klebsiella pneumoniae vaccine	Klebsiella pneumoniae infection	.	B96.1
DIB007899	Dengue fever vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB007900	ADU-623	Glioblastoma	191	C71
DIB007901	Cannabinoid CB1 receptor agonists	Multiple sclerosis	340	G35
DIB007902	Anti-inhibitor coagulant complex	Bleeding	.	R58
DIB007903	Bovine alkaline phosphatase iv	Renal failure	584, 585	N17, N18, N19
DIB007904	CAL	Bone metastases	.	C79.51
DIB007905	ET-001	Influenza virus infections	487	J10, J11
DIB007906	CDP-845	Cancer	140-229	C00-C96
DIB007907	Nanotherapeutics	Cancer	140-229	C00-C96
DIB007908	LH superagonists	Infertility	.	N46,N97.0
DIB007909	DR-5001	Adenovirus infection	.	B97.0
DIB007910	Recombinant SSDF program	Inflammatory diseases	.	.
DIB007911	ITV-4	HIV infections	42	B20
DIB007912	ND-0801	Attention deficit hyperactivity disorder	314	F90
DIB007913	Globorix	Hepatitis B virus infection	.	B16
DIB007914	DAVLB-HYDRAZIDE	Cancer	140-229	C00-C96
DIB007915	EGFR-targeting BiTE antibodies	Adenocarcinoma	140-199	C00-C75, C7A, C7B
DIB007916	IDC-7181	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007917	VEGF-165b protein therapy	Cancer	140-229	C00-C96
DIB007918	Eptaplatin	Cancer	.	C00-C97
DIB007919	GEM-ALS	Motor neurone disease	335.2	G12.2
DIB007920	Alpha-7 nicotinic agonist	Neurological disease	.	G00-G99
DIB007921	ALX-40-4C	Human immunodeficiency virus infection	.	B20
DIB007922	SSRI-5HT1A program	Discovery agent	.	.
DIB007923	SDZ-FOX-988	Diabetes	250	E08-E13
DIB007924	RP-63494	Pain	338,780	R52, G89
DIB007925	NSC-134754	Cancer	140-229	C00-C96
DIB007926	R-1395	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007927	GW-473178	Heart arrhythmia	.	I47-I49
DIB007928	CB1 receptor antagonist	Diabetes mellitus	250	E08-E13
DIB007929	Small-molecule cardiovascular therapeutics	Cardiovascular disease	390-459	I00-I99
DIB007930	GTU MultiHIV vaccine	HIV infections	42	B20
DIB007931	Limtop	Keratosis	.	L57.0
DIB007932	BDNA-003	Chlamydia infection	.	A74.9
DIB007933	FT-201	Insulin dependent diabetes	.	E10
DIB007934	HIV vaccine	HIV infections	42	B20
DIB007935	GLY-515n	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB007936	CB2 agonists	Inflammatory diseases	.	.
DIB007937	Fully-human monoclonal antibodies	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007938	HIV-1 vaccine	HIV-1 infections	42	B20
DIB007939	Antithrombin III	Sepsis	.	A40-A41
DIB007940	Plovamer acetate	Multiple sclerosis	340	G35
DIB007941	ARC1779	Heart disease	.	I00-I52
DIB007942	Terpenoid-modified bisphosphonate program	Cancer	.	C00-C97
DIB007943	RVLYSIN	Cancer	140-229	C00-C96
DIB007944	MRP1 inhibitors	Cancer	140-229	C00-C96
DIB007945	Itarnafloxin	Leukaemia	.	C91-C95
DIB007946	Allervax Cat	Allergy	995.3	T78.4
DIB007947	Tovaxin	Multiple sclerosis	340	G35
DIB007948	GR-40370	Migraine	346	G43
DIB007949	TAK-379	Diabetes mellitus type 2	.	E11
DIB007950	Desensitization therapy	Allergy	995.3	T78.4
DIB007951	MMP-13 inhibitors	Osteoarthritis	715	M15-M19, M47
DIB007952	Ethyl chloride	Pain	338,780	R52, G89
DIB007953	Galectin-3C	Cancer	140-229	C00-C96
DIB007954	PA-508	Cardiovascular disease	390-459	I00-I99
DIB007955	CST-101	Cancer	140-229	C00-C96
DIB007956	Sodium phenylacetate/sodium benzoate	Hepatic encephalopathy	.	K72
DIB007957	MDP-01	Cancer	140-229	C00-C96
DIB007958	Cyp17 inhibitors	Prostate tumor	185	C61
DIB007959	177Lu-AMBA	Breast cancer	.	C50
DIB007960	GPR119 agonist	Metabolic disorders	.	E70-E90
DIB007961	MLN7243	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB007962	Lu-AA44608	Mood disorders	.	F06.3
DIB007963	Cyclophilin inhibitors	HIV infections	42	B20
DIB007964	Glycosphingolipid inhibitors	Male contraception	.	Z30.2
DIB007965	PTX-007	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB007966	H pylori vaccine	Helicobacter pylori infection	41.86	B96.81
DIB007967	Peru-15 pCTB	Diarrhea	.	A09,K59.1
DIB007968	CBS-9106	Cancer	.	C00-C97
DIB007969	Factor XIa inhibitors	Blood clotting disorder	286	D65-D69
DIB007970	Transdur-sufentanil	Pain	.	G89
DIB007971	NRP-388	Pain	338,780	R52, G89
DIB007972	AB-3D3	Ovarian cancer	.	C56
DIB007973	SARS vaccine	SARS coronavirus infection	.	J12.81
DIB007974	NAPIRIMUS	Immuno-suppressant	.	T86.0
DIB007975	PNT-200	Cancer	140-229	C00-C96
DIB007976	Gadoversetamide	Myocardial infarction	410	I21, I22
DIB007977	PDE 9 inhibitor	Alzheimer's disease	331	G30
DIB007978	Benzobicyclo-octane-based TNF-alpha inhibitors	Autoimmune diseases	.	D84.9
DIB007979	Porcine pancreatic islet cell therapy	Insulin dependent diabetes	.	E10
DIB007980	Abaperidone	Schizophrenia	295	F20
DIB007981	HBV vaccine	Hepatitis B virus infection	.	B16
DIB007982	KUR-212	Wound healing	.	S91.3
DIB007983	PU-2049	Psoriasis	696	L40
DIB007984	Adenovirus vector E2b-deleted WT-1 gene targeting vaccine	Cancer	140-229	C00-C96
DIB007985	BIOO-4	Discovery agent	.	.
DIB007986	TS-80	Fungal infections	110-118	B35-B49
DIB007987	EGF	Wound healing	.	T14.0-T14.1
DIB007988	PTC-725	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB007989	Targeted nanoparticles	Cardiovascular disease	390-459	I00-I99
DIB007990	Glycine type-1 transporter inhibitors	Psychotic disorders	.	F20-F29
DIB007991	99mTc-labelled adrenomedullin (pulmonary disease), PulmoScience	Pulmonary hypertension	416	I27.0, I27.2
DIB007992	Recombinant human keratinocyte growth factor-2	Skin burns	940-949	T20-T31
DIB007993	Epidemic keratoconjunctivitis therapy	Adenovirus infection	.	B97.0
DIB007994	IMX-MSP4	Plasmodium vivax infection	.	B54
DIB007995	Sm-14	Schistosomiasis	120	B65
DIB007996	Antidepressants	Major depressive disorder	296.2, 296.3	F32, F33
DIB007997	MPS-AAV8	Maroteaux-Lamy syndrome	.	E76.29
DIB007998	Aramchol	Lipid metabolism disorder	.	E75-E78
DIB007999	Felbinac	Arthritis	710-719	M00-M25
DIB008000	Benzyldihydroxyoctenone	Cancer	140-229	C00-C96
DIB008001	Protein A mimetics	Autoimmune diseases	.	D84.9
DIB008002	Teglicar	Diabetes mellitus	.	E10-E14
DIB008003	Hyaluronan synthase modulators	Cancer	140-229	C00-C96
DIB008004	TA-104	Osteoporosis	733	M80-M81
DIB008005	Levormeloxifene non-steroidal	Breast cancer	174, 175, 217	C50, D24
DIB008006	Anti-inflammatory G-protein modulators	Parkinson's disease	.	G20
DIB008007	ISIS-HBV	Hepatitis B virus infection	.	B16
DIB008008	IMGN-853	Solid tumours	.	C00-C75,C7A,C7B
DIB008009	EC-SOD	Rheumatold arthritis	.	M05-M06
DIB008010	Adenosine A2a receptor antagonists	Parkinson's disease	.	G20
DIB008011	VIT-45	Iron deficiency anaemia	.	D50
DIB008012	HS-HCV	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008013	Pyrimidinediones	HIV infections	42	B20
DIB008014	BIM-26226	Cancer	.	C00-C97
DIB008015	Mycobacterium tuberculosis FtsZ polymerization inhibitors	Mycobacterium infection	.	A31
DIB008016	PP-099	Myocardial infarction	410	I21, I22
DIB008017	GI-5402	Endotoxic shock	.	R57.8
DIB008018	Trifarotene	Cutaneous T cell lymphoma	.	C84.0,C84.1
DIB008019	Malaria vaccine	Plasmodium malariae infection	.	B50
DIB008020	MC-4001	Ocular disease	.	H00-H59
DIB008021	ALV-003	Celiac disease	579	K90.0
DIB008022	NS-649	Alzheimer's disease	.	G30,F00
DIB008023	INS-117548	Glaucoma	.	H40-H42
DIB008024	SDZ-ASD-732	Inflammatory diseases	.	.
DIB008025	AZ-599	Pain	338,780	R52, G89
DIB008026	Glysopep	Deep vein thrombosis	453.4	I80.2
DIB008027	GR-91272	Cognitive impairment	.	F06.7
DIB008028	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB008029	Long-acting polysialic acid-interferon alpha 2b conjugate	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008030	KSG-504	Pancreatic disease	.	K85-K86
DIB008031	TVX-001	Influenza virus infections	487	J10, J11
DIB008032	RP-G28	Lactose intolerance	.	E73.9
DIB008033	Dendritic cell-based exosome vaccine	Lung cancer	162	C33-C34
DIB008034	OPN-401	Inflammatory diseases	.	.
DIB008035	CM-101	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB008036	LPCN-1090	Cough	786.2	R05
DIB008037	C-Rx	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008038	Tcelna	Multile sclerosis	.	G35
DIB008039	Humanized mAb program	Prostate tumor	185	C61
DIB008040	LAS-31180	Heart failure	.	I50
DIB008041	MDCK cell culture-based live attenuated virus vaccine	Influenza virus infections	487	J10, J11
DIB008042	CK-2289	Cardiac failure	.	I50
DIB008043	Vaccines	Infectious disease	001-139	A00-B99
DIB008044	VISION 5	Glaucoma	365	H40-H42
DIB008045	MVP-009	Discovery agent	.	.
DIB008046	MIM-3Ae	Ocular disease	.	H00-H59
DIB008047	AG-AFZ709	Genitourinary disease	.	N00-N99
DIB008048	Choline salicylate	Inflammatory diseases	.	.
DIB008049	A3 adenosine receptor allosteric enhancers	Ischemia	459.89	I99.8
DIB008050	CSL-362-AML	Leukaemia	.	C91-C95
DIB008051	Ensemblin macrocycle	Immune disorder	.	D80-D89
DIB008052	Preverex	Restenosis	.	I51.89
DIB008053	PerCvax	Hepatitis C virus infection	.	B18.2
DIB008054	Metabotropic glutamate receptor 2 inhibitors	Major depressive disorder	296.2, 296.3	F32, F33
DIB008055	Loxapine inhaled	Relapsed lymphoma	202.8	C81-C96
DIB008056	Neuroendocrine agent	Metabolic disorders	.	E70-E90
DIB008057	INDUS-860	Major depressive disorder	296.2, 296.3	F32, F33
DIB008058	Neuroprotectant therapeutics	Alzheimer's disease	331	G30
DIB008059	DNA nanoparticles	Cystic fibrosis	277	E84
DIB008060	CLT-011 binding compounds	Ocular disease	.	H00-H59
DIB008061	SG-1311	Glioblastoma	191	C71
DIB008062	MFH-244	Ischemia	459.89	I99.8
DIB008063	CO-18	Obesity	278	E66
DIB008064	MM-Q01	Gastrointestinal disease	.	K00-K93
DIB008065	Dendrigen	HIV infections	42	B20
DIB008066	Sevelamer hydrochloride	Hyperphosphatemia	.	E83
DIB008067	H5N1 influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB008068	99mTc-nitrocade	Diagnosis	.	Y57.6
DIB008069	Colestipol	Hypercholesterolemia	272	E78.0
DIB008070	RP-316	Hemorrhagic dhock	.	R57.1
DIB008071	Vanilloid VR1 receptor antagonists	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB008072	DDFHy144	Active rheumatoid arthritis	.	M05-M06
DIB008073	ETV-005	Influenza virus infections	487	J10, J11
DIB008074	Propiram fumarate	Cancer pain	338,780	R52, G89
DIB008075	Undisclosed protein	Discovery agent	.	.
DIB008076	Aom-0977	Obesity	278	E66
DIB008077	PAC-14028	Atopic dermatitis	.	L20
DIB008078	Sulconazole	Fungal infection	.	B35-B49
DIB008079	Modified adenovirus delta24-RGD	Glioblastoma	191	C71
DIB008080	Protease activated receptor-1 antagonist	Atherosclerosis	414.0, 440	I70
DIB008081	HIV integrase inhibitor	HIV infections	42	B20
DIB008082	Small molecule therapy	Transplant rejection	.	T86
DIB008083	Pim-1 kinase inhibitors	Cancer	140-229	C00-C96
DIB008084	GP-1-468	Angina pectoris	413	I20
DIB008085	Skeletal targeted radiotherapy	Bone metastases	198.5	C79.51
DIB008086	AFM-19	Allergy	995.3	T78.4
DIB008087	G17DT	Gastric cancer	.	C16
DIB008088	GivaRex	Cancer	140-229	C00-C96
DIB008089	TD-1414	Impetigo	684	L01
DIB008090	Fosfructose	Asthma	493	J45
DIB008091	NRP409	Hormone deficiency	.	E00-E90
DIB008092	ATL101	Influenza virus infections	.	J10-J11
DIB008093	TACE inhibitor	Rheumatold arthritis	714	M05-M06
DIB008094	KTN3379	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB008095	Ryzodeq	Diabetes mellitus type 2	.	E11
DIB008096	RIG-I agonists	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008097	Anticancer therapeutic	Prostate tumor	185	C61
DIB008098	BPL-004 series	Influenza virus infections	487	J10, J11
DIB008099	MPL-containing Pollinex allergy desensitization vaccine	Allergy	.	T78.4
DIB008100	Oncophage vitespen	Hepatitis B virus infection	.	B19.10
DIB008101	HYG-112	Discovery agent	.	.
DIB008102	CM-2397	Pain	338,780	R52, G89
DIB008103	ABT-494	Rheumatold arthritis	.	M05-M06
DIB008104	Oxymera	Obesity	278	E66
DIB008105	VLP vaccines	Plasmodium infection	.	B54
DIB008106	M-216765	Hypertension	401	I10, I11, I12, I13, I15
DIB008107	ATX-101	Submental fat removal	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB008108	Pegmusirudin	Angina	413	I20
DIB008109	AM-260	Osteoarthritis	715	M15-M19, M47
DIB008110	Perflexane-lipid microsphere	Cardiovascular disease	390-459	I00-I99
DIB008111	Anticancer therapy	Cancer	140-229	C00-C96
DIB008112	Colorectal cancer therapeutics	Colorectal cancer	153, 154	C18-C21
DIB008113	Ammonium chloride	Urinary tract infections	599	N39.0
DIB008114	SAND-5 RGD	Ischemia	.	I99.8
DIB008115	Prosorba	Breast cancer	174, 175, 217	C50, D24
DIB008116	NSD-801	Ataxia	.	R26.0
DIB008117	Anthrax DNA vaccine	Bacillus anthracis infection	.	A22
DIB008118	ICO-25	Breast cancer	.	C50
DIB008119	CLR-3001	Major depressive disorder	296.2, 296.3	F32, F33
DIB008120	Rubitecan	Human immunodeficiency virus infection	.	B20
DIB008121	AG-3293	Cancer	140-229	C00-C96
DIB008122	Dimercaprol	Poison intoxication	.	T36-T50
DIB008123	EZH2 Inhibitor (cancer) GlaxoSmithKline	Cancer	140-229	C00-C96
DIB008124	Antimalarial peroxides	Plasmodium infection	.	B54
DIB008125	ANG-400 series	Cancer	140-229	C00-C96
DIB008126	Monoclonal antibodies	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB008127	SERCA 2a activators	Cardiac failure	.	I50
DIB008128	Delorazepam	Anxiety disorder	300	F40-F42
DIB008129	MKC-180	Obesity	278	E66
DIB008130	EQ-917	Cancer	140-229	C00-C96
DIB008131	HPV vaccine	Papillomavirus infections	.	B97.7
DIB008132	Paeoniflorin	Parkinson's disease	.	G20
DIB008133	YM-116	Cancer	140-229	C00-C96
DIB008134	YM-976	Asthma	.	J45
DIB008135	ALF-5755	Liver failure	.	K72.9
DIB008136	Polyclonal IgY antibody	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB008137	SIR-1047	Retinopathy	362.0-362.2	H35-H35.2
DIB008138	T-51	Prostate tumor	185	C61
DIB008139	Group B streptococcal vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008140	SPD-465	Attention deficit hyperactivity disorder	314	F90
DIB008141	Bopindolol	Hypertension	401	I10, I11, I12, I13, I15
DIB008142	Cyclosporin-based therapies	Brain injury	.	S09.90
DIB008143	SST-4/5 mimetics	Cancer	140-229	C00-C96
DIB008144	OCV-101	Pancreatic cancer	.	C25
DIB008145	AC vaccine	Lung cancer	162	C33-C34
DIB008146	TDI-0103	Motor neurone disease	335.2	G12.2
DIB008147	ATI-9242	Schizophrenia	295	F20
DIB008148	CFTR inhibitors	Diarrhea	787.91	A09, K59.1
DIB008149	Hepatitis B virus infection therapy	Hepatitis B virus infection	.	B16
DIB008150	Posintro	Discovery agent	.	.
DIB008151	U300	Diabetes mellitus type 2	.	E11
DIB008152	IDN-5390	Cancer	140-229	C00-C96
DIB008153	NSL-105	Neuropathic pain	338,780	R52, G89
DIB008154	BMN-701	Pompe's disease	.	E74.0
DIB008155	SC-002	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008156	NC-005	Attention deficit hyperactivity disorder	314	F90
DIB008157	F-50028	Respiratory syncytial virus 	.	A00-B99
DIB008158	Vaccine	Hepatitis B virus infection	.	B16
DIB008159	S-15261	Diabetes mellitus	.	E10-E14
DIB008160	Sodium channel blockers	Pain	338,780	R52, G89
DIB008161	IC-041	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB008162	Glycogen synthase kinase-3beta inhibitors	Neurodegenerative diseases	.	G30-G32
DIB008163	Nerelimomab	Rheumatold arthritis	714	M05-M06
DIB008164	MM-131	Cancer	140-229	C00-C96
DIB008165	CMX-157	HIV infections	42	B20
DIB008166	Non-nucleoside therapeutics	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008167	THR-18	Asthma	.	J45
DIB008168	BMS-955176	HIV-1 infections	42	B20
DIB008169	AIK33	Dermatitis	692.9	L20-L30
DIB008170	Pradefovir	Hepatitis virus infection	.	K75.9
DIB008171	MOR-6292	Pain	338,780	R52, G89
DIB008172	BMS-181885	Migraine	.	G43
DIB008173	Panimun Bioral	Fungal infection	110-118	B35-B49
DIB008174	Inhaled insulin product	Diabetes mellitus	250	E08-E13
DIB008175	NELDAZOSIN	Hypertension	401	I10, I11, I12, I13, I15
DIB008176	VER-155008	Cancer	140-229	C00-C96
DIB008177	Marine organism anticancer compounds	Cancer	140-229	C00-C96
DIB008178	Metallo-topiramate	Seizures	.	G40,R56
DIB008179	Talactoferrin	Diabetic foot ulcer	.	E08-E13
DIB008180	Vapaliximab	Inflammatory diseases	.	.
DIB008181	Briciclib	Solid tumours	.	C00-C75,C7A,C7B
DIB008182	Peptides	Cancer	.	C00-C97
DIB008183	EP-42675	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB008184	Atamestane-plus- Toremifene	Breast cancer	174, 175	C50
DIB008185	DMNT inhibitors	Cancer	.	C00-C97
DIB008186	AAV2 GDNF	Parkinson's disease	332	F02.3, G20
DIB008187	CD4 red blood cell electroinsertion	HIV infections	42	B20
DIB008188	CGP-55847	Cancer	.	C00-C97
DIB008189	Concatameric CTLA4Ig	Discovery agent	.	.
DIB008190	GM2-n	Discovery agent	.	.
DIB008191	AB-1134-targeting monoclonal antibodies	Ovarian cancer	.	C56
DIB008192	Human monoclonal antibody	SARS coronavirus infection	.	J12.81
DIB008193	Vadimezan	Solid tumours	.	C00-C75,C7A,C7B
DIB008194	ELS-130	Raynaud's disease	.	I73.01
DIB008195	PBI-220	Bacillus anthracis infection	.	A22
DIB008196	MCI-826	Asthma	.	J45
DIB008197	ASF-1057	Erythema	.	L51.9
DIB008198	TB-09	Cancer	140-229	C00-C96
DIB008199	HRC-101	Blood transfusion	.	D50-D89
DIB008200	Figopitant	Diabetes mellitus	.	E10-E14
DIB008201	AV-201	Parkinson's disease	.	G20
DIB008202	Gadolinium based C60 fullerene-paclitaxel-ZME-018 conjugates	Cancer	140-229	C00-C96
DIB008203	TTA-A8	Insomnia	.	F51.0,G47.0
DIB008204	MF-101	Hepatitis virus infection	.	K75.9
DIB008205	Sch-34826	Hypertension	401	I10, I11, I12, I13, I15
DIB008206	Vesigenurtacel-L	Bladder cancer	188	C67
DIB008207	TGF beta-1 inhibitor peptides	Age related macular degeneration	.	H35.30
DIB008208	INC-103	Hypercholesterolaemia	.	E78.0
DIB008209	I-A09	Mycobacterium tuberculosis infection	.	A15-A19
DIB008210	Ciclosporin intravenous	Brain injury	.	S06
DIB008211	SQ-32709	Arteriosclerosis	.	I70
DIB008212	Diclofenac nano-formulation	Multiple myeloma	.	C90.0
DIB008213	CR-8020	Influenza virus A infection	.	J11.1
DIB008214	VBY- 825	Cancer	140-229	C00-C96
DIB008215	Probodies	Inflammatory diseases	.	.
DIB008216	Galarubicin	Solid tumours	.	C00-C75,C7A,C7B
DIB008217	Targeted nanoparticles	Inflammatory diseases	.	.
DIB008218	NSC-364432	Cancer	.	C00-C97
DIB008219	Prolastin	Alpha-1 antitrypsin deficiency	.	E88.0
DIB008220	PAR-2 modulator	Atopic dermatitis	691.8	L20
DIB008221	UR-9660	Fungal infection	.	B35-B49
DIB008222	VZV inhibitors	Varicella zoster virus infections	.	B01,B02
DIB008223	CR-4374	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB008224	OS-440	Gastric cancer	151	C16
DIB008225	MiRNA-based therapeutics	Melanoma	172	C43
DIB008226	LFA-102	Cancer	140-229	C00-C96
DIB008227	Timothy grass pollen extracts	Allergic reaction	995.3	T78.4
DIB008228	PDNA rVSV vector-based malaria vaccine	Plasmodium infection	.	B54
DIB008229	VRC-SRSDNA015-00-VP	SARS coronavirus infection	.	J12.81
DIB008230	Oleuropein program	Inflammatory diseases	.	.
DIB008231	VE-821	Cancer	140-229	C00-C96
DIB008232	IMD-026260	Cancer	140-229	C00-C96
DIB008233	Hu1-48SR	Cancer	140-229	C00-C96
DIB008234	Beta-interferon	Multiple sclerosis	340	G35
DIB008235	Meningitec	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008236	CXCR4 antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB008237	HCG contraceptive vaccine	Female contraception	.	Z30.013
DIB008238	Histone demethylase inhibitors	Cancer	140-229	C00-C96
DIB008239	Pelareorep	Myeloma	203	C90.0
DIB008240	AIKO-151	Opiate dependence	304	F11
DIB008241	GSK-2202083A	Hepatitis B virus infection	.	B16
DIB008242	Shanvac-B	Hepatitis B virus infection	.	B16
DIB008243	Thrombomodulin	Disseminated intravascular coagulation	286.6	D65
DIB008244	T-cell receptors	Viral infections	042-075	A80-A99, B00-B34
DIB008245	ALN-RSV02	Respiratory syncytial virus 	79.6	B97.4
DIB008246	Perazine	Psychotic disorders	.	F20-F29
DIB008247	ABT-122	Rheumatold arthritis	714	M05-M06
DIB008248	EradicAide	HIV infections	42	B20
DIB008249	Bispecific antibodies	Cancer	140-229	C00-C96
DIB008250	Minor-groove DNA binders	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008251	ETX-1153c	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB008252	Small molecule Bmi-1 inhibitors	Cancer	140-229	C00-C96
DIB008253	GPCR antagonist	Inflammatory diseases	.	.
DIB008254	MC-4 mimetics	Female sexual arousal disorder	.	F52.2
DIB008255	MK-5286	Inflammatory diseases	.	.
DIB008256	Estrogen receptor beta agonists	Inflammatory diseases	.	.
DIB008257	DuP-167	Hypertension	401	I10, I11, I12, I13, I15
DIB008258	CX-701	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB008259	Voltage-gated sodium channel blockers	Pain	338,780	R52, G89
DIB008260	KRH-594	Hypertension	.	I10-I15
DIB008261	CAL	Bone metastases	198.5	C79.51
DIB008262	HIV gag/pol/nef/env DNA vaccine	HIV infections	42	B20
DIB008263	Viral RNA synthesis inhibitors	RNA virus infections	.	A00-B99
DIB008264	Heterologous liver-derived stem cells	Ornithine transcarbamylase deficiency	.	E72.4
DIB008265	AL-38583	Allergic conjunctivitis	372.14	H10.45
DIB008266	UR-11353	Inflammatory diseases	.	.
DIB008267	PWT-33597	Cancer	140-229	C00-C96
DIB008268	AC-101	Neuropathic pain	338,780	R52, G89
DIB008269	Octagam 10%	Alzheimer's disease	331	G30
DIB008270	SITOSTANOL ASCORBYL PHOSPHATE	Hyperlipidemia	.	E78.5
DIB008271	SP-1100	Fungal infection	.	B35-B49
DIB008272	RSV-F	Respiratory syncytial virus 	79.6	B97.4
DIB008273	DAB-486-IL-2	Human immunodeficiency virus infection	.	B20
DIB008274	Radiolabeled anti-PSMA huJ591 minibodies	Prostate tumor	185	C61
DIB008275	MOD-5023	Hemophilia	286	D66-D68
DIB008276	KNW-001	Cancer	140-229	C00-C96
DIB008277	Quattvaxem	Bordetella pertussis infection	.	A37.0
DIB008278	GBL-310	Keratosis	.	L57.0
DIB008279	GRNCHND-1	Arthropathy	.	M00-M14
DIB008280	DWJ-209	Alzheimer's disease	331	G30
DIB008281	SF-1	Breast cancer	174, 175, 217	C50, D24
DIB008282	Protease activated prodrug	Cancer	140-229	C00-C96
DIB008283	GS-9132	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008284	D-type cyclin mimetics	Ischemic heart diseases	410-414	I20-I25
DIB008285	Antibacterial antibodies	Staphylococcus aureus infection	.	A41.0
DIB008286	ATI-24000 series	Gastrointestinal disease	.	K00-K93
DIB008287	HL-001	Diabetes mellitus	250	E08-E13
DIB008288	99mTc-tetrofosmin	Breast cancer	174, 175, 217	C50, D24
DIB008289	Prolease-r-hFSH	Infertility	.	N46,N97.0
DIB008290	LRN-672	Ocular disease	.	H00-H59
DIB008291	Phosphopantetheine adenylyltransferase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008292	Integrin alpha-V/beta-3 receptor mAb	Atherosclerosis	414.0, 440	I70
DIB008293	Peginterferon lambda-1a	Acute myeloid leukemia	205	C92.0
DIB008294	TA-8995	Hyperlipidemia	.	E78.5
DIB008295	Neutrabiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008296	AFM-13	Hodgkin's lymphoma	.	C81
DIB008297	Tetanus vaccine	Clostridium tetani infection	001-139	A00-B99
DIB008298	Nafagrel	Bronchodilator	493	J45
DIB008299	APX-3330	Ocular cancer	.	C69
DIB008300	SPD-701	Influenza virus infections	487	J10, J11
DIB008301	Neurotrophic factor companion	Discovery agent	.	.
DIB008302	AP vaccine	Bordetella pertussis infection	.	A37.0
DIB008303	Human monoclonal antibodies	Cytomegalovirus infection	.	B25
DIB008304	RSV vaccine	Pediatric cancer	.	.
DIB008305	Prophage cancer vaccine G-series	Glioblastoma	.	C71
DIB008306	ONO-5129	Diabetes mellitus	.	E10-E14
DIB008307	Low dose fentanyl	Pain	338,780	R52, G89
DIB008308	Olvanil	Pain	.	G89
DIB008309	MN-201	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB008310	Antiviral agent	Verruca vulgaris	.	B07.9
DIB008311	PDE1A/B/C inhibitors	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB008312	PAFENOLOL	Hypertension	401	I10, I11, I12, I13, I15
DIB008313	Epoxide hydrolase inhibitors	Hypertension	401	I10, I11, I12, I13, I15
DIB008314	Amphiregulin targeting human mAbs	Psoriasis	696	L40
DIB008315	Kv1.3 potassium channel blockers	Autoimmune diseases	279.4	D84.9, M35.9
DIB008316	Anti-miR-21 antisense oligonucleotide	Cardiovascular disease	390-459	I00-I99
DIB008317	IP-10.C9	Inflammatory bowel disease	555, 556	K50, K51
DIB008318	Meglumine gadoterate	BloodCbrain barrier	.	.
DIB008319	CNTF-AX15	Obesity	278	E66
DIB008320	OP-06 program	Cancer	140-229	C00-C96
DIB008321	JD-3000 series	Plasmodium infection	.	B54
DIB008322	IC-84	Multiple sclerosis	340	G35
DIB008323	Protein misfolding therapies	Motor neurone disease	335.2	G12.2
DIB008324	FabI inhibitors	Plasmodium falciparum infection	.	B54
DIB008325	MLN-591RL	Prostate cancer	185	C61
DIB008326	SAR-215500	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008327	PAV-667	Ebola virus infection	.	A98
DIB008328	LF-160335	Asthma	493	J45
DIB008329	PCSK9 Adnectin	Cardiovascular disease	.	I00-I99
DIB008330	Factor IX-XTEN	Hemophilia	286	D66-D68
DIB008331	IMGN-007	Cancer	140-229	C00-C96
DIB008332	Anti-staphylococcus heteropolymer (HP) monoclonal antibody	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008333	Prostvac-VF	Prostate cancer	185	C61
DIB008334	Nalbuphine hydrochloride ER	Pain	338,780	R52, G89
DIB008335	FK-352	Hypertension	.	I10-I15
DIB008336	GP-1002	Influenza virus infections	487	J10, J11
DIB008337	Oralgen Mites	Allergy	995.3	T78.4
DIB008338	Fibroblast cell therapy	Parkinson's disease	.	G20
DIB008339	ISA-P53-01	Colorectal cancer	.	C18-C20,C21
DIB008340	SDZ-LAP-977	Psoriasis	696	L40
DIB008341	PDGFB gene stimulator	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB008342	Diphencyprone	Alopecia	.	L65.9
DIB008343	FGF21-PKE Adnectin	Metabolic disorders	.	E70-E90
DIB008344	Heparinoid beta-secretase inhibitors	Alzheimer's disease	331	G30
DIB008345	PP-202	Liver disease	570-574	K70-K77
DIB008346	Recombinant ADAM-10 inhibitor	Cancer	140-229	C00-C96
DIB008347	AX-205	Motor neurone disease	335.2	G12.2
DIB008348	RO-5285119	Discovery agent	.	.
DIB008349	Human monoclonal antibody	Virus infection	.	B03
DIB008350	Mammastatin	Breast cancer	174, 175, 217	C50, D24
DIB008351	Beta-interferon	Multiple sclerosis	340	G35
DIB008352	Macrolide antibiotics	Ocular inflammation	.	H00-H59
DIB008353	Oral vaccine	Cancer	140-229	C00-C96
DIB008354	IFN-alpha	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB008355	11betaHSD1 inhibitors (type 2 diabetes/metabolic syndrome), SK Chemicals	Metabolic syndrome X	277.7	E88.81
DIB008356	B-lymphocyte stimulator (BLyS)	Immunodeficiency	279.3	D84.9
DIB008357	Imilecleucel-T	Multiple sclerosis	.	G35
DIB008358	EVIRNA	Cancer	.	C00-C97
DIB008359	CH-4139	Asthma	493	J45
DIB008360	RVEc	Intoxication	.	T36-T50
DIB008361	ON-123 series	Cancer	140-229	C00-C96
DIB008362	Alpha-2/beta-1 integrin antagonists	Cancer	.	C00-C97
DIB008363	Mesenchymal stem cell therapy	Inflammatory diseases	.	.
DIB008364	Drug 2696274	Metachromatic leukodystrophy	.	E75.25
DIB008365	MUC-1 dendritic cancer vaccine	Cancer	.	C00-C97
DIB008366	MG-101	Cachexia	799.4	R64
DIB008367	Lung-derived neurotrophic factor	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB008368	Dexibuprofen	Ankylosing spondylitis	720	M08.1, M45
DIB008369	TAK-114	Ulcerative colitis	556	K51
DIB008370	Intravenous carbamazepine	Gastric cancer	151	C16
DIB008371	CPL-7075	Neuropathic pain	338,780	R52, G89
DIB008372	VLF-02	Fungal infection	.	B35-B49
DIB008373	Alzheimer's disease therapy	Alzheimer's disease	331	G30
DIB008374	HG-1051	Immune disorder	.	D80-D89
DIB008375	URG-302	Overactive bladder disorder	596.51	N32.81
DIB008376	LAS-37779	Psoriasis	696	L40
DIB008377	GsMTx4	Duchenne dystrophy	.	G71.0
DIB008378	T cell receptors	Cancer	140-229	C00-C96
DIB008379	Protein subunit vaccine	Helicobacter pylori infection	41.86	B96.81
DIB008380	MT201	Prostate cancer	185	C61
DIB008381	PLD-180	Motor neurone disease	335.2	G12.2
DIB008382	AGI-1095	Hypercholesterolemia	272	E78.0
DIB008383	MIF inhibitors	Inflammatory diseases	.	.
DIB008384	Padeliporfin photodynamic therapy	Non-small-cell lung cancer	162	C33, C34
DIB008385	S-16276-1	Rheumatold arthritis	714	M05-M06
DIB008386	Artemether analogs	Plasmodium infection	.	B54
DIB008387	NS-640	Neurodegenerative diseases	.	G30-G32
DIB008388	PF-05230901	Cachexia	799.4	R64
DIB008389	NVC-727	Conjunctivitis	372	H10
DIB008390	OG-9	Cancer	.	C00-C97
DIB008391	GE-68	Heart arrhythmia	.	I47-I49
DIB008392	GMTP-DPG	Immuno-stimulant	.	.
DIB008393	AZM-107	Irritable bowel syndrome	564.1	K58
DIB008394	SLP-0906	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008395	GSK-2018682	Immune disorder	.	D80-D89
DIB008396	MOXIFETIN HYDROGEN MALEATE	Mood disorder	.	F30-F39
DIB008397	SPD-703	Otitis media	.	H65-H67
DIB008398	PERFOSFAMIDE	Cancer	140-229	C00-C96
DIB008399	ANG-1007	Cancer	140-229	C00-C96
DIB008400	Vitatropin	Growth disorder	.	E23.0
DIB008401	AEOL-11207	Asthma	493	J45
DIB008402	OC-108	Hemorrhoids	.	I84
DIB008403	Gadocoletic acid	Coronary artery disease	410-414, 429.2	I20-I25
DIB008404	Nu-3	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008405	AL-54478	Ocular hypertension	365.04	H40.0
DIB008406	Topoisomerase inhibitors	Cancer	140-229	C00-C96
DIB008407	Thioimregs	Cancer	.	C00-C97
DIB008408	Iptakalim hydrochloride	Hypertension	.	I10-I15
DIB008409	Cathepsin K inhibitors	Bone disease	.	M00-M99
DIB008410	APD-811	Pulmonary hypertension	416	I27.0, I27.2
DIB008411	CRTX-074	Cough	786.2	R05
DIB008412	Antiparkinsonian agent	Parkinson's disease	.	G20
DIB008413	PTI-80	Alzheimer's disease	331	G30
DIB008414	ATG-Fresenius S	Transplant rejection	.	T86
DIB008415	GZ402668	Multiple sclerosis	.	G35
DIB008416	MAGE-101	Breast cancer	174, 175, 217	C50, D24
DIB008417	STAMP	Cystic fibrosis	277	E84
DIB008418	NKP-46	Solid tumours	.	C00-C75,C7A,C7B
DIB008419	BIOD-531	Type 2 diabetes	250.00, 250.02	E11
DIB008420	XP-21510	Menorrhagia	627	N92.0
DIB008421	15(S)-hydroxyeicosatetraenoic acid (ophthalmic, dry eye), Alcon	Ocular disease	.	H00-H59
DIB008422	SKF-81297	Parkinson's disease	.	G20
DIB008423	P38 kinase inhibitors	Insulin dependent diabetes	.	E10
DIB008424	Therapeutic aglycosylated antibodies	Discovery agent	.	.
DIB008425	E-3024	Diabetes mellitus type 2	.	E11
DIB008426	M-5010	Arthritic	710-719	M00-M25
DIB008427	DACTIMICIN	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB008428	SMaRT FVIII	Hemophilia	286	D66-D68
DIB008429	EDC/IL-4	Insulin dependent diabetes	.	E10
DIB008430	Rostafuroxin	Hypertension	401	I10, I11, I12, I13, I15
DIB008431	TGFK07AD	Major depressive disorder	296.2, 296.3	F32, F33
DIB008432	V-103	Contusion	.	S36.220S
DIB008433	Sirtuin-2 inhibitors	Obesity	278	E66
DIB008434	D-21151	Inflammatory diseases	.	.
DIB008435	PF-06305591	Chronic pain	338.2,780	R52.1-R52.2, G89
DIB008436	NFkB inhibitors	Asthma	493	J45
DIB008437	TNP-351	Solid tumours	.	C00-C75,C7A,C7B
DIB008438	Hemolytic disease therapy	Acquired hemolytic anemia	.	D59.9
DIB008439	CD200-specific monoclonal antibody	Cancer	140-229	C00-C96
DIB008440	BVD-523	Cancer	.	C00-C97
DIB008441	MK-49	Pain	338,780	R52, G89
DIB008442	Long-acting factor VIII	Blood clotting disorder	286	D65-D69
DIB008443	IPENOXAZONE	Alzheimer's disease	.	G30,F00
DIB008444	KBF-611	Mycobacterium tuberculosis infection	.	A15-A19
DIB008445	ERX-3722	Cancer	140-229	C00-C96
DIB008446	ALPHA-FMH	Pruritus	.	L29
DIB008447	FF-10501	Hematological malignancies	200-209	C81-C96
DIB008448	L-uridine analogs	Viral infections	042-075	A80-A99, B00-B34
DIB008449	REN-1654	Cognition disorders	.	F06.7
DIB008450	Seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB008451	TNAP inhibitors	Osteoporosis	.	M80-M81
DIB008452	Neurological disease therapy	Neurological disease	.	G00-G99
DIB008453	Mofarotene	Cancer	140-229	C00-C96
DIB008454	Propargylamine chemopotentiators	Cancer	.	C00-C97
DIB008455	AGN-191743	Allergy	.	T78.4
DIB008456	TMC-647055	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB008457	Arginine	Growth hormone deficiency	253.3	E23.0
DIB008458	MEDI-543	Cytomegalovirus infection	.	B25
DIB008459	P-27A	Plasmodium falciparum infection	.	B54
DIB008460	MGluR4 PAMs	Parkinson's disease	.	G20
DIB008461	PIC-231	Rheumatold arthritis	714	M05-M06
DIB008462	BAM-1110	Parkinson's disease	.	G20
DIB008463	Recombinant birch pollen allergen	Allergic rhinitis	477	J30
DIB008464	Bcl-2 inhibitors	Cancer	140-229	C00-C96
DIB008465	Haemophilus vaccine I	Haemophilus influenzae infection	.	J11.1
DIB008466	SEL-113	Autoimmune diseases	279.4	D84.9, M35.9
DIB008467	Metapneumovirus antibody	Respiratory tract infections	460-519	J00-J99
DIB008468	PRX-105	Poison intoxication	.	T36-T50
DIB008469	BAY-73-7977	Diabetes mellitus	250	E08-E13
DIB008470	JTT-722	Hyperlipidemia	272.0-272.4	E78
DIB008471	AR-132	Cytomegalovirus infection	.	B25
DIB008472	DA-3880	Anemia	280-285	D50-D64
DIB008473	PD-117596	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008474	FPL-68164	Asthma	493	J45
DIB008475	FM-301	Psoriasis	696	L40
DIB008476	Estratab	Osteoporosis	733	M80-M81
DIB008477	Anthrax vaccine	Bacillus anthracis infection	.	A22
DIB008478	Viquidacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008479	Porfiromycin	Head and neck cancer	140-149	C07-C14, C32-C33
DIB008480	Neu-2000	Cardiac arrest	.	I46
DIB008481	SC16LD6.5	Small-cell lung cancer	162	C33, C34
DIB008482	TK-280	Inflammatory diseases	.	.
DIB008483	IGF-drug conjugates	Cancer	140-229	C00-C96
DIB008484	RWJ-416457	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008485	NK1 antagonists	Arthritis	.	M00-M25
DIB008486	FK-070	Angina	.	I20
DIB008487	EHT-107	Cancer	140-229	C00-C96
DIB008488	EVT-103	Major depressive disorder	296.2, 296.3	F32, F33
DIB008489	Ro-19-8022	Anxiety disorder	300	F40-F42
DIB008490	LAP-001	Lipid metabolism disorder	.	E75-E78
DIB008491	NK-1005	Atrial fibrillation	427.31	I48
DIB008492	Anti HPA 1a antibodies	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB008493	G-protein therapeutics	Cardiovascular disease	390-459	I00-I99
DIB008494	Cellcom proteins	Cancer	140-229	C00-C96
DIB008495	VPAC1 antagonist	Cancer	140-229	C00-C96
DIB008496	Measles vaccine	Measles virus infection	.	B06.9
DIB008497	GSK-208108	Haemophilus influenzae infection	.	J11.1
DIB008498	AD-452	Rheumatold arthritis	714	M05-M06
DIB008499	Solithromycin oral	Bacillus anthracis infection	.	A22
DIB008500	LAS-41003	Eczema	.	L20-L30
DIB008501	Influenza A virus H5N1 cell culture-based vaccine	Influenza A virus H5N1 infections	.	J11.1
DIB008502	SDZ-210-086	Cognitive impairment	.	F06.7
DIB008503	A-5021	Viral infections	042-075	A80-A99, B00-B34
DIB008504	K-133W	Dysmenorrhea	.	N94.4-N94.6
DIB008505	CRTH2 receptor antagonists	Allergic rhinitis	477	J30
DIB008506	Biodefense CNS vaccine	Viral infections	042-075	A80-A99, B00-B34
DIB008507	BVD-CNV	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB008508	NNC-13-8119	Anxiety disorder	.	F40-F42
DIB008509	Anti-Gram-negative bacterial infection program	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008510	TKA-731	Pain	.	G89
DIB008511	FM-TP4000 series	Non-insulin dependent diabetes	.	E11.9
DIB008512	Conjugated estrogens synthetic B	Menopause	627.2	N95.0
DIB008513	GS-102	Macular degeneration	.	H35.3
DIB008514	Tgth-0100	Diabetes mellitus	250	E08-E13
DIB008515	Fluzone QIV IM	Quadrivalent inactivated influenza	487, 488	J10, J11
DIB008516	REGN-727	Diabetes mellitus type 1	.	E10
DIB008517	FR-182877	Cancer	140-229	C00-C96
DIB008518	PD gene therapy	Parkinson's disease	.	G20
DIB008519	Human-cl rhFVIII	Hypertension	.	I10-I15
DIB008520	Flanvotumab	Malignant melanoma	172	C43
DIB008521	HCV vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008522	AG-6084	Picornavirus infection	.	A00-B99
DIB008523	AX-201	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB008524	DNA vaccine	Prostate tumor	185	C61
DIB008525	DWP-451	Lung cancer	162	C33-C34
DIB008526	MVA-BN HIV Polytope	HIV infections	42	B20
DIB008527	HG-1076	Cancer	140-229	C00-C96
DIB008528	Hsp90 inhibitors	Cancer	140-229	C00-C96
DIB008529	OS-320	Parkinson's disease	.	G20
DIB008530	MVA-BN Brachyury	Cancer	.	C00-C97
DIB008531	HL-026	Alzheimer's disease	331	G30
DIB008532	OCM-111	Cancer	140-229	C00-C96
DIB008533	ASP-0777	Alzheimer's disease	331	G30
DIB008534	SAR-110894	Alzheimer's disease	.	G30,F00
DIB008535	ELEMENE	Cancer	140-229	C00-C96
DIB008536	HMPL-342	Asthma	493	J45
DIB008537	Antacids	Stomach cancer	.	C16
DIB008538	Aom-0811	Premature ejaculation	302.75	F52.4
DIB008539	Immunoconjugates	Cancer	.	C00-C97
DIB008540	NPS-2390	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB008541	Synflorix	Streptococcus pneumoniae infection	.	A00-B99
DIB008542	RN-1005	Scar tissue	.	L00-L99
DIB008543	Iodine-123-iodophenylpentadecanoic acid	Coronary artery disease	410-414, 429.2	I20-I25
DIB008544	ALM-301	Cancer	140-229	C00-C96
DIB008545	Trivalent influenza vaccine	Influenza virus infections	487	J10, J11
DIB008546	Febrifugine analogs	Plasmodium infection	.	B54
DIB008547	PNU-87663	Neurodegenerative diseases	.	G30-G32
DIB008548	IL-15 antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB008549	Visual cycle modulators	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB008550	WS-070117	Hyperlipidemia	272.0-272.4	E78
DIB008551	Bovactant	Pulmonary disease	460-519	J00-J99
DIB008552	SR-49711	Schizophrenia	295	F20
DIB008553	CD19-targeted allogeneic T-cell therapy	Acute lymphoblastic leukemia	204	C91.0
DIB008554	ANT-G12	Prostate tumor	185	C61
DIB008555	BQ-518	Hypertension	.	I10-I15
DIB008556	MSH-372	Human immunodeficiency virus infection	.	B20
DIB008557	DE-110	Xerophthalmia	.	E50.6-E50.7
DIB008558	HMR-2371	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB008559	CH-422	Asthma	493	J45
DIB008560	Radiolabeled VEGFR-1 inhibitors	Cancer	140-229	C00-C96
DIB008561	SC-51089	Pain	338,780	R52, G89
DIB008562	NI-0501	Autoimmune diseases	279.4	D84.9, M35.9
DIB008563	Albitiazolium bromide prodrugs	Plasmodium infection	.	B54
DIB008564	HER2/neu peptide vaccine	Breast cancer	174, 175, 217	C50, D24
DIB008565	AXT-914	Osteoporosis	.	M80-M81
DIB008566	GPR27 antagonists	Metabolic disorders	.	E70-E90
DIB008567	FLUNET compounds	Influenza virus infections	487	J10, J11
DIB008568	OXA-01	Cancer	140-229	C00-C96
DIB008569	HG-1384	Discovery agent	.	.
DIB008570	PT1.2	Staphylococcus aureus infection	001-139	A00-B99
DIB008571	GALL-200	Sleep apnea	.	G47.3
DIB008572	ISRAPAFANT	Asthma	.	J45
DIB008573	Luliconazole	Tinea pedis	.	B35.3
DIB008574	Draculin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB008575	Apomab	Cancer	140-229	C00-C96
DIB008576	LUM001	Primary biliary cirrhosis	.	K74.3
DIB008577	ADCON-L	Wound healing	.	S91.3
DIB008578	Zoniporide hydrochloride	Angina	.	I20
DIB008579	RSV F-protein subunit transgenic tomato plant vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB008580	Ghrelin agonists	Gastric motility disorder	.	K22.4
DIB008581	Sphingosome Encapsulated Vinorelbine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB008582	LF-521	Pain	338,780	R52, G89
DIB008583	Peptide deformylase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008584	PLX-3397	Alzheimer's disease	.	G30,F00
DIB008585	Atrimer	Autoimmune diseases	279.4	D84.9, M35.9
DIB008586	Juniper tar	Eczema	.	L20-L30
DIB008587	Synthetic conjugated estrogen	Vagina disease	.	N76.0
DIB008588	PTHr pepducins	Endocrine disease	.	E00-E35
DIB008589	ATHX-105	Obesity	278	E66
DIB008590	NaQuinate	Osteoporosis	733	M80-M81
DIB008591	Bertosamil	Angina	.	I20
DIB008592	Renin inhibitors	Hypertension	401	I10, I11, I12, I13, I15
DIB008593	PMX-500	Cancer	140-229	C00-C96
DIB008594	GSK-356278	Huntington's disease	294.1, 333.4	F02.2, G10
DIB008595	IGF-1R inhibitors	Cancer	140-229	C00-C96
DIB008596	AL-18 series	Leukemia	208.9	C91-C95
DIB008597	Tridegin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB008598	Nucleotide-competing RT inhibitors	HIV infections	42	B20
DIB008599	GX-101 program	Systemic lupus erythematosus	710	M32
DIB008600	XZK	Hyperlipidemia	.	E78.5
DIB008601	P-536	Viral infections	042-075	A80-A99, B00-B34
DIB008602	Personalized therapeutic vaccines	Lymphoma	.	C81-C96
DIB008603	H5N1 influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB008604	SDZ-PCO-400	Asthma	.	J45
DIB008605	Orazipone	Inflammatory bowel disease	555, 556	K50, K51
DIB008606	ONO-4232	Acute heart failure	428	I50
DIB008607	ZD-7288	Angina	.	I20
DIB008608	KANAb-071	Autoimmune diseases	279.4	D84.9, M35.9
DIB008609	Propyliodone	Pulmonary disease	460-519	J00-J99
DIB008610	KA-20X	Gastrointestinal cancer	.	C15-C26
DIB008611	AviFlu	Influenza virus infections	487	J10, J11
DIB008612	Imino sugars	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB008613	HMPL-011	Autoimmune diseases	279.4	D84.9, M35.9
DIB008614	Bronchostat	Bronchitis	.	J20-J21,J42
DIB008615	GlucoStem	Insulin dependent diabetes	.	E10
DIB008616	BEMORADAN	Heart failure	.	I50
DIB008617	SiRNA therapeutic	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB008618	Sulfazocine	Pain	338,780	R52, G89
DIB008619	TDI-0029	Motor neurone disease	335.2	G12.2
DIB008620	CBX-129801	Diabetic complication	.	E08-E13
DIB008621	ACTB-1003	Cancer	140-229	C00-C96
DIB008622	DMP-503	Hyperlipidemia	272.0-272.4	E78
DIB008623	BMS-182193	HIV infections	42	B20
DIB008624	Andromustine	Prostate tumor	185	C61
DIB008625	Pandemic influenza vaccines	Influenza virus infections	487	J10, J11
DIB008626	KI-0903	Immune disorder	.	D80-D89
DIB008627	GABA-A agonists	Epilepsy	345	G40
DIB008628	BL-8040	Acute myeloid leukemia	.	C92.0
DIB008629	SAH/MTA nucleosidase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008630	CogniXan	Neurological disease	.	G00-G99
DIB008631	APO-010	Multiple myeloma	.	C90.0
DIB008632	HIV vaccines	HIV infections	42	B20
DIB008633	349U85.HCL	Cardiovascular disease	.	I00-I99
DIB008634	MC-1101	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB008635	Swainsonines	Diabetes mellitus	250	E08-E13
DIB008636	Inflammation therapeutics	Inflammatory diseases	.	.
DIB008637	Plasmid DNA combination vaccine	Viral infections	042-075	A80-A99, B00-B34
DIB008638	JES-9501	Alzheimer's disease	.	G30,F00
DIB008639	Her-2/neu vaccine	Breast cancer	174, 175, 217	C50, D24
DIB008640	Melanocortin 2 inhibitors	Cushing's disease	.	E24.9
DIB008641	Cholinergic therapeutics	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB008642	GR-108359	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008643	CRISNATOL MESILATE	Solid tumours	.	C00-C75,C7A,C7B
DIB008644	Naproxen	Pain	.	G89
DIB008645	Comvax	Hepatitis B virus infection	.	B16
DIB008646	Antimicrobial peptides	Fungal infection	.	B35-B49
DIB008647	MK-6186	HIV infections	42	B20
DIB008648	ZD-0870	Fungal infections	110-118	B35-B49
DIB008649	EML-16257	Non-insulin dependent diabetes	.	E11.9
DIB008650	S-16924	Anxiety disorder	.	F40-F42
DIB008651	Sodium iodide I 131	Hyperthyroidism	242	E05
DIB008652	Purified secretory immunoglobulin	Enterocolitis	.	A04.7
DIB008653	GC-1107	Clostridium tetani infection	001-139	A00-B99
DIB008654	Alpha-4/beta-7 integrin inhibitors	Inflammatory diseases	.	.
DIB008655	ONYX-411	Cancer	.	C00-C97
DIB008656	HYP-10	Pain	338,780	R52, G89
DIB008657	FP-0240	Discovery agent	.	.
DIB008658	RI-TPO	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB008659	[99MTC]-CBPAO	Diagnosis	.	Y57.6
DIB008660	TL-118	Pancreatic cancer	157	C25
DIB008661	CX-1846	Parkinson's disease	.	G20
DIB008662	CGP-29030A	Pain	.	G89
DIB008663	Rimeporide	Myocardial infarction	410	I21, I22
DIB008664	AVE-0657	Cheyne-stokes respiration	.	R06.3
DIB008665	Fluvax	Influenza virus infections	487	J10, J11
DIB008666	Zolpidem	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB008667	Targeted ranpirnase conjugates	Cancer	140-229	C00-C96
DIB008668	NN-9926	Diabetes mellitus type 2	.	E11
DIB008669	Beloranib	Solid tumours	.	C00-C75,C7A,C7B
DIB008670	Antimalarial benzophenones	Plasmodium infection	.	B54
DIB008671	TGFTX-3	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB008672	COL-204	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB008673	RXDX 101	Solid tumours	.	C00-C75,C7A,C7B
DIB008674	TA-HPV	Cervical cancer	.	C53
DIB008675	NVC-612	Influenza virus infections	487	J10, J11
DIB008676	Anticancer program	Cancer	140-229	C00-C96
DIB008677	Monoamine oxidase-B inhibitors	Obesity	278	E66
DIB008678	Whole-cell pneumococcal vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB008679	MI-09018	Schizophrenia	295	F20
DIB008680	YM-358	Hypertension	.	I10-I15
DIB008681	NPT-CLN series	Asthma	493	J45
DIB008682	Erdosteine	Bronchitis	.	J20-J21,J42
DIB008683	Imiglitazar	Diabetes mellitus type 2	.	E11
DIB008684	BmAb-100	Cancer	140-229	C00-C96
DIB008685	BEMA buprenorphine transmucosal	Migraine	.	G43
DIB008686	H1N1 pandemic influenza vaccine (AS03 adjuvanted) 1	Influenza virus infections	487	J10, J11
DIB008687	Anaplastic lymphoma kinase inhibitors	Non-small-cell lung cancer	162	C33, C34
DIB008688	Peniel-5000	Autoimmune diseases	279.4	D84.9, M35.9
DIB008689	Erythropoietin	Anemia	280-285	D50-D64
DIB008690	CRx-401	Diabetes mellitus type 2	250	E11
DIB008691	Anti-chitinase monoclonal antibody	Inflammatory diseases	.	.
DIB008692	Co-trimoxazole	Diarrhea	.	A09,K59.1
DIB008693	AZD-3841	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB008694	Org-4094	Autoimmune diseases	279.4	D84.9, M35.9
DIB008695	P10s-Padre/Montanide ISA 51 vaccine	Breast cancer	174, 175, 217	C50, D24
DIB008696	Tolafentrine	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB008697	JNS-001	Attention deficit hyperactivity disorder	314	F90
DIB008698	NPS-31807	Psoriasis	.	L40
DIB008699	Nosiheptide analogs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008700	DNA vaccine	Hantavirus infection	.	B33.4
DIB008701	E-3030	Hyperlipidemia	.	E78.5
DIB008702	PA-799	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB008703	OligoG-COPD-5/20	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB008704	NPB-1	Non-insulin dependent diabetes	.	E11.9
DIB008705	BM-13677	Diabetes mellitus	250	E08-E13
DIB008706	Isoform-selective PI3K inhibitors	Cancer	.	C00-C97
DIB008707	Vitamin E derivative	Psychiatric disorders	.	F99
DIB008708	Vaccine	Trypanosoma cruzi infection	.	B57.2
DIB008709	IL-12/IFN-alpha gene medicine	Head and neck cancer	140-149	C07-C14, C32-C33
DIB008710	NRL-0301	Non-alcoholic steatohepatitis	.	K75.81
DIB008711	CHPMPC	Viral infections	042-075	A80-A99, B00-B34
DIB008712	Wnt pathway inhibitors	Cancer	140-229	C00-C96
DIB008713	Kanda HPV Vaccine	Papillomavirus infections	.	B97.7
DIB008714	KBRV-201	Respiratory syncytial virus 	.	B97.4
DIB008715	HPV/cervical cancer vaccine program	Papillomavirus infections	.	B97.7
DIB008716	Vaccinia immune globulin	Vaccination	.	.
DIB008717	INV-311	Inflammatory diseases	.	.
DIB008718	Clinafloxacin	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB008719	Flufirvitide-3 nasal spray	Influenza virus infections	487	J10, J11
DIB008720	RPE	Macular degeneration	362.5	H35.3
DIB008721	AZD-6553	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB008722	DMP-963	Human immunodeficiency virus infection	.	B20
DIB008723	PSD-597	Interstitial cystitis	.	N30.1
DIB008724	FK-409	Angina	.	I20
DIB008725	ONYX-015	Head and neck cancer	.	C07-C14,C32-C33
DIB008726	Lipopeptide antibiotic program	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008727	Cell mitosis inhibitors	Cancer	140-229	C00-C96
DIB008728	CVS-995	Myocardial infarction	.	I21-I22
DIB008729	UR-12519	Asthma	.	J45
DIB008730	Rolafagrel	Nephritis	.	N00-N19,N25-N29
DIB008731	Anticancer Therapy	Cancer	140-229	C00-C96
DIB008732	SPC-3	HIV infections	42	B20
DIB008733	VALERGEN-DP (subcutaneous)	Asthma	493	J45
DIB008734	AllerB	Allergy	995.3	T78.4
DIB008735	AZD-3646	Cancer	140-229	C00-C96
DIB008736	Coagulin-B	Hemophilia	286	D66-D68
DIB008737	KP-201 hydrocodone prodrug	Pain	338,780	R52, G89
DIB008738	F-14512	Cancer	140-229	C00-C96
DIB008739	LY-2811376	Alzheimer's disease	.	G30,F00
DIB008740	Heat shock protein vaccine	Meningococcal infections	36.9	A39
DIB008741	Org-6582	Major depressive disorder	296.2, 296.3	F32, F33
DIB008742	Recombinant human lysozyme	Upper respiratory infection	.	J00-06,J30-39
DIB008743	Cancer vaccine	Cancer	140-229	C00-C96
DIB008744	GSK2485852	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008745	LPS biosynthesis pathway enzyme inhibitors	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008746	Peptide vaccines	Retinopathy	362.0-362.2	H35-H35.2
DIB008747	TEN-010	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DIB008748	Prostaganin	Prostate tumor	185	C61
DIB008749	AXP-107-17	Radiation sickness	990	T66
DIB008750	BCT-194	Psoriasis	696	L40
DIB008751	Genaconazole	Fungal infections	110-118	B35-B49
DIB008752	STP-322	Liver cancer	155	C22.0
DIB008753	StrataGraft	Burns	.	T20-T25
DIB008754	AbelaDrug200	Head injury	.	S00.0,S09
DIB008755	DW-1350	Osteoporosis	733	M80-M81
DIB008756	Alpha 4 beta 2 nicotinic acetylcholine receptor (nAChR) agonist	Pain	338,780	R52, G89
DIB008757	Autologous T-cell therapy	Prostate tumor	185	C61
DIB008758	PRTT-300	Pain	338,780	R52, G89
DIB008759	CP-92	Cystic fibrosis	277	E84
DIB008760	TBDT	Overactive bladder disorder	596.51	N32.81
DIB008761	ReN-1869	Pain	.	G89
DIB008762	Vascugel	Peripheral vascular disorders	.	I73.9
DIB008763	Factor Xa antagonists	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB008764	Universal vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB008765	X-071-NAB	Arthritis	710-719	M00-M25
DIB008766	UFT/leucovorin calcium	Colorectal cancer	153, 154	C18-C21
DIB008767	VR179	Cystic fibrosis	277	E84
DIB008768	Cetamolol	Angina	.	I20
DIB008769	NCX-434	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DIB008770	AM-491	Hepatitis B virus infection	.	B16
DIB008771	GPR12 antagonists	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB008772	U-104067F	Neurological disease	.	G00-G99
DIB008773	PLR-15	Diabetic foot ulcer	.	E08-E13
DIB008774	EDP-18	Major depressive disorder	296.2, 296.3	F32, F33
DIB008775	DFRF4539A	Multiple myeloma	203	C90.0
DIB008776	DES-10	HIV infections	42	B20
DIB008777	AZM-134	Diabetes mellitus type 2	.	E11
DIB008778	Vaccine	Influenza virus infections	487	J10, J11
DIB008779	EP-37	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB008780	YM-17K	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008781	Amyloidosis therapy	Amyloidosis	.	E85
DIB008782	Alpha 2a adrenoceptor antagonists	Bladder disease	.	N30-N32
DIB008783	NW-3509	Schizophrenia	295	F20
DIB008784	HERPEFUNGIN	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008785	GR-133347	Anxiety disorder	300	F40-F42
DIB008786	SK-MS10	Gastritis	.	K29.6
DIB008787	Small molecule inhibitor	Viral infections	042-075	A80-A99, B00-B34
DIB008788	R-944	HIV infections	42	B20
DIB008789	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB008790	U-103017	Human immunodeficiency virus infection	.	B20
DIB008791	IMX-MSP3	Plasmodium falciparum infection	.	B54
DIB008792	NZ-39000	Autoimmune diseases	279.4	D84.9, M35.9
DIB008793	CAMI-103	Heart failure	.	I50
DIB008794	SG-2274	Cancer	140-229	C00-C96
DIB008795	XTL-Staph-MAb	Staphylococcus aureus infection	001-139	A00-B99
DIB008796	Antivirals	Cytomegalovirus infection	.	B25
DIB008797	Alpha crystallin inhibiting IgA mAbs	Mycobacterium tuberculosis infection	.	A15-A19
DIB008798	PLX-5622	Autoimmune diseases	.	D84.9
DIB008799	GR-199114X	Stomach ulcer	.	K25-K27
DIB008800	Tolamba	Allergic rhinitis	.	J30
DIB008801	BCH-730	Cancer	140-229	C00-C96
DIB008802	Anti-T-lymphocyte immune	Cytomegalovirus infection	.	B25
DIB008803	ZD-9379	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB008804	Renin inhibitors (hypertension/congestive heart failure) Pfizer	Heart failure	.	I50
DIB008805	Syn-1020	Pain	338,780	R52, G89
DIB008806	Peptide therapeutic	Major depressive disorder	296.2, 296.3	F32, F33
DIB008807	Small molecule dual BTK/LCK inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB008808	DAU-5750	Gastric motility disorder	.	K22.4
DIB008809	ZP-008	Pharyngitis	.	J02
DIB008810	CALAA-01	Solid tumours	.	C00-C75,C7A,C7B
DIB008811	Y-26611	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008812	Poxvirus enzyme inhibitors	Virus infection	.	B03
DIB008813	MRX-6	Contact dermatitis	692	L23, L24, L25
DIB008814	TGR inhibitors	Schistosomiasis	120	B65
DIB008815	PRX-12266	Neurological disease	.	G00-G99
DIB008816	Adarotene ester derivative back-up compounds	Cancer	140-229	C00-C96
DIB008817	EQ-318	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB008818	MC-02306	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008819	PF-5230894	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008820	KB-003	Severe asthma	493	J45
DIB008821	MDX-33	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB008822	IRX-01	Inflammatory diseases	.	.
DIB008823	Abdoscan	Gastrointestinal disease	.	K00-K93
DIB008824	MCT-125	Fatigue	.	R53
DIB008825	2-Bromopalmitate (autoimmune/inflammatory disease), MSKCC	Autoimmune diseases	279.4	D84.9, M35.9
DIB008826	AZD-2551	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB008827	Sodium chromoglycate	Asthma	493	J45
DIB008828	AQU-010	Neuropathic pain	338,780	R52, G89
DIB008829	FGFR inhibitors	Cancer	140-229	C00-C96
DIB008830	Protein subunit vaccine	Chlamydia infection	.	A74.9
DIB008831	JTV-506	Angina	.	I20
DIB008832	DW-2282	Cancer	140-229	C00-C96
DIB008833	Recombinant factor VIIa PEGylated liposomal	Factor VII deficiency	.	D68
DIB008834	HGH-CTP	Growth hormone deficiency	.	E23.0
DIB008835	18F-SMIBR-K5	Cancer	140-229	C00-C96
DIB008836	EVT-302	Smoking cessation	292	F17.2
DIB008837	EPO program	Anemia	.	D50-D64
DIB008838	E-4767	Bacterial infections	.	Z16.23
DIB008839	ZYC101a	Cervical cancer	.	C53
DIB008840	BIWB-1	Melanoma	172	C43
DIB008841	Rabies vaccine	Rabies virus infection	001-139	A00-B99
DIB008842	Mycobacterial cell wall-DNA complex	Cancer	.	C00-C97
DIB008843	Tuvirumab	Hepatitis B virus infection	.	B16
DIB008844	NS-638	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB008845	Ancrod	Blood forming organ disorders	.	D75.9
DIB008846	Phosphonate nucleosides	Cytomegalovirus infection	.	B25
DIB008847	TAK-128	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB008848	Aureobasidin A-based cyclic peptides	Fungal infections	110-118	B35-B49
DIB008849	NCX-1236	Neuropathic pain	338,780	R52, G89
DIB008850	NVLS/FX-18A	Cardiovascular disease	390-459	I00-I99
DIB008851	GW-409544	Hyperlipidemia	.	E78.5
DIB008852	Human AM/AMBP-1	Ischemia	459.89	I99.8
DIB008853	Viral capsid assembly inhibitors	Equine encephalitis virus infection	.	A83.1
DIB008854	ETX-6107	Atherosclerosis	414.0, 440	I70
DIB008855	Therapeutic vaccine	HIV infections	42	B20
DIB008856	AZD-6703	Rheumatold arthritis	714	M05-M06
DIB008857	Oligonucleotides	Nervous system cancer	.	C72.9
DIB008858	Diethylnorspermine	Cancer	140-229	C00-C96
DIB008859	MTNF-K90R	Discovery agent	.	.
DIB008860	Bis-(indole) antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008861	GS-6637	Substance dependence	.	F10-F19
DIB008862	EPI-6	Gastrointestinal disease	.	K00-K93
DIB008863	HDAC inhibitors	Cancer	140-229	C00-C96
DIB008864	GR-328713	Arteriosclerosis	.	I70
DIB008865	SRD-441	Atopic dermatitis	691.8	L20
DIB008866	99mTc-siboroxime	Diagnosis	.	Y57.6
DIB008867	ZL-N-91	Lung inflammation	.	D86
DIB008868	AL0-212	Critical limb ischemia	459.89	I99.8
DIB008869	AR-2474	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008870	ADCI	Epileptic seizure	.	G40,R56
DIB008871	Antibody-drug conjugates	Cancer	140-229	C00-C96
DIB008872	Anti-human Factor XI monoclonal antibody	Sepsis	.	A40-A41
DIB008873	MG-401	Cancer	140-229	C00-C96
DIB008874	TTP-814	Diabetes mellitus	.	E10-E14
DIB008875	CKI-27	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB008876	Gamma-secretase modulators	Alzheimer's disease	331	G30
DIB008877	Anti-HER2 bi-specific mAbs	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB008878	EBV CTLs	Lymphoma	.	C81-C96
DIB008879	Sodium sulfide sulfur	Ischemia	459.89	I99.8
DIB008880	SR-47063	Cardiac arrhythmias	.	I47-I49
DIB008881	Pleodrug	Motor neurone disease	335.2	G12.2
DIB008882	SAOB-0405	Mesothelioma	.	C45
DIB008883	BGB-283	Cancer	.	C00-C97
DIB008884	AQW-051	Alzheimer's disease	.	G30,F00
DIB008885	ET-008	Uterine cervix cancer	.	C53
DIB008886	Fully human antibodies	Cancer	140-229	C00-C96
DIB008887	Rabeximod	Rheumatold arthritis	714	M05-M06
DIB008888	TH-0318	Diabetes mellitus	250	E08-E13
DIB008889	HuMax-TF	Cancer	140-229	C00-C96
DIB008890	APC-8015F	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB008891	Hsp90 inhibitors	Cancer	140-229	C00-C96
DIB008892	Live attenuated Shigella vaccine	Shigella infections	.	A03.9
DIB008893	SWC-331	Cancer pain	338,780	R52, G89
DIB008894	PRO-052	Duchenne dystrophy	.	G71.0
DIB008895	CGEN-15001	Autoimmune diseases	279.4	D84.9, M35.9
DIB008896	Alpha-galactosidase A	Fabry disease	272.7	E75.2
DIB008897	AD-121	Rheumatold arthritis	714	M05-M06
DIB008898	Tefibazumab	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008899	AZ-17	Psoriasis	696	L40
DIB008900	TG-4023	Cancer	140-229	C00-C96
DIB008901	Nuclear factor kappa B pathway modulators	Inflammatory diseases	.	.
DIB008902	BIIB-036	Cancer	140-229	C00-C96
DIB008903	AZD-8848	Allergic rhinitis	.	J30
DIB008904	MK-0773	Osteoporosis	.	M80-M81
DIB008905	Factor IX DNA therapeutic	Factor IX deficiency	.	D67
DIB008906	LXR modulator	Atherosclerosis	414.0, 440	I70
DIB008907	RQ-00201894	Gastroesophageal reflux disease	.	K21
DIB008908	CZ-MD001 series	Diabetes mellitus	250	E08-E13
DIB008909	Etidocaine	Pain	338,780	R52, G89
DIB008910	CA-01	Cancer	140-229	C00-C96
DIB008911	AZP-2006	Alzheimer's disease	331	G30
DIB008912	KC-11404	Asthma	493	J45
DIB008913	Arthritis therapy	Immune disorder	.	D80-D89
DIB008914	CCR2 antagonist	Atherosclerosis	414.0, 440	I70
DIB008915	GPI-0100	Breast cancer	174, 175	C50
DIB008916	TK-54	Graft-versus host disease	.	T86.0
DIB008917	Inactivated polio vaccine	Poliovirus infection	.	A80.9
DIB008918	X-081-NAB	Hypereosinophilic syndrome	288.3	D72.1
DIB008919	NOX-B11	Obesity	278	E66
DIB008920	DPT/Hib vaccine	Infectious and parasitic disease	.	A00-B99
DIB008921	HT-1067	Parkinson's disease	332	F02.3, G20
DIB008922	Atrimer program	Autoimmune diseases	279.4	D84.9, M35.9
DIB008923	M-6040	Pain	338,780	R52, G89
DIB008924	11beta-hydroxysteroid dehydrogenase-1 (HSD1) inhibitors, Merck & Co	Atherosclerosis	414.0, 440	I70
DIB008925	GM-MD-01	Liver fibrosis	571	K70.3, K71.7, K74
DIB008926	Anti-CD5 humanized mAb	Cancer	140-229	C00-C96
DIB008927	Caspase 3 inhibitors	Alzheimer's disease	.	G30,F00
DIB008928	TG-1022	Obesity	278	E66
DIB008929	VLP vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB008930	VX-135	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB008931	KW-2149	Solid tumours	.	C00-C75,C7A,C7B
DIB008932	TD-4001	Bladder disease	.	N30-N32
DIB008933	CMPD-167	HIV-1 infections	42	B20
DIB008934	P-0654	Atherosclerosis	414.0, 440	I70
DIB008935	Undisclosed kinase targeted compounds	Cancer	140-229	C00-C96
DIB008936	Stem cell therapy	Heart disease	390-429	I00-I52
DIB008937	NXB-5886	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008938	SCD-211	Diabetes mellitus	250	E08-E13
DIB008939	4SC-302	Flavivirus infection	.	A86
DIB008940	ORP-100	Respiratory disease	.	J00-J99
DIB008941	CDP-850	Cancer	.	C00-C97
DIB008942	MCS-18	Autoimmune diabetes	.	E08-E13
DIB008943	SIG-990	Rosacea	.	L71
DIB008944	PF-4989216	Cancer	140-229	C00-C96
DIB008945	Tobacco plant-derived anti-idiotype vaccine	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB008946	OP-R003	Hematological malignancies	.	C81-C96
DIB008947	Seasonal H1N1 live attenuated influenza virus vaccine	Influenza virus infections	487	J10, J11
DIB008948	Methaqualone	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB008949	BIBN-99	Alzheimer's disease	.	G30,F00
DIB008950	Beriplast-P	Wound healing	.	S91.3
DIB008951	Ptk6 inhibitor	Cancer	140-229	C00-C96
DIB008952	Anti-CGEN-928 polyclonal antibody	Multiple myeloma	203	C90.0
DIB008953	Iratumumab	Lymphoma	.	C81-C96
DIB008954	N-1999-A2	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008955	G-203-2c	Pancreatic cancer	.	C25
DIB008956	PF-06293620	Diabetes mellitus type 2	.	E11
DIB008957	S-36212	Discovery agent	.	.
DIB008958	SKYFlu	Influenza virus infections	487	J10, J11
DIB008959	Recombinant subunit vaccine	Cytomegalovirus infection	.	B25
DIB008960	Anthrax protective antigen DNA vaccine	Bacillus anthracis infection	.	A22
DIB008961	Recombinant acellular pertussis vaccine	Bordetella pertussis infection	.	A37.0
DIB008962	Orphanin agonists	Constipation	564	K59.0
DIB008963	MaC46/M87o	HIV-1 infections	42	B20
DIB008964	Monoacylglycerol lipase inhibitors	Pain	338,780	R52, G89
DIB008965	Periodontitis therapy	Periodontitis	523.5	K05.4
DIB008966	RV3 rotavirus vaccine	Type 2 diabetes	250.00, 250.02	E11
DIB008967	AMG 581	Psychotic disorders	290-299	F20-F29
DIB008968	UK-432097	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB008969	Recombinant live attenuated prophylactic vaccine	Chikungunya virus infection	.	A92.0
DIB008970	EGFR inhibitors	Alopecia	.	L65.9
DIB008971	PF-4494700	Dementia	.	F01-F07
DIB008972	CXCL-10 antibody	Insulin dependent diabetes	.	E10
DIB008973	Venezuelan equine encephalitis vaccine	Equine encephalitis virus infection	.	A83.1
DIB008974	Myeloperoxidase inhibitors	Atherosclerosis	414.0, 440	I70
DIB008975	Ellipravin	Cancer	140-229	C00-C96
DIB008976	Dipeptidyl peptidase IV inhibitor program	Non-insulin dependent diabetes	.	E11.9
DIB008977	PMX-10072	Mycobacterium tuberculosis infection	.	A15-A19
DIB008978	CI-949	Asthma	.	J45
DIB008979	SPN-809	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB008980	Infanrix-DTaP-Hib	Bordetella pertussis infection	.	A37.0
DIB008981	ND-201	Mycobacterium tuberculosis infection	.	A15-A19
DIB008982	Lenapenem hydrochloride hydrate	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB008983	CB-01-16	Constipation	564	K59.0
DIB008984	NNC-26-0762	Growth hormone deficiency	.	E23.0
DIB008985	Inhaled retinoids	Respiratory tract cancer	.	C32-C34
DIB008986	DdRNAi HBV therapy	Hepatitis B virus infection	.	B16
DIB008987	PRS-190	Autoimmune diseases	279.4	D84.9, M35.9
DIB008988	Antibacterial compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB008989	RhoA inhibitors	Cancer	.	C00-C97
DIB008990	ASP-1001	Allergic rhinitis	477	J30
DIB008991	BIBS-222	Hypertension	401	I10, I11, I12, I13, I15
DIB008992	DAT-582	Nausea	.	R11
DIB008993	Azathioprine Delayed-Release minitablets	Crohn's disease	555	K50
DIB008994	LY-247195	Cardiovascular disease	390-459	I00-I99
DIB008995	PPAR gamma modulators	Diabetes mellitus	250	E08-E13
DIB008996	New compound	Diabetes mellitus type 2	.	E11
DIB008997	N-6547	Inflammatory bowel disease	555, 556	K50, K51
DIB008998	Live attenuated vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB008999	DLX-0201	Emesis	787	R11
DIB009000	HMR-4004	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009001	RNAi therapeutics	Cancer	140-229	C00-C96
DIB009002	B27PD	Uveitis	364	H20
DIB009003	LM-13765	Hyperlipidemia	272.0-272.4	E78
DIB009004	SL-591227	Ischemia	459.89	I99.8
DIB009005	NP-2	Influenza A virus infections	.	J10-J11
DIB009006	CARD-024	Cardiovascular disease	390-459	I00-I99
DIB009007	Glaucoma gene therapy	Glaucoma	365	H40-H42
DIB009008	CDK inhibitors	Cancer	140-229	C00-C96
DIB009009	IKS-04	Cancer	140-229	C00-C96
DIB009010	TDI-0054	Motor neurone disease	335.2	G12.2
DIB009011	Topiroxostat	Gout	274.00274.1274.8274.9	M10
DIB009012	BCX-25	Arthritis	710-719	M00-M25
DIB009013	Curcumin-ND	Mantle cell lymphoma	200.4	C85.7
DIB009014	Whooping cough vaccine	Bordetella pertussis infection	.	A37.0
DIB009015	Gamma secretase inhibitors	Alzheimer's disease	331	G30
DIB009016	Nipradilol	Angina	413	I20
DIB009017	Oral insulin	Diabetes mellitus type 2	.	E11
DIB009018	13-DEOXYADRIAMYCIN HYDROCHLORIDE	Solid tumours	.	C00-C75,C7A,C7B
DIB009019	Regorafenib ophthalmology	Macular degeneration	.	H35.3
DIB009020	RO-5271983	Asthma	.	J45
DIB009021	Albupoietin	Anemia	280-285	D50-D64
DIB009022	99mTc-labeled PSMA inhibitors (prostate cancer, imaging), Johns Hopkins University	Prostate tumor	185	C61
DIB009023	Gepon	HIV infections	42	B20
DIB009024	Rinfabate	Cancer	.	C00-C97
DIB009025	NP-61	Alzheimer's disease	.	G30,F00
DIB009026	Broad spectrum therapeutic vaccines	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009027	CPP-115	Substance dependence	.	F10-F19
DIB009028	Adenovector based vaccine	Influenza virus infections	487	J10, J11
DIB009029	PolyHeme	Blood forming organ disorders	.	D75.9
DIB009030	SonoRx	Gastrointestinal disease	.	K00-K93
DIB009031	AT-027	Cancer	140-229	C00-C96
DIB009032	NO synthase modulators	Atherosclerosis	414.0, 440	I70
DIB009033	Peptide therapeutic	Infectious disease	001-139	A00-B99
DIB009034	Beta-amyloid inhibitor	Alzheimer's disease	331	G30
DIB009035	MX-6	Uterine cervix cancer	.	C53
DIB009036	Botulism immune globulin	Clostridium botulinum infection	.	A05.1
DIB009037	HBsAG-HBIG complex	Hepatitis B virus infection	.	B16
DIB009038	Alpha7 nicotinic acetylcholine receptor positive allosteric modulators	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB009039	Vaccine	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB009040	SUN-1334H	Allergic rhinitis	.	J30
DIB009041	AE-O	Ovarian cancer	.	C56
DIB009042	TRO-40303	Lateral sclerosis	.	G12.2
DIB009043	ImBryon	Cancer	140-229	C00-C96
DIB009044	Piliel	Alopecia	.	L65.9
DIB009045	GFC-001	Leishmania tropica infection	.	B55.0
DIB009046	ALVAC-CEA/hB7.1	Ovarian cancer	183	C56
DIB009047	FluBIok	Inluenza virus	.	J11.1
DIB009048	S-21007	Anxiety disorder	.	F40-F42
DIB009049	TL-1892	Cancer	140-229	C00-C96
DIB009050	LY-3390334	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB009051	NN-7415	Factor IX deficiency	.	D67
DIB009052	COL-1077	Pain	338,780	R52, G89
DIB009053	JR-051	Fabry disease	272.7	E75.2
DIB009054	Heterologous liver cell therapy	Urea cycle disorders	.	E72.20
DIB009055	JBP-1	Cancer	140-229	C00-C96
DIB009056	CTCE-0501	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009057	IDR-105	Diabetes mellitus	250	E08-E13
DIB009058	PF-3864086	Pain	338,780	R52, G89
DIB009059	MIRNA-Rx07	Cancer	140-229	C00-C96
DIB009060	MR steroid	Ocular disease	.	H00-H59
DIB009061	Candoxatrilat	Heart failure	.	I50
DIB009062	IGFBP-2 DNA plasmid vaccine	Ovarian cancer	.	C56
DIB009063	VBY- 891	Autoimmune diseases	279.4	D84.9, M35.9
DIB009064	PPI-2458	Autoimmune diseases	.	D84.9
DIB009065	LY-2608204	Diabetes mellitus type 2	.	E11
DIB009066	Acetylcysteine	Liver disease	570-574	K70-K77
DIB009067	CCR5 antagonists	HIV infections	42	B20
DIB009068	CDX-1135	Macular degeneration	.	H35.3
DIB009069	L-ornithine L-aspartate	Hepatic encephalopathy	.	K72
DIB009070	HIV fusion inhibitors	HIV infections	42	B20
DIB009071	Diphtheria/tetanus toxoids	Clostridium tetani infection	001-139	A00-B99
DIB009072	LY-2624803	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB009073	HMGB-1 protein and its fragments	Bone disease	.	M00-M99
DIB009074	Antirotavirus immunogobulin Y	Diarrhea	787.91	A09, K59.1
DIB009075	KTP-001	Intervertebral disc displacement	.	M51.9
DIB009076	LY-GSK-3i	Cancer	140-229	C00-C96
DIB009077	Small molecule unspecified ion channel modulators	Respiratory disease	.	J00-J99
DIB009078	SER-203	Cancer	.	C00-C97
DIB009079	CX-1501	Alzheimer's disease	.	G30,F00
DIB009080	DXL-1215	Endometriosis	617	N80
DIB009081	DT-TX-30	Angina	.	I20
DIB009082	GSK-679586A	Asthma	493	J45
DIB009083	KUR-116	Spinal disease	.	G95.9
DIB009084	Fenquizone	Hypertension	401	I10, I11, I12, I13, I15
DIB009085	Belnacasan	Epilepsy	.	G40
DIB009086	Interferon beta HCV	Hepatitis C virus infection	.	B17.1,B18.2
DIB009087	HL-135	Arteriosclerosis	440	I70
DIB009088	GPC-3298306	Hepatocellular carcinoma	155	C22.0
DIB009089	SX-RDS1	Cancer	140-229	C00-C96
DIB009090	NPC-15199	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB009091	EV-075	Ebola virus infection	.	A98
DIB009092	Tetrandrine	Colorectal cancer	.	C18-C20,C21
DIB009093	AIM-102	Asthma	493	J45
DIB009094	CTCE-0214	Hematopoietic	.	D50-D89
DIB009095	Acne vaccines based on sialidase plus CAMP proteins	Acne vulgaris	706.1	L70.0
DIB009096	NNZ-2566	Type 1 diabetes	250.01	E10
DIB009097	DGAT-1 inhibitors	Lipid metabolism disorder	.	E75-E78
DIB009098	CS-891B	Alopecia	.	L65.9
DIB009099	VAK-694	Allergic rhinitis	477	J30
DIB009100	Neurox	Neuromuscular disease	.	N31.9
DIB009101	NC-1800	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB009102	131I-TM-601	Glioma	191	C71
DIB009103	OSE2101	Breast cancer	174, 175	C50
DIB009104	Glucocorticoid antagonists	Discovery agent	.	.
DIB009105	ZK-91587	Cardiovascular disease	.	I00-I99
DIB009106	SiRNA	Hepatitis B virus infection	.	B16
DIB009107	TACE inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB009108	Kallikrein-1 inhibitors	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB009109	AMP-423	Cancer	140-229	C00-C96
DIB009110	Oragens	Viral infections	042-075	A80-A99, B00-B34
DIB009111	NitroSense PA6	Neuropathic pain	338,780	R52, G89
DIB009112	Rift Valley fever vaccine	Rift valley fever	.	A92.4
DIB009113	PC-mAb	Restenosis	.	I51.89
DIB009114	OG-232	Cancer	140-229	C00-C96
DIB009115	BL-1872	Pain	338,780	R52, G89
DIB009116	HL-028	Asthma	493	J45
DIB009117	Grass pollen extract	Allergic reaction	995.3	T78.4
DIB009118	BAY-85-3934	Anemia	280-285	D50-D64
DIB009119	PF-4194471	HIV infections	42	B20
DIB009120	VX-661	Cystic fibrosis	.	E84
DIB009121	CIGB-300	Cervical cancer	.	C53
DIB009122	Ontazolast	Asthma	.	J45
DIB009123	Romazarit	Rheumatold arthritis	.	M05-M06
DIB009124	CP-70949	Diabetes mellitus	250	E08-E13
DIB009125	Calcineurin pathway modulators	Schizophrenia	295	F20
DIB009126	Lasmiditan	Migraine	.	G43
DIB009127	TP-434	Influenza virus infections	487	J10, J11
DIB009128	ATL-801	Non-insulin dependent diabetes	.	E11.9
DIB009129	Stage IV melanoma vaccine	Melanoma	172	C43
DIB009130	Fasitibant chloride	Osteoarthritis	.	M15-M19,M47
DIB009131	CL-387626	Viral infections	042-075	A80-A99, B00-B34
DIB009132	JKB-119	Liver disease	570-574	K70-K77
DIB009133	HG-1429	Bone disease	.	M00-M99
DIB009134	TAK-201	Allergy	995.3	T78.4
DIB009135	Monatepil maleate	Angina	.	I20
DIB009136	Erwinia chrysanthemi L-asparaginase	Acute lymphoblastic leukemia	204	C91.0
DIB009137	FR-115427	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009138	R-873	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB009139	CDT-fenofibrate	Hyperlipidemia	272.0-272.4	E78
DIB009140	S-33138	Psychotic disorders	.	F20-F29
DIB009141	Lunacalcipol	Psoriasis	.	L40
DIB009142	PlaMavax	Plasmodium infection	.	B54
DIB009143	AZD-7295	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009144	HER-2VAX	Breast cancer	174, 175, 217	C50, D24
DIB009145	CY-9701	Asthma	493	J45
DIB009146	AP-611074	Condyloma	.	A51.3
DIB009147	DABIS MALEATE	Solid tumours	.	C00-C75,C7A,C7B
DIB009148	SEphB4-HSA	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB009149	HLF 1-11	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB009150	Theradigm-HSV	Herpes simplex virus infection	54	B00
DIB009151	FTL-LTB chimera protein prophylactic vaccine	Escherichia coli infection	.	A00-B99
DIB009152	BMS-184476	Cancer	140-229	C00-C96
DIB009153	PTX-001	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009154	RG7893	Pain	338,780	R52, G89
DIB009155	RUBOXISTAURIN HYDROCHLORIDE	Lymphoma	.	C81-C96
DIB009156	T-506	Cancer	140-229	C00-C96
DIB009157	MPC-9528	Cancer	140-229	C00-C96
DIB009158	CMUS-100	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009159	SP-1062C-O	Colorectal cancer	153, 154	C18-C21
DIB009160	TDI-0099	Motor neurone disease	335.2	G12.2
DIB009161	Nasal influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB009162	Apolipoprotein E	Glaucoma	365	H40-H42
DIB009163	MT-204	Inflammatory diseases	.	.
DIB009164	TD-9594	Overactive bladder disorder	596.51	N32.81
DIB009165	SAR236553	Hypercholesterolemia	272	E78.0
DIB009166	LF-943	Ischemia	459.89	I99.8
DIB009167	AZD-2115	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB009168	MEDI-3617	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009169	AVE-2268	Diabetes mellitus	.	E10-E14
DIB009170	H9N2 avian influenza vaccine	Influenza virus infections	487	J10, J11
DIB009171	Arthritis therapeutics	Arthritis	710-719	M00-M25
DIB009172	Pentastarch	Bleeding	.	R58
DIB009173	Dipeptide therapeutic	Anxiety disorder	300	F40-F42
DIB009174	LOXO-101	Solid tumours	.	C00-C75,C7A,C7B
DIB009175	P-3378	Cancer	140-229	C00-C96
DIB009176	Conjugated-trastuzumab	Cancer	140-229	C00-C96
DIB009177	CGP-47969A	Autoimmune diseases	279.4	D84.9, M35.9
DIB009178	Humanized monoclonal antibodies	Cancer	140-229	C00-C96
DIB009179	RAGE inhibitors	Neurodegenerative diseases	.	G30-G32
DIB009180	YM-114	Nausea	.	R11
DIB009181	Hu3S193	Fallopian tube cancer	.	C57.0,D28.2
DIB009182	E coli antidote	Escherichia coli infection	.	A00-B99
DIB009183	Anti-virulence program	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009184	Ixmyelocel-T	Type 1 diabetes	250.01	E10
DIB009185	Theradigm-HBV	Viral infections	042-075	A80-A99, B00-B34
DIB009186	RNAi therapeutics	Cancer	.	C00-C97
DIB009187	Betulinol derivatives	Cancer	.	C00-C97
DIB009188	Lu-AF11167	Neurological disease	.	G00-G99
DIB009189	MUC1 peptide vaccine program	Cancer	140-229	C00-C96
DIB009190	HG-1077	Cancer	140-229	C00-C96
DIB009191	STA-9584	Cancer	.	C00-C97
DIB009192	SR-271425	Solid tumours	.	C00-C75,C7A,C7B
DIB009193	Doxorubicin-LL2 conjugate	B-cell lymphoma	202.8	C85.1
DIB009194	EDONENTAN HYDRATE	Pulmonary arterial hypertension	.	I27.0,I27.2
DIB009195	RP-58802B	Asthma	493	J45
DIB009196	DG-770	Diabetes mellitus	250	E08-E13
DIB009197	EP-217609	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB009198	BAX-855	Hemophilia A	.	D66
DIB009199	Peptide therapeutic	Pain	338,780	R52, G89
DIB009200	Sch-40120	Pruritus	.	L29
DIB009201	BMS-187257	Gastrointestinal disease	.	K00-K93
DIB009202	KI-0804	Cancer	140-229	C00-C96
DIB009203	Anticancer compounds	Cancer	140-229	C00-C96
DIB009204	ERIC-1	Cancer	140-229	C00-C96
DIB009205	5-Fluoro-2-deoxycytidine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009206	JTT-252	Type 2 diabetes	250.00, 250.02	E11
DIB009207	KP-496	Asthma	.	J45
DIB009208	CS-526	Gastroesophageal reflux disease	.	K21
DIB009209	ZY-15106	Asthma	.	J45
DIB009210	LK-410	Cancer	140-229	C00-C96
DIB009211	Azotropin	Growth disorder	.	E23.0
DIB009212	UX-002	Lysosomal storage disease	.	E75-E77
DIB009213	ICI-D-3705	Allergy	995.3	T78.4
DIB009214	MK-8521	Type 2 diabetes	250.00, 250.02	E11
DIB009215	ASOBAMAST	Asthma	.	J45
DIB009216	SKF-97426	Hyperlipidemia	.	E78.5
DIB009217	ZD-4953	Pain	338,780	R52, G89
DIB009218	DLX-105	Osteoarthritis	715	M15-M19, M47
DIB009219	R1204	Depression	311	F32
DIB009220	AD-313	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB009221	AV-101	Neuropathic pain	338,780	R52, G89
DIB009222	Cannabinoid CB2 receptor agonist	Pain	338,780	R52, G89
DIB009223	PNT-2258	Cancer	140-229	C00-C96
DIB009224	APOMINE	Osteopetrosis	.	Q78.2?
DIB009225	Prinomide triethanolamine	Inflammatory diseases	.	.
DIB009226	Undisclosed analogs	Cancer	.	C00-C97
DIB009227	IB-863	Fungal infection	.	B35-B49
DIB009228	AnergiX-IBD	Ulcerative colitis	556	K51
DIB009229	T-61	Cancer	140-229	C00-C96
DIB009230	PS522501	Metabolic disease	270-279	E70-E89
DIB009231	V116517	Osteoarthritis	.	M19.90
DIB009232	CYR-101	Schizophrenia	295	F20
DIB009233	H5N1 influenza pandemic vaccine	Influenza virus infections	487	J10, J11
DIB009234	GSK-1399686	Inflammatory bowel disease	.	K50,K51
DIB009235	Remogli ozin-etabonate	Type 2 diabetes	250.00, 250.02	E11
DIB009236	Botulinum toxin vaccine	Yersinia infections	.	A04.6
DIB009237	TUG-469	Non-insulin dependent diabetes	.	E11.9
DIB009238	OCM-8224	Breast cancer	174, 175, 217	C50, D24
DIB009239	INOC-005	Cancer	140-229	C00-C96
DIB009240	PH-94B	Anxiety disorder	300	F40-F42
DIB009241	KRH-102053	Cancer	140-229	C00-C96
DIB009242	ZP-006	Pharyngitis	.	J02
DIB009243	SA-VCP anti-complement therapy	Reperfusion injury	.	I00-I99
DIB009244	Suprofenac	Ocular inflammation	.	H00-H59
DIB009245	GTx-186	Cancer	140-229	C00-C96
DIB009246	Histoplasmin antigen	Histoplasma infection	.	B39.2
DIB009247	Non-nucleoside reverse transcriptase inhibitors	HIV infections	42	B20
DIB009248	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB009249	ITI-003 series (oral	Female sexual dysfunction	302.7	F52, R37
DIB009250	WS-CoQ10	Parkinson's disease	.	G20
DIB009251	S-23906-1	Solid tumours	.	C00-C75,C7A,C7B
DIB009252	ASP-015K	Psoriasis	.	L40
DIB009253	MRL-953	Immune disorder	.	D80-D89
DIB009254	PN-201	Herpesvirus infection	.	B00
DIB009255	Autologous T-lymphocyte cell therapy	Peripheral vascular disorders	.	I73.9
DIB009256	Antimicrobial peptide	Infectious disease	001-139	A00-B99
DIB009257	Biostrophin	Duchenne muscular dystrophy	359.1	G71.0
DIB009258	Dihydroergotamine nasal	Migraine	346	G43
DIB009259	BBR 3576	Prostate cancer	185	C61
DIB009260	RP-701	Cancer	140-229	C00-C96
DIB009261	11-beta HSD1 inhibitors (diabetes), Scottish Biomedical	Diabetes mellitus	250	E08-E13
DIB009262	SiRNA based hematopoietic gene therapy	HIV infections	42	B20
DIB009263	PTS-508a	Inflammatory diseases	.	.
DIB009264	Prophage cancer vaccine M-series	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DIB009265	AdipoCell	Heart failure	.	I50
DIB009266	Venofer	Fatigue	.	R53
DIB009267	LNA anti-miR-155	Chronic lymphocytic leukaemia	204.1	C91.1
DIB009268	Gene therapy	Multiple sclerosis	340	G35
DIB009269	LCA-AAV7	Vision disorder	.	H53
DIB009270	D-3800	Obesity	278	E66
DIB009271	Antihypercholesterolemics	Hypercholesterolemia	272	E78.0
DIB009272	Bisphosphate glucosamine salt	Osteoporosis	733	M80-M81
DIB009273	Dermatological agents	Acne vulgaris	706.1	L70.0
DIB009274	Rh Toleragens	Hematological disease	.	D50-D89
DIB009275	HuMax-TAC	Autoimmune diseases	.	D84.9
DIB009276	SiRNA targeting tissue factor	Metastasis	.	C00-C97
DIB009277	TAS-109	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009278	TC-6499-12	Irritable bowel syndrome	.	K58
DIB009279	PR-P	Glioblastoma	191	C71
DIB009280	Anti-MUC1 junction monoclonal antibody	Cancer	140-229	C00-C96
DIB009281	GTP-0125	Hypertension	401	I10, I11, I12, I13, I15
DIB009282	Z-100	HIV infections	42	B20
DIB009283	Basal lamina-targeting antiangiogenic agent	Cancer	140-229	C00-C96
DIB009284	Anticancer drugs	Cancer	140-229	C00-C96
DIB009285	Vaginal ring	Papillomavirus infections	.	B97.7
DIB009286	MenAfriVac	Neisseria meningitidis infection	.	A87
DIB009287	HYDAMTIQ	Brain ischaemia	435, 437	G45.9, I67.8
DIB009288	CX-1001	Cancer	140-229	C00-C96
DIB009289	BW-180C	Diarrhea	.	A09,K59.1
DIB009290	3F8	Cancer	.	C00-C97
DIB009291	Loviride	Human immunodeficiency virus infection	.	B20
DIB009292	CS-722	Epilepsy	.	G40
DIB009293	GLP-1 agonist	Non-insulin dependent diabetes	.	E11.9
DIB009294	OVI-117	Cancer	140-229	C00-C96
DIB009295	MTOR inhibitors	Inflammatory diseases	.	.
DIB009296	Mam-05.200	Immune disorder	.	D80-D89
DIB009297	OBP-601	HIV-1 infections	42	B20
DIB009298	GSK-625433	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009299	Anrukinzumab	Asthma	.	J45
DIB009300	GS-3822	Influenza virus infections	487	J10, J11
DIB009301	RP-5000	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB009302	Angiotensin-(1-7)	Sarcoma	.	C00-C75
DIB009303	Melanoma vaccine	Melanoma	172	C43
DIB009304	Terpenoid schweinfurthins	Cancer	.	C00-C97
DIB009305	CRTh2 receptor antagonists	Allergy	995.3	T78.4
DIB009306	GP-683	Pain	.	G89
DIB009307	BL-3010	Pain	338,780	R52, G89
DIB009308	BAY-1006578	Alzheimer's disease	331	G30
DIB009309	Hematopoietic progenitor cell therapy	Anemia	280-285	D50-D64
DIB009310	Lemuteporfin	Acne vulgaris	706.1	L70.0
DIB009311	Eye disorder therapeutic	Eye disorders	.	H00-H59
DIB009312	CWF-0710	Asthma	493	J45
DIB009313	Transgenic soybean seed therapy	Multiple sclerosis	340	G35
DIB009314	CSL-425	Influenza virus infections	487	J10, J11
DIB009315	R-116712	Pain	.	G89
DIB009316	MH-1	Cancer	.	C00-C97
DIB009317	HG-1220	Cancer	.	C00-C97
DIB009318	AT-007	Inflammatory bowel disease	555, 556	K50, K51
DIB009319	KAI-1455	Ischemic reperfusion injury	.	.
DIB009320	FCE-23819	Epilepsy	345	G40
DIB009321	Hypercalcemia vaccine	Bone metastases	198.5	C79.51
DIB009322	Anti-CD326 humanized mAb	Cancer	.	C00-C97
DIB009323	Meningitis vaccine	Neisseria meningitidis infection	.	A87
DIB009324	Therapeutic mAbs	Ovarian cancer	.	C56
DIB009325	P38 kinase inhibitors	Inflammatory diseases	.	.
DIB009326	Antisense oligonucleotide	Melanoma	172	C43
DIB009327	L-768277	Hyperthermia	.	T68
DIB009328	Small molecule mammalian sterile 20-like kinase 1 inhibitors	Ischemic heart diseases	410-414	I20-I25
DIB009329	Disufenton sodium	Ischemia	.	I99.8
DIB009330	Mutated SOD1 gene-silencing siRNA therapy	Motor neurone disease	335.2	G12.2
DIB009331	BhCG vaccine	Cancer	140-229	C00-C96
DIB009332	Cyclosporine ophthalmic sustained release	Xerophthalmia	.	E50.6-E50.7
DIB009333	Pyrvinium	Worm infections	.	B80
DIB009334	WIN-54954 analogs	Rhinovirus infection	.	J20.6?
DIB009335	C-101	Muscular dystrophy	.	G71.0
DIB009336	ANA-502	Discovery agent	.	.
DIB009337	Endixaprine	Anxiety disorder	300	F40-F42
DIB009338	AZD-1092	Diabetes mellitus	250	E08-E13
DIB009339	CEDO-8956	Hypertension	401	I10, I11, I12, I13, I15
DIB009340	ERB-257	Sepsis	995.91	A40, A41
DIB009341	Trivalent split seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB009342	Conjugated typhoid vaccine	Salmonella infection	.	A02.9
DIB009343	PTL-303	Fibrosis	709.2	L90.5
DIB009344	STAMP	Candida albicans infection	.	B37.0
DIB009345	EDP-14	Allergy	995.3	T78.4
DIB009346	ST-04	Osteoarthritis	715	M15-M19, M47
DIB009347	AHR-16303B	Hypertension	401	I10, I11, I12, I13, I15
DIB009348	[111In]B3	Cancer	140-229	C00-C96
DIB009349	MNX-160	Cachexia	799.4	R64
DIB009350	DHEA	Cardiovascular disease	390-459	I00-I99
DIB009351	EPI-0030	Cancer	.	C00-C97
DIB009352	TRx-0037	Alzheimer's disease	331	G30
DIB009353	CYT006-AngQb	Hypertension	.	I10-I15
DIB009354	Cancer therapy	Cancer	140-229	C00-C96
DIB009355	Ovarian cancer vaccine	Ovarian cancer	.	C56
DIB009356	HR-004-1	Bone disease	.	M00-M99
DIB009357	LOXORIBINE	Immuno-stimulant	.	.
DIB009358	TravelGAM	Escherichia coli infection	.	A00-B99
DIB009359	Theradigm-tuberculosis	Mycobacterium tuberculosis infection	.	A15-A19
DIB009360	BChE inhibitors	Alzheimer's disease	331	G30
DIB009361	Alpha-v/beta-5 monoclonal antibody	Acute lung injury	518	J80
DIB009362	ARGX-110	Autoimmune diseases	279.4	D84.9, M35.9
DIB009363	BBT-007	Neutropenia	288	D70
DIB009364	Nalmefene prodrugs	Alcohol use disorders	303	F10.2
DIB009365	KR-30450	Hypertension	.	I10-I15
DIB009366	QUAN-0806	Epilepsy	345	G40
DIB009367	CE-326597	Obesity	278	E66
DIB009368	BU-4601A	Asthma	.	J45
DIB009369	CYCLOPLATAM	Cancer	140-229	C00-C96
DIB009370	Peptide YY [3-36]	Obesity	278	E66
DIB009371	HPy-HP 097	Helicobacter pylori infection	41.86	B96.81
DIB009372	Vaccine	Melanoma	172	C43
DIB009373	AL-508	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB009374	INGN-101	Head and neck cancer	140-149	C07-C14, C32-C33
DIB009375	ATYR-0030	Immune disorder	.	D80-D89
DIB009376	CT-112	Inflammatory diseases	.	.
DIB009377	WBZ-7	Cancer	140-229	C00-C96
DIB009378	Intragam P	Immune disorder	.	D80-D89
DIB009379	Pitolisant hydrochloride	Narcolepsy	.	G47.4
DIB009380	KD-7332	Inflammatory diseases	.	.
DIB009381	Chemokine antagonists	Cancer	140-229	C00-C96
DIB009382	OX-23	Pain	338,780	R52, G89
DIB009383	SRP 299	Asthma	493	J45
DIB009384	CIGB-230	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009385	Sharon-3000	Periodontitis	523.5	K05.4
DIB009386	Taprenepag	Glaucoma	365	H40-H42
DIB009387	HMR-3562	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009388	LP-10	Cystitis	.	N30
DIB009389	Premarin/Pravachol	Hyperlipidemia	272.0-272.4	E78
DIB009390	CWP-231	Cancer	140-229	C00-C96
DIB009391	VALROCEMIDE	Epilepsy	345	G40
DIB009392	NKP-2235	Cancer	140-229	C00-C96
DIB009393	AMA-76	Glaucoma	365	H40-H42
DIB009394	Bovine polyclonal anti-TNF antibody	Oral mucositis	528	K12.3
DIB009395	V-0251	Labyrinthitis	.	H83.0
DIB009396	Dipeptidyl peptidase IV inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB009397	ALT-0701	Fibrosis	709.2	L90.5
DIB009398	AR-H049020	Diabetes mellitus type 1	.	E10
DIB009399	HG-1209	Cancer	.	C00-C97
DIB009400	GS-6620	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009401	MK-2578	Anemia	280-285	D50-D64
DIB009402	BKR 1 antagonist	Pain	338,780	R52, G89
DIB009403	Legumain-cleavable doxorubicin prodrugs	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009404	GM-CSF-transduced autologous cancer stem cell vaccine	Cancer	140-229	C00-C96
DIB009405	TT-223	Diabetes mellitus type 1	.	E10
DIB009406	SPP-1148	Hypertension	401	I10, I11, I12, I13, I15
DIB009407	OsteoStem	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB009408	PP-4001	Cystitis	.	N30
DIB009409	SQ-109 analogs	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB009410	SBS-1000	Diabetes mellitus	250	E08-E13
DIB009411	SeV gene vaccine	Plasmodium infection	.	B54
DIB009412	Cedar pollen allergen extract	Allergic rhinitis	477	J30
DIB009413	ICI-170809	Anxiety disorder	300	F40-F42
DIB009414	FR-165914	Diabetes mellitus	.	E10-E14
DIB009415	Naxagolide	Parkinson's disease	.	G20
DIB009416	Porcine liver cells	Liver disease	570-574	K70-K77
DIB009417	CRF-1 antagonists	Anxiety disorder	300	F40-F42
DIB009418	Guaimesal	Inflammatory diseases	.	.
DIB009419	Therapy	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009420	Small molecule therapeutic	Cancer	140-229	C00-C96
DIB009421	SMO antagonists	Cancer	140-229	C00-C96
DIB009422	IkT-041	Influenza virus infections	487	J10, J11
DIB009423	L1Q-001	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB009424	Human C-1 inhibitor	Genetic disorder	.	Q00-Q99
DIB009425	P21 activated kinase inhibitors	Autism	299	F84.0
DIB009426	CR-3663 series	Osteoarthritis	715	M15-M19, M47
DIB009427	MAb 1-7F9	Multiple myeloma	.	C90.0
DIB009428	MTOR inhibitors	Cancer	140-229	C00-C96
DIB009429	Unfractionated heparin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB009430	Aprosulate sodium	Coagulation	.	I80-I82
DIB009431	Malaria vaccine	Plasmodium infection	.	B54
DIB009432	SOU-001	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB009433	KX2-361	Glioblastoma	.	C71
DIB009434	MEN-11467	Respiratory tract inflammation	.	J00-J99
DIB009435	Org-33245	Planned abortion	.	Z31
DIB009436	Nivocasan	Fibrosis	.	L90.5
DIB009437	KDT-501	Inflammatory diseases	.	.
DIB009438	Recombinant hypoallergenic vaccine	Allergy	995.3	T78.4
DIB009439	Melacine	Melanoma	172	C43
DIB009440	ETS-6218	Fibromyalgia	729.1	M79.7
DIB009441	AP-521	Anxiety disorder	.	F40-F42
DIB009442	GS-3435	Influenza virus infections	487	J10, J11
DIB009443	AVX701	Colorectal cancer	.	C18-C20,C21
DIB009444	NM-001	Bacterial respiratory tract infection	.	J13,J15
DIB009445	KIBRA pathway modulators	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB009446	Fsn-1006	Breast cancer	174, 175, 217	C50, D24
DIB009447	Bacterial-based anti-inflammatories	Inflammatory diseases	.	.
DIB009448	XEL-005OP	Urinary tract disease	.	N00-N99
DIB009449	SBR-759	Hyperphosphatemia	.	E83
DIB009450	GS-9901	Hematological malignancies	.	C81-C96
DIB009451	SLV-338	Cardiovascular disease	.	I00-I99
DIB009452	Microtubule inhibitors	Cancer	140-229	C00-C96
DIB009453	PRO-045	Duchenne dystrophy	.	G71.0
DIB009454	CNTF, Syntex-Synergen, cell therapy	Huntington's disease	.	F02.2,G10
DIB009455	I-387	Cancer	140-229	C00-C96
DIB009456	PMUC5AC	Xerophthalmia	.	E50.6-E50.7
DIB009457	IV aprepitant	Cancer	140-229	C00-C96
DIB009458	EC-400	Macular degeneration	.	H35.3
DIB009459	PRX-07034	Obesity	.	E66
DIB009460	Nabi-HB (intramuscular)	Hepatitis B virus infection	.	B16
DIB009461	ON-01210.Na	Radiation sickness	990	T66
DIB009462	CORT-113083	Weight gain	.	R63.5
DIB009463	KI-0902	Gastrointestinal ulcer	.	K28
DIB009464	PV-705	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB009465	WY-48989	Rheumatold arthritis	714	M05-M06
DIB009466	INT-0020	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB009467	BCSP growth factors	Bone disease	.	M00-M99
DIB009468	BB-1433	Arthritis	710-719	M00-M25
DIB009469	MBS-103	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB009470	BW-A502U	Solid tumours	.	C00-C75,C7A,C7B
DIB009471	PGL-2001	Endometriosis	617	N80
DIB009472	GR-MD-02	Melanoma	172	C43
DIB009473	PMA-201	Autoimmune diseases	279.4	D84.9, M35.9
DIB009474	IC-41	Hepatitis virus infection	573.3	K75.9
DIB009475	TT-100	Non-small-cell lung cancer	162	C33, C34
DIB009476	INX-3280	Cancer	.	C00-C97
DIB009477	Viraplex	Cancer	.	C00-C97
DIB009478	Meglumine antimoniate	Leishmania braziliensis infection	.	B55.0
DIB009479	Antide	Prostate hyperplasia	.	N40
DIB009480	Recombinant sublingual immunotherapy vaccine adjuvant	Allergy	995.3	T78.4
DIB009481	ALD-451	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB009482	AC-501	Acute myeloid leukemia	205	C92.0
DIB009483	VX-366	Hematopoietic	.	D50-D89
DIB009484	F-7TG	Hemophilia	.	D66-D68
DIB009485	LY-353433	Inflammatory bowel disease	.	K50,K51
DIB009486	Recombinant human CC10	Sinusitis	.	J01,J32
DIB009487	NZ-17000 series	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009488	Type III secretion system-targeting therapy	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB009489	ATON-009	Metal intoxication	.	T56
DIB009490	Flezelastine	Asthma	.	J45
DIB009491	11A1	Alzheimer's disease	331	G30
DIB009492	F-992	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB009493	Small molecule therapeutics	Pulmonary hypertension	416	I27.0, I27.2
DIB009494	ID-93/GLA-SE	Tuberculosis	010-018	A15-A19
DIB009495	VLST-002	Autoimmune diseases	279.4	D84.9, M35.9
DIB009496	SDZ-PDI-747	Atopic dermatitis	691.8	L20
DIB009497	Beta-amyloid fragment-tetanus toxoid prophylactic vaccine	Alzheimer's disease	331	G30
DIB009498	Urushiol derivatives	Contact dermatitis	692	L23, L24, L25
DIB009499	ONO-2952	Irritable bowel syndrome	564.1	K58
DIB009500	RTA-301	Cancer	140-229	C00-C96
DIB009501	PDE4	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB009502	Botulinum toxin type A gel	Cancer	.	C00-C97
DIB009503	AZD-4619	Lipid metabolism disorder	.	E75-E78
DIB009504	NPS-1392	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009505	GT-4058	Alzheimer's disease	.	G30,F00
DIB009506	TBI-4000	Discovery agent	.	.
DIB009507	DAR program	Osteoarthritis	715	M15-M19, M47
DIB009508	SRSS-023	Migraine	346	G43
DIB009509	AT9183	Leukemia	208.9	C91-C95
DIB009510	Ubiquitin-specific protease-8 inhibitors	Cancer	140-229	C00-C96
DIB009511	BT-101	Osteoporosis	733	M80-M81
DIB009512	Pentraxin 2 derivatives	Discovery agent	.	.
DIB009513	JNJ-47910382	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB009514	AFM-20	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009515	Dendritic cell vaccine	Cancer	140-229	C00-C96
DIB009516	COTI-58	Small-cell lung cancer	.	C34.90
DIB009517	HCV-371	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009518	Vaccine	Small-cell lung cancer	162	C33, C34
DIB009519	Platinum-based anticancer therapy	Cancer	140-229	C00-C96
DIB009520	ISIS-APO(a)	Coronary artery disease	.	I20-I25
DIB009521	MbGM-CSF tumor vaccines	Melanoma	.	C43
DIB009522	Antibacterial compounds	Mycobacterium tuberculosis infection	.	A15-A19
DIB009523	FPRL1 G-protein-coupled receptor agonists	Inflammatory diseases	.	.
DIB009524	RHuEPO	Cancer	.	C00-C97
DIB009525	GNI-102	Hepatitis B virus infection	.	B16
DIB009526	ISIS-ANGPTL3	Hyperlipidemia	.	E78.5
DIB009527	Transplant acceptance inducing cells	Transplant rejection	.	T86
DIB009528	ARANOSE	Cancer	.	C00-C97
DIB009529	MAXY-G34	Neutropenia	.	D70
DIB009530	CAT-1000 series	Inflammatory diseases	.	.
DIB009531	NNC-0151-0000-0000	Rheumatold arthritis	.	M05-M06
DIB009532	Gene therapy	Congestive heart failure	428	I50
DIB009533	RP-400C	HIV infections	42	B20
DIB009534	Sodium polystyrene sulfonate	Mineral-electrolyte metabolism disorder	.	.
DIB009535	LEQ-506	Cancer	140-229	C00-C96
DIB009536	Strontium ranelate	Osteoporosis	733	M80-M81
DIB009537	SAR-115740	Pain	.	G89
DIB009538	BL-7020	Psoriasis	696	L40
DIB009539	Dexniguldipine	Cancer	140-229	C00-C96
DIB009540	VG-WNV	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB009541	PXS-4159	Asthma	493	J45
DIB009542	AM-3701	Bone metastases	198.5	C79.51
DIB009543	KRN-911	Metastasis	.	C00-C97
DIB009544	CL-508	Emesis	787	R11
DIB009545	P193 peptide mimetics	Coronary artery disease	.	I20-I25
DIB009546	DNX-3000	Cancer	140-229	C00-C96
DIB009547	Bendamustine ready-to-dilute liquid formulation	Non-Hodgkin's lymphoma	.	C85.9
DIB009548	Vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009549	AFN-1252	Staphylococcus aureus infection	.	A41.0
DIB009550	STAMP	Staphylococcus aureus infection	001-139	A00-B99
DIB009551	Circumsporozoite protein vaccine	Plasmodium falciparum infection	.	B54
DIB009552	Deramciclane	Anxiety disorder	300	F40-F42
DIB009553	[131I]-Metuximab injection	Liver cancer	.	C22
DIB009554	MRSA vaccine	MRSA infection	.	B95.62
DIB009555	PF-05402536	Smoking cessation	292	F17.2
DIB009556	SC-02	Allergy	995.3	T78.4
DIB009557	RNA synthesis inhibitors	Cancer	140-229	C00-C96
DIB009558	PKC theta inhibitors	Inflammatory diseases	.	.
DIB009559	CDCA1-derived epitope peptide vaccine	Prostate tumor	185	C61
DIB009560	DC-NILV-based cancer vaccine	Prostate tumor	185	C61
DIB009561	CERE-140	Glaucoma	365	H40-H42
DIB009562	ZELANDOPAM HYDROCHLORIDE	Hypertension	.	I10-I15
DIB009563	FR-900848	Fungal infection	.	B35-B49
DIB009564	Anti-IL-23	Inflammatory diseases	.	.
DIB009565	BUTIXOCORT PROPIONATE	Arthritic	710-719	M00-M25
DIB009566	FBT-A05	Chronic lymphocytic leukaemia	.	C91.1
DIB009567	Isbufylline	Bronchodilator	493	J45
DIB009568	JAK-STAT intracellular pathway inhibitors	Cancer	.	C00-C97
DIB009569	FP-0230	Cardiovascular disease	390-459	I00-I99
DIB009570	PN-203	Cancer	140-229	C00-C96
DIB009571	Retinoic acid related orphan receptor antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB009572	Margetuximab	Gastrointestinal cancer	.	C15-C26
DIB009573	PHA-665752	Cancer	140-229	C00-C96
DIB009574	Antidepressant	Major depressive disorder	296.2, 296.3	F32, F33
DIB009575	Hu Dreg 55	Psoriasis	.	L40
DIB009576	KAI-4169	Hyperparathyroidism	252.02, 588.81	E21.1
DIB009577	CT-2412	Cancer	140-229	C00-C96
DIB009578	Photodynamic therapy	Cancer	.	C00-C97
DIB009579	Hepatitis B recombinant vaccine	Hepatitis B virus infection	.	B16
DIB009580	ZAP inhibitors	Immune disorder	.	D80-D89
DIB009581	Group A streptococcus vaccine	Group A streptococcus infection	.	A49.1
DIB009582	ZYH-2	Diabetes mellitus type 2	.	E11
DIB009583	LJM716	Breast cancer	.	C50
DIB009584	Atu-195	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009585	LU-29252	Anxiety disorder	300	F40-F42
DIB009586	Anti-epileptic program	Epilepsy	345	G40
DIB009587	ES-1005	Hypertension	401	I10, I11, I12, I13, I15
DIB009588	Albuvirtide	HIV infections	42	B20
DIB009589	RBP-8000	Cocaine dependence	.	F14.2
DIB009590	PG-36	Cytomegalovirus infection	.	B25
DIB009591	Human coagulation factor X	Renal cancer	.	C64
DIB009592	BMS-191095	Angina	.	I20
DIB009593	HL-076	Hypertension	401	I10, I11, I12, I13, I15
DIB009594	EMS-16	Cancer	140-229	C00-C96
DIB009595	CS-3030	Thrombosis	.	I80-I82
DIB009596	Endo-CD	Cancer	140-229	C00-C96
DIB009597	PYK2 inhibitors	Osteoporosis	733	M80-M81
DIB009598	Rx-01	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009599	Tenilsetam	Alzheimer's disease	331	G30
DIB009600	Analatro	Poison intoxication	.	T36-T50
DIB009601	Nuclear receptor antagonists	Endocrine disease	.	E00-E35
DIB009602	Eastern Equine Encephalitis virus vaccine	Eastern equine encephalitis virus infection	.	A83.2
DIB009603	MC-1301	Cancer	.	C00-C97
DIB009604	TT-30	Autoimmune diseases	.	D84.9
DIB009605	Tomopenem	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB009606	AEB701	Melanoma	.	C43
DIB009607	WX-554	Cancer	140-229	C00-C96
DIB009608	WSB-961	Autoimmune diseases	279.4	D84.9, M35.9
DIB009609	H5N1 avian influenza vaccine	Influenza virus infections	487	J10, J11
DIB009610	HIV-1 protease inhibitors	HIV-1 infections	42	B20
DIB009611	Voltage-dependent T-type calcium channel subunit alpha-1H inhibitor	Pain	338,780	R52, G89
DIB009612	1069C	Cancer	140-229	C00-C96
DIB009613	QLT-091382	Sebaceous gland disease	.	L73.8
DIB009614	B-Raf kinase inhibitors	Cancer	140-229	C00-C96
DIB009615	NO-containing nanoparticles	Infectious disease	001-139	A00-B99
DIB009616	GI-13000	Hepatitis B virus infection	.	B16
DIB009617	NCX-1015	Rheumatold arthritis	.	M05-M06
DIB009618	GNE Lipoplex	Myopathy	.	M60-M63
DIB009619	Eptastigmine	Cognitive impairment	.	F06.7
DIB009620	FK-224	Asthma	.	J45
DIB009621	ACT-GRO-777	Cancer	.	C00-C97
DIB009622	Recombinant NOV	Corneal disease	.	H15-H22
DIB009623	PD-153103	HIV-1 infections	42	B20
DIB009624	Siratiazem	Angina	413	I20
DIB009625	TDI-0090	Motor neurone disease	335.2	G12.2
DIB009626	T-46.2	Cancer	140-229	C00-C96
DIB009627	IKK-2 inhibitors	Inflammatory diseases	.	.
DIB009628	VX-467	Inflammatory diseases	.	.
DIB009629	WT1 peptide vaccine	Leukemia	208.9	C91-C95
DIB009630	ANG-500 series	Cancer	140-229	C00-C96
DIB009631	PF-05212372	Asthma	493	J45
DIB009632	GCH-01	Sepsis	.	A40-A41
DIB009633	Insulin receptor modulators	Metabolic disorders	.	E70-E90
DIB009634	AZD-3118	Heart arrhythmia	.	I47-I49
DIB009635	NOX-E36	Diabetic complication	.	E08-E13
DIB009636	Apovasc	Atherosclerosis	414.0, 440	I70
DIB009637	Ad-RTS-IL-12	Malignant melanoma	172	C43
DIB009638	MGN-5804	Metabolic disorders	.	E70-E90
DIB009639	CytoregUNO	Skin cancers	.	C43-C44
DIB009640	ONO-1301	Angina	.	I20
DIB009641	AEZS-127	Cancer	140-229	C00-C96
DIB009642	PF-3635659	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB009643	GS-156 mAb	Cancer	140-229	C00-C96
DIB009644	Biferonex	Multiple sclerosis	.	G35
DIB009645	AZD-4017	Ocular hypertension	365.04	H40.0
DIB009646	AIR-insulin	Diabetes mellitus	250	E08-E13
DIB009647	TA-111	Neurological disease	.	G00-G99
DIB009648	Recombinant coagulation factors	Hemophilia	286	D66-D68
DIB009649	Vacc-C5	HIV infections	42	B20
DIB009650	Factor VIII/von Willebrand factor	Hemophilia	286	D66-D68
DIB009651	Vasotrophin	Ischemia	459.89	I99.8
DIB009652	Non-nucleoside HCV NS5B polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009653	A-6	Macular degeneration	.	H35.3
DIB009654	CRTH2 antagonists	Allergic rhinitis	477	J30
DIB009655	Ioxithalamate	Cardiovascular disease	390-459	I00-I99
DIB009656	FQN program	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009657	Mannose phosphate	Lesion	.	S00-T98
DIB009658	S-nitrosoglutathione reductase inhibitors	Asthma	493	J45
DIB009659	GNF-156	Plasmodium infection	.	B54
DIB009660	Pneumococcal conjugate vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB009661	Creatine derivatives	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB009662	BAY-60-5521	Arteriosclerosis	.	I70
DIB009663	Phenix project	Diabetes mellitus	250	E08-E13
DIB009664	SPF66	Malaria	.	B50-B54
DIB009665	HER-801	Neurological disease	.	G00-G99
DIB009666	Hydroxylase inhibitors	Inflammatory bowel disease	555, 556	K50, K51
DIB009667	IMA-950	Glioblastoma	.	C71
DIB009668	SX-AZD1	Alzheimer's disease	331	G30
DIB009669	Oxilofrine	Orthostatic hypotension	458	I95.1
DIB009670	IQP-0528	HIV infections	42	B20
DIB009671	BY-963	Myocardial disease	.	I21-I22,I40-I42
DIB009672	Enazadrem	Psoriasis	696	L40
DIB009673	SMT-D002	Seborrhea	.	L21
DIB009674	TA-993	Arteriosclerosis	440	I70
DIB009675	H-100	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009676	Inhalation	Cystic fibrosis	277	E84
DIB009677	Small molecule kinase inhibitors	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009678	SPD-453	Epilepsy	345	G40
DIB009679	Trimethobenzamide	Emesis	787	R11
DIB009680	EP-302	Cancer	140-229	C00-C96
DIB009681	Gene therapy	Glioblastoma multiforme	.	C71
DIB009682	DPC-082	Human immunodeficiency virus infection	.	B20
DIB009683	NB-002	Onychomycosis	.	B35.1
DIB009684	Small molecule boron-based therapeutics	Acne vulgaris	706.1	L70.0
DIB009685	V-0096 CR	Urticaria	.	L50
DIB009686	Beta-adrenoceptor ligands	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB009687	Transglutaminase 2 inhibitors	Cancer	.	C00-C97
DIB009688	A2E formation inhibitors	Macular degeneration	.	H35.3
DIB009689	ZM-224832	Hypertension	401	I10, I11, I12, I13, I15
DIB009690	Endosome-associated ubiquitin isopeptidase inhibitors	Pulmonary disease	460-519	J00-J99
DIB009691	Irtemazole	Hyperuricosuria	.	E79
DIB009692	Long-acting IL-11 analog	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB009693	Retinal degeneration therapy	Retinitis pigmentosa	.	H35.5
DIB009694	DTaP-IPV	Bordetella pertussis infection	.	A37.0
DIB009695	MEDI4893	Hospital-acquired pneumonia	.	J18.9
DIB009696	R-18893	HIV infections	42	B20
DIB009697	A2a antagonists	Drug dependence	303-304	F10.2-F19.2
DIB009698	Docetaxel water soluble formulation	Cancer	140-229	C00-C96
DIB009699	BMP-4	Glioblastoma	191	C71
DIB009700	HIF-PH inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009701	ISIS-10852	HIV infections	42	B20
DIB009702	99mTc-besilesomab	Bone metastases	198.5	C79.51
DIB009703	R-209130	Schizophrenia	295	F20
DIB009704	Alpha melanotropin	Lung injury	.	S00-T98
DIB009705	Pharmacological chaperones	Alzheimer's disease	331	G30
DIB009706	DYB-186	Hypercholesterolemia	272	E78.0
DIB009707	KOS-2079	Fungal infection	.	B35-B49
DIB009708	PD-132301-2	Arteriosclerosis	.	I70
DIB009709	LTX-200	Fungal infection	.	B35-B49
DIB009710	R-1518	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009711	Protein kinase inhibitor	Rheumatold arthritis	714	M05-M06
DIB009712	BBI-11008	Pain	338,780	R52, G89
DIB009713	AGN-214868	Overactive bladder disorder	.	N32.81
DIB009714	ODS-656	Osteopetrosis	.	Q78.2?
DIB009715	H5N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB009716	Havrix	Hepatitis virus infection	573.3	K75.9
DIB009717	BXL-746	Inflammatory diseases	.	.
DIB009718	Recombinant viral vector vaccine	Ebola virus infection	65.8	A98.4
DIB009719	PAT-PM-1	Pancreatic cancer	.	C25
DIB009720	IDD-3	Melanoma	.	C43
DIB009721	Synthetic peptide vaccine	HIV infections	42	B20
DIB009722	Leprovac	Mycobacterium infection	.	A31
DIB009723	Anti-inflammatory	Rheumatold arthritis	714	M05-M06
DIB009724	L-702958	Cardiac arrhythmias	.	I47-I49
DIB009725	SNP-002	Major depressive disorder	296.2, 296.3	F32, F33
DIB009726	RAGE antagonists	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB009727	Sanfetrinem cilexetil	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB009728	MDAB-16	Bone disease	.	M00-M99
DIB009729	ADAMTS-5 inhibitor	Arthritis	710-719	M00-M25
DIB009730	BPH-652	Hypercholesterolemia	272	E78.0
DIB009731	FluBiovax	Influenza virus infections	487	J10, J11
DIB009732	SeV gene vaccine	Influenza virus infections	487	J10, J11
DIB009733	PJ-2204	Migraine	346	G43
DIB009734	SiRNA therapeutics	Inflammatory diseases	.	.
DIB009735	SK-896	Gastric motility disorder	.	K22.4
DIB009736	BMS-188797	Cancer	140-229	C00-C96
DIB009737	PF-06669571	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB009738	MP-4-CO	Sickle-cell anemia	280-285	D50-D64
DIB009739	NSFQ-105	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009740	MDI-P	Asthma	493	J45
DIB009741	AGI-1096	Transplant rejection	.	Z94
DIB009742	STAT-3 inhibitor	Cancer	140-229	C00-C96
DIB009743	Hementin	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB009744	JMJ inhibitors	Cancer	140-229	C00-C96
DIB009745	Universal influenza vaccine	Influenza virus infections	487	J10, J11
DIB009746	Methyltransferase inhibitors	Cancer	140-229	C00-C96
DIB009747	Leonurine	Ischemic heart diseases	410-414	I20-I25
DIB009748	HD-148	Cancer	140-229	C00-C96
DIB009749	MIM-3Aa	Ocular disease	.	H00-H59
DIB009750	HGF-Met modulators	Cancer	140-229	C00-C96
DIB009751	Nociceptin/orphanin FQ receptor PET ligands	Psychiatric disorders	.	F99
DIB009752	H7N3 avian influenza virus live attenuated vaccine	Influenza virus infections	487	J10, J11
DIB009753	PA-1093	Multiple sclerosis	340	G35
DIB009754	CEP-41750	Rheumatold arthritis	.	M05-M06
DIB009755	Anti-obesity therapy	Obesity	278	E66
DIB009756	D-1927	Cancer	.	C00-C97
DIB009757	SERGOLEXOLE MALEATE	Migraine	.	G43
DIB009758	ICE inhibitors	Rheumatold arthritis	.	M05-M06
DIB009759	Subcuvia	Immune disorder	.	D80-D89
DIB009760	BURKE-103	Verruca vulgaris	.	B07.9
DIB009761	Sch-58500	Breast cancer	174, 175, 217	C50, D24
DIB009762	Non-beta2 receptor bronchodilators	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB009763	Anti-osteopontin-C monoclonal antibodies	Breast cancer	174, 175, 217	C50, D24
DIB009764	PRO-015	Retinitis pigmentosa	.	H35.5
DIB009765	Litenimod	Glioblastoma	.	C71
DIB009766	BP-100-1.02	Lymphoma	.	C81-C96
DIB009767	Org-34116	Anxiety disorder	300	F40-F42
DIB009768	Tumor-antigen-specific lymphocytes	Cancer	140-229	C00-C96
DIB009769	BI-RA-260	Arthritis	710-719	M00-M25
DIB009770	Betafectin	Immuno-modulator	.	D80-D89
DIB009771	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB009772	Live recombinant BCG vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB009773	Anti-beta-amyloid monoclonal antibody	Age related macular degeneration	.	H35.30
DIB009774	SAR-3419	Non-Hodgkin's lymphoma	.	C85.9
DIB009775	Recombinant subunit prophylactic vaccine	Chikungunya virus infection	.	A92.0
DIB009776	Pancopride	Nausea	.	R11
DIB009777	Non-Hodgkin's lymphoma vaccine	Haemophilus influenzae infection	.	J11.1
DIB009778	West Nile virus vaccine	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB009779	RIG-I activating 3p-siRNA therapeutics	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009780	AI-300	Uveitis	364	H20
DIB009781	PR-21	Spinal cord injuries	952	S14, S24, S34
DIB009782	Inflammatory bowel disease (IBD) therapy	Inflammatory bowel disease	555, 556	K50, K51
DIB009783	ABT-702	Pain	.	G89
DIB009784	KW-3635	Thrombosis	.	I80-I82
DIB009785	SPK-843	Fungal infection	.	B35-B49
DIB009786	ITX-7650	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009787	RGD-containing peptides	Osteoporosis	733	M80-M81
DIB009788	FOROPAFANT	Asthma	.	J45
DIB009789	Angiotensin therapeutic vaccine	Hypertension	401	I10, I11, I12, I13, I15
DIB009790	RX-0201N	Cancer	140-229	C00-C96
DIB009791	Natriuretic peptide receptor agonists	Hypertension	401	I10, I11, I12, I13, I15
DIB009792	Antifungal agents	Fungal infection	.	B35-B49
DIB009793	MRNA-046	Cancer	140-229	C00-C96
DIB009794	P2X3 receptor antagonists	Pain	338,780	R52, G89
DIB009795	Anticancer agents	Cancer	140-229	C00-C96
DIB009796	PI3K inhibitors	Cancer	140-229	C00-C96
DIB009797	TRESK openers	Pain	338,780	R52, G89
DIB009798	EP HIV-1090	HIV-1 infections	42	B20
DIB009799	Tricomin	Alopecia	.	L65.9
DIB009800	Propyphenazone	Pain	338,780	R52, G89
DIB009801	Low dose ITI-007	Sleep disorders	.	F51,G47
DIB009802	Vaxigrip QIV IM	Non-small cell lung cancer	.	C34.90
DIB009803	Beta 2 adrenoceptor agonists	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB009804	Moxidectin	Onchocerciasis	.	B73
DIB009805	A-366833	Pain	.	G89
DIB009806	Androgen receptor antagonists	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB009807	MIV-710	Bone metastases	198.5	C79.51
DIB009808	NGD-94-2	Schizophrenia	295	F20
DIB009809	D-22888	Allergy	.	T78.4
DIB009810	Ecalcidene	Acne vulgaris	.	L70.0
DIB009811	DAC:antiviral	HIV infections	42	B20
DIB009812	Fully human mAbs	Infectious disease	001-139	A00-B99
DIB009813	C-203	Inflammation	.	I20-I25
DIB009814	Influenza vaccines	Influenza virus infections	487	J10, J11
DIB009815	Emopamil	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009816	HPV 6/11 vaccine	Papillomavirus infections	.	B97.7
DIB009817	Alkylisothioureas	Neurological disease	.	G00-G99
DIB009818	XU-745	Inflammatory diseases	.	.
DIB009819	Smallpox vaccine	Virus infection	.	B03
DIB009820	XEN-403	Pain	338,780	R52, G89
DIB009821	Bevirimat	HIV infections	42	B20
DIB009822	IR-201	Arthritic	710-719	M00-M25
DIB009823	H5N1 and H1N1 influenza monoclonal antibody therapy	Influenza A virus infections	.	J11.1
DIB009824	Antivirals	Viral infections	042-075	A80-A99, B00-B34
DIB009825	Hepatitis B Hyperimmune	Hepatitis B virus infection	.	B16
DIB009826	VT-111a	Acute coronary syndrome	411.1	I20.0
DIB009827	MC-113	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB009828	BDD-20617	Parkinson's disease	.	G20
DIB009829	TRC-4186	Diabetic complication	.	E08-E13
DIB009830	BF/PC-18	Inflammatory diseases	.	.
DIB009831	RG-7348	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009832	Stromal stem cell therapy	Liver falure	.	K72
DIB009833	EDP-17	Cancer	140-229	C00-C96
DIB009834	BT-V003	Influenza virus infections	487	J10, J11
DIB009835	Macrolide motilin agonists	Gastric motility disorder	.	K22.4
DIB009836	EC-70124	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009837	18F-VEGF binding peptides (PET imaging), Genentech	Cancer	140-229	C00-C96
DIB009838	Epetirimod	Viral infections	042-075	A80-A99, B00-B34
DIB009839	LX-7101	Glaucoma	365	H40-H42
DIB009840	Colistimethate sodium	Pseudomonas infection	041.7, 482.1	B96.5, J15.1, P23.5
DIB009841	Recombinant CD28	Allergy	.	T78.4
DIB009842	TP10	Myocardial infarction	410	I21, I22
DIB009843	Resorstatin	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009844	Syk kinase inhibitors	Inflammatory diseases	.	.
DIB009845	CD4 antagonists/HIV entry inhibitors	HIV infections	42	B20
DIB009846	Colorectal cancer therapy	Colorectal cancer	153, 154	C18-C21
DIB009847	Somatostatin vaccine	Diabetes mellitus	250	E08-E13
DIB009848	V-419	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
DIB009849	F-627	Neutropenia	.	D70
DIB009850	Multipeptide vaccine combination	Melanoma	172	C43
DIB009851	IXS-312	Ocular disease	.	H00-H59
DIB009852	GSK2793660	Bronchiectasis	494, 748.61	J47, Q33.4
DIB009853	5-methoxypsoralen	Psoriasis	696	L40
DIB009854	CMD-003	Lymphoma	.	C81-C96
DIB009855	Recombinant human CC10	Asthma	.	J45
DIB009856	MER-5101	Alzheimer's disease	331	G30
DIB009857	Virion project	HIV-1 infections	42	B20
DIB009858	MOGUISTEINE	Cough	786.2	R05
DIB009859	VEGF gene therapy	Diabetic angiopathy	.	E10.5,E11.5,E12.5,E13.5,E14.5
DIB009860	TNF alpha kinoid	Autoimmune diseases	.	D84.9
DIB009861	IGF-2 receptor modulators	Cancer	140-229	C00-C96
DIB009862	SDZ-PTS-893	Osteoporosis	733	M80-M81
DIB009863	Glycopeptide	Discovery agent	.	.
DIB009864	BPL-002 series	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009865	CCK2 receptor antagonists,	Gastroesophageal reflux disease	.	K21
DIB009866	Antibacterial DNA polymerase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009867	Campyvax	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009868	Cancer therapy	Cancer	140-229	C00-C96
DIB009869	INTOPLICINE	Solid tumours	.	C00-C75,C7A,C7B
DIB009870	DRA-161	Diabetes mellitus	250	E08-E13
DIB009871	TDI-0047	Motor neurone disease	335.2	G12.2
DIB009872	BAL-2299	Psoriasis	696	L40
DIB009873	FluGEM	Influenza virus infections	487	J10, J11
DIB009874	Antiviral	Influenza virus infections	487	J10, J11
DIB009875	Leukotoxin	Autoimmune diseases	279.4	D84.9, M35.9
DIB009876	99mTc-ciprofloxacin, DRAXIS	Infections disease	.	A00-B99
DIB009877	SOM-0999	Multiple sclerosis	340	G35
DIB009878	Ad5-TRAIL	Prostate tumor	185	C61
DIB009879	AVX-470	Inflammatory bowel disease	555, 556	K50, K51
DIB009880	STEBVax	Endotoxic shock	.	R57.8
DIB009881	Brofaromine	Anxiety disorder	.	F40-F42
DIB009882	JPD-071	Inflammatory diseases	.	.
DIB009883	TG-1024	Solid tumours	.	C00-C75,C7A,C7B
DIB009884	OPC-51803	Urinary incontinence	.	N39.3-N39.4
DIB009885	HER-2 antagonists	Breast cancer	.	C50
DIB009886	L-733560	Aspergillosis	.	B44
DIB009887	Anti-inflammatory polysaccharides	Inflammatory diseases	.	.
DIB009888	IODOSTEARIC ACID	Cancer	140-229	C00-C96
DIB009889	Mast cell degranulation inhibitors	Asthma	493	J45
DIB009890	ANGX-3227	Sickle-cell anemia	280-285	D50-D64
DIB009891	FK-355	Asthma	.	J45
DIB009892	PYN-17	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009893	Alpha 4 beta 2 nicotinic acetylcholine receptor (nAChR) agonist	Alzheimer's disease	331	G30
DIB009894	Iosimide	Coronary artery disease	.	I20-I25
DIB009895	Vaccinia immune globulin	Vaccination	.	.
DIB009896	MBX-1684	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB009897	Hydromorphone hydrochloride	Pain	338,780	R52, G89
DIB009898	PRL-3 specific mAbs	Metastasis	.	C00-C97
DIB009899	ICGD	Cancer	.	C00-C97
DIB009900	GAM-501	Diabetic foot ulcer	.	E08-E13
DIB009901	BMS-223131	Erectile dysfunction	.	F52.2,N48.4
DIB009902	UX-001	Myopathy	.	M60-M63
DIB009903	T-0128	Solid tumours	.	C00-C75,C7A,C7B
DIB009904	EDP-239	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB009905	GFC-012	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB009906	LOR-2501	Solid tumours	.	C00-C75,C7A,C7B
DIB009907	SHEF-1	Age related macular degeneration	.	H35.30
DIB009908	NNC-59-0145	Osteoporosis	733	M80-M81
DIB009909	Minicell vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009910	TRI-50 antidote	Bleeding	.	R58
DIB009911	Recombinant batroxobin	Bleeding	.	R58
DIB009912	Fentanyl/droperidol	Anesthesia	338	R52
DIB009913	Hyqvia	Immunodeficiency	.	D84.9
DIB009914	Sulphur-containing lipids	Psoriasis	696	L40
DIB009915	CARZELESIN	Solid tumours	.	C00-C75,C7A,C7B
DIB009916	DA-697b	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB009917	Chymopapain	Musculoskeletal disease	.	M00-M99
DIB009918	Antioxidant/chelator program	Cataract	366	H25-H26, H28, Q12.0
DIB009919	ARA-04	Entamoeba histolytica infection	.	A06
DIB009920	TCD-717	Solid tumours	.	C00-C75,C7A,C7B
DIB009921	S-0509	Ulcerative colitis	.	K51
DIB009922	Muscarinic M3 antagonists	Overactive bladder disorder	596.51	N32.81
DIB009923	PNU-142731A	Asthma	.	J45
DIB009924	NIBR-785	Multiple sclerosis	340	G35
DIB009925	Monoclonal antibody mimetics	Cancer	140-229	C00-C96
DIB009926	GCSF	Cancer	140-229	C00-C96
DIB009927	Pim kinase inhibitors	Cancer	140-229	C00-C96
DIB009928	Alilusem	Diuretic	.	Y54.5
DIB009929	AZD-8683	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB009930	99MTC-RP-128	Diagnosis	.	Y57.6
DIB009931	13C-urea	Helicobacter pylori infection	41.86	B96.81
DIB009932	ZK-137316	Female contraception	.	Z30.013
DIB009933	Endometrial blood stem cell therapy	Heart failure	.	I50
DIB009934	AQX-1125	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB009935	Bone morphogenetic protein-2	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB009936	JSM-10292	Pain	.	G89
DIB009937	Single mAb therapy	Infectious disease	001-139	A00-B99
DIB009938	CHIR-29498	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB009939	PEV-6A	Breast cancer	174, 175	C50
DIB009940	PLD-147	Solid tumours	.	C00-C75,C7A,C7B
DIB009941	NA-808	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009942	GRC-6211	Asthma	493	J45
DIB009943	Darodipine	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB009944	Interleukin-1 antagonist	Rheumatold arthritis	.	M05-M06
DIB009945	GG-818	Prostate disorder	.	N40-N42
DIB009946	AS-1403	Breast cancer	174, 175, 217	C50, D24
DIB009947	VG-102	Cancer	140-229	C00-C96
DIB009948	HDAC8 inhibitor	Neurodegenerative diseases	.	G30-G32
DIB009949	Autologous stem cell therapy	Motor neurone disease	335.2	G12.2
DIB009950	Aldose reductase inhibitors	Diabetes mellitus	.	E10-E14
DIB009951	Corus 1030	Asthma	493	J45
DIB009952	Ferric citrate	Chronic kidney disease	.	N17-N19
DIB009953	NSD-721	Anxiety disorder	300	F40-F42
DIB009954	APX-001	Rheumatold arthritis	714	M05-M06
DIB009955	INKP-102	Gastrointestinal infection	.	A09.0
DIB009956	SeV gene vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB009957	AM-3840	Autoimmune diseases	279.4	D84.9, M35.9
DIB009958	TTH 03-002	Neurodegenerative diseases	.	G30-G32
DIB009959	EPICOAT cancer vaccine	Cancer	140-229	C00-C96
DIB009960	Zona pellucida antigens	Ovarian cancer	.	C56
DIB009961	Anascorp	Poison intoxication	.	T36-T50
DIB009962	Protein subunit vaccine	Chlamydia pneumoniae infection	.	A74.9
DIB009963	Certiva	Bordetella pertussis infection	.	A37.0
DIB009964	Human antibody	Cancer	140-229	C00-C96
DIB009965	ISIS-PTP-1BRx	Diabetes mellitus type 2	.	E11
DIB009966	Hydroxypropyl methylcellulose	Hypercholesterolemia	272	E78.0
DIB009967	Hepatitis C virus DNA vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009968	Anti-GLI1 antibodies	Cancer	140-229	C00-C96
DIB009969	Dehydroxymethylepoxyquinomicin	Cachexia	799.4	R64
DIB009970	REC-0467	Gastroesophageal reflux disease	.	K21
DIB009971	Hedgehog pathway inhibitor	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB009972	FH-510	Psychotic disorders	.	F20-F29
DIB009973	Histamine H4 receptor antagonist	Inflammatory diseases	.	.
DIB009974	STAT3 inhibitors	Cancer	140-229	C00-C96
DIB009975	Rabies vaccine	Rabies virus infection	001-139	A00-B99
DIB009976	OLT1177 gel	Pain	.	G89
DIB009977	E-2212	Alzheimer's disease	.	G30,F00
DIB009978	R-1487	Rheumatold arthritis	714	M05-M06
DIB009979	Mu opioid receptor modulators	Pain	338,780	R52, G89
DIB009980	Coluracetam	Alzheimer's disease	.	G30,F00
DIB009981	Nucleoside analogs	Hepatitis virus infection	573.3	K75.9
DIB009982	Anti-IL-6 monoclonal antibody	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
DIB009983	DD-3	Autoimmune diseases	279.4	D84.9, M35.9
DIB009984	Eflucimibe	Hyperlipidemia	.	E78.5
DIB009985	Palonidipine hydrochloride	Hypertension	401	I10, I11, I12, I13, I15
DIB009986	Tau-binding PET tracer	Alzheimer's disease	331	G30
DIB009987	JTK-109	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB009988	SMK-01/03	Ocular disease	.	H00-H59
DIB009989	Metabotropic mGluR1 agonists	Neurological disease	.	G00-G99
DIB009990	A-717	Diabetes mellitus	250	E08-E13
DIB009991	Peptidomimetics	Pain	338,780	R52, G89
DIB009992	HBV vaccine	Hepatitis B virus infection	.	B16
DIB009993	CPG23DIAB	Insulin dependent diabetes	.	E10
DIB009994	P-1075	Hypertension	.	I10-I15
DIB009995	Syntropin	Dwarfism	.	E23.0,E34.2,E45.0,Q77.4
DIB009996	Lipid soluble antioxidants	Cardiovascular disease	390-459	I00-I99
DIB009997	IP10.C8-1	Psoriasis	696	L40
DIB009998	Contusugene ladenovec	Oral cavity cancer	.	C00-C08
DIB009999	Anetumab ravantansine	Cancer	140-229	C00-C96
DIB010000	Estrogen receptor beta agonists	Endometriosis	617	N80
DIB010001	Poractant alfa	Respiratory distress syndrome	518.5, 518.82	J80
DIB010002	AcVx-25 cream	Acne vulgaris	706.1	L70.0
DIB010003	Gene therapy	Cancer	.	C00-C97
DIB010004	OCT-1547	Osteoporosis	733	M80-M81
DIB010005	CY-1787	Allergy	995.3	T78.4
DIB010006	ACE-393	Diarrhea	.	A09,K59.1
DIB010007	GPR 40 agonists	Non-insulin dependent diabetes	.	E11.9
DIB010008	WCK-1152	Respiratory tract inflammation	.	J00-J99
DIB010009	WSBI-19711A	Autoimmune diseases	279.4	D84.9, M35.9
DIB010010	RGRF	Muscle weakness	.	M62.8
DIB010011	Dibenzepin	Anxiety disorder	300	F40-F42
DIB010012	XTL-6865	Hepatitis C virus infection	.	B17.1,B18.2
DIB010013	Stepronin	Bronchitis	.	J20-J21,J42
DIB010014	GABA uptake inhibitor	Seizures	.	G40,R56
DIB010015	RBPI-21	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010016	Dihydroxyacetone	Sunburn	.	L55.9
DIB010017	Umespirone	Anxiety disorder	.	F40-F42
DIB010018	KP-413	Atopic dermatitis	691.8	L20
DIB010019	UD-CG-212	Heart failure	.	I50
DIB010020	Eptapirone	Anxiety disorder	.	F40-F42
DIB010021	AVP-786	Pain	.	G89
DIB010022	KH-901	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010023	Cystic fibrosis program	Cystic fibrosis	277	E84
DIB010024	PTI-301	Discovery agent	.	.
DIB010025	ET-004	HIV infections	42	B20
DIB010026	SMT-19969	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB010027	SL-65.1498	Anxiety disorder	300	F40-F42
DIB010028	RU-33965	Alzheimer's disease	.	G30,F00
DIB010029	ORMD-1001	Influenza virus infections	487	J10, J11
DIB010030	Cytovaxine	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB010031	BRL-32872A	Cardiac arrhythmias	.	I47-I49
DIB010032	TDI-0025	Motor neurone disease	335.2	G12.2
DIB010033	Sepimostat mesylate	Cancer	140-229	C00-C96
DIB010034	RWJ-51204	Anxiety disorder	300	F40-F42
DIB010035	F-12509A	Arteriosclerosis	.	I70
DIB010036	LY-315902	Diabetes mellitus type 2	.	E11
DIB010037	LAS-41002	Eczema	.	L20-L30
DIB010038	DW-403	Asthma	493	J45
DIB010039	Estriol E3	Multiple sclerosis	340	G35
DIB010040	CETP inhibitors	Atherosclerosis	414.0, 440	I70
DIB010041	S. aureus type 336 vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010042	AMA-1-Dico	Plasmodium falciparum infection	.	B54
DIB010043	Immunomodulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB010044	LT-0301	Cancer	140-229	C00-C96
DIB010045	CCR4 antagonists	Atopic dermatitis	691.8	L20
DIB010046	Pollen allergen immunotherapy	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DIB010047	Anticonvulsants	Epilepsy	345	G40
DIB010048	AA-102	Breast cancer	174, 175, 217	C50, D24
DIB010049	INP-04	Cancer	140-229	C00-C96
DIB010050	Ion Channel Therapy	Erectile dysfunction	.	F52.2,N48.4
DIB010051	Berupipam	Psychotic disorders	.	F20-F29
DIB010052	NFTA-105	Cardiovascular disease	390-459	I00-I99
DIB010053	Colon cancer vaccine	Colon cancer	153, 154	C18-C21
DIB010054	Human mAbs	Influenza virus infections	487	J10, J11
DIB010055	Dual-targeting compounds	Glaucoma	365	H40-H42
DIB010056	Mibampator	Alzheimer's disease	.	G30,F00
DIB010057	Humanized mAb program	Stomach cancer	.	C16
DIB010058	Mycobacterium tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB010059	Measles vaccine	Measles virus infection	.	B06.9
DIB010060	ImmuDyn	HIV infections	42	B20
DIB010061	ISG15-LNP01	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010062	Gastroesophageal reflux disease	Gastroesophageal reflux disease	530	K21
DIB010063	Plague vaccine	Yersinia infections	.	A20
DIB010064	BAY-86-4367	Cancer	140-229	C00-C96
DIB010065	PP-303	Alopecia	.	L65.9
DIB010066	ALTU-242	Gout	274.00274.1274.8274.9	M10
DIB010067	CRL-8131	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010068	VR-776	Premature ejaculation	302.75	F52.4
DIB010069	AMI-121	Gastrointestinal disease	.	K00-K93
DIB010070	Cytokine production inhibitors	Cancer	.	C00-C97
DIB010071	ADC-1013	Cancer	140-229	C00-C96
DIB010072	Transcriptional regulators	Inflammatory diseases	.	.
DIB010073	Arthritis therapeutics	Arthritis	710-719	M00-M25
DIB010074	ART-144	Osteoarthritis	715	M15-M19, M47
DIB010075	CNS-1524	Neuropathy	356.0, 356.8	G64, G90.0
DIB010076	Small molecule therapeutics	Influenza virus infections	487	J10, J11
DIB010077	MGluR4 PAM modulators	Anxiety disorder	300	F40-F42
DIB010078	APD-916	Sleep disorders	.	F51,G47
DIB010079	Anti-TLR3 mAbs	Autoimmune diseases	279.4	D84.9, M35.9
DIB010080	BECIPARCIL	Coagulation	.	I80-I82
DIB010081	AskBio009	Hemophilia B	.	D67
DIB010082	MAHDL01	Hyperlipidemia	272.0-272.4	E78
DIB010083	Dihydroorotate dehydrogenase inhibitors	Plasmodium infection	.	B54
DIB010084	SYM-008	Infectious disease	001-139	A00-B99
DIB010085	Antifungals	Fungal infection	.	B35-B49
DIB010086	BMS-189664	Myocardial infarction	.	I21-I22
DIB010087	AKT-10082	Vibrio cholerae infection	.	A00.0
DIB010088	Antibacterial compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010089	C-0333158	Atopic dermatitis	691.8	L20
DIB010090	VLCA- 04	Clostridium infection	001-139	A00-B99
DIB010091	API-31510	Squamous cell carcinoma	199	C44
DIB010092	AR-709	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB010093	Alzheimers therapeutics	Alzheimer's disease	.	G30,F00
DIB010094	MGB-101	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB010095	CR-5790 series	Osteoarthritis	715	M15-M19, M47
DIB010096	CP-4033	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010097	XEN-D0101	Atrial fibrillation	427.31	I48
DIB010098	NN-818	Brain injury	.	S06
DIB010099	LY-2590443	Migraine	346	G43
DIB010100	EBP-1597	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010101	Long-acting interferon beta conjugate	Multiple sclerosis	340	G35
DIB010102	Vecuronium bromide	Anesthesia	338	R52
DIB010103	Romurtide	Cancer	140-229	C00-C96
DIB010104	P53 mdm-2-binding domain peptides	Cancer	140-229	C00-C96
DIB010105	Pbi-shRNA STMN1 LP	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010106	Lymphocyte-specific protein tyrosine kinase inhibitors	Inflammatory diseases	.	.
DIB010107	RI-001	Respiratory syncytial virus 	.	B97.4
DIB010108	Vaccine	HIV infections	42	B20
DIB010109	T-82	Cognitive impairment	.	F06.7
DIB010110	Interleukin-3	Aplastic anemia	284	D60-D61
DIB010111	BCP-1081	Asthma	493	J45
DIB010112	VariZIG	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
DIB010113	DBP-192	Anxiety disorder	300	F40-F42
DIB010114	MK-8245	Diabetes mellitus type 2	.	E11
DIB010115	MER-4101	Influenza virus infections	487	J10, J11
DIB010116	YM-57158	Allergic rhinitis	.	J30
DIB010117	DWP-438	Cancer	140-229	C00-C96
DIB010118	AT-008	Autoimmune diseases	279.4	D84.9, M35.9
DIB010119	STS-T4	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB010120	Oral paclitaxel	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB010121	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB010122	MF-8615	Alzheimer's disease	.	G30,F00
DIB010123	Fluoropeptide vaccine	Influenza virus infections	487	J10, J11
DIB010124	Glucagon antagonists	Non-insulin dependent diabetes	.	E11.9
DIB010125	HepeX-B	Hepatitis virus infection	573.3	K75.9
DIB010126	HuMax-cMet	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010127	ROR-1 inhibitors	Chronic lymphocytic leukaemia	204.1	C91.1
DIB010128	Syntocinon nasal spray	Schizophrenia	.	F20
DIB010129	Co-2-1068	Epilepsy	345	G40
DIB010130	ITI-014 series	Hot flashes	.	N95.1
DIB010131	Viral capsid assembly inhibitors	Influenza virus infections	487	J10, J11
DIB010132	TOFIMILAST	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB010133	Quantison	Cardiovascular disease	390-459	I00-I99
DIB010134	M2 live attenuated H5N1 vaccine	Influenza virus infections	487	J10, J11
DIB010135	Gavilimomab	Graft-versus host disease	.	T86.0
DIB010136	Interferon alpha	Cancer	.	C00-C97
DIB010137	MDDR 180243	Cancer	140-229	C00-C96
DIB010138	PMA-406	Cancer	140-229	C00-C96
DIB010139	TDI-0049	Motor neurone disease	335.2	G12.2
DIB010140	RNAi therapeutic	Head and neck cancer	140-149	C07-C14, C32-C33
DIB010141	QGE-031	Medullary thyroid cancer	193	C73
DIB010142	INP-06	Pain	338,780	R52, G89
DIB010143	OraTest	Oral cavity cancer	.	C00-C08
DIB010144	ELINAFIDE MESILATE	Solid tumours	.	C00-C75,C7A,C7B
DIB010145	Spermine analogs	Cancer	140-229	C00-C96
DIB010146	Tresperimus	Ocular inflammation	.	H00-H59
DIB010147	ALD-403	Migraine	.	G43
DIB010148	LY-686017	Alcohol use disorders	.	F10
DIB010149	Soblidotin	Cancer	.	C00-C97
DIB010150	Reviroc	B-cell lymphoma	.	C85.1
DIB010151	AZD-4316	Discovery agent	.	.
DIB010152	MIM-A2	Glaucoma	365	H40-H42
DIB010153	NP-184	Angiogenesis disorder	.	I00-I99
DIB010154	AMG-548	Inflammatory diseases	.	.
DIB010155	DNA gyrase inhibitors	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010156	O-linked N-acetylglucosaminidase modulators	Alzheimer's disease	331	G30
DIB010157	VVZ-172	Pain	338,780	R52, G89
DIB010158	Insulin	Diabetes mellitus	250	E08-E13
DIB010159	Sodium nitrite	Diabetic angiopathy	250.7	E10.5, E11.5, E13.5
DIB010160	CGRP antagonists	Migraine	346	G43
DIB010161	ITV-2	HIV infections	42	B20
DIB010162	Lactococcus lactis anti-IL-27	Inflammatory bowel disease	555, 556	K50, K51
DIB010163	Isosulfan blue	Investigative surgical procedure	.	.
DIB010164	99mTc-DI-DD3B6/22-80B3	Glioblastoma	.	C71
DIB010165	Antihypertensive agent	Hypertension	401	I10, I11, I12, I13, I15
DIB010166	Meningococcal ACYW-135 vaccine	Neisseria meningitidis infection	.	A87
DIB010167	Cat hair allergenic extracts	Allergic reaction	995.3	T78.4
DIB010168	SAN-18	Rheumatold arthritis	714	M05-M06
DIB010169	ErbB1-targeting antibodies	Cancer	140-229	C00-C96
DIB010170	Droxicam	Inflammatory diseases	.	.
DIB010171	NSC-73306	Cancer	140-229	C00-C96
DIB010172	Deuterium-enriched atorvastatin derivatives	Hyperlipidemia	272.0-272.4	E78
DIB010173	PEG-TGF peptantagonist	Pulmonary fibrosis	515, 516.3	J84.1
DIB010174	PF-2393296	Neuropathic pain	338,780	R52, G89
DIB010175	YM-264	Septic shock	.	A41.9
DIB010176	HL-023	Cancer	.	C00-C97
DIB010177	WS-75624B	Cardiovascular disease	390-459	I00-I99
DIB010178	Vomeropherin	Obesity	278	E66
DIB010179	Recombinant plasminogen-based therapy	Infectious disease	001-139	A00-B99
DIB010180	F-18 T808	Alzheimer's disease	331	G30
DIB010181	SB-2343	Cancer	140-229	C00-C96
DIB010182	NVA-011	Central nervous system injury	.	P11.9
DIB010183	OP-04 program	Pancreatic cancer	.	C25
DIB010184	Multivalent carbohydrate-based vaccine	Cancer	140-229	C00-C96
DIB010185	Autologous skeletal myoblast therapy	Cardiac failure	.	I50
DIB010186	Recombinant human alkaline phosphatase	Renal failure	584, 585	N17, N18, N19
DIB010187	DAU-5884	Bronchus disease	.	J20-J22,J40-J47
DIB010188	NPT-500	Major depressive disorder	296.2, 296.3	F32, F33
DIB010189	ZP-EPO	Anemia	280-285	D50-D64
DIB010190	PharmaPEG-GM-CSF	Hematological disease	.	D50-D89
DIB010191	Anti-CD3/anti-CD20 bispecific antibody-armed activated T-cells	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB010192	Phosphatonin	Hyperphosphatemia	.	E83
DIB010193	FAP inhibitors	Cancer	.	C00-C97
DIB010194	Recombinant pox virus vaccine	Breast cancer	.	C50
DIB010195	Pagoclone	Anxiety disorder	300	F40-F42
DIB010196	Conjugated siRNA therapeutics	Cancer	140-229	C00-C96
DIB010197	O-SPC/rBRU vaccine	Shigella sonnei infection	.	A03.9
DIB010198	NNC-26-0610	Growth hormone deficiency	.	E23.0
DIB010199	Phloroglucinol	Urinary tract disease	.	N00-N99
DIB010200	SERX-1	Non-insulin dependent diabetes	.	E11.9
DIB010201	VEGF antagonist program	Age related macular degeneration	.	H35.30
DIB010202	Leptin receptor antagonists	Cancer	.	C00-C97
DIB010203	Engerix B	Hepatitis B virus infection	.	B16
DIB010204	VAS-2870	Cardiovascular disease	390-459	I00-I99
DIB010205	Epristeride	Hirsutism	.	L68.0
DIB010206	VLDM-01	Prostate hyperplasia	.	N40
DIB010207	PEGylated recombinant aglycosyl EPO	Anemia	280-285	D50-D64
DIB010208	Clovoxamine	Major depressive disorder	296.2, 296.3	F32, F33
DIB010209	Influenza B vaccine	Influenza virus infections	487	J10, J11
DIB010210	IKK inhibitors	Cancer	140-229	C00-C96
DIB010211	AZD-7545	Diabetes mellitus	250	E08-E13
DIB010212	IPZ-010	Allergy	995.3	T78.4
DIB010213	Nabumetone	Pain	.	G89
DIB010214	EP-3533	Myocardial infarction	410	I21, I22
DIB010215	Adenosine analog DNA ligase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010216	SDZ-MKS-492	Asthma	.	J45
DIB010217	Monoclonal antibody triple combination	HIV infections	42	B20
DIB010218	P2Y8 antagonists	Acute lymphoblastic leukemia	204	C91.0
DIB010219	Inactivated H7N7 influenza vaccine	Influenza virus infections	487	J10, J11
DIB010220	GLP-1	Diabetes mellitus	250	E08-E13
DIB010221	INP-03	Poison intoxication	.	T36-T50
DIB010222	KNX-Monoclonal204	Alzheimer's disease	331	G30
DIB010223	TTL-1177	Cancer	.	C00-C97
DIB010224	5-HT1B antagonists (anxiety/depression), AstraZeneca	Mood disorder	.	F30-F39
DIB010225	FK-3311	Rheumatold arthritis	.	M05-M06
DIB010226	SOR-N43	Pain	338,780	R52, G89
DIB010227	AGX-1009	HIV-1 infections	42	B20
DIB010228	C-Kit inhibitors	Cancer	140-229	C00-C96
DIB010229	PF-4325667	Diabetes mellitus	250	E08-E13
DIB010230	PEV-4	Respiratory syncytial virus 	79.6	B97.4
DIB010231	Selective estrogen receptor modulators	Female sexual dysfunction	302.7	F52, R37
DIB010232	Viroprev	Viral infections	042-075	A80-A99, B00-B34
DIB010233	Antibacterial bacteriophage therapy	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010234	RC-8800	Cancer	.	C00-C97
DIB010235	Anti-HCMV	Cytomegalovirus infection	.	B25
DIB010236	KPE-00001113	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010237	QBI-206	Cancer	140-229	C00-C96
DIB010238	HUS program	Acquired hemolytic anemia	.	D59.9
DIB010239	Sleep disorder therapy	Sleep disorders	307.4, 327, 780.5	F51, G47
DIB010240	Nasal phage therapy	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010241	PPAR dual agonists	Metabolic disorders	.	E70-E90
DIB010242	NK3 antagonist PET ligand	Psychiatric disorders	.	F99
DIB010243	PD-145065	Hypertension	.	I10-I15
DIB010244	FV-100	Adult varicella zoster virus infection	.	B02
DIB010245	ERYTHRITOL	Neurological disease	.	G00-G99
DIB010246	MORAb-022	Autoimmune diseases	.	D84.9
DIB010247	Iocetamic acid	Bladder disease	.	N30-N32
DIB010248	HBVax	Hepatitis B virus infection	.	B16
DIB010249	HRA-081025	Contraception	.	Z30
DIB010250	PHX-1766	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010251	AZD-6088	Neuropathic pain	338,780	R52, G89
DIB010252	Drug 2881078	Heart failure	.	I50
DIB010253	CD40 ligand	Solid tumours	.	C00-C75,C7A,C7B
DIB010254	AGX-1053	Cancer	140-229	C00-C96
DIB010255	CT-100	Cancer	140-229	C00-C96
DIB010256	T3	Congestive heart failure	428	I50
DIB010257	TLV-1	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB010258	HL-004	Cancer	.	C00-C97
DIB010259	JNJ-10397049	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB010260	CERC-301	Major depressive disorder	.	F32,F33
DIB010261	ND-801	Mycobacterium tuberculosis infection	.	A15-A19
DIB010262	Arylsulfatase A gene therapy	Metachromatic leukodystrophy	.	E75.25
DIB010263	Cytosolic phospholipase A2 alpha inhibitors	Inflammatory diseases	.	.
DIB010264	VIR-5103	HIV infections	42	B20
DIB010265	IO-21	Ulcer	531-534	K25-K27
DIB010266	RS-8891	Hypertension	.	I10-I15
DIB010267	PNB-04	Alzheimer's disease	331	G30
DIB010268	VM-206	Cancer	140-229	C00-C96
DIB010269	HG-1226	Cancer	140-229	C00-C96
DIB010270	Methylprednisolone	Spinal cord injuries	952	S14, S24, S34
DIB010271	Retagliptin	Non-insulin dependent diabetes	.	E11.9
DIB010272	Silyman DD	Liver disease	570-574	K70-K77
DIB010273	VAL-201	Cancer	.	C00-C97
DIB010274	GR-253035	Alzheimer's disease	.	G30,F00
DIB010275	Zanapezil	Alzheimer's disease	.	G30,F00
DIB010276	Ruthenium (II) phosphine/picolinate complexes	Mycobacterium tuberculosis infection	.	A15-A19
DIB010277	FK-317	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010278	Cardiovascular disease medicine	Cardiovascular disease	390-459	I00-I99
DIB010279	FR-901379	Pneumocystis carinii infection	.	B59
DIB010280	GIT27-NO	Cancer	140-229	C00-C96
DIB010281	TT-301	Alzheimer's disease	.	G30,F00
DIB010282	Zofroxia	Influenza virus infections	487	J10, J11
DIB010283	HBV therapy	Hepatitis virus infection	573.3	K75.9
DIB010284	Oncolysin M	Leukemia	208.9	C91-C95
DIB010285	Anti-Hepcdin antibody	Anemia	.	D50-D64
DIB010286	BAX-111	Pain	.	G89
DIB010287	CryptoGAM	Cryptosporidium infection	.	A07.2
DIB010288	MC4 antagonist	Discovery agent	.	.
DIB010289	AT1022	Pain	338,780	R52, G89
DIB010290	NC-002	Premenstrual syndrome	.	N94.3
DIB010291	TD-2749	Gastrointestinal disease	.	K00-K93
DIB010292	Anti-CD3 and anti-Her2/neu bispecific antibody-armed activated T cells	Breast cancer	.	C50
DIB010293	Withaferin A	Melanoma	172	C43
DIB010294	ROS tyrosine kinase inhibitors	Glioblastoma	191	C71
DIB010295	Ro-46-5934	Alzheimer's disease	.	G30,F00
DIB010296	GLPG-0555	Osteoarthritis	715	M15-M19, M47
DIB010297	ASP-1707	Endometriosis	.	N80
DIB010298	GC-1109	Bacillus anthracis infection	.	A22
DIB010299	Humanized monoclonal antibody	Colorectal cancer	153, 154	C18-C21
DIB010300	OBP-801	Cancer	140-229	C00-C96
DIB010301	NP-50301	Eye disorders	.	H00-H59
DIB010302	LIV-2008	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010303	Prochlorperazine inhaled	Migraine	346	G43
DIB010304	NMDA/calcium channel antagonists	Alzheimer's disease	.	G30,F00
DIB010305	DAPITANT	Pain	.	G89
DIB010306	Glucokinase activators	Diabetes mellitus type 2	.	E11
DIB010307	DTS-108	Cancer	.	C00-C97
DIB010308	DNGR-1 antibody vaccine	Cancer	140-229	C00-C96
DIB010309	GFT14	Hyperlipidemia	.	E78.5
DIB010310	L19-IL-2 fusion protein	Lymphoma	.	C81-C96
DIB010311	131I-81C6	Brain cancer	.	C71
DIB010312	NRC-2694	Cancer	140-229	C00-C96
DIB010313	AB-3001	Syndrome X	.	E88.9
DIB010314	CDR-134F194	Diabetes mellitus	250	E08-E13
DIB010315	870086 (topical, atopic dermatitis), GlaxoSmithKline	Atopic dermatitis	691.8	L20
DIB010316	UniGAM SD	Immune disorder	.	D80-D89
DIB010317	ATPase	Heart disease	390-429	I00-I52
DIB010318	FLOSATIDIL	Angina	.	I20
DIB010319	AZD-1283	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB010320	CC-11006	Cancer	.	C00-C97
DIB010321	VLN-244	Colon cancer	153, 154	C18-C21
DIB010322	14-aminocamptothecins (cancer), Thershold Pharmaceuticals	Cancer	140-229	C00-C96
DIB010323	RP-69698	Inflammatory diseases	.	.
DIB010324	Photosensitizers	Atherosclerosis	414.0, 440	I70
DIB010325	Tubulin polymerization inhibitors	Cancer	140-229	C00-C96
DIB010326	Inhibitor of PRLR	Endometriosis	.	N80
DIB010327	Vivia-008	Cancer	140-229	C00-C96
DIB010328	SAR438584	Respiratory syncytial virus 	.	B97.4
DIB010329	CLOTURIN	Cancer	140-229	C00-C96
DIB010330	ZD-6169	Urinary incontinence	.	N39.3-N39.4
DIB010331	Third-generation HIV maturation inhibitors	HIV infections	42	B20
DIB010332	S-15535	Anxiety disorder	.	F40-F42
DIB010333	SNX-2 class compounds	HIV infections	42	B20
DIB010334	TDT-077	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
DIB010335	KPE-06001	Arthritis	710-719	M00-M25
DIB010336	Tat-NR2B9c	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB010337	MMI-0100	Fibrosis	709.2	L90.5
DIB010338	Nagrestipen	Bone marrow transplantation	.	T86
DIB010339	Glutamate racemase inhibitors	Helicobacter pylori infection	41.86	B96.81
DIB010340	GRC-9332	Lipid metabolism disorder	.	E75-E78
DIB010341	FR-62765	Diabetes mellitus	.	E10-E14
DIB010342	Lymphoma vaccine	Lymphoma	202.8	C81-C96
DIB010343	SQ-609	Viral infections	042-075	A80-A99, B00-B34
DIB010344	RG-7103	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB010345	XL-041	Arteriosclerosis	.	I70
DIB010346	GLG-101	Cancer	140-229	C00-C96
DIB010347	NZ-1002	Lysosomal storage disease	.	E75-E77
DIB010348	AZM-083	Obesity	278	E66
DIB010349	Sch-207758	Cancer	140-229	C00-C96
DIB010350	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB010351	ETRX-101	Anemia	.	D50-D64
DIB010352	APH-0911	Cancer	140-229	C00-C96
DIB010353	VM-505	Breast cancer	174, 175, 217	C50, D24
DIB010354	FPL-55712	Asthma	.	J45
DIB010355	Genetically engineered anti-CD20 T-cell therapy	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB010356	XPro-1595	Inflammatory diseases	.	.
DIB010357	ChNKG2D T-cell therapy	Cancer	140-229	C00-C96
DIB010358	Fibrovax	Cancer	140-229	C00-C96
DIB010359	GSK2816126	Cancer	.	C00-C97
DIB010360	GTU-TB vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB010361	AX-208	Parkinson's disease	.	G20
DIB010362	Recombinant human CC10	Atopic dermatitis	691.8	L20
DIB010363	99mTc-sulesomab	Inflammatory bowel disease	555, 556	K50, K51
DIB010364	KPT-XXX	Autoimmune diseases	279.4	D84.9, M35.9
DIB010365	Polymyxins	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010366	Nicotinamide nucleotide transhydrogenase modulators	Diabetes mellitus	250	E08-E13
DIB010367	WIN-63759	Emphysema	492	J43
DIB010368	AB-0027-targeting monoclonal antibodies	Osteoporosis	733	M80-M81
DIB010369	Begacestat	Alzheimer's disease	.	G30,F00
DIB010370	Recombinant human neuregulin-1 beta	Chronic heart failure	428	I50
DIB010371	Microplasmin	Eye disorders	.	H00-H59
DIB010372	LB-30870	Myocardial infarction	.	I21-I22
DIB010373	Antimalarial therapy	Plasmodium infection	.	B54
DIB010374	Dystrophin exon-skipping gene therapy	Duchenne dystrophy	.	G71.0
DIB010375	INGN-007	Cancer	140-229	C00-C96
DIB010376	IG-CN-023	Neuropathic pain	338,780	R52, G89
DIB010377	T-270	Neuropathic pain	338,780	R52, G89
DIB010378	DF-1111301	Allergy	.	T78.4
DIB010379	Technetium (99m Tc) bicisate	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB010380	Long-acting hGH conjugate	Growth hormone deficiency	253.3	E23.0
DIB010381	CP-340868	Arteriosclerosis	.	I70
DIB010382	MM-121	Breast cancer	.	C50
DIB010383	ReSX-i program	Diabetes mellitus	250	E08-E13
DIB010384	Antiandrogens	Endocrine disease	.	E00-E35
DIB010385	ATL-1222	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB010386	Iodoquinol	Amoebiasis	.	A06
DIB010387	SiRNA therapy	Breast cancer	174, 175, 217	C50, D24
DIB010388	GSK-932121A	Plasmodium infection	.	B54
DIB010389	11-beta-HSD inhibitor	Diabetes mellitus	250	E08-E13
DIB010390	Meloxicam	Arthritis	.	M00-M25
DIB010391	AVR118	Leukemia	.	C91-C95
DIB010392	Monoclonal antibodies	Colorectal cancer	153, 154	C18-C21
DIB010393	Apadoline	Pain	.	G89
DIB010394	Epitope-based vaccines	Influenza virus infections	487	J10, J11
DIB010395	Cationic bacteriochlorins photodynamic therapy	Infectious disease	001-139	A00-B99
DIB010396	P-1118	Growth hormone deficiency	253.3	E23.0
DIB010397	HIV vaccine	HIV infections	42	B20
DIB010398	ETR-001	Kidney diseases	580-589	N00-N29
DIB010399	PerioPatch	Periodontal disease	.	K05
DIB010400	Prostate cancer vaccine	Prostate tumor	185	C61
DIB010401	RDEA-806	HIV infections	42	B20
DIB010402	Small molecule therapeutic	Hepatorenal syndrome	.	K76.7
DIB010403	Diabetic nephropathy therapy	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB010404	Thermostable vaccines	Rabies virus infection	001-139	A00-B99
DIB010405	NF-kappaB pathway inhibitors	Arthritis	.	M00-M25
DIB010406	Quadrivax	Hepatitis B virus infection	.	B16
DIB010407	P38 MAP kinase alpha inhibitors	Rheumatold arthritis	714	M05-M06
DIB010408	Eldacimibe	Hyperlipidemia	.	E78.5
DIB010409	Soybean-derived Staphylococcus SEB vaccine	Staphylococcus aureus infection	001-139	A00-B99
DIB010410	Mycoprex	Fungal infection	.	B35-B49
DIB010411	ICI-192605	Thrombosis	.	I80-I82
DIB010412	AD-0802	Alzheimer's disease	331	G30
DIB010413	RO-4995819	Major depressive disorder	296.2, 296.3	F32, F33
DIB010414	TNF antagonist protein	Autoimmune diseases	279.4	D84.9, M35.9
DIB010415	Anti-Clostridium perfringens toxin mAbs	Clostridium perfringens infection	001-139	A00-B99
DIB010416	Mid-brain progentitor cell therapy	Cancer	140-229	C00-C96
DIB010417	99mTc-ImmuRAID-LL1	Autoimmune diseases	279.4	D84.9, M35.9
DIB010418	E-Selectin antagonists	Diabetic angiopathy	250.7	E10.5, E11.5, E13.5
DIB010419	STNM-01	Pyloric stenosis	.	K31.1
DIB010420	KD-101	Metabolic disorders	.	E70-E90
DIB010421	RabiCide	Rabies virus infection	001-139	A00-B99
DIB010422	Abisil	Wound healing	.	S91.3
DIB010423	KRH-102140	Inflammatory diseases	.	.
DIB010424	PRS-080	Anemia	280-285	D50-D64
DIB010425	SF-101	Infectious disease	001-139	A00-B99
DIB010426	TGX-003	Bone disease	.	M00-M99
DIB010427	CC49 humanized radioimmunoconjugates	Cancer	140-229	C00-C96
DIB010428	GSK-557296	Premature ejaculation	302.75	F52.4
DIB010429	Mumps virus vaccine live	Mumps virus infection	.	B26
DIB010430	VALERGEN-DP (sublingual)	Asthma	493	J45
DIB010431	T2CA	Allergic rhinitis	477	J30
DIB010432	AW-814141	Inflammatory diseases	.	.
DIB010433	ROR gamma antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB010434	MR1-1	Brain cancer	.	C71
DIB010435	TPI-926	Neurological disease	320-359	G00-G99
DIB010436	A-76202M	Acquired immunodeficiency syndrome	.	B20-B24
DIB010437	RIPISARTAN	Hypertension	.	I10-I15
DIB010438	GBT-009	Scar conditions; Skin fibrosis	.	L90.5
DIB010439	Injectable protein based HCV infection therapies	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010440	Ion channel modulators	Arthritis	710-719	M00-M25
DIB010441	COU-1	Colon cancer	153, 154	C18-C21
DIB010442	EU-C-002	Reperfusion injury	.	I00-I99
DIB010443	MT-003	Pain	338,780	R52, G89
DIB010444	CytoGam	Cytomegalovirus infection	.	B25
DIB010445	OLAMUFLOXACIN MESILATE	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB010446	CX-99	Cancer	140-229	C00-C96
DIB010447	TMX-201	Autoimmune diseases	279.4	D84.9, M35.9
DIB010448	ATYR-1920	Genetic disorder	.	Q00-Q99
DIB010449	LFG-316	Macular degeneration	.	H35.3
DIB010450	A/Anhui/05	Influenza virus infections	.	J10-J11
DIB010451	HGF antagonist	Pancreatic cancer	.	C25
DIB010452	CGP-53716	Cancer	140-229	C00-C96
DIB010453	SAR-125844	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010454	SiRNA therapy	Huntington's disease	.	F02.2,G10
DIB010455	Nazvax-PX	Virus infection	.	B03
DIB010456	PRX-12247	Neurological disease	.	G00-G99
DIB010457	ABX-103	Cancer	140-229	C00-C96
DIB010458	BAY 11-42524	Heart failure	428	I50
DIB010459	NP-01	Diabetes mellitus type 2	.	E11
DIB010460	HRC-201	Liver cancer	.	C22
DIB010461	LY-221068	Arthritis	710-719	M00-M25
DIB010462	WAY-126227	Hypertension	401	I10, I11, I12, I13, I15
DIB010463	Antiinflammatory therapeutics	Inflammatory diseases	.	.
DIB010464	MOR-208	Autoimmune diseases	.	D84.9
DIB010465	PF-06410293	Rheumatold arthritis	.	M05-M06
DIB010466	TAK-137	Psychiatric disorders	.	F99
DIB010467	MK-0812	Multiple sclerosis	.	G35
DIB010468	L-159282	Hypertension	.	I10-I15
DIB010469	M2del11HAavir H5N1	Influenza virus infections	487	J10, J11
DIB010470	RX-465	Sarcoma	.	D69.3
DIB010471	SPI-452	HIV infections	.	B20
DIB010472	Sulfamylon	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010473	CLR-300 series	Major depressive disorder	296.2, 296.3	F32, F33
DIB010474	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB010475	Radretumab	Hematological malignancies	.	C81-C96
DIB010476	CIGB-845	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB010477	ASP8273	Non-small-cell lung carcinoma	162	C33, C34
DIB010478	MCHR-1 antagonists	Obesity	278	E66
DIB010479	LY-2541546	Osteoporosis	733	M80-M81
DIB010480	UR-8218	Hypertension	401	I10, I11, I12, I13, I15
DIB010481	SDZ-HDL-376	Atherosclerosis	414.0, 440	I70
DIB010482	West Nile virus vaccine	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB010483	CEP-37309	Leukemia	208.9	C91-C95
DIB010484	BAY1179470	Cancer	.	C00-C97
DIB010485	NV-27	Restenosis	.	I51.89
DIB010486	Hedgehog pathway antagonists	Cancer	140-229	C00-C96
DIB010487	HMR-1031	Arthritic	710-719	M00-M25
DIB010488	ALS-8176	Respiratory syncytial virus 	.	B97.4
DIB010489	IB-201	Bacillus anthracis infection	.	A22
DIB010490	BRL-42715	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB010491	Sodium thiosalicylate	Gout	274.00274.1274.8274.9	M10
DIB010492	HepBzyme	Hepatitis B virus infection	.	B16
DIB010493	GlutaVIR	HIV infections	42	B20
DIB010494	BioHib	Haemophilus influenzae infection	.	J11.1
DIB010495	Anti-angiogenesis vaccine	Cancer	140-229	C00-C96
DIB010496	AS-15 adjuvant	Discovery agent	.	.
DIB010497	PF-05280586	Cluster headache	.	G44.0
DIB010498	SiRNA molecules	Discovery agent	.	.
DIB010499	Actarit	Immune disorder	.	D80-D89
DIB010500	OPM-3023 oral	Inflammatory diseases	.	.
DIB010501	CT-1746	Colorectal cancer	153, 154	C18-C21
DIB010502	ZP-009	Pharyngitis	.	J02
DIB010503	Methylenetetrahydrofolate reductase inhibitors	Cancer	140-229	C00-C96
DIB010504	ADXS-HER2	Breast cancer	174, 175, 217	C50, D24
DIB010505	ND-1301	Schizophrenia	295	F20
DIB010506	Therapeutic program	Autoimmune diseases	279.4	D84.9, M35.9
DIB010507	ANA-505	Discovery agent	.	.
DIB010508	Pipotiazine	Schizophrenia	295	F20
DIB010509	Fruquintinib	Cancer	140-229	C00-C96
DIB010510	SB 249417	Sepsis	.	A40-A41
DIB010511	Small molecule therapeutics	Discovery agent	.	.
DIB010512	Tubulin polymerization inhibitors	Cancer	140-229	C00-C96
DIB010513	CDRI-S002-333	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB010514	MX-7091	Cancer	140-229	C00-C96
DIB010515	TRI-002	Pain	338,780	R52, G89
DIB010516	Beclamide	Psychiatric disorders	.	F99
DIB010517	CM-2236	Post-traumatic stress disorder	.	F43.1
DIB010518	Antiinfective therapeutic	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010519	NNI-AD	Alzheimer's disease	331	G30
DIB010520	VOXERGOLIDE HYDROCHLORIDE	Depression	311	F32
DIB010521	VML-262	Psoriasis	696	L40
DIB010522	Mas G-protein-coupled receptor agonists	Cardiovascular disease	390-459	I00-I99
DIB010523	Gp41 inhibitors	HIV infections	42	B20
DIB010524	Belerofon	Hepatitis C virus infection	.	B17.1,B18.2
DIB010525	YSIL6	Crohn's disease	.	K50
DIB010526	Amyloid beta peptide modulator	Alzheimer's disease	331	G30
DIB010527	Small-molecule mTOR complex 1/2 inhibitors	Polycystic kidney disease	753.1	Q61
DIB010528	Matuzumab	Gastric cancer	.	C16
DIB010529	Humanized mAb program	Melanoma	172	C43
DIB010530	PAT-SC1	Gastric cancer	.	C16
DIB010531	Lmprime P66	Leukemia	.	C91-C95
DIB010532	YM-46A	Mucolytic	.	J00-J99
DIB010533	ZK-118182	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB010534	Gene vectors	Genetic disorder	.	Q00-Q99
DIB010535	CR-4174 series	Inflammatory diseases	.	.
DIB010536	AMPK stimulators	Metabolic disorders	.	E70-E90
DIB010537	MAb based Ptc modulators	Cancer	140-229	C00-C96
DIB010538	IDX-320	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010539	Dimiracetam	Neuropathic pain	338,780	R52, G89
DIB010540	PA-10040	Cardiovascular disease	390-459	I00-I99
DIB010541	Tripropeptin C	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010542	DV-7751A	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB010543	C-Met (HGFR) inhibitors	Cancer	140-229	C00-C96
DIB010544	LTX-109	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB010545	Heparin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB010546	GLP-1-expressing stem cell therapy	Brain injury	.	S06
DIB010547	MK-3641	Allergy	995.3	T78.4
DIB010548	PF-885706	Gastroesophageal reflux disease	.	K21
DIB010549	SAR-131675	Cancer	140-229	C00-C96
DIB010550	AMG-139	Crohn's disease	555	K50
DIB010551	NVB-333	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010552	Pafuramidine	Malaria	.	B50-B54
DIB010553	CP-741952	Obesity	278	E66
DIB010554	INNO-101	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010555	Etanidazole	Cancer	140-229	C00-C96
DIB010556	PYK2 inhibitor	Osteoporosis	733	M80-M81
DIB010557	AE-37	Breast cancer	.	C50
DIB010558	Midaglizole	Asthma	493	J45
DIB010559	NNZ-3006	Metabolic disorders	.	E70-E90
DIB010560	HOO-IFOS	Cancer	140-229	C00-C96
DIB010561	Polyethylene glycol	Constipation	564	K59.0
DIB010562	Entity A patch	Cardiovascular disease	390-459	I00-I99
DIB010563	SRI-62-834	Solid tumours	.	C00-C75,C7A,C7B
DIB010564	AeroLEF	Pain	338,780	R52, G89
DIB010565	BAL-101553	Cancer	140-229	C00-C96
DIB010566	AE-o vaccine	Ovarian cancer	183	C56
DIB010567	E-7107	Cancer	.	C00-C97
DIB010568	LF-801	Asthma	493	J45
DIB010569	Theliatinib	Cancer	140-229	C00-C96
DIB010570	MK-212	Obsessive-compulsive disorder	.	F42
DIB010571	CHR-3620	Inflammatory diseases	.	.
DIB010572	Peptide program	Infectious disease	001-139	A00-B99
DIB010573	MBL-HCV1	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB010574	Phytobacx	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010575	GUT-70	Cancer	140-229	C00-C96
DIB010576	Vaccine	Cytomegalovirus infection	.	B25
DIB010577	Declopramide	Inflammatory bowel disease	.	K50,K51
DIB010578	Long-acting VPAC2 agonists	Asthma	493	J45
DIB010579	Hydromorphone prodrug	Pain	338,780	R52, G89
DIB010580	MFQ	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010581	PJ-015	Hyperlipidemia	272.0-272.4	E78
DIB010582	CGS-7181	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB010583	Undisclosed natural compound	Cancer	140-229	C00-C96
DIB010584	Peptide therapy	Asthma	493	J45
DIB010585	DAV-147	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010586	Bio-Hep-B	Hepatitis B virus infection	.	B16
DIB010587	Streptococcus pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB010588	Hematopoietic stem cells	Breast cancer	.	C50
DIB010589	Alpha-lactalbumin vaccine	Breast cancer	174, 175, 217	C50, D24
DIB010590	LNK-3186	Alzheimer's disease	331	G30
DIB010591	SGT-53	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010592	INP-02	HIV associated dementia	.	B20
DIB010593	CAP-3.2	Cancer	.	C00-C97
DIB010594	SCH-900931	Discovery agent	.	.
DIB010595	Candida albicans vaccine	Candida albicans infection	.	B37.0
DIB010596	DNA vaccine	Melanoma	172	C43
DIB010597	TS-033	Diabetes mellitus	250	E08-E13
DIB010598	TMX-202	Bladder cancer	188	C67
DIB010599	SMP-986	Overactive bladder disorder	596.51	N32.81
DIB010600	BCG vaccine	Bladder cancer	188	C67
DIB010601	Follistatin	Osteoporosis	733	M80-M81
DIB010602	L-689560	Neurodegenerative diseases	.	G30-G32
DIB010603	SUN-1334H	Allergic conjunctivitis	372.14	H10.45
DIB010604	NU-206	Gastrointestinal disease	.	K00-K93
DIB010605	Floctafenine	Arthritis	710-719	M00-M25
DIB010606	Sodium iodide symporter adenoviral gene therapy	Hepatocellular carcinoma	155	C22.0
DIB010607	Gimatecan	Breast cancer	.	C50
DIB010608	STATs-mediated cytokine activity enhancers	Leukopenia	.	D72.819
DIB010609	ONO-8809	Thrombosis	.	I80-I82
DIB010610	GPR173 antagonists	Metabolic disorders	.	E70-E90
DIB010611	MiRNA therapy	Hepatocellular carcinoma	155	C22.0
DIB010612	RSLV-125	Systemic lupus erythematosus	710	M32
DIB010613	Anti-Her-2 mAb	Cancer	140-229	C00-C96
DIB010614	Proglumetacin	Osteoarthritis	715	M15-M19, M47
DIB010615	Streptococcus pyogenes vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010616	EPI-0031	Age related macular degeneration	.	H35.30
DIB010617	CD-160130	Chronic lymphocytic leukaemia	204.1	C91.1
DIB010618	Darbufelone	Asthma	.	J45
DIB010619	Tularemia vaccine	Tularemia	.	A21.9
DIB010620	CaspaCIDe donor lymphocyte infusion	Graft-versus host disease	.	T86.0
DIB010621	LY-2828360	Pain	338,780	R52, G89
DIB010622	MCT-275	Insulin dependent diabetes	.	E10
DIB010623	Peptide-based gamma-secretase inhibitors	Alzheimer's disease	331	G30
DIB010624	Recombinant IgG grass allergen vaccine	Allergy	995.3	T78.4
DIB010625	Viral DNA replication inhibitor	Influenza virus infections	487	J10, J11
DIB010626	Diabetes therapeutics	Insulin dependent diabetes	.	E10
DIB010627	PRX-12255	Neurological disease	.	G00-G99
DIB010628	Dengue viral vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB010629	TZ-111	Neurological disease	.	G00-G99
DIB010630	DS-8273	Solid tumours	.	C00-C75,C7A,C7B
DIB010631	STP-805	Spinal cord injuries	952	S14, S24, S34
DIB010632	Hsp90 inhibitors	Cancer	140-229	C00-C96
DIB010633	Infanrix-DTaP-IPV-Hep B-Hib	Hepatitis B virus infection	.	B16
DIB010634	MEDI3902	Pseudomonas infection	.	B96.5,J15.1
DIB010635	MPC-9055	HIV infections	42	B20
DIB010636	Selurampanel	Epilepsy	.	G40
DIB010637	Dual PI3K gamma/delta inhibitors	Inflammatory diseases	.	.
DIB010638	Human recombinant protein	Cancer	.	C00-C97
DIB010639	BACE1 protein inhibitor	Alzheimer's disease	331	G30
DIB010640	Healive	Hepatitis A virus infection	.	B15.9
DIB010641	PBI-1101	Inflammatory diseases	.	.
DIB010642	VTT-301	Prostate hyperplasia	.	N40
DIB010643	Staphylococcus aureus recombinant conjugated vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010644	Multifunctional chitosan siRNA-nanoparticles	HIV-1 infections	42	B20
DIB010645	Galanin gene therapy	Epilepsy	345	G40
DIB010646	ISIS-5320	HIV infections	42	B20
DIB010647	ARC-183	Blood forming organ disorders	.	D75.9
DIB010648	Poloxafuse-R	Ischemia	459.89	I99.8
DIB010649	Anti-TNF human mAbs	Autoimmune diseases	279.4	D84.9, M35.9
DIB010650	Prostaview	Prostate tumor	185	C61
DIB010651	TS-022	Atopic dermatitis	.	L20
DIB010652	ZK-90695	Arthritis	710-719	M00-M25
DIB010653	Parasin I	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010654	Human embryonic stem cell-derived hepatocytes	Liver disease	570-574	K70-K77
DIB010655	Wnt stimulator	Osteoporosis	733	M80-M81
DIB010656	ActoBiotics	Allergy	995.3	T78.4
DIB010657	Selective androgen receptor degraders	Prostate tumor	185	C61
DIB010658	Antiviral polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010659	Vabicaserin	Psychotic disorders	.	F20-F29
DIB010660	FD-891	Cancer	140-229	C00-C96
DIB010661	T-250	Peripheral vascular disorders	.	I73.9
DIB010662	S. mutans Replacement Therapy	Infections	.	.
DIB010663	Glucan synthase inhibitors	Fungal infection	.	B35-B49
DIB010664	Alniditan	Migraine	.	G43
DIB010665	PET imaging agents	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010666	20D75	Melanoma	172	C43
DIB010667	Antifungal oligonucleotides	Candida albicans infection	.	B37.0
DIB010668	CJ-23423	Arthralgia	.	M25.5
DIB010669	Polyacrylic acid	Contraception	.	Z30
DIB010670	VLI-03B	Hepatocellular carcinoma	155	C22.0
DIB010671	Bulleyaconitine A	Pain	338,780	R52, G89
DIB010672	PXS-74	Asthma	493	J45
DIB010673	PD-0204318	Pain	338,780	R52, G89
DIB010674	TD-101	Pachyonychia	.	Q84.5
DIB010675	SPase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010676	GC-7101	Stomach ulcer	.	K25-K27
DIB010677	Bronchoselective beta agonist	Asthma	493	J45
DIB010678	Botulinum toxin antibodies	Clostridium botulinum infection	.	A05.1
DIB010679	OPI-1100	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010680	XL-765	Breast cancer	.	C50
DIB010681	CT-3556	Immune disorder	.	D80-D89
DIB010682	Polyflu	Influenza virus infections	487	J10, J11
DIB010683	SeV-IL-2 gene therapy	Cancer	140-229	C00-C96
DIB010684	Debio-0929	Cancer	140-229	C00-C96
DIB010685	Pentisomide	Heart arrhythmia	.	I47-I49
DIB010686	Nav1.7 blockers	Pain	338,780	R52, G89
DIB010687	UK-290795	Urinary incontinence	.	N39.3-N39.4
DIB010688	Penecure	Onychomycosis	.	B35.1
DIB010689	Fluoratec	Attention deficit hyperactivity disorder	.	F90
DIB010690	PIN1 PPIase inhibitors	Cancer	140-229	C00-C96
DIB010691	Genebinders	Genetic disorder	.	Q00-Q99
DIB010692	APH-0701	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB010693	GW-3600	Asthma	.	J45
DIB010694	Bradykinin B1 receptor antagonists	Pain	338,780	R52, G89
DIB010695	Fabesetron	Irritable bowel syndrome	.	K58
DIB010696	Herpesvirus protease inhibitors	Cytomegalovirus infection	.	B25
DIB010697	BI 1026706	Osteoarthritis	715	M15-M19, M47
DIB010698	Human retinal pigment epithelial cell therapy	Macular degeneration	.	H35.3
DIB010699	SLP-0904	Influenza virus infections	487	J10, J11
DIB010700	MGD006	Acute lymphoblastic leukemia	.	C91.0
DIB010701	Small molecule GPR119 agonists	Non-insulin dependent diabetes	.	E11.9
DIB010702	Helicobacter vaccine	Helicobacter pylori infection	41.86	B96.81
DIB010703	CGS-15873A	Psychotic disorders	.	F20-F29
DIB010704	Chondroitin	Cataract	366	H25-H26, H28, Q12.0
DIB010705	Chymase inhibitors	Cardiovascular disease	390-459	I00-I99
DIB010706	E-09	Solid tumours	.	C00-C75,C7A,C7B
DIB010707	HelicoVax	Helicobacter pylori infection	41.86	B96.81
DIB010708	Examorelin	Growth hormone deficiency	.	E23.0
DIB010709	KIN-1 inhibitors	Cancer	140-229	C00-C96
DIB010710	GLP-1 mimetics	Diabetes mellitus	.	E10-E14
DIB010711	R-salbutamol sulphate	Skin infections	.	L00-L99
DIB010712	S1P1 agonists	Immune disorder	.	D80-D89
DIB010713	Cx-603	Ischemic stroke	434.91	I61-I63
DIB010714	Antihypertensives	Pulmonary hypertension	416	I27.0, I27.2
DIB010715	LG-889	Factor VIII deficiency	.	D66
DIB010716	PF-06439535	Cancer	.	C00-C97
DIB010717	Isoselenocyanate Akt3 inhibitors	Cancer	140-229	C00-C96
DIB010718	Henipavirus-neutralizing antibody	Viral infections	042-075	A80-A99, B00-B34
DIB010719	Triciribine prodrug	Cancer	.	C00-C97
DIB010720	Adeno-associated virus vector-8 based gene therapy	Hurler syndrome	.	E76.01
DIB010721	AZD-9819	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB010722	WT2527	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010723	CN-2097	Neurological disease	.	G00-G99
DIB010724	Hematopoietic Factor IX gene therapy	Factor IX deficiency	.	D67
DIB010725	V-24343	Diabetes mellitus type 2	.	E11
DIB010726	Lumacaftor	Cystic fibrosis	277	E84
DIB010727	M1 muscarinic acetylcholine receptor agonist	Neurological disease	.	G00-G99
DIB010728	AE-H	HIV infections	42	B20
DIB010729	Insulin B chain vaccine	Insulin dependent diabetes	.	E10
DIB010730	VB2-011	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB010731	Anti-PSA mAbs	Prostate tumor	185	C61
DIB010732	Lactobacillus	Diarrhea	.	A09,K59.1
DIB010733	YM-17E	Hyperlipidemia	.	E78.5
DIB010734	NM504	Type 2 diabetes	250.00, 250.02	E11
DIB010735	TP-101	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010736	NS-2200	Cocaine addiction	304.2	F14.2
DIB010737	PMA-101R	Autoimmune diseases	279.4	D84.9, M35.9
DIB010738	YM-430	Hypertension	401	I10, I11, I12, I13, I15
DIB010739	TG-2001	Breast cancer	.	C50
DIB010740	LEO-27989	Psoriasis	696	L40
DIB010741	Hedgehog agonist	Parkinson's disease	332	F02.3, G20
DIB010742	PD-155392	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010743	Hormone-sensitive lipase inhibitors	Diabetes mellitus type 2	.	E11
DIB010744	Recombinant human endostatin	Cancer	.	C00-C97
DIB010745	Her2- and PSA-targeted TGX-D1	Prostate tumor	185	C61
DIB010746	HL-034	Discovery agent	.	.
DIB010747	DISC-VZV	Varicella zoster virus infections	.	B01,B02
DIB010748	PF-06664178	Cancer	140-229	C00-C96
DIB010749	CAL-202	Parainfluenza virus infection	.	J12.2
DIB010750	Direct thrombin inhibitors	Cancer	.	C00-C97
DIB010751	ANA-04	Autoimmune diseases	279.4	D84.9, M35.9
DIB010752	Thiacetazone	Mycobacterium tuberculosis infection	.	A15-A19
DIB010753	MS-424	Ischemia	.	I99.8
DIB010754	Anti-autolysin monoclonal antibody passive immunotherapy	MRSA infection	.	B95.62
DIB010755	Cx-911	Autoimmune diseases	279.4	D84.9, M35.9
DIB010756	JB-991 ophthalmological	Scar tissue	.	L00-L99
DIB010757	Anxiolytic	Anxiety disorder	300	F40-F42
DIB010758	Second-generation Hsp27 inhibitor	Cancer	140-229	C00-C96
DIB010759	MAbs targeting human growth hormone	Cancer	140-229	C00-C96
DIB010760	ABD-035	Cancer	140-229	C00-C96
DIB010761	AZD-2327	Anxiety disorder	.	F40-F42
DIB010762	Surrobodies	Diabetes mellitus	250	E08-E13
DIB010763	Org-6370	Epilepsy	345	G40
DIB010764	Bazedoxifene	Osteopetrosis	.	Q78.2?
DIB010765	MALP-2S	Pancreatic cancer	.	C25
DIB010766	AAV-GUS	Genetic disorder	.	Q00-Q99
DIB010767	MTL-007	Cancer	140-229	C00-C96
DIB010768	DuP-630	Dermatitis	.	L20-L30
DIB010769	Cobalt chelate complex CTC-96 dermatological	Conjunctivitis	372	H10
DIB010770	Furazolidinone	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010771	BILD-733	Herpes simplex virus infection	.	A60,B00
DIB010772	MC-207252	Staphylococcus aureus infection	001-139	A00-B99
DIB010773	Internalizing RNA molecules (prostate cancer) b3 bio	Prostate tumor	185	C61
DIB010774	Phosphate-uptake inhibitors	Hyperphosphatemia	.	E83
DIB010775	RVX-297	Multiple sclerosis	340	G35
DIB010776	Alzheimers disease therapeutics	Alzheimer's disease	331	G30
DIB010777	GMZ-2	Plasmodium malariae infection	.	B50
DIB010778	Oxeglitazar	Gout	.	M10
DIB010779	Ro-24-1882	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010780	ELS-110	Migraine	346	G43
DIB010781	Ro-31-6930	Hypertension	.	I10-I15
DIB010782	SF-106	Retinopathy	362.0-362.2	H35-H35.2
DIB010783	Xenoject	Autoimmune diseases	279.4	D84.9, M35.9
DIB010784	LASSBio-294 analogs	Hypertension	401	I10, I11, I12, I13, I15
DIB010785	Anti-Met/EGFR antibody	Cancer	140-229	C00-C96
DIB010786	SR-31747	Rheumatold arthritis	.	M05-M06
DIB010787	UR-8328	Asthma	493	J45
DIB010788	Anti-miR-10b antisense oligonucleotides	Metastasis	.	C00-C97
DIB010789	HL-027	Parkinson's disease	.	G20
DIB010790	Inhibitor of PI3K	Cancer	140-229	C00-C96
DIB010791	EDD7H9	Breast cancer	174, 175, 217	C50, D24
DIB010792	HL-020	Cancer	.	C00-C97
DIB010793	Glycoprotein conjugated vaccine	Staphylococcus aureus infection	001-139	A00-B99
DIB010794	T-1095	Diabetes	250	E08-E13
DIB010795	CSF-1R inhibitors	Cancer	140-229	C00-C96
DIB010796	NPS-2143	Osteoporosis	733	M80-M81
DIB010797	SAM-531	Alzheimer's disease	.	G30,F00
DIB010798	Vx-001	Breast cancer	174, 175, 217	C50, D24
DIB010799	PTL-43401	Cancer	140-229	C00-C96
DIB010800	TNF-PEG-20	Cancer	140-229	C00-C96
DIB010801	Gene therapy	Cancer	.	C00-C97
DIB010802	Revamilast	Asthma	.	J45
DIB010803	Chk 1 inhibitor	Cancer	140-229	C00-C96
DIB010804	Autologous mesenchymal stem cell therapy	Connective tissue disease	.	L94.9
DIB010805	PAC-113	Oral candidiasis	.	B37.9
DIB010806	Natural killer T cell antibody	Sickle-cell disease	.	D57
DIB010807	Recombinant Factor IX	Factor IX deficiency	.	D67
DIB010808	TAK-114	Autoimmune diseases	279.4	D84.9, M35.9
DIB010809	Amorolfine	Onychomycosis	.	B35.1
DIB010810	MP40X	Cancer	140-229	C00-C96
DIB010811	INDUS-815B	Renal disease	.	N00-N29
DIB010812	Efungumab	Breast cancer	174, 175, 217	C50, D24
DIB010813	HBV vaccine	Hepatitis B virus infection	.	B16
DIB010814	MP-PN-2	Cancer	140-229	C00-C96
DIB010815	NSD-761	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB010816	IDC-G103	Herpes simplex virus infection	.	B00
DIB010817	Undisclosed GPCR modulators	Anxiety disorder	300	F40-F42
DIB010818	Norovirus virus-like particle vaccine	Norovirus infections	001-139	A00-B99
DIB010819	SCH-900978	Cough	.	R05
DIB010820	VP-025	Alzheimer's disease	331	G30
DIB010821	Triptoreline	Prostate tumor	185	C61
DIB010822	SKP-2045	Drug delivery platform	.	.
DIB010823	Bindarit	Nephritis	.	N00-N19,N25-N29
DIB010824	Extracellular matrix	Wound healing	.	S91.3
DIB010825	CTT-54	Cancer	.	C00-C97
DIB010826	Beta-amyloid aggregation inhibitors	Alzheimer's disease	331	G30
DIB010827	Lupron 3-month depot	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB010828	CiPSC therapy	Cardiovascular disease	390-459	I00-I99
DIB010829	DAV-121	Toxicity	.	T36-T50,T51-T65
DIB010830	LAGATIDE	Diarrhea	787.91	A09, K59.1
DIB010831	SMAC mimetics	Cancer	140-229	C00-C96
DIB010832	BGB-324	Metastasis	.	C00-C97
DIB010833	PF-06743649	Gout	274.00274.1274.8274.9	M10
DIB010834	GW 597599	Mood disorder	.	F30-F39
DIB010835	SBC-102	Enzyme deficiency	.	E70-E90
DIB010836	Naltrexone	HIV infections	42	B20
DIB010837	Cathepsin B inhibitors	Cancer	140-229	C00-C96
DIB010838	Antiadhesion barrier gel	Fibrosis	709.2	L90.5
DIB010839	Ibrolipim	Hyperlipidemia	.	E78.5
DIB010840	Intrathecal electrolyte solution	Leukemia	.	C91-C95
DIB010841	HO-221	Viral infections	.	B34
DIB010842	ASG-15ME	Bladder cancer	188	C67
DIB010843	Peretinoin	Hepatocellular carcinoma	155	C22.0
DIB010844	Alfaferone	Hairy cell leukemia	202.4	C91.4
DIB010845	DasKloster 0039-01	Asbestosis	.	J61
DIB010846	C-Met kinase inhibitors	Cancer	140-229	C00-C96
DIB010847	UC-781	Human immunodeficiency virus infection	.	B20
DIB010848	Monocyte-derived stem cell therapy	Diabetes mellitus	250	E08-E13
DIB010849	Isolagen Process	Skin infections	680-709	L00-L99
DIB010850	ZT-101	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB010851	DCC-10345	Glaucoma	365	H40-H42
DIB010852	NMS-P626	Cancer	140-229	C00-C96
DIB010853	HG-1092	Immune disorder	.	D80-D89
DIB010854	Anti-sonic hedgehog monoclonal antibody	Cancer	140-229	C00-C96
DIB010855	STNM-04	Liver cirrhosis	.	K70.3,K71.7,K74
DIB010856	Kappa opioid modulators	Pain	338,780	R52, G89
DIB010857	NXD-9062	Alzheimer's disease	331	G30
DIB010858	P2X7 purinoceptor antagonists	Inflammatory diseases	.	.
DIB010859	RHIgM12B7	Cancer	.	C00-C97
DIB010860	CE-2048	Pulmonary disease	460-519	J00-J99
DIB010861	L-alanosine	Brain cancer	191	C71
DIB010862	MDDR 295183	Erectile dysfunction	.	F52.2,N48.4
DIB010863	Avanz	Allergic rhinitis	477	J30
DIB010864	ACAM-2000	Virus infection	.	B03
DIB010865	Signaling pathway kinase modulators	Cancer	140-229	C00-C96
DIB010866	MOL-2668	Asthma	493	J45
DIB010867	ZD-4190	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB010868	Protein kinase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010869	BEA-005	Cytomegalovirus infection	.	B25
DIB010870	URC102	Gout	274.00274.1274.8274.9	M10
DIB010871	CH-104	Cancer	140-229	C00-C96
DIB010872	IDP-107	Acne vulgaris	706.1	L70.0
DIB010873	Monoclonal antibody	Acute myeloid leukemia	205	C92.0
DIB010874	Human papilloma virus vaccine	Papillomavirus infections	.	B97.7
DIB010875	AUY922	Myeloma	203	C90.0
DIB010876	DE-081	Conjunctivitis	.	H10
DIB010877	PPAR gamma modulators	Atherosclerosis	414.0, 440	I70
DIB010878	F-50077	Respiratory syncytial virus 	79.6	B97.4
DIB010879	TAS-120	Multiple myeloma	203	C90.0
DIB010880	ETS-2101	Cancer	.	C00-C97
DIB010881	SSJ-183	Plasmodium falciparum infection	.	B54
DIB010882	MDX-214	Autoimmune diseases	.	D84.9
DIB010883	AGS-67E	Cancer	140-229	C00-C96
DIB010884	NK-111	Ischemic heart diseases	410-414	I20-I25
DIB010885	Lx-TB-PstS1	Bladder cancer	188	C67
DIB010886	SUVN-911	Major depressive disorder	296.2, 296.3	F32, F33
DIB010887	NTF-1836	Mycobacterium tuberculosis infection	.	A15-A19
DIB010888	HuN901-CC-1065	Cancer	140-229	C00-C96
DIB010889	Debio-1036	Autoimmune diseases	279.4	D84.9, M35.9
DIB010890	Metabolism modulator therapeutics	Metabolic disorders	.	E70-E90
DIB010891	ZS-9	Hyperkalemia	.	E87.5
DIB010892	PYM-50028	Neurological disease	.	G00-G99
DIB010893	NK-1001	Atrial fibrillation	427.31	I48
DIB010894	99mTc-labeled non-steroidal analogs (cancer, imaging/detection), Roche	Cancer	140-229	C00-C96
DIB010895	AEZS-115	Cancer	.	C00-C97
DIB010896	Sirna-AV34	Hepatitis virus infection	573.3	K75.9
DIB010897	Barucainide	Heart arrhythmia	.	I47-I49
DIB010898	Factor VIII	Factor VIII deficiency	.	D66
DIB010899	Kv1.3 blockers	Multiple sclerosis	340	G35
DIB010900	Detirelix	Breast cancer	174, 175, 217	C50, D24
DIB010901	BMN-190	Neuronal ceroid lipofuscinosis type 2	.	E75.4?
DIB010902	Amyloid beta 1-42 inhibitors	Mild cognitive impairment	331.83	F06.7
DIB010903	NP-003	Atopic dermatitis	691.8	L20
DIB010904	Topical CCR3 antagonists	Age related macular degeneration	.	H35.30
DIB010905	ErbB-2 antisense	Cancer	140-229	C00-C96
DIB010906	PEGylated pitrakinra	Allergy	995.3	T78.4
DIB010907	APIT	Cancer	140-229	C00-C96
DIB010908	RK-023	Alopecia	.	L65.9
DIB010909	Pl-3K/mTOR kinase inhibitor	Cancer	140-229	C00-C96
DIB010910	XK-469	Solid tumours	.	C00-C75,C7A,C7B
DIB010911	TAK-427	Allergic rhinitis	477	J30
DIB010912	OP-02 program	Cancer	140-229	C00-C96
DIB010913	Universal influenza vaccine	Influenza virus infections	487	J10, J11
DIB010914	NNZ-4945	Motor neurone disease	335.2	G12.2
DIB010915	Siderophore-conjugated monocarbams	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010916	Factor IX gene therapy	Factor IX deficiency	.	D67
DIB010917	F-50038	Bladder cancer	188	C67
DIB010918	SDZ-PSD-958	Psychiatric disorders	.	F99
DIB010919	Cetraxate	Peptic ulcer	531-534	K25-K27
DIB010920	Live attenuated human parainfluenza virus type 2 vaccine	Parainfluenza virus infection	.	J12.2
DIB010921	BBT-046	Cancer	.	C00-C97
DIB010922	CPG23STEM	Insulin dependent diabetes	.	E10
DIB010923	Human chorionic gonadotropin	Heart disease	390-429	I00-I52
DIB010924	Y-175L	Lupus nephritis	583.81	M32.1, N08.5
DIB010925	Tetanus toxoid	Clostridium tetani infection	001-139	A00-B99
DIB010926	CMC-001	Liver cancer	155	C22.0
DIB010927	North Chicago	Discovery agent	.	.
DIB010928	P-2281	Ulcerative colitis	556	K51
DIB010929	Cidofovir gel	Papillomavirus infections	.	B97.7
DIB010930	PA-8326	Pulmonary fibrosis	515, 516.3	J84.1
DIB010931	TBC-3711	Hypotension	.	I95
DIB010932	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB010933	D-5410	Rheumatold arthritis	714	M05-M06
DIB010934	HDAC inhibitors	Cancer	140-229	C00-C96
DIB010935	POP-1	Cancer	140-229	C00-C96
DIB010936	PEG-Interferon lambda (IL-29)	Viral infections	042-075	A80-A99, B00-B34
DIB010937	Troponin-I	Ocular disease	.	H00-H59
DIB010938	HMR-3787	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010939	Benafentrine dimaleate	Septic shock	.	A41.9
DIB010940	ON-044580	Cancer	140-229	C00-C96
DIB010941	Cystic fibrosis therapy	Cystic fibrosis	277	E84
DIB010942	ID-12	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB010943	ACREOZAST	Asthma	.	J45
DIB010944	Azithromycin	Lyme disease	88.81	A69.2
DIB010945	R-84760	Pain	.	G89
DIB010946	SW-33377	Solid tumours	.	C00-C75,C7A,C7B
DIB010947	LG-888	Factor VIII deficiency	.	D66
DIB010948	Meninge ACYW conj.	Meningococcal	36.9	A39
DIB010949	Beta-carotene	Vitamin deficiency	.	E56.9
DIB010950	Nmers	Discovery agent	.	.
DIB010951	NDD-094	Alzheimer's disease	.	G30,F00
DIB010952	PRISOTINOL	Cognition disorders	.	F06.7
DIB010953	DARPins	Cancer	140-229	C00-C96
DIB010954	CGP-20376	Parasitic infection	.	B89
DIB010955	Lymphotoxin beta receptor	Autoimmune diseases	279.4	D84.9, M35.9
DIB010956	CZ-2645	Lung inflammation	.	D86
DIB010957	ERV-ASP	Leukemia	208.9	C91-C95
DIB010958	CDR-267F018	Diabetes mellitus	250	E08-E13
DIB010959	ZP-1848	Inflammatory bowel disease	555, 556	K50, K51
DIB010960	MLN-977	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB010961	CP-83101	Arteriosclerosis	.	I70
DIB010962	Azanidazole	Parasitic infection	.	B89
DIB010963	Xerostomia therapy	Xerostomia	527.7	K11.7, R68.2
DIB010964	Yunaoning	Neisseria meningitidis infection	.	A87
DIB010965	Autologous dendritic cell vaccine	HIV-1 infections	42	B20
DIB010966	Very small embryonic-like stem cells	Osteoporosis	733	M80-M81
DIB010967	ReN-002	Insulin dependent diabetes	.	E10
DIB010968	FCE-26806	Cancer	140-229	C00-C96
DIB010969	Indanylidene analogs	Inflammatory diseases	.	.
DIB010970	UAI-101	Diabetes mellitus	250	E08-E13
DIB010971	TBC-11299	Hypertension	401	I10, I11, I12, I13, I15
DIB010972	SWT-05104	Vitiligo	709.01	L80
DIB010973	Hypertension therapy	Hypertension	401	I10, I11, I12, I13, I15
DIB010974	Pretarget technology	Gastrointestinal cancer	.	C15-C26
DIB010975	S-488410	Lung cancer	162	C33-C34
DIB010976	CGP-63446	Neurological disease	.	G00-G99
DIB010977	Norovirus vaccine	Norwalk virus infection	.	A08
DIB010978	EVP-0334	Neurodegenerative disorders	.	G31.83
DIB010979	Anticancer glycosaminoglycans	Cancer	140-229	C00-C96
DIB010980	Mifepristone	Cushing's disease	.	E24.0
DIB010981	KW-3357	Blood coagulation disorders	.	D65-D68
DIB010982	R-701	Overactive bladder disorder	596.51	N32.81
DIB010983	Ro-61-0480	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010984	Nanobody therapeutics	Alzheimer's disease	331	G30
DIB010985	TRN-101	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB010986	ZK-114043	Contraception	.	Z30
DIB010987	TGFTX-2	Diabetes mellitus	250	E08-E13
DIB010988	CS-8080	Atherosclerosis	414.0, 440	I70
DIB010989	Retinyl trimethoxybenzyl ether	Breast cancer	174, 175, 217	C50, D24
DIB010990	BMY-41802	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB010991	Y-22990	Anxiety disorder	300	F40-F42
DIB010992	Coenzyme Q10	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB010993	INNO-105	Solid tumours	.	C00-C75,C7A,C7B
DIB010994	INOC-002	Cancer	.	C00-C97
DIB010995	JNJ-26489112	Epilepsy	345	G40
DIB010996	XGP-115	Arthritis	710-719	M00-M25
DIB010997	NHT-0147	Epilepsy	345	G40
DIB010998	Votucalis ophthalmic	Allergic rhinitis	477	J30
DIB010999	SC-56525	Hypertension	401	I10, I11, I12, I13, I15
DIB011000	MONTIRELIN TETRAHYDRATE	Pain	.	G89
DIB011001	SRSS-016	Pain	338,780	R52, G89
DIB011002	Testosterone glucoside	Hypogonadism	257.2	E23.0, E28.3, E29.1
DIB011003	MVA virus-based smallpox/plague vaccine	Virus infection	.	B03
DIB011004	Hepcidin Monoclonal Antibody	Anemia	280-285	D50-D64
DIB011005	LXR agonists	Arteriosclerosis	440	I70
DIB011006	SPIRU-211	Constipation	564	K59.0
DIB011007	Kinase inhibitors	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB011008	Apaxifylline	Cognitive impairment	.	F06.7
DIB011009	Nexagon	Diabetic foot ulcer	707	L88-L89
DIB011010	Therapeutic cancer vaccines	Cancer	140-229	C00-C96
DIB011011	E coli EPVaccine	Escherichia coli infection	.	A00-B99
DIB011012	AM-425	Rheumatold arthritis	714	M05-M06
DIB011013	CB-10-01 cancer vaccine	Malignant melanoma	172	C43
DIB011014	INGN-225	Head and neck cancer	.	C07-C14,C32-C33
DIB011015	IRISQUINONE	Cancer	140-229	C00-C96
DIB011016	Epitope-based vaccine	Influenza virus infections	487	J10, J11
DIB011017	Disitertide	Macular degeneration	.	H35.3
DIB011018	GOAT inhibitors	Metabolic disorders	.	E70-E90
DIB011019	High-affinity HER2 targeting antibodies	Breast cancer	174, 175, 217	C50, D24
DIB011020	Trofosfamide	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB011021	AMG 282	Asthma	493	J45
DIB011022	ONO-5334	Osteopenia	.	M85.8
DIB011023	PTC-821	Carcinoma	.	D07.30
DIB011024	PGC-lysostaphin	Staphylococcus aureus infection	001-139	A00-B99
DIB011025	Antiinflammatory/antimicrobial series	Skin infections	.	L00-L08
DIB011026	G-207 virus construct	Glioma	191	C71
DIB011027	RNAi-based drug candidates	Brain cancer	191	C71
DIB011028	Calpain inhibitors	Cerebral infarction	.	I63
DIB011029	Glycolysis inhibitors	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB011030	AVE-3247	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB011031	RBP-7000	Non-small cell lung cancer	.	C33-C34
DIB011032	Trastuzumab-PNU-159682 antibody-drug conjugate	Cancer	140-229	C00-C96
DIB011033	E coli antibody	Escherichia coli infection	.	A00-B99
DIB011034	Theray for heart failure	Heart failure	428	I50
DIB011035	Birch pollen allergy desensitization tablet	Allergy	995.3	T78.4
DIB011036	SL-25.1188	Alzheimer's disease	.	G30,F00
DIB011037	Cyclosporine analogs	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011038	ICRAC blockers	Autoimmune diseases	279.4	D84.9, M35.9
DIB011039	ZP-012	Urinary tract infections	599	N39.0
DIB011040	PI3 kinase beta inhibitors	Cancer	140-229	C00-C96
DIB011041	LB-100	Cancer	.	C00-C97
DIB011042	Anti-CD20 mAb	Cancer	140-229	C00-C96
DIB011043	Anti-GD2 mAb	Cancer	140-229	C00-C96
DIB011044	CMS-024-02	Cancer	.	C00-C97
DIB011045	Velac Gel	Acne vulgaris	706.1	L70.0
DIB011046	FPI-01	Acute myeloid leukemia	.	C92.0
DIB011047	MSP1 prime-boost vaccine	Plasmodium malariae infection	.	B50
DIB011048	H.P. Acthar Gel	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB011049	Disease specific epitope-targeting monoclonal antibodies	Motor neurone disease	335.2	G12.2
DIB011050	GLP-1 analogs	Non-insulin dependent diabetes	.	E11.9
DIB011051	AZD-6319	Alzheimer's disease	331	G30
DIB011052	RG7841	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011053	SGX-311	Pain	338,780	R52, G89
DIB011054	MDL-201112	Colitis	.	K50-K52
DIB011055	Medicor	Discovery agent	.	.
DIB011056	Antiviral spray	Respiratory tract infections	460-519	J00-J99
DIB011057	Anticancer therapeutic	Cancer	140-229	C00-C96
DIB011058	Cholestyramine	Diarrhea	.	A09,K59.1
DIB011059	Ap4A analogs	Discovery agent	.	.
DIB011060	XEL-003FP	Onychomycosis	.	B35.1
DIB011061	Megalin antagonists	Cancer	140-229	C00-C96
DIB011062	EA-230	Bacillus anthracis infection	.	A22
DIB011063	ALB-109564(a)	Solid tumours	.	C00-C75,C7A,C7B
DIB011064	CDP-855	Autoimmune diseases	279.4	D84.9, M35.9
DIB011065	APG-103	Inflammatory diseases	.	.
DIB011066	Bermoprofen	Inflammatory diseases	.	.
DIB011067	Tetraoxane derivatives	Plasmodium falciparum infection	.	B54
DIB011068	T-109	Pain	338,780	R52, G89
DIB011069	TH-9229	Reperfusion injury	.	I00-I99
DIB011070	ROCK inhibitors	Cardiovascular disease	390-459	I00-I99
DIB011071	CRYPTOPHYCIN 52	Cancer	140-229	C00-C96
DIB011072	BLV-0703	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB011073	Metabotropic glutamate receptor 2 positive allosteric modulators	Schizophrenia	295	F20
DIB011074	Allogeneic cytotoxic T-cell therapy	Epstein Barr virus infection	.	B27
DIB011075	Enterotoxigenic E Coli vaccine	Escherichia coli infection	.	A00-B99
DIB011076	MDR-03030	Influenza virus infections	487	J10, J11
DIB011077	Metallothionein	Brain injury	.	S09.90
DIB011078	PDE IV inhibitor	Inflammatory diseases	.	.
DIB011079	Bivalent vaccine	Salmonella infection	.	A02.9
DIB011080	Thyrotropin alpha	Thyroid cancer	193	C73
DIB011081	Ad5f35-LMPd1-2-transduced autologous dendritic cells	Nasopharyngeal carcinoma	.	C11
DIB011082	SA-14-14-2	Japanese encephalitis virus infection	.	A83.0
DIB011083	E-5531	Septic shock	.	A41.9
DIB011084	Casein kinase II inhibitors	Cancer	140-229	C00-C96
DIB011085	GL-522	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB011086	ESN-XX	Alzheimer's disease	331	G30
DIB011087	Dermacyn	Diabetic foot ulcer	707	L88-L89
DIB011088	Amyloid precursor protein C-terminal fragment-targeted monoclonal antibodies	Alzheimer's disease	331	G30
DIB011089	KM-133	Psoriasis	696	L40
DIB011090	Inaperisone	Pollakiuria	.	R35
DIB011091	AT-009	Cancer	140-229	C00-C96
DIB011092	FR-129169	Arteriosclerosis	.	I70
DIB011093	GS-156 peptide	Wound healing	.	S91.3
DIB011094	XR-3054	Cancer	140-229	C00-C96
DIB011095	ST-4206	Parkinson's disease	.	G20
DIB011096	ETEC/shigella/diarrhea vaccine	Diarrhea	787.91	A09, K59.1
DIB011097	B-623	Cancer	140-229	C00-C96
DIB011098	Infanrix Hep B	Hepatitis B virus infection	.	B16
DIB011099	HF-0299	Pain	.	G89
DIB011100	Pain therapy	Pain	338,780	R52, G89
DIB011101	MIQ-001	Alzheimer's disease	331	G30
DIB011102	227Th-trastuzumab (cancer), Algeta	Cancer	140-229	C00-C96
DIB011103	Neutrophil infiltration modulator	Discovery agent	.	.
DIB011104	Bevacizumab biosimilar	Bronchiectasis	.	J47
DIB011105	IMA-901	Renal cell carcinoma	189	C64
DIB011106	CX-5011	Cancer	.	C00-C97
DIB011107	SAM-6	Melanoma	.	C43
DIB011108	KYN-54	Cancer	140-229	C00-C96
DIB011109	AF-DX-384	Gastrointestinal disease	.	K00-K93
DIB011110	NRX-1050 series	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB011111	FG-65155	Reperfusion injury	.	I00-I99
DIB011112	NK-2210	Neurological disease	.	G00-G99
DIB011113	RG-7167	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011114	Tolperisone	Muscle spasm	.	M62.838
DIB011115	Bimoclomol derivatives	Amyotrophic lateral sclerosis	335.2	G12.2
DIB011116	CGRP antagonists	Migraine	346	G43
DIB011117	SUN-9221	Hypertension	401	I10, I11, I12, I13, I15
DIB011118	FINROZOLE	Prostate disorder	.	N40-N42
DIB011119	K562/GM-CSF	Acute myeloid leukemia	205	C92.0
DIB011120	Dabelotine	Cognition disorders	.	F06.7
DIB011121	EVO-011	Cancer	140-229	C00-C96
DIB011122	HL-025	Allergy	995.3	T78.4
DIB011123	OMN-54	Cancer	140-229	C00-C96
DIB011124	MIM-D3	Alzheimer's disease	.	G30,F00
DIB011125	HE2100	Thrombocytopenia	.	D69.6
DIB011126	Leptin mimetics	Obesity	278	E66
DIB011127	Prostaglandin-E receptor 3 antagonists	Pain	338,780	R52, G89
DIB011128	OPRX	Allergic conjunctivitis	372.14	H10.45
DIB011129	AZD-4451	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB011130	Vismed	Eye disorders	.	H00-H59
DIB011131	Hemporfin photodynamic therapy	Vasculitis	.	I77.6,I80
DIB011132	REGN1400	Cancer	.	C00-C97
DIB011133	OCM-108	Breast cancer	174, 175, 217	C50, D24
DIB011134	AZD5312	Prostate cancer	.	C61
DIB011135	CT-8	Restenosis	.	I51.89
DIB011136	FL-386	Hyperlipidemia	.	E78.5
DIB011137	Ragweed extract	Allergic rhinitis	477	J30
DIB011138	ITX-4520	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011139	ALT-020-04	Ocular infection	.	H00-H59
DIB011140	IPH-1201	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011141	EHT-207 series	Epilepsy	345	G40
DIB011142	CMV vaccine	Cytomegalovirus infection	.	B25
DIB011143	VIR-201	HIV infections	42	B20
DIB011144	Protein vaccines	Cancer	140-229	C00-C96
DIB011145	Lobeglitazone	Diabetes mellitus	250	E08-E13
DIB011146	ALP-242	Cystic fibrosis	277	E84
DIB011147	Diffistat-G	Clostridium difficile infection	.	A04.7,A41.4,A48.0
DIB011148	TDI-0050	Motor neurone disease	335.2	G12.2
DIB011149	ALD-901	Pain	338,780	R52, G89
DIB011150	GPR101 antagonists	Obesity	278	E66
DIB011151	Melaxin	Melanoma	172	C43
DIB011152	Hepatitis C protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011153	MAb therapies	Cancer	140-229	C00-C96
DIB011154	LymphoScan	Lymphoma	.	C81-C96
DIB011155	WIN-902A	Obesity	278	E66
DIB011156	Elongation factor Tu inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011157	2NTX-99	Atherosclerosis	414.0, 440	I70
DIB011158	Nestin-targeted oncolytic HSV therapy	Neuroblastoma	194	C74.9
DIB011159	Anti-smallpox monoclonal antibodies	Virus infection	.	B03
DIB011160	CC-8490	Brain cancer	191	C71
DIB011161	Citrate salts	Renal disease	.	N00-N29
DIB011162	CT-1	Diabetes mellitus	250	E08-E13
DIB011163	KT-95	Inflammatory bowel disease	555, 556	K50, K51
DIB011164	VR-909	Transplant rejection	.	T86
DIB011165	BMS-181321	Diagnosis	.	Y57.6
DIB011166	MAb	Metabolic disorders	270-279	E70-E89
DIB011167	Taxane derivatives	Cancer	140-229	C00-C96
DIB011168	Ro-23-2895	Arthritis	710-719	M00-M25
DIB011169	Beta amyloid lowering agents	Alzheimer's disease	331	G30
DIB011170	PF-03800130	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB011171	CRB-15	Autoimmune diseases	279.4	D84.9, M35.9
DIB011172	AOP-200704	Heart arrhythmia	.	I47-I49
DIB011173	MVA E2 vaccine	Cancer	.	C00-C97
DIB011174	C4X-101	Endocrine disease	.	E00-E35
DIB011175	SAR-100842	Fibrosis	.	L90.5
DIB011176	Human antibodies	MRSA infection	.	B95.62
DIB011177	Genetically-engineered autologous hematopoietic stem cell therapy	Gaucher disease	272.7	E75.2
DIB011178	LP-1810	Hypercholesterolemia	272	E78.0
DIB011179	MFH-147	Septic shock	785.52	A41.9
DIB011180	RO-4987655	Cancer	140-229	C00-C96
DIB011181	RQ-00000004	Gastroesophageal reflux disease	.	K21
DIB011182	Flosulide	Pain	.	G89
DIB011183	3-DEAZAADENOSINE	Arthritic	710-719	M00-M25
DIB011184	MVA-BN JEV	Japanese encephalitis virus infection	.	A83.0
DIB011185	RBx-343E48F0	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB011186	S-33516	Arthritis	.	M00-M25
DIB011187	Thrombopoietin receptor agonists	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB011188	ISA-HPV-01	Cervical cancer	.	C53
DIB011189	CDRI-S007-867	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB011190	FAK modulator	Cancer	.	C00-C97
DIB011191	OCM-124	Glioma	191	C71
DIB011192	Ad35.CS.01	Plasmodium falciparum infection	.	B54
DIB011193	Noberastine	Asthma	.	J45
DIB011194	HAC-1 vaccine	Influenza virus infections	487	J10, J11
DIB011195	SKF-104351	Rheumatold arthritis	714	M05-M06
DIB011196	A-967079	Pain	338,780	R52, G89
DIB011197	Neurologicals	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011198	SELODENOSON	Cardiac arrhythmias	.	I47-I49
DIB011199	GSK-706769	HIV infections	42	B20
DIB011200	Cancer imaging agent	Cancer	140-229	C00-C96
DIB011201	OG-45	Dementia	290-294	F01-F07
DIB011202	Muscarinic M1 agonists	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB011203	CYT-003-QbG10	Allergic rhinitis	.	J30
DIB011204	ADCON-I	Wound healing	.	S91.3
DIB011205	Cartilage regeneration therapy	Articular cartilage disorders	.	M24.10
DIB011206	CB2 receptor agonists	Pain	338,780	R52, G89
DIB011207	ZP-005	Pharyngitis	.	J02
DIB011208	Alpha-gal glycosphingolipid	Melanoma	.	C43
DIB011209	ABIO-08-01	Amnesia	.	F04
DIB011210	PF-3654764	Allergic rhinitis	477	J30
DIB011211	ZD-9720	Arteriosclerosis	.	I70
DIB011212	T-607	Cancer	140-229	C00-C96
DIB011213	ONO-9054	Glaucoma	.	H40-H42
DIB011214	Hedgehog pathway inhibitor	Cancer	140-229	C00-C96
DIB011215	RU-46556	Endometrial cancer	.	C54.1
DIB011216	TGF-beta receptor inhibitors	Fibrosis	.	L90.5
DIB011217	Anti-CD3 activated vaccine-primed lymphocytes	Melanoma	.	C43
DIB011218	CGS-19480A	Anxiety disorder	.	F40-F42
DIB011219	ABT-107	Attention deficit hyperactivity disorder	.	F90
DIB011220	EB-101	Alzheimer's disease	331	G30
DIB011221	PF-06678552	Hyperkalemia	.	E87.5
DIB011222	Dexamethasone sodium phosphate	Uveitis	364	H20
DIB011223	Streptococcus pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB011224	Combidex	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB011225	Recombinant soluble human CD5	Sepsis	995.91	A40, A41
DIB011226	SA-ANP	Hypertension	401	I10, I11, I12, I13, I15
DIB011227	P-552-02	Cystic fibrosis	277	E84
DIB011228	NI-0401	Autoimmune diseases	279.4	D84.9, M35.9
DIB011229	AZD-2392	Asthma	493	J45
DIB011230	Nestorone transdermal spray	Endometriosis	.	N80
DIB011231	ECO-0501	Enterococcus faecalis infection	.	B95.2
DIB011232	MN-246	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB011233	Siguazodan	Allergy	.	T78.4
DIB011234	HBV infection vaccine	Hepatitis B virus infection	.	B16
DIB011235	NUCB-1000	Hepatitis B virus infection	.	B16
DIB011236	INCB-10820	Inflammatory diseases	.	.
DIB011237	ND-601	Mycobacterium tuberculosis infection	.	A15-A19
DIB011238	KRP-110	Constipation	564	K59.0
DIB011239	IL-23 receptor antagonist	Arthritis	710-719	M00-M25
DIB011240	ONO-4057	Inflammatory bowel disease	555, 556	K50, K51
DIB011241	Seridopidine	Neurological disease	.	G00-G99
DIB011242	XL-647	Polycystic kidney disease	753.1	Q61
DIB011243	Tumor vascular thrombogen	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011244	FK-041	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB011245	CEP-37248	Inflammatory diseases	.	.
DIB011246	AJ-3941	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011247	AX-9040	Transmissible spongiform encephalopathy	.	A81
DIB011248	Prostate cancer therapy	Prostate tumor	185	C61
DIB011249	CDR-134D123	Diabetes mellitus	250	E08-E13
DIB011250	RAP-160	Psoriasis	696	L40
DIB011251	JNJ-17216498	Narcolepsy	347	G47.4
DIB011252	FK-614	Diabetes mellitus type 2	.	E11
DIB011253	MB-312	Cancer	140-229	C00-C96
DIB011254	Delipidization compounds	Atherosclerosis	414.0, 440	I70
DIB011255	GA-FSH	Female infertility	628	N97.0
DIB011256	Project Sigma	Osteoporosis	733	M80-M81
DIB011257	PD-4074	Diabetes mellitus	250	E08-E13
DIB011258	NM-2026	Discovery agent	.	.
DIB011259	CY-9652	Inflammatory diseases	.	.
DIB011260	Arthritis therapeutics	Osteoporosis	733	M80-M81
DIB011261	GSK-2241658A	Melanoma	172	C43
DIB011262	BOPP	Acquired immune deficiency syndrome	42	B20
DIB011263	POL-6014	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB011264	ESBA-903	Ocular disease	.	H00-H59
DIB011265	VPM-1-002	Mycobacterium tuberculosis infection	.	A15-A19
DIB011266	B-Raf kinase inhibitors	Cancer	140-229	C00-C96
DIB011267	Ketohexokinase inhibitors	Diabetes mellitus	250	E08-E13
DIB011268	NOX-H94	Anemia	.	D50-D64
DIB011269	Stem cell-derived astrocytes	Motor neurone disease	335.2	G12.2
DIB011270	TRX-585	Cancer	.	C00-C97
DIB011271	SINOMENINE	Arthritic	710-719	M00-M25
DIB011272	ANA-246	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011273	Zadaxin/lamivudine	Hepatitis B virus infection	.	B16
DIB011274	CRE-319M2	Ischemic heart diseases	410-414	I20-I25
DIB011275	TA-383	Arthritic	710-719	M00-M25
DIB011276	PARP modulators	Discovery agent	.	.
DIB011277	HIV therapeutic vaccine	HIV infections	42	B20
DIB011278	CGP-70726	HIV-1 infections	42	B20
DIB011279	ZD-6003	Cancer	140-229	C00-C96
DIB011280	NM-3014	Discovery agent	.	.
DIB011281	P53-Mdm2 binding inhibitors	Cancer	140-229	C00-C96
DIB011282	ALD-306	Cardiovascular disease	390-459	I00-I99
DIB011283	MEP pathway inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011284	EDP-09	Ischemia	459.89	I99.8
DIB011285	TPX-100	Osteoarthritis	.	M19.90
DIB011286	CR-845 iv infusion	Pain	.	G89
DIB011287	ONO-4127Na	Allergic rhinitis	477	J30
DIB011288	Recombinant human CC10	Adult respiratory distress syndrome	518.5, 518.82	J80
DIB011289	FHT-401	Rheumatold arthritis	714	M05-M06
DIB011290	HumaRAD-OV	Ovarian cancer	.	C56
DIB011291	BO-110	Cancer	140-229	C00-C96
DIB011292	Anti-nerve growth factor monoclonal antibody	Pain	338,780	R52, G89
DIB011293	Immunotherapy/gene therapy	HIV infections	42	B20
DIB011294	CD200Fc	Autoimmune diseases	279.4	D84.9, M35.9
DIB011295	CVT-10216	Alcohol use disorders	303	F10.2
DIB011296	RQ-00203078	Neuropathic pain	338,780	R52, G89
DIB011297	PKC-theta inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB011298	NE-1530	Bronchitis	.	J20-J21,J42
DIB011299	SAN-61	Alzheimer's disease	.	G30,F00
DIB011300	Recombinant botulinum neurotoxin vaccine	Migraine	.	G43
DIB011301	Eperezolid	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB011302	MOR-105	Inflammatory diseases	.	.
DIB011303	Dendritic cell vaccine	Glioblastoma	191	C71
DIB011304	Protein kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB011305	Vero-Vac	Influenza virus infections	487	J10, J11
DIB011306	KRP-100	Discovery agent	.	.
DIB011307	Anti-RSV mAb	Respiratory syncytial virus 	79.6	B97.4
DIB011308	Contraceptive combination	Female contraception	.	Z30.013
DIB011309	BI-K0376	Acne vulgaris	706.1	L70.0
DIB011310	Universal pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB011311	Eberconazole	Fungal infection	.	B35-B49
DIB011312	CB-5083	Multiple myeloma	203	C90.0
DIB011313	LY-295501	Diabetes mellitus	250	E08-E13
DIB011314	Gene therapy	Brain cancer	.	C71
DIB011315	Secnidazole	Amoebiasis	.	A06
DIB011316	ADE-HYPT	Hypertension	401	I10, I11, I12, I13, I15
DIB011317	IP-1112	Hormone deficiency	.	E00-E90
DIB011318	GR-233548	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB011319	Allogenic mesenchymal stem cell therapy	Osteoarthritis	715	M15-M19, M47
DIB011320	LP-205A1	Cancer	.	C00-C97
DIB011321	Canvaxin	Melanoma	.	C43
DIB011322	Ilatreotide	Duodenal ulcer	.	K25-K27
DIB011323	KW-5139	Pain	.	G89
DIB011324	PA-342	Mycobacterium tuberculosis infection	.	A15-A19
DIB011325	Oligonucleotide	Leukemia	208.9	C91-C95
DIB011326	Stem cell therapeutics	Neurodegenerative diseases	.	G30-G32
DIB011327	ND-901	Plasmodium falciparum infection	.	B54
DIB011328	A-75998	Hormone deficiency	.	E00-E90
DIB011329	PXT-3003	Charcot marie tooth disease	.	G60.0
DIB011330	HBV therapeutic vaccine	Hepatitis B virus infection	.	B16
DIB011331	Vaccine targeting midkine	Cancer	140-229	C00-C96
DIB011332	Angiozyme	Cancer	.	C00-C97
DIB011333	HS-P1	Pancreatic cancer	.	C25
DIB011334	BSP-C705 series	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011335	SPI-3608	Spinal disease	.	G95.9
DIB011336	Vinconate	Amnesia	.	F04
DIB011337	Propicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011338	REC-1819	Overactive bladder disorder	596.51	N32.81
DIB011339	RG-8803	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DIB011340	DL-3 androgen receptor antagonist	Prostate tumor	185	C61
DIB011341	TACE inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB011342	IL17Qb therapeutic vaccines	Multiple sclerosis	340	G35
DIB011343	ZP-2307	Osteoporosis	733	M80-M81
DIB011344	AZD-4440	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011345	BST-1005	Cancer	140-229	C00-C96
DIB011346	Anti-FGFR2 antibodies	Cancer	140-229	C00-C96
DIB011347	TT-111	Bleeding	.	R58
DIB011348	Olsalazine	Ulcerative colitis	556	K51
DIB011349	Org-38457	Anxiety disorder	.	F40-F42
DIB011350	Sodium phosphate P 32	Bone metastases	198.5	C79.51
DIB011351	LAS-41001	Rosacea	.	L71
DIB011352	Diaspirin crosslinked hemoglobin	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011353	CNTO-736	Non-insulin dependent diabetes	.	E11.9
DIB011354	NT-503	Age related macular degeneration	.	H35.30
DIB011355	AM-94	Rotavirus infections	001-139	A00-B99
DIB011356	Pim kinase inhibitors	Cancer	.	C00-C97
DIB011357	LY-2523199	Diabetes mellitus type 2	.	E11
DIB011358	HIV vaccine	HIV infections	42	B20
DIB011359	BTT-1023	Psoriasis	.	L40
DIB011360	EML-336	Diabetes mellitus type 2	.	E11
DIB011361	CMVpp65-A0201	Cytomegalovirus infection	.	B25
DIB011362	TB-010	Breast cancer	174, 175, 217	C50, D24
DIB011363	JNJ-42847922	Major depressive disorder	296.2, 296.3	F32, F33
DIB011364	H5N1 vaccine	Influenza virus infections	487, 488	J10, J11
DIB011365	GM-CT-02	Liver fibrosis	571	K70.3, K71.7, K74
DIB011366	CLP-635	Epilepsy	345	G40
DIB011367	CGS-25462	Hypertension	401	I10, I11, I12, I13, I15
DIB011368	PG-2	Fatigue	.	R53
DIB011369	SGN-10	Cancer	140-229	C00-C96
DIB011370	NGF-hTNF	Multiple sclerosis	.	G35
DIB011371	Mitomycin-C analogs	Breast cancer	174, 175, 217	C50, D24
DIB011372	SDX-7400	Cancer	140-229	C00-C96
DIB011373	Prosstatin	Prostate hyperplasia	.	N40
DIB011374	SCLERON	Motor neurone disease	335.2	G12.2
DIB011375	PEITC	Prostate tumor	185	C61
DIB011376	PDE 4 inhibitor	Respiratory disease	.	J00-J99
DIB011377	EDP-21	Obesity	278	E66
DIB011378	Mar-99	Asthma	.	J45
DIB011379	AP-15012	Cancer	140-229	C00-C96
DIB011380	DMP-543	Parkinson's disease	.	G20
DIB011381	U77 helicase inhibitors	Herpes simplex virus infection	.	B00
DIB011382	Antibacterial/antiviral agents	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011383	Humanized mAb program	Endometrial cancer	.	C54.1
DIB011384	Vaccine	Type 2 diabetes	250.00, 250.02	E11
DIB011385	Bivatuzumab mertansine	Cancer	140-229	C00-C96
DIB011386	INT-777	Metabolic disorders	.	E70-E90
DIB011387	NLX-E201	Epilepsy	345	G40
DIB011388	SeV gene vaccine	Parkinson's disease	.	G20
DIB011389	Artemisinin trioxane dimers	Cancer	.	C00-C97
DIB011390	TX-MSD	Multiple sclerosis	340	G35
DIB011391	F-50008	Klebsiella pneumoniae infection	.	J15.0
DIB011392	ZK-001	Thrombosis	.	I80-I82
DIB011393	ATP-exclusionary kinase inhibitors	Cancer	140-229	C00-C96
DIB011394	JKB-121	Fatty liver disease	.	K70,K76.0
DIB011395	Trecovirsen sodium	HIV-1 infections	42	B20
DIB011396	Prednimustine	Cancer	140-229	C00-C96
DIB011397	DDS-07C	Pain	338,780	R52, G89
DIB011398	CLR-1401	Cancer	140-229	C00-C96
DIB011399	MRSAid	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011400	NV.BC.04	Inflammatory bowel disease	555, 556	K50, K51
DIB011401	Anti-miR-199a oligonucleotides	Ischemic heart diseases	410-414	I20-I25
DIB011402	BCX-4161	Hereditary angioedema	277.6	D84.1
DIB011403	RDX-5791	Constipation	.	K59.0
DIB011404	Hepatitis B prophylactic vaccine	Hepatitis B virus infection	.	B16
DIB011405	Vapiprost	Cardiovascular disease	390-459	I00-I99
DIB011406	THE-320	Prostate hyperplasia	.	N40
DIB011407	BBT-031	Growth disorder	.	E23.0
DIB011408	IL-2 mimetic peptides	Cancer	140-229	C00-C96
DIB011409	Antibody drug conjugates	Cancer	140-229	C00-C96
DIB011410	FR-208419	Dyspepsia	.	K30
DIB011411	NVX-144	Cancer	140-229	C00-C96
DIB011412	Anti-inflammatory/anti-proliferative agents	Dermatological disease	.	L00-L99
DIB011413	CC-122	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011414	6F4	Cancer	140-229	C00-C96
DIB011415	DNA methyltransferase inhibitors	Cancer	140-229	C00-C96
DIB011416	Org-2766	Cognitive impairment	.	F06.7
DIB011417	Mitumomab	Melanoma	.	C43
DIB011418	Virion project	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB011419	EP-342	Cancer	140-229	C00-C96
DIB011420	BGS-649	Endometriosis	.	N80
DIB011421	Sifuvirtide	HIV infections	42	B20
DIB011422	Wnt signaling pathway modulators	Cancer	140-229	C00-C96
DIB011423	ADMVA	Diabetes mellitus	.	E10-E14
DIB011424	Antifibrotic compounds	Renal fibrosis	709.2	L90.5
DIB011425	Prednisolone	Multiple sclerosis	.	G35
DIB011426	BILD-1357	Herpes simplex virus infection	54	B00
DIB011427	Evatak	Cancer	140-229	C00-C96
DIB011428	NGD-97-1	Alzheimer's disease	331	G30
DIB011429	BODY PROTECTION COMPOUND-15	Inflammatory bowel disease	555, 556	K50, K51
DIB011430	Autologous adipose-derived stem cells	Anal fistula	.	K60.3
DIB011431	Ndx-Peptide	Diabetes mellitus	250	E08-E13
DIB011432	CE-224535	Arthralgia	.	M25.5
DIB011433	MDDR 255262	Pain	338	R52
DIB011434	RNA polymerase inhibitors (tuberculosis infection) TB Alliance/Rutgers/AZ	Mycobacterium tuberculosis infection	.	A15-A19
DIB011435	IkT-051	Influenza virus infections	487	J10, J11
DIB011436	Methenamine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011437	Prophylactic influenza vaccine	Influenza virus infections	487	J10, J11
DIB011438	Toll-like receptor inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB011439	GT-2342	Neurodegenerative diseases	.	G30-G32
DIB011440	HPV-16 E7 vaccine	Papillomavirus infections	.	B97.7
DIB011441	Mabs of cancer/inflammation/immune disorder	Cancer	.	C00-C97
DIB011442	Thiomarinols	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011443	WAY-644	Aortic aneurysm	.	I71
DIB011444	NK-314	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011445	KF-18280	Inflammatory diseases	.	.
DIB011446	TRPC5 modulators	Anxiety disorder	300	F40-F42
DIB011447	CB-183315	Malignant carcinoid syndrome	.	C7A
DIB011448	IMD-4852	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB011449	TVX-006	Discovery agent	.	.
DIB011450	IEP-11	Cancer	140-229	C00-C96
DIB011451	AL-209	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB011452	REC-200	Autoimmune diseases	279.4	D84.9, M35.9
DIB011453	NPC-18166	Psychotic disorders	.	F20-F29
DIB011454	Epstein-Barr virus vaccine	Epstein Barr virus infection	.	B27
DIB011455	MSC-204	HIV infections	42	B20
DIB011456	Heparan sulfate	Angiogenesis disorder	.	I00-I99
DIB011457	LJJ-10	Cancer	140-229	C00-C96
DIB011458	NHP-229	Gastroesophageal reflux disease	.	K21
DIB011459	SOM-0777	Cancer	140-229	C00-C96
DIB011460	Bone regeneration therapy	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB011461	H5N1 influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB011462	PAZELLIPTINE TRIHYDROCHLORIDE	Cancer	140-229	C00-C96
DIB011463	ZP-011	Sinusitis	.	J01,J32
DIB011464	Cancer vaccine	Melanoma	.	C43
DIB011465	AI-200	Rheumatold arthritis	714	M05-M06
DIB011466	Vero cell seasonal influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB011467	P-2202	Syndrome X	.	E88.9
DIB011468	BUTIXOCORT	Asthma	.	J45
DIB011469	GEM-SP	Multiple sclerosis	340	G35
DIB011470	Tin-117m-labeled annexin	Heart disease	390-429	I00-I52
DIB011471	Multi-envelope HIV vaccine	HIV infections	42	B20
DIB011472	LAU-0901	Brain ischaemia	435, 437	G45.9, I67.8
DIB011473	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB011474	Lymphocyte immune globulin, anti-thymocyte globulin	Aplastic anemia	284	D60-D61
DIB011475	CH-1766	Rheumatold arthritis	714	M05-M06
DIB011476	Pentamycin vaginal tablets	Vulvovaginitis	.	N76.0
DIB011477	Atherosclerosis/rheumatoid arthritis agents	Atherosclerosis	414.0, 440	I70
DIB011478	AE-0047	Hypertension	401	I10, I11, I12, I13, I15
DIB011479	Tidembersat	Migraine	.	G43
DIB011480	Human monoclonal antibodies	HIV infections	42	B20
DIB011481	Wnk kinase inhibitors	Cancer	140-229	C00-C96
DIB011482	Smoothened receptor antagonist	Cancer	140-229	C00-C96
DIB011483	ESUPRONE	Major depressive disorder	.	F32,F33
DIB011484	RI-820	Motor neurone disease	335.2	G12.2
DIB011485	IT-139	Solid tumours	.	C00-C75,C7A,C7B
DIB011486	Galavit	Autoimmune diseases	279.4	D84.9, M35.9
DIB011487	HSV-1716	Cancer	.	C00-C97
DIB011488	Ovine corticotropin-releasing hormone	Cushing's disease	.	E24.9
DIB011489	Liposomal tretinoin	Acute promyelocytic leukemia	205	C92.4
DIB011490	MicroRNA-103/microRNA-107 antagonists	Diabetes mellitus	250	E08-E13
DIB011491	AZD-6605	Osteoarthritis	715	M15-M19, M47
DIB011492	Neuroprotectant	Neurodegenerative diseases	.	G30-G32
DIB011493	AZD-1744	Asthma	.	J45
DIB011494	ES-6864	Hypertension	.	I10-I15
DIB011495	CXCR-4 antagonist	Cancer	.	C00-C97
DIB011496	V-489	Cancer	140-229	C00-C96
DIB011497	HCV therapy	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011498	LP-661438	Cancer	140-229	C00-C96
DIB011499	PAC-10649	Arthritis	.	M00-M25
DIB011500	ATB-284	Irritable bowel syndrome	564.1	K58
DIB011501	SKF-96365	Angina	413	I20
DIB011502	BAY1129980	Cancer	140-229	C00-C96
DIB011503	GW-275175	Viral infections	042-075	A80-A99, B00-B34
DIB011504	LY3002813	Alzheimer's disease	331	G30
DIB011505	CNTO-6785	Rheumatold arthritis	.	M05-M06
DIB011506	SEP-227162	Major depressive disorder	296.2, 296.3	F32, F33
DIB011507	Topoisomerase IIA inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011508	BMS-813160	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB011509	WCK-771	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB011510	N-9xxx	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB011511	Anthrax Immune Globulin (AIG)	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011512	RBX2660	Recurrent clostridium difficile infection	.	A04.7
DIB011513	BAY-86-7548	Cancer	140-229	C00-C96
DIB011514	TBC-MN	HIV infections	42	B20
DIB011515	Glutamate racemase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011516	MCF	Cystic fibrosis	277	E84
DIB011517	FX-007	Pain	338,780	R52, G89
DIB011518	HPV E7 cervical cancer vaccine	Papillomavirus infections	.	B97.7
DIB011519	PD-151832	Parkinson's disease	.	G20
DIB011520	DM-71	Diabetes mellitus type 2	.	E11
DIB011521	Naproxcinod	Inflammatory diseases	.	.
DIB011522	AZD-1080	Alzheimer's disease	.	G30,F00
DIB011523	Antiherpes vaccine	Herpes simplex virus infection	54	B00
DIB011524	MPL-containing Pollinex allergy desensitization injectable vaccine	Angina pectoris	413	I20
DIB011525	Cytokine release modulator	Alzheimer's disease	331	G30
DIB011526	Stomach ulcer therapy	Stomach ulcer	.	K25-K27
DIB011527	Erythromycin macrolides	Inflammatory diseases	.	.
DIB011528	Nonpeptidic VLA-4 inhibitors	Inflammatory diseases	.	.
DIB011529	Nerisopam	Anxiety disorder	300	F40-F42
DIB011530	Radezolid iv	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB011531	Beta cell inducers	Insulin dependent diabetes	.	E10
DIB011532	Fluoroglycoconjugates	Cancer	140-229	C00-C96
DIB011533	Zadaxin/transarterial chemoembolization(TACE)(cisplatin)	Hepatitis virus infection	573.3	K75.9
DIB011534	SLC-022	Neuropathic pain	338,780	R52, G89
DIB011535	Diphtheria, tetanus, acellular pertussis booster vaccine	Bordetella pertussis infection	.	A37.0
DIB011536	Ascofuranone and analogs	Trypanosomiasis	086.5-086	B56-B57
DIB011537	DW-1029M	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB011538	IL-2 XL	Human immunodeficiency virus infection	.	B20
DIB011539	Levosemotiadil	Cardiac arrhythmias	.	I47-I49
DIB011540	PRS-639058	Neuropathic pain	338,780	R52, G89
DIB011541	HBDt.Fc	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011542	REC-15-2739	Prostate disease	.	N42.9
DIB011543	P24-VLP	Immune disorder	.	D80-D89
DIB011544	PL-3394	Congestive heart failure	428	I50
DIB011545	REN-850	Multiple sclerosis	340	G35
DIB011546	Protein-silencing drugs	Cancer	140-229	C00-C96
DIB011547	Diazeniumdiolate NO releasing compounds	Cancer	140-229	C00-C96
DIB011548	LD-101	Cancer	140-229	C00-C96
DIB011549	THA-902	Fibromyalgia	729.1	M79.7
DIB011550	Ulocuplumab	Hematological malignancies	200-209	C81-C96
DIB011551	FiloVax	Ebola virus infection	.	A98
DIB011552	SB-101	Cancer	140-229	C00-C96
DIB011553	Intranasal apomorphine	Sexual dysfunction	.	F52
DIB011554	BMS-275183	Cancer	140-229	C00-C96
DIB011555	Live attenuated H1N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB011556	V-0191	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB011557	ZP-010	Bronchitis	.	J20-J21,J42
DIB011558	LY-2393910	Non-insulin dependent diabetes	.	E11.9
DIB011559	ImmunoVEX HSV2	Herpes simplex virus infection	.	B00
DIB011560	TR-14531	Asthma	.	J45
DIB011561	ZFP TF	Pain	338,780	R52, G89
DIB011562	YM-337	Angiogenesis disorder	.	I00-I99
DIB011563	Anti-tubulin agents	Cancer	140-229	C00-C96
DIB011564	NOSO-74	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011565	Abuse-resistant opioid formulation	Pain	338,780	R52, G89
DIB011566	PPAR agonist program	Inflammatory bowel disease	555, 556	K50, K51
DIB011567	Butacaine	Pain	338,780	R52, G89
DIB011568	Gamma-secretase inhibitors	Cancer	140-229	C00-C96
DIB011569	Asparaginase	Acute lymphoblastic leukemia	204	C91.0
DIB011570	BMS-194796	Diagnosis	.	Y57.6
DIB011571	SUN-09	Hypertonia	.	P94.1
DIB011572	Lodenosine	Human immunodeficiency virus infection	.	B20
DIB011573	Tumor infiltrating lymphocyte	Malignant melanoma	172	C43
DIB011574	BM-13.1180	Diabetes mellitus	250	E08-E13
DIB011575	J-104132	Pulmonary arterial hypertension	.	I27.0,I27.2
DIB011576	CP-613	Pancreatic cancer	.	C25
DIB011577	Org-36764	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB011578	Prodrug vinca alkaloid derivatives	Cancer	140-229	C00-C96
DIB011579	Anti-MUC1 AR20.5 mAb	Pancreatic cancer	157	C25
DIB011580	MKG-02	Diabetes mellitus	250	E08-E13
DIB011581	STF-62247	Renal cell carcinoma	189	C64
DIB011582	Orlogin	Sleep disorders	.	F51,G47
DIB011583	NP-1998	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB011584	NT-KO-009	Neurodegenerative diseases	.	G30-G32
DIB011585	Nav1.7 subunit sodium channel blocker	Neuropathic pain	338,780	R52, G89
DIB011586	Hair cell regeneration therapy	Hypoacusis	.	H90.5
DIB011587	PDE 7 inhibitors	Immune disorder	.	D80-D89
DIB011588	Targeted vaccines	Cancer	.	C00-C97
DIB011589	Gene therapy	Melanoma	172	C43
DIB011590	LY-235723	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011591	Turosteride	Prostate disorder	.	N40-N42
DIB011592	AZM-132	Obesity	278	E66
DIB011593	AVN-628	Anxiety disorder	300	F40-F42
DIB011594	GF-15	Cancer	140-229	C00-C96
DIB011595	Milataxel	Cancer	.	C00-C97
DIB011596	TB-102	Bleeding	.	R58
DIB011597	Microglial activation inhibitor	Multiple sclerosis	340	G35
DIB011598	XL-820	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011599	CFMS kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB011600	Hypoxia-selective multi-kinase inhibitors	Non-small-cell lung cancer	162	C33, C34
DIB011601	Enkastim-ev	Cancer	140-229	C00-C96
DIB011602	XDR-TB RNA-based therapeutics	Mycobacterium tuberculosis infection	.	A15-A19
DIB011603	Gene therapy	Breast cancer	.	C50
DIB011604	ABX-201	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB011605	PD-131112	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB011606	Falcipain (cysteine protease) inhibitors	Plasmodium infection	.	B54
DIB011607	Alphaprodine	Pain	338,780	R52, G89
DIB011608	CB1 antagonists	Endocrine disease	.	E00-E35
DIB011609	AMEP	Melanoma	.	C43
DIB011610	ALBIFYLLINE	Septic shock	785.52	A41.9
DIB011611	NM-4654	Discovery agent	.	.
DIB011612	PTI-721	Pain	.	G89
DIB011613	ORE-1001	Diabetes mellitus	.	E10-E14
DIB011614	IL-4	Immune disorder	.	D80-D89
DIB011615	M-0004	Gastroesophageal reflux disease	.	K21
DIB011616	Oncopurge	Cancer	140-229	C00-C96
DIB011617	PB-102	Cancer	140-229	C00-C96
DIB011618	KIN-4050	Psoriasis	696	L40
DIB011619	CX-2076	Attention deficit hyperactivity disorder	314	F90
DIB011620	SM04755	Liver cancer	155	C22.0
DIB011621	Leucyl tRNA synthetase modulators	Mycobacterium tuberculosis infection	.	A15-A19
DIB011622	Lipid chaperones	Lipid metabolism disorder	.	E75-E78
DIB011623	The Biopump	Kidney diseases	580-589	N00-N29
DIB011624	Pentaxim	Bordetella pertussis infection	.	A37.0
DIB011625	CAN-296	Fungal infection	.	B35-B49
DIB011626	Ro-09-1428	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011627	CB-24	Cancer	140-229	C00-C96
DIB011628	AVX101	Acquired immune deficiency syndrome	42	B20
DIB011629	Fully human antibody	Cancer	140-229	C00-C96
DIB011630	PENNVAX-GP/MVA-CMDR HIV vaccine regime	HIV infections	42	B20
DIB011631	HRA-072033	Endocrine disease	.	E00-E35
DIB011632	RGH-512	Pain	338,780	R52, G89
DIB011633	Nucleoside analogs	Hepatitis B virus infection	.	B16
DIB011634	Htt-mediated toxicity inhibitors	Huntington's disease	.	F02.2,G10
DIB011635	AT-002	Autoimmune diseases	279.4	D84.9, M35.9
DIB011636	Nanogam	Immune disorder	.	D80-D89
DIB011637	GALOCITABINE	Solid tumours	.	C00-C75,C7A,C7B
DIB011638	Herpes zoster therapy	Varicella zoster virus infections	.	B01,B02
DIB011639	GLPG-0778	Arthritis	710-719	M00-M25
DIB011640	NRX compounds	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB011641	PACLITAXEL CERIBATE	Cancer	140-229	C00-C96
DIB011642	H5N1 avian influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB011643	Iothalamate	Arthropathy	.	M00-M14
DIB011644	Antihyperlipidemia agent	Hyperlipidemia	272.0-272.4	E78
DIB011645	HL-4130	Hyperlipidemia	272.0-272.4	E78
DIB011646	KIAA1363 inhibitors	Cancer	140-229	C00-C96
DIB011647	VLP vaccine	HIV infections	42	B20
DIB011648	NXN-462	Headache	.	G43-G44
DIB011649	APD-403	Emesis	787	R11
DIB011650	RP-72540	Anxiety disorder	300	F40-F42
DIB011651	SR-11237	Cancer	140-229	C00-C96
DIB011652	SAOB-0401	Cancer	140-229	C00-C96
DIB011653	Zn-DPA-I	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011654	Hepatitis B virus replication inhibitors	Hepatitis B virus infection	.	B16
DIB011655	Hemoglobin crosfumaril	Hypotension	458, 796.3	I95
DIB011656	GSI-136	Alzheimer's disease	.	G30,F00
DIB011657	UK-224671	Urinary incontinence	.	N39.3-N39.4
DIB011658	NPB-001-056	Chronic myelogenous leukemia	.	C92.1
DIB011659	Parenteral amino acids	Nutritional deficiency	.	E63.9
DIB011660	Selective estrogen receptor modulators	Cancer	140-229	C00-C96
DIB011661	Apoptosis inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011662	VK0612	Type 2 diabetes	250.00, 250.02	E11
DIB011663	AFM-11	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB011664	TAK-225	Asthma	.	J45
DIB011665	TG100801	Macular degeneration	362.5	H35.3
DIB011666	Hemagglutinin inhibitors	Influenza virus infections	487	J10, J11
DIB011667	FGF-21	Diabetes mellitus type 2	.	E11
DIB011668	MitoPBN	Mitochondrial disease	.	E88.49
DIB011669	Magnesium/zinc/lithium salts	Age related macular degeneration	.	H35.30
DIB011670	IGX-CPL3	Diarrhea	.	A09,K59.1
DIB011671	Patiromer calcium	Hyperkalemia	.	E87.5
DIB011672	CT-637	Autoimmune diseases	279.4	D84.9, M35.9
DIB011673	HER1-VSSP vaccine	Cancer	140-229	C00-C96
DIB011674	E coli adhesin-based vaccines	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011675	LMP-1/LMP-2 CTLs	Lymphoma	.	C81-C96
DIB011676	OX-ESI	Respiratory tract inflammation	.	J00-J99
DIB011677	DTPA	Radiation sickness	990	T66
DIB011678	BMN-103	Pompe's disease	.	E74.02
DIB011679	Chitosan/IL-12	Bladder cancer	188	C67
DIB011680	Fosclin	Plasmodium malariae infection	.	B50
DIB011681	BM-ca	Non-Hodgkin's lymphoma	.	C85.9
DIB011682	Allervax Ragweed	Allergy	995.3	T78.4
DIB011683	NS-2389	Major depressive disorder	296.2, 296.3	F32, F33
DIB011684	AZD-2315	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DIB011685	DRAFLAZINE	Cardiac arrhythmias	.	I47-I49
DIB011686	CL-283796	Hyperlipidemia	.	E78.5
DIB011687	Oxytocin	Autism	299	F84.0
DIB011688	CI-996	Hypertension	401	I10, I11, I12, I13, I15
DIB011689	Peroxisomicine	Cancer	140-229	C00-C96
DIB011690	XEN-401	Pain	338,780	R52, G89
DIB011691	MG-28	Cancer	140-229	C00-C96
DIB011692	Chk1 inhibitors	Cancer	140-229	C00-C96
DIB011693	HydrocoDex	Pain	.	G89
DIB011694	Anticort	Human immunodeficiency virus infection	.	B20
DIB011695	SCID-X stem cell therapy	Immune disorder	.	D80-D89
DIB011696	Short-acting thrombosis inhibitor	Disseminated intravascular coagulation	286.6	D65
DIB011697	Recombinant protein subunit vaccine	Filoviridae	.	A99
DIB011698	Sodium channel blocker	Pain	338,780	R52, G89
DIB011699	Ponezumab	Alzheimer's disease	.	G30,F00
DIB011700	IMX-MEL1	Melanoma	172	C43
DIB011701	CBNU-06	Alzheimer's disease	331	G30
DIB011702	AP-1600 series	Ocular inflammation	.	H00-H59
DIB011703	DTaP-IPV-Hib	Bordetella pertussis infection	.	A37.0
DIB011704	ORL-1 antagonists	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB011705	CD4 aptamer-siRNA chimeras	HIV infections	42	B20
DIB011706	H5 subtype avian influenza vaccine	Influenza virus infections	487	J10, J11
DIB011707	BSP-C728 series	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011708	BPL-001	Cardiovascular disease	390-459	I00-I99
DIB011709	ORMD-0901	Diabetes mellitus type 2	.	E11
DIB011710	OpRegen	Age related macular degeneration	.	H35.30
DIB011711	Tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB011712	CNVN-202	Non-small cell lung cancer	.	C33-C34
DIB011713	PF-446687	Female sexual dysfunction	302.7	F52, R37
DIB011714	Norovirus vaccine	Norwalk virus infection	.	A08
DIB011715	GTU-malaria vaccine	Plasmodium infection	.	B54
DIB011716	EiRNA	Hepatitis virus infection	573.3	K75.9
DIB011717	Azoles	Trypanosomiasis	086.5-086	B56-B57
DIB011718	PD-2024	Insulin resistance	.	E00-E90
DIB011719	BreMel/TNF alpha	Breast cancer	174, 175, 217	C50, D24
DIB011720	ZP-2571	Cancer	140-229	C00-C96
DIB011721	CG-8840	Bladder cancer	188	C67
DIB011722	Flu (pre-) pandemic	Influenza A virus infections	.	J10-J11
DIB011723	Amocarzine	Helminth infection	.	B81-B83
DIB011724	Sarmazenil	Alzheimer's disease	.	G30,F00
DIB011725	INX-189	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011726	VT-401	Muscular dystrophy	.	G71.0
DIB011727	IDV-007	Glaucoma	365	H40-H42
DIB011728	Macrofilaricide compounds	Nematode infection	.	B80
DIB011729	PAI-1-targeted monoclonal antibody	Cardiovascular disease	390-459	I00-I99
DIB011730	ITMN-8187	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011731	LY-929	Lipid metabolism disorder	.	E75-E78
DIB011732	VPC-51299	Cancer	140-229	C00-C96
DIB011733	LGH-447	Multiple myeloma	.	C90.0
DIB011734	ETC-1001	Hyperlipidemia	272.0-272.4	E78
DIB011735	A-80263	Inflammatory diseases	.	.
DIB011736	LU-26042	Aggressive non-Hodgkin's lymphoma	.	F63
DIB011737	EVO-033	Breast cancer	174, 175, 217	C50, D24
DIB011738	DR6 antagonist antibodies	Multiple sclerosis	340	G35
DIB011739	ALVAC HIV vaccine program	HIV-1 infections	42	B20
DIB011740	5-hydroxymethyl-2-furfural (sickle cell disease), AesRx LLC	Anemia	.	D50-D64
DIB011741	Gr-Rnai program	Inflammatory diseases	.	.
DIB011742	Bile acid receptor GPR131 agonist	Non-insulin dependent diabetes	.	E11.9
DIB011743	NAV therapeutic	Hemophilia B	286.1	D67
DIB011744	F-50003	Parainfluenza virus infection	.	J12.2
DIB011745	Dendritic cell therapy	Breast cancer	174, 175, 217	C50, D24
DIB011746	Hydrochloric acid	Alkalosis	.	E87.3
DIB011747	Autotaxin inhibitor	Cancer	.	C00-C97
DIB011748	Mesenchymal precursor cells	Ocular disease	.	H00-H59
DIB011749	GP-668	Angina pectoris	413	I20
DIB011750	Infectious mononucleosis vaccine	Infectious mononucleosis	.	B27.9
DIB011751	Shigistat-G	Diarrhea	787.91	A09, K59.1
DIB011752	AMELTOLIDE	Epileptic seizure	.	G40,R56
DIB011753	Rotavirus vaccine	Type 2 diabetes	250.00, 250.02	E11
DIB011754	Ceftezole	Urinary tract infections	599	N39.0
DIB011755	Oxaborole series	Leishmania donovani infection	.	B55.0
DIB011756	ER-21018	Gastrointestinal disease	.	K00-K93
DIB011757	BTL-TML-001	Influenza virus infections	487	J10, J11
DIB011758	TA-CD cocaine abuse vaccine	Cocaine addiction	304.2	F14.2
DIB011759	KM-3413	Cancer	140-229	C00-C96
DIB011760	BP-2.94	Pain	.	G89
DIB011761	SERMs	Breast cancer	174, 175, 217	C50, D24
DIB011762	Lu-AE04621	Parkinson's disease	.	G20
DIB011763	Lpathomab	Cancer	.	C00-C97
DIB011764	Brilacidin	Infections disease	.	A00-B99
DIB011765	Recombinant HSP-MUC1 fusion protein	Breast cancer	174, 175, 217	C50, D24
DIB011766	GEN-003	Herpes simplex virus infection	.	B00
DIB011767	Anti-arthritis drug	Arthritis	710-719	M00-M25
DIB011768	LP-10218	Cancer	.	C00-C97
DIB011769	Zatebradine	Angina	413	I20
DIB011770	Glucokinase activators	Non-insulin dependent diabetes	.	E11.9
DIB011771	Altastaph	Staphylococcus aureus infection	001-139	A00-B99
DIB011772	IKappaB kinase (IKK) inhibitors	Breast cancer	.	C50
DIB011773	AP-02-00 series	Lipid metabolism disorder	.	E75-E78
DIB011774	Griffithsin vaginal gel	HIV infections	42	B20
DIB011775	Isoxsuprine	Cerebrovascular disorders	.	I60-I69
DIB011776	SA-IGIV	Staphylococcus aureus infection	001-139	A00-B99
DIB011777	MM-093	Autoimmune diseases	.	D84.9
DIB011778	JY-0691	Discovery agent	.	.
DIB011779	Therapeutic program	Neurological disease	.	G00-G99
DIB011780	RG-7090	Fragile X syndrome	.	Q99.2
DIB011781	ASB-16165	Psoriasis	696	L40
DIB011782	Fms kinase inhibitors	Multiple sclerosis	340	G35
DIB011783	V-114	Myelodysplastic syndromes	238.7	D46
DIB011784	PROKR1 antagonists	Premature labour	.	O60.1,P07.3
DIB011785	H5N1 pandemic influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB011786	W4R	Colorectal cancer	.	C18-C20,C21
DIB011787	MPGES-1 inhibitors	Inflammatory diseases	.	.
DIB011788	MM-141	Cancer	.	C00-C97
DIB011789	Immunostimulant patch	Vaccination	.	.
DIB011790	Ebrotidine	Duodenal ulcer	.	K25-K27
DIB011791	ImmuRAID-HCG-99mTc	Ovarian cancer	.	C56
DIB011792	LY-290154	Asthma	493	J45
DIB011793	Menaquinone synthase inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB011794	Thermostable prophylactic measles vaccine	Measles virus infection	.	B06.9
DIB011795	Thrombopoietin receptor agonists	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB011796	Vivia-009	Cancer	140-229	C00-C96
DIB011797	TNFR1 negative allosteric modulators	Multiple sclerosis	340	G35
DIB011798	Vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011799	RNA vaccine	Allergy	995.3	T78.4
DIB011800	Sialyl Lea-KLH conjugate vaccine	Breast cancer	174, 175, 217	C50, D24
DIB011801	BMS-852927	Atherosclerosis	414.0, 440	I70
DIB011802	Brevenal	Cystic fibrosis	277	E84
DIB011803	DNA vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011804	PentaStaph	Staphylococcus aureus infection	001-139	A00-B99
DIB011805	Sebriplatin	Cancer	.	C00-C97
DIB011806	HyperAcute vaccine	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB011807	FE-202767	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB011808	APD-209	Cachexia	799.4	R64
DIB011809	Selective estrogen receptor modulators	Arthralgia	.	M25.5
DIB011810	PPS14 PCMV	Streptococcus pneumoniae infection	.	A00-B99
DIB011811	MIF antagonists	Cancer	.	C00-C97
DIB011812	Therapeutic peptide subunit vaccine	Prostate tumor	185	C61
DIB011813	Notch 1 inhibitor	Cancer	.	C00-C97
DIB011814	Alpha-1 antitrypsin	Blood coagulation disorders	.	D65-D68
DIB011815	H3 agonists	Anxiety disorder	.	F40-F42
DIB011816	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB011817	Palbociclib	Cancer	140-229	C00-C96
DIB011818	ROTIGAPTIDE	Cardiac arrhythmias	.	I47-I49
DIB011819	Multi-epitope peptide melanoma vaccine	Melanoma	172	C43
DIB011820	SCH-721015	Mesothelioma	.	C45
DIB011821	CT-3532	Cancer	140-229	C00-C96
DIB011822	CZ-775	Cancer	140-229	C00-C96
DIB011823	GLY-302 series	Infectious disease	001-139	A00-B99
DIB011824	Second generation TRPV 1 antagonists	Overactive bladder disorder	596.51	N32.81
DIB011825	OB-24	Cancer	140-229	C00-C96
DIB011826	Antibacterial	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB011827	Soy phospholipids	Ischemia	459.89	I99.8
DIB011828	Aom-0977	Cancer	140-229	C00-C96
DIB011829	CI-953	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011830	SK-1306X	Arthritis	710-719	M00-M25
DIB011831	Debio-0930	Metabolic disorders	.	E70-E90
DIB011832	CHF-1522	Non-insulin dependent diabetes	.	E11.9
DIB011833	MCD inhibitors	Obesity	278	E66
DIB011834	DOQUALAST	Hyperuricosuria	.	E79
DIB011835	IB-08C175	Graft-versus host disease	.	T86.0
DIB011836	PV-267	Multiple sclerosis	340	G35
DIB011837	Pizotyline	Headache	339, 784.0	G43-G44, R51
DIB011838	SB-206284A	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011839	NU-1001-41	Cancer	140-229	C00-C96
DIB011840	Galectin 2	Inflammatory bowel disease	555, 556	K50, K51
DIB011841	TT-173	Bleeding	.	R58
DIB011842	111In-hEGF	Breast cancer	174, 175, 217	C50, D24
DIB011843	Noscapine analogs	Cancer	140-229	C00-C96
DIB011844	Human CD40 agonist ligand	Discovery agent	.	.
DIB011845	CCX872	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB011846	LI-49	Edema	.	R60.9
DIB011847	Interferon beta gene therapy	Atherosclerosis	414.0, 440	I70
DIB011848	DPP-IV inhibitors	Diabetes mellitus	250	E08-E13
DIB011849	Neutrophil elastase inhibitor	Neutropenia	288	D70
DIB011850	ABC-3	Fibrosis	709.2	L90.5
DIB011851	Iseganan HCl oral solution	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB011852	PIRODOMAST	Asthma	.	J45
DIB011853	DPK-060	Atopic dermatitis	.	L20
DIB011854	SS1(dsFv)-PE38	Cancer	.	C00-C97
DIB011855	VBETA5.2-38-58	Multiple sclerosis	340	G35
DIB011856	PdB-W433F	Streptococcus pneumoniae infection	.	A00-B99
DIB011857	Sodium phosphate dibasic/sodium phosphate monobasic	Multiple sclerosis	340	G35
DIB011858	AFO-18	HIV-1 infections	42	B20
DIB011859	Malaria therapeutics	Plasmodium infection	.	B54
DIB011860	RESP-3000	Cardiovascular disease	390-459	I00-I99
DIB011861	H5N1 influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB011862	AKT inhibitors	Cancer	140-229	C00-C96
DIB011863	CPI-0610	Myelodysplastic syndromes	.	D46
DIB011864	GSK-2302024A	Breast cancer	174, 175, 217	C50, D24
DIB011865	ChimeriVax-Dengue	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB011866	IMGN-388	Solid tumours	.	C00-C75,C7A,C7B
DIB011867	Anti-alpha5Beta1-integrin antibody	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011868	ICT-111	Cancer	.	C00-C97
DIB011869	BB-823	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011870	HDV-interferon	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011871	Cipro oxacin dry powder	Non-small-cell lung carcinoma	162	C33, C34
DIB011872	ADXS-PSA	Prostate tumor	185	C61
DIB011873	Adeno-associated virus gene therapy	Retinopathy	362.0-362.2	H35-H35.2
DIB011874	Vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB011875	Tirapazamine derivatives	Cancer	140-229	C00-C96
DIB011876	HBV humanized antibodies	Hepatitis B virus infection	.	B16
DIB011877	Leukotriene A4 hydrolase inhibitors	Cardiovascular disease	390-459	I00-I99
DIB011878	1D05	Coronary artery disease	410-414, 429.2	I20-I25
DIB011879	Pipamperone	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB011880	SiRNA therapeutics	Discovery agent	.	.
DIB011881	IL-16	Asthma	.	J45
DIB011882	Lysosomal modulators	Alzheimer's disease	331	G30
DIB011883	Porphyromonas gingivalis vaccine	Periodontal disease	.	K05
DIB011884	Davalintide	Obesity	278	E66
DIB011885	RUT58-60	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011886	Cipro DPI	Prostate cancer	185	C61
DIB011887	PLR-9	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011888	Staphylocide	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB011889	GW-974	Breast cancer	.	C50
DIB011890	1,5-benzodiazepine NS5B polymerase inhibitors (HCV infection), Tibotec	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB011891	GX-G6	Diabetes mellitus	250	E08-E13
DIB011892	Sclerostin-targeted small-molecule therapeutics	Bone disease	.	M00-M99
DIB011893	PYN-7	Cancer	140-229	C00-C96
DIB011894	AX-200	Cardiovascular disease	.	I00-I99
DIB011895	CS-560	Allergic rhinitis	477	J30
DIB011896	Rostaporfin	Macular degeneration	362.5	H35.3
DIB011897	Nolatrexed	Solid tumours	.	C00-C75,C7A,C7B
DIB011898	Cytoskeletal kinase modulators	Cancer	140-229	C00-C96
DIB011899	BIOLUP	Systemic lupus erythematosus	710	M32
DIB011900	P70S6 kinase inhibitors	Cancer	140-229	C00-C96
DIB011901	R-594	Rheumatold arthritis	714	M05-M06
DIB011902	Interferon beta	Cancer	.	C00-C97
DIB011903	Phenazopyridine	Pain	338,780	R52, G89
DIB011904	SLP-1003	MRSA infection	.	B95.62
DIB011905	GPG	HIV infections	42	B20
DIB011906	MHC antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB011907	Aipusheng	Japanese encephalitis virus infection	.	A83.0
DIB011908	Macromolecular carrier-linked carbon monoxide releasing molecules	Acute liver failure	.	K72
DIB011909	RWJ-37868	Epilepsy	345	G40
DIB011910	MP-AA-1	Cancer	140-229	C00-C96
DIB011911	GCOL-513	Cancer	.	.
DIB011912	HG-1096	Immune disorder	.	D80-D89
DIB011913	LAS-189913	Multiple sclerosis	340	G35
DIB011914	CLDC	Hepatocellular carcinoma	155	C22.0
DIB011915	ATS-907	Glaucoma	365	H40-H42
DIB011916	DUP-734	Psychotic disorders	.	F20-F29
DIB011917	RB-6145	Solid tumours	.	C00-C75,C7A,C7B
DIB011918	Arimoclomol	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB011919	AZD6423	Suicidal ideation	.	R45.8
DIB011920	IL1aQb therapeutic vaccines	Atherosclerosis	414.0, 440	I70
DIB011921	RSV	Prophylaxis	.	I20-I25
DIB011922	Lysyl oxidase inhibitors	Cancer	140-229	C00-C96
DIB011923	DNA-binding drugs	Viral infections	042-075	A80-A99, B00-B34
DIB011924	Pegylated carboxyhemoglobin	Sickle-cell disease	282.6	D57
DIB011925	Lenvatinib mesylate	Solid tumours	.	C00-C75,C7A,C7B
DIB011926	GSK-3 inhibitor	Cancer	.	C00-C97
DIB011927	W-198	Cancer	140-229	C00-C96
DIB011928	AZD-2836	Hepatitis C virus infection	.	B17.1,B18.2
DIB011929	Alpha-sarcoglycan adenoviral gene therapy	Duchenne muscular dystrophy	.	G71.0
DIB011930	SC-49483	Acquired immunodeficiency syndrome	.	B20-B24
DIB011931	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB011932	Melperone	Alcohol use disorders	303	F10.2
DIB011933	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB011934	Endothelin B antagonists	Cardiovascular disease	390-459	I00-I99
DIB011935	Org-7797	Cardiac arrhythmias	.	I47-I49
DIB011936	TY-51924	Myocardial infarction	410	I21, I22
DIB011937	CG-023132	Inflammatory diseases	.	.
DIB011938	MEDI-8968	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB011939	Meningitis ACYW conj.	Meningitis	320-322	G00-G03
DIB011940	Pelitinib	Lymphoma	.	C81-C96
DIB011941	Tomelukast	Asthma	493	J45
DIB011942	CGS-32359	Inflammatory diseases	.	.
DIB011943	PF-06650808	Cancer	140-229	C00-C96
DIB011944	RGI-4100	Multiple sclerosis	340	G35
DIB011945	Epocarbazolin-A	Asthma	.	J45
DIB011946	Neuroprotectant	Brain injury	.	S09.90
DIB011947	SCH-1450206	Cancer	140-229	C00-C96
DIB011948	Streptococcus mutans vaccine	Dental caries	521	K02
DIB011949	Anti-ricin mAbs	Poison intoxication	.	T36-T50
DIB011950	GSK-1247446A	Influenza virus infections	487	J10, J11
DIB011951	Mucin type glycoproteins	Inflammatory diseases	.	.
DIB011952	GNE Lipoplex	Myopathy	.	M60-M63
DIB011953	SiRNA therapy	Liver cancer	155	C22.0
DIB011954	Alpha-arylamino hydroxamic acids	Bacillus anthracis infection	.	A22
DIB011955	MSC2363318A	Solid tumours	.	C00-C75,C7A,C7B
DIB011956	Gene therapy	Factor IX deficiency	.	D67
DIB011957	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB011958	H1N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB011959	Anapsos	Atopic dermatitis	691.8	L20
DIB011960	AZD-5180	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB011961	Incrementally modified drug	Hyperlipidemia	272.0-272.4	E78
DIB011962	EPT-peptide therapy	Cancer	.	C00-C97
DIB011963	SMC-0001 prodrug	Emesis	787	R11
DIB011964	PRAME-SLP	Melanoma	172	C43
DIB011965	UK-66914	Cardiac arrhythmias	.	I47-I49
DIB011966	AG-702	Genital herpes	.	A60.09
DIB011967	F-12682	Major depressive disorder	296.2, 296.3	F32, F33
DIB011968	CB1 antagonists	Metabolic disorders	.	E70-E90
DIB011969	Rhinovirus 3C protease inhibitors	Rhinovirus infection	.	J20.6?
DIB011970	PDS-0103	Herpes simplex virus infection	.	B00
DIB011971	Onyvax-O	Ovarian cancer	183	C56
DIB011972	VALERGEN-DS (sublingual)	Asthma	493	J45
DIB011973	IMD-1041	Alzheimer's disease	.	G30,F00
DIB011974	Anti melanoma oligopeptides	Melanoma	172	C43
DIB011975	Immunostimulant	Cancer	.	C00-C97
DIB011976	HR24 antibody	Melanoma	172	C43
DIB011977	Anti-respiratory syncytial virus monoclonal antibodies	Respiratory syncytial virus 	79.6	B97.4
DIB011978	IPH-41XX	Mycoses	.	B49
DIB011979	Recombinant T-cell receptor ligand	Insulin dependent diabetes	.	E10
DIB011980	Regulatory T-cell therapy	Autoimmune diseases	279.4	D84.9, M35.9
DIB011981	Nicotine-Q	Tobacco dependence	305.1	F17
DIB011982	NK-101	Brain injury	.	S09.90
DIB011983	NTE-122	Atherosclerosis	414.0, 440	I70
DIB011984	HL-1225	Diabetes mellitus	250	E08-E13
DIB011985	Gene therapy program	Motor neurone disease	335.2	G12.2
DIB011986	Synthetic surfactants	Respiratory distress syndrome	518.5, 518.82	J80
DIB011987	F-991	Allergic skin disorders	.	L00-L99
DIB011988	Glial progenitor cell therapy	Brain injury	.	S09.90
DIB011989	TP-110	Multiple myeloma	203	C90.0
DIB011990	Polynoma-1	Melanoma	172	C43
DIB011991	GSK768974	Osteoporosis	733	M80-M81
DIB011992	Wound healing agents	Wound healing	.	S91.3
DIB011993	RHAMM-R3 peptide vaccine	Cancer	.	C00-C97
DIB011994	Drug 2878175	Hepatitis virus infection	573.3	K75.9
DIB011995	RNAi therapeutics	Cancer	140-229	C00-C96
DIB011996	Metformin analogs	Cancer	140-229	C00-C96
DIB011997	P-3914	Inflammatory diseases	.	.
DIB011998	OPL-CCL2-LPM	Arthritis	.	M00-M25
DIB011999	Rapamycin analogs	Fungal infection	.	B35-B49
DIB012000	Mu opioid partial agonists	Drug dependence	303-304	F10.2-F19.2
DIB012001	AMG-JAK2-01	Myeloproliferative disorder	.	D47.1
DIB012002	H5N1 influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB012003	Grastek	Allergic rhinitis	.	J30
DIB012004	TRL-382	Neuropathic pain	338,780	R52, G89
DIB012005	MER-2101	Asthma	493	J45
DIB012006	VennVax	Virus infection	.	B03
DIB012007	RM-4865	Hepatitis B virus infection	.	B16
DIB012008	GSK-1827771	Rheumatold arthritis	714	M05-M06
DIB012009	NS-8	Urinary incontinence	.	N39.3-N39.4
DIB012010	Menomune	Viral infections	042-075	A80-A99, B00-B34
DIB012011	Herpes simplex virus (HSV) infection therapy	Herpes simplex virus infection	54	B00
DIB012012	PF-05089771	Chronic pain	338.2,780	R52.1-R52.2, G89
DIB012013	Tarextumab	Pancreatic cancer	.	C25
DIB012014	CAB-175	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012015	E1/E4-deleted adenoviral vector	Ornithine transcarbamylase deficiency	.	E72.4
DIB012016	Glutathione	HIV infections	42	B20
DIB012017	CEP-28122	Cancer	140-229	C00-C96
DIB012018	Rhopressa	Glaucoma	.	H40-H42
DIB012019	Gadoteridol	Brain diseases	.	G00-G99
DIB012020	Tiludronic acid	Osteoporosis	733	M80-M81
DIB012021	Anticancer therapeutics	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012022	Aldose reductase modulators	Discovery agent	.	.
DIB012023	HIV vaccine	Cachexia	799.4	R64
DIB012024	Bromhexine	Sjogren's syndrome	.	M35.0
DIB012025	PF-4629991	Rheumatold arthritis	714	M05-M06
DIB012026	RGI-4000 series	Discovery agent	.	.
DIB012027	SL-65.1708	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB012028	Diazepam	Epilepsy	345	G40
DIB012029	Therapeutic vaccines	Cancer	140-229	C00-C96
DIB012030	IFN-beta-CTP	Multiple sclerosis	340	G35
DIB012031	IFN-alpha 2B-XL	Hepatitis virus infection	573.3	K75.9
DIB012032	R-59494	Ischemia	459.89	I99.8
DIB012033	DuP-983	Pruritus	.	L29
DIB012034	Vivia-577	Cancer	140-229	C00-C96
DIB012035	Melanin-concentrating hormone receptor 1 antagonists	Obesity	278	E66
DIB012036	Controlled-release agent	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB012037	AC-8	Herpetic keratitis	.	B00.52
DIB012038	AN-5973	Enterobacteriaceae infection	.	A04.8
DIB012039	TSD-0014	Prostate tumor	185	C61
DIB012040	PSN-842	Obesity	278	E66
DIB012041	EchoGen	Cardiovascular disease	390-459	I00-I99
DIB012042	Phosphate binding agent	Renal disease	.	N00-N29
DIB012043	GX-401 program	Atherosclerosis	414.0, 440	I70
DIB012044	ANA971	Hepatitis virus infection	573.3	K75.9
DIB012045	FG-6874	Anemia	280-285	D50-D64
DIB012046	Pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB012047	MEDI6012	Acute coronary syndrome	.	I24.9
DIB012048	VGV-L	Lyme disease	88.81	A69.2
DIB012049	Prostaglandin	Glaucoma	365	H40-H42
DIB012050	VEGF inhibitor program	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012051	RypVax	Yersinia infections	.	A20
DIB012052	MB-314	Cancer	140-229	C00-C96
DIB012053	Viral vaccine	Viral infections	042-075	A80-A99, B00-B34
DIB012054	CP-195543	Rheumatold arthritis	.	M05-M06
DIB012055	TCV-295	Hypertension	.	I10-I15
DIB012056	Antibacterial peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012057	Mucosal smallpox vaccine	Virus infection	.	B03
DIB012058	AFPep	Breast cancer	174, 175, 217	C50, D24
DIB012059	AZM-115	Obesity	278	E66
DIB012060	TG-21	Influenza virus infections	487	J10, J11
DIB012061	Interferon alpha 2a	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012062	RPC-1063	Advanced non-Small cell lung cancer	162	C33, C34
DIB012063	HuA33	Colorectal cancer	.	C18-C20,C21
DIB012064	Neucardin	Heart failure	.	I50
DIB012065	S-117957	Neuropathic pain	338,780	R52, G89
DIB012066	Vaccine	Cancer	140-229	C00-C96
DIB012067	SBL-109	Escherichia coli infection	.	A00-B99
DIB012068	Group A Streptococcus vaccine	Group A streptococcus infection	.	A49.1
DIB012069	BMS-185857	Cancer	140-229	C00-C96
DIB012070	Bacteriophage	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB012071	ROR antagonists	Inflammatory diseases	.	.
DIB012072	Tramadol derivatives	Pain	338,780	R52, G89
DIB012073	JNJ-39220675	Alcohol use disorders	.	F10
DIB012074	Analgesics	Pain	338,780	R52, G89
DIB012075	Mesenchymal stem cell therapies	Myocardial disease	.	I21-I22,I40-I42
DIB012076	Inhibitor of NOTCH	Cancer	140-229	C00-C96
DIB012077	RV001	Graves' ophthalmopathy	.	H06.2
DIB012078	Zyn-Linker oligonucleotides	Cancer	140-229	C00-C96
DIB012079	LIRIMILAST	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB012080	Oral cholera vaccine	Vibrio cholerae infection	.	A00.0
DIB012081	GABA A receptor antagonists	Alzheimer's disease	331	G30
DIB012082	CB-5300	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB012083	INP-05	Parkinson's disease	.	G20
DIB012084	SL-301	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012085	DCVec	Cancer	140-229	C00-C96
DIB012086	EGFR-expressing Saccharomyces cerevisiae-based cancer vaccine	Non-small-cell lung cancer	162	C33, C34
DIB012087	Anti-IL-7Ra antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB012088	Butizide	Congestive heart failure	428	I50
DIB012089	BRX-1002	Cancer	140-229	C00-C96
DIB012090	Anticancer antibodies	Cancer	140-229	C00-C96
DIB012091	Anti-HIV agents	HIV infections	42	B20
DIB012092	Phylomer peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012093	S-06911	Osteoporosis	733	M80-M81
DIB012094	Dotarizine	Migraine	346	G43
DIB012095	PD-129337	Arteriosclerosis	.	I70
DIB012096	HP-228	Postoperative pain	.	G89
DIB012097	Carbonic anhydrase IX inhibitors	Cancer	140-229	C00-C96
DIB012098	BPX-501	Osteoporosis	.	M80-M81
DIB012099	4-fluoroselegiline	Dementia	290-294	F01-F07
DIB012100	MIS-416	Autoimmune diseases	.	D84.9
DIB012101	DE-310	Cancer	140-229	C00-C96
DIB012102	Receptor tyrosine kinase inhibitors	Cancer	.	C00-C97
DIB012103	SDZ-281-240	Pruritus	.	L29
DIB012104	CAD-106	Alzheimer's disease	.	G30,F00
DIB012105	KUR-113	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB012106	Mixed vaccine	Prostate tumor	185	C61
DIB012107	KI-0001	Cancer	140-229	C00-C96
DIB012108	HLM-008182	Cancer	140-229	C00-C96
DIB012109	BAL-27862	Cancer	140-229	C00-C96
DIB012110	Antifungal therapy	Fungal infection	.	B35-B49
DIB012111	TC-2216	Mood disorder	.	F30-F39
DIB012112	Rhu-pGSN	Multiple sclerosis	.	G35
DIB012113	VGV-S	Sepsis	.	A40-A41
DIB012114	Cyclin A2	Myocardial infarction	410	I21, I22
DIB012115	P53	Cancer	140-229	C00-C96
DIB012116	MK-3207	Migraine	346	G43
DIB012117	Neutrophil activation inhibitors	Pulmonary disease	460-519	J00-J99
DIB012118	Axogenesis Factor-1	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB012119	BAY-85-3474	Cancer	140-229	C00-C96
DIB012120	Anti FGFR4 mAb program	Cancer	140-229	C00-C96
DIB012121	PF-04776548	HIV infections	42	B20
DIB012122	SSR-180575	Rheumatold arthritis	.	M05-M06
DIB012123	Antigen-specific melanoma vaccine	Melanoma	.	C43
DIB012124	L-377202	Solid tumours	.	C00-C75,C7A,C7B
DIB012125	RAGE-Fc fusion protein	Diabetic complication	.	E08-E13
DIB012126	Undisclosed natural compound	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB012127	ALS-886	Respiratory distress syndrome	518.5, 518.82	J80
DIB012128	Bio-Flow	Atherosclerosis	414.0, 440	I70
DIB012129	DLO6001	Parkinson's disease	332	F02.3, G20
DIB012130	MIQ-004	Brain cancer	191	C71
DIB012131	AZD-1134	Anxiety disorder	.	F40-F42
DIB012132	CXCR3 antagonists	Autoimmune diseases	279.4	D84.9, M35.9
DIB012133	SID-530	Cancer	140-229	C00-C96
DIB012134	Brain derived neurotrophic factor	Amyotrophic lateral sclerosis	335.2	G12.2
DIB012135	BIOO-5	Cancer	140-229	C00-C96
DIB012136	Cathepsin C inhibitors	Inflammatory diseases	.	.
DIB012137	123I-iometopane	Parkinson's disease	.	G20
DIB012138	Group B streptococcus vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012139	Neu-120	Parkinson's disease	.	G20
DIB012140	ATOFLUDING	Cancer	140-229	C00-C96
DIB012141	Sipuleucel-T	HIV-1 infections	42	B20
DIB012142	HTERT-VISA-BikDD nanoparticles	Breast cancer	174, 175, 217	C50, D24
DIB012143	TZTX-001	Endometriosis	617	N80
DIB012144	Adult respiratory distress syndrome therapy	Respiratory distress syndrome	518.5, 518.82	J80
DIB012145	Balapiravir	Hepatitis C virus infection	.	B17.1,B18.2
DIB012146	Sepcidin	Sepsis	.	A40-A41
DIB012147	Vacc-5q	HIV infections	42	B20
DIB012148	AB-103	Necrotizing soft tissue infection	.	M72.6
DIB012149	Cavatak RNA	Melanoma	172	C43
DIB012150	P-1116	Anemia	280-285	D50-D64
DIB012151	A-70276	Gastrointestinal disease	.	K00-K93
DIB012152	SR-46559A	Cognitive impairment	.	F06.7
DIB012153	Valopicitabine dihydrochloride	Viral infections	042-075	A80-A99, B00-B34
DIB012154	Histone deacetylase-1 inhibitors	Cancer	140-229	C00-C96
DIB012155	BD-NP	Hypertension	401	I10, I11, I12, I13, I15
DIB012156	SEB-HuMab	Staphylococcus aureus infection	001-139	A00-B99
DIB012157	Fibrinolysin	Wound healing	.	S91.3
DIB012158	PQ-912	Dementia	.	F01-F07
DIB012159	SERA5-targeted malaria vaccine	Plasmodium falciparum infection	.	B54
DIB012160	Nicaraven	Cerebrovascular disorders	.	I60-I69
DIB012161	LXR-017	Myocardial infarction	410	I21, I22
DIB012162	GSK2696273	Chronic pain	338.2,780	R52.1-R52.2, G89
DIB012163	ETIPREDNOL DICLOACETATE	Rhinitis	.	J00,J30,J31.0
DIB012164	Chimeric monoclonal antibody	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB012165	RNAi therapy	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012166	HCV therapeutics	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012167	4991W93	Migraine	346	G43
DIB012168	Intra-oral lozenge	Fungal infection	.	B35-B49
DIB012169	Targeted two-photon photodynamic therapy	Cancer	140-229	C00-C96
DIB012170	FGI-101-1A6	Influenza virus infections	.	J10-J11
DIB012171	Dorgenmeltucel-L	Malignant melanoma	172	C43
DIB012172	Non-rapamycin mTOR/PI3K inhibitors	Cancer	140-229	C00-C96
DIB012173	CSC-500297	Obesity	278	E66
DIB012174	IL-15 smallpox vaccine	Virus infection	.	B03
DIB012175	E-6006 CITRATE	Anxiety disorder	300	F40-F42
DIB012176	PPRT-152	Major depressive disorder	296.2, 296.3	F32, F33
DIB012177	Org-6632	Cancer	140-229	C00-C96
DIB012178	FT-1050-treated umbilical cord stem cell therapy	Thrombocytopenia	.	D69.6
DIB012179	SHP-2 inhibitors	Cancer	140-229	C00-C96
DIB012180	RUTI	Mycobacterium tuberculosis infection	.	A15-A19
DIB012181	TAP311	Dyslipidemia	272	E78
DIB012182	EIF-5A1 gene-silencing siRNA	HIV infections	42	B20
DIB012183	MT1-MMP inhibitors	Atherosclerosis	414.0, 440	I70
DIB012184	CAB-051	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012185	Ada-KPYIL	Pain	.	G89
DIB012186	Tomeglovir	Viral infections	042-075	A80-A99, B00-B34
DIB012187	MBS-105	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012188	AM-1101	Atherosclerosis	414.0, 440	I70
DIB012189	PDE 10 inhibitors	Schizophrenia	295	F20
DIB012190	VLTS-934	Peripheral vascular disease	443.9	I73.9
DIB012191	Malaria DNA vaccine	Plasmodium infection	.	B54
DIB012192	FR-75094	Ischemia	459.89	I99.8
DIB012193	MBI-853NL	Staphylococcus aureus infection	001-139	A00-B99
DIB012194	CTC-23	Arthritis	710-719	M00-M25
DIB012195	ND-401	HIV infections	42	B20
DIB012196	CBD1Qb	HIV infections	42	B20
DIB012197	MLR-1045	Irritable bowel syndrome	564.1	K58
DIB012198	17,20-lyase inhibitors (prostate cancer), Takeda	Prostate tumor	185	C61
DIB012199	Somatropin biosimilar	Growth hormone deficiency	.	E23.0
DIB012200	Soluble ferric pyrophosphate	Iron deficiency anaemia	.	D50
DIB012201	AP-761	Asthma	.	J45
DIB012202	Anti-mutant-EGFR antibodies	Cancer	140-229	C00-C96
DIB012203	TriAb	Breast cancer	174, 175, 217	C50, D24
DIB012204	SYNTHETIC NEUTROPHIL INHIBITOR PEPTIDE	Rhinitis	472.0, 477	J00, J30, J31.0
DIB012205	LHW090	Kidney failure	.	N17-N19
DIB012206	BIMU-1	Cognitive impairment	.	F06.7
DIB012207	MOv18IgE	Cancer	140-229	C00-C96
DIB012208	MRZ-8456	Movement disorder	.	R25
DIB012209	Stress gene therapy	Cancer	140-229	C00-C96
DIB012210	QAX-576	Allergic rhinitis	.	J30
DIB012211	Unoprostone	Glaucoma	365	H40-H42
DIB012212	Artilide	Cardiac arrhythmias	.	I47-I49
DIB012213	PN-202	Xerophthalmia	.	E50.6-E50.7
DIB012214	SLP-0905	Enterococcus faecalis infection	.	B95.2
DIB012215	DCVax-Head/Neck	Head and neck cancer	140-149	C07-C14, C32-C33
DIB012216	Small molecule furin-like protease inhibitors	Cancer	.	C00-C97
DIB012217	ACI-636	Alzheimer's disease	331	G30
DIB012218	CLL immunotherapeutic	Chronic lymphocytic leukaemia	204.1, 208.9	C91-C95, C91.1
DIB012219	SRPIN-340	Choroidal neovascularization	.	H35
DIB012220	GSK2269557	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DIB012221	Combination therapy	Prostate tumor	185	C61
DIB012222	H-345/52	Heart arrhythmia	.	I47-I49
DIB012223	Ro-24-7429	Human immunodeficiency virus infection	.	B20
DIB012224	K-101	Onychomycosis	.	B35.1
DIB012225	RG-7185	Asthma	493	J45
DIB012226	Antibacterial agents	Staphylococcus aureus infection	001-139	A00-B99
DIB012227	Diaziquone	Cancer	.	C00-C97
DIB012228	Q-102	HIV infections	42	B20
DIB012229	Pegamotecan	Esophageal cancer	.	C15
DIB012230	NRX-4204	Diabetes mellitus	.	E10-E14
DIB012231	AbGn-100	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012232	B-raf inhibitors	Cancer	140-229	C00-C96
DIB012233	PIKAMILONE	Anxiety disorder	300	F40-F42
DIB012234	V-212	Varicella zoster virus infections	.	B01,B02
DIB012235	NT-13317	Neuropathic pain	338,780	R52, G89
DIB012236	CL-H02	Headache	339, 784.0	G43-G44, R51
DIB012237	IMC-HIV	HIV infections	42	B20
DIB012238	TA-103	Cancer	140-229	C00-C96
DIB012239	Hedgehog labelled stem cells	Breast cancer	174, 175, 217	C50, D24
DIB012240	Anti-VEGF human mAbs	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012241	IVVS-1001	Breast cancer	174, 175, 217	C50, D24
DIB012242	Biotin carboxylase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012243	JNK3 inhibitors	Central nervous system injury	.	P11.9
DIB012244	HDL-based therapeutics	Cardiovascular disease	390-459	I00-I99
DIB012245	Retinoic acid receptor-gamma agonist	Gallstone	.	K80
DIB012246	Chitosan-thiomer	Xerophthalmia	.	E50.6-E50.7
DIB012247	EHC18	Hepatitis virus infection	573.3	K75.9
DIB012248	Zolimomab aritox	Arthritis	710-719	M00-M25
DIB012249	TG-2349	Hepatitis C virus infection	.	B17.1,B18.2
DIB012250	MEDI-8662	Influenza virus infections	487	J10, J11
DIB012251	Recombinant B-cell peptide vaccine	Allergy	995.3	T78.4
DIB012252	NB-401	Bacterial respiratory tract infection	.	J13,J15
DIB012253	Capsular polysaccharide vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB012254	Coccidioidin	Dermatomycosis	.	B36.0
DIB012255	Peptide vaccine	Cancer	140-229	C00-C96
DIB012256	YM-796	Cognitive impairment	.	F06.7
DIB012257	Night blindness therapy	Ocular disease	.	H00-H59
DIB012258	PJ-3505	Cancer	140-229	C00-C96
DIB012259	Selective estrogen receptor modulators	Atrophy	.	M62.571
DIB012260	Personalized peptide vaccine	Cancer	.	C00-C97
DIB012261	TD-3633	Bladder cancer	188	C67
DIB012262	Imisopasem manganese	Pain	.	G89
DIB012263	ZYH-7	Lipid metabolism disorder	.	E75-E78
DIB012264	YM-758	Angina	413	I20
DIB012265	QAW-039	Asthma	493	J45
DIB012266	ALN-RSV01	Respiratory infections	.	J06.9
DIB012267	HIL-12 adenoviral gene therapy vector	Breast cancer	174, 175, 217	C50, D24
DIB012268	H6N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB012269	AZD-9139	Gastrointestinal disease	.	K00-K93
DIB012270	Trolamine salicylate	Pain	338,780	R52, G89
DIB012271	MystiTrip	Migraine	346	G43
DIB012272	Azapropazone	Inflammatory diseases	.	.
DIB012273	DEXIBUPROFEN LYSINE	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB012274	Polyamine analogs	Breast cancer	174, 175, 217	C50, D24
DIB012275	BACE-1 inhibitors	Alzheimer's disease	.	G30,F00
DIB012276	18F-BAY-85-8050	Cancer	140-229	C00-C96
DIB012277	TP-2758	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012278	R-1491	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012279	AIKO-152	Opiate dependence	304	F11
DIB012280	SiRNA therapy	Cancer	140-229	C00-C96
DIB012281	Bile acid derivatives	Cancer	140-229	C00-C96
DIB012282	Allergen vaccines	Allergy	995.3	T78.4
DIB012283	Ad5-AC6	Cardiac failure	.	I50
DIB012284	PRO-300	Mucositis	.	K00-K95
DIB012285	Spheron-based therapeutics	Alzheimer's disease	331	G30
DIB012286	IGIV3I Grifols 10%	Parkinson's disease	.	G20
DIB012287	Small molecule inhibitors	Toxoplasma infection	.	B58.9
DIB012288	SF-105	Infectious disease	001-139	A00-B99
DIB012289	PF-3900422	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB012290	Influvac TC	Influenza virus infections	487	J10, J11
DIB012291	OX40/OX40L upregulators	Infections disease	.	A00-B99
DIB012292	Nicotinic ACh agonists	Parkinson's disease	.	G20
DIB012293	IL-12 gene therapy	Prostate tumor	185	C61
DIB012294	CD59 gene therapy	Age related macular degeneration	.	H35.30
DIB012295	MiRNA targeting agent	Cancer	140-229	C00-C96
DIB012296	Dexamethasone palmitate	Choroidal neovascularization	.	H35
DIB012297	SB-214111	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB012298	ATN-161	Renal cancer	.	C64
DIB012299	PDS-0101	Papillomavirus infections	.	B97.7
DIB012300	Spinal cord injury therapy	Spinal cord injuries	952	S14, S24, S34
DIB012301	Odulimomab	Transplant rejection	.	T86
DIB012302	Measles vaccine	Measles virus infection	.	B06.9
DIB012303	SC-241	Anxiety disorder	300	F40-F42
DIB012304	Itazigrel	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB012305	PAI-1 antagonists	Atherosclerosis	414.0, 440	I70
DIB012306	Proteasome-gating modulators	Neurodegenerative diseases	.	G30-G32
DIB012307	Haloperidol decanoate	Schizophrenia	295	F20
DIB012308	C-Immune	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012309	Recombinant pox virus vaccine	Melanoma	.	C43
DIB012310	SR-11335	HIV-1 infections	42	B20
DIB012311	VLB-01	Epilepsy	345	G40
DIB012312	Affitope AD-02	Alzheimer's disease	.	G30,F00
DIB012313	FR-113680	Asthma	493	J45
DIB012314	Grass peptide allergy desensitization agent	Allergy	995.3	T78.4
DIB012315	NFkappaB inhibitors	Cancer	140-229	C00-C96
DIB012316	INDUS-815C	Retinopathy	362.0-362.2	H35-H35.2
DIB012317	LIK-066	Diabetes mellitus type 2	.	E11
DIB012318	Plague vaccine	Yersinia infections	.	A20
DIB012319	TNF-alpha production inhibitors	Inflammatory bowel disease	555, 556	K50, K51
DIB012320	Batabulin	Cancer	140-229	C00-C96
DIB012321	PC-24	Cancer	140-229	C00-C96
DIB012322	FE-202158	Septic shock	785.52	A41.9
DIB012323	ADAM inhibitors	Cancer	140-229	C00-C96
DIB012324	CSL-362	Acute myeloid leukemia	205	C92.0
DIB012325	NGD 91-3	Anxiety disorder	300	F40-F42
DIB012326	ICI-181037	Heart arrhythmia	.	I47-I49
DIB012327	Kynurenine mono-oxygenase inhibitors	Huntington's disease	.	F02.2,G10
DIB012328	KF-15570	Asthma	493	J45
DIB012329	CTL-401-targeted CB-1954 GDEPT	Prostate tumor	185	C61
DIB012330	Antibiotic program	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012331	Epithelial sodium channel modulators	Respiratory disorder	.	J98.9
DIB012332	LY-274614	Dementia	290-294	F01-F07
DIB012333	HL-029	Hyperlipidemia	272.0-272.4	E78
DIB012334	SYN-987	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012335	CDNA vaccine	Prostate tumor	185	C61
DIB012336	N-chlorotaurine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012337	SCY-524	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012338	Prohibitin-TP-01	Prostate tumor	185	C61
DIB012339	Encephalomyelitis virus vaccine	Encephalitis	.	A83.0
DIB012340	TLR3 agonists	Discovery agent	.	.
DIB012341	Racecadotril	Diarrhea	787.91	A09, K59.1
DIB012342	PF-3526299	Asthma	493	J45
DIB012343	MCHR1 antagonist	Obesity	278	E66
DIB012344	CA9-ADC	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012345	HDL receptor enhancer	Lipid metabolism disorder	.	E75-E78
DIB012346	RO-4998452	Diabetes mellitus type 2	.	E11
DIB012347	ACEA-1011	Cerebral infarction	.	I63
DIB012348	UR-12551	Allergy	.	T78.4
DIB012349	CPP -15	Infantile spasms	.	G40.4
DIB012350	SN-24771	Cancer	140-229	C00-C96
DIB012351	Dual PI3K-alpha/mTOR inhibitors	Cancer	140-229	C00-C96
DIB012352	Cadralazine	Hypertension	401	I10, I11, I12, I13, I15
DIB012353	WilGraf	Autoimmune diseases	279.4	D84.9, M35.9
DIB012354	Abituzumab	Colorectal cancer	.	C18-C20,C21
DIB012355	HSP90 inhibitors	Cancer	140-229	C00-C96
DIB012356	Revusiran	Amyloidosis	.	E85
DIB012357	HL-160	Cancer	140-229	C00-C96
DIB012358	E-3810	Solid tumours	.	C00-C75,C7A,C7B
DIB012359	Zap70 kinase inhibitors	Inflammatory diseases	.	.
DIB012360	NPS-4	Dermatitis	692.9	L20-L30
DIB012361	Peripheral mu opioid agonists	Pain	338,780	R52, G89
DIB012362	PPAT inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012363	Suronacrine maleate	Cognitive impairment	.	F06.7
DIB012364	Peptide deformylase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012365	HMGB1 inhibitors/antagonists	Cardiovascular disease	390-459	I00-I99
DIB012366	Anagrelide metabolite	Thrombocytosis	289.9	D75.8
DIB012367	FST-201	Otitis externa	.	H60
DIB012368	Stem cell therapy	Spinal cord injuries	952	S14, S24, S34
DIB012369	DSR-17759	Non-insulin dependent diabetes	.	E11.9
DIB012370	Dabigatran etexilate neutralizer	Blood clotting disorder	286	D65-D69
DIB012371	FP-1102	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB012372	EVP-6308	Schizophrenia	295	F20
DIB012373	HIV vaccine	HIV infections	42	B20
DIB012374	NSC-625487	Human immunodeficiency virus infection	.	B20
DIB012375	MGMTP140K gene-modified hematopoietic progenitor cells	Neutropenia	.	D70
DIB012376	CRx-189	Inflammatory bowel disease	555, 556	K50, K51
DIB012377	99mTC-NC-100668	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB012378	ErepoXen	Anemia	280-285	D50-D64
DIB012379	AZD-3199	Asthma	.	J45
DIB012380	IDX-184	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012381	Lm Prostate	Prostate tumor	185	C61
DIB012382	HSV vaccine	Herpes simplex virus infection	54	B00
DIB012383	Nerve growth factor conjugated RAP peptide	Neurodegenerative diseases	.	G30-G32
DIB012384	LY-2624587	Cancer	140-229	C00-C96
DIB012385	Analgesics	Pain	338,780	R52, G89
DIB012386	PTI-202	Pain	.	G89
DIB012387	LY2780301	Cancer	140-229	C00-C96
DIB012388	Pro-erectile agents	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB012389	IdioVax	Lymphoma	.	C81-C96
DIB012390	Reverse cholesterol transport compounds	Atherosclerosis	414.0, 440	I70
DIB012391	MPC-3100	Cancer	140-229	C00-C96
DIB012392	ATX-MS3	Multiple sclerosis	340	G35
DIB012393	TBC-427	Asthma	493	J45
DIB012394	F61F12	Cancer	140-229	C00-C96
DIB012395	Temafloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012396	Sanaria PfSPZ Vaccine	Plasmodium falciparum infection	.	B54
DIB012397	Articaine	Anesthesia	338	R52
DIB012398	Tau monoclonal antibodies	Alzheimer's disease	331	G30
DIB012399	Monovalent oral polio vaccine 1	Poliovirus infection	.	A80.9
DIB012400	Y-26763	Hypertension	401	I10, I11, I12, I13, I15
DIB012401	PAR2 antagonists	Inflammatory diseases	.	.
DIB012402	ErbB3 targeting antibodies	Cancer	140-229	C00-C96
DIB012403	Cathepsin B inhibitor	Liver disease	570-574	K70-K77
DIB012404	ED-001	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012405	AT-005	Cancer	.	C00-C97
DIB012406	AS-902330	Arthropathy	.	M00-M14
DIB012407	House dust mite allergen	Allergic conjunctivitis	372.14	H10.45
DIB012408	SAND-26	Autoimmune diseases	.	D84.9
DIB012409	Benorilate	Arthritis	710-719	M00-M25
DIB012410	GD2 ganglioside peptide mimics	Cancer	140-229	C00-C96
DIB012411	Anti Tag-72 humanized antibody	Cancer	140-229	C00-C96
DIB012412	Allosteric NMDA agonists	Neurological disease	.	G00-G99
DIB012413	TT-120	Blood clotting disorder	286	D65-D69
DIB012414	NMS-P715	Cancer	140-229	C00-C96
DIB012415	X-387	Cancer	140-229	C00-C96
DIB012416	XF series compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012417	Prophage cancer vaccine R-series	Breast cancer	174, 175	C50
DIB012418	MTI-4A2	Uterine cervix cancer	.	C53
DIB012419	NP-0336	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB012420	Mepartricin	Fungal infection	.	B35-B49
DIB012421	Poliovirus vaccine	Poliovirus infection	.	A80.9
DIB012422	MDT-2004	Pain	338,780	R52, G89
DIB012423	ARC-069	Alzheimer's disease	331	G30
DIB012424	APC-1390	Asthma	493	J45
DIB012425	Antivirals	Viral infections	042-075	A80-A99, B00-B34
DIB012426	BGB-290	Cancer	.	C00-C97
DIB012427	Follicle stimulating hormone	Infertility	.	N46,N97.0
DIB012428	GALAMUSTINE HYDROCHLORIDE	Solid tumours	.	C00-C75,C7A,C7B
DIB012429	Sylsens B	Trichophyton infection	.	B35
DIB012430	Taxol/Paraplatin/Herceptin	Breast cancer	174, 175	C50
DIB012431	Stem cell therapy	Gaucher disease	272.7	E75.2
DIB012432	ND-1.1	Influenza virus infections	.	J10-J11
DIB012433	PEEDCK	Cancer	140-229	C00-C96
DIB012434	HCV-086	Hepatitis virus infection	573.3	K75.9
DIB012435	AG-NDT802	Cough	786.2	R05
DIB012436	MUC-1-KLH vaccine	Breast cancer	174, 175, 217	C50, D24
DIB012437	Anti-inflammatory/anti-spasmodic therapeutics	Asthma	493	J45
DIB012438	AZD-7512	Anxiety disorder	300	F40-F42
DIB012439	IL-2/CD40L-expressing leukemia vaccine	Chronic lymphocytic leukaemia	.	C91.1
DIB012440	Vaccine	Chlamydia trachomatis infection	.	A74.9
DIB012441	JM-1232(-)	Anesthesia	338	R52
DIB012442	CGEN-671	Cancer	140-229	C00-C96
DIB012443	SMT-A07	Cancer	140-229	C00-C96
DIB012444	Ecabapide	Peptic ulcer	531-534	K25-K27
DIB012445	Antitumor agent	Breast cancer	174, 175, 217	C50, D24
DIB012446	Cannabinoid CB1 inverse agonists	Drug dependence	303-304	F10.2-F19.2
DIB012447	KHL-9114	Asthma	.	J45
DIB012448	Recombinant B-cell peptide vaccine	Allergy	995.3	T78.4
DIB012449	CMet-targeting BiTE antibody	Cancer	140-229	C00-C96
DIB012450	KRN-23	Hypophosphatemia	.	E83.31
DIB012451	Liatermin	Lateral sclerosis	.	G12.2
DIB012452	YH-1238	Stomach ulcer	.	K25-K27
DIB012453	I kappa B kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB012454	MH-031	Liver disease	570-574	K70-K77
DIB012455	AAV2/8-CBA-hSMN1	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DIB012456	ZD-0947	Overactive bladder disorder	596.51	N32.81
DIB012457	ART-237	Arthropathy	.	M00-M14
DIB012458	BMN-168	Phenylketonuria	.	E70.0
DIB012459	P2G12 monoclonal antibody	HIV infections	42	B20
DIB012460	PF-3491165	Atherosclerosis	414.0, 440	I70
DIB012461	PA-1637	Neurological disease	.	G00-G99
DIB012462	Alpha-synuclein gene-silencing siRNAs	Parkinson's disease	.	G20
DIB012463	SP-03	HIV infections	42	B20
DIB012464	INP-1750	Diarrhea	787.91	A09, K59.1
DIB012465	Monoamine transporter inhibitors	Narcolepsy	347	G47.4
DIB012466	AG-3296	Cancer	140-229	C00-C96
DIB012467	Melanoma vaccine	Melanoma	172	C43
DIB012468	11C-labeled sigma opioid receptor ligands, Santen	Psychotic disorders	.	F20-F29
DIB012469	Pemoline	Attention deficit hyperactivity disorder	314	F90
DIB012470	ZJM-289	Reperfusion injury	.	I00-I99
DIB012471	Dipeptidyl peptidase IV inhibitors	Diabetes mellitus type 2	.	E11
DIB012472	SMT-14224	Non-insulin dependent diabetes	.	E11.9
DIB012473	Neurological therapeutics	Neurological disease	.	G00-G99
DIB012474	OMP-52M51	Solid tumours	.	C00-C75,C7A,C7B
DIB012475	ONO-2333Ms	Anxiety disorder	.	F40-F42
DIB012476	HL-124	Hypertension	401	I10, I11, I12, I13, I15
DIB012477	VAG-624	Acne vulgaris	706.1	L70.0
DIB012478	Therapeutic agents	Influenza virus infections	487	J10, J11
DIB012479	AS-1708727	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DIB012480	IPH-24	Autoimmune diseases	279.4	D84.9, M35.9
DIB012481	DAX	Cystic fibrosis	277	E84
DIB012482	Davunetide intranasal spray	Cognitive impairment	.	F06.7
DIB012483	NESS-200P	Psychotic disorders	.	F20-F29
DIB012484	Lmvamune	Articular cartilage defects	733	M94
DIB012485	APT-222	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB012486	HPP-607	Cancer	140-229	C00-C96
DIB012487	DS-6051	Solid cancer	140-199	C00-C75, C7A, C7B
DIB012488	Saurestat	Staphylococcus aureus infection	001-139	A00-B99
DIB012489	Baquting	Bleeding	.	R58
DIB012490	GK-128	Emesis	787	R11
DIB012491	OrthoDerm	Musculoskeletal disease	.	M00-M99
DIB012492	HSC835	Hematological malignancies	200-209	C81-C96
DIB012493	H5N1 pandemic influenza mAb	Influenza virus infections	487	J10, J11
DIB012494	IPAG-13	Neuropathic pain	338,780	R52, G89
DIB012495	RVP-400-01	Prostate tumor	185	C61
DIB012496	Lipase inhibitors	Lipid metabolism disorder	.	E75-E78
DIB012497	ETI-210	Lymphoma	.	C81-C96
DIB012498	YY-162	Attention deficit hyperactivity disorder	314	F90
DIB012499	Glycanics	Inflammatory diseases	.	.
DIB012500	NPY modulators	Macular degeneration	.	H35.3
DIB012501	HS-25	Hyperbilirubinemia	.	E80.6
DIB012502	CZ-48	Cancer	140-229	C00-C96
DIB012503	BAY-44-3428	Asthma	.	J45
DIB012504	Recombinant vaccine	Allergy	995.3	T78.4
DIB012505	MK-82372	Head and neck cancer	140-149	C07-C14, C32-C33
DIB012506	Protein kinase inhibitors	Cancer	.	C00-C97
DIB012507	Tetravalent vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB012508	NS4b inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012509	Indigotindisulfonate	Bladder disease	.	N30-N32
DIB012510	SP-30	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012511	LNA-based RNA antagonists	Viral infections	042-075	A80-A99, B00-B34
DIB012512	AB-1101	Discovery agent	.	.
DIB012513	INO-3401	Influenza A virus H5N1 infections	487, 488	J10, J11
DIB012514	NPI-3114	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012515	TT-62	Viral infections	.	B34
DIB012516	Liposomal encapsulated paclitaxel (LEP)	Cancer	.	C00-C97
DIB012517	Renin inhibitors	Hypertension	401	I10, I11, I12, I13, I15
DIB012518	HS-HIV	HIV infections	42	B20
DIB012519	SLP-0907	Escherichia coli infection	.	A00-B99
DIB012520	PPAR-alpha agonists	Lipid metabolism disorder	.	E75-E78
DIB012521	TZI-41078	Arthritic	710-719	M00-M25
DIB012522	PADP	Solid tumours	.	C00-C75,C7A,C7B
DIB012523	BMS-605339	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012524	PLX8394	Melanoma	.	C43
DIB012525	Recombinant human Erbb3 fragment therapeutic tumor vaccine	Cancer	140-229	C00-C96
DIB012526	PI-0824	Autoimmune diseases	279.4	D84.9, M35.9
DIB012527	BIIC-792	Hypertension	401	I10, I11, I12, I13, I15
DIB012528	Hebergel	Viral infections	042-075	A80-A99, B00-B34
DIB012529	Autologous idiotypic cancer vaccine	Lymphoma	202.8	C81-C96
DIB012530	UC-2029	Premenstrual syndrome	.	N94.3
DIB012531	KD-7040	Pain	.	G89
DIB012532	Site-specific gene targeting agents	Cancer	140-229	C00-C96
DIB012533	VPX-595	Pain	338,780	R52, G89
DIB012534	TOK-8801	Arthritic	710-719	M00-M25
DIB012535	CSE-1034	Nosocomial infections	.	Y95
DIB012536	Hyaluronidase (ovine)	Improving resorption of radiopaque agents	.	.
DIB012537	CX-5461	Cancer	140-229	C00-C96
DIB012538	Covalent drug therapeutics	Discovery agent	.	.
DIB012539	GSK2879552	Small-cell lung cancer	.	C33-C34
DIB012540	TSERaM	Menopause	627.2	N95.0
DIB012541	OPC-8490	Cardiovascular disease	.	I00-I99
DIB012542	Naltrexone prodrugs	Alcohol use disorders	303	F10.2
DIB012543	KRX-0403	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB012544	SB-267268	Osteoporosis	.	M80-M81
DIB012545	Antibacterial antibodies	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012546	AAV gene therapy	Retinopathy	362.0-362.2	H35-H35.2
DIB012547	IPI-940	Pain	338,780	R52, G89
DIB012548	CRS-3123	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB012549	AZM-131	Obesity	278	E66
DIB012550	SB-M00026	Hepatitis B virus infection	.	B16
DIB012551	THE/DL-302	Heart failure	.	I50
DIB012552	3-deazaneplanocin derivatives (Ebola virus infection), Microbiotix	Ebola virus infection	.	A98
DIB012553	IGANIDIPINE HYDROCHLORIDE	Glaucoma	.	H40-H42
DIB012554	KLS-Bfr	Osteonecrosis	733.4	M87
DIB012555	DPN-205-734	Cardiotonic	.	I50
DIB012556	Ro-47-1317	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012557	HIV-1 RNase H inhibitors	HIV infections	42	B20
DIB012558	Palomid-529 inhaled	Alzheimer's disease	.	G30,F00
DIB012559	Nerenone	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DIB012560	RS-100975	Prostate disorder	.	N40-N42
DIB012561	BM-17.0249.2NA	Diabetes	250	E08-E13
DIB012562	TEM	Postherpetic neuralgia	.	B02.22
DIB012563	ViaDor-GLP1 agonist	Diabetes mellitus type 2	.	E11
DIB012564	IN0-8000	Hepatitis C virus infection	.	B18.2
DIB012565	SKF-110679	Growth hormone deficiency	.	E23.0
DIB012566	LY-2382770	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DIB012567	Carbon nanospheres	Allergy	995.3	T78.4
DIB012568	LM11A-31	Alzheimer's disease	.	G30,F00
DIB012569	Apolipoprotein E agonist series	Alzheimer's disease	331	G30
DIB012570	CHF-3098	Epilepsy	345	G40
DIB012571	Liposomal encapsulated doxorubicin (LED)	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
DIB012572	SDZ-89-104	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB012573	Osteopontins	Neurological disease	.	G00-G99
DIB012574	PE0139	Type 2 diabetes	250.00, 250.02	E11
DIB012575	BRL-55834	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB012576	GSK-2334470	Cancer	140-229	C00-C96
DIB012577	XL-541	Cancer	140-229	C00-C96
DIB012578	CXCR4 monoclonal antibodies	Cancer	140-229	C00-C96
DIB012579	PET imaging agent	Ovarian cancer	.	C56
DIB012580	Wetimicin	Infectious disease	001-139	A00-B99
DIB012581	TV1-Brain-1	Glioblastoma	191	C71
DIB012582	PTR-302	Discovery agent	.	.
DIB012583	HD-0701	Gastrointestinal disease	.	K00-K93
DIB012584	BMY-21950	Hyperlipidemia	.	E78.5
DIB012585	CY-725	Asthma	493	J45
DIB012586	KP-102	Macular degeneration	.	H35.3
DIB012587	GE-37468A analogs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012588	Sodium phenylbutyrate	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DIB012589	6-phosphofructo-2-kinase inhibitors (cancer), Advanced Cancer Therapeutics	Cancer	140-229	C00-C96
DIB012590	Bcl-2 protein inhibitors	Cancer	140-229	C00-C96
DIB012591	BB-76163	Inflammatory diseases	.	.
DIB012592	Nitroimidazole compounds	Trypanosomiasis	086.5-086	B56-B57
DIB012593	A-81282	Hypertension	401	I10, I11, I12, I13, I15
DIB012594	PankoMab-GEX	Cancer	140-229	C00-C96
DIB012595	Defibrotide	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB012596	GCC-AP0341	Asthma	493	J45
DIB012597	BAY 10-02670	Uterine leiomyoma	218.9	D25
DIB012598	AZD-9215	Asthma	493	J45
DIB012599	EchiTAb	Poison intoxication	.	T36-T50
DIB012600	D-amphetamine transdermal	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DIB012601	Ribosomal protein S6 kinase inhibitor	Infectious disease	001-139	A00-B99
DIB012602	Cdc34 inhibitors	Cancer	140-229	C00-C96
DIB012603	Mimovax	Alzheimer's disease	331	G30
DIB012604	Cytochrome P450-targeting prodrugs	Cancer	140-229	C00-C96
DIB012605	13-cis-retinoic acid, UCSD	Glioma	191	C71
DIB012606	OPB-111077	Hepatocellular carcinoma	.	C22.0
DIB012607	Cell culture based influenza vaccines	Influenza virus infections	487	J10, J11
DIB012608	PPAR gamma agonists	Diabetes mellitus	250	E08-E13
DIB012609	BIBH 1	Cancer	.	C00-C97
DIB012610	HYG-302	Discovery agent	.	.
DIB012611	BBT-009	Anemia	280-285	D50-D64
DIB012612	TrkB agonist	Obesity	278	E66
DIB012613	Valpentin	Pain	338,780	R52, G89
DIB012614	Protein phosphatase magnesium-dependent 1 delta inhibitors	Cancer	140-229	C00-C96
DIB012615	Thiolated chitosan nanoparticle theophylline	Inflammatory diseases	.	.
DIB012616	Sitimagene ceradenovec	Brain cancer	191	C71
DIB012617	Nolpitantium besilate	Asthma	.	J45
DIB012618	Proquazone	Osteoarthritis	715	M15-M19, M47
DIB012619	OMP-18R5	Solid tumours	.	C00-C75,C7A,C7B
DIB012620	Etazolate	Neurodegenerative diseases	.	G30-G32
DIB012621	MK-1293	Malaria	.	B50-B54
DIB012622	LY3016859	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
DIB012623	B-10	Discovery agent	.	.
DIB012624	KI-1003	Cancer	140-229	C00-C96
DIB012625	HO-4038	Myocardial infarction	410	I21, I22
DIB012626	L-757464	Prostate hyperplasia	.	N40
DIB012627	MDC-917	Cancer	.	C00-C97
DIB012628	BDD-10103	Pain	338,780	R52, G89
DIB012629	Seasonal/pandemic influenza vaccines	Influenza virus infections	487	J10, J11
DIB012630	Anti-avian influenza agent	Influenza virus infections	487	J10, J11
DIB012631	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB012632	CNS-1307	Schizophrenia	295	F20
DIB012633	NR-CO-02	Carcinoma	.	D07.30
DIB012634	ASF-1075	Psoriatic disorders	696	L40
DIB012635	MES-41073	HIV infections	42	B20
DIB012636	NF-kB kinase inhibitors	Inflammatory diseases	.	.
DIB012637	AZM-123	Fatty liver disease	.	K70,K76.0
DIB012638	Domain antibody therapy	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB012639	Theradigm-HPV	Carcinoma	.	D07.30
DIB012640	SLV-305	Gastric motility disorder	.	K22.4
DIB012641	Native human monoclonal antibody therapies program	Infectious disease	001-139	A00-B99
DIB012642	Non-PEGylated butyrylcholinesterase	Toxicity	.	T36-T50,T51-T65
DIB012643	Nano-PGE1	Peripheral arterial occlusive disease	.	I73.9
DIB012644	ZP-007	Pharyngitis	.	J02
DIB012645	BNC-210	Anxiety disorder	300	F40-F42
DIB012646	MLN-576	Acute lymphoblastic leukemia	.	C91.0
DIB012647	Hirufaxin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB012648	Chemoprotectant	Toxicity	.	T36-T50,T51-T65
DIB012649	Ro-48-8391	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012650	RAP-164	Discovery agent	.	.
DIB012651	AK-1	Cancer	.	C00-C97
DIB012652	AMB-8LK	Liver cancer	155	C22.0
DIB012653	TNFQb therapeutic vaccines	Crohn's disease	.	K50
DIB012654	Recombinant hypoallergenic vaccine	Allergic rhinitis	477	J30
DIB012655	Tau phosphorylation inhibitors	Alzheimer's disease	331	G30
DIB012656	AVA-101	Age-related macular degeneration	362.5	H35.3
DIB012657	Zinc finger protein transcription factors	Age related macular degeneration	.	H35.30
DIB012658	GCC-4401	Thrombosis	.	I80-I82
DIB012659	EC-8042	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012660	PNQX	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB012661	ABX-301	Allergy	995.3	T78.4
DIB012662	AM-577	Pain	338,780	R52, G89
DIB012663	Supravent	Heart arrhythmia	.	I47-I49
DIB012664	Teloxantrone	Cancer	140-229	C00-C96
DIB012665	GSK2140944	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012666	ATI-0810	Cancer	.	C00-C97
DIB012667	MAGE-3-transduced autologous T-cell vaccine	Melanoma	.	C43
DIB012668	Staphylococcus aureus vaccine	Staphylococcal infections	001-139	A00-B99
DIB012669	APP-018	Atherosclerosis	414.0, 440	I70
DIB012670	LEO-27847	Renal disease	.	N00-N29
DIB012671	Aimspro	Multiple sclerosis	340	G35
DIB012672	Anti-IFN-alpha human mAbs	Autoimmune diseases	279.4	D84.9, M35.9
DIB012673	ABT-413	Cancer	.	C00-C97
DIB012674	MAb therapeutics	Glioma	191	C71
DIB012675	Alacizumab pegol	Non-small cell lung cancer	.	C33-C34
DIB012676	VM-301	Dermatitis	692.9	L20-L30
DIB012677	BiTE antibodies	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012678	R-1554	Overactive bladder disorder	596.51	N32.81
DIB012679	Plant derived HIV-1 neutralizing antibodies	HIV infections	42	B20
DIB012680	RN6G	Age-related macular degeneration	362.5	H35.3
DIB012681	Anti-CD28	Immune disorder	.	D80-D89
DIB012682	Olfactory ensheathing glia cell therapy	Spinal cord injuries	952	S14, S24, S34
DIB012683	ATG002	Diabetic foot ulcer	707	L88-L89
DIB012684	SBR-111895	Metabolic disorders	.	E70-E90
DIB012685	NK-110	Muscle wasting disease	.	M62.50?
DIB012686	KM-023	HIV infections	42	B20
DIB012687	ApoB siRNA therapy	Hypercholesterolemia	272	E78.0
DIB012688	CJ-30001	Non-insulin dependent diabetes	.	E11.9
DIB012689	Small molecule therapeutic	Inflammatory diseases	.	.
DIB012690	NuroPro	Parkinson's disease	.	G20
DIB012691	Cardiometabolic therapeutics	Cardiovascular disease	390-459	I00-I99
DIB012692	NGR-hTNF	Colorectal cancer	.	C18-C20,C21
DIB012693	NKS-01	Bladder cancer	.	C67
DIB012694	IMM-160	Hepatocellular carcinoma	155	C22.0
DIB012695	Liver selective AMPK activators	Non-insulin dependent diabetes	.	E11.9
DIB012696	Botulinum toxin type F	Dystonia	.	G24
DIB012697	NP-001	Amotrophic lateral sclerosis	.	G12.21
DIB012698	Econazole nitrate foam	Chronic pain	338.2,780	R52.1-R52.2, G89
DIB012699	TAS-119	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB012700	11-beta-HSD1 inhibitors (metabolic disorder), Sanofi	Metabolic disorders	.	E70-E90
DIB012701	Drug abuse therapy	Alcohol use disorders	303	F10.2
DIB012702	Fonsartan	Hypertension	.	I10-I15
DIB012703	CEN-209	Cancer	140-229	C00-C96
DIB012704	LN-040	Leukemia	208.9	C91-C95
DIB012705	FCE-26492	Carcinoma	.	D07.30
DIB012706	UR-63325	Allergic rhinitis	.	J30
DIB012707	LQB-118	Cancer	.	C00-C97
DIB012708	MTL-005	Cancer	140-229	C00-C96
DIB012709	CLR457	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DIB012710	GS-9219	Cancer	.	C00-C97
DIB012711	Transdermal patch	Asthma	493	J45
DIB012712	EU-517	Cancer	140-229	C00-C96
DIB012713	ESBA-105	Ocular disease	.	H00-H59
DIB012714	F-16915	Atrial fibrillation	427.31	I48
DIB012715	Pratosartan	Hypertension	401	I10, I11, I12, I13, I15
DIB012716	Cannabinoid CB2 inverse agonists	Immune disorder	.	D80-D89
DIB012717	DEX-M74	Myopathy	.	M60-M63
DIB012718	CERM-11956	Angina	.	I20
DIB012719	XEL-002BI	Pain	338,780	R52, G89
DIB012720	SLP vaccine	Uterine cervix cancer	.	C53
DIB012721	New chemical entity	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB012722	Detumomab	B-cell lymphoma	.	C85.1
DIB012723	Aganepag isopropyl	Glaucoma	365	H40-H42
DIB012724	ATPase inhibitors	Cancer	140-229	C00-C96
DIB012725	Gallium maltolate	Human immunodeficiency virus infection	.	B20
DIB012726	Antimalarial compounds	Plasmodium falciparum infection	.	B54
DIB012727	FP-0210	Cardiovascular disease	390-459	I00-I99
DIB012728	HG-1071	Cancer	140-229	C00-C96
DIB012729	Carbazochrome salicylate	Bleeding	.	R58
DIB012730	MCT-485	Cancer	140-229	C00-C96
DIB012731	Virulence blockers	HIV infections	42	B20
DIB012732	ACT-N	Brain injury	.	S09.90
DIB012733	F-1394	Arteriosclerosis	.	I70
DIB012734	Midafotel	Cognition disorders	.	F06.7
DIB012735	Bioadhesive berry gel therapy	Dysplasia	.	C92.A2
DIB012736	MGN-1333	Hepatitis B virus infection	.	B16
DIB012737	Hemiacidrin	Urolithiasis	.	N20-N23
DIB012738	JTT-608	Diabetes mellitus	.	E10-E14
DIB012739	Ligase modulators	Cancer	140-229	C00-C96
DIB012740	Anti-amyloid beta antibodies	Alzheimer's disease	331	G30
DIB012741	TM-601	Cancer	.	C00-C97
DIB012742	E-5050	Hyperuricosuria	.	E79
DIB012743	Avicin D	Cancer	140-229	C00-C96
DIB012744	SCH-32615	Pain	.	G89
DIB012745	Macrolide anti-inflammatories	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB012746	ASP-8477	Neuropathic pain	338,780	R52, G89
DIB012747	DCR-MYC	Hepatocellular carcinoma	155	C22.0
DIB012748	Analgesics	Pain	338,780	R52, G89
DIB012749	PN-2XXX	Non-alcoholic steatohepatitis	.	K75.81
DIB012750	TA-7552	Atherosclerosis	414.0, 440	I70
DIB012751	LFn-p24	HIV infections	42	B20
DIB012752	TEI-6522	Arteriosclerosis	.	I70
DIB012753	Undisclosed protein	Discovery agent	.	.
DIB012754	PET radiotracer	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012755	BW-1370U87	Major depressive disorder	.	F32,F33
DIB012756	XMetS	Non-insulin dependent diabetes	.	E11.9
DIB012757	GPCR targeted therapeutics	Discovery agent	.	.
DIB012758	Pneumovax 23	Otitis media	.	H65-H67
DIB012759	MES-51151	Breast cancer	174, 175, 217	C50, D24
DIB012760	Emetine	Hepatitis virus infection	573.3	K75.9
DIB012761	Desoxyribonuclease	Female genital tract inflammation	.	N73.9
DIB012762	FPT-038	Non-insulin dependent diabetes	.	E11.9
DIB012763	PLD-177	Allergic rhinitis	.	J30
DIB012764	NOD factors	Cancer	140-229	C00-C96
DIB012765	NE-033	Psychotic disorders	.	F20-F29
DIB012766	TPI-1361-17	Obesity	278	E66
DIB012767	MAb based frz receptor modulators	Cancer	140-229	C00-C96
DIB012768	KI-0801 program	Neurological disease	.	G00-G99
DIB012769	IR208	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB012770	PF-4181366	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB012771	CTP-conjugated recombinant antigens	Cancer	140-229	C00-C96
DIB012772	Semapimod	Autoimmune diseases	.	D84.9
DIB012773	Hepatitis B viral replication inhibitors	Hepatitis B virus infection	.	B16
DIB012774	C-1205	Urinary tract infections	.	N39.0
DIB012775	Pirmenol	Heart arrhythmia	.	I47-I49
DIB012776	RGD-891	Thrombosis	.	I80-I82
DIB012777	CB-001	Leukemia	.	C91-C95
DIB012778	IVIG	Immune disorder	.	D80-D89
DIB012779	Balaglitazone	Diabetes mellitus type 1	.	E10
DIB012780	TgAAV-CFTR	Cystic fibrosis	277	E84
DIB012781	PLD-179	Urinary dysfunction	.	N39.3-N39.4
DIB012782	Cenestin	Menopause	627.2	N95.0
DIB012783	Btk inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB012784	IVN-201	Allergy	995.3	T78.4
DIB012785	SEL-73	Psychiatric disorders	.	F99
DIB012786	BBR-3438	Gastric cancer	.	C16
DIB012787	Anti-infectives	Cryptosporidium infection	.	A07.2
DIB012788	Allogeneic cellular melanoma vaccine	Melanoma	172	C43
DIB012789	IGFBP 2 variants	Cancer	140-229	C00-C96
DIB012790	Anti-VZV MAb	Varicella zoster virus infections	.	B01,B02
DIB012791	S-33084	Psychotic disorders	.	F20-F29
DIB012792	SMT-14400	Allergy	995.3	T78.4
DIB012793	Adaprolol maleate-SME	Glaucoma	365	H40-H42
DIB012794	NCX-1000	Cardiovascular disease	.	I51.6
DIB012795	ACT-178882	Cardiovascular disease	390-459	I00-I99
DIB012796	Second-generation cholesterol absorption inhibitors	Hypercholesterolemia	272	E78.0
DIB012797	CHF-4227	Osteoporosis	733	M80-M81
DIB012798	Group B streptococcus vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012799	Tetanus vaccine	Clostridium tetani infection	001-139	A00-B99
DIB012800	Semuloparin	Venous thromboembolism	453	I80-I82
DIB012801	Undecylenic acid	Dermatitis	692.9	L20-L30
DIB012802	Seprilose	Arthritis	710-719	M00-M25
DIB012803	Trivalent seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB012804	HyVec-RA	Rheumatold arthritis	714	M05-M06
DIB012805	AC-163954	Obesity	278	E66
DIB012806	Indalpine	Major depressive disorder	296.2, 296.3	F32, F33
DIB012807	THA-901	Cancer pain	338,780	R52, G89
DIB012808	Progesterone receptor agonists	Gynecological disorder	.	N70-N98
DIB012809	Tetramethylpyrazine	Neurological disease	.	G00-G99
DIB012810	MRLP-164	Skin infections	.	L00-L08
DIB012811	CY-403	Staphylococcus aureus infection	001-139	A00-B99
DIB012812	Anti-nucleolin antibodies	Cancer	140-229	C00-C96
DIB012813	Antiemetic compound	Emesis	787	R11
DIB012814	FS-205-397	Pain	338	R52
DIB012815	X-083-NAB	Psoriasis	696	L40
DIB012816	Anti-FcgammaRIIb monoclonal antibodies	Autoimmune diseases	279.4	D84.9, M35.9
DIB012817	GR-138678	Anxiety disorder	300	F40-F42
DIB012818	Undisclosed protein	Discovery agent	.	.
DIB012819	PTX-111	HIV infections	42	B20
DIB012820	Ozagrel	Xerophthalmia	.	E50.6-E50.7
DIB012821	PPL-100	HIV infections	42	B20
DIB012822	Cromolyn sodium	Atopic dermatitis	691.8	L20
DIB012823	Dendritic cell myeloma fusions	Multiple myeloma	203	C90.0
DIB012824	CIGB-247	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012825	PEN-203	Gynecological disorder	.	N70-N98
DIB012826	Dual PI3K/ERK kinase inhibitors	Cancer	140-229	C00-C96
DIB012827	GMI-1051	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB012828	Ragweed peptide allergy desensitization	Allergy	995.3	T78.4
DIB012829	PRT4445	Bleeding	.	R58
DIB012830	SAR-114137	Pain	338,780	R52, G89
DIB012831	Hormone-dependent vaccine	Prostate tumor	185	C61
DIB012832	Stroke program	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB012833	Cap-dependent translation inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB012834	Pneumococcal conjugate vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB012835	Oxothiazolidine carboxylate	HIV infections	42	B20
DIB012836	IkT-004	Polyomavirus infection	.	B97.89
DIB012837	Guanidine oseltamivir prodrug	Influenza virus infections	487	J10, J11
DIB012838	Oravax-PX	Virus infection	.	B03
DIB012839	DX-2400	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012840	NM-135	Dermatitis	.	L20-L30
DIB012841	Flurpiridaz F 18	Myocardial disease	.	I21-I22,I40-I42
DIB012842	C1q receptor therapeutics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012843	BC-RD-03	Raynaud's disease	.	I73.01
DIB012844	SSR-125329A	Immuno-modulator	.	D80-D89
DIB012845	EUR-1066	Exocrine pancreatic insufficiency	.	K86.8
DIB012846	Proteasome 20S inhibitors	Cancer	140-229	C00-C96
DIB012847	UK-240455	Nerve injury	.	T14.4
DIB012848	Allergy immunotherapy tablet	Allergy	995.3	T78.4
DIB012849	CGP-31081	Inflammatory diseases	.	.
DIB012850	FLUASTERONE	Arthritic	710-719	M00-M25
DIB012851	ZP-G-CSF	Neutropenia	288	D70
DIB012852	Multivalent Staphylococcus vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012853	A-74283	Hypertension	401	I10, I11, I12, I13, I15
DIB012854	Avian influenza vaccine	Influenza virus infections	487	J10, J11
DIB012855	FR-118487	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012856	Small molecule tau modulators	Alzheimer's disease	331	G30
DIB012857	PRX-6 gene therapy	Parkinson's disease	.	G20
DIB012858	XGP-515	Allergy	995.3	T78.4
DIB012859	RP-66471	Asthma	493	J45
DIB012860	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB012861	DNA/MVA HIV vaccine	HIV infections	.	B20
DIB012862	IMD-0354	Acne vulgaris	.	L70.0
DIB012863	NBI-5788	Multiple sclerosis	.	G35
DIB012864	ICT-121	Cancer	.	C00-C97
DIB012865	MN-2011	Age related macular degeneration	.	H35.30
DIB012866	Haemophilus influenzae B (Hib) vaccine	Haemophilus influenzae infection	.	J11.1
DIB012867	SCH-1518291	Schizophrenia	295	F20
DIB012868	HMPL-004	Inflammatory bowel disease	555, 556	K50, K51
DIB012869	DAU-6202	Bronchus disease	.	J20-J22,J40-J47
DIB012870	Nfu-PA-D4-RNP	Bacillus anthracis infection	.	A22
DIB012871	LY-2881835	Diabetes mellitus type 2	.	E11
DIB012872	EV-077	Diabetes mellitus type 2	.	E11
DIB012873	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB012874	SQ-33800	Hypertension	401	I10, I11, I12, I13, I15
DIB012875	UC-2024	Premenstrual syndrome	.	N94.3
DIB012876	FR-122788	Inflammatory diseases	.	.
DIB012877	Hsp 90 inhibitors	Cancer	.	C00-C97
DIB012878	Analgesics	Pain	338,780	R52, G89
DIB012879	TG-4010	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB012880	Glyfoline	Cancer	140-229	C00-C96
DIB012881	Tacrine analogs	Alzheimer's disease	.	G30,F00
DIB012882	NOS inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB012883	HSB-13	Neurodegenerative diseases	.	G30-G32
DIB012884	Analgesic	Pain	338,780	R52, G89
DIB012885	Temoporfin derivatives	Cancer	140-229	C00-C96
DIB012886	SAR-288233	Insulin dependent diabetes	.	E10
DIB012887	RG7641	Kidney diseases	580-589	N00-N29
DIB012888	LAS-31396	Asthma	493	J45
DIB012889	Leuvectin	Melanoma	.	C43
DIB012890	V-ATPase inhibitors	Cancer	140-229	C00-C96
DIB012891	ZD-4927	Thrombosis	.	I80-I82
DIB012892	Felbinac prodrug	Inflammatory diseases	.	.
DIB012893	Small molecule therapeutics	Osteoarthritis	715	M15-M19, M47
DIB012894	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB012895	SM-8849	Arthritic	710-719	M00-M25
DIB012896	NsG-0501	Epilepsy	345	G40
DIB012897	Non GC-C program	Gastrointestinal disease	.	K00-K93
DIB012898	Rifamycin	Infections disease	.	A00-B99
DIB012899	Desferrithiocin	Metal intoxication	.	T56
DIB012900	Highly pathogenic avian influenza (HPAI) vaccine	Influenza virus infections	487	J10, J11
DIB012901	Anti-cMET mAb	Discovery agent	.	.
DIB012902	PGCvax	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB012903	DasKloster 0080-01	Lymphangioleiomyomatosis	.	J84.81
DIB012904	IR 852	Colorectal cancer	153, 154	C18-C21
DIB012905	LF-984	Fibrosis	709.2	L90.5
DIB012906	CXCR3/CCR1 antagonists	Multiple sclerosis	.	G35
DIB012907	IL-8 receptor	Asthma	.	J45
DIB012908	Purified inactivated tetravalent vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB012909	ARTEFLENE	Malaria	.	B50-B54
DIB012910	Salicylihalamide A and B analogs	Cancer	140-229	C00-C96
DIB012911	ADL-7445	Constipation	.	K59.0
DIB012912	CTEP	Fragile X syndrome	759.83	Q99.2
DIB012913	Trichuris suis ova	Allergic rhinitis	477	J30
DIB012914	PI-083	Cancer	140-229	C00-C96
DIB012915	Genz-644282	Solid tumours	.	C00-C75,C7A,C7B
DIB012916	EW-A-401	Peripheral vascular disease	443.9	I73.9
DIB012917	GW-796406	Hypotension	.	I95
DIB012918	Carticel	Articular cartilage disorders	.	M24.10
DIB012919	H-216/44	Glaucoma	365	H40-H42
DIB012920	Sch-49209	Cancer	140-229	C00-C96
DIB012921	Alzheimers therapeutics	Alzheimer's disease	.	G30,F00
DIB012922	AC-1202	Memory loss	.	F03
DIB012923	Immunosuppressant synthetic peptide	Autoimmune diseases	279.4	D84.9, M35.9
DIB012924	SR-4554	Diagnosis	.	Y57.6
DIB012925	RG-7351	Major depressive disorder	296.2, 296.3	F32, F33
DIB012926	Fibroblast growth factor receptor 2 inhibitors	Endometrial cancer	.	C54.1
DIB012927	Invert sugar	Nutritional deficiency	.	E63.9
DIB012928	PF-03382792	Healthy elderly	.	.
DIB012929	FLAP inhibitor	Lung inflammation	.	D86
DIB012930	Expanded-spectrum neoglycosides	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012931	HSR-609	Rhinitis	.	J00,J30,J31.0
DIB012932	Polyvalent crotalid antivenin ovine fab	Poison intoxication	.	T36-T50
DIB012933	Vaccine	Salmonella infection	.	A02.9
DIB012934	PNU-248686A	Cancer	140-229	C00-C96
DIB012935	TJN-505	Heart arrhythmia	.	I47-I49
DIB012936	CPA-926	Arthritic	710-719	M00-M25
DIB012937	JBD-201	Fungal infection	.	B35-B49
DIB012938	BCH-325	Epilepsy	345	G40
DIB012939	CGTG-102	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012940	Immunomodulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB012941	Camobucol	Rheumatold arthritis	714	M05-M06
DIB012942	Rotavirus vaccine	Type 2 diabetes	250.00, 250.02	E11
DIB012943	Antibacterial compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012944	MEDI-0639	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB012945	Alpha-7 nicotinic acetylcholine receptor ligands	Neurodegenerative diseases	.	G30-G32
DIB012946	BA-058	Osteoporosis	733	M80-M81
DIB012947	A-68828	Renal disease	.	N00-N29
DIB012948	CAT-2000 series	Lipid metabolism disorder	.	E75-E78
DIB012949	Delamanid	Mycobacterium tuberculosis infection	.	A15-A19
DIB012950	Liposomal herpes simplex virus-2 glycoprotein-D vaccine	Herpes simplex virus infection	.	B00
DIB012951	HCV NS3/4A protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012952	Recombinant human relaxin	Scleroderma	701.0710.1	L94.0-L94.1, M34
DIB012953	CP-471358	Cancer	140-229	C00-C96
DIB012954	2164U90	Atherosclerosis	414.0, 440	I70
DIB012955	Naloxone hydrochloride	Toxicity	.	T36-T50,T51-T65
DIB012956	OM-197-MP-AC	Cancer	140-229	C00-C96
DIB012957	LP-20104	Cancer	140-229	C00-C96
DIB012958	Oxybutynin hydrochloride	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB012959	LTX-100	Infectious disease	001-139	A00-B99
DIB012960	UR-60427	Asthma	493	J45
DIB012961	KST-301	Cancer	.	C00-C97
DIB012962	SB-281832	Asthma	493	J45
DIB012963	ANA-012	Muscle wasting disease	.	M62.50?
DIB012964	CN54gp140-hsp70 conjugate vaccine	HIV infections	42	B20
DIB012965	ChelASE	Retinal disorders	.	H30-H36
DIB012966	HBN-1	Neurological disease	.	G00-G99
DIB012967	CBL0102	Hepatocellular carcinoma	155	C22.0
DIB012968	PP-203	Osteoporosis	733	M80-M81
DIB012969	CETi-1	Arteriosclerosis	.	I70
DIB012970	Soluble CD83	Autoimmune diseases	279.4	D84.9, M35.9
DIB012971	TDI-0094	Motor neurone disease	335.2	G12.2
DIB012972	TRPV1 antagonists	Pain	338,780	R52, G89
DIB012973	Immuncell-LC	Glioblastoma	.	C71
DIB012974	LPCN-1002	Testosterone deficiency	.	.
DIB012975	HCV cyclophilin binders/replication inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012976	Anti-FcRn antibodies	Pemphigus	.	L10.0
DIB012977	CPU-228	Cardiac failure	.	I50
DIB012978	CGEN-25007	Autoimmune diseases	279.4	D84.9, M35.9
DIB012979	RhGDF-5	Periodontal disease	.	K05
DIB012980	PTI-701	Pain	338,780	R52, G89
DIB012981	BAY-38-1315	Arteriosclerosis	.	I70
DIB012982	Therapeutic antibody program	Discovery agent	.	.
DIB012983	Gene therapy	Leukodystrophy	.	E75.25
DIB012984	FR-145237	Arteriosclerosis	.	I70
DIB012985	DT388IL-3	Acute myeloid leukemia	205	C92.0
DIB012986	RANK inhibitor peptides	Osteoporosis	733	M80-M81
DIB012987	Heptazyme	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB012988	NKTR-171	Neuropathic pain	338,780	R52, G89
DIB012989	PL-611	Diabetes mellitus	250	E08-E13
DIB012990	AG-NDP803	Inflammatory diseases	.	.
DIB012991	Itolizumab	Diabetes mellitus type 1	.	E10
DIB012992	Cefaclidine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB012993	Anpirtoline	Pain	338,780	R52, G89
DIB012994	Glionitrin A	Cancer	140-229	C00-C96
DIB012995	EDL-2000	Diabetes mellitus	250	E08-E13
DIB012996	Anti-CCR5 mAbs	HIV infections	42	B20
DIB012997	CGS-26393	Heart disease	390-429	I00-I52
DIB012998	CHR-3996	Solid tumours	.	C00-C75,C7A,C7B
DIB012999	PHN-021	Motion sickness	994.6	T75.3
DIB013000	CBR-2096	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013001	HIV vaccine	HIV infections	42	B20
DIB013002	Ultragrivak	Influenza virus infections	487	J10, J11
DIB013003	Salmonella typhimurium A1-R	Cancer	140-229	C00-C96
DIB013004	Antibacterial therapies	Mycobacterium tuberculosis infection	.	A15-A19
DIB013005	MUC-1 naked cDNA vaccine	Cancer	140-229	C00-C96
DIB013006	CGEN-712	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB013007	Anti-IP10	Crohn's disease; Ulcerative colitis	555, 556, 556.9	K50, K50-K52, K51
DIB013008	Diabetes (type I) vaccine	Insulin dependent diabetes	.	E10
DIB013009	KW-2449	Acute myeloid leukemia	.	C92.0
DIB013010	TACT	Cancer	140-229	C00-C96
DIB013011	Pox virus vector prostate specific antigen vaccine	Prostate hyperplasia	.	N40
DIB013012	Bentoquatam	Contact dermatitis	692	L23, L24, L25
DIB013013	CR-2093	Intestine cancer	.	C17-C20,C26
DIB013014	SYM-011	Cancer	140-229	C00-C96
DIB013015	PF-05230907	Nontraumatic intracerebral hemorrhage	.	I61.9
DIB013016	XZK-monascus	Hyperlipidemia	272.0-272.4	E78
DIB013017	Galantamine derivatives	Alzheimer's disease	.	G30,F00
DIB013018	Hairpin RNA	HIV infections	42	B20
DIB013019	Roledumab	Anemia	.	D50-D64
DIB013020	OPC-32508	Oral mucositis	528	K12.3
DIB013021	AR-12286	Ocular disease	.	H00-H59
DIB013022	Tempol	Spinal cord injuries	.	S14,S24,S34
DIB013023	MK-6406	Infectious disease	001-139	A00-B99
DIB013024	Pseudomonas aeruginosa vaccine	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB013025	443C81	Asthma	493	J45
DIB013026	Glycogen synthase kinase-3 inhibitors	Diabetes mellitus type 2	.	E11
DIB013027	Neuropeptide receptor blocker	Sinusitis	.	J01,J32
DIB013028	Dust mite allergen extract	Allergic rhinitis	477	J30
DIB013029	VEGF-2 gene therapy	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB013030	ASC-101	Haematological malignancies	.	C81-C96
DIB013031	StromaCel	Heart disease	390-429	I00-I52
DIB013032	BCL-002	Melanoma	172	C43
DIB013033	PN-277	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013034	123I-DRM-106	Alzheimer's disease	331	G30
DIB013035	NC-003	Myalgia	.	M79.1
DIB013036	Nonoxynol-9	Female contraception	.	Z30.013
DIB013037	KUR-213	Wound healing	.	S91.3
DIB013038	Type 1 dehydroquinase inhibitors	Staphylococcus aureus infection	001-139	A00-B99
DIB013039	PAR 1 antagonist	Cancer	.	C00-C97
DIB013040	Tuberculosis therapy	Mycobacterium tuberculosis infection	.	A15-A19
DIB013041	EL-715	Osteoporosis	733	M80-M81
DIB013042	PF-03716539	HIV infections	42	B20
DIB013043	AZM-111	Diarrhea	787.91	A09, K59.1
DIB013044	99mTc-14 F7 Mab	Breast cancer	174, 175	C50
DIB013045	Anti-IGFR 1 mAb	Discovery agent	.	.
DIB013046	NC-007	Major depressive disorder	296.2, 296.3	F32, F33
DIB013047	Molindone hydrochloride	HIV-1 infections	42	B20
DIB013048	KAG-308	Ulcerative colitis	556	K51
DIB013049	HG-1202	Cancer	.	C00-C97
DIB013050	OSI-2040	Beta thalassemia	.	D56.1
DIB013051	DRF-1042	Solid tumours	.	C00-C75,C7A,C7B
DIB013052	DX-2802	Cancer	.	C00-C97
DIB013053	SNAD	Emisphere's drug delivery	.	.
DIB013054	Glucopyranoside derivatives	Mycobacterium tuberculosis infection	.	A15-A19
DIB013055	BAN-2203	Alzheimer's disease	331	G30
DIB013056	Prophylactic dengue fever vaccine	Flavivirus infection	.	A86
DIB013057	RO-4840700	Schizophrenia	295	F20
DIB013058	TL-14077	Brain injury	.	S09.90
DIB013059	PG-11144	Cancer	140-229	C00-C96
DIB013060	CJC-1131	Diabetes mellitus type 1	.	E10
DIB013061	OSPC-rDT vaccine	Shigella sonnei infection	.	A03.9
DIB013062	Small molecule program targeting Tregs	Autoimmune diseases	279.4	D84.9, M35.9
DIB013063	J-555Y	Atopic dermatitis	691.8	L20
DIB013064	GW-42004	Lipid metabolism disorder	.	E75-E78
DIB013065	Flumazenil	Discovery agent	.	.
DIB013066	NLX-P101	Parkinson's disease	.	G20
DIB013067	SAND-5	Glomerulonephritis	.	N00,N01,N03,N18
DIB013068	JNJ-18038683	Major depressive disorder	296.2, 296.3	F32, F33
DIB013069	EDP-10	Insulin dependent diabetes	.	E10
DIB013070	TOCA-621	Melanoma	172	C43
DIB013071	AMPSL	Diabetes mellitus	250	E08-E13
DIB013072	GTPase modulators	Cancer	140-229	C00-C96
DIB013073	DIPROTEVERINE HYDROCHLORIDE	Angina	.	I20
DIB013074	BT-D005	Cancer	140-229	C00-C96
DIB013075	Pbi-shSTMN1 LP	Breast cancer	174, 175, 217	C50, D24
DIB013076	GPI-1337	Neurodegenerative diseases	.	G30-G32
DIB013077	MEDl-559	Respiratory syncytial virus 	.	B97.4
DIB013078	GSK3003891A	Respiratory syncytial virus 	.	B97.4
DIB013079	Osteoporosis therapy	Osteoporosis	733	M80-M81
DIB013080	FP-1097	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB013081	Drug 2849330	Cancer	140-229	C00-C96
DIB013082	Lachnumon	Fungal infection	.	B35-B49
DIB013083	HDM201	Hematological malignancies	.	C81-C96
DIB013084	S-111	Cancer	140-229	C00-C96
DIB013085	TABILAUTIDE	Immuno-modulator	.	D80-D89
DIB013086	CEP-5214	Solid tumours	.	C00-C75,C7A,C7B
DIB013087	PGX-200097	Schizophrenia	295	F20
DIB013088	BIIB061	Multile sclerosis	.	G35
DIB013089	KUR-112	Bone disease	.	M00-M99
DIB013090	TDI-0026	Motor neurone disease	335.2	G12.2
DIB013091	IRT-102	Pancreatic cancer	157	C25
DIB013092	Vector-delivered heat shock H11 kinase gene therapy	Ischemic heart diseases	410-414	I20-I25
DIB013093	AVI-6002	Ebola virus infection	.	A98
DIB013094	Leptin fragments	Diabetes mellitus	250	E08-E13
DIB013095	Oraqix	Anesthesia	338	R52
DIB013096	Colostatin	Colon cancer	153, 154	C18-C21
DIB013097	ZK-136798	Contraception	.	Z30
DIB013098	APX-007	Bone metastases	198.5	C79.51
DIB013099	LY-203725	Cancer	140-229	C00-C96
DIB013100	Epicutaneous anthrax vaccine	Anthrax	22	A22
DIB013101	V520 and V526 combination vaccine	HIV infections	42	B20
DIB013102	SUN-8399	Anxiety disorder	300	F40-F42
DIB013103	FH-AAV8	Familial hypercholesterolemia	272	E78.0
DIB013104	Adult stem cell therapy	Stroke	434.91	I61-I63
DIB013105	Akt-1 inhibitors	Cancer	140-229	C00-C96
DIB013106	Neuronal growth factor modulators	Alzheimer's disease	331	G30
DIB013107	Elisidepsin	Psoriasis	.	L40
DIB013108	POL-443	Hypertension	401	I10, I11, I12, I13, I15
DIB013109	Poloxafuse-I	Injury	.	S00-T88
DIB013110	LF-08-0133	Atherosclerosis	414.0, 440	I70
DIB013111	Universal influenza vaccine (H1N1 HA DNA plasmid prime)	Influenza virus infections	487	J10, J11
DIB013112	Edetate calcium disodium	Toxicity	.	T36-T50,T51-T65
DIB013113	EP-2104R	Cardiovascular disease	390-459	I00-I99
DIB013114	Bone regeneration therapy	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB013115	GA-GCSF	Neutropenia	288	D70
DIB013116	AG-SDT102	Genitourinary disease	.	N00-N99
DIB013117	BIMG80	Psychotic disorders	.	F20-F29
DIB013118	StaphVAX	Staphylococcus aureus infection	001-139	A00-B99
DIB013119	Recombinant hemoglobin	Anemia	280-285	D50-D64
DIB013120	H1N1 antigen liposomal vaccine	Influenza virus infections	487	J10, J11
DIB013121	Androgen receptor modulators (imaging	Cancer	140-229	C00-C96
DIB013122	Second generation therapeutics	Obesity	278	E66
DIB013123	ZD-6126	Cancer	.	C00-C97
DIB013124	PIC-060	Dermatitis	692.9	L20-L30
DIB013125	VT-362	Autoimmune diseases	279.4	D84.9, M35.9
DIB013126	RPK-8219	HIV infections	42	B20
DIB013127	SBC-104	Genetic disorder	.	Q00-Q99
DIB013128	Anti-botulinum mAbs	Clostridium botulinum infection	.	A05.1
DIB013129	W-205GBA2ED	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013130	MCS-110	Bone metastases	.	C79.51
DIB013131	PV-905	Liver disease	570-574	K70-K77
DIB013132	NK-102	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013133	NP-50501	Cancer	140-229	C00-C96
DIB013134	Paramyxovirus therapy	Paramyxovirus infection	.	A86
DIB013135	NT-KO-012	Neurodegenerative diseases	.	G30-G32
DIB013136	RemuneX	Melanoma	172	C43
DIB013137	PentaLyte	Blood transfusion	.	D50-D89
DIB013138	Combotox	Leukemia	208.9	C91-C95
DIB013139	Oxyntomodulin peptide	Diabetes mellitus	250	E08-E13
DIB013140	Myotubularin	Myotonic dystrophy type 1	.	G71.1
DIB013141	Ioversol	Cardiovascular disease	390-459	I00-I99
DIB013142	Hemorrhagic fever virus therapy	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB013143	TALTOBULIN	Cancer	140-229	C00-C96
DIB013144	AMZ-0026	HIV infections	42	B20
DIB013145	Taprizosin	Prostate hyperplasia	.	N40
DIB013146	Deuterated oxazolidinone antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013147	Axl targeting antibodies	Cancer	140-229	C00-C96
DIB013148	ABX-0402	Inflammatory bowel disease	555, 556	K50, K51
DIB013149	PH80-PMD	Acute migraine	346	G43
DIB013150	KP-102	Diabetes mellitus type 2	.	E11
DIB013151	AZD-7009 (iv formulation	Atrial fibrillation	427.31	I48
DIB013152	D-3252	SARS coronavirus infection	.	J12.81
DIB013153	AZD-1446	Alzheimer's disease	.	G30,F00
DIB013154	Factor VIIa inhibitors	Blood clotting disorder	286	D65-D69
DIB013155	Prodrug antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013156	Vitamin E	Cardiovascular disease	390-459	I00-I99
DIB013157	AA-193	Hyperuricosuria	.	E79
DIB013158	HDL-100	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DIB013159	99MTC-CYT-379	Diagnosis	.	Y57.6
DIB013160	ALXN1101	Molybdenum cofactor deficiency	.	E00-E90
DIB013161	5-HT 6 receptor antagonists (cognitive dysfunction), Schering Plough	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB013162	ZK-005	Wound healing	.	S91.3
DIB013163	HCV therapeutics	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB013164	BILR-355	Human immunodeficiency virus infection	.	B20
DIB013165	TG-1042	B-cell lymphoma	.	C85.1
DIB013166	Th-17 T-lymphocytes inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB013167	Sodium fluoride	Osteoporosis	733	M80-M81
DIB013168	Dust mite allergen extracts	Allergic reaction	995.3	T78.4
DIB013169	Avelumab	Cancer	.	C00-C97
DIB013170	CNS-1531	Neuropathy	356.0, 356.8	G64, G90.0
DIB013171	DOV-51892	Panic disorder	300.01, 300.21	F41.0
DIB013172	RESP-4000	Cancer	140-229	C00-C96
DIB013173	Dendritic cell PEG fusion cancer vaccine	Kidney cancer	140-229	C00-C96
DIB013174	Oltipraz	Cancer	.	C00-C97
DIB013175	PA-2794	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013176	Raloxifene	Osteoporosis	733	M80-M81
DIB013177	AR-12432	Ocular disease	.	H00-H59
DIB013178	HT-100	Duchenne muscular dystrophy	359.1	G71.0
DIB013179	ALT-801	Acute myeloid leukemia	.	C92.0
DIB013180	CT-2408R	Shock	.	T79.4
DIB013181	Pediatric anti retroviral program	Retrovirus infection	.	B33.3
DIB013182	CTL-102-GDEPT	Head and neck cancer	.	C07-C14,C32-C33
DIB013183	TOL-101	Multiple sclerosis	340	G35
DIB013184	E-0702-060	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013185	H-409/22	Cardiovascular disease	.	I00-I99
DIB013186	MDX-1204	Cancer	140-229	C00-C96
DIB013187	Vaccine	Legionella infection	.	A48.1
DIB013188	Japanese cedar pollen allergy sublingual immunotherapy	Allergy	995.3	T78.4
DIB013189	D-peptide analog HIV fusion inhibitors	HIV infections	42	B20
DIB013190	Biosuperior protein therapeutic	Hematological disease	.	D50-D89
DIB013191	Elstree-BN	Virus infection	.	B03
DIB013192	Histone deacetylase inhibitors	Cancer	140-229	C00-C96
DIB013193	Macimorelin	Growth hormone deficiency	.	E23.0
DIB013194	IVIG	Immune disorder	.	D80-D89
DIB013195	Small-cell lung cancer mAb vaccine	Small-cell lung cancer	140-229, 162	C00-C96, C33-C34
DIB013196	IgE inhibitors	Allergy	995.3	T78.4
DIB013197	131I-COU-1	Colon cancer	153, 154	C18-C21
DIB013198	Tularemia vaccine	Tularemia	.	A21.9
DIB013199	P53 tumor suppressor gene	Ovarian cancer	183	C56
DIB013200	Lintopride	Nausea	.	R11
DIB013201	RG6046	Breast cancer	174, 175	C50
DIB013202	DHFR inhibitors	Fungal infection	.	B35-B49
DIB013203	Efinaconazole	Fungal infection	.	B35-B49
DIB013204	Ricin vaccine	Parasitic infection	.	B89
DIB013205	Ecomustine	Cancer	140-229	C00-C96
DIB013206	KRN-2391	Angina	.	I20
DIB013207	M-516102	Pruritus	698	L29
DIB013208	R-524	Graft-versus host disease	.	T86.0
DIB013209	Humanized mAbs	Chikungunya virus infection	.	A92.0
DIB013210	Friulimicin topical	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013211	Promestriene	Acne vulgaris	706.1	L70.0
DIB013212	ONO-2231	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013213	PF-06649751	Parkinson's disease	.	G20
DIB013214	DW-908	Arthritis	710-719	M00-M25
DIB013215	RBI-1033	Cancer	140-229	C00-C96
DIB013216	AK-20	Non-alcoholic steatohepatitis	.	K75.81
DIB013217	Monoclonal antibodies	Acute myeloid leukemia	205	C92.0
DIB013218	GX-51	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013219	IMMU-132	Metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013220	GS-5885	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB013221	PF-1885	Anxiety disorder	.	F40-F42
DIB013222	GPR119 agonists	Diabetes mellitus	250	E08-E13
DIB013223	124I-8H9	Glioblastoma multiforme	.	C71
DIB013224	3-CLA	Cancer	140-229	C00-C96
DIB013225	ACR-125	Keratosis	.	L57.0
DIB013226	MIN-101	Schizophrenia	.	F20
DIB013227	Stiripentol	Epilepsy	345	G40
DIB013228	HRT	Estrogen deficiency	.	E28.39
DIB013229	WT1-targeted T-cell therapy	Acute lymphoblastic leukemia	204	C91.0
DIB013230	Anti EGFR mAb	Cancer	140-229	C00-C96
DIB013231	Oncoquest-CLL	Leukemia	208.9	C91-C95
DIB013232	ANG-3070	Scleroderma	701.0710.1	L94.0-L94.1, M34
DIB013233	Triacetin	Onychomycosis	.	B35.1
DIB013234	Transferrin CRM-107	Cancer	.	C00-C97
DIB013235	Placental growth factor	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013236	TDI-0043	Motor neurone disease	335.2	G12.2
DIB013237	AVE-0950	Asthma	493	J45
DIB013238	XR-5944	Gastric cancer	.	C16
DIB013239	PAT-NM-1	Cancer	140-229	C00-C96
DIB013240	SF-111	Infectious disease	001-139	A00-B99
DIB013241	NC-100150	Cardiovascular disease	390-459	I00-I99
DIB013242	Specialist adult stem cells	Cardiovascular disease	390-459	I00-I99
DIB013243	REGN-846	Atopic dermatitis	691.8	L20
DIB013244	E-1401	Acne vulgaris	706.1	L70.0
DIB013245	Neuraminidase inhibitors	Influenza virus infections	487	J10, J11
DIB013246	Povidone-iodine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013247	GRT-6005	Diabetic neuropathy	.	E10.4,E11.4,E13.4
DIB013248	P53-MDM2 inhibitors	Cancer	140-229	C00-C96
DIB013249	PIRODAVIR	Viral infections	042-075	A80-A99, B00-B34
DIB013250	Glucokinase activator	Non-insulin dependent diabetes	.	E11.9
DIB013251	C-3048	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB013252	Epidemic keratoconjunctivitis therapy	Adenovirus infection	.	B97.0
DIB013253	Atu-134	Lung injury	.	S00-T98
DIB013254	Anthrax vaccine	Bacillus anthracis infection	.	A22
DIB013255	AAV-IGF	Motor neurone disease	335.2	G12.2
DIB013256	TAK-937	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013257	Tenatumomab	Glioma	191	C71
DIB013258	Fosbretabulin disodium	Arthritic	710-719	M00-M25
DIB013259	ALD-701	Inflammatory diseases	.	.
DIB013260	Genevx	Angina	413	I20
DIB013261	Sodium glucose transporter-2 inhibitors	Obesity	278	E66
DIB013262	AZD-0902	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
DIB013263	2-deoxy-D-glucose prodrugs (glioma), MD Anderson Cancer Center	Glioma	191	C71
DIB013264	SPH-260-4	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013265	AMPK activators	Non-insulin dependent diabetes	.	E11.9
DIB013266	Ortholog screening program	Plasmodium falciparum infection	.	B54
DIB013267	Beraprost	Pulmonary arterial hypertension	.	I27.0,I27.2
DIB013268	EP4 antagonists	Inflammatory diseases	.	.
DIB013269	SX8	Staphylococcus aureus infection	001-139	A00-B99
DIB013270	BT-301	Periodontal disease	.	K05
DIB013271	SYNSORB-Cd	Diarrhea	787.91	A09, K59.1
DIB013272	AA-166	Articular cartilage disorders	.	M24.10
DIB013273	Sch-50672	Cancer	140-229	C00-C96
DIB013274	S-tenatoprazole	Peptic ulcer	.	K25-K27
DIB013275	Fc-IFN alpha 2b	Cancer	.	C00-C97
DIB013276	SGLT-2 inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB013277	RIGS CC49	Colorectal cancer	153, 154	C18-C21
DIB013278	Tankyrase inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB013279	RAP-701	Ovarian cancer	.	C56
DIB013280	ARN-810	Breast cancer	174, 175	C50
DIB013281	Insulin molecules	Diabetic complication	.	E08-E13
DIB013282	CEA RNA transfected autologous dendritic cell vaccine	Cancer	140-229	C00-C96
DIB013283	AERAS-405	Mycobacterium tuberculosis infection	.	A15-A19
DIB013284	TGN-1412	Autoimmune diseases	.	D84.9
DIB013285	Bryostatin analogs	Cancer	140-229	C00-C96
DIB013286	TGFK08AA-ER	Generalized anxiety disorder	300.02	F41.1
DIB013287	DWP-422	Arthritis	710-719	M00-M25
DIB013288	Interferon alpha-2b	Hepatitis C virus infection	.	B17.1,B18.2
DIB013289	HBX-41108	Cancer	140-229	C00-C96
DIB013290	KRP-203	Cutaneous lupus erythematosus	.	L93
DIB013291	NMHSS1-1	Glioblastoma	.	C71
DIB013292	Sodium Iodide I-131 Capsules	Thyroid disease	.	E07.9
DIB013293	LPG-1030I	Inflammatory bowel disease	555, 556	K50, K51
DIB013294	NCY-118	Septic shock	785.52	A41.9
DIB013295	AN-2898	Atopic dermatitis	.	L20
DIB013296	MEK inhibitors	Cancer	140-229	C00-C96
DIB013297	Boostrix Polio	Bordetella pertussis infection	.	A37.0
DIB013298	M-enoxaparin	Acute coronary syndrome	411.1	I20.0
DIB013299	Iodamide	Brain diseases	.	G00-G99
DIB013300	870086 (inhaled, asthma), GlaxoSmithKline	Asthma	493	J45
DIB013301	DT-2228	Major depressive disorder	296.2, 296.3	F32, F33
DIB013302	Superoxide dismutase mimetics	Retinopathy	362.0-362.2	H35-H35.2
DIB013303	MF-5137	Staphylococcus aureus infection	.	A41.0
DIB013304	PPAR-delta modulators	Diabetes mellitus	250	E08-E13
DIB013305	CM-182	Neurological disease	.	G00-G99
DIB013306	Kinase inhibitor	Cancer	140-229	C00-C96
DIB013307	AG-3287	Cancer	140-229	C00-C96
DIB013308	Cyanocobalamin	Anemia	.	D50-D64
DIB013309	CCR2 antagonists	Autoimmune diseases	.	D84.9
DIB013310	Antifungal vaccine	Mycoses	.	B49
DIB013311	FR-146687	Prostate disorder	.	N40-N42
DIB013312	Hebervis	Oral mucositis	.	K12.3
DIB013313	H2TFPC-SGlc	Colon cancer	153, 154	C18-C21
DIB013314	Oseltamivir intravenous	Ulcer	531-534	K25-K27
DIB013315	VT-346	Inflammatory diseases	.	.
DIB013316	E-0301	Acne vulgaris	.	L70.0
DIB013317	Ebola/Marburg vaccine	Ebola virus infection	65.8	A98.4
DIB013318	Ad/PSA	Prostate tumor	185	C61
DIB013319	Biciromab	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB013320	Flumatinib	Chronic myelogenous leukemia	205.1	C92.1
DIB013321	Antisense oligonucleotides	Infectious disease	001-139	A00-B99
DIB013322	WIP-901	Osteoarthritis	715	M15-M19, M47
DIB013323	Anti-SEB mAbs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013324	TAK-079	Pheumatoid arthritis	710-719	M00-M25
DIB013325	Dust mite allergen immunotherapy	Perennial allergic rhinitis	477	J30
DIB013326	AQ-RA-741	Cardiovascular disease	390-459	I00-I99
DIB013327	MTC-896	Seborrhea	.	L21
DIB013328	Androgen receptor modulator	Prostate tumor	185	C61
DIB013329	SR-1001	Multiple sclerosis	340	G35
DIB013330	Anti-VEGF-A monoclonal antibodies	Cancer	140-229	C00-C96
DIB013331	S1P1 receptor antagonists	Inflammatory diseases	.	.
DIB013332	APL-180	Heart disease	390-429	I00-I52
DIB013333	BioScavenger	Cancer	.	C00-C97
DIB013334	AZD-5213	Alzheimer's disease	.	G30,F00
DIB013335	Thrombopoietin mimetic antibodies	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB013336	PQ-1	Cancer	.	C00-C97
DIB013337	P1201-07	Metabolic disorders	.	E70-E90
DIB013338	L-373890	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB013339	PT-14	Erectile dysfunction	.	F52.2,N48.4
DIB013340	Ceftolozane sulfate	Bacterial respiratory tract infection	.	J13,J15
DIB013341	GM04-001	Influenza virus infections	487	J10, J11
DIB013342	BN-108	Cancer	140-229	C00-C96
DIB013343	YM-750	Hyperlipidemia	.	E78.5
DIB013344	NeuGene	Bacillus anthracis infection	.	A22
DIB013345	VML-252	Hyperphosphatemia	.	E83
DIB013346	DWP-09031	Alzheimer's disease	331	G30
DIB013347	IMC-TR1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013348	G530L	Obesity	278	E66
DIB013349	TBI-302	Hepatocellular carcinoma	155	C22.0
DIB013350	MPL-containing Pollinex allergy desensitization vaccine	Allergy	995.3	T78.4
DIB013351	BIBB-515	Arteriosclerosis	.	I70
DIB013352	Hepatitis A vaccine	Hepatitis A virus infection	.	B15.9
DIB013353	Combined hepatitis A and B vaccine	Hepatitis B virus infection	.	B16
DIB013354	SNALP-Wee1 siRNA	Hepatocellular carcinoma	155	C22.0
DIB013355	Live attenuated cholera vaccine	Vibrio cholerae infection	.	A00.0
DIB013356	Recombinant soluble CD6	Sepsis	995.91	A40, A41
DIB013357	Caspase inhibitors	Cardiovascular disease	390-459	I00-I99
DIB013358	Lung disease therapy	Pulmonary disease	460-519	J00-J99
DIB013359	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB013360	Autologous dendritic cell therapy	Cancer	.	C00-C97
DIB013361	Avigen Parkinson	Parkinson's disease	332	F02.3, G20
DIB013362	Xanthine oxidase inhibitor	Gout	274.00274.1274.8274.9	M10
DIB013363	FGLL	Alzheimer's disease	.	G30,F00
DIB013364	MEDI-556	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013365	MG-516	Cancer	140-229	C00-C96
DIB013366	NM-006-MENK	Cancer	140-229	C00-C96
DIB013367	CCX-354	Autoimmune diseases	.	D84.9
DIB013368	SKF-106610	Autoimmune diseases	279.4	D84.9, M35.9
DIB013369	GT-4001	Alzheimer's disease	331	G30
DIB013370	SOM-1033	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB013371	MTC-DOX	Liver cancer	155	C22.0
DIB013372	ARC-200	Cancer	140-229	C00-C96
DIB013373	AG-1284	HIV infections	42	B20
DIB013374	AVO113	Malignant glioma	.	C71.9
DIB013375	GR-213487	Cystic fibrosis	277	E84
DIB013376	Xylometazoline	Allergic rhinitis	477	J30
DIB013377	5-HT 4 agonists/partial agonists (neurogenerative diseases), Suven	Neurodegenerative diseases	.	G30-G32
DIB013378	UISH-001	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB013379	P38 kinase inhibitors	Inflammatory diseases	.	.
DIB013380	OpsoVac	Cancer	.	C00-C97
DIB013381	Ajmaline	Atrial fibrillation	427.31	I48
DIB013382	Phosphodiepryl 08	Schizophrenia	295	F20
DIB013383	Tagorizine	Allergy	995.3	T78.4
DIB013384	CH-2874	Asthma	493	J45
DIB013385	OPHD-001	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB013386	Mutations in the dystrophin gene	Cystic fibrosis	277	E84
DIB013387	Recombinant grass pollen allergens	Allergic rhinitis	477	J30
DIB013388	HQK-1004	Solid tumours	.	C00-C75,C7A,C7B
DIB013389	RNS-60	Asthma	493	J45
DIB013390	GTU-S pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB013391	Ad VEGF-C	Lymphatic disease	.	I89.8
DIB013392	SCP-123	Pain	338,780	R52, G89
DIB013393	AnergiX.MS	Multiple sclerosis	340	G35
DIB013394	HIV vaccine	HIV infections	42	B20
DIB013395	NB-007	Hepatitis B virus infection	.	B16
DIB013396	CRD-103	Bipolar disorder	.	F31
DIB013397	ACHN-975	Pseudomonas infection	.	B96.5,J15.1
DIB013398	BL-Angiostatin	Cancer	140-229	C00-C96
DIB013399	Angiostatin/paclitaxel/carboplatin	Lung cancer	162	C33-C34
DIB013400	CCX-721	Multiple myeloma	203	C90.0
DIB013401	Exenatide suspension	Type 2 diabetes	250.00, 250.02	E11
DIB013402	AG-858	Leukaemia	.	C91-C95
DIB013403	Solid tumor therapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013404	Iressa IMPRESS	Cancer	.	C00-C97
DIB013405	SIM-916	Gynecological disorder	.	N70-N98
DIB013406	Sutezolid	Tuberculosis	010-018	A15-A19
DIB013407	P2Y12 inhibitor	Atherosclerosis	414.0, 440	I70
DIB013408	DIMS-9054	Infectious disease	001-139	A00-B99
DIB013409	MM-POD1	Autoimmune diseases	279.4	D84.9, M35.9
DIB013410	C-Met kinase inhibitors	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013411	NS-004	Hypertension	401	I10, I11, I12, I13, I15
DIB013412	PF-06444752	Asthma	493	J45
DIB013413	Recombinant protective antigen vaccine	Bacillus anthracis infection	.	A22
DIB013414	Antibody (IgA) therapy	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB013415	Vaccines	Colorectal cancer	153, 154	C18-C21
DIB013416	MRLP-098	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013417	ETV-004	Toxicity	.	T36-T50,T51-T65
DIB013418	HC3-1496	Autoimmune diseases	279.4	D84.9, M35.9
DIB013419	Chlamydia vaccine	Chlamydia infection	.	A74.9
DIB013420	Nafronyl	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013421	JO-1870	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB013422	Atherosclerosis therapy	Atherosclerosis	414.0, 440	I70
DIB013423	Lidocaine vaginal gel	Dysmenorrhea	.	N94.4-N94.6
DIB013424	SC-75416	Pain	.	G89
DIB013425	AAV8-773	Achromatopsia	.	H53.51
DIB013426	HIV vaccine	HIV infections	42	B20
DIB013427	Zosyn/Tazocin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013428	Thrombin inhibitor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB013429	TRK-530	Osteoporosis	.	M80-M81
DIB013430	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB013431	Ralitoline	Epilepsy	345	G40
DIB013432	Potassium channel modulators	Autoimmune diseases	.	D84.9
DIB013433	EGFR vaccine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013434	111In anti-tPA, Novo Nordisk	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB013435	Simethicone	Dyspepsia	536.8	K30
DIB013436	Triple reuptake inhibitors	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB013437	Deuteroporphyrin	Cancer	140-229	C00-C96
DIB013438	HQK-1001	Beta thalassemia	.	D56.1
DIB013439	Bococizumab	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB013440	AMPA modulators	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB013441	TRP-2 peptide-based therapeutic cancer vaccine	Cancer	140-229	C00-C96
DIB013442	Antiparasitics	Parasitic infection	.	B89
DIB013443	VAX-161	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB013444	Carbamazepine	Epilepsy	345	G40
DIB013445	ME-3277	Thrombosis	.	I80-I82
DIB013446	ATL-844	Asthma	493	J45
DIB013447	Memapsin 2 inhibitors	Alzheimer's disease	331	G30
DIB013448	Vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB013449	CLR-151	Psychotic disorders	.	F20-F29
DIB013450	PET radiotracer	Prostate tumor	185	C61
DIB013451	NI-0701	Autoimmune diseases	.	D84.9
DIB013452	VR465	Respiratory syncytial virus 	.	B97.4
DIB013453	Ro-24-4736	Septic shock	.	A41.9
DIB013454	IPL-512602	Asthma	493	J45
DIB013455	RNAi therapeutics	Diabetes mellitus	250	E08-E13
DIB013456	PH sensitive micelles	Cancer	140-229	C00-C96
DIB013457	MS-654	Heart arrhythmia	.	I47-I49
DIB013458	LIM-kinase 2 inhibitors	Glaucoma	365	H40-H42
DIB013459	AA-184	Renal injury	.	N17.9
DIB013460	EM-6110a	Cancer	140-229	C00-C96
DIB013461	HIV MAG pDNA vaccine	HIV infections	.	B20
DIB013462	CASOPITANT MESYLATE	Anxiety disorder	.	F40-F42
DIB013463	TgBSSL	Pancreatic disorders	.	K86.9
DIB013464	RNA vaccine	Allergy	995.3	T78.4
DIB013465	MEN-10718	Cancer	140-229	C00-C96
DIB013466	ANX-042	Chronic heart failure	428	I50
DIB013467	ALS-00T2-0501	Psoriasis	696	L40
DIB013468	Recombinant yeast vaccine	Immune disorder	.	D80-D89
DIB013469	P-7170	Cancer	140-229	C00-C96
DIB013470	ZK-112993	Infertility	.	N46,N97.0
DIB013471	Alclofenac	Rheumatold arthritis	714	M05-M06
DIB013472	BM-113	Asthma	.	J45
DIB013473	Fendrix	Hepatitis B virus infection	.	B16
DIB013474	ITK inhibitors	Leukemia	.	C91-C95
DIB013475	Quinolone analogs	Mycobacterium tuberculosis infection	.	A15-A19
DIB013476	MC-02,479	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB013477	FLUPAROXAN	Depression	311	F32
DIB013478	PF-05190457	Diabetes mellitus type 2	.	E11
DIB013479	EP-1043	Non-small-cell lung carcinoma	162	C33, C34
DIB013480	KST-213	Cancer	.	C00-C97
DIB013481	Nicotinic ligands	Major depressive disorder	296.2, 296.3	F32, F33
DIB013482	EDP-08	Cancer	140-229	C00-C96
DIB013483	PF-4531083	Pain	338,780	R52, G89
DIB013484	NCE	Chronic kidney disease	.	N18
DIB013485	Glycosaminoglycans	Inflammatory diseases	.	.
DIB013486	SFV IL-12 gene therapy	Breast cancer	174, 175, 217	C50, D24
DIB013487	Meningitis B	Neisseria meningitidis infection	.	A87
DIB013488	PTX-200	Parkinson's disease	.	G20
DIB013489	Troplasminogen alfa	Myocardial infarction	.	I21-I22
DIB013490	MorphPlus	Pain	338,780	R52, G89
DIB013491	Ergoloid mesylates	Mood disorder	.	F30-F39
DIB013492	DOM-0215	Rheumatold arthritis	714	M05-M06
DIB013493	Myrcludex B	Hepatitis B virus infection	.	B16
DIB013494	V-11294A	Asthma	.	J45
DIB013495	CX-2007	Attention deficit hyperactivity disorder	314	F90
DIB013496	NXN-188	Migraine	.	G43
DIB013497	PB-200a	Fungal infection	.	B35-B49
DIB013498	Adva-R46	Cancer	140-229	C00-C96
DIB013499	SDZ-62-406	Cancer	140-229	C00-C96
DIB013500	FM-201	Rheumatold arthritis	714	M05-M06
DIB013501	Donepezil	Alzheimer's disease	331	G30
DIB013502	Cetiedil	Sickle-cell anemia	280-285	D50-D64
DIB013503	S-649266	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013504	GR-63799X	Asthma	.	J45
DIB013505	SARS vaccine	SARS coronavirus infection	.	J12.81
DIB013506	PVP-ILH liposomes	Conjunctivitis	372	H10
DIB013507	Pan-PI3K inhibitors	Cancer	140-229	C00-C96
DIB013508	Beta III tubulin targeting ddRNAi therapeutic	Lung cancer	162	C33-C34
DIB013509	DWJ-206	Stomach ulcer	.	K25-K27
DIB013510	ALT-020-02	Ocular infection	.	H00-H59
DIB013511	DBT-066	Dementia	290-294	F01-F07
DIB013512	Neuropeptide S antagonist	Neurological disease	.	G00-G99
DIB013513	Autologous anti-gp100 T-cell receptor gene-engineered peripheral blood lymphocytes	Melanoma	172	C43
DIB013514	Peptide-based vaccine	Hepatitis A virus infection	.	B15.9
DIB013515	DF-152 series	Mycobacterium tuberculosis infection	.	A15-A19
DIB013516	CLX-0921	Diabetes mellitus type 2	.	E11
DIB013517	KO-286011	Allergy	995.3	T78.4
DIB013518	RTL-551	Brain injury	.	S09.90
DIB013519	Semotiadil	Hypertension	.	I10-I15
DIB013520	Toxin-conjugated selective estrogen-receptor modulator	Breast cancer	174, 175, 217	C50, D24
DIB013521	Targeted vascular disrupting agent	Cancer	140-229	C00-C96
DIB013522	VT-310	Inflammatory diseases	.	.
DIB013523	YP-008	Psoriasis	696	L40
DIB013524	AdCMV-PR8.ha	Influenza virus infections	487	J10, J11
DIB013525	Immunoglobulin E receptor	Allergy	995.3	T78.4
DIB013526	SUN-101	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB013527	DCC-E1A	Ovarian cancer	183	C56
DIB013528	Cancer stem cell inhibitors	Cancer	140-229	C00-C96
DIB013529	RP-4000	Dementia	290-294	F01-F07
DIB013530	AM-101	Tinnitus	.	H93.1
DIB013531	HS-7	Cancer	140-229	C00-C96
DIB013532	MCP-201	Pain	338,780	R52, G89
DIB013533	CFC-222	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB013534	Aspartame	Poison intoxication	.	T36-T50
DIB013535	Agaricoglycerides	Pain	338,780	R52, G89
DIB013536	TV-1390	Multiple sclerosis	340	G35
DIB013537	Altropane	Attention deficit hyperactivity disorder	.	F90
DIB013538	Non-viral influenza vaccine	Influenza virus infections	487	J10, J11
DIB013539	SWT-06101	Fibromyalgia	729.1	M79.7
DIB013540	AB-1003	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB013541	DCVax-Brain	Brain cancer	191	C71
DIB013542	OX40L-targeting antibody	Asthma	493	J45
DIB013543	MU-1140-S	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013544	ALL-00099	Osteoarthritis	715	M15-M19, M47
DIB013545	NST-001	Tinnitus	.	H93.1
DIB013546	TDI-0042	Motor neurone disease	335.2	G12.2
DIB013547	BI-L-357	Asthma	493	J45
DIB013548	GenFusAb	Leukemia	208.9	C91-C95
DIB013549	GM-CSF vaccine	Renal cancer	.	C64
DIB013550	Allervax Dust Mite	Allergy	995.3	T78.4
DIB013551	ARC-520	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DIB013552	Novaferon	Colorectal cancer	.	C18-C20,C21
DIB013553	Aromatic ammonia spirits	Poison intoxication	.	T36-T50
DIB013554	GED-0507-34-Levo	Inflammatory bowel disease	555, 556	K50, K51
DIB013555	ADE-DERM	Scar tissue	.	L00-L99
DIB013556	Circumsporozoite protein vaccine	Plasmodium falciparum infection	.	B54
DIB013557	Acitazanolast	Allergy	995.3	T78.4
DIB013558	SPI-014	Alzheimer's disease	.	G30,F00
DIB013559	CVT-301	Parkinson's disease	.	G20
DIB013560	P11187	Type 2 diabetes	250.00, 250.02	E11
DIB013561	227Th-antibody (cancer), Algeta/Genzyme	Cancer	140-229	C00-C96
DIB013562	Ezatiostat hydrochloride	Myelodysplastic syndromes	.	D46
DIB013563	ApoCell	Autoimmune diseases	279.4	D84.9, M35.9
DIB013564	Influenza A virus vaccine	Influenza virus infections	487	J10, J11
DIB013565	SC-49992	Arterial thrombosis	.	I80-I82
DIB013566	ProCord	Spinal cord injuries	.	G95.9
DIB013567	RGI-1001	Allergy	995.3	T78.4
DIB013568	OC-229	Ischemia	459.89	I99.8
DIB013569	ABT-354	Alzheimer's disease	.	G30,F00
DIB013570	MDX-070	Prostate cancer	185	C61
DIB013571	LG-723	Melanoma	172	C43
DIB013572	Single dose epitope-based vaccine	Influenza virus infections	487	J10, J11
DIB013573	ACU-4429	Age related macular degeneration	.	H35.30
DIB013574	ITCA-638	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB013575	HE-33	Graft-versus host disease	.	T86.0
DIB013576	Dextroamphetamine sulfate	Attention deficit hyperactivity disorder	314	F90
DIB013577	Mepindolol	Angina	413	I20
DIB013578	IDM-1	Ovarian cancer	183	C56
DIB013579	4pox	Virus infection	.	B03
DIB013580	Gene therapy	Huntington's disease	.	F02.2,G10
DIB013581	GC5101B	Ulcer	531-534	K25-K27
DIB013582	KSI-4088	Nematode infection	.	B80
DIB013583	OvaSave	Autoimmune diseases	279.4	D84.9, M35.9
DIB013584	IPH-3102	Cancer	140-229	C00-C96
DIB013585	Ro-40-1641	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB013586	Macrofilaricidal compounds	Onchocerciasis	.	B73
DIB013587	Oncolysin CD6	Arthritis	710-719	M00-M25
DIB013588	Xiionix	Influenza virus infections	.	J11.1
DIB013589	Clinprost	Asthma	.	J45
DIB013590	CAB-101	Autoimmune diseases	279.4	D84.9, M35.9
DIB013591	Colostrinin-derived peptides	Neurodegenerative diseases	.	G30-G32
DIB013592	Carisoprodol	Musculoskeletal disease	.	M00-M99
DIB013593	RS-2135	Heart arrhythmia	.	I47-I49
DIB013594	Chi Lob 7/4	B-cell lymphoma	.	C85.1
DIB013595	NOX-S91	Cancer	.	C00-C97
DIB013596	YSCMA	Hematological malignancies	.	C81-C96
DIB013597	NMB-T-BMX-OS01	Cancer	140-229	C00-C96
DIB013598	LPMD	Metabolic disorders	.	E70-E90
DIB013599	Testosterone patch	Male hormonal deficiencies	.	E20-E35
DIB013600	Restenosis therapy	Restenosis	.	I51.89
DIB013601	Abloid	Alzheimer's disease	331	G30
DIB013602	Embryonic stem cell therapy	Parkinson's disease	.	G20
DIB013603	BAX-817	Hemophilia	286	D66-D68
DIB013604	Zimeldine	Major depressive disorder	296.2, 296.3	F32, F33
DIB013605	LRRK2 kinase inhibitors	Parkinson's disease	.	G20
DIB013606	Antineoplaston AS2-1	Glioblastoma	.	C71
DIB013607	AHR-16462B	Hypertension	401	I10, I11, I12, I13, I15
DIB013608	Bacteriophage-based gram-negative bacterial infection therapy	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013609	Ramoplanin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013610	CUV-3	Cancer	.	C00-C97
DIB013611	VUF-8929	Heart failure	.	I50
DIB013612	OPC-14117	Neurological disease	.	G00-G99
DIB013613	NNZ-2591	Neurodegenerative diseases	.	G30-G32
DIB013614	ImmuneFx	Cancer	140-229	C00-C96
DIB013615	V-3526	Equine encephalitis virus infection	.	A83.1
DIB013616	EISO ointment	Viral infections	042-075	A80-A99, B00-B34
DIB013617	Valetizumab	Multile sclerosis	.	G35
DIB013618	M-5120	Acne vulgaris	706.1	L70.0
DIB013619	CNB-001	Brain injury	.	S09.90
DIB013620	Alfimeprase	Peripheral vascular disease	443.9	I73.9
DIB013621	UNI-PH (1-34)	Osteoporosis	733	M80-M81
DIB013622	GSK311739	Rhinovirus infection	.	J20.6?
DIB013623	HyperAcute vaccine	Non-small-cell lung cancer	162	C33, C34
DIB013624	Antibacterial compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013625	NNC-14-0189	Epilepsy	345	G40
DIB013626	DASANTAFIL	Erectile dysfunction	.	F52.2,N48.4
DIB013627	AG-384	Cancer	.	C00-C97
DIB013628	Cannabinoids	Cancer	140-229	C00-C96
DIB013629	Neugranin	Neutropenia	.	D70
DIB013630	PHENSERINE TARTRATE	Parkinson's disease	.	G20
DIB013631	Pregabalin	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB013632	PF-05236812	Alzheimer's disease	.	G30,F00
DIB013633	T1-IR	Cancer	140-229	C00-C96
DIB013634	Calcium nanoparticles	Cancer	140-229	C00-C96
DIB013635	Influenza therapeutics	Influenza virus infections	487	J10, J11
DIB013636	WPP-201	Diabetic foot ulcer	.	E08-E13
DIB013637	CR-665	Pain	338,780	R52, G89
DIB013638	E3 ubiquitin protein ligase Cbl-b silencing siRNA therapeutics	Cancer	140-229	C00-C96
DIB013639	DTwP-Hep B-Hib vaccine	Hepatitis B virus infection	.	B16
DIB013640	Long-acting IFN-alpha	Cancer	.	C00-C97
DIB013641	Emfilermin	Infertility	.	N46,N97.0
DIB013642	Sphingosine-1-phosphate receptor-1 agonist	Immune disorder	.	D80-D89
DIB013643	Alphabody based therapy	Autoimmune diseases	279.4	D84.9, M35.9
DIB013644	Tryptophan hydroxylase 1 inhibitors	Bone disease	.	M00-M99
DIB013645	Metaxalone	Pain	338,780	R52, G89
DIB013646	Ischemic tolerant allogeneic mesenchymal stem cell therapy	Acute myocardial infarction	410	I21-I22
DIB013647	NR-LU-13	Colon cancer	153, 154	C18-C21
DIB013648	Diphtheria antitoxin	Corynebacterium diphtheriae infection	.	A36.9
DIB013649	NRLU-10	Breast cancer	174, 175, 217	C50, D24
DIB013650	Pexiganan acetate	Hypertriglyceridemia	.	E78.1
DIB013651	CXCR4 antagonist	Glioblastoma	191	C71
DIB013652	NEBO-174	Major depressive disorder	296.2, 296.3	F32, F33
DIB013653	PF-05280014	Breast cancer	.	C50
DIB013654	Hypoglycemic agents	Diabetes mellitus	250	E08-E13
DIB013655	Valtorim	Antrax	.	A22.9
DIB013656	Neuroprotective agents	Motor neurone disease	335.2	G12.2
DIB013657	PS386113	Inflammatory disorders	.	.
DIB013658	YM-543	Diabetes mellitus type 2	.	E11
DIB013659	Posiphen R-phenserine	Alzheimer's disease	.	G30,F00
DIB013660	KNX-Vaccine3A	Alzheimer's disease	331	G30
DIB013661	TrkA-XTEN	Pain	338,780	R52, G89
DIB013662	AD-519	HIV infections	42	B20
DIB013663	BAY-61-2116	Cancer	140-229	C00-C96
DIB013664	SDZ-LAV-694	Actinic keratoses	702	L57.0
DIB013665	RAPID regulated endorphins	Pain	338,780	R52, G89
DIB013666	IW-1221	Asthma	493	J45
DIB013667	Pleodrug	Diabetes mellitus	250	E08-E13
DIB013668	Hypocrellins	Ovarian cancer	.	C56
DIB013669	SOS response inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013670	Vatelizumab	Multiple sclerosis	340	G35
DIB013671	TNF alpha inhibitors	Alzheimer's disease	331	G30
DIB013672	BVA-201	Multiple sclerosis	340	G35
DIB013673	KpOmpA	Cancer	140-229	C00-C96
DIB013674	WIN-901	Asthma	493	J45
DIB013675	Chondrogel	Pediatric cancer	.	.
DIB013676	MX-6162	Breast cancer	174, 175, 217	C50, D24
DIB013677	Benzalkonium chloride	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013678	PG-102	Allergy	995.3	T78.4
DIB013679	Opioid spray	Pain	338,780	R52, G89
DIB013680	FGI-102 series	Viral infections	042-075	A80-A99, B00-B34
DIB013681	RF1V	Parasitic infection	.	B89
DIB013682	SR-33805A	Hypertension	.	I10-I15
DIB013683	CXCR3 antagonists	Rheumatold arthritis	714	M05-M06
DIB013684	Small molecule protein phosphatase 2A stimulators	Alzheimer's disease	331	G30
DIB013685	Dysferlin gene-containing recombinant AAV vector based therapy	Myopathy	.	M60-M63
DIB013686	BURKE-601	Atopic dermatitis	691.8	L20
DIB013687	Etarotene	Psoriasis	696	L40
DIB013688	TDI-0107	Motor neurone disease	335.2	G12.2
DIB013689	SL-017	Acne vulgaris	706.1	L70.0
DIB013690	Autologous T-cell therapy	B-cell lymphoma	.	C85.1
DIB013691	ALK-001	Age related macular degeneration	.	H35.30
DIB013692	SeV-Gag vaccine	HIV infections	42	B20
DIB013693	CLP-1001	Chronic heart failure	428	I50
DIB013694	Hypocretin modulators	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB013695	FA-70	Major depressive disorder	296.2, 296.3	F32, F33
DIB013696	TK-112690	Mucositis	.	K00-K95
DIB013697	BAY1161909	Cancer	.	C00-C97
DIB013698	PSP-D-GITRL	Cancer	.	C00-C97
DIB013699	Protosufloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013700	Anthrax lethal factor inhibitor	Bacillus anthracis infection	.	A22
DIB013701	SAR-548304	Hypercholesterolemia	272	E78.0
DIB013702	PF-4764793	Respiratory disease	.	J00-J99
DIB013703	Anti-CCR7 monoclonal antibody	Cancer	140-229	C00-C96
DIB013704	U-78517F	Asthma	493	J45
DIB013705	GCOL-514	Cancer	.	.
DIB013706	Inhibitor of PTEFb	Cancer	140-229	C00-C96
DIB013707	ADC-1012	Cancer	.	C00-C97
DIB013708	Myasthenia Gravis Vaccine	Myasthenia gravis	358	G70.0
DIB013709	ISS-1018	Lymphoma	.	C81-C96
DIB013710	EMZ701	Hepatitis B virus infection	.	B16
DIB013711	SB-36131	Diabetes mellitus	250	E08-E13
DIB013712	BNC-105	Mesothelioma	.	C45
DIB013713	HMGB-1 antagonists	Inflammatory diseases	.	.
DIB013714	Neomedi	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013715	Axl tyrosine kinase inhibitors	Cancer	140-229	C00-C96
DIB013716	STxB-E7	Papillomavirus infections	.	B97.7
DIB013717	AZD-0865	Gastrointestinal disease	.	K00-K93
DIB013718	FK-973	Solid tumours	.	C00-C75,C7A,C7B
DIB013719	Romergoline	Anxiety disorder	300	F40-F42
DIB013720	MGCD-290	Rheumatold arthritis	.	M05-M06
DIB013721	Succinate-ubiquinone oxidoreductase inhibitors	Cancer	140-229	C00-C96
DIB013722	NKTR-140	HIV infections	42	B20
DIB013723	IoGen	Pain	.	G89
DIB013724	KAC-776	Plasmodium infection	.	B54
DIB013725	Myo-inositol hexaphosphate	Cardiovascular disease	390-459	I00-I99
DIB013726	WF-10	Allergic rhinitis	477	J30
DIB013727	AMBAZONE	Solid tumours	.	C00-C75,C7A,C7B
DIB013728	TT-123	Blood clotting disorder	286	D65-D69
DIB013729	Inactivated virus vaccine	Yellow fever virus infection	.	A95
DIB013730	Salmonella-IL-2 cancer therapy	Cancer	140-229	C00-C96
DIB013731	VLD-631	Melanoma	172	C43
DIB013732	L-N3	Acquired immune deficiency syndrome	.	B20
DIB013733	Androgen receptor modulators	Prostate tumor	185	C61
DIB013734	PLX7486	Pancreatic cancer	.	C25
DIB013735	Adenosine deaminase transduced cell therapy	Immune disorder	.	D80-D89
DIB013736	Gene therapy	Chronic granulomatous disease	.	D71
DIB013737	XGP-210	Cancer	.	C00-C97
DIB013738	TIAPAFANT	Septic shock	.	A41.9
DIB013739	PBI-1308	Atopic dermatitis	691.8	L20
DIB013740	MNK-010	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB013741	AQ-13	Malaria	.	B50-B54
DIB013742	Human monoclonal antibody	Cytomegalovirus infection	.	B25
DIB013743	N-3601	Heart disease	390-429	I00-I52
DIB013744	HuGAL-F2	Cancer	140-229	C00-C96
DIB013745	PMA-109R	Cancer	140-229	C00-C96
DIB013746	Paracetamol prodrugs	Pain	338,780	R52, G89
DIB013747	Menitorix	Haemophilus influenzae infection	.	J11.1
DIB013748	HDL elevating compounds	Hypercholesterolaemia	.	E78.0
DIB013749	S-1255	Cardiovascular disease	390-459	I00-I99
DIB013750	Luliconazole 10%	Dry eye disease	370.33	H16.229
DIB013751	OG-Cx-833	Huntington's disease	.	F02.2,G10
DIB013752	ADRIAC-36	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013753	BAM-002	Breast cancer	174, 175, 217	C50, D24
DIB013754	Meningococcal CYW vaccine	Neisseria meningitidis infection	.	A87
DIB013755	Nepicastat	Parkinson's disease	.	G20
DIB013756	ONO-4007	Immuno-modulator	.	D80-D89
DIB013757	PLK1 inhibitors	Cancer	140-229	C00-C96
DIB013758	Saviprazole	Peptic ulcer	.	K25-K27
DIB013759	AT-003	Cancer	140-229	C00-C96
DIB013760	SENP-1 enzyme inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB013761	Nibentan	Cardiac arrhythmias	.	I47-I49
DIB013762	Ranibizumab	Hereditary hemorrhagic telangiectasia	.	I78.0
DIB013763	Tipelukast	Asthma	.	J45
DIB013764	DU-1777	Hypertension	401	I10, I11, I12, I13, I15
DIB013765	DB-160	Non-insulin dependent diabetes	.	E11.9
DIB013766	EQ-818-1	Cancer	140-229	C00-C96
DIB013767	BM-13.1196	Diabetes mellitus	250	E08-E13
DIB013768	ENT-102	Pain	338,780	R52, G89
DIB013769	MGluR5 antagonists	Autism	299	F84.0
DIB013770	Gamma-tocotrienol	Prostate tumor	185	C61
DIB013771	PEGylated ScFv program	Discovery agent	.	.
DIB013772	PLR-21	Psychiatric disorders	.	F99
DIB013773	FT-301	Muscle wasting disease	.	M62.50?
DIB013774	GS-9005	HIV infections	42	B20
DIB013775	HyperAcute vaccine	Breast cancer	174, 175, 217	C50, D24
DIB013776	C-peptide	Diabetic complication	.	E08-E13
DIB013777	AMG-181	Crohn's disease	.	K50
DIB013778	SNG-8023	Breast cancer	174, 175, 217	C50, D24
DIB013779	AC-187	Diabetes mellitus type 2	.	E11
DIB013780	AdVac Malaria Vaccine	Malaria	.	B50-B54
DIB013781	Ribonucleoside analogs	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB013782	WAY-100289	Anxiety disorder	.	F40-F42
DIB013783	Anti-IFNg	Herpes simplex virus infection	.	A60,B00
DIB013784	Boron-based compounds	Plasmodium falciparum infection	.	B54
DIB013785	Mumps skin test antigen	Allergy	995.3	T78.4
DIB013786	E-10030	Macular degeneration	.	H35.3
DIB013787	GW-549771	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013788	YT-146	Hypertension	.	I10-I15
DIB013789	Argidene gel	Dermatological disease	.	L00-L99
DIB013790	R-093777	Dyspepsia	.	K30
DIB013791	ProstaRex	Prostate tumor	185	C61
DIB013792	AMU-301	Gastroparesis	536.3	K31.8
DIB013793	Tamibarotene	Alzheimer's disease	.	G30,F00
DIB013794	OSU-2S	Cancer	140-229	C00-C96
DIB013795	Anti-EpCAM mAb	Discovery agent	.	.
DIB013796	LCB-1892	Edema	.	R60.9
DIB013797	CX-1020	Immune disorder	.	D80-D89
DIB013798	PH-794428	Growth hormone deficiency	.	E23.0
DIB013799	RTA-403 analog	Inflammatory diseases	.	.
DIB013800	4-aminosalicylate sodium (oral controlled release, ulcerative colitis), AGI Therapeutics	Inflammatory bowel disease	555, 556	K50, K51
DIB013801	Glucagon antagonists	Diabetes mellitus	250	E08-E13
DIB013802	VZ-564	Asthma	493	J45
DIB013803	IMP-731	Autoimmune diseases	279.4	D84.9, M35.9
DIB013804	Type VII collagen therapeutic	Epidermolysis bullosa	.	Q81
DIB013805	Steamchol	Gallstone	.	K82.9
DIB013806	COMT inhibitor	Parkinson's disease	.	G20
DIB013807	Neuronal cell therapy	Neurological disease	.	G00-G99
DIB013808	Antiviral program	Viral infections	042-075	A80-A99, B00-B34
DIB013809	Betamarc	Cachexia	799.4	R64
DIB013810	Muscarinic acetylcholine subtype 1 receptor antagonists	Autism	299	F84.0
DIB013811	AP-1903-activated MyD88/iCD40 dendritic cell vaccine	Cancer	140-229	C00-C96
DIB013812	ATX-201	Actinic Keratosis	702	L57.0
DIB013813	Anticancer compounds	Cancer	140-229	C00-C96
DIB013814	SP-08	Alzheimer's disease	331	G30
DIB013815	Tindamax	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013816	CPD 923	Metabolic disease	270-279	E70-E89
DIB013817	ProLindaun	Cancer	140-229	C00-C96
DIB013818	FT-105	Diabetes mellitus	250	E08-E13
DIB013819	BMS-182566	Cancer	140-229	C00-C96
DIB013820	GM1 cancer therapy	Cancer	140-229	C00-C96
DIB013821	CERE-120	Parkinson's disease	332	F02.3, G20
DIB013822	F-15441	Schizophrenia	295	F20
DIB013823	Mastalgia topical cream	Pain	338,780	R52, G89
DIB013824	ZK-151847	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB013825	ACH-2928	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB013826	PHA-690509	Cancer	140-229	C00-C96
DIB013827	Oralex	Gastrointestinal disease	.	K00-K93
DIB013828	Anti-Notch-2 receptor antibodies	Cancer	140-229	C00-C96
DIB013829	Single dose HBV vaccine	Hepatitis B virus infection	.	B16
DIB013830	H3 antagonist	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB013831	SDX-7500	Weight loss	.	R63.4
DIB013832	Anti-CD137 antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB013833	Recainam	Heart arrhythmia	.	I47-I49
DIB013834	DMP-581	Hypertension	401	I10, I11, I12, I13, I15
DIB013835	RP-656	Cancer	140-229	C00-C96
DIB013836	Calcium-sensing receptor antagonists	Osteoporosis	733	M80-M81
DIB013837	EMD-387008	Diabetes mellitus	250	E08-E13
DIB013838	Meningococcal vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013839	Lung cancer therapeutics	Lung cancer	162	C33-C34
DIB013840	BIBR-363	Hypertension	401	I10, I11, I12, I13, I15
DIB013841	APC-2059	Inflammatory bowel disease	.	K50,K51
DIB013842	Immune Globulin intravenous (human)	Immunodeficiency	.	D84.9
DIB013843	INS-1	Metabolic disorders	.	E70-E90
DIB013844	HDAC inhibitors	Cancer	.	C00-C97
DIB013845	A-928605	Cancer	140-229	C00-C96
DIB013846	Monoclonal antibody	Ulcerative colitis	556	K51
DIB013847	PF-3475952	Cancer	.	C00-C97
DIB013848	Steroid	Ocular inflammation	.	H00-H59
DIB013849	NXL-105	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013850	DLX-903/1008	Discovery agent	.	.
DIB013851	AVE-1876	Anxiety disorder	.	F40-F42
DIB013852	MX-6043	Diabetes mellitus type 2	.	E11
DIB013853	PfCS-102	Plasmodium infection	.	B54
DIB013854	Recombinant Factor VIII	Factor VIII deficiency	.	D66
DIB013855	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB013856	LY3015014	Cardiovascular disease	.	I00-I99
DIB013857	FtsZ inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013858	C-AFG	Viral infections	042-075	A80-A99, B00-B34
DIB013859	Dutogliptin	Diabetes mellitus type 2	.	E11
DIB013860	NSD-788	Anxiety disorder	300	F40-F42
DIB013861	ZD-6021	Bronchus disease	.	J20-J22,J40-J47
DIB013862	IMCgp100	Melanoma	.	C43
DIB013863	BCG Vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB013864	ABT-100	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013865	ONO-AE1-437	Asthma	.	J45
DIB013866	MAT-304	Autoimmune diseases	279.4	D84.9, M35.9
DIB013867	OTS167	Solid tumours	.	C00-C75,C7A,C7B
DIB013868	IB-06F259	Cancer	140-229	C00-C96
DIB013869	VSSP	Cancer	.	C00-C97
DIB013870	CRTX-067	Cough	786.2	R05
DIB013871	PPAR gamma agonists	Drug dependence	303-304	F10.2-F19.2
DIB013872	M-0011	Alpha-mannosidosis	.	E77.1
DIB013873	Diabetes NCE	Diabetes mellitus	250	E08-E13
DIB013874	NS-377	Alzheimer's disease	.	G30,F00
DIB013875	LSD1 inhibitors	Cancer	.	C00-C97
DIB013876	Pentacea	Small-cell lung cancer	.	C33-C34
DIB013877	SIR-1076	Retinopathy	362.0-362.2	H35-H35.2
DIB013878	JTK-002	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB013879	KU-1257	Duodenal ulcer	.	K25-K27
DIB013880	Respiratory disease therapeutics	Respiratory disorder	.	J98.9
DIB013881	Technetium TC 99M medronate	Bone disease	.	M00-M99
DIB013882	Varilrix	Varicella zoster virus infections	.	B01,B02
DIB013883	Alequel	Inflammatory bowel disease	555, 556	K50, K51
DIB013884	Dukoral	Escherichia coli infection	.	A00-B99
DIB013885	PG-50	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB013886	RNAi molecules	Discovery agent	.	.
DIB013887	Bemetizide	Congestive heart failure	428	I50
DIB013888	Monoclonals	Inflammatory diseases	.	.
DIB013889	Anti-HIV ribozyme therapy	HIV infections	42	B20
DIB013890	Sirtuin-1 activators	Obesity	278	E66
DIB013891	MP-RM-1	Cancer	140-229	C00-C96
DIB013892	Bentiromide	Pancreatic cancer	.	C25
DIB013893	Sibopirdine	Alzheimer's disease	331	G30
DIB013894	Oxyntomodulin	Obesity	278	E66
DIB013895	YPEG-Somatropin	Growth hormone deficiency	253.3	E23.0
DIB013896	CGS-18081A	Psychotic disorders	.	F20-F29
DIB013897	Long-acting VPAC2 agonist	Diabetes mellitus	250	E08-E13
DIB013898	Ara-LAMP-vax	Allergy	995.3	T78.4
DIB013899	POT-4	Macular degeneration	.	H35.3
DIB013900	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB013901	AS-602704	Alzheimer's disease	.	G30,F00
DIB013902	ABT-518	Cancer	140-229	C00-C96
DIB013903	Ion channel modulators	Cardiovascular disease	390-459	I00-I99
DIB013904	SOT-107	Brain cancer	191	C71
DIB013905	GBP-1a	Breast cancer	174, 175, 217	C50, D24
DIB013906	Nordimmun	Thrombocyte disorder	.	D65-D69
DIB013907	EG-011	Angina	413	I20
DIB013908	Antifungal agents	Fungal infection	.	B35-B49
DIB013909	Anti-MSF antibodies	Cancer	140-229	C00-C96
DIB013910	IML-1	Autoimmune diseases	279.4	D84.9, M35.9
DIB013911	Picumeterol	Bronchodilator	493	J45
DIB013912	MIA2 cytokine protein modulators	Liver fibrosis	571	K70.3, K71.7, K74
DIB013913	SPM-3672	Angina	413	I20
DIB013914	NP-252	Hypertension	.	I10-I15
DIB013915	VA-111913	Dysmenorrhea	.	N94.4-N94.6
DIB013916	Recombinant T-cell receptor ligand	Optic neuritis	.	H46
DIB013917	PI3K beta inhibitor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013918	GGTase inhibitors	Cancer	140-229	C00-C96
DIB013919	Vaccine	Ebola virus infection	.	A98
DIB013920	S-18616	Pain	338,780	R52, G89
DIB013921	NKTR-181	Pain	.	G89
DIB013922	APD-334	Autoimmune diseases	279.4	D84.9, M35.9
DIB013923	Type II secretion inhibitors	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB013924	BTM-0512	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB013925	Stem cell therapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB013926	P53 tumor suppressor	Head and neck cancer	140-149	C07-C14, C32-C33
DIB013927	IAP inhibitors	Rheumatold arthritis	714	M05-M06
DIB013928	NT-KC-005	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013929	SKL-19014	Non-insulin dependent diabetes	.	E11.9
DIB013930	HSR-6071	Asthma	.	J45
DIB013931	Atagonist of mGlu2/mGlu3	Pain	.	G89
DIB013932	21-AMINOEPOTHILONE B	Cancer	140-229	C00-C96
DIB013933	Tozadenant	Parkinson's disease	.	G20
DIB013934	Factor XIa inhibitor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB013935	EC-0746	Inflammatory diseases	.	.
DIB013936	Elisartan potassium	Hypertension	401	I10, I11, I12, I13, I15
DIB013937	Helicore-O	Helicobacter pylori infection	41.86	B96.81
DIB013938	IL-12 modulators	Diabetes mellitus	250	E08-E13
DIB013939	KT&G-101	Atrophy	.	M62.571
DIB013940	HPV 16/18/52/58 vaccine	Papillomavirus infections	.	B97.7
DIB013941	EndoAngio-GT	Cancer	140-229	C00-C96
DIB013942	MA09-hRPE cells	Ocular disease	.	H00-H59
DIB013943	R-1437	Prostate hyperplasia	.	N40
DIB013944	ISCAR	HIV infections	42	B20
DIB013945	Dextranomer	Infectious disease	001-139	A00-B99
DIB013946	SLP-1002	Fungal infection	.	B35-B49
DIB013947	BL-22	Acute lymphoblastic leukemia	.	C91.0
DIB013948	ANCA-associated vasculitis therapy	Vasculitis	.	I77.6,I80
DIB013949	F-15063	Schizophrenia	295	F20
DIB013950	Angiotensin II AT-1 antagonists	Hypertension	.	I10-I15
DIB013951	LW-10187	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB013952	F10	Influenza virus infections	487	J10, J11
DIB013953	Calcium	Osteoporosis	733	M80-M81
DIB013954	CP-0597	Asthma	.	J45
DIB013955	SECTA belomycin	Solid tumours	.	C00-C75,C7A,C7B
DIB013956	RDEA-427	HIV infections	42	B20
DIB013957	VBY- 285	Neuropathic pain	338,780	R52, G89
DIB013958	Ad5FGF-4	Angina	.	I20
DIB013959	Vilaprisan	Endometriosis	.	N80
DIB013960	Neocartilage	Pain	338,780	R52, G89
DIB013961	CFTR gene therapy	Cystic fibrosis	277	E84
DIB013962	TDI-0111	Motor neurone disease	335.2	G12.2
DIB013963	T cell receptors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013964	KD-295	Influenza H5N1 infections	.	J11.1
DIB013965	PRT-061103	Cardiovascular disease	390-459	I00-I99
DIB013966	GSK362115	Epilepsy	345	G40
DIB013967	OJP-2028	Hypertension	401	I10, I11, I12, I13, I15
DIB013968	5-HT2b antagonists (congestive heart failure), Evotec/Boehringer Ingelheim	Congestive heart failure	428	I50
DIB013969	Integrin alpha 5/beta 1	Metastasis	.	C00-C97
DIB013970	Chlamydia vaccine	Chlamydia infection	.	A74.9
DIB013971	BL-6030	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB013972	Small molecule NOS modulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB013973	S-17625	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB013974	SNP-001	Epilepsy	345	G40
DIB013975	Inhaled liposomal ciprofloxacin	Cystic fibrosis	277	E84
DIB013976	Tissue Repair Cells (TRCs)	Spinal cord injuries	.	G95.9
DIB013977	Glucagon-like peptide-1 analog	Non-insulin dependent diabetes	.	E11.9
DIB013978	P16/p53 gene therapy	Hepatocellular carcinoma	155	C22.0
DIB013979	Sanfetrinem	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB013980	Recombinant human pro-urokinase	Myocardial infarction	410	I21, I22
DIB013981	B-956	Cancer	140-229	C00-C96
DIB013982	Anti Helicobacter pylori compounds	Helicobacter pylori infection	41.86	B96.81
DIB013983	BA-207	Cardiovascular disease	390-459	I00-I99
DIB013984	Nicotinic ACh ligands	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB013985	SIM-071201	Cerebrovascular disorders	.	I60-I69
DIB013986	KI-0503	Arthropathy	.	M00-M14
DIB013987	JTT-654	Diabetes mellitus type 2	.	E11
DIB013988	CER-522	Aortic valve stenosis	.	I35.0,I06.0
DIB013989	MLN-0905	Lymphoma	202.8	C81-C96
DIB013990	Camptothecin analogs	Cancer	140-229	C00-C96
DIB013991	Phenylephrine hydrochloride gel	Fecal incontinence	.	R15
DIB013992	RCD-2	Fecal incontinence	.	R15
DIB013993	HGH-OctoDEX	Growth disorder	.	E23.0
DIB013994	CKD-406	Anemia	280-285	D50-D64
DIB013995	Tau vaccine	Alzheimer's disease	331	G30
DIB013996	MOR-103	Multiple sclerosis	.	G35
DIB013997	C5a mimetics	Inflammatory diseases	.	.
DIB013998	PF-06425090	Clostridium difficile colitis	001-139	A00-B99
DIB013999	Growth hormone releasing factor peptides	Growth hormone deficiency	253.3	E23.0
DIB014000	MS-322	Spasm	.	R25.2
DIB014001	Anti-CD3 monoclonal antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB014002	Tetanus vaccine	Clostridium tetani infection	001-139	A00-B99
DIB014003	NMDA NR2B antagonists	Major depressive disorder	296.2, 296.3	F32, F33
DIB014004	ML-04	Myelodysplastic syndromes	.	D46
DIB014005	NC-0604	Cancer	140-229	C00-C96
DIB014006	LX-1031	Irritable bowel syndrome	564.1	K58
DIB014007	NS-2979	Pain	338,780	R52, G89
DIB014008	SAFIRONIL	Transplant rejection	.	T86
DIB014009	BVF-087	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB014010	NX-002	Inflammatory bowel disease	555, 556	K50, K51
DIB014011	YourDex	Autoimmune diseases	279.4	D84.9, M35.9
DIB014012	AG-3294	Cancer	140-229	C00-C96
DIB014013	DRL-21995	Lipid metabolism disorder	.	E75-E78
DIB014014	KPC-34	Cancer	140-229	C00-C96
DIB014015	KF-17625	Asthma	493	J45
DIB014016	Recombinant human butyrylcholinesterase	Poison intoxication	.	T36-T50
DIB014017	IC 1001	Non-small-cell lung carcinoma	162	C33, C34
DIB014018	MVA-BN anthrax	Bacillus anthracis infection	.	A22
DIB014019	HBV-001-D1	Dengue	61	A90
DIB014020	NOX-200	Rheumatold arthritis	714	M05-M06
DIB014021	Dicer-substrate small interfering RNAs	Cancer	140-229	C00-C96
DIB014022	PPRT-550	Premenstrual syndrome	.	N94.3
DIB014023	AVP-4	Cancer	140-229	C00-C96
DIB014024	Antidiabetics	Non-insulin dependent diabetes	.	E11.9
DIB014025	VAR-10200	Neurodegenerative diseases	.	G30-G32
DIB014026	HYG-301	Discovery agent	.	.
DIB014027	ERC-124	Critical limb ischemia	459.89	I99.8
DIB014028	GW-1838	HIV infections	42	B20
DIB014029	BRL-61164	Epileptic seizure	.	G40,R56
DIB014030	Revacept	Arteriosclerosis	.	I70
DIB014031	Streptavidin fusion protein	Leukaemia	.	C91-C95
DIB014032	Adenosine A3 antagonists	Glaucoma	365	H40-H42
DIB014033	INS 316	Lung cancer	162	C33-C34
DIB014034	M-3000	Autoimmune diseases	279.4	D84.9, M35.9
DIB014035	PSN-9301	Diabetes mellitus	250	E08-E13
DIB014036	CNT0-3157	Asthma	493	J45
DIB014037	StarGen	Retinitis pigmentosa	.	H35.5
DIB014038	HERG potassium channel openers	Heart arrhythmia	.	I47-I49
DIB014039	Immunotherapy	Melanoma	172	C43
DIB014040	NK cell program	Cancer	140-229	C00-C96
DIB014041	TDT-044	Dermatological disease	.	L00-L99
DIB014042	Melanoma antigens	Melanoma	172	C43
DIB014043	99m-Tc-tropantiol	Brain diseases	.	G00-G99
DIB014044	Creatine ALS-08	Motor neurone disease	335.2	G12.2
DIB014045	LY-2428757	Diabetes mellitus type 2	.	E11
DIB014046	Synuclere	Parkinson's disease	.	G20
DIB014047	ALTU-237	Hyperoxaluria	.	E74.8
DIB014048	CP-66948	Gastric ulcer	.	K25
DIB014049	BIIB-024	Cancer	140-229	C00-C96
DIB014050	Anticancer agents	Cancer	140-229	C00-C96
DIB014051	CS-00018	Diabetes mellitus type 2	.	E11
DIB014052	Zn-DPA-P	Prostate tumor	185	C61
DIB014053	AZD0914	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB014054	99mTc-teboroxime	Myocardial disease	.	I21-I22,I40-I42
DIB014055	WilVent	Pulmonary disease	460-519	J00-J99
DIB014056	Laromustine	Solid tumours	.	C00-C75,C7A,C7B
DIB014057	FLUNOPROST	Nasal decongestant	.	R09.81
DIB014058	KR-31360	Nervous system inflammation	.	G00-G09
DIB014059	VALERGEN-BT (sublingual)	Asthma	493	J45
DIB014060	YM-598	Prostate cancer	185	C61
DIB014061	BIM-46187	Cancer	140-229	C00-C96
DIB014062	Heberpenta L	Hepatitis B virus infection	.	B16
DIB014063	Influenza/SARS vaccine	Influenza virus infections	487	J10, J11
DIB014064	MVA-BN RSV	Respiratory syncytial virus 	79.6	B97.4
DIB014065	Inhibitor of MPS1	Cancer	140-229	C00-C96
DIB014066	MHC-antigen peptide fusion proteins	Autoimmune diseases	279.4	D84.9, M35.9
DIB014067	JT-2724	Hypertension	401	I10, I11, I12, I13, I15
DIB014068	Aroplatin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014069	CTAP-201	Hyperparathyroidism	252.02, 588.81	E21.1
DIB014070	Second-generation KSP inhibitors	Cancer	140-229	C00-C96
DIB014071	PRO-98498	Asthma	493	J45
DIB014072	Dual-action antibiotics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014073	ZK-209614	Conjunctivitis	372	H10
DIB014074	TNF alpha gene-silencing siRNAs	Inflammatory diseases	.	.
DIB014075	L-368899	Miscarriage	.	O03
DIB014076	TZP-201	Diarrhea	.	A09,K59.1
DIB014077	Bcl gene inhibitor	Cancer	140-229	C00-C96
DIB014078	Ad35-GRIN/ENV	HIV infections	42	B20
DIB014079	Oxo-HT	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB014080	SERM program	Hot flashes	.	N95.1
DIB014081	BACE-1 inhibitors	Alzheimer's disease	331	G30
DIB014082	Ioforminol	Pulmonary embolism	.	I26.9
DIB014083	PP-200	Cancer	140-229	C00-C96
DIB014084	LT-1945	Graft-versus host disease	.	T86.0
DIB014085	JTT-551	Diabetes mellitus type 2	.	E11
DIB014086	Ecallantide	Retinal venous occlusion	.	H34.8
DIB014087	GI-248573	Bladder disease	.	N30-N32
DIB014088	Arilvax	Yellow fever virus infection	.	A95
DIB014089	Z-521	Hypophosphatemia	.	E83.31
DIB014090	ETX-1153a	MRSA infection	.	B95.62
DIB014091	SoRI-9409	Alcohol use disorders	.	F10
DIB014092	PF-05161704	Non-insulin dependent diabetes	.	E11.9
DIB014093	Ruthenium-based complexes	Cancer	140-229	C00-C96
DIB014094	IN-N01	Brain injury	.	S09.90
DIB014095	Pelubiprofen	Back pain	724.5,338,780	M54, G89, R52
DIB014096	HYG-114	Discovery agent	.	.
DIB014097	Metformin glycinate	Diabetes mellitus type 2	.	E11
DIB014098	Diphtheria-tetanus-pertussis vaccine	Bordetella pertussis infection	.	A37.0
DIB014099	XmAb-7195	Asthma	493	J45
DIB014100	HIV-IG	HIV infections	42	B20
DIB014101	TRC-8XXX series	Non-insulin dependent diabetes	.	E11.9
DIB014102	XR-774	Cancer	.	C00-C97
DIB014103	F11R inhibitors	Cardiovascular disease	390-459	I00-I99
DIB014104	Latanoprost sustained released	Glaucoma	365	H40-H42
DIB014105	Paclitaxel	Cancer	140-229	C00-C96
DIB014106	ALAMIFOVIR	Viral infections	042-075	A80-A99, B00-B34
DIB014107	NK-102	Diabetes mellitus	250	E08-E13
DIB014108	NCX-1067	Discovery agent	.	.
DIB014109	RG7842	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014110	Triple action antibiotic	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014111	Recombinant human vascular growth factor modulators	Wound healing	.	S91.3
DIB014112	ROCK inhibitors	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB014113	CLR-1404 (fluorescent analogs)	Cancer	140-229	C00-C96
DIB014114	Influenza DNA vaccine	Influenza virus infections	487	J10, J11
DIB014115	MP-0260	Ocular disease	.	H00-H59
DIB014116	Chimeric monoclonal antibody	Rheumatold arthritis	714	M05-M06
DIB014117	Obizur	Haemophilia A	286	D66
DIB014118	NSAID prodrugs	Inflammatory diseases	.	.
DIB014119	Anti-IFN gamma	Alopecia	.	L65.9
DIB014120	HRC-302	Chronic myelogenous leukemia	205.1	C92.1
DIB014121	Phosphorylcholine-targeted antibodies	Cardiovascular disease	390-459	I00-I99
DIB014122	CR-5542 series	Anxiety disorder	300	F40-F42
DIB014123	RG-4934	Arthritis	710-719	M00-M25
DIB014124	GMI-1271	Acute myeloid leukemia	205	C92.0
DIB014125	AM-3005	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014126	Adva-27a	Cancer	140-229	C00-C96
DIB014127	Mesenchymal bone marrow-derived stem cell therapy	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB014128	BIBS-39	Hypertension	401	I10, I11, I12, I13, I15
DIB014129	A-69024	Psychotic disorders	.	F20-F29
DIB014130	PF-4427429	Migraine	346	G43
DIB014131	KDM-1001	Gastritis	.	K29.6
DIB014132	ASP-2905	Schizophrenia	295	F20
DIB014133	Tyrosine kinase inhibitors	Age related macular degeneration	.	H35.30
DIB014134	EDP-19	Brain cancer	191	C71
DIB014135	Sodium channel modulators	Neuropathic pain	338,780	R52, G89
DIB014136	Tumor-specific dendritic cell vaccines	Cancer	140-229	C00-C96
DIB014137	Dog peptide allergy desensitization agent	Allergy	995.3	T78.4
DIB014138	A2AR PAM program	Osteoarthritis	715	M15-M19, M47
DIB014139	SAR-156597	Pulmonary fibrosis	515, 516.3	J84.1
DIB014140	BMS-812204	Obesity	278	E66
DIB014141	Cidofovir derivatives	Viral infections	042-075	A80-A99, B00-B34
DIB014142	Palovarotene	Emphysema	492	J43
DIB014143	Second generation taxoids	Cancer	140-229	C00-C96
DIB014144	AGS-16M8FIAGS-16C3F	Kidney cancer	140-229	C00-C96
DIB014145	Eltenac	Arthritis	710-719	M00-M25
DIB014146	MT-2090	Rheumatold arthritis	714	M05-M06
DIB014147	PSMA BiTE antibody	Acne vulgaris	.	L70.0
DIB014148	PF-06372865	Chronic pain	338.2,780	R52.1-R52.2, G89
DIB014149	RS-79063	Prostate hyperplasia	.	N40
DIB014150	Pc4 (topical formulation	Psoriasis	.	L40
DIB014151	P31-Protein	Cancer	.	C00-C97
DIB014152	Anti-CD9 mAb	Stomach cancer	.	C16
DIB014153	DC/I540/KLH vaccine	Brain cancer	.	C71
DIB014154	RPI-MN	HIV infections	42	B20
DIB014155	CGEN-791	Melanoma	.	C43
DIB014156	Lu-AA34893	Anxiety disorder	.	F40-F42
DIB014157	Naturally derived compounds	Cancer	140-229	C00-C96
DIB014158	Trimegestone/ethinyl estradiol	Contraception	.	Z30
DIB014159	RAD-140	Osteoporosis	733	M80-M81
DIB014160	EXP-865	Dementia	290-294	F01-F07
DIB014161	IDN-6384	Cancer	140-229	C00-C96
DIB014162	PHA-568487	Cognitive impairment	.	F06.7
DIB014163	AZD-3241	Parkinson's disease	.	G20
DIB014164	PAI-1 inhibitors	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB014165	NDDP	Solid tumours	.	C00-C75,C7A,C7B
DIB014166	V1A F/U	Infertility	.	N46,N97.0
DIB014167	Alphamir	HIV infections	42	B20
DIB014168	T-66	Prostate tumor	185	C61
DIB014169	Dendritic cell/WT1 class I/II peptide vaccine	Biliary cancer	.	C22,C24
DIB014170	UR-8308	Asthma	493	J45
DIB014171	ITASETRON	Nausea	.	R11
DIB014172	Phosphate-binding agent	Hyperphosphatemia	.	E83
DIB014173	HG-1438	Cancer	140-229	C00-C96
DIB014174	Recruitin	Autoimmune diseases	279.4	D84.9, M35.9
DIB014175	RBBX-01	Cancer	.	C00-C97
DIB014176	Oxibendazole	Pediatric cancer	.	.
DIB014177	Neutralase	Angiogenesis disorder	.	I00-I99
DIB014178	OCM-8124	Breast cancer	174, 175, 217	C50, D24
DIB014179	TGF beta peptide antagonists	Diabetic foot ulcer	.	E08-E13
DIB014180	P-9808	Porphyria	277.1	E80.0-E80.2
DIB014181	TSK-204	Autoimmune diseases	279.4	D84.9, M35.9
DIB014182	QR-336	Radiation sickness	990	T66
DIB014183	GlycoPEGylated erythropoietin	Cancer	.	C00-C97
DIB014184	FluVac project	Influenza virus infections	487	J10, J11
DIB014185	IW-6118	Inflammatory diseases	.	.
DIB014186	AC-607	Ischemic heart diseases	.	I20-I25
DIB014187	VLTS-587	Lung cancer	.	C33-C34
DIB014188	BXL-1H5	Pain	338,780	R52, G89
DIB014189	FB 301	Hypersensitivity	.	T78.4
DIB014190	DWP-431	Bone development disorder	.	M89
DIB014191	Interleukin-1 alpha	Hematological disease	.	D50-D89
DIB014192	Amooranin	Autoimmune diseases	279.4	D84.9, M35.9
DIB014193	Apolipoprotein E-derived peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014194	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB014195	RGI-3010	Insulin dependent diabetes	.	E10
DIB014196	ALX-0625	Migraine	346	G43
DIB014197	OCO-1112	Hyperlipidemia	.	E78.5
DIB014198	SDZ-GLC-756	Glaucoma	.	H40-H42
DIB014199	Oxycyte	Traumatic brain injury	800, 801, 803, 804, 850-854	S06
DIB014200	WS-75624A	Cardiovascular disease	390-459	I00-I99
DIB014201	LY-293284	Anxiety disorder	300	F40-F42
DIB014202	RPK-438	Respiratory syncytial virus 	79.6	B97.4
DIB014203	Hygromycin derivatives	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014204	SRI-21009	Cancer	140-229	C00-C96
DIB014205	EG-013	Fetal growth restriction	.	P05.9
DIB014206	HER2/neu peptide vaccine	Breast cancer	174, 175, 217	C50, D24
DIB014207	C-202	Epilepsy	345	G40
DIB014208	ELP-10	Leukemia	208.9	C91-C95
DIB014209	Integrase binding inhibitors	HIV-1 infections	42	B20
DIB014210	Clopamide	Edema	.	R60.9
DIB014211	GPR119 follow-on compounds	Non-insulin dependent diabetes	.	E11.9
DIB014212	PF-4287881	Respiratory tract infections	460-519	J00-J99
DIB014213	PD-148817	Arteriosclerosis	.	I70
DIB014214	KML-001	Cancer	140-229	C00-C96
DIB014215	DTPw-HBV/Hib	Hepatitis B virus infection	.	B16
DIB014216	AKP-001	Inflammatory bowel disease	555, 556	K50, K51
DIB014217	PEGylated Omniferon	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB014218	DNA vaccine	Malaria	84	B50-B54
DIB014219	BAY-17-1998	Asthma	.	J45
DIB014220	GC-1113	Anemia	280-285	D50-D64
DIB014221	GM-CAIX	Renal cancer	.	C64
DIB014222	IKH-02	Cancer	140-229	C00-C96
DIB014223	VAP-1 SSAO inhibitors	Diabetes mellitus	250	E08-E13
DIB014224	Puerarin	Alcohol use disorders	303	F10.2
DIB014225	HC-030031	Inflammatory diseases	.	.
DIB014226	Sinbaro	Osteoarthritis	715	M15-M19, M47
DIB014227	MT-2221	Rheumatold arthritis	714	M05-M06
DIB014228	PV-327	Leukemia	.	C91-C95
DIB014229	Elmustine	Cancer	140-229	C00-C96
DIB014230	IMP-701	Cancer	.	C00-C97
DIB014231	MPC-0920	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB014232	Tetracycline derivatives	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB014233	PTX-008	Cancer	140-229	C00-C96
DIB014234	XmAb-2513	Lymphoma	.	C81-C96
DIB014235	Lipoxin A4 analogs	Inflammatory bowel disease	555, 556	K50, K51
DIB014236	CDK2 inhibitors	Cancer	140-229	C00-C96
DIB014237	PRS-110	Cancer	140-229	C00-C96
DIB014238	Mab-338	Metapneumovirus infection	.	J12.3
DIB014239	FP-1201	Acute lung injury	518	J80
DIB014240	S-3304	Cancer	140-229	C00-C96
DIB014241	BBI-8000	Cancer	140-229	C00-C96
DIB014242	CXR-1002	Cancer	140-229	C00-C96
DIB014243	DPC-543	Alzheimer's disease	331	G30
DIB014244	Pridopidine	Huntington's disease	.	F02.2,G10
DIB014245	PF-06647263	Cancer	140-229	C00-C96
DIB014246	PP-1420	Obesity	278	E66
DIB014247	Innate defense regulators	Inflammatory diseases	.	.
DIB014248	Analgesic	Peripheral neuropathy	.	G64
DIB014249	ZK-153104	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB014250	AZD1772//RDX5791	Chronic kidney disease	.	N18
DIB014251	GRN-510	Pulmonary fibrosis	515, 516.3	J84.1
DIB014252	Polo-like kinase-1 inhibitors	Cancer	140-229	C00-C96
DIB014253	BE-22179	Leukaemia	.	C91-C95
DIB014254	Disorazol Z-LHRH conjugates	Ovarian cancer	.	C56
DIB014255	Orazamide orotate	Cancer	140-229	C00-C96
DIB014256	Hormonal therapy	Parkinson's disease	.	G20
DIB014257	Boron based antiparasitic compounds	Trypanosoma cruzi infection	.	B57.2
DIB014258	High ADCC anticancer mAb	Cancer	140-229	C00-C96
DIB014259	DnaA inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014260	Ferritarg P	Lymphoma	.	C81-C96
DIB014261	EGFRvIII CAR	Glioblastoma	.	C71
DIB014262	Tipredane	Allergy	995.3	T78.4
DIB014263	UC-84	HIV infections	42	B20
DIB014264	ACH-2684	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB014265	BL-1827	Cancer pain	338,780	R52, G89
DIB014266	Antimicrobials	Infectious disease	001-139	A00-B99
DIB014267	Helicase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014268	Trypanocidal compounds	Trypanosomiasis	086.5-086	B56-B57
DIB014269	PRT-060318	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB014270	Cancer immunotherapy adjuvant	Cancer	140-229	C00-C96
DIB014271	Ki-1769	Hypertension	.	I10-I15
DIB014272	Acetyl-CoA carboxylase-targeting compounds	Metabolic disorders	.	E70-E90
DIB014273	Viral entry blockers	Viral infections	042-075	A80-A99, B00-B34
DIB014274	Lorcainide	Heart arrhythmia	.	I47-I49
DIB014275	HIV vaccine	HIV infections	42	B20
DIB014276	Iodine-124-labeled F-16 scFv antibody	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014277	Vivia-007	Cancer	140-229	C00-C96
DIB014278	Glyminox	Sexually transmitted infection	.	A64
DIB014279	MT-062	Melanoma	172	C43
DIB014280	TG-3003	Cancer	140-229	C00-C96
DIB014281	GVAX Multiple	Multiple myeloma	.	C90.0
DIB014282	T-46.1	Pain	338,780	R52, G89
DIB014283	TJN-220	Hypertension	401	I10, I11, I12, I13, I15
DIB014284	Bromopride	Dyspepsia	536.8	K30
DIB014285	PSMA targeted ligands	Cancer	140-229	C00-C96
DIB014286	TA-GW	Papillomavirus infections	.	B97.7
DIB014287	ChronSeal	Fibrosis	.	L90.5
DIB014288	Glycan G-family glycogene 8 inhibitors	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB014289	Antibody therapeutics	Cancer	140-229	C00-C96
DIB014290	HSP-990	Cancer	140-229	C00-C96
DIB014291	R-IFN-1a	Hepatitis C virus infection	.	B17.1,B18.2
DIB014292	S100A9-targeting quinoline compounds	Immune disorder	.	D80-D89
DIB014293	ISV-102	Ocular infection	.	H00-H59
DIB014294	Meningococcal C/CRM-197 conjugate vaccine	Neisseria meningitidis infection	.	A87
DIB014295	AZD-2423	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB014296	D2A21	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB014297	Iopentol	Urinary tract disease	.	N00-N99
DIB014298	RGH-2721	Psychotic disorders	.	F20-F29
DIB014299	DHP-218	Hypertension	401	I10, I11, I12, I13, I15
DIB014300	EHT-899	Hepatitis B virus infection	.	B16
DIB014301	DPC-168	Allergic rhinitis	.	J30
DIB014302	Anti-miR-182 antisense oligonucleotides	Metastasis	.	C00-C97
DIB014303	ERR modulators	Breast cancer	174, 175, 217	C50, D24
DIB014304	Imitrodast	Asthma	.	J45
DIB014305	TPM-001	Peritoneal cancer	.	C48.1-C48.2
DIB014306	WIN-68577	Arthritis	.	M00-M25
DIB014307	Dual PI3K-alpha/mTOR inhibitors	Cancer	140-229	C00-C96
DIB014308	3,5-diiodothyropropionic acid	Congestive heart failure	428	I50
DIB014309	Jak2 kinase inhibitors	Leukemia	.	C91-C95
DIB014310	KA-40X	Cancer	140-229	C00-C96
DIB014311	Pirprofen	Dysmenorrhea	.	N94.4-N94.6
DIB014312	NB-506	Solid tumours	.	C00-C75,C7A,C7B
DIB014313	Rizatriptan oral film	Migraine	346	G43
DIB014314	L-786392	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014315	Malaria vaccine	Plasmodium infection	.	B54
DIB014316	DT-1687	Neurological disease	.	G00-G99
DIB014317	Octagam	Immune disorder	.	D80-D89
DIB014318	Cal-1	HIV-1 infections	42	B20
DIB014319	Flucelvax	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DIB014320	AT-006	Cancer	140-229	C00-C96
DIB014321	WF-2421	Diabetes mellitus	.	E10-E14
DIB014322	KLH-2109	Endometriosis	.	N80
DIB014323	DVC1-0101	Arteriosclerosis	.	I70
DIB014324	Anatumomab mafenatox	Breast cancer	.	C50
DIB014325	ATR-101	Malignant adrenal gland cancer	.	C74.0
DIB014326	X-linked retinoschisis gene therapy	Retinoschisis	.	H33.1
DIB014327	UR-13870	Autoimmune diseases	279.4	D84.9, M35.9
DIB014328	SPVF-2801-10	Cancer	140-229	C00-C96
DIB014329	HSR-113	Vomiting and nausea	787, 787.0	R11
DIB014330	3,5-diiodothyropropionic acid (Allan-Herndon-Dudley syndrome), Zarion Pharmaceuticals	Cardiovascular disease	.	I00-I99
DIB014331	A-79296	Herpes simplex virus infection	.	A60,B00
DIB014332	Wound healing program	Wound healing	.	S91.3
DIB014333	CVBT-141H	Coronary artery disease	.	I20-I25
DIB014334	ShigamAbs	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014335	Fus-1 tumor suppressor gene therapy - nanoparticle formulation	Non-small-cell lung carcinoma	162	C33, C34
DIB014336	HPH-116	Human immunodeficiency virus infection	.	B20
DIB014337	Flutrimazole	Fungal infection	.	B35-B49
DIB014338	GABA-A a5 agonists	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB014339	PD-117558	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014340	S-8921	Hyperlipidemia	.	E78.5
DIB014341	Hepatitis E virus vaccine	Hepatitis E virus infection	.	B17.2
DIB014342	EPB-415	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB014343	VIP agonists	Cancer	140-229	C00-C96
DIB014344	Cytomegalovirus vaccine	Cytomegalovirus infection	.	B25
DIB014345	Gemvac	Melanoma	.	C43
DIB014346	Plant-based oncology candidate	Breast cancer	174, 175	C50
DIB014347	L-693612	Glaucoma	.	H40-H42
DIB014348	HIV-1 integrase inhibitors	HIV infections	42	B20
DIB014349	Anti-TNF mAb	Discovery agent	.	.
DIB014350	GW-766994	Asthma	.	J45
DIB014351	Amphetamine	Attention deficit hyperactivity disorder	314	F90
DIB014352	ADC-9971	Allergic rhinitis	477	J30
DIB014353	TRI-1144	HIV infections	42	B20
DIB014354	PDE4 inhibitors	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB014355	GX-H9	Dwarfism	.	E23.0,E34.2,E45.0,Q77.4
DIB014356	ANA-5	Alzheimer's disease	331	G30
DIB014357	JAK-STAT inhibitors	Cancer	140-229	C00-C96
DIB014358	PF-2400013	Schizophrenia	295	F20
DIB014359	PAUF antibody	Pancreatic cancer	.	C25
DIB014360	P40 inhibitor	Psoriasis	696	L40
DIB014361	TDI-0057	Motor neurone disease	335.2	G12.2
DIB014362	XP-21279	Parkinson's disease	332	F02.3, G20
DIB014363	PF-06412562	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB014364	REGN-910	Solid tumours	.	C00-C75,C7A,C7B
DIB014365	Doxorubicin-hemoglobin conjugate	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB014366	CiPSC therapy	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB014367	Promostem	Cancer	.	C00-C97
DIB014368	Sch-57790	Alzheimer's disease	.	G30,F00
DIB014369	DM-99	Alzheimer's disease	.	G30,F00
DIB014370	Tetracycline derivatives	Inflammatory bowel disease	555, 556	K50, K51
DIB014371	KW-7158	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB014372	TG-1031	Breast cancer	.	C50
DIB014373	Methocarbamol	Musculoskeletal disease	.	M00-M99
DIB014374	IL-18 receptor modulator	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB014375	CWF-0804	Alzheimer's disease	331	G30
DIB014376	MTL-104	Cancer	140-229	C00-C96
DIB014377	IMAB-468	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014378	EMD-56133	Hypertension	401	I10, I11, I12, I13, I15
DIB014379	AC-253	Hypertension	.	I10-I15
DIB014380	AZX-100	Asthma	493	J45
DIB014381	IDR-90104	Male sexual disorders	.	F52
DIB014382	CP-601927	Gastrointestinal disease	.	K00-K93
DIB014383	LFn-p24-B-C	HIV infections	.	B20
DIB014384	Small molecule compounds	Sarcopenia	.	M62.9
DIB014385	LAS-31727	Migraine	346	G43
DIB014386	BTI320	Type 2 diabetes	250.00, 250.02	E11
DIB014387	Vaccine	Allergy	995.3	T78.4
DIB014388	Recombinant B-cell peptide vaccine	Allergy	995.3	T78.4
DIB014389	VP35A gene-targeting siRNA therapeutic	Ebola virus infection	.	A98
DIB014390	GLP-1 peptides	Diabetes mellitus	250	E08-E13
DIB014391	Z-4105	Alzheimer's disease	331	G30
DIB014392	PNU-96391A	Substance dependence	.	F10-F19
DIB014393	Neuronal nicotinic receptor agonists	Nicotine dependence	305.1	F17
DIB014394	CYC-101 program	Cancer	140-229	C00-C96
DIB014395	RU-59863	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014396	Zinc-based therapy	Infectious disease	001-139	A00-B99
DIB014397	XOMA-629	Acne vulgaris	.	L70.0
DIB014398	Autologous dendritic cell vaccines	Cancer	140-229	C00-C96
DIB014399	K-MAP	Cancer	140-229	C00-C96
DIB014400	Iodoamiloride	Cystic fibrosis	277	E84
DIB014401	PTI-303	Discovery agent	.	.
DIB014402	CAL-301	Klebsiella pneumoniae infection	.	B96.1
DIB014403	Sodium salicylate	Pain	338,780	R52, G89
DIB014404	Sharon-5000	MRSA infection	.	B95.62
DIB014405	CEREBROCRAST	Nerve injury	.	T14.4
DIB014406	Cytoporins	Fungal infection	.	B35-B49
DIB014407	SIM-6080	Angina	.	I20
DIB014408	Pemedolac	Pain	338	R52
DIB014409	Cx-501	Skin infections	680-709	L00-L99
DIB014410	Human serum albumin	Anemia	.	D50-D64
DIB014411	Peptide TNF antagonist	Arthritis	710-719	M00-M25
DIB014412	Avian H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB014413	AGI-350	Pulmonary disease	460-519	J00-J99
DIB014414	Long-acting IL-11 analog	Radiation sickness	990	T66
DIB014415	AVAC	Asthma; Atopic dermatitis	493, 691.8, 692.9	J45, L20, L20-L30
DIB014416	RB-105	Hypertension	.	I10-I15
DIB014417	Pifithrin compounds	Toxicity	.	T36-T50,T51-T65
DIB014418	Telomerase-targeted adenoviral suicide gene therapy	Cancer	140-229	C00-C96
DIB014419	S-PRAnt	Uterine leiomyoma	.	D25
DIB014420	Anti-hTfR IgG3-Av	Cancer	140-229	C00-C96
DIB014421	KDO8-P synthase inhibitors	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014422	PF-4418948	Endometriosis	617	N80
DIB014423	ReN-001	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB014424	CBI-006	Cancer	140-229	C00-C96
DIB014425	NE-28345	Pain	.	G89
DIB014426	REP-9AC	Hepatitis B virus infection	.	B16
DIB014427	ACAT inhibitor	Acne vulgaris	.	L70.0
DIB014428	Chanllergen	Allergy	995.3	T78.4
DIB014429	Angiogenesis inhibitors	Cancer	140-229	C00-C96
DIB014430	BDNA-001	Hepatitis B virus infection	.	B16
DIB014431	Claritin/Singulair	Allergic rhinitis	.	J30
DIB014432	PPAR modulators	Arteriosclerosis	.	I70
DIB014433	DuP-654	Pruritus	.	L29
DIB014434	Recombinant human stem cell factor	Anemia	280-285	D50-D64
DIB014435	MDRTB diagnostic program	Mycobacterium tuberculosis infection	.	A15-A19
DIB014436	Trunkamide	Cancer	140-229	C00-C96
DIB014437	E-0611	Keratosis	.	L57.0
DIB014438	KY-62	Leishmania donovani infection	.	B55.0
DIB014439	Functional peptides	Wound healing	.	S91.3
DIB014440	Anticancer etherlipid prodrugs	Cancer	140-229	C00-C96
DIB014441	TNF receptor	Endotoxic shock	.	R57.8
DIB014442	LaViv	Multiple sclerosis	.	G35
DIB014443	PN-951	Hematological disease	.	D50-D89
DIB014444	Desmoglein-3 antibodies	Cancer	140-229	C00-C96
DIB014445	Aspergillus vaccine	Aspergillus infection	.	B44.9
DIB014446	TNF-alpha production inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB014447	FLUINHIBIT	Influenza virus infections	487	J10, J11
DIB014448	Hsp90 inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB014449	Cat hair allergen extract	Allergy	995.3	T78.4
DIB014450	ARTELINIC ACID	Malaria	.	B50-B54
DIB014451	ALN-TTR02	Amyloidosis	.	E85
DIB014452	ORM-12741	Alzheimer's disease	.	G30,F00
DIB014453	ER-21036	Hypercholesterolemia	272	E78.0
DIB014454	CLT-010	Cancer	.	C00-C97
DIB014455	GPR 119 agonists	Non-insulin dependent diabetes	.	E11.9
DIB014456	RP-3000	Gastroesophageal reflux disease	.	K21
DIB014457	Telotristat ethyl	Carcinoid syndrome	.	E34.0
DIB014458	Aerugen	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB014459	ORG-9273	Paralysis	.	G72.3
DIB014460	Promegapoietin	Bone marrow transplantation	.	T86
DIB014461	ACAM-Cdiff)Toxoid vaccine)	Clostridium difficile infection	8.45	A04.7
DIB014462	SKL-NP2	Neuropathic pain	338,780	R52, G89
DIB014463	Barusiban	Androgen decline	.	E20-E35
DIB014464	P53 stabilizers	Cancer	140-229	C00-C96
DIB014465	Ro-31-5140	Herpes simplex virus infection	54	B00
DIB014466	SB-219994	Diabetes mellitus	.	E10-E14
DIB014467	Live-attenuated vaccines	Parasitic infection	.	B89
DIB014468	VLTS-582	Esophagitis	.	K20
DIB014469	TRC-102 iv	Cancer	140-229	C00-C96
DIB014470	BIOVANCE	Wound healing	.	T14.0-T14.1
DIB014471	Human growth hormone	Discovery agent	.	.
DIB014472	GFC-003	Cancer	140-229	C00-C96
DIB014473	GX-C4	Autoimmune diseases	279.4	D84.9, M35.9
DIB014474	Tubulin antagonists	Cancer	140-229	C00-C96
DIB014475	AZD-4877	Acute myeloid leukemia	.	C92.0
DIB014476	AcALY-18	Immune disorder	.	D80-D89
DIB014477	ATI-355	Nerve injury	.	T14.4
DIB014478	NeurArrest	Multiple sclerosis	340	G35
DIB014479	ICX-PRO	Diabetic foot ulcer	.	E08-E13
DIB014480	FST-200	Otitis externa	.	H60
DIB014481	NNC-26-0737	Growth hormone deficiency	.	E23.0
DIB014482	FK-613	Asthma	.	J45
DIB014483	Sch-49210	Cancer	140-229	C00-C96
DIB014484	NP-7557	Alzheimer's disease	.	G30,F00
DIB014485	MIP-1375	Prostate tumor	185	C61
DIB014486	Ad35	HIV-1 infections	42	B20
DIB014487	CGRP	Myocardial infarction	410	I21, I22
DIB014488	AP-5346	Head and neck cancer	.	C07-C14,C32-C33
DIB014489	BB IND-6989	Salmonella infection	.	A02.9
DIB014490	VTT-201	Prostate tumor	185	C61
DIB014491	Anti-EGFR humanized mAbs	Cancer	140-229	C00-C96
DIB014492	Protease inhibitors	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB014493	FHT-2107	Discovery agent	.	.
DIB014494	Cis-tetracosenoyl sulfatide	Motor neurone disease	335.2	G12.2
DIB014495	GHB-16L2	Influenza virus infections	487	J10, J11
DIB014496	Universal influenza vaccine	Influenza virus infections	487	J10, J11
DIB014497	MN-10026	Inflammatory diseases	.	.
DIB014498	Bilirubin oxidase	Hyperbilirubinemia	.	E80.6
DIB014499	ISF-120	Cancer	140-229	C00-C96
DIB014500	SpeB/SpeA fusion protein vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014501	KC-764	Platelet aggregatory	.	D69.1
DIB014502	H3 antagonists	Neurological disease	.	G00-G99
DIB014503	NewGam	Immune disorder	.	D80-D89
DIB014504	Vatreptacog alfa (activated)	Bleeding	.	R58
DIB014505	Chemopreventive	Lung cancer	162	C33-C34
DIB014506	SUN-E3001	Osteoporosis	733	M80-M81
DIB014507	SOM-0002	Cancer	140-229	C00-C96
DIB014508	Sulphur hexafluoride microbubble ultrasound agent	Cardiovascular disease	390-459	I00-I99
DIB014509	AM-211	Asthma	.	J45
DIB014510	Rozrolimupab	Anemia	.	D50-D64
DIB014511	Pertussis vaccine-2	Bordetella pertussis infection	.	A37.0
DIB014512	TECHNETIUM-99M-MRP20	Diagnosis	.	Y57.6
DIB014513	EDP-322	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB014514	Recombinant factor IX-Fc	Hemophilia B	.	D67
DIB014515	XP-23829	Multiple sclerosis	.	G35
DIB014516	RP-70676	Hyperlipidemia	.	E78.5
DIB014517	NP-103	Alzheimer's disease	331	G30
DIB014518	Vesicular stomatitis virus vector recombinant vaccine	Cancer	140-229	C00-C96
DIB014519	MOR-205	Cancer	140-229	C00-C96
DIB014520	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB014521	Nitroimidazoles	Mycobacterium tuberculosis infection	.	A15-A19
DIB014522	Resimmune	Melanoma	.	C43
DIB014523	CAL-401	Candida albicans infection	.	B37.0
DIB014524	PT	Autoimmune diseases	279.4	D84.9, M35.9
DIB014525	Amyl nitrite	Angina	413	I20
DIB014526	Carlumab	Pulmonary fibrosis	515, 516.3	J84.1
DIB014527	H2N2 live attenuated influenza vaccine	Influenza virus infections	487	J10, J11
DIB014528	DasKloster 0014-01	Cancer	.	C00-C97
DIB014529	PF-04475270	Glaucoma	365	H40-H42
DIB014530	CEL-021	Interstitial cystitis	.	N30.1
DIB014531	Small molecule heat shock H11 kinase activators	Ischemic heart diseases	410-414	I20-I25
DIB014532	AZD-9935	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014533	UPAR-lock	Cancer	.	C00-C97
DIB014534	HLIGHT therapy	Cancer	140-229	C00-C96
DIB014535	D-21805	Cancer	140-229	C00-C96
DIB014536	S-12968	Hypertension	401	I10, I11, I12, I13, I15
DIB014537	FBS-0701	Iron overload	.	R79.0
DIB014538	FSH	Infertility	.	N46,N97.0
DIB014539	Perbufylline	Hypertension	401	I10, I11, I12, I13, I15
DIB014540	Micacides	Viral infections	042-075	A80-A99, B00-B34
DIB014541	NPH-30907	Fungal infection	.	B35-B49
DIB014542	DAC-6152	Respiratory disease	.	J00-J99
DIB014543	MLN4760	Diabetes mellitus type 2	.	E11
DIB014544	TS-121	Depression	.	F20.4
DIB014545	JP-1201	Cancer	140-229	C00-C96
DIB014546	Rilopirox	Fungal infections	110-118	B35-B49
DIB014547	MCP-202	Overactive bladder disorder	596.51	N32.81
DIB014548	RIG-I adjuvant	Cancer	140-229	C00-C96
DIB014549	Selenotifen	Asthma	.	J45
DIB014550	Recombinant carbohydrate based vaccine adjuvants	Allergy	995.3	T78.4
DIB014551	Immunodrug vaccines (CCR5)	HIV infections	42	B20
DIB014552	Ceplene/Peg-Intron/Rebetol	Hepatitis C virus infection	.	B17.1,B18.2
DIB014553	Co-152791	Epilepsy	345	G40
DIB014554	Org-30029	Heart failure	.	I50
DIB014555	LAG-078	Lipid metabolism disorder	.	E75-E78
DIB014556	AS-1405	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014557	Anti-AGX-020 mAbs	Rheumatold arthritis	714	M05-M06
DIB014558	PfAMA-1	Plasmodium malariae infection	.	B50
DIB014559	KCO-912	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB014560	TRPM5 activators	Non-insulin dependent diabetes	.	E11.9
DIB014561	AR-7947	Non-insulin dependent diabetes	.	E11.9
DIB014562	Anticancer monoclonal antibodies	Cancer	140-229	C00-C96
DIB014563	D-20450	Inflammatory diseases	.	.
DIB014564	NVC-638	Conjunctivitis	372	H10
DIB014565	Yellow fever vaccine	Yellow fever virus infection	.	A95
DIB014566	YC-12	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014567	Ebalzotan	Anxiety disorder	.	F40-F42
DIB014568	Berlafenone	Heart arrhythmia	.	I47-I49
DIB014569	Peptidomimetic N-cadherin antagonists	Cancer	140-229	C00-C96
DIB014570	HMR-2420	Alzheimer's disease	331	G30
DIB014571	S. epidermidis vaccine	Skin infections	680-709	L00-L99
DIB014572	QAP-642	Allergic rhinitis	477	J30
DIB014573	Exatecan	Solid tumours	.	C00-C75,C7A,C7B
DIB014574	Xenalipin	Hyperlipidemia	272.0-272.4	E78
DIB014575	Ad-IFN-alpha	Bladder cancer	188	C67
DIB014576	Encapsulated cancer cells	Cancer	.	C00-C97
DIB014577	PPAR delta agonists	Atherosclerosis	414.0, 440	I70
DIB014578	GLP-1 agonist	Non-insulin dependent diabetes	.	E11.9
DIB014579	Manifaxine	Major depressive disorder	.	F32,F33
DIB014580	Adrenoleucodystrophy	Adrenoleukodystrophy	.	E71.529
DIB014581	Jak2 tyrosine inhibitors	Myeloproliferative disorder	.	D47.1
DIB014582	QGC-001	Hypertension	.	I10-I15
DIB014583	PKC-delta inhibitors	Cancer	140-229	C00-C96
DIB014584	Bispecific antobody	Insulin dependent diabetes	.	E10
DIB014585	APS-3010	Cancer	140-229	C00-C96
DIB014586	AR-H047108	Duodenal ulcer	.	K25-K27
DIB014587	LymPro	Alzheimer's disease	331	G30
DIB014588	Hepsin inhibitors	Prostate tumor	185	C61
DIB014589	Homspera	Influenza virus infections	487	J10, J11
DIB014590	Enzyme inhibitors	Cardiovascular disease	390-459	I00-I99
DIB014591	R-87366	Human immunodeficiency virus infection	.	B20
DIB014592	Neuropeptide Y receptor subtype Y5 antagonists	Major depressive disorder	296.2, 296.3	F32, F33
DIB014593	CDRI-93/478	Hypertension	401	I10, I11, I12, I13, I15
DIB014594	CB-1267	Prostate cancer	.	C61
DIB014595	Anticancer therapeutics	Cancer	140-229	C00-C96
DIB014596	Aurora kinase inhibitors	Cancer	140-229	C00-C96
DIB014597	SOM-0009	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB014598	TNF-alpha inhibitors	Inflammatory diseases	.	.
DIB014599	BMS-183729	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB014600	Protein kinase inhibitors	Cancer	140-229	C00-C96
DIB014601	GBT-009	Scar conditions; Skin fibrosis	.	L90.5
DIB014602	Ad5-NOS gene therapy	Myocardial infarction	410	I21, I22
DIB014603	FurA inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB014604	Adenoviral methioninase gene therapy/selenomethionine GDEPT	Cancer	140-229	C00-C96
DIB014605	TDI-0060	Motor neurone disease	335.2	G12.2
DIB014606	GC-003	Neutropenia	.	D70
DIB014607	Clobutinol	Cough	786.2	R05
DIB014608	LEISH-F1	Leishmania infection	.	B55.0
DIB014609	Protein vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014610	NBI-18	Cerebrovascular disorders	.	I60-I69
DIB014611	PAT-SM4	Cancer	140-229	C00-C96
DIB014612	E-5065	Bacterial infections	.	Z16.23
DIB014613	PEG-Hb/HS	Shock	.	T79.4
DIB014614	Human embryonic stem cell-derived motor neuron progenitors	Neuromuscular disease	.	N31.9
DIB014615	Next-generation lipid-based agents	Cardiovascular disease	390-459	I00-I99
DIB014616	Interferon alpha	Cancer	.	C00-C97
DIB014617	VLI-27	Pancreatic cancer	.	C25
DIB014618	Affitope AD-01	Alzheimer's disease	.	G30,F00
DIB014619	Gene therapy	Head and neck cancer	140-149	C07-C14, C32-C33
DIB014620	DNA vaccine	Measles virus infection	.	B06.9
DIB014621	Bone healing therapy	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB014622	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB014623	MCP-1 inhibitors	Arteriosclerosis	.	I70
DIB014624	Hexyl	Radiation sickness	990	T66
DIB014625	GRASPA	Acute lymphoblastic leukemia	.	C91.0
DIB014626	CY-1748	Deep vein thrombosis	453.4	I80.2
DIB014627	FCE-22716	Hypertension	.	I10-I15
DIB014628	Second-generation cystic fibrosis transmembrane conductance regulator inhibitors	Diarrhea	.	A09,K59.1
DIB014629	LAS-30989	Septic shock	785.52	A41.9
DIB014630	Human monoclonal antibodies	Staphylococcus aureus infection	001-139	A00-B99
DIB014631	SC-599	Shigella dysenteriae infection	.	A03.9
DIB014632	SR-57227	Major depressive disorder	296.2, 296.3	F32, F33
DIB014633	OtiVax	Otitis media	.	H65-H67
DIB014634	MCT-465	Cancer	.	C00-C97
DIB014635	HL-142	Discovery agent	.	.
DIB014636	TRPV1 antagonists	Neuropathic pain	338,780	R52, G89
DIB014637	GPCR119 agonist	Cancer	.	C00-C97
DIB014638	Anti-vitamin B12 receptor expression siRNAs	Cancer	140-229	C00-C96
DIB014639	Prostaglandin D2 antagonists	Allergic rhinitis	477	J30
DIB014640	CBT-101	Glaucoma	365	H40-H42
DIB014641	VR647	Asthma	.	J45
DIB014642	Fluvirin A(H1N1)	Influenza virus infections	487	J10, J11
DIB014643	TA-5493	Inflammatory diseases	.	.
DIB014644	TEI-9874	Allergy	995.3	T78.4
DIB014645	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DIB014646	C3BS-GQR-1	Myocardial infarction	410	I21, I22
DIB014647	Theradigm-p53	Cancer	.	C00-C97
DIB014648	Cardiotoxin	Cancer	140-229	C00-C96
DIB014649	NBRI-16716a	Cancer	140-229	C00-C96
DIB014650	MyoDys	Duchenne muscular dystrophy	.	G71.0
DIB014651	Epaxal	Hepatitis A virus infection	.	B15.9
DIB014652	BiovaxlD	Cardiovascular disease	.	I51.6
DIB014653	Drug screening	Cardiovascular disease	390-459	I00-I99
DIB014654	Antibiotic combination	Staphylococcus aureus infection	001-139	A00-B99
DIB014655	JTK-652	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB014656	PGE2 synthesis inhibitors	Inflammatory diseases	.	.
DIB014657	Aurora kinase inhibitors	Cancer	140-229	C00-C96
DIB014658	FR-172357	Inflammatory diseases	.	.
DIB014659	TT-235	Miscarriage	.	O03
DIB014660	Lyn kinase inhibitors	Cancer	140-229	C00-C96
DIB014661	MDDR 150200	Glaucoma	365	H40-H42
DIB014662	NFTB-104	Cardiovascular disease	390-459	I00-I99
DIB014663	CKBP-004	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014664	Youerjian	Hantavirus infection	.	B33.4
DIB014665	CHT-25	Hodgkin's lymphoma	.	C81
DIB014666	Odelepran	Alcohol use disorders	303	F10.2
DIB014667	Timothy grass extract	Allergic rhinitis	477	J30
DIB014668	SK-NBP601	Hemophilia	286	D66-D68
DIB014669	Intratect	Immune disorder	.	D80-D89
DIB014670	IPI-926	Chondrosarcoma	170.9	C41.9
DIB014671	HTI-101	Obesity	.	E66
DIB014672	MGN-2677	Restenosis	.	I51.89
DIB014673	Multimeric cell-binding compounds	Cardiovascular disease	390-459	I00-I99
DIB014674	REP8839	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB014675	NNZ-4921	Multiple sclerosis	340	G35
DIB014676	BAMAQUIMAST	Asthma	.	J45
DIB014677	M87o	HIV infections	42	B20
DIB014678	Bacteriophage	Mycobacterium tuberculosis infection	.	A15-A19
DIB014679	IFN-alpha	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB014680	Pexelizumab	Cardiovascular disease	.	I00-I99
DIB014681	CVA-21 DAF	Cancer	140-229	C00-C96
DIB014682	Immunomodulators	Inflammatory diseases	.	.
DIB014683	Parkinsons disease therapy	Parkinson's disease	.	G20
DIB014684	Meganucleases	Herpesvirus infection	.	B00
DIB014685	1-MNA	Hyperlipidemia	272.0-272.4	E78
DIB014686	CEQ-508	Familial adenomatous polyposis	.	C18,D12
DIB014687	Terutroban	Thrombosis	.	I80-I82
DIB014688	Endomorphins	Inflammatory diseases	.	.
DIB014689	Urological therapeutic	Prostate hyperplasia	.	N40
DIB014690	BIOO-3	Cancer	140-229	C00-C96
DIB014691	Irsogladine	Metastasis	.	C00-C97
DIB014692	Simplirix	Genital herpes	.	A60.09
DIB014693	Dopamine transporter modulator	Cocaine addiction	304.2	F14.2
DIB014694	CG7060	Prostate cancer	185	C61
DIB014695	AZD-5847	Mycobacterium tuberculosis infection	.	A15-A19
DIB014696	RQ-00310941	Irritable bowel syndrome	564.1	K58
DIB014697	GC-C agonists	Cardiovascular disease	390-459	I00-I99
DIB014698	Ro-07-3149	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014699	Concatameric LAG3Ig	Discovery agent	.	.
DIB014700	Nadifloxacin	Acne vulgaris	706.1	L70.0
DIB014701	ARX-424	Multiple sclerosis	340	G35
DIB014702	Testogen TDS	Hypogonadism	257.2	E23.0, E28.3, E29.1
DIB014703	MalariVax	Plasmodium infection	.	B54
DIB014704	BY-1949	Cognition disorders	.	F06.7
DIB014705	PK-236	Parkinson's disease	.	G20
DIB014706	CDNF/MANF	Parkinson's disease	.	G20
DIB014707	BMS-753951	Atherosclerosis	414.0, 440	I70
DIB014708	DA-727	Hypertension	401	I10, I11, I12, I13, I15
DIB014709	AHL	Hearing disorder	.	H90.5
DIB014710	IB-974	Fungal infection	.	B35-B49
DIB014711	Anti-LG842 antibody	Metabolic disorders	.	E70-E90
DIB014712	CAT-1920	Inflammatory bowel disease	555, 556	K50, K51
DIB014713	Anti-Ebola virus recombinant IgG monoclonal antibodies	Ebola virus infection	.	A98
DIB014714	Autosomal dominant retinitis pigmentosa	Retinitis pigmentosa	.	H35.5
DIB014715	UR-5908	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB014716	Angiotensin receptor blockers	Cardiovascular disease	390-459	I00-I99
DIB014717	Z-335	Thrombosis	.	I80-I82
DIB014718	KUR-024	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB014719	Hydralazine hydrochloride	Hypertension	401	I10, I11, I12, I13, I15
DIB014720	ALK inhibitors	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DIB014721	TMC-353121	Respiratory syncytial virus 	79.6	B97.4
DIB014722	Acne treatment	Acne vulgaris	706.1	L70.0
DIB014723	AERAS-407 rBCG	Mycobacterium tuberculosis infection	.	A15-A19
DIB014724	Anti-S aureus humanized monoclonal antibodies	Staphylococcus aureus infection	001-139	A00-B99
DIB014725	Opipramol	Anxiety disorder	300	F40-F42
DIB014726	RTU-1096	Atopic dermatitis	691.8	L20
DIB014727	Occlusin	Liver cancer	155	C22.0
DIB014728	Next generation live attenuated influenza virus vaccines	Influenza virus infections	487	J10, J11
DIB014729	Eligen insulin (oral)	Diabetes mellitus	250	E08-E13
DIB014730	IDP-113	Tinea pedis	.	B35.6
DIB014731	Analgesic/neuroprotective	Neurodegenerative diseases	.	G30-G32
DIB014732	NC-001	Nicotine dependence	305.1	F17
DIB014733	Sigma opioid antagonists	Drug dependence	303-304	F10.2-F19.2
DIB014734	A-75169	Glaucoma	365	H40-H42
DIB014735	SLP-1004	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014736	AP-1189	Atopic dermatitis	691.8	L20
DIB014737	PF-08	Attention deficit hyperactivity disorder	314	F90
DIB014738	KIN-4044	Non-small-cell lung cancer	162	C33, C34
DIB014739	NT-501	Ocular inflammation	.	H00-H59
DIB014740	Human embryonic stem cell-derived vascular progenitors	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014741	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB014742	Radiolabeled onartuzumab	Cancer	140-229	C00-C96
DIB014743	PHN-031	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DIB014744	RO-5323441	Solid tumours	.	C00-C75,C7A,C7B
DIB014745	TELUDIPINE HYDROCHLORIDE	Hypertension	.	I10-I15
DIB014746	ANG-3067	Fibrosis	709.2	L90.5
DIB014747	Indirab	Rabies virus infection	001-139	A00-B99
DIB014748	SC-42867	Pain	338,780	R52, G89
DIB014749	Benzothiazinones	Mycobacterium tuberculosis infection	.	A15-A19
DIB014750	NPC-16316	Epilepsy	.	G40
DIB014751	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB014752	H5N1 antigen liposomal vaccine	Influenza virus infections	487	J10, J11
DIB014753	CIGB-128	Basal cell cancer	.	C44
DIB014754	Microtubule polymerization-inhibiting thienopyrimidine derivatives	Cancer	140-229	C00-C96
DIB014755	Antibody therapeutic	Cancer	.	.
DIB014756	Polio IPV	Poliovirus infection	.	A80.9
DIB014757	Long-acting muscarinic M3 antagonists	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB014758	Lotilibcin dermatological cream	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014759	Benzimate	Cancer	.	C00-C97
DIB014760	Applied Genetic Gene therapy	Alpha-1 antitrypsin deficiency	273.4	E88.0
DIB014761	STI-001 program	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014762	RU-101	Xerophthalmia	.	E50.6-E50.7
DIB014763	KUR-CXCR4	Discovery agent	.	.
DIB014764	Merkel cell polyomavirus inhibitors	Cancer	140-229	C00-C96
DIB014765	Anti-amyloid beta monoclonal antibodies	Alzheimer's disease	331	G30
DIB014766	P-1101	Hepatitis B virus infection	.	B16
DIB014767	BIIB-033	Multiple sclerosis	.	G35
DIB014768	Reglixane	Diabetes mellitus	250	E08-E13
DIB014769	Cryptolepine	Non-insulin dependent diabetes	.	E11.9
DIB014770	EC-17	Renal cell carcinoma	189	C64
DIB014771	SDZ-224-015	Rheumatold arthritis	.	M05-M06
DIB014772	IGFR-1-targeting BiTE antibody	Cancer	140-229	C00-C96
DIB014773	TOCOTRIENOL	Hyperlipidemia	.	E78.5
DIB014774	MRC-375	Rheumatold arthritis	714	M05-M06
DIB014775	Factor VIIa therapy	Bleeding	.	R58
DIB014776	Doxorubicin-CEA conjugate	Breast cancer	174, 175, 217	C50, D24
DIB014777	Netivudine	Viral infections	042-075	A80-A99, B00-B34
DIB014778	PV-1019	Cancer	140-229	C00-C96
DIB014779	DA-1229	Diabetes mellitus type 2	.	E11
DIB014780	A35566-A	Cancer	140-229	C00-C96
DIB014781	C-21191	Anxiety disorder	300	F40-F42
DIB014782	Rotavirus vaccine	Type 2 diabetes	250.00, 250.02	E11
DIB014783	MB-12066	Obesity	278	E66
DIB014784	SLV-342	Atherosclerosis	414.0, 440	I70
DIB014785	BVS-212	Influenza virus infections	487	J10, J11
DIB014786	Glucosylceramide synthase inhibitor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014787	ALPRENOXIME HYDROCHLORIDE	Glaucoma	365	H40-H42
DIB014788	SER-100	Heart failure	.	I50
DIB014789	DCVax-Prostate	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB014790	GPR87 antagonists	Cancer	140-229	C00-C96
DIB014791	VRS-XXX	Discovery agent	.	.
DIB014792	NRT-300	Pain	338,780	R52, G89
DIB014793	Oligonucleotides	Cancer	140-229	C00-C96
DIB014794	NP-02	Heart disease	390-429	I00-I52
DIB014795	Ubiquitin E3 ligase pathway inhibitors	Cancer	140-229	C00-C96
DIB014796	Goxalapladib	Arteriosclerosis	.	I70
DIB014797	DS-1093	Anemia	.	D50-D64
DIB014798	A-76895	Epilepsy	345	G40
DIB014799	CLT-005	Angiogenesis disorder	.	I00-I99
DIB014800	MEDl-557	Respiratory syncytial virus 	.	B97.4
DIB014801	AZM-090	Diabetes mellitus	250	E08-E13
DIB014802	DNA vaccine	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DIB014803	Glycogen synthase kinase-3 beta inhibitor	Inflammatory diseases	.	.
DIB014804	DPC-684	Human immunodeficiency virus infection	.	B20
DIB014805	CS-712	Allergic rhinitis	477	J30
DIB014806	Acifran	Atherosclerosis	414.0, 440	I70
DIB014807	CPH-106	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB014808	Iralukast	Asthma	.	J45
DIB014809	FX-300	Inflammatory diseases	.	.
DIB014810	Oxytocin antagonists	Female sexual dysfunction	302.7	F52, R37
DIB014811	HBV vaccine	Hepatitis B virus infection	.	B16
DIB014812	Dithranol cream	Psoriasis	696	L40
DIB014813	Gp91phox transgene-encoded MFGS retrovirus vector gene therapy	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014814	MBX-400/cyclopropavir	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
DIB014815	Angiotensin II blockers	Influenza virus infections	487, 488	J10, J11
DIB014816	XIAP gene therapy	Huntington's disease	.	F02.2,G10
DIB014817	IMM-255	Influenza virus infections	487	J10, J11
DIB014818	Chk1/PARP-1 inhibitors	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014819	E-Matrix	Diabetic foot ulcer	.	E08-E13
DIB014820	RV-1088	Asthma	493	J45
DIB014821	LY-307853	Fungal infection	.	B35-B49
DIB014822	Brimonidine	Ocular hypertension	365.04	H40.0
DIB014823	JTT-552	Hyperuricemia	790.6	E79.0
DIB014824	Peptide program	Cancer	140-229	C00-C96
DIB014825	NXB-4221	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014826	AKB-9788	Edema	.	R60.9
DIB014827	CPC-201	Alzheimer's disease	331	G30
DIB014828	NG-049	Dyspepsia	536.8	K30
DIB014829	Anti-inflammatory antibody	Discovery agent	.	.
DIB014830	MX-781	Breast cancer	174, 175, 217	C50, D24
DIB014831	TDI-0098	Motor neurone disease	335.2	G12.2
DIB014832	PEG-VM-501	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
DIB014833	VR876	Diffuse large b-cell lymphoma	200	C83.3
DIB014834	Targeted secretion inhibitors	Cancer	140-229	C00-C96
DIB014835	EG-10	Inflammatory bowel disease	555, 556	K50, K51
DIB014836	SAR-161271	Diabetes mellitus type 1	.	E10
DIB014837	Monoclonal antibody-docetaxel prodrug	Cancer	.	C00-C97
DIB014838	ER-3826	Cardiovascular disease	.	I00-I99
DIB014839	Triamcinolone acetonide	Dermatitis	692.9	L20-L30
DIB014840	LLL-3348	Psoriasis	696	L40
DIB014841	IL-2 gene therapy	Melanoma	172	C43
DIB014842	Lidanserin	Hypertension	401	I10, I11, I12, I13, I15
DIB014843	SMT-C2100	Melanoma	172	C43
DIB014844	Cefuroxime axetil	Bronchitis	.	J20-J21,J42
DIB014845	PTI-320	Discovery agent	.	.
DIB014846	Finazosin	Prostate hyperplasia	.	N40
DIB014847	Albunex	Female infertility	628	N97.0
DIB014848	HGP-30W	HIV infections	42	B20
DIB014849	MRX-1	MRSA infection	41.12	A49.02
DIB014850	YPL-1101	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB014851	5-lipoxygenase inhibitors (CIP modulators), Galileo	Diabetes mellitus	.	E10-E14
DIB014852	MD-2009 program	Influenza virus infections	487	J10, J11
DIB014853	Galectin-3 inhibitors	Skin allergies	.	T78.4
DIB014854	TRIN-2755	Cancer	.	C00-C97
DIB014855	ADE-APTG	Wound healing	.	S91.3
DIB014856	Interferon beta	Breast cancer	174, 175, 217	C50, D24
DIB014857	SD-281	Inflammatory diseases	.	.
DIB014858	Metalfullerene	Alopecia	.	L65.9
DIB014859	Chlorphenesin	Fungal infection	.	B35-B49
DIB014860	SUPERVAX	Hepatitis B virus infection	.	B16
DIB014861	Deferitrin	Iron overload	.	R79.0
DIB014862	Small molecule FMS kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB014863	GX-301 program	Prostate tumor	185	C61
DIB014864	Necrosis inhibitors	Ischemia	459.89	I99.8
DIB014865	RO-48-6791	Anxiety disorder	300	F40-F42
DIB014866	Quadrivalent inactivated split virion vaccine	Influenza virus infections	487	J10, J11
DIB014867	LTX-315	Cancer	.	C00-C97
DIB014868	CGEN-25008	Cancer	140-229	C00-C96
DIB014869	ReN-003	Retinopathy	362.0-362.2	H35-H35.2
DIB014870	Mapp-66	HIV infections	42	B20
DIB014871	VRS-317	Growth hormone deficiency	.	E23.0
DIB014872	PHY-777	Cancer	140-229	C00-C96
DIB014873	MK-8666	Type 2 diabetes	250.00, 250.02	E11
DIB014874	AVI-7288	Marburg virus infection	.	A98.3
DIB014875	FM-501	Autoimmune diseases	279.4	D84.9, M35.9
DIB014876	Vepalimomab	Asthma	493	J45
DIB014877	E-5324	Hyperlipidemia	.	E78.5
DIB014878	ISIS-PKK	Hereditary angioedema	.	D84.1
DIB014879	EPO-derived peptide	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB014880	SPD602	Anemia	.	D50-D64
DIB014881	TEI-6122	Diabetes	250	E08-E13
DIB014882	Triplelastat	Kidney transplant rejection	.	T86
DIB014883	BAY1163877	Cancer	140-229	C00-C96
DIB014884	AVE-5883	Asthma	493	J45
DIB014885	CEP-37440	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB014886	Cyclosporine A	Ocular disease	.	H00-H59
DIB014887	Erythropoietin-transfected autologous cell therapy	Anemia	.	D50-D64
DIB014888	OS-390	Parkinson's disease	.	.
DIB014889	ADI	Liver cancer	155	C22.0
DIB014890	Fibroblast growth factor	Coronary artery disease	410-414, 429.2	I20-I25
DIB014891	99mTc-RP-527	Breast cancer	174, 175, 217	C50, D24
DIB014892	Inhibitor of mTOR/PI3 kinase	Cancer	.	C00-C97
DIB014893	OFA/iLRP-loaded autologous dendritic cell vaccine	HIV infections	42	B20
DIB014894	G protein beta gamma subunit inhibitors	Cardiac failure	.	I50
DIB014895	KY-382	Atherosclerosis	414.0, 440	I70
DIB014896	ProQuad	Varicella zoster virus infections	.	B01,B02
DIB014897	QX-147	Haemophilus influenzae infection	.	J11.1
DIB014898	Elongation factor 1 alpha inhibitors	Parasitic infection	.	B89
DIB014899	PPAR alpha agonists	Cardiovascular disease	390-459	I00-I99
DIB014900	PV-704	Osteoporosis	733	M80-M81
DIB014901	GDNF-producing adult stem cell therapy	Lateral sclerosis	.	G12.2
DIB014902	Telenzepine	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB014903	Bradykinin B1 receptor antagonists	Inflammatory diseases	.	.
DIB014904	AAD-2004	Alzheimer's disease	.	G30,F00
DIB014905	IG-MD-009	Cardiovascular disease	390-459	I00-I99
DIB014906	V-19	Blood clotting disorder	286	D65-D69
DIB014907	DGAT-1 inhibitors	Metabolic disorders	.	E70-E90
DIB014908	HGP-30	Acquired immune deficiency syndrome	.	B20
DIB014909	BRU-83-92	HIV-1 infections	42	B20
DIB014910	Anti-HER-2 mAb-FcgR2- FcgR4 fusion proteins	Cancer	140-229	C00-C96
DIB014911	MDX-1414	Cancer	140-229	C00-C96
DIB014912	TMX-30X	Autoimmune diseases	279.4	D84.9, M35.9
DIB014913	PharmaPEG-EPO	Hematological disease	.	D50-D89
DIB014914	MDX-1147	Prostate tumor	185	C61
DIB014915	SUN-13837	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB014916	CTL-203-targeted GDEPT CB-1954	Liver cancer	155	C22.0
DIB014917	Genz-668764	Plasmodium falciparum infection	.	B54
DIB014918	SOD1-targeting antibody	Motor neurone disease	335.2	G12.2
DIB014919	Haemophilus vaccine	Haemophilus influenzae infection	.	J11.1
DIB014920	Anti-midkine antibodies	Cancer	.	C00-C97
DIB014921	Anti-staphylococcus heteropolymer (HP) monoclonal antibody	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB014922	TG-B	Osteoporosis	733	M80-M81
DIB014923	DER-45-EV	Rosacea	.	L71
DIB014924	KUR-115	Spinal disease	.	G95.9
DIB014925	ZP-103	Metastasis	.	C00-C97
DIB014926	Debio 1347	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB014927	TENOSAL	Rheumatold arthritis	.	M05-M06
DIB014928	ATX-GD	Graves' disease	.	E05.0
DIB014929	Daporinad	Leukaemia	.	C91-C95
DIB014930	TgDCC-E1A	Breast cancer	174, 175, 217	C50, D24
DIB014931	Vaccine	Lyme disease	88.81	A69.2
DIB014932	PEGylated recombinant IFN beta 1b	Discovery agent	.	.
DIB014933	Vancomycin inhalation powder	Methicillin-resistant staphylococcus aureus	.	B95.62
DIB014934	GR-129083	Pain	338,780	R52, G89
DIB014935	CJC-1295	Cachexia	799.4	R64
DIB014936	Surrobodies	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014937	Iophendylate	Spinal cord injuries	952	S14, S24, S34
DIB014938	AFP-Scan	Liver cancer	155	C22.0
DIB014939	SK&F-95601	Peptic ulcer	.	K25-K27
DIB014940	TrkB modulators	Neurological disease	.	G00-G99
DIB014941	BMS-927711	Migraine	.	G43
DIB014942	BHH-0492	Discovery agent	.	.
DIB014943	AG-NCA805	Asthma	493	J45
DIB014944	PI3 Kinase and mTOR Inhibitor	Cancer	140-229	C00-C96
DIB014945	RG-12915	Nausea	.	R11
DIB014946	TGF-beta receptor 1 kinase inhibitors	Cancer	140-229	C00-C96
DIB014947	LBY-135	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB014948	Dipeptidyl peptidase IV modulators	Discovery agent	.	.
DIB014949	Sepsis program	Sepsis	995.91	A40, A41
DIB014950	IC-43	Rotavirus infections	.	A08.1
DIB014951	EPLIVANSERIN MESILATE	Anxiety disorder	.	F40-F42
DIB014952	SH-529	Peripheral vascular disease	443.9	I73.9
DIB014953	Breceptin	Cancer	.	C00-C97
DIB014954	Hepatitis B virus vaccine	Hepatitis B virus infection	.	B16
DIB014955	AMT-080	Duchenne dystrophy	.	G71.0
DIB014956	Tobramycin eye drop	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB014957	Growth hormone analogs	Growth disorder	.	E23.0
DIB014958	AZM-008	Arteriosclerosis	.	I70
DIB014959	PRB-6014	Lipid metabolism disorder	.	E75-E78
DIB014960	J-30	Cancer	140-229	C00-C96
DIB014961	AMT-2003	Hepatocellular carcinoma	155	C22.0
DIB014962	OCM-8055	Glioma	191	C71
DIB014963	VBY-106	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB014964	Redox metabolic modulators	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB014965	Stearoyl CoA desaturase-1 inhibitors	Obesity	278	E66
DIB014966	TAK-044	Renal failure	584, 585	N17, N18, N19
DIB014967	HSP-90 inhibitors	Cancer	140-229	C00-C96
DIB014968	Anti-Notch-3 receptor antibodies	Cancer	140-229	C00-C96
DIB014969	Polyphenol derivatives	Alzheimer's disease	331	G30
DIB014970	Macrolide antibacterials	Bacterial respiratory tract infection	.	J13,J15
DIB014971	Aloradine	Glioma	191	C71
DIB014972	Heat-killed Mycobacterium vaccae	Mycobacterium tuberculosis infection	.	A15-A19
DIB014973	AMG 333	Migraine	346	G43
DIB014974	HG-1078	Cancer	140-229	C00-C96
DIB014975	TRPM8 modulator	Cancer	.	C00-C97
DIB014976	Ro-48-8724	Multidrug resistant infection	.	A00-B99
DIB014977	Alpha-fetoprotein cancer vaccine	Hepatocellular carcinoma	155	C22.0
DIB014978	FARANOXI	Cancer	140-229	C00-C96
DIB014979	MBARC program	Alzheimer's disease	331	G30
DIB014980	P-979	Inflammatory diseases	.	.
DIB014981	CAB-2	Coronary artery disease	410-414, 429.2	I20-I25
DIB014982	Erythropoietin (EPO) conjugates	Anemia	280-285	D50-D64
DIB014983	XR-510	Hypertension	.	I10-I15
DIB014984	MK-0873	Psoriasis	696	L40
DIB014985	BL-1825	Parkinson's disease	.	G20
DIB014986	AVP-6	Prostate tumor	185	C61
DIB014987	RG-7256	Melanoma	172	C43
DIB014988	EM-2198	Diabetes mellitus	250	E08-E13
DIB014989	Antivirals	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB014990	Juvidex	Scar tissue	.	L80-L99
DIB014991	Anti-Claudin-4 monoclonal antibodies	Cancer	140-229	C00-C96
DIB014992	IDN-6439	Cancer	140-229	C00-C96
DIB014993	ABX-101	Cancer	140-229	C00-C96
DIB014994	BW-862C	Asthma	.	J45
DIB014995	TrkB negative allosteric modulators	Neurodegenerative diseases	.	G30-G32
DIB014996	NT-501 CNTF	Ovarian cancer	.	C56
DIB014997	Chloromethylpyrrolindolines	Cancer	140-229	C00-C96
DIB014998	MP-0210	Autoimmune diseases	279.4	D84.9, M35.9
DIB014999	Dexpanthenol	Wound healing	.	S91.3
DIB015000	SAR-339658	Inflammatory bowel disease	555, 556	K50, K51
DIB015001	ED-1812	Pain	338,780	R52, G89
DIB015002	Alanine racemase inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB015003	Nemorubicin	Solid tumours	.	C00-C75,C7A,C7B
DIB015004	227Th-rituximab (cancer), Algeta	Cancer	140-229	C00-C96
DIB015005	AM-365	Hepatitis B virus infection	.	B16
DIB015006	Universal influenza vaccine	Influenza virus infections	487	J10, J11
DIB015007	Lufironil	Liver cirrhosis	.	K70.3,K71.7,K74
DIB015008	Anti HER-3 antibodies	Cancer	140-229	C00-C96
DIB015009	AC-105	Spinal cord injuries	.	S24
DIB015010	Ridostin	Viral infections	042-075	A80-A99, B00-B34
DIB015011	Cadherin-11	Rheumatold arthritis	714	M05-M06
DIB015012	GPR120 agonists	Non-insulin dependent diabetes	.	E11.9
DIB015013	COL-172	Pain	.	G89
DIB015014	Linopirdine	Cognitive impairment	.	F06.7
DIB015015	Allergy therapies	Allergy	995.3	T78.4
DIB015016	Diphtheria-tetanus vaccine	Clostridium tetani infection	001-139	A00-B99
DIB015017	TTP-4000	Alzheimer's disease	.	G30,F00
DIB015018	Peptide therapy	Septic shock	785.52	A41.9
DIB015019	O6-Benzylguanine alkylade	Sarcoma	.	C00-C75
DIB015020	MGlu2 modulator	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB015021	Anticancer therapy	Cancer	140-229	C00-C96
DIB015022	HIV vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB015023	Endostatin	Cancer	.	C00-C97
DIB015024	VEGF-silencing siRNAs	Macular degeneration	.	H35.3
DIB015025	CRTh2 receptor antagonists	Allergy	995.3	T78.4
DIB015026	CAL-203	Respiratory syncytial virus 	79.6	B97.4
DIB015027	EUK-207	Neurodegenerative diseases	.	G30-G32
DIB015028	VXM-01	Cancer	140-229	C00-C96
DIB015029	Actyve hormone therapy	Infertility	.	N46,N97.0
DIB015030	Vaccine	Influenza virus infections	487	J10, J11
DIB015031	GSK3052230	Cancer	140-229	C00-C96
DIB015032	MDDR 217769	Arthritic	710-719	M00-M25
DIB015033	Iontophoretic acyclovir	Herpes simplex virus infection	.	A60,B00
DIB015034	FX-87L	Inflammatory diseases	.	.
DIB015035	CY-208243	Pain	.	G89
DIB015036	TG-N	Bone disease	.	M00-M99
DIB015037	CWF-07pre03	Diabetes mellitus	250	E08-E13
DIB015038	GT160-246	Diarrhea	.	A09,K59.1
DIB015039	Oncolym	Lymphoma	.	C81-C96
DIB015040	Propiverine	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB015041	Intranasal insulin	Diabetes mellitus	250	E08-E13
DIB015042	NI-0101	Autoimmune diseases	279.4	D84.9, M35.9
DIB015043	CP-67015	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015044	Zn-DPA-G	Glioma	191	C71
DIB015045	Dopamine D1 receptor positive allosteric modulators	Neurological disease	.	G00-G99
DIB015046	[131I]-BC8	Leukaemia	.	C91-C95
DIB015047	AE-M	Malignant melanoma	172	C43
DIB015048	HumaRESP	Respiratory syncytial virus 	79.6	B97.4
DIB015049	Chorismate synthase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015050	THA-904	Neuropathic pain	338,780	R52, G89
DIB015051	EQ-317	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015052	RSV/PIV-3 vaccine	Viral infections	042-075	A80-A99, B00-B34
DIB015053	RecAAT	Cystic fibrosis	.	E84
DIB015054	DNA vaccine	Cancer	.	C00-C97
DIB015055	Anticancer therapeutics	Cancer	140-229	C00-C96
DIB015056	UCB-0942	Epilepsy	345	G40
DIB015057	Tetanolic acid	Breast cancer	174, 175, 217	C50, D24
DIB015058	SLP-1001	Influenza virus infections	487	J10, J11
DIB015059	Levomequitazine	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DIB015060	BAY-15-2999	Heart disease	390-429	I00-I52
DIB015061	BTS-73947	Psychotic disorders	.	F20-F29
DIB015062	AB-0199-targeting monoclonal antibodies	Osteoporosis	733	M80-M81
DIB015063	CELIKALIM	Hypertension	401	I10, I11, I12, I13, I15
DIB015064	Valortim	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB015065	PA-1050040	HIV infections	42	B20
DIB015066	Panobacumab	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB015067	Tuberculosis vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB015068	403U76	Major depressive disorder	296.2, 296.3	F32, F33
DIB015069	Eterobarb	Seizures	.	G40,R56
DIB015070	Pagibaximab	Enterococcus faecalis infection	.	B95.2
DIB015071	Transferrin modulating apoptosis inducers	Cancer	140-229	C00-C96
DIB015072	KX-02	Brain cancer	.	C71
DIB015073	LC-1	Acute myeloid leukemia	.	C92.0
DIB015074	BMEC-1217B	Allergic rhinitis	477	J30
DIB015075	Diosmin	Hemorrhoids	.	I84
DIB015076	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB015077	Equine encephalitis virus vaccine	Eastern equine encephalitis virus infection	.	A83.2
DIB015078	NCTX	Cancer	.	C00-C97
DIB015079	CIGB-55	Rheumatold arthritis	714	M05-M06
DIB015080	ShRNA molecule silencing DNAPK radiosensitizer	Prostate tumor	185	C61
DIB015081	AVP-21D9	Bacillus anthracis infection	.	A22
DIB015082	LX-6171	Neurological disease	320-359	G00-G99
DIB015083	AFN-1720	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015084	Milacemide	Alzheimer's disease	.	G30,F00
DIB015085	AT-001	Cancer	140-229	C00-C96
DIB015086	Antibacterial agents	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015087	Hemin	Acute intermittent (hepatic) porphyria	.	E80.21
DIB015088	Oligonucleotides	Viral infections	042-075	A80-A99, B00-B34
DIB015089	APN-301	Melanoma	.	C43
DIB015090	GSK-2210875	Anxiety disorder	300	F40-F42
DIB015091	LPD-1050	Psoriasis	696	L40
DIB015092	EPB-500	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015093	ImmunoVEX-timelan	Melanoma	172	C43
DIB015094	A-93178	Allergy	.	T78.4
DIB015095	PDE 4 inhibitors	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB015096	Autologous renal cell carcinoma vaccine	Renal cell carcinoma	189	C64
DIB015097	LY-2228820	Cancer	140-229	C00-C96
DIB015098	E-1224	Fungal infection	.	B35-B49
DIB015099	NIP-520	Asthma	.	J45
DIB015100	APH-0812	HIV-1 infections	42	B20
DIB015101	ETEC vaccine	Escherichia coli infection	.	A00-B99
DIB015102	NADPH oxidase modulators	Inflammatory diseases	.	.
DIB015103	Ubiquitination pathway inhibitors	Cancer	.	C00-C97
DIB015104	Icotinib hydrochloride	Non-small-cell lung cancer	162	C33, C34
DIB015105	HIVAX-2	HIV infections	42	B20
DIB015106	Anti-PD-1 antibody	Cancer	.	C00-C97
DIB015107	Carbon monoxide	Cystic fibrosis	277	E84
DIB015108	NAL-GLU	Prostate cancer	185	C61
DIB015109	LYS-6KAKT1	Cancer	140-229	C00-C96
DIB015110	Coenzyme Q10 analog	Huntington's disease	.	F02.2,G10
DIB015111	EUR-1100	Eosinophilic esophagitis	.	K20.0
DIB015112	BK-PIFA	Influenza virus infections	487	J10, J11
DIB015113	MiRNA mimetics	Prostate tumor	185	C61
DIB015114	HL-1020	Rheumatold arthritis	714	M05-M06
DIB015115	EPI-A0001	Friedreich's ataxia	.	G11.1
DIB015116	F-98214	Major depressive disorder	296.2, 296.3	F32, F33
DIB015117	Transdermal compound	Discovery agent	.	.
DIB015118	SR-58894A	Gastrointestinal disease	.	K00-K93
DIB015119	ER-23006	Asthma	493	J45
DIB015120	Zaptuximab lentiviral gene therapy	Cancer	140-229	C00-C96
DIB015121	APC-200	Prostate tumor	185	C61
DIB015122	TP-9201	Thrombosis	.	I80-I82
DIB015123	LY-2189102	Cardiovascular disease	390-459	I00-I99
DIB015124	MNX-161	Asthma	493	J45
DIB015125	AZ-1297442	Pain	338,780	R52, G89
DIB015126	AP-006	Pulmonary disease	460-519	J00-J99
DIB015127	Adv-005	Lung cancer	162	C33-C34
DIB015128	Vancomycin	MRSA infection	.	B95.62
DIB015129	Lthisil	Viral infections	042-075	A80-A99, B00-B34
DIB015130	PLR-14	Rheumatold arthritis	714	M05-M06
DIB015131	CRM1 and nuclear export inhibitors	Cancer	140-229	C00-C96
DIB015132	KT2-962	Thrombosis	.	I80-I82
DIB015133	Iota-carrageenan	Influenza virus infections	487	J10, J11
DIB015134	CH-5132799	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015135	Recombinant adenovirus-poxvirus prime-boost malaria vaccine	Plasmodium malariae infection	.	B50
DIB015136	HL-157	Discovery agent	.	.
DIB015137	166Ho-phytate	Arthropathy	.	M00-M14
DIB015138	Picibanil	Carcinoma	.	D07.30
DIB015139	GCC-1290K	Parkinson's disease	.	G20
DIB015140	SWC-104	Fatigue	.	R53
DIB015141	Peptide therapeutics	Alzheimer's disease	331	G30
DIB015142	HV 1 modulators	Inflammatory diseases	.	.
DIB015143	Neurotrypsin inhibitors	Sarcopenia	.	M62.9
DIB015144	TGF-beta receptor 1 kinase inhibitor	Cancer	.	C00-C97
DIB015145	NS-696	Epilepsy	.	G40
DIB015146	Heparin	Deep vein thrombosis	.	I80.2
DIB015147	RG7342	Schizophrenia	295	F20
DIB015148	DUTPase inhibitors	Plasmodium falciparum infection	.	B54
DIB015149	DWP-10292	Retinitis pigmentosa	.	H35.5
DIB015150	GSK-2115160A	Influenza virus infections	487	J10, J11
DIB015151	Tilarginine acetate	Myocardial infarction	410	I21, I22
DIB015152	HuMV833	Cancer	140-229	C00-C96
DIB015153	SYN-1003	Pain	338,780	R52, G89
DIB015154	Omptin protease inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015155	CPHPC	Parkinson's disease	.	G20
DIB015156	Sodium lactate	Acidosis	.	E87.2
DIB015157	Toll-like receptor modulator	Autoimmune diseases	279.4	D84.9, M35.9
DIB015158	GGF-2	Heart failure	.	I50
DIB015159	RHAMLET	Cancer	140-229	C00-C96
DIB015160	AWD-12-281	Rhinitis	.	J00,J30,J31.0
DIB015161	CGEN-920	Inflammatory diseases	.	.
DIB015162	AVI-4020	Viral infections	042-075	A80-A99, B00-B34
DIB015163	Plasmodium falciparum LSA-NRC vaccine	Plasmodium falciparum infection	.	B54
DIB015164	OcuXan	Age related macular degeneration	.	H35.30
DIB015165	ACC2 project	Obesity	278	E66
DIB015166	CT-1166	Bone disease	.	M00-M99
DIB015167	LY-2510924	Renal cancer	.	C64
DIB015168	Antimalarials	Plasmodium falciparum infection	.	B54
DIB015169	ON-09300	Cancer	140-229	C00-C96
DIB015170	Prodarsan	Cockayne syndrome	.	Q87.1
DIB015171	PR-F-108C1	Inflammatory diseases	.	.
DIB015172	HIV vaccine	HIV infections	42	B20
DIB015173	ATD transdermal gel	Contraception	.	Z30
DIB015174	R-1453	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015175	Nucleotide analogs	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015176	Malaria vaccine	Plasmodium infection	.	B54
DIB015177	NOX-700	Diabetes mellitus type 2	250	E11
DIB015178	HyperGAM	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB015179	CTA-002	Cancer	140-229	C00-C96
DIB015180	HIVEC	HIV infections	42	B20
DIB015181	VVZ-149	Arthritis	710-719	M00-M25
DIB015182	VLP norovirus bivalent vaccine	Alzheimer's disease	.	G30,F00
DIB015183	MVA-85A	Mycobacterium tuberculosis infection	.	A15-A19
DIB015184	RQ-00202730	Inflammatory bowel disease	555, 556	K50, K51
DIB015185	Atherosclerosis therapy	Atherosclerosis	414.0, 440	I70
DIB015186	SEA-0400	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015187	LMV-601	Herpes simplex virus infection	.	A60,B00
DIB015188	SDZ-208911	Psychotic disorders	.	F20-F29
DIB015189	SB 418790	Diabetes mellitus type 2	.	E11
DIB015190	C5a receptor antagonists	Inflammatory diseases	.	.
DIB015191	CB-839	Leukemia	.	C91-C95
DIB015192	AE-298p	Cancer	.	C00-C97
DIB015193	Human interleukin-2	Renal cell carcinoma	189	C64
DIB015194	Telomerase inhibitors	Cancer	140-229	C00-C96
DIB015195	Gd contrast agents	Discovery agent	.	.
DIB015196	Compound A	Graft-versus host disease	.	T86.0
DIB015197	ACPC	Neurological disease	.	G00-G99
DIB015198	GS-326	Pancreatic cancer	.	C25
DIB015199	AIK11	Non-insulin dependent diabetes	.	E11.9
DIB015200	Dual 5-/15-lipoxygenase inhibitors	Diabetes mellitus	.	E10-E14
DIB015201	AWD-23-111	Heart arrhythmia	.	I47-I49
DIB015202	GTP-200	Cancer	.	C00-C97
DIB015203	IB-880	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015204	KT-3799	Carbacephem	.	.
DIB015205	PN-355	HIV-1 infections	42	B20
DIB015206	JAK1/JAK2 inhibitors	Pulmonary hypertension	416	I27.0, I27.2
DIB015207	EM-4232	Psoriasis	696	L40
DIB015208	HuM195/rGel	Leukaemia	.	C91-C95
DIB015209	Serelsa	Hematologic malignancies	.	C96.2
DIB015210	VEGFR-2 inhibitors	Cancer	140-229	C00-C96
DIB015211	Immunotoxin conjugate	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015212	Nuclear receptor agonists	Obesity	278	E66
DIB015213	SRSA-366	Neuropathic pain	338,780	R52, G89
DIB015214	TD-Pur	Diphtheria	.	A36
DIB015215	Autoimmune myocarditis vaccine	Myocarditis	.	I51.4
DIB015216	NRI-1013	Pain	338,780	R52, G89
DIB015217	Telomerase inhibitors	Cancer	140-229	C00-C96
DIB015218	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB015219	Mucosal HIV vaccine	HIV infections	42	B20
DIB015220	HCV vaccine program	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015221	Cdc25 phosphatase inhibitors	Cancer	140-229	C00-C96
DIB015222	PG-120	Autoimmune diseases	279.4	D84.9, M35.9
DIB015223	PW-2101	Angina	413	I20
DIB015224	Phenantramine analog	Plasmodium infection	.	B54
DIB015225	BrevaRex MAb	Multiple myeloma	203	C90.0
DIB015226	MEDI1841	Alzheimer's disease	.	G30,F00
DIB015227	WIN-64745	Asthma	.	J45
DIB015228	E-1455	Schizophrenia	295	F20
DIB015229	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB015230	Infanrix-DTaP-IPV-Hib	Bordetella pertussis infection	.	A37.0
DIB015231	IMP-321	Allergy	.	T78.4
DIB015232	GLPG-0634	Rheumatold arthritis	714	M05-M06
DIB015233	ToleriMab (anti-CD80/CD86)	Transplant rejection	.	T86
DIB015234	MS-1819	Exocrine pancreatic insufficiency	.	K86.8
DIB015235	PD-13201-2	Arteriosclerosis	.	I70
DIB015236	POL-7080	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015237	TPI-273	Cancer	140-229	C00-C96
DIB015238	[L/D]-aminopterin	Rheumatold arthritis	714	M05-M06
DIB015239	Immunotoxins	Parasitic infection	.	B89
DIB015240	THA-902 XL	Pain	338,780	R52, G89
DIB015241	HTRA-1 mAbs	Age related macular degeneration	.	H35.30
DIB015242	Telomerase inhibitors	Cancer	140-229	C00-C96
DIB015243	Y-23684	Anxiety disorder	300	F40-F42
DIB015244	DAC-060	Keratosis	.	L57.0
DIB015245	NTx-488	Multiple sclerosis	340	G35
DIB015246	VEN100	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015247	BM-32	Allergic rhinitis	477	J30
DIB015248	Conjugated low molecular weight heparin derivatives	Cancer	140-229	C00-C96
DIB015249	Garnocestim	Bone marrow transplantation	279.5, 996	D89.8, T86
DIB015250	Lu-AA47070	Parkinson's disease	332	F02.3, G20
DIB015251	CB-28	Aging skin	.	L00-L99
DIB015252	Diphtheria, tetanus, pertussis, polio vaccine	Bordetella pertussis infection	.	A37.0
DIB015253	H5N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB015254	LCB-2183	Asthma	.	J45
DIB015255	HIV vaccine	HIV infections	42	B20
DIB015256	Viagenpumatucel-L	Non-small-cell lung carcinoma	162	C33, C34
DIB015257	ORG-9453	Paralysis	.	G72.3
DIB015258	Anti-inflammation programs	Inflammatory diseases	.	.
DIB015259	TgAAG76	Blindness	.	H53.6
DIB015260	STP-206 live biotherapeutic	Enterocolitis	.	A04.7
DIB015261	Antifungal/antibacterial therapeutics	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015262	TA-6666	Diabetes mellitus type 2	.	E11
DIB015263	DeOvo	Pediculus capitis infestation	.	B85.0
DIB015264	HYG-201	Discovery agent	.	.
DIB015265	ELND-004	Autoimmune diseases	.	D84.9
DIB015266	NeuroCell-PD	Parkinson's disease	332	F02.3, G20
DIB015267	GAI-122	Liver disease	570-574	K70-K77
DIB015268	SND-159	Mycobacterium tuberculosis infection	.	A15-A19
DIB015269	BBB-022	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015270	RX-3117	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB015271	P38-alpha MAP kinase inhibitors	Inflammatory diseases	.	.
DIB015272	CR-4892 series	Pain	338,780	R52, G89
DIB015273	Polio vaccine	Poliovirus infection	.	A80.9
DIB015274	Oligonucleotides	Squamous cell carcinoma	199	C44
DIB015275	FI-6	Influenza virus infections	487	J10, J11
DIB015276	CLP-1004	Hypertension	.	I10-I15
DIB015277	DLX-0110	Neuropathic pain	338,780	R52, G89
DIB015278	PRX-12256	Neurological disease	.	G00-G99
DIB015279	Mutant B-Raf kinase inhibitors	Cancer	140-229	C00-C96
DIB015280	T-cell therapy	Cytomegalovirus infection	.	B25
DIB015281	XB-513	Cardiac failure	.	I50
DIB015282	Botulinum toxin vaccine	Yersinia infections	.	A04.6
DIB015283	GPR119 agonists	Non-insulin dependent diabetes	.	E11.9
DIB015284	ASIbcl vaccine	B-cell lymphoma	202.8	C85.1
DIB015285	Gedocarnil	Anxiety disorder	300	F40-F42
DIB015286	Leukemia therapy	Chronic myelogenous leukemia	205.1	C92.1
DIB015287	SNG-8006	Osteoporosis	733	M80-M81
DIB015288	Anticancer pro-soft drugs	Metastasis	.	C00-C97
DIB015289	Aglycoristocetin derivatives	Influenza virus infections	487	J10, J11
DIB015290	Trimetazidine	Angina	413	I20
DIB015291	Anti-CCR5 RNAi-transduced autologous hematopoietic stem cell therapy	HIV infections	42	B20
DIB015292	Hepatitis E virus vaccine	Hepatitis E virus infection	.	B17.2
DIB015293	Hemoglobin raffimer	Anemia	.	D50-D64
DIB015294	1954U89	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015295	TRPA1 antagonists	Pain	338,780	R52, G89
DIB015296	CCR2 modulators	Neuropathic pain	338,780	R52, G89
DIB015297	Gp75 DNA vaccine	Cancer	.	C00-C97
DIB015298	Recombinant factor VIII-Fc	Diarrhea	787.91	A09, K59.1
DIB015299	BILD-1351	Herpes simplex virus infection	.	A60,B00
DIB015300	TU-2100	Psoriasis	696	L40
DIB015301	Benalfocin	Hypertension	401	I10, I11, I12, I13, I15
DIB015302	Progestin	Female contraception	.	Z30.013
DIB015303	Next generation antibodies	Discovery agent	.	.
DIB015304	AGT-2000	Brain cancer	191	C71
DIB015305	CSL-654	Factor IX deficiency	.	D67
DIB015306	CG-200745	Cancer	140-229	C00-C96
DIB015307	SCY-078	Fungal infection	.	B35-B49
DIB015308	ALN-FLU01	Influenza virus infections	487	J10, J11
DIB015309	STA-5312	Cancer	140-229	C00-C96
DIB015310	AMX-213	Cachexia	799.4	R64
DIB015311	ABIO-05/01	Chronic myeloid leukemia	205.1	C92.1
DIB015312	N-methanocarbathymidine	Viral infections	042-075	A80-A99, B00-B34
DIB015313	DermaGraft	Diabetic complication	.	E08-E13
DIB015314	Nolatrexed	Solid tumours	.	C00-C75,C7A,C7B
DIB015315	CAP1-6D	Pancreatic cancer	.	C25
DIB015316	AS-1670542	Thrombocytopenic purpura	.	D69
DIB015317	Histone acetylase modulators	Cancer	140-229	C00-C96
DIB015318	Salirasib	Pancreatic cancer	157	C25
DIB015319	Simtuzumab	Colorectal cancer	153, 154	C18-C21
DIB015320	Beta-2 adrenergic receptor targeting mAbs	Respiratory disease	.	J00-J99
DIB015321	DAC-5889	Respiratory disease	.	J00-J99
DIB015322	Factor VIII plasmid DNA nanocapsules	Factor VIII deficiency	.	D66
DIB015323	ALX-0651	Hematological malignancies	200-209	C81-C96
DIB015324	ARX-8203 injectable	Pain	338,780	R52, G89
DIB015325	SD-102	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB015326	Carbonic anhydrase inhibitors	Glaucoma	.	H40-H42
DIB015327	Temanogrel	Cardiovascular disease	.	I00-I99
DIB015328	OBP-AI2	HIV infections	42	B20
DIB015329	NLP-61	Neurodegenerative diseases	.	G30-G32
DIB015330	Carbocisteine	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB015331	AG-1350	Human immunodeficiency virus infection	.	B20
DIB015332	VEGFR-2 inhibitors	Angiogenesis disorder	.	I00-I99
DIB015333	Flt3 tyrosine kinase inhibitors	Leukemia	208.9	C91-C95
DIB015334	99mTc-depreotide	Melanoma	.	C43
DIB015335	Synthetic TGF-beta ligands	Bone disease	.	M00-M99
DIB015336	OGX-225	Prostate tumor	185	C61
DIB015337	FCE-26605	Carcinoma	.	D07.30
DIB015338	R-65	Glaucoma	365	H40-H42
DIB015339	D-9120	Inflammatory bowel disease	555, 556	K50, K51
DIB015340	HCV-specific STAR fusions	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015341	TP-103	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015342	MOB-015	Onychomycosis	.	B35.1
DIB015343	Small molecule therapeutic	Rheumatold arthritis	714	M05-M06
DIB015344	NMS-E973	Cancer	140-229	C00-C96
DIB015345	ANA-504	Discovery agent	.	.
DIB015346	Caspase enhancer	Cancer	140-229	C00-C96
DIB015347	Proteus mirabilis vaccine	Prostate disease	.	N42.9
DIB015348	Split virion H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB015349	Monoclonal antibody	Graft-versus host disease	.	T86.0
DIB015350	MOL-2591	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB015351	OLANEXIDINE HYDROCHLORIDE	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015352	NNC-09-0026	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015353	MMP inhibitors	Cancer	.	C00-C97
DIB015354	Personalized recombinant protein vaccines	Leukemia	.	C91-C95
DIB015355	LAS-31334	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015356	Dopamine D1 agonist	Parkinson's disease	.	G20
DIB015357	CTA-001	Cancer	140-229	C00-C96
DIB015358	Lu-35138	Psychotic disorders	.	F20-F29
DIB015359	ZAP70 kinase inhibitors	Cancer	.	C00-C97
DIB015360	PD-151746	Brain injury	.	S06
DIB015361	Org-21465	Anesthesia	338	R52
DIB015362	123-iodine labeled exendin derivatives (imaging GLP-1 receptors, diabetes), Kyoto University/Arkray	Diabetes mellitus	250	E08-E13
DIB015363	Co-122739	Anxiety disorder	300	F40-F42
DIB015364	AZ-AAV9	Alzheimer's disease	331	G30
DIB015365	M-101	Blood transfusion	.	D50-D89
DIB015366	Arylimidamides	Leishmania infection	.	B55.0
DIB015367	RP-6000	Major depressive disorder	296.2, 296.3	F32, F33
DIB015368	Hookworm vaccine	Hookworm infection	.	B76.9
DIB015369	IT-121	Colorectal cancer	153, 154	C18-C21
DIB015370	RNase L activators	Viral infections	042-075	A80-A99, B00-B34
DIB015371	JDP-202	Hypertension	401	I10, I11, I12, I13, I15
DIB015372	Bacterial topoisomerase inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB015373	Listeria monocytogenes vaccine	Listeria monocytogenes infection	.	A32.9
DIB015374	Glaspimod	Hematopoietic	.	D50-D89
DIB015375	UCL-67022	Multiple myeloma	203	C90.0
DIB015376	SelG2	Sickle-cell disease	.	D57
DIB015377	PET imaging agent	Alzheimer's disease	331	G30
DIB015378	Meloxicam nano-formulation	Cancer	140-229	C00-C96
DIB015379	MD-920	Wound healing	.	S91.3
DIB015380	Stem cell therapy	Insulin dependent diabetes	.	E10
DIB015381	Nanobody therapeutics	Pulmonary disease	460-519	J00-J99
DIB015382	Armed Probodies	Glioblastoma	.	C71
DIB015383	Tisocalcitate	Psoriasis	.	L40
DIB015384	Quorum sensing blockers	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015385	IRX-03	Neutropenia	288	D70
DIB015386	NOP/opioid receptor ligands	Drug dependence	303-304	F10.2-F19.2
DIB015387	CGP-53437	Human immunodeficiency virus infection	.	B20
DIB015388	PF-4191834	Asthma	.	J45
DIB015389	NNC-0123-0000-0338	Diabetes mellitus	250	E08-E13
DIB015390	Galanin modulators	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB015391	XGP-120	Arthritis	710-719	M00-M25
DIB015392	WAS gene therapy	WiskottCAldrich syndrome	.	D82.0
DIB015393	DD-20207	Neuropathic pain	338,780	R52, G89
DIB015394	EFLETIRIZINE	Rhinitis	472.0, 477	J00, J30, J31.0
DIB015395	MK-4166	Solid tumours	.	C00-C75,C7A,C7B
DIB015396	BIK-381	Retinitis pigmentosa	.	H35.5
DIB015397	EP4 prostanoid receptor agonists	Osteoporosis	733	M80-M81
DIB015398	Thrombin inhibitors	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB015399	HER-2 vaccine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015400	AT-004	Cancer	.	C00-C97
DIB015401	4-azolyl retinoic acid analogs	Dermatological disease	.	L00-L99
DIB015402	ME-3738	Hepatitis virus infection	573.3	K75.9
DIB015403	R107474	Depression	311	F32
DIB015404	MMS-255	Multiple sclerosis	340	G35
DIB015405	Yersinia pestis DNA vaccine	Yersinia infections	.	A20
DIB015406	Small molecule therapeutics	Cancer	140-229	C00-C96
DIB015407	Glycan G-family glycogene 3 inhibitors	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB015408	IPL-423 series	Inflammatory diseases	.	.
DIB015409	AER-002	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB015410	GSK-2130579A	Acute myeloid leukemia	.	C92.0
DIB015411	MORAb-066	Pancreatic cancer	.	C25
DIB015412	MTL-003	Cancer	140-229	C00-C96
DIB015413	CCR3 antagonists	Asthma	493	J45
DIB015414	CreaVax-RA	Rheumatold arthritis	714	M05-M06
DIB015415	Finafloxacin	Urinary tract infections	.	N39.0
DIB015416	Syk inhibitor	Cancer	.	C00-C97
DIB015417	SGN-CD70A	Non-Hodgkin's lymphoma	.	C85.9
DIB015418	ALX-0646	Migraine	.	G43
DIB015419	Adeno virus based gene therapy	Pompe's disease	.	E74.02
DIB015420	AMP-579	Hyperlipidemia	.	E78.5
DIB015421	HCV protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015422	ELGODIPINE HYDROCHLORIDE	Angina	.	I20
DIB015423	BI-660848	Neuropathic pain	338,780	R52, G89
DIB015424	TJN-732	Diabetic complication	.	E08-E13
DIB015425	Photodynamic immunotherapy	Breast cancer	174, 175, 217	C50, D24
DIB015426	MT-503	Cancer	.	C00-C97
DIB015427	Darusentan	Hypotension	.	I95
DIB015428	LT biosynthesis inhibitors	Asthma	493	J45
DIB015429	Recombinant Factor IX series	Factor IX deficiency	.	D67
DIB015430	FAV-201	Lymphoma	202.8	C81-C96
DIB015431	Beta PKC inhibitors	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB015432	32-P BioSilicon	Liver cancer	155	C22.0
DIB015433	SMRX-11	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015434	CB2 agonists	Pain	.	G89
DIB015435	TAS-203	Respiratory tract inflammation	.	J00-J99
DIB015436	GDC-0853	Cancer	140-229	C00-C96
DIB015437	Lomab B	Acute myeloid leukemia	.	C92.0
DIB015438	ABC-4	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015439	Estrogen receptor beta agonist	Menopause	627.2	N95.0
DIB015440	Genimune	Autoimmune diseases	279.4	D84.9, M35.9
DIB015441	Calcium release operated calcium channels inhibitors	Respiratory tract inflammation	.	J00-J99
DIB015442	Human therapeutic antibodies	Cancer	.	C00-C97
DIB015443	Osteoporosis therapy	Osteoporosis	733	M80-M81
DIB015444	Small molecule program	Rheumatold arthritis	714	M05-M06
DIB015445	DPS-201	Atopic dermatitis	691.8	L20
DIB015446	BACE inhibitors	Alzheimer's disease	.	G30,F00
DIB015447	Ammonia	Coronary artery disease	.	I20-I25
DIB015448	M2e influenza vaccine	Influenza virus infections	487, 488	J10, J11
DIB015449	AChE peptide fragment	Alzheimer's disease	.	G30,F00
DIB015450	Parvovirus B19 vaccine	Parvovirus infections	.	B34.3
DIB015451	Pseudomonas aeruginosa protein vaccine	Pseudomonas aeruginosa infection	001-139	A00-B99
DIB015452	Anticancer stem cell therapeutics	Cancer	140-229	C00-C96
DIB015453	Vaccine	Japanese encephalitis virus infection	.	A83.0
DIB015454	PARP-1 inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015455	MGN-7455	Ischemic heart diseases	410-414	I20-I25
DIB015456	AZP-03	Metabolic disorders	.	E70-E90
DIB015457	ANA-975	Immuno-modulator	.	D80-D89
DIB015458	BOL-303259-X	Renal cancer	.	C64
DIB015459	NAB-001	Onychomycosis	.	B35.1
DIB015460	YM-099	Hypertension	401	I10, I11, I12, I13, I15
DIB015461	LA-480	Cancer	140-229	C00-C96
DIB015462	NX-CP105	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015463	Loratadine Lingual Spray	Allergic rhinitis	477	J30
DIB015464	NOX-151	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015465	HIV vaccines	HIV infections	42	B20
DIB015466	Protease inhibitors (tuberculosis infection	Mycobacterium tuberculosis infection	.	A15-A19
DIB015467	BRL-44154	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB015468	Sevelamer carbonate tablet	Hyperphosphatemia	.	E83
DIB015469	Gp41 HIV-1 vaccine	HIV infections	42	B20
DIB015470	Lanthanum polystyrene sulfonate	Hyperphosphatemia	.	E83
DIB015471	Pneumostem	Respiratory distress syndrome	518.5, 518.82	J80
DIB015472	FP-1069	Autoimmune diseases	279.4	D84.9, M35.9
DIB015473	CS-00028	Cancer	140-229	C00-C96
DIB015474	HIV gp140 protein/DNA vaccine	HIV infections	42	B20
DIB015475	VOFOPITANT HYDROCHLORIDE	Emesis	.	R11
DIB015476	SA-20896	Musculoskeletal disease	.	M00-M99
DIB015477	KTE-C19 CAR	Diffuse large B-cell lymphoma	200	C83.3
DIB015478	Therapeutic vaccine	MRSA infection	.	B95.62
DIB015479	Liposomal drug therapy	Bladder cancer	188	C67
DIB015480	MK-8655	Type 2 diabetes	250.00, 250.02	E11
DIB015481	INTERCEPT Blood System	Blood transfusion	.	D50-D89
DIB015482	KIN-4050 analogs	Melanoma	172	C43
DIB015483	Midismase	Cerebral infarction	.	I63
DIB015484	Complement inhibitors	Asthma	493	J45
DIB015485	Immunostimulating peptide vaccine	HIV infections	42	B20
DIB015486	SKF-103829	Gastrointestinal disease	.	K00-K93
DIB015487	SKF-101926	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
DIB015488	Next-generation ATHX-105 compounds	Obesity	278	E66
DIB015489	MDDR 162126	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DIB015490	Gene therapy	Heart disease	390-429	I00-I52
DIB015491	BVT.28949	Glaucoma	365	H40-H42
DIB015492	Glycerol phenylbutyrate	Hepatic encephalopathy	.	K72
DIB015493	PEGylated PYY-3-36	Metabolic disorders	.	E70-E90
DIB015494	CEQ-626	Inflammatory bowel disease	555, 556	K50, K51
DIB015495	ADX-71943	Gastroesophageal reflux disease	.	K21
DIB015496	WT1 peptide-based cancer vaccine	Cancer	140-229	C00-C96
DIB015497	IMT-1012 immunotherapeutic vaccine	Ovarian cancer	183	C56
DIB015498	DLX-521	Discovery agent	.	.
DIB015499	Meningococcal B vaccine	Neisseria meningitidis infection	.	A87
DIB015500	5-HT 6 antagonists (cognitive disorder), Suven	Neurological disease	.	G00-G99
DIB015501	HCV vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015502	PTP-1B inhibitors	Metabolic disorders	.	E70-E90
DIB015503	Flavimun	Yellow fever virus infection	.	A95
DIB015504	CRL-1018	Mycobacterium tuberculosis infection	.	A15-A19
DIB015505	Recombinant B-cell peptide vaccine	Allergy	995.3	T78.4
DIB015506	Recombinant Bet v 1 immunotherapy	Allergic rhinitis	477	J30
DIB015507	YD-501	Obesity	278	E66
DIB015508	Ensaculin hydrochloride	Parkinson's disease	.	G20
DIB015509	Fusopin	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015510	Phensuximide	Seizures	.	G40,R56
DIB015511	Monoclonal antibodies	Infectious disease	001-139	A00-B99
DIB015512	OrniFlu	Influenza virus infections	487	J10, J11
DIB015513	Cyclophilin D inhibitors	Ischemia	459.89	I99.8
DIB015514	Perospirone	Psychotic disorders	.	F20-F29
DIB015515	Mi-TUMEX	Cancer	140-229	C00-C96
DIB015516	MC-033	Atherosclerosis	414.0, 440	I70
DIB015517	Helicobacter pylori vaccine	Helicobacter pylori infection	41.86	B96.81
DIB015518	IGFR1 kinase inhibitors	Cancer	140-229	C00-C96
DIB015519	Buccal fentanyl	Pain	.	G89
DIB015520	HYG-113	Discovery agent	.	.
DIB015521	ROCICLOVIR	Viral infections	042-075	A80-A99, B00-B34
DIB015522	PT4.0	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015523	Peg-G-CSF	Cancer	140-229	C00-C96
DIB015524	Ro-25-4835	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015525	GSK-1362885	Diabetes mellitus type 2	.	E11
DIB015526	Lentinan sulfate	Cancer	140-229	C00-C96
DIB015527	Chk2 inhibitors	Cancer	140-229	C00-C96
DIB015528	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB015529	BF-1	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
DIB015530	TDI-0074	Motor neurone disease	335.2	G12.2
DIB015531	MPL-containing Pollinex allergy desensitization vaccine	Allergy	995.3	T78.4
DIB015532	CLT-003	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DIB015533	CYT-005-allQbG10	Allergic rhinitis	477	J30
DIB015534	SNK-882	Cognition disorders	.	F06.7
DIB015535	FR-133605	Arthritis	710-719	M00-M25
DIB015536	SDZ-WAG-994	Hypertension	.	I10-I15
DIB015537	JTT-251	Type 2 diabetes	250.00, 250.02	E11
DIB015538	FAP5-DM1	Cancer	140-229	C00-C96
DIB015539	HBV vaccine	Hepatitis B virus infection	.	B16
DIB015540	CNTO-607	Discovery agent	.	.
DIB015541	DBP-118	Emesis	787	R11
DIB015542	PF-04971729	Diabetes mellitus type 2	.	E11
DIB015543	PMX-700	Glioblastoma	191	C71
DIB015544	Next generation non-live liposomal vaccine	Poliovirus infection	.	A80.9
DIB015545	AIKO-150	Opiate dependence	304	F11
DIB015546	Calcium-dependent lipopeptide antibiotics	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015547	SCD-1 inhibitor	Acne vulgaris	706.1	L70.0
DIB015548	Meningococcal vaccine groups A,C,Y,W-135 conjugate	Tourette syndrome	.	F95.2
DIB015549	P2Y1 antagonists	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB015550	Anti-Her2 mAb	Discovery agent	.	.
DIB015551	OMS405	Nicotine dependence	.	F17
DIB015552	AMPK activators	Cancer	.	C00-C97
DIB015553	Melanocortin receptor modulators	Obesity	278	E66
DIB015554	Diphtheria/tetanus vaccine	Clostridium tetani infection	001-139	A00-B99
DIB015555	Alopecia therapy	Alopecia	.	L65.9
DIB015556	GS-9857	Hepatitis C virus infection	.	B17.1,B18.2
DIB015557	CNT0-0007	Ischemic stroke	434.91	I61-I63
DIB015558	AE37 peptide vaccine	Breast cancer	174, 175	C50
DIB015559	QRS-5-005	Septic shock	785.52	A41.9
DIB015560	Prostacyclin analog	Pulmonary hypertension	416	I27.0, I27.2
DIB015561	Gene therapy	Insulin dependent diabetes	.	E10
DIB015562	Priorix	Measles virus infection	.	B06.9
DIB015563	Farnesoid X receptor agonists	Diabetes mellitus	250	E08-E13
DIB015564	AC3056	Atherosclerosis	414.0, 440	I70
DIB015565	Plasmid DNA vaccine	Influenza virus infections	487	J10, J11
DIB015566	UK-156406	Myocardial infarction	.	I21-I22
DIB015567	ANA-01	Bone resorption	.	M80
DIB015568	Selective estrogen receptor beta modulators (hormone metabolism disorder) GlaxoSmithKline/Scynexis	Inflammatory diseases	.	.
DIB015569	Focetria A(H1N1)	Influenza virus infections	487	J10, J11
DIB015570	Antithrombotics	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB015571	Vaccine targeting survivin	Cancer	140-229	C00-C96
DIB015572	KN-38-7271	Ischemia	.	I99.8
DIB015573	OPHD-002	Inflammatory bowel disease	555, 556	K50, K51
DIB015574	Endoxifen	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB015575	TDI-0051	Motor neurone disease	335.2	G12.2
DIB015576	TGR5 agonists	Non-insulin dependent diabetes	.	E11.9
DIB015577	PAI-1 inhibitors	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB015578	GSK-2136773	Colorectal cancer	153, 154	C18-C21
DIB015579	ALNESPIRONE	Anxiety disorder	.	F40-F42
DIB015580	RAD-1901	Breast cancer	174, 175, 217	C50, D24
DIB015581	PEM cytokine inhibitors	Ocular disease	.	H00-H59
DIB015582	EMD-47791	Bone disease	.	M00-M99
DIB015583	PARG inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015584	Non-catalytic site HIV integrase inhibitors	HIV infections	42	B20
DIB015585	CMT-02	Charcot marie tooth disease	.	G60.0
DIB015586	Seprase inhibitors	Cancer	140-229	C00-C96
DIB015587	GW-275919	Pain	.	G89
DIB015588	GnRH immunotherapeutic	Breast cancer	.	C50
DIB015589	PPI-383	Hepatitis C virus infection	.	B17.1,B18.2
DIB015590	Indeloxazine	Dementia	290-294	F01-F07
DIB015591	OligoG CF-5/20	Cystic fibrosis	277	E84
DIB015592	Topoisomerase II inhibitor	Cancer	140-229	C00-C96
DIB015593	Lactermin	Oral mucositis	528	K12.3
DIB015594	IPAZILIDE FUMARATE	Cardiac arrhythmias	.	I47-I49
DIB015595	DSP-6952	Constipation	564	K59.0
DIB015596	NMI-3377	Cardiovascular disease	390-459	I00-I99
DIB015597	SGN-CD33A	Acute myeloid leukemia	205	C92.0
DIB015598	H5N1 influenza mAb therapy	Influenza virus infections	487	J10, J11
DIB015599	HepaGam B	Hepatitis B virus infection	.	B16
DIB015600	Dihydrocodeine	Cancer pain	338,780	R52, G89
DIB015601	RG-201	Acquired immune deficiency syndrome	42	B20
DIB015602	HCV Vaccine	Hepatitis virus infection	573.3	K75.9
DIB015603	Roquinimex	Rheumatold arthritis	.	M05-M06
DIB015604	PD-4048	Diabetes mellitus	250	E08-E13
DIB015605	CDD-98	Alzheimer's disease	.	G30,F00
DIB015606	MAb based Tie-1 modulators	Cancer	140-229	C00-C96
DIB015607	DL-017	Hypertension	401	I10, I11, I12, I13, I15
DIB015608	HPP-515	Female sexual dysfunction	302.7	F52, R37
DIB015609	Neuroprotectants	Huntington's disease	.	F02.2,G10
DIB015610	CPG23PANC	Malignant melanoma	172	C43
DIB015611	Risotilide	Heart arrhythmia	.	I47-I49
DIB015612	BGC-20-1259	Parkinson's disease	.	G20
DIB015613	CytoRet	Retinopathy	362.0-362.2	H35-H35.2
DIB015614	MTORC1/2 inhibitors	Cancer	140-229	C00-C96
DIB015615	Hepatitis delta antigen	Hepatitis D virus infection	.	B16-B18
DIB015616	HibTITER	Pneumococcal infections	.	J13
DIB015617	AV-203	Cancer	.	C00-C97
DIB015618	Pbi-shPDX-1 LP	Pancreatic cancer	.	C25
DIB015619	TAK-065	Alzheimer's disease	331	G30
DIB015620	AMPA receptor positive modulators	Neurological disease	.	G00-G99
DIB015621	SGX-511	Muscle spasm	.	M62.838
DIB015622	H1N1 pandemic influenza vaccine	Influenza virus infections	487	J10, J11
DIB015623	LNK-3248	Alzheimer's disease	331	G30
DIB015624	Kaolin/pectin	Diarrhea	787.91	A09, K59.1
DIB015625	PF-4859989	Schizophrenia	295	F20
DIB015626	Latrodectus antivenin	Poison intoxication	.	T36-T50
DIB015627	Small molecule therapeutics	Non-insulin dependent diabetes	.	E11.9
DIB015628	Anti-cocaine monoclonal antibody (mAb) 2E2	Cocaine addiction	304.2	F14.2
DIB015629	CLX-0301	Diabetes mellitus	250	E08-E13
DIB015630	Fosfluconazole	Fungal infection	.	B35-B49
DIB015631	Epithelial sodium channel inhibitors	Xerophthalmia	.	E50.6-E50.7
DIB015632	Telomere modulators	Cancer	.	C00-C97
DIB015633	BMS-210285	Diabetes mellitus type 2	.	E11
DIB015634	Photo-labeled dapivirine derivative	HIV-1 infections	42	B20
DIB015635	LG-2293	Prostate cancer	.	C61
DIB015636	Naked DNA (B-cell lymphoma) Vical/Stanford	B-cell lymphoma	202.8	C85.1
DIB015637	Dehydrocholic acid	Constipation	564	K59.0
DIB015638	Procysteine	Amyotrophic lateral sclerosis	335.2	G12.2
DIB015639	EC-234	Ischemia-reperfusion injury	.	I00-I99
DIB015640	OZ-439	Plasmodium falciparum infection	.	B54
DIB015641	Apomorphine	Parkinson's disease	.	G20
DIB015642	Hypothermic therapy	Ischemia	459.89	I99.8
DIB015643	Thrombin/fibrinogen matrix patch	Bleeding	.	R58
DIB015644	DV-7021	Liver disease	570-574	K70-K77
DIB015645	5-alpha reductase inhibitor (MedinGel, alopecia), MedinCell	Alopecia	.	L65.9
DIB015646	Fatty acid synthase inhibitors	Cancer	140-229	C00-C96
DIB015647	Bowman Birk Inhibitor Concentrate	Prostate hyperplasia	.	N40
DIB015648	ATB-429	Inflammatory bowel disease	555, 556	K50, K51
DIB015649	GSK-2315698	Amyloidosis	277.3	E85
DIB015650	Gonorrhea vaccine	Neisseria gonorrhoeae infection	.	A87
DIB015651	NVS antibody	Autoimmune diseases	279.4	D84.9, M35.9
DIB015652	BTL-TML-HSV	Oral herpes	.	B00
DIB015653	AZD-3783	Anxiety disorder	300	F40-F42
DIB015654	HG-1070	Cancer	140-229	C00-C96
DIB015655	BCH-1167	Cancer	140-229	C00-C96
DIB015656	Anticancer agents	Cancer	.	C00-C97
DIB015657	D-21775	Cancer	140-229	C00-C96
DIB015658	AZD-2914	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB015659	RAGE antibodies	Sepsis	995.91	A40, A41
DIB015660	Ad35-GRIN	HIV infections	42	B20
DIB015661	SGS-111	Cognition disorders	.	F06.7
DIB015662	GSK1995057	Adult respiratory distress syndrome	.	J80
DIB015663	Anti-HCV peptides	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015664	Recombinant Slit-2-D1-D2-Fc	Acute lung injury	518	J80
DIB015665	Oncomer	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB015666	Recombinant hypoallergenic vaccine	Allergy	995.3	T78.4
DIB015667	Fully human antibody	Cancer	140-229	C00-C96
DIB015668	Tetracycline derivatives	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DIB015669	SC-51322	Pain	338,780	R52, G89
DIB015670	JNJ-38518168	Rheumatold arthritis	.	M05-M06
DIB015671	Sharon-4000	Acne vulgaris	706.1	L70.0
DIB015672	Vincristine sulfate	Cancer	140-229	C00-C96
DIB015673	Sickle cell anemia therapeutics	Beta thalassemia	.	D56.1
DIB015674	Gp140 vaccine	HIV infections	42	B20
DIB015675	BL-7010	Celiac disease	579	K90.0
DIB015676	RO-48-8684	Anxiety disorder	300	F40-F42
DIB015677	Respiratory syncytial virus vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB015678	ONO-8711	Pain	.	G89
DIB015679	Cilobradine	Cardiac arrhythmias	.	I47-I49
DIB015680	Respiratory system therapeutics	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB015681	EC-0845	Inflammatory diseases	.	.
DIB015682	Beloxepin	Depression	311	F32
DIB015683	Raf kinase inhibitors	Psoriasis	.	L40
DIB015684	MLR-1023	Obesity	278	E66
DIB015685	PdpSC18	Hepatitis virus infection	573.3	K75.9
DIB015686	99mTc-EC-DG	Cancer	.	C00-C97
DIB015687	MNX-217	Asthma	493	J45
DIB015688	PIROTIODECANE	Ophthalmic disease	.	H00-H59
DIB015689	IP-112	Cancer	.	C00-C97
DIB015690	Sarcoma mAb vaccine	Sarcoma	.	D69.3
DIB015691	ST-1141	Functional bowel disorder	.	K00-K93
DIB015692	IL-28B immunoadjuvant	Discovery agent	.	.
DIB015693	FR-123826	Rheumatold arthritis	.	M05-M06
DIB015694	GrVax program	Melanoma	172	C43
DIB015695	PEGylated recombinant EPO	Anemia	280-285	D50-D64
DIB015696	AZM-145	Diabetes mellitus	250	E08-E13
DIB015697	Interleukin-2	Cancer	140-229	C00-C96
DIB015698	Visilizumab	Graft-versus host disease	.	T86.0
DIB015699	PT-201	Urinary dysfunction	.	N39.3-N39.4
DIB015700	AR-C-89855	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB015701	Ubiquitin ligase therapy	Clostridium botulinum infection	.	A05.1
DIB015702	Sitamaquine	Infectious and parasitic disease	.	A00-B99
DIB015703	APT project	Overactive bladder disorder	596.51	N32.81
DIB015704	CD-581	Atopic dermatitis	.	L20
DIB015705	CAT-4000 series	Inflammatory diseases	.	.
DIB015706	Plasmodium falciparum vaccine	Plasmodium falciparum infection	.	B54
DIB015707	Factor VIIIc	Factor VIII deficiency	.	D66
DIB015708	Enkastim-iv	Cancer	140-229	C00-C96
DIB015709	PEG-bHb-CO	Cardiovascular disease	390-459	I00-I99
DIB015710	TRPM8 antagonists	Pain	338,780	R52, G89
DIB015711	Dual dopamine D2 partial agonist/serotonin reuptake inhibitor	Schizophrenia	295	F20
DIB015712	Oral GPCR modulator	Atherosclerosis	414.0, 440	I70
DIB015713	SWC-246	Lung cancer	162	C33-C34
DIB015714	Ubiquitin pathway inhibitors	Cancer	140-229	C00-C96
DIB015715	ALL-4	Non-insulin dependent diabetes	.	E11.9
DIB015716	Phenolphthalein	Constipation	564	K59.0
DIB015717	Patritumab	Non-small cell lung cancer	.	C33-C34
DIB015718	BAC-zanamivir	Influenza virus infections	487	J10, J11
DIB015719	Immunotherapy	Alzheimer's disease	331	G30
DIB015720	NMI-870	Sexual dysfunction	.	F52
DIB015721	ENDG-3020	Pain	338,780	R52, G89
DIB015722	HIV-1 therapeutic vaccine	HIV infections	42	B20
DIB015723	Paclitaxel-eluting balloon catheter	Stenotic peripheral artery lesions	.	I73.9
DIB015724	TLR-9 agonists	Cancer	140-229	C00-C96
DIB015725	Inecalcitol oral	Prostate cancer	.	C61
DIB015726	Isocitrate lyase prodrug inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB015727	KI-0401	Infectious disease	001-139	A00-B99
DIB015728	Core 2 O-GlcNAc transferase inhibitor	Multiple sclerosis	340	G35
DIB015729	POL-6326	Human immunodeficiency virus infection	.	B20
DIB015730	AVI-5126	Coronary artery disease	410-414, 429.2	I20-I25
DIB015731	AZD-6538	Gastroesophageal reflux disease	.	K21
DIB015732	SEM-606	Neurological disease	.	G00-G99
DIB015733	ETV-003	Neisseria meningitidis infection	.	A87
DIB015734	NVX-412	Melanoma	172	C43
DIB015735	Neuroprotectant	Parkinson's disease	.	G20
DIB015736	G-protein biased ligands	Pain	338,780	R52, G89
DIB015737	Aderbasib	Breast cancer	.	C50
DIB015738	Sh-28-GST	Schistosomiasis	120	B65
DIB015739	SPVF-2801-30 program	Cancer	140-229	C00-C96
DIB015740	Seebri	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB015741	CDRI-85/92	Stomach ulcer	.	K25-K27
DIB015742	MC-02331	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015743	V950 vaccine	Alzheimer's disease	331	G30
DIB015744	TA-7906	Atopic dermatitis	.	L20
DIB015745	AIMP2-DX2 inhibitor	Lung cancer	162	C33-C34
DIB015746	Apoptosis inducers	Cancer	140-229	C00-C96
DIB015747	METIAPRIL	Hypotension	.	I95
DIB015748	PTI-601	Pain	338,780	R52, G89
DIB015749	LL-6531	Diabetes mellitus	250	E08-E13
DIB015750	PHE-377	Pain	.	G89
DIB015751	GCS-100	Chronic kidney disease	.	N18
DIB015752	Medium chain triglycerides	Lymphatic disease	.	I89.8
DIB015753	Pibutidine	Ulcerative colitis	.	K51
DIB015754	RNA stealth nucleosides	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015755	Hepatitis A vaccine	Hepatitis A virus infection	.	B15.9
DIB015756	EXO-230	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB015757	DiabeCell	Insulin dependent diabetes	.	E10
DIB015758	LIPO-5	HIV infections	42	B20
DIB015759	L-748415	Osteoporosis	733	M80-M81
DIB015760	D-22557	Allergy	995.3	T78.4
DIB015761	GEH-120714	Multile sclerosis	.	G35
DIB015762	RT-401	Rhinitis	472.0, 477	J00, J30, J31.0
DIB015763	DMP-851	Human immunodeficiency virus infection	.	B20
DIB015764	4Ab-028	Cytomegalovirus infection	.	B25
DIB015765	MK-6325	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB015766	NS-1608	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015767	EHT/AGN-0002	Neurodegenerative diseases	.	G30-G32
DIB015768	P-144	Ulcer	531-534	K25-K27
DIB015769	Mazapertine succinate	Psychotic disorders	.	F20-F29
DIB015770	HyperAcute Renal	Metastatic renal cancer	140-229, 189	C00-C96, C64
DIB015771	SD-726	Pain	338,780	R52, G89
DIB015772	BI-44847	Diabetes mellitus type 2	.	E11
DIB015773	Ataprost	Asthma	.	J45
DIB015774	PRAME immunotherapeutic	Non-small cell lung cancer	.	C34.90
DIB015775	Calcium levofolinate	Anemia	.	D50-D64
DIB015776	Anti-D human immunoglobulin	Acquired hemolytic anemia	.	D59.9
DIB015777	Cell adhesion inhibitors	Cardiovascular disease	390-459	I00-I99
DIB015778	HPMPA prodrugs	Cytomegalovirus infection	.	B25
DIB015779	GS-4070	Influenza virus infections	487	J10, J11
DIB015780	TDI-0106	Motor neurone disease	335.2	G12.2
DIB015781	Anti-CD45 mAbs	Lymphoma	.	C81-C96
DIB015782	IW-2143	Anxiety disorder	.	F40-F42
DIB015783	IR502	Psoriatic disorders	696	L40
DIB015784	Sclerostin targeting antibody	Bone disease	.	M00-M99
DIB015785	Neonatal group B streptococcal vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015786	Anti-miR-33 antisense oligonucleotide	Cardiovascular disease	390-459	I00-I99
DIB015787	Anti-epileptics	Epilepsy	345	G40
DIB015788	TK-115339	Cardiovascular disease	390-459	I00-I99
DIB015789	P-17 ophthalmic	Bone metastases	198.5	C79.51
DIB015790	AR-301	Pneumonia due to Methicillin susceptible Staphylococcus aureus	.	J15.211
DIB015791	ATL-1101	Psoriatic disorders	696	L40
DIB015792	Antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015793	AS-35	Asthma	.	J45
DIB015794	CI-1013	Viral infections	042-075	A80-A99, B00-B34
DIB015795	WAY-123641	Asthma	493	J45
DIB015796	Ex vivo gene therapy	B-cell lymphoma	.	C85.1
DIB015797	CIN gene therapy	Asthma	493	J45
DIB015798	HemoTech	Hematological disease	.	D50-D89
DIB015799	EphB4 inhibitors	Cancer	140-229	C00-C96
DIB015800	QS-21	Melanoma	.	C43
DIB015801	ABY-025	Bladder cancer	.	C67
DIB015802	MK-771	Motor neurone disease	335.2	G12.2
DIB015803	MP-435	Rheumatold arthritis	714	M05-M06
DIB015804	S-14506	Anxiety disorder	.	F40-F42
DIB015805	Mirostipen	Breast cancer	174, 175	C50
DIB015806	Sodium channel blockers	Neuropathic pain	338,780	R52, G89
DIB015807	SYM-009	Infectious disease	001-139	A00-B99
DIB015808	PI3K gamma inhibitors	Inflammatory diseases	.	.
DIB015809	EHT-1864	Alzheimer's disease	.	G30,F00
DIB015810	KIN-4064	Cancer	140-229	C00-C96
DIB015811	MC-4232	Hypertension	401	I10, I11, I12, I13, I15
DIB015812	HO/04/09	Acne vulgaris	706.1	L70.0
DIB015813	CEFDALOXIME PENTEXIL TOSILATE	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB015814	TP-20	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015815	KIN-806	Cancer	140-229	C00-C96
DIB015816	MP-529	Cancer	140-229	C00-C96
DIB015817	Bilive	Hepatitis B virus infection	.	B16
DIB015818	Cephalosporin derivatives	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015819	CRTH2 antagonists	Allergy	995.3	T78.4
DIB015820	VEGF/FGF antagonists	Angiogenesis disorder	.	I00-I99
DIB015821	AEA-35p	Influenza virus infections	487	J10, J11
DIB015822	M-40401	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015823	Oxytrex	Pain	338,780	R52, G89
DIB015824	DIAVERIDINE	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB015825	Dendrogenin A	Cancer	140-229	C00-C96
DIB015826	J-775Y	Allergy	995.3	T78.4
DIB015827	I-vation	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DIB015828	PD-152255	Psychiatric disorders	.	F99
DIB015829	Recombinant uteroglobin	Metastasis	.	C00-C97
DIB015830	Factor VIII-XTEN	Hemophilia	286	D66-D68
DIB015831	Vitronectin antagonists	Osteoporosis	.	M80-M81
DIB015832	BIM-21863	Obesity	278	E66
DIB015833	S-12340	Atherosclerosis	414.0, 440	I70
DIB015834	MARK3 inhibitors	Alzheimer's disease	331	G30
DIB015835	Interferon alpha	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015836	External guide sequence therapeutics	Lung inflammation	.	D86
DIB015837	Org-37663	Rheumatold arthritis	714	M05-M06
DIB015838	M-17 E. Coli	Irritable bowel syndrome	564.1	K58
DIB015839	NC-1006	Heart arrhythmia	.	I47-I49
DIB015840	KSP inhibitors	Cancer	140-229	C00-C96
DIB015841	PAN-622	Cancer	.	C00-C97
DIB015842	PCSK9 modulators	Metabolic disorders	.	E70-E90
DIB015843	EPO receptor agonists	Anemia	280-285	D50-D64
DIB015844	Apoptosis stimulators	Cancer	.	C00-C97
DIB015845	SAR-116242	Plasmodium infection	.	B54
DIB015846	CaCP-29	Sepsis	995.91	A40, A41
DIB015847	IL-7-stimulated immunoregulatory dendritic cells	Diabetes mellitus type 1	.	E10
DIB015848	ALX-0171	Respiratory syncytial virus 	79.6	B97.4
DIB015849	LY-307161 SR	Diabetes mellitus type 2	.	E11
DIB015850	GALE-301	Endometrial cancer	.	C54.1
DIB015851	Citatuzumab bogatox	Cancer	140-229	C00-C96
DIB015852	T-02	Anesthesia	338	R52
DIB015853	Anti-alpha-11 antibodies	Rheumatold arthritis	714	M05-M06
DIB015854	Folipastatin	Inflammatory diseases	.	.
DIB015855	Dendritic cell vaccine	Prostate tumor	185	C61
DIB015856	Fentanyl	Pain	338,780	R52, G89
DIB015857	Vaccine	Colorectal cancer	153, 154	C18-C21
DIB015858	Stapled peptides	Metabolic disorders	.	E70-E90
DIB015859	BMS-919373	Atrial fibrillation	427.31	I48
DIB015860	Dexpirronium	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB015861	Odiparcil	Cardiovascular disease	.	I00-I99
DIB015862	Emakalim	Angina	.	I20
DIB015863	ColoAd1	Cancer	140-229	C00-C96
DIB015864	SX-ARPC	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DIB015865	ANA-1	Alzheimer's disease	331	G30
DIB015866	XGP-110	Arthritis	710-719	M00-M25
DIB015867	Levovist	Cardiovascular disease	390-459	I00-I99
DIB015868	MTL-101	Infectious disease	001-139	A00-B99
DIB015869	COTI-4A	Small-cell lung cancer	.	C34.90
DIB015870	Kv1.3 voltage gated potassium ion channel inhibitors	Multiple sclerosis	340	G35
DIB015871	MK-5596	Obesity	278	E66
DIB015872	Anti-obesity compounds	Obesity	278	E66
DIB015873	Patamostat	Hypotension	.	I95
DIB015874	SEP-226332	Sleep apnea	.	G47.3
DIB015875	BILA-2157BS	Hypertension	401	I10, I11, I12, I13, I15
DIB015876	Semagacestat	Parkinson's disease	.	G20
DIB015877	Aurora A kinase inhibitors	Cancer	140-229	C00-C96
DIB015878	AEN-100	Motor neurone disease	335.2	G12.2
DIB015879	X-082-NAB	Systemic lupus erythematosus	710	M32
DIB015880	GR-94839	Pain	338,780	R52, G89
DIB015881	MMP-13 inhibitors	Osteoarthritis	715	M15-M19, M47
DIB015882	MT-274 lead series	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015883	Anti-sortase mAb	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB015884	VS-4718	Solid tumours	.	C00-C75,C7A,C7B
DIB015885	VS-5584	Solid tumours	.	C00-C75,C7A,C7B
DIB015886	MK-7145	Hypertension	401	I10, I11, I12, I13, I15
DIB015887	Metelimumab	Scleroderma	.	M34
DIB015888	BMS-181184	Fungal infections	110-118	B35-B49
DIB015889	NST-141	Pruritus	698	L29
DIB015890	S-2678	Immune disorder	.	D80-D89
DIB015891	Alternaria peptide allergy desensitization agent	Allergy	995.3	T78.4
DIB015892	Peptagon	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015893	DNX-2000	Autoimmune diseases	279.4	D84.9, M35.9
DIB015894	Lm Melanoma	Melanoma	172	C43
DIB015895	ERBULOZOLE	Cancer	140-229	C00-C96
DIB015896	Polynucleotide kinase 3'-phosphatase modulators	Cancer	140-229	C00-C96
DIB015897	Neuronal transplant cells	Stroke	.	I61-I63
DIB015898	Keyhole limpet hemocyanin	Bladder cancer	188	C67
DIB015899	SB-237376	Arrhythmia	.	I47-I49
DIB015900	CGP-43371	Atherosclerosis	414.0, 440	I70
DIB015901	BXT-51072	Cardiovascular disease	390-459	I00-I99
DIB015902	NDM-10107	Obesity	278	E66
DIB015903	SND-121	Infectious disease	001-139	A00-B99
DIB015904	Prolactin receptor antagonists	Cancer	140-229	C00-C96
DIB015905	LC-350189	Gout	274.00274.1274.8274.9	M10
DIB015906	VAP-1 monoclonal antibody	Inflammatory disorders	.	.
DIB015907	Tuberculosis therapy	Mycobacterium tuberculosis infection	.	A15-A19
DIB015908	GM3 ganglioside vaccine	Breast cancer	174, 175, 217	C50, D24
DIB015909	KaroMab	Cancer	140-229	C00-C96
DIB015910	ImmuFact IMP321	Melanoma	.	C43
DIB015911	PEP-223/CoVaccine HT	Prostate cancer	.	C61
DIB015912	VLD-01	Diabetic cataract	.	E10.36,E11.36
DIB015913	Protein subunit vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB015914	MPV-1743	Obesity	278	E66
DIB015915	Retroviral MGMT-transduced hematopoietic cells	Anemia	.	D50-D64
DIB015916	BL-1893	Cancer	140-229	C00-C96
DIB015917	RC-552	Neurological disease	.	G00-G99
DIB015918	Bioremineralization modulators I (bone/tooth regeneration)	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
DIB015919	Imatinib sublingual	Chronic myelogenous leukemia	205.1	C92.1
DIB015920	Dicer-substrate small interfering RNAs	Inflammatory diseases	.	.
DIB015921	CV-9103	Cancer	.	C00-C97
DIB015922	MCR antagonists	Cachexia	799.4	R64
DIB015923	AM-66	Pain	338,780	R52, G89
DIB015924	WS-63967	Cardiovascular disease	390-459	I00-I99
DIB015925	L-692429	Growth hormone deficiency	.	E23.0
DIB015926	LY-2780301	Cancer	.	C00-C97
DIB015927	H5N1 influenza vaccine	HIV infection	001-139, 042	A00-B99, B20
DIB015928	HG-1336	Neurological disease	.	G00-G99
DIB015929	ACH-1095	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015930	IPN-200	Flavivirus infection	.	A86
DIB015931	BC-821	Bladder cancer	188	C67
DIB015932	Homspera	Viral infections	.	B34
DIB015933	XR-12890	Asthma	493	J45
DIB015934	EGFR closed form stabilizers	Cancer	140-229	C00-C96
DIB015935	S pneumoniae vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB015936	RGN-259 eye drops	Vaginal yeast infection	.	B37.3
DIB015937	DopaFuse	Parkinson's disease	332	F02.3, G20
DIB015938	C-9138	Alzheimer's disease	331	G30
DIB015939	Small-molecule cetuximab binding mimics	Cancer	140-229	C00-C96
DIB015940	ZP trivalent influenza vaccine	Influenza virus infections	487	J10, J11
DIB015941	Cancer compound	Cancer	140-229	C00-C96
DIB015942	Androgen receptor antagonists	Prostate tumor	185	C61
DIB015943	FSH	Infertility	.	N46,N97.0
DIB015944	Capsaicin	Neuropathic pain	338,780	R52, G89
DIB015945	ST-570	Inflammatory diseases	.	.
DIB015946	OLPADRONIC ACID SODIUM SALT	Bone resorption	.	M80
DIB015947	XR-975	HIV infections	42	B20
DIB015948	ZD-7717	Asthma	493	J45
DIB015949	Human mAb	Huntington's disease	.	F02.2,G10
DIB015950	ICE inhibitors	Rheumatold arthritis	.	M05-M06
DIB015951	STP-900	Organ transplant rejection	.	Z94.9
DIB015952	MB-300 series	Breast cancer	174, 175, 217	C50, D24
DIB015953	Anti-asthma glycosaminoglycans	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB015954	Oshadi R	Cancer	140-229	C00-C96
DIB015955	Namitecan	Solid tumours	.	C00-C75,C7A,C7B
DIB015956	Adenovector-based vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB015957	Estrogen-like compounds	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB015958	SL-89.0591	Prostate disorder	.	N40-N42
DIB015959	Anavip	Poison intoxication	.	T36-T50
DIB015960	Myotonic dystrophy therapy	Myotonic dystrophy	.	G71.1
DIB015961	RNAi-based cancer therapy	Cancer	140-229	C00-C96
DIB015962	HVTN 502	HIV infections	42	B20
DIB015963	Sensor linked micelle	Cancer	140-229	C00-C96
DIB015964	RQ-00203066	Pain	338,780	R52, G89
DIB015965	Broad-spectrum antiviral	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015966	BL-1828	Opiate dependence	304	F11
DIB015967	Gene therapy	Neurodegenerative diseases	.	G30-G32
DIB015968	Pentosan polysulfate	Cancer	.	C00-C97
DIB015969	GTx-878	Prostate hyperplasia	.	N40
DIB015970	Bacillus anthracis therapeutics	Bacillus anthracis infection	.	A22
DIB015971	Yuganning	Influenza virus infections	487	J10, J11
DIB015972	HG-1144	Cancer	140-229	C00-C96
DIB015973	INK-1117	Solid tumours	.	C00-C75,C7A,C7B
DIB015974	TJN-135	Osteoporosis	733	M80-M81
DIB015975	PI-201	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB015976	Dinucleotide analog prodrug	Hepatitis B virus infection	.	B16
DIB015977	SALAZODINE	Arthritic	710-719	M00-M25
DIB015978	VEGFR-2 inhibitors	Angiogenesis disorder	.	I00-I99
DIB015979	AR-C86398KA	Cystic fibrosis	277	E84
DIB015980	MT-1303	Multiple sclerosis	340	G35
DIB015981	APX-009	Cancer	.	C00-C97
DIB015982	TrkA inhibitors	Cancer	140-229	C00-C96
DIB015983	YT-1006	Neuropathic pain	338,780	R52, G89
DIB015984	PAMAQUESIDE	Hyperlipidemia	.	E78.5
DIB015985	Adrenal chromaffin cells	Neuropathic pain	338,780	R52, G89
DIB015986	AG-514	Cancer	140-229	C00-C96
DIB015987	Dendritic cell vaccine	Head and neck cancer	.	C07-C14,C32-C33
DIB015988	Folate receptor alpha-targeted therapeutic vaccine	Breast cancer	174, 175, 217	C50, D24
DIB015989	R-1479	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015990	VALERGENT-BT (subcutaneous)	Asthma	493	J45
DIB015991	Ibodutant	Irritable bowel syndrome	.	K58
DIB015992	Anti-HCV antibodies	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB015993	JBD-401	Cancer	140-229	C00-C96
DIB015994	KP-100	Diabetes mellitus type 1	.	E10
DIB015995	Lornoxicam	Migraine	346	G43
DIB015996	Potassium	Hypokalemia	276.8	E87.6
DIB015997	KUL-7211	Neurogenic bladder dysfunction	.	N31.9
DIB015998	Mut Y inhibitors	Mycobacterium tuberculosis infection	.	A15-A19
DIB015999	Env glycoprotein immunogen vaccine	HIV-1 infections	42	B20
DIB016000	Z-1494-alpha	Biologic therapeutics	.	.
DIB016001	Panomifene	Cancer	140-229	C00-C96
DIB016002	BI-638683	Cancer	.	.
DIB016003	P38 MAP kinase inhibitors	Cancer	.	C00-C97
DIB016004	Ablukast	Asthma	.	J45
DIB016005	ADMDD-15	Cancer	140-229	C00-C96
DIB016006	HG-1179	Cancer	140-229	C00-C96
DIB016007	TJN-259	IgA nephropathy	.	N02.8
DIB016008	Tetracel	Bordetella pertussis infection	.	A37.0
DIB016009	USP-34 inhibitors	Pulmonary fibrosis	515, 516.3	J84.1
DIB016010	SBC-105	Metabolic disorders	.	E70-E90
DIB016011	GSK2618960	Autoimmune diseases	279.4	D84.9, M35.9
DIB016012	Amylin receptor agonists	Diabetes mellitus	.	E10-E14
DIB016013	SNG-163	Cancer	140-229	C00-C96
DIB016014	Antiherpes agents	Herpes simplex virus infection	.	A60,B00
DIB016015	CIGB-598a	Cancer	140-229	C00-C96
DIB016016	ABIO 09-01	Anxiety disorder	.	F40-F42
DIB016017	ACS-6	Respiratory distress syndrome	518.5, 518.82	J80
DIB016018	AZD-6357	Osteoarthritis	715	M15-M19, M47
DIB016019	TAK-935	Glutamate excitotoxiity	.	T36-T65
DIB016020	CHS-828	Solid tumours	.	C00-C75,C7A,C7B
DIB016021	Broad-spectrum antiviral	Influenza virus infections	487	J10, J11
DIB016022	SNN-0031	Brain injury	.	S06
DIB016023	T3D-959	Alzheimer's disease	331	G30
DIB016024	ME-344	Cancer	.	C00-C97
DIB016025	Anaplastic lymphoma kinase inhibitors	Cancer	140-229	C00-C96
DIB016026	[111In]SRVII23	Prostate tumor	185	C61
DIB016027	Barixibat	Atherosclerosis	414.0, 440	I70
DIB016028	Gemigliptin	Diabetes mellitus	250	E08-E13
DIB016029	AnervaX.DB	Insulin dependent diabetes	.	E10
DIB016030	Respiratory syncytial virus vaccine	Respiratory syncytial virus 	79.6	B97.4
DIB016031	VULM-1457	Atherosclerosis	414.0, 440	I70
DIB016032	RWJ-63556	Arthritis	.	M00-M25
DIB016033	Bacteriophage vaccine	Multiple myeloma	203	C90.0
DIB016034	Thioredoxin reductase inhibitors	Cancer	140-229	C00-C96
DIB016035	GSK-2189242A	Pneumococcal infections	.	J13
DIB016036	SF-109	Glaucoma	365	H40-H42
DIB016037	Tiospirone hydrochloride	Psychotic disorders	.	F20-F29
DIB016038	PDA-002	Ulcer	531-534	K25-K27
DIB016039	AG-2024	Arthritis	710-719	M00-M25
DIB016040	CPC-410	Cancer	140-229	C00-C96
DIB016041	Calcium-sensing receptor antagonists	Osteoporosis	733	M80-M81
DIB016042	MDT-011	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DIB016043	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB016044	MK-767 (KRP-297)	Diabetes mellitus type 2	250	E11
DIB016045	Apocuanzine	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016046	Farnesyltransferase inhibitors	Trypanosoma cruzi infection	.	B57.2
DIB016047	WIN-34B	Osteoarthritis	715	M15-M19, M47
DIB016048	Rosaramicin	Neisseria gonorrhoeae infection	.	A87
DIB016049	Autotaxin inhibitors	Cancer	140-229	C00-C96
DIB016050	VBY- 036	Neuropathic pain	338,780	R52, G89
DIB016051	HSV entry inhibitors	Viral infections	042-075	A80-A99, B00-B34
DIB016052	RBP-6000	Psychiatric disorders	290-319	F01-F99
DIB016053	PANFLUVAC	Influenza virus infections	487	J10, J11
DIB016054	MX2/120	Asthma	493	J45
DIB016055	[99mTc]Met	Cancer	140-229	C00-C96
DIB016056	P2X7 blocker	Autoimmune diseases	279.4	D84.9, M35.9
DIB016057	SK-951	Gastrointestinal disease	.	K00-K93
DIB016058	SiRNA therapeutics	Prostate tumor	185	C61
DIB016059	TRX-385	Autoimmune diseases	279.4	D84.9, M35.9
DIB016060	IVV-001	Cancer	140-229	C00-C96
DIB016061	RP-170	Carcinoma	.	D07.30
DIB016062	NPC-09	Myopathy	.	M60-M63
DIB016063	Transgenic human collagen	Wound healing	.	S91.3
DIB016064	Lprivask	Thrombosis	.	I80-I82
DIB016065	Chitosan based vaccine adjuvant	Immune disorder	.	D80-D89
DIB016066	CIGB-814	Rheumatold arthritis	.	M05-M06
DIB016067	SART3 peptide cancer vaccine	Colorectal cancer	153, 154	C18-C21
DIB016068	Matrix metalloproteinase inhibitor	Atherosclerosis	414.0, 440	I70
DIB016069	Methylphenidate extended-release liquid suspension	Attention deficit hyperactivity disorder	314	F90
DIB016070	GM-191519	Fungal infection	.	B35-B49
DIB016071	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB016072	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DIB016073	HYG-104	Discovery agent	.	.
DIB016074	ASKP-1240	Transplant rejection	.	T86
DIB016075	Empedopeptin derivatives	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016076	Suritozole	Major depressive disorder	.	F32,F33
DIB016077	Antipruritic agents	Pruritus	698	L29
DIB016078	Anthrax/plague combination DNA vaccine	Bacillus anthracis infection	.	A22
DIB016079	SC-52150	Emesis	.	R11
DIB016080	ITK inhibitors	Inflammatory diseases	.	.
DIB016081	H1N1 HA flu vaccine	Influenza virus infections	487	J10, J11
DIB016082	Choline kinase inhibitors	Cancer	140-229	C00-C96
DIB016083	Vector-expressed RNAi product	Neuropathic pain	338,780	R52, G89
DIB016084	PGC GLP-1	Diabetes mellitus	250	E08-E13
DIB016085	Sulopenem etzadroxil	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016086	IGF-1 receptor tyrosine kinase inhibitor	Breast cancer	.	C50
DIB016087	PEGylated hyaluronidase (human recombinant)	Pancreatic cancer	157	C25
DIB016088	Kinetochore-microtubule binding inhibitors	Cancer	140-229	C00-C96
DIB016089	Saliphenylhalamide	Cancer	140-229	C00-C96
DIB016090	ALT-802	Cancer	140-229	C00-C96
DIB016091	11C-R-129144	Major depressive disorder	296.2, 296.3	F32, F33
DIB016092	Ethyl esther derivative	Dermatological disease	.	L00-L99
DIB016093	CI-999	Arteriosclerosis	.	I70
DIB016094	Befunolol	Glaucoma	365	H40-H42
DIB016095	WAY-12175	Atherosclerosis	414.0, 440	I70
DIB016096	PTL-101	Pulmonary fibrosis	515, 516.3	J84.1
DIB016097	CXCR4 gene disrupted T cells	HIV infections	42	B20
DIB016098	V180	Dengue	.	A90
DIB016099	Wnt-signalling inhibitors	Cancer	140-229	C00-C96
DIB016100	DM-512	Psoriasis	696	L40
DIB016101	Antineoplaston-A3	Cancer	140-229	C00-C96
DIB016102	Chemokine antagonists	Cancer	.	C00-C97
DIB016103	Recombinant plasmin	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016104	SYNSORB-Pk	Clostridium difficile infection	.	A04.7,A41.4,A48.0
DIB016105	Optaflu	Influenza virus infections	487	J10, J11
DIB016106	CM-PK	Parkinson's disease	.	G20
DIB016107	VT-214	Immune disorder	.	D80-D89
DIB016108	MDX-1110	Lung cancer	162	C33-C34
DIB016109	NIK-616	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB016110	Monoclonal antibody	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB016111	INS-50589	Cardiovascular disease	.	I00-I99
DIB016112	Anti-Clostridium difficile mAbs	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB016113	Montelukast sodium oral soluble film	Allergy	.	T78.4
DIB016114	Org-31710	Contraception	.	Z30
DIB016115	IB-07A037	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016116	PPC-5650	Pain	338,780	R52, G89
DIB016117	TT-113	Blood clotting disorder	286	D65-D69
DIB016118	EM-138	Metastasis	.	C00-C97
DIB016119	RNase H2 modulators	Autoimmune diseases	279.4	D84.9, M35.9
DIB016120	SOC-0150	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DIB016121	Stem cell gene therapy	Beta thalassemia	.	D56.1
DIB016122	CKD-516	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016123	Bevacizumab	Glaucoma	365	H40-H42
DIB016124	Sky kinase inhibitors	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB016125	UR-5269	Rheumatold arthritis	714	M05-M06
DIB016126	XOMA-3AB	Clostridium botulinum infection	.	A05.1
DIB016127	Quinoxaline	Atherosclerosis	414.0, 440	I70
DIB016128	Flavonoids	Inflammatory diseases	.	.
DIB016129	Glycan G-family glycogene 5 inhibitors	Dementia	290-294	F01-F07
DIB016130	Testosterone cream	Hormone deficiency	.	E00-E90
DIB016131	COL-003	Myelodysplastic syndromes	.	D46.9
DIB016132	PF-06263507	Cancer	.	C00-C97
DIB016133	PEGylated IFN beta 1-a	Type 2 diabetes	250.00, 250.02	E11
DIB016134	Hsp 6/11	Condyloma	.	A51.3
DIB016135	Acetylcholine	Cataract	366	H25-H26, H28, Q12.0
DIB016136	IMT-504	Cancer	.	C00-C97
DIB016137	R-1663	Blood coagulation disorders	.	D65-D68
DIB016138	Saperconazole	Fungal infections	110-118	B35-B49
DIB016139	Cdk2 inhibitors	Cancer	140-229	C00-C96
DIB016140	Conjugated stigmines	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB016141	Cyclophilin binding compounds	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB016142	Quadrivalent pediatric combination vaccine	Bordetella pertussis infection	.	A37.0
DIB016143	Bombesin BRS3 agonists	Obesity	.	E66
DIB016144	FRM-0962	Alzheimer's disease	331	G30
DIB016145	Carbamide peroxide	Ear disease	.	H83.9
DIB016146	AN-1006	Cancer	.	C00-C97
DIB016147	Fusicoccin derivatives	Cancer	140-229	C00-C96
DIB016148	AG-SPT201	Ulcerative colitis	.	K51
DIB016149	CL-329167	Hypertension	.	I10-I15
DIB016150	DPP IV inhibitors	Diabetes mellitus	250	E08-E13
DIB016151	Rubratin	Cancer	.	C00-C97
DIB016152	DFP-11207	Solid tumours	.	C00-C75,C7A,C7B
DIB016153	MDR inhibitor	Cancer	140-229	C00-C96
DIB016154	Trivalent seasonal influenza vaccine	Influenza virus infections	487	J10, J11
DIB016155	HCV NS5B polymerase inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB016156	ChimeriVax-West Nile vaccine	Viral infections	042-075	A80-A99, B00-B34
DIB016157	Cystic fibrosis therapeutics	Cystic fibrosis	277	E84
DIB016158	Live attenuated viral vaccine	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DIB016159	EB-1,2,3 mAb	Leukemia	208.9	C91-C95
DIB016160	Gag derived peptides	HIV infections	42	B20
DIB016161	OC-10X	Macular degeneration	.	H35.3
DIB016162	UAI-201	Cancer	140-229	C00-C96
DIB016163	Nitric oxide topical	Tinea pedis	.	B35.3
DIB016164	HE2200	Hyperlipidemia	272.0-272.4	E78
DIB016165	S-364735	HIV infections	42	B20
DIB016166	PA-640	Discovery agent	.	.
DIB016167	Short chain fatty acid derivatives	Hematological disease	.	D50-D89
DIB016168	Neo-1528	Pain	338,780	R52, G89
DIB016169	M-163	HIV infections	42	B20
DIB016170	D-11B	Cancer	140-229	C00-C96
DIB016171	Alvocidib hydrochloride	Chronic lymphocytic leukaemia	.	C91.1
DIB016172	TQ-1017	Pain	338,780	R52, G89
DIB016173	Therapeutic monoclonal antibodies	Small-cell lung cancer	.	C34.90
DIB016174	TCR-transduced T-cell immunotherapy	Cancer	140-229	C00-C96
DIB016175	Pandemic influenza H1 and H5 vaccine	Influenza virus infections	487	J10, J11
DIB016176	VIR-576	HIV infections	42	B20
DIB016177	Interleukin-8 inhibitors	Myocardial infarction	.	I21-I22
DIB016178	Elsiglutide	Diarrhea	787.91	A09, K59.1
DIB016179	GNbAC-1	Multiple sclerosis	340	G35
DIB016180	FP-1039	Endometrial cancer	.	C54.1
DIB016181	SX-GLP1	Non-insulin dependent diabetes	.	E11.9
DIB016182	Artemisinin derivatives	Inflammatory diseases	.	.
DIB016183	Oxazyme	Hyperoxaluria	.	E74.8
DIB016184	Natural product anti-infective therapeutics	Infectious disease	001-139	A00-B99
DIB016185	GPBAR1 agonists	Diabetes mellitus	250	E08-E13
DIB016186	RGA-1512	Leukemia	.	C91-C95
DIB016187	CGP-56603	HIV infections	42	B20
DIB016188	RDX-002	Hyperphosphatemia	.	E83
DIB016189	MTbuVax	Mycobacterium tuberculosis infection	.	A15-A19
DIB016190	Microbicide monoclonal antibody triple combination	HIV infections	42	B20
DIB016191	E-4716	Respiratory disease	.	J00-J99
DIB016192	PHN-131	Pain	338,780	R52, G89
DIB016193	Gout therapy	Gout	274.00274.1274.8274.9	M10
DIB016194	NSP-805	Heart failure	.	I50
DIB016195	GEM-132	CMV retinitis	78.5	B25.8, H30.9
DIB016196	Rotavirus vaccine	Type 2 diabetes	250.00, 250.02	E11
DIB016197	HL-144	Discovery agent	.	.
DIB016198	Monofer	Iron deficiency anaemia	.	D50
DIB016199	JTE-607	Septic shock	.	A41.9
DIB016200	PARP-1 inhibitors	Cancer	140-229	C00-C96
DIB016201	NRG-101	Schizophrenia	295	F20
DIB016202	Debio 1143	Lymphoma	.	C81-C96
DIB016203	Inbihitor of Raf	Cancer	.	C00-C97
DIB016204	Trimelamol	Cancer	140-229	C00-C96
DIB016205	RL-6A	Breast cancer	174, 175, 217	C50, D24
DIB016206	Avitriptan	Migraine	.	G43
DIB016207	GSK-2302032A	Non-small-cell lung cancer	162	C33, C34
DIB016208	LipoNeu	Streptococcus pneumoniae infection	.	A00-B99
DIB016209	Zn-DPA-B	Breast cancer	174, 175, 217	C50, D24
DIB016210	Sac-0601	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB016211	Selective estrogen receptor modulators	Estrogen deficiency	.	E28.39
DIB016212	CT-6725	Osteoporosis	733	M80-M81
DIB016213	JEBIK V	Japanese encephalitis virus infection	.	A83.0
DIB016214	Erythropoiesis stimulants	Anemia	280-285	D50-D64
DIB016215	Femoxetine	Major depressive disorder	296.2, 296.3	F32, F33
DIB016216	CGS-26529	Inflammatory diseases	.	.
DIB016217	Influenza subunit vaccines	Influenza virus infections	487	J10, J11
DIB016218	CRB-0016	Osteoarthritis	715	M15-M19, M47
DIB016219	Angiogensis inhibitor	Angiogenesis disorder	.	I00-I99
DIB016220	FTC-092	Cancer	140-229	C00-C96
DIB016221	Aripiprazole lauroxil	Schizophrenia	.	F20
DIB016222	EcoNail	Fungal infection	.	B35-B49
DIB016223	SWA11-ZZ-PE38	Cancer	140-229	C00-C96
DIB016224	Ginkgo biloba extract	Alzheimer's disease	331	G30
DIB016225	Tetravalent dengue fever vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB016226	Zalospirone	Anxiety disorder	.	F40-F42
DIB016227	AlloDerm	Periodontal disease	.	K05
DIB016228	GR-ARA1	Cancer	.	C00-C97
DIB016229	Malate synthase	Mycobacterium tuberculosis infection	.	A15-A19
DIB016230	TetraMen-T	Neisseria meningitidis infection	.	A87
DIB016231	RWJ-22108	Allergy	.	T78.4
DIB016232	Dendritic cell-based immunotherapy	Rheumatold arthritis	714	M05-M06
DIB016233	SAR-126119	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016234	CardioPET	Coronary artery disease	.	I20-I25
DIB016235	Japanese encephalitis vaccine	Japanese encephalitis virus infection	.	A83.0
DIB016236	Gammaplex	Immune disorder	.	D80-D89
DIB016237	E-7050	Head and neck cancer	.	C07-C14,C32-C33
DIB016238	ARGX-109	Autoimmune diseases	279.4	D84.9, M35.9
DIB016239	Progestin IUS	Contraception	.	Z30
DIB016240	Pregnenolone	Schizophrenia	295	F20
DIB016241	NP-07	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DIB016242	SUN-C5174	Peripheral vascular disease	443.9	I73.9
DIB016243	Colesevelam	Hypercholesterolemia	272	E78.0
DIB016244	AV-2	Ocular disease	.	H00-H59
DIB016245	BRAF inhibitors	Cancer	140-229	C00-C96
DIB016246	ON-24160	Cancer	140-229	C00-C96
DIB016247	Anti-VEGFR-3 antibody	Cancer	140-229	C00-C96
DIB016248	GL-331	Colorectal cancer	.	C18-C20,C21
DIB016249	PDE4 inhibitors	Inflammatory diseases	.	.
DIB016250	HL-10	Respiratory distress syndrome	518.5, 518.82	J80
DIB016251	Apolizumab	Solid tumours	.	C00-C75,C7A,C7B
DIB016252	Anticancer agent	Ovarian cancer	.	C56
DIB016253	Vitamin D3 analogs	Cancer	140-229	C00-C96
DIB016254	INCB47986	Rheumatold arthritis	714	M05-M06
DIB016255	Tecogalan sodium	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016256	RCD-1	Stress urinary incontinence	.	N39.3
DIB016257	Moexiprilat	Heart failure	.	I50
DIB016258	Englitazone sodium	Diabetes mellitus type 2	.	E11
DIB016259	DA-6886	Irritable bowel syndrome	564.1	K58
DIB016260	CIGB-166	Cancer	.	C00-C97
DIB016261	RO-5310074	Autoimmune diseases	279.4	D84.9, M35.9
DIB016262	DOT1L inhibitors	Leukemia	208.9	C91-C95
DIB016263	CLX-0901	Diabetes mellitus type 2	250	E11
DIB016264	SY-300	Neurological disease	.	G00-G99
DIB016265	BAY 98-7196	Endometriosis	617	N80
DIB016266	Small molecule compounds	Duchenne dystrophy	.	G71.0
DIB016267	18F-NST-ML-10	Stroke	.	I61-I63
DIB016268	SiRNA nanoparticles	Non-small-cell lung cancer	162	C33, C34
DIB016269	PSMA subunit vaccine	Prostate cancer	185	C61
DIB016270	Barium sulfate	Gastrointestinal disease	.	K00-K93
DIB016271	Fat emulsion	Nutritional deficiency	.	E63.9
DIB016272	GLY-202	Neutropenia	288	D70
DIB016273	GSK-1322888	Gastroparesis	536.3	K31.8
DIB016274	IdeS	Autoimmune diseases	279.4	D84.9, M35.9
DIB016275	BTS-67582	Diabetes	250	E08-E13
DIB016276	GSK2849330	Cancer	.	C00-C97
DIB016277	Adhexil	Injury	.	S00-T88
DIB016278	DPI-125	Pain	338,780	R52, G89
DIB016279	Narrow spectrum antibiotics	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DIB016280	LANIQUIDAR	Cancer	140-229	C00-C96
DIB016281	NexVas VI	Vasculitis	.	I77.6,I80
DIB016282	Solid tumor therapeutic	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016283	CXL-1427	Acute decompensated heart failure	428	I50
DIB016284	CAP vaccine adjuvant	Vaccination	.	.
DIB016285	UX-003	Lysosomal storage disease	.	E75-E77
DIB016286	CaV2.2 blocker	Pain	338,780	R52, G89
DIB016287	BW-1003C87	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016288	EGFR modulators	Discovery agent	.	.
DIB016289	Calcium-activated potassium channel modulators	Atrial fibrillation	427.31	I48
DIB016290	MASP-2 inhibiting monoclonal antibodies	Inflammatory diseases	.	.
DIB016291	Norovirus vaccine	Norwalk virus infection	.	A08
DIB016292	EMR-62203	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DIB016293	Betalutin	Non-Hodgkin's lymphoma	200, 202	C82-C85
DIB016294	PEG-PLA-TNP-470	Cancer	.	C00-C97
DIB016295	F-598	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016296	CAPTAT-414	Non-small-cell lung cancer	162	C33, C34
DIB016297	CRX-675	Hepatitis virus infection	573.3	K75.9
DIB016298	Bufrudin	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB016299	Ammonium lactate	Dermatological disease	.	L00-L99
DIB016300	Posatirelin	Neurodegenerative diseases	.	G30-G32
DIB016301	Pegorgotein	Head injury	.	S00.0,S09
DIB016302	Fatty acid synthase inhibitors	Cancer	140-229	C00-C96
DIB016303	Ensemblin macrocycle	Pain	338,780	R52, G89
DIB016304	BRX-3	Bone disease	.	M00-M99
DIB016305	Labeled TSH superagonists	Thyroid cancer	193	C73
DIB016306	CGS-22745	Inflammatory diseases	.	.
DIB016307	SM-10888	Cognitive impairment	.	F06.7
DIB016308	AM-001	Dermatological disease	.	L00-L99
DIB016309	Lu-AA38466	Neurological disease	.	G00-G99
DIB016310	Anti-gluten antibodies	Celiac disease	579	K90.0
DIB016311	Anti-cutaneous leishmaniasis therapy	Leishmania infection	.	B55.0
DIB016312	Ingavirin	Influenza virus infections	487	J10, J11
DIB016313	E-1101	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB016314	BFGF	Aneurysm	.	I72
DIB016315	VVP-808	Diabetes mellitus type 2	.	E11
DIB016316	Pleuromutilins	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016317	Linotroban	Thrombosis	.	I80-I82
DIB016318	Lck tyrosine kinase inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB016319	Norisoboldine	Inflammatory diseases	.	.
DIB016320	NMI-102	Inflammatory diseases	.	.
DIB016321	H3N2 influenza vaccine	Influenza virus infections	487	J10, J11
DIB016322	WF-11605	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016323	Alkaline Phosphatase	Ulcerative colitis	556	K51
DIB016324	TDI-0039	Motor neurone disease	335.2	G12.2
DIB016325	Strontium malonate	Metabolic bone disease	.	E50-E64,E70-E90
DIB016326	MPL-containing Pollinex allergy desensitization sublingual vaccine	Allergy	995.3	T78.4
DIB016327	D-5272	Asthma	493	J45
DIB016328	Rhodopsin gene therapy	Retinitis pigmentosa	.	H35.5
DIB016329	DNA vaccine	Acute myeloid leukemia	.	C92.0
DIB016330	RWJ-68023	Irritable bowel syndrome	.	K58
DIB016331	CSN5-targeting siRNA therapy	Cancer	140-229	C00-C96
DIB016332	ShRNA apolipoprotein B100 gene siliencer	Cardiovascular disease	390-459	I00-I99
DIB016333	Renin inhibitors	Hypertension	401	I10, I11, I12, I13, I15
DIB016334	Berirab	Rabies virus infection	001-139	A00-B99
DIB016335	PC-2000 program	Hepatitis B virus infection	.	B16
DIB016336	HCV NS3 protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB016337	MDAM (y-methylene-10-deazaaminopterin)	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB016338	Combined PR1/WT1 vaccine	Myeloid leukemia	205	C92
DIB016339	Anti-folate receptor 1 humanized mAb	Ovarian cancer	.	C56
DIB016340	SR-121787	Thrombosis	.	I80-I82
DIB016341	BreMel/rGel	Breast cancer	174, 175, 217	C50, D24
DIB016342	ATI-20000 series	Metabolic disorders	.	E70-E90
DIB016343	Melanocortin MC4 agonist	Obesity	278	E66
DIB016344	MAXY-4	Autoimmune diseases	.	D84.9
DIB016345	CALANOLIDE A	Mycobacterium tuberculosis infection	.	A15-A19
DIB016346	Bisplatinum complexes	Cancer	140-229	C00-C96
DIB016347	(S)-8-hydroxy palmitic acid (cancer), Vanas Oncology	Cancer	140-229	C00-C96
DIB016348	Racotumomab	Breast cancer	.	C50
DIB016349	KB-5492	Peptic ulcer	.	K25-K27
DIB016350	Kv1.5 voltage-gated potassium channel antagonists	Atrial fibrillation	427.31	I48
DIB016351	APTO-253	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DIB016352	1D09C3	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB016353	Oxilan iohexol	Vascular disease	325, 430-459	G45-G46, I60-I95
DIB016354	SMTP compounds	Cancer	.	C00-C97
DIB016355	DAP kinase inhibitors	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016356	Dasiprotimut-T	Lymphoma	.	C81-C96
DIB016357	Protein tyrosine phosphatase 1B modulators	Obesity	278	E66
DIB016358	IMAB-027	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016359	MabionHER2	Breast cancer	174, 175, 217	C50, D24
DIB016360	UR-10324	Inflammatory diseases	.	.
DIB016361	ICT-69	Autoimmune diseases	279.4	D84.9, M35.9
DIB016362	HLA-II antagonist	Autoimmune diseases	279.4	D84.9, M35.9
DIB016363	PF-06263276	Psoriasis	.	L40
DIB016364	H3 antagonists	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB016365	Dengue fever therapeutics	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB016366	CMV vaccine	Cytomegalovirus infection	.	B25
DIB016367	CC-408	Pain	338,780	R52, G89
DIB016368	Anti-LRP6 monoclonal antibody	Cancer	140-229	C00-C96
DIB016369	Oleoyl-estrone	Obesity	.	E66
DIB016370	Epanolol	Angina	413	I20
DIB016371	Sn-117m-DTPA	Bone metastases	198.5	C79.51
DIB016372	Heart cell therapy	Cardiovascular disease	390-459	I00-I99
DIB016373	PF-3392455	Hypertension	401	I10, I11, I12, I13, I15
DIB016374	C4.4a-ADC	Cancer	140-229	C00-C96
DIB016375	PRO-367	HIV infections	42	B20
DIB016376	Org-33201	Breast cancer	174, 175, 217	C50, D24
DIB016377	AD-5075	Diabetes mellitus type 2	.	E11
DIB016378	CU-906	Cancer	140-229	C00-C96
DIB016379	Cancer therapeutics	Cancer	.	C00-C97
DIB016380	DDP-200	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB016381	P2B-001	Parkinson's disease	.	G20
DIB016382	Ro-25-7103	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016383	GR-38414	Pain	338,780	R52, G89
DIB016384	Glucagon analogs	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
DIB016385	Immunoconjugate	Cancer	140-229	C00-C96
DIB016386	Hypoxic response inhibitors	Cancer	140-229	C00-C96
DIB016387	Levorphanol extended release	Pain	.	G89
DIB016388	Kv1.3 potassium channel blockers	Autoimmune diseases	279.4	D84.9, M35.9
DIB016389	SKI-2034R	Cancer	140-229	C00-C96
DIB016390	PPK inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016391	RS-66252	Alzheimer's disease	.	G30,F00
DIB016392	Dry-powder peptide YY(3-36)	Obesity	278	E66
DIB016393	AVX-002	Rheumatold arthritis	714	M05-M06
DIB016394	BI-44370 TA	Migraine	346	G43
DIB016395	PTH analogs	Osteoporosis	733	M80-M81
DIB016396	NVX-272	Cancer	140-229	C00-C96
DIB016397	JTZ-951	Anemia	.	D50-D64
DIB016398	Anti-heparanase mAbs	Cancer	140-229	C00-C96
DIB016399	Paclitaxel coated balloon	Peripheral arterial disease	443.9	I73.9
DIB016400	GPCR modulators	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB016401	Cephaloridine	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016402	WIN-64821	Asthma	.	J45
DIB016403	BIBU-251	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB016404	Heparin low molecular weight	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB016405	Protegrins	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016406	Phospholipase A2 inhibitors	Asthma	.	J45
DIB016407	RAP-102	HIV infections	42	B20
DIB016408	Influenza vaccine patch	Influenza virus infections	487, 488	J10, J11
DIB016409	Surface plasminogen activator inhibitors	Yersinia infections	.	A20
DIB016410	LY-231617	Arthritic	710-719	M00-M25
DIB016411	VitiGam	Melanoma	172	C43
DIB016412	ICA-1	Cancer	140-229	C00-C96
DIB016413	TechneScan Q12	Heart disease	390-429	I00-I52
DIB016414	EF-4	Diabetic complication	.	E08-E13
DIB016415	Castor oil	Constipation	564	K59.0
DIB016416	Alpha-7 nicotinic acetylcholine receptor agonists	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB016417	Cadi-05	Prostate cancer	.	C61
DIB016418	Lithium	Multiple sclerosis	340	G35
DIB016419	DuP-129	Hypercholesterolemia	272	E78.0
DIB016420	BMY-22089	Hyperlipidemia	.	E78.5
DIB016421	SL-91.0893	Prostate hyperplasia	.	N40
DIB016422	VEL-0230	Rheumatold arthritis	.	M05-M06
DIB016423	Influsome-Vac	Influenza virus infections	487	J10, J11
DIB016424	Embeconazole	Fungal infection	.	B35-B49
DIB016425	Enzyme replacement therapy	Lysosomal storage disease	.	E75-E77
DIB016426	ORL1 ligands	Pain	338,780	R52, G89
DIB016427	VLP vaccines	Plasmodium infection	.	B54
DIB016428	Narrow spectrum antibiotics	Helicobacter pylori infection	41.86	B96.81
DIB016429	KR-6346	Stomach ulcer	.	K25-K27
DIB016430	Anti-TAG-72 antibody	Cancer	140-229	C00-C96
DIB016431	LL-4218	Psoriasis	696	L40
DIB016432	BCL-005	Melanoma	172	C43
DIB016433	SX-013	Obesity	278	E66
DIB016434	MN-3015	Diagnosis of coronary artery disease	410-414, 429.2	I20-I25
DIB016435	BL-1833	Headache	339, 784.0	G43-G44, R51
DIB016436	PARP inhibitors	Breast cancer	174, 175, 217	C50, D24
DIB016437	Joint disease therapy	Arthropathy	.	M00-M14
DIB016438	MDDR 143686	Solid tumours	.	C00-C75,C7A,C7B
DIB016439	SUPER-LEU-DOX	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB016440	NWP-08	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DIB016441	Human recombinant factor VIIa	Factor IX deficiency	.	D67
DIB016442	Salmonella typhi Ty21a-vectored vaccine	Bacillus anthracis infection	.	A22
DIB016443	BURKE-104	Verruca vulgaris	.	B07.9
DIB016444	SF-116	Glaucoma	365	H40-H42
DIB016445	MK-6592	Cancer	140-229	C00-C96
DIB016446	ST-7	Neutropenia	288	D70
DIB016447	ICAM-3 antibodies	Graft-versus host disease	.	T86.0
DIB016448	DasKloster 0249-01	Mycobacterium tuberculosis infection	.	A15-A19
DIB016449	Anti-mammaglobin vaccine	Breast cancer	174, 175	C50
DIB016450	FK-664	Cardiotonic	.	I50
DIB016451	Calcium channel blocker	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016452	RGel-Adnectin	Cancer	140-229	C00-C96
DIB016453	DM-199	Autoimmune diseases	279.4	D84.9, M35.9
DIB016454	NNRTIs	HIV infections	42	B20
DIB016455	Apoptosis inducers	Cancer	140-229	C00-C96
DIB016456	BW-773U82	Solid tumours	.	C00-C75,C7A,C7B
DIB016457	OPN-302	Inflammatory diseases	.	.
DIB016458	Antibacterial compounds	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016459	Frone	Hepatitis B virus infection	.	B16
DIB016460	CR-4056	Pain	338,780	R52, G89
DIB016461	Paliroden	Parkinson's disease	.	G20
DIB016462	MDL-101002	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016463	Org-37684	Anxiety disorder	.	F40-F42
DIB016464	Rupintrivir	Viral infections	042-075	A80-A99, B00-B34
DIB016465	GI-270384X	Inflammatory bowel disease	555, 556	K50, K51
DIB016466	D-1367	Arthritis	710-719	M00-M25
DIB016467	Alzheimer program	Alzheimer's disease	331	G30
DIB016468	E-4931	Asthma	493	J45
DIB016469	Multiple sclerosis peptide therapy	Multiple sclerosis	340	G35
DIB016470	Penicillin G procaine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016471	ApoVax104-HPV	Uterine cervix cancer	.	C53
DIB016472	SYM-007	Cancer	140-229	C00-C96
DIB016473	KI-0806	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB016474	Vasopressin V1b receptor antagonists	Major depressive disorder	296.2, 296.3	F32, F33
DIB016475	Ribosome recycling factor inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016476	Anti-FXI antibody	Thrombosis	.	I80-I82
DIB016477	Bone marrow therapy	Osteoporosis	.	M80-M81
DIB016478	Anticancer compounds	Cancer	140-229	C00-C96
DIB016479	Pretarget technology	B-cell lymphoma	.	C85.1
DIB016480	Protein kinase C epsilon/theta inhibitors	Inflammatory diseases	.	.
DIB016481	Antimicrobial LL-37 cathelicidin	Infectious disease	001-139	A00-B99
DIB016482	MODECAINIDE	Cardiac arrhythmias	.	I47-I49
DIB016483	REV-598	Carcinoid syndrome	.	E34.0
DIB016484	MLR-1130	Atopic dermatitis	691.8	L20
DIB016485	FR-158999	Thrombosis	.	I80-I82
DIB016486	LN-030	Prostate tumor	185	C61
DIB016487	TESTOSTERONE BUCICLATE	Contraception	.	Z30
DIB016488	Recombinant Factor IX	Hemophilia	.	D66-D68
DIB016489	BRL-44385	Viral infections	042-075	A80-A99, B00-B34
DIB016490	AZM-120	Diabetes mellitus type 2	.	E11
DIB016491	Mirisetron maleate	Anxiety disorder	.	F40-F42
DIB016492	LLL-2011	Migraine	346	G43
DIB016493	TS01	Stroke	.	I61-I63
DIB016494	OC-L vaccine	Fallopian tube cancer	.	C57.0,D28.2
DIB016495	SKF-98016	Arteriosclerosis	.	I70
DIB016496	BMY-40062	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB016497	Allostrome	Arthropathy	.	M00-M14
DIB016498	Tolerizing peptide	Allergic rhinitis	477	J30
DIB016499	DdRNAi therapy rHIV7-shl-TAR-CCR5RZ, stem cells	Human immunodeficiency virus infection	.	B20
DIB016500	AXP-107-08	Wound healing	.	S91.3
DIB016501	HCV NS3 protease inhibitors	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB016502	Octaplas LG	Thrombosis	.	I80-I82
DIB016503	IDDBCP226234	Inflammatory diseases	.	.
DIB016504	Plasmodium vivax vaccine	Plasmodium vivax infection	.	B54
DIB016505	PTH-CBD	Osteoporosis	733	M80-M81
DIB016506	CLP-1002	Congestive heart failure	428	I50
DIB016507	RP-64966	Gout	274.00274.1274.8274.9	M10
DIB016508	Pyrantel	Worm infections	.	B80
DIB016509	Recombinant subunit vaccine	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
DIB016510	ACEA-2085	Pain	338,780	R52, G89
DIB016511	PNT-400	Cancer	140-229	C00-C96
DIB016512	Cathepsin S inhibitors	Autoimmune diseases	279.4	D84.9, M35.9
DIB016513	Cartistem	Rheumatold arthritis	714	M05-M06
DIB016514	FK-739	Hypertension	401	I10, I11, I12, I13, I15
DIB016515	Beta-catenin mRNA antagonists	Cancer	140-229	C00-C96
DIB016516	DBT-1339	Alzheimer's disease	331	G30
DIB016517	HD-0801	Parkinson's disease	.	G20
DIB016518	Instiladrin	Bladder cancer	.	C67
DIB016519	Padoporfin photodynamic therapy	Prostate tumor	185	C61
DIB016520	BL-6010	Non-insulin dependent diabetes	.	E11.9
DIB016521	HB-1275	Skin infections	.	L00-L08
DIB016522	MB-11040	Autoimmune diseases	279.4	D84.9, M35.9
DIB016523	APD-515	Xerostomia	527.7	K11.7, R68.2
DIB016524	Mitumprotimut-t	Lymphoma	.	C81-C96
DIB016525	Partial PPAR gamma agonist	Hypercholesterolemia	272	E78.0
DIB016526	Crisnatol	Cancer	.	C00-C97
DIB016527	Zeniplatin	Melanoma	.	C43
DIB016528	Orphan nuclear receptor modulators	Cancer	.	C00-C97
DIB016529	MT-119	Cancer	140-229	C00-C96
DIB016530	Taprostene	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB016531	GLPG-0187	Bone metastases	198.5	C79.51
DIB016532	MB40	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016533	GLENVASTATIN	Hyperlipidemia	.	E78.5
DIB016534	SMAC mimetics	Autoimmune diseases	279.4	D84.9, M35.9
DIB016535	Benzydamine hydrochloride	Upper respiratory infection	.	J00-06,J30-39
DIB016536	AZD-4407	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB016537	PRX-1	Parkinson's disease	.	G20
DIB016538	J591-Ac-225	Prostate tumor	185	C61
DIB016539	Bepafant	Septic shock	.	A41.9
DIB016540	Q-201	Mycobacterium tuberculosis infection	.	A15-A19
DIB016541	NVX-188	Cancer	.	C00-C97
DIB016542	AKT1/2 moduator	Cancer	140-229	C00-C96
DIB016543	Sameridine	Pain	.	G89
DIB016544	FP-0110	Gastrointestinal disease	.	K00-K93
DIB016545	NV.RYM.09	Ocular disease	.	H00-H59
DIB016546	RG-101	Hepatitis C virus infection	.	B17.1,B18.2
DIB016547	MDX-1459	Cancer	140-229	C00-C96
DIB016548	CYP2B1-expressing ProCon vector	Breast cancer	174, 175, 217	C50, D24
DIB016549	EC1456	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DIB016550	V-101	Erythema	.	L51.9
DIB016551	Hepatitis B cores	Hepatitis B virus infection	.	B16
DIB016552	AV-1013	Nervous system inflammation	.	G00-G09
DIB016553	CDP-860	Solid tumours	.	C00-C75,C7A,C7B
DIB016554	STP-206	Enterocolitis	.	A04.7
DIB016555	MazF gene therapy	HIV-1 infections	42	B20
DIB016556	SF-113	Retinopathy	362.0-362.2	H35-H35.2
DIB016557	FGF-2 agonist	Huntington's disease	.	F02.2,G10
DIB016558	DiaPep-277	Autoimmune diseases	.	D84.9
DIB016559	EDP-20	Cancer	140-229	C00-C96
DIB016560	CTP-354	Pain	.	G89
DIB016561	Autologous dendritic cell-tumor cell fusion vaccine	Gastrointestinal cancer	.	C15-C26
DIB016562	Anti-S agalactiae humanized monoclonal antibodies	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016563	IQ-DAA	Bacillus anthracis infection	.	A22
DIB016564	Farnesyl pyrophosphate synthase (FPS) bisphosphonate inhibitors	Bone disease	.	M00-M99
DIB016565	Methotrexate derivatives	Rheumatold arthritis	714	M05-M06
DIB016566	DRF 10945	Hyperlipidemia	272.0-272.4	E78
DIB016567	ER-35786	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB016568	Lexibulin iv infusion	Glioblastoma	.	C71
DIB016569	PRO-001	Retinitis pigmentosa	.	H35.5
DIB016570	Chlortetracycline	Pseudomonas infection	.	B96.5,J15.1
DIB016571	TOL-3021	Leukemia	208.9	C91-C95
DIB016572	TGFK09SD-ER	Hypoactive sexual desire disorder	.	F52.0
DIB016573	Sitosterol	Hyperlipidemia	272.0-272.4	E78
DIB016574	ChronVac-B	Hepatitis B virus infection	.	B16
DIB016575	UGP-281	Obesity	278	E66
DIB016576	SKL-18287	Non-insulin dependent diabetes	.	E11.9
DIB016577	JNJ-1930942	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB016578	YM-16151-4	Hypertension	.	I10-I15
DIB016579	Rivoglitazone	Ocular inflammation	.	H00-H59
DIB016580	VPM-2-001	Cytomegalovirus infection	.	B25
DIB016581	JTT-553	Obesity	278	E66
DIB016582	MystiLol	Glaucoma	365	H40-H42
DIB016583	GPR43 positive allosteric modulators	Lipid metabolism disorder	.	E75-E78
DIB016584	ANG-3062	Fibrosis	709.2	L90.5
DIB016585	DS-8895	Solid tumours	.	C00-C75,C7A,C7B
DIB016586	Anti-CD22 antibody drug-conjugates	B-cell lymphoma	202.8	C85.1
DIB016587	H1N1 influenza vaccine	Influenza virus infections	487	J10, J11
DIB016588	CGEN-913	Inflammatory diseases	.	.
DIB016589	Nematode anticoagulant proteins	Angina	.	I20
DIB016590	Pyrazinoylguanidine	Diabetes	250	E08-E13
DIB016591	Antibacterial/antifungal compounds	Infectious disease	001-139	A00-B99
DIB016592	ASP-2151	Herpes simplex virus infection	.	A60,B00
DIB016593	Cardiomyocyte therapy	Myocardial infarction	410	I21, I22
DIB016594	Recombinant protein subunit vaccine	Infectious and parasitic disease	.	A00-B99
DIB016595	Low-dose oral interferon	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DIB016596	Dihydroergocristine	Alcohol use disorders	303	F10.2
DIB016597	AVN-492	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB016598	B-428	Cancer	140-229	C00-C96
DIB016599	Humanized monoclonal antibody conjugates	Multiple myeloma	203	C90.0
DIB016600	MT-101	Cancer	140-229	C00-C96
DIB016601	HG-1338	Cancer	140-229	C00-C96
DIB016602	ARL-67085	Thrombosis	.	I80-I82
DIB016603	MDX-1100	Crohn's disease	.	K50
DIB016604	CIGB-500	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016605	PUMA antagonist	Cardiovascular disease	390-459	I00-I99
DIB016606	Rebelex	Acute myeloid leukemia	205	C92.0
DIB016607	E-6700	Asthma	.	J45
DIB016608	Antimelanoma antibodies	Melanoma	172	C43
DIB016609	MMP-12 inhibitors	Inflammatory diseases	.	.
DIB016610	Influenza vaccine	Influenza virus infections	487	J10, J11
DIB016611	CP-903397	Schizophrenia	295	F20
DIB016612	MraY inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016613	Giracodazole	Cancer	140-229	C00-C96
DIB016614	AST-1306	Cancer	140-229	C00-C96
DIB016615	AL-072	Legionella infection	.	A48.1
DIB016616	BKT-140	Neutropenia	.	D70
DIB016617	SUN-N8075	Cerebral infarction	.	I63
DIB016618	ATryn antithrombin	Multiple sclerosis	.	G35
DIB016619	Apligraf	Diabetic foot ulcer	.	E08-E13
DIB016620	AHMA derivatives	Cancer	140-229	C00-C96
DIB016621	Unacylated ghrelin	Diabetes mellitus type 1	.	E10
DIB016622	Afuresertib	Multiple myeloma	.	C90.0
DIB016623	Glutamate NMDA receptor inhibitors	Neurodegenerative diseases	.	G30-G32
DIB016624	Bcl-xL inhibitors	Cancer	140-229	C00-C96
DIB016625	Brentuximab vedotin companion diagnostic	Lymphoma	202.8	C81-C96
DIB016626	HLA-DQ2 peptide vaccine	Celiac disease	579	K90.0
DIB016627	Droloxifene	Breast cancer	174, 175, 217	C50, D24
DIB016628	MPA-04	Stress urinary incontinence	.	N39.3
DIB016629	Kv1.1 voltage-gated potassium ion channel modulators	Pain	338,780	R52, G89
DIB016630	DPP-IV inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB016631	Cu64-CNND1-B	Breast cancer	174, 175, 217	C50, D24
DIB016632	TVX-007	Discovery agent	.	.
DIB016633	HBV-MF59	Hepatitis B virus infection	.	B16
DIB016634	RNA vaccine	Allergy	995.3	T78.4
DIB016635	Histone methyltransferase inhibitors	Cancer	140-229	C00-C96
DIB016636	CI-1002	Alzheimer's disease	.	G30,F00
DIB016637	HIV integrase inhibitors	HIV infections	42	B20
DIB016638	TM-31	Rheumatold arthritis	714	M05-M06
DIB016639	Varespladib methyl	Rheumatold arthritis	.	M05-M06
DIB016640	Terpin hydrate	Cough	786.2	R05
DIB016641	SIM-010603	Cancer	140-229	C00-C96
DIB016642	HSV thymidine kinase inhibitors	Herpes simplex virus infection	54	B00
DIB016643	Mesna	Urinary dysfunction	.	N39.3-N39.4
DIB016644	Liproca Depot	Prostate cancer	.	C61
DIB016645	Phosphatase inhibitors	Alzheimer's disease	.	G30,F00
DIB016646	Regavirumab	Cytomegalovirus infection	.	B25
DIB016647	IX207-887	Rheumatold arthritis	.	M05-M06
DIB016648	PF-3893787	Asthma	493	J45
DIB016649	Mineral oil	Constipation	564	K59.0
DIB016650	Influenza cell culture vaccine	Influenza virus infections	487, 488	J10, J11
DIB016651	PSMA ADC therapeutic	Prostate cancer	.	C61
DIB016652	DNA vaccine	Influenza virus infections	487	J10, J11
DIB016653	P1025	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016654	Recombinant human CC10	Asthma	.	J45
DIB016655	SR-27950	Eating disorder	307.5	F50
DIB016656	CME-548	Cancer	140-229	C00-C96
DIB016657	Acyclic nucleoside phosphonates	Viral infections	042-075	A80-A99, B00-B34
DIB016658	P38A MAPK inhibitors	Inflammatory diseases	.	.
DIB016659	Org-8484	Major depressive disorder	296.2, 296.3	F32, F33
DIB016660	HIV protease inhibitor	HIV infections	42	B20
DIB016661	Trivalent seasonal influenza virus-like particle vaccine	Influenza virus infections	487	J10, J11
DIB016662	Meningitis vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016663	R1549 (formerly pemtumomab)	Ovarian cancer	183	C56
DIB016664	GSK-1360707	Major depressive disorder	296.2, 296.3	F32, F33
DIB016665	HPV vaccine	Papillomavirus infections	.	B97.7
DIB016666	TMI-358	Onychomycosis	.	B35.1
DIB016667	SPD-452	Epilepsy	345	G40
DIB016668	NPI-1999	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB016669	BA-016	Cancer	140-229	C00-C96
DIB016670	PRX-12239	Neurological disease	.	G00-G99
DIB016671	SDZ-ISQ-844	Asthma	493	J45
DIB016672	AG-221	Acute myeloid leukemia	.	C92.0
DIB016673	APX-008	Bone metastases	198.5	C79.51
DIB016674	T-cell receptor mimic mAbs	Infectious disease	001-139	A00-B99
DIB016675	Oral interferons	Papillomavirus infections	.	B97.7
DIB016676	Free radical scavengers	Septic shock	.	A41.9
DIB016677	D-26344	Cancer	140-229	C00-C96
DIB016678	Miproxifene	Cancer	140-229	C00-C96
DIB016679	SY-640	Liver disease	.	K70-K77
DIB016680	Twinrix	Hepatitis B virus infection	.	B16
DIB016681	ETR-002	Diabetes mellitus	250	E08-E13
DIB016682	PI3K inhibitors	Cancer	140-229	C00-C96
DIB016683	MX-68	Obesity	.	E66
DIB016684	Influenza DNA vaccine	Influenza virus infections	487, 488	J10, J11
DIB016685	XGP-510	Allergy	995.3	T78.4
DIB016686	LEO-32731	Psoriasis	.	L40
DIB016687	AMP-X-0001	Epilepsy	345	G40
DIB016688	Typhoid vaccine	Salmonella infection	.	A02.9
DIB016689	Bcl-2 inhibitors	Cancer	140-229	C00-C96
DIB016690	Human and mouse PSMA DNA vaccines	Prostate tumor	185	C61
DIB016691	SM-04690	Osteoarthritis	.	M19.90
DIB016692	Dual 5-HT reuptake inhibitor/NK1 antagonist	Major depressive disorder	296.2, 296.3	F32, F33
DIB016693	CB-813	Hemophilia	.	D66-D68
DIB016694	EPZ-6438	Solid tumours	.	C00-C75,C7A,C7B
DIB016695	KAF156	Plasmodium falciparum infection	.	B54
DIB016696	Antimicrobial peptides	HIV infections	42	B20
DIB016697	LY-2599506	Diabetes mellitus	.	E10-E14
DIB016698	CGP-49870	Hypertension	401	I10, I11, I12, I13, I15
DIB016699	PARP inhibitors	Cancer	.	C00-C97
DIB016700	Francisella tularensis vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016701	NP-313	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB016702	CYP17 inhibitors	Prostate tumor	185	C61
DIB016703	Sodium thiosulfate	Poison intoxication	.	T36-T50
DIB016704	ZP-002	Inflammatory diseases	.	.
DIB016705	IW-001	Idiopathic pulmonary fibrosis	.	J84.1
DIB016706	DPP-IV inhibitors	Non-insulin dependent diabetes	.	E11.9
DIB016707	PF-06291874	Diabetes mellitus type 2	.	E11
DIB016708	IPH-4201	Pancreatic cancer	.	C25
DIB016709	Neuraminidase inhibitors	Influenza virus infections	487	J10, J11
DIB016710	TX-RAD	Rheumatold arthritis	714	M05-M06
DIB016711	Interferon alpha	Hepatitis virus infection	.	B15-B19
DIB016712	Thermostable prophylactic influenza vaccine	Influenza virus infections	487	J10, J11
DIB016713	ALK inhibitors	Cancer	140-229	C00-C96
DIB016714	BINOSPIRONE MESYLATE	Anxiety disorder	.	F40-F42
DIB016715	EG-Mirotin	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DIB016716	(R)-mequitazine (incontinence/respiratory disease), Pierre Fabre	Respiratory disease	.	J00-J99
DIB016717	KB-004	Hematological malignancies	.	C81-C96
DIB016718	IM0-8400	Diffuse large b-cell lymphoma	.	C83.3
DIB016719	XEP-018	Pain	338,780	R52, G89
DIB016720	UK-51656	Cardiovascular disease	390-459	I00-I99
DIB016721	CEA-targeted autologous cell vaccine	Cancer	140-229	C00-C96
DIB016722	TRIMOPROSTIL	Glaucoma	365	H40-H42
DIB016723	TZP-202	Dyspepsia	536.8	K30
DIB016724	SULOFENUR	Cancer	140-229	C00-C96
DIB016725	Dihydrofolate reductase inhibitors	Plasmodium falciparum infection	.	B54
DIB016726	MDL-27531	Epilepsy	.	G40
DIB016727	Chlamydia pn. Vax	Chlamydia infection	.	A74.9
DIB016728	P-cadherin targeting antibodies	Cancer	140-229	C00-C96
DIB016729	ML-07	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB016730	Epitinib	Cancer	140-229	C00-C96
DIB016731	LG-611	Influenza virus infections	487	J10, J11
DIB016732	KOS-1803	Cancer	140-229	C00-C96
DIB016733	Selective phospholipase A2 subtype inhibitors	Allergy	995.3	T78.4
DIB016734	ChimeriVax-JE	Japanese encephalitis virus infection	.	A83.0
DIB016735	Myoblast cell transplantation	Myocardial infarction	410	I21, I22
DIB016736	AG-PPC709	Respiratory disorder	.	J98.9
DIB016737	GL-4001	Inflammatory diseases	.	.
DIB016738	MR-1817	Pain	338,780	R52, G89
DIB016739	3K3A-APC	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016740	E2F modulators	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016741	GRNCM-1	Heart disease	390-429	I00-I52
DIB016742	Imidazole salicylate	Inflammatory diseases	.	.
DIB016743	Iopromide	X-rays imaging	.	W88
DIB016744	AEM-18	Familial hypercholesterolemia	272	E78.0
DIB016745	Cyclohexenonic long-chain fatty alcohol derivatives	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016746	S-18327	Psychotic disorders	290-299	F20-F29
DIB016747	SNX-024	Obesity	278	E66
DIB016748	HIV-1 RNase H/HIV-1 integrase inhibitors	HIV infections	42	B20
DIB016749	TA-264	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB016750	NS-49	Urinary incontinence	788.3	N39.3, N39.4, R32
DIB016751	Auxotroph vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DIB016752	CYANIDIN CHLORIDE MONOHYDRATE	Ulcer	531-534	K25-K27
DIB016753	PAN-90806	Cancer	.	C00-C97
DIB016754	JCAR015	B-cell lymphoma	.	C85.1
DIB016755	IMS	Inflammatory bowel disease	555, 556	K50, K51
DIB016756	TJN-950	Shock	.	T79.4
DIB016757	Third generation antibacterials	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016758	Besipirdine	Cognitive impairment	.	F06.7
DIB016759	Ro-23-7777	Fungal infection	.	B35-B49
DIB016760	Autologousadipose stem cell therapy	Wound healing	.	S91.3
DIB016761	AFX-300 series	Inflammatory bowel disease	555, 556	K50, K51
DIB016762	BQS-481	Cancer	140-229	C00-C96
DIB016763	Disarmin	Infectious disease	001-139	A00-B99
DIB016764	Diphtheria, tetanus, pertussis, HBV, Haemophilus influenzae vaccine	Hepatitis B virus infection	.	B16
DIB016765	SPP-800	Hypertension	401	I10, I11, I12, I13, I15
DIB016766	Small molecule therapeutics	Viral infections	042-075	A80-A99, B00-B34
DIB016767	Anticancer compounds	Cancer	140-229	C00-C96
DIB016768	Recombinant interleukin-2	Cancer	.	C00-C97
DIB016769	VX-944	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DIB016770	TNF inhibitor	Acquired immunodeficiency syndrome	.	B20-B24
DIB016771	Phospho-aspirins	Cancer	.	C00-C97
DIB016772	Benoxaprofen hydroxamate	Respiratory disease	.	J00-J99
DIB016773	SIVIG	Autoimmune diseases	279.4	D84.9, M35.9
DIB016774	Stem cell therapy	Macular degeneration	.	H35.3
DIB016775	Rx-101005	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016776	Rafabegron	Diabetes mellitus type 2	.	E11
DIB016777	KI-0905	Asthma	493	J45
DIB016778	Lovaxin M	Melanoma	172	C43
DIB016779	ABT-724	Erectile dysfunction	.	F52.2,N48.4
DIB016780	Gene therapy	Retinopathy	362.0-362.2	H35-H35.2
DIB016781	TRAIL-R Atrimer	Cancer	140-229	C00-C96
DIB016782	Factor VIII gene therapy	Hemophilia	286	D66-D68
DIB016783	REN-1053	Ischemic heart diseases	410-414	I20-I25
DIB016784	GR-107537	Pain	338,780	R52, G89
DIB016785	PMI-016	Muscle wasting disease	.	M62.50?
DIB016786	AJ-814	Atherosclerosis	414.0, 440	I70
DIB016787	Incrementally modified drug	Lung cancer	162	C33-C34
DIB016788	H1N1 pandemic influenza vaccine (AS03 adjuvanted) 2	Influenza virus infections	487	J10, J11
DIB016789	Zabofloxacin	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DIB016790	SC-114	Autoimmune diseases	279.4	D84.9, M35.9
DIB016791	FCE-25672	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DIB016792	Anti-CD3 anti-CMV bispecific antibody-armed activated T-cells	Cytomegalovirus infection	.	B25
DIB016793	RP-71483	Anxiety disorder	300	F40-F42
DIB016794	NASPANVAC	Influenza virus infections	487	J10, J11
DIB016795	MelCancerVac	Colorectal cancer	153, 154	C18-C21
DIB016796	T-2007	Epilepsy	345	G40
DIB016797	Anti-OX40 monoclonal antibody	Prostate cancer	.	C61
DIB016798	HBV therapy	Hepatitis B virus infection	.	B16
DIB016799	IMD-015213	Cancer	.	C00-C97
DIB016800	Repifermin	Oral mucositis	.	K12.3
DIB016801	AG-1321002	Fever	.	R50.9
DIB016802	Sulphasalazine	Irritable bowel syndrome	564.1	K58
DIB016803	API-023	Gastroesophageal reflux disease	.	K21
DIB016804	ST10-021	Onychomycosis	.	B35.1
DIB016805	AXL-1717	Cancer	140-229	C00-C96
DIB016806	NPY Y5 antagonists	Major depressive disorder	296.2, 296.3	F32, F33
DIB016807	Streptavidin fusion protein	Cancer	140-229	C00-C96
DIB016808	EVT-201	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DIB016809	UR-9650	Fungal infection	.	B35-B49
DIB016810	AG-879	Neuropathic pain	338,780	R52, G89
DIB016811	House dust mite allergy vaccine	Allergic rhinitis	477	J30
DIB016812	EDG-003	Major depressive disorder	296.2, 296.3	F32, F33
DIB016813	NY-008	Hypertension	401	I10, I11, I12, I13, I15
DIB016814	EM-3106B	Insulinoma	.	C25.4
DIB016815	BE-13793C	Cancer	140-229	C00-C96
DIB016816	RNasin	Cancer	140-229	C00-C96
DIB016817	Synthetic p53	Cancer	140-229	C00-C96
DIB016818	Malaria vaccine	Plasmodium falciparum infection	.	B54
DIB016819	Y-39983	Glaucoma	365	H40-H42
DIB016820	Celvapan	Influenza virus infections	487	J10, J11
DIB016821	Daclizumab	Multiple sclerosis	.	G35
DIB016822	Mutant ras vaccine	Cancer	.	C00-C97
DIB016823	XGP-410	Acne vulgaris	706.1	L70.0
DIB016824	CK-2018509	Hypertension	401	I10, I11, I12, I13, I15
DIB016825	AVI-4539	Ebola virus infection	.	A98
DIB016826	PSP-D-CD40L	Cancer	.	C00-C97
DIB016827	ETBX-011 cancer vaccine	Late-stage metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016828	GnRH	Female infertility	628	N97.0
DIB016829	CreaVax-PC	Prostate tumor	185	C61
DIB016830	KRP-105	Lipid metabolism disorder	.	E75-E78
DIB016831	Leualacin	Heart arrhythmia	.	I47-I49
DIB016832	RPR-106541	Asthma	.	J45
DIB016833	XEN-D0103	Atrial fibrillation	427.31	I48
DIB016834	PG-545	Ocular disease	.	H00-H59
DIB016835	PCL-016	Acne vulgaris	706.1	L70.0
DIB016836	Oxapenem beta-lactamase inhibitors	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016837	A-70826	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016838	Respiratory syncytial virus targeting compounds	Respiratory syncytial virus 	79.6	B97.4
DIB016839	Dofequidar fumarate	Cancer	140-229	C00-C96
DIB016840	SL-201	Cancer	140-229	C00-C96
DIB016841	TA-101	Inflammatory diseases	.	.
DIB016842	MOD-3012	Factor IX deficiency	.	D67
DIB016843	Cytochrome P450 3A inhibitors	HIV infections	42	B20
DIB016844	GPR81 agonists	Coronary artery disease	410-414, 429.2	I20-I25
DIB016845	XGP-215	Cancer	.	C00-C97
DIB016846	MMPT	Cancer	140-229	C00-C96
DIB016847	Serpacwa	Poison intoxication	.	T36-T50
DIB016848	Amiprilose	Rheumatold arthritis	714	M05-M06
DIB016849	Calcium Cav2.2 channel blocker	Pain	338,780	R52, G89
DIB016850	TA-106	Asthma	493	J45
DIB016851	Mesoglycan	Cerebrovascular disorders	.	I60-I69
DIB016852	Recombinant human CFH protein	Renal disease	.	N00-N29
DIB016853	Hi8 HBV vaccine	Hepatitis virus infection	573.3	K75.9
DIB016854	AI-100	Multiple sclerosis	340	G35
DIB016855	GlyT-1 inhibitors	Dementia	290-294	F01-F07
DIB016856	Second generation neuregulin mutants	Cardiovascular disease	390-459	I00-I99
DIB016857	JZP-2	Panic disorder	300.01, 300.21	F41.0
DIB016858	XGP-610	Reperfusion injury	.	I00-I99
DIB016859	Gadopentetate dimeglumine	Carcinoma	.	D07.30
DIB016860	PEGylated insulin	Diabetes mellitus	250	E08-E13
DIB016861	WX-037	Cancer	140-229	C00-C96
DIB016862	BAY-61-9987	Chronic obstructive pulmonary disease	.	J40-J44,J47
DIB016863	BPZE-1	Bordetella pertussis infection	.	A37.0
DIB016864	ROCK inhibitor	Glaucoma	365	H40-H42
DIB016865	S-34109	Staphylococcus aureus infection	.	A41.0
DIB016866	Smallpox DNA vaccine	Virus infection	.	B03
DIB016867	Mearubik	Measles virus infection	.	B06.9
DIB016868	TVX-011	Discovery agent	.	.
DIB016869	NTP-2014	Epilepsy	345	G40
DIB016870	PGL-3001	Female infertility	628	N97.0
DIB016871	NSC-639829	Cancer	140-229	C00-C96
DIB016872	Phosphodiesterase inhibitors	Trypanosomiasis	086.5-086	B56-B57
DIB016873	Laxatives bulk forming	Constipation	564	K59.0
DIB016874	5-HT 6 antagonists (obesity, cognitive disorder), Bristol-Myers Squibb	Obesity	278	E66
DIB016875	IB-07A085	Fungal infection	.	B35-B49
DIB016876	BCH-2051	Cancer	140-229	C00-C96
DIB016877	HCV NS5B polymerase 'primer grip' inhibitor	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB016878	IDM-4	Leukemia	.	C91-C95
DIB016879	VAN-10-4-eluting stent	Restenosis	.	I51.89
DIB016880	SMART anti-E/P selectin	Asthma	.	J45
DIB016881	Coxsackievirus	Cancer	140-229	C00-C96
DIB016882	VTP-201227	Psoriatic disorders	696	L40
DIB016883	Streptococcus pneumoniae protein vaccine	Streptococcus pneumoniae infection	.	A00-B99
DIB016884	PBT-2	Alzheimer's disease	.	G30,F00
DIB016885	ADROGOLIDE HYDROCHLORIDE	Cognitive impairment	.	F06.7
DIB016886	HL-036	Discovery agent	.	.
DIB016887	Laxatives	Constipation	564	K59.0
DIB016888	Recombinant human CC10	Autoimmune diseases	279.4	D84.9, M35.9
DIB016889	BAY-85-8102	Brain diseases	.	G00-G99
DIB016890	BIIB-021	Breast cancer	174, 175, 217	C50, D24
DIB016891	Grippol Plus	Influenza virus infections	487	J10, J11
DIB016892	TAK-850	Lymphoma	202.8	C81-C96
DIB016893	Anti-DLL-4 mAb	Cancer	140-229	C00-C96
DIB016894	Encapsulated transplanted islets	Diabetes mellitus type 1	250	E10
DIB016895	5-HT 6 modulators (cognitive impairment), Albany Molecular Research	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DIB016896	CB-2431	Osteoarthritis	715	M15-M19, M47
DIB016897	AD-439	HIV infections	42	B20
DIB016898	HRV39 vaccines	Rhinovirus infection	.	J20.6?
DIB016899	Lytic peptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016900	RESP-6000	Atopic dermatitis	691.8	L20
DIB016901	MEDI6383	Solid tumours	.	C00-C75,C7A,C7B
DIB016902	CTCE-0422	Viral infections	042-075	A80-A99, B00-B34
DIB016903	EPI-12323 combination therapy	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DIB016904	CH-928	Asthma	493	J45
DIB016905	BL-7040	Inflammatory bowel disease	.	K50,K51
DIB016906	A2a receptor antagonist	Parkinson's disease	.	G20
DIB016907	IPH-2102	Acute myeloid leukemia	.	C92.0
DIB016908	ALS-2160	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DIB016909	Turmeric extracts	Alzheimer's disease	331	G30
DIB016910	Antibodies	Influenza virus infections	487	J10, J11
DIB016911	HDL-200	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DIB016912	AdHu5-ZGP	Ebola virus infection	.	A98
DIB016913	SJ-8002	Cancer	140-229	C00-C96
DIB016914	AD-729	Osteoarthritis	715	M15-M19, M47
DIB016915	SCHAL-3	Sickle-cell anemia	280-285	D50-D64
DIB016916	SRD-285	Wound healing	.	S91.3
DIB016917	AIR-001	Hypertension	.	I10-I15
DIB016918	OM-294-DP	Cancer	140-229	C00-C96
DIB016919	Pain therapeutic	Pain	338,780	R52, G89
DIB016920	NCE-401	Fibrosis	709.2	L90.5
DIB016921	MAL formulation	Opiate dependence	304	F11
DIB016922	LIBS project	Irritable bowel syndrome	564.1	K58
DIB016923	SLV-341	Non-insulin dependent diabetes	.	E11.9
DIB016924	FASORACETAM	Cognition disorders	.	F06.7
DIB016925	Cystic fibrosis therapy	Cystic fibrosis	277	E84
DIB016926	EQ-1280	Diabetes mellitus	250	E08-E13
DIB016927	FR-171113	Thrombosis	.	I80-I82
DIB016928	Oral IKappaB kinase beta (IKKbeta) inhibitors	Inflammatory diseases	.	.
DIB016929	DRH-12	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DIB016930	Viral propagation inhibitors	Influenza virus infections	487	J10, J11
DIB016931	HG-1143	Cancer	140-229	C00-C96
DIB016932	MDA-19	Neuropathic pain	338,780	R52, G89
DIB016933	Sibutramine sulfate	Obesity	278	E66
DIB016934	TBE-80E	Tick borne encephalitis virus infection	.	A84
DIB016935	Peniel-3000	Osteoporosis	733	M80-M81
DIB016936	YP-001	Atopic dermatitis	691.8	L20
DIB016937	Anti-ErbB2 antibodies	Cancer	140-229	C00-C96
DIB016938	FT-061	Fibrosis	709.2	L90.5
DIB016939	VX-787	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DIB016940	Florifenine	Inflammatory diseases	.	.
DIB016941	AG-013	Oral mucositis	528	K12.3
DIB016942	Fzd7	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DIB016943	Bovine immunoglobulin concentrate-C parvum	Diarrhea	.	A09,K59.1
DIB016944	Angiotensin II 1-7	Adult respiratory distress syndrome	.	J80
DIB016945	ALD-806	Cancer	140-229	C00-C96
DIB016946	Cytoporins	HIV infections	42	B20
DIB016947	Autologous endothelial progenitor cell therapy	Ischemic heart diseases	410-414	I20-I25
DIB016948	Fludeoxyglucose F 18	Cancer	.	C00-C97
DIB016949	CPG23CARD	Cardiovascular disease	390-459	I00-I99
DIB016950	177Lu-DOTA-octreotate (neuroendocrine tumors), Advanced Accelerator Applications	Melanoma	172	C43
DIB016951	OXECLOSPORIN	Immuno-suppressant	.	T86.0
DIB016952	Tirapazamine	Mild alzheimer's disease	331	G30
DIB016953	ZG-451	Cancer	140-229	C00-C96
DIB016954	BVB-808	Cancer	140-229	C00-C96
DIB016955	Oral immunoglobulin	Pediatric cancer	.	.
DIB016956	Small molecule therapeutics	Non-insulin dependent diabetes	.	E11.9
DIB016957	ACE-527	Escherichia coli infection	.	A00-B99
DIB016958	ERB-041	Inflammatory bowel disease	.	K50,K51
DIB016959	Fluorine-18-labelled peptides	Cancer	140-229	C00-C96
DIB016960	Metabolic disease/type 2 diabetes therapy	Metabolic disorders	.	E70-E90
DIB016961	SAR425899	Diabetes mellitus	250	E08-E13
DIB016962	TRPA1 blockers	Inflammatory diseases	.	.
DIB016963	AnergiX.RA	Rheumatold arthritis	714	M05-M06
DIB016964	RPA gene based adenovirus 4 vector vaccine	Anthrax	22	A22
DIB016965	Beta-globin-transduced autologous hematopoietic stem cell therapy	Beta thalassemia	.	D56.1
DIB016966	GBR-401	B-cell lymphoma	.	C85.1
DIB016967	DW-908e	Allergy	.	T78.4
DIB016968	Sustained release incrementally modified drug	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DIB016969	TDI-0079	Motor neurone disease	335.2	G12.2
DIB016970	Dermatological agents	Dermatological disease	.	L00-L99
DIB016971	CMV vaccine	Cytomegalovirus infection	.	B25
DIB016972	LY-2334737	Solid tumours	.	C00-C75,C7A,C7B
DIB016973	TD-6301	Overactive bladder disorder	596.51	N32.81
DIB016974	Recombinant galectin-3	Corneal abrasion	.	S05.0
DIB016975	Glycan inhibitors	Mucopolysaccharidosis	.	E76
DIB016976	Aminohippurate sodium	Renal disease	.	N00-N29
DIB016977	MCP-204	Bladder disease	.	N30-N32
DIB016978	ON-128 series	Cancer	140-229	C00-C96
DIB016979	ANG-3407	Prostate tumor	185	C61
DIB016980	RST-001	Retinopathy	362.0-362.2	H35-H35.2
DIB016981	AMG-191	Inflammatory diseases	.	.
DIB016982	DP-109	Neurodegenerative diseases	.	G30-G32
DIB016983	DIO-901	Diabetes mellitus type 1	250	E10
DIB016984	Regenerative cell induction program	Congestive heart failure	428	I50
DIB016985	Sodium chloride	Skin burns	940-949	T20-T31
DIB016986	DZ-2640	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DIB016987	MIQ-002	Major depressive disorder	296.2, 296.3	F32, F33
DIB016988	Adenovirus 4-based vaccine	Plasmodium falciparum infection	.	B54
DIB016989	NASVAC	Hepatitis B virus infection	.	B16
DIB016990	CAK1 inhibitors	Candida albicans infection	.	B37.0
DIB016991	BIIC-2	Hypertension	401	I10, I11, I12, I13, I15
DIB016992	AVE-8112	Parkinson's disease	332	F02.3, G20
DIB016993	RNAPc2	Colorectal cancer	.	C18-C20,C21
DIB016994	ARH-1	Plasmodium infection	.	B54
DIB016995	Pyrrolostatin	Cerebrovascular ischaemia	.	G45.9,I67.8
DIB016996	IMD-4482	Alzheimer's disease	331	G30
DIB016997	LY-223982	Asthma	.	J45
DIB016998	AP-005	Ulcerative colitis	556	K51
DIB016999	CBI-008	Cancer	.	C00-C97
DIB017000	IMA-026	Asthma	493	J45
DIB017001	MEN-10690	HIV-1 infections	42	B20
DIB017002	Lumiliximab	Leukaemia	.	C91-C95
DIB017003	KF-17867	Major depressive disorder	.	F32,F33
DIB017004	TDI-0068	Motor neurone disease	335.2	G12.2
DIB017005	TD-6989	Bladder cancer	188	C67
DIB017006	YP-009	Cancer	140-229	C00-C96
DIB017007	SP-MET-1	Breast cancer	.	C50
DIB017008	Bimoclomol	Diabetes mellitus	.	E10-E14
DIB017009	CUV-9900	Dermatological disease	.	L00-L99
DIB017010	Delta-9-tetrahydrocannabinol prodrugs	Pain	338,780	R52, G89
DIB017011	NGD-94-4	Schizophrenia	295	F20
DIB017012	BB-2983	Inflammatory bowel disease	555, 556	K50, K51
DIB017013	PXS-2076	Rheumatold arthritis	714	M05-M06
DIB017014	CMB-401	Breast cancer	174, 175, 217	C50, D24
DIB017015	Hookworm vaccine	Hookworm infection	.	B76.9
DIB017016	Cat allergy vaccine	Allergic rhinitis	477	J30
DIB017017	CYP26 inhibitors	Cancer	140-229	C00-C96
DIB017018	PFKFB3 kinase inhibitors	Cancer	.	C00-C97
DIB017019	Inhibitory RNA agents	Arthritis	710-719	M00-M25
DIB017020	P-glycoprotein inhibitors	Cancer	140-229	C00-C96
DIB017021	RP-382	Hemorrhagic dhock	.	R57.1
DIB017022	HumaRAD-HN	Head and neck cancer	140-149	C07-C14, C32-C33
DIB017023	MTI-506	Breast cancer	174, 175, 217	C50, D24
DIB017024	SCN1A protein stimulator oligonucleotides	Seizures	.	G40
DIB017025	CCX-832	Psoriasis	.	L40
DIB017026	AV4025	Hepatitis C virus infection	.	B17.1,B18.2
DIB017027	SL-87.0495	Angina	.	I20
DIB017028	Diabetes therapy	Diabetes mellitus	250	E08-E13
DIB017029	APS-2010	Hepatitis B virus infection	.	B16
DIB017030	ADR-851	Vomiting and nausea	787, 787.0	R11
DIB017031	Interferon-alpha micelle	Discovery agent	.	.
DIB017032	S-312-d	Epilepsy	.	G40
DIB017033	Beta 1-6 glucan-conjugated trastuzumab	Breast cancer	174, 175, 217	C50, D24
DIB017034	RS-8359	Major depressive disorder	.	F32,F33
DIB017035	Polygeline	Blood transfusion	.	D50-D89
DIB017036	IGE-026	Allergic rhinitis	477	J30
DIB017037	Apomorphine nasal powder	Erectile dysfunction	.	F52.2,N48.4
DIB017038	Caspase inhibitors	Brain injury	.	S09.90
DIB017039	Nasal Influvac	Influenza virus infections	487	J10, J11
DIB017040	T-54	Cancer	140-229	C00-C96
DIB017041	Milameline	Cognition disorders	.	F06.7
DIB017042	Silver nitrate	Chlamydia infection	.	A74.9
DIB017043	Natural killer T-cell inhibiting antibodies	Asthma	493	J45
DIB017044	Decapeptide allergy vaccine	Allergy	995.3	T78.4
DIB017045	P56lck inhibitors	Autoimmune diseases	.	D84.9
DIB017046	L-19-PDT	Age related macular degeneration	.	H35.30
DIB017047	SiRNA agent	Cancer	.	C00-C97
DIB017048	Annexin A5	Myocardial infarction	410	I21, I22
DIB017049	MC-1 mimetics	Pigmentation disorder	.	L80-L81
DNAP001262	Vismodegib	Basal cell cancer	140-229, 173	C00-C96, C44
DNAP001262	Vismodegib	Metastatic or locally advanced basal cell carcinoma	173	C44
DNAP001262	Vismodegib	Operable basal cell carcinoma	173	C44
DNAP001263	Peginesatide acetate	Anaemia	280-285, 403, 580-589, 585.1-585.5, 585.9	D50-D64, N00-N29, N18
DNAP001264	Tafluprost	Elevated intraocular pressure 	365, 365.04, 401	H40-H42, H40.0, I10, I11, I12, I13, I15
DNAP001264	Tafluprost	Glaucoma	.	H40-H42
DNAP001265	Lucinactant	Respiratory distress syndrome	518.5, 518.82	J80
DNAP001266	Pasireotide diaspartate	Cushing's disease	255	E24.0
DNAP001267	Carfilzomib	Multiple myeloma	140-199, 203.0, 210-229	C00-C75, C7A, C7B, C90.0, D10-D36, D3A
DNAP001267	Carfilzomib	Multiple myeloma	203	C90.0
DNAP001267	Carfilzomib	Relapsed/refractory myeloma	203	C90.0
DNAP001267	Carfilzomib	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNAP001268	Omacetaxine mepesuccinate	Chronic or accelerated-phase chronic myeloid leukaemia	208.9	C91-C95
DNAP001269	Ingenol mebutate	Actinic keratosis	702	L57.0
DNAP001269	Ingenol mebutate	Basal cell cancer	173	C44
DNAP001270	Crofelemer	HIV-associated diarrhoea	.	A09
DNAP001271	Ziv-aflibercept	Metastatic colorectal cancer	153, 154	C18-C21
DNAP001272	Glucarpidase	Delayed methotrexate clearance	.	.
DNAP001273	Tbo-Filgrastim	Severe neutropaenia in non-myeloid malignancies	140-239	C00-C96
DNAP001274	Ocriplasmin	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DNAP001274	Ocriplasmin	Symptomatic vitreomacular adhesion	.	H43
DNAP001275	Teduglutide	Short bowel syndrome	579.3	K91.8
DNAP001276	Taliglucerase alfa	Gaucher disease	272.7	E75.2
DNAP001276	Taliglucerase alfa	Metabolic disorders	.	E70-E90
DNAP001277	Raxibacumab	Anthrax	22	A22
DNAP001277	Raxibacumab	Inhalation anthrax	22	A22.minor
DNAP001278	Spinosad	Head lice	132	B85.0
DNAP001279	Fidaxomicin	Clostridium difficile associated diarrhea	008.45, 787.91	A04.7, A09, K59.1
DNAP001279	Fidaxomicin	Clostridium difficile associated diarrhea	8.45	A04.7
DNAP001280	Asparaginase Erwinia chrysanthemi	Acute lymphoblastic leukemia	204	C91.0
DNAP001281	Brentuximab vedotin	Anaplastic large-cell lymphoma; Hodgkin's lymphoma	202.8	C81-C96
DNAP001281	Brentuximab vedotin	CD30-positive hematological malignancies	140-239, 200-209, 202.8	C00-C96, C81-C96
DNAP001281	Brentuximab vedotin	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DNAP001281	Brentuximab vedotin	Cutaneous T-cell lymphoma	202.1, 202.2, 202.8	C81-C96, C84.0, C84.1
DNAP001281	Brentuximab vedotin	Hodgkin's lymphoma	201, 202.1, 202.2, 202.8, 204.0-208.9	C81, C81-C96, C83-C88, C84.0, C84.1
DNAP001281	Brentuximab vedotin	Hodgkin's lymphoma	201, 202.8	C81, C81-C96
DNAP001281	Brentuximab vedotin	Hodgkin's lymphoma; Systemic anaplastic large cell lymphoma	201, 202.8	C81, C81-C96
DNAP001281	Brentuximab vedotin	Leukemia	208.9	C91-C95
DNAP001281	Brentuximab vedotin	Relapsed/refractory CD30-positive non-Hodgkin lymphoma	140-239, 200, 201, 202, 202.8	C00-C96, C81, C81-C96, C82-C85
DNAP001281	Brentuximab vedotin	Relapsed/refractory CD30-positive non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
DNAP001282	Ceftaroline fosamil	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001282	Ceftaroline fosamil	Skin and skin-structure infections; Community acquired pneumonia	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
DNAP001283	Mifamurtide	Cancer	140-229	C00-C96
DNAP001283	Mifamurtide	Osteosarcoma	170	C40-C41
DNAP001284	Vinflunine	Cancer	140-229	C00-C96
DNAP001285	Zucapsacin	Osteoarthritis	715	M15-M19, M47
DNAP001286	Collagenase clostridium histolyticum	Dupuytren's contracture	728.6	M72.0
DNAP001286	Collagenase clostridium histolyticum	Scar tissue	.	L00-L99
DNAP001287	Velaglucerase alfa	Gaucher disease	272.7	E75.2
DNAP001287	Velaglucerase alfa	Metabolic disorders	.	E70-E90
DNAP001288	Pegloticase	Gout	274.00274.1274.8274.9	M10
DNAP001289	Immune globulin subcutaneous, 20% liquid	Immune disorder	.	D80-D89
DNAP001289	Immune globulin subcutaneous, 20% liquid	Primary immunodeficiencies	.	D84.9
DNAP001290	Corifollitropin alfa	Infertility	.	N46,N97.0
DNAP001291	Nalfurafine hcl	Uremic pruritis	698	L29
DNAP001292	Catumaxomab	Malignant ascites	183, 789.5	C56, R18
DNAP001292	Catumaxomab	Malignant pleural effusion	.	J91.0
DNAP001292	Catumaxomab	Ovarian cancer	183	C56
DNAP001293	Igiv-hb	Hepatitis B virus infection	.	B16
DNAP001293	Igiv-hb	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DNAP001294	Chondrocelect	Articular cartilage disorders	.	M24.10
DNAP001294	Chondrocelect	Cartilage lesions	.	L57.0
DNAP001295	Ceftobiprole medocaril	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNAP001295	Ceftobiprole medocaril	Bacterial infection	001-139, 250, 480-486, 730, 770.0	A00-B99, E08-E13, J12, J13, J14, J15, J16, J17, J18, M86, P23
DNAP001296	Methylnaltrexone bromide	Opioid-induced constipation	564	K59.0
DNAP001297	Difluprednate	Inflammation and pain associated with ocular surgery	338,780	R52, G89
DNAP001298	Dienogest	Endometriosis	617	N80
DNAP001299	Sugammadex sodium	Poisoning	.	.
DNAP001300	Biolimus a9	Restenosis	.	I51.89
DNAP001301	Oralair grasses	Allergic conjunctivitis	372.14	H10.45
DNAP001301	Oralair grasses	Grass pollen allergic	.	J30.1
DNAP001302	Rh-thrombin	Surgical hemostasis	.	D68.59
DNAP001303	Rh-thrombomodulin	Stroke	434.91	I61-I63
DNAP001304	Sf-1019	AIDS; Chronic inflammatory demyelinating polyneuropathy; Diabetic neuropathy	42	B20
DNAP001304	Sf-1019	Diabetes mellitus	250	E08-E13
DNAP001305	Somatotropin rdna original	Growth hormone deficiency	253.3	E23.0
DNAP001306	Sphingosomal topotecan	Cancers	.	C00-D48
DNAP001307	Xp-828l	Psoriasis	696	L40
DNAP001307	Xp-828l	Psoriatic disorders	696	L40
DNAP001308	Curemisinin	Malaria	.	B50-B54
DNAP001309	Trabectedin	Cancers	171	C49
DNAP001310	Lisdexamfetamine dimesylate	Attention deficit hyperactivity disorder	.	F90
DNAP001310	Lisdexamfetamine dimesylate	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNAP001311	Citrofen	Arthritis	.	M06.9
DNAP001312	Human immune globulin	Immune disorder	.	D80-D89
DNAP001312	Human immune globulin	Immunodeficiency	.	B20
DNAP001313	Follitropin alfa/lutropin alfa	Idiopathic male factor infertility	.	N46
DNAP001314	Oralgen	Type 2 diabetes	250.00, 250.02	E11
DNAP001315	Rexin-G	Cancer	140-229	C00-C96
DNAP001315	Rexin-G	Metastatic breast cancer	140-229, 174, 175	C00-C96, C50
DNAP001315	Rexin-G	Metastatic pancreatic cancer	140-229, 157	C00-C96, C25
DNAP001315	Rexin-G	Osteosarcoma	170	C40-C41
DNAP001315	Rexin-G	Soft tissue sarcoma	171	C49
DNAP001316	131i-chtnt	Cancer	140-229	C00-C96
DNAP001317	Methoxy polyethylene glycol-epoetin beta	Emesis	.	R11
DNAP001317	Methoxy polyethylene glycol-epoetin beta	Kidney transplant rejection	.	Z48.22
DNAP001318	Rh-erythropoietin-alfa	Postoperative inflammation	998	T81
DNAP001319	Rfsh/rhfsh	Infertility	.	N46,N97.0
DNAP001320	Human thrombin	Bleeding	.	R58
DNAP001321	Epoietin delta	Hematopoiesis	.	D50-D89
DNAP001322	Colostrinin	Alzheimer's disease	331	G30
DNAP001323	Celacade	Chronic heart failure	428	I50
DNAP001323	Celacade	Chronic lymphocytic leukaemia	204.1	C91.1
DNAP001324	Anecortave acetate	Macular degeneration	362.5	H35.3
DNAP001325	Polyphenon e	Perianal warts	.	A63.0
DNAP001325	Polyphenon e	Viral infections	042-075	A80-A99, B00-B34
DNAP001326	Nix-0699	Sickle-cell disease	282.6	D57
DNAP001327	Rhpth	Osteoporosis	733	M80-M81
DNAP001328	Rh-alphaglucosidase	Pompe's disease	.	E74
DNAP001329	Nimotuzumab	Breast cancer	174, 175	C50
DNAP001329	Nimotuzumab	Head and neck cancer; Astrocytoma; Glioma	140-229, 191	C00-C96, C71
DNAP001329	Nimotuzumab	Metastatic brain cancer	140-229, 191	C00-C96, C71
DNAP001329	Nimotuzumab	Prostate cancer	185	C61
DNAP001330	Idursulfase	Hunter syndrome	.	E76.1
DNAP001330	Idursulfase	Infertility	.	N46,N97.0
DNAP001331	Antithrombin alfa	Thrombin deficiency	.	D68.59
DNAP001332	Triproamylin acetate	Diabetes	250	E08-E13
DNAP001333	Conjugated estrogens b	Hormone replacement therapy	V07.4	Z79.890
DNAP001334	L-alanyl-l-glutamine	Mucositis	.	K00-K95
DNAP001335	Ach-02	Analgesic	.	R52.1-R52.2,G89
DNAP001336	Factor 8	Hemophilia	286	D66-D68
DNAP001336	Factor 8	Lymphoma	.	C81-C96
DNAP001337	Orthokine	Arthritic	710-719	M00-M25
DNAP001338	Oral insulin	Diabetes	250	E08-E13
DNAP001338	Oral insulin	Diabetes mellitus	250	E08-E13
DNAP001339	Rhuph20	Immunodeficiency	.	D84.9
DNAP001339	Rhuph20	Reproduction	600-629	N40-N99
DNAP001340	Belotecan hydrocholoride	Small-cell lung cancer	140-229, 162	C00-C96, C33-C34
DNAP001341	Talaporfin sodium	Cancer	140-229	C00-C96
DNAP001342	Hexyl aminolevulinate	Bladder cancer	188	C67
DNAP001342	Hexyl aminolevulinate	Cancer	140-229	C00-C96
DNAP001343	Vapreotide acetate	Cancer	140-229	C00-C96
DNAP001344	Von willebrand factor	Hemostatic	.	R58
DNAP001345	H-101	Cancer	.	C00-C97
DNAP001345	H-101	Cancer	140-229	C00-C96
DNAP001346	Epipodophyllotoxin	Cancers	.	C00-D48
DNAP001347	Desirudin	Deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
DNAP001347	Desirudin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNAP001348	Hemoglobin glutamer	Anemia	280-285	D50-D64
DNAP001349	Iv human immunoglobulin	Immune disorder	.	D80-D89
DNAP001349	Iv human immunoglobulin	Immuno-modulator	.	D80-D89
DNAP001350	Pulmonary insulin	Diabetes	250	E08-E13
DNAP001351	Laronidase	Mucopolysaccharidosis	.	E76
DNAP001352	Rec-antihemophilic factor	Hemophilia	286	D66-D68
DNAP001353	Temoporfin	Bone metastases	198.5	C79.51
DNAP001353	Temoporfin	Cancer	140-229	C00-C96
DNAP001354	Biapenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001355	Amrubicin hcl	Small-cell lung cancer	140-229, 162	C00-C96, C33-C34
DNAP001356	Amrubicin hydrochloride	Cancers	140-229, 151, 188	C00-C96, C16, C67
DNAP001357	Rh-bmp-2/acs	Bone induction	.	I45.9
DNAP001358	Immunoglobulin intravenous	Viral infections	042-075	A80-A99, B00-B34
DNAP001359	Gusperimus trihydrochloride	Immuno-suppressant	.	.
DNAP001360	Falecalcitrol	Hyperparathyroidism	.	E05
DNAP001361	Fudosteine	Bronchitis	.	J20-J21,J42
DNAP001361	Fudosteine	Expectorant	.	J20-J21,J42
DNAP001362	Agalsidase alfa	Fabry disease	272.7	E75.2
DNAP001363	Op-1	Tibial nonunions	.	S82
DNAP001364	Insulin determir	Diabetes	250	E08-E13
DNAP001365	Rasburicase	Hyperuricemia	790.6	E79.0
DNAP001366	Agalsidase beta	Fabry disease	272.7	E75.2
DNAP001366	Agalsidase beta	Fabry's disease; Label expansion	272.7	E75.2
DNAP001367	Crotalidae fab	Poison intoxication	.	T36-T50
DNAP001367	Crotalidae fab	Rattlesnake antivenom	.	T36-T50
DNAP001368	Activated protein c concn	Deep vein thrombosis	453.4	I80.2
DNAP001369	Acemannan	Canine and feline spontaneous neoplasms	.	C00-C97
DNAP001369	Acemannan	HIV infections	42	B20
DNAP001370	Verteporfin	Photosensitizer	.	L40
DNAP001370	Verteporfin	Psoriasis	696	L40
DNAP001371	Trimegestone	Hormone replacement therapy	V07.4	Z79.890
DNAP001372	Maxacalcitol	Calcium metabolism	.	M80-M81
DNAP001373	Dosmalfate	Gastroprotectant	.	K25-K27
DNAP001373	Dosmalfate	Stomach ulcer	.	K25-K27
DNAP001374	Taltirelin	Central nervous system disease	.	G00-G99
DNAP001375	Egualen sodium	Ulcer	531-534	K25-K27
DNAP001376	Arteether	Parasitic infections	84	B50-B54
DNAP001376	Arteether	Plasmodium infection	.	B54
DNAP001377	Aminolevulinic acid hci	Actinic keratoses	702	L57.0
DNAP001378	Pamiteplase	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001379	Glucagon rdna	Hormone deficiency	.	E00-E90
DNAP001380	Digoxin fab	Digoxin toxicity	972.1	T46.0X1
DNAP001380	Digoxin fab	Poison intoxication	.	T36-T50
DNAP001381	Kinetin	Skin photodamage	.	L55
DNAP001382	Rapacuronium bromide	Anesthesia	338	R52
DNAP001382	Rapacuronium bromide	Muscle Relaxant	.	N39.3,N39.4,R32
DNAP001383	Melevodopa	Parkinson's disease	.	G20
DNAP001383	Melevodopa	Parkinson's disease	332	F02.3, G20
DNAP001384	Conjugated estrogens a	Hormone replacement therapy	V07.4	Z79.890
DNAP001385	Colforsin daropate hci	Asthma	493	J45
DNAP001385	Colforsin daropate hci	Cardiovascular; Metabolic disease	270-279	E70-E89
DNAP001386	Arglabin	Cancers	.	C00-D48
DNAP001387	Moroctocog alfa	Hemophilia	286	D66-D68
DNAP001388	Mobenakin	Cancer	140-229	C00-C96
DNAP001389	Human neutral insulin	Diabetes	250	E08-E13
DNAP001390	Dermatan sulfate	Deep vein thrombosis	453.4	I80.2
DNAP001391	Calfactant	Acute lung injury	518	J80
DNAP001391	Calfactant	Respiratory distress syndrome	.	J80
DNAP001392	Human insulin zinc suspension	Diabetes	250	E08-E13
DNAP001393	Protein c concentrate	Purpura fulminans	.	D65
DNAP001394	Tasonermin	Cancer	140-229	C00-C96
DNAP001395	Cefoselis	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001396	Porcine neutral insulin	Diabetes	250	E08-E13
DNAP001397	Monteplase	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001398	Flurithromycin ethylsuccinate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001399	Cefcapene pivoxil	Bacterial infection	001-139, 599.0	A00-B99, N39.0
DNAP001400	Tandospirone	Anxiety disorder	300	F40-F42
DNAP001401	Ramosetron	Vomiting and nausea	787, 787.0	R11
DNAP001402	Zotarolimus	Cancers	.	C00-D48
DNAP001403	Zinc hyaluronate	Acne vulgaris	706.1	L70.0
DNAP001403	Zinc hyaluronate	Vulnerary	.	S00-T98
DNAP001404	Certoparin sodium	Deep vein thrombosis	453.4	I80.2
DNAP001405	Prezatide copper acetate	Diabetic foot ulcer	.	E08-E13
DNAP001405	Prezatide copper acetate	Vulnerary	.	S00-T98
DNAP001406	Betain anhydrous	Homocystinuria	.	E88.9
DNAP001406	Betain anhydrous	Inborn error of metabolism	.	E88.9
DNAP001407	Thymalfasin	Hepatitis virus infection	573.3	K75.9
DNAP001408	Resp syncytial virus ig	Respiratory syncytial virus 	79.6	B97.4
DNAP001408	Resp syncytial virus ig	Viral infections	042-075	A80-A99, B00-B34
DNAP001409	Interferon gamma-n1	Fungal infections	110-118	B35-B49
DNAP001410	Factor viia	Bleeding	.	R58
DNAP001410	Factor viia	Hemophilia	286	D66-D68
DNAP001411	Nateplase	Myocardial infarction	410	I21, I22
DNAP001411	Nateplase	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001412	Lanreotide acetate	Acromegaly	253	E22.0
DNAP001412	Lanreotide acetate	Growth hormone deficiency	253.0, 253.3	E22.0, E23.0
DNAP001413	Tirilazad mesylate	Cataract	366	H25-H26, H28, Q12.0
DNAP001413	Tirilazad mesylate	Subarachnoid hemorrhage	430, 852.0, 852.1	I60, P10.3, S06.6
DNAP001414	Cefozopran hcl	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001415	Carperitide	Acute myocardial infarction	410	I21-I22
DNAP001415	Carperitide	Congestive heart failure	428	I50
DNAP001416	Mab17-1a	Adjuvant colorectal cancer	140-229	C00-C96
DNAP001416	Mab17-1a	Breast cancer	.	C50
DNAP001417	Temocapril hydrochloride	Cardiovascular disease	325, 390-459, 401, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I60-I95
DNAP001418	Docarpamine	Cardiotonic	.	I50
DNAP001418	Docarpamine	Hypertension	401	I10, I11, I12, I13, I15
DNAP001419	Zinostatin stimalamer	Brain cancer	191	C71
DNAP001419	Zinostatin stimalamer	Cancers	.	C00-D48
DNAP001420	Unoprostone isopropyl ester	Glaucoma	365	H40-H42
DNAP001421	Polaprezinc	Helicobacter pylori infection	41.86	B96.81
DNAP001421	Polaprezinc	Ulcer	531-534	K25-K27
DNAP001422	Trimetrexate glucuronate	PCP/Toxoplasmosis	.	B58
DNAP001423	Panipenem	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001424	Betamethasone butyrate propion	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DNAP001425	Pegaspargase	Cancer	140-229	C00-C96
DNAP001426	Nartograstim	Hematopoiesis	.	D50-D89
DNAP001427	Mecasermin rinfabate	Diabetes	250	E08-E13
DNAP001427	Mecasermin rinfabate	Growth failure	.	R62.8
DNAP001428	Somatomedin-1	Hormone deficiency	.	E00-E90
DNAP001429	Porcine lung surfactant	Respiratory distress syndrome	.	J80
DNAP001430	Imidapril hci	Cardiovascular disease	325, 390-459, 401, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I60-I95
DNAP001431	Sorivudine	Varicella zoster virus infections	.	B01,B02
DNAP001431	Sorivudine	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
DNAP001432	Cytarabine ocfosfate	Cancer	.	C00-C97
DNAP001432	Cytarabine ocfosfate	Cancers	205.1, 208.9	C91-C95, C91.0, C92.1
DNAP001433	Histrelin	Central precocious puberty; Endometriosis; Polycystic ovarian disease; Uterine leiomyomas; Severe premenstrual syndrome; Acute intermittent porphyria	183, 218.9, 259.1, 277.1, 617, 625.4	C56, D25, E22.8, E30.1, E80.0-E80.2, E80.2, N80, N94.3
DNAP001434	Tretinoin tocoferil	Ulcer	531-534	K25-K27
DNAP001434	Tretinoin tocoferil	Wound healing	.	S91.3
DNAP001435	Ecabet sodium	Ulcer	531-534	K25-K27
DNAP001435	Ecabet sodium	Xerophthalmia	.	E50.6-E50.7
DNAP001436	Tacalcitol	Psoriasis	696	L40
DNAP001437	Recombinant factor viii	Hemophilia	286	D66-D68
DNAP001438	Cefetamet pivoxil hcl	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001438	Cefetamet pivoxil hcl	Bacterial infection	001-139, 487, 488, 599.0	A00-B99, J10, J11, N39.0
DNAP001439	Beraprost sodium	Platelet aggregatory	.	.
DNAP001440	Cefpirome sulfate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001440	Cefpirome sulfate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104, 460-519	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, J00-J99
DNAP001441	Sapropterin hydrochloride	Hyperphenylalaninemia	.	E70.1
DNAP001442	Andrographolide	Bacillary dysentery	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001442	Andrographolide	Cancer	.	C00-C97
DNAP001443	Pro-urokinase	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001443	Pro-urokinase	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DNAP001444	Duteplase	Myocardial infarction	410	I21, I22
DNAP001444	Duteplase	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001445	Factor vlll	Hemophilia	286	D66-D68
DNAP001446	Factor ix	Hemophilia	286	D66-D68
DNAP001447	Molgramostim	Hematopoiesis	.	D50-D89
DNAP001448	Hu neutral insulin	Type 1 diabetes	250.01	E10
DNAP001449	Teceleukin	Cancer	140-229	C00-C96
DNAP001450	Ha-1a	Atrial fibrillation; Congestive heart failure	427.31, 428, 428.0	I48, I50
DNAP001450	Ha-1a	Sepsis	995.91	A40, A41
DNAP001451	Celmoleukin	Cancer	140-229	C00-C96
DNAP001452	Interferon gamma-1a	Cancer	140-229	C00-C96
DNAP001453	Fludarabine phosphate	Cancer	140-229	C00-C96
DNAP001454	Cefotiam hexetil hydrochloride	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001455	Arteflene	Parasitic infections	84	B50-B54
DNAP001456	Silteplase	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001456	Silteplase	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DNAP001457	Lenogastrim	Hematopoiesis	.	D50-D89
DNAP001458	Mirimostim	Hematopoiesis	.	D50-D89
DNAP001459	Alglucerase	Enzyme deficiency	.	.
DNAP001460	Pegademase bovine	Immuno-stimulant	.	.
DNAP001461	Cefodizime sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001462	Arbekacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001463	Ethyl icosapentate	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001464	Pumactant	Asthma	493	J45
DNAP001464	Pumactant	Respiratory distress syndrome in neonates	.	P22.0
DNAP001465	Tisokinase	Acute myocardial infarction	410	I21-I22
DNAP001466	Erythropoietin beta	Erythropoiesis	.	J00-J99
DNAP001467	Factor ix human	Hemophilia	286	D66-D68
DNAP001468	Droxidopa	Fibromyalgia	729.1	M79.7
DNAP001468	Droxidopa	Intradialytic hypotension	458	I95
DNAP001468	Droxidopa	Neurogenic orthostatic hypotension	.	I95.1
DNAP001468	Droxidopa	Orthostatic hypotension	458	I95.1
DNAP001468	Droxidopa	Parkinson's disease	332	G20
DNAP001469	Dopexamine	Cardiac failure	.	I50
DNAP001469	Dopexamine	Cardiotonic	.	I50
DNAP001470	Delapril	Cardiovascular disease	325, 390-459, 401, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I60-I95
DNAP001471	Ethanolamine oleate	Bleeding	.	R58
DNAP001471	Ethanolamine oleate	Sclerosant	.	I85.10
DNAP001472	Cefmetazole sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001473	Tiopronin	Cystine urolithiasis	594.0, 594.1, 594.2, 594.8, 594.9	N21.0-N21.9
DNAP001473	Tiopronin	Cystinuria	.	E72.0
DNAP001474	Deslorelin	Cancers	140-229, 259.1, 617	C00-C96, E22.8, E30.1, N80
DNAP001475	Lmw heparin	Coagulation	.	I80-I82
DNAP001476	Ipriflavone	Calcium metabolism	.	M80-M81
DNAP001476	Ipriflavone	Osteoporosis	733	M80-M81
DNAP001477	Rv-11	Bacterial infection	466, 490, 491	J20-J21, J42
DNAP001478	Solamargine	Cancers	.	C00-D48
DNAP001479	Interferon gamma	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
DNAP001480	Human factor viii	Hemophilia	286	D66-D68
DNAP001481	Denopamine	Cardiotonic	.	I50
DNAP001482	Alacepril	Cardiovascular disease	325, 390-459, 401, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I60-I95
DNAP001483	Epervudine	Viral infections	001-139, 053, 054.0, 054.1, 054.2, 054.3, 771.2	A00-B99, A60, B00, B02, G05.1, P35.2
DNAP001484	Hydrocortisone aceponate	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DNAP001485	Pirarubicin	Breast cancer	174, 175, 217	C50, D24
DNAP001485	Pirarubicin	Cancers	140-229, 188	C00-C96, C67
DNAP001486	Secalciferol	Calcium metabolism	.	M80-M81
DNAP001487	Limaprost	Spinal stenosis	.	M48.0
DNAP001487	Limaprost	Thrombin deficiency	010-018, 490-496, 492, 770.7	A15-A19, J40-J44, J43, J45, J47, P27.1
DNAP001488	Tibolone	Anabolic metabolism	.	.
DNAP001489	Isepamicin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001489	Isepamicin	Bacterial infection	001-139, 460-519	A00-B99, J00-J99
DNAP001490	Propentofylline propionate	Alzheimer's disease	331	G30
DNAP001490	Propentofylline propionate	Vasodilator, cerebral	.	G30
DNAP001491	Halopredone acetate	Arthritic	710-719	M00-M25
DNAP001492	Flomoxef sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001493	Flutropium bromide	Cough	786.2	R05
DNAP001494	Erythromycin acistrate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 099.4, 100-104, 597	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, N34
DNAP001494	Erythromycin acistrate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001495	Choline alfoscerate	Amnesia	.	F04
DNAP001495	Choline alfoscerate	Nootropic	.	F00-F99
DNAP001496	Carumonam	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001497	Teicoplanin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001498	Midecamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001499	Fosfomycin trometamol	Bacterial infection	001-139, 595, 599.0	A00-B99, N30, N39.0
DNAP001499	Fosfomycin trometamol	Cystitis	.	N30
DNAP001500	Gamolenic acid	Antiallergic	.	H10.45
DNAP001501	Alpha-1 antitrypsin	Alpha-1 antitrypsin deficiency	.	E88.0
DNAP001501	Alpha-1 antitrypsin	Emphysema	492	J43
DNAP001501	Alpha-1 antitrypsin	Type 1 diabetes	250.01	E10
DNAP001502	Eptazocine hbr	Pain	338	R52
DNAP001503	Doxifluridine	Cancer	140-229	C00-C96
DNAP001504	Hidrosmin	Cardiovascular disease	390-459	I00-I99
DNAP001505	Lenampicillin hci	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001506	Sultamicillin tosilate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104, 599.0	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, N39.0
DNAP001507	Cefteram pivoxil	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104, 599.0	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, N39.0
DNAP001508	Teriparatide acetate	Calcium metabolism	.	M80
DNAP001509	Cefminox sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001509	Cefminox sodium	Bacterial infection	001-139, 599.0, 995.91	A00-B99, A40, A41, N39.0
DNAP001510	Metergolin	Hyperprolactinemia	253.1	E22.1
DNAP001510	Metergolin	Migraine	346	G43
DNAP001511	Aspoxicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001512	Cefuzonam sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001513	Ornoprostil	Gastritis	.	K29.6
DNAP001513	Ornoprostil	Ulcer	531-534	K25-K27
DNAP001514	Ganglioside gm1	Cerebrovascular ischaemia	.	G45.9,I67.8
DNAP001514	Ganglioside gm1	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001515	Bucillamine	Immuno-modulator	.	D80-D89
DNAP001516	Plaunotol	Ulcer	531-534	K25-K27
DNAP001517	Guglipid	Lipoprotein disorders	.	E00-E90
DNAP001518	Hyaluronate sodium	Joint lubricant	.	.
DNAP001519	Surfactant ta	Respiratory distress syndrome	518.5, 518.82	J80
DNAP001520	Factor viii	Hemophilia	286	D66-D68
DNAP001521	Epidermal growth factor	Ocular disease	.	H00-H59
DNAP001521	Epidermal growth factor	Vulnerary	.	S00-T98
DNAP001522	Nedocromil sodium	Allergic conjunctivitis	372.14	H10.45
DNAP001522	Nedocromil sodium	Antiallergic	.	H10.45
DNAP001523	Sulbactam sodium	Bacterial infection	.	.
DNAP001524	Brovincamine fumarate	Vasodilator, cerebral	.	.
DNAP001525	Rokitamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001526	Nomegestrol acetate	Breast cancer	174, 175, 217	C50, D24
DNAP001526	Nomegestrol acetate	Gynecological conditions associated with luteal deficiency	.	N83
DNAP001527	Triptorelin	Cancers	140-229, 185	C00-C96, C61
DNAP001528	Gestrinone	Breast cancer	.	.
DNAP001529	Deflazacort	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DNAP001530	Gonadoreline-6-d-trp acetate	Cancers	140-229, 185	C00-C96, C61
DNAP001531	Idebenone	Duchenne muscular dystrophy	359.1	G71.0
DNAP001531	Idebenone	Friedreich's ataxia	.	G11.1
DNAP001531	Idebenone	Friedreich's ataxia	334	G11.1
DNAP001531	Idebenone	Nootropic	.	F00-F99
DNAP001532	Schizophyllan	Cancer	.	C00-C97
DNAP001532	Schizophyllan	Immuno-stimulant	.	C00-C97
DNAP001533	Lentinan	Cancer	.	C00-C97
DNAP001533	Lentinan	Cancers	140-229, 151	C00-C96, C16
DNAP001534	Soluble insulin	Diabetes	250	E08-E13
DNAP001535	Muromonab-cd3	Graft-versus host disease	.	T86.0
DNAP001535	Muromonab-cd3	Immuno-suppressant	.	T86.0
DNAP001536	Defibrotide	Deep vein thrombosis	453.4	I80.2
DNAP001536	Defibrotide	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
DNAP001536	Defibrotide	Venous-occlusive disorders	.	K76.5
DNAP001537	Alclometasone dipropionate	Inflammatory diseases	691.8, 692.9, 696	L20, L20-L30, L40
DNAP001538	Cefbuperazone sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001539	Thymopentin	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
DNAP001540	Cefpiramide sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001541	Rosaprostol	Ulcer	531-534	K25-K27
DNAP001542	Beta-acetyldigoxin	Cardiovascular disease	390-459	I00-I99
DNAP001543	Haem arginate	Porphyria	277.1	E80.0-E80.2
DNAP001544	Enprostil	Ulcer	531-534	K25-K27
DNAP001545	Nadroparin calcium	Coagulation	.	I80-I82
DNAP001546	Elcatonin	Calcium metabolism	.	M80-M81
DNAP001547	Doxofylline	Bronchodilator	493	J45
DNAP001548	Cimetropium bromide	Gastric motility disorder	.	K22.4
DNAP001548	Cimetropium bromide	Spasm	728.85	R25.2
DNAP001549	Miokamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001549	Miokamycin	Bronchitis	.	J20-J21,J42
DNAP001550	Astromycin sulfate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001551	Interferon alfa-2b	Viral infections	042-075	A80-A99, B00-B34
DNAP001552	Somatrem	Hormone deficiency	.	E00-E90
DNAP001553	Porcine isophane insulin	Diabetes	250	E08-E13
DNAP001554	Human insulin zn suspension	Diabetes mellitus	250	E08-E13
DNAP001555	Sulglycotide	Active duodenal ulcer	.	K26
DNAP001556	Interferon beta	Hepatitis C virus infection	.	B17.1,B18.2
DNAP001556	Interferon beta	Viral infections	042-075	A80-A99, B00-B34
DNAP001557	Ru-41740	Recurring respiratory infections	.	J01.81
DNAP001558	Enalapril maleate	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
DNAP001559	Bucladesine sodium	Cardiotonic	.	I50
DNAP001559	Bucladesine sodium	Skin ulcer	.	L97
DNAP001560	Fosfosal	Pain	338	R52
DNAP001561	Cefotetan disodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001562	Temocillin disodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001562	Temocillin disodium	Sepsis	.	A40-A41
DNAP001563	Buserelin acetate	Cancers	140-229, 174, 175, 185, 259.1, 606, 617, 628	C00-C96, C50, C61, E22.8, E30.1, N46, N80, N97.0
DNAP001564	Sofalcone	Ulcer	531-534	K25-K27
DNAP001565	Teprenone	Peptic ulcer	531-534	K25-K27
DNAP001565	Teprenone	Ulcer	531-534	K25-K27
DNAP001566	Ibopamine hci	Cardiotonic	.	I50
DNAP001567	Melinamide	Hypocholesterolemic	.	E78
DNAP001568	Enocitabine	Cancer	140-229	C00-C96
DNAP001569	Celiprolol hcl	Angina	413	I20
DNAP001569	Celiprolol hcl	Hypertension	401	I10, I11, I12, I13, I15
DNAP001570	Befunolol hci	Glaucoma	365	H40-H42
DNAP001571	Promegestone	Gynecological conditions due to luteal insufficiency	625.3, 625.4, 627.2	N94.3, N94.4-N94.6, N95.0
DNAP001572	Halometasone	Inflammatory diseases	692, 696	L20-L30, L40
DNAP001573	Oxitropium bromide	Bronchodilator	493	J45
DNAP001574	Gemeprost	Planned abortion	.	Z31
DNAP001574	Gemeprost	Preoperative dilation of cervix before surgical abortion	779.6	O04
DNAP001575	Elliptinium acetate	Cancers	.	C00-D48
DNAP001576	Sodium cellulose po4	Hypercalciuria type I	.	E83.50
DNAP001577	Antithrombin iii	Coagulation	.	I80-I82
DNAP001578	Apalcillin sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001579	Micronomicin sulfate	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001580	Extract of serenoa repens	Benign prostatic hypertrophy	600	N40
DNAP001581	Biphasic porcine insulin	Diabetes mellitus	250	E08-E13
DNAP001582	Isophane insulin	Diabetes	250	E08-E13
DNAP001583	Indoramin hcl	Hypertension	401	I10, I11, I12, I13, I15
DNAP001584	Carmofur	Cancer	140-229	C00-C96
DNAP001585	Inosine pranobex	Rheumatold arthritis	714	M05-M06
DNAP001585	Inosine pranobex	Viral infections	042-075	A80-A99, B00-B34
DNAP001586	Cefsoludin sodium	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001587	Testosterone undecanoate	Hormone deficiency	.	E00-E90
DNAP001587	Testosterone undecanoate	Hypogonadism	257.2	E23.0, E28.3, E29.1
DNAP001588	Cefotiam hcl	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001589	Sulprostone	Abortifacient	779.6	O04
DNAP001590	Ceftiofur	Bacterial infection	460-519	J00-J99
DNAP001591	Peplomycin	Breast cancer	174, 175, 217	C50, D24
DNAP001591	Peplomycin	Cancers	140-229	C00-C96
DNAP001592	Cefsulodin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001592	Cefsulodin	Pseudomonas infection	041.7, 482.1	B96.5, J15.1, P23.5
DNAP001593	Terbutyline	Hypertension	401	I10, I11, I12, I13, I15
DNAP001594	Alpha-acetyldigoxin	Cardiovascular disease	390-459	I00-I99
DNAP001595	Vasicine	Oxytocic	.	O00-O99
DNAP001596	Theobromine	Asthma	493	J45
DNAP001596	Theobromine	Vasodilator, diuretic	.	J45
DNAP001597	Stevioside	Sweetener	.	.
DNAP001598	Santonin	Parasitic infection	.	B77
DNAP001599	Sanguinarine	Dental plaque inhibitor	.	.
DNAP001600	Rotenone	Piscicide	.	.
DNAP001601	Rorifone	Cough	786.2	R05
DNAP001602	Pachycarpine	Oxytocic	.	O00-O99
DNAP001603	Khellin	Bronchodilator	493	J45
DNAP001604	Hydrastine	Haemostatic astringent	.	R58
DNAP001605	Hesperidin	Capillary fragility	.	D69.8
DNAP001606	Glaziovine	Depression	311	F32
DNAP001607	1,8-dihydroxy-anthraquinone	Laxative	.	K00-K93
DNAP001608	Cynarin	Choleretic	1	A00
DNAP001609	Cissampeline	Skeletal muscle relaxant	.	M00-M99
DNAP001610	Camphor	Rubefacient	.	.
DNAP001611	Asiaticoside	Vulnerary	.	S00-T98
DNAP001612	Anisodine	Central and peripheral nervous diseases	.	G96.9
DNAP001613	Anisodamine	Central and peripheral nervous diseases	.	G96.9
DNAP001614	Allyl isothiocyanate	Rubefacient	.	.
DNAP001615	Allantoin	Vulnerary	.	S00-T98
DNAP001616	Ajmalicine	Circulatory disorders	.	I00-I99
DNAP001617	Agrimophol	Parasitic infection	.	B77
DNAP001618	Vincamine	Cerebral stimulant	.	I60-I69
DNAP001618	Vincamine	Cerebrovascular disorders	.	I60-I69
DNAP001619	Thymol	Fungal infections	110-118	B35-B49
DNAP001620	Neoandrographolide	Bacillary dysentery	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001621	Hemsleyadin	Bacillary dysentery	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001622	Salicin	Analgesic	.	R52.1-R52.2,G89
DNAP001623	Aescin	Inflammatory disease	.	.
DNAP001624	Kawain	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001625	Lanatoside c	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001626	Lanatoside b	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001627	Lanatoside a	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001628	Gitalin	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001629	Digitalin	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001630	Convallatoxin	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001631	Adoniside	Cardiovascular disease	390-459	I00-I99
DNAP001632	Sennoside b	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001633	Sennoside a	Cardiovascular disease	325, 390-459, 430-459	G45-G46, I00-I99, I60-I95
DNAP001634	Demecolcine	Cancers	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNAP001635	Colchiceine amide	Cancers	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNAP001636	Monocrotaline	Cancers	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNAP001637	(+-)-tetrahydropalmatine	Analgesic; Sedative; Tranquillizer	.	R52.1-R52.2,G89
DNAP001638	Imiglucerase	Gaucher disease	272.7	E75.2
DNAP001639	Fibrinogen	Bleeding	.	R58
DNAP001639	Fibrinogen	Deep vein thrombosis; Pulmonary embolism	415.1, 437.6, 444.9, 453, 453.40, 671.5, 671.9	I26, I74, I80-I82, I80.2, I82, O88, T79.0-T79.1
DNAP001640	Neocarzinostatin	Cancers	.	C00-D48
DNAP001641	Somatropin	Growth hormone deficiency	253.3	E23.0
DNAP001642	Betamethasone dipropionate	Inflammation	.	.
DNAP001643	Pseudoephedrine, nor	Sympathomimetic	.	.
DNAP001644	Eupatilin	Chronic diarrhoea	.	K85, K86.0K86.1
DNAP001644	Eupatilin	Pancreatitis	577.0-577.1	K85, K86.0K86.1
DNAP001645	Methyltestosterone	Cancers	140-229, 257.2	C00-C96, E23.0, E28.3, E29.1
DNAP001646	Betamethasone sodium phosphate	Inflammation	.	.
DNAP001647	Dopamine hydrochloride	Neurological disease	.	G00-G99
DNAP001648	Fosfestrol	Cancer	140-229	C00-C96
DNAP001649	Pristinamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001650	Floxuridine	Cancers	140-199	C00-C75, C7A, C7B
DNAP001650	Floxuridine	Metastasis	.	C00-C97
DNAP001651	Megesterol acetate	Advanced breast and endometrium carcinoma	140-229	C00-C96
DNAP001652	Plicamycin	Hypercalcemia	275.42	E83.5
DNAP001652	Plicamycin	Testicular cancer	140-229	C00-C96
DNAP001653	Asparaginase	Cancers	200, 202, 202.8, 208.9	C81-C96, C82-C85, C91-C95
DNAP001653	Asparaginase	Hypersensitivity	.	T78.4
DNAP001654	Viomycin sulfate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001655	Epicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001656	Hydroxyprogesterone	Cancers	627.2	N95.0
DNAP001657	Cefroxadine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001658	Ceftezole	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001659	Fusafungine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001660	Tranylcypromine sulfate	Major depressive disorder	296.2, 296.3	F32, F33
DNAP001660	Tranylcypromine sulfate	Major depressive episode without melancholia	296.2	F32.2, F32.3
DNAP001661	Mithramycin	Cancer	140-229	C00-C96
DNAP001662	Chromomycin a3	Cancers	.	C00-D48
DNAP001663	Virginiamycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001664	Nadrolone phenylpropionate	Cancer	140-229	C00-C96
DNAP001665	Nandrolone phenpropionate	Cancers	627.2, 733.0	M80-M81, N95.0
DNAP001666	Medroxyprogesterone acetate	Cancers	140-239	C00-C96, C00-D48
DNAP001667	Rifamycin b	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001668	Thiamphenicol	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001669	Pinitol	Expectorant	.	J20-J21,J42
DNAP001670	Sarkomycin	Cancer	140-229	C00-C96
DNAP001671	Carzinophilin	Cancers	.	C00-D48
DNAP001672	Chlortetracycline	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNAP001673	Heroin diacetylmorphine	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
DNAP001673	Heroin diacetylmorphine	Pain	338,780	R52, G89
DNAP001674	Noscapine (narcotine)	Cough	786.2	R05
DNAP001675	Cotinine	Insecticide	.	F19.20
DNAP001675	Cotinine	Psychoactive substance dependence	.	F19.20
DNAP001676	Fesoterodine fumarate	Overactive bladder disorder	188, 596.51	C67, N32.81
DNAP001677	Regadenoson	Radionuclide imaging	.	.
DNAP001678	Ponatinib	Acute lymphoblastic leukemia	.	C91.0
DNAP001678	Ponatinib	Acute myeloid leukemia	205	C92.0
DNAP001678	Ponatinib	Chronic myelogenous leukemia	205.1	C92.1
DNAP001678	Ponatinib	Chronic myeloid leukaemia	208.9	C91-C95
DNAP001678	Ponatinib	Philadelphia-positive ALL and CML	204.0, 205.1	C91.0, C92.1
DNAP001679	Crizotinib	ALK-positive NSCLC	140-199, 162, 210-229	C00-C75, C33, C34, C7A, C7B, D10-D36, D3A
DNAP001679	Crizotinib	ALK-positive advanced or metastatic NSCLC	162	C33, C34
DNAP001679	Crizotinib	Non-small-cell lung carcinoma	162	C33, C34
DNAP001679	Crizotinib	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNAP001680	Enzalutamide	Hormone-refractory prostate cancer	140-229, 185	C00-C96, C61
DNAP001680	Enzalutamide	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
DNAP001681	Besifloxacin	Bacterial conjunctivitis	372	H10
DNAP001681	Besifloxacin	Ocular inflammation	.	H00-H59
DNAP001682	Florbetapir F-18	Diagnosis	.	Y57.6
DNAP001682	Florbetapir F-18	Diagnosis	331	G30
DNAP001683	Vemurafenib	Adjuvant metastatic melanoma	172	C43
DNAP001683	Vemurafenib	BRAF mutation positive metastatic melanoma	172	C43
DNAP001683	Vemurafenib	BRAF mutation positive papillary thyroid cancer	140-229, 193	C00-C96, C73
DNAP001683	Vemurafenib	Brain metastases	198.3	C79.31
DNAP001683	Vemurafenib	Colorectal cancer	153, 154	C18-C21
DNAP001683	Vemurafenib	Inoperable/unresectable thyroid cancer	.	C90.0
DNAP001683	Vemurafenib	Melanoma	172	C43
DNAP001683	Vemurafenib	Metastatic melanoma	172	C43
DNAP001683	Vemurafenib	Myeloma	203	C90.0
DNAP001683	Vemurafenib	Throid cancer	193	C73
DNAP001683	Vemurafenib	Thyroid cancer	193	C73
DNAP001684	Ivacaftor	Cystic fibrosis	277.0, 709.2	E84, L90.5
DNAP001685	Bendamustine hydrochloride	Chronic lymphocytic leukaemia	204.1	C91.1
DNAP001685	Bendamustine hydrochloride	Leukaemia	.	C91-C95
DNAP001686	Ioflupane i-123	Parkinson's disease	.	G20-G21
DNAP001687	Polidocanol	Uncomplicated spider veins; Uncomplicated reticular veins	.	I80-I89
DNAP001688	Rivaroxaban	Acute Coronary Syndrome	411.1	I20.0
DNAP001688	Rivaroxaban	Acute coronary syndrome	411.1, 434.91, 437.6, 453, 671.5, 671.9	I20.0, I61-I63, I80-I82
DNAP001688	Rivaroxaban	Major adverse cardiac events	.	I80-I82, I80.2
DNAP001688	Rivaroxaban	Prophylaxis of deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
DNAP001688	Rivaroxaban	Stroke in atrial fibrillation	411.1, 427.31, 434.91, 437.6, 453, 671.5, 671.9	I20.0, I48, I61-I63, I80-I82
DNAP001688	Rivaroxaban	Thrombosis for acute coronary syndrome	411.1	I20.0
DNAP001689	Fospropofol disodium	Monitored anaesthesia care sedation	338	R52
DNAP001690	Tofacitinib	Rheumatoid arthritis	710-719, 714	M00-M25, M05, M05-M06, M06
DNAP001691	Clevidipine butyrate	Hypertension	401	I10, I11, I12, I13, I15
DNAP001691	Clevidipine butyrate	Peri-operative hypertension	401	I10, I11, I12, I13, I15
DNAP001692	Bedaquiline	Multi-drug resistant tuberculosis	010-018	A15-A19
DNAP001692	Bedaquiline	Pulmonary multidrug-resistant tuberculosis	010-018	A15-A19
DNAP001693	Avanafil	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
DNAP001694	Regorafenib	Cancer	140-229	C00-C96
DNAP001694	Regorafenib	Gastrointestinal stromal tumor	150-159	C15-C26
DNAP001694	Regorafenib	Metastatic colorectal cancer	153, 154	C18-C21
DNAP001694	Regorafenib	Non-small-cell lung carcinoma	162	C33, C34
DNAP001694	Regorafenib	Renal cancer	189	C64
DNAP001694	Regorafenib	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNAP001695	Mirabegron	Overactive bladder disorder	596.51	N32.81
DNAP001696	Tapentadol hydrochloride	Moderate to severe acute pain	338,780	R52, G89
DNAP001697	Citric acid, magnesium oxide, sodium picosulfate	Cleansing of the colon before colonoscopy	.	.
DNAP001698	Choline C-11	Diagnosis of prostate cancer	140-229, 185	C00-C96, C61
DNAP001699	Gadobutrol	Blood-brain barrier imaging agent	.	.
DNAP001699	Gadobutrol	BloodCbrain barrier	.	.
DNAP001700	Deferiprone	Transfusional iron overload due to thalassaemia syndromes	275.03	R79.0
DNAP001701	Sipuleucel-T	Neoadjuvant early-stage prostate cancer	140-229, 185	C00-C96, C61
DNAP001701	Sipuleucel-T	Prostate cancer	140-229, 185	C00-C96, C61
DNAP001701	Sipuleucel-T	Prostate cancer	185	C61
DNAP001701	Sipuleucel-T	Recurrent early-stage prostate cancer	140-229, 185	C00-C96, C61
DNAP001702	Oestradiol valerate and dienogest	Contraception	.	Z30
DNAP001703	Benzyl alcohol	Head lice	132	B85.0
DNAP001704	Gadoxetate disodium	Imaging	.	.
DNAP001705	Iobenguane I-123	Neuroendocrine tumors	.	C7A,C7B
DNAP001705	Iobenguane I-123	Primary or metastatic phaeochromocytoma or neuroblastoma	194	C74.9
DNAP001706	Gadofosveset	Imaging	.	.
DNAP001707	YM443	Upper abdominal bloating; Early satiation associated with functional dyspepsia	536.8	K30
DNAP001708	Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate	HIV infections	42	B20
DNAP001709	Sofosbuvir	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNAP001710	MenHibrix	Neisseria meningitis prophylaxis	041.5, 320-322, 487, 488	A49.2, G00-G03, J10, J11
DNAP001711	Nimenrix	Neisseria meningitis prophylaxis	320-322	G00-G03
DNAP001712	Flu vaccine	Seasonal influenza prophylaxis	487, 488	J10, J11
DNAP001713	Combo with MEKi	Melanoma	172	C43
DNAP001714	Feraheme/ Rienso	Iron deficiency anaemia in chronic kidney disease	280	D50, N00-N29
DNAP001715	Omega-3-acid ethyl esters 90	Hyperlipidemia	272.0-272.4	E78
DNAP001716	Levacecarnine hci	Nootropic	.	F00-F99
DNC000001	Drug 7684380	Discovery agent	.	.
DNC000002	(-)-propranolol	Discovery agent	.	.
DNC000003	(+/-)-baclofen	Discovery agent	.	.
DNC000004	(2R)-2-Methyl-4,5-dideoxy	Discovery agent	.	.
DNC000005	(2R)-2-methyl-4-deoxy and 2,4-dideoxy	Discovery agent	.	.
DNC000006	(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate	Discovery agent	.	.
DNC000007	(2R,5R)-delta-methyl-alpha-acetylenic putrescine	Discovery agent	.	.
DNC000008	(35)S-labeled oligonucleotide	Discovery agent	.	.
DNC000009	(D-Arg)(9)-p19(ARF) 26-44 peptide	Discovery agent	.	.
DNC000010	(E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n	Discovery agent	.	.
DNC000011	(R)-4-[2-[3-(4-methoxy-benzoylamino)-benzyl]-piperidin-1-ylmethyl]piperidine-1-carboxylic acid amide (Ro-320-6206)	Discovery agent	.	.
DNC000012	(R)-alpha-methylhistamine	Discovery agent	.	.
DNC000013	(R)-nipecotic acid	Discovery agent	.	.
DNC000014	(R)-Rolipram	Discovery agent	.	.
DNC000015	(R)-roscovitine	Discovery agent	.	.
DNC000016	(R,S)-4-phosphonophenylglycine	Discovery agent	.	.
DNC000017	(S)-Rolipram	Discovery agent	.	.
DNC000018	(S)-UH-301	Discovery agent	.	.
DNC000019	(S)-WAY 100135	Discovery agent	.	.
DNC000020	(Z)-3-[2-(9H-fluoren-2-yloxy)ethylidene]-quinuclidine hydrochloride 31	Discovery agent	.	.
DNC000021	[(125)I] RB129	Discovery agent	.	.
DNC000022	[125I]SB-258585	Discovery agent	.	.
DNC000023	[Nphe(1)]-nociceptin (1-13)-NH(2)	Discovery agent	.	.
DNC000024	[U-13C]ascomycin	Discovery agent	.	.
DNC000025	1,1-bisphosphonate esters	Discovery agent	.	.
DNC000026	1,3,7-trihydroxyacridone	Discovery agent	.	.
DNC000027	1,4-Naphthoquinone	Discovery agent	.	.
DNC000028	10-hydroxycamptothecin	Discovery agent	.	.
DNC000029	10Z-Hymenialdisine	Discovery agent	.	.
DNC000030	13-acetate	Discovery agent	.	.
DNC000031	15-deoxy-Delta(12, 14)-prostaglandin J(2)	Discovery agent	.	.
DNC000032	15-hydroxyeicosatetraenoic acid	Discovery agent	.	.
DNC000033	17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one (4MA)	Discovery agent	.	.
DNC000034	17AAG	Breast cancer	174, 175	C50
DNC000034	17AAG	Discovery agent	.	.
DNC000035	17-allylamino-17-demethoxygeldanamycin	Discovery agent	.	.
DNC000036	18-Methoxycoronaridine	Discovery agent	.	.
DNC000036	18-Methoxycoronaridine	Drug dependence	303-304	F10.2-F19.2
DNC000037	19-nor-10-azasteroid skeleton	Discovery agent	.	.
DNC000038	1alpha,25 dihydroxyvitamin D(3)	Discovery agent	.	.
DNC000039	1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3)	Discovery agent	.	.
DNC000040	2-(1-adamantyl) piperidine	Discovery agent	.	.
DNC000041	2-(1-adamantyl) pyrrolidine	Discovery agent	.	.
DNC000042	2-(1-adamantyl)-2-methyl-pyrrolidine	Discovery agent	.	.
DNC000043	2-(2-adamantyl) piperidine	Discovery agent	.	.
DNC000044	2-(4-hydroxylphenyl)-3-(3,5-dihydroxylphenyl) propenoic acid (NNU-hdpa)	Discovery agent	.	.
DNC000045	2,3,7-trichloro-5-nitroquinoxaline (TNQX)	Discovery agent	.	.
DNC000046	2,3-Dimethoxybenzo[i]phenanthridines	Discovery agent	.	.
DNC000047	2,4,6 trinitrobenzene sulfonate 1,3-bis (2-chlorethyl)-1-nitrosourea	Discovery agent	.	.
DNC000048	2,4-diamino triazine	Discovery agent	.	.
DNC000049	2,4-diaminoquinozalines and quinoxaline-2,3-diones	Discovery agent	.	.
DNC000050	2-5A-anti-hTR	Discovery agent	.	.
DNC000051	2'-aminoimidazolylmethyluracils	Discovery agent	.	.
DNC000052	2'-deoxythymidine triphosphate	Discovery agent	.	.
DNC000053	2-PMPA	Discovery agent	.	.
DNC000054	2R,4R-APDC	Discovery agent	.	.
DNC000055	3-(1-carbamoyl-1,1-diphenylmethyl)-1-(4-methoxyphenylethyl)pyrrolidine (APP)	Discovery agent	.	.
DNC000056	3-(2-adamantyl) pyrrolidine	Discovery agent	.	.
DNC000057	3-(9-Acridinylamino)-5-(hydroxymethyl)aniline (AHMA)	Discovery agent	.	.
DNC000058	3-aminobenzamide	Discovery agent	.	.
DNC000059	3-bromopyruvate	Discovery agent	.	.
DNC000060	3-fluorovinylglycine	Discovery agent	.	.
DNC000061	3-hydroxydesaminokynurenine	Discovery agent	.	.
DNC000062	3-IB-MECA	Discovery agent	.	.
DNC000063	3-methoxydesaminokynurenine	Discovery agent	.	.
DNC000064	3-nitropropionate	Discovery agent	.	.
DNC000065	3'thiacytidine	Discovery agent	.	.
DNC000066	4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol	Discovery agent	.	.
DNC000067	4-[(diphenylmethyl)amino]-2-phenylquinazoline	Discovery agent	.	.
DNC000069	4-DAMP	Discovery agent	.	.
DNC000070	4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone	Discovery agent	.	.
DNC000071	4-hydroxy-2-nonenal	Discovery agent	.	.
DNC000072	4-iodobenzo[b]thiophene 2-carboxamidine	Discovery agent	.	.
DNC000073	4-substituted 2,4-dioxobutanoic acids	Discovery agent	.	.
DNC000074	5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine	Discovery agent	.	.
DNC000075	5,8-Dihydroxy-1,4-naphthoquinone	Discovery agent	.	.
DNC000075	5,8-Dihydroxy-1,4-naphthoquinone	Malaria	84	B50-B54
DNC000076	5,8-hydroxy-naphthoquinone	Discovery agent	.	.
DNC000077	5-amino orotate	Discovery agent	.	.
DNC000078	5-bromo orotate	Discovery agent	.	.
DNC000079	5-carboxymethylthio-3-(3'-chlorophenyl)-1,2,4-oxadiazol	Discovery agent	.	.
DNC000080	5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine	Discovery agent	.	.
DNC000081	5-deoxy-5-phosphono-D-arabinonate	Discovery agent	.	.
DNC000082	5'-deoxythymidine	Discovery agent	.	.
DNC000083	5-Fluoro orotate	Discovery agent	.	.
DNC000084	5-Fluoroorotate	Discovery agent	.	.
DNC000084	5-Fluoroorotate	Malaria	84	B50-B54
DNC000085	5-Fluorouracil	Discovery agent	.	.
DNC000086	5-hydroxy-1H-indole-3-acetic acid	Discovery agent	.	.
DNC000087	5-Hydroxyeicosatetraenoic acid	Discovery agent	.	.
DNC000088	5-iodo orotate	Discovery agent	.	.
DNC000089	5'-iodotubercidin	Discovery agent	.	.
DNC000090	5-methyl orotate	Discovery agent	.	.
DNC000091	5'-methylthioadenosine	Discovery agent	.	.
DNC000092	5-nitro-2-(3-phenylpropylamino) benzoic acid	Discovery agent	.	.
DNC000093	5-propenyl-2'-deoxyuridine triphosphate	Discovery agent	.	.
DNC000094	5-propenyl-arabinofuranosyluracil 5'-triphosphate	Discovery agent	.	.
DNC000095	667COUMATE	Discovery agent	.	.
DNC000096	677T	Discovery agent	.	.
DNC000097	6-bromoindirubin-3'-oxime (BIO)	Discovery agent	.	.
DNC000098	6-Cl-IMP	Discovery agent	.	.
DNC000099	77-LH-28-1	Dementia	.	F01-F07
DNC000099	77-LH-28-1	Discovery agent	.	.
DNC000100	7-amino-4-hydroxy-2-naphthalenesulfonic acid	Discovery agent	.	.
DNC000101	7-benzylidenenaltrexone	Discovery agent	.	.
DNC000102	7-chloro-1,3-dihydroxyacridone	Discovery agent	.	.
DNC000103	7-hydroxycoumarin	Discovery agent	.	.
DNC000104	7-tert-butyl-2, 3-dihydro-3, 3-dimethyl substituted dihydrofuran 30 (DHDMBF30)	Discovery agent	.	.
DNC000105	8-amino-5'-deoxy-5'-chloroguanosine	Discovery agent	.	.
DNC000106	8-amino-9-benzylguanine	Discovery agent	.	.
DNC000107	8-aminoguanosine	Discovery agent	.	.
DNC000108	8-aminoquinolines	Discovery agent	.	.
DNC000109	8-aza-DADMe-ImmH	Discovery agent	.	.
DNC000110	8-hydroxyguanine	Discovery agent	.	.
DNC000111	8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone	Discovery agent	.	.
DNC000112	8R-Lisuride	Discovery agent	.	.
DNC000113	8-sulfophenyl theophylline	Discovery agent	.	.
DNC000114	9-cis-retinoic acid	Discovery agent	.	.
DNC000115	9-Nitrocamptothecin (9-NC)	Discovery agent	.	.
DNC000116	9-Nitropaullone	Discovery agent	.	.
DNC000117	9-trans-retinoic acid	Discovery agent	.	.
DNC000118	A 77636	Discovery agent	.	.
DNC000118	A 77636	Parkinson's disease	.	G20
DNC000119	A-192558	Discovery agent	.	.
DNC000120	A1-adenosine receptor	Discovery agent	.	.
DNC000121	A-315675	Discovery agent	.	.
DNC000122	A-317491	Discovery agent	.	.
DNC000123	A-357300	Discovery agent	.	.
DNC000124	A-381393	Discovery agent	.	.
DNC000125	A77-1726 (monosodium salt)	Discovery agent	.	.
DNC000126	A-79175	Asthma	.	J45
DNC000126	A-79175	Discovery agent	.	.
DNC000127	A-85380	Discovery agent	.	.
DNC000128	AA-861	Allergy	.	T78.4
DNC000128	AA-861	Discovery agent	.	.
DNC000129	Abietic acid	Discovery agent	.	.
DNC000130	ABT-418	Alzheimer's disease	.	G30,F00
DNC000130	ABT-418	Discovery agent	.	.
DNC000131	ABT-491	Discovery agent	.	.
DNC000131	ABT-491	Septic shock	.	A41.9
DNC000132	ABT-492	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNC000132	ABT-492	Discovery agent	.	.
DNC000133	ABT-594	Discovery agent	.	.
DNC000134	ABT-627	Cancer	.	C00-C97
DNC000134	ABT-627	Discovery agent	.	.
DNC000135	ABX-EGF	Discovery agent	.	.
DNC000136	ABX-IL8	Discovery agent	.	.
DNC000136	ABX-IL8	Melanoma	.	C43
DNC000137	AC-260584	Discovery agent	.	.
DNC000137	AC-260584	Schizophrenia	295	F20
DNC000138	AC-42	Discovery agent	.	.
DNC000139	Acanthus ilicifolius Linn	Discovery agent	.	.
DNC000140	Acarviostatin III03	Discovery agent	.	.
DNC000141	Acarviostatin IV03	Discovery agent	.	.
DNC000142	Accutin	Discovery agent	.	.
DNC000143	ACEA	Discovery agent	.	.
DNC000144	ACEA-1328	Cancer pain	338,780	R52, G89
DNC000145	Acetyl-Ile-Glu-Thr-Asp-aldehyde	Discovery agent	.	.
DNC000146	Acetylprocainamide	Discovery agent	.	.
DNC000147	ACHP	Multiple myeloma	203	C90.0
DNC000148	Acid-activated omeprazole	Discovery agent	.	.
DNC000149	Acivicin	Discovery agent	.	.
DNC000150	Ac-Lys-[Leu(8)]-des-Arg(9)-BK	Discovery agent	.	.
DNC000151	Acriflavine	Discovery agent	.	.
DNC000151	Acriflavine	Human immunodeficiency virus infection	.	B20
DNC000152	Act1	Discovery agent	.	.
DNC000152	Act1	Wound healing	.	T14.0-T14.1
DNC000153	Actinomycin D	Discovery agent	.	.
DNC000154	Actinonin	Discovery agent	.	.
DNC000155	Actoferrin	Discovery agent	.	.
DNC000156	Acurea	Discovery agent	.	.
DNC000157	Acyclovir	Discovery agent	.	.
DNC000158	Acylureido penicillin mezlocillin	Discovery agent	.	.
DNC000159	AD 198	Discovery agent	.	.
DNC000161	Adenosine triphosphate analogues	Discovery agent	.	.
DNC000162	Adenosine-5'-O-(2-thiodiphosphate)	Discovery agent	.	.
DNC000163	Adriamycin	Discovery agent	.	.
DNC000164	AE-3763	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC000164	AE-3763	Discovery agent	.	.
DNC000165	AF150(S)	Discovery agent	.	.
DNC000166	AF267B	Discovery agent	.	.
DNC000167	AF-DX116	Discovery agent	.	.
DNC000168	AG2034	Discovery agent	.	.
DNC000168	AG2034	Solid tumours	.	C00-C75,C7A,C7B
DNC000169	AG3340	Discovery agent	.	.
DNC000170	AG490	Discovery agent	.	.
DNC000170	AG490	Immunotherapy for renal transplantation	279.5	D89.8
DNC000171	AHMA	Discovery agent	.	.
DNC000172	AjvW2	Discovery agent	.	.
DNC000173	Alanosine	Discovery agent	.	.
DNC000174	Alkaloid staurosporin	Discovery agent	.	.
DNC000175	Allylamines	Discovery agent	.	.
DNC000176	Almokalant	Cardiac arrhythmias	.	I47-I49
DNC000176	Almokalant	Discovery agent	.	.
DNC000177	Alovudine	Breast cancer	140-229, 174, 175	C00-C96, C50
DNC000177	Alovudine	HIV infections	42	B20
DNC000178	Alpha 1-PI	Discovery agent	.	.
DNC000179	Alpha1-PI	Discovery agent	.	.
DNC000180	Alpha-acarviosinyl-(1-->7)-3-alpha-D-glucopyranosylpropen	Discovery agent	.	.
DNC000181	Alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen	Discovery agent	.	.
DNC000182	Alpha-estradiol	Discovery agent	.	.
DNC000183	Alpha-eudesmol	Discovery agent	.	.
DNC000184	Alpha-methyl-alpha-phenylsuccinimide (MPS)	Discovery agent	.	.
DNC000185	Alpha-monofluoromethyl-3,4-dehydroornithine	Discovery agent	.	.
DNC000186	Alpha-monofluoromethyl-3,4-dehydroornithine ethyl ester	Discovery agent	.	.
DNC000187	Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester	Discovery agent	.	.
DNC000188	Alsterpaullone	Discovery agent	.	.
DNC000189	AM251	Discovery agent	.	.
DNC000190	AM-251	Discovery agent	.	.
DNC000191	AM336	Pain	338,780	R52, G89
DNC000193	AMD3101	Discovery agent	.	.
DNC000194	Amdoxovir	HIV infections	42	B20
DNC000194	Amdoxovir	Hepatitis B virus infection	.	B16
DNC000195	Ametantrone	Discovery agent	.	.
DNC000196	AMG 073	Discovery agent	.	.
DNC000196	AMG 073	Hypercalcaemia	.	E83.52
DNC000197	AMG-126737	Discovery agent	.	.
DNC000198	Amidox	Discovery agent	.	.
DNC000199	Amifloxacin	Discovery agent	.	.
DNC000201	Aminodeoxykanamycin	Discovery agent	.	.
DNC000202	Aminoglutethemide	Discovery agent	.	.
DNC000203	Aminoguanidine	Discovery agent	.	.
DNC000204	Aminooxyacetate	Discovery agent	.	.
DNC000205	Aminopurvalanol	Discovery agent	.	.
DNC000206	Aminopurvalanol (NG97)	Discovery agent	.	.
DNC000207	AMSH	Female sexual dysfunction	302.7	F52, R37
DNC000208	Amylin	Discovery agent	.	.
DNC000209	Amythiamicin	Discovery agent	.	.
DNC000210	Anandamide	Discovery agent	.	.
DNC000211	Ankinara	Inflammatory bowel disease; Psoriasis; Rheumatoid arthritis	555, 556, 696, 710-719, 714	K50, K51, L40, M00-M25, M05-M06
DNC000212	Antagonistic site II mutants of human IL-4	Discovery agent	.	.
DNC000213	Antalarmin	Depression	311	F32
DNC000213	Antalarmin	Discovery agent	.	.
DNC000214	Antegren	Discovery agent	.	.
DNC000214	Antegren	Multiple sclerosis	340	G35
DNC000215	Anthracycline	Discovery agent	.	.
DNC000215	Anthracycline	Solid tumours	.	C00-C75,C7A,C7B
DNC000216	Anthramycin	Discovery agent	.	.
DNC000217	Anti CD14 antibodies	Discovery agent	.	.
DNC000218	Anti-BAFF antibody	Discovery agent	.	.
DNC000219	Antibiotics	Discovery agent	.	.
DNC000220	Anti-CCR5 antibodies	Discovery agent	.	.
DNC000221	Anti-CD33 antibody, P67.6	Discovery agent	.	.
DNC000222	Anti-CXCR4 monoclonal antibody 12G5	Discovery agent	.	.
DNC000223	Anti-D	Idiopathic thrombocytopenic purpura	287.31	D69.3
DNC000224	Anti-ErbB-2 monoclonal antibody	Discovery agent	.	.
DNC000225	Anti-FMDV antibodies	Discovery agent	.	.
DNC000226	Anti-GnRH Spiegelmer	Discovery agent	.	.
DNC000227	Anti-interleukin-10 antibodies	Discovery agent	.	.
DNC000228	Antileukoprotease (ALP)	Discovery agent	.	.
DNC000229	Antimycin A	Discovery agent	.	.
DNC000230	Anti-PrP antibodies	Discovery agent	.	.
DNC000231	Antisense molecules	Discovery agent	.	.
DNC000232	Antisense oligodeoxynucleotides (ODNs)	Discovery agent	.	.
DNC000233	Antistasin	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNC000233	Antistasin	Discovery agent	.	.
DNC000234	ANX-201	Cytomegalovirus infection	.	B25
DNC000234	ANX-201	Discovery agent	.	.
DNC000235	AP22408	Discovery agent	.	.
DNC000235	AP22408	Osteoporosis	733	M80-M81
DNC000236	APC-366	Asthma	.	J45
DNC000236	APC-366	Discovery agent	.	.
DNC000237	AP-Cav	Discovery agent	.	.
DNC000238	Aphidicolin	Discovery agent	.	.
DNC000239	Apicidin	Cancers	140-229	C00-C96
DNC000240	ApoC-III	Discovery agent	.	.
DNC000241	Apomorphine SL	Discovery agent	.	.
DNC000242	Apomorphine SL	Discovery agent	.	.
DNC000243	Apramycin	Discovery agent	.	.
DNC000244	Apricitabine	HIV infections	42	B20
DNC000244	Apricitabine	Human immunodeficiency virus infection	.	B20
DNC000245	Aprophen	Discovery agent	.	.
DNC000246	Aptiganel HCl	Acute ischemic stroke	434.91	I61-I63
DNC000247	AR177	Discovery agent	.	.
DNC000247	AR177	HIV infections	42	B20
DNC000248	AR-534	Discovery agent	.	.
DNC000249	Arachidonic acid	Discovery agent	.	.
DNC000250	Arachidonyltrifluoromethyl ketone	Discovery agent	.	.
DNC000251	ARC239	Discovery agent	.	.
DNC000252	ARC-239	Discovery agent	.	.
DNC000253	AR-C68397AA	Discovery agent	.	.
DNC000254	ARN34	Discovery agent	.	.
DNC000255	Arsenite	Discovery agent	.	.
DNC000256	AS602868	Multiple myeloma	203	C90.0
DNC000257	AS-8112	Emesis	787	R11
DNC000258	AS-9705	Emesis; Gastric motility disorder	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0, 536.8, 787	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0, K30, R11
DNC000259	Ascorbate	Discovery agent	.	.
DNC000260	ASKH95	Discovery agent	.	.
DNC000261	Atipamezole	Discovery agent	.	.
DNC000261	Atipamezole	Male sexual disorders	.	F52
DNC000262	ATP	Cachexia	799.4	R64
DNC000262	ATP	Discovery agent	.	.
DNC000263	Auryntricarboxylic acid (ATA)	Discovery agent	.	.
DNC000264	Autoantibody LKM-3	Discovery agent	.	.
DNC000265	Avasimibe	Discovery agent	.	.
DNC000265	Avasimibe	Peripheral vascular disease	.	I73.9
DNC000266	AVE-0118	Atrial fibrillation	427.31	I48
DNC000266	AVE-0118	Cardiac arrhythmias	.	I47-I49
DNC000267	Axokine	Obesity	278	E66
DNC000268	Aza-C-nucleosides	Discovery agent	.	.
DNC000269	AZD-4282	Neuropathic pain	338,780	R52, G89
DNC000270	Azelastine hydrochloride	Discovery agent	.	.
DNC000271	B-9858	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DNC000271	B-9858	Discovery agent	.	.
DNC000272	B-9958	Discovery agent	.	.
DNC000272	B-9958	Inflammatory diseases	.	.
DNC000273	BABIM	Asthma	493	J45
DNC000273	BABIM	Discovery agent	.	.
DNC000274	Batimastat	Ischemic stroke	434.91	I61-I63
DNC000275	Batimistat	Discovery agent	.	.
DNC000276	BAY 50-7952	Discovery agent	.	.
DNC000277	BAY 57-1293	Discovery agent	.	.
DNC000277	BAY 57-1293	Herpes simplex virus infection	54	B00
DNC000278	Bay K 8644	Discovery agent	.	.
DNC000279	Bay x3702	Acute ischemic stroke	434.91	I61-I63
DNC000279	Bay x3702	Nerve injury	.	T14.4
DNC000280	BAY11-7082	Multiple myeloma	203	C90.0
DNC000281	BAY-12-9566	Discovery agent	.	.
DNC000281	BAY-12-9566	Transplant rejection	.	T86
DNC000282	BB-16	Discovery agent	.	.
DNC000282	BB-16	Inflammatory diseases	.	.
DNC000283	BB-3497	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000283	BB-3497	Discovery agent	.	.
DNC000284	BB-78484	Discovery agent	.	.
DNC000285	BB-78485	Discovery agent	.	.
DNC000286	BCEAB	Discovery agent	.	.
DNC000287	BCH	Discovery agent	.	.
DNC000288	BCH-2763	Discovery agent	.	.
DNC000288	BCH-2763	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNC000289	BCX-1812	Discovery agent	.	.
DNC000290	BCX-1827	Discovery agent	.	.
DNC000291	BCX-1898	Discovery agent	.	.
DNC000292	BCX-1923	Discovery agent	.	.
DNC000293	Benactyzine	Discovery agent	.	.
DNC000294	Benserazide	Discovery agent	.	.
DNC000295	Benzamidine hydrochloride	Discovery agent	.	.
DNC000296	Benzimidazole 5-carboxamide	Hepacivirus infections	070.4, 070.5, 070.70	B17.1, B18.2
DNC000297	Benzofuran-3-yl-(indol-3-yl)maleimides	Discovery agent	.	.
DNC000298	Benzomate	Discovery agent	.	.
DNC000299	Benzoquinone ansamycins	Discovery agent	.	.
DNC000300	Benzothiadiazines	Hepacivirus infections	070.4, 070.5, 070.70	B17.1, B18.2
DNC000301	Benzothiopyranoindole	Discovery agent	.	.
DNC000302	Benzylpenicillin	Discovery agent	.	.
DNC000303	Berberine	Discovery agent	.	.
DNC000304	Ber-H2/saporin	Discovery agent	.	.
DNC000305	Beta 3-adrenoceptor	Discovery agent	.	.
DNC000306	Beta 3-adrenoceptor agonists	Discovery agent	.	.
DNC000307	Beta specific inhibitors	Discovery agent	.	.
DNC000308	Beta-Alanine	Discovery agent	.	.
DNC000309	BetaARKct	Discovery agent	.	.
DNC000310	Beta-endorphin	Discovery agent	.	.
DNC000311	BH4	Discovery agent	.	.
DNC000312	BHT-920	Discovery agent	.	.
DNC000312	BHT-920	Glaucoma	365	H40-H42
DNC000313	BIA 3-202	Discovery agent	.	.
DNC000313	BIA 3-202	Parkinson's disease	.	G20
DNC000314	BIBF100	Multiple myeloma	203	C90.0
DNC000315	BIBN4096BS	Discovery agent	.	.
DNC000316	BIBO3304	Discovery agent	.	.
DNC000317	BIBP 3226	Discovery agent	.	.
DNC000317	BIBP 3226	Hypertension	.	I10-I15
DNC000318	BIBR 1048	Discovery agent	.	.
DNC000319	Bicuculline	Discovery agent	.	.
DNC000320	BILS 179 BS	Discovery agent	.	.
DNC000321	BIO-1211	Asthma	.	J45
DNC000321	BIO-1211	Discovery agent	.	.
DNC000322	Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]	Discovery agent	.	.
DNC000323	Bisbenzimide (Hoechst 33258)	Discovery agent	.	.
DNC000324	Bisindolylmaleimide-I	Discovery agent	.	.
DNC000325	Bisphosphonates	Diabetes mellitus	250	E08-E13
DNC000325	Bisphosphonates	Discovery agent	.	.
DNC000326	Bisphosphonates alendronate	Discovery agent	.	.
DNC000327	Bispyridinium compounds 87-89	Discovery agent	.	.
DNC000328	Bivalirudine	Discovery agent	.	.
DNC000329	BMS-193885	Discovery agent	.	.
DNC000330	BMS-204352	Acute ischemic stroke	434.91	I61-I63
DNC000330	BMS-204352	Nerve injury	.	T14.4
DNC000332	BMS-232632	Discovery agent	.	.
DNC000333	BMS-345541	Arthritis	710-719	M00-M25
DNC000333	BMS-345541	Discovery agent	.	.
DNC000334	BMY-27709	Discovery agent	.	.
DNC000335	BN 50730	Asthma	.	J45
DNC000335	BN 50730	Discovery agent	.	.
DNC000336	BN50727	Discovery agent	.	.
DNC000336	BN50727	Inflammatory bowel disease	.	K50,K51
DNC000337	BN50739	Cerebral infarction	.	I63
DNC000337	BN50739	Discovery agent	.	.
DNC000338	BN52021	Discovery agent	.	.
DNC000338	BN52021	Septic shock	.	A41.9
DNC000339	BN82451	Huntington's disease	294.1, 333.4	F02.2, G10
DNC000339	BN82451	Parkinson's disease	.	G20
DNC000340	Borrelidin	Discovery agent	.	.
DNC000341	Bosentan hydrate	Discovery agent	.	.
DNC000342	BQ-123	Discovery agent	.	.
DNC000342	BQ-123	Pulmonary arterial hypertension	.	I27.0,I27.2
DNC000343	BQ610	Discovery agent	.	.
DNC000344	BQ788	Discovery agent	.	.
DNC000344	BQ788	Hypertension	.	I10-I15
DNC000345	BRL 26830A	Discovery agent	.	.
DNC000345	BRL 26830A	Obesity	278	E66
DNC000346	BRL 35135	Diabetes mellitus	.	E10-E14
DNC000346	BRL 35135	Discovery agent	.	.
DNC000347	BRL 37344	Discovery agent	.	.
DNC000348	BRL 43694A	Discovery agent	.	.
DNC000349	BRL 44408	Discovery agent	.	.
DNC000350	BRL 52537 hydrochloride	Discovery agent	.	.
DNC000351	BRL 52974	Discovery agent	.	.
DNC000352	Brocresine	Discovery agent	.	.
DNC000353	Brominide tartrate	Discovery agent	.	.
DNC000354	Br-WR99210	Discovery agent	.	.
DNC000355	Bryostatin-1	Discovery agent	.	.
DNC000356	BSO	Discovery agent	.	.
DNC000357	Buthionine sulfoximine	Cancer	140-229	C00-C96
DNC000357	Buthionine sulfoximine	Discovery agent	.	.
DNC000357	Buthionine sulfoximine	Malaria	84	B50-B54
DNC000358	Butirosin B	Discovery agent	.	.
DNC000359	Butoxamine	Discovery agent	.	.
DNC000360	BVT 933	Obesity	278	E66
DNC000361	BVT.2733	Discovery agent	.	.
DNC000361	BVT.2733	Non-insulin dependent diabetes	.	E11.9
DNC000362	BW 373U86	Discovery agent	.	.
DNC000363	BW A360C	Discovery agent	.	.
DNC000364	BW A4C	Arthritis	.	M00-M25
DNC000364	BW A4C	Discovery agent	.	.
DNC000365	BW B218C	Discovery agent	.	.
DNC000366	BW B70C	Asthma	493	J45
DNC000366	BW B70C	Discovery agent	.	.
DNC000367	BW755C	Discovery agent	.	.
DNC000367	BW755C	Inflammatory diseases	.	.
DNC000368	BX 471	Discovery agent	.	.
DNC000369	BZ3	Discovery agent	.	.
DNC000370	BZ5	Discovery agent	.	.
DNC000371	BZ6	Ataxia telangiectasia	.	G11.3
DNC000371	BZ6	Discovery agent	.	.
DNC000372	Bzurea	Discovery agent	.	.
DNC000373	C-101,606	Acute ischemic stroke	434.91	I61-I63
DNC000374	C2-MAD	Discovery agent	.	.
DNC000375	C4-MAD	Discovery agent	.	.
DNC000376	C75	Discovery agent	.	.
DNC000376	C75	Obesity	278	E66
DNC000377	Ca(2+) chelator	Discovery agent	.	.
DNC000378	Caffeic acid	Discovery agent	.	.
DNC000379	Caffeic acid phenethyl ester	Discovery agent	.	.
DNC000380	Calcium carbimide	Alcohol use disorders	303	F10.2
DNC000380	Calcium carbimide	Discovery agent	.	.
DNC000381	Calpastatin	Discovery agent	.	.
DNC000382	Calphostin C	Discovery agent	.	.
DNC000383	Calyculin-A	Discovery agent	.	.
DNC000384	Camostat	Cystic fibrosis	277	E84
DNC000384	Camostat	Discovery agent	.	.
DNC000385	Camptothecin	Cancer	.	C00-C97
DNC000385	Camptothecin	Solid tumours	.	C00-C75,C7A,C7B
DNC000386	Cannabidiol	Discovery agent	.	.
DNC000387	Carazolol	Discovery agent	.	.
DNC000388	Carbenoxolone	Discovery agent	.	.
DNC000389	Carbodine	Discovery agent	.	.
DNC000390	Carpropamid	Discovery agent	.	.
DNC000391	Catalytic ribozymes	Discovery agent	.	.
DNC000392	CBR-2092	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000393	CD154	Discovery agent	.	.
DNC000394	CDP571	Crohn's disease	.	K50
DNC000394	CDP571	Discovery agent	.	.
DNC000395	CE-1037	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC000395	CE-1037	Discovery agent	.	.
DNC000396	Cebutolol	Discovery agent	.	.
DNC000397	CellCept	Discovery agent	.	.
DNC000398	CEP1347	Asthma	493	J45
DNC000398	CEP1347	Discovery agent	.	.
DNC000399	CEP-1347	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
DNC000400	CEP1348	Discovery agent	.	.
DNC000401	CEP1349	Discovery agent	.	.
DNC000402	CEP-751	Discovery agent	.	.
DNC000402	CEP-751	Neurodegenerative diseases	.	G30-G32
DNC000403	Cerivastatin	Discovery agent	.	.
DNC000403	Cerivastatin	Hyperlipidemia	.	E78.5
DNC000404	CGP 12177	Discovery agent	.	.
DNC000405	CGP 20712A	Discovery agent	.	.
DNC000406	CGP 26505	Discovery agent	.	.
DNC000408	CGP 40336A	Discovery agent	.	.
DNC000409	CGP-44532	Drug abuse	303-304	F10-F19
DNC000410	CGP 77675	Discovery agent	.	.
DNC000411	CGS 21680	Discovery agent	.	.
DNC000412	CGS 35066	Discovery agent	.	.
DNC000413	CGS 8515	Discovery agent	.	.
DNC000414	CH4474	Discovery agent	.	.
DNC000415	CHAP1	Cancers	140-229	C00-C96
DNC000416	CHAP31	Cancers	140-229	C00-C96
DNC000417	Chebulagic acid	Discovery agent	.	.
DNC000418	Chemically linked bispecific antibodies	Discovery agent	.	.
DNC000419	Chemosensitizers	Discovery agent	.	.
DNC000420	Chenodeoxycholate	Discovery agent	.	.
DNC000421	Chimeric small nucleolar RNA-TAR decoy	Discovery agent	.	.
DNC000422	Chloroaniline 1	Discovery agent	.	.
DNC000423	Chloroethylclonidine	Discovery agent	.	.
DNC000424	Chlorogenic acid	Discovery agent	.	.
DNC000425	Cholesterol	Discovery agent	.	.
DNC000426	CI-1021	Discovery agent	.	.
DNC000427	CI-1031	Discovery agent	.	.
DNC000428	CI-972	Discovery agent	.	.
DNC000428	CI-972	Rheumatold arthritis	.	M05-M06
DNC000429	CI-976	Discovery agent	.	.
DNC000429	CI-976	Hyperlipidemia	.	E78.5
DNC000430	Cibacron blue	Discovery agent	.	.
DNC000431	Ciglitazone	Endometriosis	617	N80
DNC000432	Cilengitide	Discovery agent	.	.
DNC000432	Cilengitide	Rheumatold arthritis	.	M05-M06
DNC000433	Cilostamide	Discovery agent	.	.
DNC000434	Cinaciguat	Acute decompensated heart failure	428	I50
DNC000435	Cinchoninic acid	Discovery agent	.	.
DNC000436	Ciprofloxacin+dexamethasone	Acute otitis media; Otitis externa	017.40, 055.2, 380, 381.0, 381.1, 381.2, 381.3, 381.4, 382	H60, H65, H65-H67, H66, H67
DNC000437	Cis-[PtCl(NH3)2(N7-acyclovir)]+	Discovery agent	.	.
DNC000438	Cis-4-hydroxynipecotic acid	Discovery agent	.	.
DNC000439	Cisatracurium	Discovery agent	.	.
DNC000440	CKD602	Cancer	140-229	C00-C96
DNC000440	CKD602	Discovery agent	.	.
DNC000441	CL 385319	Discovery agent	.	.
DNC000442	CL-184005	Discovery agent	.	.
DNC000442	CL-184005	Septic shock	.	A41.9
DNC000443	CL-316,243	Discovery agent	.	.
DNC000443	CL-316,243	Obesity	.	E66
DNC000444	CL-385004	Discovery agent	.	.
DNC000445	Clavulanate+Amoxicillin	Infections	001-139	A00-B99
DNC000446	Clentiazem	Angina	.	I20
DNC000446	Clentiazem	Discovery agent	.	.
DNC000447	Cl-IB-MECA	Discovery agent	.	.
DNC000447	Cl-IB-MECA	Liver cancer	.	C22
DNC000448	Clik60	Discovery agent	.	.
DNC000449	Clobenpropit	Discovery agent	.	.
DNC000450	Clodinafop	Discovery agent	.	.
DNC000451	Clomethiazole	Acute ischemic stroke	434.91	I61-I63
DNC000451	Clomethiazole	Stroke	.	I61-I63
DNC000452	Clorsulon	Discovery agent	.	.
DNC000453	Closantel 6	Discovery agent	.	.
DNC000454	Clostridial collagenase	Discovery agent	.	.
DNC000455	CMI-1145	Discovery agent	.	.
DNC000456	CMI-936	Discovery agent	.	.
DNC000457	C-myb	Pain	338,780	R52, G89
DNC000458	CNI-1493	Discovery agent	.	.
DNC000458	CNI-1493	Inflammatory bowel disease	555, 556	K50, K51
DNC000459	Co 101244	Discovery agent	.	.
DNC000460	Coformycin	Discovery agent	.	.
DNC000461	Colforsin	Discovery agent	.	.
DNC000462	Conantokins G	Discovery agent	.	.
DNC000463	Conantokins T	Discovery agent	.	.
DNC000464	Conotoxin	Discovery agent	.	.
DNC000465	Costunolide	Discovery agent	.	.
DNC000466	Coumermycin	Discovery agent	.	.
DNC000467	Coumermycin A1	Discovery agent	.	.
DNC000468	CP-100263	Emesis	787	R11
DNC000469	CP-101,606	Cancer pain	338,780	R52, G89
DNC000469	CP-101,606	Discovery agent	.	.
DNC000469	CP-101,606	Parkinson's disease	332	G20
DNC000470	CP-122721	Depression	311	F32
DNC000470	CP-122721	Major depressive disorder	.	F32,F33
DNC000471	CP154,526	Depression	311	F32
DNC000472	CP-154526	Discovery agent	.	.
DNC000473	CP-358774	Discovery agent	.	.
DNC000474	CP-461	Discovery agent	.	.
DNC000474	CP-461	Inflammatory bowel disease	.	K50,K51
DNC000475	CP-470,711	Discovery agent	.	.
DNC000476	CP-80794	Discovery agent	.	.
DNC000476	CP-80794	Hypertension	.	I10-I15
DNC000477	CP-94,253	Discovery agent	.	.
DNC000478	CP-99,994	Discovery agent	.	.
DNC000479	CQA 206-291	Discovery agent	.	.
DNC000479	CQA 206-291	Parkinson's disease	.	G20
DNC000480	CR-3124	Emesis; Nausea	787, 787.0	R11
DNC000480	CR-3124	Substance dependence	.	F10-F19
DNC000481	CRA1000	Anxiety disorder	.	F40-F42
DNC000481	CRA1000	Depression	311	F32
DNC000482	CRA1001	Depression	311	F32
DNC000483	Cromakalim	Discovery agent	.	.
DNC000484	Cryptophycin	Discovery agent	.	.
DNC000485	CT301	Discovery agent	.	.
DNC000486	CU201 (B9870)	Discovery agent	.	.
DNC000487	CV 6209	Asthma	.	J45
DNC000487	CV 6209	Discovery agent	.	.
DNC000488	CV-6504	Discovery agent	.	.
DNC000489	CV-6504 HCl	Discovery agent	.	.
DNC000489	CV-6504 HCl	Nephritis	.	N00-N19,N25-N29
DNC000490	CVT-2759	Discovery agent	.	.
DNC000490	CVT-2759	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DNC000491	Cyanide	Discovery agent	.	.
DNC000492	Cyclazosin	Discovery agent	.	.
DNC000493	Cyclobutyl	Discovery agent	.	.
DNC000494	Cycloguanil	Discovery agent	.	.
DNC000494	Cycloguanil	Plasmodium falciparum	84	B50-B54
DNC000495	Cyclopentane amide derivatives 1	Discovery agent	.	.
DNC000496	Cyclopentane amide derivatives 2	Discovery agent	.	.
DNC000497	Cyclopentane amide derivatives 3	Discovery agent	.	.
DNC000498	Cyclopentane amide derivatives 4	Discovery agent	.	.
DNC000499	Cyclopentenylcytosine	Discovery agent	.	.
DNC000500	Cyclopentylcytosine	Discovery agent	.	.
DNC000501	Cyclopiazonic acid	Discovery agent	.	.
DNC000502	Cyclopropyl	Discovery agent	.	.
DNC000503	Cyclosporin A	Discovery agent	.	.
DNC000504	Cylopentenyl cytosine	Discovery agent	.	.
DNC000505	Cymserine	Discovery agent	.	.
DNC000506	Cyprodine	Parkinson's disease	332	F02.3, G20
DNC000507	Cystamine	Discovery agent	.	.
DNC000508	D 2343	Discovery agent	.	.
DNC000509	D-43787	Allergy	995.3	T78.4
DNC000509	D-43787	Discovery agent	.	.
DNC000510	D609	Discovery agent	.	.
DNC000511	DADLE	Discovery agent	.	.
DNC000512	DADMe-ImmG	Discovery agent	.	.
DNC000513	DADMe-ImmH	Discovery agent	.	.
DNC000514	Daio-Orengedokuto (DOT)	Discovery agent	.	.
DNC000515	DANA	Discovery agent	.	.
DNC000516	Daniplestim	Discovery agent	.	.
DNC000516	Daniplestim	Osteoporosis	.	M80-M81
DNC000517	Daunomycin	Discovery agent	.	.
DNC000518	Dazoxiben	Discovery agent	.	.
DNC000519	DBO-11	Cancer pain	338,780	R52, G89
DNC000520	DBO-17	Cancer pain	338,780	R52, G89
DNC000521	DBO-83	Discovery agent	.	.
DNC000522	DC-015	Discovery agent	.	.
DNC000523	DCG IV	Discovery agent	.	.
DNC000525	DDATHF	Discovery agent	.	.
DNC000526	DDAVP	Discovery agent	.	.
DNC000527	DdC	Discovery agent	.	.
DNC000528	DdI	Discovery agent	.	.
DNC000529	Deamido-NAD	Discovery agent	.	.
DNC000530	Decoyinine	Discovery agent	.	.
DNC000531	Decyltrimethylammonium	Discovery agent	.	.
DNC000532	Delta(9)-tetrahydrocannabinol	Discovery agent	.	.
DNC000533	Deoxyfluorothymidine	Discovery agent	.	.
DNC000534	Deprenyl	Discovery agent	.	.
DNC000535	Des-Arg(9)-[Leu(8)]-BK	Discovery agent	.	.
DNC000536	Deschloroflavopiridol	Discovery agent	.	.
DNC000537	Desirudine	Discovery agent	.	.
DNC000538	Desmethoxyverapamil	Discovery agent	.	.
DNC000539	Desmethylastemizole	Discovery agent	.	.
DNC000540	Desmethylclomipramine	Discovery agent	.	.
DNC000541	Dextrorphan	Acute ischemic stroke	434.91	I61-I63
DNC000542	DFMO	Discovery agent	.	.
DNC000543	DFU	Pain	338,780	R52, G89
DNC000544	Diacerein	Discovery agent	.	.
DNC000545	Diamide	Discovery agent	.	.
DNC000546	Diaminopropyl sulfate	Discovery agent	.	.
DNC000547	Diazaborines	Discovery agent	.	.
DNC000548	Diazacholesterol	Discovery agent	.	.
DNC000549	Diazemuls	Discovery agent	.	.
DNC000550	Dibenzo-p-dioxin-2-carboxylic acid	Discovery agent	.	.
DNC000551	DIBRT	Discovery agent	.	.
DNC000552	Dicaffeoylquinic acids	HIV infections	42	B20
DNC000553	Dicaffeoyltartaric acids	HIV infections	42	B20
DNC000554	Dichloroallyl lawsone	Discovery agent	.	.
DNC000555	Dichloroally-lawsone	Discovery agent	.	.
DNC000556	Dideoxycytidine	Discovery agent	.	.
DNC000557	Didox	Cancer	.	C00-C97
DNC000557	Didox	Discovery agent	.	.
DNC000558	Difluoromethylornithine	Discovery agent	.	.
DNC000558	Difluoromethylornithine	Trypanosoma brucei gambiense	86.5	B56
DNC000559	Dihydroorotate	Discovery agent	.	.
DNC000560	Dihydropyridines	Discovery agent	.	.
DNC000561	Dihydropyrone	Hepacivirus infections	070.4, 070.5, 070.70	B17.1, B18.2
DNC000562	Di-imidazole lexitropsin	Discovery agent	.	.
DNC000563	Diketonitrile	Discovery agent	.	.
DNC000564	Dimaprit	Discovery agent	.	.
DNC000565	Dimemorfan	Discovery agent	.	.
DNC000567	Diphenylbutylpiperidines pimozide	Discovery agent	.	.
DNC000568	Dipyrone	Discovery agent	.	.
DNC000568	Dipyrone	Pain	338,780	R52, G89
DNC000569	Disodium cromoglycate	Discovery agent	.	.
DNC000570	Distamycin A	Discovery agent	.	.
DNC000571	DMP-695/696	Depression	311	F32
DNC000572	DON	Discovery agent	.	.
DNC000572	DON	Non-small-cell lung cancer	162	C33, C34
DNC000574	DPC 423	Discovery agent	.	.
DNC000574	DPC 423	Thrombosis	.	I80-I82
DNC000575	D-penicillamine	Discovery agent	.	.
DNC000576	DPP-4 inhibitor	Hyperglycaemia in type 2 diabetes mellitus	250, 790.29	E11, R73.9
DNC000577	DTD	Discovery agent	.	.
DNC000578	DU 125530	Discovery agent	.	.
DNC000578	DU 125530	Mood disorder	.	F30-F39
DNC000579	Duocarmycin	Discovery agent	.	.
DNC000580	DuP 714	Discovery agent	.	.
DNC000580	DuP 714	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DNC000581	DuP-697	Arthritis	710-719	M00-M25
DNC000581	DuP-697	Pain	338,780	R52, G89
DNC000582	Durhamycin A	Discovery agent	.	.
DNC000583	DV-7028	Cardiovascular disease	390-459	I00-I99
DNC000583	DV-7028	Discovery agent	.	.
DNC000584	DX9065	Discovery agent	.	.
DNC000585	DX-9065a	Angina	.	I20
DNC000585	DX-9065a	Discovery agent	.	.
DNC000586	E-2070	Neuropathic pain	338,780	R52, G89
DNC000587	E-6123	Asthma	.	J45
DNC000587	E-6123	Discovery agent	.	.
DNC000588	E-64	Discovery agent	.	.
DNC000589	E-913	Discovery agent	.	.
DNC000589	E-913	HIV infections	42	B20
DNC000590	EC33	Discovery agent	.	.
DNC000591	Ecteinascidins	Discovery agent	.	.
DNC000592	Edatrexate	Discovery agent	.	.
DNC000593	Edetic acid	Discovery agent	.	.
DNC000594	EDTA	Discovery agent	.	.
DNC000595	Efegatran	Discovery agent	.	.
DNC000596	Efomycine M	Discovery agent	.	.
DNC000597	EGTA	Discovery agent	.	.
DNC000598	Eleutherobin	Discovery agent	.	.
DNC000599	Ellipticine	Discovery agent	.	.
DNC000600	Elvitegravir	HIV infections	42	B20
DNC000601	Elvucitabine	HIV infections	42	B20
DNC000602	EM-800	Discovery agent	.	.
DNC000602	EM-800	Estrogen deficiency	.	E28.39
DNC000603	EMD 55900	Discovery agent	.	.
DNC000604	Enalkiren	Discovery agent	.	.
DNC000604	Enalkiren	Glaucoma	.	H40-H42
DNC000605	Enbrel	Discovery agent	.	.
DNC000606	Endothelium-derived relaxing factor (EDRF)	Discovery agent	.	.
DNC000607	Enediyne antibiotics	Discovery agent	.	.
DNC000608	Enoxaprin	Discovery agent	.	.
DNC000609	Enoxolone	Discovery agent	.	.
DNC000610	E-pentenylbutanedioic acid 32	Discovery agent	.	.
DNC000611	EPI-2010	Asthma	493	J45
DNC000611	EPI-2010	Discovery agent	.	.
DNC000612	Epibatidine	Discovery agent	.	.
DNC000613	EpiCept	Neuropathic pain	338,780	R52, G89
DNC000614	Epi-inositol	Discovery agent	.	.
DNC000615	Epiroprim	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNC000615	Epiroprim	Discovery agent	.	.
DNC000616	Epothilone B	Cancer	140-229	C00-C96
DNC000616	Epothilone B	Multiple myeloma	203	C90.0
DNC000617	ER-37328	Discovery agent	.	.
DNC000618	Erythropoietin	Anemia	.	D50-D64
DNC000618	Erythropoietin	Discovery agent	.	.
DNC000619	Eslicarbazepine	Epileptic seizures	345.9, 780.3	G40, P90, R56
DNC000619	Eslicarbazepine	Seizures	.	G40
DNC000620	Estrogen	Discovery agent	.	.
DNC000620	Estrogen	Menopause	627.2	N95.0
DNC000621	Estrogen receptor B agonist	Chemotherapy-induced mucositis	528	K12.3
DNC000622	ETH615	Dermatitis	.	L20-L30
DNC000622	ETH615	Discovery agent	.	.
DNC000623	Ethidium	Discovery agent	.	.
DNC000624	Ethidium bromide	Discovery agent	.	.
DNC000625	Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate	Discovery agent	.	.
DNC000626	Ethyl 1-[(1H-benzimidazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate	Discovery agent	.	.
DNC000627	Ethyl 1-[(1H-benzotriazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate	Discovery agent	.	.
DNC000628	Ethylene diamine	Tuberculosis	010-018	A15-A19
DNC000629	Etidronate	Discovery agent	.	.
DNC000629	Etidronate	Hypercalcemia	275.42	E83.5
DNC000630	Etomoxir	Discovery agent	.	.
DNC000630	Etomoxir	Heart failure	.	I50
DNC000631	Etorphine	Discovery agent	.	.
DNC000632	EX5	Discovery agent	.	.
DNC000633	Exendin-4	Discovery agent	.	.
DNC000634	F-0401	Discovery agent	.	.
DNC000635	Fampridine	Discovery agent	.	.
DNC000636	FANA	Discovery agent	.	.
DNC000637	Farnesyl pyrophosphate	Discovery agent	.	.
DNC000638	Fascaplysin	Discovery agent	.	.
DNC000639	Fasidotril	Discovery agent	.	.
DNC000639	Fasidotril	Hypotension	.	I95
DNC000640	Fasudil	Discovery agent	.	.
DNC000641	FAUC 113	Discovery agent	.	.
DNC000642	FdG	Discovery agent	.	.
DNC000643	FE 999011	Discovery agent	.	.
DNC000644	Fedotozine	Discovery agent	.	.
DNC000645	FGIN-1-27	Discovery agent	.	.
DNC000646	Fibrates	Dyslipidemia	272	E78
DNC000647	Fibrinogen gamma-chain peptide ligands	Discovery agent	.	.
DNC000648	Fipamezole	Acute myeloid leukemia	205	C92.0
DNC000648	Fipamezole	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
DNC000649	Fipronil	Discovery agent	.	.
DNC000650	FK-706	Discovery agent	.	.
DNC000650	FK-706	Pulmonary emphysema	.	J43
DNC000651	Flavanone	Discovery agent	.	.
DNC000652	Flavone-8-acetic acid	Discovery agent	.	.
DNC000653	FLC	Discovery agent	.	.
DNC000656	Fluoroquinolones	Discovery agent	.	.
DNC000657	Flutimide	Discovery agent	.	.
DNC000658	Fondaparinux	Discovery agent	.	.
DNC000659	FR139317	Discovery agent	.	.
DNC000659	FR139317	Hypertension	.	I10-I15
DNC000660	FR149175	Diabetes mellitus type 2	.	E11
DNC000660	FR149175	Discovery agent	.	.
DNC000661	FR161282	Discovery agent	.	.
DNC000662	FR167356	Discovery agent	.	.
DNC000663	FR167653	Discovery agent	.	.
DNC000664	Fumagillin	Discovery agent	.	.
DNC000665	Fuscoside	Discovery agent	.	.
DNC000666	G-25	Discovery agent	.	.
DNC000667	G3139	Discovery agent	.	.
DNC000668	GABA	Discovery agent	.	.
DNC000669	Gabaculine	Discovery agent	.	.
DNC000670	Gabapentin GR	Neuropathic pain	338,780	R52, G89
DNC000671	Gabexate	Discovery agent	.	.
DNC000671	Gabexate	Pancreatitis	577.0-577.1	K85, K86.0K86.1
DNC000672	Gallopamil	Discovery agent	.	.
DNC000673	Galnon	Discovery agent	.	.
DNC000674	Gamma-acetylenic GABA	Discovery agent	.	.
DNC000677	Gaster	Discovery agent	.	.
DNC000678	Gavestinel	Acute ischemic stroke	434.91	I61-I63
DNC000678	Gavestinel	Nerve injury	.	T14.4
DNC000679	GBR-12935	Discovery agent	.	.
DNC000680	GC-1	Discovery agent	.	.
DNC000681	GC-14	Discovery agent	.	.
DNC000682	GC7	Discovery agent	.	.
DNC000683	Gelsolin	Discovery agent	.	.
DNC000684	GEM 231	Discovery agent	.	.
DNC000684	GEM 231	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC000685	Gemopatrilat	Discovery agent	.	.
DNC000685	Gemopatrilat	Hypotension	.	I95
DNC000686	Geneticin	Discovery agent	.	.
DNC000687	Gepirone	Discovery agent	.	.
DNC000688	GGTI-298	Discovery agent	.	.
DNC000689	GHRP-2	Discovery agent	.	.
DNC000689	GHRP-2	Growth hormone deficiency	253.3	E23.0
DNC000690	Ginkgolide B (GKB)	Discovery agent	.	.
DNC000691	GKA1	Discovery agent	.	.
DNC000692	GKA2	Diabetes mellitus type 2	.	E11
DNC000692	GKA2	Discovery agent	.	.
DNC000693	Gliotoxin	Discovery agent	.	.
DNC000694	Glitazone	Discovery agent	.	.
DNC000695	Glucose analogue	P. falciparum infection	84	B50-B54
DNC000696	Glycopeptides	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000696	Glycopeptides	Discovery agent	.	.
DNC000697	Glycyrrhetinic acid	Discovery agent	.	.
DNC000698	Glyphosate	Discovery agent	.	.
DNC000698	Glyphosate	Malaria	84	B50-B54
DNC000699	Go6850	Discovery agent	.	.
DNC000700	Go6976	Discovery agent	.	.
DNC000701	Gossypol	P. falciparum infection	84	B50-B54
DNC000701	Gossypol	Prostate tumor	185	C61
DNC000702	GP515	Discovery agent	.	.
DNC000703	GPI 18214	Discovery agent	.	.
DNC000704	GR55562	Discovery agent	.	.
DNC000705	Green tea	Discovery agent	.	.
DNC000706	GS4071	Discovery agent	.	.
DNC000707	GTS-21	Discovery agent	.	.
DNC000707	GTS-21	Parkinson's disease	.	G20
DNC000709	Guanine	Discovery agent	.	.
DNC000710	Guanylhydrazone	Discovery agent	.	.
DNC000711	Guvacine	Discovery agent	.	.
DNC000712	GV-150013	Anxiety disorder	.	F40-F42
DNC000712	GV-150013	Discovery agent	.	.
DNC000713	GW1843	Biliary cancer	.	C22,C24
DNC000713	GW1843	Discovery agent	.	.
DNC000714	GW-311616	Discovery agent	.	.
DNC000715	GW4064	Discovery agent	.	.
DNC000716	GW4065	Discovery agent	.	.
DNC000717	GW7604	Discovery agent	.	.
DNC000718	GW7845	Discovery agent	.	.
DNC000719	GW9578	Discovery agent	.	.
DNC000720	H-1152P	Discovery agent	.	.
DNC000721	H22xKi-4	Discovery agent	.	.
DNC000722	H376/95	Discovery agent	.	.
DNC000723	Hadacidin	Discovery agent	.	.
DNC000724	Haloxyfop	Discovery agent	.	.
DNC000725	Hemicholinium	Discovery agent	.	.
DNC000726	Hemicholinium-3	Discovery agent	.	.
DNC000727	Heparin-Cantithrombin III	Discovery agent	.	.
DNC000728	Herceptin	Discovery agent	.	.
DNC000729	Hexamethonium	Discovery agent	.	.
DNC000730	Hirudin	Discovery agent	.	.
DNC000731	Hirulog	Discovery agent	.	.
DNC000732	Histamine	Discovery agent	.	.
DNC000734	HIV-1 vaccine	Discovery agent	.	.
DNC000734	HIV-1 vaccine	HIV-1 infections	42	B20
DNC000735	HKI-9924129	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000736	HMR1098	Discovery agent	.	.
DNC000737	HMR1883	Discovery agent	.	.
DNC000739	Homocamptothecins (hCPTs)	Discovery agent	.	.
DNC000740	Homorisedronate	Discovery agent	.	.
DNC000741	Howiinol A (GHM-10)	Discovery agent	.	.
DNC000742	HR325	Discovery agent	.	.
DNC000742	HR325	Rheumatold arthritis	.	M05-M06
DNC000743	HS 378	Arthritis	.	M00-M25
DNC000743	HS 378	Discovery agent	.	.
DNC000744	HS014	Discovery agent	.	.
DNC000745	HTF 919	Discovery agent	.	.
DNC000746	HU210	Discovery agent	.	.
DNC000747	Human PFT inhibitor	P. falciparum infection; Kinetoplastids	084, 085, 086	B50-B54, B55, B56, B57
DNC000748	Humulin (Human insulin isophane)	Discovery agent	.	.
DNC000749	Huperzine A	Discovery agent	.	.
DNC000749	Huperzine A	Epileptic seizures	345.9, 780.3	G40, P90, R56
DNC000750	Hydroquinone	Discovery agent	.	.
DNC000750	Hydroquinone	Melasma	.	L81.1
DNC000751	Hydroxamates	P. falciparum infection	84	B50-B54
DNC000752	Hydroxycitric acid	Discovery agent	.	.
DNC000753	Hydroxyclemastine	Discovery agent	.	.
DNC000754	Hydroxyfasudil	Discovery agent	.	.
DNC000755	Hygromycin B	Discovery agent	.	.
DNC000756	Hymenialdisine	Discovery agent	.	.
DNC000757	Hyoscine	Discovery agent	.	.
DNC000758	Hyoscyamine sulfate	Irritable bowel syndrome	564.1	K58
DNC000759	Hyperforin	Discovery agent	.	.
DNC000760	Hypericum	Discovery agent	.	.
DNC000761	Hypericum (St John's Wort)	Discovery agent	.	.
DNC000762	I-309	Discovery agent	.	.
DNC000763	Ia Quinidine	Atrial fibrillation; Pain	338, 427.31,780	I48, R52, G89
DNC000764	IB-MECA	Cancer	.	C00-C97
DNC000764	IB-MECA	Discovery agent	.	.
DNC000765	Ibogaine	Discovery agent	.	.
DNC000766	Ic Flecainide	Atrial fibrillation; Pain	338, 427.31,780	I48, R52, G89
DNC000767	IC87114	Discovery agent	.	.
DNC000768	IC980033	Discovery agent	.	.
DNC000769	ICI 118,551	Discovery agent	.	.
DNC000770	ICI 118.551	Discovery agent	.	.
DNC000771	ICI 154129	Discovery agent	.	.
DNC000772	ICI 200,355	Discovery agent	.	.
DNC000773	ICI 200,880	Discovery agent	.	.
DNC000774	ICI 207968	Discovery agent	.	.
DNC000775	ICR 62	Discovery agent	.	.
DNC000776	ICRF-154	Discovery agent	.	.
DNC000777	ICRF-193	Discovery agent	.	.
DNC000778	IDN-1965	Discovery agent	.	.
DNC000779	Ifenprodil	Cancer pain	338,780	R52, G89
DNC000779	Ifenprodil	Discovery agent	.	.
DNC000780	IFN	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNC000780	IFN	Discovery agent	.	.
DNC000781	IFN-alpha	Cancer	.	C00-C97
DNC000781	IFN-alpha	Endometriosis	617	N80
DNC000782	Igmesine	Discovery agent	.	.
DNC000782	Igmesine	Major depressive disorder	.	F32,F33
DNC000783	IkappaB-alphaM	Discovery agent	.	.
DNC000784	IL-10	Discovery agent	.	.
DNC000784	IL-10	Ulcerative colitis	556	K51
DNC000785	IL-4R	Discovery agent	.	.
DNC000786	Il-8((3-73))K11R	Discovery agent	.	.
DNC000787	IMC-1C11	Cancer	.	C00-C97
DNC000787	IMC-1C11	Discovery agent	.	.
DNC000788	IMC-C225	Discovery agent	.	.
DNC000789	Imetit	Discovery agent	.	.
DNC000790	Imidazo[4,5-e][1,4]diazapine nucleotide (I)	Discovery agent	.	.
DNC000791	Immucillin-G	Discovery agent	.	.
DNC000792	Immucillin-H	Discovery agent	.	.
DNC000792	Immucillin-H	Malaria	84	B50-B54
DNC000792	Immucillin-H	Psoriasis	.	L40
DNC000793	IN1535	Discovery agent	.	.
DNC000794	Incadronate	Discovery agent	.	.
DNC000794	Incadronate	Hypercalcemia	275.42	E83.5
DNC000795	Indatraline	Discovery agent	.	.
DNC000796	Indirubin-3'-monoxime	Discovery agent	.	.
DNC000797	Indirubin-5-sulfonate	Discovery agent	.	.
DNC000798	Indole N -acetamide	Hepacivirus infections	070.4, 070.5, 070.70	B17.1, B18.2
DNC000799	Indolophenanthridine	Discovery agent	.	.
DNC000800	Insulin Lispro	Discovery agent	.	.
DNC000801	Insulin lispro recombinant	Discovery agent	.	.
DNC000802	Interferon alfa (IFN-alpha)	Discovery agent	.	.
DNC000803	Iodine-131-tositumomab	Discovery agent	.	.
DNC000804	Iodoacetamide	Discovery agent	.	.
DNC000805	Iodotubercidin	Discovery agent	.	.
DNC000806	Ipratropium bromide	Discovery agent	.	.
DNC000807	Ipsapirone	Anxiety disorder	.	F40-F42
DNC000807	Ipsapirone	Discovery agent	.	.
DNC000808	IS20I	Discovery agent	.	.
DNC000810	ISIS 107248	Discovery agent	.	.
DNC000810	ISIS 107248	Multiple sclerosis	.	G35
DNC000811	ISIS 25302	Discovery agent	.	.
DNC000812	ISIS 3521	Discovery agent	.	.
DNC000813	ISIS 5132	Colorectal cancer	.	C18-C20,C21
DNC000813	ISIS 5132	Discovery agent	.	.
DNC000814	ISIS 5132 (CGP 69846A)	Discovery agent	.	.
DNC000815	ISO-1	Discovery agent	.	.
DNC000816	Iso-caffeine	Discovery agent	.	.
DNC000817	Isoguvacine	Discovery agent	.	.
DNC000818	Isohelenin	Discovery agent	.	.
DNC000819	Isoprenaline	Discovery agent	.	.
DNC000820	Isopsoralen	Discovery agent	.	.
DNC000821	Isoxazol	Discovery agent	.	.
DNC000822	ITdU	Discovery agent	.	.
DNC000823	J-104870	Discovery agent	.	.
DNC000824	J-109,390	Discovery agent	.	.
DNC000825	J-113397	Discovery agent	.	.
DNC000826	JB-1	Multiple myeloma	203	C90.0
DNC000827	JM216	Discovery agent	.	.
DNC000827	JM216	Solid tumours	.	C00-C75,C7A,C7B
DNC000828	JTC-801	Cancer pain	338,780	R52, G89
DNC000828	JTC-801	Discovery agent	.	.
DNC000828	JTC-801	Pain	338,780	R52, G89
DNC000829	JTV-605	Discovery agent	.	.
DNC000829	JTV-605	Dysmenorrhea	.	N94.4-N94.6
DNC000830	Juglon	Discovery agent	.	.
DNC000831	JWH-015	Discovery agent	.	.
DNC000832	JZP-4	Convulsions	.	R56.0
DNC000832	JZP-4	Epileptic seizures	345.9, 780.3	G40, P90, R56
DNC000833	Ki23819	Cancer	140-229	C00-C96
DNC000833	Ki23819	Discovery agent	.	.
DNC000834	KJM429	Discovery agent	.	.
DNC000835	KMD-3213	Discovery agent	.	.
DNC000836	KNI-727	Discovery agent	.	.
DNC000837	Kodaistatin A	Discovery agent	.	.
DNC000838	Kodaistatin C	Discovery agent	.	.
DNC000839	KR61639	Discovery agent	.	.
DNC000840	KT6006	Discovery agent	.	.
DNC000841	KT6528	Discovery agent	.	.
DNC000842	L-054852	Acromegaly	253	E22.0
DNC000843	L17	Discovery agent	.	.
DNC000844	L-269,289	Discovery agent	.	.
DNC000845	L-364,718	Discovery agent	.	.
DNC000845	L-364,718	Pain	.	G89
DNC000846	L-370,518	Discovery agent	.	.
DNC000847	L-374,087	Discovery agent	.	.
DNC000847	L-374,087	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNC000848	L-652,343	Discovery agent	.	.
DNC000849	L-658,758	Discovery agent	.	.
DNC000850	L-671,480	Discovery agent	.	.
DNC000851	L-674,573	Discovery agent	.	.
DNC000852	L-685,818	Discovery agent	.	.
DNC000853	L-689,037	Discovery agent	.	.
DNC000854	L-694,458	Cystic fibrosis	.	E84
DNC000854	L-694,458	Discovery agent	.	.
DNC000855	L-697,661	Discovery agent	.	.
DNC000855	L-697,661	Human immunodeficiency virus infection	.	B20
DNC000856	L-708,906	Discovery agent	.	.
DNC000857	L-731,988	Discovery agent	.	.
DNC000858	L-735,821	Discovery agent	.	.
DNC000859	L-745,870	Discovery agent	.	.
DNC000859	L-745,870	Psychotic disorders	.	F20-F29
DNC000860	Lactoferrin	Discovery agent	.	.
DNC000860	Lactoferrin	Solid tumours	.	C00-C75,C7A,C7B
DNC000862	Laudanosine	Discovery agent	.	.
DNC000863	LB30057	Discovery agent	.	.
DNC000864	LB30812	Discovery agent	.	.
DNC000865	LBH539	Multiple myeloma	203	C90.0
DNC000866	L-canaline	Discovery agent	.	.
DNC000867	Lead acetate	Discovery agent	.	.
DNC000868	Lefaxin	Discovery agent	.	.
DNC000869	Lepirudine	Discovery agent	.	.
DNC000870	Lerdelimumab	Discovery agent	.	.
DNC000871	Leu-enkephalin	Discovery agent	.	.
DNC000872	Leupeptin	Discovery agent	.	.
DNC000872	Leupeptin	Malaria	84	B50-B54
DNC000873	Levalbuterol	Discovery agent	.	.
DNC000874	Levcromakalim	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC000874	Levcromakalim	Discovery agent	.	.
DNC000875	Lexipafant	Discovery agent	.	.
DNC000875	Lexipafant	Nerve injury	.	T14.4
DNC000877	Licostinel	Acute ischemic stroke	434.91	I61-I63
DNC000877	Licostinel	Neurological disease	.	G00-G99
DNC000878	Lisuride patch	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
DNC000879	Lithium chloride	Discovery agent	.	.
DNC000880	Lithocholate	Discovery agent	.	.
DNC000881	LLZ16406	Discovery agent	.	.
DNC000882	LLZ16407	Discovery agent	.	.
DNC000883	L-NG-nitroarginine methyl ester	Discovery agent	.	.
DNC000884	Lobatamide A	Discovery agent	.	.
DNC000885	Lobatamide B	Discovery agent	.	.
DNC000886	Lobatamide C	Discovery agent	.	.
DNC000887	Lobatamide D	Discovery agent	.	.
DNC000888	Lobatamide F	Discovery agent	.	.
DNC000889	Lorglumide	Discovery agent	.	.
DNC000889	Lorglumide	Pancreatic disorders	.	K86.9
DNC000890	Loxiglumide	Discovery agent	.	.
DNC000894	LU302146	Discovery agent	.	.
DNC000894	LU302146	Pulmonary hypertension	416	I27.0, I27.2
DNC000895	LU302872	Discovery agent	.	.
DNC000896	Luteolin	Discovery agent	.	.
DNC000897	Luvox	Discovery agent	.	.
DNC000898	LY178002	Discovery agent	.	.
DNC000899	LY214352	Discovery agent	.	.
DNC000900	LY256548	Discovery agent	.	.
DNC000901	LY266500	Discovery agent	.	.
DNC000902	LY278584	Discovery agent	.	.
DNC000903	LY288513	Anxiety disorder	300	F40-F42
DNC000903	LY288513	Discovery agent	.	.
DNC000904	LY294002	Hematologic malignancies	200-209	C81-C96
DNC000905	LY309887	Cancer	140-229	C00-C96
DNC000905	LY309887	Discovery agent	.	.
DNC000906	LY333531	Cancer	.	C00-C97
DNC000907	LY341495	Discovery agent	.	.
DNC000908	LY344864	Discovery agent	.	.
DNC000909	LY53857	Discovery agent	.	.
DNC000910	LY-593039	Discovery agent	.	.
DNC000911	M100907	Discovery agent	.	.
DNC000911	M100907	Sleep disorders	.	F51,G47
DNC000912	M55113	Discovery agent	.	.
DNC000913	M55551	Discovery agent	.	.
DNC000915	Maribavir	Cytomegalovirus	78.5	B25.8, H30.9
DNC000915	Maribavir	Discovery agent	.	.
DNC000916	MCI	Discovery agent	.	.
DNC000917	MDL 100,453	Discovery agent	.	.
DNC000918	MDL 101,731	Discovery agent	.	.
DNC000918	MDL 101,731	Gastric cancer	.	C16
DNC000919	Meclofenamate	Discovery agent	.	.
DNC000920	Meglitinide	Discovery agent	.	.
DNC000921	Melagatran dipeptide	Discovery agent	.	.
DNC000922	Melanocortin-4 Receptor antagonist	Anorexia nervosa cachexia	307.1, 799.4	F50.0-F50.1, R64
DNC000923	Melogatran	Discovery agent	.	.
DNC000924	MEN13510	Asthma	493	J45
DNC000924	MEN13510	Discovery agent	.	.
DNC000925	Mepacrine	Discovery agent	.	.
DNC000926	Metanephrine	Discovery agent	.	.
DNC000927	Metaproterenol	Discovery agent	.	.
DNC000928	Metastat	Acne vulgaris	.	L70.0
DNC000928	Metastat	Discovery agent	.	.
DNC000929	Metazamide	Discovery agent	.	.
DNC000930	Metazosin	Cardiotonic	.	I50
DNC000930	Metazosin	Discovery agent	.	.
DNC000931	Met-enkephalin	Discovery agent	.	.
DNC000931	Met-enkephalin	Pain	338,780	R52, G89
DNC000932	Methanandamide	Discovery agent	.	.
DNC000933	Methotrexate	Discovery agent	.	.
DNC000934	Methoxyestradiol	Discovery agent	.	.
DNC000935	Methoxyverapamil	Discovery agent	.	.
DNC000936	Methyl arachidonyl fluorophosphonate	Discovery agent	.	.
DNC000937	Methylene blue	Discovery agent	.	.
DNC000938	Methylglyoxal (bis) guanylhydrazone	Discovery agent	.	.
DNC000939	Methylglyoxal bis(guanylhydrazone)	Discovery agent	.	.
DNC000940	Methyllycaconitine	Discovery agent	.	.
DNC000942	Metrenperone	Discovery agent	.	.
DNC000943	MF-8623	Discovery agent	.	.
DNC000944	MGBG	Discovery agent	.	.
DNC000944	MGBG	Head and neck cancer	.	C07-C14,C32-C33
DNC000945	Micrococcin	Discovery agent	.	.
DNC000946	Microxine	Pain	338,780	R52, G89
DNC000947	Mimosine	Discovery agent	.	.
DNC000948	Mini-antibody(scFv)	Discovery agent	.	.
DNC000949	Minodronate	Discovery agent	.	.
DNC000950	Mivazerol	Angina pectoris	413	I20
DNC000950	Mivazerol	Discovery agent	.	.
DNC000951	MK0886	Discovery agent	.	.
DNC000952	MK-869	Depression	311	F32
DNC000953	MK-886	Asthma	.	J45
DNC000953	MK-886	Discovery agent	.	.
DNC000954	MK-912	Discovery agent	.	.
DNC000955	MMI270	Discovery agent	.	.
DNC000956	MOL 6131	Discovery agent	.	.
DNC000957	Monoclonal antibodies	Discovery agent	.	.
DNC000958	Morphine-6-glucuronide	Cancer pain	338,780	R52, G89
DNC000958	Morphine-6-glucuronide	Pain	338,780	R52, G89
DNC000959	Mosapride	Discovery agent	.	.
DNC000960	MR-889	Discovery agent	.	.
DNC000960	MR-889	Mucolytic	.	J00-J99
DNC000961	MRS-1220	Discovery agent	.	.
DNC000962	MRS-2179	Discovery agent	.	.
DNC000964	MSI-1956	Asthma	493	J45
DNC000964	MSI-1956	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC000965	MT-500	Discovery agent	.	.
DNC000965	MT-500	Migraine	.	G43
DNC000966	MTdU	Discovery agent	.	.
DNC000967	MTII Melanotan-II	Female sexual dysfunction	302.7	F52, R37
DNC000968	Mu O-conotoxin	Pain	338,780	R52, G89
DNC000969	Mumbaistatin	Discovery agent	.	.
DNC000970	Muscarine	Discovery agent	.	.
DNC000971	Muscimol	Discovery agent	.	.
DNC000972	Mutated growth hormone	Acromegaly	253	E22.0
DNC000973	Mycophenolic acid glucuronide	Discovery agent	.	.
DNC000974	Myo-inositol	Discovery agent	.	.
DNC000975	N-(3-(aminosulfonyl)-4-chloro-2-hydroxyphenyl)-N'-(2,3-dichlorophenyl) urea	Discovery agent	.	.
DNC000976	N-(phosphonacetyl)-L-aspartate	Discovery agent	.	.
DNC000977	N-(phosphonacetyl)-L-aspartate (PALA)	Discovery agent	.	.
DNC000978	N,N-dialkyl-dipeptidylamines	Discovery agent	.	.
DNC000979	N-(6)-methyl-2'-deoxyadenosine-3':5'-bisphosphate	Discovery agent	.	.
DNC000980	N1-guanyl-1,7-diaminoheptane	Discovery agent	.	.
DNC000981	N-acetylcysteine	Discovery agent	.	.
DNC000982	NADPH	Discovery agent	.	.
DNC000983	Nafamostat	Discovery agent	.	.
DNC000983	Nafamostat	Pancreatitis	577.0-577.1	K85, K86.0K86.1
DNC000985	N-alkyl urea hydroxamic acids	Discovery agent	.	.
DNC000986	Nalorphine	Discovery agent	.	.
DNC000987	N-alpha-methyl histamine	Discovery agent	.	.
DNC000988	Naltrindole	Discovery agent	.	.
DNC000989	NAN-190	Discovery agent	.	.
DNC000990	Naphthoquinone analogs	Discovery agent	.	.
DNC000991	Naphthyridinomycin	Discovery agent	.	.
DNC000992	Naproxene	Pain; Endometriosis	338, 617.0,780	N80, R52, G89
DNC000993	NAX-5055	Epileptic seizures	345.9, 780.3	G40, P90, R56
DNC000994	NB1011	Breast cancer	.	C50
DNC000994	NB1011	Discovery agent	.	.
DNC000995	NB-3040	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000996	NB3178	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000997	NB3322	Gram-positive bacteria infection; Gram-negative bacteria infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC000998	NB-598	Discovery agent	.	.
DNC000999	NBI-27914	Depression	311	F32
DNC001000	N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide	Discovery agent	.	.
DNC001001	NC1153	Immunotherapy for renal transplantation	279.5	D89.8
DNC001002	NC-2100	Discovery agent	.	.
DNC001003	NE21650	Discovery agent	.	.
DNC001004	Neamine	Discovery agent	.	.
DNC001005	Neomycin B	Discovery agent	.	.
DNC001006	Neomycin B-arginine conjugate	Discovery agent	.	.
DNC001007	NEP inhibitor	Female sexual dysfunction	302.7	F52, R37
DNC001008	Neplanocin A	Discovery agent	.	.
DNC001009	Netropsin	Discovery agent	.	.
DNC001010	New analgesic drugs	Discovery agent	.	.
DNC001011	NFPS	Discovery agent	.	.
DNC001012	NGX-267	Discovery agent	.	.
DNC001012	NGX-267	Schizophrenia	.	F20
DNC001013	NH-3	Discovery agent	.	.
DNC001014	NH-4	Discovery agent	.	.
DNC001015	N-hydroxy-nor-L-arginine	Discovery agent	.	.
DNC001016	N-hydroxysulfonamides	Discovery agent	.	.
DNC001017	Nickel chloride	Discovery agent	.	.
DNC001018	Nicotine replacement	Discovery agent	.	.
DNC001020	NIP-142	Atrial fibrillation	427.31	I48
DNC001021	Niravoline	Discovery agent	.	.
DNC001021	Niravoline	Pain	.	G89
DNC001022	NIS-62949	Discovery agent	.	.
DNC001023	Nitracrine	Discovery agent	.	.
DNC001024	Nitroglycerine	Discovery agent	.	.
DNC001025	NK-104	Discovery agent	.	.
DNC001026	NK3201	Discovery agent	.	.
DNC001027	N-methylbicuculline	Discovery agent	.	.
DNC001028	N-methyl-Pip-F-homoF-vinyl sulfonyl phenyl (N-methyl-Pip-F-hF-VS phi)	Discovery agent	.	.
DNC001029	NNC 05-2045	Discovery agent	.	.
DNC001030	NNC 711	Discovery agent	.	.
DNC001031	Nogalamycin	Discovery agent	.	.
DNC001032	Nonsteroidal anti-inflammatory drugs (NSAIDs)	Discovery agent	.	.
DNC001033	Noradrenaline	Discovery agent	.	.
DNC001034	Noradrenalone (arterenone)	Discovery agent	.	.
DNC001035	Norastemizole	Discovery agent	.	.
DNC001036	Nor-binaltorphimine dihydrochloride	Discovery agent	.	.
DNC001037	Nordihydroguaiaretic acid	Cancer	.	C00-C97
DNC001037	Nordihydroguaiaretic acid	Discovery agent	.	.
DNC001038	Nortropinyl-arylsulfonylurea 3	Discovery agent	.	.
DNC001039	Norzimelidine	Discovery agent	.	.
DNC001040	NP12	Alzheimer's disease	.	G30,F00
DNC001040	NP12	Discovery agent	.	.
DNC001041	N-phosphonacetyl-L-aspartate	Discovery agent	.	.
DNC001042	NPS 568	Discovery agent	.	.
DNC001042	NPS 568	Hyperproliferative skin disorders	.	L00-L99
DNC001043	NPY-1 antagonist	Eating disorders reduction in food intake obesity anxiety	307.5	F50
DNC001044	NPY-5 receptor antagonist	Eating disorder; Obesity	278, 307.5	E66, F50
DNC001045	NS398	Pain; Endometriosis	338, 617.0,780	N80, R52, G89
DNC001046	NS-398	Pain; Endometriosis	338, 617.0,780	N80, R52, G89
DNC001046	NS-398	Rheumatold arthritis	.	M05-M06
DNC001047	NSAIDs	Pain; Endometriosis	338, 617.0,780	N80, R52, G89
DNC001048	NSC 665564	Discovery agent	.	.
DNC001049	NU7026	Cancer	140-229	C00-C96
DNC001049	NU7026	Discovery agent	.	.
DNC001050	N-unsubstituted carbamate esters	Discovery agent	.	.
DNC001051	Nuvance	Acquired immunodeficiency syndrome	.	B20-B24
DNC001051	Nuvance	Discovery agent	.	.
DNC001052	NVP-ADW742	Multiple myeloma	203	C90.0
DNC001053	NVP-PDF386 (VRC4887)	Discovery agent	.	.
DNC001054	O-3-hexose derivatives	Discovery agent	.	.
DNC001054	O-3-hexose derivatives	Malaria	84	B50-B54
DNC001055	Ofloxacin otic	Acute otitis media; Otitis externa	017.40, 055.2, 380, 381.0, 381.1, 381.2, 381.3, 381.4, 382	H60, H65, H65-H67, H66, H67
DNC001056	Okadaic acid	Discovery agent	.	.
DNC001057	Olomoucine	Discovery agent	.	.
DNC001058	Olprinone	Discovery agent	.	.
DNC001059	Olterodine	Discovery agent	.	.
DNC001060	Oltipraz	Colorectal cancer	.	C18-C20,C21
DNC001060	Oltipraz	Discovery agent	.	.
DNC001061	ONO-6818	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC001061	ONO-6818	Discovery agent	.	.
DNC001062	OPC-21268	Cardiotonic	.	I50
DNC001062	OPC-21268	Discovery agent	.	.
DNC001063	OPC-31260	Discovery agent	.	.
DNC001064	Orotate	Discovery agent	.	.
DNC001065	Orotic acid	Discovery agent	.	.
DNC001066	Orthovanadate	Discovery agent	.	.
DNC001067	OSI-75	Discovery agent	.	.
DNC001068	Otenzepad	Discovery agent	.	.
DNC001068	Otenzepad	Heart failure	.	I50
DNC001069	Otilonium bromide	Gastric motility disorder	.	K22.4
DNC001069	Otilonium bromide	Irritable bowel syndrome	564.1	K58
DNC001070	Oxaprotiline	Anxiety disorder	300	F40-F42
DNC001070	Oxaprotiline	Discovery agent	.	.
DNC001071	Oxazolidinones	Discovery agent	.	.
DNC001071	Oxazolidinones	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001072	Oxidized glutathione	Discovery agent	.	.
DNC001073	Oximidine I	Discovery agent	.	.
DNC001074	Oximidine II	Discovery agent	.	.
DNC001075	Oxindole 16 (compound 3)	Discovery agent	.	.
DNC001076	Oxindole 94	Discovery agent	.	.
DNC001077	Oxindole 95	Discovery agent	.	.
DNC001078	Oxindole derivative	Malaria	84	B50-B54
DNC001079	Oxindole derivatives	Discovery agent	.	.
DNC001080	Oxolinic acid	Discovery agent	.	.
DNC001081	Oxotremorine	Discovery agent	.	.
DNC001082	Oxybutynine	Discovery agent	.	.
DNC001083	Ozagrel	Discovery agent	.	.
DNC001084	Ozagrel hydrochloride	Discovery agent	.	.
DNC001085	P(1)-(6-Hydroxymethylpterin)-P(2)-(5'-adenosyl)diphosphate	Discovery agent	.	.
DNC001086	P(1)-(6-Hydroxymethylpterin)-P(4)-(5'-adenosyl)tetraphosphate	Discovery agent	.	.
DNC001087	P32/98	Autism	.	F84.0
DNC001087	P32/98	Discovery agent	.	.
DNC001088	PA-824	Mycobacterium tuberculosis infection	.	A15-A19
DNC001088	PA-824	Tuberculosis	010-018	A15-A19
DNC001089	PAI-1	Discovery agent	.	.
DNC001090	PAI-2	Discovery agent	.	.
DNC001091	PALA	Discovery agent	.	.
DNC001092	Palmitoylethanolamide	Discovery agent	.	.
DNC001093	Parthenolide	Discovery agent	.	.
DNC001094	PCG1	Obesity	278	E66
DNC001095	PD0183813	Discovery agent	.	.
DNC001096	PD-116,948	Discovery agent	.	.
DNC001097	PD136450	Discovery agent	.	.
DNC001098	PD142893	Discovery agent	.	.
DNC001099	PD156707	Discovery agent	.	.
DNC001100	PD166285	Discovery agent	.	.
DNC001101	PD166866	Discovery agent	.	.
DNC001102	PD173074	Discovery agent	.	.
DNC001103	PD180970	Discovery agent	.	.
DNC001104	PD182905	Discovery agent	.	.
DNC001105	PD184352	Discovery agent	.	.
DNC001106	PD98059	Cancer	.	C00-C97
DNC001106	PD98059	Discovery agent	.	.
DNC001107	PDGF gene therapy	Diabetic foot ulcer	707	L88-L89
DNC001108	Penfluridol	Discovery agent	.	.
DNC001108	Penfluridol	Schizophrenia	295	F20
DNC001109	Penicillin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001109	Penicillin	Discovery agent	.	.
DNC001110	Pepstatin	Discovery agent	.	.
DNC001110	Pepstatin	Malaria	84	B50-B54
DNC001111	Peptide aldehydes	Discovery agent	.	.
DNC001112	Peptide alpha-keto-beta-aldehyde-based inhibitors	Discovery agent	.	.
DNC001113	Pergularinine	Discovery agent	.	.
DNC001114	Perindopril erbumine	Discovery agent	.	.
DNC001115	Pervanadate	Discovery agent	.	.
DNC001116	Phaclofen	Discovery agent	.	.
DNC001117	Phenacetin	Discovery agent	.	.
DNC001118	Phenazone	Discovery agent	.	.
DNC001119	Phenylarsine oxide	Discovery agent	.	.
DNC001120	Phorbol 12-myristate	Discovery agent	.	.
DNC001121	Phosphoramidon	Discovery agent	.	.
DNC001122	Piboserod	Atrial fibrillation	.	I48
DNC001122	Piboserod	Discovery agent	.	.
DNC001123	Piceatannol	Discovery agent	.	.
DNC001124	Picrotoxinin	Discovery agent	.	.
DNC001125	Pimagedine	Discovery agent	.	.
DNC001125	Pimagedine	Maillard reaction	.	F43.0
DNC001126	Pinusolide	Discovery agent	.	.
DNC001127	Piretanide	Discovery agent	.	.
DNC001128	PJ34	Discovery agent	.	.
DNC001129	PK 11195	Discovery agent	.	.
DNC001130	PK11195	Discovery agent	.	.
DNC001131	PKI166	Discovery agent	.	.
DNC001131	PKI166	Esophageal cancer	.	C15
DNC001132	PKI-166	Discovery agent	.	.
DNC001133	Platelet factor 4 (PF-4)	Discovery agent	.	.
DNC001134	Plumbagin	Discovery agent	.	.
DNC001135	PMEA	Discovery agent	.	.
DNC001136	P-MPPI	Discovery agent	.	.
DNC001137	PNRI-299	Discovery agent	.	.
DNC001138	PNU156804	Discovery agent	.	.
DNC001138	PNU156804	Immunotherapy for renal transplantation	279.5	D89.8
DNC001139	Podophyllotoxin	Condyloma	.	A51.3
DNC001139	Podophyllotoxin	Discovery agent	.	.
DNC001140	Polyporic acid	Discovery agent	.	.
DNC001141	Ponalrestat	Discovery agent	.	.
DNC001141	Ponalrestat	Gout	.	M10
DNC001143	PP2	Discovery agent	.	.
DNC001144	PPA	Discovery agent	.	.
DNC001145	PPACK	Discovery agent	.	.
DNC001146	Prasterone	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC001146	Prasterone	Discovery agent	.	.
DNC001147	Pregnenolone	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DNC001147	Pregnenolone	Discovery agent	.	.
DNC001148	Pregnenolone-16alpha-carbonitrile (PCN)	Discovery agent	.	.
DNC001149	Premafloxacin	Discovery agent	.	.
DNC001150	Premarin	Discovery agent	.	.
DNC001152	Propionate	Discovery agent	.	.
DNC001153	Propyl thiouracile	Discovery agent	.	.
DNC001154	Protoporphyrin IX	Discovery agent	.	.
DNC001155	Prucalopride	Discovery agent	.	.
DNC001156	PS-1145	Multiple myeloma	203	C90.0
DNC001157	PS-341	Discovery agent	.	.
DNC001158	PS-519	Discovery agent	.	.
DNC001158	PS-519	Ischemia-reperfusion injury	.	I00-I99
DNC001159	Psora-4	Discovery agent	.	.
DNC001160	Psoralen	Discovery agent	.	.
DNC001161	PTAC	Discovery agent	.	.
DNC001162	Pumiliotoxin 251D	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001163	Purpurin	Discovery agent	.	.
DNC001164	Purvalanol	Discovery agent	.	.
DNC001165	Purvalanol A	Discovery agent	.	.
DNC001166	Purvalanol B	Discovery agent	.	.
DNC001167	Pycnogenol	Discovery agent	.	.
DNC001168	Pyrazofurin	Discovery agent	.	.
DNC001169	Pyridinyl imidazole compounds	Discovery agent	.	.
DNC001170	Pyridobenzimidazole	Fungal diseases	110-118	B35-B49
DNC001171	Pyridostigmine bromide	Discovery agent	.	.
DNC001172	Pyridoxal 5'-phosphate	Discovery agent	.	.
DNC001174	Pyrilamine	Discovery agent	.	.
DNC001175	Pyrilamine Maleate	Discovery agent	.	.
DNC001176	Pyrimidinyl acylthiourea	Discovery agent	.	.
DNC001177	Pyrrolidine dithiocarbamate	Discovery agent	.	.
DNC001178	Pyrrolopyrimidine	Discovery agent	.	.
DNC001179	Quinacrine azide	Discovery agent	.	.
DNC001180	Quinacrine dihydrochloride	Discovery agent	.	.
DNC001181	Quinacrine HCl	Discovery agent	.	.
DNC001182	Quinalizarin	Discovery agent	.	.
DNC001183	Quinelorane	Discovery agent	.	.
DNC001183	Quinelorane	Male sexual disorders	.	F52
DNC001184	Quinizarin	Discovery agent	.	.
DNC001185	Quinones	Discovery agent	.	.
DNC001186	Quizalofop	Discovery agent	.	.
DNC001187	R 80122	Cardiovascular disease	.	I00-I99
DNC001187	R 80122	Discovery agent	.	.
DNC001188	R0-93877	Discovery agent	.	.
DNC001189	R121919	Depression	311	F32
DNC001189	R121919	Discovery agent	.	.
DNC001190	R-568	Discovery agent	.	.
DNC001191	R-68151	Discovery agent	.	.
DNC001191	R-68151	Psoriasis	696	L40
DNC001192	R-820	Discovery agent	.	.
DNC001193	R-85355	Discovery agent	.	.
DNC001194	Raclopride	Discovery agent	.	.
DNC001194	Raclopride	Psychotic disorders	.	F20-F29
DNC001195	Radicicol	Discovery agent	.	.
DNC001196	R-alpha-methyl histamine	Discovery agent	.	.
DNC001197	Rapamycin	Discovery agent	.	.
DNC001197	Rapamycin	Multiple myeloma	203	C90.0
DNC001198	Rapamycin complexed with immunophilin FKBP12	Discovery agent	.	.
DNC001199	Rauwolscine	Discovery agent	.	.
DNC001200	Rebamipide	Discovery agent	.	.
DNC001200	Rebamipide	Peptic ulcer	531-534	K25-K27
DNC001201	REC2615	Female sexual dysfunction	302.7	F52, R37
DNC001202	Receptor-Fc fusion proteins	Discovery agent	.	.
DNC001203	Redoxal	Discovery agent	.	.
DNC001205	Resveratrol	Discovery agent	.	.
DNC001206	Reveromycin A	Discovery agent	.	.
DNC001207	RGD	Discovery agent	.	.
DNC001208	RhuCD40L	Discovery agent	.	.
DNC001209	RhuMAb HER2	Discovery agent	.	.
DNC001210	Ribavirin-TP	Discovery agent	.	.
DNC001211	Ribostamycin	Discovery agent	.	.
DNC001212	Rifalazil	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNC001212	Rifalazil	Tuberculosis	010-018	A15-A19
DNC001213	Rilpivirine	HIV infections	42	B20
DNC001213	Rilpivirine	Human immunodeficiency virus infection	.	B20
DNC001214	Rimantadine isomer 1	Discovery agent	.	.
DNC001215	Rimantadine isomer 2	Discovery agent	.	.
DNC001216	RIS	Discovery agent	.	.
DNC001217	Ritanserin	Anxiety disorder	300	F40-F42
DNC001217	Ritanserin	Discovery agent	.	.
DNC001218	RJR-2403	Cognition disorders	.	F06.7
DNC001218	RJR-2403	Discovery agent	.	.
DNC001219	Ro 20-1724	Asthma	.	J45
DNC001219	Ro 20-1724	Discovery agent	.	.
DNC001220	Ro 28-2653	Discovery agent	.	.
DNC001221	Ro 5-4864	Discovery agent	.	.
DNC001222	Ro 63-1908	Discovery agent	.	.
DNC001223	Ro092210	Discovery agent	.	.
DNC001224	Ro-23-9424	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNC001224	Ro-23-9424	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001225	RO-25-6981	Cancer pain	338,780	R52, G89
DNC001226	Ro48-8071	Discovery agent	.	.
DNC001227	Ro-64-6198	Discovery agent	.	.
DNC001228	Robalzotan	Anxiety disorder	.	F40-F42
DNC001228	Robalzotan	Discovery agent	.	.
DNC001229	Robalzotan monohydrobromide	Discovery agent	.	.
DNC001230	Roche 28-2653	Discovery agent	.	.
DNC001231	Ropinirole CR	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
DNC001232	Roscovitine	Discovery agent	.	.
DNC001233	Rotigitine	Parkinson's disease	332	F02.3, G20
DNC001234	Rotigotine	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
DNC001235	Rp-adenosine 3',5'-cyclic monophosphothioate triethylamine (Rp-cAMPS)	Discovery agent	.	.
DNC001236	RS 86	Alzheimer's disease	331	G30
DNC001236	RS 86	Discovery agent	.	.
DNC001237	RS-100302	Atrial fibrillation	427.31	I48
DNC001238	RS-1636	Discovery agent	.	.
DNC001239	RS-1653	Discovery agent	.	.
DNC001240	RS-61980	Discovery agent	.	.
DNC001241	RTI-76	Discovery agent	.	.
DNC001242	RWJ-140998	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001243	RWJ-3981	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001244	RWJ-49815	Fungal diseases	110-118	B35-B49
DNC001245	RWJ-67657	Arthritic	710-719	M00-M25
DNC001245	RWJ-67657	Pain	338,780	R52, G89
DNC001246	S 0957	Discovery agent	.	.
DNC001247	S 1743	Discovery agent	.	.
DNC001248	S 202 791	Discovery agent	.	.
DNC001249	S 3025	Discovery agent	.	.
DNC001250	S-(-)-enantiomer of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP)	Discovery agent	.	.
DNC001251	S-(-)-Lisuride	Discovery agent	.	.
DNC001252	S-(-)-sulpiride	Discovery agent	.	.
DNC001253	S-(2-boronoethyl)-L-cysteine	Discovery agent	.	.
DNC001254	S1627	Discovery agent	.	.
DNC001255	S-19528	Eating disorders reduction in food intake	307.5	F50
DNC001256	S-20951	Atrial fibrillation	427.31	I48
DNC001257	S-2238	Discovery agent	.	.
DNC001258	S-25585	Eating disorders reduction in food intake	307.5	F50
DNC001259	S-4048	Discovery agent	.	.
DNC001260	S-5751	Discovery agent	.	.
DNC001260	S-5751	Rhinitis	.	J00,J30,J31.0
DNC001261	S-8510	Discovery agent	.	.
DNC001261	S-8510	Nootropic	.	F00-F99
DNC001262	S-9947	Atrial fibrillation	427.31	I48
DNC001263	Sabadinine	Discovery agent	.	.
DNC001264	Sabcomeline	Discovery agent	.	.
DNC001265	Saframycin A	Discovery agent	.	.
DNC001266	Salicylhydroxamic acid	Discovery agent	.	.
DNC001267	Salicylihalamide A	Discovery agent	.	.
DNC001268	Saline	Discovery agent	.	.
DNC001269	SAM486A	Discovery agent	.	.
DNC001269	SAM486A	Solid tumours	.	C00-C75,C7A,C7B
DNC001270	Sampatrilat	Discovery agent	.	.
DNC001270	Sampatrilat	Hypotension	.	I95
DNC001271	Sant7	Multiple myeloma	203	C90.0
DNC001272	Sarafotoxin 6C	Discovery agent	.	.
DNC001273	Sarcodictyin A	Discovery agent	.	.
DNC001274	Satavaptan Lixivaptan	Ascites; Hyponatraemia	276.1, 789.5	E87.1, R18
DNC001275	Saxitoxin	Discovery agent	.	.
DNC001276	SB 202190	Pain	338,780	R52, G89
DNC001277	SB 202235	Discovery agent	.	.
DNC001277	SB 202235	Inflammatory diseases	.	.
DNC001278	SB 203106	Discovery agent	.	.
DNC001279	SB 203186	Discovery agent	.	.
DNC001280	SB 203580	Discovery agent	.	.
DNC001281	SB 206553	Discovery agent	.	.
DNC001282	SB 206553 hydrochloride	Discovery agent	.	.
DNC001283	SB 224289	Discovery agent	.	.
DNC001284	SB 225002	Discovery agent	.	.
DNC001285	SB 227122	Discovery agent	.	.
DNC001286	SB 235699	Discovery agent	.	.
DNC001286	SB 235699	Psoriasis	696	L40
DNC001287	SB 236057-A	Discovery agent	.	.
DNC001288	SB 239063	Pain	338,780	R52, G89
DNC001289	SB 243213	Discovery agent	.	.
DNC001290	SB 258585	Discovery agent	.	.
DNC001291	SB 265610	Discovery agent	.	.
DNC001292	SB 269970-A	Discovery agent	.	.
DNC001293	SB 272844	Discovery agent	.	.
DNC001294	SB 656104-A	Discovery agent	.	.
DNC001295	SB-207266A	Discovery agent	.	.
DNC001295	SB-207266A	Irritable bowel syndrome	.	K58
DNC001296	SB216763	Discovery agent	.	.
DNC001297	SB-225002	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC001298	SB-332235	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC001298	SB-332235	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC001299	SBTI	Discovery agent	.	.
DNC001300	SC41661A	Asthma	.	J45
DNC001300	SC41661A	Discovery agent	.	.
DNC001301	SC-79407	Discovery agent	.	.
DNC001302	SC-83157	Discovery agent	.	.
DNC001303	SCH 351125	Discovery agent	.	.
DNC001304	Sch 37370	Asthma	.	J45
DNC001304	Sch 37370	Discovery agent	.	.
DNC001305	SCH 44643	Discovery agent	.	.
DNC001306	SCH 50911	Discovery agent	.	.
DNC001307	SCH-23390	Discovery agent	.	.
DNC001308	SCH58261	Discovery agent	.	.
DNC001309	SCH66336	Discovery agent	.	.
DNC001309	SCH66336	Lymphoma	.	C81-C96
DNC001311	SCIO469	Discovery agent	.	.
DNC001312	Scyllo-inositol	Discovery agent	.	.
DNC001313	SDZ 205,557	Anxiety disorder	300	F40-F42
DNC001313	SDZ 205,557	Discovery agent	.	.
DNC001314	SDZ 216-525	Discovery agent	.	.
DNC001315	Secretory leukocyte protease inhibitor	Discovery agent	.	.
DNC001316	Selective inhibitors of PTP1B	Obesity	278	E66
DNC001317	Selenazofurin	Discovery agent	.	.
DNC001318	Selenocompounds	Discovery agent	.	.
DNC001319	Selfotel	Acute ischemic stroke	434.91	I61-I63
DNC001319	Selfotel	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC001320	Senktide	Discovery agent	.	.
DNC001321	Septide	Discovery agent	.	.
DNC001322	SF303	Discovery agent	.	.
DNC001323	S-hexylglutathione	Discovery agent	.	.
DNC001324	SHU9119	Discovery agent	.	.
DNC001325	SIB-1508Y	Discovery agent	.	.
DNC001325	SIB-1508Y	Parkinson's disease	332	F02.3, G20
DNC001326	SIB-1533A	Discovery agent	.	.
DNC001327	SIB-1553A	Alzheimer's disease	.	G30,F00
DNC001327	SIB-1553A	Discovery agent	.	.
DNC001328	SIB-1663	Discovery agent	.	.
DNC001329	SIB-1765F	Discovery agent	.	.
DNC001330	SIL-4R	Discovery agent	.	.
DNC001331	Silymarin	Discovery agent	.	.
DNC001332	Sinefungin	Discovery agent	.	.
DNC001333	Sivelestat	Discovery agent	.	.
DNC001334	SK&F 107649	Discovery agent	.	.
DNC001335	SK&F 86002	Discovery agent	.	.
DNC001335	SK&F 86002	Rheumatold arthritis	.	M05-M06
DNC001336	SK509	Discovery agent	.	.
DNC001337	SK549	Discovery agent	.	.
DNC001338	SK554	Discovery agent	.	.
DNC001339	SKF 38393	Diabetes mellitus type 2	.	E11
DNC001339	SKF 38393	Discovery agent	.	.
DNC001340	SKF-97541	Discovery agent	.	.
DNC001341	SL65.0155	Discovery agent	.	.
DNC001341	SL65.0155	Parkinson's disease	.	G20
DNC001342	SL65.0472	Cardiovascular disease	.	I00-I99
DNC001342	SL65.0472	Discovery agent	.	.
DNC001343	SLV306	Discovery agent	.	.
DNC001344	SM 11044	Asthma	493	J45
DNC001344	SM 11044	Discovery agent	.	.
DNC001345	SN-38	Cancer	.	C00-C97
DNC001345	SN-38	Discovery agent	.	.
DNC001346	SN429	Discovery agent	.	.
DNC001346	SN429	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNC001347	SNAP-5114	Discovery agent	.	.
DNC001348	SNC-80	Discovery agent	.	.
DNC001349	SNX-111	Discovery agent	.	.
DNC001351	Sodium nitroprusside	Discovery agent	.	.
DNC001352	Sodium orthovanadate	Discovery agent	.	.
DNC001353	Sodium valproate	Discovery agent	.	.
DNC001354	Somatoprim	Acromegaly	.	E22.0
DNC001354	Somatoprim	Acromegaly	253	E22.0
DNC001355	Somatostatin analogues	Discovery agent	.	.
DNC001356	SP600125	Discovery agent	.	.
DNC001357	Sphingosine	Discovery agent	.	.
DNC001358	Spiramycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001358	Spiramycin	Discovery agent	.	.
DNC001359	Spiro[cyclopropane-1,2-adamantan]-2-amine	Discovery agent	.	.
DNC001360	Spiro[piperidine-2,2-adamantane]	Discovery agent	.	.
DNC001361	Spiro[pyrrolidine-2,2-adamantane]	Discovery agent	.	.
DNC001362	Spiroglumide	Discovery agent	.	.
DNC001362	Spiroglumide	Stomach disease	.	K30-K31
DNC001363	SPR-210	Diabetic complication	.	E08-E13
DNC001363	SPR-210	Discovery agent	.	.
DNC001364	SPT	Discovery agent	.	.
DNC001365	SQ32,910	Discovery agent	.	.
DNC001366	SR 120819A	Discovery agent	.	.
DNC001366	SR 120819A	Eating disorder	.	F50
DNC001367	SR 121463 A	Discovery agent	.	.
DNC001368	SR 49059	Discovery agent	.	.
DNC001368	SR 49059	Hyponatremia	.	E87.1
DNC001369	SR121463	Discovery agent	.	.
DNC001370	SR121463B	Discovery agent	.	.
DNC001371	SR141716A	Discovery agent	.	.
DNC001372	SR144528	Discovery agent	.	.
DNC001373	SR-45023A (Apomine)	Discovery agent	.	.
DNC001374	SR48,968	Discovery agent	.	.
DNC001375	SR95531	Discovery agent	.	.
DNC001376	SRI 63-441	Discovery agent	.	.
DNC001377	SSR125543A	Depression	311	F32
DNC001378	SSR240600	Discovery agent	.	.
DNC001378	SSR240600	Urinary incontinence	.	N39.3-N39.4
DNC001379	Stachyflin	Discovery agent	.	.
DNC001380	Staurosporine	Discovery agent	.	.
DNC001381	Sterculic acid	Discovery agent	.	.
DNC001382	Steroidal and non-steroidal inhibitors	Discovery agent	.	.
DNC001383	STI571	Discovery agent	.	.
DNC001384	SU10991	Multiple myeloma	203	C90.0
DNC001385	SU4984	Discovery agent	.	.
DNC001386	SU5402	Multiple myeloma	203	C90.0
DNC001387	SU5403	Discovery agent	.	.
DNC001388	SU-5416	Discovery agent	.	.
DNC001389	SU9516	Discovery agent	.	.
DNC001390	Sulfenamido-sulfonamides	Discovery agent	.	.
DNC001391	Sulfonamide	Discovery agent	.	.
DNC001392	Sulfonylthioureas	Discovery agent	.	.
DNC001393	Sulphameth oxazole	P. falciparum infection	84	B50-B54
DNC001394	SUN N4057	Coronary artery disease	.	I20-I25
DNC001394	SUN N4057	Discovery agent	.	.
DNC001395	SUN-C8257	Discovery agent	.	.
DNC001396	SWR-0342SA	Obesity	278	E66
DNC001397	Synaptosomal membrane antigen D3	Discovery agent	.	.
DNC001398	T01312	Discovery agent	.	.
DNC001399	T0901317	Discovery agent	.	.
DNC001400	T-1105	Discovery agent	.	.
DNC001401	T-1106	Discovery agent	.	.
DNC001401	T-1106	Viral infections	042-075	A80-A99, B00-B34
DNC001402	T-1249	Discovery agent	.	.
DNC001402	T-1249	HIV infections	42	B20
DNC001403	TA1-RTA	Discovery agent	.	.
DNC001404	TAD	Discovery agent	.	.
DNC001406	Talipexole	Discovery agent	.	.
DNC001407	Talisomycin	Discovery agent	.	.
DNC001408	Tallimustine	Discovery agent	.	.
DNC001408	Tallimustine	Solid tumours	.	C00-C75,C7A,C7B
DNC001409	TAM-67	Discovery agent	.	.
DNC001410	TAS-103	Discovery agent	.	.
DNC001410	TAS-103	Solid tumours	.	C00-C75,C7A,C7B
DNC001411	Taxol	Discovery agent	.	.
DNC001412	TBC 11251 (TBC)	Discovery agent	.	.
DNC001413	TBHQ	Discovery agent	.	.
DNC001414	TCPOBOP	Discovery agent	.	.
DNC001415	TCV-309	Discovery agent	.	.
DNC001415	TCV-309	Septic shock	.	A41.9
DNC001416	TD-1792	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001416	TD-1792	Gram-positive infections	.	A36.9
DNC001417	TD-5108	Discovery agent	.	.
DNC001417	TD-5108	Gastroparesis	536.3	K31.8
DNC001418	TEI-8362	Discovery agent	.	.
DNC001419	Telaprevir	Endometriosis	617	N80
DNC001419	Telaprevir	Hepatitis C virus infection	.	B17.1,B18.2
DNC001420	Telavancin	Depression	311	F32
DNC001420	Telavancin	Staphylococcus aureus infection	.	A41.0
DNC001421	Tellurium	Discovery agent	.	.
DNC001422	Telomestatin	Multiple myeloma	203	C90.0
DNC001423	Tepoxalin	Asthma	.	J45
DNC001423	Tepoxalin	Discovery agent	.	.
DNC001424	Tetrachlorosalicylanilide	Discovery agent	.	.
DNC001425	Tetraethylammonium (TEA)	Discovery agent	.	.
DNC001426	Tetrahydroimidazo[4,5,1-jk]-[1,4]benzodiazepin-2(1H)-one	Discovery agent	.	.
DNC001427	TGF-beta receptor kinase inhibitor	Idiopathic pulmonary fibrosis	516.3	J84.1
DNC001428	Thiadiazolo[2,3-a]pyrimidine	Discovery agent	.	.
DNC001429	Thiamazole	Discovery agent	.	.
DNC001431	Thiazolidinedione	Alzheimer's disease	.	G30,F00
DNC001431	Thiazolidinedione	Discovery agent	.	.
DNC001432	Thiocarbamate	Discovery agent	.	.
DNC001433	Thiocarlide	Discovery agent	.	.
DNC001434	Thiolactomycin	Discovery agent	.	.
DNC001434	Thiolactomycin	Malaria	84	B50-B54
DNC001435	Thioperamide	Cognitive impairment	.	F06.7
DNC001435	Thioperamide	Obesity	278	E66
DNC001436	Thiophene sulfonamide	Discovery agent	.	.
DNC001436	Thiophene sulfonamide	Malaria	84	B50-B54
DNC001437	Thiorphan	Discovery agent	.	.
DNC001438	Thiostrepton	Discovery agent	.	.
DNC001439	THIP	Discovery agent	.	.
DNC001439	THIP	Sleep disorders	.	F51,G47
DNC001440	THPO	Discovery agent	.	.
DNC001441	TI1	Discovery agent	.	.
DNC001442	TI3	Discovery agent	.	.
DNC001443	TI4	Discovery agent	.	.
DNC001444	Tiapride	Alcohol use disorders	303	F10.2
DNC001444	Tiapride	Discovery agent	.	.
DNC001445	Tick anticoagulant peptide	Discovery agent	.	.
DNC001446	Tick anticoagulant peptide (TAP)	Discovery agent	.	.
DNC001447	Tin protoporphyrin	Discovery agent	.	.
DNC001448	TIP	Discovery agent	.	.
DNC001449	Tipifarnib	Discovery agent	.	.
DNC001449	Tipifarnib	Solid tumours	.	C00-C75,C7A,C7B
DNC001450	TIPP	Discovery agent	.	.
DNC001451	Tissue factor pathway inhibitor (TFPI)	Discovery agent	.	.
DNC001452	TMPyP4	Multiple myeloma	203	C90.0
DNC001453	TNP-470	Discovery agent	.	.
DNC001453	TNP-470	Solid tumours	.	C00-C75,C7A,C7B
DNC001454	Toll-like receptor 4 inhibition	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001455	Tolrestat	Diabetic cataract	.	E10.36,E11.36
DNC001455	Tolrestat	Discovery agent	.	.
DNC001456	Tonazocine mesylate	Discovery agent	.	.
DNC001458	Trans-hydroxytamoxifen	Discovery agent	.	.
DNC001459	Trapidil	Discovery agent	.	.
DNC001460	Trapoxin	Discovery agent	.	.
DNC001461	Trecadrine	Discovery agent	.	.
DNC001462	Triapine	Discovery agent	.	.
DNC001462	Triapine	Nerve injury	.	T14.4
DNC001463	Triazine	Discovery agent	.	.
DNC001464	Trichostatin	Discovery agent	.	.
DNC001465	Trichostatin A	Cancers	140-229	C00-C96
DNC001466	Tricyclics	Kinetoplastids	085, 086	B55, B56, B57
DNC001467	Trifluoromethionine	Discovery agent	.	.
DNC001468	Trifluperidol	Discovery agent	.	.
DNC001469	Triglycyl-lysine-vasopressin	Discovery agent	.	.
DNC001470	Trimetoquinol	Discovery agent	.	.
DNC001471	Trimidox	Cancer	.	C00-C97
DNC001471	Trimidox	Discovery agent	.	.
DNC001472	Triparanol	Discovery agent	.	.
DNC001473	Triptolide	Autoimmune diseases	279.4	D84.9, M35.9
DNC001473	Triptolide	Discovery agent	.	.
DNC001474	Trispyridinium compounds 91-95	Discovery agent	.	.
DNC001475	TrkA-IgG	Discovery agent	.	.
DNC001476	Tubacin	Multiple myeloma	203	C90.0
DNC001477	Tylophorinidine	Discovery agent	.	.
DNC001478	Tyrphostin AG490	Discovery agent	.	.
DNC001479	U 75302	Allergy	995.3	T78.4
DNC001479	U 75302	Discovery agent	.	.
DNC001480	U0126	Discovery agent	.	.
DNC001481	U50,488H	Discovery agent	.	.
DNC001482	U-50488H	Discovery agent	.	.
DNC001483	UCL-1390	Eating disorder; Epilepsy; Pain	307.5, 338,780	F50, R52, G89
DNC001484	Uinagolide	Discovery agent	.	.
DNC001485	UK 14,304	Discovery agent	.	.
DNC001485	UK 14,304	Glaucoma	365	H40-H42
DNC001486	UK-279,276	Ischemic stroke	434.91	I61-I63
DNC001486	UK-279,276	Stroke	.	I61-I63
DNC001488	Ulinastatin	Discovery agent	.	.
DNC001488	Ulinastatin	Premature labour	.	O60.1,P07.3
DNC001489	UR-12670	Discovery agent	.	.
DNC001490	Urapidil	Discovery agent	.	.
DNC001490	Urapidil	Hypertension	401	I10, I11, I12, I13, I15
DNC001491	Uridine	Depression	311	F32
DNC001491	Uridine	Discovery agent	.	.
DNC001492	UTP	Discovery agent	.	.
DNC001493	V-165	Discovery agent	.	.
DNC001494	Vanadate	Discovery agent	.	.
DNC001495	Vertex 745 (VX745)	Discovery agent	.	.
DNC001496	Vinylsulphones	P. falciparum infection	84	B50-B54
DNC001497	Viozan	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC001497	Viozan	Discovery agent	.	.
DNC001498	Vitamin A	Acne vulgaris	706.1	L70.0
DNC001498	Vitamin A	Discovery agent	.	.
DNC001499	Vitamin B6	Discovery agent	.	.
DNC001500	Vitamin K	Discovery agent	.	.
DNC001501	Vitamin K3	Discovery agent	.	.
DNC001501	Vitamin K3	Prostate cancer	185	C61
DNC001502	Vitaxin	Discovery agent	.	.
DNC001502	Vitaxin	Solid tumours	.	C00-C75,C7A,C7B
DNC001503	Volatile anesthetics	Discovery agent	.	.
DNC001504	VP-343	Discovery agent	.	.
DNC001505	VRC3375	Discovery agent	.	.
DNC001506	VX-148	Discovery agent	.	.
DNC001506	VX-148	Psoriasis	696	L40
DNC001507	VX-497	Discovery agent	.	.
DNC001507	VX-497	Hepatitis virus infection	573.3	K75.9
DNC001508	WAY 100135	Discovery agent	.	.
DNC001509	WAY-100635	Discovery agent	.	.
DNC001509	WAY-100635	Eating disorder	.	F50
DNC001510	WAY-132983	Discovery agent	.	.
DNC001511	WAY-177820	Cancer	140-229	C00-C96
DNC001511	WAY-177820	Discovery agent	.	.
DNC001512	WEB 2086	Asthma	.	J45
DNC001512	WEB 2086	Discovery agent	.	.
DNC001513	WL-1001	P. falciparum infection; Trypanosoma	084, 086	B50-B54, B56
DNC001514	Wortmannin	Hematologic malignancies	200-209	C81-C96
DNC001515	WR85915	Discovery agent	.	.
DNC001516	WR99210	Discovery agent	.	.
DNC001516	WR99210	Plasmodium infection	.	B54
DNC001517	Xolair	Allergic rhinitis	477	J30
DNC001517	Xolair	Discovery agent	.	.
DNC001518	XV454	Discovery agent	.	.
DNC001519	Y-25130	Discovery agent	.	.
DNC001520	Y-27632	Asthma	.	J45
DNC001520	Y-27632	Discovery agent	.	.
DNC001521	Y-39041	Discovery agent	.	.
DNC001522	Y-40613	Discovery agent	.	.
DNC001523	YC-1	Discovery agent	.	.
DNC001524	YM 087	Discovery agent	.	.
DNC001524	YM 087	Hyponatremia	.	E87.1
DNC001525	YM087	Discovery agent	.	.
DNC001526	YM60828	Discovery agent	.	.
DNC001527	YM872	Acute ischemic stroke	434.91	I61-I63
DNC001527	YM872	Coronary artery disease	.	I20-I25
DNC001528	YM-96765	Discovery agent	.	.
DNC001529	YVAD	Discovery agent	.	.
DNC001530	YW3548	Discovery agent	.	.
DNC001531	Zamifenacin	Discovery agent	.	.
DNC001531	Zamifenacin	Urinary incontinence	.	N39.3-N39.4
DNC001532	ZD-0892	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC001532	ZD-0892	Discovery agent	.	.
DNC001533	ZD1604	Discovery agent	.	.
DNC001534	ZD2079	Diabetes mellitus	.	E10-E14
DNC001534	ZD2079	Discovery agent	.	.
DNC001535	ZD6416	Discovery agent	.	.
DNC001535	ZD6416	Pain	338,780	R52, G89
DNC001536	ZD7114	Diabetes mellitus	.	E10-E14
DNC001536	ZD7114	Discovery agent	.	.
DNC001537	ZD-8321	Discovery agent	.	.
DNC001538	ZD9331	Discovery agent	.	.
DNC001539	Zithromax	Discovery agent	.	.
DNC001540	Z-LEHD-fmk	Discovery agent	.	.
DNC001541	ZM-230487	Asthma	.	J45
DNC001541	ZM-230487	Discovery agent	.	.
DNC001542	Zn2+	Discovery agent	.	.
DNC001544	Zydis selegiline	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
DNC001545	OGX-427 + Paclitaxel	Breast cancer; Ovarian cancer; Bladder cancer; Prostate cancer; Lung cancer	140-229, 162, 183, 188	C00-C96, C33-C34, C56, C67
DNC001546	ISIS 2922 + Ganciclovir	Viral infections	042-075	A80-A99, B00-B34
DNC001547	ISIS 2922 + foscarnet 3' -azido-3'-deoxythymidine 2'-3'-dideoxycytidine	Viral infections	042-075	A80-A99, B00-B34
DNC001548	RBI034 (2-5A antisense compound) + Ribavirin	Upper and lower respiratory tract disease	460-519	J00-J99
DNC001549	G3139 + Paclitaxel	Small-cell lung cancer	162.9	C34.90
DNC001550	G3139 + Fludarabine	Relapsed acute leukemia	204-208	C91-C95
DNC001551	G3139 + cytarabine (ARA-C)	Relapsed acute leukemia	204-208	C91-C95
DNC001552	G3139 + G-CSF	Relapsed acute leukemia	204-208	C91-C95
DNC001553	G3139 + Dacarbazine	Advanced melanoma	172	C43
DNC001554	G3139 + Thalidomide	Multiple myeloma	203	C90.0
DNC001555	G3139 + Dexamethasone	Multiple myeloma	203	C90.0
DNC001556	G3139 + Irinotecan	Metastatic colorectal cancer	153, 154	C18-C21
DNC001557	Cantide + Cisplatin	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC001558	Cantide + 5-FU	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC001559	Cantide + adriamycin	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC001560	TS antisense + 5-FU	Cancer	140-229	C00-C96
DNC001561	TS antisense + raltitrexed	Cancer	140-229	C00-C96
DNC001562	MCL-1-specific antisense oligonucleotide + Imatinib (STI571)	Systemic mastocytosis	202.6, 757.33	C96.2, Q82.2
DNC001563	MCL-1-specific antisense oligonucleotide + midostaurin(PKC412)	Systemic mastocytosis	202.6, 757.33	C96.2, Q82.2
DNC001564	MCL-1-specific antisense oligonucleotide + nilotinib (AMN107)	Systemic mastocytosis	202.6, 757.33	C96.2, Q82.2
DNC001565	Affinitak + Gemcitabine	Non-small-cell lung carcinoma	162	C33, C34
DNC001566	Affinitak + Cisplatin	Non-small-cell lung carcinoma	162	C33, C34
DNC001567	QPI-1002	Acute kidney injury	584	N17
DNC001567	QPI-1002	Renal artery disease	.	I70.1
DNC001568	PF-04523655	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNC001569	PcTx1	Pain	338,780	R52, G89
DNC001570	APETX2	Pain	338,780	R52, G89
DNC001572	A-803467	Pain	338,780	R52, G89
DNC001575	CJ 11,974-01	Pain	338,780	R52, G89
DNC001576	DUP 697	Pain	338,780	R52, G89
DNC001577	Bimetopyrole	Pain	338,780	R52, G89
DNC001578	QX-314	Pain	338,780	R52, G89
DNC001579	E-2050	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC001579	E-2050	Pain	338,780	R52, G89
DNC001580	SB-221420-A	Pain	338,780	R52, G89
DNC001581	NMED-160	Pain	.	G89
DNC001581	NMED-160	Pain	338,780	R52, G89
DNC001582	NS-7	Nerve injury	.	T14.4
DNC001582	NS-7	Pain	338,780	R52, G89
DNC001583	PD173212	Pain	338,780	R52, G89
DNC001584	PD176078	Pain	338,780	R52, G89
DNC001585	Ajinomoto 1	Pain	338,780	R52, G89
DNC001586	Ajinomoto 2	Pain	338,780	R52, G89
DNC001587	Ajinomoto 3	Pain	338,780	R52, G89
DNC001588	Euro-Celtique 1	Pain	338,780	R52, G89
DNC001589	Euro-Celtique 2	Pain	338,780	R52, G89
DNC001590	Euro-Celtique 3	Pain	338,780	R52, G89
DNC001591	Euro-Celtique 4	Pain	338,780	R52, G89
DNC001592	Neuromed 2	Pain	338,780	R52, G89
DNC001593	Neuromed 5	Pain	338,780	R52, G89
DNC001594	Ono 1	Pain	338,780	R52, G89
DNC001595	Ono 2	Pain	338,780	R52, G89
DNC001596	Ono 3	Pain	338,780	R52, G89
DNC001597	Parke-Davis 1	Pain	338,780	R52, G89
DNC001598	Parke-Davis 9	Pain	338,780	R52, G89
DNC001599	SU6668	Solid tumours	.	C00-C75,C7A,C7B
DNC001599	SU6668	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC001600	SU5416	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC001601	NOX 2149	Pain; Stress	300, 338,780	F40-F42, R52, G89
DNC001602	NOX 2137a/b	Pain; Stress	300, 338,780	F40-F42, R52, G89
DNC001603	LD201t1	Inflammatory diseases	.	.
DNC001604	IGEL1.2	Allergic diseases	995.3	T78.4
DNC001605	D17.4	Myasthenia gravis	358	G70.0
DNC001606	2'-NH2-30-ligand	Inflammatory diseases	.	.
DNC001607	CD4 specific aptamer 14	Immuno-suppressant	.	T86.0
DNC001608	Ligand 1.1	HIV infections	42	B20
DNC001609	ADR58	Rheumatold arthritis	714	M05-M06
DNC001610	DD7	Septic shock; Myocardial ischaemia-reperfusion injury; Acute respiratory distress syndrome	492, 518.5, 518.82, 785.52	A41.9, J43, J80
DNC001611	ED1	Septic shock; Myocardial ischaemia-reperfusion injury; Acute respiratory distress syndrome	492, 518.5, 518.82, 785.52	A41.9, J43, J80
DNC001612	ED45	Septic shock; Myocardial ischaemia-reperfusion injury; Acute respiratory distress syndrome	492, 518.5, 518.82, 785.52	A41.9, J43, J80
DNC001614	Del 60 tetramer	Cancer immunotherapy	140-229	C00-C96
DNC001615	SE RNA	HIV infections	42	B20
DNC001616	CGP77675	Kidney diseases	580-589	N00-N29
DNC001617	3-MeSO2-DDE	Discovery agent	.	.
DNC001618	Epostane	Termination of early pregnancy	779.6	O04
DNC001619	4-MA	Discovery agent	.	.
DNC001620	Ryanodine	Discovery agent	.	.
DNC001621	Tetracaine	Discovery agent	.	.
DNC001622	Ruthenium red	Discovery agent	.	.
DNC001623	Dantrolene	Discovery agent	.	.
DNC001624	Nitrobenzylthioinosine	Discovery agent	.	.
DNC001625	Dipyridamole	Discovery agent	.	.
DNC001626	Dilazep	Discovery agent	.	.
DNC001627	SL125	Congestive heart failure; Myocardial fibrosis; Hyperaldosteronism	255.1, 425.0, 425.3, 428, 428.0, 709.2	E26, I42.0, I42.5, I50, L90.5
DNC001628	Tendamistat	Discovery agent	.	.
DNC001629	2'-O-Methyl G-Clamp Containing Oligonucleotides	Discovery agent	.	.
DNC001630	DNA aptamer with consensus sequences targeted to the stem 3-strand (5-CCCTAGTTA) of TAR RNA	Discovery agent	.	.
DNC001631	DNA aptamer with consensus sequences complementary to the TAR apical loop (5-CTCCC)	Discovery agent	.	.
DNC001632	Antisense EGFR oligodeoxynucleotide enveloped in Lipofectin	Discovery agent	.	.
DNC001633	21-mer antisense phosphorothioate oligonucleotide	Discovery agent	.	.
DNC001634	Antisense hTERT mRNA oligodeoxynucleotide	Discovery agent	.	.
DNC001635	Antisense oligonucleotides complementary to CIRL-1 mRNA	Discovery agent	.	.
DNC001636	Antisense oligonucleotides complementary to CIRL-3 mRNA	Discovery agent	.	.
DNC001637	Antisense oligonucleotides targeting beta-arrestin	Discovery agent	.	.
DNC001638	Antisense PDGFR-beta	Discovery agent	.	.
DNC001639	APP antisense oligonucleotides	Discovery agent	.	.
DNC001640	C-fos antisense oligonucleotide	Discovery agent	.	.
DNC001641	ISIS 2503	Discovery agent	.	.
DNC001642	ISIS 2570	Cancer	140-229	C00-C96
DNC001642	ISIS 2570	Discovery agent	.	.
DNC001643	ISIS 6957	Discovery agent	.	.
DNC001644	MiR-375	Discovery agent	.	.
DNC001645	PAI-1 specific siRNA	Discovery agent	.	.
DNC001646	SB-699551-A	Discovery agent	.	.
DNC001647	Sc-43076	Discovery agent	.	.
DNC001648	Sc-43077	Discovery agent	.	.
DNC001649	Sumatriptan	Migraine	346	G43
DNC001650	8-OH-DPAT	Discovery agent	.	.
DNC001650	8-OH-DPAT	Parkinson's disease	.	G20
DNC001651	RU 24969	Discovery agent	.	.
DNC001652	Cyanopindolol	Discovery agent	.	.
DNC001653	MM-111	Breast cancer	.	C50
DNC001653	MM-111	Discovery agent	.	.
DNC001654	BRL54443	Discovery agent	.	.
DNC001655	B173	Discovery agent	.	.
DNC001656	Platensimycin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC001657	RWJ-49968	Fungal diseases	110-118	B35-B49
DNC001658	RWJ-61907	Fungal diseases	110-118	B35-B49
DNC001660	ISIS 103669	Discovery agent	.	.
DNC001661	ISIS 103671	Discovery agent	.	.
DNC001662	ISIS 103736	Discovery agent	.	.
DNC001663	ISIS 103701	Discovery agent	.	.
DNC001664	ISIS 103708	Discovery agent	.	.
DNC001665	ISIS 103747	Discovery agent	.	.
DNC001666	ISIS 103752	Discovery agent	.	.
DNC001667	ISIS 103803	Discovery agent	.	.
DNC001668	ISIS 103806	Discovery agent	.	.
DNC001669	ISIS 103771	Discovery agent	.	.
DNC001670	ISIS 103819	Discovery agent	.	.
DNC001671	ISIS 114170	Discovery agent	.	.
DNC001672	ISIS 114184	Discovery agent	.	.
DNC001673	ISIS 114197	Discovery agent	.	.
DNC001674	ISIS 114232	Discovery agent	.	.
DNC001675	ISIS 147919	Discovery agent	.	.
DNC001676	ISIS 100742	Discovery agent	.	.
DNC001677	ISIS 100743	Discovery agent	.	.
DNC001678	ISIS 100748	Discovery agent	.	.
DNC001679	ISIS 100749	Discovery agent	.	.
DNC001680	ISIS 100750	Discovery agent	.	.
DNC001681	ISIS 28465	Discovery agent	.	.
DNC001682	ISIS 28466	Discovery agent	.	.
DNC001683	ISIS 28472	Discovery agent	.	.
DNC001684	ISIS 28477	Discovery agent	.	.
DNC001685	ISIS 23559	Discovery agent	.	.
DNC001686	ISIS 23544	Discovery agent	.	.
DNC001687	ISIS 23722	Discovery agent	.	.
DNC001687	ISIS 23722	Solid tumours	.	C00-C75,C7A,C7B
DNC001688	ISIS 23718	Discovery agent	.	.
DNC001689	ISIS 23705	Discovery agent	.	.
DNC001690	ISIS 23707	Discovery agent	.	.
DNC001691	ISIS 29219	Discovery agent	.	.
DNC001692	ISIS 29223	Discovery agent	.	.
DNC001693	ISIS 29224	Discovery agent	.	.
DNC001694	ISIS 29232	Discovery agent	.	.
DNC001695	ISIS 29233	Discovery agent	.	.
DNC001696	ISIS 29234	Discovery agent	.	.
DNC001697	ISIS 29236	Discovery agent	.	.
DNC001698	ISIS 29237	Discovery agent	.	.
DNC001699	ISIS 29239	Discovery agent	.	.
DNC001700	ISIS 29243	Discovery agent	.	.
DNC001701	ISIS 29244	Discovery agent	.	.
DNC001702	ISIS 29246	Discovery agent	.	.
DNC001703	ISIS 29255	Discovery agent	.	.
DNC001704	ISIS 29256	Discovery agent	.	.
DNC001705	ISIS 29257	Discovery agent	.	.
DNC001706	ISIS 29469	Discovery agent	.	.
DNC001707	ISIS 29470	Discovery agent	.	.
DNC001708	ISIS 29471	Discovery agent	.	.
DNC001709	ISIS 29475	Discovery agent	.	.
DNC001710	ISIS 29477	Discovery agent	.	.
DNC001711	ISIS 104211	Discovery agent	.	.
DNC001712	ISIS 104253	Discovery agent	.	.
DNC001713	ISIS 104254	Discovery agent	.	.
DNC001714	ISIS 104255	Discovery agent	.	.
DNC001715	ISIS 104256	Discovery agent	.	.
DNC001716	ISIS 104257	Discovery agent	.	.
DNC001717	ISIS 104258	Discovery agent	.	.
DNC001718	ISIS 101960	Discovery agent	.	.
DNC001719	ISIS 101952	Discovery agent	.	.
DNC001720	ISIS 101983	Discovery agent	.	.
DNC001721	ISIS 101984	Discovery agent	.	.
DNC001722	ISIS 101985	Discovery agent	.	.
DNC001723	ISIS 101986	Discovery agent	.	.
DNC001724	ISIS 101987	Discovery agent	.	.
DNC001725	ISIS 101995	Discovery agent	.	.
DNC001726	ISIS 101996	Discovery agent	.	.
DNC001727	ISIS 101997	Discovery agent	.	.
DNC001728	ISIS 101998	Discovery agent	.	.
DNC001729	ISIS 3306	Discovery agent	.	.
DNC001730	ISIS 3303	Discovery agent	.	.
DNC001731	ISIS 3309	Discovery agent	.	.
DNC001732	ISIS 114527	Discovery agent	.	.
DNC001733	ISIS 114530	Discovery agent	.	.
DNC001734	ISIS 114531	Discovery agent	.	.
DNC001735	ISIS 114532	Discovery agent	.	.
DNC001736	ISIS 114537	Discovery agent	.	.
DNC001737	ISIS 14548	Discovery agent	.	.
DNC001738	ISIS 114559	Discovery agent	.	.
DNC001739	ISIS 114563	Discovery agent	.	.
DNC001740	ISIS 191729	Discovery agent	.	.
DNC001741	ISIS 191731	Discovery agent	.	.
DNC001742	ISIS 191755	Discovery agent	.	.
DNC001743	ISIS 191756	Discovery agent	.	.
DNC001744	ISIS 191759	Discovery agent	.	.
DNC001745	ISIS 191761	Discovery agent	.	.
DNC001746	ISIS 140148	Discovery agent	.	.
DNC001747	ISIS 140153	Discovery agent	.	.
DNC001748	ISIS 140157	Discovery agent	.	.
DNC001749	ISIS 140158	Discovery agent	.	.
DNC001750	ISIS 140161	Discovery agent	.	.
DNC001751	ISIS 3307	Discovery agent	.	.
DNC001752	ISIS 150450	Discovery agent	.	.
DNC001753	ISIS 150451	Discovery agent	.	.
DNC001754	ISIS 150452	Discovery agent	.	.
DNC001755	ISIS 150453	Discovery agent	.	.
DNC001756	ISIS 150454	Discovery agent	.	.
DNC001757	ISIS 150463	Discovery agent	.	.
DNC001758	ISIS 150464	Discovery agent	.	.
DNC001759	ISIS 10639	Discovery agent	.	.
DNC001760	ISIS 2502	Discovery agent	.	.
DNC001761	ISIS 2503	Breast cancer	174, 175	C50
DNC001761	ISIS 2503	Discovery agent	.	.
DNC001762	ISIS 6186	Discovery agent	.	.
DNC001763	ISIS 13920	Cancer	140-229	C00-C96
DNC001764	ISIS 6958	Discovery agent	.	.
DNC001765	ISIS 6957	Discovery agent	.	.
DNC001766	ISIS 7453	Discovery agent	.	.
DNC001767	ISIS 144396	Discovery agent	.	.
DNC001768	ISIS 144368	Discovery agent	.	.
DNC001769	ISIS 144379	Discovery agent	.	.
DNC001770	ISIS 133712	Discovery agent	.	.
DNC001771	ISIS 133726	Discovery agent	.	.
DNC001772	ISIS 140180	Discovery agent	.	.
DNC001773	ISIS 329956	Discovery agent	.	.
DNC001774	ISIS 330012	Discovery agent	.	.
DNC001775	ISIS 330031	Discovery agent	.	.
DNC001776	ISIS 133726	Cardiovascular disease	.	I00-I99
DNC001776	ISIS 133726	Discovery agent	.	.
DNC001777	ISIS 2324	Discovery agent	.	.
DNC001778	ISIS 1753	Discovery agent	.	.
DNC001779	ISIS 1751	Discovery agent	.	.
DNC001780	ISIS 7848	Discovery agent	.	.
DNC001781	ISIS 7849	Discovery agent	.	.
DNC001782	ISIS 7851	Discovery agent	.	.
DNC001783	ISIS 7855	Discovery agent	.	.
DNC001784	ISIS 7847	Discovery agent	.	.
DNC001785	ISIS 6717	Discovery agent	.	.
DNC001786	ISIS 6729	Discovery agent	.	.
DNC001787	ISIS 9058	Discovery agent	.	.
DNC001788	ISIS 5132	Discovery agent	.	.
DNC001789	ISIS 6720	Discovery agent	.	.
DNC001790	ISIS 6717	Discovery agent	.	.
DNC001791	ISIS 6729	Discovery agent	.	.
DNC001792	ISIS 7851	Discovery agent	.	.
DNC001793	ISIS 7855	Discovery agent	.	.
DNC001794	ISIS 7847	Discovery agent	.	.
DNC001795	ISIS 7853	Discovery agent	.	.
DNC001796	ISIS 15770	Cancer	140-229	C00-C96
DNC001797	ISIS 11061	Discovery agent	.	.
DNC001798	ISIS 10707	Discovery agent	.	.
DNC001799	ISIS 147788	Discovery agent	.	.
DNC001800	ISIS 147764	Discovery agent	.	.
DNC001801	ISIS 147483	Discovery agent	.	.
DNC001802	ISIS 9002	Discovery agent	.	.
DNC001803	ISIS 9003	Discovery agent	.	.
DNC001804	ISIS 9005	Discovery agent	.	.
DNC001805	ISIS 12882	Discovery agent	.	.
DNC001806	ISIS 12883	Discovery agent	.	.
DNC001807	ISIS 12884	Discovery agent	.	.
DNC001808	ISIS 25237	Discovery agent	.	.
DNC001809	ISIS 196103	Discovery agent	.	.
DNC001810	ISIS 1570	Discovery agent	.	.
DNC001810	ISIS 1570	Pouchitis	.	K91.8
DNC001811	ISIS 1931	Discovery agent	.	.
DNC001812	ISIS 1939	Discovery agent	.	.
DNC001812	ISIS 1939	Inflammatory diseases	.	.
DNC001813	ISIS 2302	Discovery agent	.	.
DNC001814	ISIS 2974	Discovery agent	.	.
DNC001815	ISIS 3067	Discovery agent	.	.
DNC001816	ISIS 3224	Discovery agent	.	.
DNC001817	ISIS 11665	Discovery agent	.	.
DNC001818	ISIS 11159	Discovery agent	.	.
DNC001819	ISIS 11158	Discovery agent	.	.
DNC001820	ISIS 10582	Discovery agent	.	.
DNC001821	ISIS 2490	Discovery agent	.	.
DNC001822	ISIS 2491	Discovery agent	.	.
DNC001823	ISIS 2105	Discovery agent	.	.
DNC001823	ISIS 2105	Papillomavirus infections	.	B97.7
DNC001824	ISIS 2922	Discovery agent	.	.
DNC001825	ISIS 111992	Discovery agent	.	.
DNC001826	ISIS 111993	Discovery agent	.	.
DNC001827	ISIS 111997	Discovery agent	.	.
DNC001828	ISIS 112000	Discovery agent	.	.
DNC001829	ISIS 112001	Discovery agent	.	.
DNC001830	ISIS 112002	Discovery agent	.	.
DNC001831	ISIS 112003	Discovery agent	.	.
DNC001832	ISIS 112004	Discovery agent	.	.
DNC001833	ISIS 112005	Discovery agent	.	.
DNC001834	ISIS 112019	Discovery agent	.	.
DNC001835	ISIS 112020	Discovery agent	.	.
DNC001836	ISIS 112021	Discovery agent	.	.
DNC001837	ISIS 112022	Discovery agent	.	.
DNC001838	ISIS 112023	Discovery agent	.	.
DNC001839	ISIS 112024	Discovery agent	.	.
DNC001840	ISIS 1820	Discovery agent	.	.
DNC001841	ISIS 1822	Discovery agent	.	.
DNC001842	ISIS 2177	Discovery agent	.	.
DNC001843	ISIS 1827	Discovery agent	.	.
DNC001844	ISIS 1831	Discovery agent	.	.
DNC001845	ISIS 1821	Discovery agent	.	.
DNC001846	ISIS 9060	Discovery agent	.	.
DNC001847	ISIS 9061	Discovery agent	.	.
DNC001848	ISIS 9062	Discovery agent	.	.
DNC001849	ISIS 9063	Discovery agent	.	.
DNC001850	ISIS 9064	Discovery agent	.	.
DNC001851	ISIS 9065	Discovery agent	.	.
DNC001852	ISIS 9066	Discovery agent	.	.
DNC001853	ISIS 9067	Discovery agent	.	.
DNC001854	ISIS 9068	Discovery agent	.	.
DNC001855	ISIS 9069	Discovery agent	.	.
DNC001856	ISIS 9070	Discovery agent	.	.
DNC001857	ISIS 9071	Discovery agent	.	.
DNC001858	ISIS 9061	Discovery agent	.	.
DNC001859	ISIS 9069	Discovery agent	.	.
DNC001860	ISIS 10228	Discovery agent	.	.
DNC001861	ISIS 24448	Discovery agent	.	.
DNC001862	ISIS 24453	Discovery agent	.	.
DNC001863	ISIS 24454	Discovery agent	.	.
DNC001864	ISIS 24475	Discovery agent	.	.
DNC001865	ISIS 24477	Discovery agent	.	.
DNC001866	ISIS 112690	Discovery agent	.	.
DNC001867	ISIS 112694	Discovery agent	.	.
DNC001868	ISIS 112696	Discovery agent	.	.
DNC001869	ISIS 112699	Discovery agent	.	.
DNC001870	ISIS 112711	Discovery agent	.	.
DNC001871	ISIS 112724	Discovery agent	.	.
DNC001872	ISIS 112580	Discovery agent	.	.
DNC001873	ISIS 112590	Discovery agent	.	.
DNC001874	ISIS 112592	Discovery agent	.	.
DNC001875	ISIS 112599	Discovery agent	.	.
DNC001876	ISIS 13741	Discovery agent	.	.
DNC001877	ISIS 14144	Discovery agent	.	.
DNC001878	ISIS 13727	Discovery agent	.	.
DNC001879	ISIS 13730	Discovery agent	.	.
DNC001880	ISIS 13740	Discovery agent	.	.
DNC001881	ISIS 13743	Discovery agent	.	.
DNC001882	ISIS 9984	Discovery agent	.	.
DNC001883	ISIS 4764	Discovery agent	.	.
DNC001884	ISIS 11929	Discovery agent	.	.
DNC001885	ISIS 4759	Discovery agent	.	.
DNC001886	ISIS 2686	Discovery agent	.	.
DNC001887	ISIS 4756	Discovery agent	.	.
DNC001888	ISIS 4730	Discovery agent	.	.
DNC001889	ISIS 4729	Discovery agent	.	.
DNC001890	ISIS 2674	Discovery agent	.	.
DNC001891	ISIS 4719	Discovery agent	.	.
DNC001892	ISIS 2678	Discovery agent	.	.
DNC001893	ISIS 3521	Discovery agent	.	.
DNC001893	ISIS 3521	Non-Hodgkin's lymphoma	.	C85.9
DNC001894	ISIS 9606	Discovery agent	.	.
DNC001895	ISIS 4189	Discovery agent	.	.
DNC001896	ISIS 102450	Discovery agent	.	.
DNC001897	ISIS 102454	Discovery agent	.	.
DNC001898	ISIS 102458	Discovery agent	.	.
DNC001899	ISIS 102462	Discovery agent	.	.
DNC001900	ISIS 102466	Discovery agent	.	.
DNC001901	ISIS 102478	Discovery agent	.	.
DNC001902	ISIS 102482	Discovery agent	.	.
DNC001903	ISIS 102486	Discovery agent	.	.
DNC001904	ISIS 102490	Discovery agent	.	.
DNC001905	ISIS 102558	Discovery agent	.	.
DNC001906	ISIS 102563	Discovery agent	.	.
DNC001907	ISIS 102584	Discovery agent	.	.
DNC001908	ISIS 102599	Discovery agent	.	.
DNC001909	ISIS 102604	Discovery agent	.	.
DNC001910	ISIS 102609	Discovery agent	.	.
DNC001911	ISIS 102614	Discovery agent	.	.
DNC001912	ISIS 102619	Discovery agent	.	.
DNC001913	ISIS 102624	Discovery agent	.	.
DNC001914	ISIS 102629	Discovery agent	.	.
DNC001915	ISIS 102633	Discovery agent	.	.
DNC001916	ISIS 102660	Discovery agent	.	.
DNC001917	ISIS 102664	Discovery agent	.	.
DNC001918	ISIS 102668	Discovery agent	.	.
DNC001919	ISIS 102676	Discovery agent	.	.
DNC001920	ISIS 116505	Discovery agent	.	.
DNC001921	ISIS 116507	Discovery agent	.	.
DNC001922	ISIS 116508	Discovery agent	.	.
DNC001923	ISIS 107772	Discovery agent	.	.
DNC001924	ISIS 107773	Discovery agent	.	.
DNC001925	ISIS 107774	Discovery agent	.	.
DNC001926	ISIS 107775	Discovery agent	.	.
DNC001927	ISIS 107776	Discovery agent	.	.
DNC001928	ISIS 107791	Discovery agent	.	.
DNC001929	ISIS 107792	Discovery agent	.	.
DNC001930	ISIS 113715	Discovery agent	.	.
DNC001931	ISIS 5884	Discovery agent	.	.
DNC001932	ISIS 3792	Discovery agent	.	.
DNC001933	ISIS 5874	Discovery agent	.	.
DNC001934	ISIS 5876	Discovery agent	.	.
DNC001935	ISIS 5875	Discovery agent	.	.
DNC001936	ISIS 3805	Discovery agent	.	.
DNC001937	ISIS 3801	Discovery agent	.	.
DNC001938	ISIS 3804	Discovery agent	.	.
DNC001939	ISIS 110064	Discovery agent	.	.
DNC001940	ISIS 110065	Discovery agent	.	.
DNC001941	ISIS 110066	Discovery agent	.	.
DNC001942	ISIS 110067	Discovery agent	.	.
DNC001943	ISIS 110068	Discovery agent	.	.
DNC001944	ISIS 110073	Discovery agent	.	.
DNC001945	ISIS 110074	Discovery agent	.	.
DNC001946	ISIS 12659	Discovery agent	.	.
DNC001947	ISIS 12660	Discovery agent	.	.
DNC001948	ISIS 2922	Discovery agent	.	.
DNC001949	ISIS 3246	Discovery agent	.	.
DNC001950	ISIS 2918	Discovery agent	.	.
DNC001951	ISIS 2919	Discovery agent	.	.
DNC001952	ISIS 2920	Discovery agent	.	.
DNC001953	ISIS 2921	Discovery agent	.	.
DNC001954	ISIS 3300	Discovery agent	.	.
DNC001955	ISIS 6432	Discovery agent	.	.
DNC001956	ISIS 6443	Discovery agent	.	.
DNC001957	ISIS 6431	Discovery agent	.	.
DNC001958	ISIS 6442	Discovery agent	.	.
DNC001959	ISIS 6435	Discovery agent	.	.
DNC001960	ISIS 6434	Discovery agent	.	.
DNC001961	ISIS 6445	Discovery agent	.	.
DNC001962	ISIS 6553	Discovery agent	.	.
DNC001963	ISIS 6581	Discovery agent	.	.
DNC001964	ISIS 6603	Discovery agent	.	.
DNC001965	ISIS 17020	Discovery agent	.	.
DNC001966	ISIS 19211	Discovery agent	.	.
DNC001967	ISIS 19212	Discovery agent	.	.
DNC001968	ISIS 19213	Discovery agent	.	.
DNC001969	ISIS 19217	Discovery agent	.	.
DNC001970	ISIS 19218	Discovery agent	.	.
DNC001971	ISIS 19219	Discovery agent	.	.
DNC001972	ISIS 19220	Discovery agent	.	.
DNC001973	ISIS 19221	Discovery agent	.	.
DNC001974	ISIS 11155	Discovery agent	.	.
DNC001975	ISIS 20577	Discovery agent	.	.
DNC001976	ISIS 20579	Discovery agent	.	.
DNC001977	ISIS 20585	Discovery agent	.	.
DNC001978	ISIS 20586	Discovery agent	.	.
DNC001979	ISIS 20990	Discovery agent	.	.
DNC001980	ISIS 20993	Discovery agent	.	.
DNC001981	ISIS 20994	Discovery agent	.	.
DNC001982	ISIS 20995	Discovery agent	.	.
DNC001983	ISIS 13805	Discovery agent	.	.
DNC001984	ISIS 13812	Discovery agent	.	.
DNC001985	ISIS 25073	Discovery agent	.	.
DNC001986	ISIS 25074	Discovery agent	.	.
DNC001987	ISIS 25075	Discovery agent	.	.
DNC001988	ISIS 25078	Discovery agent	.	.
DNC001989	ISIS 25079	Discovery agent	.	.
DNC001990	ISIS 25080	Discovery agent	.	.
DNC001991	ISIS 25081	Discovery agent	.	.
DNC001992	ISIS 25082	Discovery agent	.	.
DNC001993	ISIS 25113	Discovery agent	.	.
DNC001994	ISIS 25114	Discovery agent	.	.
DNC001995	ISIS 25115	Discovery agent	.	.
DNC001996	ISIS 25116	Discovery agent	.	.
DNC001997	ISIS 25117	Discovery agent	.	.
DNC001998	ISIS 25118	Discovery agent	.	.
DNC001999	ISIS 25123	Discovery agent	.	.
DNC002000	ISIS 25124	Discovery agent	.	.
DNC002001	ISIS 25125	Discovery agent	.	.
DNC002002	ISIS 25126	Discovery agent	.	.
DNC002003	ISIS 25127	Discovery agent	.	.
DNC002004	ISIS 25128	Discovery agent	.	.
DNC002005	ISIS 105990	Discovery agent	.	.
DNC002006	ISIS 105990	Discovery agent	.	.
DNC002007	ISIS 106008	Discovery agent	.	.
DNC002008	ISIS 105987	Discovery agent	.	.
DNC002009	ISIS 105989	Discovery agent	.	.
DNC002010	ISIS 17152	Discovery agent	.	.
DNC002011	ISIS 17148	Discovery agent	.	.
DNC002012	ISIS 113176	Discovery agent	.	.
DNC002013	ISIS 113187	Discovery agent	.	.
DNC002014	ISIS 113209	Discovery agent	.	.
DNC002015	ISIS 113210	Discovery agent	.	.
DNC002016	ISIS 116359	Discovery agent	.	.
DNC002017	ISIS 116360	Discovery agent	.	.
DNC002018	ISIS 116361	Discovery agent	.	.
DNC002019	ISIS 116362	Discovery agent	.	.
DNC002020	ISIS 116363	Discovery agent	.	.
DNC002021	ISIS 116414	Discovery agent	.	.
DNC002022	ISIS 9133	Discovery agent	.	.
DNC002023	ISIS 9139	Discovery agent	.	.
DNC002024	ISIS 10373	Discovery agent	.	.
DNC002025	ISIS 113131	Discovery agent	.	.
DNC002026	ISIS 31982	Discovery agent	.	.
DNC002027	ISIS 31996	Discovery agent	.	.
DNC002028	ISIS 31963	Discovery agent	.	.
DNC002029	ISIS 32000	Discovery agent	.	.
DNC002030	ISIS 32002	Discovery agent	.	.
DNC002031	ISIS 32003	Discovery agent	.	.
DNC002032	ISIS 32004	Discovery agent	.	.
DNC002033	ISIS 32005	Discovery agent	.	.
DNC002034	ISIS 32006	Discovery agent	.	.
DNC002035	ISIS 32008	Discovery agent	.	.
DNC002036	ISIS 32010	Discovery agent	.	.
DNC002037	ISIS 32014	Discovery agent	.	.
DNC002038	ISIS 32015	Discovery agent	.	.
DNC002039	ISIS 32020	Discovery agent	.	.
DNC002040	ISIS 32021	Discovery agent	.	.
DNC002041	ISIS 32024	Discovery agent	.	.
DNC002042	ISIS 32028	Discovery agent	.	.
DNC002043	ISIS 32035	Discovery agent	.	.
DNC002044	ISIS 32039	Discovery agent	.	.
DNC002045	ISIS 18078	Cancer	140-229	C00-C96
DNC002046	ISIS 6739	Discovery agent	.	.
DNC002047	ISIS 6748	Discovery agent	.	.
DNC002048	ISIS 6755	Discovery agent	.	.
DNC002049	ISIS 6756	Discovery agent	.	.
DNC002050	ISIS 16179	Discovery agent	.	.
DNC002051	ISIS 116625	Discovery agent	.	.
DNC002052	ISIS 116654	Discovery agent	.	.
DNC002053	ISIS 116670	Discovery agent	.	.
DNC002054	ISIS 116648	Discovery agent	.	.
DNC002055	ISIS 116631	Discovery agent	.	.
DNC002056	ISIS 116632	Discovery agent	.	.
DNC002057	ISIS 183881	Discovery agent	.	.
DNC002058	ISIS 183881	Discovery agent	.	.
DNC002059	ISIS 183882	Discovery agent	.	.
DNC002060	ISIS 183883	Discovery agent	.	.
DNC002061	ISIS 183901	Discovery agent	.	.
DNC002062	ISIS 183897	Discovery agent	.	.
DNC002063	ISIS 183910	Discovery agent	.	.
DNC002064	ISIS 183911	Discovery agent	.	.
DNC002065	ISIS 183912	Discovery agent	.	.
DNC002066	ISIS 134499	Discovery agent	.	.
DNC002067	ISIS 134532	Discovery agent	.	.
DNC002068	ISIS 134524	Discovery agent	.	.
DNC002069	ISIS 134528	Discovery agent	.	.
DNC002070	ISIS 134563	Discovery agent	.	.
DNC002071	ISIS 134564	Discovery agent	.	.
DNC002072	ISIS 134565	Discovery agent	.	.
DNC002073	ISIS 134566	Discovery agent	.	.
DNC002074	ISIS 134583	Discovery agent	.	.
DNC002075	ISIS 134601	Discovery agent	.	.
DNC002076	ISIS 134602	Discovery agent	.	.
DNC002077	ISIS 134603	Discovery agent	.	.
DNC002078	ISIS 134604	Discovery agent	.	.
DNC002079	ISIS 134605	Discovery agent	.	.
DNC002080	ISIS 134606	Discovery agent	.	.
DNC002081	ISIS 134607	Discovery agent	.	.
DNC002082	ISIS 134608	Discovery agent	.	.
DNC002083	ISIS 134609	Discovery agent	.	.
DNC002084	ISIS 116847	Discovery agent	.	.
DNC002084	ISIS 116847	Non-insulin dependent diabetes	.	E11.9
DNC002085	ISIS 25544	Discovery agent	.	.
DNC002086	ISIS 25547	Discovery agent	.	.
DNC002087	ISIS 25549	Discovery agent	.	.
DNC002088	ISIS 25551	Discovery agent	.	.
DNC002089	ISIS 25552	Discovery agent	.	.
DNC002090	ISIS 25554	Discovery agent	.	.
DNC002091	ISIS 25563	Discovery agent	.	.
DNC002092	ISIS 25564	Discovery agent	.	.
DNC002093	ISIS 25565	Discovery agent	.	.
DNC002094	ISIS 25566	Discovery agent	.	.
DNC002095	ISIS 25567	Discovery agent	.	.
DNC002096	ISIS 16507	Cancer	140-229	C00-C96
DNC002097	ISIS 16507	Cancer	140-229	C00-C96
DNC002098	ISIS 16518	Cancer	140-229	C00-C96
DNC002099	ISIS 113019	Discovery agent	.	.
DNC002100	ISIS 113020	Discovery agent	.	.
DNC002101	ISIS 113021	Discovery agent	.	.
DNC002102	ISIS 113022	Discovery agent	.	.
DNC002103	ISIS 113048	Discovery agent	.	.
DNC002104	ISIS 7942	Discovery agent	.	.
DNC002105	ISIS 7948	Discovery agent	.	.
DNC002106	ISIS 109351	Discovery agent	.	.
DNC002107	ISIS 109352	Discovery agent	.	.
DNC002108	ISIS 109353	Discovery agent	.	.
DNC002109	ISIS 109354	Discovery agent	.	.
DNC002110	ISIS 109355	Discovery agent	.	.
DNC002111	ISIS 9022	Discovery agent	.	.
DNC002112	ISIS 9023	Discovery agent	.	.
DNC002113	ISIS 9025	Discovery agent	.	.
DNC002114	ISIS 9007	Discovery agent	.	.
DNC002115	ISIS 9008	Discovery agent	.	.
DNC002116	ISIS 17252	Discovery agent	.	.
DNC002117	ISIS 10303	Discovery agent	.	.
DNC002118	ISIS 10310	Discovery agent	.	.
DNC002119	ISIS 10311	Discovery agent	.	.
DNC002120	ISIS 11219	Discovery agent	.	.
DNC002121	ISIS 11220	Discovery agent	.	.
DNC002122	ISIS 11221	Discovery agent	.	.
DNC002123	ISIS 11223	Discovery agent	.	.
DNC002124	ISIS 11224	Discovery agent	.	.
DNC002125	ISIS 15998	Discovery agent	.	.
DNC002126	ISIS 16005	Discovery agent	.	.
DNC002127	ISIS 16010	Discovery agent	.	.
DNC002128	ISIS 16009	Discovery agent	.	.
DNC002129	ISIS 15999	Discovery agent	.	.
DNC002130	ISIS 188755	Discovery agent	.	.
DNC002131	ISIS 188757	Discovery agent	.	.
DNC002132	ISIS 188759	Discovery agent	.	.
DNC002133	ISIS 188761	Discovery agent	.	.
DNC002134	ISIS 188763	Discovery agent	.	.
DNC002135	ISIS 188778	Discovery agent	.	.
DNC002136	ISIS 188780	Discovery agent	.	.
DNC002137	ISIS 188781	Discovery agent	.	.
DNC002138	ISIS 188782	Discovery agent	.	.
DNC002139	ISIS 18473	Discovery agent	.	.
DNC002140	ISIS 103375	Discovery agent	.	.
DNC002141	ISIS 103386	Discovery agent	.	.
DNC002142	ISIS 103387	Discovery agent	.	.
DNC002143	ISIS 100913	Discovery agent	.	.
DNC002144	ISIS 100935	Discovery agent	.	.
DNC002145	ISIS 100939	Discovery agent	.	.
DNC002146	ISIS 100929	Discovery agent	.	.
DNC002147	ISIS 23412	Discovery agent	.	.
DNC002148	ISIS 23414	Discovery agent	.	.
DNC002149	ISIS 23416	Discovery agent	.	.
DNC002150	ISIS 23452	Discovery agent	.	.
DNC002151	ISIS 23454	Discovery agent	.	.
DNC002152	ISIS 23459	Discovery agent	.	.
DNC002153	ISIS 232828	Discovery agent	.	.
DNC002154	ISIS 347573	Discovery agent	.	.
DNC002155	ISIS 347577	Discovery agent	.	.
DNC002156	ISIS 114442	Discovery agent	.	.
DNC002157	ISIS 114372	Discovery agent	.	.
DNC002158	ISIS 114388	Discovery agent	.	.
DNC002159	ISIS 114390	Discovery agent	.	.
DNC002160	ISIS 114404	Discovery agent	.	.
DNC002161	ISIS 114397	Discovery agent	.	.
DNC002162	ISIS 114399	Discovery agent	.	.
DNC002163	ISIS 114371	Discovery agent	.	.
DNC002164	ISIS 107612	Discovery agent	.	.
DNC002165	ISIS 107642	Discovery agent	.	.
DNC002166	ISIS 107652	Discovery agent	.	.
DNC002167	ISIS 107676	Discovery agent	.	.
DNC002168	ISIS 107681	Discovery agent	.	.
DNC002169	ISIS 19634	Discovery agent	.	.
DNC002170	ISIS 19639	Discovery agent	.	.
DNC002171	ISIS 19647	Discovery agent	.	.
DNC002172	ISIS 19649	Discovery agent	.	.
DNC002173	ISIS 19650	Discovery agent	.	.
DNC002174	ISIS 19651	Discovery agent	.	.
DNC002175	ISIS 19657	Discovery agent	.	.
DNC002176	ISIS 19658	Discovery agent	.	.
DNC002177	ISIS 19659	Discovery agent	.	.
DNC002178	ISIS 19675	Discovery agent	.	.
DNC002179	ISIS 19676	Discovery agent	.	.
DNC002180	ISIS 19677	Discovery agent	.	.
DNC002181	ISIS 28405	Discovery agent	.	.
DNC002182	ISIS 28407	Discovery agent	.	.
DNC002183	ISIS 28425	Discovery agent	.	.
DNC002184	ISIS 175510	Discovery agent	.	.
DNC002185	ISIS 298697	Discovery agent	.	.
DNC002186	ISIS 298711	Discovery agent	.	.
DNC002187	ISIS 298712	Discovery agent	.	.
DNC002188	ISIS 298699	Discovery agent	.	.
DNC002189	ISIS 298700	Discovery agent	.	.
DNC002190	ISIS 298701	Discovery agent	.	.
DNC002191	ISIS 298702	Discovery agent	.	.
DNC002192	ISIS 298743	Discovery agent	.	.
DNC002193	ISIS 298744	Discovery agent	.	.
DNC002194	ISIS 298745	Discovery agent	.	.
DNC002195	ISIS 298746	Discovery agent	.	.
DNC002196	ISIS 133206	Discovery agent	.	.
DNC002197	ISIS 133207	Discovery agent	.	.
DNC002198	ISIS 133208	Discovery agent	.	.
DNC002199	ISIS 133211	Discovery agent	.	.
DNC002200	ISIS 133242	Discovery agent	.	.
DNC002201	ISIS 133243	Discovery agent	.	.
DNC002202	ISIS 133244	Discovery agent	.	.
DNC002203	ISIS 133245	Discovery agent	.	.
DNC002204	ISIS 119262	Discovery agent	.	.
DNC002205	ISIS 119263	Discovery agent	.	.
DNC002206	ISIS 119264	Discovery agent	.	.
DNC002207	ISIS 119281	Discovery agent	.	.
DNC002208	ISIS 119282	Discovery agent	.	.
DNC002209	ISIS 119283	Discovery agent	.	.
DNC002210	ISIS 119284	Discovery agent	.	.
DNC002211	ISIS 119285	Discovery agent	.	.
DNC002212	ISIS 119286	Discovery agent	.	.
DNC002213	ISIS 16108	Discovery agent	.	.
DNC002214	ISIS 16112	Discovery agent	.	.
DNC002215	ISIS 16121	Discovery agent	.	.
DNC002216	ISIS 16123	Discovery agent	.	.
DNC002217	ISIS 16124	Discovery agent	.	.
DNC002218	ISIS 173840	Discovery agent	.	.
DNC002219	ISIS 173848	Discovery agent	.	.
DNC002220	ISIS 173831	Discovery agent	.	.
DNC002221	ISIS 173813	Discovery agent	.	.
DNC002222	ISIS 111084	Discovery agent	.	.
DNC002223	ISIS 111085	Discovery agent	.	.
DNC002224	ISIS 111086	Discovery agent	.	.
DNC002225	ISIS 111105	Discovery agent	.	.
DNC002226	ISIS 111117	Discovery agent	.	.
DNC002227	ISIS 111118	Discovery agent	.	.
DNC002228	ISIS 111119	Discovery agent	.	.
DNC002229	ISIS 111120	Discovery agent	.	.
DNC002230	ISIS 111121	Discovery agent	.	.
DNC002231	ISIS 122970	Discovery agent	.	.
DNC002232	ISIS 122971	Discovery agent	.	.
DNC002233	ISIS 122974	Discovery agent	.	.
DNC002234	ISIS 122975	Discovery agent	.	.
DNC002235	ISIS 122976	Discovery agent	.	.
DNC002236	ISIS 122984	Discovery agent	.	.
DNC002237	ISIS 122985	Discovery agent	.	.
DNC002238	ISIS 122986	Discovery agent	.	.
DNC002239	ISIS 122990	Discovery agent	.	.
DNC002240	ISIS 122991	Discovery agent	.	.
DNC002241	ISIS 222035	Discovery agent	.	.
DNC002242	ISIS 222039	Discovery agent	.	.
DNC002243	ISIS 222041	Discovery agent	.	.
DNC002244	ISIS 222043	Discovery agent	.	.
DNC002245	ISIS 222039	Discovery agent	.	.
DNC002246	ISIS 222041	Discovery agent	.	.
DNC002247	ISIS 222043	Discovery agent	.	.
DNC002248	ISIS 222001	Discovery agent	.	.
DNC002249	ISIS 103486	Discovery agent	.	.
DNC002250	ISIS 103489	Discovery agent	.	.
DNC002251	ISIS 103471	Discovery agent	.	.
DNC002252	ISIS 103473	Discovery agent	.	.
DNC002253	ISIS 103582	Discovery agent	.	.
DNC002254	ISIS 103601	Discovery agent	.	.
DNC002255	ISIS 103612	Discovery agent	.	.
DNC002256	ISIS 103613	Discovery agent	.	.
DNC002257	ISIS 103615	Discovery agent	.	.
DNC002258	ISIS 103616	Discovery agent	.	.
DNC002259	ISIS 103619	Discovery agent	.	.
DNC002260	ISIS 103620	Discovery agent	.	.
DNC002261	ISIS 103621	Discovery agent	.	.
DNC002262	ISIS 103622	Discovery agent	.	.
DNC002263	ISIS 103624	Discovery agent	.	.
DNC002264	ISIS 103629	Discovery agent	.	.
DNC002265	ISIS 103631	Discovery agent	.	.
DNC002266	ISIS 103635	Discovery agent	.	.
DNC002267	ISIS 156449	Discovery agent	.	.
DNC002268	ISIS 156451	Discovery agent	.	.
DNC002269	ISIS 156452	Discovery agent	.	.
DNC002270	ISIS 156453	Discovery agent	.	.
DNC002271	ISIS 156471	Discovery agent	.	.
DNC002272	ISIS 156472	Discovery agent	.	.
DNC002273	ISIS 156473	Discovery agent	.	.
DNC002274	ISIS 156474	Discovery agent	.	.
DNC002275	ISIS 156475	Discovery agent	.	.
DNC002276	ISIS 138612	Discovery agent	.	.
DNC002277	ISIS 138613	Discovery agent	.	.
DNC002278	ISIS 138616	Discovery agent	.	.
DNC002279	ISIS 138647	Discovery agent	.	.
DNC002280	ISIS 138648	Discovery agent	.	.
DNC002281	ISIS 138649	Discovery agent	.	.
DNC002282	ISIS 138678	Discovery agent	.	.
DNC002283	ISIS 3308	Discovery agent	.	.
DNC002284	ISIS 3304	Discovery agent	.	.
DNC002285	ISIS 148715	Discovery agent	.	.
DNC002286	ISIS 29135	Discovery agent	.	.
DNC002287	ISIS 29136	Discovery agent	.	.
DNC002288	ISIS 29137	Discovery agent	.	.
DNC002289	ISIS 29138	Discovery agent	.	.
DNC002290	ISIS 29139	Discovery agent	.	.
DNC002291	ISIS 29154	Discovery agent	.	.
DNC002292	ISIS 29155	Discovery agent	.	.
DNC002293	ISIS 29156	Discovery agent	.	.
DNC002294	ISIS 29159	Discovery agent	.	.
DNC002295	ISIS 29160	Discovery agent	.	.
DNC002296	ISIS 29161	Discovery agent	.	.
DNC002297	ISIS 29112	Discovery agent	.	.
DNC002298	ISIS 29176	Discovery agent	.	.
DNC002299	ISIS 29177	Discovery agent	.	.
DNC002300	ISIS 29178	Discovery agent	.	.
DNC002301	ISIS 29200	Discovery agent	.	.
DNC002302	ISIS 29201	Discovery agent	.	.
DNC002303	ISIS 29202	Discovery agent	.	.
DNC002304	ISIS 113858	Discovery agent	.	.
DNC002305	ISIS 113871	Discovery agent	.	.
DNC002306	ISIS 113872	Discovery agent	.	.
DNC002307	ISIS 113873	Discovery agent	.	.
DNC002308	ISIS 113874	Discovery agent	.	.
DNC002309	ISIS 113902	Discovery agent	.	.
DNC002310	ISIS 113903	Discovery agent	.	.
DNC002311	ISIS 113904	Discovery agent	.	.
DNC002312	ISIS 113905	Discovery agent	.	.
DNC002313	ISIS 113906	Discovery agent	.	.
DNC002314	ISIS 113907	Discovery agent	.	.
DNC002315	ISIS 113908	Discovery agent	.	.
DNC002316	ISIS 113909	Discovery agent	.	.
DNC002317	ISIS 109110	Discovery agent	.	.
DNC002318	ISIS 109111	Discovery agent	.	.
DNC002319	ISIS 109112	Discovery agent	.	.
DNC002320	ISIS 109113	Discovery agent	.	.
DNC002321	ISIS 109114	Discovery agent	.	.
DNC002322	ISIS 109115	Discovery agent	.	.
DNC002323	ISIS 109116	Discovery agent	.	.
DNC002324	ISIS 109490	Discovery agent	.	.
DNC002325	ISIS 109491	Discovery agent	.	.
DNC002326	ISIS 109502	Discovery agent	.	.
DNC002327	ISIS 109524	Discovery agent	.	.
DNC002328	ISIS 109525	Discovery agent	.	.
DNC002329	ISIS 109526	Discovery agent	.	.
DNC002330	ISIS 343867	Discovery agent	.	.
DNC002331	ISIS 341881	Discovery agent	.	.
DNC002332	A-317920	Attention deficit hyperactivity disorder	314	F90
DNC002333	A-331440	Obesity	278	E66
DNC002334	Asperlicin	Gastrointestinal disorders	530-558	K20-K64
DNC002335	Azelaic bishydroxamic acid	Discovery agent	.	.
DNC002336	BAG956	Hematologic malignancies	200-209	C81-C96
DNC002337	CG-1521	Cancer	140-229	C00-C96
DNC002337	CG-1521	Discovery agent	.	.
DNC002338	Ciproxifan	Dementia	290-294	F01-F07
DNC002338	Ciproxifan	Obesity	278	E66
DNC002339	Devazepide	Gastrointestinal disorders	530-558	K20-K64
DNC002340	DR2313	Permanent and transient stroke	434.91, 435.9	G45.9, I61-I63
DNC002341	EB-47	Discovery agent	.	.
DNC002342	FUB 649	Discovery agent	.	.
DNC002342	FUB 649	Hypersomnia	.	G47.1
DNC002343	GSK189254A	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DNC002344	GSK690693	Hematologic malignancies	200-209	C81-C96
DNC002345	Immepip	Discovery agent	.	.
DNC002346	Immethridine	Discovery agent	.	.
DNC002347	JNJ-10181457	Sleep and cognitive disorders	290-294, 294.0, 307.4, 327, 327.0, 780.09, 780.5, 780.9, 780.93	F01-F07, F04, F05, F51, G47, R41.3
DNC002348	JNJ-5207852	Discovery agent	.	.
DNC002348	JNJ-5207852	Narcolepsy	347	G47.4
DNC002349	KOSN1559	Cancers	140-229	C00-C96
DNC002350	KP772	Discovery agent	.	.
DNC002351	Lactoquinomycin	Hematologic malignancies	200-209	C81-C96
DNC002352	LY433221	Depression	311	F32
DNC002353	LY433222	Depression	311	F32
DNC002354	Macbecin	Cancers	140-229	C00-C96
DNC002355	Methimepip	Discovery agent	.	.
DNC002356	MM36	Discovery agent	.	.
DNC002357	NNC 0038-0000-1202	Discovery agent	.	.
DNC002358	PI-103	Hematologic malignancies	200-209	C81-C96
DNC002359	Proxyfan	Discovery agent	.	.
DNC002360	PU24S	Cancers	140-229	C00-C96
DNC002361	PU3	Breast cancer	174, 175	C50
DNC002361	PU3	Cancer	.	C00-C97
DNC002362	PU-H58	Cancers	140-229	C00-C96
DNC002363	S33005	Depression	311	F32
DNC002364	SCH79687	Central nervous system disease	.	G00-G09,G10-G13,G35-G37
DNC002364	SCH79687	Discovery agent	.	.
DNC002365	Suberic bishydroxamic acid	Discovery agent	.	.
DNC002366	Thieno-phenanthridin-6-one	Brain ischaemia	435, 437	G45.9, I67.8
DNC002367	Trapoxin A	Discovery agent	.	.
DNC002368	Trifluoromethylketone	Discovery agent	.	.
DNC002369	UCL1972	Discovery agent	.	.
DNC002370	VER 50589	Breast cancer	174, 175, 217	C50, D24
DNC002370	VER 50589	Cancers	140-229	C00-C96
DNC002371	VUF 5681	Discovery agent	.	.
DNC002372	VUF5391	Discovery agent	.	.
DNC002373	WK-X-34	Discovery agent	.	.
DNC002374	ZSTK474	Cancer	140-229	C00-C96
DNC002374	ZSTK474	Hematologic malignancies	200-209	C81-C96
DNC002375	BILN-2061	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DNC002375	BILN-2061	Hepatitis virus infection	.	B15-B19
DNC002376	1,3-bis(1,3-benzothiazol-2-ylthio)acetone	Melanoma; Glioma	172, 191	C43, C71
DNC002377	3-benzofuran-2-yl-2-benzothiazol-2-yl-3-oxo-propanenitrile	Melanoma; Glioma	172, 191	C43, C71
DNC002378	5-fluoro-1H-indole-2-carboxylic acid	Melanoma; Glioma	172, 191	C43, C71
DNC002379	Anti-miR-191 modified oligonucleotide	Hepatocellular carcinoma	155	C22.0
DNC002380	Anti-p32 human monoclonal antibody 2.15	Breast cancer	174, 175	C50
DNC002381	AVP-13546	Refractory autoimmune diseases	279.4	D84.9, M35.9
DNC002382	AVP-13748	Autoimmune diseases	279.4	D84.9, M35.9
DNC002382	AVP-13748	Refractory autoimmune diseases	279.4	D84.9, M35.9
DNC002383	BI 2536	Chronic myeloid leukemia	205.1	C92.1
DNC002384	Biaryl thiophenes	Inflammatory disorders	.	.
DNC002385	BMS-488516	Inflammatory disorders	.	.
DNC002386	BMS-509744	Inflammatory disorders	.	.
DNC002387	BMS-863233	Hematological malignancies	.	C81-C96
DNC002387	BMS-863233	Solid tumours; Hematologic malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNC002388	BPKDi	Cancer	140-229	C00-C96
DNC002389	Calcineurin	T-cell mediated immune dysfunction	279.1	D83.1
DNC002390	Cerulenin	Meningioma	225.2	C70, D32
DNC002391	CGP37157	Ischemia	459.89	I99.8
DNC002391	CGP37157	Neurodegenerative diseases	330-337	G30-G32
DNC002392	CID755673	Cancer	140-229	C00-C96
DNC002393	COR100140	Refractory autoimmune diseases	279.4	D84.9, M35.9
DNC002394	CRT0066101	Cancer	140-229	C00-C96
DNC002395	DSM1	Malaria	84	B50-B54
DNC002395	DSM1	Plasmodium falciparum infection	.	B54
DNC002396	DSM2	Malaria	84	B50-B54
DNC002397	G6976	Cancer	140-229	C00-C96
DNC002398	HAd5-vectored E1 vaccine Ad5-E1	Viral infections	042-075	A80-A99, B00-B34
DNC002399	ISO-1	Refractory autoimmune diseases	279.4	D84.9, M35.9
DNC002399	ISO-1	Sepsis	.	A40-A41
DNC002400	K252a	Cancer	140-229	C00-C96
DNC002401	L-erythro-3-hydroxyaspartate	Neurodegenerations; Epilepsy; Neuropathic pain; Drug addiction; Schizophrenia	295, 303-304, 330-337, 338, 345, 356.0, 356.8,780	F10-F19, F20, G30-G32, G40, G64, G90.0, R52, G89
DNC002402	Lobeline	Psychostimulant abuse	303-305	F10-F19
DNC002402	Lobeline	Substance dependence	.	F10-F19
DNC002403	Malonic acid	Neurodegenerations; Epilepsy; Neuropathic pain; Drug addiction; Schizophrenia	295, 303-304, 330-337, 338, 345, 356.0, 356.8,780	F10-F19, F20, G30-G32, G40, G64, G90.0, R52, G89
DNC002404	Mycophenolic acid	Chikungunya viral infection	065.4, 066.3	A92.0
DNC002405	NAPQI	Refractory autoimmune diseases	279.4	D84.9, M35.9
DNC002406	Narciclasine	Melanomas	172	C43
DNC002407	NMS-1116354	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC002408	PF-4957325-00	Inflammatory disorders	.	.
DNC002409	PYZD-4409	Cancer	140-229	C00-C96
DNC002409	PYZD-4409	Leukemia	208.9	C91-C95
DNC002410	PYZD-4409	Multiple myeloma	203	C90.0
DNC002411	Reserpine	Psychostimulant abuse	303-305	F10-F19
DNC002412	Staurosporine	Cancer	140-229	C00-C96
DNC002413	Tetrabenazine	Psychostimulant abuse	303-305	F10-F19
DNC002414	WRR605	Amebiasis	6	A06
DNC002415	N,N-dimethylarginine	Discovery agent	.	.
DNC002416	4r-Fluoro-N6-Ethanimidoyl-L-Lysine	Discovery agent	.	.
DNC002417	7-Nitroindazole	Discovery agent	.	.
DNC002418	Ethylisothiourea	Discovery agent	.	.
DNC002419	Thiocoumarin	Discovery agent	.	.
DNC002420	S-Ethylisothiourea	Discovery agent	.	.
DNC002421	N-Omega-Propyl-L-Arginine	Discovery agent	.	.
DNC002422	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	Discovery agent	.	.
DNC002423	Heme	Discovery agent	.	.
DNC002424	6-Nitroindazole	Discovery agent	.	.
DNC002425	B-Octylglucoside	Discovery agent	.	.
DNC002426	N-Omega-Hydroxy-L-Arginine	Discovery agent	.	.
DNC002427	7,8-Dihydro-L-Biopterin	Discovery agent	.	.
DNC002428	Imidazole	Discovery agent	.	.
DNC002429	L-Thiocitrulline	Discovery agent	.	.
DNC002430	7,8-dihydrobiopterin	Discovery agent	.	.
DNC002431	5-Nitroindazole	Discovery agent	.	.
DNC002432	4-(1H-IMIDAZOL-1-YL)PHENOL	Discovery agent	.	.
DNC002433	1-N-Acetyl-Beta-D-Glucosamine	Discovery agent	.	.
DNC002434	Beta-D-Glucose	Discovery agent	.	.
DNC002435	2-Methyl-2,4-Pentanediol	Discovery agent	.	.
DNC002436	Phosphonoserine	Discovery agent	.	.
DNC002437	2'-Monophosphoadenosine 5'-Diphosphoribose	Discovery agent	.	.
DNC002438	Lauric Acid	Discovery agent	.	.
DNC002439	MYRISTIC ACID	Discovery agent	.	.
DNC002440	Alpha-D-Mannose	Discovery agent	.	.
DNC002441	Fucose	Discovery agent	.	.
DNC002442	O-Acetylserine	Discovery agent	.	.
DNC002443	2-(1,1'-Biphenyl-4-Yl)Propanoic Acid	Discovery agent	.	.
DNC002444	Protoporphyrin Ix Containing Co	Discovery agent	.	.
DNC002445	2-Bromoacetyl Group	Discovery agent	.	.
DNC002446	Flufenamic Acid	Discovery agent	.	.
DNC002446	Flufenamic Acid	Dysmenorrhea	.	N94.4-N94.6
DNC002447	Beta-D-Mannose	Discovery agent	.	.
DNC002448	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	Discovery agent	.	.
DNC002449	Acetic Acid Salicyloyl-Amino-Ester	Discovery agent	.	.
DNC002450	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	Discovery agent	.	.
DNC002451	Flurbiprofen Methyl Ester	Discovery agent	.	.
DNC002452	Phenacetin	Discovery agent	.	.
DNC002453	Arachidonic Acid	Discovery agent	.	.
DNC002454	Epothilone B	Discovery agent	.	.
DNC002455	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	Discovery agent	.	.
DNC002456	Adenosine-5'-Diphosphate	Discovery agent	.	.
DNC002457	4-Iodobenzo[B]Thiophene-2-Carboxamidine	Discovery agent	.	.
DNC002458	CRA_8696	Discovery agent	.	.
DNC002459	Gamma-Carboxy-Glutamic Acid	Discovery agent	.	.
DNC002460	Lysophosphotidylserine	Discovery agent	.	.
DNC002461	Methyl L-phenylalaninate	Discovery agent	.	.
DNC002462	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	Discovery agent	.	.
DNC002463	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	Discovery agent	.	.
DNC002464	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	Discovery agent	.	.
DNC002465	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	Discovery agent	.	.
DNC002466	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	Discovery agent	.	.
DNC002467	Beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	Discovery agent	.	.
DNC002468	N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE	Discovery agent	.	.
DNC002469	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	Discovery agent	.	.
DNC002470	D-phenylalanyl-N-benzyl-L-prolinamide	Discovery agent	.	.
DNC002471	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	Discovery agent	.	.
DNC002472	4-TERT-BUTYLBENZENESULFONIC ACID	Discovery agent	.	.
DNC002473	AC-(D)PHE-PRO-BOROLYS-OH	Discovery agent	.	.
DNC002474	AC-(D)PHE-PRO-BOROHOMOLYS-OH	Discovery agent	.	.
DNC002475	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	Discovery agent	.	.
DNC002476	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	Discovery agent	.	.
DNC002477	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	Discovery agent	.	.
DNC002478	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	Discovery agent	.	.
DNC002479	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	Discovery agent	.	.
DNC002480	2-NAPHTHALENESULFONIC ACID	Discovery agent	.	.
DNC002481	BENZOTHIAZOLE	Discovery agent	.	.
DNC002482	Laevulinic Acid	Discovery agent	.	.
DNC002483	4-Oxosebacic Acid	Discovery agent	.	.
DNC002484	Porphobilinogen	Discovery agent	.	.
DNC002485	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	Discovery agent	.	.
DNC002486	Beta-Mercaptoethanol	Discovery agent	.	.
DNC002487	4,7-Dioxosebacic Acid	Discovery agent	.	.
DNC002488	5-hydroxyvaleric acid	Discovery agent	.	.
DNC002489	2-Amino-N,3,3-Trimethylbutanamide	Discovery agent	.	.
DNC002490	N-Isopropyl-N'-Hydroxyguanidine	Discovery agent	.	.
DNC002491	N-Butyl-N'-Hydroxyguanidine	Discovery agent	.	.
DNC002492	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	Discovery agent	.	.
DNC002493	Flavin-Adenine Dinucleotide	Discovery agent	.	.
DNC002494	Riboflavin Monophosphate	Discovery agent	.	.
DNC002495	S-Ethyl-N-Phenyl-Isothiourea	Discovery agent	.	.
DNC002496	N5-(1-Imino-3-Butenyl)-L-Ornithine	Discovery agent	.	.
DNC002497	5-N-Allyl-Arginine	Discovery agent	.	.
DNC002498	Acetate Ion	Discovery agent	.	.
DNC002499	Nitroarginine	Discovery agent	.	.
DNC002500	4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid	Discovery agent	.	.
DNC002501	Oxamic Acid	Discovery agent	.	.
DNC002502	Alpha-Phosphoribosylpyrophosphoric Acid	Discovery agent	.	.
DNC002503	Pyrophosphate 2-	Discovery agent	.	.
DNC002504	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	Discovery agent	.	.
DNC002505	3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol	Discovery agent	.	.
DNC002506	9-Deazaguanine	Discovery agent	.	.
DNC002507	Oxalate Ion	Discovery agent	.	.
DNC002508	Arecoline	Discovery agent	.	.
DNC002508	Arecoline	Parkinson's disease	.	G20
DNC002509	Hydroxyalanine	Discovery agent	.	.
DNC002510	Tris(Hydroxymethyl)Aminomethane	Discovery agent	.	.
DNC002511	Compound 15	Discovery agent	.	.
DNC002512	Compound 19	Discovery agent	.	.
DNC002513	Compound 16	Discovery agent	.	.
DNC002514	Compound 18	Discovery agent	.	.
DNC002515	Compound 4-D	Discovery agent	.	.
DNC002516	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	Discovery agent	.	.
DNC002517	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	Discovery agent	.	.
DNC002518	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	Discovery agent	.	.
DNC002519	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	Discovery agent	.	.
DNC002520	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE	Discovery agent	.	.
DNC002521	RALOXIFENE CORE	Discovery agent	.	.
DNC002522	2-HYDROXY-3,5-DIIODOBENZOIC ACID	Discovery agent	.	.
DNC002523	Calusterone	Discovery agent	.	.
DNC002524	9alpha-Fluorocortisol	Discovery agent	.	.
DNC002525	Dihydrotestosterone	Discovery agent	.	.
DNC002525	Dihydrotestosterone	Prostate hyperplasia	.	N40
DNC002526	Methyltrienolone	Discovery agent	.	.
DNC002527	Daidzin	Discovery agent	.	.
DNC002528	Crotonaldehyde	Discovery agent	.	.
DNC002529	SR11254	Discovery agent	.	.
DNC002530	CD564	Discovery agent	.	.
DNC002531	Dodecyl-Alpha-D-Maltoside	Discovery agent	.	.
DNC002532	BMS184394	Discovery agent	.	.
DNC002533	Pyroglutamic Acid	Discovery agent	.	.
DNC002534	1,4-Dithiothreitol	Discovery agent	.	.
DNC002535	Guanosine-5'-Triphosphate	Discovery agent	.	.
DNC002536	2-Sulfhydryl-Ethanol	Discovery agent	.	.
DNC002537	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	Discovery agent	.	.
DNC002538	3-ISOBUTYL-1-METHYLXANTHINE	Discovery agent	.	.
DNC002539	Phosphoaminophosphonic Acid-Adenylate Ester	Discovery agent	.	.
DNC002540	5alpha-Androstan-3,17-Dione	Discovery agent	.	.
DNC002541	TTNPB	Discovery agent	.	.
DNC002542	Bicine	Discovery agent	.	.
DNC002543	Uridine Diphosphate Galactose	Discovery agent	.	.
DNC002544	Uridine-Diphosphate-N-Acetylgalactosamine	Discovery agent	.	.
DNC002545	Uridine-5'-Diphosphate	Discovery agent	.	.
DNC002546	Beta-Hydroxy Aspartic Acid	Discovery agent	.	.
DNC002547	10-Propargyl-5,8-Dideazafolic Acid	Discovery agent	.	.
DNC002548	2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose	Discovery agent	.	.
DNC002549	4-Iodopyrazole	Discovery agent	.	.
DNC002550	Beta-(2-Naphthyl)-Alanine	Discovery agent	.	.
DNC002551	8-Azaguanine	Discovery agent	.	.
DNC002552	Immucillin-G	Discovery agent	.	.
DNC002553	Guanine	Discovery agent	.	.
DNC002554	2'3'-Dideoxyinosine	Discovery agent	.	.
DNC002555	Peldesine	Discovery agent	.	.
DNC002556	9-Deazainosine	Discovery agent	.	.
DNC002557	Guanosine	Discovery agent	.	.
DNC002558	Ribose-1-Phosphate	Discovery agent	.	.
DNC002559	3-Deoxyguanosine	Discovery agent	.	.
DNC002560	MT-Immucillin-H	Discovery agent	.	.
DNC002561	Hypoxanthine	Discovery agent	.	.
DNC002562	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	Discovery agent	.	.
DNC002563	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	Discovery agent	.	.
DNC002564	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	Discovery agent	.	.
DNC002565	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	Discovery agent	.	.
DNC002566	(4e)-4-Aminohex-4-Enoic Acid	Discovery agent	.	.
DNC002567	4-Amino Hexanoic Acid	Discovery agent	.	.
DNC002568	Palmitic Acid	Discovery agent	.	.
DNC002569	Uridine-5'-Monophosphate	Discovery agent	.	.
DNC002570	2-(N-Morpholino)-Ethanesulfonic Acid	Discovery agent	.	.
DNC002571	Prostaglandin G2	Discovery agent	.	.
DNC002572	L-2-Amino-4-(Guanidinooxy)Butyric Acid	Discovery agent	.	.
DNC002573	3-Bromo-7-Nitroindazole	Discovery agent	.	.
DNC002574	N-(3-(Aminomethyl)Benzyl)Acetamidine	Discovery agent	.	.
DNC002575	1,2,4-Triazole-Carboxamidine	Discovery agent	.	.
DNC002576	2-Aminothiazoline	Discovery agent	.	.
DNC002577	Se-Ethyl-Isoselenourea	Discovery agent	.	.
DNC002578	2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine	Discovery agent	.	.
DNC002579	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	Discovery agent	.	.
DNC002580	Hydroxydimethylarsine Oxide	Discovery agent	.	.
DNC002581	7-Nitroindazole-2-Carboxamidine	Discovery agent	.	.
DNC002582	N5-Iminoethyl-L-Ornithine	Discovery agent	.	.
DNC002583	5,6-Cyclic-Tetrahydropteridine	Discovery agent	.	.
DNC002584	6s-5,6,7,8-Tetrahydrobiopterin	Discovery agent	.	.
DNC002585	S-(Dimethylarsenic)Cysteine	Discovery agent	.	.
DNC002586	L-Homoarginine	Discovery agent	.	.
DNC002587	S-Isopropyl-Isothiourea	Discovery agent	.	.
DNC002588	Cacodylate Ion	Discovery agent	.	.
DNC002589	2-Propanol, Isopropanol	Discovery agent	.	.
DNC002590	N-(Chlorophenyl)-N'-Hydroxyguanidine	Discovery agent	.	.
DNC002591	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	Discovery agent	.	.
DNC002592	1-Hydroxy-3-Methylbutane	Discovery agent	.	.
DNC002593	3-Phenyl-1,2-Propandiol	Discovery agent	.	.
DNC002594	2-Methyl-3-(2-Aminothiazolo)Propanal	Discovery agent	.	.
DNC002595	2-Cyclopropylmethylenepropanal	Discovery agent	.	.
DNC002596	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	Discovery agent	.	.
DNC002597	N-Methyl-N-(Methylbenzyl)Formamide	Discovery agent	.	.
DNC002598	1-Hydroxy-2-Amino-3-Cyclohexylpropane	Discovery agent	.	.
DNC002599	Pyridoxamine-5'-Phosphate	Discovery agent	.	.
DNC002600	D-Phenylalanine	Discovery agent	.	.
DNC002601	N'-Pyridoxyl-Lysine-5'-Monophosphate	Discovery agent	.	.
DNC002602	Heparin Pentasaccharide	Discovery agent	.	.
DNC002603	N-Formylmethionine	Discovery agent	.	.
DNC002604	S,S-(2-Hydroxyethyl)Thiocysteine	Discovery agent	.	.
DNC002605	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	Discovery agent	.	.
DNC002606	Degraded Cephaloridine	Discovery agent	.	.
DNC002607	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	Discovery agent	.	.
DNC002608	GC-24	Discovery agent	.	.
DNC002608	GC-24	Hyperthyroidism	242	E05
DNC002609	1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE	Discovery agent	.	.
DNC002610	Methyl Mercury Ion	Discovery agent	.	.
DNC002611	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	Discovery agent	.	.
DNC002612	2'-deoxyuridylic acid	Discovery agent	.	.
DNC002613	6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE	Discovery agent	.	.
DNC002614	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE	Discovery agent	.	.
DNC002615	Sri-9662	Discovery agent	.	.
DNC002616	Sri-9439	Discovery agent	.	.
DNC002617	Biopterin	Discovery agent	.	.
DNC002618	N-Pyridoxyl-Glycine-5-Monophosphate	Discovery agent	.	.
DNC002619	C16-Fatty-Acyl-Substrate-Mimic	Discovery agent	.	.
DNC002620	Genz-10850	Discovery agent	.	.
DNC002621	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Discovery agent	.	.
DNC002622	5-PENTYL-2-PHENOXYPHENOL	Discovery agent	.	.
DNC002623	TRICLOSAN	Discovery agent	.	.
DNC002624	Cholic Acid	Discovery agent	.	.
DNC002625	Delta-Amino Valeric Acid	Discovery agent	.	.
DNC002626	Alpha-Aminobutyric Acid	Discovery agent	.	.
DNC002627	5,7-Dichlorokynurenic Acid	Discovery agent	.	.
DNC002628	(R)-4-Amino-Isoxazolidin-3-One	Discovery agent	.	.
DNC002629	D-Serine	Discovery agent	.	.
DNC002630	Cycloleucine	Discovery agent	.	.
DNC002631	Acetoacetyl-Coenzyme A	Discovery agent	.	.
DNC002632	Orotic Acid	Discovery agent	.	.
DNC002633	Decylamine-N,N-Dimethyl-N-Oxide	Discovery agent	.	.
DNC002634	Brequinar Analog	Discovery agent	.	.
DNC002635	Antiproliferative Agent A771726	Discovery agent	.	.
DNC002636	Lauryl Dimethylamine-N-Oxide	Discovery agent	.	.
DNC002637	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	Discovery agent	.	.
DNC002638	3-Hydroxyhippuric acid	Discovery agent	.	.
DNC002639	Mdl 101,146	Discovery agent	.	.
DNC002639	Mdl 101,146	Inflammatory diseases	.	.
DNC002640	Putrescine	Burns and burn infection	001-139	A00-B99
DNC002640	Putrescine	Discovery agent	.	.
DNC002641	Pyridoxine-5'-Phosphate	Discovery agent	.	.
DNC002642	Alpha-Difluoromethylornithine	Discovery agent	.	.
DNC002643	G418	Discovery agent	.	.
DNC002644	Tributylstannanyl	Discovery agent	.	.
DNC002645	2-Methyl-2-Propanol	Discovery agent	.	.
DNC002646	N-Trimethyllysine	Discovery agent	.	.
DNC002647	Gabaculine	Discovery agent	.	.
DNC002648	Huperaine A	Discovery agent	.	.
DNC002649	Propidium	Discovery agent	.	.
DNC002650	3,6,9,12,15-Pentaoxaheptadecane	Discovery agent	.	.
DNC002651	1-Deoxy-1-Thio-Heptaethylene Glycol	Discovery agent	.	.
DNC002652	Tetraethylene Glycol	Discovery agent	.	.
DNC002653	Methylphosphonic Acid Ester Group	Discovery agent	.	.
DNC002654	Beta-L-fucose	Discovery agent	.	.
DNC002655	MF268	Alzheimer's disease	.	G30,F00
DNC002655	MF268	Discovery agent	.	.
DNC002656	Methyl Phosphinic Acid	Discovery agent	.	.
DNC002657	3-[(1s)-1-(Dimethylamino)Ethyl]Phenol	Discovery agent	.	.
DNC002658	(R)-tacrine(10)-hupyridone	Discovery agent	.	.
DNC002659	(S)-tacrine(10)-hupyridone	Discovery agent	.	.
DNC002660	TACRINE(8)-4-AMINOQUINOLINE	Discovery agent	.	.
DNC002661	(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE	Discovery agent	.	.
DNC002662	3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM	Discovery agent	.	.
DNC002663	1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE	Discovery agent	.	.
DNC002664	Inositol 1,3,4,5-Tetrakisphosphate	Discovery agent	.	.
DNC002665	Aniracetam	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC002665	Aniracetam	Discovery agent	.	.
DNC002666	Trifluoroethanol	Discovery agent	.	.
DNC002667	(R)-Mesopram	Discovery agent	.	.
DNC002668	Filaminast	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC002668	Filaminast	Discovery agent	.	.
DNC002669	8-Bromo-Adenosine-5'-Monophosphate	Discovery agent	.	.
DNC002670	LFA703	Discovery agent	.	.
DNC002671	Maleic Acid	Discovery agent	.	.
DNC002672	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Discovery agent	.	.
DNC002673	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	Discovery agent	.	.
DNC002674	Tanaproget	Discovery agent	.	.
DNC002674	Tanaproget	Estrogen deficiency	.	E28.39
DNC002675	Cysteinesulfonic Acid	Discovery agent	.	.
DNC002676	3-Hydroxy-3-Methyl-Glutaric Acid	Discovery agent	.	.
DNC002677	Rutin	Discovery agent	.	.
DNC002678	Biliverdine Ix Alpha	Discovery agent	.	.
DNC002679	Carboxyatractyloside	Discovery agent	.	.
DNC002680	Cardiolipin	Discovery agent	.	.
DNC002681	Di-Stearoyl-3-Sn-Phosphatidylcholine	Discovery agent	.	.
DNC002682	Meta-Tyrosine	Discovery agent	.	.
DNC002683	Double Oxidized Cysteine	Discovery agent	.	.
DNC002684	Cysteine Sulfenic Acid	Discovery agent	.	.
DNC002685	Cytidine-5'-Monophosphate	Discovery agent	.	.
DNC002686	Rolicyclidine	Discovery agent	.	.
DNC002687	SC-74020	Discovery agent	.	.
DNC002688	3,6-Dihydroxy-Xanthene-9-Propionic Acid	Discovery agent	.	.
DNC002689	3-Sulfinoalanine	Discovery agent	.	.
DNC002690	Glutathionylspermidine Disulfide	Discovery agent	.	.
DNC002691	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	Discovery agent	.	.
DNC002692	Oxidized Glutathione Disulfide	Discovery agent	.	.
DNC002693	Meta-Nitro-Tyrosine	Discovery agent	.	.
DNC002694	3,5 DIBROMOTYROSINE	Discovery agent	.	.
DNC002695	Aldosterone	Discovery agent	.	.
DNC002696	B-Nonylglucoside	Discovery agent	.	.
DNC002697	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	Discovery agent	.	.
DNC002698	Sucrose Octasulfate	Discovery agent	.	.
DNC002699	O2-Sulfo-Glucuronic Acid	Discovery agent	.	.
DNC002700	N,O6-Disulfo-Glucosamine	Discovery agent	.	.
DNC002701	Naphthalene Trisulfonate	Discovery agent	.	.
DNC002702	5-AMINO-NAPHTALENE-2-MONOSULFONATE	Discovery agent	.	.
DNC002703	4-Hydroxy-2-Butanone	Discovery agent	.	.
DNC002704	Gpi-1046	Discovery agent	.	.
DNC002704	Gpi-1046	Parkinson's disease	.	G20
DNC002705	Methyl Methylsulfinylmethyl Sulfide	Discovery agent	.	.
DNC002706	Rapamycin Immunosuppressant Drug	Discovery agent	.	.
DNC002707	FKB-001	Discovery agent	.	.
DNC002708	Heptyl-Beta-D-Glucopyranoside	Discovery agent	.	.
DNC002709	L-709,587	Discovery agent	.	.
DNC002710	Soraphen A	Discovery agent	.	.
DNC002711	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	Discovery agent	.	.
DNC002712	Isopropyl Alcohol	Discovery agent	.	.
DNC002713	Selenazole-4-Carboxyamide-Adenine Dinucleotide	Discovery agent	.	.
DNC002714	6-Chloropurine Riboside, 5'-Monophosphate	Discovery agent	.	.
DNC002715	Inosinic Acid	Discovery agent	.	.
DNC002716	Verdoheme	Discovery agent	.	.
DNC002717	12-Phenylheme	Discovery agent	.	.
DNC002718	2-Phenylheme	Discovery agent	.	.
DNC002719	1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone	Discovery agent	.	.
DNC002720	Inhibitor Idd 384	Discovery agent	.	.
DNC002721	Alrestatin	Discovery agent	.	.
DNC002722	Fidarestat(Stereoisomer)	Discovery agent	.	.
DNC002723	N-Acetylalanine	Discovery agent	.	.
DNC002724	IDD552	Discovery agent	.	.
DNC002725	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	Discovery agent	.	.
DNC002726	IDD594	Discovery agent	.	.
DNC002727	SU4984	Discovery agent	.	.
DNC002728	Homoserine Lactone	Discovery agent	.	.
DNC002729	Norleucine	Discovery agent	.	.
DNC002730	Flavopiridol	Discovery agent	.	.
DNC002731	Dimethylallyl Diphosphate	Discovery agent	.	.
DNC002732	Isopentyl Pyrophosphate	Discovery agent	.	.
DNC002733	Geranyl Diphosphate	Discovery agent	.	.
DNC002734	ISOPENTENYL PYROPHOSPHATE	Discovery agent	.	.
DNC002735	Seocalcitol	Discovery agent	.	.
DNC002735	Seocalcitol	Rickets	.	E55
DNC002736	19-nor-14-epi-23-yne-1,25 dihydroxyvitamin D3	Discovery agent	.	.
DNC002737	Phenylalanylmethane	Discovery agent	.	.
DNC002738	Genistein	Discovery agent	.	.
DNC002739	Para-Mercury-Benzenesulfonic Acid	Discovery agent	.	.
DNC002740	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	Discovery agent	.	.
DNC002741	Hexane-1,6-Diol	Discovery agent	.	.
DNC002742	2-(3,4-Dihydroxyphenyl)Acetic Acid	Discovery agent	.	.
DNC002743	Lipid Fragment	Discovery agent	.	.
DNC002744	Phosphomethylphosphonic Acid Adenosyl Ester	Discovery agent	.	.
DNC002745	PLATENSIMYCIN	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC002745	PLATENSIMYCIN	Discovery agent	.	.
DNC002746	Decanoic Acid	Discovery agent	.	.
DNC002747	Caprylic acid	Discovery agent	.	.
DNC002748	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	Discovery agent	.	.
DNC002749	Glutathione Sulfonic Acid	Discovery agent	.	.
DNC002750	S-Hexylglutathione	Discovery agent	.	.
DNC002751	Cibacron Blue	Discovery agent	.	.
DNC002752	4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid	Discovery agent	.	.
DNC002753	RU78299	Discovery agent	.	.
DNC002754	RU84687	Discovery agent	.	.
DNC002755	RU79256	Discovery agent	.	.
DNC002756	N6-Benzyl Adenosine-5'-Diphosphate	Discovery agent	.	.
DNC002757	RU85493	Discovery agent	.	.
DNC002758	RU78262	Discovery agent	.	.
DNC002759	Malonic acid	Discovery agent	.	.
DNC002760	RU83876	Discovery agent	.	.
DNC002761	RU90395	Discovery agent	.	.
DNC002762	RU79072	Discovery agent	.	.
DNC002763	RU78783	Discovery agent	.	.
DNC002764	PASBN	Discovery agent	.	.
DNC002765	RU82129	Discovery agent	.	.
DNC002766	PAS219	Discovery agent	.	.
DNC002767	DPI59	Discovery agent	.	.
DNC002768	RU82197	Discovery agent	.	.
DNC002769	Phenylphosphate	Discovery agent	.	.
DNC002770	RU78300	Discovery agent	.	.
DNC002771	RU79073	Discovery agent	.	.
DNC002772	RU82209	Discovery agent	.	.
DNC002773	ISO24	Discovery agent	.	.
DNC002774	RU85053	Discovery agent	.	.
DNC002775	Oxalic Acid	Discovery agent	.	.
DNC002776	RU78191	Discovery agent	.	.
DNC002777	RU81843	Discovery agent	.	.
DNC002778	Purvalanol A	Discovery agent	.	.
DNC002779	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	Discovery agent	.	.
DNC002780	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE	Discovery agent	.	.
DNC002781	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	Discovery agent	.	.
DNC002782	Staurosporine	Discovery agent	.	.
DNC002783	K-252a	Discovery agent	.	.
DNC002784	Phosphocholine	Discovery agent	.	.
DNC002785	Glycinamide Ribonucleotide	Discovery agent	.	.
DNC002786	Alsterpaullone	Discovery agent	.	.
DNC002787	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	Discovery agent	.	.
DNC002788	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	Discovery agent	.	.
DNC002789	CRA_10655	Discovery agent	.	.
DNC002790	Benzamidine	Discovery agent	.	.
DNC002791	2-Amino-5-Hydroxy-Benzimidazole	Discovery agent	.	.
DNC002792	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	Discovery agent	.	.
DNC002793	Thieno[2,3-B]Pyridine-2-Carboxamidine	Discovery agent	.	.
DNC002794	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	Discovery agent	.	.
DNC002795	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	Discovery agent	.	.
DNC002796	O-Sialic Acid	Discovery agent	.	.
DNC002797	Beta-D-Glucopyranose Spirohydantoin	Discovery agent	.	.
DNC002798	Fluoro-Phosphite Ion	Discovery agent	.	.
DNC002799	Nojirimycine Tetrazole	Discovery agent	.	.
DNC002800	Indirubin-5-Sulphonate	Discovery agent	.	.
DNC002801	2-Deoxy-Glucose-6-Phosphate	Discovery agent	.	.
DNC002802	C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide	Discovery agent	.	.
DNC002803	Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide	Discovery agent	.	.
DNC002804	Alpha-D-Glucose-1-Phosphate	Discovery agent	.	.
DNC002805	N-Acetyl-N'-Beta-D-Glucopyranosyl Urea	Discovery agent	.	.
DNC002806	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	Discovery agent	.	.
DNC002807	1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose	Discovery agent	.	.
DNC002808	4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	Discovery agent	.	.
DNC002809	Heptulose-2-Phosphate	Discovery agent	.	.
DNC002810	N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea	Discovery agent	.	.
DNC002811	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	Discovery agent	.	.
DNC002812	Phosphonothreonine	Discovery agent	.	.
DNC002813	SB220025	Arthritis	710-719	M00-M25
DNC002813	SB220025	Discovery agent	.	.
DNC002814	N-Methylleucine	Discovery agent	.	.
DNC002815	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	Discovery agent	.	.
DNC002816	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	Discovery agent	.	.
DNC002817	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	Discovery agent	.	.
DNC002818	UBIQUINONE-2	Discovery agent	.	.
DNC002819	2-Aminoethanimidic Acid	Discovery agent	.	.
DNC002820	3-Amino-4-Oxybenzyl-2-Butanone	Discovery agent	.	.
DNC002821	3-Methylphenylalanine	Discovery agent	.	.
DNC002822	2-Pyridinethiol	Discovery agent	.	.
DNC002823	Diphenylacetic Acid	Discovery agent	.	.
DNC002824	S-Methylcysteine	Discovery agent	.	.
DNC002825	1h-Benoximidazole-2-Carboxylic Acid	Discovery agent	.	.
DNC002826	N-Aminoethylmorpholine	Discovery agent	.	.
DNC002827	Dimethyltryptamine	Discovery agent	.	.
DNC002828	(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione	Discovery agent	.	.
DNC002829	6-Carboxymethyluracil	Discovery agent	.	.
DNC002830	Uracil	Dermatitis	.	L20-L30
DNC002830	Uracil	Discovery agent	.	.
DNC002831	5-Iodouracil	Discovery agent	.	.
DNC002832	S-P-Nitrobenzyloxycarbonylglutathione	Discovery agent	.	.
DNC002833	S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione	Discovery agent	.	.
DNC002834	S-Benzyl-Glutathione	Discovery agent	.	.
DNC002835	3-Methylpyridine	Discovery agent	.	.
DNC002836	WAY-151693	Discovery agent	.	.
DNC002837	Hydroxyaminovaline	Discovery agent	.	.
DNC002838	1-Methyloxy-4-Sulfone-Benzene	Discovery agent	.	.
DNC002839	Myo-Inositol	Discovery agent	.	.
DNC002840	2-(1H-pyrazol-3-yl)-1H-benzimidazole	Discovery agent	.	.
DNC002841	3h-Indole-5,6-Diol	Discovery agent	.	.
DNC002842	Nitrilotriacetic Acid	Discovery agent	.	.
DNC002843	Alpha-D-Fucose	Discovery agent	.	.
DNC002844	Parecoxib	Discovery agent	.	.
DNC002845	1,4-Diethylene Dioxide	Discovery agent	.	.
DNC002846	6-hydroxydopa quinone	Discovery agent	.	.
DNC002847	2,6-DICHLORO-N-IMIDAZOLIDIN-2-YLIDENEANILINE	Discovery agent	.	.
DNC002848	Bis-Napthyl Beta-Ketophosphonic Acid	Discovery agent	.	.
DNC002849	(3r)-1-Acetyl-3-Methylpiperidine	Discovery agent	.	.
DNC002850	Ethyl Oxo(Piperidin-1-Yl)Acetate	Discovery agent	.	.
DNC002851	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	Discovery agent	.	.
DNC002852	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	Discovery agent	.	.
DNC002853	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	Discovery agent	.	.
DNC002854	Inhibitor of P38 Kinase	Discovery agent	.	.
DNC002855	3-(Benzyloxy)Pyridin-2-Amine	Discovery agent	.	.
DNC002856	2-Chlorophenol	Discovery agent	.	.
DNC002857	Triazolopyridine	Discovery agent	.	.
DNC002858	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	Discovery agent	.	.
DNC002859	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	Discovery agent	.	.
DNC002860	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	Discovery agent	.	.
DNC002861	Alpha-Aminoisobutyric Acid	Discovery agent	.	.
DNC002862	SP4160	Discovery agent	.	.
DNC002863	SP2456	Discovery agent	.	.
DNC002864	Guanosine-5'-Diphosphate	Discovery agent	.	.
DNC002865	Benzylsulfinic Acid	Discovery agent	.	.
DNC002866	5-iodotubercidin	Discovery agent	.	.
DNC002867	Diprenorphine	Discovery agent	.	.
DNC002868	I-5	Discovery agent	.	.
DNC002869	Indirubin-3'-Monoxime	Discovery agent	.	.
DNC002870	3-Phosphoglycerol	Discovery agent	.	.
DNC002871	1na	Discovery agent	.	.
DNC002872	6-Amino Hexanoic Acid	Discovery agent	.	.
DNC002873	5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID	Discovery agent	.	.
DNC002874	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	Discovery agent	.	.
DNC002875	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	Discovery agent	.	.
DNC002876	Alpha-D-Glucose-6-Phosphate	Discovery agent	.	.
DNC002877	Formycin	Discovery agent	.	.
DNC002878	5'-Deoxy-5'-(Methylthio)-Tubercidin	Discovery agent	.	.
DNC002879	Piclamilast	Discovery agent	.	.
DNC002879	Piclamilast	Rheumatold arthritis	.	M05-M06
DNC002880	Benzylcysteine	Discovery agent	.	.
DNC002881	L-Myo-Inositol-1-Phosphate	Discovery agent	.	.
DNC002882	1-Hydroxyamine-2-Isobutylmalonic Acid	Discovery agent	.	.
DNC002883	2-Thiomethyl-3-Phenylpropanoic Acid	Discovery agent	.	.
DNC002884	Glycinamid	Discovery agent	.	.
DNC002885	Batimastat	Discovery agent	.	.
DNC002885	Batimastat	Rheumatold arthritis	.	M05-M06
DNC002886	2-HYDROXYCARBAMOYL-4-METHYL-PENTANOIC ACID	Discovery agent	.	.
DNC002887	3-AMINO-AZACYCLOTRIDECAN-2-ONE	Discovery agent	.	.
DNC002888	Duroquinone	Discovery agent	.	.
DNC002889	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	Discovery agent	.	.
DNC002890	Inositol-(1,3,4,5)-Tetrakisphosphate	Discovery agent	.	.
DNC002891	2-Amino-3-Oxo-4-Sulfo-Butyric Acid	Discovery agent	.	.
DNC002892	CP-271485	Discovery agent	.	.
DNC002893	PF-00356231	Discovery agent	.	.
DNC002894	N-(biphenyl-4-ylsulfonyl)-D-leucine	Discovery agent	.	.
DNC002895	N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine	Discovery agent	.	.
DNC002896	N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide	Discovery agent	.	.
DNC002897	N-oxo-2-(phenylsulfonylamino)ethanamide	Discovery agent	.	.
DNC002898	N-[(4-methoxyphenyl)sulfonyl]-D-alanine	Discovery agent	.	.
DNC002899	6-Phosphogluconic Acid	Discovery agent	.	.
DNC002900	Erythose-4-Phosphate	Discovery agent	.	.
DNC002901	B-2-Octylglucoside	Discovery agent	.	.
DNC002902	Hexadecanal	Discovery agent	.	.
DNC002903	Heptane-1,2,3-Triol	Discovery agent	.	.
DNC002904	Heptyl 1-Thiohexopyranoside	Discovery agent	.	.
DNC002905	Deoxyuridine-5'-Diphosphate	Discovery agent	.	.
DNC002906	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	Discovery agent	.	.
DNC002907	2-Amino-6-Chloropyrazine	Discovery agent	.	.
DNC002908	6-O-Cyclohexylmethyl Guanine	Discovery agent	.	.
DNC002909	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	Discovery agent	.	.
DNC002910	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	Discovery agent	.	.
DNC002911	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	Discovery agent	.	.
DNC002912	Lysine Nz-Carboxylic Acid	Discovery agent	.	.
DNC002913	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	Discovery agent	.	.
DNC002914	OLOMOUCINE II	Discovery agent	.	.
DNC002915	TRIAZOLOPYRIMIDINE	Discovery agent	.	.
DNC002916	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	Discovery agent	.	.
DNC002917	5-hydroxynaphthalene-1-sulfonamide	Discovery agent	.	.
DNC002918	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	Discovery agent	.	.
DNC002919	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	Discovery agent	.	.
DNC002920	N-phenyl-1H-pyrazole-3-carboxamide	Discovery agent	.	.
DNC002921	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	Discovery agent	.	.
DNC002922	N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE	Discovery agent	.	.
DNC002923	Glyoxalate, Glyoxylate	Discovery agent	.	.
DNC002924	Pyridoxyl-Alanine-5-Phosphate	Discovery agent	.	.
DNC002925	Thymidine-5'-Phosphate	Discovery agent	.	.
DNC002926	Thymidine-5'-Triphosphate	Discovery agent	.	.
DNC002927	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	Discovery agent	.	.
DNC002928	3'-Azido-3'-Deoxythymidine-5'-Monophosphate	Discovery agent	.	.
DNC002929	5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate	Discovery agent	.	.
DNC002930	Diphosphate	Discovery agent	.	.
DNC002931	Deoxythymidine	Discovery agent	.	.
DNC002932	2',3'-Dideoxythymidine-5'-Monophosphate	Discovery agent	.	.
DNC002933	2'-Deoxyuridine	Discovery agent	.	.
DNC002934	3-Phosphoglyceric Acid	Discovery agent	.	.
DNC002935	Namn	Discovery agent	.	.
DNC002936	3-Beta-Hydroxy-5-Androsten-17-One	Discovery agent	.	.
DNC002937	Equilenin	Discovery agent	.	.
DNC002938	Isocitric Acid	Discovery agent	.	.
DNC002939	Uridine-Diphosphate-N-Acetylglucosamine	Discovery agent	.	.
DNC002940	2-Phosphoglyceric Acid	Discovery agent	.	.
DNC002941	2-(Phosphonooxy)Butanoic Acid	Discovery agent	.	.
DNC002942	Arabinose-5-Phosphate	Discovery agent	.	.
DNC002943	Fumarate	Discovery agent	.	.
DNC002944	D-tartaric acid	Discovery agent	.	.
DNC002945	4-iodo-acetamido phenylboronic acid	Discovery agent	.	.
DNC002946	O-Benzylsulfonyl-Serine	Discovery agent	.	.
DNC002947	Nicotinamide-Adenine-Dinucleotide	Discovery agent	.	.
DNC002948	5-Fluorolevulinic Acid	Discovery agent	.	.
DNC002949	Levulinic Acid	Discovery agent	.	.
DNC002950	Thiamin Diphosphate	Discovery agent	.	.
DNC002951	8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione	Discovery agent	.	.
DNC002952	6-Hydroxymethyl-7,8-Dihydropterin	Discovery agent	.	.
DNC002953	9-Methylguanine	Discovery agent	.	.
DNC002954	2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol	Discovery agent	.	.
DNC002955	7,8-Dihydroneopterin	Discovery agent	.	.
DNC002956	Aminomethylcyclohexane	Discovery agent	.	.
DNC002957	Cyclohexylammonium Ion	Discovery agent	.	.
DNC002958	L-Iso-Aspartate	Discovery agent	.	.
DNC002959	1-Anilino-8-Naphthalene Sulfonate	Discovery agent	.	.
DNC002960	Benzoyl-Arginine-Alanine-Methyl Ketone	Discovery agent	.	.
DNC002961	WRR-99	Discovery agent	.	.
DNC002962	WRR-112	Discovery agent	.	.
DNC002963	WRR-204	Discovery agent	.	.
DNC002964	3,4-Dihydroxycinnamic Acid	Discovery agent	.	.
DNC002965	5-Chloryl-2,4,6-Quinazolinetriamine	Discovery agent	.	.
DNC002966	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	Discovery agent	.	.
DNC002967	5-Phenylsulfanyl-2,4-Quinazolinediamine	Discovery agent	.	.
DNC002968	Cytidine-5'-Diphosphate	Discovery agent	.	.
DNC002969	N-Methylmesoporphyrin	Discovery agent	.	.
DNC002970	N-Methylmesoporphyrin Containing Copper	Discovery agent	.	.
DNC002971	2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate	Discovery agent	.	.
DNC002972	Deoxyuridine-5'-Triphosphate	Discovery agent	.	.
DNC002973	3-Hydroxy-Myristic Acid	Discovery agent	.	.
DNC002974	Xylopyranose	Discovery agent	.	.
DNC002975	N-(1-PHENYL-PROPYL)-FORMAMIDE	Discovery agent	.	.
DNC002976	Deamido-Nad+	Discovery agent	.	.
DNC002977	Tu-514	Discovery agent	.	.
DNC002978	Palmitoleic Acid	Discovery agent	.	.
DNC002979	3-(heptyloxy)benzoic acid	Discovery agent	.	.
DNC002980	Phthalic Acid	Discovery agent	.	.
DNC002981	5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate	Discovery agent	.	.
DNC002982	2-Deoxy-2fluoro-Glucose	Discovery agent	.	.
DNC002983	N-(5'-Phosphopyridoxyl)-D-Alanine	Discovery agent	.	.
DNC002984	Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate	Discovery agent	.	.
DNC002985	Propanoic Acid	Discovery agent	.	.
DNC002986	D-Alanine	Discovery agent	.	.
DNC002987	Quinolinic Acid	Discovery agent	.	.
DNC002988	Cephalosporin Analog	Discovery agent	.	.
DNC002989	Cephalosporin C	Discovery agent	.	.
DNC002990	Formaldehyde	Discovery agent	.	.
DNC002991	Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine	Discovery agent	.	.
DNC002992	2-[(Dioxidophosphino)Oxy]Benzoate	Discovery agent	.	.
DNC002993	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	Discovery agent	.	.
DNC002994	Tetrabutylammonium Ion	Discovery agent	.	.
DNC002995	(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE	Discovery agent	.	.
DNC002996	M-Aminophenylboronic Acid	Discovery agent	.	.
DNC002997	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	Discovery agent	.	.
DNC002998	Hydrolyzed Cephalothin	Discovery agent	.	.
DNC002999	4-(Carboxyvin-2-Yl)Phenylboronic Acid	Discovery agent	.	.
DNC003000	4,4'-Biphenyldiboronic Acid	Discovery agent	.	.
DNC003001	Sucrose	Discovery agent	.	.
DNC003002	3-Nitrophenylboronic Acid	Discovery agent	.	.
DNC003003	4-Carboxyphenylboronic Acid	Discovery agent	.	.
DNC003004	Acylated Ceftazidime	Discovery agent	.	.
DNC003005	Benzo[B]Thiophene-2-Boronic Acid	Discovery agent	.	.
DNC003006	4-[(METHYLSULFONYL)AMINO]BENZOIC ACID	Discovery agent	.	.
DNC003007	2-phenyl-1H-imidazole-4-carboxylic acid	Discovery agent	.	.
DNC003008	PCNOTAXIME GROUP	Discovery agent	.	.
DNC003009	N-(Sulfanylacetyl)Tyrosylprolylmethioninamide	Discovery agent	.	.
DNC003010	GM6001	Discovery agent	.	.
DNC003011	N,N'-Bis(4-Amino-2-Methylquinolin-6-Yl)Urea	Discovery agent	.	.
DNC003012	Formic Acid	Discovery agent	.	.
DNC003013	D-Mannose 1-Phosphate	Discovery agent	.	.
DNC003014	Alpha-D-Mannose-6-Phosphate	Discovery agent	.	.
DNC003015	Maltose	Discovery agent	.	.
DNC003016	Shikimate-3-Phosphate	Discovery agent	.	.
DNC003017	Glyphosate	Discovery agent	.	.
DNC003018	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	Discovery agent	.	.
DNC003019	4,6-Dideoxyglucose	Discovery agent	.	.
DNC003020	Phosphoenolpyruvate	Discovery agent	.	.
DNC003021	3-Fluoro-2-(Phosphonooxy)Propanoic Acid	Discovery agent	.	.
DNC003022	1-Deoxy-Ribofuranose-5'-Phosphate	Discovery agent	.	.
DNC003023	Bestatin	Acute myeloid leukemia	205	C92.0
DNC003023	Bestatin	Discovery agent	.	.
DNC003024	7-AMINO-4-METHYL-CHROMEN-2-ONE	Discovery agent	.	.
DNC003025	S-Adenosyl-L-Homocysteine	Discovery agent	.	.
DNC003026	9-(4-Hydroxy-3-(Hydroxymethyl)but-1-Yl)Guanine	Discovery agent	.	.
DNC003027	5-Iodo-2'-Deoxyuridine-5'-Monophosphate	Discovery agent	.	.
DNC003028	9-(4-Hydroxybutyl)-N2-Phenylguanine	Discovery agent	.	.
DNC003029	6-(Dihydroxy-Isobutyl)-Thymine	Discovery agent	.	.
DNC003030	9-Hydroxypropyladenine, R-Isomer	Discovery agent	.	.
DNC003031	(South)-Methanocarba-Thymidine	Discovery agent	.	.
DNC003032	9-Hydroxypropyladenine, S-Isomer	Discovery agent	.	.
DNC003033	5-Bromovinyldeoxyuridine	Discovery agent	.	.
DNC003034	5-Iododeoxyuridine	Discovery agent	.	.
DNC003035	5-Bromothienyldeoxyuridine	Discovery agent	.	.
DNC003036	6-Hydroxypropylthymine	Discovery agent	.	.
DNC003037	Coenzyme A	Discovery agent	.	.
DNC003038	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	Discovery agent	.	.
DNC003039	Beta-Sialic Acid	Discovery agent	.	.
DNC003040	Lactose	Discovery agent	.	.
DNC003041	1,4-Butanediol	Discovery agent	.	.
DNC003042	Glucose-Uridine-C1,5'-Diphosphate	Discovery agent	.	.
DNC003043	Phosphonotyrosine	Discovery agent	.	.
DNC003044	Epothilone D	Breast cancer	174, 175	C50
DNC003044	Epothilone D	Discovery agent	.	.
DNC003045	(P-Iodophenylacetylamino)Methylphosphinic Acid	Discovery agent	.	.
DNC003046	Lpc-Ether	Discovery agent	.	.
DNC003047	(6s)-5,6,7,8-Tetrahydrofolate	Discovery agent	.	.
DNC003048	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	Discovery agent	.	.
DNC003049	Ly231514 Tetra Glu	Discovery agent	.	.
DNC003050	5,10-Methylene-6-Hydrofolic Acid	Discovery agent	.	.
DNC003051	S-Oxymethionine	Discovery agent	.	.
DNC003052	Tosyl-D-Proline	Discovery agent	.	.
DNC003053	N-Carboxymethionine	Discovery agent	.	.
DNC003054	LY341770	Discovery agent	.	.
DNC003055	N,O-Didansyl-L-Tyrosine	Discovery agent	.	.
DNC003056	2'-5'dideoxyuridine	Discovery agent	.	.
DNC003057	Sp-876	Discovery agent	.	.
DNC003058	2'-Deoxyguanosine-5'-Monophosphate	Discovery agent	.	.
DNC003059	Sp-722	Discovery agent	.	.
DNC003060	2-bromophenol	Discovery agent	.	.
DNC003061	4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN	Discovery agent	.	.
DNC003062	Hadacidin	Discovery agent	.	.
DNC003063	Hydantocidin-5'-Monophosphate	Discovery agent	.	.
DNC003064	Hydantocidin-5'-Phosphate	Discovery agent	.	.
DNC003065	(C8-R)-Hydantocidin 5'-Phosphate	Discovery agent	.	.
DNC003066	(Carboxyhydroxyamino)Ethanoic Acid	Discovery agent	.	.
DNC003067	(C8-S)-Hydantocidin 5'-Phosphate	Discovery agent	.	.
DNC003068	2'-Monophosphoadenosine-5'-Diphosphate	Discovery agent	.	.
DNC003069	3-Hydroxyisoxazole-4-Carboxylic Acid	Discovery agent	.	.
DNC003070	4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid	Discovery agent	.	.
DNC003071	Naphthalene-2,6-disulfonic acid	Discovery agent	.	.
DNC003072	3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID	Discovery agent	.	.
DNC003073	[Pterin-6-Yl Methanyl]-Phosphonophosphate	Discovery agent	.	.
DNC003074	Dihydroorotic Acid	Discovery agent	.	.
DNC003075	N-Carbamoyl-L-Aspartate	Discovery agent	.	.
DNC003076	R048-8071	Discovery agent	.	.
DNC003077	Tetradecane	Discovery agent	.	.
DNC003078	Lanosterol	Discovery agent	.	.
DNC003079	4-(Acetylamino)-3-Amino Benzoic Acid	Discovery agent	.	.
DNC003080	4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID	Discovery agent	.	.
DNC003081	4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID	Discovery agent	.	.
DNC003082	Bb-3497	Discovery agent	.	.
DNC003083	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	Discovery agent	.	.
DNC003084	10-Formyl-5,8,10-Trideazafolic Acid	Discovery agent	.	.
DNC003085	(10r)-10-Formyl-5,8,10-Trideazafolic Acid	Discovery agent	.	.
DNC003086	Cytidine-5'-Triphosphate	Discovery agent	.	.
DNC003087	Carbamic Acid	Discovery agent	.	.
DNC003088	N-(2-Acetamido)Iminodiacetic Acid	Discovery agent	.	.
DNC003089	2'-Deoxycytidine-5'-Monophosphate	Discovery agent	.	.
DNC003090	3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE	Discovery agent	.	.
DNC003091	Myristoyl-Coa	Discovery agent	.	.
DNC003092	HOMOPHENYLALANINYLMETHANE	Discovery agent	.	.
DNC003093	BENZOYL-TYROSINE-ALANINE-METHYL KETONE	Discovery agent	.	.
DNC003094	S-Oxy Cysteine	Discovery agent	.	.
DNC003095	Tetramethylammonium Ion	Discovery agent	.	.
DNC003096	O-Sialic Acid (Chair Conformation)	Discovery agent	.	.
DNC003097	Cmp-2-Keto-3-Deoxy-Octulosonic Acid	Discovery agent	.	.
DNC003098	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	Discovery agent	.	.
DNC003099	D-Methionine	Discovery agent	.	.
DNC003100	Ovalicin	Discovery agent	.	.
DNC003101	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID	Discovery agent	.	.
DNC003102	Ethyl Dihydrogen Phosphate	Discovery agent	.	.
DNC003103	Methionine Phosphonate	Discovery agent	.	.
DNC003104	5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine	Discovery agent	.	.
DNC003105	Trifluoromethionine	Discovery agent	.	.
DNC003106	Difluoromethionine	Discovery agent	.	.
DNC003107	Methionine Phosphinate	Discovery agent	.	.
DNC003108	1-Deoxy-D-Xylulose-5-Phosphate	Discovery agent	.	.
DNC003109	Trypanothione	Discovery agent	.	.
DNC003110	Furo[2,3d]Pyrimidine Antifolate	Discovery agent	.	.
DNC003111	Xanthine	Discovery agent	.	.
DNC003112	Ribose-5-Phosphate	Discovery agent	.	.
DNC003113	9-Deazahypoxanthine	Discovery agent	.	.
DNC003114	2-Hydroxymethyl-Pyrrolidine-3,4-Diol	Discovery agent	.	.
DNC003115	Benzenesulfonyl	Discovery agent	.	.
DNC003116	Cytosine Arabinose-5'-Phosphate	Discovery agent	.	.
DNC003117	2',3'-Dideoxycytidine-5'-Monophosphate	Discovery agent	.	.
DNC003118	Brodimoprim-4,6-Dicarboxylate	Discovery agent	.	.
DNC003119	8-Iodo-Guanine	Discovery agent	.	.
DNC003120	Butylphosphonate	Discovery agent	.	.
DNC003121	4-ANDROSTENE-3-17-DIONE	Discovery agent	.	.
DNC003122	Acarbose Derived Hexasaccharide	Discovery agent	.	.
DNC003123	N-Tridecanoic Acid	Discovery agent	.	.
DNC003124	Elaidoylamide	Discovery agent	.	.
DNC003125	2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL	Discovery agent	.	.
DNC003126	Butanoic Acid	Discovery agent	.	.
DNC003127	Carboxylic PRPP	Discovery agent	.	.
DNC003128	4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid	Discovery agent	.	.
DNC003129	2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid	Discovery agent	.	.
DNC003130	Bcx-1812	Discovery agent	.	.
DNC003131	2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid	Discovery agent	.	.
DNC003132	5-Hydroxymethyl-Chonduritol	Discovery agent	.	.
DNC003133	4,6-Dideoxy-4-Amino-Alpha-D-Glucose	Discovery agent	.	.
DNC003134	6-Hydroxyuridine-5'-Phosphate	Discovery agent	.	.
DNC003135	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	Discovery agent	.	.
DNC003136	N-(pyridin-3-ylmethyl)aniline	Discovery agent	.	.
DNC003137	(4-fluorophenyl)(pyridin-4-yl)methanone	Discovery agent	.	.
DNC003138	1-(2,2'-bithiophen-5-yl)methanamine	Discovery agent	.	.
DNC003139	N-[4-(benzyloxy)phenyl]glycinamide	Discovery agent	.	.
DNC003140	4-amino-N-[4-(benzyloxy)phenyl]butanamide	Discovery agent	.	.
DNC003141	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	Discovery agent	.	.
DNC003142	1-(4-thiophen-2-ylphenyl)methanamine	Discovery agent	.	.
DNC003143	N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline	Discovery agent	.	.
DNC003144	4-(2-amino-1,3-thiazol-4-yl)phenol	Discovery agent	.	.
DNC003145	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	Discovery agent	.	.
DNC003146	Aspartate Semialdehyde	Discovery agent	.	.
DNC003147	3'-Oxo-Adenosine	Discovery agent	.	.
DNC003148	D-Eritadenine	Discovery agent	.	.
DNC003149	Adenosine Monotungstate	Discovery agent	.	.
DNC003150	Fructose	Discovery agent	.	.
DNC003150	Fructose	Emesis	787	R11
DNC003151	Ado-P-Ch2-P-Ps-Ado	Discovery agent	.	.
DNC003152	Diethylphosphono Group	Discovery agent	.	.
DNC003153	Carbaphosphonate	Discovery agent	.	.
DNC003154	6-Deoxy-Alpha-D-Glucose	Discovery agent	.	.
DNC003155	Hemi-Babim	Discovery agent	.	.
DNC003156	CRA_1144	Discovery agent	.	.
DNC003157	Dephospho Coenzyme A	Discovery agent	.	.
DNC003158	4'-Phosphopantetheine	Discovery agent	.	.
DNC003159	Diclosan	Discovery agent	.	.
DNC003160	Fexaramine	Discovery agent	.	.
DNC003161	Methionine Sulfoxide	Discovery agent	.	.
DNC003162	Guanosine-5',3'-Tetraphosphate	Discovery agent	.	.
DNC003163	Phosphomethylphosphonic Acid Guanylate Ester	Discovery agent	.	.
DNC003164	5-Formyl-6-Hydrofolic Acid	Discovery agent	.	.
DNC003165	Monastrol	Discovery agent	.	.
DNC003166	4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	Discovery agent	.	.
DNC003167	(R)-Mevalonate	Discovery agent	.	.
DNC003168	Ge2270a	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC003168	Ge2270a	Discovery agent	.	.
DNC003169	Uridine-5'-Diphosphate-Mannose	Discovery agent	.	.
DNC003170	Phenyl-Uridine-5'-Diphosphate	Discovery agent	.	.
DNC003171	3-Amino-5-Phenylpentane	Discovery agent	.	.
DNC003172	Cobalt Hexammine Ion	Discovery agent	.	.
DNC003173	4-(Acetylamino)-3-Guanidinobenzoic Acid	Discovery agent	.	.
DNC003174	Bromo-WR99210	Discovery agent	.	.
DNC003175	Aconitate Ion	Discovery agent	.	.
DNC003176	Monoisopropyl Ester Phosphonic Acid Group	Discovery agent	.	.
DNC003177	Thymine	Discovery agent	.	.
DNC003178	Pterin-6-Yl-Methyl-Monophosphate	Discovery agent	.	.
DNC003179	Malate Like Intermediate	Discovery agent	.	.
DNC003180	Citraconic acid	Discovery agent	.	.
DNC003181	Indole Naphthyridinone	Discovery agent	.	.
DNC003182	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Discovery agent	.	.
DNC003183	Dihydrofolic Acid	Discovery agent	.	.
DNC003184	5,10-Dideazatetrahydrofolic Acid	Discovery agent	.	.
DNC003185	Cyclic Adenosine Monophosphate	Discovery agent	.	.
DNC003186	Cyclic Guanosine Monophosphate	Discovery agent	.	.
DNC003187	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	Discovery agent	.	.
DNC003188	BIPHENYL-4-YL-ACETALDEHYDE	Discovery agent	.	.
DNC003189	1-Hydroxy-1-Thio-Glycerol	Discovery agent	.	.
DNC003190	Z-Pro-Prolinal	Discovery agent	.	.
DNC003191	Monothioglycerol	Discovery agent	.	.
DNC003192	9-N-Phenylmethylamino-Tacrine	Discovery agent	.	.
DNC003193	Butyrylthiocholine	Discovery agent	.	.
DNC003194	DODECANESULFONATE ION	Discovery agent	.	.
DNC003195	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	Discovery agent	.	.
DNC003196	(1R)-MENTHYL HEXYL PHOSPHONATE GROUP	Discovery agent	.	.
DNC003197	(1S)-MENTHYL HEXYL PHOSPHONATE GROUP	Discovery agent	.	.
DNC003198	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	Discovery agent	.	.
DNC003199	Methoxy arachidonyl fluorophosphonate	Discovery agent	.	.
DNC003200	1-DODECANOL	Discovery agent	.	.
DNC003201	Isatin	Discovery agent	.	.
DNC003202	N-Methyl-N-Propargyl-1(R)-Aminoindan	Discovery agent	.	.
DNC003203	Farnesol	Discovery agent	.	.
DNC003204	[(1e)-4-Phenylbut-1-Enyl]Benzene	Discovery agent	.	.
DNC003205	N-Propargyl-1(S)-Aminoindan	Discovery agent	.	.
DNC003206	5-Hydroxy-N-Propargyl-1(R)-Aminoindan	Discovery agent	.	.
DNC003207	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	Discovery agent	.	.
DNC003208	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	Discovery agent	.	.
DNC003209	DECYL(DIMETHYL)PHOSPHINE OXIDE	Discovery agent	.	.
DNC003210	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	Discovery agent	.	.
DNC003211	Dioxothiomolybdenum(VI) ion	Discovery agent	.	.
DNC003212	Y-700	Discovery agent	.	.
DNC003212	Y-700	Gout	.	M10
DNC003213	FR221647	Discovery agent	.	.
DNC003214	6-Hydroxy-7,8-Dihydro Purine Nucleoside	Discovery agent	.	.
DNC003215	FR117016	Discovery agent	.	.
DNC003216	FR236913	Discovery agent	.	.
DNC003217	6-Hydroxy-1,6-Dihydro Purine Nucleoside	Discovery agent	.	.
DNC003218	FR233623	Discovery agent	.	.
DNC003219	FR239087	Discovery agent	.	.
DNC003220	FR230513	Discovery agent	.	.
DNC003221	1-Deaza-Adenosine	Discovery agent	.	.
DNC003222	Purine Riboside	Discovery agent	.	.
DNC003223	(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol	Discovery agent	.	.
DNC003224	6-O-Phosphoryl Inosine Monophosphate	Discovery agent	.	.
DNC003225	Guanosine-5'-Monophosphate	Discovery agent	.	.
DNC003226	FARNESYL DIPHOSPHATE	Discovery agent	.	.
DNC003227	GERANYLGERANYL DIPHOSPHATE	Discovery agent	.	.
DNC003228	5-phenyl-1H-indazol-3-amine	Discovery agent	.	.
DNC003229	METOPRINE, METHODICHLOROPHEN	Discovery agent	.	.
DNC003230	N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE	Discovery agent	.	.
DNC003231	4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE	Discovery agent	.	.
DNC003232	N-Acetylmethionine	Discovery agent	.	.
DNC003233	2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE	Discovery agent	.	.
DNC003234	HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE	Discovery agent	.	.
DNC003235	Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam	Discovery agent	.	.
DNC003236	2-Thioethenamine	Discovery agent	.	.
DNC003237	2,3-Didehydroalanine	Discovery agent	.	.
DNC003238	(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE	Discovery agent	.	.
DNC003239	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	Discovery agent	.	.
DNC003240	2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE	Discovery agent	.	.
DNC003241	6-Methylamino-5-Nitroisocytosine	Discovery agent	.	.
DNC003242	Pteroic Acid	Discovery agent	.	.
DNC003243	2'-deoxyuridine 5'-alpha,beta-imido-diphosphate	Discovery agent	.	.
DNC003244	FARNESYL THIOPYROPHOSPHATE	Discovery agent	.	.
DNC003245	NITROCEFIN	Discovery agent	.	.
DNC003246	Adenosine-5-Diphosphoribose	Discovery agent	.	.
DNC003247	BVDU-MP	Discovery agent	.	.
DNC003248	Myxopyronin B	Discovery agent	.	.
DNC003249	Tagetitoxin	Discovery agent	.	.
DNC003250	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	Discovery agent	.	.
DNC003251	2-(cyclohexylamino)benzoic acid	Discovery agent	.	.
DNC003252	N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE	Discovery agent	.	.
DNC003253	3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE	Discovery agent	.	.
DNC003254	6-MORPHOLIN-4-YL-9H-PURINE	Discovery agent	.	.
DNC003255	Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate	Discovery agent	.	.
DNC003256	TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE	Discovery agent	.	.
DNC003257	S-Hydroxycysteine	Discovery agent	.	.
DNC003258	L-Tyrosinamide	Discovery agent	.	.
DNC003259	Undecyl-Phosphinic Acid Butyl Ester	Discovery agent	.	.
DNC003260	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	Discovery agent	.	.
DNC003261	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	Discovery agent	.	.
DNC003262	(5BETA)-PREGNANE-3,20-DIONE	Discovery agent	.	.
DNC003263	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	Discovery agent	.	.
DNC003264	3,6,9,12,15,18-HEXAOXAICOSANE	Discovery agent	.	.
DNC003265	2-chloro-5-nitro-N-phenylbenzamide	Discovery agent	.	.
DNC003266	Dimethylformamide	Discovery agent	.	.
DNC003267	P-Anisic Acid	Discovery agent	.	.
DNC003268	5'-S-ethyl-5'-thioadenosine	Discovery agent	.	.
DNC003269	5-(2-hydroxyethyl)nonane-1,9-diol	Discovery agent	.	.
DNC003270	3,7,3',4'-TETRAHYDROXYFLAVONE	Discovery agent	.	.
DNC003271	FAMOXADONE	Discovery agent	.	.
DNC003272	1,3-DIPHENYLUREA	Discovery agent	.	.
DNC003273	Heptanoic Acid	Discovery agent	.	.
DNC003274	Pyruvoyl Group	Discovery agent	.	.
DNC003275	UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE	Discovery agent	.	.
DNC003276	2,3-DIMETHYL-1,4-NAPHTHOQUINONE	Discovery agent	.	.
DNC003277	2-tert-butylbenzene-1,4-diol	Discovery agent	.	.
DNC003278	5'-Guanosine-Diphosphate-Monothiophosphate	Discovery agent	.	.
DNC003279	Diphthamide	Discovery agent	.	.
DNC003280	N-BENZOYL-D-ALANINE	Discovery agent	.	.
DNC003281	D-Gluconhydroximo-1,5-Lactam	Discovery agent	.	.
DNC003282	Gluconolactone	Discovery agent	.	.
DNC003283	ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	Discovery agent	.	.
DNC003284	4-Hydroxy-Aconitate Ion	Discovery agent	.	.
DNC003285	Alpha-Methylisocitric Acid	Discovery agent	.	.
DNC003286	Tricarballylic Acid	Discovery agent	.	.
DNC003287	Monoisopropylphosphorylserine	Discovery agent	.	.
DNC003288	Cholesterol-Sulfate	Discovery agent	.	.
DNC003289	Cholesterol	Discovery agent	.	.
DNC003290	Olomoucine	Discovery agent	.	.
DNC003291	Hymenialdisine	Discovery agent	.	.
DNC003292	SU9516	Discovery agent	.	.
DNC003293	Purvalanol	Discovery agent	.	.
DNC003294	Metiamide	Discovery agent	.	.
DNC003295	Delta1-dihydrotestosterone	Discovery agent	.	.
DNC003296	Boldenone	Discovery agent	.	.
DNC003297	HYDROXYFASUDIL	Discovery agent	.	.
DNC003298	Etorphine	Discovery agent	.	.
DNC003299	Dihydromorphine	Discovery agent	.	.
DNC003300	Resveratrol	Diabetes mellitus type 2	.	E11
DNC003300	Resveratrol	Discovery agent	.	.
DNC003301	1-Guanidinium-7-Aminoheptane	Discovery agent	.	.
DNC003303	Nimesulide	Discovery agent	.	.
DNC003304	Thiorphan	Discovery agent	.	.
DNC003305	Phosphoramidon	Discovery agent	.	.
DNC003306	Enalkiren	Discovery agent	.	.
DNC003307	GENTAMICIN C1A	Discovery agent	.	.
DNC003308	Dazoxiben	Discovery agent	.	.
DNC003309	ONO-6818	Discovery agent	.	.
DNC003310	Canaline	Discovery agent	.	.
DNC003311	MMDA	Discovery agent	.	.
DNC003312	Sti-571	Discovery agent	.	.
DNC003313	Hirulog	Discovery agent	.	.
DNC003314	(S)-Rolipram	Discovery agent	.	.
DNC003315	(R)-Rolipram	Discovery agent	.	.
DNC003316	4-Methoxyamphetamine	Discovery agent	.	.
DNC003317	Piretanide	Congestive heart failure	428	I50
DNC003317	Piretanide	Discovery agent	.	.
DNC003318	Mevastatin	Discovery agent	.	.
DNC003319	4-Androstenedione	Discovery agent	.	.
DNC003320	Aminoguanidine	Discovery agent	.	.
DNC003321	Fidarestat	Choroidal neovascularization	.	H35
DNC003321	Fidarestat	Discovery agent	.	.
DNC003322	Tolrestat	Discovery agent	.	.
DNC003323	Sorbinil	Discovery agent	.	.
DNC003324	3,4-Methylenedioxymethamphetamine	Discovery agent	.	.
DNC003325	3-Methylthiofentanyl	Discovery agent	.	.
DNC003326	Dimethylthiambutene	Discovery agent	.	.
DNC003327	Ethylmorphine	Discovery agent	.	.
DNC003328	Carfentanil	Discovery agent	.	.
DNC003329	3-Methylfentanyl	Discovery agent	.	.
DNC003330	Phenylmercury	Discovery agent	.	.
DNC003331	2-Phosphoglycolic Acid	Discovery agent	.	.
DNC003332	4-Carboxycinnamic Acid	Discovery agent	.	.
DNC003333	2-[(2-methoxy-5-methylphenoxy)methyl]pyridine	Discovery agent	.	.
DNC003334	4-[(5-methoxy-2-methylphenoxy)methyl]pyridine	Discovery agent	.	.
DNC003335	SEBACIC ACID	Discovery agent	.	.
DNC003336	2,6-DICARBOXYNAPHTHALENE	Discovery agent	.	.
DNC003337	1,3,5-BENZENETRICARBOXYLIC ACID	Discovery agent	.	.
DNC003338	Thenoyltrifluoroacetone	Discovery agent	.	.
DNC003339	Equilin	Discovery agent	.	.
DNC003340	EM-1745	Discovery agent	.	.
DNC003341	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	Discovery agent	.	.
DNC003342	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	Discovery agent	.	.
DNC003343	3-(5-methoxy-1H-indol-3-yl)propanoic acid	Discovery agent	.	.
DNC003344	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	Discovery agent	.	.
DNC003345	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	Discovery agent	.	.
DNC003346	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	Discovery agent	.	.
DNC003347	CB1954	Cancer	.	C00-C97
DNC003347	CB1954	Discovery agent	.	.
DNC003348	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	Discovery agent	.	.
DNC003349	5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC003350	PARA-(BENZOYL)-PHENYLALANINE	Discovery agent	.	.
DNC003351	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	Discovery agent	.	.
DNC003352	3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID	Discovery agent	.	.
DNC003353	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	Discovery agent	.	.
DNC003354	S-2-(Boronoethyl)-L-Cysteine	Discovery agent	.	.
DNC003355	4-Flourobenzenesulfonamide	Discovery agent	.	.
DNC003356	4-(Hydroxymercury)Benzoic Acid	Discovery agent	.	.
DNC003357	N-Benzyl-4-Sulfamoyl-Benzamide	Discovery agent	.	.
DNC003358	AL5424	Discovery agent	.	.
DNC003359	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	Discovery agent	.	.
DNC003360	3,5-Difluorobenzenesulfonamide	Discovery agent	.	.
DNC003361	Al7089a	Discovery agent	.	.
DNC003362	AL7182	Discovery agent	.	.
DNC003363	Cyanamide	Discovery agent	.	.
DNC003364	Dansylamide	Discovery agent	.	.
DNC003365	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	Discovery agent	.	.
DNC003366	AL7099A	Discovery agent	.	.
DNC003367	2,6-Difluorobenzenesulfonamide	Discovery agent	.	.
DNC003368	4-Methylimidazole	Discovery agent	.	.
DNC003369	AL5927	Discovery agent	.	.
DNC003370	1,2,4-Triazole	Discovery agent	.	.
DNC003371	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	Discovery agent	.	.
DNC003372	4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	Discovery agent	.	.
DNC003373	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	Discovery agent	.	.
DNC003374	AL4623	Discovery agent	.	.
DNC003375	Mercuribenzoic Acid	Discovery agent	.	.
DNC003376	AL5300	Discovery agent	.	.
DNC003377	3-Mercuri-4-Aminobenzenesulfonamide	Discovery agent	.	.
DNC003378	AL6528	Discovery agent	.	.
DNC003379	N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE	Discovery agent	.	.
DNC003380	6-ethoxy-1,3-benzothiazole-2-sulfonamide	Discovery agent	.	.
DNC003381	N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE	Discovery agent	.	.
DNC003382	4,5-DICHLOROBENZENE-1,3-DISULFONAMIDE	Discovery agent	.	.
DNC003383	Indane-5-sulfonamide	Discovery agent	.	.
DNC003384	SULTHIAME	Discovery agent	.	.
DNC003385	4-(2-AMINOETHYL)BENZENESULFONAMIDE	Discovery agent	.	.
DNC003386	Diminazene	Discovery agent	.	.
DNC003387	Glycerol	Discovery agent	.	.
DNC003388	3r-Hydroxydecanoyl-Coa	Discovery agent	.	.
DNC003389	Nicotinamide	Discovery agent	.	.
DNC003390	1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID	Discovery agent	.	.
DNC003391	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	Discovery agent	.	.
DNC003392	Compound 9	Discovery agent	.	.
DNC003393	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	Discovery agent	.	.
DNC003394	Sp7343-Sp7964	Discovery agent	.	.
DNC003395	2-(Oxalyl-Amino)-Benzoic Acid	Discovery agent	.	.
DNC003396	Novo Nordisk a/S Compound	Discovery agent	.	.
DNC003397	PNU177836	Discovery agent	.	.
DNC003398	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	Discovery agent	.	.
DNC003399	ISOTHIAZOLIDINONE ANALOG	Discovery agent	.	.
DNC003400	1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE	Discovery agent	.	.
DNC003401	1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXYISOQUINOLINE	Discovery agent	.	.
DNC003402	METHOXYUNDECYLPHOSPHINIC ACID	Discovery agent	.	.
DNC003403	N-[O-Phosphono-Pyridoxyl]-Isoleucine	Discovery agent	.	.
DNC003404	Alpha-ketoisovalerate	Discovery agent	.	.
DNC003405	Clorobiocin	Discovery agent	.	.
DNC003406	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	Discovery agent	.	.
DNC003407	(2s)-Pyrrolidin-2-Ylmethylamine	Discovery agent	.	.
DNC003408	Iodo-Phenylalanine	Discovery agent	.	.
DNC003409	Diisopropylphosphono Group	Discovery agent	.	.
DNC003410	1-(1-phenylcyclopentyl)methylamine	Discovery agent	.	.
DNC003411	1-biphenyl-2-ylmethanamine	Discovery agent	.	.
DNC003412	O-Phosphoethanolamine	Discovery agent	.	.
DNC003413	10-CF3C(OH)2-DDACTHF	Discovery agent	.	.
DNC003414	Benzoic Acid	Discovery agent	.	.
DNC003414	Benzoic Acid	Fungal infection	.	B35-B49
DNC003415	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	Discovery agent	.	.
DNC003416	N-Cyclohexyl-N'-Decylurea	Discovery agent	.	.
DNC003417	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	Discovery agent	.	.
DNC003418	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	Discovery agent	.	.
DNC003419	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	Discovery agent	.	.
DNC003420	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	Discovery agent	.	.
DNC003421	SR12813	Arteriosclerosis	.	I70
DNC003421	SR12813	Discovery agent	.	.
DNC003422	7-Methyl-Guanosine-5'-Triphosphate	Discovery agent	.	.
DNC003423	Camptothecin	Cancer	.	C00-C97
DNC003424	MMI-175	Discovery agent	.	.
DNC003425	4-(4-FLUOROBENZYL)PIPERIDINE	Discovery agent	.	.
DNC003426	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE	Discovery agent	.	.
DNC003427	N~3~-BENZYLPYRIDINE-2,3-DIAMINE	Discovery agent	.	.
DNC003428	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE	Discovery agent	.	.
DNC003429	4-(2-aminoethyl)-2-cyclohexylphenol	Discovery agent	.	.
DNC003430	4-(2-aminoethyl)-2-ethylphenol	Discovery agent	.	.
DNC003431	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	Discovery agent	.	.
DNC003432	(11E)-OCTADEC-11-ENOIC ACID	Discovery agent	.	.
DNC003433	Dodecane-Trimethylamine	Discovery agent	.	.
DNC003434	Fructose-6-Phosphate	Discovery agent	.	.
DNC003435	Hydroxyacetic Acid	Discovery agent	.	.
DNC003436	Geldanamycin	Discovery agent	.	.
DNC003437	17-Dmag	Breast cancer	174, 175	C50
DNC003437	17-Dmag	Discovery agent	.	.
DNC003438	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	Discovery agent	.	.
DNC003439	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	Discovery agent	.	.
DNC003440	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	Discovery agent	.	.
DNC003441	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	Discovery agent	.	.
DNC003442	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	Discovery agent	.	.
DNC003443	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	Discovery agent	.	.
DNC003444	5'-Deoxy-5'-Methylthioadenosine	Discovery agent	.	.
DNC003445	7-Hydroxystaurosporine	Chronic lymphocytic leukaemia	.	C91.1
DNC003445	7-Hydroxystaurosporine	Discovery agent	.	.
DNC003446	Rbt205 Inhibitor	Discovery agent	.	.
DNC003447	Glucose-6-Phosphate	Discovery agent	.	.
DNC003448	7-Methyl-Gpppa	Discovery agent	.	.
DNC003449	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	Discovery agent	.	.
DNC003450	Glycerol-2-Phosphate	Discovery agent	.	.
DNC003451	3-Hydroxypyruvic Acid	Discovery agent	.	.
DNC003452	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	Discovery agent	.	.
DNC003453	Quercetin	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC003453	Quercetin	Discovery agent	.	.
DNC003454	Myricetin	Discovery agent	.	.
DNC003455	5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE	Discovery agent	.	.
DNC003456	2-Deoxy-2-Amino Glucitol-6-Phosphate	Discovery agent	.	.
DNC003457	Glutamine Hydroxamate	Discovery agent	.	.
DNC003458	Glucosamine 6-Phosphate	Discovery agent	.	.
DNC003459	6-Hydroxymethylpterin	Discovery agent	.	.
DNC003460	D-Myo-Inositol-1,4,5-Triphosphate	Discovery agent	.	.
DNC003461	N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)	Discovery agent	.	.
DNC003462	Carba-Nicotinamide-Adenine-Dinucleotide	Discovery agent	.	.
DNC003463	NU1025	Discovery agent	.	.
DNC003464	3-Methoxybenzamide	Discovery agent	.	.
DNC003465	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	Discovery agent	.	.
DNC003466	3,4-Dihydro-5-Methyl-Isoquinolinone	Discovery agent	.	.
DNC003467	2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide	Discovery agent	.	.
DNC003468	6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE	Discovery agent	.	.
DNC003469	N-(Phosphonacetyl)-L-Aspartic Acid	Discovery agent	.	.
DNC003470	Spermidine	Discovery agent	.	.
DNC003471	Taurocholic Acid	Discovery agent	.	.
DNC003471	Taurocholic Acid	Type 2 diabetes	250.00, 250.02	E11
DNC003472	Fotemustine	Cancer	.	C00-C97
DNC003472	Fotemustine	Discovery agent	.	.
DNC003473	Formycin B	Discovery agent	.	.
DNC003474	3,5-Dinitrocatechol	Discovery agent	.	.
DNC003475	BIA	Discovery agent	.	.
DNC003475	BIA	Non-insulin dependent diabetes	.	E11.9
DNC003476	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	Discovery agent	.	.
DNC003477	7,8-dihydroxy-4-phenyl-2H-chromen-2-one	Discovery agent	.	.
DNC003478	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID	Discovery agent	.	.
DNC003479	13-Acetylphorbol	Discovery agent	.	.
DNC003480	Icrf-187	Discovery agent	.	.
DNC003481	3'-THIO-THYMIDINE-5'-PHOSPHATE	Discovery agent	.	.
DNC003482	2,5-Anhydroglucitol-1,6-Biphosphate	Discovery agent	.	.
DNC003483	Mdl-29951	Discovery agent	.	.
DNC003484	7-Hydroxy-Pyrazolo[4,3-D]Pyrimidine	Discovery agent	.	.
DNC003485	4-Piperidino-Piperidine	Discovery agent	.	.
DNC003486	N-Methylnaloxonium	Discovery agent	.	.
DNC003487	Deoxy-Bigchap	Discovery agent	.	.
DNC003488	Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate	Discovery agent	.	.
DNC003489	4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID	Discovery agent	.	.
DNC003490	Forskolin	Discovery agent	.	.
DNC003491	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	Discovery agent	.	.
DNC003492	Para-Isopropylaniline	Discovery agent	.	.
DNC003493	(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine	Discovery agent	.	.
DNC003494	(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE	Discovery agent	.	.
DNC003495	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline	Discovery agent	.	.
DNC003496	Naphthyridine Inhibitor	Discovery agent	.	.
DNC003497	16,17-Androstene-3-Ol	Discovery agent	.	.
DNC003498	FARNESYL	Discovery agent	.	.
DNC003499	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	Discovery agent	.	.
DNC003500	Carbenoxolone	Discovery agent	.	.
DNC003501	Tenocyclidine	Discovery agent	.	.
DNC003502	Barbital	Discovery agent	.	.
DNC003503	Barbituric acid derivative	Discovery agent	.	.
DNC003504	CGS-314447	Discovery agent	.	.
DNC003505	GR-127935	Discovery agent	.	.
DNC003505	GR-127935	Major depressive disorder	296.2, 296.3	F32, F33
DNC003506	MANUMYCIN A	Discovery agent	.	.
DNC003507	L-775606	Discovery agent	.	.
DNC003508	NBQX	Discovery agent	.	.
DNC003508	NBQX	Neurological disease	.	G00-G99
DNC003509	8-benzyl-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003510	FR-73966	Discovery agent	.	.
DNC003511	PIRITREXIM	Bladder cancer	.	C67
DNC003511	PIRITREXIM	Discovery agent	.	.
DNC003512	LY-294002	Discovery agent	.	.
DNC003513	(4-Phenoxy-phenyl)-quinazolin-4-yl-amine	Discovery agent	.	.
DNC003514	2-(trifluoromethyl)benzaldehyde thiosemicarbazone	Discovery agent	.	.
DNC003515	Ro-151310	Discovery agent	.	.
DNC003516	Ro-154513	Discovery agent	.	.
DNC003517	8-(3,4-dichlorophenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003518	8-(2,3,4-trimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003519	FR-230481	Discovery agent	.	.
DNC003520	FR-226928	Discovery agent	.	.
DNC003521	5-(4-bromophenyl)-2-furaldehyde thiosemicarbazone	Discovery agent	.	.
DNC003522	8-(3,4-dimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003523	1,2-NAPHTHOQUINONE	Discovery agent	.	.
DNC003524	L-655708	Discovery agent	.	.
DNC003525	2-methoxy-1-naphthaldehyde thiosemicarbazone	Discovery agent	.	.
DNC003526	8-(2,6-Dichloro-phenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003527	4-(4-Benzyl-piperazin-1-yl)-1H-benzoimidazole	Discovery agent	.	.
DNC003528	SCH-44342	Discovery agent	.	.
DNC003529	8-(2,4-dimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003530	3-(4-Benzyl-piperazin-1-yl)-phenol	Discovery agent	.	.
DNC003531	4-(4-Benzyl-piperazin-1-yl)-1H-indole	Discovery agent	.	.
DNC003532	SB-224289	Discovery agent	.	.
DNC003533	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide	Discovery agent	.	.
DNC003534	LY-293559	Discovery agent	.	.
DNC003535	3-(trifluoromethyl)benzaldehyde thiosemicarbazone	Discovery agent	.	.
DNC003536	3,5-dichlorobenzaldehyde thiosemicarbazone	Discovery agent	.	.
DNC003537	3,4-dichlorobenzaldehyde thiosemicarbazone	Discovery agent	.	.
DNC003538	FR-233118	Discovery agent	.	.
DNC003539	4-(4-Benzyl-piperazin-1-yl)-7-bromo-1H-indole	Discovery agent	.	.
DNC003540	CGS-15943	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC003540	CGS-15943	Discovery agent	.	.
DNC003541	8-(3,5-dimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003542	CGS-26303	Discovery agent	.	.
DNC003543	4-(4-Benzyl-piperazin-1-yl)-5-chloro-1H-indole	Discovery agent	.	.
DNC003544	RY-066	Discovery agent	.	.
DNC003545	8-Pyridin-4-yl-9H-purine-2,6-diamine	Discovery agent	.	.
DNC003546	DMP-757	Discovery agent	.	.
DNC003547	(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid	Discovery agent	.	.
DNC003548	Disulergine	Discovery agent	.	.
DNC003549	SB-258719	Discovery agent	.	.
DNC003550	GR-133686	Discovery agent	.	.
DNC003551	Tetrahydro-pyrimidin-2-ylideneamine	Discovery agent	.	.
DNC003552	(S)-2-Amino-6-[(E)-ethylimino]-hexanoic acid	Discovery agent	.	.
DNC003553	SEROTONIN	Discovery agent	.	.
DNC003554	QUIPAZINE	Discovery agent	.	.
DNC003555	N-[3-(2-Ethyl-benzooxazol-7-yl)-propyl]-acetamide	Discovery agent	.	.
DNC003556	CGS-27023A	Discovery agent	.	.
DNC003557	Azocan-(2Z)-ylideneamine	Discovery agent	.	.
DNC003558	METHIOTHEPIN	Discovery agent	.	.
DNC003559	Doxorubicin-Formaldehyde Conjugate	Discovery agent	.	.
DNC003560	L-652731	Discovery agent	.	.
DNC003561	Piperidin-(2E)-ylideneamine	Discovery agent	.	.
DNC003562	ZACOPRIDE	Anxiety disorder	.	F40-F42
DNC003562	ZACOPRIDE	Discovery agent	.	.
DNC003563	2-(4-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol	Discovery agent	.	.
DNC003564	SC-58451	Discovery agent	.	.
DNC003565	HEPTYPHYSOSTIGMINE	Discovery agent	.	.
DNC003566	9-Ethyl-8-phenylethynyl-9H-purin-6-ylamine	Discovery agent	.	.
DNC003567	CB-3717	Discovery agent	.	.
DNC003568	Ro-63-0563	Discovery agent	.	.
DNC003569	CC-1088	Crohn's disease	.	K50
DNC003569	CC-1088	Discovery agent	.	.
DNC003570	N-(3-Benzooxazol-7-yl-propyl)-butyramide	Discovery agent	.	.
DNC003571	Azepan-(2Z)-ylideneamine	Discovery agent	.	.
DNC003572	[1,3]Oxazinan-(2E)-ylideneamine	Discovery agent	.	.
DNC003573	PREMETREXED	Discovery agent	.	.
DNC003574	CIPEMASTAT	Discovery agent	.	.
DNC003574	CIPEMASTAT	Rheumatold arthritis	.	M05-M06
DNC003575	ABIRATERONE	Discovery agent	.	.
DNC003575	ABIRATERONE	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
DNC003576	2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol	Discovery agent	.	.
DNC003577	3-(2-Amino-ethyl)-2-methyl-1H-indol-5-ol	Discovery agent	.	.
DNC003578	2-Amino-5-(N-nitro-guanidino)-pentanoic acid	Discovery agent	.	.
DNC003579	1-Naphthalen-1-yl-piperazine	Discovery agent	.	.
DNC003580	NECA	Discovery agent	.	.
DNC003581	L-778123	Discovery agent	.	.
DNC003581	L-778123	Lymphoma	.	C81-C96
DNC003582	N-(3-Benzooxazol-7-yl-propyl)-acetamide	Discovery agent	.	.
DNC003583	Azonan-(2Z)-ylideneamine	Discovery agent	.	.
DNC003584	CHLOROPHENYLPIPERAZINE	Discovery agent	.	.
DNC003585	SB-269970	Discovery agent	.	.
DNC003585	SB-269970	Sleep disorders	307.4, 327, 780.5	F51, G47
DNC003586	SB-258741	Discovery agent	.	.
DNC003587	L-659989	Discovery agent	.	.
DNC003588	[1,3]Thiazinan-(2E)-ylideneamine	Discovery agent	.	.
DNC003589	BMS-214662	Discovery agent	.	.
DNC003590	SB-656104	Discovery agent	.	.
DNC003591	SPIPERONE	Discovery agent	.	.
DNC003592	SB-357134	Discovery agent	.	.
DNC003593	ROLIPRAM	Discovery agent	.	.
DNC003594	N-(3-Benzooxazol-7-yl-propyl)-propionamide	Discovery agent	.	.
DNC003595	L-680573	Discovery agent	.	.
DNC003596	3-Phenylsulfanylmethyl-quinoxaline-5,7-diamine	Discovery agent	.	.
DNC003597	Ro-04-6790	Discovery agent	.	.
DNC003598	4-(3-Methyl-indole-1-sulfonyl)-phenylamine	Discovery agent	.	.
DNC003599	VERAGUENSIN	Discovery agent	.	.
DNC003600	KYS-05042	Discovery agent	.	.
DNC003601	2-(phosphonomethyl)pentanedioic acid	Discovery agent	.	.
DNC003602	2-Hydroxycarbamoylmethyl-pentanedioic acid	Discovery agent	.	.
DNC003603	3-(1H-Indol-2-yl)-1H-quinolin-2-one	Discovery agent	.	.
DNC003604	AR-HO29953XX	Discovery agent	.	.
DNC003605	KYS-05001	Discovery agent	.	.
DNC003606	2-(3-Hydroxycarbamoyl-propyl)-pentanedioic acid	Discovery agent	.	.
DNC003607	3-Benzenesulfinyl-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC003608	KYS-05040	Discovery agent	.	.
DNC003609	2-Hydroxycarbamoyl-pentanedioic acid	Discovery agent	.	.
DNC003610	2-(2-Hydroxycarbamoyl-ethyl)-pentanedioic acid	Discovery agent	.	.
DNC003611	BOHEMINE	Discovery agent	.	.
DNC003612	6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one	Discovery agent	.	.
DNC003613	3-Benzenesulfonyl-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC003614	18-Methylaminocoronaridine	Discovery agent	.	.
DNC003615	2-Methoxyethyl 18-methoxycoronaridinate	Discovery agent	.	.
DNC003616	PNU-95666E	Discovery agent	.	.
DNC003617	(H-261)Boc-His-Pro-Phe-His-Leu(OH)-Val-Ile-His-OH	Discovery agent	.	.
DNC003618	2-(3-Mercapto-propyl)-pentanedioic acid	Discovery agent	.	.
DNC003619	18-methoxycoronaridinate 2-methoxyethylamide	Discovery agent	.	.
DNC003620	KYS-05041	Discovery agent	.	.
DNC003621	15-nor-18-Methoxycornaridine	Discovery agent	.	.
DNC003622	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC003623	2-Hydroxyethyl 18-methoxycoronaridinate	Discovery agent	.	.
DNC003624	SK-683	Discovery agent	.	.
DNC003625	5,6-Bis-p-tolylamino-isoindole-1,3-dione	Discovery agent	.	.
DNC003626	3-Benzimidazol-2-ylhydroquinolin-2-one	Discovery agent	.	.
DNC003627	18-Dimethylaminocoronaridine	Discovery agent	.	.
DNC003628	XR-5118	Cancer	.	C00-C97
DNC003628	XR-5118	Discovery agent	.	.
DNC003629	FK-633	Discovery agent	.	.
DNC003629	FK-633	Restenosis	.	I51.89
DNC003630	(S)-2-Amino-1-thiazolidin-3-yl-propane-1-thione	Discovery agent	.	.
DNC003631	N,N-Dimethylaminoethyl 18-methoxycoronaridinate	Discovery agent	.	.
DNC003632	UK-356618	Discovery agent	.	.
DNC003633	1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole	Discovery agent	.	.
DNC003634	EMATE	Discovery agent	.	.
DNC003635	3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine	Discovery agent	.	.
DNC003636	Benzyl-(9-isopropyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC003637	2-Acetylaminoethyl 18-methoxycoronaridinate	Discovery agent	.	.
DNC003638	CGP-53353	Discovery agent	.	.
DNC003639	18-methoxycoronaridinate 2-Hydroxyethylamide	Discovery agent	.	.
DNC003640	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	Discovery agent	.	.
DNC003641	L-791943	Discovery agent	.	.
DNC003642	6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003643	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one	Discovery agent	.	.
DNC003644	8-Phenyl-1-propyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC003645	Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu	Discovery agent	.	.
DNC003646	6-Benzyloxy-9H-purin-2-ylamine	Discovery agent	.	.
DNC003647	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide	Discovery agent	.	.
DNC003648	5-Methylsulfanyl-thiophene-2-carboxamidine	Discovery agent	.	.
DNC003649	Glu-Pro-Gln-F2Pmp-Glu-Glu-Ile-Pro-Ile-Tyr-Leu	Discovery agent	.	.
DNC003650	ZOPOLRESTAT	Diabetic complication	.	E08-E13
DNC003650	ZOPOLRESTAT	Discovery agent	.	.
DNC003651	8-PHENYL THEOPHYLLINE	Discovery agent	.	.
DNC003652	(-)-3-(1-Propyl-piperidin-3-yl)-benzonitrile	Discovery agent	.	.
DNC003653	(+)-3-(1-Propyl-piperidin-3-yl)-phenol	Discovery agent	.	.
DNC003654	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	Discovery agent	.	.
DNC003655	N-(6-Hydroxycarbamoyl-hexyl)-benzamide	Discovery agent	.	.
DNC003656	Dequalinium Analogue	Discovery agent	.	.
DNC003657	SB-271046	Discovery agent	.	.
DNC003658	2-amidino-4-iodobenzothiophene	Discovery agent	.	.
DNC003659	Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	Discovery agent	.	.
DNC003660	Dequalinium Analogue	Discovery agent	.	.
DNC003661	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one	Discovery agent	.	.
DNC003662	6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003663	6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003664	1-Butyl-8-phenyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC003665	CDP840	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC003665	CDP840	Discovery agent	.	.
DNC003666	2-(4-Hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC003667	6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003668	Rogletimide	Breast cancer	.	C50
DNC003668	Rogletimide	Discovery agent	.	.
DNC003669	SC-795	Discovery agent	.	.
DNC003670	UH-232	Discovery agent	.	.
DNC003671	6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003672	6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003673	PSAMMAPLIN A	Discovery agent	.	.
DNC003674	Dequalinium Analogue	Discovery agent	.	.
DNC003675	6-Benzenesulfonyl-2H-pyridazin-3-one	Discovery agent	.	.
DNC003676	Dequalinium Analogue	Discovery agent	.	.
DNC003677	6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003678	L-696418	Discovery agent	.	.
DNC003679	6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC003680	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one	Discovery agent	.	.
DNC003681	AL-43	Discovery agent	.	.
DNC003682	4-Benzo[b]thiophen-4-yl-1H-imidazole	Discovery agent	.	.
DNC003683	LY-292728	Discovery agent	.	.
DNC003684	L-760790	Discovery agent	.	.
DNC003685	L-747201	Discovery agent	.	.
DNC003686	BALANOL	Discovery agent	.	.
DNC003687	1-(2-Oxo-2-p-tolyl-ethyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC003688	4-(3-Phenoxy-propyl)-1H-imidazole	Discovery agent	.	.
DNC003689	LY-282210	Discovery agent	.	.
DNC003690	IODOPROXYFAN	Discovery agent	.	.
DNC003691	5-(4-Methoxy-phenyl)-1-phenyl-1H-benzoimidazole	Discovery agent	.	.
DNC003692	BOSENTAN SODIUM	Discovery agent	.	.
DNC003693	3'-Methoxy-4'Hydroxyclomiphene	Discovery agent	.	.
DNC003694	DINOPROST	Abortion	779.6	O04
DNC003694	DINOPROST	Discovery agent	.	.
DNC003695	4-(4-Phenyl-butyl)-1H-imidazole	Discovery agent	.	.
DNC003696	ZK-230211	Discovery agent	.	.
DNC003697	L-741604	Discovery agent	.	.
DNC003698	4-[3-(4-Methoxy-phenoxy)-propyl]-1H-imidazole	Discovery agent	.	.
DNC003699	SKF-106760	Discovery agent	.	.
DNC003699	SKF-106760	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DNC003700	1-(3,3-Dimethyl-2-oxo-butyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC003701	L-708568	Discovery agent	.	.
DNC003702	5-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Discovery agent	.	.
DNC003703	VER-3323	Discovery agent	.	.
DNC003704	FUTOENONE	Discovery agent	.	.
DNC003705	Ro-60-0175	Discovery agent	.	.
DNC003706	8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Discovery agent	.	.
DNC003707	BMS-182874	Discovery agent	.	.
DNC003707	BMS-182874	Hypertension	401	I10, I11, I12, I13, I15
DNC003708	5-Phenethyl-quinazoline-2,4-diamine	Discovery agent	.	.
DNC003709	PD-167341	Discovery agent	.	.
DNC003710	PD-151307	Discovery agent	.	.
DNC003711	VELNACRINE	Cognitive impairment	.	F06.7
DNC003711	VELNACRINE	Discovery agent	.	.
DNC003712	5-((E)-Styryl)-quinazoline-2,4-diamine	Discovery agent	.	.
DNC003713	VER-5593	Discovery agent	.	.
DNC003714	ILOMASTAT	Discovery agent	.	.
DNC003715	6-chlorotacrine hydrochloride	Discovery agent	.	.
DNC003716	VER-5384	Discovery agent	.	.
DNC003717	SC-44463	Discovery agent	.	.
DNC003718	ICI-200880	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC003718	ICI-200880	Discovery agent	.	.
DNC003719	L-732138	Discovery agent	.	.
DNC003720	Ac-His-DPhe-Arg-Trp-NH2	Discovery agent	.	.
DNC003721	CP-339818	Discovery agent	.	.
DNC003722	CP-96345	Discovery agent	.	.
DNC003723	ABT-839	Discovery agent	.	.
DNC003723	ABT-839	Non-small cell lung cancer	.	C33-C34
DNC003724	7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Discovery agent	.	.
DNC003725	MDL-18962	Discovery agent	.	.
DNC003726	SB-203580	Discovery agent	.	.
DNC003727	ONAPRISTONE	Contraception	.	Z30
DNC003727	ONAPRISTONE	Discovery agent	.	.
DNC003728	IK-682	Discovery agent	.	.
DNC003729	CP-394531	Discovery agent	.	.
DNC003730	4-Sulfamoyloxy-benzoic acid hexyl ester	Discovery agent	.	.
DNC003731	4-Sulfamoyloxy-benzoic acid propyl ester	Discovery agent	.	.
DNC003732	COUMATE	Breast cancer	.	C50
DNC003732	COUMATE	Discovery agent	.	.
DNC003733	A-119637	Discovery agent	.	.
DNC003734	BELFOSDIL	Angina	.	I20
DNC003734	BELFOSDIL	Discovery agent	.	.
DNC003735	4-Sulfamoyloxy-benzoic acid cyclooctyl ester	Discovery agent	.	.
DNC003736	ONO-1581	Discovery agent	.	.
DNC003737	CGS-13080	Asthma	.	J45
DNC003737	CGS-13080	Discovery agent	.	.
DNC003738	2-Phenyl-3-pyridin-4-ylmethylene-chroman-4-one	Discovery agent	.	.
DNC003739	2-(5-Nonyloxy-1H-indol-3-yl)-ethylamine	Discovery agent	.	.
DNC003740	4-Sulfamoyloxy-benzoic acid octyl ester	Discovery agent	.	.
DNC003741	4-Sulfamoyloxy-benzoic acid cyclopentyl ester	Discovery agent	.	.
DNC003742	4-Sulfamoyloxy-benzoic acid cyclohexyl ester	Discovery agent	.	.
DNC003743	L-745337	Asthma	.	J45
DNC003743	L-745337	Discovery agent	.	.
DNC003744	(+/-)-7-methoxy-2-phenylchroman-4-one	Discovery agent	.	.
DNC003745	Pro-His-Pro-Phe-His-Leu(CH2NH)Val-Ile-His-Lys	Discovery agent	.	.
DNC003746	1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC003747	4-Sulfamoyloxy-benzoic acid pentyl ester	Discovery agent	.	.
DNC003748	CP-409069	Discovery agent	.	.
DNC003749	CP-105696	Discovery agent	.	.
DNC003749	CP-105696	Inflammatory bowel disease	.	K50,K51
DNC003750	2-Phenyl-3-pyridin-4-ylmethylene-chroman-4-one	Discovery agent	.	.
DNC003751	4-Sulfamoyloxy-benzoic acid butyl ester	Discovery agent	.	.
DNC003752	4-Sulfamoyloxy-benzoic acid heptyl ester	Discovery agent	.	.
DNC003753	BMY-7378	Discovery agent	.	.
DNC003754	RU-43044	Discovery agent	.	.
DNC003755	RWJ-68354	Discovery agent	.	.
DNC003756	(3S,4R)-3-Benzyl-7-isopropyl-chroman-4-ol	Discovery agent	.	.
DNC003757	EMATE	Discovery agent	.	.
DNC003758	CGS-22652	Angina	.	I20
DNC003758	CGS-22652	Discovery agent	.	.
DNC003759	4-Sulfamoyloxy-benzoic acid nonyl ester	Discovery agent	.	.
DNC003760	4-Sulfamoyloxy-benzoic acid cycloheptyl ester	Discovery agent	.	.
DNC003761	PS-777621	Discovery agent	.	.
DNC003762	1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC003763	A-123189	Discovery agent	.	.
DNC003764	DENBUFYLLINE	Cognition disorders	.	F06.7
DNC003764	DENBUFYLLINE	Discovery agent	.	.
DNC003765	SNAP-8719	Discovery agent	.	.
DNC003766	LY-117018	Discovery agent	.	.
DNC003767	CGS-23885	Asthma	.	J45
DNC003767	CGS-23885	Discovery agent	.	.
DNC003768	N-Phenethyl-2-(toluene-4-sulfonylamino)-benzamide	Discovery agent	.	.
DNC003769	6,7-Dimethoxy-3-pyridin-3-yl-quinoline	Discovery agent	.	.
DNC003770	ABANOQUIL	Discovery agent	.	.
DNC003771	[2-(1H-Benzoimidazol-4-yloxy)-ethyl]-benzyl-amine	Discovery agent	.	.
DNC003772	4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid	Discovery agent	.	.
DNC003773	INDORAMIN	Discovery agent	.	.
DNC003773	INDORAMIN	Hypertension	401	I10, I11, I12, I13, I15
DNC003774	HMR-1883	Discovery agent	.	.
DNC003774	HMR-1883	Heart disease	.	I00-I52
DNC003775	TEBUFELONE	Discovery agent	.	.
DNC003775	TEBUFELONE	Pain	.	G89
DNC003776	7-Chloro-2-phenyl-[1,8]naphthyridin-4-ol	Discovery agent	.	.
DNC003777	Benzyl-[2-(1H-indazol-4-yloxy)-ethyl]-amine	Discovery agent	.	.
DNC003778	6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline	Discovery agent	.	.
DNC003779	PD-172939	Discovery agent	.	.
DNC003780	5,10-Dioxy-2-phenyl-benzo[g]pteridin-4-ylamine	Discovery agent	.	.
DNC003781	Cyclopentyl-(9-methyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC003782	7-Fluoro-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003783	6,7-Dimethoxy-3-thiophen-2-yl-quinoline	Discovery agent	.	.
DNC003784	7-Methoxy-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003785	5-Fluoro-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003786	7-Dimethylamino-2-phenyl-[1,8]naphthyridin-4-ol	Discovery agent	.	.
DNC003787	3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003788	4-(6,7-Dimethoxy-quinolin-3-yl)-phenol	Discovery agent	.	.
DNC003789	SC-57666	Discovery agent	.	.
DNC003789	SC-57666	Rheumatold arthritis	.	M05-M06
DNC003790	OROIDIN	Discovery agent	.	.
DNC003791	PD-98059	Discovery agent	.	.
DNC003792	7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline	Discovery agent	.	.
DNC003793	WB-4101	Discovery agent	.	.
DNC003794	L-363377	Acromegaly	.	E22.0
DNC003794	L-363377	Discovery agent	.	.
DNC003795	6,7-Difluoro-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003796	6,7-Dimethoxy-3-p-tolyl-quinoline	Discovery agent	.	.
DNC003797	SK&F-104078	Discovery agent	.	.
DNC003798	Benzyl-[2-(1H-indol-4-yloxy)-ethyl]-amine	Discovery agent	.	.
DNC003799	L-745870	Discovery agent	.	.
DNC003800	6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline	Discovery agent	.	.
DNC003801	6,7-Dimethoxy-3-phenylethynyl-quinoline	Discovery agent	.	.
DNC003802	3-Cyclopentyl-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003803	6-Methoxy-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003804	3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003805	4,5-Dibromo-1H-pyrrole-2-carboxylic acid amide	Discovery agent	.	.
DNC003806	6,7-Dimethoxy-3-((E)-styryl)-quinoline	Discovery agent	.	.
DNC003807	3-Pyridin-3-yl-quinoline-6,7-diol	Discovery agent	.	.
DNC003808	Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine	Discovery agent	.	.
DNC003809	5,7-Dimethoxy-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003810	DEBROMOHYMENIALDISINE	Discovery agent	.	.
DNC003811	7-Methyl-2-propyl-[1,8]naphthyridin-4-ol	Discovery agent	.	.
DNC003812	N-Benzyl-2-(toluene-4-sulfonylamino)-benzamide	Discovery agent	.	.
DNC003813	3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003814	RG-13022	Discovery agent	.	.
DNC003815	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine	Discovery agent	.	.
DNC003816	GNF-PF-2224	Discovery agent	.	.
DNC003817	ALDISIN	Discovery agent	.	.
DNC003818	7-Bromo-2-phenyl-[1,8]naphthyridin-4-ol	Discovery agent	.	.
DNC003819	3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003820	5,7-Dimethyl-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003821	PD-172938	Discovery agent	.	.
DNC003822	6,7-Dimethoxy-3-(2-methoxy-phenyl)-quinoline	Discovery agent	.	.
DNC003823	3-Benzyloxy-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003824	6,7-Dimethoxy-3-phenyl-quinoline	Discovery agent	.	.
DNC003825	SB-265123	Discovery agent	.	.
DNC003826	RPR-101511	Discovery agent	.	.
DNC003827	5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one	Discovery agent	.	.
DNC003828	3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003829	3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003830	E-4031	Cardiac arrhythmias	.	I47-I49
DNC003830	E-4031	Discovery agent	.	.
DNC003831	3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003832	3-Thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003833	3-(2-Benzylamino-ethoxy)-phenol	Discovery agent	.	.
DNC003834	3-((E)-Styryl)-quinoline	Discovery agent	.	.
DNC003835	N'-Acridin-9-yl-N,N-diethyl-butane-1,4-diamine	Discovery agent	.	.
DNC003836	3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003837	4-(2-Benzylamino-ethoxy)-1,3-dihydro-indol-2-one	Discovery agent	.	.
DNC003838	3-(1H-Indol-3-yl)-quinoline	Discovery agent	.	.
DNC003839	3-Cyclohexylethynyl-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003840	6,7-Dichloro-3-thiophen-3-yl-quinoline	Discovery agent	.	.
DNC003841	6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline	Discovery agent	.	.
DNC003842	AGN-193080	Discovery agent	.	.
DNC003843	Bexlosteride	Discovery agent	.	.
DNC003844	1-(4-cyano-2-hydroxyphenyl)-3-phenylurea	Discovery agent	.	.
DNC003845	Imidazolidin-2-ylidene-quinoxalin-6-yl-amine	Discovery agent	.	.
DNC003846	1,2,5,6-tetrahydro pyrido[1,2-a]quinolin-3-one	Discovery agent	.	.
DNC003847	MK-386	Acne vulgaris	.	L70.0
DNC003847	MK-386	Discovery agent	.	.
DNC003848	PKF-241-466	Discovery agent	.	.
DNC003849	N-(5-Bromo-quinoxalin-6-yl)-guanidine	Discovery agent	.	.
DNC003850	PS-222036	Discovery agent	.	.
DNC003851	Alpha-Hydroxy-Midazolam	Discovery agent	.	.
DNC003852	1-(2-Hydroxy-3-nitro-phenyl)-3-phenyl-urea	Discovery agent	.	.
DNC003853	AMENTOFLAVONE	Discovery agent	.	.
DNC003854	L-755507	Discovery agent	.	.
DNC003855	1-(2-hydroxy-4-nitrophenyl)-3-phenylurea	Discovery agent	.	.
DNC003856	METHYLTHIOADENOSINE	Discovery agent	.	.
DNC003856	METHYLTHIOADENOSINE	Multiple sclerosis	340	G35
DNC003857	PS-662477	Discovery agent	.	.
DNC003858	AGN-192172	Discovery agent	.	.
DNC003859	A-62176	Discovery agent	.	.
DNC003860	PKF-242-484	Discovery agent	.	.
DNC003861	PS-154636-1	Discovery agent	.	.
DNC003862	3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one	Discovery agent	.	.
DNC003863	PS-444035	Discovery agent	.	.
DNC003864	1-(2-Hydroxy-5-nitro-phenyl)-3-phenyl-urea	Discovery agent	.	.
DNC003865	PS-725074	Discovery agent	.	.
DNC003866	Imidazolidin-2-ylidene-o-tolyl-amine	Discovery agent	.	.
DNC003867	CGP-12177A	Discovery agent	.	.
DNC003868	PHENSERINE	Discovery agent	.	.
DNC003869	1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine	Discovery agent	.	.
DNC003870	4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine	Discovery agent	.	.
DNC003871	Prodipine	Discovery agent	.	.
DNC003872	1-Benzyl-4-(3-oxazol-5-yl-pyrrol-1-yl)-piperidine	Discovery agent	.	.
DNC003873	L-375378	Discovery agent	.	.
DNC003874	4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenol	Discovery agent	.	.
DNC003875	Azaphenylalanine derivative	Discovery agent	.	.
DNC003876	ELAROFIBAN	Discovery agent	.	.
DNC003876	ELAROFIBAN	Thrombosis	.	I80-I82
DNC003877	4-Methyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine	Discovery agent	.	.
DNC003878	1-Benzyl-4-(2-oxazol-5-yl-pyrrol-1-yl)-piperidine	Discovery agent	.	.
DNC003879	3-Methyl-2H-benzo[f]quinazolin-1-one	Discovery agent	.	.
DNC003880	FENOXIMONE	Discovery agent	.	.
DNC003881	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline	Discovery agent	.	.
DNC003882	Azaphenylalanine derivative	Discovery agent	.	.
DNC003883	1-Benzyl-4-pyrrol-1-yl-piperidine	Discovery agent	.	.
DNC003884	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003885	2-(4-Amino-3'-chloro-biphenyl-3-yl)-propan-2-ol	Discovery agent	.	.
DNC003886	MK-11	Discovery agent	.	.
DNC003887	Azaphenylalanine derivative	Discovery agent	.	.
DNC003888	GNF-PF-4292	Discovery agent	.	.
DNC003889	PD-153035	Discovery agent	.	.
DNC003889	PD-153035	Psoriasis	.	L40
DNC003890	LY-341495	Discovery agent	.	.
DNC003891	1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine	Discovery agent	.	.
DNC003892	GNF-PF-5411	Discovery agent	.	.
DNC003893	G(D-Pen)-G-H-R-G-D-L-R-C-A	Discovery agent	.	.
DNC003894	VESNARINONE	Cardiac failure	.	I50
DNC003894	VESNARINONE	Discovery agent	.	.
DNC003895	Azaphenylalanine derivative	Discovery agent	.	.
DNC003896	CGS-17867A	Alcohol use disorders	303	F10.2
DNC003896	CGS-17867A	Discovery agent	.	.
DNC003897	4-Ethyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine	Discovery agent	.	.
DNC003898	3-Amino-5,6-dihydro-2H-benzo[f]quinazolin-1-one	Discovery agent	.	.
DNC003899	MK-10	Discovery agent	.	.
DNC003900	RWJ-53419	Discovery agent	.	.
DNC003901	CI-930	Discovery agent	.	.
DNC003902	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC003903	VOLINANSERIN	Discovery agent	.	.
DNC003904	6-Heptyl-4-hydroxy-3-octanoyl-pyran-2-one	Discovery agent	.	.
DNC003905	XEMILOFIBAN	Discovery agent	.	.
DNC003905	XEMILOFIBAN	Peripheral vascular disease	.	I73.9
DNC003906	1-Methyl-1,2,3,4-tetrahydro-isoquinoline-6,7-diol	Discovery agent	.	.
DNC003907	GHRELIN	Gastrointestinal disorders	530-558	K20-K64
DNC003908	BB-1101	Discovery agent	.	.
DNC003908	BB-1101	Multiple sclerosis	340	G35
DNC003909	SIBRAFIBAN	Angina	.	I20
DNC003909	SIBRAFIBAN	Discovery agent	.	.
DNC003910	N6-CYCLOPENTYLADENOSINE	Discovery agent	.	.
DNC003911	DMP-696	Anxiety disorder	300	F40-F42
DNC003911	DMP-696	Discovery agent	.	.
DNC003912	Cyclostellettamine derivative	Discovery agent	.	.
DNC003913	3-Decanoyl-4-hydroxy-6-nonyl-pyran-2-one	Discovery agent	.	.
DNC003914	4-Benzenesulfonylamino-N-hydroxy-benzamide	Discovery agent	.	.
DNC003915	4-Benzenesulfonyl-1-(3-phenyl-propyl)-piperidine	Discovery agent	.	.
DNC003916	(+)-BUTACLAMOL	Discovery agent	.	.
DNC003917	4-Hydroxy-3-nonanoyl-6-octyl-pyran-2-one	Discovery agent	.	.
DNC003918	ORBOFIBAN	Angina	.	I20
DNC003918	ORBOFIBAN	Discovery agent	.	.
DNC003919	2,3-Dihydro-1H-indol-5-ol	Discovery agent	.	.
DNC003920	4-Benzenesulfonyl-1-phenethyl-piperidine	Discovery agent	.	.
DNC003921	CGS-18320B	Discovery agent	.	.
DNC003922	2-Mercapto-pentanedioic acid	Discovery agent	.	.
DNC003923	Y-c[D-Pen-(2S,3R)-2-Me-(2')Nal-GSFC]KR-NH2	Discovery agent	.	.
DNC003924	SK&F-104856	Discovery agent	.	.
DNC003925	SK&F-106686	Discovery agent	.	.
DNC003926	2-(4-Mercapto-butyl)-pentanedioic acid	Discovery agent	.	.
DNC003927	Y-c[D-Pen-(2R,3R)-2-Me-(2')Nal-GSFC]KR-NH2	Discovery agent	.	.
DNC003928	LY-292223	Discovery agent	.	.
DNC003929	NU-2058	Discovery agent	.	.
DNC003930	4-(1-Imidazol-1-yl-vinyl)-benzonitrile	Discovery agent	.	.
DNC003931	[1-Benzyl-1H-quinolin-(4E)-ylidene]-hexyl-amine	Discovery agent	.	.
DNC003932	2-(3-Methylsulfanyl-propyl)-pentanedioic acid	Discovery agent	.	.
DNC003933	5-Mercapto-pentanoic acid	Discovery agent	.	.
DNC003934	Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2	Discovery agent	.	.
DNC003935	4-(3-Chloro-phenoxy)-6,7-dimethoxy-quinazoline	Discovery agent	.	.
DNC003936	Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2	Discovery agent	.	.
DNC003937	6-(Cyclohex-3-enylmethoxy)-9H-purin-2-ylamine	Discovery agent	.	.
DNC003938	FADROZOLE	Discovery agent	.	.
DNC003939	SNAP-5089	Discovery agent	.	.
DNC003939	SNAP-5089	Heart arrhythmia	.	I47-I49
DNC003940	2-Mercaptomethyl-pentanedioic acid	Discovery agent	.	.
DNC003941	4-Methyl-5,6-dihydro-pyrido[1,2-a]quinolin-3-one	Discovery agent	.	.
DNC003942	2-(5-Mercapto-pentyl)-pentanedioic acid	Discovery agent	.	.
DNC003943	RPR-108518A	Discovery agent	.	.
DNC003944	2-(2-Mercapto-ethyl)-pentanedioic acid	Discovery agent	.	.
DNC003945	LY-293646	Discovery agent	.	.
DNC003946	L-738167	Discovery agent	.	.
DNC003947	2-Phosphonooxy-pentanedioic acid	Discovery agent	.	.
DNC003948	6-(3-Methyl-benzyloxy)-9H-purin-2-ylamine	Discovery agent	.	.
DNC003949	L-734217	Discovery agent	.	.
DNC003949	L-734217	Thrombosis	.	I80-I82
DNC003950	RO-319790	Discovery agent	.	.
DNC003950	RO-319790	Rheumatold arthritis	714	M05-M06
DNC003951	NIGULDIPINE	Discovery agent	.	.
DNC003952	Y-c[D-Pen-(2S,3S)-2-Me-(2')Nal-GSFC]KR-NH2	Discovery agent	.	.
DNC003953	BIBP-3226	Discovery agent	.	.
DNC003954	SK&F-105854	Discovery agent	.	.
DNC003955	L-709780	Discovery agent	.	.
DNC003956	SK&F-86466	Discovery agent	.	.
DNC003957	2-(2-Phosphonooxy-ethyl)-pentanedioic acid	Discovery agent	.	.
DNC003958	6-(3-Amino-benzyloxy)-9H-purin-2-ylamine	Discovery agent	.	.
DNC003959	Y-c[D-Pen-(2')Nal-GSFC]KR-NH2	Discovery agent	.	.
DNC003960	Y-c[D-Pen-D-(2')Nal-GSFC]KR-NH2	Discovery agent	.	.
DNC003961	Y-c[D-Pen-(2R,3S)-2-Me-(2')Nal-GSFC]KR-NH2	Discovery agent	.	.
DNC003962	L-767679	Discovery agent	.	.
DNC003963	1-Benzyl-7-chloro-4-hexyloxy-quinolinium	Discovery agent	.	.
DNC003964	CORYNANTHEINE	Discovery agent	.	.
DNC003965	2-Phenyl-3-(2-piperidin-1-yl-ethyl)-1H-indole	Discovery agent	.	.
DNC003966	1-Methyl-5-(4-phenylazo-phenyl)-piperidin-2-one	Discovery agent	.	.
DNC003967	5-(4-Phenoxy-phenyl)-pyrimidine-2,4,6-trione	Discovery agent	.	.
DNC003968	2-Phenyl-3-piperidin-4-yl-1H-indole	Discovery agent	.	.
DNC003969	SC-54701A	Discovery agent	.	.
DNC003970	1-Methyl-5-phenyl-piperidin-2-one	Discovery agent	.	.
DNC003971	2-Methoxy-N-(3-methyl-2-phenyl-butyl)-benzamide	Discovery agent	.	.
DNC003972	5-Biphenyl-4-yl-5-hexyl-pyrimidine-2,4,6-trione	Discovery agent	.	.
DNC003973	LY-266111	Discovery agent	.	.
DNC003974	DITOLYLGUANIDINE	Discovery agent	.	.
DNC003975	VK-19911	Discovery agent	.	.
DNC003976	3-(1-Phenethyl-piperidin-3-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003977	SC-47643	Discovery agent	.	.
DNC003978	GALANGIN	Discovery agent	.	.
DNC003979	5-(4-Chloro-phenyl)-1-methyl-piperidin-2-one	Discovery agent	.	.
DNC003980	3-(1-Benzyl-piperidin-4-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003981	CYCLORGDFV	Discovery agent	.	.
DNC003982	5-(4-Chloro-phenyl)-1-methyl-piperidine-2-thione	Discovery agent	.	.
DNC003983	3-(1-Phenethyl-piperidin-4-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003984	BRL-37344	Discovery agent	.	.
DNC003985	5-Hexyl-5-phenyl-pyrimidine-2,4,6-trione	Discovery agent	.	.
DNC003986	5-Methyl-5-phenyl-pyrimidine-2,4,6-trione	Discovery agent	.	.
DNC003987	5-Biphenyl-4-yl-5-ethyl-pyrimidine-2,4,6-trione	Discovery agent	.	.
DNC003988	3-(1-Methyl-piperidin-3-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003989	3-(1-Methyl-piperidin-4-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003990	3-(1-Benzyl-piperidin-3-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003991	3-(1-Methyl-piperidin-2-yl)-2-phenyl-1H-indole	Discovery agent	.	.
DNC003992	2-Phenyl-3-piperidin-3-yl-1H-indole	Discovery agent	.	.
DNC003993	ACTINOPLANIC ACID A	Discovery agent	.	.
DNC003994	UH-301	Discovery agent	.	.
DNC003995	5-Chloro-1-(4-chloro-benzyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC003996	(4-Dipropylamino-cyclohexylidene)-acetonitrile	Discovery agent	.	.
DNC003997	1-(3-Methoxy-benzyl)-5-methyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC003998	4-Dipropylamino-cyclohex-1-enecarbonitrile	Discovery agent	.	.
DNC003999	LG-121071	Discovery agent	.	.
DNC004000	4-HYDROXYTAMOXIFEN	Discovery agent	.	.
DNC004001	L-745631	Cancer	140-229	C00-C96
DNC004001	L-745631	Discovery agent	.	.
DNC004002	4-[1,2-bis(4-hydroxyphenyl)hex-1-enyl]phenol	Discovery agent	.	.
DNC004003	(4-Ethynyl-cyclohex-3-enyl)-dipropyl-amine	Discovery agent	.	.
DNC004004	4-[2,2-bis(4-hydroxyphenyl)-1-methylvinyl]phenol	Discovery agent	.	.
DNC004005	2-(4-Dipropylamino-cyclohexylidene)-malononitrile	Discovery agent	.	.
DNC004006	(3Z)-1H-indole-2,3-dione 3-thiosemicarbazone	Discovery agent	.	.
DNC004007	4-[1,2-bis(4-hydroxyphenyl)vinyl]phenol	Discovery agent	.	.
DNC004008	(4-Phenylethynyl-cyclohex-3-enyl)-dipropyl-amine	Discovery agent	.	.
DNC004009	(Z)-2-Methyl-3-tetradecyl-but-2-enedioic acid	Discovery agent	.	.
DNC004010	[1,1':2',1'']Terphenyl-4'-carbaldehyde oxime	Discovery agent	.	.
DNC004011	4-[1,2-bis(4-hydroxyphenyl)but-1-enyl]phenol	Discovery agent	.	.
DNC004012	4-[1,2-bis(4-hydroxyphenyl)pent-1-enyl]phenol	Discovery agent	.	.
DNC004013	SB-213068	Discovery agent	.	.
DNC004014	Sulfamic acid 4-(2-methoxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004015	SB-223245	Discovery agent	.	.
DNC004016	BRL-48482	Discovery agent	.	.
DNC004017	Z-Arg-Leu-Val-Agly-Ile-Val-Trp-NH2	Discovery agent	.	.
DNC004018	1-Methoxy-6-phenyl-6H-benzo[c]chromene	Discovery agent	.	.
DNC004019	Sulfamic acid 3-benzoyl-phenyl ester	Discovery agent	.	.
DNC004020	Z-Ala-Leu-Tyr(Me)-Agly-Ile-Val-OMe	Discovery agent	.	.
DNC004021	4-[1-(4-hydroxyphenyl)-2-phenylvinyl]phenol	Discovery agent	.	.
DNC004022	6-Allyloxy-9H-purin-2-ylamine	Discovery agent	.	.
DNC004023	3-{3-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	Discovery agent	.	.
DNC004024	4-[1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenol	Discovery agent	.	.
DNC004025	Z-Arg-Leu-Val-Agly-Trp-Val-Ala-NH2	Discovery agent	.	.
DNC004026	Sulfamic acid 3-(3-hydroxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004027	Z-Ala-Leu-His-Agly-Ile-Val-OMe	Discovery agent	.	.
DNC004028	Sulfamic acid 4-(3-methoxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004029	Sulfamic acid 3-(3-methoxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004030	Sulfamic acid 3-(4-hydroxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004031	SB-209247	Discovery agent	.	.
DNC004032	2,5-Bis-(3-cyclopentyloxy-4-methoxy-phenyl)-furan	Discovery agent	.	.
DNC004033	Z-Ala-Leu-lle-Agly-Ile-Val-OMe	Discovery agent	.	.
DNC004034	Z-Ala-Leu-Phe-Agly-Ile-Val-OMe	Discovery agent	.	.
DNC004035	4-[1-(4-hydroxyphenyl)-2-phenylhex-1-enyl]phenol	Discovery agent	.	.
DNC004036	Boc-Agly-Val-Agly-OEt	Discovery agent	.	.
DNC004037	GAMMA-AMINO-BUTANOIC ACID	Discovery agent	.	.
DNC004038	LY-255283	Asthma	.	J45
DNC004038	LY-255283	Discovery agent	.	.
DNC004039	4-(2,5-Diphenyl-furan-3-yl)-morpholine	Discovery agent	.	.
DNC004040	YM-511	Breast cancer	.	C50
DNC004040	YM-511	Discovery agent	.	.
DNC004041	Z-leu-Val-Agly-Val-OBzl	Discovery agent	.	.
DNC004042	Z-Ala-Leu-Nal-Agly-Ile-Val-OMe	Discovery agent	.	.
DNC004043	4-[1-(4-hydroxyphenyl)-2-phenylprop-1-enyl]phenol	Discovery agent	.	.
DNC004044	4-[1-(4-hydroxyphenyl)-2-phenylpent-1-enyl]phenol	Discovery agent	.	.
DNC004045	4-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	Discovery agent	.	.
DNC004046	CP-424391-18	Discovery agent	.	.
DNC004047	PNU-142372	Discovery agent	.	.
DNC004048	Sulfamic acid 3-(4-methoxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004049	3-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	Discovery agent	.	.
DNC004050	SB-201146	Discovery agent	.	.
DNC004051	Z-Ala-Leu-lle-Agly-Ile-Val-NHBzl	Discovery agent	.	.
DNC004052	1-Methoxy-6-phenyl-6H-benzo[c]chromen-8-ylamine	Discovery agent	.	.
DNC004053	L-371257	Discovery agent	.	.
DNC004054	Z-Arg-Leu-Val-Agly-Ala-Gly-NH2	Discovery agent	.	.
DNC004055	Z-Arg-Leu-Val-Agly-Ileu-Val-OMe	Discovery agent	.	.
DNC004056	Sulfamic acid 4-(2-hydroxy-benzoyl)-phenyl ester	Discovery agent	.	.
DNC004057	DMP-728	Discovery agent	.	.
DNC004057	DMP-728	Thrombosis	.	I80-I82
DNC004058	SB-201993	Discovery agent	.	.
DNC004058	SB-201993	Psoriasis	.	L40
DNC004059	(-)-ROLIPRAM	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC004059	(-)-ROLIPRAM	Discovery agent	.	.
DNC004060	2,5-Bis-(3,4-dimethoxy-phenyl)-furan	Discovery agent	.	.
DNC004061	4-(1,2-Diphenyl-but-1-enyl)-phenol	Discovery agent	.	.
DNC004062	CI-218872	Discovery agent	.	.
DNC004063	(2,5-Diphenyl-furan-3-yl)-phenyl-methanone	Discovery agent	.	.
DNC004064	Sulfamic acid 4-benzoyl-phenyl ester	Discovery agent	.	.
DNC004065	ACYCLOVIR DIPHOSPHATE	Discovery agent	.	.
DNC004066	Z-Arg-Leu-Val-Agly-Val-Ala-NH2	Discovery agent	.	.
DNC004067	Ro-37-9790	Discovery agent	.	.
DNC004068	7-Methoxy-3-pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004069	2-Benzyl-6-methoxy-5-oxazol-5-yl-1H-indole	Discovery agent	.	.
DNC004070	6-Methoxy-5-oxazol-5-yl-2-phenyl-1H-indole	Discovery agent	.	.
DNC004071	PP2-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	Discovery agent	.	.
DNC004072	KENPAULLONE	Discovery agent	.	.
DNC004073	WIN-63395	Discovery agent	.	.
DNC004074	RS-130830	Discovery agent	.	.
DNC004074	RS-130830	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DNC004075	ML-3375	Discovery agent	.	.
DNC004076	SC-58272	Discovery agent	.	.
DNC004077	N-(4-Phenyl-pyridin-2-yl)-guanidine	Discovery agent	.	.
DNC004078	3-Pyridin-4-yl-quinoline-6,7-diol	Discovery agent	.	.
DNC004079	7-Phenoxy-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC004080	PYRIDINE	Discovery agent	.	.
DNC004081	SC-5003	Discovery agent	.	.
DNC004082	5-[(1R)-1-ammonioethyl]isoxazol-3-olate	Discovery agent	.	.
DNC004083	AZAKENPAULLONE	Discovery agent	.	.
DNC004084	8-Phenyl-octanoic acid hydroxyamide	Discovery agent	.	.
DNC004085	(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine	Discovery agent	.	.
DNC004086	Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp	Discovery agent	.	.
DNC004087	Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	Discovery agent	.	.
DNC004088	ML-3163	Discovery agent	.	.
DNC004089	Cosalane derivative	Discovery agent	.	.
DNC004090	Thieno analogue of kenpaullone	Discovery agent	.	.
DNC004091	3-Pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004092	ML-3403	Discovery agent	.	.
DNC004093	PP1-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	Discovery agent	.	.
DNC004094	6-Methoxy-3-pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004095	7-Chloro-3-pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004096	(2E,4S)-4-ammoniopent-2-enoate	Discovery agent	.	.
DNC004097	(4R)-4-ammoniopentanoate	Discovery agent	.	.
DNC004098	7-Biphenyl-4-yl-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC004099	(4S)-4-ammoniopentanoate	Discovery agent	.	.
DNC004100	5,7-Dimethoxy-3-pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004101	5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004102	3-Pyridin-4-yl-quinoline-5,7-diol	Discovery agent	.	.
DNC004103	Ro-32-3555	Discovery agent	.	.
DNC004104	6,7-Dimethoxy-3-pyridin-4-yl-quinoline	Discovery agent	.	.
DNC004105	4-Methyl-pyridine	Discovery agent	.	.
DNC004106	3-Pyridin-4-yl-quinolin-7-ol	Discovery agent	.	.
DNC004107	COSALANE	Discovery agent	.	.
DNC004108	5-[(1S)-1-ammonioethyl]isoxazol-3-olate	Discovery agent	.	.
DNC004109	ICI-200355	Discovery agent	.	.
DNC004110	NU-6027	Discovery agent	.	.
DNC004111	MDL-11939	Anxiety disorder	300	F40-F42
DNC004111	MDL-11939	Discovery agent	.	.
DNC004112	MANOALIDE	Arthritis	.	M00-M25
DNC004112	MANOALIDE	Discovery agent	.	.
DNC004113	SKF-107260	Discovery agent	.	.
DNC004114	2-(5-Methoxy-1H-indol-3-yl)-1-methyl-ethylamine	Discovery agent	.	.
DNC004115	LAVENDUSTIN A	Discovery agent	.	.
DNC004116	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide	Discovery agent	.	.
DNC004117	L-741626	Discovery agent	.	.
DNC004118	ZOTEPINE	Anxiety disorder	300	F40-F42
DNC004118	ZOTEPINE	Discovery agent	.	.
DNC004119	L-658758	Discovery agent	.	.
DNC004120	SB-207043	Discovery agent	.	.
DNC004121	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide	Discovery agent	.	.
DNC004122	N-Hydroxy-4-phenylacetylamino-benzamide	Discovery agent	.	.
DNC004123	(1-Phenethyl-piperidin-4-yl)-phenyl-methanone	Discovery agent	.	.
DNC004124	(R)-2-(Benzylamino-methyl)-chroman-7-ol	Discovery agent	.	.
DNC004125	3-(2-Amino-propyl)-1H-indol-5-ol	Discovery agent	.	.
DNC004126	4-Butyrylamino-N-hydroxy-benzamide	Discovery agent	.	.
DNC004127	6-Cyclohexylmethoxy-pyrimidine-2,4,5-triamine	Discovery agent	.	.
DNC004128	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide	Discovery agent	.	.
DNC004129	(+)-NIGULDIPINE	Discovery agent	.	.
DNC004130	Pro-His-Pro-His-Phe-Phe-Val-Tyr-Lys	Discovery agent	.	.
DNC004131	Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro	Discovery agent	.	.
DNC004132	SU-11652	Discovery agent	.	.
DNC004133	IODOMELATONIN	Discovery agent	.	.
DNC004134	PD-158780	Discovery agent	.	.
DNC004135	Pro-His-Pro-His-Leu-Phe-Val-Tyr	Discovery agent	.	.
DNC004136	PD-83176	Discovery agent	.	.
DNC004137	Pro-His-Pro-His-Phe-Phe-Val-Tyr	Discovery agent	.	.
DNC004138	(-)-NIGULDIPINE	Discovery agent	.	.
DNC004139	PD-81723	Discovery agent	.	.
DNC004140	3-[3-(2-Hydroxy-ethoxy)-phenyl]-1H-quinolin-2-one	Discovery agent	.	.
DNC004141	Pseudopeptide derivative	Discovery agent	.	.
DNC004142	PHLORIZIN	Discovery agent	.	.
DNC004143	Pseudopeptide derivative	Discovery agent	.	.
DNC004144	MOXONIDINE	Alcohol use disorders	303	F10.2
DNC004144	MOXONIDINE	Discovery agent	.	.
DNC004145	A-286982	Discovery agent	.	.
DNC004146	PROSTRATIN	Discovery agent	.	.
DNC004146	PROSTRATIN	HIV infections	42	B20
DNC004147	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one	Discovery agent	.	.
DNC004148	Azaperone	Discovery agent	.	.
DNC004149	2-(3,4,5-Trihydroxy-benzylidene)-malononitrile	Discovery agent	.	.
DNC004150	RWJ-68157	Discovery agent	.	.
DNC004151	3-(4-Phenyl-piperidin-1-ylmethyl)-1H-indole	Discovery agent	.	.
DNC004152	3-(4-Phenyl-piperazin-1-ylmethyl)-1H-indole	Discovery agent	.	.
DNC004153	AP-227	Discovery agent	.	.
DNC004154	UK-78282	Discovery agent	.	.
DNC004154	UK-78282	Inflammatory diseases	.	.
DNC004155	SK&F-86002	Discovery agent	.	.
DNC004156	5-Chloro-3-ethyl-1-(4-fluoro-phenyl)-1H-indole	Discovery agent	.	.
DNC004157	SB-216763	Discovery agent	.	.
DNC004158	PD-29361	Discovery agent	.	.
DNC004159	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime	Discovery agent	.	.
DNC004160	TERRITREM B	Discovery agent	.	.
DNC004161	MK-499	Cardiac arrhythmias	.	I47-I49
DNC004161	MK-499	Discovery agent	.	.
DNC004162	L000021649	Discovery agent	.	.
DNC004163	PD-157667	Discovery agent	.	.
DNC004164	SCH-365351	Discovery agent	.	.
DNC004165	RWJ-69736	Discovery agent	.	.
DNC004166	ISOCLOZAPINE	Discovery agent	.	.
DNC004167	SCH-351591	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC004167	SCH-351591	Discovery agent	.	.
DNC004168	3-(4-Methyl-piperidin-1-ylmethyl)-1H-indole	Discovery agent	.	.
DNC004169	PD-32577	Discovery agent	.	.
DNC004170	RWJ-38063	Discovery agent	.	.
DNC004171	L-739758	Discovery agent	.	.
DNC004172	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ylamine	Discovery agent	.	.
DNC004173	2-(4-Phenoxy-benzyl)-1H-benzoimidazole	Discovery agent	.	.
DNC004174	6-Methoxy-2-(4-phenoxy-benzyl)-1H-benzoimidazole	Discovery agent	.	.
DNC004175	7-Fluoro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004176	Macrocyclic tripeptide motif	Discovery agent	.	.
DNC004177	SNAP-5150	Discovery agent	.	.
DNC004178	L-733060	Discovery agent	.	.
DNC004179	CP-99994	Discovery agent	.	.
DNC004179	CP-99994	Pain	.	G89
DNC004180	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-4-ol	Discovery agent	.	.
DNC004181	1H-1,2,3-benzotriazol-1-amine	Discovery agent	.	.
DNC004182	L-741742	Discovery agent	.	.
DNC004183	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ol	Discovery agent	.	.
DNC004184	1,3-Dihydro-naphtho[2,3-d]imidazol-2-one	Discovery agent	.	.
DNC004185	PURPUROGALLIN	Discovery agent	.	.
DNC004186	7-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004187	TAZOBACTAM SODIUM	Discovery agent	.	.
DNC004188	8-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004189	L-746233	Discovery agent	.	.
DNC004190	L-736281	Discovery agent	.	.
DNC004191	N-(Ethylphosphoryl)-L-isoleucyl-L-Trp-NHCH3	Discovery agent	.	.
DNC004192	5-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004193	BMY-20844	Discovery agent	.	.
DNC004194	1,3-Dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004195	7-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004196	1,3,9,9a-Tetrahydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004197	6-Nitro-2-(4-phenoxy-benzyl)-1H-benzoimidazole	Discovery agent	.	.
DNC004198	8-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004199	7-Ethoxy-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	Discovery agent	.	.
DNC004200	1-Propyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004201	1-Phenethyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004202	OPC-13013	Discovery agent	.	.
DNC004203	1-Butyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004204	FORMESTANE	Discovery agent	.	.
DNC004205	1-Prop-2-ynyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004206	1-Cyclopentyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004207	LUF-5433	Discovery agent	.	.
DNC004208	ZAPRINAST	Discovery agent	.	.
DNC004209	1-Allyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004210	CGP-71683A	Discovery agent	.	.
DNC004210	CGP-71683A	Eating disorder	.	F50
DNC004211	L-249313	Discovery agent	.	.
DNC004212	5-Butyl-8-phenyl-3H-[1,2,4]triazolo[5,1-i]purine	Discovery agent	.	.
DNC004213	CGS-15943	Discovery agent	.	.
DNC004214	BUFROLIN	Discovery agent	.	.
DNC004215	3-Methyl-1-phenethyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004216	1-Benzyl-3-methyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004217	LG-120838	Discovery agent	.	.
DNC004218	3,6-Diphenyl-1-oxa-7-aza-spiro[4.5]decane	Discovery agent	.	.
DNC004219	LUF-5417	Discovery agent	.	.
DNC004220	CLAVARINONE	Discovery agent	.	.
DNC004221	RO-201724	Discovery agent	.	.
DNC004222	3-Isobutyl-1-methyl-3,9-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC004223	4-Methoxy-N-(3-phenyl-isoquinolin-1-yl)-benzamide	Discovery agent	.	.
DNC004224	HTS-466284	Discovery agent	.	.
DNC004225	N*4*-(3-Bromo-phenyl)-quinazoline-4,7-diamine	Discovery agent	.	.
DNC004226	Cartazolate	Discovery agent	.	.
DNC004227	N-(4-m-Tolylamino-quinazolin-7-yl)-acrylamide	Discovery agent	.	.
DNC004228	RPR-113829	Discovery agent	.	.
DNC004229	3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	Discovery agent	.	.
DNC004230	4-(3-Bromo-phenylamino)-quinazoline-6,7-diol	Discovery agent	.	.
DNC004231	(3-Bromo-phenyl)-(5-nitro-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC004232	F-G-G-F-T-G-MeA-R-K-S-A-R-K-L-A-N-Q-CONH2	Discovery agent	.	.
DNC004233	MLN-518	Acute myeloid leukemia	.	C92.0
DNC004233	MLN-518	Discovery agent	.	.
DNC004234	F-G-G-F-T-G-A-R-K-S-A-R-K-L-MeA-N-Q-CONH2	Discovery agent	.	.
DNC004235	3-(4-Phenoxy-phenyl)-1H-pyrazole	Discovery agent	.	.
DNC004236	RPR-114334	Discovery agent	.	.
DNC004237	F-G-G-F-T-G-A-R-K-S-Aib-R-K-L-A-N-Q-COOH	Discovery agent	.	.
DNC004238	4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine	Discovery agent	.	.
DNC004239	3-[4-(4-Fluoro-phenoxy)-phenyl]-1H-pyrazole	Discovery agent	.	.
DNC004240	3-Ethoxy-9H-beta-carboline	Discovery agent	.	.
DNC004241	V-102862	Discovery agent	.	.
DNC004242	4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	Discovery agent	.	.
DNC004243	F-G-G-F-T-G-Aib-R-K-S-A-R-K-L-A-N-Q-COOH	Discovery agent	.	.
DNC004244	INOGATRAN	Discovery agent	.	.
DNC004244	INOGATRAN	Myocardial infarction	.	I21-I22
DNC004245	LY-326449	Discovery agent	.	.
DNC004246	2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	Discovery agent	.	.
DNC004247	F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-CONH2	Discovery agent	.	.
DNC004248	Geldanamycin-estradiol hybrid	Discovery agent	.	.
DNC004249	PD-0183812	Discovery agent	.	.
DNC004249	PD-0183812	Retinoblastoma	.	C69.2
DNC004250	1-(4-Butoxy-phenyl)-1H-imidazole	Discovery agent	.	.
DNC004251	Tilmacoxib	Colon polyps	.	K63.5
DNC004251	Tilmacoxib	Discovery agent	.	.
DNC004252	F-G-G-F-T-G-Aib-R-K-S-Aib-R-K-L-A-N-Q-CONH2	Discovery agent	.	.
DNC004253	F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-COOH	Discovery agent	.	.
DNC004254	Benzyl-quinazolin-4-yl-amine	Discovery agent	.	.
DNC004255	PD-168393	Discovery agent	.	.
DNC004256	NOCICEPTIN	Discovery agent	.	.
DNC004256	NOCICEPTIN	Headache	339, 784.0	G43-G44, R51
DNC004257	2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine	Discovery agent	.	.
DNC004258	2-Hexyloxy-5-imidazol-1-yl-pyridine	Discovery agent	.	.
DNC004259	Geldanamycin-estradiol hybrid	Discovery agent	.	.
DNC004260	N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide	Discovery agent	.	.
DNC004261	SC-58125	Discovery agent	.	.
DNC004262	F-G-G-F-T-G-A-R-K-S-A-R-K-L-Aib-N-Q-COOH	Discovery agent	.	.
DNC004263	F-G-G-F-T-G-Aib-R-K-S-A-R-K-L-A-N-Q-CONH2	Discovery agent	.	.
DNC004264	LY-317644	Discovery agent	.	.
DNC004265	F-G-G-F-T-G-A-R-K-S-Aib-R-K-L-A-N-Q-CONH2	Discovery agent	.	.
DNC004266	F-G-G-F-T-G-MeA-R-K-S-A-R-K-L-A-N-Q-COOH	Discovery agent	.	.
DNC004267	F-G-G-F-T-G-A-R-K-S-A-R-K-L-MeA-N-Q-COOH	Discovery agent	.	.
DNC004268	F-G-G-F-T-G-A-R-K-S-A-R-K-L-Aib-N-Q-CONH2	Discovery agent	.	.
DNC004269	Substance P	Discovery agent	.	.
DNC004270	2,8-Diamino-9-benzyl-1,9-dihydro-purin-6-one	Discovery agent	.	.
DNC004271	RO-44-3888	Discovery agent	.	.
DNC004272	SB-202026	Discovery agent	.	.
DNC004273	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one	Discovery agent	.	.
DNC004274	Ro-43-5054	Discovery agent	.	.
DNC004275	L-703014	Discovery agent	.	.
DNC004275	L-703014	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
DNC004276	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one	Discovery agent	.	.
DNC004277	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one	Discovery agent	.	.
DNC004278	1-Pyridin-2-yl-3-quinolin-5-yl-urea	Discovery agent	.	.
DNC004279	4-amino-6-(4-octylphenyl)hexanoic acid	Discovery agent	.	.
DNC004280	SB-202190	Discovery agent	.	.
DNC004281	IMAZODAN	Discovery agent	.	.
DNC004282	1-(7-Hydroxy-naphthalen-1-yl)-3-pyridin-2-yl-urea	Discovery agent	.	.
DNC004283	SCH-63390	Discovery agent	.	.
DNC004284	ANDROSTENEDONE	Discovery agent	.	.
DNC004285	MK-852	Discovery agent	.	.
DNC004285	MK-852	Thrombosis	.	I80-I82
DNC004286	ROXIFIBAN	Discovery agent	.	.
DNC004287	ZD-2486	Angina	.	I20
DNC004287	ZD-2486	Discovery agent	.	.
DNC004288	N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea	Discovery agent	.	.
DNC004289	RP-23618	Arthritis	.	M00-M25
DNC004289	RP-23618	Discovery agent	.	.
DNC004290	L-750034	Discovery agent	.	.
DNC004291	1,5-Dihydro-imidazo[2,1-b]quinazolin-2-one	Discovery agent	.	.
DNC004292	Quinapril analogue	Discovery agent	.	.
DNC004293	1-(1H-Indazol-6-yl)-3-pyridin-2-yl-urea	Discovery agent	.	.
DNC004294	GSK-9578	Discovery agent	.	.
DNC004295	1-(9-Oxo-9H-fluoren-4-yl)-3-pyridin-2-yl-urea	Discovery agent	.	.
DNC004296	LAMIFIBAN	Angina	.	I20
DNC004296	LAMIFIBAN	Discovery agent	.	.
DNC004297	DMP-802	Discovery agent	.	.
DNC004298	SB-208651	Discovery agent	.	.
DNC004298	SB-208651	Thrombosis	.	I80-I82
DNC004299	7-Iodo-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one	Discovery agent	.	.
DNC004300	SDZ-64-412	Discovery agent	.	.
DNC004301	L-734115	Discovery agent	.	.
DNC004302	TETRAHYDROBENXIMIDAZOLE	Discovery agent	.	.
DNC004303	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one	Discovery agent	.	.
DNC004304	GR-144053	Discovery agent	.	.
DNC004305	Ro-43-8857	Discovery agent	.	.
DNC004306	PEPSTATIN A	Discovery agent	.	.
DNC004307	8-AMINOGUANINE	Discovery agent	.	.
DNC004308	LOTRAFIBAN	Cardiovascular disease	.	I00-I99
DNC004308	LOTRAFIBAN	Discovery agent	.	.
DNC004309	Gantofiban	Arteriosclerosis	.	I70
DNC004309	Gantofiban	Discovery agent	.	.
DNC004310	2,4,5-Triarylimidazole analogue	Discovery agent	.	.
DNC004311	PD-169316	Discovery agent	.	.
DNC004312	SCH-58261	Discovery agent	.	.
DNC004313	3-amino-5-(4-octylphenyl)pentanoic acid	Discovery agent	.	.
DNC004314	L-756568	Discovery agent	.	.
DNC004315	6-Benzyloxy-5-nitro-pyrimidine-2,4-diamine	Discovery agent	.	.
DNC004316	TANNIN analogue	Discovery agent	.	.
DNC004317	PD-155080	Discovery agent	.	.
DNC004317	PD-155080	Hypertension	401	I10, I11, I12, I13, I15
DNC004318	6-Chloro-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole	Discovery agent	.	.
DNC004319	TANNIN analogue	Discovery agent	.	.
DNC004320	8-Chloro-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole	Discovery agent	.	.
DNC004321	PD-163140	Discovery agent	.	.
DNC004322	TANNIN analogue	Discovery agent	.	.
DNC004323	(2-Indol-1-yl-ethyl)-dimethyl-amine	Discovery agent	.	.
DNC004324	GBR-12909	Discovery agent	.	.
DNC004325	RS-39066	Discovery agent	.	.
DNC004326	Dicarba-Closo-Dodecaborane analogue	Discovery agent	.	.
DNC004327	L-731735	Cancer	140-229	C00-C96
DNC004327	L-731735	Discovery agent	.	.
DNC004328	Dicarba-Closo-Dodecaborane analogue	Discovery agent	.	.
DNC004329	TANNIN analogue	Discovery agent	.	.
DNC004330	Ac-W-F-F-N-Y-Y-W	Discovery agent	.	.
DNC004331	Ac-w-F-F-N-Y-Y-W	Discovery agent	.	.
DNC004332	PUNICAFOLIN	Discovery agent	.	.
DNC004333	TANNIN analogue	Discovery agent	.	.
DNC004334	(1H-Benzoimidazol-5-yl)-(1H-imidazol-2-yl)-amine	Discovery agent	.	.
DNC004335	TANNIN analogue	Discovery agent	.	.
DNC004336	TANNIN analogue	Discovery agent	.	.
DNC004337	[2-(6-Methoxy-indol-1-yl)-ethyl]-dimethyl-amine	Discovery agent	.	.
DNC004338	TANNIN	Discovery agent	.	.
DNC004339	7-Chloro-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole	Discovery agent	.	.
DNC004340	(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine	Discovery agent	.	.
DNC004341	TANNIN analogue	Discovery agent	.	.
DNC004342	TANNIN	Discovery agent	.	.
DNC004343	1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole	Discovery agent	.	.
DNC004344	TANNIN analogue	Discovery agent	.	.
DNC004345	TANNIN analogue	Discovery agent	.	.
DNC004346	W-F-F-N--Y-Y-W	Discovery agent	.	.
DNC004347	(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine	Discovery agent	.	.
DNC004348	2,2,4-Trimethyl-6-phenyl-1,2-dihydro-quinoline	Discovery agent	.	.
DNC004349	PD-156707	Discovery agent	.	.
DNC004349	PD-156707	Heart failure	.	I50
DNC004350	TANNIN analogue	Discovery agent	.	.
DNC004351	Bhg-F-N-Y-Y-W	Discovery agent	.	.
DNC004352	Ac-bhg-F-N-Y-Y-W	Discovery agent	.	.
DNC004353	Dicarba-Closo-Dodecaborane analogue	Discovery agent	.	.
DNC004354	6-Benzyloxy-5-nitroso-pyrimidine-2,4-diamine	Discovery agent	.	.
DNC004355	TANNIN analogue	Discovery agent	.	.
DNC004356	(1H-Imidazol-2-yl)-quinoxalin-6-yl-amine	Discovery agent	.	.
DNC004357	TANNIN analogue	Discovery agent	.	.
DNC004358	Iva-His-Pro-Phe-His-Sta-Leu-Phe-NH2	Discovery agent	.	.
DNC004359	6-Azido-8-(3-iodo-phenyl)-quinoline	Discovery agent	.	.
DNC004360	S-(N-4chlorophenyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004361	Iva-His-Pro-Phe-His-AHPPA-Leu-Phe-NH2	Discovery agent	.	.
DNC004362	HBR-985	Discovery agent	.	.
DNC004363	(S)-WILLARDIINE	Discovery agent	.	.
DNC004364	GLUTAMATE	Discovery agent	.	.
DNC004365	2-Morpholin-4-yl-8-phenylethynyl-chromen-4-one	Discovery agent	.	.
DNC004366	8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline	Discovery agent	.	.
DNC004367	S-(N-hexyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004368	3-[2-(3,5-Dimethoxy-phenyl)-vinyl]-furan	Discovery agent	.	.
DNC004369	Pipendoxifene	Discovery agent	.	.
DNC004370	6-Imidazol-1-ylmethyl-8-phenyl-quinoline	Discovery agent	.	.
DNC004371	S-(N-heptyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004372	S-(N-butyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004373	S-(N-pentyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004374	DALTROBAN	Discovery agent	.	.
DNC004375	SOMATOSTATIN	Discovery agent	.	.
DNC004376	5-Fluoro-2-hydroxy-N-isopropyl-benzamide	Discovery agent	.	.
DNC004377	S-(N-phenyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004378	KAINATE	Discovery agent	.	.
DNC004379	U-92032	Discovery agent	.	.
DNC004380	8-(3-Azido-phenyl)-6-pyridin-4-ylmethyl-quinoline	Discovery agent	.	.
DNC004381	A-420983	Discovery agent	.	.
DNC004382	ZK-119010	Carcinoma	.	D07.30
DNC004382	ZK-119010	Discovery agent	.	.
DNC004383	TRISMETHOXYRESVERATROL	Discovery agent	.	.
DNC004384	(2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol	Discovery agent	.	.
DNC004385	2-Hydroxy-N-(3-phenyl-propyl)-benzamide	Discovery agent	.	.
DNC004386	(3-Phenyl-propyl)-quinazolin-4-yl-amine	Discovery agent	.	.
DNC004387	8-(3-Azido-phenyl)-6-iodo-quinoline	Discovery agent	.	.
DNC004388	S-(N-methyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004389	S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004390	S-(N-ethyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004391	Iva-His-Pro-Phe-His-ACHPA-Leu-Phe-NH2	Discovery agent	.	.
DNC004392	S-(N-propyl-N-hydroxycarbamoyl)glutathione	Discovery agent	.	.
DNC004393	4-[2-(3,5-Dimethoxy-phenyl)-vinyl]-pyridine	Discovery agent	.	.
DNC004394	2-[2-(3,5-Dimethoxy-phenyl)-vinyl]-thiophene	Discovery agent	.	.
DNC004395	Isoquinolin-1-yl-(3-phenyl-propyl)-amine	Discovery agent	.	.
DNC004396	(S)-AMPA	Discovery agent	.	.
DNC004397	N-(2,4-Dimethoxy-phenyl)-3,5-dimethoxy-benzamide	Discovery agent	.	.
DNC004398	3,5,7-Trimethoxy-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC004399	NSC-19028	Discovery agent	.	.
DNC004400	1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one	Discovery agent	.	.
DNC004401	NEUROKININ B	Discovery agent	.	.
DNC004402	LEUKOTRIENE_B4	Discovery agent	.	.
DNC004403	DESMETHEYLASTEMIZOLE	Discovery agent	.	.
DNC004404	CHROMOTROPATE	Discovery agent	.	.
DNC004405	3-(4-Methoxy-benzenesulfonyl)-cyclohexanethiol	Discovery agent	.	.
DNC004406	RO-316233	Discovery agent	.	.
DNC004407	SC-50073	Discovery agent	.	.
DNC004408	[1,4]Thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC004409	7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine	Discovery agent	.	.
DNC004410	3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine	Discovery agent	.	.
DNC004411	SCH-442416	Discovery agent	.	.
DNC004412	SC-50135	Discovery agent	.	.
DNC004413	((E)-7-But-2-enyl)-azepan-(2Z)-ylideneamine	Discovery agent	.	.
DNC004414	MDL-74156	Discovery agent	.	.
DNC004415	SB-415286	Discovery agent	.	.
DNC004416	[1,5]Thiazocan-(4E)-ylideneamine	Discovery agent	.	.
DNC004417	KRP-297	Discovery agent	.	.
DNC004417	KRP-297	Hyperlipidemia	.	E78.5
DNC004418	PD-160946	Discovery agent	.	.
DNC004419	SC-41390	Discovery agent	.	.
DNC004420	EVANS BLUE	Discovery agent	.	.
DNC004421	SC-51146	Discovery agent	.	.
DNC004422	3,4-bis(indol-3-yl)maleimide derivative	Discovery agent	.	.
DNC004423	SC-53229	Discovery agent	.	.
DNC004424	PD-171729	Discovery agent	.	.
DNC004425	PD-161182	Discovery agent	.	.
DNC004426	N-DESMETHYLCLOZAPINE	Discovery agent	.	.
DNC004426	N-DESMETHYLCLOZAPINE	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
DNC004427	7-Butyl-azepan-(2Z)-ylideneamine	Discovery agent	.	.
DNC004428	2-(2-Amino-ethyl)-7-imino-azepane	Discovery agent	.	.
DNC004429	Sulfamic acid 2-nonyl-4-oxo-4H-chromen-6-yl ester	Discovery agent	.	.
DNC004430	SC-52073	Discovery agent	.	.
DNC004431	Benzo[g]quinazolin-4-yl-(3-bromo-phenyl)-amine	Discovery agent	.	.
DNC004432	TRYPAN BLUE	Colour dead tissues	.	.
DNC004432	TRYPAN BLUE	Discovery agent	.	.
DNC004433	SC-50676	Discovery agent	.	.
DNC004434	2-(5-Thiophen-2-yl-1H-indol-3-yl)-ethylamine	Discovery agent	.	.
DNC004435	SC-48928	Discovery agent	.	.
DNC004435	SC-48928	Psoriasis	.	L40
DNC004436	L-741671	Discovery agent	.	.
DNC004436	L-741671	Emesis	.	R11
DNC004437	4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one	Discovery agent	.	.
DNC004438	NSC-407228	Discovery agent	.	.
DNC004439	RPR-118071	Discovery agent	.	.
DNC004440	SC-52569	Discovery agent	.	.
DNC004441	ISOCONAZOLE	Discovery agent	.	.
DNC004442	[1,4]Oxazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC004443	3-(4-Phenoxy-benzenesulfonyl)-cyclohexanethiol	Discovery agent	.	.
DNC004444	TERIKALANT	Cardiac arrhythmias	.	I47-I49
DNC004444	TERIKALANT	Discovery agent	.	.
DNC004445	RP-58866	Discovery agent	.	.
DNC004446	GF-109203	Discovery agent	.	.
DNC004447	3-(2-Amino-ethyl)-5-imino-[1,4]oxazepane	Discovery agent	.	.
DNC004448	(3-Bromo-phenyl)-quinazolin-4-yl-amine	Discovery agent	.	.
DNC004449	3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol	Discovery agent	.	.
DNC004450	3-Butyl-[1,4]oxazepan-(5Z)-ylideneamine	Discovery agent	.	.
DNC004451	8-(Biphenyl-4-yloxy)-2-oxo-octanoic acid	Discovery agent	.	.
DNC004452	5,6,7-Trimethyl-2-p-tolyl-chromen-4-one	Discovery agent	.	.
DNC004453	3-(4-Methoxy-benzenesulfonyl)-propane-1-thiol	Discovery agent	.	.
DNC004454	ZIPRASIDONE HYDROCHLORIDE	Discovery agent	.	.
DNC004455	CIRSIMARITIN	Discovery agent	.	.
DNC004456	SC-53228	Asthma	.	J45
DNC004456	SC-53228	Discovery agent	.	.
DNC004457	KF-17837	Discovery agent	.	.
DNC004458	RPR-120844	Discovery agent	.	.
DNC004459	LY-255283	Discovery agent	.	.
DNC004460	3-(4-Methoxy-benzenesulfonyl)-cyclopentanethiol	Discovery agent	.	.
DNC004461	7-(Biphenyl-4-yloxy)-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC004462	N*4*-(3-Bromo-phenyl)-quinazoline-4,6,7-triamine	Discovery agent	.	.
DNC004463	4-Imidazol-1-ylmethyl-1-nitro-xanthen-9-one	Discovery agent	.	.
DNC004464	DesGly-NH2,d(CH2)5[D-Tyr2,Thr4,Orn8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004465	8-Imidazol-1-ylmethyl-5-nitro-chromen-4-one	Discovery agent	.	.
DNC004466	D(CH2)5[Tyr(Me)2,Thr4,Orn8(5/6C-Flu),Tyr-NH29]VT	Discovery agent	.	.
DNC004467	Firocoxib	Discovery agent	.	.
DNC004468	D[Lys8(5/6-Flu)]VT	Discovery agent	.	.
DNC004469	6-Amino-benzothiazole-2-sulfonic acid amide	Discovery agent	.	.
DNC004470	[HO1][Lys8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004471	FADROZOLE	Discovery agent	.	.
DNC004472	[HO1][Orn8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004473	[HO1][Thr4,Orn8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004474	[HO1][Orn8(5/6C-Rhm)]VT	Discovery agent	.	.
DNC004475	4-((1H-imidazol-1-yl)methyl)benzonitrile	Discovery agent	.	.
DNC004476	6-Imidazol-1-yl-isoquinoline	Discovery agent	.	.
DNC004477	D[Thr4,Lys8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004478	3-((1H-imidazol-1-yl)methyl)-9H-xanthen-9-one	Discovery agent	.	.
DNC004479	6-Hydroxy-benzothiazole-2-sulfonic acid amide	Discovery agent	.	.
DNC004480	D[Orn8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004481	D(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr9-NH2]VT	Discovery agent	.	.
DNC004482	N*4*-Benzyl-pyrido[4,3-d]pyrimidine-4,7-diamine	Discovery agent	.	.
DNC004483	1-(4-Cyanobenzyl)-5-methyl-1H-imidazole	Discovery agent	.	.
DNC004484	5-Bromo-8-imidazol-1-ylmethyl-chromen-4-one	Discovery agent	.	.
DNC004485	FADROZOLE HCL	Discovery agent	.	.
DNC004486	RPR-108514A	Discovery agent	.	.
DNC004487	[HO1][Thr4,Lys8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004488	D[Thr4,Orn8(5/6C-Flu)]VT	Discovery agent	.	.
DNC004489	5-Imidazol-1-yl-5,6,7,8-tetrahydro-quinoline	Discovery agent	.	.
DNC004490	1-Bromo-4-imidazol-1-ylmethyl-xanthen-9-one	Discovery agent	.	.
DNC004491	BMS-262084	Discovery agent	.	.
DNC004492	3-(4,5-Bis-biphenyl-4-yl-1H-imidazol-2-yl)-phenol	Discovery agent	.	.
DNC004493	Ro-31-4724	Arthritis	710-719	M00-M25
DNC004493	Ro-31-4724	Discovery agent	.	.
DNC004494	ISOPPADS	Discovery agent	.	.
DNC004495	7-((1H-imidazol-1-yl)methyl)-4H-chromen-4-one	Discovery agent	.	.
DNC004496	7-[1,2,4]Triazol-4-ylmethyl-chromen-4-one	Discovery agent	.	.
DNC004497	1,1,1-Trifluoro-8-phenoxy-octan-2-one	Discovery agent	.	.
DNC004498	1-Naphthalen-2-yl-piperazine	Discovery agent	.	.
DNC004499	6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one	Discovery agent	.	.
DNC004500	DL-benzylsuccinic acid	Discovery agent	.	.
DNC004501	ARPFAQK-FAM	Discovery agent	.	.
DNC004502	N-Butyl-N'-(4-methyl-benzoyl)-guanidine	Discovery agent	.	.
DNC004503	1-(7-Methoxy-naphthalen-2-yl)-piperazine	Discovery agent	.	.
DNC004504	CI-1018	Asthma	.	J45
DNC004504	CI-1018	Discovery agent	.	.
DNC004505	6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one	Discovery agent	.	.
DNC004506	3-(4-Amino-phenyl)-1-methyl-pyrrolidine-2,5-dione	Discovery agent	.	.
DNC004507	N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine	Discovery agent	.	.
DNC004508	AVPIAQKSEK-FAM	Discovery agent	.	.
DNC004509	6-(2-Imidazol-1-yl-vinyl)-1H-quinolin-2-one	Discovery agent	.	.
DNC004510	8-(Biphenyl-3-yloxy)-1,1,1-trifluoro-octan-2-one	Discovery agent	.	.
DNC004511	MR-20492	Discovery agent	.	.
DNC004512	MR-20496	Discovery agent	.	.
DNC004513	1-(7-Methoxy-2-phenyl-chroman-4-yl)-1H-imidazole	Discovery agent	.	.
DNC004514	PNU-107859	Discovery agent	.	.
DNC004515	BMS-193884	Discovery agent	.	.
DNC004515	BMS-193884	Pulmonary arterial hypertension	.	I27.0,I27.2
DNC004516	EMBELIN	Discovery agent	.	.
DNC004517	5-Bromo-6-methoxy-9H-beta-carboline	Discovery agent	.	.
DNC004518	PNU-142372	Discovery agent	.	.
DNC004519	3-(4-Amino-phenyl)-3-ethyl-pyrrolidine-2,5-dione	Discovery agent	.	.
DNC004520	MR-20814	Discovery agent	.	.
DNC004521	L-702-539	Discovery agent	.	.
DNC004522	7-hydroxy-2-phenylchroman-4-one	Discovery agent	.	.
DNC004523	BMS-187308	Discovery agent	.	.
DNC004523	BMS-187308	Hypertension	401	I10, I11, I12, I13, I15
DNC004524	1,1,1-Trifluoro-8-(4-phenoxy-phenoxy)-octan-2-one	Discovery agent	.	.
DNC004525	3-(4-Amino-phenyl)-3-methyl-pyrrolidine-2,5-dione	Discovery agent	.	.
DNC004526	3-(4-Amino-phenyl)-pyrrolidine-2,5-dione	Discovery agent	.	.
DNC004527	4-Imidazol-1-yl-2-phenyl-chroman-7-ol	Discovery agent	.	.
DNC004528	7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (S)-[(R)-1-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-ETHYL]-METHYL-AMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC004529	AG-490	Discovery agent	.	.
DNC004530	Carboron Cluster with phenol	Discovery agent	.	.
DNC004531	2-benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile	Discovery agent	.	.
DNC004532	SEMAXINIB	Discovery agent	.	.
DNC004533	Carboron Cluster with phenol	Discovery agent	.	.
DNC004534	2-cyano-3-(3,4-dihydroxyphenyl)acrylamide	Discovery agent	.	.
DNC004535	AAL-993	Discovery agent	.	.
DNC004536	2-phenyl-1,2'-spirobi[1H-indene]-5'-ol	Discovery agent	.	.
DNC004537	7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (3,5-BIS-TRIFLUOROMETHYL-BENZYL)-METHYL-AMIDE (STRUCTURAL MIX)	Discovery agent	.	.
DNC004538	2-phenyl-1,2'-spirobi[1H-indene]-5-ol	Discovery agent	.	.
DNC004539	NSC-651016	Discovery agent	.	.
DNC004540	SB-210313	Discovery agent	.	.
DNC004541	AG-538	Discovery agent	.	.
DNC004542	7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (S)-[(S)-1-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-ETHYL]-METHYL-AMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC004543	L-689065	Discovery agent	.	.
DNC004544	Carboron Cluster with phenol	Discovery agent	.	.
DNC004545	Carboron Cluster with phenol	Discovery agent	.	.
DNC004546	2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-6-ol	Discovery agent	.	.
DNC004547	5-Isopropyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole	Discovery agent	.	.
DNC004548	Carboron Cluster with phenol	Discovery agent	.	.
DNC004549	Carboron Cluster with phenol	Discovery agent	.	.
DNC004550	Carboron Cluster with phenol	Discovery agent	.	.
DNC004551	L-165461	Discovery agent	.	.
DNC004552	Gly-Arg-Gly-Asp-Ser-Pro-Lys	Discovery agent	.	.
DNC004553	L-796449	Discovery agent	.	.
DNC004554	Carboron Cluster with phenol	Discovery agent	.	.
DNC004555	[2-(5-Ethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine	Discovery agent	.	.
DNC004556	N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide	Discovery agent	.	.
DNC004557	SCH-211803	Discovery agent	.	.
DNC004557	SCH-211803	Parkinson's disease	.	G20
DNC004558	2-(4,5-Dihydroxy-indan-1-ylidene)-malononitrile	Discovery agent	.	.
DNC004559	5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole	Discovery agent	.	.
DNC004560	2-(5,6-Dihydroxy-indan-1-ylidene)-malononitrile	Discovery agent	.	.
DNC004561	CSNLSTCVLGKLSQELc[DKLHO]YPRTNTGSGTP-amide	Discovery agent	.	.
DNC004562	DuP-714	Discovery agent	.	.
DNC004563	ANDROSTENEDIONE	Discovery agent	.	.
DNC004564	FGGFTGCRKSCRK	Discovery agent	.	.
DNC004565	L-657925	Discovery agent	.	.
DNC004566	FGGFTCARKCARK	Discovery agent	.	.
DNC004567	CGS-21680	Discovery agent	.	.
DNC004567	CGS-21680	Hypertension	.	I10-I15
DNC004568	SQ-29548	Discovery agent	.	.
DNC004569	FGGFTGARKCARKC	Discovery agent	.	.
DNC004570	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole	Discovery agent	.	.
DNC004571	CFGGFTCARKSARK	Discovery agent	.	.
DNC004572	FGGFTGCRKSARKC	Discovery agent	.	.
DNC004573	CGNLSTCBLGTYTQDFNKFHZYPQTAIGVGAP-amide	Discovery agent	.	.
DNC004574	CGNLSTCBLGTYTQDF[DKFHO]YPQTAIGVGAP-amide	Discovery agent	.	.
DNC004575	FGGFTGCRKSCRK	Discovery agent	.	.
DNC004576	FGGFTGARKSARKLADE	Discovery agent	.	.
DNC004577	FGGFTGARKSARKL	Discovery agent	.	.
DNC004578	CSNLSTCVLGKLSQELNKLHBYPRTNTGSGTP-amide	Discovery agent	.	.
DNC004579	CSNLSTCVLGKLSQELc[DKLQK]YPRTNTGSGTP-amide	Discovery agent	.	.
DNC004580	CGNLSTCMLGTYTQDFNPFHTFPQTAIGVGAP-amide	Discovery agent	.	.
DNC004581	CFGGFTCARKSARK	Discovery agent	.	.
DNC004582	CGNLSTCMLGTYTQDFc[DKFHK]FPQTAIGVGAP-amide	Discovery agent	.	.
DNC004583	Cyclo[Cys6,Cys10]N/OFQ(1-13)NH2	Discovery agent	.	.
DNC004584	FGGFTGARKCARKC	Discovery agent	.	.
DNC004585	CGNLSTCMLGTYTQDFNKPHTFPQTAIGVGAP-amide	Discovery agent	.	.
DNC004586	CSNLSTCVLGKLSQELc[DKLHK]YPRTNTGSGTP-amide	Discovery agent	.	.
DNC004587	CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-amide	Discovery agent	.	.
DNC004588	1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione	Discovery agent	.	.
DNC004589	GW-501516	Diabetes mellitus type 1	.	E10
DNC004589	GW-501516	Discovery agent	.	.
DNC004590	FGGFTGARKSARK	Discovery agent	.	.
DNC004591	METHACHOLINE	Asthma	493	J45
DNC004591	METHACHOLINE	Discovery agent	.	.
DNC004592	3-(5-Thiophen-3-yl-pyridin-3-yl)-1H-indole	Discovery agent	.	.
DNC004593	TR-14035	Discovery agent	.	.
DNC004593	TR-14035	Multiple sclerosis	.	G35
DNC004594	MEDETOMIDINE	Discovery agent	.	.
DNC004594	MEDETOMIDINE	Pain	338	R52
DNC004595	MDL-2170	Discovery agent	.	.
DNC004596	FGGFTGCRKSARKC	Discovery agent	.	.
DNC004597	CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-amide	Discovery agent	.	.
DNC004598	CFGGFTGARKCARK	Discovery agent	.	.
DNC004599	CFGGFTGARKCARK	Discovery agent	.	.
DNC004600	CGNLSTCMLGTYTQDFNPKHTFPQTAIGVGAP-amide	Discovery agent	.	.
DNC004601	H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1645)	Discovery agent	.	.
DNC004602	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide	Discovery agent	.	.
DNC004603	CytotoxinPeptide Conjugate	Discovery agent	.	.
DNC004604	H-Lys-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1669)	Discovery agent	.	.
DNC004605	CytotoxinPeptide Conjugate	Discovery agent	.	.
DNC004606	BRADYKININ	Discovery agent	.	.
DNC004607	PD-157672	Discovery agent	.	.
DNC004608	CytotoxinPeptide Conjugate	Discovery agent	.	.
DNC004609	H-DArg-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1638)	Discovery agent	.	.
DNC004610	H-DArg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1431)	Discovery agent	.	.
DNC004611	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide	Discovery agent	.	.
DNC004612	3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione	Discovery agent	.	.
DNC004613	N-(4-Chloro-7-p-tolyl-isoquinolin-1-yl)-guanidine	Discovery agent	.	.
DNC004614	8-Oxo-8-phenyl-octanoic acid	Discovery agent	.	.
DNC004615	3-(4-Amino-phenyl)-3-heptyl-piperidine-2,6-dione	Discovery agent	.	.
DNC004616	Mozavaptan	Discovery agent	.	.
DNC004617	3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione	Discovery agent	.	.
DNC004618	FK-453	Discovery agent	.	.
DNC004618	FK-453	Renal failure	.	N17-N19
DNC004619	N-(7-Benzyloxy-isoquinolin-1-yl)-guanidine	Discovery agent	.	.
DNC004620	DIHYDRORALOXIFENE	Discovery agent	.	.
DNC004621	Octanedioic acid hydroxyamide pyridin-4-ylamide	Discovery agent	.	.
DNC004622	RWJ-50353	Discovery agent	.	.
DNC004623	3-(4-Methoxy-benzenesulfonyl)-hexane-1-thiol	Discovery agent	.	.
DNC004624	ICI-164384	Breast cancer	174, 175, 217	C50, D24
DNC004624	ICI-164384	Discovery agent	.	.
DNC004625	Octanedioic acid hydroxyamide pyridin-2-ylamide	Discovery agent	.	.
DNC004626	N-[5-(Formyl-hydroxy-amino)-pentyl]-benzamide	Discovery agent	.	.
DNC004627	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide	Discovery agent	.	.
DNC004628	LIVIDOMYCIN A	Discovery agent	.	.
DNC004629	(-)-CATECHINGALLATE	Discovery agent	.	.
DNC004630	N-(5-Benzyloxy-isoquinolin-1-yl)-guanidine	Discovery agent	.	.
DNC004631	GW-8510	Discovery agent	.	.
DNC004632	1-(4-Methoxy-benzenesulfonyl)-heptane-3-thiol	Discovery agent	.	.
DNC004633	GW-5074	Discovery agent	.	.
DNC004634	HOE-33258	Discovery agent	.	.
DNC004635	3-(4-Amino-phenyl)-3-propyl-piperidine-2,6-dione	Discovery agent	.	.
DNC004636	3-(4-Amino-phenyl)-3-hexyl-piperidine-2,6-dione	Discovery agent	.	.
DNC004637	3-(4-Methoxy-benzenesulfonyl)-pentane-1-thiol	Discovery agent	.	.
DNC004638	4-(4-Methoxy-benzenesulfonyl)-butane-2-thiol	Discovery agent	.	.
DNC004639	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide	Discovery agent	.	.
DNC004640	CGP-60474	Cancer	140-229	C00-C96
DNC004640	CGP-60474	Discovery agent	.	.
DNC004641	Sulfamic acid chroman-2-ylmethyl ester	Discovery agent	.	.
DNC004642	Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester	Discovery agent	.	.
DNC004643	5-Indan-(1E)-ylidenemethyl-1H-imidazole	Discovery agent	.	.
DNC004644	5-Indan-(1Z)-ylidenemethyl-1H-imidazole	Discovery agent	.	.
DNC004645	5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole	Discovery agent	.	.
DNC004646	5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole	Discovery agent	.	.
DNC004647	DEOXYNOJIRIMYCIN	Discovery agent	.	.
DNC004647	DEOXYNOJIRIMYCIN	Pompe's disease	.	E74.0
DNC004648	1-(oxazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC004649	(Z)-1,1,1-Trifluoro-nonadec-10-en-2-one	Discovery agent	.	.
DNC004650	1,1,1-Trifluoro-undecan-2-one	Discovery agent	.	.
DNC004651	1,1,1-Trifluoro-tridecan-2-one	Discovery agent	.	.
DNC004652	1,1,1-Trifluoro-nonadecan-2-one	Discovery agent	.	.
DNC004653	1,1,1-Trifluoro-7-phenylheptan-2-one	Discovery agent	.	.
DNC004654	1,1,1-Trifluoro-8-phenyl-octan-2-one	Discovery agent	.	.
DNC004655	1,1,1-Trifluoro-9-phenyl-nonan-2-one	Discovery agent	.	.
DNC004656	(Z)-1-(benzo[d]oxazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC004657	1-Benzooxazol-2-yl-6-phenyl-hexan-1-one	Discovery agent	.	.
DNC004658	1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one	Discovery agent	.	.
DNC004659	OL-92	Discovery agent	.	.
DNC004660	1-Oxazolo[4,5-b]pyridin-2-yl-octadec-9-yn-1-one	Discovery agent	.	.
DNC004661	OL-135	Discovery agent	.	.
DNC004661	OL-135	Pain	338,780	R52, G89
DNC004662	1-(5-Pyridin-2-yl-oxazol-2-yl)-octadec-9-yn-1-one	Discovery agent	.	.
DNC004663	CAPSAZEPINE	Discovery agent	.	.
DNC004664	A-80426	Discovery agent	.	.
DNC004665	S-34324	Discovery agent	.	.
DNC004666	INDISULAM	Discovery agent	.	.
DNC004666	INDISULAM	Lymphoma	.	C81-C96
DNC004667	Carzenide	Discovery agent	.	.
DNC004668	4-Hydrazinocarbonyl-benzenesulfonamide	Discovery agent	.	.
DNC004669	4-Hydrazinocarbonyl-benzenesulfonamide	Discovery agent	.	.
DNC004670	2-Sulfamoyl-benzoic acid methyl ester	Discovery agent	.	.
DNC004671	2-Hydrazinocarbonyl-benzenesulfonamide	Discovery agent	.	.
DNC004672	4-Hydrazino-benzenesulfonamide	Discovery agent	.	.
DNC004673	3-Fluoro-4-hydrazino-benzenesulfonamide	Discovery agent	.	.
DNC004674	3-Chloro-4-hydrazino-benzenesulfonamide	Discovery agent	.	.
DNC004675	2-Amino-benzenesulfonamide	Discovery agent	.	.
DNC004676	2-hydrazinylbenzenesulfonamide	Discovery agent	.	.
DNC004677	2-(N''-Acetyl-hydrazino)-benzenesulfonamide	Discovery agent	.	.
DNC004678	LUF-5853	Discovery agent	.	.
DNC004679	E-6837	Discovery agent	.	.
DNC004680	2-(4-Phenoxy-phenyl)-1H-benzoimidazol-5-ylamine	Discovery agent	.	.
DNC004681	5-Nitro-2-(4-phenoxy-phenyl)-1H-benzoimidazole	Discovery agent	.	.
DNC004682	RAZAXABAN HYDROCHLORIDE	Discovery agent	.	.
DNC004683	(4-Fluoro-phenyl)-(9H-purin-6-yl)-amine	Discovery agent	.	.
DNC004684	(4-Fluoro-phenyl)-(9-methyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC004685	6-Phenylsulfanyl-9H-purine	Discovery agent	.	.
DNC004686	3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004687	3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004688	3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004689	PG-01037	Discovery agent	.	.
DNC004690	6-(4-Fluoro-phenylsulfanyl)-9H-purine	Discovery agent	.	.
DNC004691	4-Phenylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine	Discovery agent	.	.
DNC004692	3-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004693	3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004694	3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004695	3-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004696	3-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004697	6-Benzylsulfanyl-9H-purine	Discovery agent	.	.
DNC004698	3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004699	3-[4-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004700	3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004701	3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004702	3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004703	3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004704	3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004705	4-Indan-(1E)-ylidenemethyl-pyridine	Discovery agent	.	.
DNC004706	4-Indan-(1Z)-ylidenemethyl-pyridine	Discovery agent	.	.
DNC004707	4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004708	4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004709	4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004710	4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004711	4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004712	4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004713	FISETIN	Discovery agent	.	.
DNC004714	APIGENIN	Discovery agent	.	.
DNC004715	CHRYSIN	Discovery agent	.	.
DNC004716	4-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004717	4-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC004718	6-[(E)-2-(4-Fluoro-phenyl)-vinyl]-9H-purine	Discovery agent	.	.
DNC004719	Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Cys14]SRIF	Discovery agent	.	.
DNC004720	Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF CH-288	Discovery agent	.	.
DNC004721	Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]SRIF	Discovery agent	.	.
DNC004722	Des-AA1,5-[Tyr2,D-Trp8,IAmp9]Cbm-SRIF	Discovery agent	.	.
DNC004723	Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]Cbm-SRIF	Discovery agent	.	.
DNC004724	Des-AA1,2,5-[D-Trp8,Tyr11]SRIF	Discovery agent	.	.
DNC004725	SRIF-28	Discovery agent	.	.
DNC004726	Des-AA5-[D-Trp8]SRIF	Discovery agent	.	.
DNC004727	Des-AA1,2,5-[D-Trp8,IAmp9]SRIF CH-275	Discovery agent	.	.
DNC004728	Des-AA1,2,5-[D-Nal8,IAmp9]SRIF	Discovery agent	.	.
DNC004729	Des-AA1,2,5-[(NalphaMe)Cys3,D-Nal8,IAmp9]SRIF	Discovery agent	.	.
DNC004730	Des-AA1,2,5-[(NalphaMe)Lys4,D-Nal8,IAmp9]SRIF	Discovery agent	.	.
DNC004731	Des-AA1,2,5-[(NalphaMe)D-Nal8,IAmp9]SRIF	Discovery agent	.	.
DNC004732	Des-AA1,2,5-[D-Nal8,(NalphaMe)IAmp9]SRIF	Discovery agent	.	.
DNC004733	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Phe11]SRIF	Discovery agent	.	.
DNC004734	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Thr12]SRIF	Discovery agent	.	.
DNC004735	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Ser13]SRIF	Discovery agent	.	.
DNC004736	9-Benzyl-6-phenylsulfanyl-9H-purine	Discovery agent	.	.
DNC004737	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Cys14]SRIF	Discovery agent	.	.
DNC004738	Des-AA1,2,5-[(NalphaMe)Cys3,D-Trp8,IAmp9]SRIF	Discovery agent	.	.
DNC004739	Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9]SRIF	Discovery agent	.	.
DNC004740	Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Thr12]SRIF	Discovery agent	.	.
DNC004741	Des-AA1,2,5-[IAmp9,Tyr11]-SRIF	Discovery agent	.	.
DNC004742	9-Benzyl-6-(4-fluoro-phenylsulfanyl)-9H-purine	Discovery agent	.	.
DNC004743	9-(4-Fluoro-benzyl)-6-phenylsulfanyl-9H-purine	Discovery agent	.	.
DNC004744	Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9,Tyr11]SRIF	Discovery agent	.	.
DNC004745	Des-AA1,2,5-[D-Trp8,IAmp9,Tyr11]Cbm-SRIF	Discovery agent	.	.
DNC004746	Des-AA1,2,5-[D-Trp8,IAmp9,m-I-Tyr11]Cbm-SRIF	Discovery agent	.	.
DNC004747	Des-AA1,2,5-[D-Nal8,(NalphaMe)IAmp9,Tyr11]SRIF	Discovery agent	.	.
DNC004748	Des-AA1,2,4,13-[D-Trp8]SRIF	Discovery agent	.	.
DNC004749	Des-AA1,2,4,5-[D-Trp8]SRIF	Discovery agent	.	.
DNC004750	Des-AA1,2,4,5,13-[D-Trp8]-SRIF	Discovery agent	.	.
DNC004751	Des-AA1,4,5,13-[Tyr2,D-Trp8]-SRIF	Discovery agent	.	.
DNC004752	Des-AA1,2,4,12,13-[D-Trp8]SRIF	Discovery agent	.	.
DNC004753	Des-AA1,2,5,12,13-[D-Trp8]SRIF	Discovery agent	.	.
DNC004754	Des-AA1,2,5,12,13-[D-Trp8,IAmp9]SRIF	Discovery agent	.	.
DNC004755	1-(4-Bromo-benzyl)-3-quinazolin-8-yl-urea	Discovery agent	.	.
DNC004756	ODT-8	Discovery agent	.	.
DNC004757	Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF	Discovery agent	.	.
DNC004758	Des-AA1,2,4,5,11,12,13-[D-Trp8]SRIF	Discovery agent	.	.
DNC004759	Des-AA1,2,4,5,10,12,13-[D-Trp8]SRIF	Discovery agent	.	.
DNC004760	Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Ser13]SRIF	Discovery agent	.	.
DNC004761	2-Pyrrolidin-1-yl-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004762	2-[1,4]Oxazepan-4-yl-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004763	2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004764	4-Morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004765	4-Piperidin-1-yl-chromen-2-one	Discovery agent	.	.
DNC004766	6-Methyl-4-morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004767	8-Methyl-4-morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004768	6-Methoxy-4-morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004769	7-Methoxy-4-morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004770	8-Methoxy-4-morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004771	6-Chloro-4-morpholin-4-yl-chromen-2-one	Discovery agent	.	.
DNC004772	ALPHA-NAPHTHOFLAVONE	Discovery agent	.	.
DNC004773	2-(2-Fluoro-phenyl)-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004774	2-(3-Fluoro-phenyl)-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004775	2-(4-Amino-phenyl)-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004776	2-Pyridin-3-yl-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004777	2-Morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one	Discovery agent	.	.
DNC004778	2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one	Discovery agent	.	.
DNC004779	[N40,Pro1,Tyr4,Nle 14]BB	Discovery agent	.	.
DNC004780	Universal ligand	Discovery agent	.	.
DNC004781	[N40,Pro1,Tyr4]BB	Discovery agent	.	.
DNC004782	[(N4-Bzdig)0]BB(7-14)	Discovery agent	.	.
DNC004783	[(N4-Bzdig)0,Nle14]BB(7-14)	Discovery agent	.	.
DNC004784	[Tyr4]Bombesin	Discovery agent	.	.
DNC004785	2-Morpholin-4-yl-benzo[h]chromene-4-thione	Discovery agent	.	.
DNC004786	2-thiomorpholino-4H-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004787	2-morpholino-4H-benzo[g]chromen-4-one	Discovery agent	.	.
DNC004788	3-morpholino-1H-benzo[f]chromen-1-one	Discovery agent	.	.
DNC004789	4-Morpholin-4-yl-benzo[g]chromen-2-one	Discovery agent	.	.
DNC004790	4-Thiomorpholin-4-yl-benzo[g]chromen-2-one	Discovery agent	.	.
DNC004791	4-Morpholin-4-yl-benzo[h]chromen-2-one	Discovery agent	.	.
DNC004792	1-Morpholin-4-yl-benzo[f]chromen-3-one	Discovery agent	.	.
DNC004793	2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one	Discovery agent	.	.
DNC004794	8-Methyl-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC004795	7-Methoxy-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC004796	8-Methoxy-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC004797	2-Morpholin-4-yl-6-phenyl-chromen-4-one	Discovery agent	.	.
DNC004798	8-Phenyl-2-piperidin-1-yl-chromen-4-one	Discovery agent	.	.
DNC004799	8-Phenyl-2-thiomorpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC004800	2-(piperidin-1-yl)-4H-benzo[h]chromen-4-one	Discovery agent	.	.
DNC004801	CHF-2819	Discovery agent	.	.
DNC004802	7-Mercapto-heptanoic acid phenylamide	Discovery agent	.	.
DNC004803	8-Mercapto-octanoic acid phenylamide	Discovery agent	.	.
DNC004804	6-Mercapto-hexanoic acid phenylamide	Discovery agent	.	.
DNC004805	5-Mercapto-pentanoic acid phenylamide	Discovery agent	.	.
DNC004806	6-Phenoxy-hexane-1-thiol	Discovery agent	.	.
DNC004807	N-(6-Mercapto-hexyl)-benzamide	Discovery agent	.	.
DNC004808	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester	Discovery agent	.	.
DNC004809	7-Mercapto-heptanoic acid biphenyl-4-ylamide	Discovery agent	.	.
DNC004810	7-Mercapto-heptanoic acid biphenyl-3-ylamide	Discovery agent	.	.
DNC004811	7-Mercapto-heptanoic acid pyridin-3-ylamide	Discovery agent	.	.
DNC004812	7-Mercapto-heptanoic acid quinolin-3-ylamide	Discovery agent	.	.
DNC004813	7-Mercapto-heptanoic acid benzothiazol-2-ylamide	Discovery agent	.	.
DNC004814	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide	Discovery agent	.	.
DNC004815	NERATINIB	Discovery agent	.	.
DNC004815	NERATINIB	Lymphoma	.	C81-C96
DNC004816	GNF-PF-607	Discovery agent	.	.
DNC004817	E[c(RGDyK)]2	Discovery agent	.	.
DNC004818	N*6*-Benzyl-quinazoline-2,4,6-triamine	Discovery agent	.	.
DNC004819	E[c(RGDyK)]2-PTX conjugate	Discovery agent	.	.
DNC004820	4-Benzyl-1-chroman-2-ylmethyl-piperidine	Discovery agent	.	.
DNC004821	Varespladib sodium	Inflammation	.	I20-I25
DNC004822	2-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one	Discovery agent	.	.
DNC004823	3-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one	Discovery agent	.	.
DNC004824	3-(4-Benzyl-piperidin-1-ylmethyl)-chromen-4-one	Discovery agent	.	.
DNC004825	UK-427857	Discovery agent	.	.
DNC004826	Ac-I[CVVQDWGAHRC]T-NH2	Discovery agent	.	.
DNC004827	Ac-I[CVTQDWGHHRC]T-NH2	Discovery agent	.	.
DNC004828	Ac-I[CVSQDWGHHRC]T-NH2	Discovery agent	.	.
DNC004829	Ac-I[CVHQDWGHHRC]T-NH2	Discovery agent	.	.
DNC004830	Ac-I[CVFQDWGHHRC]T-NH2	Discovery agent	.	.
DNC004831	Ac-I[CVYQDWGAHRC]T-NH2	Discovery agent	.	.
DNC004832	Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine	Discovery agent	.	.
DNC004833	1-Benzyl-4-chroman-2-ylmethyl-piperazine	Discovery agent	.	.
DNC004834	Ac-I[CVWQDWGWHRC]T-NH2	Discovery agent	.	.
DNC004835	Ac-I[CVWQDWGHHRC]T-NH2	Discovery agent	.	.
DNC004836	Ac-I[CVWQDWGAHRC]T	Discovery agent	.	.
DNC004837	Ac-I[CV(Dht)QDWGAHRC]T	Discovery agent	.	.
DNC004838	Ac-I[CV(Yphs)QDWGAHRC]I-NH2	Discovery agent	.	.
DNC004839	Ac-I[CVWQDWG(Abu)HRC]T-NH2	Discovery agent	.	.
DNC004840	Ac-I[CV(2Igl)QDWGAHRC]T	Discovery agent	.	.
DNC004841	Ac-I[CV(2Igl)QDWGAHRC]T-NH2	Discovery agent	.	.
DNC004842	Ac-I[CV(Bta)QDWGAHRC]T	Discovery agent	.	.
DNC004843	Ac-I[CV(Bta)QDWGAHRC]T-NH2	Discovery agent	.	.
DNC004844	Ac-I[CV(Bpa)QDWGAHRC]T	Discovery agent	.	.
DNC004845	Ac-I[CV(Bpa)QDWGAHRC]T-NH2	Discovery agent	.	.
DNC004846	Ac-I[CV(1Nal)QDWGAHRC]T	Discovery agent	.	.
DNC004847	Ac-I[CV(2Nal)QDWGAHRC]T	Discovery agent	.	.
DNC004848	Ac-I[CV(2Nal)QDWGAHRC]T-NH2	Discovery agent	.	.
DNC004849	Ac-I[CVWQDWGAHRC]dT	Discovery agent	.	.
DNC004850	2-(4-Methyl-piperazin-1-yl)-quinoline	Discovery agent	.	.
DNC004851	2-(4-Propyl-piperazin-1-yl)-quinoline	Discovery agent	.	.
DNC004852	2-(4-Isopropyl-piperazin-1-yl)-quinoline	Discovery agent	.	.
DNC004853	2-[4-(1-Ethyl-propyl)-piperazin-1-yl]-quinoline	Discovery agent	.	.
DNC004854	2-(4-Cyclopropyl-piperazin-1-yl)-quinoline	Discovery agent	.	.
DNC004855	2-(4-Cyclopentyl-piperazin-1-yl)-quinoline	Discovery agent	.	.
DNC004856	3-(3-methylthiophen-2-yl)pyridine	Discovery agent	.	.
DNC004857	NBI-42902	Discovery agent	.	.
DNC004857	NBI-42902	Prostate cancer	.	C61
DNC004858	5-Pyridin-3-yl-thiophene-2-carbaldehyde oxime	Discovery agent	.	.
DNC004859	T-98475	Discovery agent	.	.
DNC004860	Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine	Discovery agent	.	.
DNC004861	(5-(pyridin-3-yl)furan-2-yl)methanamine	Discovery agent	.	.
DNC004862	A-349821	Discovery agent	.	.
DNC004863	4-Benzyl-1-chroman-3-ylmethyl-piperidine	Discovery agent	.	.
DNC004864	9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purine	Discovery agent	.	.
DNC004865	1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole	Discovery agent	.	.
DNC004866	2-[1-(2-Chloro-phenyl)-1H-pyrrol-2-yl]-ethylamine	Discovery agent	.	.
DNC004867	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC004868	5-METHOXYTRYPTAMINE	Discovery agent	.	.
DNC004869	OCTOCLOTHEPIN	Discovery agent	.	.
DNC004870	PYRIPYROPENE A	Discovery agent	.	.
DNC004871	N-hydroxycarbamate derivative	Discovery agent	.	.
DNC004872	N-hydroxycarbamate derivative	Discovery agent	.	.
DNC004873	N-hydroxycarbamate derivative	Discovery agent	.	.
DNC004874	N-hydroxycarbamate derivative	Discovery agent	.	.
DNC004875	Correloid	Discovery agent	.	.
DNC004876	Correloid derivative	Discovery agent	.	.
DNC004877	Correloid derivative	Discovery agent	.	.
DNC004878	NPS-2143	Discovery agent	.	.
DNC004879	N-hydroxycarbamate derivative	Discovery agent	.	.
DNC004880	N-hydroxycarbamate derivative	Discovery agent	.	.
DNC004881	(E)-(thiophen-2-ylmethylidene)amino benzoate	Discovery agent	.	.
DNC004882	(2-hydroxy-3-phenoxypropyl)(propan-2-yl)amine	Discovery agent	.	.
DNC004883	N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine	Discovery agent	.	.
DNC004884	N4-(3-chlorophenyl)quinazoline-4,6-diamine	Discovery agent	.	.
DNC004885	P-TOLUENESULFONAMIDE	Discovery agent	.	.
DNC004886	MAFENIDE	Discovery agent	.	.
DNC004887	4-(2-Amino-ethyl)-benzenesulfonamide	Discovery agent	.	.
DNC004888	4-Amino-3-fluoro-benzenesulfonamide	Discovery agent	.	.
DNC004889	4-Amino-3-chloro-benzenesulfonamide	Discovery agent	.	.
DNC004890	4-Amino-3-bromo-benzenesulfonamide	Discovery agent	.	.
DNC004891	4-Amino-3-iodo-benzenesulfonamide	Discovery agent	.	.
DNC004892	2,4-Disulfamyltrifluoromethylaniline	Discovery agent	.	.
DNC004893	Des-His1[Glu9]glucagon-NH2	Discovery agent	.	.
DNC004894	BUCINDOLOL	Discovery agent	.	.
DNC004894	BUCINDOLOL	Hypertension	.	I10-I15
DNC004895	5-amino-1,3,4-thiadiazole-2-sulfonamide	Discovery agent	.	.
DNC004896	Benzothiazole-2-sulfonic acid amide	Discovery agent	.	.
DNC004897	4-(hydroxymethyl)benzenesulfonamide	Discovery agent	.	.
DNC004898	2-methyl-4-(pyridin-3-ylethynyl)thiazole	Discovery agent	.	.
DNC004899	NU-8231	Discovery agent	.	.
DNC004900	4-(2-Hydroxy-ethyl)-benzenesulfonamide	Discovery agent	.	.
DNC004901	SP-4206	Autoimmune diseases	.	D84.9
DNC004901	SP-4206	Discovery agent	.	.
DNC004902	Benzaldehyde O-benzoyloxime	Discovery agent	.	.
DNC004903	3,4-difluorobenzaldehyde O-benzoyloxime	Discovery agent	.	.
DNC004904	4-fluorobenzaldehyde O-benzoyloxime	Discovery agent	.	.
DNC004905	2-Furan-2-yl-3-phenethyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC004906	ICI-199441	Discovery agent	.	.
DNC004907	4-(Naphthalene-1-sulfonyl)-phenylamine	Discovery agent	.	.
DNC004908	1-(2-Methoxy-phenyl)-piperazine	Discovery agent	.	.
DNC004909	3-Phenethyl-2-phenyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC004910	3-Amino-benzenesulfonamide	Discovery agent	.	.
DNC004911	Thioureido sulfonamide	Discovery agent	.	.
DNC004912	Aminocarbonyl dihydrogen phosphate	Discovery agent	.	.
DNC004913	Benzyl derivative of M6G	Discovery agent	.	.
DNC004914	MEN-14933	Discovery agent	.	.
DNC004915	BENZOLAMIDE	Discovery agent	.	.
DNC004916	Thioureido sulfonamide	Discovery agent	.	.
DNC004917	M6G thiosaccharide analogue	Discovery agent	.	.
DNC004918	Thioureido sulfonamide	Discovery agent	.	.
DNC004919	M6G thiosaccharide analogue	Discovery agent	.	.
DNC004920	Methyl-phosphonic acid	Discovery agent	.	.
DNC004921	Phenyl-phosphonic acid	Discovery agent	.	.
DNC004922	SPARFOSIC ACID	Discovery agent	.	.
DNC004923	Deprotected cogener of M6G	Discovery agent	.	.
DNC004924	RS-513815	Discovery agent	.	.
DNC004925	RWJ-68141	Discovery agent	.	.
DNC004926	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine	Discovery agent	.	.
DNC004927	SILODOSIN	Benign prostatic hyperplasia	600	N40
DNC004927	SILODOSIN	Discovery agent	.	.
DNC004928	SNAP-7915	Discovery agent	.	.
DNC004929	(-)-SNAP-5089	Discovery agent	.	.
DNC004930	SNAP-6201	Discovery agent	.	.
DNC004931	L-771688	Discovery agent	.	.
DNC004931	L-771688	Prostate disorder	.	N40-N42
DNC004932	(-)-SNAP-5399	Discovery agent	.	.
DNC004933	RS-17053	Discovery agent	.	.
DNC004933	RS-17053	Prostate hyperplasia	.	N40
DNC004934	UPIDOSIN	Discovery agent	.	.
DNC004935	Ro-700004	Discovery agent	.	.
DNC004936	SNAP-5150	Discovery agent	.	.
DNC004937	AR-129330	Discovery agent	.	.
DNC004938	L-765314	Discovery agent	.	.
DNC004939	AM-630	Discovery agent	.	.
DNC004940	A-315456	Discovery agent	.	.
DNC004941	A-131701	Discovery agent	.	.
DNC004942	RS-100329	Discovery agent	.	.
DNC004943	NAFTOPIDIL	Discovery agent	.	.
DNC004943	NAFTOPIDIL	Hypertension	401	I10, I11, I12, I13, I15
DNC004944	SNAP-5036	Discovery agent	.	.
DNC004945	Ro-11-04253	Discovery agent	.	.
DNC004946	4-(3,4-Diethoxy-benzylamino)-benzamidine	Discovery agent	.	.
DNC004947	Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester	Discovery agent	.	.
DNC004948	Sulfamic acid 3-sulfamoyloxy-phenyl ester	Discovery agent	.	.
DNC004949	[Cu(CN)2]-	Discovery agent	.	.
DNC004950	Oxalate sodium	Discovery agent	.	.
DNC004951	Malonate sodium	Discovery agent	.	.
DNC004952	PYRUVATE SODIUM	Discovery agent	.	.
DNC004953	ATC-0175	Discovery agent	.	.
DNC004953	ATC-0175	Major depressive disorder	.	F32,F33
DNC004954	SODIUM CITRATE	Discovery agent	.	.
DNC004955	[Au(CN)2]-	Discovery agent	.	.
DNC004956	[Fe(CN)6]4-	Discovery agent	.	.
DNC004957	Sodium 2,3,5,6-tetrafluorobenzoate	Discovery agent	.	.
DNC004958	SULFAMATE	Discovery agent	.	.
DNC004959	Sulfamic acid 4-sulfamoyloxy-butyl ester	Discovery agent	.	.
DNC004960	Sulfamic acid 6-sulfamoyloxy-hexyl ester	Discovery agent	.	.
DNC004961	Sulfamic acid 7-sulfamoyloxy-heptyl ester	Discovery agent	.	.
DNC004962	Octane-1,8-diyl disulfamate	Discovery agent	.	.
DNC004963	SULFAMIDE	Discovery agent	.	.
DNC004964	BICARBONATE	Discovery agent	.	.
DNC004965	Decane-1,10-diyl disulfamate	Discovery agent	.	.
DNC004966	Sulfamic acid 12-sulfamoyloxy-dodecyl ester	Discovery agent	.	.
DNC004967	Sulfamic acid 16-sulfamoyloxy-hexadecyl ester	Discovery agent	.	.
DNC004968	2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide	Discovery agent	.	.
DNC004969	Oxalyl-DAP derivative	Discovery agent	.	.
DNC004970	Oxalyl-DAP derivative	Discovery agent	.	.
DNC004971	2-Amino-4-phosphono-butyric acid	Discovery agent	.	.
DNC004972	Pyrrolidine-1-carbonitrile	Discovery agent	.	.
DNC004973	Alpha-MSH	Dermatological disease	.	L00-L99
DNC004973	Alpha-MSH	Discovery agent	.	.
DNC004974	KYS-05041	Discovery agent	.	.
DNC004975	KYS-05042	Discovery agent	.	.
DNC004976	4-Methylamino-benzenesulfonamide	Discovery agent	.	.
DNC004977	4-(N-Methyl-hydrazino)-benzenesulfonamide	Discovery agent	.	.
DNC004978	N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide	Discovery agent	.	.
DNC004979	Meglutol	Discovery agent	.	.
DNC004980	KYS-05050	Cancer	.	C00-C97
DNC004980	KYS-05050	Discovery agent	.	.
DNC004981	SB-381320	Discovery agent	.	.
DNC004982	ICI-204448	Discovery agent	.	.
DNC004982	ICI-204448	Pain	338,780	R52, G89
DNC004983	SK&F-64139	Discovery agent	.	.
DNC004984	SK&F-29661	Discovery agent	.	.
DNC004985	7-Nitro-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC004986	3-Methyl-7-nitro-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC004987	3-(1-Pyridin-2-yl-1H-pyrrol-3-yl)-benzonitrile	Discovery agent	.	.
DNC004988	3-(3-Pyridin-2-yl-pyrrol-1-yl)-benzonitrile	Discovery agent	.	.
DNC004989	3-(1-Pyridin-2-yl-1H-pyrazol-3-yl)-benzonitrile	Discovery agent	.	.
DNC004990	3-(3-Pyridin-2-yl-pyrazol-1-yl)-benzonitrile	Discovery agent	.	.
DNC004991	3-(1-Pyridin-2-yl-1H-pyrazol-4-yl)-benzonitrile	Discovery agent	.	.
DNC004992	2-(4-Hydroxy-phenyl)-benzofuran-5-ol	Discovery agent	.	.
DNC004993	7-Bromo-2-(4-hydroxy-phenyl)-benzofuran-5-ol	Discovery agent	.	.
DNC004994	2-(4-Hydroxy-phenyl)-7-methoxy-benzofuran-5-ol	Discovery agent	.	.
DNC004995	HIMBACINE	Discovery agent	.	.
DNC004996	2-Methyl-4-phenylethynyl-thiazole	Discovery agent	.	.
DNC004997	2-Methyl-4-o-tolylethynyl-thiazole	Discovery agent	.	.
DNC004998	2-methyl-4-(m-tolylethynyl)thiazole	Discovery agent	.	.
DNC004999	2-Methyl-4-p-tolylethynyl-thiazole	Discovery agent	.	.
DNC005000	4-Biphenyl-2-ylethynyl-2-methyl-thiazole	Discovery agent	.	.
DNC005001	3-Phenyl-1-(2-methylthiazol-4-ylethynyl)benzene	Discovery agent	.	.
DNC005002	4-Biphenyl-4-ylethynyl-2-methyl-thiazole	Discovery agent	.	.
DNC005003	2-(2-Methyl-thiazol-4-ylethynyl)-pyridine	Discovery agent	.	.
DNC005004	4-(2-Methyl-thiazol-4-ylethynyl)-pyridine	Discovery agent	.	.
DNC005005	U-0126	Discovery agent	.	.
DNC005006	4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005007	5-Methyl-4-propyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005008	5-Ethyl-4-propyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005009	Hexahydro-pyrrolizin-(3E)-ylideneamine	Discovery agent	.	.
DNC005010	Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine	Discovery agent	.	.
DNC005011	Octahydro-isoindol-(1Z)-ylideneamine	Discovery agent	.	.
DNC005012	Thiazolidin-(2E)-ylideneamine	Discovery agent	.	.
DNC005013	1-(2-Bromo-phenyl)-3-(2,4-dihydroxy-phenyl)-urea	Discovery agent	.	.
DNC005014	Methanesulfonamide derivative	Discovery agent	.	.
DNC005015	Methanesulfonamide derivative	Discovery agent	.	.
DNC005016	Methanesulfonamide derivative	Discovery agent	.	.
DNC005017	Methanesulfonamide derivative	Discovery agent	.	.
DNC005018	4-Butyl-thiazolidin-(2E)-ylideneamine	Discovery agent	.	.
DNC005019	Hexahydro-cyclopenta[b]pyrrol-(2Z)-ylideneamine	Discovery agent	.	.
DNC005020	4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine	Discovery agent	.	.
DNC005021	4-Pyridin-3-yl-5-quinolin-4-yl-thiazol-2-ylamine	Discovery agent	.	.
DNC005022	Methanesulfonamide derivative	Discovery agent	.	.
DNC005023	Cynooxide anion	Discovery agent	.	.
DNC005024	Methanesulfonamide derivative	Discovery agent	.	.
DNC005025	Methanesulfonamide derivative	Discovery agent	.	.
DNC005026	2-(4-Fluoro-indole-1-sulfonyl)-benzoic acid	Discovery agent	.	.
DNC005027	2-(5-Bromo-indole-1-sulfonyl)-benzoic acid	Discovery agent	.	.
DNC005028	3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005029	4-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005030	5-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005031	4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005032	5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005033	4-Methyl-5-propyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005034	N-(5-Amino-6-oxo-heptyl)-acetamidine	Discovery agent	.	.
DNC005035	Pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005036	[2-(3H-Indol-1-yl)-ethyl]-dimethyl-amine	Discovery agent	.	.
DNC005037	[2-(3-Benzyl-3H-indol-1-yl)-ethyl]-dimethyl-amine	Discovery agent	.	.
DNC005038	Hexadecanoic acid	Discovery agent	.	.
DNC005039	3-Carbazol-9-yl-propionic acid	Discovery agent	.	.
DNC005040	4-Carbazol-9-yl-butyric acid	Discovery agent	.	.
DNC005041	5-Carbazol-9-yl-pentanoic acid	Discovery agent	.	.
DNC005042	3-Methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005043	4-Methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005044	5-Methyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005045	4-Ethyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005046	4-Isopropyl-pyrrolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC005047	2-(Carbazole-9-sulfonyl)-benzoic acid	Discovery agent	.	.
DNC005048	2-(3-Methyl-indole-1-sulfonyl)-benzoic acid	Discovery agent	.	.
DNC005049	2-(4-Methyl-indole-1-sulfonyl)-benzoic acid	Discovery agent	.	.
DNC005050	2-(6-Methoxy-indole-1-sulfonyl)-benzoic acid	Discovery agent	.	.
DNC005051	Azide	Discovery agent	.	.
DNC005052	HYDROSULFIDE	Discovery agent	.	.
DNC005053	7-Chloro-2-(4-hydroxy-phenyl)-benzofuran-5-ol	Discovery agent	.	.
DNC005054	2-(4-Hydroxy-phenyl)-7-methyl-benzofuran-5-ol	Discovery agent	.	.
DNC005055	KR-62436	Discovery agent	.	.
DNC005055	KR-62436	Non-insulin dependent diabetes	.	E11.9
DNC005056	2-(2,6-Dimethyl-benzyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC005057	NH2-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-CONH2	Discovery agent	.	.
DNC005058	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005059	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005060	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005061	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005062	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005063	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005064	GLP-17-(7-36) derivative	Discovery agent	.	.
DNC005065	8-(1,3,3-Trimethyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005066	A-224940	Discovery agent	.	.
DNC005067	Isoindolinone Urea derivative	Discovery agent	.	.
DNC005068	2-(4-tert-Butyl-phenyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC005069	(3-Tetradecylamino-cyclopentyl)-phosphonic acid	Discovery agent	.	.
DNC005070	(3-Tetradecylamino-cyclohexyl)-phosphonic acid	Discovery agent	.	.
DNC005071	[3-(4-Nonyl-benzylamino)-propyl]-phosphonic acid	Discovery agent	.	.
DNC005072	ZK-164015	Discovery agent	.	.
DNC005073	8-Butoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005074	8-Cyclobutylmethoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005075	8-(2-Cyclopropyl-ethoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005076	8-Pentyloxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005077	8-(2-Methyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005078	8-(3-Methyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005079	8-Cyclopentylmethoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005080	8-Hexyloxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005081	8-(3,3-Dimethyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005082	8-(3,3,3-trifluoropropoxy)quinolin-2-amine	Discovery agent	.	.
DNC005083	Gold trichloride sodium chloride	Discovery agent	.	.
DNC005084	3-(N-alkylamino) propylphosphonic acid derivative	Discovery agent	.	.
DNC005085	3-(tetradecylamino)propylphosphonic acid	Discovery agent	.	.
DNC005086	2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol	Discovery agent	.	.
DNC005087	8-(3-Methoxy-3-methyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005088	8-Isopropoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005089	8-sec-Butoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005090	DAMGO	Discovery agent	.	.
DNC005091	8-(1-Methyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005092	8-(1,2-Dimethyl-propoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005093	8-(1-Ethyl-propoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005094	8-(2-Methoxy-1-methyl-ethoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005095	8-Cyclohexyloxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005096	8-(3-Methyl-cyclopentyloxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005097	8-(2-Methyl-cyclohexyloxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005098	8-(2-Ethoxy-1-methyl-ethoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005099	8-(3-Methyl-cyclohexyloxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005100	8-(4-Methyl-cyclohexyloxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005101	8-Cycloheptyloxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005102	8-(2-Ethyl-1-methyl-butoxy)-quinolin-2-ylamine	Discovery agent	.	.
DNC005103	8-Methoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005104	8-Propoxy-quinolin-2-ylamine	Discovery agent	.	.
DNC005105	3-(1H-Indol-3-yl)-4-phenylamino-pyrrole-2,5-dione	Discovery agent	.	.
DNC005106	P2,P3 Ketoamide derivative	Discovery agent	.	.
DNC005107	ZM-336372	Discovery agent	.	.
DNC005108	3-Nitro-benzenesulfonamide	Discovery agent	.	.
DNC005109	ISONIPECOTAMIDE	Discovery agent	.	.
DNC005110	TYRPHOSTIN AG-1478	Discovery agent	.	.
DNC005111	2-Phenyl-4-[1,2,4]triazol-1-yl-chroman-7-ol	Discovery agent	.	.
DNC005112	FLUPERAMIDE	Discovery agent	.	.
DNC005113	SULFATE	Discovery agent	.	.
DNC005114	Phenyl Boronic acid	Discovery agent	.	.
DNC005115	Phenoxyarsonous acid	Discovery agent	.	.
DNC005116	4-Thiocyanato-benzenesulfonamide	Discovery agent	.	.
DNC005117	4-Nitro-benzenesulfonamide	Discovery agent	.	.
DNC005118	CHLORIDE	Discovery agent	.	.
DNC005118	CHLORIDE	Solid tumours	.	C00-C75,C7A,C7B
DNC005119	IODIDE	Discovery agent	.	.
DNC005120	CYANATE	Discovery agent	.	.
DNC005121	6-Nitro-benzothiazole-2-sulfonic acid amide	Discovery agent	.	.
DNC005122	NITRATE	Discovery agent	.	.
DNC005123	SN-429	Discovery agent	.	.
DNC005124	2-(1-(phenylsulfonyl)-1H-indol-3-yl)ethanamine	Discovery agent	.	.
DNC005125	2-(3-(phenylsulfonyl)-1H-indol-1-yl)ethanamine	Discovery agent	.	.
DNC005126	(R)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005127	BN-82002	Cancer	140-229	C00-C96
DNC005127	BN-82002	Discovery agent	.	.
DNC005128	Aminobenzolamide derivative	Discovery agent	.	.
DNC005129	2,3-dihydro-1H-indene-5-sulfonamide	Discovery agent	.	.
DNC005130	1-acetamido-5-sulfonamidoindane	Discovery agent	.	.
DNC005131	2-acetamido-5-sulfonamidoindane	Discovery agent	.	.
DNC005132	4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide	Discovery agent	.	.
DNC005133	Phenylarsonic acid	Discovery agent	.	.
DNC005134	Trisodium phosphate	Discovery agent	.	.
DNC005135	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	Discovery agent	.	.
DNC005136	Carbamoyl phosphate disodium	Discovery agent	.	.
DNC005137	FLUORO-NEPLANOCIN A	Discovery agent	.	.
DNC005138	3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005139	3-Propyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005140	3-Isobutyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005141	3-Butyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005142	(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005143	N-arylpiperazine derivative	Discovery agent	.	.
DNC005144	N-arylpiperazine derivative	Discovery agent	.	.
DNC005145	N-arylpiperazine derivative	Discovery agent	.	.
DNC005146	N-arylpiperazine derivative	Discovery agent	.	.
DNC005147	N-arylpiperazine derivative	Discovery agent	.	.
DNC005148	Des-Arg10-Leu9-Kallidin	Discovery agent	.	.
DNC005149	2-Methyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005150	N-arylpiperazine derivative	Discovery agent	.	.
DNC005151	N-arylpiperazine derivative	Discovery agent	.	.
DNC005152	N-arylpiperazine derivative	Discovery agent	.	.
DNC005153	N-arylpiperazine derivative	Discovery agent	.	.
DNC005154	N-arylpiperazine derivative	Discovery agent	.	.
DNC005155	3-Methyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005156	7-Methyl-[1,4]thiazepan-(5E)-ylideneamine	Discovery agent	.	.
DNC005157	(5-Imino-[1,4]thiazepan-3-yl)-methanol	Discovery agent	.	.
DNC005158	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005159	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005160	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005161	LY-334370	Discovery agent	.	.
DNC005161	LY-334370	Migraine	.	G43
DNC005162	2-Acetylamino-indan-5-sulfonic acid hydrate	Discovery agent	.	.
DNC005163	2-Amino-indan-5-sulfonic acid	Discovery agent	.	.
DNC005164	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005165	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005166	(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid	Discovery agent	.	.
DNC005167	[1,4]Oxazepan-(3E)-ylideneamine	Discovery agent	.	.
DNC005168	[1,4]Thiazepan-(3E)-ylideneamine	Discovery agent	.	.
DNC005169	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005170	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005171	Estrogen platinum(II) hybrid derivative	Discovery agent	.	.
DNC005172	Des-Arg10-Kallidin	Discovery agent	.	.
DNC005173	GW-328267	Allergic rhinitis	.	J30
DNC005173	GW-328267	Discovery agent	.	.
DNC005174	2-(3-Piperidin-1-yl-propyl)-3H-quinazolin-4-one	Discovery agent	.	.
DNC005175	Drug 311440	Discovery agent	.	.
DNC005176	Drug 311383	Discovery agent	.	.
DNC005177	Drug 311951	Discovery agent	.	.
DNC005178	Drug 311952	Discovery agent	.	.
DNC005179	3-Amino-benzamide	Discovery agent	.	.
DNC005180	Phenyltoloxamine	Allergy	995.3	T78.4
DNC005180	Phenyltoloxamine	Discovery agent	.	.
DNC005181	Etoloxamine	Discovery agent	.	.
DNC005182	1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine	Discovery agent	.	.
DNC005183	1-[2-(2-Benzyl-phenoxy)-ethyl]-piperidine	Discovery agent	.	.
DNC005184	4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine	Discovery agent	.	.
DNC005185	1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine	Discovery agent	.	.
DNC005186	(2-Benzyl-phenyl)-(2-pyrrolidin-1-yl-ethyl)-amine	Discovery agent	.	.
DNC005187	2,3,4,5-Tetrabromo-6-(2,4-dibromo-phenoxy)-phenol	Discovery agent	.	.
DNC005188	3,4,6-Tribromo-2-(2,4-dibromo-phenoxy)-phenol	Discovery agent	.	.
DNC005189	3,4-Dibromo-2-(5-bromo-2-hydroxy-phenoxy)-phenol	Discovery agent	.	.
DNC005190	3,6,8-Tribromo-dibenzo[1,4]dioxin-1-ol	Discovery agent	.	.
DNC005191	SPONGIADIOXIN A	Discovery agent	.	.
DNC005192	Polybrominated diphenyl ether derivative	Discovery agent	.	.
DNC005193	PLOGLITAZONE	Discovery agent	.	.
DNC005194	BIOCHANIN	Discovery agent	.	.
DNC005195	TESAGLITAZAR	Diabetes mellitus type 1	.	E10
DNC005195	TESAGLITAZAR	Discovery agent	.	.
DNC005196	Ragaglitazar	Diabetes mellitus type 1	.	E10
DNC005196	Ragaglitazar	Discovery agent	.	.
DNC005197	5-Chloro-2-methyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC005198	ZM-241385	Discovery agent	.	.
DNC005199	3-(4-Pyridin-2-yl-pyrazol-1-yl)-benzonitrile	Discovery agent	.	.
DNC005200	3-(4-Pyridin-2-yl-imidazol-1-yl)-benzonitrile	Discovery agent	.	.
DNC005201	3-(2-Pyridin-2-yl-2H-tetrazol-5-yl)-benzonitrile	Discovery agent	.	.
DNC005202	3-(5-Pyridin-2-yl-tetrazol-2-yl)-benzonitrile	Discovery agent	.	.
DNC005203	BMS-189323	Discovery agent	.	.
DNC005204	BMS-245782	Discovery agent	.	.
DNC005205	5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine	Discovery agent	.	.
DNC005206	4-Pyridin-2-yl-5-quinolin-2-yl-thiazol-2-ylamine	Discovery agent	.	.
DNC005207	PYRAZOLOPYRIDAZINE 1	Discovery agent	.	.
DNC005208	PYRAZOLOPYRIDAZINE 2	Discovery agent	.	.
DNC005209	R-121919	Anxiety disorder	.	F40-F42
DNC005209	R-121919	Discovery agent	.	.
DNC005210	NORBINALTORPHIMINE	Discovery agent	.	.
DNC005211	2-(6-Hydroxy-naphthalen-2-yl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005212	4-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol	Discovery agent	.	.
DNC005213	2-(4-Hydroxy-phenyl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005214	3-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	Discovery agent	.	.
DNC005215	4-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	Discovery agent	.	.
DNC005216	2-(3-Fluoro-4-hydroxy-phenyl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005217	2-(3-Chloro-4-hydroxy-phenyl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005218	5-Chloro-2-(4-hydroxy-phenyl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005219	2-(3-Butoxy-4-hydroxy-phenyl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005220	2-(4-Hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005221	2-(3-Fluoro-4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005222	2-(3-Chloro-4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005223	2-(2-Chloro-4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005224	4-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol	Discovery agent	.	.
DNC005225	6-Chloro-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005226	3-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	Discovery agent	.	.
DNC005227	2-(4-Hydroxy-phenyl)-7-methoxy-benzooxazol-5-ol	Discovery agent	.	.
DNC005228	7-Bromo-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005229	Cholecystokinin-9	Discovery agent	.	.
DNC005230	7-Ethyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005231	2-(4-Hydroxy-phenyl)-7-propyl-benzooxazol-5-ol	Discovery agent	.	.
DNC005232	2-(4-Hydroxy-phenyl)-7-isopropyl-benzooxazol-5-ol	Discovery agent	.	.
DNC005233	7-Butyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005234	7-Ethynyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005235	7-Allyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005236	2-(4-Hydroxy-phenyl)-7-vinyl-benzooxazol-5-ol	Discovery agent	.	.
DNC005237	5-Methyl-3,4-diphenyl-isoxazole	Discovery agent	.	.
DNC005238	2-(4-Hydroxy-phenyl)-7-propenyl-benzooxazol-5-ol	Discovery agent	.	.
DNC005239	5-Ethyl-3,4-diphenyl-isoxazole	Discovery agent	.	.
DNC005240	2-(4-Hydroxy-phenyl)-7-phenyl-benzooxazol-5-ol	Discovery agent	.	.
DNC005241	4-Benzo[d]isoxazol-3-yl-benzene-1,3-diol	Discovery agent	.	.
DNC005242	3-(2-Hydroxy-phenyl)-benzo[d]isoxazol-6-ol	Discovery agent	.	.
DNC005243	3-(4-Hydroxy-phenyl)-benzo[d]isoxazol-6-ol	Discovery agent	.	.
DNC005244	3-(4-Hydroxy-phenyl)-benzo[d]isoxazol-5-ol	Discovery agent	.	.
DNC005245	4-isothiocyanatobenzenesulfonamide	Discovery agent	.	.
DNC005246	Macrolide derivative	Discovery agent	.	.
DNC005247	Macrolide derivative	Discovery agent	.	.
DNC005248	2-(5-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005249	2-(6-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005250	2-(4-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	Discovery agent	.	.
DNC005251	2-Naphthalen-1-yl-benzooxazol-6-ol	Discovery agent	.	.
DNC005252	2-(6-Hydroxy-naphthalen-1-yl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005253	2-(6-Hydroxy-naphthalen-2-yl)-benzooxazol-5-ol	Discovery agent	.	.
DNC005254	3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole	Discovery agent	.	.
DNC005255	Icopezil maleate	Cognitive impairment	.	F06.7
DNC005255	Icopezil maleate	Discovery agent	.	.
DNC005256	6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purine	Discovery agent	.	.
DNC005257	2-morpholin-4-yl-8-thiophen-2-ylchromen-4-one	Discovery agent	.	.
DNC005258	NU-7432	Discovery agent	.	.
DNC005259	2-morpholin-4-yl-8-thiophen-3-ylchromen-4-one	Discovery agent	.	.
DNC005260	AG-014376	Discovery agent	.	.
DNC005261	PD-128763	Discovery agent	.	.
DNC005262	NU-1025	Discovery agent	.	.
DNC005263	Doxorubicin-Formaldehyde Conjugate	Discovery agent	.	.
DNC005264	Doxorubicin-Formaldehyde Conjugate	Discovery agent	.	.
DNC005265	WR-089120	Discovery agent	.	.
DNC005266	(E)-1-(4-Nitro-phenyl)-3-pyridin-2-yl-propenone	Discovery agent	.	.
DNC005267	WR-080539	Discovery agent	.	.
DNC005268	N-(2,4-Dichloro-benzoyl)-benzenesulfonamide	Discovery agent	.	.
DNC005269	4-Chloro-N-(2-chloro-benzoyl)-benzenesulfonamide	Discovery agent	.	.
DNC005270	4-Chloro-N-(3-chloro-benzoyl)-benzenesulfonamide	Discovery agent	.	.
DNC005271	4-Chloro-N-(4-chloro-benzoyl)-benzenesulfonamide	Discovery agent	.	.
DNC005272	4-Chloro-N-(2-methyl-benzoyl)-benzenesulfonamide	Discovery agent	.	.
DNC005273	N-(3-Bromo-benzoyl)-4-chloro-benzenesulfonamide	Discovery agent	.	.
DNC005274	4-Chloro-N-(4-nitro-benzoyl)-benzenesulfonamide	Discovery agent	.	.
DNC005275	5-Nitro-1H-indole-2,3-dione	Discovery agent	.	.
DNC005276	2-(1-benzyl-1H-indol-3-yl)-N,N-dimethylethanamine	Discovery agent	.	.
DNC005277	[2-(3-Benzyl-indol-1-yl)-ethyl]-dimethyl-amine	Discovery agent	.	.
DNC005278	Glu-Leu-Asp-Leu-(CHOH-CH2)-Ala-Ala-Glu-Phe	Discovery agent	.	.
DNC005279	SB-747651A	Discovery agent	.	.
DNC005280	JWH-252	Discovery agent	.	.
DNC005281	JWH-167	Discovery agent	.	.
DNC005282	WIN-55212-2	Discovery agent	.	.
DNC005283	JWH-208	Discovery agent	.	.
DNC005284	JWH-251	Discovery agent	.	.
DNC005285	JWH-205	Discovery agent	.	.
DNC005286	JWH-253	Discovery agent	.	.
DNC005287	JWH-306	Discovery agent	.	.
DNC005288	JWH-209	Discovery agent	.	.
DNC005289	JWH-250	Discovery agent	.	.
DNC005290	JWH-302	Discovery agent	.	.
DNC005291	JWH-202	Discovery agent	.	.
DNC005292	JWH-201	Discovery agent	.	.
DNC005293	JWH-314	Discovery agent	.	.
DNC005294	JWH-311	Discovery agent	.	.
DNC005295	JWH-313	Discovery agent	.	.
DNC005296	JWH-203	Discovery agent	.	.
DNC005297	JWH-204	Discovery agent	.	.
DNC005298	JWH-237	Discovery agent	.	.
DNC005299	JWH-303	Discovery agent	.	.
DNC005300	JWH-206	Discovery agent	.	.
DNC005301	JWH-207	Discovery agent	.	.
DNC005302	JWH-249	Discovery agent	.	.
DNC005303	JWH-305	Discovery agent	.	.
DNC005304	JWH-248	Discovery agent	.	.
DNC005305	JWH-312	Discovery agent	.	.
DNC005306	JWH-315	Discovery agent	.	.
DNC005307	Tert-butyl (2S)-1-cyanopyrrolidine-2-carboxylate	Discovery agent	.	.
DNC005308	REVERSINE	Discovery agent	.	.
DNC005309	N*6*-Cyclohexyl-N*2*-ethyl-9H-purine-2,6-diamine	Discovery agent	.	.
DNC005310	N*6*-Cyclohexyl-N*2*-phenyl-9H-purine-2,6-diamine	Discovery agent	.	.
DNC005311	N*2*-Benzyl-N*6*-cyclohexyl-9H-purine-2,6-diamine	Discovery agent	.	.
DNC005312	N*6*-Cyclooctyl-N*2*-phenyl-9H-purine-2,6-diamine	Discovery agent	.	.
DNC005313	Cyclohexyl-(2-phenoxy-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC005314	Cyclohexyl-(2-phenylsulfanyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC005315	Phosphoric acid monododecyl ester	Discovery agent	.	.
DNC005316	Phosphoric acid monotetradecyl ester	Discovery agent	.	.
DNC005317	Phosphoric acid monodec-9-enyl ester	Discovery agent	.	.
DNC005318	SC-514	Discovery agent	.	.
DNC005319	Phosphoric acid mono-((E)-dec-4-enyl) ester	Discovery agent	.	.
DNC005320	Phosphoric acid mono-((E)-dodec-9-enyl) ester	Discovery agent	.	.
DNC005321	Phosphoric acid mono-((E)-tetradec-9-enyl) ester	Discovery agent	.	.
DNC005322	Phosphoric acid mono-((E)-tetradec-11-enyl) ester	Discovery agent	.	.
DNC005323	Thiophosphoric acid decyl ester	Discovery agent	.	.
DNC005324	Thiophosphoric acid dodecyl ester	Discovery agent	.	.
DNC005325	Thiophosphoric acid dec-9-enyl ester	Discovery agent	.	.
DNC005326	Thiophosphoric acid (E)-dodec-9-enyl ester	Discovery agent	.	.
DNC005327	Thiophosphoric acid (E)-tetradec-9-enyl ester	Discovery agent	.	.
DNC005328	Decyl-phosphonic acid	Discovery agent	.	.
DNC005329	3,6-Dihydroxy-2-(4-hydroxy-phenyl)-inden-1-one	Discovery agent	.	.
DNC005330	3,4,6-Trihydroxy-2-(4-hydroxy-phenyl)-inden-1-one	Discovery agent	.	.
DNC005331	Dodecyl-phosphonic acid	Discovery agent	.	.
DNC005332	Tetradecyl-phosphonic acid	Discovery agent	.	.
DNC005333	(1,1-Difluoro-pentadecyl)-phosphonic acid	Discovery agent	.	.
DNC005334	2-Imidazol-1-yl-7-methoxy-3-phenyl-chromen-4-one	Discovery agent	.	.
DNC005335	2-Phenyl-2H-pyrazolo[4,3-c]quinoline	Discovery agent	.	.
DNC005336	4-Methoxy-2-phenyl-2H-pyrazolo[4,3-c]quinoline	Discovery agent	.	.
DNC005337	SALVINORIN A	Discovery agent	.	.
DNC005338	HERKINORIN	Discovery agent	.	.
DNC005339	GCCSHPACAGNNQHIC*	Discovery agent	.	.
DNC005340	AZALINE B	Discovery agent	.	.
DNC005341	DEGARELIX	Discovery agent	.	.
DNC005342	Degarelix analogue	Discovery agent	.	.
DNC005343	Degarelix analogue	Discovery agent	.	.
DNC005344	Degarelix analogue	Discovery agent	.	.
DNC005345	Degarelix analogue	Discovery agent	.	.
DNC005346	Degarelix analogue	Discovery agent	.	.
DNC005347	Degarelix analogue	Discovery agent	.	.
DNC005348	Degarelix analogue	Discovery agent	.	.
DNC005349	Degarelix analogue	Discovery agent	.	.
DNC005350	Degarelix analogue	Discovery agent	.	.
DNC005351	Degarelix analogue	Discovery agent	.	.
DNC005352	Degarelix analogue	Discovery agent	.	.
DNC005353	Degarelix analogue	Discovery agent	.	.
DNC005354	Degarelix analogue	Discovery agent	.	.
DNC005355	Degarelix analogue	Discovery agent	.	.
DNC005356	Degarelix analogue	Discovery agent	.	.
DNC005357	Degarelix analogue	Discovery agent	.	.
DNC005358	Degarelix analogue	Discovery agent	.	.
DNC005359	Degarelix analogue	Discovery agent	.	.
DNC005360	Degarelix analogue	Discovery agent	.	.
DNC005361	GCCSNPVCHLEHSNLC*	Discovery agent	.	.
DNC005362	Degarelix analogue	Discovery agent	.	.
DNC005363	Degarelix analogue	Discovery agent	.	.
DNC005364	Degarelix analogue	Discovery agent	.	.
DNC005365	Degarelix analogue	Discovery agent	.	.
DNC005366	Degarelix analogue	Discovery agent	.	.
DNC005367	Degarelix analogue	Discovery agent	.	.
DNC005368	Degarelix analogue	Discovery agent	.	.
DNC005369	Degarelix analogue	Discovery agent	.	.
DNC005370	Degarelix analogue	Discovery agent	.	.
DNC005371	Degarelix analogue	Discovery agent	.	.
DNC005372	Degarelix analogue	Discovery agent	.	.
DNC005373	Degarelix analogue	Discovery agent	.	.
DNC005374	3,7-Bis-dimethylamino-phenothiazin-5-ylium	Discovery agent	.	.
DNC005375	MOLEPHANTIN	Discovery agent	.	.
DNC005376	MOLEPHANTININ	Discovery agent	.	.
DNC005377	SCANDENOLIDE	Discovery agent	.	.
DNC005378	ISOGOIAZENSOLIDE	Discovery agent	.	.
DNC005379	15-ACETOXY-EREMANTHOLIDE B	Discovery agent	.	.
DNC005380	15-DEOXYBUDLEIN A	Discovery agent	.	.
DNC005381	ATRIPLICIOLIDTIGLATE	Discovery agent	.	.
DNC005382	BUDLEIN A	Discovery agent	.	.
DNC005383	INDOPROFEN	Discovery agent	.	.
DNC005383	INDOPROFEN	Gout	274.00274.1274.8274.9	M10
DNC005384	RAPARIXIN	Discovery agent	.	.
DNC005385	(R)-N-Hydroxy-2-(4-isobutyl-phenyl)-propionamide	Discovery agent	.	.
DNC005386	(R)-2-(4-Isobutyl-phenyl)-N-methoxy-propionamide	Discovery agent	.	.
DNC005387	(R)-2-(4-Isobutyl-phenyl)-propionamide	Discovery agent	.	.
DNC005388	FR-181157	Discovery agent	.	.
DNC005389	VER-49009	Discovery agent	.	.
DNC005390	2-Phenyl-cyclopropylamine hydrochloride	Discovery agent	.	.
DNC005391	HYDRAZINECARBOXAMIDE	Discovery agent	.	.
DNC005392	TOLOXATONE	Discovery agent	.	.
DNC005393	HELENALIN	Discovery agent	.	.
DNC005394	FR-193262	Discovery agent	.	.
DNC005395	PD-173074	Discovery agent	.	.
DNC005396	(R)-3-(4-Isobutyl-phenyl)-butan-2-one	Discovery agent	.	.
DNC005397	2-(3-Isopropyl-phenyl)-propionic acid	Discovery agent	.	.
DNC005398	2-(3-Isobutyl-phenyl)-propionic acid	Discovery agent	.	.
DNC005399	2-[3-(2-Methyl-butyl)-phenyl]-propionic acid	Discovery agent	.	.
DNC005400	2-[3-(1-Phenyl-ethyl)-phenyl]-propionic acid	Discovery agent	.	.
DNC005401	2-[3-(1-Hydroxy-propyl)-phenyl]-propionic acid	Discovery agent	.	.
DNC005402	XANTHOSTIGMINE	Discovery agent	.	.
DNC005403	6-(3-Nitro-phenyl)-3H-benzothiazol-2-one	Discovery agent	.	.
DNC005404	8-Nitro-6H,11H-indeno[1,2-c]isoquinolin-5-one	Discovery agent	.	.
DNC005405	8-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one	Discovery agent	.	.
DNC005406	9-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one	Discovery agent	.	.
DNC005407	8-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one	Discovery agent	.	.
DNC005408	9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one	Discovery agent	.	.
DNC005409	Carbocyclic Peptidomimetic	Discovery agent	.	.
DNC005410	R-KETOPROFEN	Discovery agent	.	.
DNC005411	IBUPROPHEN	Discovery agent	.	.
DNC005412	4-Benzoylamino-N-hydroxy-benzamide	Discovery agent	.	.
DNC005413	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide	Discovery agent	.	.
DNC005414	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide	Discovery agent	.	.
DNC005415	(E)-Octadec-9-enal	Discovery agent	.	.
DNC005416	(5E,8E,11E,14E)-Icosa-5,8,11,14-tetraenal	Discovery agent	.	.
DNC005417	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide	Discovery agent	.	.
DNC005418	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide	Discovery agent	.	.
DNC005419	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide	Discovery agent	.	.
DNC005420	SR-147778	Discovery agent	.	.
DNC005420	SR-147778	Obesity	.	E66
DNC005421	AGN-34	Discovery agent	.	.
DNC005422	LY-354740	Discovery agent	.	.
DNC005423	NVP-DPP728	Diabetes mellitus type 2	.	E11
DNC005423	NVP-DPP728	Discovery agent	.	.
DNC005424	6-Furan-2-yl-9-phenyl-9H-purin-2-ylamine	Discovery agent	.	.
DNC005425	9-benzyl-6-(furan-2-yl)-9H-purin-2-amine	Discovery agent	.	.
DNC005426	6-Furan-2-yl-9-phenethyl-9H-purin-2-ylamine	Discovery agent	.	.
DNC005427	QUINPIROLE	Discovery agent	.	.
DNC005428	MCL-129	Discovery agent	.	.
DNC005429	ML-253764	Discovery agent	.	.
DNC005430	HU-210	Discovery agent	.	.
DNC005431	1-Phenyl-propane-1,2-dione	Discovery agent	.	.
DNC005432	BENZOIN	Discovery agent	.	.
DNC005433	2,2-Dimethoxy-1,2-diphenyl-ethanone	Discovery agent	.	.
DNC005434	Heptane-2,3-dione	Discovery agent	.	.
DNC005435	BENZOQUINONE	Discovery agent	.	.
DNC005436	3,5-Di-tert-butyl-[1,2]benzoquinone	Discovery agent	.	.
DNC005437	3,4,5,6-Tetrachloro-[1,2]benzoquinone	Discovery agent	.	.
DNC005438	CHLORANIL	Discovery agent	.	.
DNC005439	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005440	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005441	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005442	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005443	BENZIL	Discovery agent	.	.
DNC005444	1,2-bis(4-fluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC005445	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005446	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005447	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005448	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005449	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005450	CARIPORIDE	Angina	413	I20
DNC005450	CARIPORIDE	Discovery agent	.	.
DNC005451	N-(5-Phenyl-furan-2-carbonyl)-guanidine	Discovery agent	.	.
DNC005452	1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione	Discovery agent	.	.
DNC005453	1,2-Bis-(2-chloro-phenyl)-ethane-1,2-dione	Discovery agent	.	.
DNC005454	1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione	Discovery agent	.	.
DNC005455	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005456	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005457	Edotreotide	Acromegaly	.	E22.0
DNC005457	Edotreotide	Discovery agent	.	.
DNC005458	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005459	N-(5-o-Tolyl-furan-2-carbonyl)-guanidine	Discovery agent	.	.
DNC005460	N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine	Discovery agent	.	.
DNC005461	N-[5-(2-Ethyl-phenyl)-furan-2-carbonyl]-guanidine	Discovery agent	.	.
DNC005462	1,2-bis(3,5-difluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC005463	1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC005464	4-(2-Oxo-2-phenyl-acetyl)-benzoic acid	Discovery agent	.	.
DNC005465	1-(4-Chloro-phenyl)-2-phenyl-ethane-1,2-dione	Discovery agent	.	.
DNC005466	1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione	Discovery agent	.	.
DNC005467	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005468	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005469	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005470	Radiolabeled octreotide derivative	Discovery agent	.	.
DNC005471	N-(5-m-Tolyl-furan-2-carbonyl)-guanidine	Discovery agent	.	.
DNC005472	1-Phenyl-2-p-tolyl-ethane-1,2-dione	Discovery agent	.	.
DNC005473	1,2-Di-p-tolyl-ethane-1,2-dione	Discovery agent	.	.
DNC005474	1-(3,4-Dimethyl-phenyl)-2-phenyl-ethane-1,2-dione	Discovery agent	.	.
DNC005475	1-(4-Methoxy-phenyl)-2-phenyl-ethane-1,2-dione	Discovery agent	.	.
DNC005476	1,2-Bis-(4-methoxy-phenyl)-ethane-1,2-dione	Discovery agent	.	.
DNC005477	1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione	Discovery agent	.	.
DNC005478	1-(4-Nitro-phenyl)-2-phenyl-ethane-1,2-dione	Discovery agent	.	.
DNC005479	1,2-Bis-(3-nitro-phenyl)-ethane-1,2-dione	Discovery agent	.	.
DNC005480	(3,5-Dibromo-4-butoxy-phenyl)-acetic acid	Discovery agent	.	.
DNC005481	(3,5-Dibromo-4-pentyloxy-phenyl)-acetic acid	Discovery agent	.	.
DNC005482	(3,5-Dibromo-4-hexyloxy-phenyl)-acetic acid	Discovery agent	.	.
DNC005483	3-(3,5-Dibromo-4-hexyloxy-phenyl)-propionic acid	Discovery agent	.	.
DNC005484	PHA-680632	Chronic myelogenous leukemia	.	C92.1
DNC005484	PHA-680632	Discovery agent	.	.
DNC005485	LIDORESTAT	Diabetic complication	.	E08-E13
DNC005485	LIDORESTAT	Discovery agent	.	.
DNC005486	1-Chloro-4-(1-phenyl-cyclohexanesulfonyl)-benzene	Discovery agent	.	.
DNC005487	BAY-60-7550	Discovery agent	.	.
DNC005488	COUMESTROL	Discovery agent	.	.
DNC005489	3-(4-Hydroxy-phenyl)-4H-chromen-7-ol	Discovery agent	.	.
DNC005490	Bisquinolinium derivative	Discovery agent	.	.
DNC005491	Bisquinolinium derivative	Discovery agent	.	.
DNC005492	Bisquinolinium derivative	Discovery agent	.	.
DNC005493	Bisquinolinium derivative	Discovery agent	.	.
DNC005494	Bisquinolinium derivative	Discovery agent	.	.
DNC005495	Bisquinolinium derivative	Discovery agent	.	.
DNC005496	Bisquinolinium derivative	Discovery agent	.	.
DNC005497	Bisquinolinium derivative	Discovery agent	.	.
DNC005498	Bisquinolinium derivative	Discovery agent	.	.
DNC005499	Bisquinolinium derivative	Discovery agent	.	.
DNC005500	Bisquinolinium derivative	Discovery agent	.	.
DNC005501	DIADZEIN	Discovery agent	.	.
DNC005502	Bisquinolinium derivative	Discovery agent	.	.
DNC005503	Bisquinolinium derivative	Discovery agent	.	.
DNC005504	Bisquinolinium derivative	Discovery agent	.	.
DNC005505	Bisquinolinium derivative	Discovery agent	.	.
DNC005506	Bisquinolinium derivative	Discovery agent	.	.
DNC005507	Bisquinolinium derivative	Discovery agent	.	.
DNC005508	Bisquinolinium derivative	Discovery agent	.	.
DNC005509	Bisquinolinium derivative	Discovery agent	.	.
DNC005510	Bisquinolinium derivative	Discovery agent	.	.
DNC005511	Bisquinolinium derivative	Discovery agent	.	.
DNC005512	Bisquinolinium derivative	Discovery agent	.	.
DNC005513	Bisquinolinium derivative	Discovery agent	.	.
DNC005514	Bisquinolinium derivative	Discovery agent	.	.
DNC005515	Bisquinolinium derivative	Discovery agent	.	.
DNC005516	Bisquinolinium derivative	Discovery agent	.	.
DNC005517	Bisquinolinium derivative	Discovery agent	.	.
DNC005518	NDP-SYSMEHFRWGKPVG	Discovery agent	.	.
DNC005519	AEKKDEGPYRMEHFRWGSPPKD	Discovery agent	.	.
DNC005520	GPYRMEHFRWGSPPKD-NH2	Discovery agent	.	.
DNC005521	Ac-YRMEHdFRWGSPPKD-NH2	Discovery agent	.	.
DNC005522	Ac-YR[CEHdFRWC]SPPKD-NH2	Discovery agent	.	.
DNC005523	Vasopressin Analogue	Discovery agent	.	.
DNC005524	Vasopressin Analogue	Discovery agent	.	.
DNC005525	Vasopressin Analogue	Discovery agent	.	.
DNC005526	Vasopressin Analogue	Discovery agent	.	.
DNC005527	Vasopressin Analogue	Discovery agent	.	.
DNC005528	Vasopressin Analogue	Discovery agent	.	.
DNC005529	Vasopressin Analogue	Discovery agent	.	.
DNC005530	Vasopressin Analogue	Discovery agent	.	.
DNC005531	Vasopressin Analogue	Discovery agent	.	.
DNC005532	Ac-YR[CEHdFRWC]-NH2	Discovery agent	.	.
DNC005533	Ac-YR[CEHFRWC]-NH2	Discovery agent	.	.
DNC005534	Ac-YRMEHdFRWG-NH2	Discovery agent	.	.
DNC005535	Ac-YRC(Me)*EHdFRWC(Me)NH2	Discovery agent	.	.
DNC005536	Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2	Discovery agent	.	.
DNC005537	Ac-YR[CEH(pCl-dF)RWC]-NH2	Discovery agent	.	.
DNC005538	Ac-YR[CEH(pF-dF)RWC]-NH2	Discovery agent	.	.
DNC005539	Ac-YR[CE(1-Me-H)dFRWC]-NH2	Discovery agent	.	.
DNC005540	Ac-[CEHdFRWC]-NH2	Discovery agent	.	.
DNC005541	Ac-YCit[CEHdFRWC]-NH2	Discovery agent	.	.
DNC005542	Ac-YK[CEHdFRWC]-NH2	Discovery agent	.	.
DNC005543	Ac-R[CEHdFRWC]-NH2	Discovery agent	.	.
DNC005544	Ac-dR[CEHdFRWC]-NH2	Discovery agent	.	.
DNC005545	1-Adamantan-1-yl-3-(4-hydroxy-decyl)-urea	Discovery agent	.	.
DNC005546	1-adamantan-1-yl-3-(4-pentyloxybutyl)urea	Discovery agent	.	.
DNC005547	1-Adamantan-1-yl-3-decyl-urea	Discovery agent	.	.
DNC005548	1-(3-Chloro-phenyl)-3-(4-hydroxy-decyl)-urea	Discovery agent	.	.
DNC005549	K-252a analogue	Discovery agent	.	.
DNC005550	K-252a analogue	Discovery agent	.	.
DNC005551	K-252a analogue	Discovery agent	.	.
DNC005552	K-252a analogue	Discovery agent	.	.
DNC005553	K-252a analogue	Discovery agent	.	.
DNC005554	K-252a analogue	Discovery agent	.	.
DNC005555	Dodecanoic acid adamantan-1-ylamide	Discovery agent	.	.
DNC005556	2-Adamantan-1-yl-N-decyl-acetamide	Discovery agent	.	.
DNC005557	K-252a analogue	Discovery agent	.	.
DNC005558	K-252a analogue	Discovery agent	.	.
DNC005559	1-Cyclohexyl-3-phenethyl-urea	Discovery agent	.	.
DNC005560	2-Cyclohexyl-N-phenethyl-acetamide	Discovery agent	.	.
DNC005561	N-Cyclohexyl-4-phenyl-butyramide	Discovery agent	.	.
DNC005562	1-(3-Chloro-phenyl)-3-cyclohexyl-urea	Discovery agent	.	.
DNC005563	N-(3-Chloro-phenyl)-2-cyclohexyl-acetamide	Discovery agent	.	.
DNC005564	1-Cyclohexyl-3-(4-methoxy-phenyl)-urea	Discovery agent	.	.
DNC005565	2-Cyclohexyl-N-(4-methoxy-phenyl)-acetamide	Discovery agent	.	.
DNC005566	N-Cyclohexyl-2-(4-methoxy-phenyl)-acetamide	Discovery agent	.	.
DNC005567	1-Cyclohexyl-3-phenyl-urea	Discovery agent	.	.
DNC005568	2-Cyclohexyl-N-phenyl-acetamide	Discovery agent	.	.
DNC005569	N-Cyclohexyl-2-phenyl-acetamide	Discovery agent	.	.
DNC005570	BP-897	Cocaine dependence	.	F14.2
DNC005570	BP-897	Discovery agent	.	.
DNC005571	6-(2,5-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005572	6-(2,6-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005573	6-(2-Chloro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005574	6-(4-Hydroxy-2-methoxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005575	6-(4-Hydroxy-2-methyl-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005576	6-(3-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005577	6-(3-Chloro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005578	6-(3,5-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005579	8-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005580	8-Chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005581	1,8-Dichloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005582	6-(4-Hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005583	6-(3-Hydroxy-phenyl)-naphthalen-1-ol	Discovery agent	.	.
DNC005584	6-(4-Hydroxy-phenyl)-naphthalen-1-ol	Discovery agent	.	.
DNC005585	6-(2-Hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005586	6-(3-Hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005587	6-Phenyl-naphthalen-2-ol	Discovery agent	.	.
DNC005588	7-(4-Hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005589	7-(3-Hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005590	7-Phenyl-naphthalen-2-ol	Discovery agent	.	.
DNC005591	4-Naphthalen-2-yl-phenol	Discovery agent	.	.
DNC005592	1-Chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005593	Pyz11-D-Trp8-SRIF	Discovery agent	.	.
DNC005594	Pyz6-D-Trp8-SRIF	Discovery agent	.	.
DNC005595	Pyz7-D-Trp8-SRIF	Discovery agent	.	.
DNC005596	D-Trp8-SRIF-14	Discovery agent	.	.
DNC005597	Ala11-SRIF-14-amide	Discovery agent	.	.
DNC005598	Ala6-SRIF-14-amide	Discovery agent	.	.
DNC005599	Ala7-SRIF-14-amide	Discovery agent	.	.
DNC005600	1-Bromo-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005601	1-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005602	6-(4-Hydroxy-phenyl)-1-phenyl-naphthalen-2-ol	Discovery agent	.	.
DNC005603	6-(4-Hydroxy-phenyl)-1-methyl-naphthalen-2-ol	Discovery agent	.	.
DNC005604	6-(4-Hydroxy-phenyl)-1-methoxy-naphthalen-2-ol	Discovery agent	.	.
DNC005605	6-(4-Hydroxy-phenyl)-1-nitro-naphthalen-2-ol	Discovery agent	.	.
DNC005606	6-(2-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC005607	LIPOCRINE	Discovery agent	.	.
DNC005608	CYTISINE	Discovery agent	.	.
DNC005609	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide	Discovery agent	.	.
DNC005610	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide	Discovery agent	.	.
DNC005611	WAY-466	Discovery agent	.	.
DNC005612	AR-129330	Discovery agent	.	.
DNC005613	(E)-3-(4-tert-Butyl-phenyl)-N-phenyl-acrylamide	Discovery agent	.	.
DNC005614	6-amino-5-bromouracil	Discovery agent	.	.
DNC005615	3-Indan-(1Z)-ylidenemethyl-pyridine	Discovery agent	.	.
DNC005616	3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005617	3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005618	3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005619	3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005620	3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005621	4-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005622	4-[6-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005623	4-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005624	4-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005625	5-[5-Methoxy-indan-(1E)-ylidenemethyl]-thiazole	Discovery agent	.	.
DNC005626	5-[5-Methoxy-indan-(1Z)-ylidenemethyl]-thiazole	Discovery agent	.	.
DNC005627	5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine	Discovery agent	.	.
DNC005628	5-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyrimidine	Discovery agent	.	.
DNC005629	3-Fluoren-9-ylidenemethyl-pyridine	Discovery agent	.	.
DNC005630	3-(2,2-Diphenyl-vinyl)-pyridine	Discovery agent	.	.
DNC005631	4-Fluoren-9-ylidenemethyl-pyridine	Discovery agent	.	.
DNC005632	4-(2,2-Diphenyl-vinyl)-pyridine	Discovery agent	.	.
DNC005633	3-[3-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005634	3-[3-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005635	3-[3-Phenyl-indan-(1E)-ylidenemethyl]-pyridine	Discovery agent	.	.
DNC005636	VATALANIB	Discovery agent	.	.
DNC005636	VATALANIB	Solid tumours	.	C00-C75,C7A,C7B
DNC005637	Phenyl-(5-phenyl-oxazol-2-yl)-amine	Discovery agent	.	.
DNC005638	Norbinaltorphimine derivative	Discovery agent	.	.
DNC005639	2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile	Discovery agent	.	.
DNC005640	(2-Methoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine	Discovery agent	.	.
DNC005641	3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile	Discovery agent	.	.
DNC005642	(3-Phenoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine	Discovery agent	.	.
DNC005643	[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol	Discovery agent	.	.
DNC005644	(5-Phenyl-oxazol-2-yl)-m-tolyl-amine	Discovery agent	.	.
DNC005645	4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide	Discovery agent	.	.
DNC005646	Norbinaltorphimine derivative	Discovery agent	.	.
DNC005647	Norbinaltorphimine derivative	Discovery agent	.	.
DNC005648	Norbinaltorphimine derivative	Discovery agent	.	.
DNC005649	3-Indan-(1E)-ylidenemethyl-pyridine	Discovery agent	.	.
DNC005650	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005651	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005652	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005653	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005654	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005655	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005656	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005657	Huprine-Tacrine Heterodimer	Discovery agent	.	.
DNC005658	(+/-)-huprineY hydrochloride	Discovery agent	.	.
DNC005659	4-Methyl-piperidin-(2E)-ylideneamine	Discovery agent	.	.
DNC005660	3,4-Dihydro-1H-quinolin-(2E)-ylideneamine	Discovery agent	.	.
DNC005661	(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine	Discovery agent	.	.
DNC005662	(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine	Discovery agent	.	.
DNC005663	METRIFUDIL	Discovery agent	.	.
DNC005664	4-Inden-(1E)-ylidenemethyl-phenylamine	Discovery agent	.	.
DNC005665	[2-(3-Benzyl-3H-inden-1-yl)-ethyl]-methyl-amine	Discovery agent	.	.
DNC005666	4-(3H-Inden-1-ylmethyl)-phenylamine	Discovery agent	.	.
DNC005667	4-(1H-Inden-1-ylmethyl)-phenylamine	Discovery agent	.	.
DNC005668	4-Indan-1-ylmethyl-phenylamine	Discovery agent	.	.
DNC005669	4-(Indan-1-ylsulfanyl)-phenylamine	Discovery agent	.	.
DNC005670	4-(Indane-1-sulfonyl)-phenylamine	Discovery agent	.	.
DNC005671	MURAGLITAZAR	Discovery agent	.	.
DNC005672	4-(1H-Indol-3-ylmethyl)-phenylamine	Discovery agent	.	.
DNC005673	N-[4-(trifluoromethyl)phenyl]sulfamide	Discovery agent	.	.
DNC005674	N-(4-cyanophenyl)sulfamide	Discovery agent	.	.
DNC005675	N-(pentafluorophenyl)sulfamide	Discovery agent	.	.
DNC005676	4-benzylphthalazin-1(2H)-one	Discovery agent	.	.
DNC005677	KU-58684	Discovery agent	.	.
DNC005678	LYCOGARUBIN B	Discovery agent	.	.
DNC005679	CDDO	Discovery agent	.	.
DNC005680	(2,6-Diamino-pyridin-3-yl)-phenyl-methanone	Discovery agent	.	.
DNC005681	5-Amino-[1,3,4]thiadiazole-2-thiol	Discovery agent	.	.
DNC005682	N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide	Discovery agent	.	.
DNC005683	Azaline B derivative	Discovery agent	.	.
DNC005684	Azaline B derivative	Discovery agent	.	.
DNC005685	Azaline B derivative	Discovery agent	.	.
DNC005686	Azaline B derivative	Discovery agent	.	.
DNC005687	Azaline B derivative	Discovery agent	.	.
DNC005688	Azaline B derivative	Discovery agent	.	.
DNC005689	Azaline B derivative	Discovery agent	.	.
DNC005690	Azaline B derivative	Discovery agent	.	.
DNC005691	Azaline B derivative	Discovery agent	.	.
DNC005692	Azaline B derivative	Discovery agent	.	.
DNC005693	Sulfanilamide derivative	Discovery agent	.	.
DNC005694	Sulfanilamide derivative	Discovery agent	.	.
DNC005695	Sulfanilamide derivative	Discovery agent	.	.
DNC005696	Sulfanilamide derivative	Discovery agent	.	.
DNC005697	Sulfanilamide derivative	Discovery agent	.	.
DNC005698	Sulfanilamide derivative	Discovery agent	.	.
DNC005699	BVT-14225	Discovery agent	.	.
DNC005700	Sulfanilamide derivative	Discovery agent	.	.
DNC005701	Sulfanilamide derivative	Discovery agent	.	.
DNC005702	Sulfanilamide derivative	Discovery agent	.	.
DNC005703	Sulfanilamide derivative	Discovery agent	.	.
DNC005704	THIOCITRULLINE	Discovery agent	.	.
DNC005705	L-NIO	Discovery agent	.	.
DNC005706	BMS-248360	Discovery agent	.	.
DNC005706	BMS-248360	Hypertension	401	I10, I11, I12, I13, I15
DNC005707	IM-023911	Discovery agent	.	.
DNC005708	Prifelone	Discovery agent	.	.
DNC005709	IM-094261	Discovery agent	.	.
DNC005710	4-(4-m-Tolylamino-phthalazin-1-yl)-benzamide	Discovery agent	.	.
DNC005711	4-(4-p-Tolylamino-phthalazin-1-yl)-benzamide	Discovery agent	.	.
DNC005712	BEMESETRON	Discovery agent	.	.
DNC005713	L-006235-1	Discovery agent	.	.
DNC005714	3-(naphthalen-2-yl)pyridine	Discovery agent	.	.
DNC005715	3-(6-methoxynaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC005716	6-Pyridin-3-yl-naphthalen-2-ol	Discovery agent	.	.
DNC005717	3-(6-Bromo-naphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC005718	3-(6-Ethoxy-naphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC005719	6-(pyridin-3-yl)-2-naphthonitrile	Discovery agent	.	.
DNC005720	3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC005721	3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC005722	(S)-2-Amino-1-azetidin-1-yl-2-cyclohexyl-ethanone	Discovery agent	.	.
DNC005723	3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC005724	1-Benzenesulfonyl-3-piperidin-3-yl-1H-indole	Discovery agent	.	.
DNC005725	3-Phenanthren-9-yl-pyridine	Discovery agent	.	.
DNC005726	1-Naphthalen-2-yl-1H-imidazole	Discovery agent	.	.
DNC005727	1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole	Discovery agent	.	.
DNC005728	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005729	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005730	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005731	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005732	1-(6-Methoxy-naphthalen-2-yl)-1H-imidazole	Discovery agent	.	.
DNC005733	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005734	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005735	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005736	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005737	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005738	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005739	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005740	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005741	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005742	3,4-diarylpyrazoline derivative	Discovery agent	.	.
DNC005743	3-Imidazol-1-yl-quinoline	Discovery agent	.	.
DNC005744	5-Naphthalen-2-yl-1H-imidazole	Discovery agent	.	.
DNC005745	5-Naphthalen-2-yl-oxazole	Discovery agent	.	.
DNC005746	D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Asp-NH2	Discovery agent	.	.
DNC005747	H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2	Discovery agent	.	.
DNC005748	ACETYLSULFANILAMIDE	Discovery agent	.	.
DNC005749	2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide	Discovery agent	.	.
DNC005750	N-(4-Sulfamoyl-phenyl)-propionamide	Discovery agent	.	.
DNC005751	N-(4-Sulfamoyl-phenyl)-butyramide	Discovery agent	.	.
DNC005752	N-(4-Sulfamoyl-phenyl)-isobutyramide	Discovery agent	.	.
DNC005753	Pentanoic acid (4-sulfamoyl-phenyl)-amide	Discovery agent	.	.
DNC005754	2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide	Discovery agent	.	.
DNC005755	N-(4-Sulfamoyl-phenyl)-benzamide	Discovery agent	.	.
DNC005756	4-Methanesulfonylamino-benzenesulfonamide	Discovery agent	.	.
DNC005757	4-Benzenesulfonylamino-benzenesulfonamide	Discovery agent	.	.
DNC005758	4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide	Discovery agent	.	.
DNC005759	3-(3-Phenyl-ureido)-benzenesulfonamide	Discovery agent	.	.
DNC005760	3-Morpholin-4-ylmethyl-5H-phenanthridin-6-one	Discovery agent	.	.
DNC005761	4-(5-Morpholin-4-yl-pentyl)-2H-phthalazin-1-one	Discovery agent	.	.
DNC005762	4-(4-Morpholin-4-yl-butyl)-2H-phthalazin-1-one	Discovery agent	.	.
DNC005763	2-Ethyl-5-methoxy-3-piperidin-4-yl-1H-indole	Discovery agent	.	.
DNC005764	RU-24969	Discovery agent	.	.
DNC005765	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005766	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005767	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005768	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005769	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005770	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005771	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005772	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005773	N-alkyl Gly-boro-Pro derivative	Discovery agent	.	.
DNC005774	(LTB4-(Csa)4)2-Glu-H Conjugate	Discovery agent	.	.
DNC005775	2-Cyclopent-1-enylethynyl-pyridine	Discovery agent	.	.
DNC005776	2-Cyclohex-1-enylethynyl-pyridine	Discovery agent	.	.
DNC005777	2-Cyclohexylethynyl-pyridine	Discovery agent	.	.
DNC005778	3-Benzyl-7-methyl-[1,8]naphthyridin-4-ol	Discovery agent	.	.
DNC005779	5-Azido-6-benzyl-2-methyl-[1,8]naphthyridine	Discovery agent	.	.
DNC005780	3-Benzyl-7-methyl-[1,8]naphthyridine-4-thiol	Discovery agent	.	.
DNC005781	BMS-536924	Discovery agent	.	.
DNC005782	5-p-Tolyl-1H-[1,2,3]triazole	Discovery agent	.	.
DNC005783	GNF-PF-2322	Discovery agent	.	.
DNC005784	GNF-PF-1550	Discovery agent	.	.
DNC005785	L-888607	Discovery agent	.	.
DNC005786	Pen(Acm)AQFRKEKETFC(Acm)-OH	Discovery agent	.	.
DNC005787	Cyclo(1,12)PenIYDTKGKNVLC-OH	Discovery agent	.	.
DNC005788	(S)-FLURBIPROFEN	Discovery agent	.	.
DNC005789	SC-0030	Discovery agent	.	.
DNC005790	L-365260	Anxiety disorder	.	F40-F42
DNC005790	L-365260	Discovery agent	.	.
DNC005791	DTPA Conjugate	Discovery agent	.	.
DNC005792	SCH-205831	Discovery agent	.	.
DNC005792	SCH-205831	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNC005793	BAY-59-7939	Discovery agent	.	.
DNC005794	4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridine	Discovery agent	.	.
DNC005795	1,2-Bis-(4-hydroxy-phenyl)-3H-inden-5-ol	Discovery agent	.	.
DNC005796	2-(4-Hydroxy-phenyl)-1-p-tolyl-3H-inden-5-ol	Discovery agent	.	.
DNC005797	L-mannitol derivative	Discovery agent	.	.
DNC005798	SC-560	Discovery agent	.	.
DNC005799	SLV-314	Discovery agent	.	.
DNC005800	Urea derivative	Discovery agent	.	.
DNC005801	Urea derivative	Discovery agent	.	.
DNC005802	Urea derivative	Discovery agent	.	.
DNC005803	Urea derivative	Discovery agent	.	.
DNC005804	Urea derivative	Discovery agent	.	.
DNC005805	Urea derivative	Discovery agent	.	.
DNC005806	9-Methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine	Discovery agent	.	.
DNC005807	ST-1535	Discovery agent	.	.
DNC005808	ALLOXAZINE	Discovery agent	.	.
DNC005809	ISTRADEFYLLINE	Discovery agent	.	.
DNC005809	ISTRADEFYLLINE	Major depressive disorder	.	F32,F33
DNC005810	ICI-118551	Cardiovascular disease	390-459	I00-I99
DNC005810	ICI-118551	Discovery agent	.	.
DNC005811	NIPECOTIC ACID	Discovery agent	.	.
DNC005812	DIZOCILPINE	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC005812	DIZOCILPINE	Discovery agent	.	.
DNC005813	9H-purine derivative	Discovery agent	.	.
DNC005814	9H-purine derivative	Discovery agent	.	.
DNC005815	HYNIC Conjugate	Discovery agent	.	.
DNC005816	METHOCTRAMINE	Discovery agent	.	.
DNC005817	MESULERGINE	Discovery agent	.	.
DNC005818	5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol	Discovery agent	.	.
DNC005819	ELLIPTINIUM	Discovery agent	.	.
DNC005820	9-Methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole	Discovery agent	.	.
DNC005821	9-Bromo-5,11-dimethyl-6H-pyrido[4,3-b]carbazole	Discovery agent	.	.
DNC005822	HYNIC Analogue	Discovery agent	.	.
DNC005823	6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005824	6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005825	(3-Ethoxy-pyridin-2-yl)-pyridin-2-yl-amine	Discovery agent	.	.
DNC005826	PRALNACASAN	Discovery agent	.	.
DNC005826	PRALNACASAN	Rheumatold arthritis	.	M05-M06
DNC005827	5-Chloro-2-(4-hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC005828	5-Bromo-2-(4-hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC005829	4-Chloro-2-(4-hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC005830	4-Bromo-2-(4-hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC005831	2-(4-Hydroxy-phenyl)-4-vinyl-quinolin-6-ol	Discovery agent	.	.
DNC005832	4-Ethyl-2-(4-hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC005833	4-Ethynyl-2-(4-hydroxy-phenyl)-quinolin-6-ol	Discovery agent	.	.
DNC005834	2-(4-Hydroxy-phenyl)-4-methoxy-quinolin-6-ol	Discovery agent	.	.
DNC005835	SB-227931	Discovery agent	.	.
DNC005836	HYNIC Conjugate	Discovery agent	.	.
DNC005837	N-Hydroxy-4-(4-methoxy-phenyl)-4-oxo-butyramide	Discovery agent	.	.
DNC005838	N-Hydroxycarbamoylmethyl-4-methoxy-benzamide	Discovery agent	.	.
DNC005839	4-(4-Butoxy-phenyl)-N-hydroxy-4-oxo-butyramide	Discovery agent	.	.
DNC005840	4-Butoxy-N-hydroxycarbamoylmethyl-benzamide	Discovery agent	.	.
DNC005841	N-Hydroxy-4-oxo-4-(4-phenoxy-phenyl)-butyramide	Discovery agent	.	.
DNC005842	N-Hydroxycarbamoylmethyl-4-phenoxy-benzamide	Discovery agent	.	.
DNC005843	1-Benzyl-4-methyl-piperazine	Discovery agent	.	.
DNC005844	1-Methyl-4-(1-phenyl-ethyl)-piperazine	Discovery agent	.	.
DNC005845	(R)-3-Prop-2-ynylamino-indan-5-ol	Discovery agent	.	.
DNC005846	(R)-Indan-1-yl-methyl-prop-2-ynyl-amine	Discovery agent	.	.
DNC005847	1,4-diphenyl-(1E,3E)-1,3-butadiene	Discovery agent	.	.
DNC005848	1H-Indole-2,3-dione	Discovery agent	.	.
DNC005849	LAZEBEMIDE	Discovery agent	.	.
DNC005850	Phenyl-(3-phenyl-1H-indazol-6-yl)-amine	Discovery agent	.	.
DNC005851	SCH-356036	Discovery agent	.	.
DNC005852	3-(2-Dimethylamino-ethyl)-1-methyl-1H-indol-4-ol	Discovery agent	.	.
DNC005853	1-Butyl-3-(2-dimethylamino-ethyl)-1H-indol-4-ol	Discovery agent	.	.
DNC005854	3-(2-Dimethylamino-ethyl)-1H-indol-6-ol	Discovery agent	.	.
DNC005855	3-(2-Dimethylamino-ethyl)-2-methyl-1H-indol-4-ol	Discovery agent	.	.
DNC005856	[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine	Discovery agent	.	.
DNC005857	3-(2-Pyrrolidin-1-yl-ethyl)-1H-indol-4-ol	Discovery agent	.	.
DNC005858	3-Dimethylaminomethyl-1H-indol-4-ol	Discovery agent	.	.
DNC005859	3-Dimethylaminomethyl-1-methyl-1H-indol-4-ol	Discovery agent	.	.
DNC005860	3-(3-Dimethylamino-propyl)-1H-indol-4-ol	Discovery agent	.	.
DNC005861	3-(2-Dimethylamino-propyl)-1H-indol-4-ol	Discovery agent	.	.
DNC005862	1-(2-Dimethylamino-ethyl)-1H-indol-4-ol	Discovery agent	.	.
DNC005863	CMI-977	Discovery agent	.	.
DNC005864	6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005865	6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005866	6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005867	6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005868	6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one	Discovery agent	.	.
DNC005869	SCH-37370	Discovery agent	.	.
DNC005870	6-Phenylmethanesulfonyl-2H-pyridazin-3-one	Discovery agent	.	.
DNC005871	RUPATADINE	Discovery agent	.	.
DNC005872	MDL-28163	Discovery agent	.	.
DNC005873	MDL-105212	Asthma	493	J45
DNC005873	MDL-105212	Discovery agent	.	.
DNC005874	SQ-26332	Discovery agent	.	.
DNC005875	L-159093	Discovery agent	.	.
DNC005876	ML-10302	Discovery agent	.	.
DNC005876	ML-10302	Gastrointestinal disease	.	K00-K93
DNC005877	L-159689	Discovery agent	.	.
DNC005877	L-159689	Hypertension	401	I10, I11, I12, I13, I15
DNC005878	[1,2,4]triazolo[1,5-a]quinoxalin-4(5H)-one	Discovery agent	.	.
DNC005879	3-(3-chloro-1H-pyrazol-5-yl)quinoxalin-2(1H)-one	Discovery agent	.	.
DNC005880	2-(1H-benzo[d]imidazol-2-yl)quinoxaline	Discovery agent	.	.
DNC005881	2-(4-methyl-1H-benzo[d]imidazol-2-yl)quinoxaline	Discovery agent	.	.
DNC005882	2-(4-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline	Discovery agent	.	.
DNC005883	2-(4-ethylthiobenzimidazol-2-yl)quinoxaline	Discovery agent	.	.
DNC005884	2-(4-nitro-1H-benzo[d]imidazol-2-yl)quinoxaline	Discovery agent	.	.
DNC005885	2-(5-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline	Discovery agent	.	.
DNC005886	2-(1H-imidazo[4,5-c]pyridin-2-yl)quinoxaline	Discovery agent	.	.
DNC005887	(1H-indol-2-yl)(piperazin-1-yl)methanone	Discovery agent	.	.
DNC005888	JNJ-7777120	Discovery agent	.	.
DNC005888	JNJ-7777120	Inflammatory diseases	.	.
DNC005889	JNJ-7777120	Discovery agent	.	.
DNC005890	(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine	Discovery agent	.	.
DNC005891	JNJ-10198409	Discovery agent	.	.
DNC005892	NEBICAPONE	Discovery agent	.	.
DNC005893	1-(3,4-dihydroxy-2-nitrophenyl)-2-phenylethanone	Discovery agent	.	.
DNC005894	6,7-dihydroxy-8-nitro-1-tetralone	Discovery agent	.	.
DNC005895	5,6-dihydroxy-7-nitro-2,3-dihydroinden-1-one	Discovery agent	.	.
DNC005896	2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	Discovery agent	.	.
DNC005897	BX-471	Discovery agent	.	.
DNC005897	BX-471	Multiple sclerosis	.	G35
DNC005898	DICLOFENAC SODIUM	Discovery agent	.	.
DNC005899	2-[(2,2-diphenylacetyl)amino]benzoic acid	Discovery agent	.	.
DNC005900	M-Phenoxybenzoic Acid For Cis-Isomer	Discovery agent	.	.
DNC005901	4-amino-6-chlorobenzene-1,3-disulfonamide	Discovery agent	.	.
DNC005902	4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide	Discovery agent	.	.
DNC005903	N-(tert-butoxycarbonyl)-valyl-glycine-nitrile	Discovery agent	.	.
DNC005904	N-(tert-butoxycarbonyl)-norvalyl-glycine-nitrile	Discovery agent	.	.
DNC005905	N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile	Discovery agent	.	.
DNC005906	N-(benzyloxycarbonyl)-leucyl-glycine-nitrile	Discovery agent	.	.
DNC005907	N-(tert-butoxycarbonyl)-isoleucyl-glycine-nitrile	Discovery agent	.	.
DNC005908	N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile	Discovery agent	.	.
DNC005909	N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile	Discovery agent	.	.
DNC005910	N-(tert-butoxycarbonyl)-tyrosyl-glycine-nitrile	Discovery agent	.	.
DNC005911	N-(2-naphthylsulfonyl)-glycyl-glycine-nitrile	Discovery agent	.	.
DNC005912	N-acetyl-phenylalanyl-glycine-nitrile	Discovery agent	.	.
DNC005913	N-benzoyl-phenylalanyl-glycine-nitrile	Discovery agent	.	.
DNC005914	N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile	Discovery agent	.	.
DNC005915	C[-Arg-Gly-Asp-Acpca19-]	Discovery agent	.	.
DNC005916	C[-Arg-Gly-Asp-Acpca20-]	Discovery agent	.	.
DNC005917	C[-Arg-Gly-Asp-Acpca21-]	Discovery agent	.	.
DNC005918	C[-Arg-Gly-Asp-Acpca22-]	Discovery agent	.	.
DNC005919	C[-Arg-Gly-Asp-Acpca35-]	Discovery agent	.	.
DNC005920	C[-Arg-Gly-Asp-Acpca36-]	Discovery agent	.	.
DNC005921	C[-Arg-Gly-Asp-Acpca34-]	Discovery agent	.	.
DNC005922	C-[-Arg-Gly-Asp-Acpca30-]	Discovery agent	.	.
DNC005923	C-[-Arg-Gly-Asp-Acpca31-]	Discovery agent	.	.
DNC005924	C-[-Arg-Gly-Asp-Acpca32-]	Discovery agent	.	.
DNC005925	C-[-Arg-Gly-Asp-Acpca33-]	Discovery agent	.	.
DNC005926	ST-1646	Discovery agent	.	.
DNC005927	PHENYLDIFLUOROMETHANESULFONAMIDE	Discovery agent	.	.
DNC005928	PHENYLMETHANESULFONAMIDE	Discovery agent	.	.
DNC005929	PHENYLSULFAMATE	Discovery agent	.	.
DNC005930	4-methylphenyl-difluoromethanesulfonamide	Discovery agent	.	.
DNC005931	4-nitrophenyl-difluoromethanesulfonamide	Discovery agent	.	.
DNC005932	(2-bromophenyl)difluoromethanesulfonamide	Discovery agent	.	.
DNC005933	3-bromophenyl-difluoromethanesulfonamide	Discovery agent	.	.
DNC005934	(4-bromophenyl)difluoromethanesulfonamide	Discovery agent	.	.
DNC005935	4-methyl-2-oxo-2H-chromen-7-yl sulfamate	Discovery agent	.	.
DNC005936	3-chloro-4-(4-chloro-2-hydroxyphenoxy)benzamide	Discovery agent	.	.
DNC005937	2-(4-amino-2-chlorophenoxy)-5-chlorophenol	Discovery agent	.	.
DNC005938	5-chloro-2-(2-chloro-4-nitrophenoxy)phenol	Discovery agent	.	.
DNC005939	5-chloro-2-(2-chloro-4-hydroxyphenoxy)phenol	Discovery agent	.	.
DNC005940	(S)-sirtinol	Discovery agent	.	.
DNC005941	(R)-sirtinol	Discovery agent	.	.
DNC005942	Para-sirtinol	Discovery agent	.	.
DNC005943	Meta-sirtinol	Discovery agent	.	.
DNC005944	RR(17)PZ	Discovery agent	.	.
DNC005945	Bo(15)PZ	Discovery agent	.	.
DNC005946	ATOSIBAN	Discovery agent	.	.
DNC005947	4-(4,6-dinitro-1H-indol-1-ylsulfonyl)benzenamine	Discovery agent	.	.
DNC005948	1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole	Discovery agent	.	.
DNC005949	4-(piperazin-1-yl)-1H-indole	Discovery agent	.	.
DNC005950	4-(1H-indol-1-ylsulfonyl)benzenamine	Discovery agent	.	.
DNC005951	7-hydroxy-2-(morpholin-4-yl)chromen-4-one	Discovery agent	.	.
DNC005952	2-morpholinobenzo[h]quinolin-4(1H)-one	Discovery agent	.	.
DNC005953	2-morpholin-4-yl-6-phenyl-4H-thiopyran-4-one	Discovery agent	.	.
DNC005954	2-morpholino-6-phenyl-4H-pyran-4-one	Discovery agent	.	.
DNC005955	8-(4-acetylphenyl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005956	2-morpholin-4-yl-8-phenoxathiin-4-ylchromen-4-one	Discovery agent	.	.
DNC005957	8-(1H-indol-5-yl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005958	8-(4-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005959	8-(3-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005960	8-(4-chlorophenyl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005961	8-dibenzofuran-4-yl-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005962	8-furan-2-yl-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005963	2-morpholin-4-yl-8-naphthalen-2-ylchromen-4-one	Discovery agent	.	.
DNC005964	8-biphenyl-2-yl-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005965	8-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005966	2-morpholin-4-yl-8-styrylchromen-4-one	Discovery agent	.	.
DNC005967	7-phenyloxyethoxy-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC005968	7-ethyloxyethoxy-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC005969	7-phenylethoxy-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC005970	7-benzoyloxy-2-(morpholin-4-yl)-chromen-4-one	Discovery agent	.	.
DNC005971	7-benzyloxy-2-(morpholin-4-yl)-chromen-4-one	Discovery agent	.	.
DNC005972	7-propoxy-2-(morpholin-4-yl)-chromen-4-one	Discovery agent	.	.
DNC005973	6-(4-hydroxyphenyl)-2-morpholino-4H-chromen-4-one	Discovery agent	.	.
DNC005974	6-(3-hydroxyphenyl)-2-morpholino-4H-chromen-4-one	Discovery agent	.	.
DNC005975	2-morpholino-6-(naphthalen-1-yl)-4H-chromen-4-one	Discovery agent	.	.
DNC005976	2-morpholino-6-(thianthren-1-yl)-4H-chromen-4-one	Discovery agent	.	.
DNC005977	6-(4-fluorostyryl)-2-morpholino-4H-chromen-4-one	Discovery agent	.	.
DNC005978	6-biphenyl-2-yl-2-morpholin-4-yl-chromen-4-one	Discovery agent	.	.
DNC005979	6-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one	Discovery agent	.	.
DNC005980	L-454560	Discovery agent	.	.
DNC005981	L-869298	Discovery agent	.	.
DNC005982	N-(3-(trifluoromethyl)benzyl)-4-phenoxybenzamide	Discovery agent	.	.
DNC005983	N-(3-(trifluoromethoxy)benzyl)-4-phenoxybenzamide	Discovery agent	.	.
DNC005984	N-(4-(trifluoromethyl)benzyl)-4-phenoxybenzamide	Discovery agent	.	.
DNC005985	N-(4-methyl-benzyl)-4-phenoxy-benzamide	Discovery agent	.	.
DNC005986	DIFLUOROBENZTROPINE	Discovery agent	.	.
DNC005987	3-chlorophenyl 2-oxo-2H-chromene-3-carboxylate	Discovery agent	.	.
DNC005988	4-(3-phenyl-1H-indol-2-yl)phenol	Discovery agent	.	.
DNC005989	4-(2-phenyl-1H-indol-3-yl)phenol	Discovery agent	.	.
DNC005990	4-(3-(4-hydroxyphenyl)-1H-indol-2-yl)phenol	Discovery agent	.	.
DNC005991	2,3-diphenyl-1H-indole	Discovery agent	.	.
DNC005992	4-(2-phenyl-1H-benzo[d]imidazol-1-yl)phenol	Discovery agent	.	.
DNC005993	Bbs-Arg-(D-Pip)-Gly-S-(GS)1-Gly-Hir	Discovery agent	.	.
DNC005994	Bbs-Arg-(D-Pip)-Gly-S-(GS)3-Gly-Hir	Discovery agent	.	.
DNC005995	Bbs-Arg-(D-Pip)-Gly-S-(GS)5-Gly-Hir	Discovery agent	.	.
DNC005996	Bbs-Arg-(D-Pip)-Gly-(SPHYEKVS)-Gly-Hir	Discovery agent	.	.
DNC005997	Bbs-Arg-(D-Pip)-Gly-(SPH(pY)EKVS)-Gly-Hir	Discovery agent	.	.
DNC005998	Bbs-Arg-(D-Pip)-Gly-(EQKLISEEDL)-Gly-Hir	Discovery agent	.	.
DNC005999	Bbs-Arg-(D-Pip)-Gly-S-(GS)7-Gly-Hir	Discovery agent	.	.
DNC006000	Bbs-Arg-(D-Pip)-Gly-S-(GS)9-Gly-Hir	Discovery agent	.	.
DNC006001	Bbs-Arg-(D-Pip)-Gly-S-(GS)11-Gly-Hir	Discovery agent	.	.
DNC006002	Bbs-Arg-(D-Pip)-Gly-S-(GS)13-Gly-Hir	Discovery agent	.	.
DNC006003	3-(1,2-dihydroacenaphthylen-3-yl)pyridine	Discovery agent	.	.
DNC006004	3-(1,2-dihydroacenaphthylen-5-yl)pyridine	Discovery agent	.	.
DNC006005	FR-180204	Discovery agent	.	.
DNC006006	2-[(biphenyl-4-carbonyl)-amino]-benzoic acid	Discovery agent	.	.
DNC006007	2-(2-naphthamido)benzoic acid	Discovery agent	.	.
DNC006008	2-(2-bromo-2-naphthamido)benzoic acid	Discovery agent	.	.
DNC006009	3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide	Discovery agent	.	.
DNC006010	CB-676475	Discovery agent	.	.
DNC006011	A-641359	Discovery agent	.	.
DNC006012	4-iodophenyl-alaninyl-(S)-2-cyano-pyrrolidine	Discovery agent	.	.
DNC006013	A-770041	Discovery agent	.	.
DNC006014	(E)-N-(4-methoxyphenyl)undec-2-enamide	Discovery agent	.	.
DNC006015	AM-404	Discovery agent	.	.
DNC006016	CP-55940	Discovery agent	.	.
DNC006017	N-(2,4-dimethoxyphenethyl)oleamide	Discovery agent	.	.
DNC006018	N-(3,5-dimethoxyphenethyl)oleamide	Discovery agent	.	.
DNC006019	N-(4-methoxyphenethyl)oleamide	Discovery agent	.	.
DNC006020	N-(4-methoxybenzyl)oleamide	Discovery agent	.	.
DNC006021	N-(4-methoxyphenyl)oleamide	Discovery agent	.	.
DNC006022	N-(4-morpholinophenyl)docos-13-enamide	Discovery agent	.	.
DNC006023	N-(2,4-dimethoxyphenethyl)docos-13-enamide	Discovery agent	.	.
DNC006024	N-(3,5-dimethoxyphenethyl)docos-13-enamide	Discovery agent	.	.
DNC006025	(E)-N-(3,5-dimethoxyphenethyl)undec-2-enamide	Discovery agent	.	.
DNC006026	(E)-N-(4-methoxyphenethyl)undec-2-enamide	Discovery agent	.	.
DNC006027	4-phenyl-4-[1H-imidazol-2-yl]-piperidine	Discovery agent	.	.
DNC006028	NSC-663284	Discovery agent	.	.
DNC006029	BN-82685	Discovery agent	.	.
DNC006030	BREQUINAR	Discovery agent	.	.
DNC006031	(R)-2-(biphenyl-4-sulfonylamino)-propionic acid	Discovery agent	.	.
DNC006032	BIPHALIN	Discovery agent	.	.
DNC006033	L-779450	Discovery agent	.	.
DNC006034	A-432411	Discovery agent	.	.
DNC006035	4-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	Discovery agent	.	.
DNC006036	5-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	Discovery agent	.	.
DNC006037	GNF-PF-600	Discovery agent	.	.
DNC006038	TPA-023	Anxiety disorder	.	F40-F42
DNC006038	TPA-023	Discovery agent	.	.
DNC006039	HU-210	Discovery agent	.	.
DNC006040	JWH-133	Discovery agent	.	.
DNC006041	SR-144,528	Discovery agent	.	.
DNC006042	ASKENDOSIDE B	Discovery agent	.	.
DNC006043	KOJIC ACID	Discovery agent	.	.
DNC006044	PGlu-His-Trp-Ser-His-D-Tyr-Leu-Arg-Pro-Gly-NH2	Discovery agent	.	.
DNC006045	MCL-145	Discovery agent	.	.
DNC006046	MCL-144	Discovery agent	.	.
DNC006047	MCL-139	Discovery agent	.	.
DNC006048	Bis-((-)-N-propargylmorphinan-3-yl) sebacoylate	Discovery agent	.	.
DNC006049	MCL-182	Discovery agent	.	.
DNC006050	MCL-117	Discovery agent	.	.
DNC006051	(-)-cyclorphan	Discovery agent	.	.
DNC006052	BUTORPHAN	Discovery agent	.	.
DNC006053	1-(2-aminoethyl)-1H-indazol-6-ol	Discovery agent	.	.
DNC006054	N-isoleucylthiazolidine	Discovery agent	.	.
DNC006055	Cyclohexylglycine-(2S)-cyanopyrrolidine	Discovery agent	.	.
DNC006056	1-((S)-2-aminopropyl)-1H-indazol-6-ol	Discovery agent	.	.
DNC006057	1-((R)-2-aminopropyl)-1H-indazol-6-ol	Discovery agent	.	.
DNC006058	(2S)-1-(6-methoxy-1H-indazol-1-yl)propan-2-amine	Discovery agent	.	.
DNC006059	1-((S)-2-aminopropyl)-7-methyl-1H-indazol-6-ol	Discovery agent	.	.
DNC006060	1-((S)-2-aminopropyl)-7-fluoro-1H-indazol-6-ol	Discovery agent	.	.
DNC006061	1-((S)-2-aminopropyl)-7-chloro-1H-indazol-6-ol	Discovery agent	.	.
DNC006062	1-((S)-2-aminopropyl)-7-iodo-1H-indazol-6-ol	Discovery agent	.	.
DNC006063	5-MEO-DMT	Discovery agent	.	.
DNC006064	2-(Benzylamino)-6-(3-acetamidophenyl)pyrazine	Discovery agent	.	.
DNC006065	2-(Phenylamino)-6-(3-acetamidophenyl)pyrazine	Discovery agent	.	.
DNC006066	4-((pyridin-4-ylthio)methyl)benzene-1,2-diol	Discovery agent	.	.
DNC006067	3,3,3-tris(4-chlorophenyl)propanoic acid	Discovery agent	.	.
DNC006068	FVPTDVGPFAF	Discovery agent	.	.
DNC006069	FVPTDVGAFAF	Discovery agent	.	.
DNC006070	FVPTDVG-Tic-FAF-Tic	Discovery agent	.	.
DNC006071	FVATDVGPFAF	Discovery agent	.	.
DNC006072	FV-Aib-TDVGPFAF	Discovery agent	.	.
DNC006073	FV-Hyp-TDVGPFAF	Discovery agent	.	.
DNC006074	FV-Tic-TDVGPFAF	Discovery agent	.	.
DNC006075	N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate	Discovery agent	.	.
DNC006076	S-Benzyl-brassinin	Discovery agent	.	.
DNC006077	6-phenylsulfanylhexanoic acid hydroxamide	Discovery agent	.	.
DNC006078	6-benzenesulfonylhexanoic acid hydroxamide	Discovery agent	.	.
DNC006079	6-benzenesulfinylhexanoic acid hydroxamide	Discovery agent	.	.
DNC006080	PGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2	Discovery agent	.	.
DNC006081	TAK-013	Discovery agent	.	.
DNC006081	TAK-013	Uterine leiomyoma	.	D25
DNC006082	(3-methyl-4-(4-phenoxybenzoyl)phenyl)acetic acid	Discovery agent	.	.
DNC006083	4-[4-benzyloxy)benzoyl]benzoic acid	Discovery agent	.	.
DNC006084	4-[4-(benzhydryloxy)benzoyl]benzoic acid	Discovery agent	.	.
DNC006085	4-[3-(benzyloxy)benzoyl]benzoic acid	Discovery agent	.	.
DNC006086	4-[4-(benzylamino)benzoyl]benzoic acid	Discovery agent	.	.
DNC006087	4-[4-(benzoylamino)benzoyl]benzoic acid	Discovery agent	.	.
DNC006088	4-(4-phenoxybenzoyl)benzoic acid	Discovery agent	.	.
DNC006089	(E)-3-(4-(4-phenoxybenzoyl)phenyl)acrylic acid	Discovery agent	.	.
DNC006090	3-[4-(4-phenoxybenzoyl)phenyl]propanoic acid	Discovery agent	.	.
DNC006091	4-(4-phenoxybenzoyl)phenylacetic acid	Discovery agent	.	.
DNC006092	(3-fluoro-4-(4-phenoxybenzoyl)phenyl)acetic acid	Discovery agent	.	.
DNC006093	{4-[4-(4-bromophenoxy)benzoyl]phenyl}acetic acid	Discovery agent	.	.
DNC006094	3-(4-Phenylethynylbenzoyl)nonanoic acid	Discovery agent	.	.
DNC006095	3-(4-(2-phenylethynyl)benzoyl)pentanoic acid	Discovery agent	.	.
DNC006096	4-(4-(dec-1-ynyl)phenyl)-4-oxobutanoic acid	Discovery agent	.	.
DNC006097	YM-175735	Discovery agent	.	.
DNC006098	1,3,5-triphenylimidazolidine-2,4-dione	Discovery agent	.	.
DNC006099	RIMONABANT HYDROCHLORIDE	Discovery agent	.	.
DNC006100	1,3,5-tris(4-chlorophenyl)imidazolidine-2,4-dione	Discovery agent	.	.
DNC006101	PD-169469	Discovery agent	.	.
DNC006102	PD-169469	Discovery agent	.	.
DNC006103	4-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide	Discovery agent	.	.
DNC006104	3-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide	Discovery agent	.	.
DNC006105	1-(3-benzyloxy-pyridin-2-yl)-3-phenyl-urea	Discovery agent	.	.
DNC006106	C[Thr-Tyr-Thr-His-DNaf-Arg-Trp-Thr-Ile-Pro]	Discovery agent	.	.
DNC006107	C[Ser-Tyr-Thr-His-Dphe-Arg-Trp-Thr-Ile-Pro]	Discovery agent	.	.
DNC006108	A-690344	Discovery agent	.	.
DNC006108	A-690344	Schizophrenia	295	F20
DNC006109	A-437203	Discovery agent	.	.
DNC006109	A-437203	Psychotic disorders	.	F20-F29
DNC006110	4-(2-(3-fluorophenyl)ethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006111	(E)-3-[2-(2-methyl-4-thiazolyl)vinyl]pyridine	Discovery agent	.	.
DNC006112	3-[(2-methyl-4-thiazolyl)ethynyl]-5-vinylpyridine	Discovery agent	.	.
DNC006113	3-bromo-5-[(2-methyl-4-thiazolyl)ethynyl]pyridine	Discovery agent	.	.
DNC006114	2-ethynyl-4-(3-fluorophenylethynyl)thiazole	Discovery agent	.	.
DNC006115	2-bromo-4-(3-fluorophenylethynyl)thiazole	Discovery agent	.	.
DNC006116	4-(3-fluorophenylethynyl)-2-thiazolylamine	Discovery agent	.	.
DNC006117	N-[4-(3-pyridylethynyl)-2-thiazolyl]acetamide	Discovery agent	.	.
DNC006118	4-(3-pyridylethynyl)-2-thiazolylamine	Discovery agent	.	.
DNC006119	3-[(5-ethyl-2-methyl-4-thiazolyl)ethynyl]pyridine	Discovery agent	.	.
DNC006120	3-[(2,5-dimethyl-4-thiazolyl)ethynyl]pyridine	Discovery agent	.	.
DNC006121	2-methyl-4-(3-thienylethynyl)thiazole	Discovery agent	.	.
DNC006122	2-methyl-4-(2-thienylethynyl)thiazole	Discovery agent	.	.
DNC006123	2-[(2-methyl-4-thiazolyl)ethynyl]pyrazine	Discovery agent	.	.
DNC006124	5-[(2-methyl-4-thiazolyl)ethynyl]pyrimidine	Discovery agent	.	.
DNC006125	2-methyl-6-(phenylethynyl)pyridine	Discovery agent	.	.
DNC006126	3-[(2-methyl-4-thiazolyl)ethynyl]benzamide	Discovery agent	.	.
DNC006127	3-[(2-methyl-4-thiazolyl)ethynyl]phenol	Discovery agent	.	.
DNC006128	3-[(2-methyl-4-thiazolyl)ethynyl]benzonitrile	Discovery agent	.	.
DNC006129	4-(3-chlorophenylethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006130	4-(2-methoxyphenylethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006131	4-(3-methoxyphenylethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006132	4-(3,5-difluorophenylethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006133	4-(2-fluorophenylethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006134	4-(2-(4-fluorophenyl)ethynyl)-2-methylthiazole	Discovery agent	.	.
DNC006135	N-(cyanomethyl)cyclohex-1-ene-1-carboxamide	Discovery agent	.	.
DNC006136	N-(1-((cyanomethyl)carbamoyl)cyclohexyl)benzamide	Discovery agent	.	.
DNC006137	Z-YVAD-CHO	Discovery agent	.	.
DNC006138	Z-VAD-CHO	Discovery agent	.	.
DNC006139	9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one	Discovery agent	.	.
DNC006140	3-aminoacetamido-4'-methylfuro[3,2-g]coumarin	Discovery agent	.	.
DNC006141	7-acetonyloxy-3-acetylamino-8-methoxycoumarin	Discovery agent	.	.
DNC006142	4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one	Discovery agent	.	.
DNC006143	4-methyl-2H-benzofuro[3,2-g]chromen-2-one	Discovery agent	.	.
DNC006144	4-hydroxybenzaldehyde	Discovery agent	.	.
DNC006145	1-(4-hydroxyphenyl)prop-2-en-1-one	Discovery agent	.	.
DNC006146	VANILLIN	Discovery agent	.	.
DNC006147	4-hydroxybenzylamine	Discovery agent	.	.
DNC006148	4-hydroxy-3-nitrobenzaldehyde	Discovery agent	.	.
DNC006149	NAPHTHYRIDINONE	Discovery agent	.	.
DNC006150	A-706149	Discovery agent	.	.
DNC006151	VER-2692	Discovery agent	.	.
DNC006152	O-DESMETHYL TRAMADOL	Discovery agent	.	.
DNC006153	6-oxo-estrone	Discovery agent	.	.
DNC006154	N-ethyl estradiol-16-methyl carboxamide	Discovery agent	.	.
DNC006155	N-N-diethyl estradiol-16-methyl carboxamide	Discovery agent	.	.
DNC006156	N-methyl estradiol-16-methyl carboxamide	Discovery agent	.	.
DNC006157	N-isopropyl estradiol-16-methyl carboxamide	Discovery agent	.	.
DNC006158	N-methyl-N-ethyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006159	N-methoxyethyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006160	N-(furan-2-ylmethyl)-estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006161	N-ethyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006162	N,N-diethyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006163	N-methyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006164	N-isopropyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006165	N-methyl-N-ethyl estrone-16-methyl carboxamide	Discovery agent	.	.
DNC006166	Ethyl estrone-16-methylcarboxylate	Discovery agent	.	.
DNC006167	N-(4'-methyl-piperazinyl) estradiol-16-carboxamide	Discovery agent	.	.
DNC006168	N-(pyridin-4-ylmethyl) estradiol-16-carboxamide	Discovery agent	.	.
DNC006169	N-(1'-Phenyl-ethyl) estradiol-16-carboxamide	Discovery agent	.	.
DNC006170	N-(pyridin-3-ylmethyl) estradiol-16-carboxamide	Discovery agent	.	.
DNC006171	N-(furan-2-ylmethyl)estradiol-16-carboxamide	Discovery agent	.	.
DNC006172	N-isopropyl estradiol-16-carboxamide	Discovery agent	.	.
DNC006173	N-methyl-N-ethyl estradiol-16-carboxamide	Discovery agent	.	.
DNC006174	Methyl estradiol-16-beta-carboxylate	Discovery agent	.	.
DNC006175	16-(pyridin-4-yl)methyl-estradiol	Discovery agent	.	.
DNC006176	16-(pyridin-2-yl)methyl-estradiol	Discovery agent	.	.
DNC006177	16-(pyridin-3-yl)methyl-estradiol	Discovery agent	.	.
DNC006178	16-(4-cyano-benzylidene)-estradiol	Discovery agent	.	.
DNC006179	16-(2',2'-Dimethyl)-propylidene-estradiol	Discovery agent	.	.
DNC006180	16-isobutylidene-estradiol	Discovery agent	.	.
DNC006181	16-(4-dimethylamino-benzylidene)-estradiol	Discovery agent	.	.
DNC006182	16-(pyridin-4-yl)methylene-estradiol	Discovery agent	.	.
DNC006183	16-(pyridin-2-yl)methylene-estradiol	Discovery agent	.	.
DNC006184	16-(pyridin-3-yl)methylene-estradiol	Discovery agent	.	.
DNC006185	16-(thiophen-2-yl)methylene-estrone	Discovery agent	.	.
DNC006186	16-(2',2'-Dimethyl)-propylidene-estrone	Discovery agent	.	.
DNC006187	16-isobutylidene-estrone	Discovery agent	.	.
DNC006188	16-(4-dimethylamino-benzylidene)-estrone	Discovery agent	.	.
DNC006189	16-beta-ethoxymethyl-estrone	Discovery agent	.	.
DNC006190	16-beta-hydroxymethyl-estradiol	Discovery agent	.	.
DNC006191	16beta-cyano-estradiol	Discovery agent	.	.
DNC006192	6-oxo-16-formyl-estrone	Discovery agent	.	.
DNC006193	SCH-388714	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DNC006193	SCH-388714	Discovery agent	.	.
DNC006194	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione	Discovery agent	.	.
DNC006195	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	Discovery agent	.	.
DNC006196	3,4-diphenyl-1H-pyrrole-2,5-dione	Discovery agent	.	.
DNC006197	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	Discovery agent	.	.
DNC006198	GSK-5182	Discovery agent	.	.
DNC006199	N-ethyl-4-hydroxy-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006200	4-hydroxy-N-phenyl-N-propylbenzenesulfonamide	Discovery agent	.	.
DNC006201	4-hydroxy-N-isopropyl-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006202	4-hydroxy-N-neopentyl-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006203	N-benzyl-4-hydroxy-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006204	N-cyclohexyl-4-hydroxy-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006205	4-hydroxy-N,N-diphenylbenzenesulfonamide	Discovery agent	.	.
DNC006206	N-butyl-4-hydroxy-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006207	N-allyl-4-hydroxy-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC006208	N-(2-hexyloxy-4-nitrophenyl)methanesulfonamide	Discovery agent	.	.
DNC006209	N-(2-nonyloxy-4-nitrophenyl)methanesulfonamide	Discovery agent	.	.
DNC006210	N-(2-Propyloxy-4-nitrophenyl)methanesulfonamide	Discovery agent	.	.
DNC006211	Des-bromoaplysamine-1	Discovery agent	.	.
DNC006212	APLYSAMINE	Discovery agent	.	.
DNC006213	CL-387785	Discovery agent	.	.
DNC006214	GABAZINE	Discovery agent	.	.
DNC006215	4-benzyl-5-(4-piperidyl)isothiazol-3-ol	Discovery agent	.	.
DNC006216	5-(4-piperidyl)-4-propylisothiazol-3-ol	Discovery agent	.	.
DNC006217	4-Methyl-5-(4-piperidyl)isothiazol-3-ol	Discovery agent	.	.
DNC006218	PYROVALERONE	Discovery agent	.	.
DNC006219	1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006220	1-(3-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006221	1-(2-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006222	1-(4-nitrophenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006223	4-(2-pyrrolidin-1-yl-pentanoyl)benzonitrile	Discovery agent	.	.
DNC006224	1-(3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006225	1-(4-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006226	1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006227	1-(4-fluorophenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC006228	2pyrrolidin-1-yl-1-phenylpentan-1-one	Discovery agent	.	.
DNC006229	Pyrrolo[3,4-e]indole-1,3(2H,6H)-dione	Discovery agent	.	.
DNC006230	1,7,8,9-tetrahydro-1,5-diaza-trindene-4,6-dione	Discovery agent	.	.
DNC006231	5-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Discovery agent	.	.
DNC006232	4-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Discovery agent	.	.
DNC006233	Pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Discovery agent	.	.
DNC006234	4-amino-1,8-naphthalimide	Discovery agent	.	.
DNC006235	5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol	Discovery agent	.	.
DNC006236	VNA-932	Discovery agent	.	.
DNC006237	KU-0058948	Discovery agent	.	.
DNC006237	KU-0058948	Ovarian cancer	.	C56
DNC006238	2-morpholino-7-(2-phenylethynyl)-4H-chromen-4-one	Discovery agent	.	.
DNC006239	2-morpholino-7-phenyl-4H-chromen-4-one	Discovery agent	.	.
DNC006240	8-methyl-2-morpholino-7-phenoxy-4H-chromen-4-one	Discovery agent	.	.
DNC006241	8-methyl-2-morpholino-7-phenyl-4H-chromen-4-one	Discovery agent	.	.
DNC006242	(S)-tert-butyl 1-oxohexan-2-ylcarbamate	Discovery agent	.	.
DNC006243	(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate	Discovery agent	.	.
DNC006244	(S)-tert-butyl 4-methyl-1-oxopentan-2-ylcarbamate	Discovery agent	.	.
DNC006245	2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile	Discovery agent	.	.
DNC006246	C[RGDf-(R)-N-Me-alpha-TfmF]	Discovery agent	.	.
DNC006247	C[RGDf-(S)-N-Me-alpha-TfmF]	Discovery agent	.	.
DNC006248	C[RGD-(R)-alpha-TfmfV]	Discovery agent	.	.
DNC006249	C[RGD-(S)-alpha-TfmfV]	Discovery agent	.	.
DNC006250	C[RGDf-(S,R)-alpha-Dfm-F]	Discovery agent	.	.
DNC006251	C[RGDf-(R)-alpha-TfmF]	Discovery agent	.	.
DNC006252	C[RGDf-(S)-alpha-TfmF]	Discovery agent	.	.
DNC006253	C[RGDf-(R)-alpha-TfmV]	Discovery agent	.	.
DNC006254	C[RGDf-(S)-alpha-TfmV]	Discovery agent	.	.
DNC006255	C(RGDfMeF)	Discovery agent	.	.
DNC006256	C(RGDfF)	Discovery agent	.	.
DNC006257	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-Boc	Discovery agent	.	.
DNC006258	H-Tyr-D-Ala-Gly-Phe-NH-NH-(NMe)Phe-Asp-Nle-Trp-Ac	Discovery agent	.	.
DNC006259	Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-NMeNle-D-Trp-Boc	Discovery agent	.	.
DNC006260	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Ac	Discovery agent	.	.
DNC006261	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Boc	Discovery agent	.	.
DNC006262	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-H	Discovery agent	.	.
DNC006263	C[Nle-His-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006264	Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC006265	C[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006266	C[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006267	C[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006268	C[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006269	C[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006270	C[Nle-Gln-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006271	C[Nle-Glu-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006272	C[Nle-Asp-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006273	C[Nle-Pro-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006274	C[Nle-His-D-Nal(2')-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006275	C[Nle-Glu-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006276	C[Nle-Nle-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006277	C[Nle-Val-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006278	C[Nle-Pro-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006279	C[Nle-Asp-D-Phe-Arg-Trp-Glu]-NH2	Discovery agent	.	.
DNC006280	AG-1879	Discovery agent	.	.
DNC006281	(5-amino-1-phenyl-1H-pyrazol-4-yl)phenylmethanone	Discovery agent	.	.
DNC006282	Ro-3201195	Discovery agent	.	.
DNC006283	Detrothyronine	Discovery agent	.	.
DNC006284	TAK-652	Discovery agent	.	.
DNC006285	Isoquinoline-1,3,4(2H)-trione	Discovery agent	.	.
DNC006286	2-(4-fluoro-benzyl)isoquinoline-1,3,4-trione	Discovery agent	.	.
DNC006287	2-(4-methoxy-benzyl)isoquinoline-1,3,4-trione	Discovery agent	.	.
DNC006288	2-phenethylisoquinoline-1,3,4-trione	Discovery agent	.	.
DNC006289	2-benzylisoquinoline-1,3,4-trione	Discovery agent	.	.
DNC006290	2-allylisoquinoline-1,3,4-trione	Discovery agent	.	.
DNC006291	2-methylisoquinoline-1,3,4-trione	Discovery agent	.	.
DNC006292	6-amino-5-chlorouracil hydrochloride	Discovery agent	.	.
DNC006293	5-chloro-6-hydrazinouracil hydrochloride	Discovery agent	.	.
DNC006294	5-bromo-6-(cyclopropylamino)uracil hydrochloride	Discovery agent	.	.
DNC006295	5-bromo-6-hydrazinouracil hydrochloride	Discovery agent	.	.
DNC006296	NU-6102	Discovery agent	.	.
DNC006297	2,5-bis(2-methoxyphenyl)thiophene	Discovery agent	.	.
DNC006298	4-(5-(4-(methylamino)phenyl)thiophen-2-yl)phenol	Discovery agent	.	.
DNC006299	4-(5-(4-aminophenyl)thiophen-2-yl)phenol	Discovery agent	.	.
DNC006300	4-(5-(4-methoxyphenyl)thiophen-2-yl)benzenamine	Discovery agent	.	.
DNC006301	2-(4-nitrophenyl)-5-(4-methoxyphenyl)thiophene	Discovery agent	.	.
DNC006302	4-(5-(4-aminophenyl)thiophen-2-yl)benzenamine	Discovery agent	.	.
DNC006303	4-(5-(4-methoxyphenyl)thiophen-2-yl)phenol	Discovery agent	.	.
DNC006304	2,5-bis(4-Hydroxyphenyl)thiophene	Discovery agent	.	.
DNC006305	2,5-bis(4-methoxyphenyl)thiophene	Discovery agent	.	.
DNC006306	2,5-bis(4-nitrophenyl)thiophene	Discovery agent	.	.
DNC006307	(1-phenylcyclopentyl)methanamine	Discovery agent	.	.
DNC006308	(2-(2-chlorophenyl)pyridin-3-yl)methanamine	Discovery agent	.	.
DNC006309	C-(2'-Chloro-biphenyl-2-yl)-methylamine	Discovery agent	.	.
DNC006310	(2-chloro-6-phenoxyphenyl)methanamine	Discovery agent	.	.
DNC006311	(1R,2S)-1,2-diphenylethane-1,2-diamine	Discovery agent	.	.
DNC006312	(1R,2R)-1,2-diphenylethane-1,2-diamine	Discovery agent	.	.
DNC006313	2-(2-chlorophenyl)-2-morpholinoethanamine	Discovery agent	.	.
DNC006314	Sanggenon C	Discovery agent	.	.
DNC006315	RK-682	Discovery agent	.	.
DNC006316	Kuwanon L	Discovery agent	.	.
DNC006317	Mulberrofuran C	Discovery agent	.	.
DNC006318	Sanggenon G	Discovery agent	.	.
DNC006319	3-hydroxy-4,7-dimethyl-6H-benzo[c]chromen-6-one	Discovery agent	.	.
DNC006320	EFFUSOL	Discovery agent	.	.
DNC006321	4,6,6,7-tetramethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006322	4,6,7,10-tetramethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006323	6-ethyl-4,7-dimethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006324	4,6,7-trimethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006325	4,6,10-trimethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006326	4,10-dimethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006327	4,7-dimethyl-6H-benzo[c]chromene-3,8-diol	Discovery agent	.	.
DNC006328	3,8-dihydroxy-7-methyl-6H-benzo[c]chromen-6-one	Discovery agent	.	.
DNC006329	3,8-dihydroxy-4-methyl-6H-benzo[c]chromen-6-one	Discovery agent	.	.
DNC006330	3-hydroxy-8,10-dimethyl-6H-benzo[c]chromen-6-one	Discovery agent	.	.
DNC006331	3-hydroxy-4,10-dimethyl-6H-benzo[c]chromen-6-one	Discovery agent	.	.
DNC006332	3-hydroxy-4-methyl-6H-benzo[c]chromen-6-one	Discovery agent	.	.
DNC006333	TMI-05	Discovery agent	.	.
DNC006334	Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3	Discovery agent	.	.
DNC006335	Tic-D-Phe-Arg-2-Nal-NHCH3	Discovery agent	.	.
DNC006336	IM-094882	Discovery agent	.	.
DNC006337	4-(isoquinolin-5-yl)-N-m-tolylphthalazin-1-amine	Discovery agent	.	.
DNC006338	4-(isoquinolin-5-yl)-N-o-tolylphthalazin-1-amine	Discovery agent	.	.
DNC006339	OLEOYLETHANOLAMIDE	Discovery agent	.	.
DNC006340	N'-(2-phenylallyl)hydrazine hydrochloride	Discovery agent	.	.
DNC006341	3-(1H-inden-2-yl)pyridine	Discovery agent	.	.
DNC006342	3-[(Z)-2-phenylvinyl]pyridine	Discovery agent	.	.
DNC006343	1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole	Discovery agent	.	.
DNC006344	4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC006345	3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC006346	3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC006347	3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC006348	3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC006349	3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine	Discovery agent	.	.
DNC006350	3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC006351	3-(5-methoxy-1H-inden-2-yl)pyridine	Discovery agent	.	.
DNC006352	3-(3,4-dihydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC006353	4-ISOPROPYLPHENSERINE	Discovery agent	.	.
DNC006354	TOLSERINE	Discovery agent	.	.
DNC006355	BW-28C51	Discovery agent	.	.
DNC006356	(-)-Phenserine	Alzheimer's disease	331	G30
DNC006356	(-)-Phenserine	Discovery agent	.	.
DNC006357	Iso-OMPA	Discovery agent	.	.
DNC006358	GW-788388	Cancer	.	C00-C97
DNC006358	GW-788388	Discovery agent	.	.
DNC006359	BMS-540215	Discovery agent	.	.
DNC006360	15-isobutyrylmiguanin	Discovery agent	.	.
DNC006361	4,5-ISOBUDLEIN A	Discovery agent	.	.
DNC006362	HELENALINMETHACRYLATE	Discovery agent	.	.
DNC006363	Helenalin-2-methylbutyrate	Discovery agent	.	.
DNC006364	2-oxoguaia-1,4,11(13)-trien-12,8alpha-olide	Discovery agent	.	.
DNC006365	2-oxoguaia-1,4(15), 11(13)-trien-12,8beta-olide	Discovery agent	.	.
DNC006366	3,4-epoxydehydroleucodin	Discovery agent	.	.
DNC006367	2beta-methoxy-2-deethoxyphantomolin	Discovery agent	.	.
DNC006368	15-deoxygoiazensolide	Discovery agent	.	.
DNC006369	CENTRATHERIN	Discovery agent	.	.
DNC006370	ENHYDRIN	Discovery agent	.	.
DNC006371	7-hydroxycostunolide	Discovery agent	.	.
DNC006372	9alpha-acetoxy-miller-1(10)Z-enolide	Discovery agent	.	.
DNC006373	4beta,15-epoxy-miller-9Z-enolide	Discovery agent	.	.
DNC006374	4beta,15-epoxy-miller-9E-enolide	Discovery agent	.	.
DNC006375	1beta-methoxy-miller-9Z-enolide	Discovery agent	.	.
DNC006376	Miller-9Z-enolide	Discovery agent	.	.
DNC006377	Miller-9E-enolide	Discovery agent	.	.
DNC006378	O-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine	Discovery agent	.	.
DNC006379	N-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine	Discovery agent	.	.
DNC006380	N-arachidonoyl-O-(2-hydroxyethyl)hydroxylamine	Discovery agent	.	.
DNC006381	O-oleoyl-N-(2-hydroxyethyl)hydroxylamine	Discovery agent	.	.
DNC006382	N-oleoyl-N-(2-hydroxyethyl)hydroxylamine	Discovery agent	.	.
DNC006383	N-oleoyl-O-(2-hydroxyethyl)hydroxylamine	Discovery agent	.	.
DNC006384	VL-0395	Discovery agent	.	.
DNC006385	VL-1499	Discovery agent	.	.
DNC006386	VL-0699	Discovery agent	.	.
DNC006387	VL-2799	Discovery agent	.	.
DNC006388	Cyclo(RGDfV) (control)	Discovery agent	.	.
DNC006389	Cypate-[(RGD)4-NH2]2	Discovery agent	.	.
DNC006390	Cypate-[(RGD)4-NH2]1	Discovery agent	.	.
DNC006391	Cypate-[(RGD)3-NH2]2	Discovery agent	.	.
DNC006392	Cypate-[(RGD)3-NH2]1	Discovery agent	.	.
DNC006393	Cypate-[(RGD)2-NH2]2	Discovery agent	.	.
DNC006394	Cypate-[(RGD)2-NH2]1	Discovery agent	.	.
DNC006395	Cyclo[RGDfK(cypate)]	Discovery agent	.	.
DNC006396	5,7-dihydroxy-3-phenyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC006397	7-hydroxy-3-(4-hydroxyphenyl)-3H-quinazolin-4-one	Discovery agent	.	.
DNC006398	THIOGENISTEIN	Discovery agent	.	.
DNC006399	6-ethyl-3-(3-methylbutoxycarbonyl)-4-quinolone	Discovery agent	.	.
DNC006400	6-benzyl-3-ethoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC006401	6-bromo-3-ethoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC006402	QUINIDINE SULFATE	Discovery agent	.	.
DNC006403	GBR-12289	Discovery agent	.	.
DNC006404	GB-12819	Discovery agent	.	.
DNC006405	BS 9106	Discovery agent	.	.
DNC006406	BS 7581	Discovery agent	.	.
DNC006407	GBR 12530	Discovery agent	.	.
DNC006408	BS 7840	Discovery agent	.	.
DNC006409	Ac-Bth-Thr(PO3H2)-Pip-Nal-Gln-NH2	Discovery agent	.	.
DNC006410	Ac-Phe-Thr(PO3H2)-Pip-Nal-Gln-NH2	Discovery agent	.	.
DNC006411	Ac-Phe-D-Thr(PO3H2)-Pip-Nal-Gln-NH2	Discovery agent	.	.
DNC006412	ELLAGIC ACID	Discovery agent	.	.
DNC006413	[Cys-Trp-Arg-Nva-Arg-Tyr-NH2]2	Discovery agent	.	.
DNC006414	AR-C70484XX	Discovery agent	.	.
DNC006415	UCB-101333-3	Discovery agent	.	.
DNC006416	Sub[-Tyr-Arg-Leu-Arg-Tyr-NH2]2	Discovery agent	.	.
DNC006417	H-[Trp-Arg-Nva-Arg-Tyr]3-NH2	Discovery agent	.	.
DNC006418	H-[Trp-Arg-Nva-Arg-Tyr]2-NH2	Discovery agent	.	.
DNC006419	Sub[-Trp-Arg-Nva-Arg-Tyr-NH2]2	Discovery agent	.	.
DNC006420	Adp[-Trp-Arg-Nva-Arg-Tyr-NH2]2	Discovery agent	.	.
DNC006421	Pim[-Trp-Arg-Nva-Arg-Tyr-NH2]2	Discovery agent	.	.
DNC006422	2-(3-chlorobenzyloxy)-6-chloroisonicotinonitrile	Discovery agent	.	.
DNC006423	3-(3-(3-chlorobenzyloxy)-5-methylphenyl)pyridine	Discovery agent	.	.
DNC006424	2-(3-(benzyloxy)phenyl)isoindoline-1,3-dione	Discovery agent	.	.
DNC006425	N-(5-chlorobenzo[d]oxazol-2-yl)benzenesulfonamide	Discovery agent	.	.
DNC006426	3-isopropylnaphthalene-1,2-dione	Discovery agent	.	.
DNC006427	3-isopropyl-4-phenylnaphthalene-1,2-dione	Discovery agent	.	.
DNC006428	4-(p-toluidino)-3-isopropylnaphthalene-1,2-dione	Discovery agent	.	.
DNC006429	3-isopropyl-4-(phenylamino)naphthalene-1,2-dione	Discovery agent	.	.
DNC006430	3-isopropyl-4-(phenylthio)naphthalene-1,2-dione	Discovery agent	.	.
DNC006431	RAZAXABAN	Discovery agent	.	.
DNC006432	Ro-4396686	Discovery agent	.	.
DNC006433	(R)-1-((S)-morpholin-2-yl)-1,2-diphenylethanol	Discovery agent	.	.
DNC006434	L-873724	Asthma	493	J45
DNC006434	L-873724	Discovery agent	.	.
DNC006435	N-methyl-2-(pyridin-3-yloxy)ethanamine	Discovery agent	.	.
DNC006436	N-ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine	Discovery agent	.	.
DNC006437	N,N-dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine	Discovery agent	.	.
DNC006438	N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine	Discovery agent	.	.
DNC006439	N-methyl-N-(pyridin-3-ylmethyl)ethanamine	Discovery agent	.	.
DNC006440	N,N-dimethyl(pyridin-3-yl)methanamine	Discovery agent	.	.
DNC006441	N,N-dimethyl-2-(pyridin-3-yloxy)ethanamine	Discovery agent	.	.
DNC006442	2-(2-((benzylamino)methyl)phenoxy)-5-chlorophenol	Discovery agent	.	.
DNC006443	2-(4-chloro-2-hydroxyphenoxy)benzenaminium	Discovery agent	.	.
DNC006444	R-flurbiprofen	Discovery agent	.	.
DNC006445	Bis(2,4-dinitrophenyl)sulfane	Discovery agent	.	.
DNC006446	4,6-dinitrobenzo[c][1,2,5]thiadiazole	Discovery agent	.	.
DNC006447	4-nitrobenzo[c][1,2,5]thiadiazole	Discovery agent	.	.
DNC006448	SR-973	Discovery agent	.	.
DNC006449	OCHNAFLAVONE	Discovery agent	.	.
DNC006450	N'-(phenylsulfonyl)quinoline-6-carbohydrazide	Discovery agent	.	.
DNC006451	N'-(phenylsulfonyl)benzofuran-2-carbohydrazide	Discovery agent	.	.
DNC006452	4-(4-chlorophenylthio)-2-(pyridin-2-yl)pyrimidine	Discovery agent	.	.
DNC006453	2-(pyridin-2-yl)-4-(m-tolylthio)pyrimidine	Discovery agent	.	.
DNC006454	4-(3-bromophenylthio)-2-(pyridin-2-yl)pyrimidine	Discovery agent	.	.
DNC006455	4-(3-chlorophenylthio)-2-(pyridin-2-yl)pyrimidine	Discovery agent	.	.
DNC006456	6-bromo-1-methyl-3-(pyridin-4-yl)-1H-indole	Discovery agent	.	.
DNC006457	3-(furan-3-yl)-1-methyl-1H-indole	Discovery agent	.	.
DNC006458	1-methyl-1H-indole-3-carbaldehyde	Discovery agent	.	.
DNC006459	1-methyl-1H-indole-3-carbonitrile	Discovery agent	.	.
DNC006460	6-bromo-3-(pyridin-4-yl)-1H-indole	Discovery agent	.	.
DNC006461	2-methyl-3-(pyridin-4-yl)-1H-indol-6-amine	Discovery agent	.	.
DNC006462	2-methyl-3-(pyridin-4-yl)-1H-indole	Discovery agent	.	.
DNC006463	3-(pyridin-4-yl)-1H-indol-7-amine	Discovery agent	.	.
DNC006464	1-methyl-1H-indole-3-carboxamide	Discovery agent	.	.
DNC006465	3-(pyridin-4-yl)-1H-indol-6-amine	Discovery agent	.	.
DNC006466	3-(thiophen-3-yl)-1H-indol-6-amine	Discovery agent	.	.
DNC006467	3-(furan-3-yl)-1H-indole	Discovery agent	.	.
DNC006468	3-(pyridin-4-yl)-1H-indole	Discovery agent	.	.
DNC006469	3-methoxy-4-(oxazol-5-yl)aniline	Discovery agent	.	.
DNC006470	1-methoxy-3-(3-(pyridin-4-yl)-1H-indol-6-yl)urea	Discovery agent	.	.
DNC006471	Ethyl 3-(pyridin-4-yl)-1H-indole-6-carboxylate	Discovery agent	.	.
DNC006472	6-phenyl-3-(pyridin-4-yl)-1H-indole	Discovery agent	.	.
DNC006473	1-(3-cyano-1-methyl-1H-indol-6-yl)-3-phenylurea	Discovery agent	.	.
DNC006474	3-(3-cyano-1H-indol-6-yl)-1-methyl-1-phenylurea	Discovery agent	.	.
DNC006475	5-methoxy-2-(4-aminophenyl)benzofuran	Discovery agent	.	.
DNC006476	2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol	Discovery agent	.	.
DNC006477	SB-13	Discovery agent	.	.
DNC006478	5-hydroxy-2-(4-dimethylaminophenyl)benzofuran	Discovery agent	.	.
DNC006479	5-methoxy-2-(4-dimethylaminophenyl)benzofuran	Discovery agent	.	.
DNC006480	5-hydroxy-2-(4-methylaminophenyl)benzofuran	Discovery agent	.	.
DNC006481	5-methoxy-2-(4-methylaminophenyl)benzofuran	Discovery agent	.	.
DNC006482	5-hydroxy-2-(4-aminophenyl)benzofuran	Discovery agent	.	.
DNC006483	L-746530	Discovery agent	.	.
DNC006484	KMI-596	Discovery agent	.	.
DNC006485	8-Octyl-benzolactam-V9	Discovery agent	.	.
DNC006486	2-nonylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006487	2-butylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006488	2-propylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006489	2-ethylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006490	2-pentafluorophenylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006491	2-cyclohexylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006492	2-valproylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006493	1-pentafluorophenylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006494	1-cyclohexylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006495	1-valproylamido-5-sulfonamidoindane	Discovery agent	.	.
DNC006496	SNF-9007	Discovery agent	.	.
DNC006497	Tyr-D-Nle-Gly-D-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC006498	Tyr-D-Ala-Gly-D-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC006499	Tyr-D-Phe-Gly-D-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC006500	Tyr-D-Nle-Gly-D-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006501	Tyr-D-Ala-Gly-D-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006502	Tyr-D-Phe-Gly-D-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006503	Tyr-D-Nle-Gly-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC006504	Tyr-D-Ala-Gly-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC006505	Tyr-D-Phe-Gly-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC006506	Tyr-Gly-Gly-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006507	Tyr-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006508	Tyr-D-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006509	Tyr-D-Nle-Gly-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006510	Tyr-D-Ala-Gly-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006511	Tyr-D-Phe-Gly-Trp-NMeNle-Asp-Phe-NH2	Discovery agent	.	.
DNC006512	2-benzyl-5-mercaptopentanoic acid	Discovery agent	.	.
DNC006513	1,6-bis(4'-methylaminophenyl)-hexa-1,3,5-triene	Discovery agent	.	.
DNC006514	1,6-bis(4'-aminophenyl)-hexa-1,3,5-triene	Discovery agent	.	.
DNC006515	1,6-Bis(4'-hydroxyphenyl)-hexa-1,3,5-triene	Discovery agent	.	.
DNC006516	1,6-bis(4'-dimethylaminophenyl)-hexa-1,3,5-triene	Discovery agent	.	.
DNC006517	1,6-bis(4'-nitrophenyl)-hexa-1,3,5-triene	Discovery agent	.	.
DNC006518	2-(3-carboxybenzyl)succinic acid	Discovery agent	.	.
DNC006519	3-(2-carboxy-3-phosphonopropyl)benzoic acid	Discovery agent	.	.
DNC006520	3-[(1-carboxy-4-mercaptobutyl)thio]benzoic acid	Discovery agent	.	.
DNC006521	3-(1-carboxy-4-mercaptobutoxy)benzoic acid	Discovery agent	.	.
DNC006522	2-(3-cyanobenzyl)-5-mercaptopentanoic acid	Discovery agent	.	.
DNC006523	2-(3-carbamoylbenzyl)-5-mercaptopentanoic acid	Discovery agent	.	.
DNC006524	3-(2-carbamoyl-5-mercaptopentyl)benzoic acid	Discovery agent	.	.
DNC006525	2-(2-carboxy-7-mercaptoheptyl)benzoic acid	Discovery agent	.	.
DNC006526	3-(2-carboxy-6-mercaptohexyl)benzoic acid	Discovery agent	.	.
DNC006527	3-(2-carboxy-4-mercaptobutyl)benzoic acid	Discovery agent	.	.
DNC006528	3-(2-carboxy-3-mercaptopropyl)benzoic acid	Discovery agent	.	.
DNC006529	4-(2-carboxy-5-mercaptopentyl)benzoic acid	Discovery agent	.	.
DNC006530	3-(2-carboxy-5-mercaptopentyl)benzoic acid	Discovery agent	.	.
DNC006531	2-(2-carboxy-5-mercaptopentyl)benzoic acid	Discovery agent	.	.
DNC006532	2,6-diphenyl-9H-purine	Discovery agent	.	.
DNC006533	8-cyclohexyl-6-(4-tolyl)-2-phenyl-9H-purine	Discovery agent	.	.
DNC006534	LUF-5957	Discovery agent	.	.
DNC006535	LUF-5962	Discovery agent	.	.
DNC006536	LUF-5956	Discovery agent	.	.
DNC006537	8-propyl-2,6-diphenyl-9H-purine	Discovery agent	.	.
DNC006538	2,6,8-triphenyl-9H-purine	Discovery agent	.	.
DNC006539	2-(4-methoxyphenyl)-6-phenyl-9H-purine	Discovery agent	.	.
DNC006540	2-tolyl-6-phenyl-9H-purine	Discovery agent	.	.
DNC006541	2-(4-chlorophenyl)-6-phenyl-9H-purine	Discovery agent	.	.
DNC006542	2,6-bis(4-tolyl)-9H-purine	Discovery agent	.	.
DNC006543	2,6-bis(4-methoxyphenyl)-9H-purine	Discovery agent	.	.
DNC006544	2,6-bis(4-chlorophenyl)-9H-purine	Discovery agent	.	.
DNC006545	5-amino-2-p-tolyl-oxazole-4-carboxylic acid amide	Discovery agent	.	.
DNC006546	5-amino-2-phenyl-oxazole-4-carboxylic acid amide	Discovery agent	.	.
DNC006547	4-amino-biphenyl-3-carboxylic acid amide	Discovery agent	.	.
DNC006548	3-amino-benzo[b]thiophene-2-carboxylic acid amide	Discovery agent	.	.
DNC006549	2-amino-quinoline-3-carboxylic acid amide	Discovery agent	.	.
DNC006550	2-amino-5-phenylthiophene-3-carboxamide	Discovery agent	.	.
DNC006551	6-phenyl-thieno[3,2-d]pyrimidin-4-ylamine	Discovery agent	.	.
DNC006552	3-amino-5-(4-chlorophenyl)thiophene-2-carboxamide	Discovery agent	.	.
DNC006553	10-trifluoroacetyl-DDACTHF	Discovery agent	.	.
DNC006554	LOMETREXOL	Discovery agent	.	.
DNC006554	LOMETREXOL	Solid tumours	.	C00-C75,C7A,C7B
DNC006555	[1,1':2',1'']-terphenyl-4,3'',5''-triol	Discovery agent	.	.
DNC006556	4,3'',5''-trimethoxy-[1,1':2',1'']-terphenyl	Discovery agent	.	.
DNC006557	6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol	Discovery agent	.	.
DNC006558	3'',5''-dimethoxy-[1,1':2',1'']-terphenyl-4-ol	Discovery agent	.	.
DNC006559	4,3'',5''-trimethoxy-[1,1':3',1'']-terphenyl	Discovery agent	.	.
DNC006560	3'',5''-dimethoxy-[1,1':3',1'']-terphenyl-4-ol	Discovery agent	.	.
DNC006561	(E)-4-(3,5-dimethoxystyryl)phenol	Discovery agent	.	.
DNC006562	PTosyl-Glu(OtBu)-Ala-LeuVSMe	Discovery agent	.	.
DNC006563	Cbz-Ile-t-ButylhomoGlu-Ala-LeuVSMe	Discovery agent	.	.
DNC006564	Cbz-Ile-Leu-Ala-LeuVSMe	Discovery agent	.	.
DNC006565	Ac-hPhe-Leu-Phe-LeuVSMe	Discovery agent	.	.
DNC006566	Ac-hPhe-Leu-Ala-LeuVSMe	Discovery agent	.	.
DNC006567	Cbz-Glu(OtBu)-Ala-LeuVSMe	Discovery agent	.	.
DNC006568	Cbz-Ile-Pro-Ala-LeuVSMe	Discovery agent	.	.
DNC006569	Cbz-Ile-t-ButylGln-Ala-LeuVSMe	Discovery agent	.	.
DNC006570	Cbz-Ile-MetO2-Ala-LeuVSMe	Discovery agent	.	.
DNC006571	Cbz-Ile-hPhe-Ala-LeuVSMe	Discovery agent	.	.
DNC006572	Cbz-Ile-Phe-Ala-LeuVSMe	Discovery agent	.	.
DNC006573	Ac-hPhe-Leu-Gly-LeuVSMe	Discovery agent	.	.
DNC006574	MELAGATRAN	Discovery agent	.	.
DNC006575	N-benzyl-N-isobutylpiperidin-4-amine	Discovery agent	.	.
DNC006576	Isobutyl-(4-methyl-benzyl)-piperidin-4-yl-amine	Discovery agent	.	.
DNC006577	4-methyl-N-(naphthalen-1-yl)thiazol-2-amine	Discovery agent	.	.
DNC006578	4-tert-butyl-N-(naphthalen-1-yl)oxazol-2-amine	Discovery agent	.	.
DNC006579	N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine	Discovery agent	.	.
DNC006580	N-(4-tert-butylthiazol-2-yl)isoquinolin-5-amine	Discovery agent	.	.
DNC006581	N-(4-tert-butylthiazol-2-yl)quinolin-5-amine	Discovery agent	.	.
DNC006582	4-tert-butyl-N-(2-isopropylphenyl)thiazol-2-amine	Discovery agent	.	.
DNC006583	4-tert-butyl-N-m-tolylthiazol-2-amine	Discovery agent	.	.
DNC006584	4-tert-butyl-N-o-tolylthiazol-2-amine	Discovery agent	.	.
DNC006585	4-tert-butyl-N-phenylthiazol-2-amine	Discovery agent	.	.
DNC006586	N-(naphthalen-1-yl)-4-phenylthiazol-2-amine	Discovery agent	.	.
DNC006587	N-(naphthalen-1-yl)-4-neopentylthiazol-2-amine	Discovery agent	.	.
DNC006588	4-tert-butyl-N-(naphthalen-1-yl)thiazol-2-amine	Discovery agent	.	.
DNC006589	4-isopropyl-N-(naphthalen-1-yl)thiazol-2-amine	Discovery agent	.	.
DNC006590	Sunepitron	Discovery agent	.	.
DNC006591	Bis-(5-hydroxy-1H-indol-2-yl)-methanone	Discovery agent	.	.
DNC006592	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone	Discovery agent	.	.
DNC006593	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone	Discovery agent	.	.
DNC006594	AG1295	Discovery agent	.	.
DNC006595	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone	Discovery agent	.	.
DNC006596	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone	Discovery agent	.	.
DNC006597	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone	Discovery agent	.	.
DNC006598	Di(1H-indol-2-yl)methanone	Discovery agent	.	.
DNC006599	BAS-01373578	Discovery agent	.	.
DNC006600	BAS-00672722	Discovery agent	.	.
DNC006601	BAS-00387275	Discovery agent	.	.
DNC006602	BAS-01047341	Discovery agent	.	.
DNC006603	BAS-00387328	Discovery agent	.	.
DNC006604	BAS-00387347	Discovery agent	.	.
DNC006605	BAS-01047655	Discovery agent	.	.
DNC006606	BAS-4844343	Discovery agent	.	.
DNC006607	BAS-09534324	Discovery agent	.	.
DNC006608	BAS-450225	Discovery agent	.	.
DNC006609	BAS-0338872	Discovery agent	.	.
DNC006610	BAS-0338868	Discovery agent	.	.
DNC006611	BAS-0338876	Discovery agent	.	.
DNC006612	3,7-dihydroxy-flavone	Discovery agent	.	.
DNC006613	KAEMPFEROL	Discovery agent	.	.
DNC006614	MORIN	Discovery agent	.	.
DNC006615	ISORHAMNETIN	Discovery agent	.	.
DNC006616	EPICATECHIN GALLATE	Discovery agent	.	.
DNC006617	EPIGALOCATECHIN GALLATE	Discovery agent	.	.
DNC006618	GALLOCATECHIN GALLATE	Discovery agent	.	.
DNC006619	Ac-Cys-Ile-cyclo[Phe-Lys]-Tyr-Tyr	Discovery agent	.	.
DNC006620	Ac-Cys-Ile-cyclo[Phe-Lys]-Tyr-Tyr	Discovery agent	.	.
DNC006621	Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Phe]	Discovery agent	.	.
DNC006622	Cyclo[Ac-Cys-Ile-Phe]-Lys-Tyr-Tyr	Discovery agent	.	.
DNC006623	Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Tyr]	Discovery agent	.	.
DNC006624	Ac-Cys-Ile-Tyr-Lys-Phe(4-N3)-Tyr	Discovery agent	.	.
DNC006625	Ac-Cys-Ile-Tyr-Lys-Phe(4-CN)-Tyr	Discovery agent	.	.
DNC006626	Ac-Cys-Ile-Tyr-Lys-Phe(4-I)-Tyr	Discovery agent	.	.
DNC006627	Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Tyr-Phe	Discovery agent	.	.
DNC006628	Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Phe(4-NO2)	Discovery agent	.	.
DNC006629	Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Phe(4-NO2)	Discovery agent	.	.
DNC006630	Ac-Cys-Ile-Phe(4-NO2)-Lys-Phe(4-NO2)-Tyr	Discovery agent	.	.
DNC006631	Ac-Cys-Ile-Tyr-Lys-Tyr-Phe(4-NO2)	Discovery agent	.	.
DNC006632	Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Tyr	Discovery agent	.	.
DNC006633	Ac-Cys-Ile-Tyr-Lys-Phe(4-Cl)-Tyr	Discovery agent	.	.
DNC006634	Huprine X	Discovery agent	.	.
DNC006635	C(Arg-Gly-Asp-D-Phe-Val)	Discovery agent	.	.
DNC006636	RGDechi	Discovery agent	.	.
DNC006637	NUTLIN-3	Discovery agent	.	.
DNC006638	PLSQETFSDLWKLLPEN-NH2	Discovery agent	.	.
DNC006639	Beta,beta-dimethylmelatonin	Discovery agent	.	.
DNC006640	Beta-methylmelatonin	Discovery agent	.	.
DNC006641	(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate	Discovery agent	.	.
DNC006642	4-nitrophenylsulfamide	Discovery agent	.	.
DNC006643	4-methoxyphenylsulfamide	Discovery agent	.	.
DNC006644	PHENYLSULFAMIDE	Discovery agent	.	.
DNC006645	DEGARELIX	Discovery agent	.	.
DNC006645	DEGARELIX	Female infertility	.	N97.0
DNC006646	[4Aph(CO-NH-OCH3)5,D-4Aph(CO-NH-OCH3)6]degarelix	Discovery agent	.	.
DNC006647	[D-4Aph(CO-NH-(C2H4O)2-C2H5)6]degarelix	Discovery agent	.	.
DNC006648	[D-4Aph(CO-NH-OCH3)6]degarelix	Discovery agent	.	.
DNC006649	[D-4Aph(CO-NH-OH)6]degarelix	Discovery agent	.	.
DNC006650	[4Aph(CO-(C2H4O)3-C2H4-NH-CO-NH-OCH3)5]degarelix	Discovery agent	.	.
DNC006651	[4Aph(CO-NH-(C2H4O)2-C2H5)5]degarelix	Discovery agent	.	.
DNC006652	[4Aph(CO-NH-OCH3)5]degarelix	Discovery agent	.	.
DNC006653	[4Aph(CO-NH-OH)5]degarelix	Discovery agent	.	.
DNC006654	[D-Dab(CO-NH-OCH3)3]degarelix	Discovery agent	.	.
DNC006655	[D-Dab(CO-NH-OH)3]degarelix	Discovery agent	.	.
DNC006656	[D-Dap(CO-NH-OH)3]degarelix	Discovery agent	.	.
DNC006657	ACYLINE	Discovery agent	.	.
DNC006657	ACYLINE	Prostate cancer	185	C61
DNC006658	[D-Dap(CO-NH-OCH3)3]degarelix	Discovery agent	.	.
DNC006659	N4-(3-methylphenyl)-4,6-quinazolinediamine	Discovery agent	.	.
DNC006660	BM-573	Discovery agent	.	.
DNC006661	N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide	Discovery agent	.	.
DNC006662	N-(6-ethoxypyridin-2-yl)acetamide	Discovery agent	.	.
DNC006663	N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide	Discovery agent	.	.
DNC006664	N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide	Discovery agent	.	.
DNC006665	N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide	Discovery agent	.	.
DNC006666	N-(1H-benzo[d]imidazol-2-yl)-3-cyanobenzamide	Discovery agent	.	.
DNC006667	CAULERPIN	Discovery agent	.	.
DNC006668	1-(4-(1H-pyrazol-1-yl)benzyl)-4-phenylpiperazine	Discovery agent	.	.
DNC006669	16-alphaH,17-isovaleryloxy-ent-kauran-19-oic acid	Discovery agent	.	.
DNC006670	Carboxylated glucosamine	Discovery agent	.	.
DNC006671	2-(4'-chloro-biphenyl-4-sulfonyl)-pentanoic acid	Discovery agent	.	.
DNC006672	EMD-281014	Discovery agent	.	.
DNC006673	3-oxoolean-12-en-27-oic acid	Discovery agent	.	.
DNC006674	18alpha-Glycyrrhetic acid	Discovery agent	.	.
DNC006675	18beta-Glycyrrhetic acid	Discovery agent	.	.
DNC006676	Methyl 3beta-hydroxyolean-12-en-28-oate	Discovery agent	.	.
DNC006677	OLEANOLIC_ACID	Discovery agent	.	.
DNC006678	3beta,6beta-dihydroxyolean-12-en-27-oic acid	Discovery agent	.	.
DNC006679	3alpha,24-dihydroxyolean-12-en-27-oic acid	Discovery agent	.	.
DNC006680	3beta-hydroxyurs-12-en-27-oic acid	Discovery agent	.	.
DNC006681	Methyl3beta-hydroxyolean-12-en-27-oate	Discovery agent	.	.
DNC006682	3beta-acetoxyolean-12-en-27-oic acid	Discovery agent	.	.
DNC006683	3beta-hydroxyolean-12-en-27-oic acid	Discovery agent	.	.
DNC006684	2-(3,4-dimethoxybenzamido)thiophene-3-carboxamide	Discovery agent	.	.
DNC006685	A-80040	Discovery agent	.	.
DNC006686	CP-640186	Discovery agent	.	.
DNC006687	C(his-D-phe-arg-trp-Aoc)	Discovery agent	.	.
DNC006688	C(his-D-phe-arg-trp-Ahp)	Discovery agent	.	.
DNC006689	C(his-D-phe-arg-trp-Ahx)	Discovery agent	.	.
DNC006690	C(his-D-phe-arg-trp-Abu)	Discovery agent	.	.
DNC006691	C(his-L-phe-arg-trp-Aoc)	Discovery agent	.	.
DNC006692	4-(6-methoxy-1H-indol-1-ylsulfonyl)benzenamine	Discovery agent	.	.
DNC006693	4-(4-methoxy-1H-indol-1-ylsulfonyl)benzenamine	Discovery agent	.	.
DNC006694	JNJ-7706621	Discovery agent	.	.
DNC006695	H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2	Discovery agent	.	.
DNC006696	N-(3-phenoxycinnamyl)-N-hydroxyacetamide	Discovery agent	.	.
DNC006697	H-c[Cys-Phe-DTrp-Lys-Thr-Cys]-OH	Discovery agent	.	.
DNC006698	H-D-Phe-c[Cys-Ala-D-Trp-Lys-Thr-Cys]-Thr-NH2	Discovery agent	.	.
DNC006699	Demotensin 4	Discovery agent	.	.
DNC006700	Demotensin 3	Discovery agent	.	.
DNC006701	Demotensin 2	Discovery agent	.	.
DNC006702	Demotensin 1	Discovery agent	.	.
DNC006703	NEUROTENSIN	Discovery agent	.	.
DNC006704	Ac-ICV(1MeW)QDWGAHRCT-NH2	Discovery agent	.	.
DNC006705	Ac-ICVWQD(5fW)GAHRCT-NH2	Discovery agent	.	.
DNC006706	Ac-ICV(2Nal)QDWGAHRCT-NH2	Discovery agent	.	.
DNC006707	Ac-ICV(1MeW)QDWGAHRCT-NH2	Discovery agent	.	.
DNC006708	Ac-ICV(5MeW)QDWGAHRCT-NH2	Discovery agent	.	.
DNC006709	Ac-ICV(5fW)QDWGAHRCT-NH2	Discovery agent	.	.
DNC006710	Ac-ICVWQDWGAHRCT-NH2	Discovery agent	.	.
DNC006711	A-443654	Discovery agent	.	.
DNC006712	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole	Discovery agent	.	.
DNC006713	2-(4-fluorophenylsulfonamido)-1-naphthoic acid	Discovery agent	.	.
DNC006714	2-(phenylsulfonamido)-1-naphthoic acid	Discovery agent	.	.
DNC006715	5-butyl-2-(phenylsulfonamido)benzoic acid	Discovery agent	.	.
DNC006716	2-(phenylsulfonamido)-5-propylbenzoic acid	Discovery agent	.	.
DNC006717	5-ethyl-2-(phenylsulfonamido)benzoic acid	Discovery agent	.	.
DNC006718	3,5-dimethyl-2-(phenylsulfonamido)benzoic acid	Discovery agent	.	.
DNC006719	5-methyl-2-(phenylsulfonamido)benzoic acid	Discovery agent	.	.
DNC006720	5-bromo-2-(4-chlorophenylsulfonamido)benzoic acid	Discovery agent	.	.
DNC006721	3-chloro-N-(6-chloropyridin-2-yl)benzamide	Discovery agent	.	.
DNC006722	3-bromo-N-(6-methylpyridin-2-yl)benzamide	Discovery agent	.	.
DNC006723	3-cyano-N-(6-methylpyridin-2-yl)benzamide	Discovery agent	.	.
DNC006724	3-iodo-N-(6-methylpyridin-2-yl)benzamide	Discovery agent	.	.
DNC006725	3-methyl-N-(6-methylpyridin-2-yl)benzamide	Discovery agent	.	.
DNC006726	3-chloro-N-(4-methylthiazol-2-yl)benzamide	Discovery agent	.	.
DNC006727	PHA-543613	Cognitive impairment	.	F06.7
DNC006727	PHA-543613	Discovery agent	.	.
DNC006728	D-Phe-Arg-2-Nal-NHCH3	Discovery agent	.	.
DNC006729	3-(imidazolylmethyl)-4'-methoxyflavone	Discovery agent	.	.
DNC006730	4'-cyano-3-(imidazolylmethyl)flavone	Discovery agent	.	.
DNC006731	4'-bromo-3-(imidazolylmethyl)flavone	Discovery agent	.	.
DNC006732	3-(imidazolylmethyl)-4'-nitroflavone	Discovery agent	.	.
DNC006733	3-(imidazolylmethyl)flavone	Discovery agent	.	.
DNC006734	4'-cyano-3-(imidazolylmethyl)-7-methoxyflavone	Discovery agent	.	.
DNC006735	4'-bromo-3-(imidazolylmethyl)-7-methoxyflavone	Discovery agent	.	.
DNC006736	3-(imidazolylmethyl)-7-methoxy-4'-nitroflavone	Discovery agent	.	.
DNC006737	(2S,3R)-2-(benzyloxy)-3-methoxycyclohexanone	Discovery agent	.	.
DNC006738	3-(1-benzylpiperidin-4-yl)-5-chloro-1H-indole	Discovery agent	.	.
DNC006739	PSB-601	Discovery agent	.	.
DNC006740	1-(3-tritylaminopropyl)uracil	Discovery agent	.	.
DNC006741	(5R,6S)-5,6-bis(benzyloxy)cyclohex-2-enone	Discovery agent	.	.
DNC006742	(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone	Discovery agent	.	.
DNC006743	1-benzoyl-2-benzyl-1,2-dihydropyridin-3(6H)-one	Discovery agent	.	.
DNC006744	1-[4-hydroxy-3-(tritylaminomethyl)butyl]uracil	Discovery agent	.	.
DNC006745	1-[(Z)-4-trityloxy-2-butenyl]uracil	Discovery agent	.	.
DNC006746	1-[2-(trityloxy)ethoxymethyl]uracil	Discovery agent	.	.
DNC006747	H-Dmt-Aba-Gly-NH-CH2-Bid	Discovery agent	.	.
DNC006748	H-Dmt-Aba-Gly-NH-Ph	Discovery agent	.	.
DNC006749	H-Dmt-Aba-Gly-NH-CH2-Ph	Discovery agent	.	.
DNC006750	ENDOMORPHIN 2	Discovery agent	.	.
DNC006751	H-Dmt-Tic-Gly-NH-CH2-Bid	Discovery agent	.	.
DNC006752	H-Dmt-Tic-Gly-NH-Ph	Discovery agent	.	.
DNC006753	H-Dmt-Tic-Gly-NH-Bzl	Discovery agent	.	.
DNC006754	WIN-35065-2	Discovery agent	.	.
DNC006755	LEUPRORELIN	Discovery agent	.	.
DNC006756	1-[3-(4-biphenyl)-(1,2,4-triazol-4-yl) ]-3-phenol	Discovery agent	.	.
DNC006757	1-[3-(3-biphenyl)-(1,2,4-triazol-4-yl) ]-3-phenol	Discovery agent	.	.
DNC006758	COMBRETASTATIN	Discovery agent	.	.
DNC006759	2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine	Discovery agent	.	.
DNC006760	(S)-2-amino-N-(1-cyano-2-phenylethyl)acetamide	Discovery agent	.	.
DNC006761	3-tapap	Discovery agent	.	.
DNC006762	(E)-3-(4-chlorophenylimino)indolin-2-one	Discovery agent	.	.
DNC006763	(E)-3-(2,3-dichlorophenylimino)indolin-2-one	Discovery agent	.	.
DNC006764	1-(2-(diethylamino)quinazolin-4-yl)-3-phenylurea	Discovery agent	.	.
DNC006765	1-phenyl-3-(2-(pyridin-3-yl)quinazolin-4-yl)urea	Discovery agent	.	.
DNC006766	1-phenyl-3-(quinazolin-4-yl)urea	Discovery agent	.	.
DNC006767	1-phenyl-3-(2-(pyridin-2-yl)quinazolin-4-yl)urea	Discovery agent	.	.
DNC006768	1-phenyl-3-(3-(pyridin-2-yl)isoquinolin-1-yl)urea	Discovery agent	.	.
DNC006769	VUF-8507	Discovery agent	.	.
DNC006770	VUF-8504	Discovery agent	.	.
DNC006771	7-hydroxy-1,2,9,9a-tetrahydrofluoren-3-one	Discovery agent	.	.
DNC006772	NSC-66811	Discovery agent	.	.
DNC006773	3-(2,5-dimethyl-1H-pyrrol-1-yl)benzoic acid	Discovery agent	.	.
DNC006774	17-methyl-4'-methyldihydromorphinone	Discovery agent	.	.
DNC006775	MC-CAM	Discovery agent	.	.
DNC006776	Clocinnamox	Discovery agent	.	.
DNC006777	NSC-622445	Discovery agent	.	.
DNC006778	Adociasulfate-2	Discovery agent	.	.
DNC006779	NU-6027	Discovery agent	.	.
DNC006780	4-(2-benzenesulfonylphenyl)piperazine	Discovery agent	.	.
DNC006781	4-(4-benzenesulfonylphenyl)piperazine	Discovery agent	.	.
DNC006782	4-(3-benzenesulfonylphenyl)piperazine	Discovery agent	.	.
DNC006783	4-(4-benzenesulfonamidophenyl)piperazine	Discovery agent	.	.
DNC006784	4-(3-benzenesulfonamidophenyl)piperazine	Discovery agent	.	.
DNC006785	2-(4-(benzenesulfonyl)phenyl)-1-aminoethane	Discovery agent	.	.
DNC006786	N-(4-(2-aminoethyl)phenyl)benzenesulfonamide	Discovery agent	.	.
DNC006787	2-(3-phenylthio)phenyl)-1-aminoethane	Discovery agent	.	.
DNC006788	2-(3-benzenesulfonyl)phenyl-1-aminoethane	Discovery agent	.	.
DNC006789	N-(3-(2-aminoethyl)phenyl)benzenesulfonamide	Discovery agent	.	.
DNC006790	N-(3-(3-aminopropyl)phenyl)benzenesulfonamide	Discovery agent	.	.
DNC006791	N-(3-(aminomethyl)phenyl)benzenesulfonamide	Discovery agent	.	.
DNC006792	N-(3-aminophenyl)benzenesulfonamide	Discovery agent	.	.
DNC006793	N-phenyl-3-(2-aminoethyl)benzenesulfonamide	Discovery agent	.	.
DNC006794	CP-808844	Discovery agent	.	.
DNC006795	2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid	Discovery agent	.	.
DNC006796	BMS-480404	Discovery agent	.	.
DNC006797	3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine	Discovery agent	.	.
DNC006798	9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Discovery agent	.	.
DNC006799	1-(3,4-dihydronaphthalen-1-yl)ethanone	Discovery agent	.	.
DNC006800	1-(bis(3-bromophenyl)methylene)thiosemicarbazide	Discovery agent	.	.
DNC006801	1-(1-(3-nitrophenyl)propylidene)thiosemicarbazide	Discovery agent	.	.
DNC006802	3-phenyl-1,4-dihydroindeno[1,2-c]pyrazole	Discovery agent	.	.
DNC006803	1-(1,4-diphenylbutan-2-yl)piperazine	Discovery agent	.	.
DNC006804	1-(1,3-diphenylpropyl)piperazine	Discovery agent	.	.
DNC006805	1-(2-(2-ethoxyphenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006806	1-(2-(naphthalen-1-yl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006807	1-(2-(naphthalen-2-yl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006808	1-(1-phenyl-2-(pyridin-2-yl)ethyl)piperazine	Discovery agent	.	.
DNC006809	1-(1-phenyl-2-(pyridin-4-yl)ethyl)piperazine	Discovery agent	.	.
DNC006810	1-(2-(2-chlorophenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006811	BMS-740808	Discovery agent	.	.
DNC006812	1-(3,4-dichlorophenyl)-3-hydroxyurea	Discovery agent	.	.
DNC006813	1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006814	(R)-DULOXETINE	Discovery agent	.	.
DNC006815	1-(1,2-diphenylethyl)piperazine	Discovery agent	.	.
DNC006816	1-(2-(3-chlorophenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006817	3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile	Discovery agent	.	.
DNC006818	1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006819	1-(2-(2-bromophenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006820	1-(1-phenyl-2-o-tolylethyl)piperazine	Discovery agent	.	.
DNC006821	1-(2-(2-ethylphenyl)-1-phenylethyl)piperazine	Discovery agent	.	.
DNC006822	1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine	Discovery agent	.	.
DNC006823	2-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile	Discovery agent	.	.
DNC006824	3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzamide	Discovery agent	.	.
DNC006825	3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol	Discovery agent	.	.
DNC006826	5-phenylamino-4-cyano-3-hydroxy-isothiazole	Discovery agent	.	.
DNC006827	4-hydroxy-6-nitro-3-phenylquinolin-2(1H)-one	Discovery agent	.	.
DNC006828	4-((4-methoxyphenyl)diazenyl)benzenesulfonamide	Discovery agent	.	.
DNC006829	NSC-27236	Discovery agent	.	.
DNC006830	3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide	Discovery agent	.	.
DNC006831	NSC-654077	Discovery agent	.	.
DNC006832	2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide	Discovery agent	.	.
DNC006833	Rofecoxib analogue	Discovery agent	.	.
DNC006834	1-benzyl-5'-O-tritylinosine	Discovery agent	.	.
DNC006835	1-(cyclohexyl)methyl-5'-O-tritylinosine	Discovery agent	.	.
DNC006836	1-(cyclopropyl)methyl-5'-O-tritylinosine	Discovery agent	.	.
DNC006837	1-allyl-5'-O-tritylinosine	Discovery agent	.	.
DNC006838	1-propyl-5'-O-tritylinosine	Discovery agent	.	.
DNC006839	MCL-450	Discovery agent	.	.
DNC006840	MCL-451	Discovery agent	.	.
DNC006841	8-carboxamidocyclazocine	Discovery agent	.	.
DNC006842	ICI-174864	Discovery agent	.	.
DNC006843	D-Phe-Arg-2-Nal-NHCH3	Discovery agent	.	.
DNC006844	Ac-His-D-Phe-Arg-2-Nal-NHCH3	Discovery agent	.	.
DNC006845	DEOXY SALVINORIN A	Discovery agent	.	.
DNC006846	SALVINORIN B	Discovery agent	.	.
DNC006847	Salvinorin A (ester)	Discovery agent	.	.
DNC006848	6-o-tolylquinazolin-2-amine	Discovery agent	.	.
DNC006849	2-(4-(3-chlorophenyl)but-1-ynyl)-6-methylpyridine	Discovery agent	.	.
DNC006850	2-methyl-6-(4-phenylpent-1-ynyl)pyridine	Discovery agent	.	.
DNC006851	2-methyl-6-(5-phenylpent-1-ynyl)pyridine	Discovery agent	.	.
DNC006852	2-methyl-6-(4-phenylbut-1-ynyl)pyridine	Discovery agent	.	.
DNC006853	2-methyl-6-(3-(phenylthio)prop-1-ynyl)pyridine	Discovery agent	.	.
DNC006854	N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine	Discovery agent	.	.
DNC006855	2-methyl-6-(3-(p-tolyloxy)prop-1-ynyl)pyridine	Discovery agent	.	.
DNC006856	2-(3-(3-methoxyphenoxy)prop-1-ynyl)pyridine	Discovery agent	.	.
DNC006857	6-ile-ustiloxin	Discovery agent	.	.
DNC006858	Ustiloxin F	Discovery agent	.	.
DNC006859	Ustiloxin D	Discovery agent	.	.
DNC006860	USTILOXIN A	Discovery agent	.	.
DNC006861	DOLASTATIN-10	Cancer	140-229	C00-C96
DNC006861	DOLASTATIN-10	Discovery agent	.	.
DNC006862	ENIPORIDE	Cardiac arrhythmias	.	I47-I49
DNC006862	ENIPORIDE	Discovery agent	.	.
DNC006863	2,5-dimethoxy-4-bromophenethylamine	Discovery agent	.	.
DNC006864	C-(5-bromo-4,7-dimethoxyindan-1-yl)methylamine	Discovery agent	.	.
DNC006865	N-(4-(3-(pyridin-2-yl)acryloyl)phenyl)acetamide	Discovery agent	.	.
DNC006866	Ac-RYYRIK-NH2	Discovery agent	.	.
DNC006867	Ac-RYYRIK-GGG-K-(NH2)-YRFB-GGGGG	Discovery agent	.	.
DNC006868	Ac-RYYRIK-K-(NH2)-YRFB	Discovery agent	.	.
DNC006869	Ac-RYYRIK-GGG-K-(NH2)-YAFGYPS-GG	Discovery agent	.	.
DNC006870	Ac-RYYRIK-K-(NH2)-YAFGYPS	Discovery agent	.	.
DNC006871	PD-0173955	Discovery agent	.	.
DNC006872	AMINOFENTANYL	Discovery agent	.	.
DNC006873	CARBOXYFENTANYL	Discovery agent	.	.
DNC006874	KYS-05064	Discovery agent	.	.
DNC006875	KYS-05070	Discovery agent	.	.
DNC006876	KYS-05071	Discovery agent	.	.
DNC006877	KYS-05074	Discovery agent	.	.
DNC006878	4-(3-methylpyridin-2-yl)-N-p-tolylbenzamide	Discovery agent	.	.
DNC006879	N-(4-tert-butylphenyl)-4-(pyridin-2-yl)benzamide	Discovery agent	.	.
DNC006880	1-adamantan-1-yl-3-piperidin-4-yl-urea	Discovery agent	.	.
DNC006881	1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea	Discovery agent	.	.
DNC006882	1-adamantan-1-yl-3-(1-benzyl-piperidin-4-yl)-urea	Discovery agent	.	.
DNC006883	1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea	Discovery agent	.	.
DNC006884	1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea	Discovery agent	.	.
DNC006885	1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea	Discovery agent	.	.
DNC006886	Cis-N,5-dibenzyl-6-oxomorpholine-3-carboxamide	Discovery agent	.	.
DNC006887	Hoo-Phe-Orn-Pro-hle-Pff-Phe-NH2	Discovery agent	.	.
DNC006888	Ac-Phe-[Orn-Pro-cha-Trp-Arg]	Discovery agent	.	.
DNC006889	12-(3-Adamantan-1-yl-ureido)-dodeca noic acid	Discovery agent	.	.
DNC006890	6-amino-4-trifluoromethylquinolin-2(1H)-one	Discovery agent	.	.
DNC006891	6-N-propyl -4-trifluoromethylquinolin-2(1H)-one	Discovery agent	.	.
DNC006892	LGD-2226	Discovery agent	.	.
DNC006893	GW-3965	Discovery agent	.	.
DNC006894	TW-37	Discovery agent	.	.
DNC006895	QEDIIRNIARHLAQVGDSMDR	Discovery agent	.	.
DNC006896	N-phenyl-2,3,4-trihydroxy-5-benzyl-benzamide	Discovery agent	.	.
DNC006897	2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide	Discovery agent	.	.
DNC006898	DEHYDROZINGERONE	Discovery agent	.	.
DNC006899	Chrysamine -G	Discovery agent	.	.
DNC006900	CURCUMIN	Cancer	.	C00-C97
DNC006900	CURCUMIN	Discovery agent	.	.
DNC006901	2'-amino-3,4,4',5-tetramethoxy-(Z)-stillbene	Discovery agent	.	.
DNC006902	2,3'-diamino-3,4,4',5-tetramethoxy-(Z)-stillbene	Discovery agent	.	.
DNC006903	3-bromo-4,4',5-trimethoxy-(Z)-stilbene	Discovery agent	.	.
DNC006904	3,4',5-trimethoxy-(Z)-stilbene	Discovery agent	.	.
DNC006905	3,4,4',5-tetramethoxy-(Z)-stilbene	Discovery agent	.	.
DNC006906	2-amino-3,4',5-trimethoxy-(Z)-stillbene	Discovery agent	.	.
DNC006907	2-amino-3,4,4',5-tetramethoxy-(Z)-stillbene	Discovery agent	.	.
DNC006908	GNF-PF-3427	Discovery agent	.	.
DNC006909	GNF-PF-3878	Discovery agent	.	.
DNC006910	GNF-PF-2857	Discovery agent	.	.
DNC006911	1-(benzyloxy)-2-(2-phenylethyl)benzene	Discovery agent	.	.
DNC006912	3-{[2-(2-phenylethyl)phenoxy]methyl}pyridine	Discovery agent	.	.
DNC006913	2-{[2-(2-phenylethyl)phenoxy]methyl}pyridine	Discovery agent	.	.
DNC006914	1-[(3-methoxybenzyl)oxy]-2-(2-phenylethyl)benzene	Discovery agent	.	.
DNC006915	1-(benzyloxy)-2-[2-(3-methoxyphenyl)ethyl]benzene	Discovery agent	.	.
DNC006916	Prop-2-ynyl 4-sulfamoylbenzoate	Discovery agent	.	.
DNC006917	N-propynyl amidebenzenesulphonide	Discovery agent	.	.
DNC006918	(+/-)-6-(2-chlorophenyl)cyclohex-3-enamine	Discovery agent	.	.
DNC006919	ABT-341	Discovery agent	.	.
DNC006920	2-(4-bromo-2-(hydroxymethyl)phenoxy)acetic acid	Discovery agent	.	.
DNC006921	2-(4-bromo-2-tert-butylphenoxy)acetic acid	Discovery agent	.	.
DNC006922	2-(2-benzoyl-4-bromophenoxy)acetic acid	Discovery agent	.	.
DNC006923	2-(2-acetyl-4-bromophenoxy)acetic acid	Discovery agent	.	.
DNC006924	2-(4-bromo-2-formylphenoxy)acetic acid	Discovery agent	.	.
DNC006925	2-(2-formylphenoxy)acetic acid	Discovery agent	.	.
DNC006926	WAY-254011	Discovery agent	.	.
DNC006927	5-iodo,5'-deoxytubercidin	Discovery agent	.	.
DNC006928	AZD-0530	Discovery agent	.	.
DNC006929	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol	Discovery agent	.	.
DNC006930	3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol	Discovery agent	.	.
DNC006931	2-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol	Discovery agent	.	.
DNC006932	4-(phenyldiazenyl)-1H-pyrazole-3,5-diamine	Discovery agent	.	.
DNC006933	3-noradamantyl-1,3-dipropylxanthine	Discovery agent	.	.
DNC006934	BMS-587101	Discovery agent	.	.
DNC006935	3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine	Discovery agent	.	.
DNC006936	3-(5-((methylthio)methyl)furan-2-yl)pyridine	Discovery agent	.	.
DNC006937	(5-pyridin-3-yl-furan-2-yl)methanethiol	Discovery agent	.	.
DNC006938	2-fluoro-5-(3-methylthiophen-2-yl)pyridine	Discovery agent	.	.
DNC006939	3-(pyridin-3-yl)prop-2-yn-1-amine	Discovery agent	.	.
DNC006940	(5-phenylfuran-2-yl)methanamine	Discovery agent	.	.
DNC006941	MOTILIN	Discovery agent	.	.
DNC006942	HESPERADIN	Discovery agent	.	.
DNC006943	ZM-447439	Discovery agent	.	.
DNC006944	AZD-1152-HQPA	Discovery agent	.	.
DNC006945	ADS-103253	Discovery agent	.	.
DNC006946	ADS-103274	Discovery agent	.	.
DNC006947	ADS-102891	Discovery agent	.	.
DNC006948	ADS-103293	Discovery agent	.	.
DNC006949	ADS-103316	Discovery agent	.	.
DNC006950	ADS-103254	Discovery agent	.	.
DNC006951	ADS-103168	Discovery agent	.	.
DNC006952	ADS-103214	Discovery agent	.	.
DNC006953	ADS-103294	Discovery agent	.	.
DNC006954	N-(1-benzylpiperidin-4-yl)-3,5-dimethoxybenzamide	Discovery agent	.	.
DNC006955	N-(4-amino-2-propylquinolin-6-yl)cinnamamide	Discovery agent	.	.
DNC006956	7-(4-(dimethylamino)phenoxy)-N-hydroxyheptanamide	Discovery agent	.	.
DNC006957	N-hydroxy-7-(naphthalen-2-yloxy)heptanamide	Discovery agent	.	.
DNC006958	7-(1H-indol-5-yloxy)-N-hydroxyheptanamide	Discovery agent	.	.
DNC006959	ADS-100380	Discovery agent	.	.
DNC006960	ADS-102550	Discovery agent	.	.
DNC006961	3-(benzyloxy)-2-(4-chlorophenyl)thiazolidin-4-one	Discovery agent	.	.
DNC006962	3-(4-methoxybenzyloxy)-2-phenylthiazolidin-4-one	Discovery agent	.	.
DNC006963	2-phenoxy-1-(2-p-tolylthiazolidin-3-yl)ethanone	Discovery agent	.	.
DNC006964	N-hydroxy-2,2'-bithiophene-5-carboxamide	Discovery agent	.	.
DNC006965	N-hydroxy-5-phenylthiophene-2-carboxamide	Discovery agent	.	.
DNC006966	N-hydroxy-5-(pyridin-2-yl)thiophene-2-carboxamide	Discovery agent	.	.
DNC006967	N-hydroxy-5-(pyridin-3-yl)thiophene-2-carboxamide	Discovery agent	.	.
DNC006968	N-hydroxy-5-(pyridin-4-yl)thiophene-2-carboxamide	Discovery agent	.	.
DNC006969	7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide	Discovery agent	.	.
DNC006970	3-(3-(benzamido)-5-nitrobenzamido)propanoic acid	Discovery agent	.	.
DNC006971	3-(3-(carbamoyl)benzamido)-3-phenylpropanoic acid	Discovery agent	.	.
DNC006972	3-(3-(carbamoyl)benzamido)propanoic acid	Discovery agent	.	.
DNC006973	JWH-370	Discovery agent	.	.
DNC006974	JWH-366	Discovery agent	.	.
DNC006975	JWH-347	Discovery agent	.	.
DNC006976	JWH-309	Discovery agent	.	.
DNC006977	JWH-348	Discovery agent	.	.
DNC006978	JWH-245	Discovery agent	.	.
DNC006979	JWH-308	Discovery agent	.	.
DNC006980	JWH-243	Discovery agent	.	.
DNC006981	JWH-371	Discovery agent	.	.
DNC006982	JWH-364	Discovery agent	.	.
DNC006983	JWH-244	Discovery agent	.	.
DNC006984	JWH-293	Discovery agent	.	.
DNC006985	JWH-363	Discovery agent	.	.
DNC006986	JWH-246	Discovery agent	.	.
DNC006987	JWH-368	Discovery agent	.	.
DNC006988	JWH-367	Discovery agent	.	.
DNC006989	JWH-346	Discovery agent	.	.
DNC006990	JWH-372	Discovery agent	.	.
DNC006991	JWH-369	Discovery agent	.	.
DNC006992	JWH-307	Discovery agent	.	.
DNC006993	JWH-292	Discovery agent	.	.
DNC006994	JWH-373	Discovery agent	.	.
DNC006995	JWH-365	Discovery agent	.	.
DNC006996	JWH-146	Discovery agent	.	.
DNC006997	JWH-147	Discovery agent	.	.
DNC006998	JWH-145	Discovery agent	.	.
DNC006999	JWH-150	Discovery agent	.	.
DNC007000	JWH-156	Discovery agent	.	.
DNC007001	5-(4-hydroxy-2,6-dimethylstyryl)nicotinic acid	Discovery agent	.	.
DNC007002	N-benzyl-4-cyclopentylpiperazine-1-carboxamide	Discovery agent	.	.
DNC007003	Methyl 6-(3-cyclohexylureido)hexanoate	Discovery agent	.	.
DNC007004	Methyl 4-(3-cyclohexylureido)butanoate	Discovery agent	.	.
DNC007005	BISINDOLYLMALEIMIDE IX	Discovery agent	.	.
DNC007006	2-azido-N6-methyl-9-(beta-D-ribofuranosyl)adenine	Discovery agent	.	.
DNC007007	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane	Discovery agent	.	.
DNC007008	8-benzylnaringenin	Discovery agent	.	.
DNC007009	8-(2,2-dimethylpropyl)naringenin	Discovery agent	.	.
DNC007010	8-(2-methylpropyl)naringenin	Discovery agent	.	.
DNC007011	8-(3-methylbutyl)naringenin	Discovery agent	.	.
DNC007012	8-n-undecylnaringenin	Discovery agent	.	.
DNC007013	8-n-nonylnaringenin	Discovery agent	.	.
DNC007014	8-n-heptylnaringenin	Discovery agent	.	.
DNC007015	8-n-pentylnaringenin	Discovery agent	.	.
DNC007016	8-n-propylnaringenin	Discovery agent	.	.
DNC007017	8-methylnaringenin	Discovery agent	.	.
DNC007018	SOPHORAFLAVANONE B	Discovery agent	.	.
DNC007019	NARINGENIN	Discovery agent	.	.
DNC007020	AS-1397	Discovery agent	.	.
DNC007021	KSP-BCS-1-alpha-CHF2-20-epi-22-oxabishomo-26-OH	Discovery agent	.	.
DNC007022	KSP-BCS-1-alpha-CHF2-1624F2-2	Discovery agent	.	.
DNC007023	A-425444	Discovery agent	.	.
DNC007024	ABT-670	Discovery agent	.	.
DNC007025	1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine	Discovery agent	.	.
DNC007026	1-[6-(triphenylmethoxy)hexyl]thymine	Discovery agent	.	.
DNC007027	1-[5-(triphenylmethoxy)pentyl]thymine	Discovery agent	.	.
DNC007028	SKI-758	Discovery agent	.	.
DNC007028	SKI-758	Ischemia	.	I99.8
DNC007029	3-hydroxy-2-phenylquinoline-4-carboxylic acid	Discovery agent	.	.
DNC007030	(RS/SR)-2-[1-(4-chlorophenyl)hexyl]piperidine	Discovery agent	.	.
DNC007031	(RS/SR)-2-[1-(4-chlorophenyl)pentyl]piperidine	Discovery agent	.	.
DNC007032	(RS/SR)-2-[1-(4-chlorophenyl)butyl]piperidine	Discovery agent	.	.
DNC007033	(RS/SR)-2-[1-(4-chlorophenyl)propyl]piperidine	Discovery agent	.	.
DNC007034	(RS/SR)-2-[1-(4-chlorophenyl)ethyl]piperidine	Discovery agent	.	.
DNC007035	1-phenyl-1-(piperidin-2-yl)propan-2-one	Discovery agent	.	.
DNC007036	(RS/SR)-2-[1-(3,4-dichlorophenyl)butyl]piperidine	Discovery agent	.	.
DNC007037	Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007038	Cyclo(-D-Tyr-L-Ala-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007039	Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-Sar-)	Discovery agent	.	.
DNC007040	Cyclo(-D-Tyr-D-Arg-L-Arg-L-MeNal-Gly-)	Discovery agent	.	.
DNC007041	Cyclo(-D-Tyr-D-Arg-L-MeArg-L-Nal-Gly-)	Discovery agent	.	.
DNC007042	Cyclo(-D-Tyr-D-MeArg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007043	Cyclo(-D-MeTyr-D-Arg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007044	Cyclo(-D-Tyr-L-Arg-L-Arg-L-Ala-Sar-)	Discovery agent	.	.
DNC007045	Cyclo(-D-Tyr-L-Arg-L-Arg-L-MeNal-Gly-)	Discovery agent	.	.
DNC007046	Cyclo(-D-Tyr-L-Arg-L-MeArg-L-Nal-Gly-)	Discovery agent	.	.
DNC007047	Cyclo(-D-Tyr-L-MeArg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007048	Cyclo(-D-MeTyr-L-Arg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007049	Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-beta-Ala-)	Discovery agent	.	.
DNC007050	Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Pic-)	Discovery agent	.	.
DNC007051	Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-D-Ala-)	Discovery agent	.	.
DNC007052	Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Ala-)	Discovery agent	.	.
DNC007053	Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-beta-Ala-)	Discovery agent	.	.
DNC007054	Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-D-Ala-)	Discovery agent	.	.
DNC007055	Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-L-Ala-)	Discovery agent	.	.
DNC007056	Cyclo(-D-Tyr-D-Ala-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007057	Cyclo(-D-Ala-D-Arg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007058	Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-Gly-)	Discovery agent	.	.
DNC007059	ZAPOTIN	Discovery agent	.	.
DNC007060	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-H	Discovery agent	.	.
DNC007061	H-Tyr-D-Ala-Gly-Phe-NH-NH-Trp-D-Nle-D-Asp-D-Phe-H	Discovery agent	.	.
DNC007062	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-Bo	Discovery agent	.	.
DNC007063	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Phe-D-Asp-D-Nle-Trp-H	Discovery agent	.	.
DNC007064	LY-389795	Discovery agent	.	.
DNC007065	LY-379268	Discovery agent	.	.
DNC007066	Ethyl 3-(biphenyl-3-ylamino)-2-cyanoacrylate	Discovery agent	.	.
DNC007067	Diethyl 2-((biphenyl-3-ylamino)methylene)malonate	Discovery agent	.	.
DNC007068	2-methylsulfanylestradiol 3,17-O,O-bis-sulfamate	Discovery agent	.	.
DNC007069	2-ethylestradiol 3,17-O,O-bis-sulfamate	Discovery agent	.	.
DNC007070	2-methoxyestradiol 3,17-O,O-bis-sulfamate	Discovery agent	.	.
DNC007071	Estradiol 3,17-O,O-bis-sulfamate	Discovery agent	.	.
DNC007072	Estradiol 17-O-sulfamate	Discovery agent	.	.
DNC007073	2-methoxyestradiol-17-O-sulfamate	Discovery agent	.	.
DNC007074	OXYRESVERATROL	Discovery agent	.	.
DNC007075	2,4,3',5'-tetrahydroxybibenzyl	Discovery agent	.	.
DNC007076	Oleic acid anilide	Discovery agent	.	.
DNC007077	3-benzyl-1-cyclohexylpyrrolidin-2-one	Discovery agent	.	.
DNC007078	1-(2-adamantyl)-3-benzylpyrrolidin-2-one	Discovery agent	.	.
DNC007079	7-(naphthalen-2-yl)benzo[e][1,2,4]triazin-3-amine	Discovery agent	.	.
DNC007080	3-(3-aminobenzo[e][1,2,4]triazin-7-yl)phenol	Discovery agent	.	.
DNC007081	3-(2-(naphthalen-2-ylmethyl)phenyl)acrylic acid	Discovery agent	.	.
DNC007082	3-(2-(4-methoxycinnamyl)phenyl)acrylic acid	Discovery agent	.	.
DNC007083	3-(2-cinnamylphenyl)acrylic acid	Discovery agent	.	.
DNC007084	3-(2-((E)-3-phenylprop-1-enyl)phenyl)acrylic acid	Discovery agent	.	.
DNC007085	CP-690550	Discovery agent	.	.
DNC007086	HOMOEPIBATIDINE	Discovery agent	.	.
DNC007087	6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007088	6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007089	6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007090	6-hydroxy-2-methyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007091	6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007092	6-methoxy-2,9-dimethyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007093	6-methoxy-2-methyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC007094	6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC007095	N,N-diethyl-2-(1H-indol-3-yl)ethanamine	Discovery agent	.	.
DNC007096	1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea	Discovery agent	.	.
DNC007097	3-methoxy-N',2-diphenylquinoline-4-carbohydrazide	Discovery agent	.	.
DNC007098	4-(ethylthio)-6-phenyl-1,3,5-triazin-2-amine	Discovery agent	.	.
DNC007099	2-amino-6-phenyl-4-p-tolylnicotinonitrile	Discovery agent	.	.
DNC007100	C(RGDfV)	Discovery agent	.	.
DNC007101	A-348441	Diabetes mellitus type 2	250	E11
DNC007101	A-348441	Discovery agent	.	.
DNC007102	FARGLITAZAR	Diabetes mellitus type 1	.	E10
DNC007102	FARGLITAZAR	Discovery agent	.	.
DNC007103	NSC-316158	Discovery agent	.	.
DNC007104	NSC-224124	Discovery agent	.	.
DNC007105	NSC-645808	Discovery agent	.	.
DNC007106	NSC-106547	Discovery agent	.	.
DNC007107	NSC-73410	Discovery agent	.	.
DNC007108	NSC-2113	Discovery agent	.	.
DNC007109	NSC-339580	Discovery agent	.	.
DNC007110	NSC-275420	Discovery agent	.	.
DNC007111	NSC-354279	Discovery agent	.	.
DNC007112	NSC-339583	Discovery agent	.	.
DNC007113	NSC-645827	Discovery agent	.	.
DNC007114	N-(4-(benzyloxy)phenethyl)pyridin-4-amine	Discovery agent	.	.
DNC007115	ABT-737	Discovery agent	.	.
DNC007116	4-cyclohexylamino-pyrimidine-2-carbonitrile	Discovery agent	.	.
DNC007117	2-cyclohexylamino-pyridine-2-carbonitrile	Discovery agent	.	.
DNC007118	2-cyclohexylamino-pyrimidine-4-carbonitrile	Discovery agent	.	.
DNC007119	BUTEIN	Discovery agent	.	.
DNC007120	EPIGALLOCATECHIN	Discovery agent	.	.
DNC007121	(+)K-252a	Discovery agent	.	.
DNC007122	N-{4-[(benzylamino)sulfonyl]-1-naphthyl}benzamide	Discovery agent	.	.
DNC007123	N-(4-phenylsulfamoyl-naphthalen-1-yl)-benzamide	Discovery agent	.	.
DNC007124	PHELLIGRIDIN I	Discovery agent	.	.
DNC007125	LAROPIPRANT	Discovery agent	.	.
DNC007126	DIASTEREOMER 2	Discovery agent	.	.
DNC007127	2,6-dimethyl-8-ethyl-1-deazapurine	Discovery agent	.	.
DNC007128	LUF-5981	Discovery agent	.	.
DNC007129	LUF-5816	Discovery agent	.	.
DNC007130	2,6-diphenyl-8-tButyl-1-deazapurine	Discovery agent	.	.
DNC007131	2,6-diphenyl-8-(1-ethylpropyl)-1-deazapurine	Discovery agent	.	.
DNC007132	LUF-5978	Discovery agent	.	.
DNC007133	LUF-5980	Discovery agent	.	.
DNC007134	2,6-dphenyl-8-propyl-1-deazapurine	Discovery agent	.	.
DNC007135	2,6-diphenyl-8-ethyl-1-deazapurine	Discovery agent	.	.
DNC007136	2,6-diphenyl-8-methyl-1-deazapurine	Discovery agent	.	.
DNC007137	2,6-diphenyl-1-deazapurine	Discovery agent	.	.
DNC007138	5,7-diphenyl-3H-imidazo[4,5-b]pyridin-2-ol	Discovery agent	.	.
DNC007139	2-(7-phenylheptanoyl)oxazole-5-carboxylic acid	Discovery agent	.	.
DNC007140	2-(7-phenylheptanoyl)oxazole-5-carbonitrile	Discovery agent	.	.
DNC007141	SB-216995	Discovery agent	.	.
DNC007142	2,3,4-trihydroxybenzoic acid	Discovery agent	.	.
DNC007143	GALLICACID	Discovery agent	.	.
DNC007144	BAICALEIN	Discovery agent	.	.
DNC007145	3-isopr-sal-cyclosal-d4TMP	Discovery agent	.	.
DNC007146	3-sal-cyclosal-d4TMP	Discovery agent	.	.
DNC007147	5-methyl-cyclosal-d4TMP	Discovery agent	.	.
DNC007148	Cyclosal-d4TMP	Discovery agent	.	.
DNC007149	3-phenyl-cyclosal-d4TMP	Discovery agent	.	.
DNC007150	N6-methoxy-2-[(4-methoxyphenyl)ethynyl]adenosine	Discovery agent	.	.
DNC007151	2-[(4-acetylphenyl)ethynyl]-N6-methoxyadenosine	Discovery agent	.	.
DNC007152	2-[(4-fluorophenyl)ethynyl]-N6-methoxyadenosine	Discovery agent	.	.
DNC007153	N6-methoxy-2-[(4-pentylphenyl)ethynyl]adenosine	Discovery agent	.	.
DNC007154	N6-methoxy-2-[(4-methylphenyl)ethynyl]adenosine	Discovery agent	.	.
DNC007155	N6-methoxy-2-[(4-pyridinyl)ethynyl]adenosine	Discovery agent	.	.
DNC007156	N6-methoxy-2-[(3-pyridinyl)ethynyl]-adenosine	Discovery agent	.	.
DNC007157	N6-methoxy-2-[(2-pyridinyl)ethynyl]adenosine	Discovery agent	.	.
DNC007158	2-(4-hydroxypent-1-yl)-N6-methoxyadenosine	Discovery agent	.	.
DNC007159	2-(5-cyano-1-pent-1-ynyl)-N6-methoxyadenosine	Discovery agent	.	.
DNC007160	N6-methoxy-2-[2-(trimethylsilyl)ethynyl]adenosine	Discovery agent	.	.
DNC007161	2-(hex-1-ynyl)-N6-methoxyadenosine	Discovery agent	.	.
DNC007162	2-ethynyl-N6-methoxyadenosine	Discovery agent	.	.
DNC007163	N6-methoxy-2-phenylethynyladenosine	Discovery agent	.	.
DNC007164	N-(2-benzyloxy-4-nitrophenyl)methanesulfonamide	Discovery agent	.	.
DNC007165	ECOPLADIB	Discovery agent	.	.
DNC007166	CIMICOXIB	Discovery agent	.	.
DNC007166	CIMICOXIB	Pain	.	G89
DNC007167	JNJ-10311795	Asthma; Chronic obstructive pulmonary disease	460-519, 490-492, 493, 494-496	J00-J99, J40-J44, J45, J47
DNC007167	JNJ-10311795	Discovery agent	.	.
DNC007168	4-(4-aminophenyl)-1H-indazol-3yl-amine	Discovery agent	.	.
DNC007169	N-[4-(3-amino-1H-indazol-4-yl)phenyl]benzamide	Discovery agent	.	.
DNC007170	4-azidobenzenesulfonamide	Discovery agent	.	.
DNC007171	GINKGOLIDE A	Discovery agent	.	.
DNC007172	10-methoxy-ginkgolide C	Discovery agent	.	.
DNC007173	3,14-DIDEHYDROGINKGOLIDE A	Discovery agent	.	.
DNC007174	Ginkgolide M	Discovery agent	.	.
DNC007175	Ginkgolide J	Discovery agent	.	.
DNC007176	Ginkgolide C	Discovery agent	.	.
DNC007177	GINKOLIDE B	Discovery agent	.	.
DNC007178	1-methyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007179	1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC007180	1-(4-chlorobenzyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC007181	1-benzyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007182	1-phenyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007183	1-butyryl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007184	1-propionyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007185	1-(2-iodoethyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC007186	1-(2-bromoethyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC007187	1-hexadecyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007188	1-dodecyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007189	6-bromo-5-methyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007190	4-chloro-7-methyl-1H-indole-2,3-dione	Discovery agent	.	.
DNC007191	6,7-dichloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007192	5,7-dichloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007193	4,7-dichloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007194	4,6-dichloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007195	4,5-dichloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007196	7-(trifluoromethyl)-1H-indole-2,3-dione	Discovery agent	.	.
DNC007197	7-chloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007198	5-(trifluoromethoxy)-1H-indole-2,3-dione	Discovery agent	.	.
DNC007199	5-chloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007200	4-chloro-1H-indole-2,3-dione	Discovery agent	.	.
DNC007201	R-N6-(phenylisopropyl)adenosine	Discovery agent	.	.
DNC007202	2-(2''-indolylethyloxy)adenosine	Discovery agent	.	.
DNC007203	2-(3''-pyrrolylethyloxy)adenosine	Discovery agent	.	.
DNC007204	2-(3''-indolylethyloxy)adenosine	Discovery agent	.	.
DNC007205	2-phenylpropoxyadenosine	Discovery agent	.	.
DNC007206	2-(3''-(5''-iodo-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007207	2-(3''-(5''-bromo-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007208	2-(3''(5''-chloro-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007209	2-(3''-(5''-fluoro-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007210	2-(3''(7''-bromo-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007211	2-(3''-(4''-bromo-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007212	2-(3''-(6''-bromo-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007213	2-(3''-(6''-chloro-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007214	6-ethylamino-2-(3''-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007215	6-guanidino-2-(3''-indolylethyloxy)adenosine	Discovery agent	.	.
DNC007216	2-(3''-(5''-hydroxyindolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007217	2-(3''-(5''-methoxy-indolyl)ethyloxy)adenosine	Discovery agent	.	.
DNC007218	2-(3''-(benzoimidazole-1''-yl)ethyloxy)adenosine	Discovery agent	.	.
DNC007219	2-(3''-(benzotriazole-1''-yl)ethyloxy)adenosine	Discovery agent	.	.
DNC007220	3-(3'-furyl)-aniline	Discovery agent	.	.
DNC007221	4-(3'-furyl)-aniline	Discovery agent	.	.
DNC007222	5-(piperidin-4-yl)isoxazol-3-ol	Discovery agent	.	.
DNC007223	4-Phenyl-5-piperidin-4-yl-isoxazol-3-ol	Discovery agent	.	.
DNC007224	6-(4-chlorophenyl)-2-morpholin-4-ylpyridin-4-ol	Discovery agent	.	.
DNC007225	6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one	Discovery agent	.	.
DNC007226	6-isopropyl-2-morpholin-4-yl-4H-thiopyran-4-one	Discovery agent	.	.
DNC007227	6-(4-chlorophenyl)-4-morpholino-2H-pyran-2-one	Discovery agent	.	.
DNC007228	6-(4-methoxyphenyl)-4-morpholino-2H-pyran-2-one	Discovery agent	.	.
DNC007229	4-morpholino-6-phenyl-2H-pyran-2-one	Discovery agent	.	.
DNC007230	2-(4-methoxyphenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007231	2-(3-methoxyphenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007232	2-(2-methoxyphenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007233	2-(4-fluorophenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007234	2-(4-chlorophenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007235	2-morpholino-6-styryl-4H-pyran-4-one	Discovery agent	.	.
DNC007236	2-(3-acetylphenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007237	4-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile	Discovery agent	.	.
DNC007238	3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile	Discovery agent	.	.
DNC007239	2-(2-aminophenyl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007240	2-biphenyl-4-yl-6-morpholin-4-yl-pyran-4-one	Discovery agent	.	.
DNC007241	3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzoic acid	Discovery agent	.	.
DNC007242	3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzaldehyde	Discovery agent	.	.
DNC007243	2-morpholino-6-(naphthalen-2-yl)-4H-pyran-4-one	Discovery agent	.	.
DNC007244	2-morpholino-6-(naphthalen-1-yl)-4H-pyran-4-one	Discovery agent	.	.
DNC007245	2-(benzofuran-2-yl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007246	2-(1H-indol-5-yl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007247	2-(furan-2-yl)-6-morpholino-4H-pyran-4-one	Discovery agent	.	.
DNC007248	2-morpholino-6-(thiophen-3-yl)-4H-pyran-4-one	Discovery agent	.	.
DNC007249	2-morpholino-6-(thiophen-2-yl)-4H-pyran-4-one	Discovery agent	.	.
DNC007250	KU-55933	Cancer	.	C00-C97
DNC007250	KU-55933	Discovery agent	.	.
DNC007251	2-dibenzofuran-4-yl-6-morpholin-4-yl-pyran-4-one	Discovery agent	.	.
DNC007252	2-morpholino-6-(quinolin-8-yl)-4H-pyran-4-one	Discovery agent	.	.
DNC007253	Bis-cyclosal-d4TMP	Discovery agent	.	.
DNC007254	4-(2-oxohexadecanamido)butanoic acid	Discovery agent	.	.
DNC007255	3,4-dichloroisocoumarin	Discovery agent	.	.
DNC007256	8-aza-11-deoxyprostaglandin E1	Discovery agent	.	.
DNC007257	1-(3,4-dihydroxy-5-nitrophenyl)-2-phenoxyethanone	Discovery agent	.	.
DNC007258	4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole	Discovery agent	.	.
DNC007259	WIN_35428	Discovery agent	.	.
DNC007260	WIN-35066-2	Discovery agent	.	.
DNC007261	WAY-169916	Discovery agent	.	.
DNC007262	4-(1-cyclopentyl-7-fluoro-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007263	4-(7-chloro-1-cyclopentyl-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007264	4-(7-chloro-1-cyclohexyl-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007265	4-(7-chloro-1-propyl-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007266	4-(7-methyl-1-propyl-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007267	4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007268	4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol	Discovery agent	.	.
DNC007269	Ac-Asp-Glu-Val-Asp-CHO	Discovery agent	.	.
DNC007270	7,8,3',4'-tetrahydroxyflavone	Discovery agent	.	.
DNC007271	1,3-bis(3,4-dihydroxyphenyl)prop-2-en-1-one	Discovery agent	.	.
DNC007272	N-(2,6-diphenylpyrimidin-4-yl)benzamide	Discovery agent	.	.
DNC007273	N-(4,6-diphenylpyrimidin-2-yl)-2-ethylbutyramide	Discovery agent	.	.
DNC007274	N-(4,6-diphenylpyrimidin-2-yl)-3-methylbutyramide	Discovery agent	.	.
DNC007275	LUF-5737	Discovery agent	.	.
DNC007276	Pentanoic acid (4,6-diphenylpyrimidin-2-yl)amide	Discovery agent	.	.
DNC007277	LUF-5735	Discovery agent	.	.
DNC007278	N-(4,6-diphenylpyrimidin-2-yl)propionamide	Discovery agent	.	.
DNC007279	N-(4,5-diphenylpyrimidin-2-yl)acetamide	Discovery agent	.	.
DNC007280	N-(4,6-diphenylpyrimidin-2-yl)-3-chlorobenzamide	Discovery agent	.	.
DNC007281	N-(4,6-diphenylpyrimidin-2-yl)benzamide	Discovery agent	.	.
DNC007282	LUF-5764	Discovery agent	.	.
DNC007283	LUF-5767	Discovery agent	.	.
DNC007284	N-(2,6-diphenylpyrimidin-4-yl)-2-ethylbutyramide	Discovery agent	.	.
DNC007285	N-(2,6-diphenylpyrimidin-4-yl)-3-methylbutyramide	Discovery agent	.	.
DNC007286	N-(2,6-diphenylpyrimidin-4-yl)isobutyramide	Discovery agent	.	.
DNC007287	Hexanoic Acid (2,6-diphenylpyrimidin-4-yl)amide	Discovery agent	.	.
DNC007288	N-(2,6-diphenylpyrimidin-4-yl)butyramide	Discovery agent	.	.
DNC007289	N-(2,6-diphenylpyrimidin-4-yl)propionamide	Discovery agent	.	.
DNC007290	N-(2,6-diphenylpyrimidin-4-yl)acetamide	Discovery agent	.	.
DNC007291	N-(4,6-diphenylpyrimidin-2-yl)-4-chlorobenzamide	Discovery agent	.	.
DNC007292	1-(4-nonylbenzyl)azetidine-3-carboxylic acid	Discovery agent	.	.
DNC007293	1-(4-nonylbenzyl)pyrrolidine-3-carboxylic acid	Discovery agent	.	.
DNC007294	1-(4-nonylbenzyl)pyrrolidin-3-ylphosphonic acid	Discovery agent	.	.
DNC007295	4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate	Discovery agent	.	.
DNC007296	4-((+/-)-(1H-imidazol-1-yl)-(E)-retinoic acid	Discovery agent	.	.
DNC007297	N-(3-phenoxypyridin-4-yl)methanesulfonamide	Discovery agent	.	.
DNC007298	N-(3-phenoxy-4-pyridinyl)propanesulfonamide	Discovery agent	.	.
DNC007299	N-(3-phenoxy-4-pyridinyl)ethanesulfonamide	Discovery agent	.	.
DNC007300	1-(9H-fluoren-9-yl)-1H-imidazole	Discovery agent	.	.
DNC007301	1-(9-Phenyl-9H-fluoren-9-yl)1H-imidazole	Discovery agent	.	.
DNC007302	4-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one	Discovery agent	.	.
DNC007303	4-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one	Discovery agent	.	.
DNC007304	6-((1H-imidazol-1-yl)methyl)-2H-chromene-2-thione	Discovery agent	.	.
DNC007305	7-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one	Discovery agent	.	.
DNC007306	7-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one	Discovery agent	.	.
DNC007307	6-((1H-imidazol-1-yl)methyl)-2H-chromene-2-thione	Discovery agent	.	.
DNC007308	1-(9-phenyl-9H-fluoren-9-yl)-1H-1,2,4-triazole	Discovery agent	.	.
DNC007309	2-(3-(3-bromophenyl)ureido)-4-chlorobenzoic acid	Discovery agent	.	.
DNC007310	2-(3-bromobenzoylamino)-4-chlorobenzoic acid	Discovery agent	.	.
DNC007311	PDDF	Discovery agent	.	.
DNC007312	6-iodo-4'-methylaminoflavone	Discovery agent	.	.
DNC007313	6-iodo-4'-hydroxyflavone	Discovery agent	.	.
DNC007314	6-iodo-4'-methoxyflavone	Discovery agent	.	.
DNC007315	6-iodo-4'-dimethyaminoflavone	Discovery agent	.	.
DNC007316	1-(2'-chlorophenyl)penta-1,4-dien-3-one	Discovery agent	.	.
DNC007317	1-(bis(4-chlorophenyl)methyl)-3-phenylurea	Discovery agent	.	.
DNC007318	1-[bis(4-bromophenyl)methyl]-3-phenylthiourea	Discovery agent	.	.
DNC007319	1-[bis(4-chlorophenyl)methyl]-3-phenylthiourea	Discovery agent	.	.
DNC007320	1-[bis(4-iodophenyl)methyl]-3-(4-bromophenyl)urea	Discovery agent	.	.
DNC007321	1-[bis(4-chlorophenyl)methyl]-3-(4-chlorophenyl)-	Discovery agent	.	.
DNC007322	1-(bis(4-bromophenyl)methyl)-3-phenylurea	Discovery agent	.	.
DNC007323	3-[3-(benzylmethylamino)propoxy]xanthen-9-one	Discovery agent	.	.
DNC007324	3-[8-(benzylmethylamino)octyloxy]xanthen-9-one	Discovery agent	.	.
DNC007325	3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one	Discovery agent	.	.
DNC007326	3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one	Discovery agent	.	.
DNC007327	3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one	Discovery agent	.	.
DNC007328	3-[4-(benzylmethylamino)butoxy]xanthen-9-one	Discovery agent	.	.
DNC007329	3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one	Discovery agent	.	.
DNC007330	3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one	Discovery agent	.	.
DNC007331	3-[10-(benzylmethylamino)decyloxy]xanthen-9-one	Discovery agent	.	.
DNC007332	3-[9-(benzylmethylamino)nonyloxy]xanthen-9-one	Discovery agent	.	.
DNC007333	KKHT-10608	Discovery agent	.	.
DNC007334	KKHT-10609	Discovery agent	.	.
DNC007335	KKHT-10613	Discovery agent	.	.
DNC007336	KKHT-11018	Discovery agent	.	.
DNC007337	KKHT-10318	Discovery agent	.	.
DNC007338	KKHT-20818	Discovery agent	.	.
DNC007339	KKHT-20718	Discovery agent	.	.
DNC007340	KKHT-20918	Discovery agent	.	.
DNC007341	KKHT-10618	Discovery agent	.	.
DNC007342	Petrosaspongiolide M	Discovery agent	.	.
DNC007343	(S)-pyrrolidin-2-yl(thiazolidin-3-yl)methanone	Discovery agent	.	.
DNC007344	N-Phenyl-5-phenylimidazo[1,5-a]pyrazin-8-amine	Discovery agent	.	.
DNC007345	BMS-279700	Discovery agent	.	.
DNC007346	GNF-PF-1967	Discovery agent	.	.
DNC007347	2-methyl-6-((3-methoxyphenyl)ethynyl)-pyridine	Discovery agent	.	.
DNC007348	GNF-PF-4599	Discovery agent	.	.
DNC007349	1-guanidino-7-isoquinolinesulphonamide	Discovery agent	.	.
DNC007350	4-chloro-1-guanidino-7-isoquinolinesulphonamide	Discovery agent	.	.
DNC007351	1-guanidino-N-phenyl-7-isoquinolinesulphonamide	Discovery agent	.	.
DNC007352	[D-Gln3,D-Ncy(SO2,isopropyl)7]acyline	Discovery agent	.	.
DNC007353	[D-Gln3,D-Ncy(SO,isopropyl)7]acyline	Discovery agent	.	.
DNC007354	[D-Gln3,D-Ncy(isopropyl)7]acyline	Discovery agent	.	.
DNC007355	[D-Gln3,Ncy(SO2,isopropyl)7]acyline	Discovery agent	.	.
DNC007356	[D-Gln3,Ncy(SO,isopropyl)7]acyline	Discovery agent	.	.
DNC007357	[D-Gln3,Ncy(isopropyl)7]acyline	Discovery agent	.	.
DNC007358	[D-Ncy(SO,methyl)10]acyline	Discovery agent	.	.
DNC007359	[D-Ncy(methyl)10] acyline	Discovery agent	.	.
DNC007360	[Ncy(SO,methyl)10]acyline	Discovery agent	.	.
DNC007361	[Ncy(methyl)10]acyline	Discovery agent	.	.
DNC007362	[D-Ncy(SO,isopropyl)7]acyline	Discovery agent	.	.
DNC007363	[D-Ncy(isopropyl)7]acyline	Discovery agent	.	.
DNC007364	[Ncy(SO,isopropyl)7]acyline	Discovery agent	.	.
DNC007365	[Ncy(isopropyl)7]acyline	Discovery agent	.	.
DNC007366	[D-Ncy(SO,methyl)4]acyline	Discovery agent	.	.
DNC007367	[D-Ncy(methyl)4]acyline	Discovery agent	.	.
DNC007368	[Ncy(SO,methyl)4]acyline	Discovery agent	.	.
DNC007369	[Ncy(methyl)4]acyline	Discovery agent	.	.
DNC007370	[Ncy(2-naphthyl)1]acyline	Discovery agent	.	.
DNC007371	[D-Ncy(2-naphthyl)1]acyline	Discovery agent	.	.
DNC007372	GRL-7234	Discovery agent	.	.
DNC007373	L-Val-L-boroPro	Discovery agent	.	.
DNC007374	L-Ala-L-boroPro	Discovery agent	.	.
DNC007375	D-Val-L-boroPro	Discovery agent	.	.
DNC007376	DPDPE	Discovery agent	.	.
DNC007377	ELAEOCARPENINE	Discovery agent	.	.
DNC007378	ISOELAEOCARPINE	Discovery agent	.	.
DNC007379	(-)-3,3'-bisdemethylpinoresinol	Discovery agent	.	.
DNC007380	(-)-pinoresinol	Discovery agent	.	.
DNC007381	(+)-3,3'-bisdemethyltanegool	Discovery agent	.	.
DNC007382	Bis(benzo[b]furan-2-yl)methanone	Discovery agent	.	.
DNC007383	(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone	Discovery agent	.	.
DNC007384	Bis(5-aminobenzo[b]furan-2-yl)methanone	Discovery agent	.	.
DNC007385	Bis(5-acetoxybenzo[b]furan-2-yl)methanone	Discovery agent	.	.
DNC007386	Bis(6-hydroxybenzo[b]furan-2-yl)methanone	Discovery agent	.	.
DNC007387	Bis(5-hydroxybenzo[b]furan-2-yl)methanone	Discovery agent	.	.
DNC007388	2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide	Discovery agent	.	.
DNC007389	2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide	Discovery agent	.	.
DNC007390	2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide	Discovery agent	.	.
DNC007391	2-(benzyloxyamino)-N-hydroxyhexanamide	Discovery agent	.	.
DNC007392	2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide	Discovery agent	.	.
DNC007393	2-(benzyloxyamino)-N-hydroxyacetamide	Discovery agent	.	.
DNC007394	2-chloro-6(methylamino)purine	Discovery agent	.	.
DNC007395	Boldine methiodide	Discovery agent	.	.
DNC007396	Glaucine methiodide	Discovery agent	.	.
DNC007397	N-methyllaurotetanine methiodide	Discovery agent	.	.
DNC007398	BOLDINE	Discovery agent	.	.
DNC007399	Predicentrine methiodide	Discovery agent	.	.
DNC007400	3-bromoboldine	Discovery agent	.	.
DNC007401	3,8-dibromoboldine	Discovery agent	.	.
DNC007402	R-226161	Discovery agent	.	.
DNC007403	MAGGIEMYCIN	Discovery agent	.	.
DNC007404	3-methoxy-N-(4-methylthiazol-2-yl)benzamide	Discovery agent	.	.
DNC007405	3,4,5-trimethoxy-N-(thiazol-2-yl)benzamide	Discovery agent	.	.
DNC007406	N-(thiazol-2-yl)benzamide	Discovery agent	.	.
DNC007407	4-(dimethylamino)-N-(thiazol-2-yl)benzamide	Discovery agent	.	.
DNC007408	2-(4-methoxyphenyl)-N-(thiazol-2-yl)acetamide	Discovery agent	.	.
DNC007409	2-phenyl-N-(thiazol-2-yl)acetamide	Discovery agent	.	.
DNC007410	4-methoxy-N-(thiazol-2-yl)benzamide	Discovery agent	.	.
DNC007411	2-phenyl-N-(1,3,4-thiadiazol-2-yl)acetamide	Discovery agent	.	.
DNC007412	N-(4-methylthiazol-2-yl)-2-phenylacetamide	Discovery agent	.	.
DNC007413	N-(5-methylthiazol-2-yl)-2-phenylacetamide	Discovery agent	.	.
DNC007414	N-(1,3,4-thiadiazol-2-yl)benzamide	Discovery agent	.	.
DNC007415	N-(4-methylthiazol-2-yl)benzamide	Discovery agent	.	.
DNC007416	N-(5-methylthiazol-2-yl)benzamide	Discovery agent	.	.
DNC007417	1-(4-methoxyphenyl)-3-(1,3,4-thiadiazol-2-yl)urea	Discovery agent	.	.
DNC007418	1-(4-methoxyphenyl)-3-(4-methylthiazol-2-yl)urea	Discovery agent	.	.
DNC007419	1-(4-methoxyphenyl)-3-(5-methylthiazol-2-yl)urea	Discovery agent	.	.
DNC007420	3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide	Discovery agent	.	.
DNC007421	PHA-767491	Discovery agent	.	.
DNC007422	ARZOXIFENE	Breast cancer	174, 175	C50
DNC007422	ARZOXIFENE	Discovery agent	.	.
DNC007423	URSOLIC ACID	Discovery agent	.	.
DNC007424	LICOAGROCHALCONE A	Discovery agent	.	.
DNC007425	Abyssinin I	Discovery agent	.	.
DNC007426	5-deoxyabyssinin II	Discovery agent	.	.
DNC007427	SIGMOIDIN A	Discovery agent	.	.
DNC007428	Abyssinin II	Discovery agent	.	.
DNC007429	SIGMOIDIN B	Discovery agent	.	.
DNC007430	Sigmoidin F	Discovery agent	.	.
DNC007431	Abyssinoflavanone VII	Discovery agent	.	.
DNC007432	Abyssinoflavanone VI	Discovery agent	.	.
DNC007433	Dodeca-2E,4E-dienoic acid isobutylamide	Discovery agent	.	.
DNC007434	(R,R)-(-)-fenoterol	Discovery agent	.	.
DNC007435	(S,R)-(+)-fenoterol	Discovery agent	.	.
DNC007436	(R,S)-(-)-fenoterol	Discovery agent	.	.
DNC007437	(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one	Discovery agent	.	.
DNC007438	H-Tyr-D-Ala-Gly-Phe-D-Leu	Discovery agent	.	.
DNC007439	L-732138	Discovery agent	.	.
DNC007440	(S)-2-amino-1-(4-methylthiophenyl)-propane	Discovery agent	.	.
DNC007441	(S)-2-amino-1-(4-butylthiophenyl)-propane	Discovery agent	.	.
DNC007442	(S)-2-amino-1-(4-propylthiophenyl)-propane	Discovery agent	.	.
DNC007443	(S)-2-amino-1-(4-ethylthiophenyl)-propane	Discovery agent	.	.
DNC007444	3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol	Discovery agent	.	.
DNC007445	1,2-dihydro-3-(2,3,4-trimethoxyphenyl)naphthalene	Discovery agent	.	.
DNC007446	2-(2,3,4-trimethoxyphenyl)-1H-indene	Discovery agent	.	.
DNC007447	4-[4-(benzyloxy)piperidino]butyl-3-fluorobenzoate	Discovery agent	.	.
DNC007448	4-[4-(benzyloxy)piperidino]butyl-3-chlorobenzoate	Discovery agent	.	.
DNC007449	4-[4-(benzyloxy)piperidino]butyl-4-nitrobenzoate	Discovery agent	.	.
DNC007450	4-[4-(benzyloxy)piperidino]butyl-4-fluorobenzoate	Discovery agent	.	.
DNC007451	4-[4-(benzyloxy)piperidino]butyl-4-chlorobenzoate	Discovery agent	.	.
DNC007452	4-[4-(benzyloxy)piperidino]butyl benzoate	Discovery agent	.	.
DNC007453	2-(2-butoxypyrimidin-4-ylamino)benzoic acid	Discovery agent	.	.
DNC007454	2-(2-(butylamino)pyrimidin-4-ylamino)benzoic acid	Discovery agent	.	.
DNC007455	2-(2-phenoxypyrimidin-4-ylamino)benzoic acid	Discovery agent	.	.
DNC007456	2-(2-sec-butoxypyrimidin-4-ylamino)benzoic acid	Discovery agent	.	.
DNC007457	2-(2-(pentyloxy)pyrimidin-4-ylamino)benzoic acid	Discovery agent	.	.
DNC007458	2-(2-propoxypyrimidin-4-ylamino)benzoic acid	Discovery agent	.	.
DNC007459	2-(2-(phenylamino)pyrimidin-4-ylamino)benzamide	Discovery agent	.	.
DNC007460	TG-100435	Discovery agent	.	.
DNC007461	3-(4-aminophenyl)thieno[3,2-c]pyridin-4-amine	Discovery agent	.	.
DNC007462	MCL-443	Discovery agent	.	.
DNC007463	MCL-428	Discovery agent	.	.
DNC007464	MCL-432	Discovery agent	.	.
DNC007465	MCL-435	Discovery agent	.	.
DNC007466	MCL-444	Discovery agent	.	.
DNC007467	MCL-429	Discovery agent	.	.
DNC007468	MCL-449	Discovery agent	.	.
DNC007469	MCL-434	Discovery agent	.	.
DNC007470	CYCLORPHAN	Discovery agent	.	.
DNC007471	MCL-433	Discovery agent	.	.
DNC007472	MCL-431	Discovery agent	.	.
DNC007473	BMS-564929	Discovery agent	.	.
DNC007474	3-((3-bromothiophen-2-yl)methylene)indolin-2-one	Discovery agent	.	.
DNC007475	8-methyl-4H,7H-indolo[6,5,4-cd]indol-5-one	Discovery agent	.	.
DNC007476	WHI-P180	Discovery agent	.	.
DNC007477	SU-5402	Discovery agent	.	.
DNC007478	KNI-10006	Discovery agent	.	.
DNC007479	KNI-272	Discovery agent	.	.
DNC007479	KNI-272	Human immunodeficiency virus infection	.	B20
DNC007480	KNI-227	Discovery agent	.	.
DNC007481	KNI-10033	Discovery agent	.	.
DNC007482	KNI-10315	Discovery agent	.	.
DNC007483	KNI-10316	Discovery agent	.	.
DNC007484	KNI-10314	Discovery agent	.	.
DNC007485	KNI-10342	Discovery agent	.	.
DNC007486	KNI-10341	Discovery agent	.	.
DNC007487	KNI-10368	Discovery agent	.	.
DNC007488	KNI-10372	Discovery agent	.	.
DNC007489	KNI-10313	Discovery agent	.	.
DNC007490	KNI-10332	Discovery agent	.	.
DNC007491	KNI-10232	Discovery agent	.	.
DNC007492	KNI-10062	Discovery agent	.	.
DNC007493	KNI-10061	Discovery agent	.	.
DNC007494	1-(3,3-diphenylpropyl)-4-phenylpiperidin-4-ol	Discovery agent	.	.
DNC007495	4-phenyl-1-(3-phenylpropyl)piperidin-4-ol	Discovery agent	.	.
DNC007496	1-benzyl-4-phenylpiperidin-4-ol	Discovery agent	.	.
DNC007497	4-phenyl-1-(1-phenylpropan-2-yl)piperidin-4-ol	Discovery agent	.	.
DNC007498	4-phenyl-1-(1-phenylethyl)piperidin-4-ol	Discovery agent	.	.
DNC007499	4-phenyl-1-(phenyl(o-tolyl)methyl)piperidin-4-ol	Discovery agent	.	.
DNC007500	1-benzhydryl-4-(benzyloxy)-4-phenylpiperidine	Discovery agent	.	.
DNC007501	1-benzhydryl-4-phenyl-4-propoxypiperidine	Discovery agent	.	.
DNC007502	1-benzhydryl-4-ethoxy-4-phenylpiperidine	Discovery agent	.	.
DNC007503	1-benzhydryl-4-methoxy-4-phenylpiperidine	Discovery agent	.	.
DNC007504	1-(dio-tolylmethyl)-4-phenylpiperidin-4-ol	Discovery agent	.	.
DNC007505	4-phenyl-1-(phenyl(p-tolyl)methyl)piperidin-4-ol	Discovery agent	.	.
DNC007506	4-phenyl-1-(phenyl(m-tolyl)methyl)piperidin-4-ol	Discovery agent	.	.
DNC007507	4-phenyl-1-(phenyl(o-tolyl)methyl)piperidin-4-ol	Discovery agent	.	.
DNC007508	4-phenyl-1-(phenyl(o-tolyl)methyl)piperidin-4-ol	Discovery agent	.	.
DNC007509	1-benzhydryl-4-phenylpiperidin-4-ol	Discovery agent	.	.
DNC007510	1-(2-ethoxy-1-phenylethyl)-4-phenylpiperidin-4-ol	Discovery agent	.	.
DNC007511	1-(1,2-diphenylethyl)-4-phenylpiperidin-4-ol	Discovery agent	.	.
DNC007512	4-phenyl-1-(1-phenylheptyl)piperidin-4-ol	Discovery agent	.	.
DNC007513	4-phenyl-1-(1-phenylhexyl)piperidin-4-ol	Discovery agent	.	.
DNC007514	4-phenyl-1-(1-phenylpentyl)piperidin-4-ol	Discovery agent	.	.
DNC007515	4-phenyl-1-(1-phenylbutyl)piperidin-4-ol	Discovery agent	.	.
DNC007516	4-phenyl-1-(1-phenylpropyl)piperidin-4-ol	Discovery agent	.	.
DNC007517	AMG-487	Discovery agent	.	.
DNC007517	AMG-487	Psoriasis	.	L40
DNC007518	Ser-Tyr-Ser-Nle-Glu-His-Dphe-Arg	Discovery agent	.	.
DNC007519	His-DPhe-Arg-Trp	Discovery agent	.	.
DNC007520	N-formyl-methionyl-leucyl-phenylalanine	Discovery agent	.	.
DNC007521	1-(isoquinolin-5-yl)-3-(1-phenylpropyl)urea	Discovery agent	.	.
DNC007522	1-benzhydryl-3-(isoquinolin-5-yl)urea	Discovery agent	.	.
DNC007523	(R)-1-(1H-indazol-4-yl)-3-(1-p-tolylethyl)urea	Discovery agent	.	.
DNC007524	(S)-1-(1H-indazol-4-yl)-3-(1-p-tolylethyl)urea	Discovery agent	.	.
DNC007525	ZK-814048	Discovery agent	.	.
DNC007526	ZK-810388	Discovery agent	.	.
DNC007527	ZK-813039	Deep vein thrombosis	453.4	I80.2
DNC007527	ZK-813039	Discovery agent	.	.
DNC007528	BX-201	Discovery agent	.	.
DNC007529	BX-517	Discovery agent	.	.
DNC007530	SB-431542	Discovery agent	.	.
DNC007531	IN-1166	Discovery agent	.	.
DNC007532	QUISQUALATE	Discovery agent	.	.
DNC007533	3-biphenyl-4-ylethynyl-5-methyl-[1,2,4]triazine	Discovery agent	.	.
DNC007534	3-(3-bromophenylethynyl)-5-methyl[1,2,4]triazine	Discovery agent	.	.
DNC007535	5-(3-chlorophenylethynyl)-5-methyl[1,2,4]triazine	Discovery agent	.	.
DNC007536	3-(3-methylphenylethynyl)-5-methyl[1,2,4]triazine	Discovery agent	.	.
DNC007537	5-methyl-3-phenylethynyl[1,2,4]triazine	Discovery agent	.	.
DNC007538	3-(4-hexylthiosemicarbazono)methyl-benzoic acid	Discovery agent	.	.
DNC007539	4-(4-cyclohexylthiosemicarbazono)methyl-phenol	Discovery agent	.	.
DNC007540	3-(4-cyclohexylthiosemicarbazono)methyl-phenol	Discovery agent	.	.
DNC007541	2-(4-cyclohexylthiosemicarbazono)methyl-phenol	Discovery agent	.	.
DNC007542	MHL cyclohexylthiosemicarbazone	Discovery agent	.	.
DNC007543	SALVINICIN B	Discovery agent	.	.
DNC007544	Salvinicin A	Discovery agent	.	.
DNC007545	1-(isoquinolin-5-yl)-3-(4-morpholinobenzyl)urea	Discovery agent	.	.
DNC007546	ENDIANDRIN A	Discovery agent	.	.
DNC007547	DI-O-METHYLENDIANDRIN A	Discovery agent	.	.
DNC007548	N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide	Discovery agent	.	.
DNC007549	UK-383367	Discovery agent	.	.
DNC007550	RTI-219	Discovery agent	.	.
DNC007551	RTI-5989-31	Discovery agent	.	.
DNC007552	Indirubin-3-methoxime	Discovery agent	.	.
DNC007553	Indirubin-3-oxime	Discovery agent	.	.
DNC007554	6-bromoindirubin-3-oxime	Discovery agent	.	.
DNC007555	Indirubin-3-acetoxime	Discovery agent	.	.
DNC007556	7-fluoroindirubin-3-oxime	Discovery agent	.	.
DNC007557	7-iodoindirubin-3-oxime	Discovery agent	.	.
DNC007558	7-fluoroindirubin-3-acetoxime	Discovery agent	.	.
DNC007559	7-chloroindirubin-3-oxime	Discovery agent	.	.
DNC007560	7-bromoindirubin-3-oxime	Discovery agent	.	.
DNC007561	7-bromoindirubin-3-acetoxime	Discovery agent	.	.
DNC007562	N-adamantyl-N'-cyclohexylurea	Discovery agent	.	.
DNC007563	Cis-1-adamantan-1-yl-3-(4-methoxycyclohexyl)urea	Discovery agent	.	.
DNC007564	Cis-1-adamantan-1-yl-3-(4-hydroxycyclohexyl)urea	Discovery agent	.	.
DNC007565	1-adamantan-1-yl-3-(4-hydroxybutyl)urea	Discovery agent	.	.
DNC007566	1-adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea	Discovery agent	.	.
DNC007567	SNAP-94847	Discovery agent	.	.
DNC007568	N-(1-acetylpiperidin-4-yl)-N'-(adamant-1-yl)urea	Discovery agent	.	.
DNC007569	AP-2238	Discovery agent	.	.
DNC007570	AP-2243	Discovery agent	.	.
DNC007571	LIDOFLAZINE	Angina	413	I20
DNC007571	LIDOFLAZINE	Discovery agent	.	.
DNC007572	N,N'-dicyclohexyl-urea	Discovery agent	.	.
DNC007573	ISOGRANULATIMIDE	Discovery agent	.	.
DNC007574	BIS-IMIDE A	Discovery agent	.	.
DNC007575	GRANULATIMIDE	Discovery agent	.	.
DNC007576	2-benzyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Discovery agent	.	.
DNC007577	2-phenyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Discovery agent	.	.
DNC007578	2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Discovery agent	.	.
DNC007579	2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Discovery agent	.	.
DNC007580	2-phenyl-2H-pyrazolo[3,4-c]quinolin-4-amine	Discovery agent	.	.
DNC007581	2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine	Discovery agent	.	.
DNC007582	2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine	Discovery agent	.	.
DNC007583	LVVYPWT	Discovery agent	.	.
DNC007584	AVVYPWT	Discovery agent	.	.
DNC007585	LVAYPWT	Discovery agent	.	.
DNC007586	LVVAPWT	Discovery agent	.	.
DNC007587	Cyclic LVVYPWT	Discovery agent	.	.
DNC007588	LAVYPWT	Discovery agent	.	.
DNC007589	ALCURONIUM	Anesthesia	338	R52
DNC007589	ALCURONIUM	Discovery agent	.	.
DNC007590	TOXIFERINE	Discovery agent	.	.
DNC007591	Trans,trans-1,3-bis-(4-hydroxycyclohexyl)urea	Discovery agent	.	.
DNC007592	Caproctamine HCl	Discovery agent	.	.
DNC007593	SB-731489	Discovery agent	.	.
DNC007594	N-[4-(1,3-benzodioxol-5-yl)phenyl]sulfamide	Discovery agent	.	.
DNC007595	N-[4'-(ethylsulfonyl)-3-fluoro-4-biphenylyl]urea	Discovery agent	.	.
DNC007596	N-{4'-[(trifluoromethyl)sulfonyl]-4-biphenyl}urea	Discovery agent	.	.
DNC007597	N-{4'-[(trifluoromethyl)thio]-4-biphenyl}urea	Discovery agent	.	.
DNC007598	N-(4'-bromo-3,3'-difluoro-4-biphenylyl)urea	Discovery agent	.	.
DNC007599	N-(4'-t-butyl-4-biphenylyl)urea	Discovery agent	.	.
DNC007600	N-(4'-isopropyl-4-biphenylyl)urea	Discovery agent	.	.
DNC007601	N-(4'-methyl-4-biphenylyl)urea	Discovery agent	.	.
DNC007602	N-[3'-(trifluoromethyl)-4-biphenylyl]urea	Discovery agent	.	.
DNC007603	N-(4'-chloro-4-biphenylyl)methanesulfonamide	Discovery agent	.	.
DNC007604	4'-(trifluoromethyl)-4-biphenylyl carbamate	Discovery agent	.	.
DNC007605	4'-(trifluoromethyl)-4-biphenylyl sulfamate	Discovery agent	.	.
DNC007606	N-[4'-(trifluoromethyl)-4-biphenylyl]sulfamide	Discovery agent	.	.
DNC007607	N-[4'-(trifluoromethyl)-4-biphenylyl]thiourea	Discovery agent	.	.
DNC007608	N-[4'-(trifluoromethyl)-4-biphenylyl]urea	Discovery agent	.	.
DNC007609	4'-(trifluoromethyl)-4-biphenylsulfonamide	Discovery agent	.	.
DNC007610	4'-(trifluoromethyl)-4-biphenylol	Discovery agent	.	.
DNC007611	4'-trifluoromethyl-biphenyl-4-ylamine	Discovery agent	.	.
DNC007612	Methyl[4'-(trifluoromethyl)-4-biphenylyl]amine	Discovery agent	.	.
DNC007613	4-(trifluoromethyl)biphenyl	Discovery agent	.	.
DNC007614	1-adamantan-1-yl-3-(2-hydroxyethyl)urea	Discovery agent	.	.
DNC007615	1-adamantan-1-yl-3-(4-pentyloxycylclohexyl)urea	Discovery agent	.	.
DNC007616	1-adamantan-1-yl-3-(6-propyloxyhexyl)urea	Discovery agent	.	.
DNC007617	1-adamantan-1-yl-3-(6-hydroxyhexyl)urea	Discovery agent	.	.
DNC007618	1-adamantan-1-yl-3-(5-butoxypentyl)urea	Discovery agent	.	.
DNC007619	1-adamantan-1-yl-3-(5-hydroxypentyl)urea	Discovery agent	.	.
DNC007620	1-adamantan-1-yl-3-(3-hexyloxypropyl)urea	Discovery agent	.	.
DNC007621	1-adamantan-1-yl-3-(3-hydroxypropyl)urea	Discovery agent	.	.
DNC007622	1-adamantan-1-yl-3-(2-heptyloxyethyl)urea	Discovery agent	.	.
DNC007623	GR-113808	Discovery agent	.	.
DNC007624	ARGENINE VASOPRESSIN	Discovery agent	.	.
DNC007625	Relcovaptan	Discovery agent	.	.
DNC007626	HO-LVA	Discovery agent	.	.
DNC007627	[Lys8(Alexa 488) ]PVA	Discovery agent	.	.
DNC007628	[Lys8(Alexa 546) ]PVA	Discovery agent	.	.
DNC007629	(1H-pyrazol-1-yl)(o-tolyl)methanone	Discovery agent	.	.
DNC007630	(4-bromo-1H-pyrazol-1-yl)(o-tolyl)methanone	Discovery agent	.	.
DNC007631	(4-bromo-1H-pyrazol-1-yl)(m-tolyl)methanone	Discovery agent	.	.
DNC007632	(4-chloro-1H-pyrazol-1-yl)(o-tolyl)methanone	Discovery agent	.	.
DNC007633	(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone	Discovery agent	.	.
DNC007634	(3-nitro-1H-pyrazol-1-yl)(phenyl)methanone	Discovery agent	.	.
DNC007635	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone	Discovery agent	.	.
DNC007636	4-methoxy-N'-(2-phenylacetyl)benzohydrazide	Discovery agent	.	.
DNC007637	N,N-bis(cyanomethyl)-3,4-dimethoxybenzamide	Discovery agent	.	.
DNC007638	2-methylbut-3-yn-2-yl 4-methoxybenzoate	Discovery agent	.	.
DNC007639	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone	Discovery agent	.	.
DNC007640	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone	Discovery agent	.	.
DNC007641	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide	Discovery agent	.	.
DNC007642	(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone	Discovery agent	.	.
DNC007643	MAACKIAIN	Discovery agent	.	.
DNC007644	KURAIDIN	Discovery agent	.	.
DNC007645	Sophoraflavanone G	Discovery agent	.	.
DNC007646	Kushenol N	Discovery agent	.	.
DNC007647	KURARINONE	Discovery agent	.	.
DNC007648	FORMONONETIN	Discovery agent	.	.
DNC007649	Folate gamma-hydroxamic acid	Discovery agent	.	.
DNC007650	Methotrexate gamma-L-phenylalaninehydroxamic acid	Discovery agent	.	.
DNC007651	Folate gamma-L-phenylalaninehydroxamic acid	Discovery agent	.	.
DNC007652	ARACHIDONYL TRIFLUOROMETHYLKETONE	Discovery agent	.	.
DNC007653	1,2-bis(2,3,4-trifluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007654	1,2-bis(2,3,5-trifluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007655	1,2-bis(2,3,6-trifluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007656	1,2-bis(2,5-difluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007657	1,2-bis(2,3-fluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007658	1,2-bis(3,4-difluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007659	1,2-bis(2,6-difluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007660	1,2-bis(2,4-difluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007661	1,2-bis(3-fluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007662	1,2-bis(2-fluorophenyl)ethane-1,2-dione	Discovery agent	.	.
DNC007663	1,2-bis(3,4,5-trifluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007664	1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007665	1,2-bis(2,3,5-trifluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007666	1,2-bis(3,5-difluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007667	1,2-bis(2,5-difluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007668	1,2-bis(2,3-difluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007669	1,2-bis(3,4-difluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007670	1,2-bis(2,6-difluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007671	1,2-bis(2,4-difluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007672	1,2-bis(3-fluorophenyl)-2-hydroxyethanon	Discovery agent	.	.
DNC007673	1,2-bis(2-fluorophenyl)-2-hydroxyethanone	Discovery agent	.	.
DNC007674	C[homoPhe-Hca-Glu-Gly-Leu-Glu-Glu]-NH2	Discovery agent	.	.
DNC007675	OM00-3	Discovery agent	.	.
DNC007676	MCL-445	Discovery agent	.	.
DNC007677	MCL-446	Discovery agent	.	.
DNC007678	MCL-447	Discovery agent	.	.
DNC007679	MCL-448	Discovery agent	.	.
DNC007680	MCL-458	Discovery agent	.	.
DNC007681	MCL-457	Discovery agent	.	.
DNC007682	MCL-183	Discovery agent	.	.
DNC007683	MCL-147	Discovery agent	.	.
DNC007684	MCL-149	Discovery agent	.	.
DNC007685	BERGAPTOL	Discovery agent	.	.
DNC007686	Geranylcoumarin	Discovery agent	.	.
DNC007687	Methotrexate gamma-L-proline-hydroxamic acid	Discovery agent	.	.
DNC007688	Methotrexate gamma-hydroxamic acid	Discovery agent	.	.
DNC007689	Folate gamma-L-proline-hydroxamic acid	Discovery agent	.	.
DNC007690	Methyl 2-(naphthalen-2-yl)benzoate	Discovery agent	.	.
DNC007691	[Gly(But)7]OT	Discovery agent	.	.
DNC007692	[Aib7]OT	Discovery agent	.	.
DNC007693	[D-Tic7]OT	Discovery agent	.	.
DNC007694	[L-Tic7]OT	Discovery agent	.	.
DNC007695	[Pip7]OT	Discovery agent	.	.
DNC007696	[Mpa1, D-Tic7]OT	Discovery agent	.	.
DNC007697	[Mpa1, L-Tic7]OT	Discovery agent	.	.
DNC007698	[Mpa1, D-Tyr(Et)2, Aib7, D-Tic9]OT	Discovery agent	.	.
DNC007699	[Mpa1, D-Tyr(Et)2, Aib7]OT	Discovery agent	.	.
DNC007700	[Mpa1, D-Tyr(Et)2, Gly(But)3, Gly(But)7]OT	Discovery agent	.	.
DNC007701	[Mpa1, D-Tyr(Et)2, Gly(But)7]OT	Discovery agent	.	.
DNC007702	[Mpa1, D-Tyr(Et)2, Pip7]OT	Discovery agent	.	.
DNC007703	[Mpa1, D-Tyr(Et)2, D-Tic7, Aib9]OT	Discovery agent	.	.
DNC007704	[Mpa1, D-Tyr(Et)2, D-Tic7, D-Tic9]OT	Discovery agent	.	.
DNC007705	[Mpa1, D-Tyr(Et)2, D-Tic7]OT	Discovery agent	.	.
DNC007706	[Mpa1, D-Tyr(Et)2, L-Tic7]OT	Discovery agent	.	.
DNC007707	[Mpa1, D-Tic2, Aib7]OT	Discovery agent	.	.
DNC007708	4-(2-(aminomethyl)phenyl)-1-benzylpiperidin-4-ol	Discovery agent	.	.
DNC007709	1-benzhydryl-4-(pyridin-2-yl)piperidin-4-ol	Discovery agent	.	.
DNC007710	1-benzhydryl-4-(thiophen-2-yl)piperidin-4-ol	Discovery agent	.	.
DNC007711	1-benzhydryl-4-(furan-2-yl)piperidin-4-ol	Discovery agent	.	.
DNC007712	1-benzhydryl-4-(3-phenylpropyl)piperidin-4-ol	Discovery agent	.	.
DNC007713	1-benzhydryl-4-benzylpiperidin-4-ol	Discovery agent	.	.
DNC007714	1-benzhydryl-4-cyclohexylpiperidin-4-ol	Discovery agent	.	.
DNC007715	1-benzhydryl-4-hexylpiperidin-4-ol	Discovery agent	.	.
DNC007716	1-benzhydryl-4-tert-butylpiperidin-4-ol	Discovery agent	.	.
DNC007717	1-benzhydryl-4-butylpiperidin-4-ol	Discovery agent	.	.
DNC007718	1-benzhydryl-4-isopropylpiperidin-4-ol	Discovery agent	.	.
DNC007719	1-benzhydryl-4-cyclopropylpiperidin-4-ol	Discovery agent	.	.
DNC007720	1-benzhydryl-4-(4-methoxyphenyl)piperidin-4-ol	Discovery agent	.	.
DNC007721	1-benzhydryl-4-(3-methoxyphenyl)piperidin-4-ol	Discovery agent	.	.
DNC007722	1-benzhydryl-4-(2-methoxyphenyl)piperidin-4-ol	Discovery agent	.	.
DNC007723	1-benzhydryl-4-(4-butylphenyl)piperidin-4-ol	Discovery agent	.	.
DNC007724	1-benzhydryl-4-(4-propylphenyl)piperidin-4-ol	Discovery agent	.	.
DNC007725	1-benzhydryl-4-(4-ethylphenyl)piperidin-4-ol	Discovery agent	.	.
DNC007726	1-benzhydryl-4-p-tolylpiperidin-4-ol	Discovery agent	.	.
DNC007727	1-benzhydryl-4-m-tolylpiperidin-4-ol	Discovery agent	.	.
DNC007728	1-benzhydryl-4-o-tolylpiperidin-4-ol	Discovery agent	.	.
DNC007729	1-benzhydryl-4-(4-bromophenyl)piperidin-4-ol	Discovery agent	.	.
DNC007730	1-benzhydryl-4-(4-chlorophenyl)piperidin-4-ol	Discovery agent	.	.
DNC007731	1-benzhydryl-4-(4-fluorophenyl)piperidin-4-ol	Discovery agent	.	.
DNC007732	1-benzhydryl-4-(3-fluorophenyl)piperidin-4-ol	Discovery agent	.	.
DNC007733	1-benzhydryl-4-(2-fluorophenyl)piperidin-4-ol	Discovery agent	.	.
DNC007734	5-hydroxy-2-phenylisoindoline-1,3-dione	Discovery agent	.	.
DNC007735	1-(2-amino-benzothiazol-6-yl)-2-ethyl-isothiourea	Discovery agent	.	.
DNC007736	1-(2-amino-benzothiazol-5-yl)-2-ethyl-isothiourea	Discovery agent	.	.
DNC007737	BX-471	Discovery agent	.	.
DNC007738	4-(1H-indol-3-yl)-N,N-dimethylcyclohex-3-enamine	Discovery agent	.	.
DNC007739	4-phenyl-2-(phenylamino)pyrimidine-5-carbonitrile	Discovery agent	.	.
DNC007740	2-(p-toluidino)-4-phenylpyrimidine-5-carbonitrile	Discovery agent	.	.
DNC007741	LOMERIZINE	Discovery agent	.	.
DNC007742	KMI-538	Discovery agent	.	.
DNC007743	KMI-494	Discovery agent	.	.
DNC007744	KMI-172	Discovery agent	.	.
DNC007745	BMS-1	Discovery agent	.	.
DNC007746	2-(1-o-tolyl-1H-pyrrol-3-yl)ethanamine	Discovery agent	.	.
DNC007747	2-(2'-methyl-biphenyl-3-yl)-ethylamine	Discovery agent	.	.
DNC007748	(2-biphenyl-3-yl-ethyl)-dimethyl-amine	Discovery agent	.	.
DNC007749	3-butyl-1-(naphthalen-1-yl)piperidin-4-amine	Discovery agent	.	.
DNC007750	(3S,4R)-3-butyl-1-phenylpiperidin-4-amine	Discovery agent	.	.
DNC007751	1-benzhydryl-3-butylpiperidin-4-amine	Discovery agent	.	.
DNC007752	DIRLOTAPIDE	Discovery agent	.	.
DNC007753	LRHYLNLLTRQRY-NH2	Discovery agent	.	.
DNC007754	(2-(4-chlorobenzyloxy)-5-bromophenyl)methanamine	Discovery agent	.	.
DNC007755	4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine	Discovery agent	.	.
DNC007756	N-(2-(4-chlorobenzyloxy)-5-bromobenzyl)ethanamine	Discovery agent	.	.
DNC007757	5-(1,1-dimethyl-heptyl)-2-pyridin-3-yl-phenol	Discovery agent	.	.
DNC007758	4'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	Discovery agent	.	.
DNC007759	3'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	Discovery agent	.	.
DNC007760	2'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	Discovery agent	.	.
DNC007761	4-(1,1-dimethyl-heptyl)-3'-methoxy-biphenyl-2-ol	Discovery agent	.	.
DNC007762	4-(1,1-dimethyl-heptyl)-2'-methoxy-biphenyl-2-ol	Discovery agent	.	.
DNC007763	4'-(1,1-dimethyl-heptyl)-3,5-dimethyl-biphenyl	Discovery agent	.	.
DNC007764	(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one	Discovery agent	.	.
DNC007765	SU-6689	Discovery agent	.	.
DNC007766	9-(5',5'-difluoro-5'-phosphonopentyl)guanine	Discovery agent	.	.
DNC007767	LTERHKILHRLLQEGSPSD	Discovery agent	.	.
DNC007768	TESTOSTERONE PROPIONATE	Discovery agent	.	.
DNC007769	5'-deoxy-5'-ureidoadenosine	Discovery agent	.	.
DNC007770	PF-429242	Discovery agent	.	.
DNC007771	2-(N-(2-Ffuorophenyl)pyrrol-3-yl) acetic acid	Discovery agent	.	.
DNC007772	2-(N-(2-fluorophenyl)pyrrol-2-yl) acetic acid	Discovery agent	.	.
DNC007773	N6-(3-Iodobenzyl)-2'-O-methyladenosine	Discovery agent	.	.
DNC007774	1-(4-(4-phenyl-1-piperazinyl)butyl)indolin-2-one	Discovery agent	.	.
DNC007775	2-(adamantan-1-ylamino)-5,5-diethyl-oxazol-4-one	Discovery agent	.	.
DNC007776	2-(cyclooctylamino)-5,5-diethyloxazol-4(5H)-one	Discovery agent	.	.
DNC007777	2-(benzylamino)-5,5-diethyloxazol-4(5H)-one	Discovery agent	.	.
DNC007778	5,5-diethyl-2-(phenethylamino)oxazol-4(5H)-one	Discovery agent	.	.
DNC007779	(10H-phenothiazin-10-yl)(phenyl)methanone	Discovery agent	.	.
DNC007780	1,2-di(10H-phenothiazin-10-yl)ethane-1,2-dione	Discovery agent	.	.
DNC007781	Anthracen-10-yl(10H-phenothiazin-10-yl)methanone	Discovery agent	.	.
DNC007782	Naphthalen-2-yl(10H-phenothiazin-10-yl)methanone	Discovery agent	.	.
DNC007783	Naphthalen-1-yl(10H-phenothiazin-10-yl)methanone	Discovery agent	.	.
DNC007784	2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone	Discovery agent	.	.
DNC007785	1-(10H-phenothiazin-10-yl)-4-phenylbutan-1-one	Discovery agent	.	.
DNC007786	1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one	Discovery agent	.	.
DNC007787	1-(10H-phenothiazin-10-yl)-2-phenylbutan-1-one	Discovery agent	.	.
DNC007788	1-(10H-phenothiazin-10-yl)-3-phenylpropan-1-one	Discovery agent	.	.
DNC007789	1-(10H-phenothiazin-10-yl)-2-phenylpropan-1-one	Discovery agent	.	.
DNC007790	1-(10H-phenothiazin-10-yl)-2-phenylethanone	Discovery agent	.	.
DNC007791	(4-nitrophenyl)(10H-phenothiazin-10-yl)methanone	Discovery agent	.	.
DNC007792	(4-bromophenyl)(10H-phenothiazin-10-yl)methanone	Discovery agent	.	.
DNC007793	(10H-phenothiazin-10-yl)(p-tolyl)methanone	Discovery agent	.	.
DNC007794	(3-bromophenyl)(10H-phenothiazin-10-yl)methanone	Discovery agent	.	.
DNC007795	(10H-phenothiazin-10-yl)(m-tolyl)methanone	Discovery agent	.	.
DNC007796	(10H-phenothiazin-10-yl)(o-tolyl)methanone	Discovery agent	.	.
DNC007797	1-phenyl-3-(2-(pyridin-4-yl)thiazol-4-yl)urea	Discovery agent	.	.
DNC007798	3-(2-phenylthiazol-4-yl)quinolin-2(1H)-one	Discovery agent	.	.
DNC007799	6-(4-((phenethylamino)methyl)phenoxy)nicotinamide	Discovery agent	.	.
DNC007800	6-(4-(2-(benzylamino)ethyl)phenoxy)picolinamide	Discovery agent	.	.
DNC007801	6-(4-(2-(benzylamino)ethyl)phenoxy)nicotinamide	Discovery agent	.	.
DNC007802	LY-255582	Discovery agent	.	.
DNC007803	5-(4-((phenethylamino)methyl)phenoxy)picolinamide	Discovery agent	.	.
DNC007804	4-(4-((phenethylamino)methyl)phenoxy)benzamide	Discovery agent	.	.
DNC007805	6-(4-((benzylamino)methyl)phenoxy)nicotinamide	Discovery agent	.	.
DNC007806	6-(4-(3-(benzylamino)propyl)phenoxy)nicotinamide	Discovery agent	.	.
DNC007807	(4-benzylpiperidin-1-yl)(m-tolyl)methanone	Discovery agent	.	.
DNC007808	(4-benzylpiperidin-1-yl)(p-tolyl)methanone	Discovery agent	.	.
DNC007809	(4-benzylpiperidin-1-yl)(2-fluorophenyl)methanone	Discovery agent	.	.
DNC007810	(4-benzylpiperidin-1-yl)(3-chlorophenyl)methanone	Discovery agent	.	.
DNC007811	(4-phenylpiperazin-1-yl)(p-tolyl)methanone	Discovery agent	.	.
DNC007812	ERTIPROTAFIB	Diabetes mellitus type 2	.	E11
DNC007812	ERTIPROTAFIB	Discovery agent	.	.
DNC007813	3,2'-bis-trifluoromethyl-biphenyl-4-carbonitrile	Discovery agent	.	.
DNC007814	1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine	Discovery agent	.	.
DNC007815	N-(3-(1H-indol-4-yloxy)propyl)cyclopentanamine	Discovery agent	.	.
DNC007816	N-(3-(1H-indol-4-yloxy)propyl)cyclohexanamine	Discovery agent	.	.
DNC007817	4-(1H-indol-4-yloxy)-1-(isopropylamino)butan-2-ol	Discovery agent	.	.
DNC007818	SCH-725737	Discovery agent	.	.
DNC007819	SCH-725739	Discovery agent	.	.
DNC007820	ST-198	Cardiovascular disease	390-459	I00-I99
DNC007820	ST-198	Discovery agent	.	.
DNC007821	NSC-30552	Discovery agent	.	.
DNC007822	NSC-661755	Discovery agent	.	.
DNC007823	NSC-292213	Discovery agent	.	.
DNC007824	NSC-172033	Discovery agent	.	.
DNC007825	NEODYSIDENIN	Discovery agent	.	.
DNC007826	DYSIDENIN	Discovery agent	.	.
DNC007827	NSC-125034	Discovery agent	.	.
DNC007828	24-thiacycloartanol	Discovery agent	.	.
DNC007829	KYS-05090	Discovery agent	.	.
DNC007830	Ac-Asp-Arg-Leu-Asp-Ser-OH	Discovery agent	.	.
DNC007831	METHOCTRAMINE HYDROCHLORIDE	Discovery agent	.	.
DNC007832	5'-amino-5'-deoxy-alpha-D-thymidine	Discovery agent	.	.
DNC007833	3-benzoyl-1-pentyl-1,4-dihydroquinolin-4-one	Discovery agent	.	.
DNC007834	7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin	Discovery agent	.	.
DNC007835	3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one	Discovery agent	.	.
DNC007836	3-(dibutylamino)-1-(4-hexylphenyl)propan-1-one	Discovery agent	.	.
DNC007837	1-(4-hexylphenyl)-3-morpholinopropan-1-one	Discovery agent	.	.
DNC007838	1-(4-hexylphenyl)-3-(propylamino)propan-1-one	Discovery agent	.	.
DNC007839	(E)-1-(4-heptylphenyl)but-2-en-1-one	Discovery agent	.	.
DNC007840	4-(4-hexylphenyl)-4-oxobut-2-enoic acid	Discovery agent	.	.
DNC007841	2-hexylphenyl acrylate	Discovery agent	.	.
DNC007842	1-(4-octylphenyl)prop-2-en-1-one	Discovery agent	.	.
DNC007843	1-(4-heptylphenyl)prop-2-en-1-one	Discovery agent	.	.
DNC007844	(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid	Discovery agent	.	.
DNC007845	3-bromo-1-(4-hexylphenyl)propan-1-one	Discovery agent	.	.
DNC007846	4-hexylphenyl propiolate	Discovery agent	.	.
DNC007847	(4-hexylphenyl)(oxiran-2-yl)methanone	Discovery agent	.	.
DNC007848	5-isopropyl-2-(phenylamino)thiazol-4(5H)-one	Discovery agent	.	.
DNC007849	2-(2-chlorophenylamino)-5-methylthiazol-4(5H)-one	Discovery agent	.	.
DNC007850	2-(o-toluidino)-5-isopropylthiazol-4(5H)-one	Discovery agent	.	.
DNC007851	NSC-23180	Discovery agent	.	.
DNC007852	5,6-dinitroacenaphthoquinone	Discovery agent	.	.
DNC007853	Phenanthrene-9,10-dione	Discovery agent	.	.
DNC007854	1,2-indanedione	Discovery agent	.	.
DNC007855	11,12-dihydro-dibenzo[a,e]cyclooctene-5,6-dione	Discovery agent	.	.
DNC007856	Thieno[3,2-e][1]benzothiophene-4,5-dione	Discovery agent	.	.
DNC007857	1,10-phenanthroline-5,6-dione	Discovery agent	.	.
DNC007858	Acenanthrene-9,10-dione	Discovery agent	.	.
DNC007859	ACENAPHTHOQUINONE	Discovery agent	.	.
DNC007860	1,2-dicyclohexylethane-1,2-dione	Discovery agent	.	.
DNC007861	N-(2-aminophenyl)-4-methoxybenzamide	Discovery agent	.	.
DNC007862	N-(2-aminophenyl)quinoxaline-6-carboxamide	Discovery agent	.	.
DNC007863	CI-994	Cancer	140-229	C00-C96
DNC007863	CI-994	Discovery agent	.	.
DNC007864	ES-936	Discovery agent	.	.
DNC007865	WAY-181187	Anxiety disorder	.	F40-F42
DNC007865	WAY-181187	Discovery agent	.	.
DNC007866	2-(1-tosyl-1H-indol-3-yl)ethanamine	Discovery agent	.	.
DNC007867	Tiazofurin adenine dinucleotide	Discovery agent	.	.
DNC007868	TN-14003	Acute lymphoblastic leukemia	204	C91.0
DNC007868	TN-14003	Discovery agent	.	.
DNC007869	6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007870	6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007871	6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007872	6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007873	6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007874	5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007875	6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007876	6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007877	6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007878	5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione	Discovery agent	.	.
DNC007879	C(-GRGDfL-)	Discovery agent	.	.
DNC007880	N-(2-aminophenyl)-4-(chroman-3-ylmethyl)benzamide	Discovery agent	.	.
DNC007881	6-(2-phenethylisoindolin-5-yloxy)nicotinamide	Discovery agent	.	.
DNC007882	6-(2-benzylisoindolin-5-yloxy)nicotinamide	Discovery agent	.	.
DNC007883	SQ-24798	Discovery agent	.	.
DNC007884	(+/-)-5-amino-2-(mercaptomethyl)pentanoic acid	Discovery agent	.	.
DNC007885	UK-396082	Discovery agent	.	.
DNC007885	UK-396082	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNC007886	2-(3-biphenyl-4-yl-propionylamino)-benzoic acid	Discovery agent	.	.
DNC007887	2-(3-(naphthalen-2-yl)propanamido)benzoic acid	Discovery agent	.	.
DNC007888	6'-methylepibatidine	Discovery agent	.	.
DNC007889	CMI-489	Discovery agent	.	.
DNC007890	Oxametacin	Discovery agent	.	.
DNC007891	4-amino-2H-chromen-2-one	Discovery agent	.	.
DNC007892	N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]lauramide	Discovery agent	.	.
DNC007893	N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]undecanamide	Discovery agent	.	.
DNC007894	N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]linoleamide	Discovery agent	.	.
DNC007895	EPIERENONE	Discovery agent	.	.
DNC007896	2-benzoylaminoquinazoline-4-carboxyanilide	Discovery agent	.	.
DNC007897	2-acetylaminoquinazoline-4-carboxyanilide	Discovery agent	.	.
DNC007898	1,2-dihydro-2-oxoquinazoline-4-carboxyanilide	Discovery agent	.	.
DNC007899	2-aminoquinazoline-4-carboxy-(4-bromophenyl)amide	Discovery agent	.	.
DNC007900	2-aminoquinazoline-4-carboxyanilide	Discovery agent	.	.
DNC007901	BI-1356	Discovery agent	.	.
DNC007901	BI-1356	Type 2 diabetes	250.00, 250.02	E11
DNC007902	(4-guanidino-benzyl)-carbamic acid benzyl ester	Discovery agent	.	.
DNC007903	PYY(3-36)	Discovery agent	.	.
DNC007903	PYY(3-36)	Obesity	278	E66
DNC007904	AcPYY(26-36)	Discovery agent	.	.
DNC007905	AcPYY(25-36)	Discovery agent	.	.
DNC007906	PYY(25-36)	Discovery agent	.	.
DNC007907	AcPYY(22-36)	Discovery agent	.	.
DNC007908	PYY(22-36)	Discovery agent	.	.
DNC007909	AcNPY(25-36)	Discovery agent	.	.
DNC007910	KYS-05080	Discovery agent	.	.
DNC007911	KYS-05077	Discovery agent	.	.
DNC007912	CEP-6800	Discovery agent	.	.
DNC007913	PFFFFF	Discovery agent	.	.
DNC007914	4-(3-phenoxylphenyl)-5-cyano-2H-1,2,3-triazole	Discovery agent	.	.
DNC007915	4-(4-bromophenyl)-5-cyano-2H-1,2,3-triazole	Discovery agent	.	.
DNC007916	4-(4-chlorophenyl)-5-cyano-2H-1,2,3-triazole	Discovery agent	.	.
DNC007917	4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole	Discovery agent	.	.
DNC007918	LE 300	Discovery agent	.	.
DNC007919	2-(3-aminophenyl)-3-mercaptopropanoic acid	Discovery agent	.	.
DNC007920	2-(3-guanidinophenyl)-3-mercaptopropanoic acid	Discovery agent	.	.
DNC007921	3-mercapto-2-(piperidin-3-yl)propanoic acid	Discovery agent	.	.
DNC007922	3-mercapto-2-(piperidin-4-yl)propanoic acid	Discovery agent	.	.
DNC007923	SCH-412348	Discovery agent	.	.
DNC007924	1-(2-bromophenyl)-3-(4-cyano-2-hydroxyphenyl)urea	Discovery agent	.	.
DNC007925	1-(5-chloro-2-hydroxy-4-nitrophenyl)-3-phenylurea	Discovery agent	.	.
DNC007926	1-(3-cyano-2-hydroxyphenyl)-3-phenylurea	Discovery agent	.	.
DNC007927	N,N-dimethyl-2-(1-tosyl-1H-indol-3-yl)ethanamine	Discovery agent	.	.
DNC007928	4-((1H-indol-1-yl)methyl)benzenamine	Discovery agent	.	.
DNC007929	3-(4-(benzyloxy)-3,5-dibromophenyl)propanoic acid	Discovery agent	.	.
DNC007930	1-benzyl-4-(2,4-dichlorophenyl)pyrrolidin-3-amine	Discovery agent	.	.
DNC007931	4-(2,4-dichlorophenyl)-1-phenylpyrrolidin-3-amine	Discovery agent	.	.
DNC007932	4-(2,4-dichlorophenyl)-1-tosylpyrrolidin-3-amine	Discovery agent	.	.
DNC007933	AcDRGDS	Discovery agent	.	.
DNC007934	(E)-2-(4-fluorostyryl)-5-(phenylsulfinyl)pyridine	Discovery agent	.	.
DNC007935	(E)-2-(4-fluorostyryl)-5-(phenylsulfonyl)pyridine	Discovery agent	.	.
DNC007936	Adamantan-1-yl-(4-ethyl-piperazin-1-yl)-methanone	Discovery agent	.	.
DNC007937	Adamantan-1-yl-pyrrolidin-1-yl-methanone	Discovery agent	.	.
DNC007938	Adamantan-1-yl-piperazin-1-yl-methanone	Discovery agent	.	.
DNC007939	1-(4-ethylpiperazin-1-yl)-2-phenylethanone	Discovery agent	.	.
DNC007940	Adamantan-1-yl-piperidin-1-yl-methanone	Discovery agent	.	.
DNC007941	Adamantan-2-yl-piperidin-1-yl-methanone	Discovery agent	.	.
DNC007942	H-Tyr-Gly-Gly-Phe-Met-OH	Discovery agent	.	.
DNC007943	H-Aba-ala-Gly-Phe-Met-OH	Discovery agent	.	.
DNC007944	H-Aba-ser-Gly-Phe-Leu-Thr-OH	Discovery agent	.	.
DNC007945	H-Cdp-ser-Gly-Phe-Leu-Thr-OH	Discovery agent	.	.
DNC007946	H-mCpa-ser-Gly-Phe-Leu-Thr-OH	Discovery agent	.	.
DNC007947	H-Aba-Gly-Gly-Phe-Leu-OH	Discovery agent	.	.
DNC007948	H-Cdp-Gly-Gly-Phe-Leu-OH	Discovery agent	.	.
DNC007949	H-Aba-ala-Gly-Phe-leu-OH	Discovery agent	.	.
DNC007950	H-Cdp-ala-Gly-Phe-leu-OH	Discovery agent	.	.
DNC007951	H-mCpa-ala-Gly-Phe-leu-OH	Discovery agent	.	.
DNC007952	H-Apa-ala-Gly-Phe-leu-OH	Discovery agent	.	.
DNC007953	H-Cpa-Gly-Gly-Phe-Met-NH2	Discovery agent	.	.
DNC007954	H-Tyr-Gly-Gly-Phe-Met-NH2	Discovery agent	.	.
DNC007955	H-Cpa-Gly-Gly-Phe-Met-OH	Discovery agent	.	.
DNC007956	H-Poa-ser-Gly-Phe-Leu-Thr-OH	Discovery agent	.	.
DNC007957	H-mCpa-Gly-Gly-Phe-Leu-OH	Discovery agent	.	.
DNC007958	H-Cxp-ala-Gly-Phe-leu-OH	Discovery agent	.	.
DNC007959	H-Cpa-c[pen-Gly-Phe-pen]OH	Discovery agent	.	.
DNC007960	H-Tyr-c[pen-Gly-Phe-pen]OH	Discovery agent	.	.
DNC007961	NSC-95397	Discovery agent	.	.
DNC007962	(-)-hydroxycitrate	Discovery agent	.	.
DNC007963	CHYMOSTATIN	Discovery agent	.	.
DNC007964	Rac-2q	Discovery agent	.	.
DNC007965	7-ethyl-6H-chromeno[4,3-b]quinoline-3,9-diol	Discovery agent	.	.
DNC007966	7-ethynyl-6H-chromeno[4,3-b]quinoline-3,9-diol	Discovery agent	.	.
DNC007967	7-vinyl-6H-chromeno[4,3-b]quinoline-3,9-diol	Discovery agent	.	.
DNC007968	7-bromo-6H-chromeno[4,3-b]quinoline-3,9-diol	Discovery agent	.	.
DNC007969	7-chloro-6H-chromeno[4,3-b]quinoline-3,9-diol	Discovery agent	.	.
DNC007970	2-(phenylsulfonyl)-1-(thiophen-3-yl)ethanone	Discovery agent	.	.
DNC007971	1-(phenylsulfonyl)butan-2-one	Discovery agent	.	.
DNC007972	1,1-diphenyl-3-(phenylsulfonyl)propan-2-one	Discovery agent	.	.
DNC007973	1-(3,5-dimethylphenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007974	1-(4-nitrophenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007975	1-(3,4-dichlorophenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007976	1-(3-methoxyphenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007977	1-(4-chlorophenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007978	1-(4-fluorophenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007979	1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone	Discovery agent	.	.
DNC007980	2-(phenylsulfonyl)-1-p-tolylethanone	Discovery agent	.	.
DNC007981	1-phenyl-3-(phenylsulfonyl)propan-1-one	Discovery agent	.	.
DNC007982	N-benzyl-N-(phenylsulfonyl)benzamide	Discovery agent	.	.
DNC007983	1-(4-fluorophenyl)-3-(phenylsulfonyl)propan-1-one	Discovery agent	.	.
DNC007984	2-benzyl-4,5,6,7-tetrachloroisoindoline-1,3-dione	Discovery agent	.	.
DNC007985	5-chloro-2-(4-phenylbutyl)isoindoline-1,3-dione	Discovery agent	.	.
DNC007986	2-(2-hexylphenyl)isoindoline-1,3-dione	Discovery agent	.	.
DNC007987	2-(2-phenethylphenyl)isoindoline-1,3-dione	Discovery agent	.	.
DNC007988	N-phenyl-5,6-dip-tolylpyrazine-2-carboxamide	Discovery agent	.	.
DNC007989	N-isopentyl-5,6-dip-tolylpyrazine-2-carboxamide	Discovery agent	.	.
DNC007990	N-isopropyl-5,6-dip-tolylpyrazine-2-carboxamide	Discovery agent	.	.
DNC007991	N-ethyl-5,6-dip-tolylpyrazine-2-carboxamide	Discovery agent	.	.
DNC007992	N-methyl-5,6-dip-tolylpyrazine-2-carboxamide	Discovery agent	.	.
DNC007993	2-(4-chloro-2-cyclohexylphenoxy)acetic acid	Discovery agent	.	.
DNC007994	Methyl 2-(4-chloro-2-cyclohexylphenoxy)acetate	Discovery agent	.	.
DNC007995	2-(2-allyl-4-chlorophenoxy)acetic acid	Discovery agent	.	.
DNC007996	2-(4-chloro-2-cycloheptylphenoxy)acetic acid	Discovery agent	.	.
DNC007997	2-(4-chloro-2-cyclopentylphenoxy)acetic acid	Discovery agent	.	.
DNC007998	2-(2-cyclohexyl-4-methoxyphenoxy)acetic acid	Discovery agent	.	.
DNC007999	2-(2-cyclohexyl-4-methylphenoxy)acetic acid	Discovery agent	.	.
DNC008000	2-(4-cyano-2-cyclohexylphenoxy)acetic acid	Discovery agent	.	.
DNC008001	2-(2-cyclohexyl-4-fluorophenoxy)acetic acid	Discovery agent	.	.
DNC008002	2-(4-bromo-2-cyclohexylphenoxy)acetic acid	Discovery agent	.	.
DNC008003	2-(2-cyclohexylphenoxy)acetic acid	Discovery agent	.	.
DNC008004	4-(4-chloro-2-cyclohexylphenoxy)butanoic acid	Discovery agent	.	.
DNC008005	3-(4-chloro-2-cyclohexylphenoxy)propanoic acid	Discovery agent	.	.
DNC008006	TYLOPHORININE	Discovery agent	.	.
DNC008007	[(R)-(+)-deoxytylophorinidine	Discovery agent	.	.
DNC008008	DCB-3503	Discovery agent	.	.
DNC008009	BMS-196085	Diabetes mellitus	.	E10-E14
DNC008009	BMS-196085	Discovery agent	.	.
DNC008010	4-tert-butyl-N-hydroxybenzamide	Discovery agent	.	.
DNC008011	N-oleoyl-dopamine	Discovery agent	.	.
DNC008012	N-hydroxy-4-(2-oleamidoethyl)benzamide	Discovery agent	.	.
DNC008013	N-(3,4,5-trihydroxyphenethyl)oleamide	Discovery agent	.	.
DNC008014	N-(2-aminoethyl)isoquinoline-5-sulfonamide	Discovery agent	.	.
DNC008015	OXYMORPHINDOLE CHLORIDE	Discovery agent	.	.
DNC008016	4-hydroxyphenethyl 3,4,5-trihydroxybenzoate	Discovery agent	.	.
DNC008017	2-hydroxyphenethyl 3,4,5-trihydroxybenzoate	Discovery agent	.	.
DNC008018	3-hydroxyphenethyl 3,4,5-trihydroxybenzoate	Discovery agent	.	.
DNC008019	RU-58841	Acne vulgaris	.	L70.0
DNC008019	RU-58841	Discovery agent	.	.
DNC008020	3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine	Discovery agent	.	.
DNC008021	N3-GHQMFYYPra-NH2	Discovery agent	.	.
DNC008022	[4',4''']-biflavone	Discovery agent	.	.
DNC008023	[3,4''']biflavone	Discovery agent	.	.
DNC008024	[6,3''']biflavone	Discovery agent	.	.
DNC008025	[6,4''']biflavone	Discovery agent	.	.
DNC008026	6,7-dimethoxy-4-(2-phenylethynyl)quinazoline	Discovery agent	.	.
DNC008027	6,7-diethoxy-4-(5-phenylpent-1-enyl)quinazoline	Discovery agent	.	.
DNC008028	6,7-diethoxy-4-(4-phenylbut-1-enyl)quinazoline	Discovery agent	.	.
DNC008029	6,7-diethoxy-4-styrylquinazoline	Discovery agent	.	.
DNC008030	4-biphenyl-2-ylethynyl-6,7-dimethoxy-quinazoline	Discovery agent	.	.
DNC008031	6,7-dimethoxy-4-(3-phenoxyprop-1-ynyl)quinazoline	Discovery agent	.	.
DNC008032	6,7-dimethoxy-4-(4-phenylbut-1-ynyl)quinazoline	Discovery agent	.	.
DNC008033	Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-)	Discovery agent	.	.
DNC008034	Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-)	Discovery agent	.	.
DNC008035	Cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-)	Discovery agent	.	.
DNC008036	Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-)	Discovery agent	.	.
DNC008037	Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-)	Discovery agent	.	.
DNC008038	Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-)	Discovery agent	.	.
DNC008039	Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)	Discovery agent	.	.
DNC008040	Cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)	Discovery agent	.	.
DNC008041	Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-)	Discovery agent	.	.
DNC008042	Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)	Discovery agent	.	.
DNC008043	Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-)	Discovery agent	.	.
DNC008044	Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-)	Discovery agent	.	.
DNC008045	Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-)	Discovery agent	.	.
DNC008046	S6-nitrobenzyl mercaptopurine riboside	Discovery agent	.	.
DNC008047	(5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol	Discovery agent	.	.
DNC008048	ANDROSTENEDIOL	Discovery agent	.	.
DNC008049	2-(allyloxy)-N8-hydroxy-N1-phenyloctanediamide	Discovery agent	.	.
DNC008050	N8-hydroxy-2-methoxy-N1-phenyloctanediamide	Discovery agent	.	.
DNC008051	N8,2-dihydroxy-N1-phenyloctanediamide	Discovery agent	.	.
DNC008052	2-(benzyloxy)-N7-hydroxy-N1-phenylheptanediamide	Discovery agent	.	.
DNC008053	N7-hydroxy-N1-phenyl-2-propoxyheptanediamide	Discovery agent	.	.
DNC008054	N7-hydroxy-2-methoxy-N1-phenylheptanediamide	Discovery agent	.	.
DNC008055	6-(3-aminopropyl)benzo[h]isoquinolin-1(2H)-one	Discovery agent	.	.
DNC008056	9-chlorobenzo[h]isoquinolin-1(2H)-one	Discovery agent	.	.
DNC008057	N-(2-morpholinophenyl)-5-nitrofuran-2-carboxamide	Discovery agent	.	.
DNC008058	BUTAPROST	Discovery agent	.	.
DNC008059	N-(2-chloroethyl)icosa-5,8,11,14-tetraenamide	Discovery agent	.	.
DNC008060	K-777	Discovery agent	.	.
DNC008061	FR-901277	Discovery agent	.	.
DNC008062	FR-901451	Discovery agent	.	.
DNC008063	SB-201076	Discovery agent	.	.
DNC008064	MANZAMINE A	Discovery agent	.	.
DNC008065	12,13-DEHYDRO-8-O-ACETYLMANZAMINE A	Discovery agent	.	.
DNC008066	12,13-DEHYDROMANZAMINE A	Discovery agent	.	.
DNC008067	8-O-(4-bromobenzenesulfonyl)manzamine F	Discovery agent	.	.
DNC008068	8-O-(4-chlorobenzenesulfonyl)manzamine F	Discovery agent	.	.
DNC008069	Manzamine E	Discovery agent	.	.
DNC008070	6-deoxymanzamine X	Discovery agent	.	.
DNC008071	9-N-ETHYL-8-ETHOXY-MANZAMINE A	Discovery agent	.	.
DNC008072	9-N-METHYL-8-METHOXY-MANZAMINE A	Discovery agent	.	.
DNC008073	8-O-(4-toluenesulfonyl)manzamine A	Discovery agent	.	.
DNC008074	6-hydroxymanzamine A	Discovery agent	.	.
DNC008075	8-OH-MANZAMINE A	Discovery agent	.	.
DNC008076	COCHINCHINENIN B	Discovery agent	.	.
DNC008077	COCHINCHINENENE B	Discovery agent	.	.
DNC008078	E-GUGGULSTERONE	Discovery agent	.	.
DNC008079	12-O-deacetyl-12-epi-19-deoxy-21-hydroxyscalarin	Discovery agent	.	.
DNC008080	PALMATINE	Discovery agent	.	.
DNC008081	JATRORRHIZINE	Discovery agent	.	.
DNC008082	PERIPENTADENINE	Discovery agent	.	.
DNC008083	CHLOROCYCLINONE A	Discovery agent	.	.
DNC008084	CHLOROCYCLINONE D	Discovery agent	.	.
DNC008085	CHLOROCYCLINONE C	Discovery agent	.	.
DNC008086	CHLOROCYCLINONE B	Discovery agent	.	.
DNC008087	Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008088	C[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008089	C[CO-2,3-pyrazine-CO-D-Phe-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008090	C[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008091	C[CO-2,3-pyrazine-CO-D-Nal(2)-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008092	C[CO-(CH2)2-CO-Nle-D-Phe-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008093	C[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008094	C[CO-(CH2)3-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008095	C[CO-o-C6H4-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2	Discovery agent	.	.
DNC008096	MK-9	Discovery agent	.	.
DNC008097	Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2	Discovery agent	.	.
DNC008098	9-benzyl-6-(benzylamino)-9H-purine-2-carbonitrile	Discovery agent	.	.
DNC008099	6-(benzylamino)-9-butyl-9H-purine-2-carbonitrile	Discovery agent	.	.
DNC008100	2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine	Discovery agent	.	.
DNC008101	2-phenyl-N,N-bis(o-tolylthiomethyl)ethanamine	Discovery agent	.	.
DNC008102	N,N-bis(tosylmethyl)hexan-1-amine	Discovery agent	.	.
DNC008103	Phenyl-N,N-bis(tosylmethyl)methanamine	Discovery agent	.	.
DNC008104	1-phenylthio-N,N-dimethyltryptamine	Discovery agent	.	.
DNC008105	EDMT	Discovery agent	.	.
DNC008106	5-(2-fluorobenzyloxy)quinazoline-2,4-diamine	Discovery agent	.	.
DNC008107	JNJ-17203212	Cough	786.2	R05
DNC008107	JNJ-17203212	Discovery agent	.	.
DNC008108	JNJ-16259685	Anxiety disorder	.	F40-F42
DNC008108	JNJ-16259685	Discovery agent	.	.
DNC008109	2'-Me-tecadenoson	Discovery agent	.	.
DNC008110	2-chloro-2'-C-methyl-tecadenoson	Discovery agent	.	.
DNC008111	2-chloro-N6-cyclopentyladenosine	Discovery agent	.	.
DNC008112	N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide	Discovery agent	.	.
DNC008113	N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)	Discovery agent	.	.
DNC008114	6-(3-(pyridin-4-yl)phenyl)naphthalen-2-ol	Discovery agent	.	.
DNC008115	KN-62	Discovery agent	.	.
DNC008116	N-(4-iodophenyl)-4-(trifluoromethyl)benzamide	Discovery agent	.	.
DNC008117	N-(4-iodophenyl)-4-(trifluoromethoxy)benzamide	Discovery agent	.	.
DNC008118	BMS-639623	Discovery agent	.	.
DNC008118	BMS-639623	Inflammatory diseases	.	.
DNC008119	GSK-188909	Discovery agent	.	.
DNC008120	MEMOQUIN	Discovery agent	.	.
DNC008121	THIOCTIC ACID	Discovery agent	.	.
DNC008122	CAPROCTAMINE	Discovery agent	.	.
DNC008123	CVT-6694	Discovery agent	.	.
DNC008124	CVT-7124	Discovery agent	.	.
DNC008125	GT-1282	Discovery agent	.	.
DNC008126	BMS-640994	Discovery agent	.	.
DNC008127	5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol	Discovery agent	.	.
DNC008128	Salvinorin B 2-methoxy-2-propyl ether	Discovery agent	.	.
DNC008129	Salvinorin B tetrahydropyran-2-yl ether	Discovery agent	.	.
DNC008130	Salvinorin B butoxymethyl ether	Discovery agent	.	.
DNC008131	Salvinorin B 1-ethoxyethyl ether	Discovery agent	.	.
DNC008132	Salvinorin B 1-ethoxyethyl ether	Discovery agent	.	.
DNC008133	Salvinorin B fluoromethyl ether	Discovery agent	.	.
DNC008134	Salvinorin B methylthiomethyl ether	Discovery agent	.	.
DNC008135	Salvinorin B benzyloxymethyl ether	Discovery agent	.	.
DNC008136	Salvinorin B 2-methoxyethoxymethyl ether	Discovery agent	.	.
DNC008137	Salvinorin B 2,2,2-trifluoroethoxymethyl ether	Discovery agent	.	.
DNC008138	Salvinorin B 2-fluoroethoxymethyl ether	Discovery agent	.	.
DNC008139	Salvinorin B tert-butoxymethyl ether	Discovery agent	.	.
DNC008140	Salvinorin B isopropoxymethyl ether	Discovery agent	.	.
DNC008141	Salvinorin B propoxymethyl ether	Discovery agent	.	.
DNC008142	Salvinorin B ethoxymethyl ether	Discovery agent	.	.
DNC008143	Salvinorin B methoxymethyl ether	Discovery agent	.	.
DNC008144	5-chloro-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008145	5,6-dichloro-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008146	N,N-dimethyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008147	4-propyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008148	4-ethyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008149	3,4-dihydroquinazolin-2-amine hydrobromide	Discovery agent	.	.
DNC008150	8-chloro-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008151	5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008152	8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008153	5-chloro-4-methyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008154	RB 2	Discovery agent	.	.
DNC008155	SB-416	Discovery agent	.	.
DNC008156	PSB-716	Discovery agent	.	.
DNC008157	3-phenyl-4-(phenylamino)-1H-pyrrole-2,5-dione	Discovery agent	.	.
DNC008158	1,1,1-trifluoro-3-(octylthio)propan-2-one	Discovery agent	.	.
DNC008159	2,2-dimethyl-3-methyleneheptadecane	Discovery agent	.	.
DNC008160	3-(decylthio)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC008161	1,1,1-trifluoro-3-(hexylthio)propan-2-one	Discovery agent	.	.
DNC008162	1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one	Discovery agent	.	.
DNC008163	1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one	Discovery agent	.	.
DNC008164	1,1,1-trifluorododecan-2-one	Discovery agent	.	.
DNC008165	3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC008166	3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC008167	3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC008168	3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC008169	N-butyl-4-methyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008170	4-methyl-N-propyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008171	N,4-dimethyl-3,4-dihydroquinazolin-2-amine	Discovery agent	.	.
DNC008172	AR-C102222	Discovery agent	.	.
DNC008173	L-NIL	Discovery agent	.	.
DNC008174	BAY-11-7082	Discovery agent	.	.
DNC008175	9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	Discovery agent	.	.
DNC008176	9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	Discovery agent	.	.
DNC008177	9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	Discovery agent	.	.
DNC008178	5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	Discovery agent	.	.
DNC008179	5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide	Discovery agent	.	.
DNC008180	5-chloro-N-(quinolin-8-yl)thiophene-2-sulfonamide	Discovery agent	.	.
DNC008181	N-(quinolin-8-yl)thiophene-2-sulfonamide	Discovery agent	.	.
DNC008182	2-amino-N-(quinolin-8-yl)benzenesulfonamide	Discovery agent	.	.
DNC008183	2-nitro-N-(quinolin-8-yl)benzenesulfonamide	Discovery agent	.	.
DNC008184	4-nitro-N-(quinolin-8-yl)benzenesulfonamide	Discovery agent	.	.
DNC008185	GSK-221149A	Discovery agent	.	.
DNC008185	GSK-221149A	Premature labour	.	O60.1,P07.3
DNC008186	(S)-pyrrolidin-1-yl(pyrrolidin-2-yl)methanone	Discovery agent	.	.
DNC008187	FM1-10	Discovery agent	.	.
DNC008188	FM1-43	Discovery agent	.	.
DNC008189	SACCHARIN	Discovery agent	.	.
DNC008190	2-phenyl-2,3-dihydrobenzo[h]chromen-4-one	Discovery agent	.	.
DNC008191	LIQUIRTIGENIN	Discovery agent	.	.
DNC008192	7-hydroxy-2-(3-hydroxyphenyl)chroman-4-one	Discovery agent	.	.
DNC008193	2-(4-hydroxyphenyl)-7-methoxychroman-4-one	Discovery agent	.	.
DNC008194	2-(3-hydroxyphenyl)-7-methoxychroman-4-one	Discovery agent	.	.
DNC008195	Ohioensin F	Discovery agent	.	.
DNC008196	Ohioensin C	Discovery agent	.	.
DNC008197	OHIOENSIN A	Discovery agent	.	.
DNC008198	Ohioensin G	Discovery agent	.	.
DNC008199	Cbz-Val-Pro-Val-(2-benzoxazole)	Discovery agent	.	.
DNC008200	Ac-Ala-Pro-Val-(2-benzoxazole)	Discovery agent	.	.
DNC008201	PhSO2-Gly-(Me-Gly)-Arg-(2-thiazole)	Discovery agent	.	.
DNC008202	JNJ-28583867	Discovery agent	.	.
DNC008203	1-(1-(4-thiophen-3-ylphenyl)ethyl)-1H-imidazole	Discovery agent	.	.
DNC008204	1-(1-(4-thiophen-3-yl-phenyl)propyl)-1Himidazole	Discovery agent	.	.
DNC008205	4-(benzylideneamino)benzenesulfonamide	Discovery agent	.	.
DNC008206	4-(4-methyl-phenyliminomethyl)-benzenesulfonamide	Discovery agent	.	.
DNC008207	4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide	Discovery agent	.	.
DNC008208	4-phenyliminomethyl-benzenesulfonamide	Discovery agent	.	.
DNC008209	4-(3-hydroxy-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008210	4-(3-methoxy-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008211	4-(4-methoxy-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008212	4-(4-methyl-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008213	4-(4-hydroxy-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008214	4-(3-nitro-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008215	4-(4-nitro-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008216	4-(4-fluoro-benzylideneamino)-benzenesulfonamide	Discovery agent	.	.
DNC008217	Ada-RYYRIK-NH2	Discovery agent	.	.
DNC008218	Bz--RYYRIK-NH2	Discovery agent	.	.
DNC008219	EtBut-RYYRIK-NH2	Discovery agent	.	.
DNC008220	2,2-diMeBut-RYYRIK-NH2	Discovery agent	.	.
DNC008221	T-BuAc-RYYRIK-NH2	Discovery agent	.	.
DNC008222	2-MePen-RYYRIK-NH2	Discovery agent	.	.
DNC008223	Hex-RYYRIK-NH2	Discovery agent	.	.
DNC008224	Piv-RYYRIK-NH2	Discovery agent	.	.
DNC008225	MeBut-RYYRIK-NH2	Discovery agent	.	.
DNC008226	IsoVa-RYYRIK-NH2	Discovery agent	.	.
DNC008227	Va-RYYRIK-NH2	Discovery agent	.	.
DNC008228	IsoBu-RYYRIK-NH2	Discovery agent	.	.
DNC008229	Bu-RYYRIK-NH2	Discovery agent	.	.
DNC008230	Pr-RYYRIK-NH2	Discovery agent	.	.
DNC008231	Ac-RYYRIK-NH2	Discovery agent	.	.
DNC008232	For-RYYRIK-NH2	Discovery agent	.	.
DNC008233	H-RYYRIK-NH2	Discovery agent	.	.
DNC008234	1-(4-(benzyloxy)phenethyl)pyrrolidine	Discovery agent	.	.
DNC008235	1-(2-(naphthalen-2-yl)ethyl)pyrrolidine	Discovery agent	.	.
DNC008236	5-methoxy-2-(2-(pyrrolidin-1-yl)ethyl)-1H-indole	Discovery agent	.	.
DNC008237	2-(2-(pyrrolidin-1-yl)ethyl)-1H-indole	Discovery agent	.	.
DNC008238	(R)-1-(4-methoxyphenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008239	(S)-1-(4-methoxyphenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008240	1-(4-methoxyphenethyl)pyrrolidine	Discovery agent	.	.
DNC008241	(R)-1-(3-methoxyphenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008242	(S)-1-(3-methoxyphenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008243	1-(3-methoxyphenethyl)pyrrolidine	Discovery agent	.	.
DNC008244	(R)-1-(2-methoxyphenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008245	(S)-1-(2-methoxyphenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008246	1-(2-methoxyphenethyl)pyrrolidine	Discovery agent	.	.
DNC008247	(R)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine	Discovery agent	.	.
DNC008248	(S)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine	Discovery agent	.	.
DNC008249	1-(2-p-tolyl-ethyl)-pyrrolidine	Discovery agent	.	.
DNC008250	(R)-2-methyl-1-(2-m-tolyl-ethyl)-pyrrolidine	Discovery agent	.	.
DNC008251	(S)-2-methyl-1-(2-m-tolyl-ethyl)-pyrrolidine	Discovery agent	.	.
DNC008252	1-(2-m-tolyl-ethyl)-pyrrolidine	Discovery agent	.	.
DNC008253	1-[2-(2,4,6-trimethyl-phenyl)-ethyl]-pyrrolidine	Discovery agent	.	.
DNC008254	(R)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)phenol	Discovery agent	.	.
DNC008255	(S)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)phenol	Discovery agent	.	.
DNC008256	2-(2-(pyrrolidin-1-yl)ethyl)phenol	Discovery agent	.	.
DNC008257	(R)-1-(4-nitrophenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008258	(S)-1-(4-nitrophenethyl)-2-methylpyrrolidine	Discovery agent	.	.
DNC008259	1-(4-nitrophenethyl)pyrrolidine	Discovery agent	.	.
DNC008260	5-(2-(pyrrolidin-1-yl)ethyl)isothiazole	Discovery agent	.	.
DNC008261	5-ethyl-2-(2-(pyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008262	(R)-4-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008263	(S)-4-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008264	4-(2-(pyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008265	(R)-3-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008266	(R)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008267	(S)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC008268	N-(2-oxazolemethyl)milnacipran	Discovery agent	.	.
DNC008269	N,Ndimethyl milnacipran	Discovery agent	.	.
DNC008270	2-(2-chlorophenyl)-2,2-diphenylethanamide	Discovery agent	.	.
DNC008271	N,N-dimethyl-2,2,2-triphenylacetamide	Discovery agent	.	.
DNC008272	N-ethyl-2,2,2-triphenylacetamide	Discovery agent	.	.
DNC008273	N-methyl-2,2,2-triphenylacetamide	Discovery agent	.	.
DNC008274	TRIPHENYLMETHANAMINE	Discovery agent	.	.
DNC008275	Triphenylacetic acid methyl ester	Discovery agent	.	.
DNC008276	2-trityl-4,5-dihydrooxazole	Discovery agent	.	.
DNC008277	(2-fluorophenyl)-(4-fluorophenyl)phenylacetamide	Discovery agent	.	.
DNC008278	2,2-bis-(3-fluorophenyl)-2-phenylacetamide	Discovery agent	.	.
DNC008279	4-fluorophenyl-2,2-diphenylacetamide	Discovery agent	.	.
DNC008280	2-fluorophenyl-2,2-diphenylacetamide	Discovery agent	.	.
DNC008281	2,2,2-tris-(3-fluorophenyl)-acetamide	Discovery agent	.	.
DNC008282	2,2-bis-(2-fluorophenyl)-2-phenylacetamide	Discovery agent	.	.
DNC008283	2,2,2-tris-(4-fluorophenyl)-acetamide	Discovery agent	.	.
DNC008284	2-(2,4-difluorophenyl)-2,2-diphenylacetamide	Discovery agent	.	.
DNC008285	2-(3,4-Difluorophenyl)-2,2-diphenylacetamide	Discovery agent	.	.
DNC008286	Bis(4-fluorophenyl)-2-fluorophenylacetamide	Discovery agent	.	.
DNC008287	Bis(4-fluorophenyl)phenylacetamide	Discovery agent	.	.
DNC008288	MERIOLIN 8	Discovery agent	.	.
DNC008289	MERIOLIN 6	Discovery agent	.	.
DNC008290	MERIOLIN 5	Discovery agent	.	.
DNC008291	MERIOLIN 4	Discovery agent	.	.
DNC008292	MERIOLIN 3	Discovery agent	.	.
DNC008293	MERIOLIN 2	Discovery agent	.	.
DNC008294	MERIOLIN 1	Discovery agent	.	.
DNC008295	MERIOLIN 7	Discovery agent	.	.
DNC008296	ADENOSINETRIPHOSPHATE	Discovery agent	.	.
DNC008297	PF-526014	Discovery agent	.	.
DNC008298	N,N-dimethyl(2-phenoxyphenyl)methanamine	Discovery agent	.	.
DNC008299	CEP-18770	Discovery agent	.	.
DNC008300	N-hydroxybenzo[b]thiophene-2-carboxamide	Discovery agent	.	.
DNC008301	BCX-3408	Discovery agent	.	.
DNC008302	Cis-2-aminocyclohexylcarbamoylphosphonic acid	Discovery agent	.	.
DNC008303	2-methoxyestrrone-3-O-sulfamate	Discovery agent	.	.
DNC008304	CP-316311	Discovery agent	.	.
DNC008305	H-Tyr-D-Ala-Gly Phe-Pro-Leu-Trp-O-3,5-Bzl(CF3)2	Discovery agent	.	.
DNC008306	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NMe-3,5-Bzl(CF3)2	Discovery agent	.	.
DNC008307	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NH-3,5-Bzl(CF3)2	Discovery agent	.	.
DNC008308	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NMe-Bzl	Discovery agent	.	.
DNC008309	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NH-Bzl	Discovery agent	.	.
DNC008310	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-O-Bzl	Discovery agent	.	.
DNC008311	3-chloro-4-(4-hydroxyphenyl)salicylaldoxime	Discovery agent	.	.
DNC008312	A-740003	Discovery agent	.	.
DNC008313	Octanoic acid biphenyl-2-ylamide	Discovery agent	.	.
DNC008314	Nonanoic acid biphenyl-2-ylamide	Discovery agent	.	.
DNC008315	(Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide	Discovery agent	.	.
DNC008316	1-(oxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC008317	1-(oxazol-2-yl)-4-(piperidin-4-yl)butan-1-one	Discovery agent	.	.
DNC008318	2-(methylsulfonylthio)ethyl 2-propylpentanoate	Discovery agent	.	.
DNC008319	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione	Discovery agent	.	.
DNC008320	Cyclo-[-Arg-Gly-Asp-Amp21-]	Discovery agent	.	.
DNC008321	Cyclo-[-Arg-Gly-Asp-Amp26-]	Discovery agent	.	.
DNC008322	Cyclo-[-Arg-Gly-Asp-Amp22-]	Discovery agent	.	.
DNC008323	Cyclo-[-Arg-Gly-Asp-Amp23-]	Discovery agent	.	.
DNC008324	Cyclo-[-Arg-Gly-Asp-Amp24-]	Discovery agent	.	.
DNC008325	Cyclo-[-Arg-Gly-Asp-Amp27-]	Discovery agent	.	.
DNC008326	Cyclo-[-Arg-Gly-Asp-Amp28-]	Discovery agent	.	.
DNC008327	Cyclo-[-Arg-Gly-Asp-Amp25-]	Discovery agent	.	.
DNC008328	4-ethynyl benzene sulfonamide	Discovery agent	.	.
DNC008329	A-796260	Discovery agent	.	.
DNC008329	A-796260	Pain	338,780	R52, G89
DNC008330	AM-1241	Discovery agent	.	.
DNC008331	SK&F-96365	Discovery agent	.	.
DNC008332	N-(3,4-dihydroxybenzyl)oleamide	Discovery agent	.	.
DNC008333	N-hydroxy-4-(oleamidomethyl)benzamide	Discovery agent	.	.
DNC008334	5-(2-oxoindolin-5-yl)-1H-pyrrole-2-carbonitrile	Discovery agent	.	.
DNC008335	3-(3,3-dimethyl-2-oxoindolin-5-yl)benzonitrile	Discovery agent	.	.
DNC008336	WAY-255348	Cancer	.	C00-C97
DNC008336	WAY-255348	Discovery agent	.	.
DNC008337	2,3-dichloro-1,4-naphthoquinone	Discovery agent	.	.
DNC008338	2,2-dimethyl-2H-benzo[g]chromene-5,10-dione	Discovery agent	.	.
DNC008339	JUGLONE	Discovery agent	.	.
DNC008340	1,4-naphtho-quinone	Discovery agent	.	.
DNC008341	2-methoxy-1,4-naphthoquinone	Discovery agent	.	.
DNC008342	BIRB796	Discovery agent	.	.
DNC008343	(5-phenyl-3H-benzo[d]imidazol-4-yl)methanamine	Discovery agent	.	.
DNC008344	CP-320626	Discovery agent	.	.
DNC008345	ANALOGUE A	Discovery agent	.	.
DNC008346	ER-119884	Discovery agent	.	.
DNC008347	2-(2-(2,6-dimethylphenylamino)phenyl)acetic acid	Discovery agent	.	.
DNC008348	2-(2,4-dichlorophenoxy)-5-(3-phenylpropyl)phenol	Discovery agent	.	.
DNC008349	2-(2,4-dichlorophenoxy)-5-phenethylphenol	Discovery agent	.	.
DNC008350	5-benzyl-2-(2,4-dichlorophenoxy)phenol	Discovery agent	.	.
DNC008351	4-(2,4-dichloro-phenoxy)-4'-fluoro-biphenyl-3-ol	Discovery agent	.	.
DNC008352	4-(2,4-dichlorophenoxy)-4'-methylbiphenyl-3-ol	Discovery agent	.	.
DNC008353	4-(2,4-dichlorophenoxy)-3'-methylbiphenyl-3-ol	Discovery agent	.	.
DNC008354	4-(2,4-dichloro-phenoxy)-2'-methyl-biphenyl-3-ol	Discovery agent	.	.
DNC008355	2-(2,4-dichlorophenoxy)-5-isopentylphenol	Discovery agent	.	.
DNC008356	2-(2,4-dichlorophenoxy)-5-(2-methylbutyl)phenol	Discovery agent	.	.
DNC008357	2-(2,4-dichlorophenoxy)-5-isobutylphenol	Discovery agent	.	.
DNC008358	5-butyl-2-(2,4-dichlorophenoxy)phenol	Discovery agent	.	.
DNC008359	2-(2,4-dichlorophenoxy)-5-propylphenol	Discovery agent	.	.
DNC008360	2-(2,4-dichlorophenoxy)-5-ethylphenol	Discovery agent	.	.
DNC008361	4-(2,4-dichlorophenoxy)-3-hydroxybenzonitrile	Discovery agent	.	.
DNC008362	4-(2,4-dichloro-phenoxy)-biphenyl-3-ol	Discovery agent	.	.
DNC008363	2-(2,4-dichlorophenoxy)-5-methylphenol	Discovery agent	.	.
DNC008364	JWH-385	Discovery agent	.	.
DNC008365	JWH-345	Discovery agent	.	.
DNC008366	JWH-337	Discovery agent	.	.
DNC008367	JWH-344	Discovery agent	.	.
DNC008368	JWH-325	Discovery agent	.	.
DNC008369	JWH-392	Discovery agent	.	.
DNC008370	JWH-343	Discovery agent	.	.
DNC008371	JWH-402	Discovery agent	.	.
DNC008372	JWH-405	Discovery agent	.	.
DNC008373	JWH-342	Discovery agent	.	.
DNC008374	JWH-406	Discovery agent	.	.
DNC008375	JWH-407	Discovery agent	.	.
DNC008376	JWH-297	Discovery agent	.	.
DNC008377	JWH-295	Discovery agent	.	.
DNC008378	JWH-401	Discovery agent	.	.
DNC008379	JWH-404	Discovery agent	.	.
DNC008380	JWH-324	Discovery agent	.	.
DNC008381	JWH-403	Discovery agent	.	.
DNC008382	JWH-323	Discovery agent	.	.
DNC008383	JWH-296	Discovery agent	.	.
DNC008384	JWH-294	Discovery agent	.	.
DNC008385	Ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate	Discovery agent	.	.
DNC008386	YM-348	Discovery agent	.	.
DNC008387	(2S)-1-(1H-furo[2,3-g]indazol-1-yl)propan-2-amine	Discovery agent	.	.
DNC008388	(2S)-1-(6-fluoro-1H-indazol-1-yl)propan-2-amine	Discovery agent	.	.
DNC008389	(2S)-1-(5-fluoro-1H-indazol-1-yl)propan-2-amine	Discovery agent	.	.
DNC008390	4-(4'-Benzamidoanilino)-6,7-dimethoxyquinazoline	Discovery agent	.	.
DNC008391	AS-601245	Discovery agent	.	.
DNC008392	HTS-05058	Discovery agent	.	.
DNC008393	LFM-A13	Discovery agent	.	.
DNC008394	SP-600125	Discovery agent	.	.
DNC008395	Bornyl (3,4,5-trihydroxy)-cinnamate	Discovery agent	.	.
DNC008396	7,8,9,10-tetrahydro-6H-furo-[3,2-g][3]benzazepine	Discovery agent	.	.
DNC008397	7,8,9,10-tetrahydro-6H-furo-[2,3-g][3]benzazepine	Discovery agent	.	.
DNC008398	6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine	Discovery agent	.	.
DNC008399	MINALRESTAT	Diabetes mellitus	.	E10-E14
DNC008399	MINALRESTAT	Discovery agent	.	.
DNC008400	QUERCITRIN	Discovery agent	.	.
DNC008401	FALCARINDIOL	Discovery agent	.	.
DNC008402	ANISOCOUMARIN H	Discovery agent	.	.
DNC008403	ULIPRISTAL ACETATE	Discovery agent	.	.
DNC008404	2-Amino-4,6-diphenyl-pyrimidine	Discovery agent	.	.
DNC008405	2-Amino-4,6-diphenyl-pyrimidin-5-carbonitrile	Discovery agent	.	.
DNC008406	4-Amino-2,6-diphenyl-pyrimidine-5-carbonitrile	Discovery agent	.	.
DNC008407	2,6-Diphenyl-pyrimidin-4-ylamine	Discovery agent	.	.
DNC008408	5-methylenearisteromycin	Discovery agent	.	.
DNC008409	ARISTEROMYCIN	Discovery agent	.	.
DNC008410	NORARISTEROMYCIN	Discovery agent	.	.
DNC008411	4,12,17-dehydroxyriccardin C	Discovery agent	.	.
DNC008412	4,17-dehydroxyriccardin C	Discovery agent	.	.
DNC008413	12,17-dehydroxyriccardin C	Discovery agent	.	.
DNC008414	4-dehydroxyriccardin C	Discovery agent	.	.
DNC008415	12-dehydroxyriccardin C	Discovery agent	.	.
DNC008416	17-dehydroxyriccardin C	Discovery agent	.	.
DNC008417	Riccardin C	Discovery agent	.	.
DNC008418	MURAGLITAZAR	Discovery agent	.	.
DNC008418	MURAGLITAZAR	Metabolic disorders	.	E70-E90
DNC008419	THEBAINE	Discovery agent	.	.
DNC008420	CODEINONE	Discovery agent	.	.
DNC008421	ORIPAVINE	Discovery agent	.	.
DNC008422	MORPHINONE	Discovery agent	.	.
DNC008423	LGD-5552	Discovery agent	.	.
DNC008424	2,3-dihydroxypropanal	Discovery agent	.	.
DNC008425	CVT-6883	Asthma	.	J45
DNC008425	CVT-6883	Discovery agent	.	.
DNC008426	2-(3-hydroxyphenyl)quinolin-6-ol	Discovery agent	.	.
DNC008427	3-(3-hydroxyphenyl)quinolin-7-ol	Discovery agent	.	.
DNC008428	5-(6-hydroxy-2-naphthyl)pyridin-3-ol	Discovery agent	.	.
DNC008429	3-(6-hydroxy-2-naphthyl)benzoic acid	Discovery agent	.	.
DNC008430	3-(2-naphthyl)phenol	Discovery agent	.	.
DNC008431	Piridronic acid	Discovery agent	.	.
DNC008432	NE-10575	Discovery agent	.	.
DNC008433	YM-175	Discovery agent	.	.
DNC008434	NERIDRONIC ACID	Bone disease	.	M00-M99
DNC008434	NERIDRONIC ACID	Discovery agent	.	.
DNC008435	N,N'-(1',10'-decylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC008436	N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC008437	MK-0364	Discovery agent	.	.
DNC008438	VUF-10148	Discovery agent	.	.
DNC008439	VUF-10214	Discovery agent	.	.
DNC008440	4-butyl-N-(pyridin-3-yl)benzamide	Discovery agent	.	.
DNC008441	4-(cyclohexylamino)-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008442	4-(methyl(nonyl)amino)-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008443	4-(methyl(octyl)amino)-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008444	4-(hexyl(methyl)amino)-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008445	4-(butyl(methyl)amino)-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008446	4-tert-butyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008447	4-nonyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008448	4-octyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008449	4-heptyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008450	4-hexyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008451	4-propyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008452	4-butyl-N-(quinolin-3-yl)benzamide	Discovery agent	.	.
DNC008453	4-butyl-N-(isoquinolin-5-yl)benzamide	Discovery agent	.	.
DNC008454	4-butyl-N-(7-hydroxynaphthalen-1-yl)benzamide	Discovery agent	.	.
DNC008455	4-butyl-N-phenylbenzamide	Discovery agent	.	.
DNC008456	2-(4-pentylphenyl)-N-(pyridin-3-yl)acetamide	Discovery agent	.	.
DNC008457	N-methyl-4-pentyl-N-(pyridin-3-yl)benzamide	Discovery agent	.	.
DNC008458	4-decyl-N-(pyridin-3-yl)benzamide	Discovery agent	.	.
DNC008459	4-octyl-N-(pyridin-3-yl)benzamide	Discovery agent	.	.
DNC008460	4-pentyl-N-pyridin-3-yl benzamide	Discovery agent	.	.
DNC008461	4-heptyl-N-(pyridin-3-yl)benzamide	Discovery agent	.	.
DNC008462	BMS-645737	Discovery agent	.	.
DNC008463	AZUMAMIDE E	Discovery agent	.	.
DNC008464	AZUMAMIDE C	Discovery agent	.	.
DNC008465	AZUMAMIDE B	Discovery agent	.	.
DNC008466	Phenyl(2-(trifluoromethyl)quinolin-4-yl)methanol	Discovery agent	.	.
DNC008467	2-chloro-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008468	2-chloro-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008469	4-(thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine	Discovery agent	.	.
DNC008470	4-(furan-2-yl)thieno[3,2-d]pyrimidin-2-amine	Discovery agent	.	.
DNC008471	2-ethyl-4-(pyridin-2-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008472	2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008473	2-ethyl-4-(furan-3-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008474	2-ethyl-4-(furan-2-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008475	2-ethyl-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC008476	2-amino-N-benzyl-6-phenyl-9H-purine-9-carboxamide	Discovery agent	.	.
DNC008477	9-(3-aminobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	Discovery agent	.	.
DNC008478	9-(4-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	Discovery agent	.	.
DNC008479	9-(3-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	Discovery agent	.	.
DNC008480	6-(furan-2-yl)-9H-purin-2-amine	Discovery agent	.	.
DNC008481	4-(furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine	Discovery agent	.	.
DNC008482	1-(1,3-diphenylpropylidene)thiosemicarbazide	Discovery agent	.	.
DNC008483	1-(phenyl(p-tolyl)methylene)thiosemicarbazide	Discovery agent	.	.
DNC008484	5-Biphenyl-4-ylmethyl-2-isobutyl-2H-tetrazole	Discovery agent	.	.
DNC008485	5-Biphenyl-4-ylmethyl-1-isobutyl-1H-tetrazole	Discovery agent	.	.
DNC008486	FIG 1	Discovery agent	.	.
DNC008487	MERCK-544	Discovery agent	.	.
DNC008488	1-(3,4-dichlorophenyl)-3-(3,5-dichlorophenyl)urea	Discovery agent	.	.
DNC008489	5-hexyl-2-phenoxyphenol	Discovery agent	.	.
DNC008490	5-hexyl-2-(pyridin-2-yloxy)phenol	Discovery agent	.	.
DNC008491	5-hexyl-2-(pyrazin-2-yloxy)phenol	Discovery agent	.	.
DNC008492	5-hexyl-2-(pyrimidin-2-yloxy)phenol	Discovery agent	.	.
DNC008493	5-hexyl-2-(pyridin-4-yloxy)phenol	Discovery agent	.	.
DNC008494	5-hexyl-2-(pyridin-3-yloxy)phenol	Discovery agent	.	.
DNC008495	N-(4-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide	Discovery agent	.	.
DNC008496	N-(3-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide	Discovery agent	.	.
DNC008497	N-(2-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide	Discovery agent	.	.
DNC008498	2-(4-aminophenoxy)-5-hexylphenol	Discovery agent	.	.
DNC008499	2-(3-aminophenoxy)-5-hexylphenol	Discovery agent	.	.
DNC008500	2-(2-aminophenoxy)-5-hexylphenol	Discovery agent	.	.
DNC008501	5-hexyl-2-(4-nitrophenoxy)phenol	Discovery agent	.	.
DNC008502	5-hexyl-2-(3-nitrophenoxy)phenol	Discovery agent	.	.
DNC008503	5-hexyl-2-(2-nitrophenoxy)phenol	Discovery agent	.	.
DNC008504	2-(4-hexyl-2-methoxyphenoxy)pyrimidine	Discovery agent	.	.
DNC008505	2-(4,6-dimethoxypyrimidin-2-yloxy)-5-hexylphenol	Discovery agent	.	.
DNC008506	ICI-199441	Discovery agent	.	.
DNC008507	DYNORPHIN A	Discovery agent	.	.
DNC008508	PH-709829	Discovery agent	.	.
DNC008509	PARABEN	Discovery agent	.	.
DNC008510	SALICYLATE	Discovery agent	.	.
DNC008511	4-CYANOPHENOL	Discovery agent	.	.
DNC008512	RESORCINOL	Discovery agent	.	.
DNC008513	CATECHOL	Discovery agent	.	.
DNC008514	2-(4-tosylpiperazin-1-yl)nicotinonitrile	Discovery agent	.	.
DNC008515	1-(3-nitropyridin-2-yl)-4-tosylpiperazine	Discovery agent	.	.
DNC008516	1-(3-chloropyridin-2-yl)-4-tosylpiperazine	Discovery agent	.	.
DNC008517	1-(3-methylpyridin-2-yl)-4-tosylpiperazine	Discovery agent	.	.
DNC008518	10-hydroxy-18-methoxybetaenone	Discovery agent	.	.
DNC008519	ISAINDIGOTONE	Discovery agent	.	.
DNC008520	PF-228	Discovery agent	.	.
DNC008521	Olean-12-en-3beta,15alpha-diol	Discovery agent	.	.
DNC008522	LUPEOL	Discovery agent	.	.
DNC008523	QNEQCPQVSac	Discovery agent	.	.
DNC008524	QCPac	Discovery agent	.	.
DNC008525	QSPac	Discovery agent	.	.
DNC008526	QCP	Discovery agent	.	.
DNC008527	8-chloro-quinoline-3-carbonitrile	Discovery agent	.	.
DNC008528	N-(2-(5-methoxybenzofuran-3-yl)ethyl)acetamide	Discovery agent	.	.
DNC008529	5-methoxycarbonylamino-N-acetyltryptamine	Discovery agent	.	.
DNC008530	BOLINAQUINONE	Discovery agent	.	.
DNC008531	DYSIDINE	Discovery agent	.	.
DNC008532	2-Amino-N-[4-(phenylmethoxy)phenyl]-acetamide	Discovery agent	.	.
DNC008533	N1-[4-(Phenylmethoxy)phenyl]-L-aspartamine	Discovery agent	.	.
DNC008534	N1-[4-(Phenylmethoxy)phenyl]-L-glutamine	Discovery agent	.	.
DNC008535	N5-[4-(Phenylmethoxy)phenyl]-D-glutamine	Discovery agent	.	.
DNC008536	N5-[4-(Phenylmethoxy)phenyl]-L-glutamine	Discovery agent	.	.
DNC008537	N4-[4-(Phenylmethoxy)phenyl]-L-aspartamine	Discovery agent	.	.
DNC008538	N1-[4-(Phenylmethoxy)phenyl]-D-aspartamine	Discovery agent	.	.
DNC008539	N1-[4-(Phenylmethoxy)phenyl]-D-glutamine	Discovery agent	.	.
DNC008540	4-Amino-N-[4-(phenylmethoxy)phenyl]butanamide	Discovery agent	.	.
DNC008541	N5-[4-(Phenylmethoxy)phenyl]-L-glutamamide	Discovery agent	.	.
DNC008542	N5-[4-(2-Oxo-3-phenylpropoxy)phenyl]-L-glutamine	Discovery agent	.	.
DNC008543	N5-[4-(3-Phenylpropoxy)phenyl]-L-glutamine	Discovery agent	.	.
DNC008544	N5-[4-(2-phenylethoxy)phenyl]-L-glutamine	Discovery agent	.	.
DNC008545	N5-[4-(N-Phenylamino)phenyl]-L-glutamine	Discovery agent	.	.
DNC008546	N5-[4-Benzylphenyl]-L-glutamamide	Discovery agent	.	.
DNC008547	N5-(4-Phenoxyphenyl)-L-glutamine	Discovery agent	.	.
DNC008548	N5-[(4-Phenoxy)-3-pyridyl]-L-glutamamide	Discovery agent	.	.
DNC008549	N5-[4-(1H-pyrrol-1-yl)phenyl]-L-glutamamide	Discovery agent	.	.
DNC008550	N6-[4-(4-methylphenoxy)phenyl]-L-homoglutamine	Discovery agent	.	.
DNC008551	N5-[4-(4-(3-Furyl)phenoxy)phenyl]-L-glutamamide	Discovery agent	.	.
DNC008552	N5-[4-(4-methylphenoxy)phenyl]-L-glutamamide	Discovery agent	.	.
DNC008553	N5-[4-(3-methylphenoxy)phenyl]-L-glutamamide	Discovery agent	.	.
DNC008554	N5-[4-(2-methylphenoxy)phenyl]-L-glutamamide	Discovery agent	.	.
DNC008555	4S-4,5-Diamino-N-(4-phenoxyphenyl)pentanamide	Discovery agent	.	.
DNC008556	(R)-ONDANSETRON	Discovery agent	.	.
DNC008557	(5Z,9Z)-5,9-heptacosadienoic acid	Discovery agent	.	.
DNC008558	4',5,7-trihydroxy-6,8-dimethylisoflavone	Discovery agent	.	.
DNC008559	TOPOSTATIN	Discovery agent	.	.
DNC008560	PIROXANTRONE	Cancer	.	C00-C97
DNC008560	PIROXANTRONE	Discovery agent	.	.
DNC008561	LOSOXANTRONE	Breast cancer	.	C50
DNC008561	LOSOXANTRONE	Discovery agent	.	.
DNC008562	6-Hydroxy-5,7-dimethyl-beta-carboline	Discovery agent	.	.
DNC008563	8-Hydroxy-5,7,9-trimethyl-delta-carboline	Discovery agent	.	.
DNC008564	8-Hydroxy-7,9-dimethyl-delta-carboline	Discovery agent	.	.
DNC008565	EM1396	Discovery agent	.	.
DNC008566	EM-1424	Discovery agent	.	.
DNC008567	NAVPNLRGDLQVLAQKVART	Discovery agent	.	.
DNC008568	5'-(N-ethyl-N-isopropyl)amiloride	Discovery agent	.	.
DNC008569	(S-(2-oxo)pentadecyl-CoA)	Discovery agent	.	.
DNC008570	AP-21967	Discovery agent	.	.
DNC008571	C-16-(S)-3-methylindolerapamycin	Discovery agent	.	.
DNC008572	RPKPfQwFwLL-NH2	Discovery agent	.	.
DNC008573	WFwGG-NH2	Discovery agent	.	.
DNC008574	QwFwLL-NH2	Discovery agent	.	.
DNC008575	AwFwLL-NH2	Discovery agent	.	.
DNC008576	DwFwLL-NH2	Discovery agent	.	.
DNC008577	DprwFwLL-NH2	Discovery agent	.	.
DNC008578	HwFwLL-NH2	Discovery agent	.	.
DNC008579	RwFwLL-NH2	Discovery agent	.	.
DNC008580	KwFwLL-NH2	Discovery agent	.	.
DNC008581	WFwLL-NH2	Discovery agent	.	.
DNC008582	Aloxistatin	Discovery agent	.	.
DNC008582	Aloxistatin	Neurological disease	.	G00-G99
DNC008583	ALBANOL A	Discovery agent	.	.
DNC008584	MORACHALCONE A	Discovery agent	.	.
DNC008585	Broussoflavonol F	Discovery agent	.	.
DNC008586	(2S)-euchrenone a7	Discovery agent	.	.
DNC008587	(2S)-5,7,2',4'-tetrahydroxyflavanone	Discovery agent	.	.
DNC008588	(2S)-abyssinone II	Discovery agent	.	.
DNC008589	ISOLICOFLAVONOL	Discovery agent	.	.
DNC008590	Isogemichalcone C	Discovery agent	.	.
DNC008591	DEMETHYLZEYLASTERONE	Discovery agent	.	.
DNC008592	(S)-benzyl 4-chloro-3-oxobutan-2-ylcarbamate	Discovery agent	.	.
DNC008593	4-(4-(2-nitrovinyl)phenoxysulfonyl)benzoic acid	Discovery agent	.	.
DNC008594	4-(2-nitrovinyl)phenol	Discovery agent	.	.
DNC008595	RG-50810	Discovery agent	.	.
DNC008596	AG-213	Discovery agent	.	.
DNC008597	2-methoxy-4-(2-nitrovinyl)phenol	Discovery agent	.	.
DNC008598	4-(2-nitroprop-1-enyl)benzene-1,2-diol	Discovery agent	.	.
DNC008599	4-(2-nitrovinyl)benzene-1,2-diol	Discovery agent	.	.
DNC008600	5-octyl-2-phenoxyphenol	Discovery agent	.	.
DNC008601	1H-indole-4,7-dione	Discovery agent	.	.
DNC008602	Exiguamine A	Discovery agent	.	.
DNC008603	ANNULIN C	Discovery agent	.	.
DNC008604	USIMINE A	Discovery agent	.	.
DNC008605	USNIC ACID	Discovery agent	.	.
DNC008606	ENDOMORPHIN-1	Discovery agent	.	.
DNC008607	YGWFL-NH2	Discovery agent	.	.
DNC008608	Ac-YGGFL-NH2	Discovery agent	.	.
DNC008609	YGGWL-NH2	Discovery agent	.	.
DNC008610	[LEU5]ENKEPHALIN	Discovery agent	.	.
DNC008611	YPAA-NH2	Discovery agent	.	.
DNC008612	YAWF-NH2	Discovery agent	.	.
DNC008613	H-Tyr-Pro-Ala-Phe-NH2	Discovery agent	.	.
DNC008614	YPWA-NH2	Discovery agent	.	.
DNC008615	(4-sulfamoylphenylethylthioureido)fluorescein	Discovery agent	.	.
DNC008616	IPRONIAZIDE	Discovery agent	.	.
DNC008617	3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC008618	3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC008619	5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol	Discovery agent	.	.
DNC008620	3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine	Discovery agent	.	.
DNC008621	6-(4-Methylpyridin-3-yl)-2-naphthonitrile	Discovery agent	.	.
DNC008622	3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine	Discovery agent	.	.
DNC008623	3-(6-Methoxy-3-methylnaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC008624	4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline	Discovery agent	.	.
DNC008625	4-(6-Methoxynaphthalen-2-yl)isoquinoline	Discovery agent	.	.
DNC008626	3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine	Discovery agent	.	.
DNC008627	2-(1-Imidazol-1-yl-ethyl)-9H-carbazole	Discovery agent	.	.
DNC008628	1-((9H-Fluoren-2-yl)ethyl)-1H-imidazole	Discovery agent	.	.
DNC008629	1-((9H-Fluoren-2-yl)methyl)-1H-imidazole	Discovery agent	.	.
DNC008630	7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol	Discovery agent	.	.
DNC008631	1-(1-(Biphenyl-4-yl)allyl)-1H-imidazole	Discovery agent	.	.
DNC008632	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-4-ol	Discovery agent	.	.
DNC008633	1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole	Discovery agent	.	.
DNC008634	1-(Bis-biphenyl-4-yl-methyl)-1H-imidazole	Discovery agent	.	.
DNC008635	1-(1-Biphenyl-4-yl-2-phenyl-ethyl)-1H-imidazole	Discovery agent	.	.
DNC008636	1-(1-Biphenyl-4-yl-3-methyl-butyl)-1H-imidazole	Discovery agent	.	.
DNC008637	1-(1-Biphenyl-4-yl-pentyl)-1H-imidazole	Discovery agent	.	.
DNC008638	1-(1-Biphenyl-4-yl-2-methyl-propyl)-1H-imidazole	Discovery agent	.	.
DNC008639	1-(1-Biphenyl-4-yl-butyl)-1H-imidazole	Discovery agent	.	.
DNC008640	1-(1-Biphenyl-4-yl-propyl)-1H-imidazole	Discovery agent	.	.
DNC008641	1-(1-Biphenyl-4-yl-ethyl)-1H-imidazole	Discovery agent	.	.
DNC008642	NSC-87877	Discovery agent	.	.
DNC008643	CONESSINE	Discovery agent	.	.
DNC008644	ICARIIN	Discovery agent	.	.
DNC008645	3,7-Bis(2-hydroxyethyl)icaritin	Discovery agent	.	.
DNC008646	7-(2-Hydroxyethyl)-3-O-rhamnosylicariin	Discovery agent	.	.
DNC008647	ICARITIN	Breast cancer	.	C50
DNC008647	ICARITIN	Discovery agent	.	.
DNC008648	Icariside II	Discovery agent	.	.
DNC008649	8-prenylquercetin	Discovery agent	.	.
DNC008650	8-prenylapigenin	Discovery agent	.	.
DNC008651	4,5-Bis(4-methoxyphenyl)-1,2-selenazole	Discovery agent	.	.
DNC008652	4,5-Bis(4-chlorophenyl)-1,2-selenazole	Discovery agent	.	.
DNC008653	4-(4-Chlorophenyl)-5-p-tolyl-1,2-selenazole	Discovery agent	.	.
DNC008654	5-(4-Chlorophenyl)-4-p-tolyl-1,2-selenazole	Discovery agent	.	.
DNC008655	5-(4-Methoxyphenyl)-4-p-tolyl-1,2-selenazole	Discovery agent	.	.
DNC008656	(-)-DEBROMOFLUSTRAMINE B	Discovery agent	.	.
DNC008657	DEMETHYLDEBROMOFLUSTRAMINE B	Discovery agent	.	.
DNC008658	(+/-)-DEBROMOFLUSTRAMINE B	Discovery agent	.	.
DNC008659	Dideazaacyclotetrahydrofolic acid	Discovery agent	.	.
DNC008660	JNJ-1661010	Discovery agent	.	.
DNC008661	((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine	Discovery agent	.	.
DNC008662	NISOXETINE	Discovery agent	.	.
DNC008663	MDL-28618	Discovery agent	.	.
DNC008664	BMS-694153	Discovery agent	.	.
DNC008664	BMS-694153	Migraine	346	G43
DNC008665	SR-125543A	Discovery agent	.	.
DNC008666	MK-0354	Discovery agent	.	.
DNC008667	3-(4H-Imidazol-4-yl)benzenethiol	Discovery agent	.	.
DNC008668	3-(1H-Imidazol-4-yl)benzenethiol	Discovery agent	.	.
DNC008669	2-(1H-Imidazol-4-yl)benzene-1,3-diol	Discovery agent	.	.
DNC008670	2-(1H-Imidazol-4-yl)phenol	Discovery agent	.	.
DNC008671	4-Phenylimidazole	Discovery agent	.	.
DNC008672	Dehydropipernonaline	Discovery agent	.	.
DNC008673	Pellitorin	Discovery agent	.	.
DNC008674	PIPERROLEIN B	Discovery agent	.	.
DNC008675	PIPERNONALINE	Discovery agent	.	.
DNC008676	N4,N6-dibenzylpyrimidine-4,6-dicarboxamide	Discovery agent	.	.
DNC008677	L-1-amino-4-phosphonobutanoic acid	Discovery agent	.	.
DNC008678	(S,S)-reboxetine	Discovery agent	.	.
DNC008679	PTR-3046	Discovery agent	.	.
DNC008680	3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate	Discovery agent	.	.
DNC008681	NSC-289311	Discovery agent	.	.
DNC008682	NSC-368272	Discovery agent	.	.
DNC008683	NSC-368280	Discovery agent	.	.
DNC008684	NSC-625409	Discovery agent	.	.
DNC008685	NSC-666292	Discovery agent	.	.
DNC008686	NSC-356483	Discovery agent	.	.
DNC008687	NSC-12999	Discovery agent	.	.
DNC008688	NSC-131736	Discovery agent	.	.
DNC008689	NSC-356781	Discovery agent	.	.
DNC008690	NSC-683634	Discovery agent	.	.
DNC008691	NSC-75308	Discovery agent	.	.
DNC008692	5-((1H-imidazol-1-yl)methyl)-7,8-dihydroquinoline	Discovery agent	.	.
DNC008693	5-(2-(1H-imidazol-1-yl)ethyl)quinoline	Discovery agent	.	.
DNC008694	7-((1H-imidazol-1-yl)methyl)isoquinoline	Discovery agent	.	.
DNC008695	1-(2-(benzo[b]thiophen-4-yl)ethyl)-1H-imidazole	Discovery agent	.	.
DNC008696	NSC-369087	Discovery agent	.	.
DNC008697	7-hydroxy-3-phenyl-2H-chromen-2-one	Discovery agent	.	.
DNC008698	3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one	Discovery agent	.	.
DNC008699	Benzofuran-2-yl(indolin-1-yl)methanone	Discovery agent	.	.
DNC008700	3-acetyl-7-hydroxy-2H-chromen-2-one	Discovery agent	.	.
DNC008701	4-iodo-6-phenylpyrimidine	Discovery agent	.	.
DNC008702	Ethyl 7-hydroxy-2-oxo-2H-chromene-3-carboxylate	Discovery agent	.	.
DNC008703	2-(4-hydroxystyryl)quinolin-8-ol	Discovery agent	.	.
DNC008704	3-(1H-pyrazol-3-yl)benzoic acid	Discovery agent	.	.
DNC008705	Azithromycinarylalkylhydroxamic Acid	Discovery agent	.	.
DNC008706	Desclasinose Azithromycinarylalkyl Hydroxamate	Discovery agent	.	.
DNC008707	Azithromycin-N-benzyltriazolylhexahydroxamic Acid	Discovery agent	.	.
DNC008708	Azithromycin-N-benzyltriazolyloctahydroxamic Acid	Discovery agent	.	.
DNC008709	Azithromycin-N-benzyltriazolylnonahydroxamic Acid	Discovery agent	.	.
DNC008710	Azithromycin-N-benzyltriazolyldecahydroxamic Acid	Discovery agent	.	.
DNC008711	GNF-PF-5188	Discovery agent	.	.
DNC008712	N1-(4-bromophenyl)-N2,N2-dipentylphthalamide	Discovery agent	.	.
DNC008713	AM-1714	Discovery agent	.	.
DNC008714	JWH-120	Discovery agent	.	.
DNC008715	JWH-151	Discovery agent	.	.
DNC008716	JWH-229	Discovery agent	.	.
DNC008717	JWH-268	Discovery agent	.	.
DNC008718	ABT-888	Breast cancer	.	C50
DNC008718	ABT-888	Discovery agent	.	.
DNC008719	(biphenyl-3-ylamino)methylenediphosphonic acid	Discovery agent	.	.
DNC008720	BENZOYLENUREA	Discovery agent	.	.
DNC008721	3-(2-Bromophenyl)-2-thioxo-(1H )-quinazolin-4-one	Discovery agent	.	.
DNC008722	2,5-bis(4-hydroxybenzylidene)cyclopentanone	Discovery agent	.	.
DNC008723	Go-Y026	Discovery agent	.	.
DNC008724	1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one	Discovery agent	.	.
DNC008725	Go-Y022	Discovery agent	.	.
DNC008726	4-isopropyl-2-(phenoxymethyl)morpholine	Discovery agent	.	.
DNC008727	2-((2-ethoxyphenoxy)methyl)-4-isopropylmorpholine	Discovery agent	.	.
DNC008728	4,6-Dinitro salicylic acid	Discovery agent	.	.
DNC008729	5-Chlorosalicylic Acid	Discovery agent	.	.
DNC008730	9-(Aminomethyl)-9,10-dihydroanthracene	Discovery agent	.	.
DNC008731	1-methoxy-9-aminomethyl-9,10-dihydroanthracene	Discovery agent	.	.
DNC008732	2-methoxy-9-aminomethyl-9,10-dihydroanthracene	Discovery agent	.	.
DNC008733	3-methoxy-9-aminomethyl-9,10-dihydroanthracene	Discovery agent	.	.
DNC008734	4-methoxy-9-aminomethyl-9,10-dihydroanthracene	Discovery agent	.	.
DNC008735	N6-[(4-Amino)-phenyl]-9-benzyl-2-phenyladenine	Discovery agent	.	.
DNC008736	N6-[(4-Nitro)-phenyl]-9-benzyl-2-phenyladenine	Discovery agent	.	.
DNC008737	N5-(1-iminobut-3-enyl)-L-ornithine	Discovery agent	.	.
DNC008738	N5-(1-iminobutyl)-L-ornithine	Discovery agent	.	.
DNC008739	N5-(1-iminopropyl)-L-ornithine	Discovery agent	.	.
DNC008740	N-omega-allyl-L-arginine	Discovery agent	.	.
DNC008741	N-omega-propargyl-L-arginine	Discovery agent	.	.
DNC008742	MPrP	Discovery agent	.	.
DNC008743	(S)-Norfluoxetine	Discovery agent	.	.
DNC008744	(R)-Norfluoxetine	Discovery agent	.	.
DNC008745	CYCLAZOCINE	Discovery agent	.	.
DNC008746	3-desoxy-3-carboxamidonaltrexone	Discovery agent	.	.
DNC008747	METAZOCINE	Discovery agent	.	.
DNC008748	PHENAZOCINE	Discovery agent	.	.
DNC008749	MR-2034	Discovery agent	.	.
DNC008750	KETOCYCLAZOCINE	Discovery agent	.	.
DNC008751	Naltrexone-6-beta-ol	Discovery agent	.	.
DNC008752	Naltrexone-6-alpha-ol	Discovery agent	.	.
DNC008753	CARIPORIDE METHYLSULFONATE	Discovery agent	.	.
DNC008754	4-(isopropylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008755	4-(propylthio)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008756	2-methoxy-4-(2-methoxyphenylthio)benzonitrile	Discovery agent	.	.
DNC008757	4-(isopropylthio)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008758	2-methoxy-4-(o-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008759	4-(2,6-dimethylphenylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008760	4-(mesitylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008761	2-methoxy-4-(propylthio)benzonitrile	Discovery agent	.	.
DNC008762	3-chloro-4-(o-tolylthio)benzonitrile	Discovery agent	.	.
DNC008763	3-chloro-4-(o-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008764	3-methoxy-4-(o-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008765	4-(butylthio)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008766	4-(cyclopropylmethylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008767	2-methoxy-4-(m-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008768	4-(butylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008769	4-(o-tolylthio)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008770	2-methoxy-4-(p-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008771	3-methoxy-4-(m-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008772	4-(cyclobutylmethylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008773	4-(isopentylthio)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008774	4-(o-tolyloxy)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008775	4-(mesitylthio)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008776	4-(m-tolyloxy)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008777	4-(isopentylthio)-2-methoxybenzonitrile	Discovery agent	.	.
DNC008778	3-methoxy-4-(p-tolyloxy)benzonitrile	Discovery agent	.	.
DNC008779	4-(p-tolyloxy)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC008780	1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid	Discovery agent	.	.
DNC008781	KM-233	Discovery agent	.	.
DNC008782	DELTA 8-TETRAHYDROCANNOBINOL	Discovery agent	.	.
DNC008783	2,4,4-triphenylimidazoline	Discovery agent	.	.
DNC008784	ISOQUINE	Discovery agent	.	.
DNC008784	ISOQUINE	Plasmodium infection	.	B54
DNC008785	DESETHYL AMODIAQUINE	Discovery agent	.	.
DNC008786	Neurotensin(8-13)	Discovery agent	.	.
DNC008787	SERGLIFLOZIN A	Discovery agent	.	.
DNC008788	Remogliflozin	Discovery agent	.	.
DNC008789	SR-48692	Discovery agent	.	.
DNC008790	WAY-207024	Discovery agent	.	.
DNC008791	CHO793076	Discovery agent	.	.
DNC008792	1,4-Dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC008793	5,6,8-Trimethoxy-1,4-dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC008794	5,8-Dimethoxy-4-methylquinolin-2(1H)-one	Discovery agent	.	.
DNC008795	6-Methyl-[1,3]dioxolo[4,5-h]quinolin-8(9H)-one	Discovery agent	.	.
DNC008796	6,7,8-Trimethoxy-4-methylquinolin-2(1H)-one	Discovery agent	.	.
DNC008797	7,8-Dimethoxy-1,4-dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC008798	6,8-Dimethoxy-4-methylquinolin-2(1H)-one	Discovery agent	.	.
DNC008799	6,7,8-Trimethoxy-1,4-dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC008800	5,6,8-Trimethoxy-4-methylquinolin-2(1H)-one	Discovery agent	.	.
DNC008801	8-Methoxy-1,4-dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC008802	6,8-Dimethoxy-1,4-dimethylquinolin-2(1H)-one	Discovery agent	.	.
DNC008803	9-Methyl-9H-adenine	Discovery agent	.	.
DNC008804	8-Bromo-9-methyl-9H-adenine	Discovery agent	.	.
DNC008805	9-Ethyl-9H-adenine	Discovery agent	.	.
DNC008806	8-Bromo-9-ethyl-9H-adenine	Discovery agent	.	.
DNC008807	9-Propyl-9H-adenine	Discovery agent	.	.
DNC008808	8-Bromo-9-propyl-9H-adenine	Discovery agent	.	.
DNC008809	9-Isopropyl-9H-adenine	Discovery agent	.	.
DNC008810	8-Bromo-9-isopropyl-9H-adenine	Discovery agent	.	.
DNC008811	8-Bromo-9-(sec-butyl)-9H-adenine	Discovery agent	.	.
DNC008812	8-bromo-9-isobutyl-9H-purin-6-amine	Discovery agent	.	.
DNC008813	8-Bromo-9-(2-butyl)-9H-adenine	Discovery agent	.	.
DNC008814	8-Bromo-9-(but-3-enyl)-9H-adenine	Discovery agent	.	.
DNC008815	9-Allyl-8-bromo-9H-adenine	Discovery agent	.	.
DNC008816	9-Cyclobutyl-9H-adenine	Discovery agent	.	.
DNC008817	8-Bromo-9-cyclobutyl-9H-adenine	Discovery agent	.	.
DNC008818	9-Cyclopentyl-9H-adenine	Discovery agent	.	.
DNC008819	8-Bromo-9-cyclopentyl-9H-adenine	Discovery agent	.	.
DNC008820	8-Bromo-9-cyclohexyl-9H-adenine	Discovery agent	.	.
DNC008821	2-(6-amino-8-bromo-9H-purin-9-yl)ethanol	Discovery agent	.	.
DNC008822	8-Bromo-9-(3-hydroxypropyl)-9H-adenine	Discovery agent	.	.
DNC008823	8-Bromo-9-(2-hydroxypropyl)-9H-adenine	Discovery agent	.	.
DNC008824	8-Bromo-9-(2,3-dihydroxypropyl)-9H-adenine	Discovery agent	.	.
DNC008825	9-Benzyl-8-bromo-9H-adenine	Discovery agent	.	.
DNC008826	8-Bromo-9-phenylethyl-9H-adenine	Discovery agent	.	.
DNC008827	8-Br-adenine	Discovery agent	.	.
DNC008828	7-Propyl-7H-adenine	Discovery agent	.	.
DNC008829	7-Isopropyl-7H-adenine	Discovery agent	.	.
DNC008830	9-(sec-Butyl)-9H-adenine	Discovery agent	.	.
DNC008831	9-Butyl-9H-adenine	Discovery agent	.	.
DNC008832	9-But-3-enyl-9H-adenine	Discovery agent	.	.
DNC008833	9-Cyclopropyl-9H-adenine	Discovery agent	.	.
DNC008834	9-Cycloheptyl-9H-adenine	Discovery agent	.	.
DNC008835	9-(2-Hydroxyethyl)-9H-adenine	Discovery agent	.	.
DNC008836	9-(3-Hydroxypropyl)-9H-adenine	Discovery agent	.	.
DNC008837	9-(2-Hydroxypropyl)-9H-adenine	Discovery agent	.	.
DNC008838	(S)-DHPA	Discovery agent	.	.
DNC008839	9-BENZYL-9H-ADENINE	Discovery agent	.	.
DNC008840	9-Phenylethyl-9H-adenine	Discovery agent	.	.
DNC008841	4'-(2-butylbenzofuran-3-yl)biphenyl-4-ol	Discovery agent	.	.
DNC008842	4'-((2-butylbenzofuran-3-yl)methyl)biphenyl-4-ol	Discovery agent	.	.
DNC008843	HALOPEMIDE	Discovery agent	.	.
DNC008844	5-tosyl-5H-dibenzo[b,d]azepin-7(6H)-one	Discovery agent	.	.
DNC008845	4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one	Discovery agent	.	.
DNC008846	1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole	Discovery agent	.	.
DNC008847	(1R,5R)-30-OXO-19-OXA-2,6,10,12-TETRAAZAHEXACYCLO[18.6.2.1^{2,5}.1^{14,18}.0^{8,12}.0^{23,27}]TRIACONTA-8,10,14(29),15,17,20(28),21,23(27)-OCTAENE-17-CARBONITRILE (STRUCTURAL MIX)	Discovery agent	.	.
DNC008848	DESMETHYLOLANZAPINE	Discovery agent	.	.
DNC008849	2-aminopyridine	Discovery agent	.	.
DNC008850	2-amino-4,6-dimethylpyridine	Discovery agent	.	.
DNC008851	L-Nw-nitroarginine	Discovery agent	.	.
DNC008852	Cochliobolic acid	Discovery agent	.	.
DNC008853	ABYSSINONE V	Discovery agent	.	.
DNC008854	4'-hydroxy-6,3',5'-triprenylisoflavonone	Discovery agent	.	.
DNC008855	3,9-dihydroxy-2,10-diprenylpterocap-6a-ene	Discovery agent	.	.
DNC008856	Petrosaspongiolide M	Discovery agent	.	.
DNC008857	Petrosaspongiolide P	Discovery agent	.	.
DNC008858	CACOSPONGIONOLIDE B	Discovery agent	.	.
DNC008859	CACOSPONGIONOLIDE	Discovery agent	.	.
DNC008860	Cacospongionolide E	Discovery agent	.	.
DNC008861	Makaluvamine N	Discovery agent	.	.
DNC008862	ANIBAMINE	Discovery agent	.	.
DNC008863	Kaempferol-3-O-methyl ether	Discovery agent	.	.
DNC008864	8(S)-amino-2(R)-methyl-7-oxononanoic acid	Discovery agent	.	.
DNC008865	5-desgalloylstachyurin	Discovery agent	.	.
DNC008866	CASUARIIN	Discovery agent	.	.
DNC008867	Tellimagrandin II	Discovery agent	.	.
DNC008868	PEDUNCULAGIN	Discovery agent	.	.
DNC008869	1,2,3,4,6-penta-O-galloyl-beta-D-glucose	Discovery agent	.	.
DNC008870	ACETOSIDE	Discovery agent	.	.
DNC008871	LEUCOSCEPTOSIDE A	Discovery agent	.	.
DNC008872	Plantainoside D	Discovery agent	.	.
DNC008873	FORSYTHIASIDE	Discovery agent	.	.
DNC008874	CALCEOLARIOSIDE B	Discovery agent	.	.
DNC008875	CALCEOLARIOSIDE A	Discovery agent	.	.
DNC008876	2,6-dihydroxy-1,7-dimethoxyxanthone	Discovery agent	.	.
DNC008877	3,4-dihydroxyxanthone	Discovery agent	.	.
DNC008878	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Discovery agent	.	.
DNC008879	4-phenyl-1,2,3,6-tetrahydropyridine	Discovery agent	.	.
DNC008880	CHLORODEOXYURIDINE	Discovery agent	.	.
DNC008881	BROMODEOXYURIDINE	Discovery agent	.	.
DNC008882	LYSERGIC ACID DIETHYLAMIDE	Discovery agent	.	.
DNC008883	Racemic DOI	Discovery agent	.	.
DNC008884	CINANSERIN	Discovery agent	.	.
DNC008885	1-[5-(4-Chlorophenyl)-2-furoyl]piperazine	Discovery agent	.	.
DNC008886	SYN-1327	Discovery agent	.	.
DNC008887	5-amino-3-(N-methylpiperidin-4-yl)-1H-indole	Discovery agent	.	.
DNC008888	METHYLENEDIOXYMETHAMPHETAMINE	Discovery agent	.	.
DNC008889	3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol	Discovery agent	.	.
DNC008890	3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol	Discovery agent	.	.
DNC008891	3-[3-(4-hydroxyphenyl)isoxazol-5-yl]phenol	Discovery agent	.	.
DNC008892	N,N-Dimethylsphingosine	Discovery agent	.	.
DNC008893	C[Glu21-Lys26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008894	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-NH2	Discovery agent	.	.
DNC008895	C[Cpa19-Lys26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008896	C[hGlu22-Lys26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008897	C[Asp22-Lys26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008898	C[Glu22-Orn26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008899	C[Glu22-Lys26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008900	C[Glu26-Lys30][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008901	C[Glu24-Lys28][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008902	C[Glu23-Lys27][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008903	C[Glu22-Lys26][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008904	C[Glu21-Lys25][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008905	Glu20-Lys24][Gly8][GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008906	C[Glu19-Lys23][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008907	C[Glu18-Lys22][Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008908	[Gly8, aib22]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008909	[Gly8,Glu22]GLP-1(7,37)-NH2	Discovery agent	.	.
DNC008910	[Gly8]GLP-1(7-37)-NH2	Discovery agent	.	.
DNC008911	4-(3-Pent-1-ynyl-benzyl)-1H-imidazole	Discovery agent	.	.
DNC008912	4-(3-Phenylethynyl-benzyl)-1H-imidazole	Discovery agent	.	.
DNC008913	N-hydroxy-2,3-bis(phenylsulfonamido)propanamide	Discovery agent	.	.
DNC008914	2-(1-dodecyl-1H-indol-3-yl)acetic acid	Discovery agent	.	.
DNC008915	(Z)-2-(1-decyl-2-oxoindolin-3-ylidene)acetic acid	Discovery agent	.	.
DNC008916	(E)-2-(1-decyl-2-oxoindolin-3-ylidene)acetic acid	Discovery agent	.	.
DNC008917	2-(o-toluidino)-5-ethylthiazol-4(5H)-one	Discovery agent	.	.
DNC008918	MK-571	Asthma	.	J45
DNC008918	MK-571	Discovery agent	.	.
DNC008919	4(Z)-(5'-Deoxyadenosin-5'-ylidene)butanoic acid	Discovery agent	.	.
DNC008920	5(E)-(5'-Deoxyadenosin-5'-ylidene)pentanoic acid	Discovery agent	.	.
DNC008921	D-Pro-Phe-Arg chloromethyl ketone	Discovery agent	.	.
DNC008922	(R)-(-)-alpha-methylhistamine	Discovery agent	.	.
DNC008923	IODOPHENPROPIT	Discovery agent	.	.
DNC008924	L-660771	Discovery agent	.	.
DNC008925	LIAROZOLE	Dermatological disease	.	L00-L99
DNC008925	LIAROZOLE	Discovery agent	.	.
DNC008926	R-115866	Discovery agent	.	.
DNC008927	3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine	Discovery agent	.	.
DNC008928	3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC008929	3-(3-Benzylnaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC008930	BMS-695735	Discovery agent	.	.
DNC008930	BMS-695735	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC008931	(R)-1-(2-aminoacetyl)pyrrolidin-2-ylboronic acid	Discovery agent	.	.
DNC008932	4-benzyl-2,6-diisobutylamino-pyrimidine	Discovery agent	.	.
DNC008933	N,N,N-Triisobutyl-pyrimidine-2,4,6-triamine	Discovery agent	.	.
DNC008934	6-ethyl-2,4-diisobutylaminopyrimidine	Discovery agent	.	.
DNC008935	2,4-Dibenzylamino-6-isopentylpyrimidine	Discovery agent	.	.
DNC008936	2,4-diisobutylamino-6-isopentylpyrimidine	Discovery agent	.	.
DNC008937	6-butyl-2,4-dipropylaminopyrimidine	Discovery agent	.	.
DNC008938	4-Phenylspiro[chromene-2,4'-piperidine]	Discovery agent	.	.
DNC008939	BW-373U86	Discovery agent	.	.
DNC008940	4-(Spiro[chromene-2,4'-piperidine]-4-yl)phenol	Discovery agent	.	.
DNC008941	4-(p-Tolyl)spiro[chromene-2,4'-piperidine]	Discovery agent	.	.
DNC008942	Rotungenic acid	Discovery agent	.	.
DNC008943	Oleanonic acid	Discovery agent	.	.
DNC008944	UVAOL	Discovery agent	.	.
DNC008945	Spathodic acid	Discovery agent	.	.
DNC008946	19alpha,24-dihydroxyurs-12-en-3-on-28-oic acid	Discovery agent	.	.
DNC008947	24-hydroxyursolic acid	Discovery agent	.	.
DNC008948	Pomolic acid	Discovery agent	.	.
DNC008949	NIKKOMYCIN	Discovery agent	.	.
DNC008950	GSK-690693	Discovery agent	.	.
DNC008950	GSK-690693	Lymphoma	.	C81-C96
DNC008951	Isosorbide-2-(methylcarbamate)-5-mononitrate	Discovery agent	.	.
DNC008952	Isosorbide-2-benzyl carbamate	Discovery agent	.	.
DNC008953	Isosorbide-2-(butylcarbamate)-5-benzoate	Discovery agent	.	.
DNC008954	Isosorbide-2-(methylcarbamate)-5-benzoate	Discovery agent	.	.
DNC008955	Isosorbide-2-benzylcarbamate-5-isonicotinate	Discovery agent	.	.
DNC008956	Isosorbide-2-benzylcarbamate-5-nicotinate	Discovery agent	.	.
DNC008957	Isosorbide-2-(benzylcarbamate)-5-benzoate	Discovery agent	.	.
DNC008958	Isosorbide-2-benzylcarbamate-5-triflate	Discovery agent	.	.
DNC008959	Isosorbide-2-benzylcarbamate-5-cyclopentanoate	Discovery agent	.	.
DNC008960	Isosorbide-2-benzylcarbamate-5-cyclopropanoate	Discovery agent	.	.
DNC008961	Isosorbide-2-benzylcarbamate-5-pentanoate	Discovery agent	.	.
DNC008962	Isosorbide-2-benzylcarbamate-5-propionate	Discovery agent	.	.
DNC008963	Isosorbide-2-benzylcarbamate-5-acetate	Discovery agent	.	.
DNC008964	Isosorbide-2-(benzylcarbamate)-5-mononitrate	Discovery agent	.	.
DNC008965	Isosorbide-2-(cyclohexylcarbamate)-5-mononitrate	Discovery agent	.	.
DNC008966	Isosorbide-2-(butylcarbamate)-5-mononitrate	Discovery agent	.	.
DNC008967	Isosorbide-2-(propylcarbamate)-5-mononitrate	Discovery agent	.	.
DNC008968	Isosorbide-2-(ethylcarbamate)-5-mononitrate	Discovery agent	.	.
DNC008969	GSK-9772	Discovery agent	.	.
DNC008970	A-846714	Discovery agent	.	.
DNC008971	A-943931	Discovery agent	.	.
DNC008972	N-Benzyl-4-(2-diphenyl)-1-piperazinehexanamide	Discovery agent	.	.
DNC008973	Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-Bzl	Discovery agent	.	.
DNC008974	AZD-2281	Discovery agent	.	.
DNC008975	A-795614	Discovery agent	.	.
DNC008976	N-(3,4-Dichlorophenyl)propyl-ETAV	Discovery agent	.	.
DNC008977	N-Benzyl-ETAV	Discovery agent	.	.
DNC008978	FETAV	Discovery agent	.	.
DNC008979	N-(Naphthalene-2-yl)ethyl-ETAV	Discovery agent	.	.
DNC008980	N-(3,4-Difluorophenyl)propyl-ETAV	Discovery agent	.	.
DNC008981	N-Phenylethyl-ETAV	Discovery agent	.	.
DNC008982	N-Cyclohexylethyl-ETAV	Discovery agent	.	.
DNC008983	N-Phenylpropyl-ETAV	Discovery agent	.	.
DNC008984	N-Cyclohexylmethyl-ETAV	Discovery agent	.	.
DNC008985	N-Butyl-ETAV	Discovery agent	.	.
DNC008986	N-Propyl-ETAV	Discovery agent	.	.
DNC008987	YGRKKRRQRRR-KLSSIESDV	Discovery agent	.	.
DNC008988	KSG-YEKLSSIESDV	Discovery agent	.	.
DNC008989	KSG-LDTKNYKQTSV	Discovery agent	.	.
DNC008990	N-Ethyl-ETAV	Discovery agent	.	.
DNC008991	N-Methyl-ETAV	Discovery agent	.	.
DNC008992	CEP-6331	Discovery agent	.	.
DNC008993	CEP-5104	Discovery agent	.	.
DNC008994	WAY-252623	Atherosclerosis	414.0, 440	I70
DNC008994	WAY-252623	Discovery agent	.	.
DNC008995	WAY-214950	Discovery agent	.	.
DNC008996	A-987306	Discovery agent	.	.
DNC008997	GALANIN	Discovery agent	.	.
DNC008998	SB-222200	Discovery agent	.	.
DNC008999	RS-102,221	Discovery agent	.	.
DNC009000	1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine	Discovery agent	.	.
DNC009001	SARALASIN	Discovery agent	.	.
DNC009001	SARALASIN	Hypertension	401	I10, I11, I12, I13, I15
DNC009002	SINCALIDE	Discovery agent	.	.
DNC009002	SINCALIDE	Pancreatic disease	.	K85-K86
DNC009003	ET-1	Discovery agent	.	.
DNC009004	NDP-alpha-MSH	Discovery agent	.	.
DNC009005	[Sar9,Met(O2)11]-SP	Discovery agent	.	.
DNC009006	NEUROPEPTIDE-Y	Discovery agent	.	.
DNC009007	HCGRPalpha	Discovery agent	.	.
DNC009008	Endothelin-3	Discovery agent	.	.
DNC009009	Cyclohexylcarbamic acidbiphenyl-3-yl ester	Discovery agent	.	.
DNC009010	Naphthalen-2-yl cyclohexylcarbamate	Discovery agent	.	.
DNC009011	3'-carbamoylbiphenyl-3-yl 6-phenylhexylcarbamate	Discovery agent	.	.
DNC009012	4-(cyclohexylmethylcarbamoyloxy)benzoic acid	Discovery agent	.	.
DNC009013	H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2	Discovery agent	.	.
DNC009014	4-fluorobenzoyl-Phe-Gly-Leu-Arg-Trp-NH2	Discovery agent	.	.
DNC009015	NSC-746457	Discovery agent	.	.
DNC009016	BURTTINONE	Discovery agent	.	.
DNC009017	SM-131	Discovery agent	.	.
DNC009018	ELACRIDAR	Cancer	140-229	C00-C96
DNC009018	ELACRIDAR	Discovery agent	.	.
DNC009019	GR-218231	Discovery agent	.	.
DNC009020	6,7-dimethoxy-N-m-tolylquinazolin-4-amine	Discovery agent	.	.
DNC009021	HTS-00213	Discovery agent	.	.
DNC009022	HTS-02876	Discovery agent	.	.
DNC009023	N-benzylacetimidamide hydrobromide	Discovery agent	.	.
DNC009024	(S)-N-(1-phenylethyl)acetimidamide hydrobromide	Discovery agent	.	.
DNC009025	WAY-196025	Discovery agent	.	.
DNC009026	EFIPLADIB	Asthma	.	J45
DNC009026	EFIPLADIB	Discovery agent	.	.
DNC009027	BMS-187745	Discovery agent	.	.
DNC009027	BMS-187745	Hyperlipidemia	.	E78.5
DNC009028	(Sar)WTLNSAGYLLGPKKKK	Discovery agent	.	.
DNC009029	(Sar)WTLNSAGYLLGPKK(Lys-MPEG4)K	Discovery agent	.	.
DNC009030	(Sar)WTLNSAGYLLGPKK(Lys-stearoyl)K	Discovery agent	.	.
DNC009031	(Sar)WTLNSAGYLLGPKK(Lys-palmitoyl)K	Discovery agent	.	.
DNC009032	(Sar)WTLNSAGYLLGPKK(Lys-myristoyl)K	Discovery agent	.	.
DNC009033	(Sar)WTLNSAGYLLGPKK(Lys-lauroyl)K	Discovery agent	.	.
DNC009034	(Sar)WTLNSAGYLLGPKK(Lys-decanoyl)K	Discovery agent	.	.
DNC009035	(Sar)WTLNSAGYLLGPKK(Lys-octanoyl)K	Discovery agent	.	.
DNC009036	4,5-Bis(4-methoxyphenyl)isothiazole	Discovery agent	.	.
DNC009037	4,5-Bis(4-chlorophenyl)isothiazole	Discovery agent	.	.
DNC009038	4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiol-3-one	Discovery agent	.	.
DNC009039	5'-Deoxy-5'-(N,N-dimethylamino)-8-methyladenosine	Discovery agent	.	.
DNC009040	[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine	Discovery agent	.	.
DNC009041	5'-Deoxy-5'-dimethylsulfonioadenosine chloride	Discovery agent	.	.
DNC009042	5'-Deoxy-5'-(N,N-dimethylamino)adenosine	Discovery agent	.	.
DNC009043	4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide	Discovery agent	.	.
DNC009044	Quinoline-8-sulfonamide	Discovery agent	.	.
DNC009045	1,4-phenylene disulfamate	Discovery agent	.	.
DNC009046	GSK-369796	Discovery agent	.	.
DNC009047	Desethyl isoquine	Discovery agent	.	.
DNC009048	BMS-777607	Discovery agent	.	.
DNC009049	Pyridine-2,4-dicarboxylic acid	Discovery agent	.	.
DNC009050	1S,2R-milnacipran	Discovery agent	.	.
DNC009051	MB-07344	Discovery agent	.	.
DNC009051	MB-07344	Hyperlipidemia	272.0-272.4	E78
DNC009052	CRX-526	Discovery agent	.	.
DNC009053	SM-122	Discovery agent	.	.
DNC009054	3-(1H-indol-3-yl)-N-methyl-3-phenylpropan-1-amine	Discovery agent	.	.
DNC009055	5-(3-butylpyrrolidin-3-yl)-1H-indole	Discovery agent	.	.
DNC009056	5-(3-benzylpyrrolidin-3-yl)-1-methyl-1H-indole	Discovery agent	.	.
DNC009057	5-(3-(4-fluorobenzyl)pyrrolidin-3-yl)-1H-indole	Discovery agent	.	.
DNC009058	3-(benzo[b]thiophen-5-yl)-3-benzylpyrrolidine	Discovery agent	.	.
DNC009059	5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX)	Discovery agent	.	.
DNC009060	1-(3,4-dichlorophenyl)-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC009061	N-(4-hydroxybiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC009062	N-(2-aminophenyl)nicotinamide	Discovery agent	.	.
DNC009063	N-(4-aminobiphenyl-3-yl)nicotinamide	Discovery agent	.	.
DNC009064	N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide	Discovery agent	.	.
DNC009065	2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole	Discovery agent	.	.
DNC009066	NPC-567	Discovery agent	.	.
DNC009066	NPC-567	Rhinitis	472.0, 477	J00, J30, J31.0
DNC009067	U-44069	Discovery agent	.	.
DNC009068	UCM-5600	Discovery agent	.	.
DNC009069	Ac-IETD-CHO	Discovery agent	.	.
DNC009070	Ac-VEID-CHO	Discovery agent	.	.
DNC009071	AR-A014418	Discovery agent	.	.
DNC009072	AM-281	Discovery agent	.	.
DNC009073	ADOCIAQUINONE B	Discovery agent	.	.
DNC009074	4-ethoxynaphthalene-1,2-dione	Discovery agent	.	.
DNC009075	ANTHRAQUINONE	Discovery agent	.	.
DNC009076	5,6,7,8-tetrahydroanthracene-1,4-dione	Discovery agent	.	.
DNC009077	6-desoxonaltrexone	Discovery agent	.	.
DNC009078	Naltrexone methiodide	Discovery agent	.	.
DNC009079	CCDC 710249, HCl salt	Discovery agent	.	.
DNC009080	WR-190706	Discovery agent	.	.
DNC009081	WR-289009	Discovery agent	.	.
DNC009082	WR-289016	Discovery agent	.	.
DNC009083	WR-289012	Discovery agent	.	.
DNC009084	WR-289010	Discovery agent	.	.
DNC009085	WR-203581	Discovery agent	.	.
DNC009086	ST-2986	Discovery agent	.	.
DNC009087	ST-2987	Cancer	140-229	C00-C96
DNC009087	ST-2987	Discovery agent	.	.
DNC009088	ST-3050	Discovery agent	.	.
DNC009089	AM-2S	Discovery agent	.	.
DNC009090	TIPROLISANT	Discovery agent	.	.
DNC009091	UCL-2138	Discovery agent	.	.
DNC009092	1-(3-(4-(fluoromethyl)phenoxy)propyl)piperidine	Discovery agent	.	.
DNC009093	1-(3-(4-(2-fluoroethyl)phenoxy)propyl)piperidine	Discovery agent	.	.
DNC009094	2-oxo-N-phenyl-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009095	2-oxo-N-m-tolyl-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009096	2-oxo-N-p-tolyl-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009097	N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009098	Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate	Discovery agent	.	.
DNC009099	4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid	Discovery agent	.	.
DNC009100	N-cyclohexyl-2-oxo-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009101	N-isobutyl-2-oxo-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009102	N-(2-aminoethyl)-2-oxo-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009103	N-benzyl-2-oxo-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009104	N-Methyl-N-phenyl-2-oxo-2H-chromene-3-carboxamide	Discovery agent	.	.
DNC009105	2-chloro-4-(o-tolyloxy)benzonitrile	Discovery agent	.	.
DNC009106	4-(mesityloxy)-2-(trifluoromethyl)benzonitrile	Discovery agent	.	.
DNC009107	1-Adamantan-1-yl-3-phenyl-urea	Discovery agent	.	.
DNC009108	1-Adamantan-1-yl-3-(2-hydroxy-phenyl)-urea	Discovery agent	.	.
DNC009109	1-Adamantan-1-yl-3-(3-hydroxy-phenyl)-urea	Discovery agent	.	.
DNC009110	1-Adamantan-1-yl-3-(4-hydroxy-phenyl)-urea	Discovery agent	.	.
DNC009111	1-Adamantan-1-yl-3-(2-methoxy-phenyl)-urea	Discovery agent	.	.
DNC009112	1-Adamantan-1-yl-3-(3-methoxy-phenyl)-urea	Discovery agent	.	.
DNC009113	1-Adamantan-1-yl-3-(4-methoxy-phenyl)-urea	Discovery agent	.	.
DNC009114	3-(3-Adamantan-1-yl-ureido)-benzoic acid	Discovery agent	.	.
DNC009115	4-(3-Adamantan-1-yl-ureido)-benzoic acid	Discovery agent	.	.
DNC009116	[4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid	Discovery agent	.	.
DNC009117	Sodium trithiocarbonate	Discovery agent	.	.
DNC009118	Ditiocarb sodium	Discovery agent	.	.
DNC009118	Ditiocarb sodium	HIV infections	42	B20
DNC009119	3-Benzyl-5-isopropyl-8-methylchromen-2-one	Discovery agent	.	.
DNC009120	5-Methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one	Discovery agent	.	.
DNC009121	2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one	Discovery agent	.	.
DNC009122	GW-3430	Discovery agent	.	.
DNC009123	1-(pyridin-4-yl)piperazine	Discovery agent	.	.
DNC009124	1-(pyridin-2-yl)piperazine	Discovery agent	.	.
DNC009125	ERIBAXABAN	Discovery agent	.	.
DNC009125	ERIBAXABAN	Phlebothrombosis	.	I80-I82
DNC009126	2,6-di-t-butylphenol	Discovery agent	.	.
DNC009127	BUTYLATEDHYDROXYTOLUENE	Discovery agent	.	.
DNC009128	2,6-di-tert-butyl-4-methoxyphenol	Discovery agent	.	.
DNC009129	GUAIACOL	Discovery agent	.	.
DNC009130	3-hydroxy-2-methoxybenzaldehyde	Discovery agent	.	.
DNC009131	Di(2,6-dimethylphenol)	Discovery agent	.	.
DNC009132	Di(2,6-diisopropylphenol)	Discovery agent	.	.
DNC009133	Di(2,6-di-t-butylphenol)	Discovery agent	.	.
DNC009134	4-((naphthalen-2-yloxy)methyl)piperidine	Discovery agent	.	.
DNC009135	(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine	Discovery agent	.	.
DNC009136	(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine	Discovery agent	.	.
DNC009137	(+/-)-3-((naphthalen-2-yloxy)methyl)pyrrolidine	Discovery agent	.	.
DNC009138	(S)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile	Discovery agent	.	.
DNC009139	(R)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile	Discovery agent	.	.
DNC009140	6-(piperidin-4-ylmethoxy)-2-naphthonitrile	Discovery agent	.	.
DNC009141	7-(piperidin-4-ylmethoxy)-2-naphthonitrile	Discovery agent	.	.
DNC009142	1-(2-(naphthalen-2-yl)ethyl)piperazine	Discovery agent	.	.
DNC009143	1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine	Discovery agent	.	.
DNC009144	LITOXETINE	Discovery agent	.	.
DNC009144	LITOXETINE	Mood disorder	.	F30-F39
DNC009145	L-709049	Discovery agent	.	.
DNC009146	Ac-DEVD-CHO	Discovery agent	.	.
DNC009147	6-isobutyl-4-methylpyridin-2-amine	Discovery agent	.	.
DNC009148	6-(2-Fluoropropyl)-4-methylpyridin-2-amine	Discovery agent	.	.
DNC009149	4-Methyl-6-(2-methylprop-1-enyl)pyridin-2-amine	Discovery agent	.	.
DNC009150	(E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine	Discovery agent	.	.
DNC009151	1-(6-Amino-4-methylpyridin-2-yl)propan-2-ol	Discovery agent	.	.
DNC009152	6-(3-Fluoropropyl)-4-methylpyridin-2-amine	Discovery agent	.	.
DNC009153	6-(4-Fluorobutyl)-4-methylpyridin-2-amine	Discovery agent	.	.
DNC009154	1-(3-(2-(3-methoxyphenoxy)ethoxy)propyl)azepane	Discovery agent	.	.
DNC009155	BRECANAVIR	Discovery agent	.	.
DNC009155	BRECANAVIR	Human immunodeficiency virus infection	.	B20
DNC009156	3-(4-sulfamoylphenyl)propanoic acid	Discovery agent	.	.
DNC009157	4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide	Discovery agent	.	.
DNC009158	2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine	Discovery agent	.	.
DNC009159	N6-((+/-)-endo-norborn-2-yl)adenosine	Discovery agent	.	.
DNC009160	BI-32169	Discovery agent	.	.
DNC009161	3,5-dibromo-2-(2,4-dibromophenoxy)phenol	Discovery agent	.	.
DNC009162	3,4,5-tribromo-2-(2', 4'-dibromo-phenoxy)phenol	Discovery agent	.	.
DNC009163	2,3,4-tribromo-6-(2,4-dibromophenoxy)phenol	Discovery agent	.	.
DNC009164	VARIECOLIN	Discovery agent	.	.
DNC009165	TILIROSIDE	Discovery agent	.	.
DNC009166	Cyclotheonamide E	Discovery agent	.	.
DNC009167	Cyclotheonamide E4	Discovery agent	.	.
DNC009168	Cyclotheonamide E5	Discovery agent	.	.
DNC009169	(Z)-7-octedecan-9-ynoic acid	Discovery agent	.	.
DNC009170	(Z)-5-octadecen-7,9-diynoic acid	Discovery agent	.	.
DNC009171	(E)-5-octadecen-7,9-diynoic acid	Discovery agent	.	.
DNC009172	7,9-tetradecadiynoic acid	Discovery agent	.	.
DNC009173	7,9-octadecadiynoic acid	Discovery agent	.	.
DNC009174	9-octadecynoic acid	Discovery agent	.	.
DNC009175	(E)-octadecan-9-ynoic acid	Discovery agent	.	.
DNC009176	6-hydroxy-7,9-octadecadiynoic acid	Discovery agent	.	.
DNC009177	3-(1,3 dodecadiynyl)-6-oxiranebutanoic acid	Discovery agent	.	.
DNC009178	AURASPERONE A	Discovery agent	.	.
DNC009179	4'-Demethyl-epipodophyllotoxin	Discovery agent	.	.
DNC009180	4'-Demethyl-4beta-amino-4-desoxypodophyllotoxin	Discovery agent	.	.
DNC009181	4,5,6-trihydroxy-3-methylphthalide	Discovery agent	.	.
DNC009182	LEUCETTAMINE A	Discovery agent	.	.
DNC009183	LEUCETTAMIDINE	Discovery agent	.	.
DNC009184	Dimethylnordihydroguarierate acid	Discovery agent	.	.
DNC009185	IGERNELLIN	Discovery agent	.	.
DNC009186	Hydrohalisulfate 1	Discovery agent	.	.
DNC009187	Halisulfate 1	Discovery agent	.	.
DNC009188	Subersic acid	Discovery agent	.	.
DNC009189	Jaspic acid	Discovery agent	.	.
DNC009190	JASPAQUINOL	Discovery agent	.	.
DNC009191	(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol	Discovery agent	.	.
DNC009192	(+)-(5S,8S,10S)-20-methoxypuupehenol	Discovery agent	.	.
DNC009193	(+)-(5S,8S,9R,10S)-20-methoxypuupehenone	Discovery agent	.	.
DNC009194	CHLOROPUUPEHENONE	Discovery agent	.	.
DNC009195	PUUPEHENONE	Discovery agent	.	.
DNC009196	(-)-7-N-methyldibromophakellin	Discovery agent	.	.
DNC009197	KM-233	Discovery agent	.	.
DNC009198	KM-233-M	Discovery agent	.	.
DNC009199	KM-233	Discovery agent	.	.
DNC009200	(+/-)-3-(but-3-enyl)-1-pent-4-enoylazetidin-2-one	Discovery agent	.	.
DNC009201	(+/-)-3-allyl-1-pent-4-enoylazetidin-2-one	Discovery agent	.	.
DNC009202	3,3-di(pent-4-enyl)azetidin-2-one	Discovery agent	.	.
DNC009203	(+/-)-3-(pent-4-enyl)azetidin-2-one	Discovery agent	.	.
DNC009204	(+/-)-3-allylazetidin-2-one	Discovery agent	.	.
DNC009205	Trans-3-(o-tolyloxy)-2,3-dihydro-1H-inden-1-amine	Discovery agent	.	.
DNC009206	Cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine	Discovery agent	.	.
DNC009207	SUBSTANCE P	Discovery agent	.	.
DNC009208	Methyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009209	Cyclopentyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009210	Tert-butyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009211	Butyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009212	Isopropyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009213	Naphthalen-2-yl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009214	Naphthalen-1-yl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009215	4-chlorophenyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009216	3-chlorophenyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009217	4-methoxyphenyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009218	3-methoxyphenyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009219	2-methoxyphenyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009220	P-tolyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009221	M-tolyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009222	O-tolyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009223	Phenyl 10H-phenothiazine-10-carboxylate	Discovery agent	.	.
DNC009224	4-(2-((dimethylamino)methyl)phenoxy)benzonitrile	Discovery agent	.	.
DNC009225	L-790070	Autoimmune diseases	279.4	D84.9, M35.9
DNC009225	L-790070	Discovery agent	.	.
DNC009226	Angiotensin IV	Discovery agent	.	.
DNC009227	IN-1130	Discovery agent	.	.
DNC009228	6-tosyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole	Discovery agent	.	.
DNC009229	KYS-05065	Discovery agent	.	.
DNC009230	KYS-05055	Discovery agent	.	.
DNC009231	KYS-05056	Discovery agent	.	.
DNC009232	KYS-05057	Discovery agent	.	.
DNC009233	2,7-Bis[3-(piperidino)propionamido]anthraquinone	Discovery agent	.	.
DNC009234	2,7-Bis[3-(pyrrolidino)propionamido]anthraquinone	Discovery agent	.	.
DNC009235	WAY-256805	Discovery agent	.	.
DNC009235	WAY-256805	Pain	338,780	R52, G89
DNC009236	2,7-Dinitroantraquinone	Discovery agent	.	.
DNC009237	2,7-Bis(cyclohexanecarbonamido)anthraquinone	Discovery agent	.	.
DNC009238	2,7-Bis(cyclopentanecarbonamido)anthraquinone	Discovery agent	.	.
DNC009239	2,7-Bis(cyclopropanecarbonamido)anthraquinone	Discovery agent	.	.
DNC009240	2,7-Bis(phenylpropionamido)anthraquinone	Discovery agent	.	.
DNC009241	2,7-Bis(phenylacetamido)anthraquinone	Discovery agent	.	.
DNC009242	2,7-Bis(benzoamido)anthraquinone	Discovery agent	.	.
DNC009243	2,7-Bis(butyramido)anthraquinone	Discovery agent	.	.
DNC009244	2,7-Bis(propionamido)anthraquinone	Discovery agent	.	.
DNC009245	2,7-Bis(acetamido)anthraquinone	Discovery agent	.	.
DNC009246	2,7-Bis(4-chlorobutyramido)anthraquinone	Discovery agent	.	.
DNC009247	2,7-Bis[3-(piperazino)propionamido]anthraquinone	Discovery agent	.	.
DNC009248	2,7-Bis(3-chloropropionamido)anthraquinone	Discovery agent	.	.
DNC009249	2,7-Bis[2-(piperazino)acetamido]anthraquinone	Discovery agent	.	.
DNC009250	2,7-Bis[2-(piperidino)acetamido]anthraquinone	Discovery agent	.	.
DNC009251	2,7-diaminoanthraquinone	Discovery agent	.	.
DNC009252	2,7-Bis[2-(diethylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009253	2,7-Bis[3-(ethylamino)propionamido]anthraquinone	Discovery agent	.	.
DNC009254	2,7-Bis[3-(propylamino)propionamido]anthraquinone	Discovery agent	.	.
DNC009255	2,7-Bis[3-(butylamino)propionamido]anthraquinone	Discovery agent	.	.
DNC009256	2,7-Bis[2-(isobutylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009257	2,7-Bis[2-(isopropylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009258	2,7-Bis[2-(ethylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009259	2,7-Bis[2-(propylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009260	2,7-Bis[2-(dimethylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009261	2,7-Bis[2-(pyrrolidino)acetamido]anthraquinone	Discovery agent	.	.
DNC009262	2,7-Bis[2-(butylamino)acetamido]anthraquinone	Discovery agent	.	.
DNC009263	2,7-Bis(chloroacetamido)anthraquinone	Discovery agent	.	.
DNC009264	6-hydroxybenzo[d][1,3]oxathiol-2-one	Discovery agent	.	.
DNC009265	GARCINONE D	Discovery agent	.	.
DNC009266	Gamma-mangostin	Discovery agent	.	.
DNC009267	SB-328872	Discovery agent	.	.
DNC009268	SB-436811	Asthma	.	J45
DNC009268	SB-436811	Discovery agent	.	.
DNC009269	(R)-2,11-Diaminoaporphine	Discovery agent	.	.
DNC009270	(R)-11-Amino-2-methoxyaporphine	Discovery agent	.	.
DNC009271	MCL-516	Discovery agent	.	.
DNC009272	5,N-Dihydroxythalidomide	Discovery agent	.	.
DNC009273	1-Benzyl-3-phenylquinazoline-2,4(1H,3H)-dione	Discovery agent	.	.
DNC009274	3-Phenyl-1-propylquinazoline-2,4(1H,3H)-dione	Discovery agent	.	.
DNC009275	Sophoraflavanone G	Discovery agent	.	.
DNC009276	(2S)-2'-methoxy kurarinone	Discovery agent	.	.
DNC009277	KUSHENOL A	Discovery agent	.	.
DNC009278	LEACHIANONE A	Discovery agent	.	.
DNC009279	8alpha,19-dihydroxylabd-13 E-en-15-oic acid	Discovery agent	.	.
DNC009280	KC-12291	Discovery agent	.	.
DNC009281	C-014C	Discovery agent	.	.
DNC009282	NSC-94258	Discovery agent	.	.
DNC009283	Cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)	Discovery agent	.	.
DNC009284	YM-26734	Discovery agent	.	.
DNC009284	YM-26734	Rheumatold arthritis	714	M05-M06
DNC009285	DIDODECANOYLPHLOROGLUCINOL	Discovery agent	.	.
DNC009286	ERITORAN	Discovery agent	.	.
DNC009286	ERITORAN	Septic shock	.	A41.9
DNC009287	6-(2-aminophenoxy)benzo[d]isothiazol-3-amine	Discovery agent	.	.
DNC009288	SDZ-201106	Discovery agent	.	.
DNC009289	GNF-PF-1694	Discovery agent	.	.
DNC009290	TETRAHYDROLIPSTATIN	Discovery agent	.	.
DNC009291	N-(4-Propylaminobutyl)-4-biphenylcarboxamide	Discovery agent	.	.
DNC009292	N-(4-Dipropylaminobutyl)-4-biphenylcarboxamide	Discovery agent	.	.
DNC009293	[2-(6-Chloro-purin-9-yl)ethyl]-bisphosphonic acid	Discovery agent	.	.
DNC009294	[2-(Purin-9-yl)ethyl]-bisphosphonic acid	Discovery agent	.	.
DNC009295	[2-(Imidazol-2-yl-thio)ethyl]-bisphosphonic acid	Discovery agent	.	.
DNC009296	[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid	Discovery agent	.	.
DNC009297	[2-(Pyrazol-1-yl)ethyl]-bisphosphonic acid	Discovery agent	.	.
DNC009298	[2-(Imidazol-1-yl)ethyl]-bisphosphonic acid	Discovery agent	.	.
DNC009299	GSK-189254	Discovery agent	.	.
DNC009299	GSK-189254	Parkinson's disease	.	G20
DNC009300	KNI-10079	Discovery agent	.	.
DNC009301	KNI-10080	Discovery agent	.	.
DNC009302	KNI-10081	Discovery agent	.	.
DNC009303	KNI-10092	Discovery agent	.	.
DNC009304	KNI-10093	Discovery agent	.	.
DNC009305	KNI-10094	Discovery agent	.	.
DNC009306	KNI-10369	Discovery agent	.	.
DNC009307	KNI-10216	Discovery agent	.	.
DNC009308	KNI-10217	Discovery agent	.	.
DNC009309	KNI-10113	Discovery agent	.	.
DNC009310	KNI-10124	Discovery agent	.	.
DNC009311	KNI-10125	Discovery agent	.	.
DNC009312	KNI-10106	Discovery agent	.	.
DNC009313	KNI-10087	Discovery agent	.	.
DNC009314	KNI-10088	Discovery agent	.	.
DNC009315	KNI-10095	Discovery agent	.	.
DNC009316	KNI-10255	Discovery agent	.	.
DNC009317	KNI-10256	Discovery agent	.	.
DNC009318	KNI-10265	Discovery agent	.	.
DNC009319	KNI-10074	Discovery agent	.	.
DNC009320	KNI-10260	Discovery agent	.	.
DNC009321	KNI-10152	Discovery agent	.	.
DNC009322	KNI-10266	Discovery agent	.	.
DNC009323	KNI-10155	Discovery agent	.	.
DNC009324	KNI-1293	Discovery agent	.	.
DNC009325	KNI-10283	Discovery agent	.	.
DNC009326	KNI-10282	Discovery agent	.	.
DNC009327	KNI-10529	Discovery agent	.	.
DNC009328	KNI-10539	Discovery agent	.	.
DNC009329	KNI-10541	Discovery agent	.	.
DNC009330	KNI-10538	Discovery agent	.	.
DNC009331	KNI-10526	Discovery agent	.	.
DNC009332	KNI-10527	Discovery agent	.	.
DNC009333	HAEGTFTSDVSSYLEGQAAKEIFAWLVKGR	Discovery agent	.	.
DNC009334	3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol	Discovery agent	.	.
DNC009335	3-[5-(4-hydroxyphenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC009336	3,4'-(thiophene-2,4-diyl)diphenol	Discovery agent	.	.
DNC009337	3,3'-Pyridine-2,5-diyldiphenol	Discovery agent	.	.
DNC009338	3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol	Discovery agent	.	.
DNC009339	3,3'-(1,2,4-thiadiazole-3,5-diyl)diphenol	Discovery agent	.	.
DNC009340	3,3'-thiene-2,5-diyldiphenol	Discovery agent	.	.
DNC009341	1,1':4',1''-terphenyl-3,3''-diol	Discovery agent	.	.
DNC009342	3,3'-Thiene-2,4-diyldiphenol	Discovery agent	.	.
DNC009343	3,3'-(1,2,4,5-tetrazine-3,6-diyl)diphenol	Discovery agent	.	.
DNC009344	3,3-(1,3-Thiazole-2,5-diyl)diphenol	Discovery agent	.	.
DNC009345	3,3'-(1,2,4-Thiadiazol-2,5-diyl)diphenol	Discovery agent	.	.
DNC009346	3-(5-phenyl-2-thienyl)phenol	Discovery agent	.	.
DNC009347	3,3'-(1,3-Thiazol-2,4-diyl)diphenol	Discovery agent	.	.
DNC009348	1,1':4',1''-terphenyl-3,4''-diol	Discovery agent	.	.
DNC009349	3,3'-pyrazine-2,5-diyldiphenol	Discovery agent	.	.
DNC009350	PF-0998425	Discovery agent	.	.
DNC009351	2'-Hydroxy-3-methoxy-biphenyl-4-carbonitrile	Discovery agent	.	.
DNC009352	GOSSYPETIN	Discovery agent	.	.
DNC009353	1-(1-Benzyl-2-biphenyl-4-yl-ethyl)-1H-imidazole	Discovery agent	.	.
DNC009354	Benzyl-biphenyl-4-ylmethyl-imidazol-1-yl-amine	Discovery agent	.	.
DNC009355	2-(2-(4-tert-butylphenoxy)acetamido)benzoic acid	Discovery agent	.	.
DNC009356	3-(1H-indol-1-yl)-N-methyl-3-phenylpropan-1-amine	Discovery agent	.	.
DNC009357	(R)-(-)-11-hydroxy-N-n-propylnoraporphine	Discovery agent	.	.
DNC009358	11-Heptanoyloxy-N-n-propylnoraporphine	Discovery agent	.	.
DNC009359	11-Hexanoyloxy-N-n-propylnoraporphine	Discovery agent	.	.
DNC009360	11-Butyryloxy-N-n-propylnoraporphine	Discovery agent	.	.
DNC009361	11-Propionyloxy-N-n-propylnoraporphine	Discovery agent	.	.
DNC009362	11-valeryloxynoraporphine	Discovery agent	.	.
DNC009363	6,7-dibromoquinoline-5,8-dione	Discovery agent	.	.
DNC009364	SB-782443	Discovery agent	.	.
DNC009365	H-Arg-Arg-Pro-Tyr-Ile-Aac-OH	Discovery agent	.	.
DNC009366	H-Arg-Arg-Pro-Tyr-Ile-N-Me-Leu-OH	Discovery agent	.	.
DNC009367	H-Arg-Arg-Pro-Tyr-N-Me-Ile-Leu-OH	Discovery agent	.	.
DNC009368	H-Arg-N-Me-Arg-Pro-Tyr-Ile-Leu-OH	Discovery agent	.	.
DNC009369	Arg-Arg-Pro-Tyr-Ile-Leu-OH	Discovery agent	.	.
DNC009370	(-)-Cercosporamide	Discovery agent	.	.
DNC009371	NP-506	Discovery agent	.	.
DNC009372	5-aminoisoquinolin-1(2H)-one	Discovery agent	.	.
DNC009373	2-(4-methoxyphenyl)quinoline-8-carboxamide	Discovery agent	.	.
DNC009374	2-phenylquinoline-8-carboxamide	Discovery agent	.	.
DNC009375	2-ethylquinoline-8-carboxamide	Discovery agent	.	.
DNC009376	2-Methylquinoline-8-carboxamide	Discovery agent	.	.
DNC009377	3-Prop-1-ynylquinoline-8-carboxamide	Discovery agent	.	.
DNC009378	3-Ethenylquinoline-8-carboxamide	Discovery agent	.	.
DNC009379	3-Ethylquinoline-8-carboxamide	Discovery agent	.	.
DNC009380	3-Ethynylquinoline-8-carboxamide	Discovery agent	.	.
DNC009381	3-Methylquinoline-8-carboxamide	Discovery agent	.	.
DNC009382	Quinoline-8-carboxamide	Discovery agent	.	.
DNC009383	3-Phenylquinoline-8-carboxamide	Discovery agent	.	.
DNC009384	Cyclo(1,10)H-EIYDPGDDIK-OH	Discovery agent	.	.
DNC009385	Cyclo(1,10)EIYDPGDDIK	Discovery agent	.	.
DNC009386	Cyclo(1,11)H-ESIYDPGDDIK-OH	Discovery agent	.	.
DNC009387	12-EPI-SALVINORIN A	Discovery agent	.	.
DNC009388	(E)-N-(4-Phenylthiazol-2-yl) cinnamamide	Discovery agent	.	.
DNC009389	N-(4-Phenylthiazol-2-yl)isonicotinamide	Discovery agent	.	.
DNC009390	3-(4-methoxyphenyl)quinoxaline-5-carboxamide	Discovery agent	.	.
DNC009391	3-(4-cyanophenyl)quinoxaline-5-carboxamide	Discovery agent	.	.
DNC009392	3-(4-aminophenyl)quinoxaline-5-carboxamide	Discovery agent	.	.
DNC009393	1,2,3,4,4a,5-hexahydrophenanthridin-6(10bH)-one	Discovery agent	.	.
DNC009394	3-aminobenzo[c][1,5]naphthyridin-6(5H)-one	Discovery agent	.	.
DNC009395	Benzo[c][1,5]naphthyridin-6(5H)-one	Discovery agent	.	.
DNC009396	2-(1-benzyl-1H-inden-3-yl)-N,N-dimethylethanamine	Discovery agent	.	.
DNC009397	UCM-454	Discovery agent	.	.
DNC009398	N-(3-(3-methoxyphenyl)-3-phenylallyl)acetamide	Discovery agent	.	.
DNC009399	4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline	Discovery agent	.	.
DNC009400	GNF-PF-5434	Discovery agent	.	.
DNC009401	N-1,3,4-thiadiazol-2-ylsulfamide	Discovery agent	.	.
DNC009402	N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide	Discovery agent	.	.
DNC009403	N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide	Discovery agent	.	.
DNC009404	N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Discovery agent	.	.
DNC009405	N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Discovery agent	.	.
DNC009406	N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide	Discovery agent	.	.
DNC009407	4-(methyl(4-phenylthiazol-2-yl)amino)phenol	Discovery agent	.	.
DNC009408	2-(biphenyl-4-ylsulfonamido)pentanedioic acid	Discovery agent	.	.
DNC009409	Ethyl 2-cyano-2-(quinoxalin-2(1H)-ylidene)acetate	Discovery agent	.	.
DNC009410	2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol	Discovery agent	.	.
DNC009411	4-amino-3-(4-(hexyloxy)phenyl)-4-oxobutanoic acid	Discovery agent	.	.
DNC009412	4-(2,2'-bithiophen-5-ylmethyleneamino)phenol	Discovery agent	.	.
DNC009413	Adenosine Monophosphate (Amp)	Discovery agent	.	.
DNC009414	CORDOIN	Discovery agent	.	.
DNC009415	CHALCONE	Discovery agent	.	.
DNC009416	3-Bromo-5-phenylsalicylc acid	Discovery agent	.	.
DNC009417	CAMBINOL	Discovery agent	.	.
DNC009418	PF-00734200	Diabetes mellitus type 2	.	E11
DNC009418	PF-00734200	Discovery agent	.	.
DNC009419	KF-A5	Discovery agent	.	.
DNC009420	KF-A6	Discovery agent	.	.
DNC009421	BETRIXABAN	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC009421	BETRIXABAN	Discovery agent	.	.
DNC009422	GW-4064	Discovery agent	.	.
DNC009423	SIPATRIGINE	Discovery agent	.	.
DNC009423	SIPATRIGINE	Neurological disease	.	G00-G99
DNC009424	BW-202W92	Discovery agent	.	.
DNC009425	(E)-5-Styrylisatin	Discovery agent	.	.
DNC009426	(E)-5-(3-Chlorostyryl)isatin	Discovery agent	.	.
DNC009427	(E)-5-(3-Fluorostyryl)isatin	Discovery agent	.	.
DNC009428	(E)-6-Styrylisatin	Discovery agent	.	.
DNC009429	(E)-8-(3-chlorostyryl)-caffeine	Discovery agent	.	.
DNC009430	N-(Biphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide	Discovery agent	.	.
DNC009431	TETRAHYDROQUINOLINE A	Discovery agent	.	.
DNC009432	TETRAHYDROQUINOLINE B	Discovery agent	.	.
DNC009433	1-(3-(benzyloxy)-2-methylphenyl)piperazine	Discovery agent	.	.
DNC009434	NU-6086	Discovery agent	.	.
DNC009435	NU-6094	Discovery agent	.	.
DNC009436	Rac-cis-N-arachidonoylcyclopropanolamide	Discovery agent	.	.
DNC009437	(1S,2S)-N-Arachidonoylcyclopropanolamide	Discovery agent	.	.
DNC009438	(1R,2S)-N-Arachidonoylcyclopropanolamide	Discovery agent	.	.
DNC009439	(1R,2R)-N-Arachidonoylcyclopropanolamide	Discovery agent	.	.
DNC009440	(1R,2S)-N-Oleoylcyclopropanolamide	Discovery agent	.	.
DNC009441	(1S,2S)-N-Oleoylcyclopropanolamide	Discovery agent	.	.
DNC009442	Rac-trans-N-oleoylcyclopropanolamide	Discovery agent	.	.
DNC009443	(1S,2R)-N-Oleoylcyclopropanolamide	Discovery agent	.	.
DNC009444	Cis-N-oleoylcyclopropanolamide	Discovery agent	.	.
DNC009445	(1R,2R)-N-Oleoylcyclopropanolamide	Discovery agent	.	.
DNC009446	BMS-561388	Anxiety disorder	300	F40-F42
DNC009446	BMS-561388	Discovery agent	.	.
DNC009447	LUFFARIELLOLIDE	Discovery agent	.	.
DNC009448	6-bromoaplysinopsin	Discovery agent	.	.
DNC009449	N-3'-ethylaplysinopsin	Discovery agent	.	.
DNC009450	6-bromo-2'-de-N-methylaplysinopsin	Discovery agent	.	.
DNC009451	(-)-isoelaeocarpiline	Discovery agent	.	.
DNC009452	Grandisine F	Discovery agent	.	.
DNC009453	Grandisine D	Discovery agent	.	.
DNC009454	Grandisine C	Discovery agent	.	.
DNC009455	POLYGALATENOSIDE B	Discovery agent	.	.
DNC009456	TASPINE	Discovery agent	.	.
DNC009457	Guttiferone I	Discovery agent	.	.
DNC009458	IMPERATORIN	Discovery agent	.	.
DNC009459	P-hydroxyphenethyl trans-ferulate	Discovery agent	.	.
DNC009460	Cyclo[(6-bromotryptophan)arginine]	Discovery agent	.	.
DNC009461	BARETTIN	Discovery agent	.	.
DNC009462	1-methyltryptophan	Discovery agent	.	.
DNC009463	2-HYDROXYGARVIN A	Discovery agent	.	.
DNC009464	Garveatin C	Discovery agent	.	.
DNC009465	GARVEATIN A	Discovery agent	.	.
DNC009466	Garveatin E	Discovery agent	.	.
DNC009467	2-hydroxygarveatin E	Discovery agent	.	.
DNC009468	ANNULIN B	Discovery agent	.	.
DNC009469	ANNULIN A	Discovery agent	.	.
DNC009470	LOPHOCLADINE A	Discovery agent	.	.
DNC009471	Abyssinone-IV	Discovery agent	.	.
DNC009472	Abyssinone-VI-4-O-methyl ether	Discovery agent	.	.
DNC009473	Docosapentaenoic acid	Discovery agent	.	.
DNC009474	3 beta-O-acetyloleanolic acid	Discovery agent	.	.
DNC009475	NOCARDIMICIN A	Discovery agent	.	.
DNC009476	GNF-PF-5618	Discovery agent	.	.
DNC009477	Nocardimicin C	Discovery agent	.	.
DNC009478	Nocardimicin D	Discovery agent	.	.
DNC009479	Noccardimicin E	Discovery agent	.	.
DNC009480	Nocardimicin F	Discovery agent	.	.
DNC009481	LONCHOCARPUSONE	Discovery agent	.	.
DNC009482	4-hydroxylonchocarpin	Discovery agent	.	.
DNC009483	3-methoxy-4-hydroxylonchocarpin	Discovery agent	.	.
DNC009484	SIDEROXYLONAL A	Discovery agent	.	.
DNC009485	SIDEROXYLONAL B	Discovery agent	.	.
DNC009486	Sideroxylonal C	Discovery agent	.	.
DNC009487	SCH-210971	Discovery agent	.	.
DNC009488	Manzamine Y	Discovery agent	.	.
DNC009489	Neo-kauluamine	Discovery agent	.	.
DNC009490	(8R,8'R)-4-hydroxycubebinone	Discovery agent	.	.
DNC009491	(8R,8'R,9'S)-5-methoxyclusin	Discovery agent	.	.
DNC009492	Alpha-methylcubebin	Discovery agent	.	.
DNC009493	HINOKININ	Discovery agent	.	.
DNC009494	(-)-cubebin	Discovery agent	.	.
DNC009495	(-)-clusin	Discovery agent	.	.
DNC009496	(-)-cubebininolide	Discovery agent	.	.
DNC009497	DIHYDROCUBEBIN	Discovery agent	.	.
DNC009498	(-)-yatein	Discovery agent	.	.
DNC009499	ETHOXYCLUSIN	Discovery agent	.	.
DNC009500	(-)-cubebinin	Discovery agent	.	.
DNC009501	(-)-dihydroclusin	Discovery agent	.	.
DNC009502	(-)-thujaplicatintrimethyl ether	Discovery agent	.	.
DNC009503	MEDIORESINOL	Discovery agent	.	.
DNC009504	CREMASTRINE	Discovery agent	.	.
DNC009505	N-methyllaurotetanine	Discovery agent	.	.
DNC009506	ESCHOLTZINE	Discovery agent	.	.
DNC009507	7-O-b-D-Glucopyranosyl-a-homonojirimycin	Discovery agent	.	.
DNC009508	Alpha-Homonojirimycin	Discovery agent	.	.
DNC009509	L-Isofagomine	Discovery agent	.	.
DNC009510	ISOFAGOMINE	Discovery agent	.	.
DNC009511	1,5-Dideoxy-1,5-imino-D-xylitol	Discovery agent	.	.
DNC009512	SB-242235	Arthritic	710-719	M00-M25
DNC009512	SB-242235	Discovery agent	.	.
DNC009513	ISOFORMONENTIN	Discovery agent	.	.
DNC009514	PACTIMIBE	Arteriosclerosis	.	I70
DNC009514	PACTIMIBE	Discovery agent	.	.
DNC009515	GSK-8062	Discovery agent	.	.
DNC009516	1-(2-mercaptoethyl)-3-(m-tolylsulfonyl)urea	Discovery agent	.	.
DNC009517	1-(4-aminophenylsulfonyl)-3-(2-mercaptoethyl)urea	Discovery agent	.	.
DNC009518	N-(2-(1H-Indol-3-yl)ethyl)biphenyl-4-carboxamide	Discovery agent	.	.
DNC009519	BAICALIN	Discovery agent	.	.
DNC009519	BAICALIN	HIV infections	42	B20
DNC009520	Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine	Discovery agent	.	.
DNC009521	2-Amino-6-furan-2-yl-4-phenyl-nicotinonitrile	Discovery agent	.	.
DNC009522	2-Amino-4,6-diphenyl-nicotinonitrile	Discovery agent	.	.
DNC009523	2-Amino-4,6-di-furan-2-yl-nicotinonitrile	Discovery agent	.	.
DNC009524	2-Amino-6-phenyl-4-thiophen-2-yl-nicotinonitrile	Discovery agent	.	.
DNC009525	2-Amino-4-phenyl-6-thiophen-2-yl-nicotinonitrile	Discovery agent	.	.
DNC009526	2-Amino-4,6-di-thiophen-2-yl-nicotinonitrile	Discovery agent	.	.
DNC009527	2-Amino-4-furan-2-yl-6-phenyl-nicotinonitrile	Discovery agent	.	.
DNC009528	[D-Asp7,Lys10]N/OFQ(1-13)NH2	Discovery agent	.	.
DNC009529	[Asp6,Lys10]N/OFQ(1-13)NH2	Discovery agent	.	.
DNC009530	Cyclo[DAsp7,Lys10]N/OFQ(1-13)NH2	Discovery agent	.	.
DNC009531	Cyclo-[Asp6,Lys10]N/OFQ(1-13)NH2	Discovery agent	.	.
DNC009532	Cyclo[Cys7,Cys10]N/OFQ(1-13)NH2	Discovery agent	.	.
DNC009533	L-368899	Discovery agent	.	.
DNC009534	BVT-2733	Discovery agent	.	.
DNC009535	NSC-341622	Discovery agent	.	.
DNC009536	ROSETTACIN	Discovery agent	.	.
DNC009537	1-Bromo-6-(3-hydroxyphenyl)-2-naphthol	Discovery agent	.	.
DNC009538	6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol	Discovery agent	.	.
DNC009539	3-Hydroxy-7-(3-hydroxyphenyl)-1-naphthonitrile	Discovery agent	.	.
DNC009540	7-Hydroxy-3-(3-hydroxyphenyl)-1-naphthonitrile	Discovery agent	.	.
DNC009541	2-Hydroxy-N,6-bis(3-hydroxyphenyl)-1-naphthamide	Discovery agent	.	.
DNC009542	PSB-6426	Discovery agent	.	.
DNC009543	Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	Discovery agent	.	.
DNC009544	Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	Discovery agent	.	.
DNC009545	Trans-2-fluoro-2-p-tolylcyclopropanamine	Discovery agent	.	.
DNC009546	Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine	Discovery agent	.	.
DNC009547	Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine	Discovery agent	.	.
DNC009548	Trans-2-fluoro-2-phenylcyclopropylamin	Discovery agent	.	.
DNC009549	Cis-2-Fluoro-2-(4-methoxyphenyl)cyclopropylamine	Discovery agent	.	.
DNC009550	Cis-2-(para-fluorophenyl)cyclopropylamine	Discovery agent	.	.
DNC009551	Cis-2-(4-chlorophenyl)-2-fluorocyclopropanamine	Discovery agent	.	.
DNC009552	Cis-2-fluoro-2-phenylcyclopropanamine	Discovery agent	.	.
DNC009553	Cis-2-phenylcyclopropylamine	Discovery agent	.	.
DNC009554	1-[4-(Benzothiazol-2-yloxy)benzyl]piperidin-4-ol	Discovery agent	.	.
DNC009555	2-(4-Piperidin-1-ylmethylphenoxy)benzothiazole	Discovery agent	.	.
DNC009556	2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole	Discovery agent	.	.
DNC009557	2-[4-(2-Morpholin-4-ylethoxy)phenoxy]benzooxazole	Discovery agent	.	.
DNC009558	2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzothiazole	Discovery agent	.	.
DNC009559	2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzooxazole	Discovery agent	.	.
DNC009560	JNJ-10392980	Discovery agent	.	.
DNC009561	4-AMINOPHENOL	Discovery agent	.	.
DNC009562	N-(3,3-Diphenyl)propyl-2-phenylacetamide	Discovery agent	.	.
DNC009563	N-(3-Phenyl)propyl-2-(4-bromophenylacetamide)	Discovery agent	.	.
DNC009564	N-(3-Phenyl)propyl-2,2-diphenylacetamide	Discovery agent	.	.
DNC009565	N-(3,3-Diphenyl)propyl-2,2-diphenylacetamide	Discovery agent	.	.
DNC009566	VIP	Discovery agent	.	.
DNC009567	N-(6-phenoxypyridin-3-yl)-1H-indole-3-carboxamide	Discovery agent	.	.
DNC009568	SB-243213	Anxiety disorder	.	F40-F42
DNC009568	SB-243213	Discovery agent	.	.
DNC009569	VOROZOLE	Discovery agent	.	.
DNC009570	VOROZOLE	Bladder cancer	.	C67
DNC009570	VOROZOLE	Discovery agent	.	.
DNC009571	Mycophenolic bis(sulfonamide)	Discovery agent	.	.
DNC009572	VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2	Discovery agent	.	.
DNC009573	Ac-WVTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009574	Ac-WVTH[Cit]LAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009575	1,1,1-trifluoroheptadecan-2-one	Discovery agent	.	.
DNC009576	1,1,1,2,2-Pentafluoro-8-phenyl-octan-3-one	Discovery agent	.	.
DNC009577	1,1,1,2,2-Pentafluoro-9-phenyl-nonan-3-one	Discovery agent	.	.
DNC009578	1,1,1-Trifluoro-4-(4-hexyloxy-phenyl)-butan-2-one	Discovery agent	.	.
DNC009579	1,1,1-Trifluoro-6-(4-hexyloxy-phenyl)-hexan-2-one	Discovery agent	.	.
DNC009580	4-(4-Decyloxy-phenyl)-1,1,1-trifluoro-butan-2-one	Discovery agent	.	.
DNC009581	6-(4-Decyloxy-phenyl)-1,1,1-trifluoro-hexan-2-one	Discovery agent	.	.
DNC009582	1,1,1,3-Tetrafluoro-heptadecan-2-one	Discovery agent	.	.
DNC009583	2-(4-phenoxyphenoxy)ethanamine	Discovery agent	.	.
DNC009584	2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine	Discovery agent	.	.
DNC009585	AZD-5438	Discovery agent	.	.
DNC009585	AZD-5438	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNC009586	(S)-Ethyl 6-(2-oxohexadecanamido)decanoate	Discovery agent	.	.
DNC009587	(S)-tert-Butyl 4-(2-oxohexadecanamido)pentanoate	Discovery agent	.	.
DNC009588	(S)-Methyl 4-(2-oxohexadecanamido)octanoate	Discovery agent	.	.
DNC009589	Tert-Butyl 5-(2-oxohexadecanamido)pentanoate	Discovery agent	.	.
DNC009590	Allyl 4-(2-oxohexadecanamido)butanoate	Discovery agent	.	.
DNC009591	Tert-Butyl 3-(2-oxohexadecanamido)propanoate	Discovery agent	.	.
DNC009592	Tert-Butyl 2-(2-oxohexadecanamido)acetate	Discovery agent	.	.
DNC009593	Ethyl 2-(2-oxohexadecanamido)acetate	Discovery agent	.	.
DNC009594	Methyl 2-(2-oxohexadecanamido)acetate	Discovery agent	.	.
DNC009595	Ethyl 4-(2-oxohexadecanamido)benzoate	Discovery agent	.	.
DNC009596	N-(4-Ethoxybutyl)-2-oxohexadecanamide	Discovery agent	.	.
DNC009597	Methyl 2-(2-oxo-8-phenyloctanamido)acetate	Discovery agent	.	.
DNC009598	Tert-Butyl 3-(2-oxo-8-phenyloctanamido)propanoate	Discovery agent	.	.
DNC009599	2-Tosylnaphthalene-1,4-diol	Discovery agent	.	.
DNC009600	2-(methylsulfonyl)naphthalene-1,4-diol	Discovery agent	.	.
DNC009601	2-(phenylsulfonyl)naphthalene-1,4-diol	Discovery agent	.	.
DNC009602	2-(4-chlorophenylsulfonyl)naphthalene-1,4-diol	Discovery agent	.	.
DNC009603	2-(4-propylphenylsulfonyl)naphthalene-1,4-diol	Discovery agent	.	.
DNC009604	2-(naphthalen-2-ylsulfonyl)naphthalene-1,4-diol	Discovery agent	.	.
DNC009605	2-tosylanthracene-1,4-diol	Discovery agent	.	.
DNC009606	2-tosylnaphthalene-1,4-dione	Discovery agent	.	.
DNC009607	4-Propyl-1-[3-(phenylpropoxy)propyl]piperidine	Discovery agent	.	.
DNC009608	4-Butyl-1-[3-(phenylpropoxy)propyl]piperidine	Discovery agent	.	.
DNC009609	4-Benzyl-1-[3-phenylpropoxy)propyl]piperidine	Discovery agent	.	.
DNC009610	1-(3-(3-phenylpropoxy)propyl)piperidine	Discovery agent	.	.
DNC009611	5'-deoxy-4'-hydroxy-5'-methylthio-DADMe-ImmH	Discovery agent	.	.
DNC009612	(+/-)-5'-deoxy-4'-fluoro-5'-methylthio-DADMe-ImmH	Discovery agent	.	.
DNC009613	5'-phenylthio-ImmH	Discovery agent	.	.
DNC009614	5'-Methylthio-ImmH	Discovery agent	.	.
DNC009615	UK-371800	Discovery agent	.	.
DNC009615	UK-371800	Erectile dysfunction	.	F52.2,N48.4
DNC009616	UK-343664	Discovery agent	.	.
DNC009617	2-(4-benzylphenoxy)ethanamine	Discovery agent	.	.
DNC009618	1-butoxy-4-phenoxybenzene	Discovery agent	.	.
DNC009619	1-(pentyloxy)-4-phenoxybenzene	Discovery agent	.	.
DNC009620	4-(4-propoxyphenoxy)phenol	Discovery agent	.	.
DNC009621	4-(4-butoxyphenoxy)phenol	Discovery agent	.	.
DNC009622	4-(4-(pentyloxy)phenoxy)phenol	Discovery agent	.	.
DNC009623	6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one	Discovery agent	.	.
DNC009624	3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin	Discovery agent	.	.
DNC009625	3,4-Benzo-7-acetonyloxy-8-methoxycoumarin	Discovery agent	.	.
DNC009626	3,4-Benzo-7-acetonyloxy-8-methylcoumarin	Discovery agent	.	.
DNC009627	7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin	Discovery agent	.	.
DNC009628	7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin	Discovery agent	.	.
DNC009629	4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin	Discovery agent	.	.
DNC009630	N5-(1-iminopent-3-enyl)-L-ornithine	Discovery agent	.	.
DNC009631	VA-106483	Discovery agent	.	.
DNC009631	VA-106483	Nocturia	.	R35
DNC009632	MOFEGILINE	Cognitive impairment	.	F06.7
DNC009632	MOFEGILINE	Discovery agent	.	.
DNC009633	3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine	Discovery agent	.	.
DNC009634	6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol	Discovery agent	.	.
DNC009635	3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine	Discovery agent	.	.
DNC009636	6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one	Discovery agent	.	.
DNC009637	5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one	Discovery agent	.	.
DNC009638	5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one	Discovery agent	.	.
DNC009639	6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one	Discovery agent	.	.
DNC009640	6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione	Discovery agent	.	.
DNC009641	7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one	Discovery agent	.	.
DNC009642	GWTLNSAGYLLGPHAV-NH2	Discovery agent	.	.
DNC009643	N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide	Discovery agent	.	.
DNC009644	N-(1H-indazol-5-yl)icosa-5,8,11,14-tetraenamide	Discovery agent	.	.
DNC009645	N-(4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide	Discovery agent	.	.
DNC009646	N-(1H-indazol-5-yl)acetamide	Discovery agent	.	.
DNC009647	WVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2	Discovery agent	.	.
DNC009648	Ac-VTHRLAGLLSRSGGVVKNNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009649	Ac-VTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009650	Ac-WVTH[Cit]LAGLLSRSGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009651	Ac-WVTHRLAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009652	Ac-WVTHQLAGLLSQSGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009653	Ac-WVTH[hArg]LAGLLS[hArg]SGGVVRKNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009654	Ac-WVEHRLKGELSRKGGVV[hArg]KNFVPTDVGPFAF-NH2	Discovery agent	.	.
DNC009655	L-Tryptophan-L-aspartic acid	Discovery agent	.	.
DNC009656	L-Tryptophan-L-2-aminoadipic acid	Discovery agent	.	.
DNC009657	L-Tryptophan-L-leucine	Discovery agent	.	.
DNC009658	N1-(biphenyl-3-yl)-N8-hydroxyoctanediamide	Discovery agent	.	.
DNC009659	N-(biphenyl-3-yl)-6-(sulfamoylamino)hexanamide	Discovery agent	.	.
DNC009660	N-phenyl-6-(sulfamoylamino)hexanamide	Discovery agent	.	.
DNC009661	N-(quinolin-8-yl)-6-(sulfamoylamino)hexanamide	Discovery agent	.	.
DNC009662	N-(quinolin-6-yl)-6-(sulfamoylamino)hexanamide	Discovery agent	.	.
DNC009663	N-(quinolin-3-yl)-6-(sulfamoylamino)hexanamide	Discovery agent	.	.
DNC009664	CYCLOPAMINE	Discovery agent	.	.
DNC009665	N-benzyl-4-bromo-3-(morpholinosulfonyl)benzamide	Discovery agent	.	.
DNC009666	Sodium sulfamate	Discovery agent	.	.
DNC009667	Sodium phenylarsonate	Discovery agent	.	.
DNC009668	4-(2-thienyl)benzene-1,2-diamine	Discovery agent	.	.
DNC009669	4-(3-thienyl)benzene-1,2-diamine)	Discovery agent	.	.
DNC009670	14-O-phenylpropylnaltrexone	Discovery agent	.	.
DNC009671	5-Fluoro-6-ethyluridine-5'-O-monophosphate	Discovery agent	.	.
DNC009672	5-fluoro-6-amino-UMP	Discovery agent	.	.
DNC009673	5-fluoro-6-iodo-UMP	Discovery agent	.	.
DNC009674	5-fluoro-6-azido-UMP	Discovery agent	.	.
DNC009675	EPIANDROSTERONE	Discovery agent	.	.
DNC009676	C[RGDf-(3S)-Carboxymorpholine]	Discovery agent	.	.
DNC009677	C[RGDf-(3R)-Carboxymorpholine]	Discovery agent	.	.
DNC009678	CHIR-98023	Discovery agent	.	.
DNC009679	2-Aminomethyl-5-(phenyl)tetrahydrofuran	Discovery agent	.	.
DNC009680	2-Aminomethyl-5-(p-chlorophenyl)tetrahydrofuran	Discovery agent	.	.
DNC009681	2-Aminomethyl-5-(p-bromophenyl)tetrahydrofuran	Discovery agent	.	.
DNC009682	2-(Aminomethyl)-5-(2'-naphthyl)tetrahydrofuran	Discovery agent	.	.
DNC009683	2-(Aminomethyl)-5-(1'-naphthyl)tetrahydrofuran	Discovery agent	.	.
DNC009684	2-(Aminomethyl)-5-phenethyltetrahydrofuran	Discovery agent	.	.
DNC009685	2-Aminomethyl-5-(p-methoxyphenyl)tetrahydrofuran	Discovery agent	.	.
DNC009686	2-(Aminomethyl)-5-(1'-naphthethyl)tetrahydrofuran	Discovery agent	.	.
DNC009687	2-(2'-Aminoethyl)-5-benzyltetrahydrofuran	Discovery agent	.	.
DNC009688	2-Aminomethyl-5-(p-t-butylphenyl)tetrahydrofuran	Discovery agent	.	.
DNC009689	L-Tryptophan-L-arginine	Discovery agent	.	.
DNC009690	L-Tryptophan-L-asparagine	Discovery agent	.	.
DNC009691	L-Tryptophan-L-glutamine	Discovery agent	.	.
DNC009692	PD-068235	Discovery agent	.	.
DNC009693	GW-9662	Discovery agent	.	.
DNC009694	2-chloro-5-nitro-N-(pyridin-4-yl)benzamide	Discovery agent	.	.
DNC009695	METAGLIDASEN	Diabetes mellitus type 1	.	E10
DNC009695	METAGLIDASEN	Discovery agent	.	.
DNC009696	17-allylamino-17-desmethoxy-geldanamycin	Discovery agent	.	.
DNC009697	GSK-345931A	Discovery agent	.	.
DNC009697	GSK-345931A	Pain	338,780	R52, G89
DNC009698	2-amino-2,3-dihydro-1H-indene-5-sulfonamide	Discovery agent	.	.
DNC009699	2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid	Discovery agent	.	.
DNC009700	(R)-3-(1'-Adamantanecarbonyl)amino-caprolactam	Discovery agent	.	.
DNC009701	(S)-3-(1'-Adamantanecarbonyl)amino-caprolactam	Discovery agent	.	.
DNC009702	(S)-3-(2',2'-Dimethyl-propionyl)amino-caprolactam	Discovery agent	.	.
DNC009703	3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide	Discovery agent	.	.
DNC009704	VU0238429	Discovery agent	.	.
DNC009705	VU0119498	Discovery agent	.	.
DNC009706	Dihexan-3-yl 5-(hydroxymethyl)isophthalate	Discovery agent	.	.
DNC009707	Diheptan-3-yl 5-(hydroxymethyl)isophthalate	Discovery agent	.	.
DNC009708	1,2-dioctanoyl-sn-glycerol	Discovery agent	.	.
DNC009709	BRYOSTATIN	Alzheimer's disease	331	G30
DNC009709	BRYOSTATIN	Discovery agent	.	.
DNC009710	MK-0668	Discovery agent	.	.
DNC009711	2-(ethoxycarbonyl)-1H-indole-5-carboxylic acid	Discovery agent	.	.
DNC009712	PSB-0739	Discovery agent	.	.
DNC009713	PSB-0702	Discovery agent	.	.
DNC009714	C[L-Phe-D-pro-L-Phe-L-trp]	Discovery agent	.	.
DNC009715	C[L-Phe-D-pro-L-Phe-D-trp]	Discovery agent	.	.
DNC009716	C[L-Tyr-D-pro-L-Phe-D-trp]	Discovery agent	.	.
DNC009717	C[L-Phe-D-pro-L-Tyr-D-trp]	Discovery agent	.	.
DNC009718	C[L-mTyr-D-pro-L-Phe-D-trp]	Discovery agent	.	.
DNC009719	C[L-Phe-D-pro-L-mTyr-D-trp]	Discovery agent	.	.
DNC009720	C[L-Tyr(OMe)-D-pro-L-Phe-D-trp]	Discovery agent	.	.
DNC009721	C[L-Phe-D-pro-L-Tyr(OMe)-D-trp]	Discovery agent	.	.
DNC009722	C[L-Ala-D-pro-L-Phe-D-trp]	Discovery agent	.	.
DNC009723	Ac-D-pro-L-Phe-D-trp-L-Phe-NH2	Discovery agent	.	.
DNC009724	Ac-L-Phe-D-trp-L-Phe-D-pro-NH2	Discovery agent	.	.
DNC009725	3-[7'-(Methoxy)-napht-2'-yl]-quinuclidine-2-ene	Discovery agent	.	.
DNC009726	3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene	Discovery agent	.	.
DNC009727	Methyl 2-(Benzylamino)-1H-indole-3-carboxylate	Discovery agent	.	.
DNC009728	Methyl 2-(Diallylamino)-1H-indole-3-carboxylate	Discovery agent	.	.
DNC009729	(N-(3-phenoxycinnamyl)-acetohydroxamic acid	Discovery agent	.	.
DNC009730	DIMETHYLSPINGOSINE	Discovery agent	.	.
DNC009731	1-Benzyl-4-(4-phenylpiperazin-1-yl)phthalazine	Discovery agent	.	.
DNC009732	PSB-0788	Discovery agent	.	.
DNC009733	PSB-09120	Discovery agent	.	.
DNC009734	OSIP-339391	Discovery agent	.	.
DNC009735	SB-298	Discovery agent	.	.
DNC009736	PSB-1115	Discovery agent	.	.
DNC009737	Ac-Nle-c[Asp-His-DNaI(2')-Pro-Trp-Lys]-NH2	Discovery agent	.	.
DNC009738	AC-Nle-c[Asp-His-DPhe-Pro-Trp-Lys]-NH2	Discovery agent	.	.
DNC009739	2-chloro-N-(6-cyanopyridin-3-yl)propanamide	Discovery agent	.	.
DNC009740	Ezetimibe-glucuronide	Discovery agent	.	.
DNC009741	Ro-66-1168	Discovery agent	.	.
DNC009742	ZANKIREN	Discovery agent	.	.
DNC009742	ZANKIREN	Hypertension	.	I10-I15
DNC009743	1,3-bis(nitrooxy)propan-2-yl 2-acetoxybenzoate	Discovery agent	.	.
DNC009744	N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide	Discovery agent	.	.
DNC009745	N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide	Discovery agent	.	.
DNC009746	4-(5-bromo-1H-indol-3-yl)pyrimidin-2-amine	Discovery agent	.	.
DNC009747	OXDEX	Discovery agent	.	.
DNC009748	(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline	Discovery agent	.	.
DNC009749	FLUPENTIXOLE	Discovery agent	.	.
DNC009750	10,11-dihydro-5H-dibenzo[b,f]azepine	Discovery agent	.	.
DNC009751	2-(4-chlorobenzylidene)cyclopentylmethyl ether	Discovery agent	.	.
DNC009752	2-(4-Chlorobenzylidene)cyclopentanone	Discovery agent	.	.
DNC009753	2-(4-chlorobenzylidene)cyclopentyl ethyl ether	Discovery agent	.	.
DNC009754	3-Phenylcyclopentanecarboxylic acid	Discovery agent	.	.
DNC009755	2,2-Dibenzylcyclopentanol	Discovery agent	.	.
DNC009756	FR-173657	Discovery agent	.	.
DNC009757	2-phenyl-N-(pyridin-4-yl)quinazolin-4-amine	Discovery agent	.	.
DNC009758	AP-24226	Discovery agent	.	.
DNC009759	AP-24163	Discovery agent	.	.
DNC009760	2-tert-Butyldimethylsilyloxylycorine	Discovery agent	.	.
DNC009761	1-Acetoxy-2-tert-butyldimethylsilyl-oxylycorine	Discovery agent	.	.
DNC009762	1-Acetoxylycorine	Discovery agent	.	.
DNC009763	1,2-Diacetoxylycorine	Discovery agent	.	.
DNC009764	2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide	Discovery agent	.	.
DNC009765	N-Hydroxy-E-3-(4'-cyanobiphenyl-4-yl)-acrylamide	Discovery agent	.	.
DNC009766	5-(Biphenyl-4-yl)-pentanoic acid N-hydroxyamide	Discovery agent	.	.
DNC009767	N-Hydroxy-E-3-(biphenyl-4-yl)-acrylamide	Discovery agent	.	.
DNC009768	N-Hydroxy-E-3-(4'-chlorobiphenyl-4-yl)-acrylamide	Discovery agent	.	.
DNC009769	1-(4-aminophenyl)-2-pyrrolidin-1-yl-pentan-1-one	Discovery agent	.	.
DNC009770	N-cyclopentyl-6-(2-phenylethynyl)nicotinamide	Discovery agent	.	.
DNC009771	Trans-(R(S))-2-Hydroxy-1-phenylethyl nitrate	Discovery agent	.	.
DNC009772	Trans-(1S(R),2S(R))-2-Hydroxycyclooctyl nitrate	Discovery agent	.	.
DNC009773	13-(3-Pentyluredo)tridec-8(Z)-enoic acid	Discovery agent	.	.
DNC009774	13-(3-n-Pentylthioureido)tridec-8(Z)-enoic Acid	Discovery agent	.	.
DNC009775	13-(n-Pentylcarbamoyloxy)tridec-8(Z)-enoic acid	Discovery agent	.	.
DNC009776	13-(3-n-Pentylureido)tridec-8(E)-enoic acid	Discovery agent	.	.
DNC009777	13-(3-n-Pentylureido)tridec-8-ynoic acid	Discovery agent	.	.
DNC009778	13-(3-n-Pentylureido)tridec-5(Z)-enoic acid	Discovery agent	.	.
DNC009779	12-(3-n-Hexylureido)dodec-8(Z)-enoic acid	Discovery agent	.	.
DNC009780	Methyl 14-(3-n-butylureido)tetradec-8(Z)-enoate	Discovery agent	.	.
DNC009781	16-(3-Ethylureido)hexadec-11(Z)-enoic acid	Discovery agent	.	.
DNC009782	12-(3-n-Pentylureidooxy)dodec-8(Z)-enoic acid	Discovery agent	.	.
DNC009783	13-n-Heptanamidotridec-8(Z)-enoic acid	Discovery agent	.	.
DNC009784	13-(N-Methyl-n-heptnamido)tridec-8(Z)-enoic acid	Discovery agent	.	.
DNC009785	13-(N-Isopropylheptanamido)tridec-8(Z)-enoic acid	Discovery agent	.	.
DNC009786	13-n-Heptanamidotridec-5-ynoic acid	Discovery agent	.	.
DNC009787	14-(n-Hexylamino)-14-oxotetradec-8(Z)-enoic acid	Discovery agent	.	.
DNC009788	13-(5-n-Pentylfuran-2-yl)tridec-8(Z)-enoic acid	Discovery agent	.	.
DNC009789	9-(3-n-Pentylureido)non-4(Z)-enoic acid	Discovery agent	.	.
DNC009790	9-(3-n-Pentylureido)non-4-ynoic acid	Discovery agent	.	.
DNC009791	2-(cycloheptylamino)-2-oxoethyl 2-aminonicotinate	Discovery agent	.	.
DNC009792	1-(4-(Hexyloxy)phenyl)-3-morpholinopropan-1-one	Discovery agent	.	.
DNC009793	4-(3-(Dimethylamino)propanoyl)-N-hexylbenzamide	Discovery agent	.	.
DNC009794	3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one	Discovery agent	.	.
DNC009795	Pyrazolo[1,5-a]pyrimidine-3-carboxylate	Discovery agent	.	.
DNC009796	S-tubercidinylhomocysteine	Discovery agent	.	.
DNC009797	(L-)-S-adenosyl-L-homocysteine	Discovery agent	.	.
DNC009798	(E)-12-Nitrooctadec-12-enoic Acid	Discovery agent	.	.
DNC009799	(E)-13-Nitrooctadec-12-enoic Acid	Discovery agent	.	.
DNC009800	(9Z,12E)-12-nitrooctadeca-9,12-dienoic acid	Discovery agent	.	.
DNC009801	(E)-10-Nitrohexadec-9-enoic Acid	Discovery agent	.	.
DNC009802	(E)-9-Nitrohexadec-9-enoicAcid	Discovery agent	.	.
DNC009803	(E)-9-nitrooctadec-9-enoic acid	Discovery agent	.	.
DNC009804	(E)-10-nitrooctadec-9-enoic acid	Discovery agent	.	.
DNC009805	(E)-5-Nitrooctadec-5-enoic Acid	Discovery agent	.	.
DNC009806	(E)-6-Nitrooctadec-5-enoic Acid	Discovery agent	.	.
DNC009807	4-butylphenylboronic acid	Discovery agent	.	.
DNC009808	4-methoxyphenylboronic acid	Discovery agent	.	.
DNC009809	4-bromophenylboronic acid	Discovery agent	.	.
DNC009810	Biphenyl-4-ylboronic acid	Discovery agent	.	.
DNC009811	4-phenoxyphenylboronic acid	Discovery agent	.	.
DNC009812	Beta-naphthylboronic acid	Discovery agent	.	.
DNC009813	Styrylboronic acid	Discovery agent	.	.
DNC009814	4-methylstyrylboronic acid	Discovery agent	.	.
DNC009815	2-(biphenyl-4-yl)vinylboronic acid	Discovery agent	.	.
DNC009816	Phenethylboronic acid	Discovery agent	.	.
DNC009817	3-phenylprop-1-enylboronic acid	Discovery agent	.	.
DNC009818	P-tolylboronic acid	Discovery agent	.	.
DNC009819	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3-ol	Discovery agent	.	.
DNC009820	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,4-diol	Discovery agent	.	.
DNC009821	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,5-diol	Discovery agent	.	.
DNC009822	2-(2-((benzylamino)methyl)phenoxy)-5-chlorophenol	Discovery agent	.	.
DNC009823	1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine	Discovery agent	.	.
DNC009824	3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine	Discovery agent	.	.
DNC009825	1-benzyl-1H-pyrrolo[3,2-b]pyridine	Discovery agent	.	.
DNC009826	1-(2-nitrophenethyl)-1H-pyrrolo[3,2-b]pyridine	Discovery agent	.	.
DNC009827	N-hydroxy-6-oxo-6-phenylhexanamide	Discovery agent	.	.
DNC009828	N-hydroxy-7-oxo-7-phenylheptanamide	Discovery agent	.	.
DNC009829	8-Oxo-8-phenyl-octanoic acid hydroxyamide	Discovery agent	.	.
DNC009830	N-hydroxy-9-oxo-9-phenylnonanamide	Discovery agent	.	.
DNC009831	N-hydroxy-7-(4-methoxyphenyl)-7-oxoheptanamide	Discovery agent	.	.
DNC009832	N-hydroxy-7-(naphthalen-2-yl)-7-oxoheptanamide	Discovery agent	.	.
DNC009833	N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide	Discovery agent	.	.
DNC009834	N-hydroxy-8-(2-methoxyphenyl)-8-oxooctanamide	Discovery agent	.	.
DNC009835	N-hydroxy-8-(4-methoxyphenyl)-8-oxooctanamide	Discovery agent	.	.
DNC009836	8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide	Discovery agent	.	.
DNC009837	8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide	Discovery agent	.	.
DNC009838	N-hydroxy-8-(naphthalen-2-yl)non-8-enamide	Discovery agent	.	.
DNC009839	N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide	Discovery agent	.	.
DNC009840	N-hydroxy-8-(naphthalen-2-yl)octanamide	Discovery agent	.	.
DNC009841	N,8-dihydroxy-8-(naphthalen-2-yl)octanamide	Discovery agent	.	.
DNC009842	Bis-7-tacrine	Discovery agent	.	.
DNC009843	1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea	Discovery agent	.	.
DNC009844	1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea	Discovery agent	.	.
DNC009845	BMS-269223	Discovery agent	.	.
DNC009846	2-(2-(2,5-dichlorophenylamino)phenyl)acetic acid	Discovery agent	.	.
DNC009847	2-(2-(2-chlorophenylamino)phenyl)acetic acid	Discovery agent	.	.
DNC009848	2-(2-(2-fluorophenylamino)phenyl)acetic acid	Discovery agent	.	.
DNC009849	2-(2-(2-fluorophenoxy)phenyl)acetic acid	Discovery agent	.	.
DNC009850	2-(2-(2-chlorophenoxy)phenyl)acetic acid	Discovery agent	.	.
DNC009851	HONOKIOL	Discovery agent	.	.
DNC009852	METHYLHONOKIOL	Discovery agent	.	.
DNC009853	5,3'-Dipropyl-biphenyl-2,4'-diol	Discovery agent	.	.
DNC009854	4'-Methoxy-5,3'-dipropyl-biphenyl-2ol	Discovery agent	.	.
DNC009855	2,4'-Diacetoxy-5,3'-di-(2-propenyl)-biphenyl	Discovery agent	.	.
DNC009856	2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl	Discovery agent	.	.
DNC009857	4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide	Discovery agent	.	.
DNC009858	N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide	Discovery agent	.	.
DNC009859	N-(3,3-diphenyl-propyl)-nicotinamide	Discovery agent	.	.
DNC009860	N-(3,3-Diphenyl-propyl)-isonicotinamide	Discovery agent	.	.
DNC009861	N-[3,3-Bis-(4-fluorophenyl)-propyl]-nicotinamide	Discovery agent	.	.
DNC009862	N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide	Discovery agent	.	.
DNC009863	4,4-Diphenyl-N-(pyridin-3-yl)-butyramide	Discovery agent	.	.
DNC009864	N-(4,4-Diphenyl-butyl)-nicotinamide	Discovery agent	.	.
DNC009865	N-(3-Phenyl-propyl)-nicotinamide	Discovery agent	.	.
DNC009866	1,1-diphenyl-2-(3-tropanyl)ethanol	Discovery agent	.	.
DNC009867	(4-methoxyphenyl)(4-phenylazepan-1-yl)methanone	Discovery agent	.	.
DNC009868	1-(4-ethylphenylsulfonyl)-4-phenylazepan-4-ol	Discovery agent	.	.
DNC009869	1-(4-chlorophenylsulfonyl)-4-phenylazepan-4-ol	Discovery agent	.	.
DNC009870	1-(4-methoxyphenylsulfonyl)-4-phenylazepan-4-ol	Discovery agent	.	.
DNC009871	1-(4-tert-butylphenylsulfonyl)azepan-4-ol	Discovery agent	.	.
DNC009872	1-(4-tert-butylphenylsulfonyl)-4-methoxyazepane	Discovery agent	.	.
DNC009873	5-(piperidin-1-ylsulfonyl)indoline-2,3-dione	Discovery agent	.	.
DNC009874	5-(azetidin-1-ylsulfonyl)indoline-2,3-dione	Discovery agent	.	.
DNC009875	5-(azepan-1-ylsulfonyl)indoline-2,3-dione	Discovery agent	.	.
DNC009876	5-(pyrrolidin-1-ylsulfonyl)indoline-2,3-dione	Discovery agent	.	.
DNC009877	R-dimethindene	Discovery agent	.	.
DNC009878	VER-24052	Discovery agent	.	.
DNC009879	VER-156084	Discovery agent	.	.
DNC009879	VER-156084	Neuropathic pain	338,780	R52, G89
DNC009880	VER-156085	Discovery agent	.	.
DNC009881	PF-3409409	Attention deficit hyperactivity disorder	314	F90
DNC009881	PF-3409409	Discovery agent	.	.
DNC009882	Tiotropium Bromide	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC009882	Tiotropium Bromide	Discovery agent	.	.
DNC009883	MK-1925	Discovery agent	.	.
DNC009884	EPIMER A	Discovery agent	.	.
DNC009885	ISOMER A	Discovery agent	.	.
DNC009886	ISOMER A	Discovery agent	.	.
DNC009887	6-Hydroxyflavanone	Discovery agent	.	.
DNC009888	5-Methoxyflavone	Discovery agent	.	.
DNC009889	NSC-26745	Discovery agent	.	.
DNC009890	2-bromo-4-methylphenyl 2-nitrobenzoate	Discovery agent	.	.
DNC009891	N-(3,5-dichlorophenyl)-2-nitrobenzamide	Discovery agent	.	.
DNC009892	N-(4-(diethylamino)phenyl)-2-nitrobenzamide	Discovery agent	.	.
DNC009893	2-nitro-N-(2,4,5-trichlorophenyl)benzamide	Discovery agent	.	.
DNC009894	N-(3,5-dimethoxyphenyl)-4-methyl-2-nitrobenzamide	Discovery agent	.	.
DNC009895	N-(2,4-dichlorophenyl)-2-nitrobenzamide	Discovery agent	.	.
DNC009896	N-(2,4-dimethylphenyl)-2-nitrobenzamide	Discovery agent	.	.
DNC009897	N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide	Discovery agent	.	.
DNC009898	4-chloro-N-(2,5-dichlorophenyl)-3-nitrobenzamide	Discovery agent	.	.
DNC009899	N-(3,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide	Discovery agent	.	.
DNC009900	N-(2,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide	Discovery agent	.	.
DNC009901	(E)-5-(4-Hydroxybenzylidene)-1-phenethylhydantoin	Discovery agent	.	.
DNC009902	GW-637185X	Discovery agent	.	.
DNC009903	ST-2741	Discovery agent	.	.
DNC009904	SB-269970	Discovery agent	.	.
DNC009905	Glycyrrhizic acid	Discovery agent	.	.
DNC009906	6beta-naltrexol HCl	Discovery agent	.	.
DNC009907	PD-0166326	Discovery agent	.	.
DNC009908	PD-0173952	Discovery agent	.	.
DNC009909	PD-0173956	Discovery agent	.	.
DNC009910	PD-0173958	Discovery agent	.	.
DNC009911	PD-0179483	Discovery agent	.	.
DNC009912	PD-0180970	Discovery agent	.	.
DNC009913	CGP-57380	Discovery agent	.	.
DNC009914	SU 6656	Discovery agent	.	.
DNC009915	GW-5074	Discovery agent	.	.
DNC009916	PURVALANOLA	Discovery agent	.	.
DNC009917	NM-PP1	Discovery agent	.	.
DNC009918	MONODICTYOCHROMONE B	Discovery agent	.	.
DNC009919	N-{4-[2-(4-Methoxyphenyl)ethyl]phenyl}phthalimide	Discovery agent	.	.
DNC009920	N-{4-[2-(3-Methoxyphenyl)ethyl]phenyl}phthalimide	Discovery agent	.	.
DNC009921	N-{4-[2-(4-Hydroxyphenyl)ethyl]phenyl}phthalimide	Discovery agent	.	.
DNC009922	N-{4-[2-(3-Hydroxyphenyl)ethyl]phenyl}phthalimide	Discovery agent	.	.
DNC009923	Huprine Y	Discovery agent	.	.
DNC009924	[3H]A-804598	Discovery agent	.	.
DNC009925	STYLISSADINE A	Discovery agent	.	.
DNC009926	STYLISSADINE B	Discovery agent	.	.
DNC009927	CVT-12012	Diabetes mellitus	250	E08-E13
DNC009927	CVT-12012	Discovery agent	.	.
DNC009928	Cis-2,6-dimethyl-1-methyl sulfonyl piperidine	Discovery agent	.	.
DNC009929	1-benzene sulfonyl-cis-2,6-dimethyl piperidine	Discovery agent	.	.
DNC009930	NSC-94891	Discovery agent	.	.
DNC009931	NSC-613604	Discovery agent	.	.
DNC009932	NSC-122427	Discovery agent	.	.
DNC009933	NSC-93358	Discovery agent	.	.
DNC009934	KNI-764	Discovery agent	.	.
DNC009934	KNI-764	Human immunodeficiency virus infection	.	B20
DNC009935	AX-006	Discovery agent	.	.
DNC009936	AX-048	Discovery agent	.	.
DNC009937	4-[2-(2-Thienyl)acetamido]benzenesulfonamide	Discovery agent	.	.
DNC009938	4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide	Discovery agent	.	.
DNC009939	4-(2-Phenylacetamido)benzenesulfonamide	Discovery agent	.	.
DNC009940	4-(2-Phenylacetamidomethyl)benzenesulfonamide	Discovery agent	.	.
DNC009941	4-(2-Phenylacetamidoethyl)benzenesulfonamide	Discovery agent	.	.
DNC009942	4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide	Discovery agent	.	.
DNC009943	4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide	Discovery agent	.	.
DNC009944	4-(2-Phenylacetamido)-3-bromobenzenesulfonamide	Discovery agent	.	.
DNC009945	4-(2-Pyridin-2-ylacetamido)benzenesulfonamide	Discovery agent	.	.
DNC009946	4-(2-Pyridin-4-ylacetamido)benzenesulfonamide	Discovery agent	.	.
DNC009947	2,2-bis(4-chlorophenyl)-N-hydroxyacetamide	Discovery agent	.	.
DNC009948	2,2-bis(3-fluorophenyl)-N-hydroxyacetamide	Discovery agent	.	.
DNC009949	2,2-bis(4-fluorophenyl)-N-hydroxyacetamide	Discovery agent	.	.
DNC009950	N-hydroxy-9H-xanthene-9-carboxamide	Discovery agent	.	.
DNC009951	N-hydroxy-9,10-dihydroanthracene-9-carboxamide	Discovery agent	.	.
DNC009952	N-hydroxy-2,2-diphenylpropanamide	Discovery agent	.	.
DNC009953	N-hydroxy-2,2-diphenylacetamide	Discovery agent	.	.
DNC009954	2-(1,4'-bipiperidin-1'-yl)thiazolo[4,5-b]pyridine	Discovery agent	.	.
DNC009955	2-(1,4'-bipiperidin-1'-yl)thiazolo[4,5-c]pyridine	Discovery agent	.	.
DNC009956	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid	Discovery agent	.	.
DNC009957	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide	Discovery agent	.	.
DNC009958	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide	Discovery agent	.	.
DNC009959	N-Hydroxy-2-(4-methoxy-benzenesulfonyl)benzamide	Discovery agent	.	.
DNC009960	(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid	Discovery agent	.	.
DNC009961	5-(biphenyl-4-yl)-3-methoxypentanoic acid	Discovery agent	.	.
DNC009962	5-(biphenyl-4-yl)-3-oxopentanoic acid	Discovery agent	.	.
DNC009963	2-(2-(biphenyl-4-yl)ethylthio)acetic acid	Discovery agent	.	.
DNC009964	2-(2-(biphenyl-4-yl)ethylsulfinyl)acetic acid	Discovery agent	.	.
DNC009965	2-(2-(biphenyl-4-yl)ethylsulfonyl)acetic acid	Discovery agent	.	.
DNC009966	5-(4'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid	Discovery agent	.	.
DNC009967	5-(3'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid	Discovery agent	.	.
DNC009968	Yohimbine Hydrochloride	Discovery agent	.	.
DNC009969	Octyl sulfamate	Discovery agent	.	.
DNC009970	Decyl sulfamate	Discovery agent	.	.
DNC009971	4-amino-1,2,5-oxadiazole-3-carboximidamide	Discovery agent	.	.
DNC009972	1-Biphenyl-4-ylmaleimide	Discovery agent	.	.
DNC009973	1-Biphenyl-4-ylmethylmaleimide	Discovery agent	.	.
DNC009974	Phenyl-1,4-bismaleimide	Discovery agent	.	.
DNC009975	1,4-bis(malimido)xylene	Discovery agent	.	.
DNC009976	1,10-(methylenedi-4,1-phenylene)bismaleimide	Discovery agent	.	.
DNC009977	1,8-bis-maleimidodiethyleneglycol	Discovery agent	.	.
DNC009978	N-arachidonylmaleimide	Discovery agent	.	.
DNC009979	Methylarachidonyl fluorophosphonate	Discovery agent	.	.
DNC009980	Biphenyl-3-ylcarbamic acid cyclohexyl ester	Discovery agent	.	.
DNC009981	LY-2183240	Discovery agent	.	.
DNC009982	2-phenyl-2H-pyrazolo[4,3-d]pyrimidin-7(6H)-one	Discovery agent	.	.
DNC009983	5,5-Diphenyl-2-iminohydantoin	Discovery agent	.	.
DNC009984	Gly-Arg-Gly-Asp-Ser	Discovery agent	.	.
DNC009985	3,3-dimethyl-5-m-tolyl-2,3-dihydro-1H-inden-1-one	Discovery agent	.	.
DNC009986	3 9-DIHYDRO-N-DESMETHYL-N-ISOPROPYLERYTHROMYCIN A	Discovery agent	.	.
DNC009987	ABT-229	Discovery agent	.	.
DNC009987	ABT-229	Pain	.	G89
DNC009988	3-[5-(3,4-Difluorophenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC009989	3-[5-(4-Fluorophenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC009990	3-[5-(4-Hydroxyphenyl)-2-thienyl]-5-methylphenol	Discovery agent	.	.
DNC009991	3,3'-(3-Methylthiene-2,5-diyl]diphenol	Discovery agent	.	.
DNC009992	3-[5-(3-Fluorophenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC009993	3,3'-(3-Phenylthiene-2,5-diyl)diphenol	Discovery agent	.	.
DNC009994	4-[5-(3-Hydroxyphenyl)-2-thienyl]benzene-1,2-diol	Discovery agent	.	.
DNC009995	4-Methyl-1,1':4',1''-terphenyl-3,4''-diol	Discovery agent	.	.
DNC009996	3,3',3''-Thiene-2,3,5-triyltriphenol	Discovery agent	.	.
DNC009997	1,1':4',1''-terphenyl-3,3''-diol	Discovery agent	.	.
DNC009998	2-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC009999	2-Fluoro-4-[5-(3-hydroxyphenyl)-3-thienyl]phenol	Discovery agent	.	.
DNC010000	4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol	Discovery agent	.	.
DNC010001	4-Fluoro-1,1':4',1''-terphenyl-3,3''-diol	Discovery agent	.	.
DNC010002	4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol	Discovery agent	.	.
DNC010003	3-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC010004	2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol	Discovery agent	.	.
DNC010005	Ethyl Bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetate	Discovery agent	.	.
DNC010006	3-Benzyl-4-hydroxy-6,7-dimethyl-2H-chromen-2-one	Discovery agent	.	.
DNC010007	3-Benzyl-4-hydroxy-2H-benzo[h]chromen-2-one	Discovery agent	.	.
DNC010008	2-Benzyl-1-hydroxy-3H-benzo[f]chromen-3-one	Discovery agent	.	.
DNC010009	4-Hydroxy-3-(1-naphthylmethyl)-2H-chromen-2-one	Discovery agent	.	.
DNC010010	4-Hydroxy-3-(2-naphthylmethyl)-2H-chromen-2-one	Discovery agent	.	.
DNC010011	3-Benzyl-4-hydroxy-2H-chromen-2-one	Discovery agent	.	.
DNC010012	3-(3,4-Dimethylbenzyl)-4-hydroxy-2H-chromen-2-one	Discovery agent	.	.
DNC010013	MASLINIC ACID	Discovery agent	.	.
DNC010014	Augustic acid	Discovery agent	.	.
DNC010015	3-epi-masilinic acid	Discovery agent	.	.
DNC010016	4-(benzylideneamino)benzoic acid	Discovery agent	.	.
DNC010017	4-(4-tert-butylbenzylideneamino)benzoic acid	Discovery agent	.	.
DNC010018	4-(4-hydroxybenzylideneamino)benzoic acid	Discovery agent	.	.
DNC010019	Methyl 4-(4-tert-butylbenzylideneamino)benzoate	Discovery agent	.	.
DNC010020	Methyl 4-(4-hydroxybenzylideneamino)benzoate	Discovery agent	.	.
DNC010021	4-((benzylideneamino)methyl)benzenesulfonamide	Discovery agent	.	.
DNC010022	2-(benzylideneamino)ethanesulfonamide	Discovery agent	.	.
DNC010023	2-(4-tert-butylbenzylideneamino)ethanesulfonamide	Discovery agent	.	.
DNC010024	2-(4-hydroxybenzylideneamino)ethanesulfonamide	Discovery agent	.	.
DNC010025	(R)-2-amino-3-(4-octylphenylamino)propan-1-ol	Discovery agent	.	.
DNC010026	(R)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide	Discovery agent	.	.
DNC010027	(S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide	Discovery agent	.	.
DNC010028	(S)-2-amino-6-hydroxy-N-(4-octylphenyl)hexanamide	Discovery agent	.	.
DNC010029	SR-149415	Discovery agent	.	.
DNC010030	N-adamantanemethyloxypentyl-1-deoxynojirimycin	Discovery agent	.	.
DNC010031	Atropisomer 1	Discovery agent	.	.
DNC010032	4-(2-(3-fluorophenoxy)-4-methylphenyl)piperidine	Discovery agent	.	.
DNC010033	4-(2-(2-fluoro-5-methylphenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010034	4-(2-(3-chlorophenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010035	4-(2-fluoro-6-(4-fluorophenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010036	1-(2-(4-fluorophenoxy)phenyl)piperazine	Discovery agent	.	.
DNC010037	1-(2-(3-fluorophenoxy)phenyl)piperazine	Discovery agent	.	.
DNC010038	4-(2-(benzyloxy)-3-fluorophenyl)piperidine	Discovery agent	.	.
DNC010039	4-(2-(benzyloxy)-6-fluorophenyl)piperidine	Discovery agent	.	.
DNC010040	4-(2-(3-fluorophenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010041	4-(2-(4-fluorophenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010042	1-(2-((3-fluorophenoxy)methyl)phenyl)piperazine	Discovery agent	.	.
DNC010043	4-(2-fluoro-6-(3-fluorophenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010044	4-(3-fluoro-2-phenoxyphenyl)piperidine	Discovery agent	.	.
DNC010045	1-(2-(benzyloxy)phenyl)piperazine	Discovery agent	.	.
DNC010046	1-(2-(2-fluorobenzyloxy)phenyl)piperazine	Discovery agent	.	.
DNC010047	4-(2-(2-fluorobenzyloxy)phenyl)piperidine	Discovery agent	.	.
DNC010048	4-(2-fluoro-6-phenoxyphenyl)piperidine	Discovery agent	.	.
DNC010049	4-(2-((3-fluorophenoxy)methyl)phenyl)piperidine	Discovery agent	.	.
DNC010050	4-(2-phenoxyphenyl)piperidine	Discovery agent	.	.
DNC010051	4-(2-(benzyloxy)phenyl)piperidine	Discovery agent	.	.
DNC010052	4-(2-(4-fluorobenzyloxy)phenyl)piperidine	Discovery agent	.	.
DNC010053	4-(2-(4-fluorophenoxy)-4-methylphenyl)piperidine	Discovery agent	.	.
DNC010054	1-(2-phenoxyphenyl)piperazine	Discovery agent	.	.
DNC010055	1-(2-(phenoxymethyl)phenyl)piperazine	Discovery agent	.	.
DNC010056	4-(2-(phenoxymethyl)phenyl)piperidine	Discovery agent	.	.
DNC010057	2-oxo-2H-thiochromene-3-carboxylic acid	Discovery agent	.	.
DNC010058	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Discovery agent	.	.
DNC010059	COUMARIN	Discovery agent	.	.
DNC010060	HERNIARIN	Discovery agent	.	.
DNC010061	ETHOXYCOUMARIN	Discovery agent	.	.
DNC010062	7-propoxy-2H-chromen-2-one	Discovery agent	.	.
DNC010063	7-butoxy-2H-chromen-2-one	Discovery agent	.	.
DNC010064	7-(benzyloxy)-2H-chromen-2-one	Discovery agent	.	.
DNC010065	7-phenethoxy-2H-chromen-2-one	Discovery agent	.	.
DNC010066	7-methoxy-2-oxo-2H-chromene-4-carboxylic acid	Discovery agent	.	.
DNC010067	2-oxo-2H-chromene-3-carboxylic acid	Discovery agent	.	.
DNC010068	6-methyl-2-oxo-2H-chromene-3-carboxylic acid	Discovery agent	.	.
DNC010069	8-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Discovery agent	.	.
DNC010070	Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate	Discovery agent	.	.
DNC010071	6-(hydroxymethyl)-2H-chromen-2-one	Discovery agent	.	.
DNC010072	6-(aminomethyl)-2H-chromen-2-one	Discovery agent	.	.
DNC010073	2-Benzyl-4-piperazin-1-yl-1H-benzimidazole	Discovery agent	.	.
DNC010074	Phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide	Discovery agent	.	.
DNC010075	D-264	Discovery agent	.	.
DNC010076	(-)-5-hydroxy-2-(dipropylamino)tetralin	Discovery agent	.	.
DNC010077	D-237	Discovery agent	.	.
DNC010078	D-366	Discovery agent	.	.
DNC010079	D-315	Discovery agent	.	.
DNC010080	N-Benzyl-17-(cyclopropylmethyl)morphinan-3-amine	Discovery agent	.	.
DNC010081	17-(Cyclopropylmethyl)-N-phenylmorphinan-3-amine	Discovery agent	.	.
DNC010082	N-Benzyl-17-(cyclobutylmethyl)morphinan-3-amine	Discovery agent	.	.
DNC010083	17-(Cyclobutylmethyl)-N-phenylmorphinan-3-amine	Discovery agent	.	.
DNC010084	17-Methylmorphinan-3-yl 4-Iodophenyl Carbamate	Discovery agent	.	.
DNC010085	N-(17-Methylmorphinan-3-yl)-N'-phenylurea	Discovery agent	.	.
DNC010086	N-(4-Iodophenyl)-N'-(17-methylmorphinan-3-yl)urea	Discovery agent	.	.
DNC010087	2-Hydroxymethyl-3-hydroxymorphinan	Discovery agent	.	.
DNC010088	2-Benzylaminomethyl-3-hydroxymorphinan	Discovery agent	.	.
DNC010089	WAY-208466	Discovery agent	.	.
DNC010090	4-(1H-1,2,3-triazol-5-yl)pyridine	Discovery agent	.	.
DNC010091	5-aminoquinolin-8-ol	Discovery agent	.	.
DNC010092	4-aminonaphthalen-1-ol	Discovery agent	.	.
DNC010093	Naphthalene-1,4-diol	Discovery agent	.	.
DNC010094	5-(isopropylamino)quinolin-8-ol	Discovery agent	.	.
DNC010095	4-(methylamino)naphthalen-1-ol	Discovery agent	.	.
DNC010096	4-(ethylamino)naphthalen-1-ol	Discovery agent	.	.
DNC010097	4-(propylamino)naphthalen-1-ol	Discovery agent	.	.
DNC010098	4-(Isopropylamino)-1-naphthol	Discovery agent	.	.
DNC010099	4-(tert-butylamino)naphthalen-1-ol	Discovery agent	.	.
DNC010100	4-(Pent-3-ylamino)-1-naphthol	Discovery agent	.	.
DNC010101	4-(Cyclohexylamino)-1-naphthol	Discovery agent	.	.
DNC010102	4-(Benzylamino)-1-naphthol	Discovery agent	.	.
DNC010103	4-(2-(diethylamino)ethylamino)-1-naphthol	Discovery agent	.	.
DNC010104	4-(2-Hydroxyethoxy)-1-naphthol	Discovery agent	.	.
DNC010105	4-methoxynaphthalen-1-amine	Discovery agent	.	.
DNC010106	4-phenylthiazole-2-thiol	Discovery agent	.	.
DNC010107	2,3-dihydrobenzo[d]thiazole-2-thiol	Discovery agent	.	.
DNC010108	Isosorbide-2-benzylcarbamate-5-(o-toluate)	Discovery agent	.	.
DNC010109	(R)-2-(4-Benzylphenoxymethyl)pyrrolidine	Discovery agent	.	.
DNC010110	1-[4-(4-Iodophenoxy)phenyl]piperazine	Discovery agent	.	.
DNC010111	1-(4-Phenoxyphenyl)piperazine	Discovery agent	.	.
DNC010112	4-[2-(4-Benzylphenoxy)ethyl]pyridine	Discovery agent	.	.
DNC010113	(4-(thiophen-2-yl)phenyl)methanamine	Discovery agent	.	.
DNC010114	DG-041	Discovery agent	.	.
DNC010114	DG-041	Peripheral vascular disease	443.9	I73.9
DNC010115	2-(N-Cyclopropylamino)-3-chloropropiophenone	Discovery agent	.	.
DNC010116	1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one	Discovery agent	.	.
DNC010117	2-(N-tert-Butylamino)-3'-chlorooctanophenone	Discovery agent	.	.
DNC010118	1-(4-bromophenyl)-2-(tert-butylamino)propan-1-one	Discovery agent	.	.
DNC010119	2-(N-tert-Butylamino)-4'-chloropropiophenone	Discovery agent	.	.
DNC010120	2-(N-tert-Butylamino)propiophenone	Discovery agent	.	.
DNC010121	2-(tert-Butylamino)-3',4'-dichlorobutyrophenone	Discovery agent	.	.
DNC010122	2-(N,N-Diethylamino)-3'-chloropropiophenone	Discovery agent	.	.
DNC010123	2-(N-Cyclopentylamino)-3'-chloropropiophenone	Discovery agent	.	.
DNC010124	2-(N-tert-Butylamino)-3',4'-dichloropropiophenone	Discovery agent	.	.
DNC010125	2-(N-Isopropylamino)-3'-chloropropiophenone	Discovery agent	.	.
DNC010126	2-(N-tert-Butylamino)-3'-chloroheptanophenone	Discovery agent	.	.
DNC010127	2-(tert-Butylamino)-3',4'-dichloropentanophenone	Discovery agent	.	.
DNC010128	2-(tert-Butylamino)-3'-fluoropropiophenone	Discovery agent	.	.
DNC010129	2-(N-tert-Butylamino)-3'-chloropentanophenone	Discovery agent	.	.
DNC010130	1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one	Discovery agent	.	.
DNC010131	2-(tert-butylamino)-1-(3-chlorophenyl)butan-1-one	Discovery agent	.	.
DNC010132	1-(3-bromophenyl)-2-(tert-butylamino)propan-1-one	Discovery agent	.	.
DNC010133	2-(N-tert-Butylamino)-3'-chlorohexanophenone	Discovery agent	.	.
DNC010134	BMS-344577	Discovery agent	.	.
DNC010135	SCH-54470	Discovery agent	.	.
DNC010136	3,3-diethyl-1-phenylazetidine-2,4-dione	Discovery agent	.	.
DNC010137	3,3-Diethyl-1-o-tolylazetidine-2,4-dione	Discovery agent	.	.
DNC010138	3,3-Diethyl-1-(pyridin-3-yl)azetidine-2,4-dione	Discovery agent	.	.
DNC010139	1-benzyl-3,3-diethylazetidine-2,4-dione	Discovery agent	.	.
DNC010140	3-Ethyl-3-isobutyl-1-phenylazetidine-2,4-dione	Discovery agent	.	.
DNC010141	3-butyl-3-ethyl-1-phenylazetidine-2,4-dione	Discovery agent	.	.
DNC010142	3-Benzyl-3-ethyl-1-phenylazetidine-2,4-dione	Discovery agent	.	.
DNC010143	3-Benzyl-3-methyl-1-phenylazetidine-2,4-dione	Discovery agent	.	.
DNC010144	1-benzyl-3,3-dimethylazetidine-2,4-dione	Discovery agent	.	.
DNC010145	3-chloro-N-(4-(phenyldiazenyl)phenyl)benzamide	Discovery agent	.	.
DNC010146	N1,N4-bis(5-chloro-2-methylphenyl)succinamide	Discovery agent	.	.
DNC010147	3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile	Discovery agent	.	.
DNC010148	5-(3,4-dichlorophenyl)-1H-pyrazol-3-ol	Discovery agent	.	.
DNC010149	Mulberrofuran W	Discovery agent	.	.
DNC010150	Kuwanon J	Discovery agent	.	.
DNC010151	Mulberrofuran D	Discovery agent	.	.
DNC010152	Kuwanon R	Discovery agent	.	.
DNC010153	ALBAFURAN A	Discovery agent	.	.
DNC010154	Kuwanon V	Discovery agent	.	.
DNC010155	1-(4-p-Tolyl-butyl)-piperidine	Discovery agent	.	.
DNC010156	[1-(4-p-Tolyl-butyl)-piperidin-4-yl]-methanol	Discovery agent	.	.
DNC010157	Diphenyl(piperidin-4-yl)methanol	Discovery agent	.	.
DNC010158	GRASSYSTATIN A	Discovery agent	.	.
DNC010159	AGELADINE A	Discovery agent	.	.
DNC010160	LICOAGROCHACONE A	Discovery agent	.	.
DNC010161	MF-152	Discovery agent	.	.
DNC010162	OSCILLARIN	Discovery agent	.	.
DNC010163	DYSINOSIN A	Discovery agent	.	.
DNC010164	CHLORODYSINOSIN A	Discovery agent	.	.
DNC010165	JNJ-28318706	Discovery agent	.	.
DNC010166	SB-706375	Discovery agent	.	.
DNC010167	Tyr-Pro-Trp-D-Val-Bn	Discovery agent	.	.
DNC010168	Tyr-Pro-Phe-D-Val-Bn	Discovery agent	.	.
DNC010169	Tyr-Pro-Trp-D-Ala-Bn	Discovery agent	.	.
DNC010170	Tyr-Pro-Phe-D-Ala-Bn	Discovery agent	.	.
DNC010171	Tyr-Pro-Trp-Gly-Bn	Discovery agent	.	.
DNC010172	Tyr-Pro-Phe-Ala-Bn	Discovery agent	.	.
DNC010173	N-(piperidin-4-yl)-N-propyl-2-naphthamide	Discovery agent	.	.
DNC010174	N-cyclobutyl-N-(piperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC010175	(R)-N-isopropyl-N-(pyrrolidin-3-yl)-2-naphthamide	Discovery agent	.	.
DNC010176	(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide	Discovery agent	.	.
DNC010177	(S)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide	Discovery agent	.	.
DNC010178	2-(tert-butylamino)-1-p-tolylpropan-1-one	Discovery agent	.	.
DNC010179	2-(tert-Butylamino)-3',5'-difluoropropiophenone	Discovery agent	.	.
DNC010180	N-benzyl-6-(3,3,3-trifluoropropoxy)nicotinamide	Discovery agent	.	.
DNC010181	6-amino-N-(3,3-diphenylpropyl)nicotinamide	Discovery agent	.	.
DNC010182	6-amino-N-(2,4-dichlorobenzyl)nicotinamide	Discovery agent	.	.
DNC010183	4-(1H-indol-5-ylamino)-5-styrylnicotinonitrile	Discovery agent	.	.
DNC010184	4-(3H-indol-4-ylamino)-5-styrylnicotinonitrile	Discovery agent	.	.
DNC010185	4-(1H-indol-6-ylamino)-5-styrylnicotinonitrile	Discovery agent	.	.
DNC010186	4-(1H-indol-5-yloxy)-5-styrylnicotinonitrile	Discovery agent	.	.
DNC010187	N-(biphenyl-4-yl)benzo[d]isoxazol-3-amine	Discovery agent	.	.
DNC010188	N-(biphenyl-3-yl)benzo[d]isoxazol-3-amine	Discovery agent	.	.
DNC010189	N-(naphthalen-2-yl)benzo[d]isoxazol-3-amine	Discovery agent	.	.
DNC010190	N-(naphthalen-1-yl)benzo[d]isoxazol-3-amine	Discovery agent	.	.
DNC010191	Norcisapride	Discovery agent	.	.
DNC010191	Norcisapride	Gastroesophageal reflux disease	.	K21
DNC010192	3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one	Discovery agent	.	.
DNC010193	3-(3-methoxyphenyl)-6-methyl-2H-chromen-2-one	Discovery agent	.	.
DNC010194	3-(4-hydroxyphenyl)-6-methyl-2H-chromen-2-one	Discovery agent	.	.
DNC010195	4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	Discovery agent	.	.
DNC010196	3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide	Discovery agent	.	.
DNC010197	3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	Discovery agent	.	.
DNC010198	3-((4-aminophenyl)diazenyl)benzenesulfonamide	Discovery agent	.	.
DNC010199	PRONTOCIL	Discovery agent	.	.
DNC010200	STEPHOLIDINE	Discovery agent	.	.
DNC010201	DIHYDREXIDINE	Discovery agent	.	.
DNC010202	Tyr-D-Ala-Gly-Phe-Met-NH2	Discovery agent	.	.
DNC010203	4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide	Discovery agent	.	.
DNC010204	Sodium phenylaminomethanesulfonate	Discovery agent	.	.
DNC010205	Sodium N-methylphenylaminomethanesulfonate	Discovery agent	.	.
DNC010206	9-[2-(1-Phosphonobutan-2-yloxy)ethyl]hypoxanthine	Discovery agent	.	.
DNC010207	9-[2-(1-Phosphonopropan-2-yloxy)ethyl]guanine	Discovery agent	.	.
DNC010208	9-[2-(1-Phosphonobutan-2-yloxy)ethyl]guanine	Discovery agent	.	.
DNC010209	9-(2-aminoethyl)-9,10-dihydroanthracene	Discovery agent	.	.
DNC010210	2-(9,10-dihydroanthracen-9-yl)-N-methylethanamine	Discovery agent	.	.
DNC010211	9-(2-aminopropyl)-9,10-dihydroanthracene	Discovery agent	.	.
DNC010212	2,2-Diphenyl-ethylamine	Discovery agent	.	.
DNC010213	N,N-dimethyl-2,2-diphenylethanamine	Discovery agent	.	.
DNC010214	N-methyl-3,3-diphenylpropan-1-amine	Discovery agent	.	.
DNC010215	N,N-Dimethyl-3,3-diphenylpropan-1-amine	Discovery agent	.	.
DNC010216	4,4-Diphenylbutan-1-amine	Discovery agent	.	.
DNC010217	N-methyl-4,4-diphenylbutan-1-amine	Discovery agent	.	.
DNC010218	N,N-dimethyl-4,4-diphenylbutan-1-amine	Discovery agent	.	.
DNC010219	3,3-diphenylpropan-1-amine	Discovery agent	.	.
DNC010220	6-(4-Methylpiperazin-1-yl)pyrimidine-2,4-diamine	Discovery agent	.	.
DNC010221	6-(4-methylpiperazin-1-yl)-9Hpurine	Discovery agent	.	.
DNC010222	9-benzyl-6-(4-methylpiperazin-1-yl)-9H-purine	Discovery agent	.	.
DNC010223	6-(4-Methylpiperazin-1-yl)-9H-purin-2-amine	Discovery agent	.	.
DNC010224	WAY-254011	Discovery agent	.	.
DNC010225	{2-[3-(Phenylsulfonyl)-1H-indol-4-yl]ethyl}amine	Discovery agent	.	.
DNC010226	2-Methyl-1(3)H-anthrasimidazole-6,11-dione	Discovery agent	.	.
DNC010227	NSC-745795	Discovery agent	.	.
DNC010228	2-Butyl-1(3)H-anthra[1,2-d]imidazole-6,11-dione	Discovery agent	.	.
DNC010229	2-Heptyl-1(3)H-anthra[1,2-d]imidazole-6,11-dione	Discovery agent	.	.
DNC010230	NSC-745796	Discovery agent	.	.
DNC010231	NSC-745794	Discovery agent	.	.
DNC010232	NSC-745797	Discovery agent	.	.
DNC010233	NSC-745798	Discovery agent	.	.
DNC010234	NSC-745799	Discovery agent	.	.
DNC010235	NSC-745883	Discovery agent	.	.
DNC010236	NSC-745884	Discovery agent	.	.
DNC010237	NSC-745886	Discovery agent	.	.
DNC010238	NSC-745885	Discovery agent	.	.
DNC010239	2,3-Dimethylnaphtho[2,3-f]quinoxaline-7,12-dione	Discovery agent	.	.
DNC010240	NSC-745887	Discovery agent	.	.
DNC010241	NSC-745888	Discovery agent	.	.
DNC010242	2-(2-methylquinolin-4-ylamino)-N-phenylacetamide	Discovery agent	.	.
DNC010243	R-NORDULOXETINE	Discovery agent	.	.
DNC010244	(S)-NORDULOXETINE	Discovery agent	.	.
DNC010245	IODORESINIFERATOXIN	Discovery agent	.	.
DNC010246	4-(furan-3-yl)-2,6-di(thiophen-2-yl)pyridine	Discovery agent	.	.
DNC010247	PF-3274167	Discovery agent	.	.
DNC010247	PF-3274167	Female sexual arousal disorder	.	F52.2
DNC010248	4-(piperazin-1-yl)thieno[2,3-d]pyrimidine	Discovery agent	.	.
DNC010249	6-methyl-4-(piperazin-1-yl)furo[2,3-d]pyrimidine	Discovery agent	.	.
DNC010250	6-bromo-8-(piperazin-1-yl)imidazo[1,2-a]pyrazine	Discovery agent	.	.
DNC010251	4-(piperazin-1-yl)thieno[3,2-c]pyridine	Discovery agent	.	.
DNC010252	4-(piperazin-1-yl)thieno[3,2-d]pyrimidine	Discovery agent	.	.
DNC010253	4-(piperazin-1-yl)furo[3,2-c]pyridine	Discovery agent	.	.
DNC010254	6-(piperazin-1-yl)-9-propyl-9H-purine	Discovery agent	.	.
DNC010255	4-(piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine	Discovery agent	.	.
DNC010256	2-(piperazin-1-yl)-5,6,7,8-tetrahydroquinoline	Discovery agent	.	.
DNC010257	1-(piperazin-1-yl)isoquinoline	Discovery agent	.	.
DNC010258	(+/-)-nantenine	Discovery agent	.	.
DNC010259	GNF-PF-2094	Discovery agent	.	.
DNC010260	HARMINE	Discovery agent	.	.
DNC010261	4-(6-morpholino-9H-purin-2-yl)phenol	Discovery agent	.	.
DNC010262	(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol	Discovery agent	.	.
DNC010263	4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine	Discovery agent	.	.
DNC010264	4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine	Discovery agent	.	.
DNC010265	3-(6-morpholino-9H-purin-2-yl)phenol	Discovery agent	.	.
DNC010266	2-(6-morpholino-9H-purin-2-yl)phenol	Discovery agent	.	.
DNC010267	4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine	Discovery agent	.	.
DNC010268	2-phenyl-2H-indazole-7-carboxamide	Discovery agent	.	.
DNC010269	5-amino-3,4-dihydroisoquinolin-1(2H)-one	Discovery agent	.	.
DNC010270	2,3-dihydro-1H-benzo[de]isoquinolin-1-one	Discovery agent	.	.
DNC010271	6-(4-chlorophenylamino)-N,N-diethylnicotinamide	Discovery agent	.	.
DNC010272	2-fluoronorepinehprine	Discovery agent	.	.
DNC010273	6-fluoronorepinehprine	Discovery agent	.	.
DNC010274	E-6-O-p-methoxycinnamoyl scandoside methyl ester	Discovery agent	.	.
DNC010275	N1,N3-bis(3-methoxybenzyl)isophthalamide	Discovery agent	.	.
DNC010276	AP18 5	Discovery agent	.	.
DNC010277	3-Methyl-4-phenylbut-3-en-2-one oxime	Discovery agent	.	.
DNC010278	DIMEBOLIN	Discovery agent	.	.
DNC010279	2H-chromeno[2,3-d]pyrimidine-2,4(3H)-dione	Discovery agent	.	.
DNC010280	CP-810123	Discovery agent	.	.
DNC010281	Piperidine-1-carboxylic acid adamantan-2-ylamide	Discovery agent	.	.
DNC010282	2-(2-benzhydryl-4-phenylthiazol-5-yl)acetic acid	Discovery agent	.	.
DNC010283	9-(N-benzylaminomethyl)-9,10-dihydroanthracene	Discovery agent	.	.
DNC010284	2-(2,4-diphenylthiazol-5-yl)acetic acid	Discovery agent	.	.
DNC010285	(S)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	Discovery agent	.	.
DNC010286	(R)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	Discovery agent	.	.
DNC010287	(S)(+)-7-methyl-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010288	(R)(+)-7-methyl-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010289	(S)(+)-7-methyl-2-phenylchroman-4-one	Discovery agent	.	.
DNC010290	(R)(+)-7-methyl-2-phenylchroman-4-one	Discovery agent	.	.
DNC010291	(S)(+)-7-fluoro-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010292	(R)(+)-7-fluoro-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010293	(S)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	Discovery agent	.	.
DNC010294	(R)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	Discovery agent	.	.
DNC010295	(S)(+)-7-fluoro-2-phenylchroman-4-one	Discovery agent	.	.
DNC010296	(R)(+)-7-fluoro-2-phenylchroman-4-one	Discovery agent	.	.
DNC010297	7-methoxy-2-p-tolyl-4H-chromene-4-thione	Discovery agent	.	.
DNC010298	7-methyl-2-p-tolyl-4H-chromene-4-thione	Discovery agent	.	.
DNC010299	7-fluoro-2-p-tolyl-4H-chromene-4-thione	Discovery agent	.	.
DNC010300	7-fluoro-2-(4-fluorophenyl)-4H-chromene-4-thione	Discovery agent	.	.
DNC010301	2-(4-methoxyphenyl)-4H-chromene-4-thione	Discovery agent	.	.
DNC010302	2-p-tolyl-4H-chromene-4-thione	Discovery agent	.	.
DNC010303	7-methoxy-2-p-tolyl-4H-chromen-4-one	Discovery agent	.	.
DNC010304	7-fluoro-2-(4-methoxyphenyl)-4H-chromen-4-one	Discovery agent	.	.
DNC010305	7-fluoro-2-p-tolyl-4H-chromen-4-one	Discovery agent	.	.
DNC010306	NSC-93405	Discovery agent	.	.
DNC010307	2-p-tolyl-4H-chromen-4-one	Discovery agent	.	.
DNC010308	(+/-)-7-methoxy-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010309	(+/-)-2-(4-fluorophenyl)-7-methoxychroman-4-one	Discovery agent	.	.
DNC010310	(+/-)-2-(4-methoxyphenyl)-7-methylchroman-4-one	Discovery agent	.	.
DNC010311	(+/-)-7-methyl-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010312	(+/-)-2-(4-fluorophenyl)-7-methylchroman-4-one	Discovery agent	.	.
DNC010313	(+/-)-7-methyl-2-phenylchroman-4-one	Discovery agent	.	.
DNC010314	(+/-)-7-fluoro-2-(4-methoxyphenyl)chroman-4-one	Discovery agent	.	.
DNC010315	(+/-)-7-fluoro-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010316	(+/-)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	Discovery agent	.	.
DNC010317	(+/-)-7-fluoro-2-phenylchroman-4-one	Discovery agent	.	.
DNC010318	NSC-50187	Discovery agent	.	.
DNC010319	(+/-)-2-p-tolylchroman-4-one	Discovery agent	.	.
DNC010320	(+/-)-2-(4-fluorophenyl)chroman-4-one	Discovery agent	.	.
DNC010321	NSC-50393	Discovery agent	.	.
DNC010322	2-(4-fluorophenyl)-7-methoxy-4H-chromen-4-one	Discovery agent	.	.
DNC010323	SU-11248	Discovery agent	.	.
DNC010324	SU-9516	Discovery agent	.	.
DNC010325	SU-5614	Discovery agent	.	.
DNC010326	SU-6656	Discovery agent	.	.
DNC010327	SU-4984	Discovery agent	.	.
DNC010328	(E)-3-(4-hydroxybenzylidene)indolin-2-one	Discovery agent	.	.
DNC010329	(Z)-5-Amino-3-(4-methoxybenzylidene)indolin-2-one	Discovery agent	.	.
DNC010330	4-(2-fluoro-6-(2-fluorophenoxy)phenyl)piperidine	Discovery agent	.	.
DNC010331	2-phenoxy-3-(piperidin-4-yl)pyridine	Discovery agent	.	.
DNC010332	2-(2-fluorophenoxy)-3-(piperidin-4-yl)pyridine	Discovery agent	.	.
DNC010333	2-(2-chlorophenoxy)-3-(piperidin-4-yl)pyridine	Discovery agent	.	.
DNC010334	2-(2-methoxyphenoxy)-3-(piperidin-4-yl)pyridine	Discovery agent	.	.
DNC010335	3-(piperidin-4-yl)-2-(o-tolyloxy)pyridine	Discovery agent	.	.
DNC010336	1-(2-(2-chlorophenoxy)pyridin-3-yl)piperazine	Discovery agent	.	.
DNC010337	[(3-Bromophenyl)-m-tolyl-ketone]thiosemicarbazone	Discovery agent	.	.
DNC010338	[(3-Bromophenyl)-p-tolyl-ketone]thiosemicarbazone	Discovery agent	.	.
DNC010339	Bis(3-Fluorophenyl)-ketone]thiosemicarbazone	Discovery agent	.	.
DNC010340	11-keto-beta-boswellicacid	Discovery agent	.	.
DNC010341	3-acetyl-11-keto-beta-boswellic acid	Discovery agent	.	.
DNC010342	Ganoderic acid A	Discovery agent	.	.
DNC010343	3-epicorosolic acid methyl ester	Discovery agent	.	.
DNC010344	Tormentic acid methyl ester	Discovery agent	.	.
DNC010345	11-keto-ursolic acid	Discovery agent	.	.
DNC010346	3-acetyl-11-keto-ursolic acid	Discovery agent	.	.
DNC010347	Corosolic acid	Discovery agent	.	.
DNC010348	N-(7-methoxy-4-phenylbenzofuran-2-yl)acetamide	Discovery agent	.	.
DNC010349	Methyl 7-methoxy-4-phenylbenzofuran-2-ylcarbamate	Discovery agent	.	.
DNC010350	Phenyl 7-methoxy-4-phenylbenzofuran-2-ylcarbamate	Discovery agent	.	.
DNC010351	Isosorbide-di-(propylcarbamate)	Discovery agent	.	.
DNC010352	Isosorbide-di-(butylcarbamate)	Discovery agent	.	.
DNC010353	Isosorbide-di-(benzylcarbamate)	Discovery agent	.	.
DNC010354	Isosorbide-di-(ethylcarbamate)	Discovery agent	.	.
DNC010355	8-Benzyloxycaffeine	Discovery agent	.	.
DNC010356	8-(3-Chlorobenzyloxy)caffeine	Discovery agent	.	.
DNC010357	8-(3-Bromobenzyloxy)caffeine	Discovery agent	.	.
DNC010358	8-(3-Fluorobenzyloxy)caffeine	Discovery agent	.	.
DNC010359	8-[(3-Trifluoromethyl)benzyloxy]caffeine	Discovery agent	.	.
DNC010360	8-(3-Methylbenzyloxy)caffeine	Discovery agent	.	.
DNC010361	8-(3-Methoxybenzyloxy)caffeine	Discovery agent	.	.
DNC010362	4-(Bis(2-chloroethyl)amino)-N-p-tolylbenzamide	Discovery agent	.	.
DNC010363	1-Imidazol-1-yl-3-(4-octylphenoxy)propan-2-one	Discovery agent	.	.
DNC010364	1-amino-4-chloroanthracene-9,10-dione	Discovery agent	.	.
DNC010365	1,4-diaminoanthracene-9,10-dione	Discovery agent	.	.
DNC010366	1-amino-4-methoxyanthracene-9,10-dione	Discovery agent	.	.
DNC010367	1-amino-2,4-bis(phenylthio)anthracene-9,10-dione	Discovery agent	.	.
DNC010368	1-amino-2-phenoxyanthracene-9,10-dione	Discovery agent	.	.
DNC010369	1-aminoanthracene-9,10-dione	Discovery agent	.	.
DNC010370	2-amino-3-(m-tolylamino)naphthalene-1,4-dione	Discovery agent	.	.
DNC010371	(3-amino-5-bromobenzofuran-2-yl)(phenyl)methanone	Discovery agent	.	.
DNC010372	4-amino-2-p-tolylisoindoline-1,3-dione	Discovery agent	.	.
DNC010373	PARAOXON	Discovery agent	.	.
DNC010374	NSC-622444	Discovery agent	.	.
DNC010375	NSC-623548	Discovery agent	.	.
DNC010376	NSC-137546	Discovery agent	.	.
DNC010377	NSC-56071	Discovery agent	.	.
DNC010378	NSC-319745	Discovery agent	.	.
DNC010379	NSC-106084	Discovery agent	.	.
DNC010380	NSC-345763	Discovery agent	.	.
DNC010381	NSC-54162	Discovery agent	.	.
DNC010382	NSC-154957	Discovery agent	.	.
DNC010383	NSC-158324	Discovery agent	.	.
DNC010384	NSC-57893	Discovery agent	.	.
DNC010385	NSC-138419	Discovery agent	.	.
DNC010386	NSC-348926	Discovery agent	.	.
DNC010387	NSC-401077	Discovery agent	.	.
DNC010388	S-Adenosylhomocysteine	Discovery agent	.	.
DNC010389	2,4-dichloro-5-sulfamoylbenzoic acid	Discovery agent	.	.
DNC010390	Acerogenin A	Discovery agent	.	.
DNC010391	ACEROGENIN B	Discovery agent	.	.
DNC010392	Acerogenin C	Discovery agent	.	.
DNC010393	2-fluorophenyl 4-butoxyphenylcarbamate	Discovery agent	.	.
DNC010394	2-fluorophenyl 4-(heptyloxy)phenylcarbamate	Discovery agent	.	.
DNC010395	2-fluorophenyl 4-(octyloxy)phenylcarbamate	Discovery agent	.	.
DNC010396	2-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate	Discovery agent	.	.
DNC010397	2-fluorophenyl 4-(undecyloxy)phenylcarbamate	Discovery agent	.	.
DNC010398	2-fluorophenyl 4-(dodecyloxy)phenylcarbamate	Discovery agent	.	.
DNC010399	4-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate	Discovery agent	.	.
DNC010400	4-methoxyphenyl 1-(4-butoxyphenyl)propylcarbamate	Discovery agent	.	.
DNC010401	Phenyl 1-(4-butoxyphenyl)propylcarbamate	Discovery agent	.	.
DNC010402	3-(trifluoromethyl)phenyl 4-butoxybenzylcarbamate	Discovery agent	.	.
DNC010403	3-chlorophenyl 4-butoxybenzylcarbamate	Discovery agent	.	.
DNC010404	2,4-difluorophenyl 4-butoxybenzylcarbamate	Discovery agent	.	.
DNC010405	2-fluorophenyl 4-butoxybenzylcarbamate	Discovery agent	.	.
DNC010406	Pyridin-3-yl 4-butoxybenzylcarbamate	Discovery agent	.	.
DNC010407	4-fluorophenyl 4-butoxybenzylcarbamate	Discovery agent	.	.
DNC010408	Propan-2-one O-4-ethoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010409	Propan-2-one O-4-propoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010410	Propan-2-one O-4-butoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010411	Propan-2-one O-4-(pentyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010412	Propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010413	Propan-2-one O-4-(heptyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010414	Propan-2-one O-4-(octyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010415	Propan-2-one O-4-(nonyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010416	Propan-2-one O-4-(decyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010417	Benzaldehyde O-4-methoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010418	Benzaldehyde O-4-ethoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010419	Benzaldehyde O-4-propoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010420	Benzaldehyde O-4-butoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010421	Benzaldehyde O-4-(pentyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010422	Benzaldehyde O-4-(hexyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010423	Benzaldehyde O-4-(heptyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010424	Benzaldehyde O-4-(octyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010425	Benzaldehyde O-4-(nonyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010426	Benzaldehyde O-4-(decyloxy)phenylcarbamoyl oxime	Discovery agent	.	.
DNC010427	Nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010428	Nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010429	Nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010430	Propan-2-one O-3-butoxyphenylcarbamoyl oxime	Discovery agent	.	.
DNC010431	Propan-2-one O-4-butoxybenzylcarbamoyl oxime	Discovery agent	.	.
DNC010432	2-fluorophenyl 4-phenoxyphenylcarbamate	Discovery agent	.	.
DNC010433	2-fluorophenyl 4'-ethylbiphenyl-4-ylcarbamate	Discovery agent	.	.
DNC010434	Phenyl 4-(hexyloxy)phenylcarbamate	Discovery agent	.	.
DNC010435	Phenyl 4-(heptyloxy)phenylcarbamate	Discovery agent	.	.
DNC010436	Phenyl 4-(octyloxy)phenylcarbamate	Discovery agent	.	.
DNC010437	Phenyl 4-(decyloxy)phenylcarbamate	Discovery agent	.	.
DNC010438	Phenyl 4-(undecyloxy)phenylcarbamate	Discovery agent	.	.
DNC010439	Phenyl 4-(dodecyloxy)phenylcarbamate	Discovery agent	.	.
DNC010440	2-fluorophenyl 4-(hexyloxy)phenylcarbamate	Discovery agent	.	.
DNC010441	2-fluorophenyl 4-(decyloxy)phenylcarbamate	Discovery agent	.	.
DNC010442	4-fluorophenyl 4-butoxyphenylcarbamate	Discovery agent	.	.
DNC010443	1-Benzyl-4-(3-hydroxyphenyl)piperidine	Discovery agent	.	.
DNC010444	1-(3-Hydroxyphenyl)-4-propylpiperazine	Discovery agent	.	.
DNC010445	3-(N-propylpiperidin-4-yl)phenol	Discovery agent	.	.
DNC010446	1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperazine	Discovery agent	.	.
DNC010447	1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperidine	Discovery agent	.	.
DNC010448	1-[3-(Methylsulfonyl)phenyl]-4-propylpiperazine	Discovery agent	.	.
DNC010449	4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine	Discovery agent	.	.
DNC010450	Preclamol	Discovery agent	.	.
DNC010451	PKC-412	Discovery agent	.	.
DNC010451	PKC-412	Leukaemia	.	C91-C95
DNC010452	Syringic Acid	Discovery agent	.	.
DNC010453	FERULIC ACID	Discovery agent	.	.
DNC010454	P-Coumaric Acid	Discovery agent	.	.
DNC010455	PHENOL	Discovery agent	.	.
DNC010456	SLV-320	Discovery agent	.	.
DNC010456	SLV-320	Heart failure	.	I50
DNC010457	Tonapofylline	Discovery agent	.	.
DNC010458	FK-838	Discovery agent	.	.
DNC010458	FK-838	Hypertension	.	I10-I15
DNC010459	2-(2-Bromophenylthio)-N,N-dimethylethanamine	Discovery agent	.	.
DNC010460	2-(2-Bromophenoxy)-N,N-dimethylethanamine	Discovery agent	.	.
DNC010461	2-(Biphenyl-2-ylthio)-N,N-dimethylethanamine	Discovery agent	.	.
DNC010462	2-(Biphenyl-2-yloxy)-N,N-dimethylethanamine	Discovery agent	.	.
DNC010463	(R)-8-phenyl-N,N-dipropylchroman-3-amine	Discovery agent	.	.
DNC010464	N,N-dimethyl-2-(2'-methylbiphenyl-3-yl)ethanamine	Discovery agent	.	.
DNC010465	2-(N-Pyrrolidinyl)-3'-fluoropropiophenone	Discovery agent	.	.
DNC010466	2-(N-Pyrrolidinyl)-3'-methylpropiophenone	Discovery agent	.	.
DNC010467	2-(N-Pyrrolidinyl)-3'-methoxypropiophenone	Discovery agent	.	.
DNC010468	N-(5-Benzoyl-4-phenylthiazol-2-yl)benzamide	Discovery agent	.	.
DNC010469	Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate	Discovery agent	.	.
DNC010470	SB-220025	Discovery agent	.	.
DNC010471	SB-218655	Discovery agent	.	.
DNC010472	Dihydro-quinolinone	Discovery agent	.	.
DNC010473	[R]-Mesopram	Discovery agent	.	.
DNC010474	ZARDAVERINE	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNC010474	ZARDAVERINE	Discovery agent	.	.
DNC010475	2-(N-Cyclopentylamino)-3'-fluoropropiophenone	Discovery agent	.	.
DNC010476	2-(N-Pyrrolidinyl)-3'-bromopropiophenone	Discovery agent	.	.
DNC010477	2-(N-Cyclopentylamino)-3'-methylpropiophenone	Discovery agent	.	.
DNC010478	2-(N-Cyclopentylamino)-3'-bromopropiophenone	Discovery agent	.	.
DNC010479	2-(tert-butylamino)-1-m-tolylpropan-1-one	Discovery agent	.	.
DNC010480	2-(N-Cyclopentylamino)-3'-methoxypropiophenone	Discovery agent	.	.
DNC010481	2-(N-Pyrrolidinyl)-3'-nitropropiophenone	Discovery agent	.	.
DNC010482	10-methoxy-N(1)-methylburnamine-17-O-veratrate	Discovery agent	.	.
DNC010483	Alstiphyllanine D	Discovery agent	.	.
DNC010484	Alstiphyllanine E	Discovery agent	.	.
DNC010485	Alstiphyllanine F	Discovery agent	.	.
DNC010486	Burnamine-17-O-3',4',5'-trimethoxybenzoate	Discovery agent	.	.
DNC010487	Acid blue 25	Discovery agent	.	.
DNC010488	PSB-0963	Discovery agent	.	.
DNC010489	7-(3,6,9,12-tetraoxatricos-22-enyl)theophylline	Discovery agent	.	.
DNC010490	BENZYLIMIDAZOLE	Discovery agent	.	.
DNC010491	1-(4-fluorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC010492	1-(4-Bromobenzyl)-1H-imidazole	Discovery agent	.	.
DNC010493	(4-((1H-imidazol-1-yl)methyl)phenyl)methanol	Discovery agent	.	.
DNC010494	1-(4-Aminobenzyl)-1H-imidazole	Discovery agent	.	.
DNC010495	1-(3-Fluorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC010496	1-(3-Chlorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC010497	1-(3-Bromobenzyl)-1H-imidazole	Discovery agent	.	.
DNC010498	(3-((1H-imidazol-1-yl)methyl)phenyl)methanol	Discovery agent	.	.
DNC010499	3-((1H-imidazol-1-yl)methyl)aniline	Discovery agent	.	.
DNC010500	Methyl 3-(1-Benzyl-1H-imidazol-5-yl)-propanoate	Discovery agent	.	.
DNC010501	3-(1-Benzyl-1H-imidazol-5-yl)-1-propanol	Discovery agent	.	.
DNC010502	3-[1-(4-Cyanobenzyl)-1H-imidazol-5-yl]-1-propanol	Discovery agent	.	.
DNC010503	3-[1-(4-Bromobenzyl)-1H-imidazol-5-yl]-1-propanol	Discovery agent	.	.
DNC010504	1-Benzyl-5-phenyl-1H-imidazole	Discovery agent	.	.
DNC010505	1-(4-Cyanobenzyl)-5-phenyl-1H-imidazole	Discovery agent	.	.
DNC010506	1-(4-Fluorobenzyl)-5-phenyl-1H-imidazole	Discovery agent	.	.
DNC010507	1-(4-Chlorobenzyl)-5-phenyl-1H-imidazole	Discovery agent	.	.
DNC010508	1-(4-Bromobenzyl)-5-phenyl-1H-imidazole	Discovery agent	.	.
DNC010509	1-(4-Methoxybenzyl)-5-phenyl-1H-imidazole	Discovery agent	.	.
DNC010510	1-(4-Cyanobenzyl)-5-bromo-1H-imidazole	Discovery agent	.	.
DNC010511	1-(4-Cyanobenzyl)-5-formyl-1H-imidazole	Discovery agent	.	.
DNC010512	1-(4-Cyanobenzyl)-5-hydroxymethyl-1H-imidazole	Discovery agent	.	.
DNC010513	1-(4-Cyanobenzyl)-5-(4-pyridyl)-1H-imidazole	Discovery agent	.	.
DNC010514	1-(4-Cyanobenzyl)-5-(2-fluorophenyl)-1H-imidazole	Discovery agent	.	.
DNC010515	1-(4-Cyanobenzyl)-5-(2-methylphenyl)-1H-imidazole	Discovery agent	.	.
DNC010516	1-(4-Cyanobenzyl)-5-(3-fluorophenyl)-1H-imidazole	Discovery agent	.	.
DNC010517	1-(4-Cyanobenzyl)-5-(3-methylphenyl)-1H-imidazole	Discovery agent	.	.
DNC010518	1-(4-Cyanobenzyl)-5-(4-fluorophenyl)-1H-imidazole	Discovery agent	.	.
DNC010519	1-(4-Cyanobenzyl)-5-(4-methylphenyl)-1H-imidazole	Discovery agent	.	.
DNC010520	R-fadrozole	Discovery agent	.	.
DNC010521	GalB2	Discovery agent	.	.
DNC010522	GwTLNSAGYLLGPHAVGNHRSFSDKNGLTS-CONH2	Discovery agent	.	.
DNC010523	WTLNSAGYLL-CONH2	Discovery agent	.	.
DNC010524	WTLNSAGYLLGPHAVGNHPSFSDKNGLTS-CONH2	Discovery agent	.	.
DNC010525	2',4'-dicyanobiphenyl-4-yl sulfamate	Discovery agent	.	.
DNC010526	1-(biphenyl-3-ylmethyl)-1H-1,2,4-triazole	Discovery agent	.	.
DNC010527	GWTLNSAGYLLGPPPALALA-CONH2	Discovery agent	.	.
DNC010528	GWTLNSAGYLLGPPPGFSPFR-CONH2	Discovery agent	.	.
DNC010529	GWTLNSAGYLLGPRHYINLITRQRY-CONH2	Discovery agent	.	.
DNC010530	GALANTIDE	Discovery agent	.	.
DNC010531	GWTLNSAGYLLGPrPKPQQwFwLL-CONH2	Discovery agent	.	.
DNC010532	[Sar1Ala]GAL-B2	Discovery agent	.	.
DNC010533	[Sar1Gly]GAL-B2	Discovery agent	.	.
DNC010534	[N-Ac,des-Sar]Gal-B2	Discovery agent	.	.
DNC010535	[N-Me,des-Sar]Gal-B2	Discovery agent	.	.
DNC010536	Gal-B5	Discovery agent	.	.
DNC010537	4-Benzyloxybenzo[b]thiophene-2-carboxamidine	Discovery agent	.	.
DNC010538	4-Phenyl-benzo[b]thiophene-2-carboxamidine	Discovery agent	.	.
DNC010539	5-Benzyloxy-benzo[b]thiophene-2-carboxamidine	Discovery agent	.	.
DNC010540	6-Benzyloxybenzo[b]thiophene-2-carboxamidine	Discovery agent	.	.
DNC010541	(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine	Discovery agent	.	.
DNC010542	(+/-)-2-(4'-Propoxyphenyl)thiomorpholine	Discovery agent	.	.
DNC010543	(+/-)-2-(4'-Butoxyphenyl)thiomorpholine	Discovery agent	.	.
DNC010544	(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholin-5-one	Discovery agent	.	.
DNC010545	(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one	Discovery agent	.	.
DNC010546	(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine	Discovery agent	.	.
DNC010547	(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one	Discovery agent	.	.
DNC010548	(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one	Discovery agent	.	.
DNC010549	(+/-)-2-(4'-Methoxyphenyl)thiomorpholine	Discovery agent	.	.
DNC010550	GSK-0660	Discovery agent	.	.
DNC010551	GSK-3787	Discovery agent	.	.
DNC010552	N-Methyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010553	N-Isopropyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010554	N-tert-Butyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010555	N-Neopentyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010556	N-Cyclobutyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010557	N-Cyclopentyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010558	N-Cyclohexyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010559	N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010560	N-Phenyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010561	N-p-Tolyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010562	N-o-Tolyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010563	N-Benzyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010564	N,N-Dimethyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010565	N,N-Diethyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010566	N,N-Dipropyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010567	N,N-Diisopropyl-1'H-phenothiazine-1'-carboxamide	Discovery agent	.	.
DNC010568	(1'H-Phenothiazin-1'-yl)(piperidin-1-yl)methanone	Discovery agent	.	.
DNC010569	Morpholino(1'H-phenothiazin-1'-yl)methanone	Discovery agent	.	.
DNC010570	PKI-402	Cancer	140-229	C00-C96
DNC010570	PKI-402	Discovery agent	.	.
DNC010571	GLYCYRRHIZIN	Discovery agent	.	.
DNC010571	GLYCYRRHIZIN	Influenza virus infections	.	J10-J11
DNC010572	N-(Propylamide-benzophenone)-1-deoxynojirimycin	Discovery agent	.	.
DNC010573	N-(Propylamide-acetophenone)-1-deoxynojirimycin	Discovery agent	.	.
DNC010574	3-anilino-5-benzylthio-1,2,4-triazole	Discovery agent	.	.
DNC010575	2-(3-(3,5-dichlorophenyl)ureido)benzoic acid	Discovery agent	.	.
DNC010576	N-(6-chloro-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010577	N-(6-(4-hydroxyphenyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010578	N-(6-(4-aminophenyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010579	N-(6-(3-hydroxyphenyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010580	N-(6-(trifluoromethyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010581	N-(6-bromo-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010582	N-(6-(furan-3-yl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010583	N-(6-(pyridin-4-yl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010584	N-(6-(thiophen-3-yl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010585	N-(6-phenyl-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010586	N-(6-(2-chlorophenyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010587	(E)-N-(6-(prop-1-enyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010588	N-(6-chloro-5-phenyl-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010589	N-(6-chloro-5-p-tolyl-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010590	N-(6-benzyl-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010591	N-(6-(4-fluorophenyl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010592	N-(6-phenethyl-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010593	N-(6-(pyridin-3-yl)-1H-indazol-3-yl)butyramide	Discovery agent	.	.
DNC010594	L-796568	Discovery agent	.	.
DNC010594	L-796568	Obesity	.	E66
DNC010595	MCL-154	Discovery agent	.	.
DNC010596	MCL-153	Discovery agent	.	.
DNC010597	[Sar1,Tdf8]AngII	Discovery agent	.	.
DNC010598	[Sar1,Bpa8]AngII	Discovery agent	.	.
DNC010599	[Sar1,Tdf3]AngII	Discovery agent	.	.
DNC010600	[Sar1,Bpa3]AngII	Discovery agent	.	.
DNC010601	[Sar1,Tdf2]AngII	Discovery agent	.	.
DNC010602	[Sar1,Bpa2]AngII	Discovery agent	.	.
DNC010603	[Tdf1]AngII	Discovery agent	.	.
DNC010604	[Bpa1]AngII	Discovery agent	.	.
DNC010605	ANGIOTENSIN II	Discovery agent	.	.
DNC010606	EMD-534085	Discovery agent	.	.
DNC010606	EMD-534085	Hematological malignancies	.	C81-C96
DNC010607	4-phenyl-6-propylpyrimidine-2-carbonitrile	Discovery agent	.	.
DNC010608	4-propyl-6-m-tolylpyrimidine-2-carbonitrile	Discovery agent	.	.
DNC010609	4-cycloheptyl-6-propylpyrimidine-2-carbonitrile	Discovery agent	.	.
DNC010610	4-cyclooctyl-6-propylpyrimidine-2-carbonitrile	Discovery agent	.	.
DNC010611	4-cyclohexyl-6-propylpyrimidine-2-carbonitrile	Discovery agent	.	.
DNC010612	H-KPPR-OH	Discovery agent	.	.
DNC010613	SODIUM PERFLUOROHEXANESULFONAMIDE	Discovery agent	.	.
DNC010614	SCH-225336	Discovery agent	.	.
DNC010615	4-methylaminomethyl-7-methoxycoumarin	Discovery agent	.	.
DNC010616	RESCOVITINE	Discovery agent	.	.
DNC010617	5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil	Discovery agent	.	.
DNC010618	(4-benzhydrylpiperazin-1-yl)(cyclohexyl)methanone	Discovery agent	.	.
DNC010619	4-benzhydryl-N-cyclohexylpiperazine-1-carboxamide	Discovery agent	.	.
DNC010620	4-benzhydryl-N-butylpiperazine-1-carboxamide	Discovery agent	.	.
DNC010621	N-(2-(furan-2-yl)-3,4'-bipyridin-6-yl)acetamide	Discovery agent	.	.
DNC010622	3-(phenylsulfonyl)-1-(piperidin-4-yl)-1H-indole	Discovery agent	.	.
DNC010623	3-(phenylsulfonyl)-1-(piperidin-3-yl)-1H-indole	Discovery agent	.	.
DNC010624	3-(phenylsulfonyl)-1-(pyrrolidin-3-yl)-1H-indole	Discovery agent	.	.
DNC010625	(2'Z,3'E)-7-Azaindirubin-3'-oxime	Discovery agent	.	.
DNC010626	PAULLONE	Discovery agent	.	.
DNC010627	RO-320432	Discovery agent	.	.
DNC010628	CT-98024	Discovery agent	.	.
DNC010629	SB-415286	Discovery agent	.	.
DNC010630	1,9-bis(pyridinium)-nonane dibromide	Discovery agent	.	.
DNC010631	1,10-bis(pyridinium)-decane dibromide	Discovery agent	.	.
DNC010632	1,11-bis(pyridinium)-undecane dibromide	Discovery agent	.	.
DNC010633	Endothelin-2	Discovery agent	.	.
DNC010634	Neuropeptide Y	Discovery agent	.	.
DNC010635	RWJ-671818	Discovery agent	.	.
DNC010635	RWJ-671818	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNC010636	NSC-656158	Discovery agent	.	.
DNC010637	4-(Quinolin-4-yl)-N-p-tolylpyrimidin-2-amine	Discovery agent	.	.
DNC010638	4-(Quinolin-3-yl)-N-p-tolylpyrimidin-2-amine	Discovery agent	.	.
DNC010639	LEUCETTAMINE B	Discovery agent	.	.
DNC010640	Para-chloroamphetamine	Discovery agent	.	.
DNC010641	2-Amino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC010642	METHYLENEDIOXYAMPHETAMINE	Discovery agent	.	.
DNC010643	N-(3-(phenylthio)pyridin-4-yl)methanesulfonamide	Discovery agent	.	.
DNC010644	N-(3-phenylamino-4-pyridinyl)methanesulfonamide	Discovery agent	.	.
DNC010645	(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate	Discovery agent	.	.
DNC010646	(S)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate	Discovery agent	.	.
DNC010647	PHENMEDIPHAM	Discovery agent	.	.
DNC010648	AMPEROZIDE	Alcohol use disorders	.	F10
DNC010648	AMPEROZIDE	Discovery agent	.	.
DNC010649	NICARBAZIN	Discovery agent	.	.
DNC010650	Lapatinib ditosylate	Discovery agent	.	.
DNC010651	6-chloro-N-(3-chlorophenyl)quinazolin-4-amine	Discovery agent	.	.
DNC010652	LORNEIC ACID A	Discovery agent	.	.
DNC010653	Lecanindole D	Discovery agent	.	.
DNC010654	PF-18298	Discovery agent	.	.
DNC010655	Ro-4882224	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DNC010655	Ro-4882224	Discovery agent	.	.
DNC010656	Ro-4938581	Discovery agent	.	.
DNC010657	4-(3-hexylureido)-N-phenylbenzenesulfonamide	Discovery agent	.	.
DNC010658	JNJ-17148066	Discovery agent	.	.
DNC010659	JNJ-26529126	Discovery agent	.	.
DNC010660	JNJ-26529152	Discovery agent	.	.
DNC010661	JNJ-19398990	Discovery agent	.	.
DNC010662	N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide	Discovery agent	.	.
DNC010663	N-(1-benzofuran-3-ylmethyl)sulfamide	Discovery agent	.	.
DNC010664	N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide	Discovery agent	.	.
DNC010665	ERYTHRIBYSSIN A	Discovery agent	.	.
DNC010666	NEORAUTENOL	Discovery agent	.	.
DNC010667	ERYBREADIN B	Discovery agent	.	.
DNC010668	3,9-Dihydroxy-4-prenyl-[6aR,11aR]pterocarpan	Discovery agent	.	.
DNC010669	FOLITENOL	Discovery agent	.	.
DNC010670	Erybreadin D	Discovery agent	.	.
DNC010671	Erysubin E	Discovery agent	.	.
DNC010672	Erybreadin C	Discovery agent	.	.
DNC010673	N-(4-fluorobenzyl)-N-(pyridin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC010674	2-Allylthio-6-amino-3-benzyl-quinazolin-4(3H)-one	Discovery agent	.	.
DNC010675	2-Allylthio-3-benzyl-6-nitro-quinazolin-4(3H)-one	Discovery agent	.	.
DNC010676	4-(biphenyl-3-yl)-5-(piperidin-4-yl)isoxazol-3-ol	Discovery agent	.	.
DNC010677	GSK-1070916	Cancer	140-229	C00-C96
DNC010677	GSK-1070916	Discovery agent	.	.
DNC010678	4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	Discovery agent	.	.
DNC010679	LUF-6258	Discovery agent	.	.
DNC010680	OSI-906	Discovery agent	.	.
DNC010680	OSI-906	Solid tumours	.	C00-C75,C7A,C7B
DNC010681	3-(4-dimethylamino-benzylidenyl)-2-indolinone	Discovery agent	.	.
DNC010682	(R)-2-(2-naphthamido)-3-m-tolylpropanoic acid	Discovery agent	.	.
DNC010683	(R)-3-(2-naphthamido)-4-m-tolylbutanoic acid	Discovery agent	.	.
DNC010684	(R)-2-(2-naphthamido)-3-p-tolylpropanoic acid	Discovery agent	.	.
DNC010685	(R)-2-(2-naphthamido)-5-phenylpent-4-ynoic acid	Discovery agent	.	.
DNC010686	(R,)-2-(2-naphthamido)-5-phenylpent-4-enoic acid	Discovery agent	.	.
DNC010687	EUGENOL	Discovery agent	.	.
DNC010688	Sphingosine-1-phosphate	Acne vulgaris	.	L70.0
DNC010688	Sphingosine-1-phosphate	Discovery agent	.	.
DNC010689	N-(3-(3-methoxyphenyl)propyl)acetamide	Discovery agent	.	.
DNC010690	N-(3-(3-methoxyphenyl)propyl)propionamide	Discovery agent	.	.
DNC010691	N-(3-(2-hydroxy-5-methoxyphenyl)propyl)acetamide	Discovery agent	.	.
DNC010692	N-(3-(2,5-dimethoxyphenyl)propyl)acetamide	Discovery agent	.	.
DNC010693	N-(3-(2-ethoxy-5-methoxyphenyl)propyl)acetamide	Discovery agent	.	.
DNC010694	N-(3-(5-methoxy-2-propoxyphenyl)propyl)acetamide	Discovery agent	.	.
DNC010695	N-(3-(4-hydroxy-3-methoxyphenyl)propyl)acetamide	Discovery agent	.	.
DNC010696	2-morpholino-1,1,2-triphenylethanol	Discovery agent	.	.
DNC010697	3-methyl-2-morpholino-1,1-diphenylbutan-1-ol	Discovery agent	.	.
DNC010698	2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol	Discovery agent	.	.
DNC010699	2-morpholino-1,1-di(pyridin-3-yl)hexan-1-ol	Discovery agent	.	.
DNC010700	2-morpholino-1,1-di(pyridin-3-yl)octan-1-ol	Discovery agent	.	.
DNC010701	2-phenyl-1,1-di(pyridin-3-yl)ethanol	Discovery agent	.	.
DNC010702	2-amino-2-phenyl-1,1-di(pyridin-3-yl)ethanol	Discovery agent	.	.
DNC010703	N-(3,5-Dimethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010704	N-(3-Ethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010705	N-(3,4-Dimethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010706	N-Hydroxy-N'-(3-methylphenyl)octanediamide	Discovery agent	.	.
DNC010707	N-Hydroxy-N'-(4-methoxyphenyl)octanediamide	Discovery agent	.	.
DNC010708	N-Hydroxy-N'-(4-methylphenyl)octanediamide	Discovery agent	.	.
DNC010709	N-(4-Ethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010710	N-Hydroxy-N'-(2-methylphenyl)octanediamide	Discovery agent	.	.
DNC010711	N-(2,4-Dimethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010712	N-(2-Ethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010713	N-(2,3-Dimethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010714	N-(2,5-Dimethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010715	N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide	Discovery agent	.	.
DNC010716	N-hydroxy-2-(4-methoxyphenylsulfonamido)acetamide	Discovery agent	.	.
DNC010717	2-(4-bromophenylsulfonamido)-N-hydroxyacetamide	Discovery agent	.	.
DNC010718	CGS-27023A	Discovery agent	.	.
DNC010718	CGS-27023A	Rheumatold arthritis	.	M05-M06
DNC010719	(2R,3S,4S,5R)-2-nonylpiperidine-3,4,5-triol	Discovery agent	.	.
DNC010720	(2R,3S,4S,5R)-2-propylpiperidine-3,4,5-triol	Discovery agent	.	.
DNC010721	(2R,3S,4S,5R)-2-hexylpiperidine-3,4,5-triol	Discovery agent	.	.
DNC010722	BMS-687453	Discovery agent	.	.
DNC010723	GSK-1564023A	Discovery agent	.	.
DNC010724	GSK-325971A	Discovery agent	.	.
DNC010725	PAMAPIMOD	Discovery agent	.	.
DNC010725	PAMAPIMOD	Rheumatold arthritis	714	M05-M06
DNC010726	Talmapimod	Discovery agent	.	.
DNC010727	KOTALANOL	Discovery agent	.	.
DNC010728	Gymnochrome E	Discovery agent	.	.
DNC010729	2-phenylpyrazolo-[1,5-a]pyridine-7-carboxamide	Discovery agent	.	.
DNC010730	2-phenyl-2H-benzo[d][1,2,3]triazole-4-carboxamide	Discovery agent	.	.
DNC010731	2-(4-Chlorophenyl)-2H-indazole-7-carboxamide	Discovery agent	.	.
DNC010732	2-(3-Chlorophenyl)-2H-indazole-7-carboxamide	Discovery agent	.	.
DNC010733	2-(2-Chlorophenyl)-2H-indazole-7-carboxamide	Discovery agent	.	.
DNC010734	2-Benzyl-2H-indazole-7-carboxamide	Discovery agent	.	.
DNC010735	(2'Z,3'E)-5-Nitro-5'-hydroxy-indirubin-3'-oxime	Discovery agent	.	.
DNC010736	(2'Z,3'E)-5-Chloro-5'-hydroxy-indirubin-3'-oxime	Discovery agent	.	.
DNC010737	(2'Z,3'E)-5-Fluoro-5'-hydroxy-indirubin-3'-oxime	Discovery agent	.	.
DNC010738	(2'Z,3'E)-5-Nitro-5'-chloro-indirubin-3'-oxime	Discovery agent	.	.
DNC010739	(2'Z,3'E)-5-Chloro-5'-chloro-indirubin-3'-oxime	Discovery agent	.	.
DNC010740	(2'Z,3'E)-5-Fluoro-5'-chloro-indirubin-3'-oxime	Discovery agent	.	.
DNC010741	(2'Z,3'E)-5-Nitro-5'-fluoro-indirubin-3'-oxime	Discovery agent	.	.
DNC010742	(2'Z,3'E)-5-Chloro-5'-fluoro-indirubin-3'-oxime	Discovery agent	.	.
DNC010743	(2'Z,3'E)-5-Fluoro-5'-fluoro-indirubin-3'-oxime	Discovery agent	.	.
DNC010744	(2'Z,3'E)-5-Nitro-5'-methyl-indirubin-3'-oxime	Discovery agent	.	.
DNC010745	(2'Z,3'E)-5-Nitro-5'-methoxy-indirubin-3'-oxime	Discovery agent	.	.
DNC010746	(2'Z,3'E)-5-Fluoro-5'-methoxy-indirubin-3'-oxime	Discovery agent	.	.
DNC010747	5-nitroindirubin-3'-oxime	Discovery agent	.	.
DNC010748	(2'Z,3'E)-5-Fluoro-5'-methyl-indirubin-3'-oxime	Discovery agent	.	.
DNC010749	(2'Z,3'E)-5-Chloro-5'-methyl-indirubin-3'-oxime	Discovery agent	.	.
DNC010750	NSC-637991	Discovery agent	.	.
DNC010751	NSC-637992	Discovery agent	.	.
DNC010752	NSC-637993	Discovery agent	.	.
DNC010753	NSC-637994	Discovery agent	.	.
DNC010754	NSC-645809	Breast cancer	174, 175	C50
DNC010754	NSC-645809	Discovery agent	.	.
DNC010755	NSC-645811	Discovery agent	.	.
DNC010756	NSC-645812	Discovery agent	.	.
DNC010757	NSC-645831	Discovery agent	.	.
DNC010758	NSC-645833	Discovery agent	.	.
DNC010759	NSC-645834	Discovery agent	.	.
DNC010760	NSC-645835	Discovery agent	.	.
DNC010761	NSC-645836	Discovery agent	.	.
DNC010762	NSC-660838	Discovery agent	.	.
DNC010763	NSC-660839	Discovery agent	.	.
DNC010764	NSC-660840	Discovery agent	.	.
DNC010765	NSC-660841	Discovery agent	.	.
DNC010766	SPERMINE	Discovery agent	.	.
DNC010767	PF-877423	Discovery agent	.	.
DNC010768	1-(4-CHLOROPHENYL)-2-(2,4-DICHLOROPHENYL)-5-(METHYLSULFINYL)-N-(PIPERIDIN-1-YL)-1H-IMIDAZOLE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010769	4,5-dibenzylbenzene-1,2-diol	Discovery agent	.	.
DNC010770	N-(4-amino-4'-fluorobiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010771	N-(2-amino-5-(benzofuran-2-yl)phenyl)benzamide	Discovery agent	.	.
DNC010772	N-(4-amino-4'-bromobiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010773	N-(4-amino-3'-methoxybiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010774	N-(3'-acetyl-4-aminobiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010775	N-(4-amino-3'-methylbiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010776	N-(2-amino-5-(furan-2-yl)phenyl)benzamide	Discovery agent	.	.
DNC010777	N-(4'-acetyl-4-aminobiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010778	N-(4-amino-4'-methoxybiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010779	N-(2-amino-5-(pyridin-4-yl)phenyl)benzamide	Discovery agent	.	.
DNC010780	N-(2-amino-5-(furan-3-yl)phenyl)benzamide	Discovery agent	.	.
DNC010781	N-(4-amino-4'-vinylbiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010782	N-(4-aminobiphenyl-3-yl)benzamide	Discovery agent	.	.
DNC010783	N-(2-amino-5-(thiazol-2-yl)phenyl)benzamide	Discovery agent	.	.
DNC010784	N-(2-aminophenyl)benzamide	Discovery agent	.	.
DNC010785	3-(4-phenyl-6-(thiophen-2-yl)pyridin-2-yl)-phenol	Discovery agent	.	.
DNC010786	3-(4-phenyl-6-(thiophen-3-yl)pyridin-2-yl)-phenol	Discovery agent	.	.
DNC010787	3-(6-(furan-2-yl)-4-phenylpyridin-2-yl)-phenol	Discovery agent	.	.
DNC010788	3,3'-(4-phenylpyridine-2,6-diyl)diphenol	Discovery agent	.	.
DNC010789	4,4'-(4-phenylpyridine-2,6-diyl)diphenol	Discovery agent	.	.
DNC010790	3-(2,6-diphenylpyridin-4-yl)phenol	Discovery agent	.	.
DNC010791	3-(2-phenyl-6-(thiophen-2-yl)pyridin-4-yl)-phenol	Discovery agent	.	.
DNC010792	3-(2-phenyl-6-(thiophen-3-yl)pyridin-4-yl)-phenol	Discovery agent	.	.
DNC010793	3-(4-phenyl-2,4'-bipyridin-6-yl)phenol	Discovery agent	.	.
DNC010794	4-(4,6-diphenylpyridin-2-yl)phenol	Discovery agent	.	.
DNC010795	3-(6-phenyl-2,4'-bipyridin-4-yl)phenol	Discovery agent	.	.
DNC010796	4-(6-phenyl-2,4'-bipyridin-4-yl)phenol	Discovery agent	.	.
DNC010797	9-Hydroxy-7,8-benzoflavone	Discovery agent	.	.
DNC010798	MR-16089	Discovery agent	.	.
DNC010799	MR-20494	Discovery agent	.	.
DNC010800	1-[(7-Fluoronaphth-2-yl)methyl]-1H-imidazole	Discovery agent	.	.
DNC010801	N-[2-(4'-Nitrophenyl)ethyl]-imidazole	Discovery agent	.	.
DNC010802	1-(3-(4-fluorophenyl)propyl)-1H-imidazole	Discovery agent	.	.
DNC010803	3,4-bis(3,4-dimethoxyphenyl)furan-2(5H)-one	Discovery agent	.	.
DNC010804	11BETA,13-DIHYDRO-10-EPI-8-DEOXYCUMAM-BRIN B	Discovery agent	.	.
DNC010805	7,4'-Dihydroxyflavone	Discovery agent	.	.
DNC010806	MR-20814	Discovery agent	.	.
DNC010807	DEHYDROLEUCODIN	Discovery agent	.	.
DNC010808	LUDARTIN	Discovery agent	.	.
DNC010809	10-EPI-8-DEOXY-CUMAMBRIN B	Discovery agent	.	.
DNC010810	RU-56187	Discovery agent	.	.
DNC010811	4'-(6-Methoxypyridin-3-yl)biphenyl-3-ol	Discovery agent	.	.
DNC010812	3'-(5-Chloro-2-thienyl)biphenyl-3-ol	Discovery agent	.	.
DNC010813	3-[4-(5-Chloro-2-thienyl)pyridin-2-yl]phenol	Discovery agent	.	.
DNC010814	4'-(5-Chloro-2-thienyl)biphenyl-3-ol	Discovery agent	.	.
DNC010815	3'-(1-Benzothien-2-yl)biphenyl-3-ol	Discovery agent	.	.
DNC010816	3-[2-(5-Chloro-2-thienyl)pyridin-4-yl]phenol	Discovery agent	.	.
DNC010817	3-[6-(5-Chloro-2-thienyl)pyridin-2-yl]phenol	Discovery agent	.	.
DNC010818	4-oxo-4H-chromene-3-carboxylic acid	Discovery agent	.	.
DNC010819	N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)	Discovery agent	.	.
DNC010820	MK-499	Discovery agent	.	.
DNC010821	ROCAGLAMIDE	Discovery agent	.	.
DNC010822	ARTOBILOXANTHONE	Discovery agent	.	.
DNC010823	ARTORIGIDIN A	Discovery agent	.	.
DNC010824	1,1,1-Trifluoro-5-(4-octylphenoxy)pentan-2-one	Discovery agent	.	.
DNC010825	1,1,1,2,2,3,3-heptafluoro-8-phenyloctan-4-ol	Discovery agent	.	.
DNC010826	1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one	Discovery agent	.	.
DNC010827	1,1,1,2,2,3,3,5-octafluoro-8-phenyloctan-4-one	Discovery agent	.	.
DNC010828	1,1,1,2,2,4-hexafluoro-7-phenylheptan-3-one	Discovery agent	.	.
DNC010829	1,1,1,3-Tetrafluoro-7-phenylheptan-2-one	Discovery agent	.	.
DNC010830	(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one	Discovery agent	.	.
DNC010831	1,1,1,3-Tetrafluoro-6-phenylhexan-2-one	Discovery agent	.	.
DNC010832	4-(2-(4-Methoxyphenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010833	2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010834	4-(2-(4-Cyclohexylphenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010835	4-(2-(3-tert-Butylphenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010836	4-(2-(4-tert-Butylphenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010837	4-(2-(3,4-Dimethylphenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010838	4-(2-(4-Methylphenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010839	4-(2-(Phenylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010840	4-(2-(Cyclohexylamino)ethyl)-1H-imidazole	Discovery agent	.	.
DNC010841	6-cinnamoyl-N-methylstephasunoline	Discovery agent	.	.
DNC010842	N-methylstephisoferulin	Discovery agent	.	.
DNC010843	6-cinnamoylhernandine	Discovery agent	.	.
DNC010844	LONGANINE	Discovery agent	.	.
DNC010845	AKNADILACTAM	Discovery agent	.	.
DNC010846	N-methylstephuline	Discovery agent	.	.
DNC010847	PROSTEPHABYSSINE	Discovery agent	.	.
DNC010848	2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (DIASTEREOMERIC MIX)	Discovery agent	.	.
DNC010849	1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010850	1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010851	(R/S)-2-((4-benzylphenoxy)methyl)piperidine	Discovery agent	.	.
DNC010852	(R/S)-2-((4-phenoxyphenoxy)methyl)piperidine	Discovery agent	.	.
DNC010853	(R)-2-((4-benzylphenoxy)methyl)piperidine	Discovery agent	.	.
DNC010854	(R)-2-((4-phenoxyphenoxy)methyl)piperidine	Discovery agent	.	.
DNC010855	(S)-2-((4-phenoxyphenoxy)methyl)piperidine	Discovery agent	.	.
DNC010856	(R/S)-2-((4-benzylphenoxy)methyl)piperazine	Discovery agent	.	.
DNC010857	VCP-28	Discovery agent	.	.
DNC010858	AMG-9090	Discovery agent	.	.
DNC010859	AMG-5445	Discovery agent	.	.
DNC010860	AMG-2504	Discovery agent	.	.
DNC010861	AMG-7160	Discovery agent	.	.
DNC010862	2-methyl-1-(thiophen-2-yl)pent-1-en-3-one oxime	Discovery agent	.	.
DNC010863	2-methyl-1-(thiophen-3-yl)pent-1-en-3-one oxime	Discovery agent	.	.
DNC010864	2-methyl-1-(pyridin-3-yl)pent-1-en-3-one oxime	Discovery agent	.	.
DNC010865	2-methyl-1-(pyridin-4-yl)pent-1-en-3-one oxime	Discovery agent	.	.
DNC010866	4-Imidazol-1-ylmethylthioxanthen-9-one	Discovery agent	.	.
DNC010867	1-(4-Nitro-2-phenylsulfanylbenzyl)-1H-imidazole	Discovery agent	.	.
DNC010868	1-(4-nitro-2-phenoxybenzyl)-1H-imidazole	Discovery agent	.	.
DNC010869	4-Imidazol-1-ylmethyl-1-nitrothioxanthen-9-one	Discovery agent	.	.
DNC010870	4-Imidazol-1-ylmethylxanthen-9-one	Discovery agent	.	.
DNC010871	4-Imidazol-1-ylmethyl-2-nitroxanthen-9-one	Discovery agent	.	.
DNC010872	1-Imidazol-1-ylmethylxanthen-9-one	Discovery agent	.	.
DNC010873	1-(2-phenoxybenzyl)-1H-imidazole	Discovery agent	.	.
DNC010874	4-Imidazol-1-ylmethyl-3-nitroxanthen-9-one	Discovery agent	.	.
DNC010875	2-Imidazol-1-ylmethylxanthen-9-one	Discovery agent	.	.
DNC010876	N-(3,5-dichlorophenyl)imidodicarbonimidic diamide	Discovery agent	.	.
DNC010877	MK-1256	Discovery agent	.	.
DNC010878	BROUSSONIN A	Discovery agent	.	.
DNC010879	TUPICHINOL C	Discovery agent	.	.
DNC010880	C[YYDEKLEE]-NH2	Discovery agent	.	.
DNC010881	C[YYAEGLEE]-NH2	Discovery agent	.	.
DNC010882	C[YYDEGLEE]-NH2	Discovery agent	.	.
DNC010883	7-Phloroethol	Discovery agent	.	.
DNC010884	TRIPHLOROETHOL A	Discovery agent	.	.
DNC010885	DIECKOL	Discovery agent	.	.
DNC010886	PHLOROFUCOFUROECKOL A	Discovery agent	.	.
DNC010887	Eckol	Discovery agent	.	.
DNC010888	DIOXINODEHYDROECKOL	Discovery agent	.	.
DNC010889	AMG-221	Discovery agent	.	.
DNC010889	AMG-221	Metabolic disorders	.	E70-E90
DNC010890	1-(biphenyl-4-yl)-3-(4-(piperidin-1-yl)butyl)urea	Discovery agent	.	.
DNC010891	MANIDIPINE	Discovery agent	.	.
DNC010892	VITAMIN K2	Discovery agent	.	.
DNC010893	TRICLABENDAZOLE	Discovery agent	.	.
DNC010893	TRICLABENDAZOLE	Helminth infection	.	B81-B83
DNC010894	PF-02367982	Discovery agent	.	.
DNC010894	PF-02367982	Endometriosis	617	N80
DNC010895	4-(2,4-diethyl-1H-pyrrol-3-yloxy)benzonitrile	Discovery agent	.	.
DNC010896	1-(2-allylphenoxy)-3-morpholinopropan-2-ol	Discovery agent	.	.
DNC010897	1-(2-isopropylphenoxy)-3-morpholinopropan-2-ol	Discovery agent	.	.
DNC010898	OLEIC ACID	Discovery agent	.	.
DNC010899	LINOLEIC ACID	Discovery agent	.	.
DNC010900	(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol	Discovery agent	.	.
DNC010901	1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010902	1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010903	1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010904	N-hydroxysulfamide	Discovery agent	.	.
DNC010905	6-(3-Benzoyl-ureido)-hexanoic acid hydroxyamide	Discovery agent	.	.
DNC010906	7-(3-Benzoyl-ureido)-heptanoic acid hydroxyamide	Discovery agent	.	.
DNC010907	8-(3-Benzoyl-ureido)-octanoic acid hydroxyamide	Discovery agent	.	.
DNC010908	MK-4305	Discovery agent	.	.
DNC010908	MK-4305	Insomnia	.	F51.0,G47.0
DNC010909	1-(1-phenyl-1H-tetrazol-5-ylthio)propan-2-one	Discovery agent	.	.
DNC010910	1-phenyl-2-(1-phenyl-1H-tetrazol-5-yloxy)ethanone	Discovery agent	.	.
DNC010911	1-phenyl-4-(1-phenyl-1H-tetrazol-5-yl)butan-2-one	Discovery agent	.	.
DNC010912	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010913	N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXY-2-METHYLPROPANAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010914	(2S)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010915	(2R)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010916	N-(7-(2-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010917	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010918	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXY-2,2-DIMETHYLPROPANAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010919	(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010920	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010921	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(1-HYDROXY-2-METHYLPROPAN-2-YL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010922	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010922	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Ovarian cancer	183	C56
DNC010923	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-((R)-1-HYDROXYETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC010924	(R)-6-(2-(2-methylpyrrolidin-1-yl)ethyl)quinoline	Discovery agent	.	.
DNC010925	2-(2-Hydroxyethyl)anthra[1,9-cd]pyrazol-6(2H)-one	Discovery agent	.	.
DNC010926	2-(2-Aminoethyl)anthra[1,9-cd]pyrazol-6(2H)-one	Discovery agent	.	.
DNC010927	SB-525334	Discovery agent	.	.
DNC010928	SB-505124	Discovery agent	.	.
DNC010929	5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one	Discovery agent	.	.
DNC010930	5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate	Discovery agent	.	.
DNC010931	Jaspic acid	Discovery agent	.	.
DNC010932	(-)-zileuton	Discovery agent	.	.
DNC010933	PUUPEHEDIONE	Discovery agent	.	.
DNC010934	Isojaspic acid	Discovery agent	.	.
DNC010935	PALOSURAN	Discovery agent	.	.
DNC010935	PALOSURAN	Renal failure	.	N17-N19
DNC010936	ZD-2138	Asthma	.	J45
DNC010936	ZD-2138	Discovery agent	.	.
DNC010937	2,5-dideoxy-2,5-imino-D-altritol	Discovery agent	.	.
DNC010938	Beta-1-C-Butyl-1-deoxygalactonojirimycin	Discovery agent	.	.
DNC010939	1-deoxygalactonojirimycin	Discovery agent	.	.
DNC010940	4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide	Discovery agent	.	.
DNC010941	4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010942	4-(Quinolinoxy)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010943	4-(4-Fluorophenoxy)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010944	4-(4-Cyanophenoxy)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010945	4-Ethoxy-3-pyridinesulfonamide	Discovery agent	.	.
DNC010946	4-Methoxy-3-pyridinesulfonamide	Discovery agent	.	.
DNC010947	4-Hydrazino-3-pyridinesulfonamide	Discovery agent	.	.
DNC010948	4-(Methylhydrazino)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010949	4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010950	4-(Allylamino)-3-pyridinesulfonamide	Discovery agent	.	.
DNC010951	4-(Carbamolymethylthio)pyridine-3-sulfonamide	Discovery agent	.	.
DNC010952	4-Benzythiopyridine-3-sulfonamide	Discovery agent	.	.
DNC010953	4-(2-Propynylthio)pyridine-3-sulfonamide	Discovery agent	.	.
DNC010954	4-(Cyanomethylthio)pyridine-3-sulfonamide	Discovery agent	.	.
DNC010955	4-Methylthiopyridine-3-sulfonamide	Discovery agent	.	.
DNC010956	4,4'-thiodipyridine-3-sulfonamide	Discovery agent	.	.
DNC010957	O-spiroketal glucoside	Discovery agent	.	.
DNC010958	2-(thiazol-4-yl)-1H-benzo[d]imidazol-5-amine	Discovery agent	.	.
DNC010959	5-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole	Discovery agent	.	.
DNC010960	5-chloro-2-(pyridin-2-yl)-1H-benzo[d]imidazole	Discovery agent	.	.
DNC010961	2-(pyridin-2-yl)-1H-benzo[d]imidazol-5-amine	Discovery agent	.	.
DNC010962	2-(pyridin-2-yl)-1H-benzo[d]imidazole	Discovery agent	.	.
DNC010963	2-(pyridin-2-yl)-1H-imidazo[4,5-c]pyridine	Discovery agent	.	.
DNC010964	OXYQUINOLINE	Discovery agent	.	.
DNC010965	5-fluoro-2-(pyridin-2-yl)-1H-benzo[d]imidazole	Discovery agent	.	.
DNC010966	NIFEVIROC	Discovery agent	.	.
DNC010967	5-(2-phenethylpiperazin-1-yl)-1H-indazole	Discovery agent	.	.
DNC010968	2-chloro-N-(o-tolylcarbamoyl)benzamide	Discovery agent	.	.
DNC010969	N'-(2-fluorobenzoyl)-2-naphthohydrazide	Discovery agent	.	.
DNC010970	5-chloro-4-nitrothiophene-2-sulfonamide	Discovery agent	.	.
DNC010971	2,5-dichloro-N-phenylthiophene-3-sulfonamide	Discovery agent	.	.
DNC010972	2,5-dichloro-N-p-tolylthiophene-3-sulfonamide	Discovery agent	.	.
DNC010973	(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol	Discovery agent	.	.
DNC010974	(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol	Discovery agent	.	.
DNC010975	3,5-Dimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010976	2,4-Dimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010977	2,4-Dimethoxy-3'-amino-trans-stilbene	Discovery agent	.	.
DNC010978	2,5-Dimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010979	2,3-Dimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010980	3,4-Dimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010981	3,4,5-Trimethoxy-3'-amino-trans-stilbene	Discovery agent	.	.
DNC010982	3,4,5-Trimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010983	2,3,4-Trimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010984	2,3,5-Trimethoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010985	3-Nitro-4'-nitro-trans-stilbene	Discovery agent	.	.
DNC010986	3-Methoxyl-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010987	4-(3,5-Dimethoxyphenethyl)benzenamine	Discovery agent	.	.
DNC010988	4-(3,4-Dimethoxyphenethyl)aniline	Discovery agent	.	.
DNC010989	4-(3,4,5-Trimethoxyphenethyl)aniline	Discovery agent	.	.
DNC010990	3,4'-(Ethane-1,2-diyl)dibenzenamine	Discovery agent	.	.
DNC010991	3-Amino-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010992	3,5-Diamino-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010993	3,5-Diacetoxy-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010994	3,5-Dihydroxyl-4'-amino-trans-stilbene	Discovery agent	.	.
DNC010995	2-(1H-Imidazol-1-yl)-1-(4-nitrophenyl)ethanone	Discovery agent	.	.
DNC010996	1-(4-Aminophenyl)-2-(1H-imidazol-1-yl)ethanone	Discovery agent	.	.
DNC010997	3-methyl-6-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC010998	2-methyl-6-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC010999	3-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC011000	1-(7-methyl-9H-carbazol-3-yl)ethanone	Discovery agent	.	.
DNC011001	6-fluoro-2-methyl-9H-carbazole	Discovery agent	.	.
DNC011002	Methyl 7-tert-butyl-9H-carbazole-3-carboxylate	Discovery agent	.	.
DNC011003	2-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC011004	2-tert-butyl-9H-carbazole	Discovery agent	.	.
DNC011005	2-ethyl-9H-carbazole	Discovery agent	.	.
DNC011006	2-isopropyl-9H-carbazole	Discovery agent	.	.
DNC011007	2-(difluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC011008	2-(trifluoromethoxy)-9H-carbazole	Discovery agent	.	.
DNC011009	2-tert-butoxy-9H-carbazole	Discovery agent	.	.
DNC011010	Methyl 9H-carbazole-2-carboxylate	Discovery agent	.	.
DNC011011	9H-carbazole-2-carbaldehyde	Discovery agent	.	.
DNC011012	7-tert-butyl-9H-carbazole-3-carboxylic acid	Discovery agent	.	.
DNC011013	2-tert-butyl-7-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC011014	3-tert-butyl-9H-carbazole	Discovery agent	.	.
DNC011015	9H-carbazole-3-carbaldehyde	Discovery agent	.	.
DNC011016	1-tert-butyl-9H-carbazole	Discovery agent	.	.
DNC011017	1-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC011018	9-methyl-2-(trifluoromethyl)-9H-carbazole	Discovery agent	.	.
DNC011019	2,3,4,11-tetrahydro-1H-benzo[a]carbazole	Discovery agent	.	.
DNC011020	11H-benzo[a]carbazole	Discovery agent	.	.
DNC011021	2-methyl-9H-carbazole	Discovery agent	.	.
DNC011022	Resveratrol Potassium4,-Sulfate	Discovery agent	.	.
DNC011023	Resveratrol Potassium3-Sulfate	Discovery agent	.	.
DNC011024	6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)	Discovery agent	.	.
DNC011025	1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC011026	1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	Discovery agent	.	.
DNC011027	GNF-PF-4478	Discovery agent	.	.
DNC011028	4-((1H-Imidazol-4-yl)methyl)-1-phenylpiperidine	Discovery agent	.	.
DNC011029	4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine	Discovery agent	.	.
DNC011030	4'-(1-(pyridin-4-yl)propyl)biphenyl-3-ol	Discovery agent	.	.
DNC011031	4'-(2-methyl-1-(pyridin-4-yl)propyl)biphenyl-3-ol	Discovery agent	.	.
DNC011032	3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol	Discovery agent	.	.
DNC011033	3-fluoro-4'-(1-(pyridin-4-yl)propyl)biphenyl-4-ol	Discovery agent	.	.
DNC011034	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol	Discovery agent	.	.
DNC011035	4'-(Pyridin-4-ylmethyl)biphenyl-3-amine	Discovery agent	.	.
DNC011036	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine	Discovery agent	.	.
DNC011037	SYMBIOPOLYOL	Discovery agent	.	.
DNC011038	1,6-bis(4-phenylpiperazin-1-yl)hexane	Discovery agent	.	.
DNC011039	1,6-bis(4-m-tolylpiperazin-1-yl)hexane	Discovery agent	.	.
DNC011040	1,6-bis(4-(3-methoxyphenyl)piperazin-1-yl)hexane	Discovery agent	.	.
DNC011041	1,6-bis(4-(3-chlorophenyl)piperazin-1-yl)hexane	Discovery agent	.	.
DNC011042	6-chloro-N-(pyridin-3-yl)indoline-1-carboxamide	Discovery agent	.	.
DNC011043	5-chloro-N-(pyridin-3-yl)indoline-1-carboxamide	Discovery agent	.	.
DNC011044	N-(pyridin-3-yl)indoline-1-carboxamide	Discovery agent	.	.
DNC011045	(S)-1-(5,6-difluoro-1H-indol-1-yl)propan-2-amine	Discovery agent	.	.
DNC011046	(R,S)-1-(6-fluoro-1H-indol-1-yl)propan-2-amine	Discovery agent	.	.
DNC011047	(R,S)-1-(5-bromo-1H-indol-1-yl)propan-2-amine	Discovery agent	.	.
DNC011048	(R,S)-1-(5-chloro-1H-indol-1-yl)propan-2-amine	Discovery agent	.	.
DNC011049	(R,S)-1-(5-fluoro-1H-indol-1-yl)propan-2-amine	Discovery agent	.	.
DNC011050	(R,S)-1-(5-methyl-1H-indol-1-yl)propan-2-amine	Discovery agent	.	.
DNC011051	APLYSINOPSIN	Discovery agent	.	.
DNC011052	LARGAZOLE	Discovery agent	.	.
DNC011053	3-(dimethylamino)phenyl phenylcarbamate	Discovery agent	.	.
DNC011054	1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide	Discovery agent	.	.
DNC011055	(-)-Tolserine	Discovery agent	.	.
DNC011056	(-)-Cymserine	Discovery agent	.	.
DNC011057	(-)-Phenethylcymserine	Discovery agent	.	.
DNC011058	BETA-HYDROXYETHYL THEOPHYLLINE	Discovery agent	.	.
DNC011059	GNF-PF-2700	Discovery agent	.	.
DNC011060	N-(8-(3-cyanophenyl)-9H-purin-6-yl)pentanamide	Discovery agent	.	.
DNC011061	3-(6-(phenylamino)-9H-purin-8-yl)benzonitrile	Discovery agent	.	.
DNC011062	N,8-diphenyl-9H-purin-6-amine	Discovery agent	.	.
DNC011063	6-(3-(trifluoromethyl)phenyl)picolinonitrile	Discovery agent	.	.
DNC011064	KNI-10737	Discovery agent	.	.
DNC011065	KNI-10763	Discovery agent	.	.
DNC011066	KNI-10761	Discovery agent	.	.
DNC011067	KNI-10762	Discovery agent	.	.
DNC011068	KNI-10740	Discovery agent	.	.
DNC011069	KNI-10743	Discovery agent	.	.
DNC011070	KNI-10741	Discovery agent	.	.
DNC011071	KNI-10760	Discovery agent	.	.
DNC011072	KNI-10742	Discovery agent	.	.
DNC011073	KNI-10758	Discovery agent	.	.
DNC011074	KNI-10759	Discovery agent	.	.
DNC011075	DEPUDECIN	Discovery agent	.	.
DNC011076	NILTUBACIN	Discovery agent	.	.
DNC011077	4-Phenylbutyrohydroxamic acid	Discovery agent	.	.
DNC011078	Octanedioic acid bis-hydroxyamide	Discovery agent	.	.
DNC011079	Hexane-1,6-diamine	Discovery agent	.	.
DNC011080	Pentane-1,5-diamine	Discovery agent	.	.
DNC011081	N1-(2-aminoethyl)ethane-1,2-diamine	Discovery agent	.	.
DNC011082	N1-(naphthalen-1-yl)ethane-1,2-diamine	Discovery agent	.	.
DNC011083	TRIENTINE	Discovery agent	.	.
DNC011083	TRIENTINE	Inborn error of metabolism	.	E88.9
DNC011084	(S)-enastron	Discovery agent	.	.
DNC011085	(S)-dimethylenastron	Discovery agent	.	.
DNC011086	BENZENESULFONAMIDE	Discovery agent	.	.
DNC011087	(S)-FTY720P	Discovery agent	.	.
DNC011088	2-(benzyloxy)naphthalene	Discovery agent	.	.
DNC011089	Tamoxifen methyl iodide	Discovery agent	.	.
DNC011090	Tamoxifen ethyl bromide	Discovery agent	.	.
DNC011091	Tamoxifen isopropyl bromide	Discovery agent	.	.
DNC011092	Tamoxifen butyl bromide	Discovery agent	.	.
DNC011093	COCAINE.HCL	Discovery agent	.	.
DNC011094	ESCITALOPRAM OXALATE	Discovery agent	.	.
DNC011095	3-(4-Hydroxyphenyl)-7-isopropoxychromen-4-one	Discovery agent	.	.
DNC011096	3-(4-Hydroxyphenyl)-7-isobutoxychromen-4-one	Discovery agent	.	.
DNC011097	7-Cyclopentyloxy-3-(4-hydroxyphenyl)chromen-4-one	Discovery agent	.	.
DNC011098	2-(carboxymethylamino)-2-oxoacetic acid	Discovery agent	.	.
DNC011099	PRUVANSERIN	Discovery agent	.	.
DNC011099	PRUVANSERIN	Sleep disorders	.	F51,G47
DNC011100	NELOTANSERIN	Discovery agent	.	.
DNC011100	NELOTANSERIN	Sleep disorders	.	F51,G47
DNC011101	4-[1-(4'-Methoxybiphenyl-4-yl)propyl]pyridine	Discovery agent	.	.
DNC011102	3-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	Discovery agent	.	.
DNC011103	4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	Discovery agent	.	.
DNC011104	4'-(Pyridin-4-ylmethyl)biphenyl-4-amine	Discovery agent	.	.
DNC011105	N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide	Discovery agent	.	.
DNC011106	4'-(Pyridin-4-ylmethyl)biphenyl-4-carboxamide	Discovery agent	.	.
DNC011107	4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine	Discovery agent	.	.
DNC011108	4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine	Discovery agent	.	.
DNC011109	4-(4-(thiophen-3-yl)benzyl)pyridine	Discovery agent	.	.
DNC011110	4-(4-(thiophen-2-yl)benzyl)pyridine	Discovery agent	.	.
DNC011111	5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole	Discovery agent	.	.
DNC011112	4-[4-(6-methoxynaphthalen-2-yl)benzyl]pyridine	Discovery agent	.	.
DNC011113	6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol	Discovery agent	.	.
DNC011114	JWH-441	Discovery agent	.	.
DNC011115	JWH-442	Discovery agent	.	.
DNC011116	JWH-440	Discovery agent	.	.
DNC011117	JWH-342	Discovery agent	.	.
DNC011118	HOMOERIODICTYOL	Discovery agent	.	.
DNC011119	PINOCEMBRIN	Discovery agent	.	.
DNC011120	ERIODICTYOL	Discovery agent	.	.
DNC011121	ISOSAKUTANETIN	Discovery agent	.	.
DNC011122	DIOSMETIN	Discovery agent	.	.
DNC011123	KAEMPFERIDE	Discovery agent	.	.
DNC011124	TAMARIXETIN	Discovery agent	.	.
DNC011125	CHRYSOERIOL	Discovery agent	.	.
DNC011126	ACACETIN	Discovery agent	.	.
DNC011127	8-azabicyclo[3.2.1]octan-3-yloxy-benzamide	Discovery agent	.	.
DNC011128	2-(6-phenylhexyl)pyrido[2,3-d]pyrimidin-4(3H)-one	Discovery agent	.	.
DNC011129	2-(4-phenylbutyl)pyrido[2,3-d]pyrimidin-4(3H)-one	Discovery agent	.	.
DNC011130	2-(cinnamyloxy)pyrido[2,3-d]pyrimidin-4(3H)-one	Discovery agent	.	.
DNC011131	S-(2-Chlorobenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011132	S-(3-Chlorobenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011133	S-(4-Chlorobenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011134	S-(4-Fluorobenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011135	S-(4-Bromobenzyl)isothiourea hydrobromide	Discovery agent	.	.
DNC011136	S-(4-Methylbenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011137	S-(4-Ethylbenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011138	S-(4-Methoxybenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011139	S-(4-Cyanobenzyl)isothiourea hydrobromide	Discovery agent	.	.
DNC011140	S-(4-Nitrobenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011141	S-(2,4-Dichlorobenzyl)isothiourea hydrobromide	Discovery agent	.	.
DNC011142	S-(3,4-Dichlorobenzyl)isothiourea hydrochloride	Discovery agent	.	.
DNC011143	4-Chlorobenzenemethanethiol	Discovery agent	.	.
DNC011144	2-Chlorobenzenemethanethiol	Discovery agent	.	.
DNC011145	BENZENEMETHANETHIOL	Discovery agent	.	.
DNC011146	4-Fluorobenzenemethanethiol	Discovery agent	.	.
DNC011147	4-Methylbenzenemethanethiol	Discovery agent	.	.
DNC011148	4-Methoxybenzenemethanethiol	Discovery agent	.	.
DNC011149	2,4-Dichlorobenzenemethanethiol	Discovery agent	.	.
DNC011150	3,4-Dichlorobenzenemethanethiol	Discovery agent	.	.
DNC011151	NABILONE	Discovery agent	.	.
DNC011151	NABILONE	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNC011152	4-(2'-(trifluoromethyl)biphenyl-3-yl)oxazole	Discovery agent	.	.
DNC011153	4-(2'-(trifluoromethoxy)biphenyl-3-yl)oxazole	Discovery agent	.	.
DNC011154	4-(2'-(trifluoromethoxy)biphenyl-3-yl)thiazole	Discovery agent	.	.
DNC011155	1,2,3,4,6-penta-O-galloyl-D-glucopyranose	Discovery agent	.	.
DNC011156	N-(4-(phenylamino)quinazolin-6-yl)acrylamide	Discovery agent	.	.
DNC011157	Seco-exiguamine	Discovery agent	.	.
DNC011158	EXIGUAMINE B	Discovery agent	.	.
DNC011159	Exiguamine A hydrochloride	Discovery agent	.	.
DNC011160	AR-C133057XX	Discovery agent	.	.
DNC011161	4-methyl-6-propylpyridin-2-amine	Discovery agent	.	.
DNC011162	4-methylpyridin-2-amine	Discovery agent	.	.
DNC011163	AS-605240	Discovery agent	.	.
DNC011164	L-136662	Discovery agent	.	.
DNC011165	3-(2-Bromophenyl)-6-methylcoumarin	Discovery agent	.	.
DNC011166	8-Bromo-6-methyl-3-phenylcoumarin	Discovery agent	.	.
DNC011167	8-Bromo-6-methyl-3-(4'-methoxyphenyl)coumarin	Discovery agent	.	.
DNC011168	CATECHIN	Discovery agent	.	.
DNC011169	2-Hydroxycinnamic acid	Discovery agent	.	.
DNC011170	XANOMELINE	Discovery agent	.	.
DNC011171	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Discovery agent	.	.
DNC011172	ETHYLPHENSERINE	Discovery agent	.	.
DNC011173	QUILOSTIGMINE	Discovery agent	.	.
DNC011174	GANSTIGMINE	Discovery agent	.	.
DNC011175	2-((1H-imidazol-4-yl)methyl)pyridine	Discovery agent	.	.
DNC011176	3-((1H-imidazol-4-yl)methyl)pyridine	Discovery agent	.	.
DNC011177	1-Methoxy-3-(oxiran-2-ylmethoxy)-9H-xanthen-9-one	Discovery agent	.	.
DNC011178	Oxalylaminobenzoic acid	Discovery agent	.	.
DNC011179	Isoxazolecarboxylic acid	Discovery agent	.	.
DNC011180	FORMYLCHROMONE	Discovery agent	.	.
DNC011181	Isochroman mono-carboxylic acid	Discovery agent	.	.
DNC011182	NITD609	Discovery agent	.	.
DNC011182	NITD609	Plasmodium falciparum infection	.	B54
DNC011183	SM-337	Discovery agent	.	.
DNC011184	4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol	Discovery agent	.	.
DNC011185	4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol	Discovery agent	.	.
DNC011186	ZARAGOZIC ACIDS A	Discovery agent	.	.
DNC011187	PKC-412	Discovery agent	.	.
DNC011188	CI-1040	Discovery agent	.	.
DNC011189	Go-6976	Discovery agent	.	.
DNC011190	STAUROSPORINONE	Discovery agent	.	.
DNC011191	KT-5720	Discovery agent	.	.
DNC011192	BOCEPREVIR	Discovery agent	.	.
DNC011192	BOCEPREVIR	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DNC011193	1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide	Discovery agent	.	.
DNC011194	1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide	Discovery agent	.	.
DNC011195	1,3-propanediphosphonic acid	Discovery agent	.	.
DNC011196	1'-tosylspiro[indene-1,4'-piperidine]	Discovery agent	.	.
DNC011197	L-372662	Discovery agent	.	.
DNC011198	DELPHINIDIN CHLORIDE	Discovery agent	.	.
DNC011199	PELARGONIDIN CHLORIDE	Discovery agent	.	.
DNC011200	CYANIDIN	Discovery agent	.	.
DNC011201	3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide	Discovery agent	.	.
DNC011202	N-(2-Methyl-1H-indol-5-yl)benzamide	Discovery agent	.	.
DNC011203	3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide	Discovery agent	.	.
DNC011204	N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide	Discovery agent	.	.
DNC011205	2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole	Discovery agent	.	.
DNC011206	2-(2-cyclohexylidenehydrazinyl)-4-p-tolylthiazole	Discovery agent	.	.
DNC011207	2-(2-cyclohexylidenehydrazinyl)-4-phenylthiazole	Discovery agent	.	.
DNC011208	2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole	Discovery agent	.	.
DNC011209	N-(2-bromobenzoyloxy)-4-chlorobenzamide	Discovery agent	.	.
DNC011210	S-benzo[d]oxazol-2-yl O-butyl carbonothioate	Discovery agent	.	.
DNC011211	1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea	Discovery agent	.	.
DNC011212	6-phenylpyridazin-3-yl thiophene-2-carboxylate	Discovery agent	.	.
DNC011213	1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea	Discovery agent	.	.
DNC011214	3-(1-benzylpiperidin-4-yloxy)benzamide	Discovery agent	.	.
DNC011215	ST-1025	Discovery agent	.	.
DNC011216	3-benzyl-6-methylbenzo[d]oxazol-2(3H)-one	Discovery agent	.	.
DNC011217	3-benzyl-5-fluorobenzo[d]oxazol-2(3H)-one	Discovery agent	.	.
DNC011218	PONKORANOL	Discovery agent	.	.
DNC011219	Bile acid	Discovery agent	.	.
DNC011220	7-Hydroxy-4-phenylcoumarin	Discovery agent	.	.
DNC011221	1-(1-Adamantyl)-3-(1-propionylpiperidin-4-yl)urea	Discovery agent	.	.
DNC011222	1-Octyl-3-(1-propionylpiperidin-4-yl)urea	Discovery agent	.	.
DNC011223	1-Cycloheptyl-3-(1-propionylpiperidin-4-yl)urea	Discovery agent	.	.
DNC011224	1-Cyclohexyl-3-(1-propionylpiperidin-4-yl)urea	Discovery agent	.	.
DNC011225	1-(1-Propionylpiperidin-4-yl)-3-m-tolylurea	Discovery agent	.	.
DNC011226	1-(1-Propionylpiperidin-4-yl)-3-p-tolylurea	Discovery agent	.	.
DNC011227	1-Phenyl-3-(1-propionylpiperidin-4-yl)urea	Discovery agent	.	.
DNC011228	1-(1-Propionylpiperidin-4-yl)-3-o-tolylurea	Discovery agent	.	.
DNC011229	SB-207710	Discovery agent	.	.
DNC011230	N-n-propyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011231	N-n-pentyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011232	N-n-hexyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011233	N-n-heptyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011234	N-n-octyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011235	N-n-nonyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011236	N-n-dodecyl-7-methoxytacrine hydrochloride	Discovery agent	.	.
DNC011237	7-methoxytacrine	Discovery agent	.	.
DNC011238	DIETHOXYFLOURESCEIN	Discovery agent	.	.
DNC011239	BEFIRADOL	Discovery agent	.	.
DNC011239	BEFIRADOL	Pain	.	G89
DNC011240	WR-99210	Discovery agent	.	.
DNC011241	5-phenyl-2-(4-(piperidin-1-yl)butyl)oxazole	Discovery agent	.	.
DNC011242	ST-1093	Discovery agent	.	.
DNC011243	4-nitrophenyl phosphate	Discovery agent	.	.
DNC011244	Beta-Carboline-3-carboxylic acid t-butyl ester	Discovery agent	.	.
DNC011245	3-propoxy-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011246	Ethyl 9H-pyrido[3,4-b]indole-3-carboxylate	Discovery agent	.	.
DNC011247	Ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate	Discovery agent	.	.
DNC011248	Sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate	Discovery agent	.	.
DNC011249	3-(isopentyloxy)-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011250	3-(benzyloxy)-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011251	3-butoxy-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011252	3-isobutoxy-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011253	3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011254	3-ethoxy-9H-pyrido[3,4-b]indole	Discovery agent	.	.
DNC011255	1-(2-methoxyphenyl)-4-pentylpiperazine	Discovery agent	.	.
DNC011256	N-(2-chlorobenzyl)-5-(4-chlorophenyl)nicotinamide	Discovery agent	.	.
DNC011257	5-(4-chlorophenyl)-N-(2-methylbenzyl)nicotinamide	Discovery agent	.	.
DNC011258	N-benzyl-5-(4-chlorophenyl)nicotinamide	Discovery agent	.	.
DNC011259	2-Hexadecynoic acid	Discovery agent	.	.
DNC011260	Piperidine-1-carboxylic acid adamantan-2-yl ester	Discovery agent	.	.
DNC011261	Bis(3-bromophenyl)(4-hydroxy)thiosemicarbazone	Discovery agent	.	.
DNC011262	Bis(3-bromophenyl)(5-hydroxy)thiosemicarbazone	Discovery agent	.	.
DNC011263	(3-Bromobenzoylpyridine)thiosemicarbazone	Discovery agent	.	.
DNC011264	[2-Phenylacetophenone]thiosemicarbazone	Discovery agent	.	.
DNC011265	CP-305202	Discovery agent	.	.
DNC011266	Ro-66-1168	Discovery agent	.	.
DNC011267	Ro-65-7219	Discovery agent	.	.
DNC011268	3-(3-aminocyclopentyl)-1H-indole-5-carbonitrile	Discovery agent	.	.
DNC011269	Fluoro loxoprofen	Discovery agent	.	.
DNC011270	Loxoprofen sodium	Discovery agent	.	.
DNC011271	6-Fluoromelatonin	Discovery agent	.	.
DNC011272	ADRENOGLOMERULOTROPIN	Discovery agent	.	.
DNC011273	FENDILINE	Discovery agent	.	.
DNC011274	(5-methoxy-1H-indol-3-yl)methanamine	Discovery agent	.	.
DNC011275	SB-206553	Discovery agent	.	.
DNC011276	3'-bromopropiophenonethiosemicarbazone	Discovery agent	.	.
DNC011277	3',4'-dichloroacetophenonethiosemicarbazone	Discovery agent	.	.
DNC011278	4-(piperazin-1-yl)-3-tosyl-1H-indazole	Discovery agent	.	.
DNC011279	5-(4-Methylpiperazin-1-yl)-3-tosyl-1H-indazole	Discovery agent	.	.
DNC011280	6-(piperazin-1-yl)-3-tosyl-1H-indazole	Discovery agent	.	.
DNC011281	De-O-sulfonated kotalanol	Discovery agent	.	.
DNC011282	SALACINOL	Discovery agent	.	.
DNC011283	2-phenyl-N-(1-phenylethyl)quinoline-4-carboxamide	Discovery agent	.	.
DNC011284	N-phenethyl-2-phenylquinoline-4-carboxamide	Discovery agent	.	.
DNC011285	5'-methylthio-immucillin-H	Discovery agent	.	.
DNC011286	3-((2-Pyrrolidine-1-yl)-ethyl)uracil	Discovery agent	.	.
DNC011287	N-(1-oxobutan-2-yl)-3-(trifluoromethyl)benzamide	Discovery agent	.	.
DNC011288	3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC011289	Mycophenolic hydroxamic acid	Discovery agent	.	.
DNC011290	6-(9H-carbazol-9-yl)-N-hydroxyhexanamide	Discovery agent	.	.
DNC011291	Asp-BrPmp-Leu	Discovery agent	.	.
DNC011292	4-(4-benzyl-1H-1,2,3-triazol-1-yl)phenol	Discovery agent	.	.
DNC011293	5-Benzyloxytryptamine	Discovery agent	.	.
DNC011294	2-(5-fluoro-1H-indol-3-yl)ethanamine	Discovery agent	.	.
DNC011295	ELIPRODIL	Discovery agent	.	.
DNC011295	ELIPRODIL	Multiple sclerosis	340	G35
DNC011296	5-(4-Phenylbutoxy)psoralen	Discovery agent	.	.
DNC011297	NSC-65069	Discovery agent	.	.
DNC011298	NSC-99528	Discovery agent	.	.
DNC011299	NSC-106080	Discovery agent	.	.
DNC011300	NSC-621351	Discovery agent	.	.
DNC011301	NSC-77833	Discovery agent	.	.
DNC011302	NSC-78017	Discovery agent	.	.
DNC011303	NSC-78021	Discovery agent	.	.
DNC011304	NSC-86715	Discovery agent	.	.
DNC011305	NSC-97374	Discovery agent	.	.
DNC011306	NSC-99495	Discovery agent	.	.
DNC011307	NSC-115890	Discovery agent	.	.
DNC011308	NSC-180969	Discovery agent	.	.
DNC011309	NSC-204996	Discovery agent	.	.
DNC011310	NSC-238146	Discovery agent	.	.
DNC011311	NSC-300853	Discovery agent	.	.
DNC011312	NSC-306843	Discovery agent	.	.
DNC011313	NSC-356819	Discovery agent	.	.
DNC011314	NSC-356820	Discovery agent	.	.
DNC011315	NSC-359466	Discovery agent	.	.
DNC011316	NSC-381864	Discovery agent	.	.
DNC011317	NSC-640353	Discovery agent	.	.
DNC011318	NSC-640556	Discovery agent	.	.
DNC011319	NSC-640558	Discovery agent	.	.
DNC011320	NSC-640559	Discovery agent	.	.
DNC011321	NSC-640566	Discovery agent	.	.
DNC011322	NSC-640583	Discovery agent	.	.
DNC011323	NSC-640584	Discovery agent	.	.
DNC011324	NSC-649091	Discovery agent	.	.
DNC011325	NSC-665126	Discovery agent	.	.
DNC011326	NSC-669977	Discovery agent	.	.
DNC011327	NSC-676468	Discovery agent	.	.
DNC011328	NSC-677939	Discovery agent	.	.
DNC011329	NSC-693571	Discovery agent	.	.
DNC011330	NSC-720622	Discovery agent	.	.
DNC011331	7-methoxy-8-propionyl-2H-chromen-2-one	Discovery agent	.	.
DNC011332	7-ethoxy-8-propionyl-2H-chromen-2-one	Discovery agent	.	.
DNC011333	8-Propionyl-7-propoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011334	8-acetyl-7-propoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011335	7-hydroxy-8-propionyl-2H-chromen-2-one	Discovery agent	.	.
DNC011336	8-acetyl-7-butoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011337	8-acetyl-7-ethoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011338	8-acetyl-7-(benzyloxy)-2H-chromen-2-one	Discovery agent	.	.
DNC011339	8-Acetyl-7-hydroxy-2H-chromen-2-one	Discovery agent	.	.
DNC011340	8-acetyl-7-methoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011341	UMBELLIFERONE	Discovery agent	.	.
DNC011342	6-Acetyl-7-ethoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011343	6-acetyl-7-propoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011344	6-acetyl-7-methoxy-2H-chromen-2-one	Discovery agent	.	.
DNC011345	7-hydroxy-6-propionyl-2H-chromen-2-one	Discovery agent	.	.
DNC011346	6-Acetyl-7-hydroxy-2H-chromen-2-one	Discovery agent	.	.
DNC011347	GNF-PF-2272	Discovery agent	.	.
DNC011348	GNF-PF-5134	Discovery agent	.	.
DNC011349	ZEARALANONE	Discovery agent	.	.
DNC011350	GNF-PF-67	Discovery agent	.	.
DNC011351	RHEIN	Discovery agent	.	.
DNC011352	GNF-PF-3037	Discovery agent	.	.
DNC011353	GNF-PF-2893	Discovery agent	.	.
DNC011354	ECONAZOLE NITRATE	Discovery agent	.	.
DNC011355	BITHIONOL	Discovery agent	.	.
DNC011355	BITHIONOL	Trematode infection	.	B66.9
DNC011356	CLIOQUINOL	Discovery agent	.	.
DNC011357	CHLOROXINE	Discovery agent	.	.
DNC011357	CHLOROXINE	Erythema	.	L51.9
DNC011358	NALTREXONE HYDROCHLORIDE	Discovery agent	.	.
DNC011359	HESPERIDINE	Discovery agent	.	.
DNC011360	GNF-PF-3464	Discovery agent	.	.
DNC011361	NSC-180246	Discovery agent	.	.
DNC011362	NSC-87509	Discovery agent	.	.
DNC011363	NSC-66209	Discovery agent	.	.
DNC011364	GNF-PF-2812	Discovery agent	.	.
DNC011365	GNF-PF-3832	Discovery agent	.	.
DNC011366	GNF-PF-2307	Discovery agent	.	.
DNC011367	GNF-PF-78	Discovery agent	.	.
DNC011368	GNF-PF-826	Discovery agent	.	.
DNC011369	ALTENUSIN	Discovery agent	.	.
DNC011370	ROSMARINIC ACID	Discovery agent	.	.
DNC011370	ROSMARINIC ACID	Rheumatold arthritis	714	M05-M06
DNC011371	CEPHALOCHROMIN	Discovery agent	.	.
DNC011372	LIOTHYRONINE SODIUM	Discovery agent	.	.
DNC011373	SULFURETIN	Discovery agent	.	.
DNC011374	GNF-PF-3955	Discovery agent	.	.
DNC011375	GNF-PF-1591	Discovery agent	.	.
DNC011376	NSC-1771	Discovery agent	.	.
DNC011377	NSC-119913	Discovery agent	.	.
DNC011378	NSC-119911	Discovery agent	.	.
DNC011379	2-Benzhydryl-7-hydroxy-chromen-4-one	Discovery agent	.	.
DNC011380	Prenyl pyrophosphate analogue	Discovery agent	.	.
DNC011381	2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one	Discovery agent	.	.
DNC011382	4-Furan-2-yl-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011383	2-Benzyl-7-hydroxy-chromen-4-one	Discovery agent	.	.
DNC011384	Divaplon	Discovery agent	.	.
DNC011385	N-(9H-beta-Carbolin-3-yl)-acetamide	Discovery agent	.	.
DNC011386	N-(9H-beta-Carbolin-3-yl)-formamide	Discovery agent	.	.
DNC011387	HI-172	Discovery agent	.	.
DNC011388	6-nitroquipazine	Discovery agent	.	.
DNC011389	6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one	Discovery agent	.	.
DNC011390	Prenyl pyrophosphate analogue	Discovery agent	.	.
DNC011391	6,7-Dihydroxy-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC011392	8-(2,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC011393	9H-beta-Carboline-3-carboxylic acid ethyl ester	Discovery agent	.	.
DNC011394	4-Allyl-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011395	(9H-beta-Carbolin-3-yl)-ethyl-amine	Discovery agent	.	.
DNC011396	HI-242	Discovery agent	.	.
DNC011397	EMIVIRINE	Discovery agent	.	.
DNC011397	EMIVIRINE	Human immunodeficiency virus infection	.	B20
DNC011398	7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one	Discovery agent	.	.
DNC011399	HI-241	Discovery agent	.	.
DNC011400	Prenyl pyrophosphate analogue	Discovery agent	.	.
DNC011401	4-Bromo-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011402	(9H-beta-Carbolin-3-yl)-carbamic acid ethyl ester	Discovery agent	.	.
DNC011403	HI-445	Discovery agent	.	.
DNC011404	TIBO	Discovery agent	.	.
DNC011405	R-82150	Discovery agent	.	.
DNC011405	R-82150	Human immunodeficiency virus infection	.	B20
DNC011406	(R,S)-AMPA	Discovery agent	.	.
DNC011407	4-Benzyl-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011408	7-Hydroxy-6-nitro-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC011409	4-Chloro-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011410	RP-68303	Discovery agent	.	.
DNC011411	7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one	Discovery agent	.	.
DNC011412	8-(3,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC011413	8-(2,5-dimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC011414	HI-280	Discovery agent	.	.
DNC011415	HI-236	Discovery agent	.	.
DNC011416	HI-240	Discovery agent	.	.
DNC011417	4-Iodo-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011418	Prenyl pyrophosphate analogue	Discovery agent	.	.
DNC011419	6-Nitro-4-phenyl-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC011420	HI-281	Discovery agent	.	.
DNC011421	2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one	Discovery agent	.	.
DNC011422	8-(2,4,6-trimethoxyphenyl)-9H-purine-2,6-diamine	Discovery agent	.	.
DNC011423	6-Nitro-2-piperazin-1-yl-4-vinyl-quinoline	Discovery agent	.	.
DNC011424	MRS-2160	Discovery agent	.	.
DNC011425	Prenyl pyrophosphate analogue	Discovery agent	.	.
DNC011426	ISOGUANOSINE	Discovery agent	.	.
DNC011427	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea	Discovery agent	.	.
DNC011428	TROVIRDINE	Discovery agent	.	.
DNC011429	2-Methyl-1,2-di-pyridin-3-yl-propane	Discovery agent	.	.
DNC011430	4,5-Dimethoxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011431	2-Methyl-1,2-di-pyridin-3-yl-1-methoxypropane	Discovery agent	.	.
DNC011432	THYMELEATOXIN	Discovery agent	.	.
DNC011433	Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2	Discovery agent	.	.
DNC011434	2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-one	Discovery agent	.	.
DNC011435	8-Piperazin-1-yl-imidazo[1,2-a]pyrazine	Discovery agent	.	.
DNC011436	Acetic acid 2-heptylselanyl-phenyl ester	Discovery agent	.	.
DNC011437	INDOLACTUM	Discovery agent	.	.
DNC011438	Ingenol-3-bezoate	Discovery agent	.	.
DNC011439	(D)Phe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2	Discovery agent	.	.
DNC011440	D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(CTAP)	Discovery agent	.	.
DNC011441	JMV 1802	Discovery agent	.	.
DNC011442	JMV 1693	Discovery agent	.	.
DNC011443	Acetic acid 2-heptylsulfanyl-phenyl ester	Discovery agent	.	.
DNC011444	3-[1-ethyl-2-(3-hydroxyphenyl)butyl]phenol	Discovery agent	.	.
DNC011445	D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2(CTOP)	Discovery agent	.	.
DNC011446	2-Methyl-1,2-di-pyridin-3-yl-propan-1-one oxime	Discovery agent	.	.
DNC011447	Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2	Discovery agent	.	.
DNC011448	P-IODOAMPHETAMINE	Discovery agent	.	.
DNC011449	Acetic acid 2-hept-2-ynylsulfanyl-phenyl ester	Discovery agent	.	.
DNC011450	ANTHRONE	Discovery agent	.	.
DNC011451	PYROGALLOL	Discovery agent	.	.
DNC011452	METYRAPOL	Discovery agent	.	.
DNC011453	1,5-Dihydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011454	10-Acetyl-1,8-dihydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011455	2-Methyl-1,2-di-pyridin-3-yl-propyliodide	Discovery agent	.	.
DNC011456	1-Methyl-4-p-tolyl-piperidine-4-carbonitrile	Discovery agent	.	.
DNC011457	CGP-27492	Discovery agent	.	.
DNC011458	1,8-Dichloro-10H-anthracen-9-one	Discovery agent	.	.
DNC011459	JMV 1719	Discovery agent	.	.
DNC011460	Acetic acid 2-pentylsulfanyl-phenyl ester	Discovery agent	.	.
DNC011461	3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine	Discovery agent	.	.
DNC011462	Acetic acid 2-hex-2-ynylsulfanyl-phenyl ester	Discovery agent	.	.
DNC011463	Acetic acid 2-hexylsulfanyl-phenyl ester	Discovery agent	.	.
DNC011464	1,2-Dihydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011465	JMV 1813	Discovery agent	.	.
DNC011466	5-Phenyl-pentanoic acid benzyl-hydroxy-amide	Discovery agent	.	.
DNC011467	1-Hydroxy-8-methoxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011468	1-Hydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011469	5-Bromo-8-piperazin-1-yl-imidazo[1,2-a]pyrazine	Discovery agent	.	.
DNC011470	NAPHTHAZALIN	Discovery agent	.	.
DNC011471	D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2(CTP)	Discovery agent	.	.
DNC011472	JMV 1803	Discovery agent	.	.
DNC011473	Acetic acid 2-hept-3-ynylsulfanyl-phenyl ester	Discovery agent	.	.
DNC011474	1-Phenyl-2-pyridin-3-yl-propan-1-one	Discovery agent	.	.
DNC011475	4-Hydroxy-5-methoxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011476	10-Benzoyl-1,8-dihydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011477	3-(2-Chloro-1,1-dimethyl-2-phenyl-ethyl)-pyridine	Discovery agent	.	.
DNC011478	D-Phe-Cys-Tyr--Trp-Lys-Thr-Pen-Thr-NH2	Discovery agent	.	.
DNC011479	1,8-Dihydroxy-2-propionyl-10H-anthracen-9-one	Discovery agent	.	.
DNC011480	LOFENTANIL	Discovery agent	.	.
DNC011481	DELTORPHIN	Discovery agent	.	.
DNC011482	2-Methylamino-succinic acid(NMDA)	Discovery agent	.	.
DNC011483	2-Methyl-1,2-di-pyridin-3-yl-propylchloride	Discovery agent	.	.
DNC011484	JMV 1799	Discovery agent	.	.
DNC011485	JMV 1801	Discovery agent	.	.
DNC011486	1,8,9-Trimethoxy-9,10-dihydro-anthracene	Discovery agent	.	.
DNC011487	JMV 1535	Discovery agent	.	.
DNC011488	Phorbol 12,13-butyrate	Discovery agent	.	.
DNC011489	4,5-Dihydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011490	2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-ol	Discovery agent	.	.
DNC011491	3,4-Dihydroxy-10H-anthracen-9-one	Discovery agent	.	.
DNC011492	1,3,8-Trihydroxy-6-methyl-10H-anthracen-9-one	Discovery agent	.	.
DNC011493	D-PhGly-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2	Discovery agent	.	.
DNC011494	N-Benzyl-2-(1H-indol-3-yl)-2-oxo-acetamide	Discovery agent	.	.
DNC011495	3-Methyl-2-phenyl-2H-chromeno[4,3-c]pyrazol-4-one	Discovery agent	.	.
DNC011496	L-697661	Discovery agent	.	.
DNC011497	Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH	Discovery agent	.	.
DNC011498	ISOLOXAPINE	Discovery agent	.	.
DNC011499	(6-Benzylamino-9H-beta-carbolin-3-yl)-methanol	Discovery agent	.	.
DNC011500	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione	Discovery agent	.	.
DNC011501	CGS-9896	Discovery agent	.	.
DNC011502	NORHARMANE	Discovery agent	.	.
DNC011503	9H-beta-Carbolin-6-ylamine	Discovery agent	.	.
DNC011504	N-(3-Phenyl-[1,2,4]thiadiazol-5-yl)-benzamide	Discovery agent	.	.
DNC011505	N,N'-Bis-(4-butyl-phenyl)-guanidine	Discovery agent	.	.
DNC011506	N-(4-Pyridin-2-yl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC011507	1-Phenyl-3-(4-pyridin-2-yl-thiazol-2-yl)-urea	Discovery agent	.	.
DNC011508	DERMORPHIN	Discovery agent	.	.
DNC011509	N,N'-Bis-(4-isopropyl-phenyl)-guanidine	Discovery agent	.	.
DNC011510	2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine	Discovery agent	.	.
DNC011511	6,8-Dichloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Discovery agent	.	.
DNC011512	(9H-beta-Carbolin-3-yl)-methanol	Discovery agent	.	.
DNC011513	LUF-5437	Discovery agent	.	.
DNC011514	1,3-Diphenyl-1H-chromeno[4,3-c]pyrazol-4-one	Discovery agent	.	.
DNC011515	N,N'-Bis-(4-ethyl-phenyl)-guanidine	Discovery agent	.	.
DNC011516	GNF-PF-173	Discovery agent	.	.
DNC011517	3-Methyl-1-phenyl-1H-chromeno[4,3-c]pyrazol-4-one	Discovery agent	.	.
DNC011518	AMIFLAMINE	Discovery agent	.	.
DNC011519	Benzyl-(9H-beta-carbolin-6-yl)-amine	Discovery agent	.	.
DNC011520	ATEVIRDINE	Discovery agent	.	.
DNC011520	ATEVIRDINE	Human immunodeficiency virus infection	.	B20
DNC011521	ZK-93423	Discovery agent	.	.
DNC011521	ZK-93423	Epileptic seizures	345.9, 780.3	G40, P90, R56
DNC011522	3-Benzylamino-5-ethyl-6-methyl-1H-pyridin-2-one	Discovery agent	.	.
DNC011523	N,N'-Bis-(4-butoxy-phenyl)-guanidine	Discovery agent	.	.
DNC011524	N,N'-Bis-(4-hexyl-phenyl)-guanidine	Discovery agent	.	.
DNC011525	1-(2,3-Dihydro-1H-indol-5-ylmethyl)-propylamine	Discovery agent	.	.
DNC011526	1-(9H-beta-Carbolin-3-yl)-ethanone	Discovery agent	.	.
DNC011527	UFP-502	Discovery agent	.	.
DNC011528	N,N'-Bis-(4-sec-butyl-phenyl)-guanidine	Discovery agent	.	.
DNC011529	PD-135478	Discovery agent	.	.
DNC011530	1-Methyl-5-oxa-spiro[2.4]heptan-4-one	Discovery agent	.	.
DNC011531	4-Benzyl-1-(2-phenoxy-ethyl)-piperidine	Discovery agent	.	.
DNC011532	4-[3-(4-Phenyl-butylamino)-propyl]-phenol	Discovery agent	.	.
DNC011533	6,6-Dimethyl-2-oxa-spiro[4.4]nonan-1-one	Discovery agent	.	.
DNC011534	PSB-1115	Discovery agent	.	.
DNC011535	Isopropyl-methyl-prop-2-ynyl-amine hydrochloride	Discovery agent	.	.
DNC011536	2-(1H-Imidazol-4-yl)-cyclopropylamine	Discovery agent	.	.
DNC011537	Butyl-methyl-prop-2-ynyl-amine hydrochloride	Discovery agent	.	.
DNC011538	C-[2-(1H-Imidazol-4-yl)-cyclopropyl]-methylamine	Discovery agent	.	.
DNC011539	Heptyl-methyl-prop-2-ynyl-amine hydrochloride	Discovery agent	.	.
DNC011540	Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Ser-Val-Tyr-Phe-Cys)	Discovery agent	.	.
DNC011541	6,9-Dimethyl-2-oxa-spiro[4.4]nonan-1-one	Discovery agent	.	.
DNC011542	Somatostatin Analogue	Discovery agent	.	.
DNC011543	Somatostatin Analogue	Discovery agent	.	.
DNC011544	VUF-5297	Discovery agent	.	.
DNC011545	(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Aoc-Arg	Discovery agent	.	.
DNC011546	SK&F-96321	Discovery agent	.	.
DNC011547	Somatostatin Analogue	Discovery agent	.	.
DNC011548	3-Ethyl-3-isopropyl-dihydro-furan-2-one	Discovery agent	.	.
DNC011549	3-tert-Butyl-3-ethyl-dihydro-furan-2-one	Discovery agent	.	.
DNC011550	PK-11195	Discovery agent	.	.
DNC011551	Morphinan Cyclic Imine analogue	Discovery agent	.	.
DNC011552	3,3-Diethyl-dihydro-furan-2-one	Discovery agent	.	.
DNC011553	PD-135385	Discovery agent	.	.
DNC011554	PD-135146	Discovery agent	.	.
DNC011555	SK&F-38393	Discovery agent	.	.
DNC011556	Morphinan Cyclic Imine analogue	Discovery agent	.	.
DNC011557	Morphinan Cyclic Imine analogue	Discovery agent	.	.
DNC011558	Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Val-Tyr-Phe-Cys)	Discovery agent	.	.
DNC011559	4-[2-(5-Phenyl-pentylamino)-ethyl]-phenol	Discovery agent	.	.
DNC011560	4-Benzyl-1-phenethyl-piperidine hydrochloride	Discovery agent	.	.
DNC011561	Morphinan Cyclic Imine analogue	Discovery agent	.	.
DNC011562	(D)Arg-Arg-Pro-Hyp-Gly-Phe-Ser-(d)Phe-Phe-Arg	Discovery agent	.	.
DNC011563	(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Tic-Arg	Discovery agent	.	.
DNC011564	4-{2-[Ethyl-(4-phenyl-butyl)-amino]-ethyl}-phenol	Discovery agent	.	.
DNC011565	Phenethyl-(3-phenyl-propyl)-amine	Discovery agent	.	.
DNC011566	PD-135222	Discovery agent	.	.
DNC011567	TAK-536	Discovery agent	.	.
DNC011567	TAK-536	Hypertension	401	I10, I11, I12, I13, I15
DNC011568	3-Ethyl-3-methyl-dihydro-furan-2-one	Discovery agent	.	.
DNC011569	N*1*-(5-Methyl-2-nitro-phenyl)-butane-1,4-diamine	Discovery agent	.	.
DNC011570	4-[2-(4-Benzyl-piperidin-1-yl)-ethoxy]-phenol	Discovery agent	.	.
DNC011571	(D)Arg-Arg-Pro-Hyp-Gly-Thi-Cys-(D)Phe-Phe-Cys-Arg	Discovery agent	.	.
DNC011572	PD-128483	Discovery agent	.	.
DNC011573	PD-137821	Discovery agent	.	.
DNC011574	C-[2-(1H-Imidazol-4-yl)-cyclopropyl]-methylamine	Discovery agent	.	.
DNC011575	2-[2-(1H-Imidazol-4-yl)-cyclopropyl]-ethylamine	Discovery agent	.	.
DNC011576	C-[2-(1H-Imidazol-4-yl)-cyclopropyl]-methylamine	Discovery agent	.	.
DNC011577	6-Methyl-2-oxa-spiro[4.4]nonan-1-one	Discovery agent	.	.
DNC011578	Phenethyl-(4-phenyl-butyl)-amine	Discovery agent	.	.
DNC011579	3,3-Diisopropyl-dihydro-furan-2-one	Discovery agent	.	.
DNC011580	3-Isopropyl-3-methyl-dihydro-furan-2-one	Discovery agent	.	.
DNC011581	BRL-61063	Allergy	.	T78.4
DNC011581	BRL-61063	Discovery agent	.	.
DNC011582	Methyl-pentyl-prop-2-ynyl-amine oxalic acid	Discovery agent	.	.
DNC011583	4-[2-(4-Phenyl-butylamino)-ethyl]-phenol	Discovery agent	.	.
DNC011584	N-[4-(4-Phenyl-piperazin-1-yl)-butyl]-benzamide	Discovery agent	.	.
DNC011585	Morphinan Cyclic Imine analogue	Discovery agent	.	.
DNC011586	2-[2-(1H-Imidazol-4-yl)-cyclopropyl]-ethylamine	Discovery agent	.	.
DNC011587	4-[2-(4-Phenyl-butoxy)-ethyl]-phenol	Discovery agent	.	.
DNC011588	4-[2-(6-Phenyl-hexylamino)-ethyl]-phenol	Discovery agent	.	.
DNC011589	PD-135540	Discovery agent	.	.
DNC011590	1,1-Dimethyl-5-oxa-spiro[2.4]heptan-4-one	Discovery agent	.	.
DNC011591	VUF-5296	Discovery agent	.	.
DNC011592	4-[2-(3-Phenyl-propylamino)-ethyl]-phenol	Discovery agent	.	.
DNC011593	4-[3-(5-Phenyl-pentylamino)-propyl]-phenol	Discovery agent	.	.
DNC011594	Morphinan Cyclic Imine analogue	Discovery agent	.	.
DNC011595	2-Oxa-spiro[4.4]nonan-1-one	Discovery agent	.	.
DNC011596	PD-135188	Discovery agent	.	.
DNC011597	PD-137789	Discovery agent	.	.
DNC011598	Somatostatin Analogue	Discovery agent	.	.
DNC011599	PD-135111	Discovery agent	.	.
DNC011600	4-[2-(4-Phenyl-piperidin-1-yl)-ethoxy]-phenol	Discovery agent	.	.
DNC011601	2-(1H-Imidazol-4-yl)-cyclopropylamine	Discovery agent	.	.
DNC011602	C-[2-(1H-Imidazol-4-yl)-cyclopropyl]-methylamine	Discovery agent	.	.
DNC011603	1-Methyl-8-phenyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011604	2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole	Discovery agent	.	.
DNC011605	9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011606	4-Hept-3-ynyl-1H-imidazole	Discovery agent	.	.
DNC011607	2-(4-Butoxy-phenoxy)-N-hydroxy-acetamide	Discovery agent	.	.
DNC011608	8-Hydroxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one	Discovery agent	.	.
DNC011609	TRYPTOLINE	Discovery agent	.	.
DNC011610	4-Bromo-N-hydroxy-benzamide	Discovery agent	.	.
DNC011611	4-Butoxy-N-hydroxy-N-methyl-benzamide	Discovery agent	.	.
DNC011612	N-Hydroxy-N-methyl-3-phenanthren-2-yl-acrylamide	Discovery agent	.	.
DNC011613	N-Hydroxy-N-methyl-2-naphthalen-2-yl-propionamide	Discovery agent	.	.
DNC011614	2-(4-Amino-phenyl)-8-methyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011615	N-Hydroxy-4-isobutyl-benzamide	Discovery agent	.	.
DNC011616	Ecopipam	Cocaine dependence	.	F14.2
DNC011616	Ecopipam	Discovery agent	.	.
DNC011617	10-Propyl-10H-dibenzo[b,f][1,4]thiazepin-11-one	Discovery agent	.	.
DNC011618	4,9-Dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011619	4-Hex-3-ynyl-1H-imidazole	Discovery agent	.	.
DNC011620	Indolocarbazole analogue	Discovery agent	.	.
DNC011621	3-Hydroxy-benzamide	Discovery agent	.	.
DNC011622	5-Methoxy-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011623	6-Methoxy-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011624	6-Bromo-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011625	Indolocarbazole analogue	Discovery agent	.	.
DNC011626	3-Biphenyl-3-yl-N-hydroxy-N-methyl-acrylamide	Discovery agent	.	.
DNC011627	2-(4-Methoxy-phenyl)-8-methyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011628	4-(7-Methyl-oct-3-ynyl)-1H-imidazole	Discovery agent	.	.
DNC011629	Phenanthrene-3-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011630	2H-Isoquinolin-1-one	Discovery agent	.	.
DNC011631	6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011632	1-Dibenzo[b,f]oxepin-10-yl-4-methyl-piperazine	Discovery agent	.	.
DNC011633	8-Phenyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011634	6-Phenylsulfanylmethyl-pteridine-2,4-diamine	Discovery agent	.	.
DNC011635	2-(4-Amino-phenyl)-8-hydroxy-3H-quinazolin-4-one	Discovery agent	.	.
DNC011636	VERONGAMINE	Discovery agent	.	.
DNC011637	ATEVIRDINE SULPHATE	Discovery agent	.	.
DNC011638	Biphenyl-4-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011639	N-Hydroxy-2-naphthalen-2-yl-acetamide	Discovery agent	.	.
DNC011640	A-313326	Discovery agent	.	.
DNC011641	N-Hydroxy-N-methyl-benzamide	Discovery agent	.	.
DNC011642	CGS-19281A	Discovery agent	.	.
DNC011643	4-(7,7-Dimethyl-oct-3-ynyl)-1H-imidazole	Discovery agent	.	.
DNC011644	3-Benzoyl-N-hydroxy-benzamide	Discovery agent	.	.
DNC011645	N-Hydroxy-3-naphthalen-2-yl-N-phenyl-acrylamide	Discovery agent	.	.
DNC011646	8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one	Discovery agent	.	.
DNC011647	5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011648	2-(3-Methyl-3H-imidazol-4-yl)-ethylamine	Discovery agent	.	.
DNC011649	N-Hydroxy-3-naphthalen-2-yl-N-p-tolyl-acrylamide	Discovery agent	.	.
DNC011650	8-Methyl-2-phenyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011651	Phenanthrene-2-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011652	2-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acetamide	Discovery agent	.	.
DNC011653	7-Methoxy-9H-beta-carboline	Discovery agent	.	.
DNC011654	PNU-22394	Discovery agent	.	.
DNC011655	N-Hydroxy-4-iodo-benzamide	Discovery agent	.	.
DNC011656	N-hydroxy-4-(naphthalen-1-yl)benzamide	Discovery agent	.	.
DNC011657	6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011658	7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011659	4-(6-Cyclohexyl-hex-3-ynyl)-1H-imidazole	Discovery agent	.	.
DNC011660	Naphthalene-2-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011661	N-Hydroxy-N-methyl-3-naphthalen-2-yl-acrylamide	Discovery agent	.	.
DNC011662	10-Allyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	Discovery agent	.	.
DNC011663	2-(4-Hydroxy-phenyl)-8-methyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011664	2,4-Diamino-butyric acid(GABA)	Discovery agent	.	.
DNC011665	4-(6-Cyclopentyl-hex-3-ynyl)-1H-imidazole	Discovery agent	.	.
DNC011666	N-Hydroxy-N-methyl-3-phenanthren-9-yl-acrylamide	Discovery agent	.	.
DNC011667	2-(4-Butoxy-phenoxy)-N-hydroxy-N-methyl-acetamide	Discovery agent	.	.
DNC011668	2,3,4,5-Tetrafluoro-6-pentafluorophenylazo-phenol	Discovery agent	.	.
DNC011669	8-Hydroxy-2-phenyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011670	L-158282	Discovery agent	.	.
DNC011671	N-Hydroxy-2-methyl-3-naphthalen-2-yl-acrylamide	Discovery agent	.	.
DNC011672	5-Bromo-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011673	2-(4-Butoxy-phenoxy)-N-hydroxy-propionamide	Discovery agent	.	.
DNC011674	2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol	Discovery agent	.	.
DNC011675	5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011676	3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acrylamide	Discovery agent	.	.
DNC011677	Indolocarbazole analogue	Discovery agent	.	.
DNC011678	RWJ-16979	Discovery agent	.	.
DNC011679	GR-175737	Discovery agent	.	.
DNC011680	Biphenyl-3-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011681	3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide	Discovery agent	.	.
DNC011682	N-Hydroxy-N-methyl-3-naphthalen-2-yl-propionamide	Discovery agent	.	.
DNC011683	7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011684	8-Methoxy-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011685	N-Hydroxy-4-naphthalen-2-yl-benzamide	Discovery agent	.	.
DNC011686	N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide	Discovery agent	.	.
DNC011687	4,4'-dihydroxyoctafluoroazobenzene	Discovery agent	.	.
DNC011688	7-Bromo-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011689	Indolocarbazole analogue	Discovery agent	.	.
DNC011690	8-Methyl-2-(4-nitro-phenyl)-3H-quinazolin-4-one	Discovery agent	.	.
DNC011691	2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011692	Ibuproxam	Discovery agent	.	.
DNC011692	Ibuproxam	Respiratory disease	.	J00-J99
DNC011693	2,8-Dimethyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011694	8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011695	8-Bromo-4,9-dihydro-3H-beta-carboline	Discovery agent	.	.
DNC011696	Indolocarbazole analogue	Discovery agent	.	.
DNC011697	Indolocarbazole analogue	Discovery agent	.	.
DNC011698	N-Hydroxy-N-methyl-2,3,3-triphenyl-acrylamide	Discovery agent	.	.
DNC011699	8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Discovery agent	.	.
DNC011700	2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide	Discovery agent	.	.
DNC011701	10-Propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	Discovery agent	.	.
DNC011702	10-Ethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	Discovery agent	.	.
DNC011703	8-Methoxy-2-phenyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011704	4-(8-Phenyl-oct-3-ynyl)-1H-imidazole	Discovery agent	.	.
DNC011705	TRYPTAMINE	Discovery agent	.	.
DNC011706	Indolocarbazole analogue	Discovery agent	.	.
DNC011707	Anthracene-2-carboxylic acid hydroxyamide	Discovery agent	.	.
DNC011708	N-Hydroxy-3-naphthalen-2-yl-propionamide	Discovery agent	.	.
DNC011709	10-Isopropyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	Discovery agent	.	.
DNC011710	8-Methoxy-2-methyl-3H-quinazolin-4-one	Discovery agent	.	.
DNC011711	N-Hydroxy-N-methyl-3-phenanthren-3-yl-acrylamide	Discovery agent	.	.
DNC011712	C-(1H-Indol-3-yl)-methylamine	Discovery agent	.	.
DNC011713	GT-2016	Alzheimer's disease	.	G30,F00
DNC011713	GT-2016	Discovery agent	.	.
DNC011714	L-158809	Discovery agent	.	.
DNC011714	L-158809	Hypertension	401	I10, I11, I12, I13, I15
DNC011715	N-Hydroxy-3-phenyl-acrylamide	Discovery agent	.	.
DNC011716	N-Hydroxy-3-naphthalen-2-yl-acrylamide	Discovery agent	.	.
DNC011717	2-(4-Azido-phenyl)-8-methoxy-3H-quinazolin-4-one	Discovery agent	.	.
DNC011718	Azapeptide derivative	Discovery agent	.	.
DNC011719	Azapeptide derivative	Discovery agent	.	.
DNC011720	Azapeptide derivative	Discovery agent	.	.
DNC011721	Azapeptide derivative	Discovery agent	.	.
DNC011722	2-(3-Chloro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011723	2-(2-Methyl-benzoyl)-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011724	Azapeptide derivative	Discovery agent	.	.
DNC011725	Azapeptide derivative	Discovery agent	.	.
DNC011726	RO-147437	Discovery agent	.	.
DNC011727	2-(4-Methoxy-phenyl)-5-phenyl-thiazol-4-ol	Discovery agent	.	.
DNC011728	2-(2-Bromo-benzoyl)-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011729	RO-145975	Discovery agent	.	.
DNC011730	2-(2-Methoxy-benzoyl)-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011731	DNQX	Discovery agent	.	.
DNC011732	Azapeptide derivative	Discovery agent	.	.
DNC011733	2-(2-Nitro-benzoyl)-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011734	PSILOCIN	Discovery agent	.	.
DNC011735	Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester	Discovery agent	.	.
DNC011736	Azapeptide derivative	Discovery agent	.	.
DNC011737	6-Bromo-2-(2-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011738	2-(2-Chloro-benzoyl)-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011739	2-(2-Iodo-benzoyl)-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011740	Azapeptide derivative	Discovery agent	.	.
DNC011741	6-Chloro-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC011742	6-Bromo-2-(4-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011743	Azapeptide derivative	Discovery agent	.	.
DNC011744	Azapeptide derivative	Discovery agent	.	.
DNC011745	6-Bromo-2-(3-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011746	Azapeptide derivative	Discovery agent	.	.
DNC011747	RO-194603	Discovery agent	.	.
DNC011748	7-Chloro-3-nitro-3,4-dihydro-1H-quinolin-2-one	Discovery agent	.	.
DNC011749	Azapeptide derivative	Discovery agent	.	.
DNC011750	Azapeptide derivative	Discovery agent	.	.
DNC011751	Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester	Discovery agent	.	.
DNC011752	RO-145974	Discovery agent	.	.
DNC011753	6-Fluoro-2-(3-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011754	2-(3-Bromo-phenyl)-6-nitro-chromen-4-one	Discovery agent	.	.
DNC011755	CARAMIPEN	Discovery agent	.	.
DNC011756	1,3-Diethyl-8-phenyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011757	6-Nitro-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC011758	6-Chloro-2-(3-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011759	SL-3111	Discovery agent	.	.
DNC011760	Brolamfetamine	Discovery agent	.	.
DNC011761	Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester	Discovery agent	.	.
DNC011762	Azapeptide derivative	Discovery agent	.	.
DNC011763	NSC-73613	Discovery agent	.	.
DNC011764	6-Nitro-2-(3-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011765	NSC-93394	Discovery agent	.	.
DNC011766	2-Cyclopropanecarbonyl-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011767	Azapeptide derivative	Discovery agent	.	.
DNC011768	Azapeptide derivative	Discovery agent	.	.
DNC011769	5-Methyl-2-p-tolyl-thiazol-4-ol	Discovery agent	.	.
DNC011770	PHENIDONE	Discovery agent	.	.
DNC011771	2-(3-Bromo-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011772	Azapeptide derivative	Discovery agent	.	.
DNC011773	Azapeptide derivative	Discovery agent	.	.
DNC011774	Azapeptide derivative	Discovery agent	.	.
DNC011775	6-Bromo-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC011776	Azapeptide derivative	Discovery agent	.	.
DNC011777	6-Bromo-2-(3-bromo-phenyl)-chromen-4-one	Discovery agent	.	.
DNC011778	2-Acetyl-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011779	2-Propionyl-cyclohexane-1,3-dione	Discovery agent	.	.
DNC011780	Azapeptide derivative	Discovery agent	.	.
DNC011781	9-Methoxy-1,2,3,4-tetrahydro-anthracen-2-ylamine	Discovery agent	.	.
DNC011782	CGS-12066B	Anxiety disorder	.	F40-F42
DNC011782	CGS-12066B	Discovery agent	.	.
DNC011783	(R)-2-Amino-5-phosphono-pentanoic acid	Discovery agent	.	.
DNC011784	PO3 2-Ile-Trp-O-3K	Discovery agent	.	.
DNC011785	CGS-27830	Discovery agent	.	.
DNC011786	3-Butyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-ol	Discovery agent	.	.
DNC011787	1-(9H-beta-Carbolin-3-yl)-butan-1-one	Discovery agent	.	.
DNC011788	N,N-diCPM[D-Pro-10]Dyn A-(1-11)	Discovery agent	.	.
DNC011789	DYNORPHIN A	Discovery agent	.	.
DNC011790	(3-Chloro-phenyl)-piperazin-1-yl-methanone	Discovery agent	.	.
DNC011791	4-Methoxy-5-phenyl-6-thia-10b-aza-benzo[e]azulene	Discovery agent	.	.
DNC011792	3-Benzyloxy-2-phenyl-piperidine	Discovery agent	.	.
DNC011793	ACETYLCHOLINE CHLORIDE	Discovery agent	.	.
DNC011794	1-(2,5-Dimethoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011795	5-Phenyl-6-thia-10b-aza-benzo[e]azulene	Discovery agent	.	.
DNC011796	ETICLOPRIDE	Discovery agent	.	.
DNC011797	3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indole	Discovery agent	.	.
DNC011798	2-Piperazin-1-yl-phenol	Discovery agent	.	.
DNC011799	1-(3-Trifluoromethyl-phenyl)-piperazine	Discovery agent	.	.
DNC011800	1,1-Dimethyl-4-phenyl-piperazin-1-ium iodide	Discovery agent	.	.
DNC011801	N-CPM[D-Pro-10]Dyn A-(1-11)	Discovery agent	.	.
DNC011802	N,N-diallyl[D-Pro-10]Dyn A-(1-11)	Discovery agent	.	.
DNC011803	3-Isobutoxy-9H-beta-carboline	Discovery agent	.	.
DNC011804	3-(2,2-Dimethyl-propoxy)-9H-beta-carboline	Discovery agent	.	.
DNC011805	N-allyl[D-Pro-10]Dyn A-(1-11)	Discovery agent	.	.
DNC011806	PO3 2-Leu-Trp-O-3K	Discovery agent	.	.
DNC011807	3-Butoxy-9H-beta-carboline	Discovery agent	.	.
DNC011808	AP-7	Discovery agent	.	.
DNC011809	3-Propoxy-9H-beta-carboline	Discovery agent	.	.
DNC011810	BETA-CCM	Discovery agent	.	.
DNC011811	PO3 2-Leu-Nal-O-3K	Discovery agent	.	.
DNC011812	PO3 2-Nle-Trp-O-3K	Discovery agent	.	.
DNC011813	3-(3-Methyl-butoxy)-9H-beta-carboline	Discovery agent	.	.
DNC011814	TERTATOLOL	Discovery agent	.	.
DNC011814	TERTATOLOL	Hypertension	401	I10, I11, I12, I13, I15
DNC011815	1-(2,5-Dimethoxy-4-methyl-phenyl)-piperazine	Discovery agent	.	.
DNC011816	2-Dipropylamino-1,2,3,4-tetrahydro-anthracen-9-ol	Discovery agent	.	.
DNC011817	2-Phenyl-3-(1-phenyl-ethoxy)-piperidine	Discovery agent	.	.
DNC011818	8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine	Discovery agent	.	.
DNC011819	3-Methoxy-9H-beta-carboline	Discovery agent	.	.
DNC011820	3-Ethyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-ol	Discovery agent	.	.
DNC011821	3-sec-Butoxy-9H-beta-carboline	Discovery agent	.	.
DNC011822	3-((S)-Azetidin-2-yloxy)-5-iodo-pyridine	Discovery agent	.	.
DNC011823	3-Amino-1-(2-amino-5-methoxy-phenyl)-propan-1-one	Discovery agent	.	.
DNC011824	N,N-dibenzyl[D-Pro-10]Dyn A-(1-11)	Discovery agent	.	.
DNC011825	1-(4-Bromo-2,5-dimethoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011826	3-Isopropoxy-9H-beta-carboline	Discovery agent	.	.
DNC011827	N-benzyl[D-Pro-10]Dyn A-(1-11)	Discovery agent	.	.
DNC011828	CHOLINE	Discovery agent	.	.
DNC011829	U-69593	Discovery agent	.	.
DNC011830	(1R,2R)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine	Discovery agent	.	.
DNC011831	5-Methoxy-1-phenyl-1H-benzoimidazole	Discovery agent	.	.
DNC011832	1-(2-Phenoxy-ethyl)-1H-imidazole	Discovery agent	.	.
DNC011833	1-Phenyl-1H-benzoimidazol-5-ol	Discovery agent	.	.
DNC011834	(1S,2S)-2-(1H-Imidazol-4-yl)-cyclopentylamine	Discovery agent	.	.
DNC011835	PD-85639	Discovery agent	.	.
DNC011836	(R)-2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol	Discovery agent	.	.
DNC011837	4-(2-Imidazol-1-yl-ethoxy)-benzamide	Discovery agent	.	.
DNC011838	4-((2S,3R)-2-Methyl-pyrrolidin-3-yl)-1H-imidazole	Discovery agent	.	.
DNC011839	Zwitterionic sulfobetaine derivative	Discovery agent	.	.
DNC011840	1,3-Dipropyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011841	4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine	Discovery agent	.	.
DNC011842	1-Ethyl-4-(2-methoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011843	3-Methyl-9H-beta-carboline	Discovery agent	.	.
DNC011844	(1R,2S)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine	Discovery agent	.	.
DNC011845	[Cyclopentyl-(2-nitro-benzoyl)-amino]-acetic acid	Discovery agent	.	.
DNC011846	N-Carboxymethyl-N-cyclopentyl-phthalamic acid	Discovery agent	.	.
DNC011847	Propyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine	Discovery agent	.	.
DNC011848	1-(2-Methoxy-phenyl)-4-propyl-piperazine	Discovery agent	.	.
DNC011849	RIP	Discovery agent	.	.
DNC011850	Zwitterionic sulfobetaine derivative	Discovery agent	.	.
DNC011851	1-Butyl-4-(2-methoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011852	4-((2R,3S)-2-Methyl-pyrrolidin-3-yl)-1H-imidazole	Discovery agent	.	.
DNC011853	Zwitterionic sulfobetaine derivative	Discovery agent	.	.
DNC011854	RWJ-25730	Discovery agent	.	.
DNC011854	RWJ-25730	Psychotic disorders	.	F20-F29
DNC011855	Ethyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine	Discovery agent	.	.
DNC011856	Zwitterionic sulfobetaine derivative	Discovery agent	.	.
DNC011857	FLUMEZAPINE	Discovery agent	.	.
DNC011858	Zwitterionic sulfobetaine derivative	Discovery agent	.	.
DNC011859	7-Allyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011860	Ro-32-0557	Discovery agent	.	.
DNC011861	PNU-91571	Discovery agent	.	.
DNC011861	PNU-91571	Insomnia	.	F51.0,G47.0
DNC011862	U-78875	Anxiety disorder	300	F40-F42
DNC011862	U-78875	Discovery agent	.	.
DNC011863	3-Hydroxy-4-phenyl-5H-furan-2-one	Discovery agent	.	.
DNC011864	1,3-Diallyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011865	1,3,7-Tripropyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011866	1,3-Diethyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011867	5-Hexyl-5-phenyl-imidazolidine-2,4-dione	Discovery agent	.	.
DNC011868	H-Tyr-c[D-Orn-(D or L)Atc-Glu]-NH2	Discovery agent	.	.
DNC011869	Ro-24-0238	Discovery agent	.	.
DNC011869	Ro-24-0238	Septic shock	.	A41.9
DNC011870	Irindalone	Discovery agent	.	.
DNC011870	Irindalone	Inflammatory diseases	.	.
DNC011871	1,3-Diisobutyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011872	7-Allyl-1,3-dimethyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011873	JL-18	Discovery agent	.	.
DNC011874	A-78773	Asthma	.	J45
DNC011874	A-78773	Discovery agent	.	.
DNC011875	PHENCYCLIDINE	Discovery agent	.	.
DNC011876	R-N-PROPYLNORAPOMORPHINE	Discovery agent	.	.
DNC011877	1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011878	5-Heptyl-5-phenyl-imidazolidine-2,4-dione	Discovery agent	.	.
DNC011879	5-Nonyl-5-phenyl-imidazolidine-2,4-dione	Discovery agent	.	.
DNC011880	1-Allyl-3,7-dimethyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011881	2-Hydroxy-2-phenyl-nonanoic acid amide	Discovery agent	.	.
DNC011882	EPIDEPRIDE	Discovery agent	.	.
DNC011883	1,3-Dibenzyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011884	CYPROTERONE ACETATE	Discovery agent	.	.
DNC011885	H-Tyr-c[D-Orn-Aic-Glu]-NH2	Discovery agent	.	.
DNC011886	3-Isopropyl-1-methyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011887	ETICLOPRIDE	Discovery agent	.	.
DNC011888	(4-Hydroxy-phenoxy)-acetic acid	Discovery agent	.	.
DNC011889	IMIRESTAT	Diabetes mellitus	.	E10-E14
DNC011889	IMIRESTAT	Discovery agent	.	.
DNC011890	1,3-Diallyl-7-methyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC011891	H-Tyr-D-Ala-Aic-Asp-Val-Val-Gly-NH2	Discovery agent	.	.
DNC011892	RTI-5989-25	Discovery agent	.	.
DNC011893	PB-28	Discovery agent	.	.
DNC011894	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011895	1-(2-Butoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011896	6,7-Dimethoxy-4-phenoxy-quinoline	Discovery agent	.	.
DNC011897	4-(3-Ethoxy-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC011898	6-Benzyl-2-sec-butylsulfanyl-3H-pyrimidin-4-one	Discovery agent	.	.
DNC011899	PHENYLPIPERAZINE	Discovery agent	.	.
DNC011900	6,7-Dimethoxy-4-(2-methoxy-phenoxy)-quinoline	Discovery agent	.	.
DNC011901	1-(2-Fluoro-phenyl)-piperazine	Discovery agent	.	.
DNC011902	H-Tyr-D-Ala-(R or S)Atc-Asp-Val-Val-Gly-NH2	Discovery agent	.	.
DNC011903	6-Benzyl-2-cyclohexylsulfanyl-3H-pyrimidin-4-one	Discovery agent	.	.
DNC011904	OXAMATE	Discovery agent	.	.
DNC011905	BRL-26175	Discovery agent	.	.
DNC011906	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011907	6,7-Dimethoxy-4-(3-nitro-phenoxy)-quinoline	Discovery agent	.	.
DNC011908	6,7-Dimethoxy-4-m-tolyloxy-quinoline	Discovery agent	.	.
DNC011909	3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine	Discovery agent	.	.
DNC011910	3-Iodyl-benzoic acid	Discovery agent	.	.
DNC011911	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011912	1-(2-Isopropoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011913	4-(3-Fluoro-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC011914	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011915	6,7-Dimethoxy-4-(4-methoxy-phenoxy)-quinoline	Discovery agent	.	.
DNC011916	2-Piperazin-1-yl-benzonitrile	Discovery agent	.	.
DNC011917	4-(3-Ethyl-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC011918	4-Iodyl-benzoic acid	Discovery agent	.	.
DNC011919	CLEBOPRIDE	Discovery agent	.	.
DNC011920	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011921	L-748780	Discovery agent	.	.
DNC011922	L-761000	Discovery agent	.	.
DNC011923	1-Iodyl-3-nitro-benzene	Discovery agent	.	.
DNC011924	Deltorphin C	Discovery agent	.	.
DNC011925	6-Benzyl-2-isobutylsulfanyl-3H-pyrimidin-4-one	Discovery agent	.	.
DNC011926	1-Iodyl-4-nitro-benzene	Discovery agent	.	.
DNC011927	TIOSPIRONE	Discovery agent	.	.
DNC011928	CGP-62464	Discovery agent	.	.
DNC011929	6-Benzyl-2-cyclopentylsulfanyl-3H-pyrimidin-4-one	Discovery agent	.	.
DNC011930	1-METHYLXANTHINE	Discovery agent	.	.
DNC011931	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011932	1-(2-Ethoxy-phenyl)-piperazine	Discovery agent	.	.
DNC011933	RTI-5989-23	Discovery agent	.	.
DNC011934	4-(2,3-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC011935	4-(3,5-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Discovery agent	.	.
DNC011936	NILVADIPINE	Discovery agent	.	.
DNC011937	1-(3-Fluoro-phenyl)-piperazine	Discovery agent	.	.
DNC011938	ZANOTERONE	Discovery agent	.	.
DNC011938	ZANOTERONE	Prostate hyperplasia	.	N40
DNC011939	Hydrogen peroxide	Discovery agent	.	.
DNC011939	Hydrogen peroxide	Infectious disease	001-139	A00-B99
DNC011940	Delta-kappa opioid heterodimer	Discovery agent	.	.
DNC011941	1-(3-Nitro-phenyl)-piperazine	Discovery agent	.	.
DNC011942	CV-4093	Discovery agent	.	.
DNC011943	Iodyl-benzene	Discovery agent	.	.
DNC011944	3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenol	Discovery agent	.	.
DNC011945	H-Tyr-D-Ala-Tic-Asp-Val-Val-Gly-NH2	Discovery agent	.	.
DNC011946	MIANSERIN HYDROCHLORIDE	Discovery agent	.	.
DNC011947	6,7-Dimethoxy-4-(3-methoxy-phenoxy)-quinoline	Discovery agent	.	.
DNC011948	3-Aminomethyl-5-methyl-hexanoic acid	Discovery agent	.	.
DNC011949	1-(3-Cyano-phenyl)-1H-pyrazole-4-carboxylic acid	Discovery agent	.	.
DNC011950	AMINOBENZTROPINE	Discovery agent	.	.
DNC011951	TEFLUDAZINE	Discovery agent	.	.
DNC011952	Etisulergine	Discovery agent	.	.
DNC011953	2-p-Tolyl-6H-pyrazolo[1,5-c]quinazolin-5-one	Discovery agent	.	.
DNC011954	PD-144550	Discovery agent	.	.
DNC011955	2-Phenyl-5,6-dihydro-pyrazolo[1,5-c]quinazoline	Discovery agent	.	.
DNC011956	2-Pyridin-2-yl-6H-pyrazolo[1,5-c]quinazolin-5-one	Discovery agent	.	.
DNC011957	2-Phenyl-6H-pyrazolo[1,5-c]quinazolin-5-one	Discovery agent	.	.
DNC011958	2-Furan-2-yl-6H-pyrazolo[1,5-c]quinazolin-5-one	Discovery agent	.	.
DNC011959	HMR-1556	Discovery agent	.	.
DNC011960	(4S,5R)-4,5-Dimethyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011961	N-hydroxyglycine derivative	Discovery agent	.	.
DNC011962	PD-123319	Discovery agent	.	.
DNC011963	PD-140548	Discovery agent	.	.
DNC011964	Benzyl-(2-phenyl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC011965	Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC011966	2-Thiophen-2-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011967	RAUWOLFIA SERPENTINA ROOT	Discovery agent	.	.
DNC011968	5-Methyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011969	PD-140547	Discovery agent	.	.
DNC011970	(4S,5R)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011971	Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC011972	2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011973	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala	Discovery agent	.	.
DNC011974	1,2-Dihydro-indazol-3-one	Discovery agent	.	.
DNC011975	CGS-8216	Discovery agent	.	.
DNC011975	CGS-8216	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
DNC011976	4-Ethyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011977	5-Ethyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011978	REV-5901	Discovery agent	.	.
DNC011979	2-(4-Phenyl-butyl)-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011980	2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011981	2-Phenethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011982	2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011983	2-Naphthalen-1-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011984	(4S,5S)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011985	Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC011986	2-(1H-Indol-3-ylmethyl)-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011987	2-Pyridin-3-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011988	DIGITOXIGENIN	Discovery agent	.	.
DNC011989	Oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011990	3-Carbamoyl-6-chloro-1H-indole-2-carboxylic acid	Discovery agent	.	.
DNC011991	PD-136621	Discovery agent	.	.
DNC011992	BW-755C	Discovery agent	.	.
DNC011993	1-Methyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011994	N-hydroxyglycine derivative	Discovery agent	.	.
DNC011995	Benzyl-methyl-[1-(1H-pyrrol-2-yl)-vinyl]-amine	Discovery agent	.	.
DNC011996	2-Benzyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011997	2-Pyridin-2-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC011998	(4S,5S)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC011999	(4S,5R)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC012000	4-Methyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC012001	CGS-9895	Discovery agent	.	.
DNC012002	N-hydroxyglycine derivative	Discovery agent	.	.
DNC012003	2-Methyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC012004	2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC012005	2-(4-Diethylamino-but-2-ynyl)-isoindole-1,3-dione	Discovery agent	.	.
DNC012006	AKUAMMIGINE	Discovery agent	.	.
DNC012007	2-Phenyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC012008	Ro-5-4864	Discovery agent	.	.
DNC012009	Sar-Arg-Val-Tyr-Ile-His-Pro-Ile	Discovery agent	.	.
DNC012010	Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC012011	1-Benzyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC012012	2-Pyridin-4-ylmethyl-1,2-dihydro-indazol-3-one	Discovery agent	.	.
DNC012013	5-Bromomethyl-oxazolidin-(2Z)-ylideneamine	Discovery agent	.	.
DNC012014	ONO-1714	Discovery agent	.	.
DNC012014	ONO-1714	Septic shock	.	A41.9
DNC012015	KELATORPHAN	Discovery agent	.	.
DNC012016	Butyl-indol-1-yl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012017	2-Amino-6-(3-bromo-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012018	Indol-1-yl-prop-2-ynyl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012019	2-Amino-6-(3-chloro-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012020	PIPEROXAN	Discovery agent	.	.
DNC012021	Indol-1-yl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012022	2-Amino-6-(naphthalene-2-sulfonyl)-benzonitrile	Discovery agent	.	.
DNC012023	2-Phenyl-3H-imidazo[4,5-c]quinoline	Discovery agent	.	.
DNC012024	2-Thiophen-2-yl-3H-imidazo[4,5-c]quinoline	Discovery agent	.	.
DNC012025	ALPIDEM	Anxiety disorder	300	F40-F42
DNC012025	ALPIDEM	Discovery agent	.	.
DNC012026	SOPHOFLAVESCENOL	Discovery agent	.	.
DNC012027	Indol-1-yl-methyl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012028	(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012029	2-Amino-6-(2-cyano-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012030	Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine	Discovery agent	.	.
DNC012031	2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline	Discovery agent	.	.
DNC012032	2-Amino-6-(3-chloro-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012033	1-Benzenesulfonyl-2-nitro-benzene	Discovery agent	.	.
DNC012034	Ethyl-indol-1-yl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012035	2-Amino-6-p-tolylsulfanyl-benzonitrile	Discovery agent	.	.
DNC012036	3-Methoxycarbonyl-2-methyl-9H-beta-carbolin-2-ium	Discovery agent	.	.
DNC012037	2-Amino-6-(toluene-2-sulfonyl)-benzonitrile	Discovery agent	.	.
DNC012038	2-Amino-6-(3-cyano-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012039	2-Amino-6-(3-fluoro-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012040	2-Amino-6-phenylsulfanyl-benzonitrile	Discovery agent	.	.
DNC012041	2-Isoxazol-3-yl-3H-imidazo[4,5-c]quinoline	Discovery agent	.	.
DNC012042	2-(4-Chloro-phenyl)-3H-imidazo[4,5-c]quinoline	Discovery agent	.	.
DNC012043	2-Amino-6-(4-chloro-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012044	2-Amino-6-(toluene-3-sulfonyl)-benzonitrile	Discovery agent	.	.
DNC012045	(2-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012046	2-Amino-6-(2-chloro-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012047	2-Amino-6-(2-fluoro-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012048	2-Amino-6-m-tolylsulfanyl-benzonitrile	Discovery agent	.	.
DNC012049	2-Amino-6-(2-methoxy-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012050	METHYLNORADRENALINE	Discovery agent	.	.
DNC012051	2-Amino-6-(2-cyano-benzenesulfinyl)-benzonitrile	Discovery agent	.	.
DNC012052	TRAMAZOLINE	Discovery agent	.	.
DNC012053	KURARINOL	Discovery agent	.	.
DNC012054	Indol-1-yl-propyl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012055	(3-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine	Discovery agent	.	.
DNC012056	2-Amino-6-(naphthalene-1-sulfonyl)-benzonitrile	Discovery agent	.	.
DNC012057	2-Amino-6-(3-bromo-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012058	2-Amino-6-(2-bromo-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012059	2-Amino-6-benzenesulfonyl-benzonitrile	Discovery agent	.	.
DNC012060	2-Amino-6-(toluene-4-sulfonyl)-benzonitrile	Discovery agent	.	.
DNC012061	1-nitro-2-(2-nitrophenylsulfonyl)benzene	Discovery agent	.	.
DNC012062	2-Amino-6-(2-cyano-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012063	2-Amino-6-(3-methoxy-phenylsulfanyl)-benzonitrile	Discovery agent	.	.
DNC012064	2-Amino-6-(2-chloro-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012065	5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione	Discovery agent	.	.
DNC012066	2-Amino-6-(toluene-3-sulfinyl)-benzonitrile	Discovery agent	.	.
DNC012067	2-Amino-6-(3-bromo-benzenesulfinyl)-benzonitrile	Discovery agent	.	.
DNC012068	2-Amino-6-(3-cyano-benzenesulfonyl)-benzonitrile	Discovery agent	.	.
DNC012069	Pyrrolidin-1-yl-thiourea	Discovery agent	.	.
DNC012070	Derivative of methotrexate	Discovery agent	.	.
DNC012071	Derivative of methotrexate	Discovery agent	.	.
DNC012072	(S)-2-Amino-4-methylsulfanyl-butane-1-thiol	Discovery agent	.	.
DNC012073	FUSIDIENOL	Discovery agent	.	.
DNC012074	L-739750	Discovery agent	.	.
DNC012075	4-Pyridin-2-yl-piperazine-1-carboxylic acid amide	Discovery agent	.	.
DNC012076	N-(3,3-Dimethyl-butyl)-4-hexyloxy-benzamide	Discovery agent	.	.
DNC012077	(1-Amino-3-methylsulfanyl-propyl)-phosphinic acid	Discovery agent	.	.
DNC012078	[des-His1,Tyr5,Glu9,D-Phe10]glucagon-NH2	Discovery agent	.	.
DNC012079	7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine	Discovery agent	.	.
DNC012080	[D-Ala2]Met-enkephalinamide	Discovery agent	.	.
DNC012081	L-739749	Cancer	140-229	C00-C96
DNC012081	L-739749	Discovery agent	.	.
DNC012082	(S)-2-Amino-4-methyl-pentane-1-thiol	Discovery agent	.	.
DNC012083	(1-Amino-2-phenyl-ethyl)-phosphinic acid	Discovery agent	.	.
DNC012084	3-(3-Carboxy-propionylamino)-benzoic acid	Discovery agent	.	.
DNC012085	3-(3-Chloro-phenyl)-5,7-dihydroxy-chromen-4-one	Discovery agent	.	.
DNC012086	(1-Amino-3-methyl-butyl)-phosphinic acid	Discovery agent	.	.
DNC012087	3-Phenyl-pyrrolidine	Discovery agent	.	.
DNC012088	3-Naphthalen-1-yl-1-propyl-pyrrolidine	Discovery agent	.	.
DNC012089	1-Propyl-3-(3-trifluoromethyl-phenyl)-pyrrolidine	Discovery agent	.	.
DNC012090	[des-His1,Tyr5,Glu9]glucagon-NH2	Discovery agent	.	.
DNC012091	(1-Amino-3-phenyl-propyl)-phosphinic acid	Discovery agent	.	.
DNC012092	(S)-2-Amino-4-phenyl-butane-1-thiol	Discovery agent	.	.
DNC012093	3-Phenyl-1-propyl-pyrrolidine	Discovery agent	.	.
DNC012094	3-(2,5-Dioxo-pyrrolidin-1-yl)-benzoic acid	Discovery agent	.	.
DNC012095	1-(3-Bromomethyl-phenyl)-2,2,2-trifluoro-ethanone	Discovery agent	.	.
DNC012096	(1-Amino-ethyl)-phosphinic acid	Discovery agent	.	.
DNC012097	RTI-20	Discovery agent	.	.
DNC012098	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane	Discovery agent	.	.
DNC012099	3-Naphthalen-1-yl-pyrrolidine	Discovery agent	.	.
DNC012100	(5-Methoxy-chroman-3-yl)-dipropyl-amine	Discovery agent	.	.
DNC012101	N-(3,3-Dimethyl-butyl)-4-indol-1-yl-benzamide	Discovery agent	.	.
DNC012102	(S)-2-Amino-2-phenyl-ethanethiol	Discovery agent	.	.
DNC012103	Trequinsin	Discovery agent	.	.
DNC012104	(Amino-phenyl-methyl)-phosphinic acid	Discovery agent	.	.
DNC012105	Derivative of methotrexate	Discovery agent	.	.
DNC012106	3-Methoxymethyl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012107	Dimepheptanol	Discovery agent	.	.
DNC012108	CYLINDROL A	Discovery agent	.	.
DNC012109	N-(3,3-Dimethyl-cyclopentyl)-4-hexyloxy-benzamide	Discovery agent	.	.
DNC012110	MEZILAMINE	Discovery agent	.	.
DNC012111	PREUSSOMERIN	Discovery agent	.	.
DNC012112	[des-His1,Tyr5,Glu9,D-Ala10]glucagon-NH2	Discovery agent	.	.
DNC012113	MK-056	Discovery agent	.	.
DNC012114	7-Methyl-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine	Discovery agent	.	.
DNC012115	4-Hydroxy-piperidine-3-carboxylic acid	Discovery agent	.	.
DNC012116	UK-129485	Discovery agent	.	.
DNC012117	(1,2,3,4-Tetrahydro-isoquinolin-3-yl)-methanol	Discovery agent	.	.
DNC012118	6-(Allyl-methyl-amino)-4,4-diphenyl-heptan-3-ol	Discovery agent	.	.
DNC012119	3-(1-Propyl-pyrrolidin-3-yl)-phenol	Discovery agent	.	.
DNC012120	N-(2-Diethylamino-ethyl)-4-hexyloxy-benzamide	Discovery agent	.	.
DNC012121	MORPHINE SULFATE	Discovery agent	.	.
DNC012122	SULFOARECOLINE	Discovery agent	.	.
DNC012123	Derivative of methotrexate	Discovery agent	.	.
DNC012124	3-(3-Methanesulfonyl-phenyl)-1-propyl-pyrrolidine	Discovery agent	.	.
DNC012125	(S)-2-Amino-propane-1-thiol	Discovery agent	.	.
DNC012126	(S)-2-Amino-3-phenyl-propane-1-thiol	Discovery agent	.	.
DNC012127	[des-His1,Tyr5,Glu9,D-Tyr10]glucagon-NH2	Discovery agent	.	.
DNC012128	ARTEMINOLIDE	Discovery agent	.	.
DNC012129	4-(2-Butyl-benzoimidazol-1-ylmethyl)-phenol	Discovery agent	.	.
DNC012130	Cyclosporin A analogue	Discovery agent	.	.
DNC012131	3-(6-Amino-purin-9-yl)-6-phenyl-hexan-2-ol	Discovery agent	.	.
DNC012132	3-(6-Amino-purin-9-yl)-non-5-en-2-ol	Discovery agent	.	.
DNC012133	N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine	Discovery agent	.	.
DNC012134	3-Bromo-6-nitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC012135	3-(6-Amino-purin-9-yl)-8-phenyl-octan-2-ol	Discovery agent	.	.
DNC012136	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012137	HOE-694	Discovery agent	.	.
DNC012137	HOE-694	Heart arrhythmia	.	I47-I49
DNC012138	L-768673	Discovery agent	.	.
DNC012139	Cyclosporin A analogue	Discovery agent	.	.
DNC012140	Alkylene Linked Bis-Galanthamine derivative	Discovery agent	.	.
DNC012141	Cyclosporin A analogue	Discovery agent	.	.
DNC012142	3-(6-Amino-purin-9-yl)-non-5-en-2-ol	Discovery agent	.	.
DNC012143	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012144	Cyclosporin A analogue	Discovery agent	.	.
DNC012145	2-(3-Methyl-piperazin-1-yl)-6-nitro-quinoline	Discovery agent	.	.
DNC012146	6-Iodo-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC012147	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012148	N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine	Discovery agent	.	.
DNC012149	[(40-OH)MeLeu]4-Cyclosporin A	Discovery agent	.	.
DNC012150	6,8-Dinitro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC012151	N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine	Discovery agent	.	.
DNC012152	N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine	Discovery agent	.	.
DNC012153	Cyclosporin A analogue	Discovery agent	.	.
DNC012154	[(40-OH) MeLeu]4-CsA derivatives	Discovery agent	.	.
DNC012155	N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012156	Carboxylic Acid Metabolite (E-3174)	Discovery agent	.	.
DNC012157	[(40-OH) MeLeu]4-CsA derivatives	Discovery agent	.	.
DNC012158	3-(6-Amino-purin-9-yl)-6-o-tolyl-hexan-2-ol	Discovery agent	.	.
DNC012159	3-(6-Amino-purin-9-yl)-4-p-tolyl-butan-2-ol	Discovery agent	.	.
DNC012160	2-Propyl-pentanoic acid 4-sulfamoyl-benzylamide	Discovery agent	.	.
DNC012161	N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine	Discovery agent	.	.
DNC012162	Cyclosporin A analogue	Discovery agent	.	.
DNC012163	Cyclosporin A analogue	Discovery agent	.	.
DNC012164	[(D)MeSer]3-[(40-OH) MeLeu]4-Cyclosporin A	Discovery agent	.	.
DNC012165	N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine	Discovery agent	.	.
DNC012166	YM-90K	Convulsions	.	R56.0
DNC012166	YM-90K	Discovery agent	.	.
DNC012167	[(40-OH) MeLeu]4-CsA derivatives	Discovery agent	.	.
DNC012168	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012169	Cyclosporin A analogue	Discovery agent	.	.
DNC012170	3-(6-Amino-purin-9-yl)-5-m-tolyl-pentan-2-ol	Discovery agent	.	.
DNC012171	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012172	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012173	N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine	Discovery agent	.	.
DNC012174	6-Chloro-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC012175	Cyclosporin A analogue	Discovery agent	.	.
DNC012176	3-(6-Amino-purin-9-yl)-4-butoxy-butan-2-ol	Discovery agent	.	.
DNC012177	3-(6-Amino-purin-9-yl)-non-5-yn-2-ol	Discovery agent	.	.
DNC012178	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012179	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012180	2-Propyl-pentanoic acid 4-sulfamoyl-benzyl ester	Discovery agent	.	.
DNC012181	[(40-OH) MeLeu]4-CsA derivatives	Discovery agent	.	.
DNC012182	[(40-OH) MeLeu]4-CsA derivatives	Discovery agent	.	.
DNC012183	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012184	Alkylene Linked Bis-Galanthamine derivative	Discovery agent	.	.
DNC012185	Cyclosporin A analogue	Discovery agent	.	.
DNC012186	Alkylene Linked Bis-Galanthamine derivative	Discovery agent	.	.
DNC012187	2-[1,4]Diazepan-1-yl-6-nitro-quinoline	Discovery agent	.	.
DNC012188	6-Bromo-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC012189	N-METHYLSPIPERONE	Discovery agent	.	.
DNC012190	L-692289	Discovery agent	.	.
DNC012191	Cyclosporin A analogue	Discovery agent	.	.
DNC012192	3-(6-Amino-purin-9-yl)-4-phenethyloxy-butan-2-ol	Discovery agent	.	.
DNC012193	6-Phenylaminomethyl-quinazoline-2,4-diamine	Discovery agent	.	.
DNC012194	Opioid Peptide [d-Ala(8)]Dynorphin derivative	Discovery agent	.	.
DNC012195	3-(6-Amino-purin-9-yl)-7-phenyl-heptan-2-ol	Discovery agent	.	.
DNC012196	(5-Bromo-pentyl)-trimethyl-ammonium	Discovery agent	.	.
DNC012197	(2-Ethoxy-ethyl)-trimethyl-ammonium iodide	Discovery agent	.	.
DNC012198	Trimethyl-(4-oxo-pentyl)-ammonium iodide	Discovery agent	.	.
DNC012199	(2-Chloro-9-methyl-9H-purin-6-yl)-phenyl-amine	Discovery agent	.	.
DNC012200	(1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine	Discovery agent	.	.
DNC012201	(2-Chloro-ethyl)-trimethyl-ammonium chloride	Discovery agent	.	.
DNC012202	WIN-49596	Discovery agent	.	.
DNC012203	2-BFi	Discovery agent	.	.
DNC012204	MDL-28161	Discovery agent	.	.
DNC012205	Asp-Tyr(OSO3H)-Met-Gly-Trp-Met-Asp-Phe	Discovery agent	.	.
DNC012206	H-SMGLPCVVM-OH	Discovery agent	.	.
DNC012207	Allyl-trimethyl-ammonium	Discovery agent	.	.
DNC012208	CHOLINE IODIDE	Discovery agent	.	.
DNC012209	(3-Bromo-propyl)-trimethyl-ammonium	Discovery agent	.	.
DNC012210	2-(6-Imidazol-1-yl-hexyl)-isoindole-1,3-dione	Discovery agent	.	.
DNC012211	Pyrrolidin-3-yl-acetic acid	Discovery agent	.	.
DNC012212	(4-Iodo-butyl)-trimethyl-ammonium iodide	Discovery agent	.	.
DNC012213	LUBELUZOLE	Discovery agent	.	.
DNC012213	LUBELUZOLE	Neurological disease	.	G00-G99
DNC012214	Cyclohexyl-(9-ethyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012215	1,2,3,4-Tetrahydro-naphthalen-2-ylamine	Discovery agent	.	.
DNC012216	(2-Butyryloxy-ethyl)-trimethyl-ammonium iodide	Discovery agent	.	.
DNC012217	2-(8-Imidazol-1-yl-octyl)-isoindole-1,3-dione	Discovery agent	.	.
DNC012218	(4-Bromo-butyl)-trimethyl-ammonium	Discovery agent	.	.
DNC012219	5-Phenyl-6-thia-10b-aza-benzo[e]azulen-4-one	Discovery agent	.	.
DNC012220	2-(10-Imidazol-1-yl-decyl)-isoindole-1,3-dione	Discovery agent	.	.
DNC012221	(1-Phenyl-propyl)-(9-phenyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012222	Cyclopentyl-(9-ethyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012223	(9-Methyl-9H-purin-6-yl)-phenyl-amine	Discovery agent	.	.
DNC012224	3-[1-ethyl-2-(3-hydroxyphenyl)butyl]phenol	Discovery agent	.	.
DNC012225	Cyclopentyl-(9-phenyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012226	(1-Phenyl-propyl)-(9-phenyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012227	Hexyl-trimethyl-ammonium	Discovery agent	.	.
DNC012228	8-Methoxy-2-(4-methyl-piperazin-1-yl)-quinoline	Discovery agent	.	.
DNC012229	Phenyl-(9-phenyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012230	But-3-enyl-trimethyl-ammonium bromide	Discovery agent	.	.
DNC012231	Cyclohexyl-(9-methyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012232	4-(4-Fluoro-benzyl)-piperidine hydrochloride	Discovery agent	.	.
DNC012233	4-Benzyl-1-methyl-piperidine hydrochloride	Discovery agent	.	.
DNC012234	CORILAGIN	Discovery agent	.	.
DNC012235	6-Thia-10b-aza-benzo[e]azulen-4-one	Discovery agent	.	.
DNC012236	Dimethyl-pent-4-enyl-ammonium bromide	Discovery agent	.	.
DNC012237	9-Phenyl-9H-purin-6-ylamine	Discovery agent	.	.
DNC012238	2-Methyl-8-phenyl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012239	CYPRODIME	Discovery agent	.	.
DNC012240	2-(6-Cyclopentylamino-purin-9-yl)-ethanol	Discovery agent	.	.
DNC012241	Cyclopentyl-(9-cyclopentyl-9H-purin-6-yl)-amine	Discovery agent	.	.
DNC012242	8-Methoxy-2-piperazin-1-yl-quinoline	Discovery agent	.	.
DNC012243	(3-Hydroxy-2-methyl-phenyl)-trimethyl-ammonium	Discovery agent	.	.
DNC012244	Trimethyl-(3-nitro-phenyl)-ammonium iodide	Discovery agent	.	.
DNC012245	Enecadin	Discovery agent	.	.
DNC012246	(2-Mercapto-ethyl)-trimethyl-ammonium iodide	Discovery agent	.	.
DNC012247	C-(9H-Thioxanthen-9-yl)-methylamine	Discovery agent	.	.
DNC012248	DICHLOROISOPROTERENOL	Discovery agent	.	.
DNC012249	3-(Octahydro-quinolizin-1-yl)-phenol	Discovery agent	.	.
DNC012250	6-Nitro-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012251	L-687414	Discovery agent	.	.
DNC012252	Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine	Discovery agent	.	.
DNC012253	Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine	Discovery agent	.	.
DNC012254	C-(5H-Dibenzo[a,d]cyclohepten-5-yl)-methylamine	Discovery agent	.	.
DNC012255	4-(10H-Anthracen-9-ylidene)-1-methyl-piperidine	Discovery agent	.	.
DNC012256	2-(1H-Imidazol-4-ylmethyl)-4-phenyl-thiazole	Discovery agent	.	.
DNC012257	L-698532	Discovery agent	.	.
DNC012257	L-698532	Neurological disease	.	G00-G99
DNC012258	1-Methyl-1,3-dihydro-indol-2-one	Discovery agent	.	.
DNC012259	U-89267	Discovery agent	.	.
DNC012260	3-(1-Propyl-piperidin-3-yl)-phenol	Discovery agent	.	.
DNC012261	DELTORPHIN-II	Discovery agent	.	.
DNC012262	DELTORPHIN	Discovery agent	.	.
DNC012263	1,2,3,4-Tetrahydro-naphthalen-1-ylamine	Discovery agent	.	.
DNC012264	5,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012265	3-(Octahydro-quinolizin-3-yl)-phenol	Discovery agent	.	.
DNC012266	5,7-Dichloro-4-hydroxy-3-phenyl-1H-quinolin-2-one	Discovery agent	.	.
DNC012267	PHENETHYLAMINE	Discovery agent	.	.
DNC012268	3-(Octahydro-indolizin-8-yl)-phenol	Discovery agent	.	.
DNC012269	RIPAZEPAM	Discovery agent	.	.
DNC012270	3-(Octahydro-indolizin-8-yl)-phenol	Discovery agent	.	.
DNC012271	L-695902	Discovery agent	.	.
DNC012272	3-(Octahydro-indolizin-8-yl)-phenol	Discovery agent	.	.
DNC012273	PD-134308	Anxiety disorder	.	F40-F42
DNC012273	PD-134308	Discovery agent	.	.
DNC012274	C-(9H-Xanthen-9-yl)-methylamine	Discovery agent	.	.
DNC012275	3-Benzoyl-7-chloro-4-hydroxy-1H-quinolin-2-one	Discovery agent	.	.
DNC012276	Ro-21-7767	Discovery agent	.	.
DNC012277	6-Chloro-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012278	2-Pyridin-3-yl-7-aza-bicyclo[2.2.1]heptane	Discovery agent	.	.
DNC012279	5,7-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol	Discovery agent	.	.
DNC012280	1-(1-Benzo[b]thiophen-2-yl-cyclopentyl)-azepane	Discovery agent	.	.
DNC012281	PD-168077	Discovery agent	.	.
DNC012282	1-Benzo[b]thiophen-2-yl-cycloheptylamine	Discovery agent	.	.
DNC012283	1-Propyl-3-p-tolyl-piperidine hydrochloride	Discovery agent	.	.
DNC012284	1-Propyl-3-m-tolyl-piperidine hydrochloride	Discovery agent	.	.
DNC012285	CGP-191	Discovery agent	.	.
DNC012286	3-Cyclohexyl-1-propyl-piperidine hydrochloride	Discovery agent	.	.
DNC012287	1-Benzo[b]thiophen-2-yl-cyclopentylamine	Discovery agent	.	.
DNC012288	4-Chloro-5,7-diphenyl-7H-pyrrolo[2,3-d]pyrimidine	Discovery agent	.	.
DNC012289	1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane	Discovery agent	.	.
DNC012290	1-Benzo[b]thiophen-2-yl-cyclohexylamine	Discovery agent	.	.
DNC012291	CV-11194	Discovery agent	.	.
DNC012292	NAFOXIDINE	Discovery agent	.	.
DNC012293	FLUTROLINE	Discovery agent	.	.
DNC012294	N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)-acetamide	Discovery agent	.	.
DNC012295	3-Phenyl-1-propyl-piperidine hydrochloride	Discovery agent	.	.
DNC012296	1-(1-Benzo[b]thiophen-2-yl-cycloheptyl)-azepane	Discovery agent	.	.
DNC012297	1-Propyl-3-o-tolyl-piperidine hydrochloride	Discovery agent	.	.
DNC012298	7-(2-Amino-ethyl)-4-hydroxy-3H-benzothiazol-2-one	Discovery agent	.	.
DNC012299	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012300	1-(4-Cyano-thiazol-2-yl)-3-phenethyl-thiourea	Discovery agent	.	.
DNC012301	GYKI-52466	Alzheimer's disease	.	G30,F00
DNC012301	GYKI-52466	Discovery agent	.	.
DNC012302	PT-102	Discovery agent	.	.
DNC012303	PT-104	Discovery agent	.	.
DNC012304	7-(2-Dipropylamino-ethyl)-3H-benzothiazol-2-one	Discovery agent	.	.
DNC012305	Isoquinoline-3-carboxylic acid methyl ester	Discovery agent	.	.
DNC012306	6-Dimethylamino-2-methyl-hex-4-ynal oxime	Discovery agent	.	.
DNC012307	1-(3-Phenyl-propyl)-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012308	1-Thiazol-2-yl-3-(2-o-tolyl-ethyl)-thiourea	Discovery agent	.	.
DNC012309	PT-103	Discovery agent	.	.
DNC012310	1-Benzyl-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012311	PT-101	Discovery agent	.	.
DNC012312	3-Chloro-9H-beta-carboline	Discovery agent	.	.
DNC012313	5-Hex-5-enyl-2-nonyl-3,4-dihydro-2H-pyrrole	Discovery agent	.	.
DNC012314	PT-319	Discovery agent	.	.
DNC012315	1-(2-Phenyl-propyl)-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012316	R-82913	Discovery agent	.	.
DNC012316	R-82913	Human immunodeficiency virus infection	.	B20
DNC012317	LY-73497	Discovery agent	.	.
DNC012318	RES-701-1	Discovery agent	.	.
DNC012319	7,12-Dihydro-7,12-diaza-indeno[1,2-a]fluorene	Discovery agent	.	.
DNC012320	PT-313	Discovery agent	.	.
DNC012321	7,12-Dihydro-5,7,12-triaza-indeno[1,2-a]fluorene	Discovery agent	.	.
DNC012322	7-Pyrrolidin-1-yl-hept-5-yn-2-one	Discovery agent	.	.
DNC012323	7-Dimethylamino-3-methyl-hept-5-yn-2-one	Discovery agent	.	.
DNC012324	PT-106	Discovery agent	.	.
DNC012325	PT-306	Discovery agent	.	.
DNC012326	PT-304	Discovery agent	.	.
DNC012327	PT-320	Discovery agent	.	.
DNC012328	TROVIRDINE	Discovery agent	.	.
DNC012329	GYKI-53655	Discovery agent	.	.
DNC012330	7-Pyrrolidin-1-yl-hept-5-yn-2-one oxime	Discovery agent	.	.
DNC012331	PT-308	Discovery agent	.	.
DNC012332	9H-beta-Carbolin-3-ol	Discovery agent	.	.
DNC012333	1-(2-Furan-2-yl-ethyl)-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012334	3-Isothiocyanato-9H-beta-carboline	Discovery agent	.	.
DNC012335	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012336	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012337	2-Hex-5-enyl-5-non-8-enyl-pyrrolidine	Discovery agent	.	.
DNC012338	MAZAPERTINE	Discovery agent	.	.
DNC012339	1-(4-Butyl-thiazol-2-yl)-3-phenethyl-thiourea	Discovery agent	.	.
DNC012340	1-Phenethyl-3-[1,3,4]thiadiazol-2-yl-thiourea	Discovery agent	.	.
DNC012341	PT-312	Discovery agent	.	.
DNC012342	PT-310	Discovery agent	.	.
DNC012343	PT-302	Discovery agent	.	.
DNC012344	3-Nitro-9H-beta-carboline	Discovery agent	.	.
DNC012345	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012346	PT-315	Discovery agent	.	.
DNC012347	1-Benzothiazol-2-yl-3-phenethyl-thiourea	Discovery agent	.	.
DNC012348	PT-108	Discovery agent	.	.
DNC012349	4-(4-Methyl-indan-1-yl)-1H-imidazole	Discovery agent	.	.
DNC012350	7-Dimethylamino-hept-5-yn-2-one	Discovery agent	.	.
DNC012351	7-Dimethylamino-hept-5-yn-2-one oxime	Discovery agent	.	.
DNC012352	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012353	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012354	2-Hex-5-enyl-5-nonyl-pyrrolidine	Discovery agent	.	.
DNC012355	PT-307	Discovery agent	.	.
DNC012356	PT-309	Discovery agent	.	.
DNC012357	1-(2-Pyridin-2-yl-ethyl)-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012358	GUANIDINONALTRINDOLE	Discovery agent	.	.
DNC012359	2-Hex-5-enyl-5-non-8-enyl-3,4-dihydro-2H-pyrrole	Discovery agent	.	.
DNC012360	PT-316	Discovery agent	.	.
DNC012361	PT-314	Discovery agent	.	.
DNC012362	PT-317	Discovery agent	.	.
DNC012363	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide	Discovery agent	.	.
DNC012364	PT-311	Discovery agent	.	.
DNC012365	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012366	A-70108	Discovery agent	.	.
DNC012367	1-Aminomethyl-3-cyclohexyl-isochroman-5,6-diol	Discovery agent	.	.
DNC012368	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012369	PT-322	Discovery agent	.	.
DNC012370	SKF-89124A	Discovery agent	.	.
DNC012371	RES-701-1-C-terminal analogue	Discovery agent	.	.
DNC012372	(R)PK-11195	Discovery agent	.	.
DNC012373	8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012374	Tyr-Pro-L-(NMe)Phe-D-Pro-NH2	Discovery agent	.	.
DNC012375	8-Bromo-3-hydroxy-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012376	Tyr-Pro-D-(NMe)Phe-D-Pro-NH2	Discovery agent	.	.
DNC012377	Tyr-Pro-D-Phe-Pro-NH2	Discovery agent	.	.
DNC012378	SC-50560	Discovery agent	.	.
DNC012379	3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012380	Tyr-Pro-L-(NMe)Phe-Pro-NH2	Discovery agent	.	.
DNC012381	8-Chloro-3-hydroxy-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012382	SPANTIDE	Discovery agent	.	.
DNC012383	1-Phenyl-1H-benzoimidazole	Discovery agent	.	.
DNC012384	Tyr-Pro-L-Phe-D-Pro-NH2	Discovery agent	.	.
DNC012385	Tyr-Pro-L-Phe-Pro-NH2	Discovery agent	.	.
DNC012386	3-Hydroxy-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012387	R-56865	Angina pectoris	413	I20
DNC012387	R-56865	Discovery agent	.	.
DNC012388	2-(3-Methoxy-phenyl)-1-methyl-ethylamine	Discovery agent	.	.
DNC012389	IBZM	Discovery agent	.	.
DNC012390	8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012391	2-(4-Bromo-phenyl)-1-methyl-ethylamine	Discovery agent	.	.
DNC012392	2-(4-Bromo-2-methoxy-phenyl)-1-methyl-ethylamine	Discovery agent	.	.
DNC012393	Tyr-(NMe)Ala-L-Phe-D-Pro-NH2	Discovery agent	.	.
DNC012394	2-(2-Methoxy-phenyl)-1-methyl-ethylamine	Discovery agent	.	.
DNC012395	Tyr-Pro-D-Phe-D-Pro-NH2	Discovery agent	.	.
DNC012396	3-Hydroxy-7-nitro-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012397	1-(2,5-dimethoxyphenyl)propan-2-amine	Discovery agent	.	.
DNC012398	Tetragastrin	Discovery agent	.	.
DNC012399	4-Benzoimidazol-1-yl-phenylamine	Discovery agent	.	.
DNC012400	3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione	Discovery agent	.	.
DNC012401	2-(2-Amino-propyl)-5-bromo-4-methoxy-phenol	Discovery agent	.	.
DNC012402	TZI-41127	Discovery agent	.	.
DNC012403	3-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012404	CI-992	Discovery agent	.	.
DNC012404	CI-992	Hypertension	.	I10-I15
DNC012405	Azapeptide	Discovery agent	.	.
DNC012406	3-p-Tolyl-8-aza-bicyclo[3.2.1]octane	Discovery agent	.	.
DNC012407	4-Methyl-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012408	Azapeptide	Discovery agent	.	.
DNC012409	6-Nitro-2-(4-nitro-phenyl)-chromen-4-one	Discovery agent	.	.
DNC012410	Azapeptide	Discovery agent	.	.
DNC012411	2,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012412	3,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012413	Azapeptide	Discovery agent	.	.
DNC012414	1,3,8-Trimethyl-3,7-dihydro-purine-2,6-dione	Discovery agent	.	.
DNC012415	Azapeptide	Discovery agent	.	.
DNC012416	Azapeptide	Discovery agent	.	.
DNC012417	8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane	Discovery agent	.	.
DNC012418	Azapeptide	Discovery agent	.	.
DNC012419	4-tert-Butyl-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012420	Azapeptide	Discovery agent	.	.
DNC012421	4-Bromo-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012422	Azapeptide	Discovery agent	.	.
DNC012423	Azapeptide	Discovery agent	.	.
DNC012424	N-(4-Phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012425	Ridine-5-carboxylic acid ethyl ester	Discovery agent	.	.
DNC012426	4-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012427	4-Nitro-N-(4-phenyl-thiazol-2-yl)-benzamide	Discovery agent	.	.
DNC012428	(2S,3S)-3-Carboxy-2,3-dihydroxy-pentanedioic acid	Discovery agent	.	.
DNC012429	Compound RES-701-1(1-10)/[A15]ET-1	Discovery agent	.	.
DNC012430	7-Methoxy-1H-indazole	Discovery agent	.	.
DNC012431	4-Methoxymethyl-3,6-dipropoxy-9H-beta-carboline	Discovery agent	.	.
DNC012432	2-(9-Benzyl-9H-purin-6-ylamino)-ethanol	Discovery agent	.	.
DNC012433	2-Phenoxymethyl-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC012434	7-chloro-3-hydroxyquinazoline-2,4-dione	Discovery agent	.	.
DNC012435	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol	Discovery agent	.	.
DNC012436	Opaviraline	Discovery agent	.	.
DNC012436	Opaviraline	Human immunodeficiency virus infection	.	B20
DNC012437	RES-701-1	Discovery agent	.	.
DNC012438	TRACIZOLINE	Discovery agent	.	.
DNC012439	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile	Discovery agent	.	.
DNC012440	ET-1	Discovery agent	.	.
DNC012441	NITRAQUAZONE	Discovery agent	.	.
DNC012442	Compound [S15]ET-1	Discovery agent	.	.
DNC012443	4-cycloheptyliden(4-hydroxyphenyl)methylphenol	Discovery agent	.	.
DNC012444	RX-821002	Discovery agent	.	.
DNC012445	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile	Discovery agent	.	.
DNC012446	Compound SRTX6b	Discovery agent	.	.
DNC012447	Compound ET-3	Discovery agent	.	.
DNC012448	Compound RES-701-1(1-10)/[A15]ET-3	Discovery agent	.	.
DNC012449	SK&F-89626	Discovery agent	.	.
DNC012450	2-Phenethyl-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC012451	Linear peptide of RES-701-1	Discovery agent	.	.
DNC012452	Compound RES-701-1(1-10)/[A15]SRTX6b	Discovery agent	.	.
DNC012453	5,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione	Discovery agent	.	.
DNC012454	5,7-Dibromo-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012455	7-nitro-1H-indazole	Discovery agent	.	.
DNC012456	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile	Discovery agent	.	.
DNC012457	2,4-bis-docosanoylamino-benzenesulfonate	Discovery agent	.	.
DNC012458	2,3,3-Triphenyl-acrylonitrile	Discovery agent	.	.
DNC012459	5,7-Dichloro-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012460	5,6,7-Trichloro-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012461	6,7-Dichloro-1,4-dihydro-quinoxaline-2,3-dione	Discovery agent	.	.
DNC012462	1',2',3',6'-Tetrahydro-[2,4']bipyridinyl	Discovery agent	.	.
DNC012463	6,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione	Discovery agent	.	.
DNC012464	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile	Discovery agent	.	.
DNC012465	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile	Discovery agent	.	.
DNC012466	4-cyclopentyliden(4-hydroxyphenyl)methylphenol	Discovery agent	.	.
DNC012467	SCH-24518	Discovery agent	.	.
DNC012468	2-Furan-2-yl-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC012469	1-(3-Fluoro-pyridin-2-yl)-4-methyl-piperazine	Discovery agent	.	.
DNC012470	(9-Benzyl-9H-purin-6-yl)-cyclopropyl-amine	Discovery agent	.	.
DNC012471	2-(4-Benzyl-piperazin-1-yl)-benzothiazole	Discovery agent	.	.
DNC012472	4-cyclohexyliden(4-hydroxyphenyl)methylphenol	Discovery agent	.	.
DNC012473	PSEUDOCOCAINE	Discovery agent	.	.
DNC012474	Naltrexone semicarbazone	Discovery agent	.	.
DNC012475	Leucine-enkephalin	Discovery agent	.	.
DNC012476	2,3,4,5-Tetrahydro-1H-benzo[c]azepine	Discovery agent	.	.
DNC012477	1,2,3,4,5,6-Hexahydro-benzo[c]azocine	Discovery agent	.	.
DNC012478	1,2,3,4-tetrahydroisoquinoline	Discovery agent	.	.
DNC012479	NAFAZATROM	Discovery agent	.	.
DNC012480	FLUANISONE	Discovery agent	.	.
DNC012481	2,3,4,5-Tetrahydro-benzo[f][1,4]oxazepine	Discovery agent	.	.
DNC012482	3-Methyl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012483	LIFARIZINE	Discovery agent	.	.
DNC012484	4-Pentadeca-1,3,6-trienylsulfanyl-butyric acid	Discovery agent	.	.
DNC012485	IODOSULPIRIDE	Discovery agent	.	.
DNC012486	2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine	Discovery agent	.	.
DNC012487	R-87027	Discovery agent	.	.
DNC012488	2-[4-(1H-Indol-5-yl)-phenyl]-propionic acid	Discovery agent	.	.
DNC012489	(R)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012490	N-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide	Discovery agent	.	.
DNC012491	6,7,8,9-Tetrahydro-5-thia-8-aza-benzocycloheptene	Discovery agent	.	.
DNC012492	Dynorphin(1-8)	Discovery agent	.	.
DNC012493	2-(3'-Ethylsulfanyl-biphenyl-4-yl)-propionic acid	Discovery agent	.	.
DNC012494	SQ-34919	Discovery agent	.	.
DNC012495	2,3-Dihydro-1H-isoindole	Discovery agent	.	.
DNC012496	Oxymorphone semicarbazone hydrochloride	Discovery agent	.	.
DNC012497	LUBELUZOLE	Discovery agent	.	.
DNC012498	2-(3'-Allyl-biphenyl-4-yl)-propionic acid	Discovery agent	.	.
DNC012499	8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine	Discovery agent	.	.
DNC012500	N-hydroxy-N'-[1-(4-isobutylphenyl)ethyl]urea	Discovery agent	.	.
DNC012501	IODOPRIDE	Discovery agent	.	.
DNC012502	ACECLIDINE	Discovery agent	.	.
DNC012502	ACECLIDINE	Glaucoma	365	H40-H42
DNC012503	(S)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012504	Alpha-Methyl-4-biphenyl-acetic acid	Discovery agent	.	.
DNC012505	2-(3'-Vinyl-biphenyl-4-yl)-propionic acid	Discovery agent	.	.
DNC012506	2-(3'-Ethyl-biphenyl-4-yl)-propionic acid	Discovery agent	.	.
DNC012507	2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepine	Discovery agent	.	.
DNC012508	(2-Amino-4,5-dihydro-thiazol-4-yl)-acetic acid	Discovery agent	.	.
DNC012509	PD-138915	Discovery agent	.	.
DNC012510	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012511	PT-113	Discovery agent	.	.
DNC012512	1H-Pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012513	PT-115	Discovery agent	.	.
DNC012514	PT-114	Discovery agent	.	.
DNC012515	TRANSTORINE	Discovery agent	.	.
DNC012516	1H-Imidazo[4,5-c]quinolin-4-ylamine HCl	Discovery agent	.	.
DNC012517	3-(2,4-Dimethyl-phenyl)-1-propyl-piperidine	Discovery agent	.	.
DNC012518	PD-137342	Discovery agent	.	.
DNC012519	N-(2,3-Dihydro-1H-phenalen-2-yl)-acetamide	Discovery agent	.	.
DNC012520	5-Isopropyl-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012521	5-Phenethyl-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012522	3-(3,5-Dimethyl-phenyl)-1-propyl-piperidine	Discovery agent	.	.
DNC012523	PD-138916	Discovery agent	.	.
DNC012524	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012525	N-[2-(5-Hydroxy-1H-indol-3-yl)-ethyl]-acetamide	Discovery agent	.	.
DNC012526	(1H-Imidazo[4,5-c]quinolin-4-yl)-phenyl-amine HCl	Discovery agent	.	.
DNC012527	PD-137337	Discovery agent	.	.
DNC012528	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012529	PT-112	Cancer	140-229	C00-C96
DNC012529	PT-112	Discovery agent	.	.
DNC012530	3-(2,6-Dimethyl-phenyl)-1-propyl-piperidine	Discovery agent	.	.
DNC012531	PD-138917	Discovery agent	.	.
DNC012532	PD-140723	Discovery agent	.	.
DNC012533	CI-1044	Discovery agent	.	.
DNC012534	4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid	Discovery agent	.	.
DNC012535	[3-(Biphenyl-4-yloxy)-propyl]-dimethyl-amine	Discovery agent	.	.
DNC012536	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012537	4-Ethoxy-7-((E)-styryl)-furo[3,2-g]chromen-5-one	Discovery agent	.	.
DNC012538	ISONICOTINIC ACID	Discovery agent	.	.
DNC012539	3-(3,5-Dimethyl-phenyl)-piperidine	Discovery agent	.	.
DNC012540	CI-988	Discovery agent	.	.
DNC012541	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012542	5-Propyl-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012543	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012544	5-Benzyl-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012545	2-Cyclopentyl-1H-imidazo[4,5-c]quinolin-4-ylamine	Discovery agent	.	.
DNC012546	PD-135118	Discovery agent	.	.
DNC012547	3,5,7-Triethoxy-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC012548	5-(3-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012549	4,6-Dichloro-1H-indole-2-carboxylic acid	Discovery agent	.	.
DNC012550	2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine	Discovery agent	.	.
DNC012551	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012552	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012553	Piriqualone	Discovery agent	.	.
DNC012554	5-Butyl-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012555	3-(2,3-Dimethyl-phenyl)-piperidine	Discovery agent	.	.
DNC012556	PT-110	Discovery agent	.	.
DNC012557	3-(2,5-Dimethyl-phenyl)-1-propyl-piperidine	Discovery agent	.	.
DNC012558	3-(3,4-Dimethyl-phenyl)-piperidine	Discovery agent	.	.
DNC012559	Macrocyclic lipopeptidolactone derivative	Discovery agent	.	.
DNC012560	CYCLAZOCINE	Discovery agent	.	.
DNC012561	PT-109	Discovery agent	.	.
DNC012562	3-(3,4-Dimethyl-phenyl)-1-propyl-piperidine	Discovery agent	.	.
DNC012563	PD-135666	Discovery agent	.	.
DNC012564	5-(3-Phenyl-propyl)-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012565	5-(4-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid	Discovery agent	.	.
DNC012566	3-(2,3-Dimethyl-phenyl)-1-propyl-piperidine	Discovery agent	.	.
DNC012567	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012568	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012569	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012570	1-(1-Phenyl-propyl)-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012571	IQM-95333	Discovery agent	.	.
DNC012572	MR-1029	Discovery agent	.	.
DNC012573	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012574	4-Phosphonomethyl-piperidine-2-carboxylic acid	Discovery agent	.	.
DNC012575	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012576	[N-[2-[(3'-N'-PROPYL-3''ALPHA-(BIS(4-FLUORORPHENYL)METHOXY)TROPANE-2''BETA-CARBOXYLIC ACID METHYL ESTER)(2-MERCAPTOETHYL)AMINO]ACETYL]-2-AMINOETHANETHIOLATO]RHENIUM(V) OXIDE (DIASTEREOMERIC MIX)	Discovery agent	.	.
DNC012577	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012578	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012579	HI-443	Discovery agent	.	.
DNC012580	MR-2034	Discovery agent	.	.
DNC012581	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012582	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012583	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012584	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012585	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012586	BRL-46470	Anxiety disorder	.	F40-F42
DNC012586	BRL-46470	Discovery agent	.	.
DNC012587	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012588	N-methoxyquinuclidine-3-carboximidoyl fluoride	Discovery agent	.	.
DNC012589	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012590	1-(2-Phenoxy-ethyl)-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012591	1-(2-Chloro-phenyl)-piperazine	Discovery agent	.	.
DNC012592	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012593	HI-244	Discovery agent	.	.
DNC012594	BRL-55473	Discovery agent	.	.
DNC012595	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012596	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012597	2-(1H-Indol-3-yl)-2-oxo-N-phenethyl-acetamide	Discovery agent	.	.
DNC012598	RO-054520	Discovery agent	.	.
DNC012599	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012600	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012601	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012602	L-701324	Cerebrovascular ischaemia	.	G45.9,I67.8
DNC012602	L-701324	Discovery agent	.	.
DNC012603	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012604	(beta-CCE)9H-beta-Carboline-3-carboxylic acid	Discovery agent	.	.
DNC012605	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012606	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012607	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012608	6-(4-Methyl-piperazin-1-yl)-phenanthridine	Discovery agent	.	.
DNC012609	PD-115199	Discovery agent	.	.
DNC012610	9-Aminomethyl-9H-fluorene-2,5,6-triol	Discovery agent	.	.
DNC012611	2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012612	MR-1526	Discovery agent	.	.
DNC012613	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012614	6-(2-Dipropylamino-ethyl)-biphenyl-2,3-diol	Discovery agent	.	.
DNC012615	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012616	N-methoxyquinuclidine-3-carboximidoyl chloride	Discovery agent	.	.
DNC012617	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012618	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012619	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012620	L-162234	Discovery agent	.	.
DNC012621	9-Aminomethyl-9H-fluorene-3,4-diol	Discovery agent	.	.
DNC012622	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012623	1-Furan-2-ylmethyl-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012624	MR-2266	Discovery agent	.	.
DNC012625	4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline	Discovery agent	.	.
DNC012626	1-Thiazol-2-yl-3-(2-p-tolyl-ethyl)-thiourea	Discovery agent	.	.
DNC012627	1-Adamantan-1-ylmethyl-3-thiazol-2-yl-thiourea	Discovery agent	.	.
DNC012628	3-(2-Methyl-2-aza-bicyclo[3.3.1]non-5-yl)-phenol	Discovery agent	.	.
DNC012629	6-(2-Amino-ethyl)-biphenyl-2,3-diol	Discovery agent	.	.
DNC012630	6-(2-Amino-ethyl)-biphenyl-2,3,4'-triol	Discovery agent	.	.
DNC012631	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012632	6-(2-Dipropylamino-ethyl)-biphenyl-2,3,4'-triol	Discovery agent	.	.
DNC012633	Peptide Boronic Acid analogue	Discovery agent	.	.
DNC012634	4-Biphenyl-4-yl-2-methyl-1H-imidazole	Discovery agent	.	.
DNC012635	1-(1H-Indol-4-yloxy)-3-phenethylamino-propan-2-ol	Discovery agent	.	.
DNC012636	4-((E)-1-Naphthalen-1-yl-propenyl)-1H-imidazole	Discovery agent	.	.
DNC012637	1-Aminomethyl-3-phenyl-isochroman-5,6-diol	Discovery agent	.	.
DNC012638	1-Aminomethyl-isochroman-5,6-diol	Discovery agent	.	.
DNC012639	4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole	Discovery agent	.	.
DNC012640	2-Hexyl-4-(4-isobutyl-phenyl)-1H-imidazole	Discovery agent	.	.
DNC012641	4-Biphenyl-4-yl-2-hexyl-1H-imidazole	Discovery agent	.	.
DNC012642	9-Mercaptomethyl-10-oxo-azecane-2-carboxylic acid	Discovery agent	.	.
DNC012643	[2,2':5',2'']Terthiophene-4-carbaldehyde	Discovery agent	.	.
DNC012644	4-(2,3-Dihydro-1H-phenalen-1-yl)-1H-imidazole	Discovery agent	.	.
DNC012645	LEVONORDEFRIN	Discovery agent	.	.
DNC012646	4-[3-(4-Butyl-phenoxy)-propyl]-1H-imidazole	Discovery agent	.	.
DNC012647	2-(2-Phenyl-1H-indol-3-yl)-N,N-dipropyl-acetamide	Discovery agent	.	.
DNC012648	[2,2':5',2'']Terthiophene-4,5''-dicarbaldehyde	Discovery agent	.	.
DNC012649	4-[3-(4-Ethynyl-phenoxy)-propyl]-1H-imidazole	Discovery agent	.	.
DNC012650	4-Biphenyl-4-yl-2-cyclohexylmethyl-1H-imidazole	Discovery agent	.	.
DNC012651	Siramesine	Discovery agent	.	.
DNC012652	4-((Z)-1-Naphthalen-1-yl-propenyl)-1H-imidazole	Discovery agent	.	.
DNC012653	2-(1-Pentyl-hexyl)-4-phenyl-1H-imidazole	Discovery agent	.	.
DNC012654	N,N-Dihexyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	Discovery agent	.	.
DNC012655	BREMAZOCINE	Discovery agent	.	.
DNC012656	Monoctanoin component C	Discovery agent	.	.
DNC012657	UFP-512	Discovery agent	.	.
DNC012658	4-(1-Naphthalen-1-yl-vinyl)-1H-imidazole	Discovery agent	.	.
DNC012659	SCH-12679	Discovery agent	.	.
DNC012660	N-Hexyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	Discovery agent	.	.
DNC012661	1-Aminomethyl-isochroman-5,6-diol hydrobromide	Discovery agent	.	.
DNC012662	N,N-Diethyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	Discovery agent	.	.
DNC012663	N,N-Dimethyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	Discovery agent	.	.
DNC012664	4-(1-Naphthalen-1-yl-propyl)-1H-imidazole	Discovery agent	.	.
DNC012665	4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole	Discovery agent	.	.
DNC012666	[2,2':5',2'']Terthiophen-4-yl-methanol	Discovery agent	.	.
DNC012667	Ac-His-Trp-Ala-Val-Ala-His-Leu-Met-NH2	Discovery agent	.	.
DNC012668	5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012669	Tyr-Gly-Gly-Phe-c(Cys-Arg-Arg-Ile-Cys)-Arg-lys	Discovery agent	.	.
DNC012670	WAY-100135	Anxiety disorder	300	F40-F42
DNC012670	WAY-100135	Discovery agent	.	.
DNC012671	ANALOG OF DYNORPHIN A	Discovery agent	.	.
DNC012672	Tyr-Gly-Gly-Phe-leu-c(Cys-Arg-Ile-Arg-Cys)-lys	Discovery agent	.	.
DNC012673	TQX-173	Discovery agent	.	.
DNC012674	1,2,3,4,4a,5,10,10a-Octahydro-benzo[g]quinoline	Discovery agent	.	.
DNC012675	5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012676	AGROCLAVINE	Discovery agent	.	.
DNC012677	5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline	Discovery agent	.	.
DNC012678	Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr(Beta-D-Glc)-Gly-NH2	Discovery agent	.	.
DNC012679	CP-293019	Discovery agent	.	.
DNC012680	Tyr-D-Ala-Phe-Thr(-D-Glc)-Tyr-Pro-Ser-NH2	Discovery agent	.	.
DNC012681	5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012682	5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012683	5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012684	(CH3)CCO-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2	Discovery agent	.	.
DNC012685	9H-beta-Carboline-3-carboxylic acid propyl ester	Discovery agent	.	.
DNC012686	5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012687	(R/R)BEFLOXATONE	Discovery agent	.	.
DNC012688	5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012689	Tyr-D-Ala-Phe-Asp-Val-Val-Thr[Beta-D-Glc]-Gly-NH2	Discovery agent	.	.
DNC012690	(Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one	Discovery agent	.	.
DNC012691	(Z)-2,2-Dimethyl-1-oxazol-2-yl-octadec-9-en-1-one	Discovery agent	.	.
DNC012692	Tyr-D-Ala-Phe-Thr[-D-Glc(OAc)4]-Tyr-Pro-Ser-NH2	Discovery agent	.	.
DNC012693	Ac-His-Trp-Ala-Val-D-Ala-His-Leu-Met-NH2	Discovery agent	.	.
DNC012694	Ac-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2	Discovery agent	.	.
DNC012695	TEPA (possesses cytotoxic activity)	Discovery agent	.	.
DNC012696	5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one	Discovery agent	.	.
DNC012697	9H-beta-Carboline-3-carboxylic acid butyl ester	Discovery agent	.	.
DNC012698	SDZ-205557	Discovery agent	.	.
DNC012699	Acetyl-Ala-Ala-Pro-Ala-trifluromethane	Discovery agent	.	.
DNC012700	Macrocyclic Quinazolinone analogue	Discovery agent	.	.
DNC012701	LHRH	Discovery agent	.	.
DNC012701	LHRH	Endometriosis	617	N80
DNC012702	RPR-118723	Discovery agent	.	.
DNC012703	5-p-Tolylsulfanyl-quinazoline-2,4-diamine	Discovery agent	.	.
DNC012704	Macrocyclic Quinazolinone analogue	Discovery agent	.	.
DNC012705	(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid	Discovery agent	.	.
DNC012706	5-Phenylsulfanyl-quinazoline-2,4-diamine	Discovery agent	.	.
DNC012707	(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid	Discovery agent	.	.
DNC012708	(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid	Discovery agent	.	.
DNC012709	Macrocyclic Quinazolinone analogue	Discovery agent	.	.
DNC012710	HEPT	Discovery agent	.	.
DNC012711	(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid	Discovery agent	.	.
DNC012712	LEVORPHANOL HYDROCHLORIDE	Discovery agent	.	.
DNC012713	Macrocyclic Quinazolinone analogue	Discovery agent	.	.
DNC012714	RPR-104632	Discovery agent	.	.
DNC012715	Macrocyclic Quinazolinone analogue	Discovery agent	.	.
DNC012716	Macrocyclic Quinazolinone analogue	Discovery agent	.	.
DNC012717	(S)APOMORPHINE	Discovery agent	.	.
DNC012718	Acetyl-Pro-Ala-Pro-Ala-trifluoro methane	Discovery agent	.	.
DNC012719	T-98475	Discovery agent	.	.
DNC012720	4,5,7-Trichloro-3-hydroxy-1H-quinolin-2-one	Discovery agent	.	.
DNC012721	OXYMORPHINDOLE	Discovery agent	.	.
DNC012722	4-Bromo-3-hydroxy-1H-quinolin-2-one	Discovery agent	.	.
DNC012723	4-Bromo-5,7-dichloro-3-hydroxy-1H-quinolin-2-one	Discovery agent	.	.
DNC012724	4-Chloro-3-hydroxy-1H-quinolin-2-one	Discovery agent	.	.
DNC012725	Cyclopentyl-(3,4-dichloro-phenyl)-acetonitrile	Discovery agent	.	.
DNC012726	[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine	Discovery agent	.	.
DNC012727	FR-166124	Discovery agent	.	.
DNC012728	H-D-Tic-c[Cys-Tyr-D-Trp-Arg-Thr-Pen]-Thr-NH2	Discovery agent	.	.
DNC012729	1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol	Discovery agent	.	.
DNC012730	H-D-Tca-c[Cys-Tyr-D-Trp-Arg-Thr-Pen]-Thr-NH2	Discovery agent	.	.
DNC012731	H-D-Trp-c[Cys-Tyr-D-Trp-Arg-Thr-Pen]-Thr-NH2	Discovery agent	.	.
DNC012732	1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol	Discovery agent	.	.
DNC012733	Cyclohexyl-(3,4-dichloro-phenyl)-acetonitrile	Discovery agent	.	.
DNC012734	HEXESTROL	Discovery agent	.	.
DNC012735	Dicarba-closo-dodecaborane derivative	Discovery agent	.	.
DNC012736	(1-Phenyl-ethyl)-(2-phenyl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC012737	4-Cyclohexyl-4-hydroxy-but-2-enoic acid	Discovery agent	.	.
DNC012738	4-Hydroxy-4-phenyl-butyric acid	Discovery agent	.	.
DNC012739	CGNLSTCMLGTYTQDFc[DKFHO]FPQTAIGVGAP-amide	Discovery agent	.	.
DNC012740	4-Hydroxy-4-phenyl-but-2-enoic acid	Discovery agent	.	.
DNC012741	BRL-24682	Discovery agent	.	.
DNC012742	(1-Phenyl-ethyl)-(2-phenyl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC012743	4-hydroxy-but-2-enoate	Discovery agent	.	.
DNC012744	ICI-174864	Discovery agent	.	.
DNC012745	Benzhydryl-(2-phenyl-quinazolin-4-yl)-amine	Discovery agent	.	.
DNC012746	4-Hydroxy-pent-2-enoic acid	Discovery agent	.	.
DNC012747	4-Hydroxy-3-methyl-but-2-enoic acid	Discovery agent	.	.
DNC012748	Boc-Asp-Tyr(So3-)-Nle-Gly-Trp-Asp-Phe-NH2	Discovery agent	.	.
DNC012749	BRL-25594	Discovery agent	.	.
DNC012750	RS-14491	Discovery agent	.	.
DNC012751	SB-213698	Discovery agent	.	.
DNC012752	5-hydroxy-pentanoate	Discovery agent	.	.
DNC012753	SCH-57726	Discovery agent	.	.
DNC012754	SC-53116	Discovery agent	.	.
DNC012754	SC-53116	Gastric motility disorder	.	K22.4
DNC012755	4-Hydroxy-pentanoic acid	Discovery agent	.	.
DNC012756	4-Hydroxy-3-methyl-butyric acid	Discovery agent	.	.
DNC012757	Asp-D-Glu-Leu-Glu-Cha-Cys	Discovery agent	.	.
DNC012758	C-Naphthalen-1-yl-methylamine	Discovery agent	.	.
DNC012759	ONO-3805	Discovery agent	.	.
DNC012759	ONO-3805	Prostate disorder	.	N40-N42
DNC012760	SC-51895	Discovery agent	.	.
DNC012761	C-(6-Methoxy-naphthalen-1-yl)-methylamine	Discovery agent	.	.
DNC012762	8-Methoxy-1,2,3,4-tetrahydro-benzo[h]isoquinoline	Discovery agent	.	.
DNC012763	DIDEAZAFOLATE	Discovery agent	.	.
DNC012764	AcGlu-Dif-Ile-Cha-Cys	Discovery agent	.	.
DNC012765	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one	Discovery agent	.	.
DNC012766	IRL-1841	Discovery agent	.	.
DNC012767	AcAsp-Glu-Dif-Glu-Cha-Cys	Discovery agent	.	.
DNC012768	1,2,3,4-Tetrahydro-benzo[h]isoquinolin-8-ol	Discovery agent	.	.
DNC012769	4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione	Discovery agent	.	.
DNC012770	Ac-Glu-Cha-Cys	Discovery agent	.	.
DNC012771	AcAsp-Glu-Met-Glu-Nal-Cyse	Discovery agent	.	.
DNC012772	AcAsp-Gla-Leu-Ile-Cha-Cys	Discovery agent	.	.
DNC012773	AcAsp-Glu-Met-Glu-Cha-Cys	Discovery agent	.	.
DNC012774	AcAsp-Glu-Met-Glu-Glu-Cys	Discovery agent	.	.
DNC012775	(11H-Dibenzo[b,e][1,4]dioxepin-8-yl)-acetic acid	Discovery agent	.	.
DNC012776	AcAsp-Glu-Dif-Lys-Cha-Cys	Discovery agent	.	.
DNC012777	SC-55634	Discovery agent	.	.
DNC012778	(11H-Dibenzo[b,e][1,4]dioxepin-2-yl)-acetic acid	Discovery agent	.	.
DNC012779	AcDif-Glu-Cha-Cys	Discovery agent	.	.
DNC012780	5-Aminomethyl-naphthalen-2-ol	Discovery agent	.	.
DNC012781	AcAsp-Glu-Dif-Ile-Cha-Cys	Discovery agent	.	.
DNC012782	AcDif-Ile-Cha-Cys	Discovery agent	.	.
DNC012783	(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid	Discovery agent	.	.
DNC012784	AcAsp-D-Glu-Leu-Glu-Cha-Cys	Discovery agent	.	.
DNC012785	SC-52892	Discovery agent	.	.
DNC012786	SC-52458	Discovery agent	.	.
DNC012787	2-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC012788	IRL-1722	Discovery agent	.	.
DNC012789	AcAsp-Glu-Leu-Glu-Cha-Cys	Discovery agent	.	.
DNC012790	FK-143	Discovery agent	.	.
DNC012790	FK-143	Prostate disorder	.	N40-N42
DNC012791	IRL-2500	Discovery agent	.	.
DNC012792	4-Chloro-7-methyl-2-phenyl-[1,8]naphthyridine	Discovery agent	.	.
DNC012793	1,2,3,4-Tetrahydro-isoquinolin-7-ol	Discovery agent	.	.
DNC012794	9-Amino-1,2,3,4-tetrahydro-acridine-1,7-diol	Discovery agent	.	.
DNC012795	AcGlu-Dif-Glu-Cha-Cys	Discovery agent	.	.
DNC012796	3-Imidazol-1-ylmethyl-2-isopropyl-1H-indole	Discovery agent	.	.
DNC012797	4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol	Discovery agent	.	.
DNC012798	ZIMELIDINE	Discovery agent	.	.
DNC012799	2-(4-Methyl-piperazin-1-yl)-4-phenyl-pyrimidine	Discovery agent	.	.
DNC012800	6-m-Tolyl-pteridine-2,4,7-triamine	Discovery agent	.	.
DNC012801	CGS-13767	Discovery agent	.	.
DNC012802	6-(2-Phenylsulfanyl-ethyl)-pteridine-2,4-diamine	Discovery agent	.	.
DNC012803	4-(3-Hydroxy-piperidin-3-yl)-benzene-1,2-diol	Discovery agent	.	.
DNC012804	PRAVADOLINE	Discovery agent	.	.
DNC012805	RU-59063	Discovery agent	.	.
DNC012806	8-(3-Fluoro-phenyl)-9-methyl-9H-purin-6-ylamine	Discovery agent	.	.
DNC012807	1-Ethyl-3-imidazol-1-ylmethyl-1H-indole	Discovery agent	.	.
DNC012808	4-Morpholin-2-yl-benzene-1,2-diol	Discovery agent	.	.
DNC012809	3-Imidazol-1-ylmethyl-1H-indole	Discovery agent	.	.
DNC012810	A-87049	Discovery agent	.	.
DNC012811	5-(2-Amino-ethyl)-2-chloro-phenol hydrobromide	Discovery agent	.	.
DNC012812	9-Phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine	Discovery agent	.	.
DNC012813	6,7-Diphenyl-pteridine-2,4-diamine	Discovery agent	.	.
DNC012814	ETONITAZENE	Discovery agent	.	.
DNC012815	Mibolerone	Discovery agent	.	.
DNC012816	(-)-HUPERZINE B	Discovery agent	.	.
DNC012817	BIS(8)-HUPERZINE B	Discovery agent	.	.
DNC012818	BIS(9)-HUPERZINE B	Discovery agent	.	.
DNC012819	BIS(12)-HUPERZINE B	Discovery agent	.	.
DNC012820	Bis(14)-Huperzine B	Discovery agent	.	.
DNC012821	Bis(14)-Huperzine B	Discovery agent	.	.
DNC012822	BIS(16)-HUPERZINE B	Discovery agent	.	.
DNC012823	BIS(18)-HUPERZINE B	Discovery agent	.	.
DNC012824	BIS(20)-HUPERZINE B	Discovery agent	.	.
DNC012825	AcAsp-Glu-Cha-Val-Prb-Cys	Discovery agent	.	.
DNC012826	AcAsp-Glu-Dif-Glu-Cha-Fab	Discovery agent	.	.
DNC012827	AcAsp-Glu-Cha-Val-Prb-Cpg	Discovery agent	.	.
DNC012828	AcAsp-D-Glu-Leu-Glu-Cha-Cys	Discovery agent	.	.
DNC012829	AcAsp-Glu-Leu-Glu-Cha-Cys	Discovery agent	.	.
DNC012830	AcAsp-D-Gla-Leu-Ile-Cha-Cys	Discovery agent	.	.
DNC012831	Boc-Ile-Leu-L-(difluoro)aminobutyric aid	Discovery agent	.	.
DNC012832	Cbz-Ile-Leu-L-(difluoro)aminobutyric acid	Discovery agent	.	.
DNC012833	AcAsp-Glu-Dif-Ile-Cha-Cys-Pro-Nle-Asp-ValNH2	Discovery agent	.	.
DNC012834	AcAsp-Glu-Dif-Ile-Cha-Cys-Pro-Cha-Asp-ValNH2	Discovery agent	.	.
DNC012835	AcGlu-Asp-Val-Val-Leu-Cys-Iqc-Nle-Thr-TyrNH2	Discovery agent	.	.
DNC012836	AcAsp-Glu-Dif-Ile-Cha-Cys-Iqc-Nle-Thr-TyrNH2	Discovery agent	.	.
DNC012837	SCH-68631	Discovery agent	.	.
DNC012838	PATULIN	Discovery agent	.	.
DNC012839	2,4,6-Trihydroxy-3-nitro-N-tridecyl-benzamide	Discovery agent	.	.
DNC012840	3-Fluoromethyl-1,2,3,4-tetrahydro-isoquinoline	Discovery agent	.	.
DNC012841	MDL-105519	Discovery agent	.	.
DNC012842	2-(3-Phenoxy-benzoylamino)-benzoic acid	Discovery agent	.	.
DNC012843	2-(4-Fluoro-3-phenoxy-benzoylamino)-benzoic acid	Discovery agent	.	.
DNC012844	2-(4-Bromo-3-phenoxy-benzoylamino)-benzoic acid	Discovery agent	.	.
DNC012845	4-Benzyl-1-indan-2-ylmethyl-piperidine	Discovery agent	.	.
DNC012846	ZIDOVUDINE TRIPHOSPHATE	Discovery agent	.	.
DNC012847	Fullerene Derivative	Discovery agent	.	.
DNC012848	Fullerene Derivative	Discovery agent	.	.
DNC012849	Fullerene Derivative	Discovery agent	.	.
DNC012850	Fullerene Derivative	Discovery agent	.	.
DNC012851	Fullerene Derivative	Discovery agent	.	.
DNC012852	Fullerene Derivative	Discovery agent	.	.
DNC012853	Fullerene Derivative	Discovery agent	.	.
DNC012854	[Tyr-Pro-Phe-Phe-NH-CH2-]2	Discovery agent	.	.
DNC012855	Tyr-Pro-Phe-Phe-OCH3	Discovery agent	.	.
DNC012856	Tyr-Pro-Phe-Phe-NHNH2	Discovery agent	.	.
DNC012857	[Tyr-Pro-Phe-NH-]2	Discovery agent	.	.
DNC012858	[Tyr-Pro-Phe-NH-CH2-]2	Discovery agent	.	.
DNC012859	[Tyr-Pro-Phe-Phe-NH-]2	Discovery agent	.	.
DNC012860	DEMETHOXYCURCUMIN	Discovery agent	.	.
DNC012861	BMS-316810	Discovery agent	.	.
DNC012862	6-Styryl-naphthalene-2-carboxamidine	Discovery agent	.	.
DNC012863	8-Bromo-6-styryl-naphthalene-2-carboxamidine	Discovery agent	.	.
DNC012864	8-Furan-3-yl-6-styryl-naphthalene-2-carboxamidine	Discovery agent	.	.
DNC012865	ZONAMPANEL	Discovery agent	.	.
DNC012866	1,3-Bis-(3-imidazolidin-2-yl-phenyl)-urea	Discovery agent	.	.
DNC012867	ROXINDOLE	Discovery agent	.	.
DNC012867	ROXINDOLE	Psychotic disorders	.	F20-F29
DNC012868	(R)-Piperidine-3-carboxylic acid	Discovery agent	.	.
DNC012869	(S)-Piperidine-3-carboxylic acid	Discovery agent	.	.
DNC012870	5-(1-Methyl-pyrrolidin-2-yl)-2-phenethyl-pyridine	Discovery agent	.	.
DNC012871	(R)-2-(4-Isobutyl-phenyl)-N-phenyl-propionamide	Discovery agent	.	.
DNC012872	1,2-Di-naphthalen-2-yl-ethane-1,2-dione	Discovery agent	.	.
DNC012873	H-Dmt-D-Arg(NO2)-Phe-Lys(Z)-NH2	Discovery agent	.	.
DNC012874	H-Dmt-D-Arg(NO2)-Phe-Lys(Z)-OH	Discovery agent	.	.
DNC012875	(R)-2-Amino-7-phosphono-heptanoic acid	Discovery agent	.	.
DNC012876	ALLOPREGNANOLONE	Discovery agent	.	.
DNC012877	ELTANOLONE	Discovery agent	.	.
DNC012877	ELTANOLONE	Premenstrual syndrome	.	N94.3
DNC012878	BMS-404683	Discovery agent	.	.
DNC012879	PB-80	Discovery agent	.	.
DNC012880	PB-81	Discovery agent	.	.
DNC012881	TRICIRIBINE	Discovery agent	.	.
DNC012881	TRICIRIBINE	Solid tumours	.	C00-C75,C7A,C7B
DNC012882	PB-27	Discovery agent	.	.
DNC012883	TROVIRDINE HYDROCHLORIDE	Discovery agent	.	.
DNC012883	TROVIRDINE HYDROCHLORIDE	Human immunodeficiency virus infection	.	B20
DNC012884	4-Naphthalen-2-yl-5-piperidin-4-yl-isoxazol-3-ol	Discovery agent	.	.
DNC012885	4-Naphthalen-1-yl-5-piperidin-4-yl-isoxazol-3-ol	Discovery agent	.	.
DNC012886	4-Benzyl-5-piperidin-4-yl-isoxazol-3-ol	Discovery agent	.	.
DNC012887	DEOXYTHYMIDINE_TRIPHOSPHATE	Discovery agent	.	.
DNC012888	2',3'-Dideoxyadenosine Triphosphate (Ddatp)	Discovery agent	.	.
DNC012889	2'-3'-dideoxy-7-deaza-guaninetriphosphate	Discovery agent	.	.
DNC012890	GABAZINE	Discovery agent	.	.
DNC012891	2-Fluoro-6-(3-phenoxy-benzoylamino)-benzoic acid	Discovery agent	.	.
DNC012892	2-Hydroxy-6-(3-phenoxy-benzoylamino)-benzoic acid	Discovery agent	.	.
DNC012893	2-[3-(Pyridin-4-yloxy)-benzoylamino]-benzoic acid	Discovery agent	.	.
DNC012894	3-(4-Methanesulfonyl-phenyl)-1-phenyl-propynone	Discovery agent	.	.
DNC012895	ISODISPAR B	Discovery agent	.	.
DNC012896	3,6-bis(Dmt-Tic-NH-methyl)-2(1H)-pyrazinone	Discovery agent	.	.
DNC012897	3,6-bis(Dmt-Tic-NH-ethyl)-2(1H)-pyrazinone	Discovery agent	.	.
DNC012898	3,6-bis(Dmt-Tic-NH-propyl)-2(1H)-pyrazinone	Discovery agent	.	.
DNC012899	3,6-bis(Dmt-Tic-NH-butyl)-2(1H)-pyrazinone	Discovery agent	.	.
DNC012900	1,4-bis-(Dmt-Tic-amino)butane	Discovery agent	.	.
DNC012901	1,6-bis-(Dmt-Tic-amino)hexane	Discovery agent	.	.
DNC012902	1,10-bis-(Dmt-Tic-amino)decane	Discovery agent	.	.
DNC012903	1,6-bis-(N,N-dimethyl-Dmt-Tic-NH)hexane	Discovery agent	.	.
DNC012904	H-Dmt-Tic-OH	Discovery agent	.	.
DNC012905	H-Dmt-Tic-NH-(CH2)6-NH-Dmt-H	Discovery agent	.	.
DNC012906	N-(5-chloro-2-(phenylthio)phenyl)butyramide	Discovery agent	.	.
DNC012907	1-pentenyl-4-(aminosulfonyl)benzoate	Discovery agent	.	.
DNC012908	Allyl 4-(aminosulfonyl)benzoate	Discovery agent	.	.
DNC012909	COLCHINOL	Discovery agent	.	.
DNC012910	N-(2-methoxybenzyl)cinnamamidine	Discovery agent	.	.
DNC012911	H-Dmt-Tic-NH-(CH2)6-NH-Phe-H	Discovery agent	.	.
DNC012912	H-Dmt-Tic-NH-(CH2)6-NH-Tic-H	Discovery agent	.	.
DNC012913	6-hydroxy-3-(3',5'-dihydroxyphenyl)coumarin	Discovery agent	.	.
DNC012914	4-((1H-imidazol-4-yl)methyl)-1-heptylpiperidine	Discovery agent	.	.
DNC012915	Isopropyl 3-(phenylthio)-1H-indole-2-carboxylate	Discovery agent	.	.
DNC012916	4-hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one	Discovery agent	.	.
DNC012917	3-phenyl-4-hydroxyquinolin-2(1H)-one	Discovery agent	.	.
DNC012918	SC-52491	Discovery agent	.	.
DNC012918	SC-52491	Irritable bowel syndrome	564.1	K58
DNC012919	HALOXYSTEROL A	Discovery agent	.	.
DNC012920	24-ethylcholest-6-ene-3,5-diol	Discovery agent	.	.
DNC012921	24-ethyl-cholest-7-ene-3,5,6-triol	Discovery agent	.	.
DNC012922	LAWSARITOL	Discovery agent	.	.
DNC012923	(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol	Discovery agent	.	.
DNC012924	Haloxysterol D	Discovery agent	.	.
DNC012925	Haloxysterol C	Discovery agent	.	.
DNC012926	HALOXYSTEROL B	Discovery agent	.	.
DNC012927	OBIDOXIME	Discovery agent	.	.
DNC012928	TRIMEDOXIME	Discovery agent	.	.
DNC012929	CHLORPYRIFOS	Discovery agent	.	.
DNC012930	5-(piperidin-4-yl)isothiazol-3-ol	Discovery agent	.	.
DNC012931	N-mesityl-6-methyl-3-tosylpyridin-2-amine	Discovery agent	.	.
DNC012932	N-mesityl-4,6-dimethyl-3-tosylpyridin-2-amine	Discovery agent	.	.
DNC012933	4-(3,5-dichlorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012934	4-(3,4-dichlorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012935	4-(2,5-dichlorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012936	4-(2,3-dichlorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012937	4-(3,5-dimethylbenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012938	4-(3,4-dimethylbenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012939	4-(3-cyanobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012940	4-(2-cyanobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012941	4-(3-nitrobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012942	4-(2-nitrobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012943	4-(4-tert-butylbenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012944	4-(3-methoxybenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012945	4-(2-methoxybenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012946	2-amino-4-(2-methyl-benzylsulfanyl)-butyric acid	Discovery agent	.	.
DNC012947	4-(3-fluorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012948	4-(4-chlorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012949	4-(3-chlorobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012950	4-(4-bromobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012951	4-(3-bromobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012952	4-(2-bromobenzylthio)-2-aminobutanoic acid	Discovery agent	.	.
DNC012953	(S)-2-amino-2-phenylpropanoic acid	Discovery agent	.	.
DNC012954	2-amino-2-(thiophen-2-yl)acetic acid	Discovery agent	.	.
DNC012955	2-amino-2-(3-chloro-4-fluorophenyl)acetic acid	Discovery agent	.	.
DNC012956	2-amino-2-(2,4-difluorophenyl)acetic acid	Discovery agent	.	.
DNC012957	2-amino-2-(2,3-difluorophenyl)acetic acid	Discovery agent	.	.
DNC012958	(S)-2-amino-2-p-tolylacetic acid	Discovery agent	.	.
DNC012959	2-amino-2-(3-bromophenyl)acetic acid	Discovery agent	.	.
DNC012960	2-amino-2-(3-chlorophenyl)acetic acid	Discovery agent	.	.
DNC012961	2-amino-2-(2-fluorophenyl)acetic acid	Discovery agent	.	.
DNC012962	(S)-2-amino-2-o-tolylacetic acid	Discovery agent	.	.
DNC012963	(S)-2-amino-4-(benzylthio)butanoic acid	Discovery agent	.	.
DNC012964	ETHIONINE	Discovery agent	.	.
DNC012965	(S)-2-amino-3-(benzylthio)propanoic acid	Discovery agent	.	.
DNC012966	Rac-2-amino-5-cyclohexylpentanoic acid	Discovery agent	.	.
DNC012967	Rac-2-amino-4-phenylbutanoic acid	Discovery agent	.	.
DNC012968	PHENYLALANINE	Discovery agent	.	.
DNC012969	(S)-2-amino-3-cyclohexylpropanoic acid	Discovery agent	.	.
DNC012970	(S)-phenylglycine	Discovery agent	.	.
DNC012971	(S)-2-amino-2-cyclohexylacetic acid	Discovery agent	.	.
DNC012972	1-(4-chlorophenyl)-4-phenyl-1H-imidazole	Discovery agent	.	.
DNC012973	2-(4-chlorophenyl)-5-phenyl-4-isoxazolin-3-one	Discovery agent	.	.
DNC012974	4-(4-chlorophenyl)-1-pyrid-2-yl-pyrazole	Discovery agent	.	.
DNC012975	Gly-Pip-Glu	Discovery agent	.	.
DNC012976	Gly-b7Pro-Glu	Discovery agent	.	.
DNC012977	Gly-Hyp-Glu	Discovery agent	.	.
DNC012978	Gly-Amp-Glu	Discovery agent	.	.
DNC012979	Nle-Pro-Glu	Discovery agent	.	.
DNC012980	Phe-Pro-Glu	Discovery agent	.	.
DNC012981	(D)-Ala-Pro-Glu	Discovery agent	.	.
DNC012982	Ala-Pro-Glu	Discovery agent	.	.
DNC012983	A-62824	Discovery agent	.	.
DNC012984	AM-411	Discovery agent	.	.
DNC012985	3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine	Discovery agent	.	.
DNC012986	1-(3-benzylquinoxalin-2-yl)hydrazine	Discovery agent	.	.
DNC012987	1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine	Discovery agent	.	.
DNC012988	1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine	Discovery agent	.	.
DNC012989	2-(3-benzylquinoxalin-2-ylamino)ethanol	Discovery agent	.	.
DNC012990	6-benzyl-3-propylaminocarbonyl-4-quinolone	Discovery agent	.	.
DNC012991	3-butylaminocarbonyl-6-ethyl-4-quinolone	Discovery agent	.	.
DNC012992	6-ethyl-3-propylaminocarbonyl-4-quinolone	Discovery agent	.	.
DNC012993	6-bromo-3-ethoxycarbonyl-2-methyl-4-quinolone	Discovery agent	.	.
DNC012994	3-ethoxycarbonyl-6-ethyl-2-methyl-4-quinolone	Discovery agent	.	.
DNC012995	6-benzyl-3-propoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC012996	GNF-PF-3645	Discovery agent	.	.
DNC012997	3-ethoxycarbonyl-6-propyl-4-quinolone	Discovery agent	.	.
DNC012998	3-butoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC012999	3-ethoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC013000	3-carboxy-6-ethyl-4-quinolone	Discovery agent	.	.
DNC013001	6-ethyl-3-(3-pentoxycarbonyl)-4-quinolone	Discovery agent	.	.
DNC013002	6-ethyl-3-i-propoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC013003	3-cyclopentoxycarbonyl-6-ethyl-4-quinolone	Discovery agent	.	.
DNC013004	6-ethyl-3-(2-ethylbutoxycarbonyl)-4-quinolone	Discovery agent	.	.
DNC013005	6-ethyl-3-pentoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC013006	6-ethyl-3-(2-methylbutoxycarbonyl)-4-quinolone	Discovery agent	.	.
DNC013007	3-butoxycarbonyl-6-ethyl-4-quinolone	Discovery agent	.	.
DNC013008	6-ethyl-3-propoxycarbonyl-4-quinolone	Discovery agent	.	.
DNC013009	GNF-PF-4421	Discovery agent	.	.
DNC013010	6-cyano-7-nitroquinoxaline-2,3-dione	Discovery agent	.	.
DNC013011	1-(piperidin-3-ylmethyl)pyridin-2(1H)-one	Discovery agent	.	.
DNC013012	1-(piperidin-4-ylmethyl)pyridin-2(1H)-one	Discovery agent	.	.
DNC013013	N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide	Discovery agent	.	.
DNC013014	N-(2,4-dihydroxybenzyl)-3,4-dihydroxybenzamide	Discovery agent	.	.
DNC013015	N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide	Discovery agent	.	.
DNC013016	MELARSOPROL	Discovery agent	.	.
DNC013016	MELARSOPROL	Trypanosomiasis	086.5-086	B56-B57
DNC013017	4-(4-chlorobenzyl)-2-methylphthalazin-1(2H)-one	Discovery agent	.	.
DNC013018	4-(4-chlorobenzyl)-2-allylphthalazin-1(2H)-one	Discovery agent	.	.
DNC013019	4-benzyl-2-methylphthalazin-1(2H)-one	Discovery agent	.	.
DNC013020	4-(4-chlorobenzyl)phthalazin-1(2H)-one	Discovery agent	.	.
DNC013021	4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC013022	4-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC013023	3-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC013024	N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC013025	3-cyano-N-(1,4-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC013026	N-(1,4-diphenyl-1H-pyrazol-5-yl)benzamide	Discovery agent	.	.
DNC013027	N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide	Discovery agent	.	.
DNC013028	(H-Dmt-Tic-Glu-NH-(CH(2))(5)-CO-Dap(6DMN)-NH(2)	Discovery agent	.	.
DNC013029	H-Tyr-Pro-Dap(6DMN)-Phe-NH2	Discovery agent	.	.
DNC013030	H-Tyr-Pro-Phe-Phe-NH-(CH2)5-(C=O)-Dap(6DMN)-NH2	Discovery agent	.	.
DNC013031	H-Dmt-Tic-Glu-Dap(6DMN)-NH(2)	Discovery agent	.	.
DNC013032	Benzyl 4-aminobutyl(3-aminopropyl)carbamate	Discovery agent	.	.
DNC013033	NSC-380292	Discovery agent	.	.
DNC013034	11-methyl-6,11-dihydro-5H-benzo[a]carbazol-9-ol	Discovery agent	.	.
DNC013035	6,11-dihydrothiochromeno[4,3-b]indol-8-ol	Discovery agent	.	.
DNC013036	Tyr-Pro-Phe-D-Phg-NH2	Discovery agent	.	.
DNC013037	Tyr-Pro-Phe-Phg-NH2	Discovery agent	.	.
DNC013038	Tyr-Pro-Phe-Hfe-NH2	Discovery agent	.	.
DNC013039	Tyr-Pro-D-Phg-Phe-NH2	Discovery agent	.	.
DNC013040	Tyr-Pro-Phg-Phe-NH2	Discovery agent	.	.
DNC013041	Tyr-Pro-Hfe-Phe-NH2	Discovery agent	.	.
DNC013042	Tyr-Pro-Phg-Pro-NH2	Discovery agent	.	.
DNC013043	Tyr-Pro-Hfe-Pro-NH2	Discovery agent	.	.
DNC013044	MORPHICEPTIN	Discovery agent	.	.
DNC013045	(S)-(-)-(4,5,6-trimethoxyindan-1-yl)methanamine	Discovery agent	.	.
DNC013046	(R)-(+)-(4,5,6-trimethoxyindan-1-yl)methanamine	Discovery agent	.	.
DNC013047	MESCALINE	Discovery agent	.	.
DNC013048	Bip-tyr-thr-ala-pro-phe	Discovery agent	.	.
DNC013049	Bip-tyr-thr-pro-thr(obzl)-gly	Discovery agent	.	.
DNC013050	Bip-tyr-thr-pro-ala-thr(obzl)-gly	Discovery agent	.	.
DNC013051	Bip-tyr-thr-pro-lys-thr(obzl)-gly	Discovery agent	.	.
DNC013052	Bip-tyr(3bzl)-thr-pro-lys-thr	Discovery agent	.	.
DNC013053	Bip-tyr-thr-pro-lys-thr	Discovery agent	.	.
DNC013054	Bip-tyr-ala-pro-lys-thr(obzl)-gly	Discovery agent	.	.
DNC013055	AZALANSTAT	Discovery agent	.	.
DNC013055	AZALANSTAT	Hyperlipidemia	.	E78.5
DNC013056	4-(2-aminoethyl)-1,2,5-oxadiazol-3-ol	Discovery agent	.	.
DNC013057	3-methoxy-N-(6-methylpyridin-2-yl)benzamide	Discovery agent	.	.
DNC013058	SIB-1893	Discovery agent	.	.
DNC013059	SIB-1757	Discovery agent	.	.
DNC013060	3-chloro-N-(6-methylpyridin-2-yl)benzamide	Discovery agent	.	.
DNC013061	H-Gly-D-dmP-Glu-OH	Discovery agent	.	.
DNC013062	H-Gly-dmP-Glu-OH	Discovery agent	.	.
DNC013063	H-Gly-PMe-Glu-OH	Discovery agent	.	.
DNC013064	HTS-00798	Discovery agent	.	.
DNC013065	4-(thiazol-2-yl)phenyl butylcarbamate	Discovery agent	.	.
DNC013066	Dhp-c[D-Cys-Gly-Phe(pNO2)-D-Cys]NH2	Discovery agent	.	.
DNC013067	[Dcp1]Dyn A(1-11)-NH2	Discovery agent	.	.
DNC013068	Dcp-c[D-Cys-Gly-Phe(pNO2)-D-Cys]NH2	Discovery agent	.	.
DNC013069	6-amino-uridine monophosphate	Discovery agent	.	.
DNC013070	6-aza-uridine monophosphate	Discovery agent	.	.
DNC013071	RIVASTIGMINE TARTRATE	Discovery agent	.	.
DNC013072	GENESERINE	Discovery agent	.	.
DNC013073	NalBzOH	Discovery agent	.	.
DNC013074	M6S	Discovery agent	.	.
DNC013075	M3A6S	Discovery agent	.	.
DNC013076	M3Pr6S	Discovery agent	.	.
DNC013077	M3IBu6S	Discovery agent	.	.
DNC013078	M3P6S	Discovery agent	.	.
DNC013079	DM6S	Discovery agent	.	.
DNC013080	M3S	Discovery agent	.	.
DNC013081	M3B6S	Discovery agent	.	.
DNC013082	DM3A6S	Discovery agent	.	.
DNC013083	DM3B6S	Discovery agent	.	.
DNC013084	MM3A6S	Discovery agent	.	.
DNC013085	MM3B6S	Discovery agent	.	.
DNC013086	C6S	Discovery agent	.	.
DNC013087	DC6S	Discovery agent	.	.
DNC013088	1-(4-chlorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013089	1-(4-iodobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013090	1-(4-nitrobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013091	1-(4-methyl-benzyl)-1H-imidazole	Discovery agent	.	.
DNC013092	4-((1H-imidazol-1-yl)methyl)phenol	Discovery agent	.	.
DNC013093	1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole	Discovery agent	.	.
DNC013094	1-(3,5-difluorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013095	1-(3,4-difluorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013096	1-(3,5-dichlorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013097	1-(3,4-dichlorobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013098	1-(3,5-dibromobenzyl)-1H-imidazole	Discovery agent	.	.
DNC013099	4-hydroxy-8-nitro-3-phenylquinolin-2(1H)-one	Discovery agent	.	.
DNC013100	2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine	Discovery agent	.	.
DNC013101	H-Dmt-Tic-Lys(Z)-NH-CH2-Ph	Discovery agent	.	.
DNC013102	3-demethoxy-3D-glucopyranosylaminothiocolchicine	Discovery agent	.	.
DNC013103	3-demethoxy-3-L-fucopyranosylaminothiocolchicine	Discovery agent	.	.
DNC013104	3-demethoxy-3-D-mannopyranosylaminothiocolchicine	Discovery agent	.	.
DNC013105	3-demethoxy-3-D-xylopyranosylaminothiocolchicine	Discovery agent	.	.
DNC013106	3-demethoxy-3-D-lyxopyranosylaminothiocolchicine	Discovery agent	.	.
DNC013107	THIOCOLCHICOSIDE	Discovery agent	.	.
DNC013107	THIOCOLCHICOSIDE	Muscle spasm	.	M62.838
DNC013108	STRYCHNINE	Discovery agent	.	.
DNC013109	3-amino-3-demethoxythiocolchicine	Discovery agent	.	.
DNC013110	H-Dmt-Tic-NH-CH[(CH2)4-NH2]-Bid	Discovery agent	.	.
DNC013111	H-Dmt-Tic-NH-CH[(CH2)4-NH-Ac]-Bid	Discovery agent	.	.
DNC013112	H-Dmt-Tic-NH-(D)-CH[(CH2)4-NH-Z]-Bid	Discovery agent	.	.
DNC013113	H-Dmt-Tic-NH-CH[(CH2)4-NH-Z]-Bid	Discovery agent	.	.
DNC013114	H-Dmt-Tic-Lys-NH-Ph	Discovery agent	.	.
DNC013115	H-Dmt-Tic-Lys(Ac)-NH-Ph	Discovery agent	.	.
DNC013116	H-Dmt-Tic-Lys(Z)-NH-Ph	Discovery agent	.	.
DNC013117	H-Dmt-Tic-Lys-NH-CH2-Ph	Discovery agent	.	.
DNC013118	H-Dmt-Tic-Lys(Ac)-NH-CH2-Ph	Discovery agent	.	.
DNC013119	2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC013120	CI-1041	Discovery agent	.	.
DNC013120	CI-1041	Epilepsy	345	G40
DNC013121	N-3-(4-bromophenyl)propyl imidazole	Discovery agent	.	.
DNC013122	1-(3-(4-chlorophenyl)propyl)-1H-imidazole	Discovery agent	.	.
DNC013123	1-(4-bromophenethyl)-1H-imidazole	Discovery agent	.	.
DNC013124	1-(4-chlorophenethyl)-1H-imidazole	Discovery agent	.	.
DNC013125	1-(3-phenylpropyl)-1H-imidazole	Discovery agent	.	.
DNC013126	YRFB	Discovery agent	.	.
DNC013127	10R-hydroxylobelane	Discovery agent	.	.
DNC013128	10S-hydroxylobelane	Discovery agent	.	.
DNC013129	8S-hydroxylobelane	Discovery agent	.	.
DNC013130	8R-hydroxylobelane	Discovery agent	.	.
DNC013131	10R-hydroxylobel-7-ene	Discovery agent	.	.
DNC013132	10S-hydroxylobel-7-ene	Discovery agent	.	.
DNC013133	8S-hydroxylobel-9-ene	Discovery agent	.	.
DNC013134	8R-hydroxylobel-9-ene	Discovery agent	.	.
DNC013135	UBP-302	Discovery agent	.	.
DNC013136	3alpha-(bis-chloro-phenylmethoxy)tropane	Discovery agent	.	.
DNC013137	Dihydrexidine	Discovery agent	.	.
DNC013137	Dihydrexidine	Psychotic disorders	.	F20-F29
DNC013138	4-(3-cyclohexylureido)butanoic acid	Discovery agent	.	.
DNC013139	9-hydrazino-1,2,3,4-tetrahydroacridine	Discovery agent	.	.
DNC013140	H-Dmt-Tic-(2S,3S)-beta-MeCha-Phe-OH	Discovery agent	.	.
DNC013141	H-Tyr-Tic-Cha-Phe-OH	Discovery agent	.	.
DNC013142	H-Tyr-Tic-Phe-Phe-OH	Discovery agent	.	.
DNC013143	H-Dmt-Tic-(2R,3S)-beta-MeCha-Phe-NH2	Discovery agent	.	.
DNC013144	H-Dmt-Tic-(2S,3R)-beta-MeCha-Phe-NH2	Discovery agent	.	.
DNC013145	H-Dmt-Tic-(2R,3R)-beta-MeCha-Phe-NH2	Discovery agent	.	.
DNC013146	H-Dmt-Tic-(2S,3S)-beta-MeCha-Phe-NH2	Discovery agent	.	.
DNC013147	H-Dmt-Tic-(2R,3S)-beta-MeCha-Phe-OH	Discovery agent	.	.
DNC013148	H-Dmt-Tic-(2S,3R)-beta-MeCha-Phe-OH	Discovery agent	.	.
DNC013149	H-Dmt-Tic-(2R,3R)-beta-MeCha-Phe-OH	Discovery agent	.	.
DNC013150	EUPATORIOPICRIN	Discovery agent	.	.
DNC013151	CYNAROPICRIN	Discovery agent	.	.
DNC013152	CNICIN	Discovery agent	.	.
DNC013153	2-acetyl-3-hydroxycyclohex-2-enone	Discovery agent	.	.
DNC013154	3-hydroxy-2-propionylcyclohex-2-enone	Discovery agent	.	.
DNC013155	Dmt-Pro-Phe-D-2-Nal-NH2	Discovery agent	.	.
DNC013156	Dmt-Pro-Trp-D-2-Nal-NH2	Discovery agent	.	.
DNC013157	Dmt-Pro-Phe-D-1-Nal-NH2	Discovery agent	.	.
DNC013158	D[D-3-Pal2]AVP	Discovery agent	.	.
DNC013159	D[Val4]AVP	Discovery agent	.	.
DNC013160	DVDAVP	Discovery agent	.	.
DNC013161	D[Arg4,Dab8]VP	Discovery agent	.	.
DNC013162	D[Arg4,Orn8]VP	Discovery agent	.	.
DNC013163	D[Arg4,Lys8]VP	Discovery agent	.	.
DNC013164	D[Arg4]AVP	Discovery agent	.	.
DNC013165	D[Orn4,Orn8]VP	Discovery agent	.	.
DNC013166	D[Orn4,Lys8]VP	Discovery agent	.	.
DNC013167	D[Orn4]AVP	Discovery agent	.	.
DNC013168	D[Leu4,Dap8]VP	Discovery agent	.	.
DNC013169	D[Leu4,Dab8]VP	Discovery agent	.	.
DNC013170	D[Leu4,Orn8]VP	Discovery agent	.	.
DNC013171	D[Leu4,Lys8]VP	Discovery agent	.	.
DNC013172	D[Leu4]AVP	Discovery agent	.	.
DNC013173	D[Cha4,Dap8]VP	Discovery agent	.	.
DNC013174	D[Cha4,Dab8]VP	Discovery agent	.	.
DNC013175	D[Cha4,Orn8]VP	Discovery agent	.	.
DNC013176	D[Cha4,Lys8]VP	Discovery agent	.	.
DNC013177	D[Cha4]AVP	Discovery agent	.	.
DNC013178	N-phenyl-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013179	N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine	Discovery agent	.	.
DNC013180	N-(propargyl),N-(pyrrol-2-ylmethyl)amine	Discovery agent	.	.
DNC013181	N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013182	N-propargyl-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013183	(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013184	N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine	Discovery agent	.	.
DNC013185	N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine	Discovery agent	.	.
DNC013186	N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine	Discovery agent	.	.
DNC013187	N-(benzyl),N-(pyrrol-2-ylmethyl)amine	Discovery agent	.	.
DNC013188	N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013189	N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013190	N-2-phenylethyl-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013191	N-benzyl,N-methyl-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013192	N-benzyl-1H-pyrrole-2-carboxamide	Discovery agent	.	.
DNC013193	2-(4-benzyl-piperidin-1-ylmethyl)-1H-indol-6-ol	Discovery agent	.	.
DNC013194	H-Tyr-c[D-Allylgly-Gly-Phe-L-Allylgly]NH2	Discovery agent	.	.
DNC013195	H-Tyr-c[D-Cys-Gly-Phe-D-Cys]NH2	Discovery agent	.	.
DNC013196	H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]NH2	Discovery agent	.	.
DNC013197	H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]NH2	Discovery agent	.	.
DNC013198	H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]NH2	Discovery agent	.	.
DNC013199	H-Tyr-c[D-Cys-Gly-Phe-L-Cys]NH2	Discovery agent	.	.
DNC013200	H-Tyr-c[D-Allylgly-Gly-Phe-L-Allylgly]NH2	Discovery agent	.	.
DNC013201	H-Tyr-c[D-Allylgly-Gly-Phe-L-Allylgly]NH2	Discovery agent	.	.
DNC013202	2-amino-N1-benzyl-N3-hydroxymalonamide	Discovery agent	.	.
DNC013203	N1-hydroxy-2-isobutyl-N3-phenethylmalonamide	Discovery agent	.	.
DNC013204	N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide	Discovery agent	.	.
DNC013205	2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide	Discovery agent	.	.
DNC013206	2-benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide	Discovery agent	.	.
DNC013207	2-benzyl-N1-hydroxy-N3-phenethylmalonamide	Discovery agent	.	.
DNC013208	N1-(4-fluorobenzyl)-2-benzyl-N3-hydroxymalonamide	Discovery agent	.	.
DNC013209	N1-(4-chlorobenzyl)-2-benzyl-N3-hydroxymalonamide	Discovery agent	.	.
DNC013210	N1,2-dibenzyl-N3-hydroxymalonamide	Discovery agent	.	.
DNC013211	N1-(3-phenoxybenzyl)-N3-hydroxymalonamide	Discovery agent	.	.
DNC013212	N-biphenyl-3-ylmethyl-N'-hydroxy-malonamide	Discovery agent	.	.
DNC013213	N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide	Discovery agent	.	.
DNC013214	N1-(4-chlorobenzyl)-2-amino-N3-hydroxymalonamide	Discovery agent	.	.
DNC013215	N-butyl-2-(1H-indol-3-yl)-2-oxoacetamide	Discovery agent	.	.
DNC013216	N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide	Discovery agent	.	.
DNC013217	N-benzyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide	Discovery agent	.	.
DNC013218	N-butyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide	Discovery agent	.	.
DNC013219	3-(3-benzylamino)-piperidin-2-one	Discovery agent	.	.
DNC013220	3-aminooxy-1-aminopropane	Discovery agent	.	.
DNC013221	H-Dmt-Tic-Glu-NH2	Discovery agent	.	.
DNC013222	H-Dmt-Tic-Glu-NH-(CH2)5-NH2	Discovery agent	.	.
DNC013223	NSC-37173	Discovery agent	.	.
DNC013224	NSC-26699	Discovery agent	.	.
DNC013225	NSC-88915	Cancer	140-229	C00-C96
DNC013225	NSC-88915	Discovery agent	.	.
DNC013226	NSC-126445	Discovery agent	.	.
DNC013227	NSC-324572	Discovery agent	.	.
DNC013228	NSC-47729	Discovery agent	.	.
DNC013229	NSC-58046	Discovery agent	.	.
DNC013230	NSC-45592	Discovery agent	.	.
DNC013231	NSC-37031	Discovery agent	.	.
DNC013232	NSC-30171	Discovery agent	.	.
DNC013233	(2S)-aminobutyryl-(R)-pipecolinic acid amide	Discovery agent	.	.
DNC013234	(2S)-aminobutyryl-L-proline-(2S)-methylbutylamide	Discovery agent	.	.
DNC013235	(2S)-aminobutyryl-L-proline (R)-sec-butylamide	Discovery agent	.	.
DNC013236	(2S)-aminobutyryl-L-proline isobutylamide	Discovery agent	.	.
DNC013237	(2S)-aminobutyryl-L-proline n-pentylamide	Discovery agent	.	.
DNC013238	(2S)-aminobutyryl-L-proline n-butylamide	Discovery agent	.	.
DNC013239	(2S)-aminobutyryl-L-proline n-propylamide	Discovery agent	.	.
DNC013240	Alpha-methylalanyl-L-proline butylamide	Discovery agent	.	.
DNC013241	L-isoleucyl-L-prolinamide	Discovery agent	.	.
DNC013242	L-leucyl-L-prolinamide	Discovery agent	.	.
DNC013243	L-norleucyl-L-prolinamide	Discovery agent	.	.
DNC013244	L-norvalyl-L-prolinamide	Discovery agent	.	.
DNC013245	(2S)-aminobutyryl-L-prolinamide	Discovery agent	.	.
DNC013246	L-valyl-L-prolinamide	Discovery agent	.	.
DNC013247	L-valyl-L-proline benzylamide	Discovery agent	.	.
DNC013248	L-valyl-L-proline hexylamide	Discovery agent	.	.
DNC013249	1,4-dihydroindeno[1,2-c]-pyrazole	Discovery agent	.	.
DNC013250	N6-(4-hydroxybenzyl)adenine riboside	Discovery agent	.	.
DNC013251	N1-benzyl-N3-hydroxy-2-isobutylmalonamide	Discovery agent	.	.
DNC013252	4-amino-N-(2-chlorophenyl)benzenesulfonamide	Discovery agent	.	.
DNC013253	4-amino-N-(4-chlorophenyl)benzenesulfonamide	Discovery agent	.	.
DNC013254	4-amino-N-p-tolylbenzenesulfonamide	Discovery agent	.	.
DNC013255	4-amino-N-(4-iodophenyl)benzenesulfonamide	Discovery agent	.	.
DNC013256	PD-146176	Atherosclerosis	414.0, 440	I70
DNC013256	PD-146176	Discovery agent	.	.
DNC013257	ISOSCOPOLETIN	Discovery agent	.	.
DNC013258	SCOPOLETIN	Discovery agent	.	.
DNC013259	Bis(5-methoxybenzo[b]furan-2-yl)methanone	Discovery agent	.	.
DNC013260	SODIUM ZINC DIHYDROLIPOYLHISTIDINATE	Discovery agent	.	.
DNC013261	3-(2,4-dihydroxyphenyl)propionic acid	Discovery agent	.	.
DNC013262	3-(2,4-dihydroxyphenyl)-propionic acid ethylester	Discovery agent	.	.
DNC013263	3-(2,4-dihydroxyphenyl)-propionic acid octylester	Discovery agent	.	.
DNC013264	Erythro-3,4-dichloromethylphenidate hydrochloride	Discovery agent	.	.
DNC013265	Threo-3,4-dichlororitalinol hydrochloride	Discovery agent	.	.
DNC013266	Threo-ritalinol methyl ether hydrochloride	Discovery agent	.	.
DNC013267	Threo-ritalinol hydrochloride	Discovery agent	.	.
DNC013268	1-benzylpiperidine hydrochloride	Discovery agent	.	.
DNC013269	2-phenylpiperidine hydrochloride	Discovery agent	.	.
DNC013270	Threo-N-ethylritalinol hydrochloride	Discovery agent	.	.
DNC013271	Threo-1-aza-5-phenyl[4.4.0]decane hydrochloride	Discovery agent	.	.
DNC013272	DEXMETHYLPHENIDATE HYDROCHLORIDE	Attention deficit hyperactivity disorder	314	F90
DNC013272	DEXMETHYLPHENIDATE HYDROCHLORIDE	Discovery agent	.	.
DNC013273	Dmt-Pro-Imp-Phe-NH2	Discovery agent	.	.
DNC013274	Tyr-Pro-Imp-Phe-NH2	Discovery agent	.	.
DNC013275	Dmt-Pro-Emp-Phe-NH2	Discovery agent	.	.
DNC013276	Tyr-Pro-Emp-Phe-NH2	Discovery agent	.	.
DNC013277	Dmt-Pro-Tmp-Phe-NH2	Discovery agent	.	.
DNC013278	Tyr-Pro-Tmp-Phe-NH	Discovery agent	.	.
DNC013279	Dmt-Pro-Dmt-Phe-NH2	Discovery agent	.	.
DNC013280	Tyr-Pro-Dmt-Phe-NH2	Discovery agent	.	.
DNC013281	Dmt-Pro-Dmp-Phe-NH2	Discovery agent	.	.
DNC013282	Tyr-Pro-Dmp-Phe-NH2	Discovery agent	.	.
DNC013283	Dmt-Pro-3,5Dmp-Phe-NH2	Discovery agent	.	.
DNC013284	Tyr-Pro-3,5Dmp-Phe-NH2	Discovery agent	.	.
DNC013285	Dmt-Pro-Mmp-Phe-NH2	Discovery agent	.	.
DNC013286	Tyr-Pro-Mmp-Phe-NH	Discovery agent	.	.
DNC013287	Dmt-Pro-Phe-Phe-NH2	Discovery agent	.	.
DNC013288	N-guanyl-1,7-diaminoheptane	Discovery agent	.	.
DNC013289	2-(2-methoxyphenyl)-1H-indene	Discovery agent	.	.
DNC013290	5-(2-1H-indenyl)-1,3-benzodioxole	Discovery agent	.	.
DNC013291	ATC-120	Discovery agent	.	.
DNC013292	4-[4-(benzhydryloxy)piperidino]butyl benzoate	Discovery agent	.	.
DNC013293	N-(1-(4-phenylbutyl)piperidin-4-yl)-1-naphthamide	Discovery agent	.	.
DNC013294	N-(1-(1-phenylethyl)piperidin-4-yl)-1-naphthamide	Discovery agent	.	.
DNC013295	N-(1-phenethylpiperidin-4-yl)-1-naphthamide	Discovery agent	.	.
DNC013296	N-(1-(4-phenylbutyl)piperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013297	N-(1-(1-phenylethyl)piperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013298	N-(1-phenethylpiperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013299	N-(1-benzylpiperidine-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013300	2-EPI-2-THIOSALVINORIN B	Discovery agent	.	.
DNC013301	2-EPI-2-THIOSALVINORIN A	Discovery agent	.	.
DNC013302	2-THIOSALVINORIN B	Discovery agent	.	.
DNC013303	4-(1H-indol-3-yl)-1-morpholinobutan-1-one	Discovery agent	.	.
DNC013304	3-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013305	3-(2-methylbenzo[d]thiazol-5-yl)benzonitrile	Discovery agent	.	.
DNC013306	7-(4,6-dimethylpyrimidin-2-yl)-2-methylquinoline	Discovery agent	.	.
DNC013307	7-(4,6-dimethoxypyrimidin-2-yl)-2-methylquinoline	Discovery agent	.	.
DNC013308	7-(4-methoxypyrimidin-2-yl)-2-methylquinoline	Discovery agent	.	.
DNC013309	Cis-H-Tyr-c[D-AllylGly-Gly-Phe-D-Allylgly]-OH	Discovery agent	.	.
DNC013310	H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]-OH	Discovery agent	.	.
DNC013311	Trans-H-Tyr-c[D-AllylGly-Gly-Phe-D-Allylgly]-OH	Discovery agent	.	.
DNC013312	Cyclopentyl(5-(pyridin-2-yl)oxazol-2-yl)methanone	Discovery agent	.	.
DNC013313	2-chloro-1-(5-(pyridin-2-yl)oxazol-2-yl)ethanone	Discovery agent	.	.
DNC013314	AMG-628	Discovery agent	.	.
DNC013314	AMG-628	Pain	338,780	R52, G89
DNC013315	WIN-35065	Discovery agent	.	.
DNC013316	(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate	Discovery agent	.	.
DNC013317	(+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate	Discovery agent	.	.
DNC013318	N2-[4-(benzyloxy)benzyl]glycinamide	Discovery agent	.	.
DNC013319	N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide	Discovery agent	.	.
DNC013320	N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide	Discovery agent	.	.
DNC013321	(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide	Discovery agent	.	.
DNC013322	(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}serinamide	Discovery agent	.	.
DNC013323	(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	Discovery agent	.	.
DNC013324	(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	Discovery agent	.	.
DNC013325	(S)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}serinamide	Discovery agent	.	.
DNC013326	(S)-N2-[4-(benzyloxy)benzyl]serinamide	Discovery agent	.	.
DNC013327	(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}alaninamide	Discovery agent	.	.
DNC013328	(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	Discovery agent	.	.
DNC013329	(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	Discovery agent	.	.
DNC013330	(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide	Discovery agent	.	.
DNC013331	(S)-N2-[4-(benzyloxy)benzyl]alaninamide	Discovery agent	.	.
DNC013332	N2-{4-[(4-nitrobenzyl)oxy]benzyl}glycinamide	Discovery agent	.	.
DNC013333	N2-{4-[(3-chlorobenzyl)oxy]benzyl}glycinamide	Discovery agent	.	.
DNC013334	N-alpha-amidino-Tyr(Me)-Pro-Trp-p-Cl-Phe-NH2	Discovery agent	.	.
DNC013335	N-alpha-amidino-Tyr(Me)-D-Pro-Gly-Trp-Phe-NH2	Discovery agent	.	.
DNC013336	N-alpha-amidino-Tyr(Me)-Pro-Trp-Phe-NH2	Discovery agent	.	.
DNC013337	Carinatumins B (2)	Discovery agent	.	.
DNC013338	2,2',4,4',6'-pentahydroxychalcone	Discovery agent	.	.
DNC013339	2,2',4,4'-tetrahydroxy-6'-methoxychalcone	Discovery agent	.	.
DNC013340	2,2',4,4'-tetrahydroxychalcone	Discovery agent	.	.
DNC013341	(-)-huperzine B	Discovery agent	.	.
DNC013342	(2S,1'R,2'S)-2-(2'-phosphonocyclopropyl)glycine	Discovery agent	.	.
DNC013343	N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine	Discovery agent	.	.
DNC013344	N-[4-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine	Discovery agent	.	.
DNC013345	N-(1-(4-nitrobenzyl)piperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013346	N-(1-(4-bromobenzyl)piperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013347	N-(1-(3-bromobenzyl)piperidin-4-yl)-2-naphthamide	Discovery agent	.	.
DNC013348	N-(1-(3-bromobenzyl)piperidin-4-yl)-1-naphthamide	Discovery agent	.	.
DNC013349	(R)-1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine	Discovery agent	.	.
DNC013350	(R)-(-)-10-methyl-11-hydroxyaporphine	Discovery agent	.	.
DNC013351	3-isobutoxy-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013352	3-hydroxy-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013353	5-(2-methylquinolin-7-yl)nicotinonitrile	Discovery agent	.	.
DNC013354	3-ethoxy-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013355	3-bromo-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013356	3-methoxy-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013357	5-(2-methylquinolin-7-yl)isophthalonitrile	Discovery agent	.	.
DNC013358	3-methyl-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013359	3-chloro-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013360	3-fluoro-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013361	7-(4-methoxyphenyl)-2-methylquinoline	Discovery agent	.	.
DNC013362	7-(2-methoxyphenyl)-2-methylquinoline	Discovery agent	.	.
DNC013363	2-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC013364	3-(2-methylquinolin-7-yl)phenol	Discovery agent	.	.
DNC013365	7-(3-chlorophenyl)-2-methylquinoline	Discovery agent	.	.
DNC013366	(3-(2-methylquinolin-7-yl)phenyl)methanol	Discovery agent	.	.
DNC013367	7-(3-(methoxymethyl)phenyl)-2-methylquinoline	Discovery agent	.	.
DNC013368	1-(3-(2-methylquinolin-7-yl)phenyl)ethanone	Discovery agent	.	.
DNC013369	2-methyl-7-m-tolylquinoline	Discovery agent	.	.
DNC013370	7-(3-fluorophenyl)-2-methylquinoline	Discovery agent	.	.
DNC013371	7-(3-methoxyphenyl)-2-methylquinoline	Discovery agent	.	.
DNC013372	2-methyl-7-(pyridin-3-yl)quinoline	Discovery agent	.	.
DNC013373	2-(3-(2-methylquinolin-7-yl)phenyl)acetonitrile	Discovery agent	.	.
DNC013374	2-methyl-7-phenylquinoline	Discovery agent	.	.
DNC013375	7-methyl-2-phenylpyrido[2,3-d]pyrimidine	Discovery agent	.	.
DNC013376	2-(3,5-dichlorophenyl)pyrido[2,3-d]pyrimidine	Discovery agent	.	.
DNC013377	2-(3-bromophenyl)pyrido[2,3-d]pyrimidine	Discovery agent	.	.
DNC013378	2-(3-bromophenyl)-7-methylpyrido[2,3-d]pyrimidine	Discovery agent	.	.
DNC013379	7-methyl-2-m-tolylpyrido[2,3-d]pyrimidine	Discovery agent	.	.
DNC013380	H-Tyr-Pro-Phe-Phe-NH-CH2-CH2-NH Tic Dmt-H	Discovery agent	.	.
DNC013381	H-Dmt-Tic-NH-CH2-CH2-NH2	Discovery agent	.	.
DNC013382	3-phenyl-9H-indeno[1,2-e][1,2,4]triazin-9-one	Discovery agent	.	.
DNC013383	3-(phenoxymethyl)-5H-indeno[1,2-c]pyridazin-5-one	Discovery agent	.	.
DNC013384	2-methyl-9H-indeno[2,1-d]pyrimidin-9-one	Discovery agent	.	.
DNC013385	2-phenyl-9H-indeno[2,1-d]pyrimidine	Discovery agent	.	.
DNC013386	2-phenyl-5H-indeno[1,2-d]pyrimidine	Discovery agent	.	.
DNC013387	6,11-dihydro-5H-benzo[a]carbazole	Discovery agent	.	.
DNC013388	(S)-2-Amino-N-cyclopentyl-7-mercaptoheptanamide	Discovery agent	.	.
DNC013389	2-phenyl-1,8-naphthyridine	Discovery agent	.	.
DNC013390	7-(3-methoxyphenyl)-2-methyl-1,6-naphthyridine	Discovery agent	.	.
DNC013391	2-methyl-7-m-tolyl-1,6-naphthyridine	Discovery agent	.	.
DNC013392	2-(3-bromophenyl)-7-methyl-1,8-naphthyridine	Discovery agent	.	.
DNC013393	2-(3-chlorophenyl)-7-methyl-1,8-naphthyridine	Discovery agent	.	.
DNC013394	2-(3,5-difluorophenyl)-7-methyl-1,8-naphthyridine	Discovery agent	.	.
DNC013395	2-methyl-7-m-tolyl-1,8-naphthyridine	Discovery agent	.	.
DNC013396	3-(7-methyl-1,8-naphthyridin-2-yl)benzonitrile	Discovery agent	.	.
DNC013397	2-methyl-7-phenyl-1,8-naphthyridine	Discovery agent	.	.
DNC013398	3-methoxy-5-(1,5-naphthyridin-3-yl)benzonitrile	Discovery agent	.	.
DNC013399	3-(3,4-dimethylphenyl)-1,5-naphthyridine	Discovery agent	.	.
DNC013400	3-m-tolyl-1,5-naphthyridine	Discovery agent	.	.
DNC013401	3-(1,5-naphthyridin-3-yl)benzonitrile	Discovery agent	.	.
DNC013402	7-(3,5-dimethoxyphenyl)-1,6-naphthyridine	Discovery agent	.	.
DNC013403	3-methoxy-5-(1,6-naphthyridin-7-yl)benzonitrile	Discovery agent	.	.
DNC013404	3-fluoro-5-(1,6-naphthyridin-7-yl)benzonitrile	Discovery agent	.	.
DNC013405	7-(3-fluoro-5-methylphenyl)-1,6-naphthyridine	Discovery agent	.	.
DNC013406	7-m-tolyl-1,6-naphthyridine	Discovery agent	.	.
DNC013407	2-(3,4-dimethylphenyl)-1,8-naphthyridine	Discovery agent	.	.
DNC013408	2-(3,5-dimethoxyphenyl)-1,8-naphthyridine	Discovery agent	.	.
DNC013409	2-m-tolyl-1,8-naphthyridine	Discovery agent	.	.
DNC013410	3-(1,8-naphthyridin-2-yl)benzonitrile	Discovery agent	.	.
DNC013411	S-2-(o-toluidino)-2-oxoethyl carbamothioate	Discovery agent	.	.
DNC013412	AM-4768	Discovery agent	.	.
DNC013413	AM-1715	Discovery agent	.	.
DNC013414	AM-1710	Discovery agent	.	.
DNC013415	Arg-Pro-Lys-Pro-Ala-Ser-Phe-Phe-Gly-Leu-Met-NH2	Discovery agent	.	.
DNC013416	Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2	Discovery agent	.	.
DNC013417	Arg-Pro-Lys-Pro-Ala-Gln-Phe-Phe-Gly-Leu-Met-NH2	Discovery agent	.	.
DNC013418	Arg-Pro-Lys-Pro-Gln-Ser-Phe-Phe-Gly-Leu-Met-NH2	Discovery agent	.	.
DNC013419	6'-Iodononivamide	Discovery agent	.	.
DNC013420	4-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol	Discovery agent	.	.
DNC013421	5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol	Discovery agent	.	.
DNC013422	5-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol	Discovery agent	.	.
DNC013423	7-(3,5-dihydroxyphenyl)naphthalene-1,3-diol	Discovery agent	.	.
DNC013424	N-(2-methyl-2-phenylpropyl)pyrazine-2-carboxamide	Discovery agent	.	.
DNC013425	N-phenethylquinoxaline-2-carboxamide	Discovery agent	.	.
DNC013426	N-(2-phenylpropyl)quinoxaline-2-carboxamide	Discovery agent	.	.
DNC013427	2-((3-iodophenyl)(o-tolyloxy)methyl)morpholine	Discovery agent	.	.
DNC013428	2-((2-iodophenoxy)(phenyl)methyl)morpholine	Discovery agent	.	.
DNC013429	ETHISTERONE	Discovery agent	.	.
DNC013430	SKS-927	Discovery agent	.	.
DNC013431	1-(3-(phenylthio)propyl)-4-m-tolylpiperazine	Discovery agent	.	.
DNC013432	N-(6-methylpyridin-2-yl)-5-phenylpicolinamide	Discovery agent	.	.
DNC013433	N-hydroxy-3-(naphthalen-1-yl)acrylamide	Discovery agent	.	.
DNC013434	N-hydroxy-3-phenoxybenzamide	Discovery agent	.	.
DNC013435	N-hydroxy-1-naphthamide	Discovery agent	.	.
DNC013436	H-Tyr-c[cys-Gly-Phe(p-NO2)-cys]NH2	Discovery agent	.	.
DNC013437	4-bromo-1H-indazole	Discovery agent	.	.
DNC013438	7-chloro-1H-indazole	Discovery agent	.	.
DNC013439	7-bromo-1H-indazole	Discovery agent	.	.
DNC013440	6-bromo-1H-indazole	Discovery agent	.	.
DNC013441	4-iodo-1H-indazole	Discovery agent	.	.
DNC013442	6-chloro-1H-indazole	Discovery agent	.	.
DNC013443	5-iodo-1H-indazole	Discovery agent	.	.
DNC013444	5-bromo-1H-indazole	Discovery agent	.	.
DNC013445	4-chloro-1H-indazole	Discovery agent	.	.
DNC013446	5-chloro-1H-indazole	Discovery agent	.	.
DNC013447	3-(4-(o-toluidino)pyrimidin-2-ylamino)benzamide	Discovery agent	.	.
DNC013448	1-(3-phenoxypropyl)-4-(piperidin-1-yl)piperidine	Discovery agent	.	.
DNC013449	1'-(4-Methyl-benzyl)-[1,4']bipiperidinyl	Discovery agent	.	.
DNC013450	N-(3-phenethoxybenzyl)-4-hydroxybenzamide	Discovery agent	.	.
DNC013451	2-arachidonoylglycerol	Discovery agent	.	.
DNC013452	Atorvastatin calcium	Discovery agent	.	.
DNC013453	PITAVASTATIN CALCIUM	Discovery agent	.	.
DNC013454	Rosuvastatin calcium	Discovery agent	.	.
DNC013455	3-(4-bromophenyl)-1,1-dimethylthiourea	Discovery agent	.	.
DNC013456	3-(4-bromobenzyl)-1,1-dimethylselenourea	Discovery agent	.	.
DNC013457	1-cyclohexyl-1-isopropyl-3,3-dimethylselenourea	Discovery agent	.	.
DNC013458	3-dodecyl-1,1-dimethylthiourea	Discovery agent	.	.
DNC013459	CRYPTADINE B	Discovery agent	.	.
DNC013460	(R)-3-(4-propylmorpholin-2-yl)phenol	Discovery agent	.	.
DNC013461	(-)-3-O-acetylspectaline	Discovery agent	.	.
DNC013462	Tyr-(S)-Aba-Gly-Phe-NH2	Discovery agent	.	.
DNC013463	Tyr-(R)-Aba-Gly-Phe-NH2	Discovery agent	.	.
DNC013464	Tyr-(S)-spiro-Aba-Gly-Phe-NH2	Discovery agent	.	.
DNC013465	Tyr-(R)-spiro-Aba-Gly-Phe-NH2	Discovery agent	.	.
DNC013466	PK-11195	Discovery agent	.	.
DNC013467	PF-3052334	Atherosclerosis	414.0, 440	I70
DNC013467	PF-3052334	Discovery agent	.	.
DNC013468	6-phenylethynyl-nicotinic acid methyl ester	Discovery agent	.	.
DNC013469	2-phenylethynyl-5,6,7,8-tetrahydro-quinoline	Discovery agent	.	.
DNC013470	Pyrazine-2-carboxylic acid adamantan-1-ylamide	Discovery agent	.	.
DNC013471	Quinoline-2-carboxylic acid adamantan-1-ylamide	Discovery agent	.	.
DNC013472	Quinoline-3-carboxylic acid adamantan-1-ylamide	Discovery agent	.	.
DNC013473	Quinoxaline-2-carboxylic acid adamantan-1-ylamide	Discovery agent	.	.
DNC013474	2-benzyloxy-7,8-dihydro-6H-quinolin-5-one	Discovery agent	.	.
DNC013475	2-phenylethynyl-5,6,7,8-tetrahydro-quinolin-5-ol	Discovery agent	.	.
DNC013476	2-phenylethynyl-7,8-dihydro-6H-quinolin-5-one	Discovery agent	.	.
DNC013477	Xanthosine-5'-monophosphate disodium salt	Discovery agent	.	.
DNC013478	PREDICENTRINE	Discovery agent	.	.
DNC013479	GLAUCINE	Discovery agent	.	.
DNC013480	(S)-BULBOCAPNINE	Discovery agent	.	.
DNC013481	MELOSMINE	Discovery agent	.	.
DNC013482	NORSTEPHALAGINE	Discovery agent	.	.
DNC013483	ANOLOBINE	Discovery agent	.	.
DNC013484	ANONAINE	Discovery agent	.	.
DNC013485	PUKATEINE	Discovery agent	.	.
DNC013486	1,2,3,7,12,12a-hexahydro-1-aza-pleiadene-5,6-diol	Discovery agent	.	.
DNC013487	1,2,3,7,12,12a-hexahydro-1-aza-pleiaden-5-ol	Discovery agent	.	.
DNC013488	DIPROTIN A	Discovery agent	.	.
DNC013489	Dmt-Sar-Phe-D-2-Nal-NH	Discovery agent	.	.
DNC013490	Tyr-Sar-Phe-D-2-Nal-NH2	Discovery agent	.	.
DNC013491	Dmt-Pro-Phe-D-2-Nal-NH2	Discovery agent	.	.
DNC013492	Tyr-Pro-Phe-D-2-Nal-NH2	Discovery agent	.	.
DNC013493	1-(4-(methylsulfonyl)phenyl)-3-phenylurea	Discovery agent	.	.
DNC013494	1-(4-(methylsulfonyl)phenyl)-3-p-tolylurea	Discovery agent	.	.
DNC013495	N-ALLYLNORGALANTHAMINE	Discovery agent	.	.
DNC013496	N-(14-methylallyl)norgalanthamine	Discovery agent	.	.
DNC013497	3-(butylthio)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC013498	1,1,1-trifluoro-3-(hexylsulfonyl)propan-2-one	Discovery agent	.	.
DNC013499	1,1,1-trifluoro-3-(hexylsulfinyl)propan-2-one	Discovery agent	.	.
DNC013500	3-(butylsulfinyl)-1,1,1-trifluoropropan-2-one	Discovery agent	.	.
DNC013501	(Z)-1-(4-phenyloxazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013502	1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one	Discovery agent	.	.
DNC013503	1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one	Discovery agent	.	.
DNC013504	1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one	Discovery agent	.	.
DNC013505	(Z)-1-(pyridazin-3-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013506	1-(1,3,4-oxadiazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013507	1-(5-(pyridin-2-yl)oxazol-2-yl)pentan-1-one	Discovery agent	.	.
DNC013508	1-(5-(pyridin-2-yl)oxazol-2-yl)octan-1-one	Discovery agent	.	.
DNC013509	1-(5-(pyridin-2-yl)oxazol-2-yl)dodecan-1-one	Discovery agent	.	.
DNC013510	1-(5-phenyloxazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013511	1-(5-methyloxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC013512	1-(5-fluorooxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC013513	2-(2-(pyrrolidin-1-yl)ethyl)pyridine	Discovery agent	.	.
DNC013514	ALTANSERIN	Discovery agent	.	.
DNC013515	3-(biphenyl-4-yl)-1-(oxazol-2-yl)propan-1-one	Discovery agent	.	.
DNC013516	1-(oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one	Discovery agent	.	.
DNC013517	6-(2-mercaptoacetamido)-N-phenylhexanamide	Discovery agent	.	.
DNC013518	S-2,9-dioxo-9-(phenylamino)nonyl ethanethioate	Discovery agent	.	.
DNC013519	9-mercapto-8-oxo-N-phenylnonanamide	Discovery agent	.	.
DNC013520	(R)-(-)-N-propyl-2-methoxy-11-hydroxynoraporphine	Discovery agent	.	.
DNC013521	(R)-(-)-N-ethyl-2-methoxy-11-hydroxynoraporphine	Discovery agent	.	.
DNC013522	(R)-(-)-2-methoxy-11-hydroxyaporphine	Discovery agent	.	.
DNC013523	(R)-(-)-2-methoxy-N-npropylnorapomorphine	Discovery agent	.	.
DNC013524	2-methoxyapomorphine	Discovery agent	.	.
DNC013525	CP-376395	Discovery agent	.	.
DNC013526	2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine	Discovery agent	.	.
DNC013527	N2-(3-trifluoromethylphenyl)guanine	Discovery agent	.	.
DNC013528	5-propyl-2'-deoxyuridine	Discovery agent	.	.
DNC013529	Edoxudine	Discovery agent	.	.
DNC013530	L-5-iodo-2'-deoxyuridine	Discovery agent	.	.
DNC013531	L-5-(bromovinyl)deoxyuridine	Discovery agent	.	.
DNC013532	CP-4497	Discovery agent	.	.
DNC013533	GFPEGG	Discovery agent	.	.
DNC013534	GFPDGG	Discovery agent	.	.
DNC013535	GFPTGG	Discovery agent	.	.
DNC013536	GLPTGG	Discovery agent	.	.
DNC013537	F(4-Fluoro)VAE	Discovery agent	.	.
DNC013538	1-(4-aminosulfonylphenyl)-2-(2-pyridyl)acetylene	Discovery agent	.	.
DNC013539	1-(4-aminosulfonylphenyl)-2-(4-pyridyl)acetylene	Discovery agent	.	.
DNC013540	XR-9456	Discovery agent	.	.
DNC013541	XR-9504	Discovery agent	.	.
DNC013542	XR-9577	Discovery agent	.	.
DNC013543	XR-9544	Discovery agent	.	.
DNC013544	1-[(prop-1-ylamino)ethyl]-1,1-bisphosphonic acid	Discovery agent	.	.
DNC013545	1-(but-2-ylamino)ethyl 1,I-bisphosphonic acid	Discovery agent	.	.
DNC013546	1-[(prop-2-ylamino)ethyl]-1,1-bisphosphonicacid	Discovery agent	.	.
DNC013547	1-[(cyclohexylamino)ethyl]-1,1-bisphosphonicacid	Discovery agent	.	.
DNC013548	1-[(tert-butylamino)ethyl]-1,1-bisphosphonicacid	Discovery agent	.	.
DNC013549	1-[(n-oct-1-ylamino)ethyl]-1,1-bisphosphonic acid	Discovery agent	.	.
DNC013550	1-[(n-hex-1-ylamino)ethyl]-1,1-bisphosphonic acid	Discovery agent	.	.
DNC013551	1-[(n-but-1-ylamino)ethyl]-1,1-bisphosphonic acid	Discovery agent	.	.
DNC013552	(1-hydroxy-1-phosphono-heptyl)-phosphonic acid	Discovery agent	.	.
DNC013553	H-Dmt-Tic-NH-CH2-Imid	Discovery agent	.	.
DNC013554	H-Dmt-Tic-NH-CH2-ImidPh	Discovery agent	.	.
DNC013555	H-Dmt-Tic-NH-CH2-Indn	Discovery agent	.	.
DNC013556	H-Dmt-Tic-NH-CH2-Indl	Discovery agent	.	.
DNC013557	H-Dmt-Tic-NH-CH2-Bta	Discovery agent	.	.
DNC013558	H-Dmt-Tic-NH-CH2-Boa	Discovery agent	.	.
DNC013559	D-211B	Discovery agent	.	.
DNC013560	D-211A	Discovery agent	.	.
DNC013561	D-257C	Discovery agent	.	.
DNC013562	D-257A	Discovery agent	.	.
DNC013563	D-166A	Discovery agent	.	.
DNC013564	D-254C	Discovery agent	.	.
DNC013565	1-(1-phenylethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013566	1-(1,4-diacetylphenyl)dithiosemicarbazide	Discovery agent	.	.
DNC013567	1-(1-(pyridin-3-yl)ethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013568	1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013569	1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013570	1-(1-(4-bromophenyl)ethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013571	1-(1-(4-fluorophenyl)ethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013572	1-(1-p-tolylethylidene)thiosemicarbazide	Discovery agent	.	.
DNC013573	TROPOLONE	Discovery agent	.	.
DNC013574	N,N'-(1',2'-ethylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013575	N,N'-(1',12'-dodecydene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013576	N,N'-(1',11'-undecydene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013577	N,N'-(1',8'-octylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013578	N,N'-(1',7'-heptylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013579	N,N'-(1',6-hexylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013580	N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013581	MEPTAZINOL	Discovery agent	.	.
DNC013581	MEPTAZINOL	Pain	338,780	R52, G89
DNC013582	N,N'-(1',4'-butylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013583	N,N'-(1',3'-propylene)-bis-(-)-nor-MEP	Discovery agent	.	.
DNC013584	SB-0304	Discovery agent	.	.
DNC013585	H-Tyr-NMe-D-Ala-Phe-Sar-NH2	Discovery agent	.	.
DNC013586	1-hydroxy-3-phenylurea	Discovery agent	.	.
DNC013587	PHENYLTHIOUREA	Discovery agent	.	.
DNC013588	3hydroxy-1-methyl-1-phenylurea	Discovery agent	.	.
DNC013589	1-(4-bromophenyl)-3-hydroxyurea	Discovery agent	.	.
DNC013590	1-hydroxy-3-(4-(trifluoromethyl)phenyl)urea	Discovery agent	.	.
DNC013591	1-hydroxy-3-(4-nitrophenyl)urea	Discovery agent	.	.
DNC013592	1-(4-(benzyloxy)phenyl)-3-hydroxyurea	Discovery agent	.	.
DNC013593	ASTRAGALIN	Discovery agent	.	.
DNC013594	Kaempferol-3-O-(2''-O-galloyl)-glucoside	Discovery agent	.	.
DNC013595	CONTIGOSIDE B	Discovery agent	.	.
DNC013596	SCUTELLAREIN	Discovery agent	.	.
DNC013597	WOGONIN	Discovery agent	.	.
DNC013598	FUKUGETIN	Discovery agent	.	.
DNC013599	3-O-METHYLQUERCETIN	Discovery agent	.	.
DNC013600	PERSICARIN	Discovery agent	.	.
DNC013601	ROBINETIN	Discovery agent	.	.
DNC013602	DIHYDROKAEMPFEROL	Discovery agent	.	.
DNC013603	Anthoptilide C	Discovery agent	.	.
DNC013604	3-Iodoboldine	Discovery agent	.	.
DNC013605	3-Chloroboldine	Discovery agent	.	.
DNC013606	ADIPATE	Discovery agent	.	.
DNC013607	GLUTARATE	Discovery agent	.	.
DNC013608	FLUORESCEIN	Discovery agent	.	.
DNC013608	FLUORESCEIN	Ocular disease	.	H00-H59
DNC013609	AMINOHIPPURIC ACID	Discovery agent	.	.
DNC013610	3R14S-OCHRATOXIN A	Discovery agent	.	.
DNC013611	HEPTANOATE	Discovery agent	.	.
DNC013612	CCNCSSKWCRDHSRCC	Discovery agent	.	.
DNC013613	ZNCCNCSSKWCRDHSRCC	Discovery agent	.	.
DNC013614	CCNCSSKWCRDHARCC	Discovery agent	.	.
DNC013615	CCNCSSKWCRAHSRCC	Discovery agent	.	.
DNC013616	CCNCSAKWCRDHSRCC	Discovery agent	.	.
DNC013617	CCNCASKWCRDHSRCC	Discovery agent	.	.
DNC013618	CCACSSKWCRDHSRCC	Discovery agent	.	.
DNC013619	ZRCCNCSSKWCRDHSRCC	Discovery agent	.	.
DNC013620	N-butylgalactonojirimycin	Discovery agent	.	.
DNC013621	SNEWIQPRLPQH	Discovery agent	.	.
DNC013622	Conantokin-R	Discovery agent	.	.
DNC013623	Conantokin-G	Discovery agent	.	.
DNC013624	2-(4-aminophenylsulfonamido)acetic acid	Discovery agent	.	.
DNC013625	(R)-(-)-2-Methyl-apomorphine hydrochloride	Discovery agent	.	.
DNC013626	(R)-(-)-2-Phenyl-apomorphine hydrochloride	Discovery agent	.	.
DNC013627	5-thia-8,11,14,17-eicosatetraenoic acid	Discovery agent	.	.
DNC013628	Eicosapentaenoic acid	Discovery agent	.	.
DNC013628	Eicosapentaenoic acid	Familial adenomatous polyposis	.	C18,D12
DNC013629	DOCOSAHEXAENOIC ACID	Alzheimer's disease	331	G30
DNC013629	DOCOSAHEXAENOIC ACID	Discovery agent	.	.
DNC013630	LINOLENIC ACID	Discovery agent	.	.
DNC013631	VAGANINE D	Discovery agent	.	.
DNC013632	LY-2318912	Discovery agent	.	.
DNC013633	THEASINENSIN A	Discovery agent	.	.
DNC013634	Procyanidin B-2 3,3'-di-O-gallate	Discovery agent	.	.
DNC013635	1,2,6-tri-O-galloyl-beta-D-glucose	Discovery agent	.	.
DNC013636	ETHYLGALLATE	Discovery agent	.	.
DNC013637	OCTYL_GALLATE	Discovery agent	.	.
DNC013638	N-dodecylgallate	Discovery agent	.	.
DNC013639	N-cetylgallate	Discovery agent	.	.
DNC013640	EUGENIIN	Discovery agent	.	.
DNC013641	1(beta)-O-galloylpedunculagin	Discovery agent	.	.
DNC013642	GERANIIN	Discovery agent	.	.
DNC013643	FUROSIN	Discovery agent	.	.
DNC013644	Mallotinic acid	Discovery agent	.	.
DNC013645	Mallotusinic acid	Discovery agent	.	.
DNC013646	Chebulinic acid	Discovery agent	.	.
DNC013647	Sanguiin H-6	Discovery agent	.	.
DNC013648	Trisnorsqualene alcohol	Discovery agent	.	.
DNC013649	Trisnorsqualene cyclopropylamine	Discovery agent	.	.
DNC013650	Trisnorsqualene difluoromethylidene	Discovery agent	.	.
DNC013651	NVP-TAE684	Discovery agent	.	.
DNC013651	NVP-TAE684	Lymphoma	202.8	C81-C96
DNC013652	FAICAR	Discovery agent	.	.
DNC013653	1-(4-Bromo-2,5-difluorophenyl)-2-aminopropane	Discovery agent	.	.
DNC013654	1-(10-Bromoanthracen-9-yl)-2-aminopropane	Discovery agent	.	.
DNC013655	2-(1H-indol-3-yl)-N,N-dimethylethanamine	Discovery agent	.	.
DNC013656	2-(3,5-dimethoxy-4-phenethoxyphenyl)ethanamine	Discovery agent	.	.
DNC013657	1-(2,6-dimethoxy-4-methylphenyl)propan-2-amine	Discovery agent	.	.
DNC013658	DOM	Discovery agent	.	.
DNC013659	1-(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine	Discovery agent	.	.
DNC013660	Racemic DOTFM	Discovery agent	.	.
DNC013661	EPALRESTATE	Discovery agent	.	.
DNC013662	Apigenin-7-O-beta-D-glucuronide methyl ester	Discovery agent	.	.
DNC013663	Apigenin-7-O-beta-D-glucuronide	Discovery agent	.	.
DNC013664	[R-(-)-Apomorphine-2-yl]-(2'-hydroxy-ethyl)ether	Discovery agent	.	.
DNC013665	2-{[R-(-)-Apomorphine-2'-oxy]ethoxy}-ethanol	Discovery agent	.	.
DNC013666	Bis-{[R-(-)-apomorphine-2-oxy]ethyl} ether	Discovery agent	.	.
DNC013667	1,2-Bis-[R-(-)-apomorphine-2'-oxy]ethane	Discovery agent	.	.
DNC013668	(+/-)-7-hydroxy-2-(N,N-di-n-propylamino)tetralin	Discovery agent	.	.
DNC013669	D-219	Discovery agent	.	.
DNC013670	D-210	Discovery agent	.	.
DNC013671	D-190	Discovery agent	.	.
DNC013672	D-192	Discovery agent	.	.
DNC013673	D-193	Discovery agent	.	.
DNC013674	D-189	Discovery agent	.	.
DNC013675	D-220	Discovery agent	.	.
DNC013676	D-218	Discovery agent	.	.
DNC013677	D-203	Discovery agent	.	.
DNC013678	GALANTAMINE HYDROBROMIDE	Discovery agent	.	.
DNC013679	4-formylphenyl-O-beta-D-ribopyranoside	Discovery agent	.	.
DNC013680	4-formylphenyl-O-beta-Dglucopyranoside	Discovery agent	.	.
DNC013681	1-(2-morpholinoethyl)-1H-indol-3-yl acetate	Discovery agent	.	.
DNC013682	H-Dmt-Tic-Asp-NH-Bzl	Discovery agent	.	.
DNC013683	H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid	Discovery agent	.	.
DNC013684	H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid(N1-Me)	Discovery agent	.	.
DNC013685	H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid(N1-Me)	Discovery agent	.	.
DNC013686	H-Dmt-Tic-D-Asp-N(Me)-Ph	Discovery agent	.	.
DNC013687	H-Dmt-Tic-Asp-N(Me)-Ph	Discovery agent	.	.
DNC013688	H-Dmt-Tic-D-Asp-NH-Ph	Discovery agent	.	.
DNC013689	H-Dmt-Tic-Asp-NH-Ph	Discovery agent	.	.
DNC013690	H-Dmt-Tic-Gly-N(Me)-Ph	Discovery agent	.	.
DNC013691	CARCININE	Discovery agent	.	.
DNC013692	Kazinol C	Discovery agent	.	.
DNC013693	KAZINOL S	Discovery agent	.	.
DNC013694	Broussonin C	Discovery agent	.	.
DNC013695	Kazinol F	Discovery agent	.	.
DNC013696	4-hexyl resorcinol	Discovery agent	.	.
DNC013697	PF-622	Discovery agent	.	.
DNC013697	PF-622	Pain	338,780	R52, G89
DNC013698	N-isobutylnoroxymorphone	Discovery agent	.	.
DNC013699	GBR-12909	Discovery agent	.	.
DNC013700	N-(2-hydroxyethyl)linoleoylamide	Discovery agent	.	.
DNC013701	N-(2-iodethyl)arachidonylamide	Discovery agent	.	.
DNC013702	N-(2-iodoethyl)linoleoylamide	Discovery agent	.	.
DNC013703	MCL-515	Discovery agent	.	.
DNC013704	6,7'-oxybis(2-phenyl-4H-chromen-4-one)	Discovery agent	.	.
DNC013705	6-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine	Discovery agent	.	.
DNC013706	2'-Hydroxychalcone	Discovery agent	.	.
DNC013707	1-(2-hydroxyphenyl)-3-p-tolylprop-2-en-1-one	Discovery agent	.	.
DNC013708	4-benzyloxy-2'-hydroxychalcone	Discovery agent	.	.
DNC013709	3-Bromo-2'-hydroxy-4-methoxychalcone	Discovery agent	.	.
DNC013710	3,4-dibenzyloxy-2'-hydroxychalcone	Discovery agent	.	.
DNC013711	3-benzyloxy-4-methoxy-2'-hydroxychalcone	Discovery agent	.	.
DNC013712	2,3-dimethoxy-2'-hydroxychalcone	Discovery agent	.	.
DNC013713	2,4-dimethoxy-2'-hydroxychalcone	Discovery agent	.	.
DNC013714	2'-hydroxy-3,4,5-trimethoxychalcone	Discovery agent	.	.
DNC013715	Sodium maleate	Discovery agent	.	.
DNC013716	N-butylresorcinol	Discovery agent	.	.
DNC013717	4-adamantyl resorcinol	Discovery agent	.	.
DNC013718	5-(phenylethynyl)pyrimidine	Discovery agent	.	.
DNC013719	2-(m-tolylethynyl)pyrimidine	Discovery agent	.	.
DNC013720	2-(phenylethynyl)pyrimidine	Discovery agent	.	.
DNC013721	2-ethoxy-5-(m-tolylethynyl)pyrimidine	Discovery agent	.	.
DNC013722	5-(2-m-tolylethynyl)pyrimidine	Discovery agent	.	.
DNC013723	Alpha-7-Deoxyhomonojirimycin	Discovery agent	.	.
DNC013724	Hyacinthacine B3	Discovery agent	.	.
DNC013725	SULBACTAM	Discovery agent	.	.
DNC013726	1-Ethylidenethiosemicarbazide	Discovery agent	.	.
DNC013727	1-Propylidenethiosemicarbazide	Discovery agent	.	.
DNC013728	1-(3-Methylbutylidene)thiosemicarbazide	Discovery agent	.	.
DNC013729	1-(But-2-enylidene)thiosemicarbazide	Discovery agent	.	.
DNC013730	1-(3-Phenylallylidene)thiosemicarbazide	Discovery agent	.	.
DNC013731	1-(Propan-2-ylidene)thiosemicarbazide	Discovery agent	.	.
DNC013732	1-(Butan-2-ylidene)thiosemicarbazide	Discovery agent	.	.
DNC013733	1-(4-Methylpent-3-en-2-ylidene)thiosemicarbazide	Discovery agent	.	.
DNC013734	1-Cyclopentylidenethiosemicarbazide	Discovery agent	.	.
DNC013735	1-Cyclohexylidenethiosemicarbazide	Discovery agent	.	.
DNC013736	1-(3-Oxocyclohexylidene)thiosemicarbazide	Discovery agent	.	.
DNC013737	1-(2,5-Dimethyl-1H-pyrrol-1-yl)thiourea	Discovery agent	.	.
DNC013738	4-hydroxysaprothoquinone	Discovery agent	.	.
DNC013739	(-)-eseroline	Discovery agent	.	.
DNC013740	AKUAMMINE	Discovery agent	.	.
DNC013741	DIHYDROAKUAMMINE	Discovery agent	.	.
DNC013742	(+/-)-TRANS-U-50488 METHANESULFONATE	Discovery agent	.	.
DNC013743	(+)-(1R,1'S)-thaligrisine hydrochloride	Discovery agent	.	.
DNC013744	(+)-(1R,1'S)-berbamunine hydrochloride	Discovery agent	.	.
DNC013745	(-)-(1S,1'R)-O,O-dimethylgrisbine hydrochloride	Discovery agent	.	.
DNC013746	(R,S)-homoaromaline hydrochloride	Discovery agent	.	.
DNC013747	(S,S)-oxandrine hydrochloride	Discovery agent	.	.
DNC013748	(S,R)-isotetrandrine hydrochloride	Discovery agent	.	.
DNC013749	(S,R)-pseudoxandrine hydrochloride	Discovery agent	.	.
DNC013750	(S,R)-antioquine hydrochloride	Discovery agent	.	.
DNC013751	(S)-secoantioquine hydrochloride	Discovery agent	.	.
DNC013752	Asterric acid	Discovery agent	.	.
DNC013753	Isorhamnetin 3,7-disulfate	Discovery agent	.	.
DNC013754	Tamarixetin 3-glucoside-7-sulfate	Discovery agent	.	.
DNC013755	2,5-imino-2,5,6-trideoxy-D-manno-heptitol	Discovery agent	.	.
DNC013756	2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol	Discovery agent	.	.
DNC013757	NOR-ROEFRACTINE	Discovery agent	.	.
DNC013758	(R)-(+)-coclaurine	Discovery agent	.	.
DNC013759	CIRSIMARIN	Discovery agent	.	.
DNC013760	4ALPHA-(HYDROXYMETHYL)-4ALPHA-DEMETHYLTERRITREM B	Discovery agent	.	.
DNC013761	2-(2-Methylpropanoyl)-1,3,5-benzenetriol	Discovery agent	.	.
DNC013762	NOSTOCARBOLINE	Discovery agent	.	.
DNC013763	2-Methyl-beta-carboline-2-ium iodide	Discovery agent	.	.
DNC013764	Patuletin 3-O-beta-D-robinobioside	Discovery agent	.	.
DNC013765	6-methoxykaempferol 3-O-beta-D-robinobioside	Discovery agent	.	.
DNC013766	Patuletin 3-O-beta-D-galactoside	Discovery agent	.	.
DNC013767	Crocusatin-K	Discovery agent	.	.
DNC013768	N-isopropylnorlitebamineN-methoiodide	Discovery agent	.	.
DNC013769	N-isopropylnorlitebamine	Discovery agent	.	.
DNC013770	N-benzylnorlitebamine	Discovery agent	.	.
DNC013771	N-allylnorlitebamine	Discovery agent	.	.
DNC013772	N-isobutylnorlitebamine	Discovery agent	.	.
DNC013773	N-butylnorlitebamine	Discovery agent	.	.
DNC013774	N-propylnorlitebamine	Discovery agent	.	.
DNC013775	Zaragozic acid C	Discovery agent	.	.
DNC013776	Kuanoniamine D	Discovery agent	.	.
DNC013777	(RS)-tacrine(10)-hupyridone	Discovery agent	.	.
DNC013778	(S,S)-(-)-bis(12)-hupyridone	Discovery agent	.	.
DNC013779	(S,S)-(-)-bis(10)-hupyridone	Discovery agent	.	.
DNC013780	GALLAMINE	Anesthesia	338	R52
DNC013780	GALLAMINE	Discovery agent	.	.
DNC013781	DECIDIUM	Discovery agent	.	.
DNC013782	EDROPHONIUM BROMIDE	Discovery agent	.	.
DNC013783	Galanthamine derivative	Discovery agent	.	.
DNC013784	3-Bromo-1H-indazole-7-carbonitrile	Discovery agent	.	.
DNC013785	3-bromo-7-nitro-1H-indazole	Discovery agent	.	.
DNC013786	AMINOTHIAZOLINE	Discovery agent	.	.
DNC013787	2-Cyclohexylacetic acidbiphenyl-3-yl ester	Discovery agent	.	.
DNC013788	Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013789	Phenylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013790	8-Phenyloctylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013791	6-Phenylhexylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013792	4-Phenylbutylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013793	Indan-2-ylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013794	Phenethylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013795	Furan-2-ylmethylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013796	Benzylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013797	Adamant-1-ylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013798	Cyclohexylmethylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013799	Cyclopentylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013800	Cyclobutylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013801	N-Octylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013802	N-Hexylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013803	N-Butylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013804	Isopropylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013805	Allylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013806	Methylcarbamic Acid Biphenyl-3-yl Ester	Discovery agent	.	.
DNC013807	Tyr-Pro-Phe-Phe-OCH2OH	Discovery agent	.	.
DNC013808	Tyr-Pro-Phe-Phe-OC(CH3)3	Discovery agent	.	.
DNC013809	Tyr-Pro-Phe-Phe-OCH2CH3	Discovery agent	.	.
DNC013810	Tyr-Pro-Phe-Phe-N(CH3)2	Discovery agent	.	.
DNC013811	Tyr-Pro-Phe-Phe-NHCH3	Discovery agent	.	.
DNC013812	23-hydroxybetulinic acid	Discovery agent	.	.
DNC013813	BETULIN	Discovery agent	.	.
DNC013814	ASIATIC ACID	Discovery agent	.	.
DNC013815	3alpha-Hydroxyurs-12-en-28-oic Acid	Discovery agent	.	.
DNC013816	6-Methyl-4-(4-benzoylpiperazin-1-yl)coumarin	Discovery agent	.	.
DNC013817	6-Methyl-4-(4-phenylpiperazin-1-yl)coumarin	Discovery agent	.	.
DNC013818	6-Methyl-4-(4-o-tolylpiperazin-1-yl)coumarin	Discovery agent	.	.
DNC013819	3-(4-Benzoylpiperazine-1-carbonyl)coumarin	Discovery agent	.	.
DNC013820	3-(4-o-Tolylpiperazine-1-carbonyl)coumarin	Discovery agent	.	.
DNC013821	3-(4-Phenylpiperazin-1-carbonyl)coumarin	Discovery agent	.	.
DNC013822	2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol	Discovery agent	.	.
DNC013823	AM-92016	Discovery agent	.	.
DNC013824	Isosorbide-2-benzylcarbamate-5-tosylate	Discovery agent	.	.
DNC013825	H-D-Phe-c[Cys-Tyr-DTrp-Orn-Thr-Pen]-Thr-NH2	Discovery agent	.	.
DNC013826	Antanal 1	Discovery agent	.	.
DNC013827	Antanal 2	Discovery agent	.	.
DNC013828	(E,E)-8-(4-Phenylbutadien-1-yl)caffeine	Discovery agent	.	.
DNC013829	(E,E)-8-[4-(3-Fluorophenyl)butadien-1-yl]caffeine	Discovery agent	.	.
DNC013830	(E,E)-8-[4-(3-Bromophenyl)butadien-1-yl]caffeine	Discovery agent	.	.
DNC013831	(E,E)-8-[4-(3-Chlorophenyl)butadien-1-yl]caffeine	Discovery agent	.	.
DNC013832	(Z)-8-(3-chlorostyryl)caffeine	Discovery agent	.	.
DNC013833	N-glycylglycinehydroxamic acid	Discovery agent	.	.
DNC013834	Primary alcohol metabolite of celecoxib	Discovery agent	.	.
DNC013835	3-(ethoxycarbonyl)phenylboronic acid	Discovery agent	.	.
DNC013836	3-(trifluoromethyl)phenylboronic acid	Discovery agent	.	.
DNC013837	3-cyanophenylboronic acid	Discovery agent	.	.
DNC013838	Biphenyl-3-ylboronic acid	Discovery agent	.	.
DNC013839	3-methoxyphenylboronic acid	Discovery agent	.	.
DNC013840	4-fluorophenylboronic acid	Discovery agent	.	.
DNC013841	4-(trifluoromethyl)phenylboronic acid	Discovery agent	.	.
DNC013842	4-nitrophenylboronic acid	Discovery agent	.	.
DNC013843	4-cyanophenylboronic acid	Discovery agent	.	.
DNC013844	4-nonylphenylboronic acid	Discovery agent	.	.
DNC013845	2-fluorophenylboronic acid	Discovery agent	.	.
DNC013846	2-methoxyphenylboronic acid	Discovery agent	.	.
DNC013847	Benzo[b]thiophen-2-ylboronic acid	Discovery agent	.	.
DNC013848	Benzofuran-2-ylboronic acid	Discovery agent	.	.
DNC013849	6-fluoropyridin-3-ylboronic acid	Discovery agent	.	.
DNC013850	BTNP	Discovery agent	.	.
DNC013851	SUAM-1221	Amnesia	.	F04
DNC013851	SUAM-1221	Discovery agent	.	.
DNC013852	AL- 16082	Discovery agent	.	.
DNC013852	AL- 16082	Glaucoma	365	H40-H42
DNC013853	3-methyl-2(1H)-thioxo-4(3H)-quinazolinone	Discovery agent	.	.
DNC013854	2-Hydrazino-3-methyl-4(3H)-quinazolinone	Discovery agent	.	.
DNC013855	5-(4-Methoxyphenyl)-4-p-tolylisothiazole	Discovery agent	.	.
DNC013856	5-(4-Chlorophenyl)-4-p-tolylisothiazole	Discovery agent	.	.
DNC013857	4-(4-Chlorophenyl)-5-p-tolylisothiazole	Discovery agent	.	.
DNC013858	5-(4-Chlorophenyl)-4-(4-methoxyphenyl)isothiazole	Discovery agent	.	.
DNC013859	4-(4-Chlorophenyl)-5-(4-methoxyphenyl)isothiazole	Discovery agent	.	.
DNC013860	4-(5-(4-Hydroxyphenyl)isothiazol-4-yl)phenol	Discovery agent	.	.
DNC013861	4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiole-3-thione	Discovery agent	.	.
DNC013862	5-(4-Chlorophenyl)-4-p-tolyl-3H-1,2-dithiol-3-one	Discovery agent	.	.
DNC013863	4-(4-Chlorophenyl)-5-p-tolyl-3H-1,2-dithiol-3-one	Discovery agent	.	.
DNC013864	YM-35278	Discovery agent	.	.
DNC013865	Cudraxanthone M	Discovery agent	.	.
DNC013866	Cudraxanthone D	Discovery agent	.	.
DNC013867	Cudratricusxanthone F	Discovery agent	.	.
DNC013868	Cudraxanthone L	Discovery agent	.	.
DNC013869	MACLURAXANTHONE	Discovery agent	.	.
DNC013870	CUDRATRICUSXANTHONE	Discovery agent	.	.
DNC013871	MANGIFERIN	Discovery agent	.	.
DNC013872	IMRECOXIB	Discovery agent	.	.
DNC013873	3-Benzyl-5-methoxy-7-methylchromen-2-one	Discovery agent	.	.
DNC013874	3-Benzyl-5-methoxychromen-2-one	Discovery agent	.	.
DNC013875	2-Benzylbenzo[f]chromen-3-one	Discovery agent	.	.
DNC013876	N-cyclohexylquinazolin-4-amine	Discovery agent	.	.
DNC013877	N-cyclohexylquinolin-4-amine	Discovery agent	.	.
DNC013878	4-(cyclohexyloxy)quinazoline	Discovery agent	.	.
DNC013879	N-(2,3-dihydro-1H-inden-2-yl)quinazolin-4-amine	Discovery agent	.	.
DNC013880	N-(2,3-dihydro-1H-inden-2-yl)isoquinolin-1-amine	Discovery agent	.	.
DNC013881	TINGENONE	Discovery agent	.	.
DNC013882	TINGENIN B	Discovery agent	.	.
DNC013883	TRIPTOCALLINE A	Discovery agent	.	.
DNC013884	SEMIPLENAMIDE A	Discovery agent	.	.
DNC013885	Semiplenamide G	Discovery agent	.	.
DNC013886	SEMIPLENAMIDE B	Discovery agent	.	.
DNC013887	CATECHIN	Discovery agent	.	.
DNC013888	EPICATECHIN	Discovery agent	.	.
DNC013889	EPICATECHIN	Discovery agent	.	.
DNC013890	CYLINDOL A	Discovery agent	.	.
DNC013891	TURBINATINE	Discovery agent	.	.
DNC013892	Zaragozic Acid D2	Discovery agent	.	.
DNC013893	Zaragozic Acid D	Discovery agent	.	.
DNC013894	Zaragozic Acid C	Discovery agent	.	.
DNC013895	ZARAGOZIC ACID B	Discovery agent	.	.
DNC013896	Palodesangren E	Discovery agent	.	.
DNC013897	Palodesangren D	Discovery agent	.	.
DNC013898	Palodesangren C	Discovery agent	.	.
DNC013899	OXENDLONE	Discovery agent	.	.
DNC013900	Aerophobin-1	Discovery agent	.	.
DNC013901	5-{8(Z),11(Z),14-pentadecatrienyl}resorcinol	Discovery agent	.	.
DNC013902	5-{8(Z),-pentadecenyl}resorcinol	Discovery agent	.	.
DNC013903	5-{8(Z),11(Z)-pentadecadienyl}resorcinol	Discovery agent	.	.
DNC013904	1-anilinonaphthalene-8-sulfonic acid	Discovery agent	.	.
DNC013905	FENOFIBRIC ACID	Discovery agent	.	.
DNC013906	KOTALANOL	Discovery agent	.	.
DNC013907	5-(2-(2,5-dimethylphenyl)ethynyl)pyrimidine	Discovery agent	.	.
DNC013908	5-Biphenyl-4-ylethynyl-pyrimidine	Discovery agent	.	.
DNC013909	5-(2-(3,5-difluorophenyl)ethynyl)pyrimidine	Discovery agent	.	.
DNC013910	5-(2-(4-fluoro-3-methylphenyl)ethynyl)pyrimidine	Discovery agent	.	.
DNC013911	5-(2-(3-chlorophenyl)ethynyl)pyrimidine	Discovery agent	.	.
DNC013912	(2S,4R)-4-(3-Methoxy-3-oxopropyl)glutamic Acid	Discovery agent	.	.
DNC013913	2S,4R-4-METHYLGLUTAMATE	Discovery agent	.	.
DNC013914	Domoric acid	Discovery agent	.	.
DNC013915	DIHYDROKAINATE	Discovery agent	.	.
DNC013916	CEPHARANTINE	Discovery agent	.	.
DNC013917	N1,N2-bis(dihydrocaffeoyl)spermine	Discovery agent	.	.
DNC013918	Petrosamine	Discovery agent	.	.
DNC013919	1-phenyl-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013920	1-(thiophen-2-yl)-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013921	1-(benzofuran-2-yl)-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013922	6-(3-aza-bicyclo[3.1.0]hexan-1-yl)quinoline	Discovery agent	.	.
DNC013923	1-(naphthalen-2-yl)-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013924	1-Biphenyl-4-yl-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013925	(cis)-1,6-diphenyl-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013926	6,6-dimethyl-1-phenyl-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013927	1-fluoro-5-phenyl-3-aza-bicyclo[3.1.0]hexane	Discovery agent	.	.
DNC013928	VU0080241	Discovery agent	.	.
DNC013929	FGGFTRKRKSARKLANQ	Discovery agent	.	.
DNC013930	FGGFTGARKRKRKLANQ	Discovery agent	.	.
DNC013931	FGGFTGARKSARKRKNQ	Discovery agent	.	.
DNC013932	FGGFTGARKSARKLARK	Discovery agent	.	.
DNC013933	FGGFTGARKSARKRKRK	Discovery agent	.	.
DNC013934	FGGFTGARKSARKKRNQ	Discovery agent	.	.
DNC013935	FGGFTGARKSARKRRNQ	Discovery agent	.	.
DNC013936	FGGFTGARKSARKKKNQ	Discovery agent	.	.
DNC013937	FGGFTGARKSARKRANQ	Discovery agent	.	.
DNC013938	FGGFTGARKSARKKANQ	Discovery agent	.	.
DNC013939	FGGFTGARKSARKAANQ	Discovery agent	.	.
DNC013940	FGGFTGARKSARKVANQ	Discovery agent	.	.
DNC013941	FGGFTGARKSARKFANQ	Discovery agent	.	.
DNC013942	FGGFTGARKSARKYANQ	Discovery agent	.	.
DNC013943	FGGFTGARKSARKWANQ	Discovery agent	.	.
DNC013944	FGGFTGARKSARKLRNQ	Discovery agent	.	.
DNC013945	FGGFTGARKSARKLKNQ	Discovery agent	.	.
DNC013946	FGGFTGARKSARKLLNQ	Discovery agent	.	.
DNC013947	FGGFTGARKSARKLVNQ	Discovery agent	.	.
DNC013948	FGGFTGARKSARKLFNQ	Discovery agent	.	.
DNC013949	FGGFTGARKSARKLYNQ	Discovery agent	.	.
DNC013950	FGGFTGARKSARKLWNQ	Discovery agent	.	.
DNC013951	TRK-820	Discovery agent	.	.
DNC013952	N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine	Discovery agent	.	.
DNC013953	N-Phenyl-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013954	N-Methyl,N-phenyl-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013955	N-Benzyl-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013956	N-Benzyl,N-methyl-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013957	N-(2-Phenylethyl)-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013958	N-(3-Phenylpropyl)-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013959	N-(4-Phenylbutyl)-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013960	N-(1H-Indol-2-ylmethyl)-N-phenylamine	Discovery agent	.	.
DNC013961	N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine	Discovery agent	.	.
DNC013962	N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine	Discovery agent	.	.
DNC013963	N-((1H-indol-2-yl)methyl)(phenyl)methanamine	Discovery agent	.	.
DNC013964	N-((1H-indol-2-yl)methyl)-2-phenylethanamine	Discovery agent	.	.
DNC013965	N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine	Discovery agent	.	.
DNC013966	N-Phenyl-1-methyl-1H-indole-2-carboxamide	Discovery agent	.	.
DNC013967	(2S,3S)-iodoreboxetine	Discovery agent	.	.
DNC013968	(2R,3R)-iodoreboxetine	Discovery agent	.	.
DNC013969	4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol	Discovery agent	.	.
DNC013970	UCL-1972	Discovery agent	.	.
DNC013971	3,5-dichlorosalicylic acid	Discovery agent	.	.
DNC013972	3-chloro-1-(4-hydroxyphenyl)propan-1-one	Discovery agent	.	.
DNC013973	1,5-bis(4-chlorophenyl)-1H-1,2,3-triazole	Discovery agent	.	.
DNC013974	BMS-561388	Discovery agent	.	.
DNC013975	ISOPILINE	Discovery agent	.	.
DNC013976	NORBOLDINE	Discovery agent	.	.
DNC013977	SECOCULARIDINE	Discovery agent	.	.
DNC013978	COCLAURINE	Discovery agent	.	.
DNC013979	DIMETHYLGRISABINE	Discovery agent	.	.
DNC013980	ANTIOQUINE	Discovery agent	.	.
DNC013981	OBABERINE	Discovery agent	.	.
DNC013982	ISOTETRANDRINE	Discovery agent	.	.
DNC013983	O-methyldauricine	Discovery agent	.	.
DNC013984	HOMOAROMOLINE	Discovery agent	.	.
DNC013985	Quercetin 3-O-neohesperidoside	Discovery agent	.	.
DNC013986	Isorhamnetin 3-O-rhamnoside	Discovery agent	.	.
DNC013987	TENELLONE B	Discovery agent	.	.
DNC013988	TENELLONE A	Discovery agent	.	.
DNC013989	S-sulpho-L-cysteine	Discovery agent	.	.
DNC013990	BUDDLEDIN A	Discovery agent	.	.
DNC013991	ZM-211965	Discovery agent	.	.
DNC013991	ZM-211965	Inflammatory diseases	.	.
DNC013992	CLEMATOMANDSHURICA SAPONIN A	Discovery agent	.	.
DNC013993	CLEMATOMANDSHURICA SAPONIN B	Discovery agent	.	.
DNC013994	VALIOLAMINE	Discovery agent	.	.
DNC013995	Methyl 2-(7-phenylheptanoyl)oxazole-5-carboxylate	Discovery agent	.	.
DNC013996	1-(1,3,4-thiadiazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013997	1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013998	1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one	Discovery agent	.	.
DNC013999	7-Phenyl-1-(pyridazin-3-yl)-heptan-1-one	Discovery agent	.	.
DNC014000	7-Phenyl-1-(1,3,4-thiadiazol-2-yl)-heptan-1-one	Discovery agent	.	.
DNC014001	7-Phenyl-1-(thiazol-2-yl)-heptan-1-one	Discovery agent	.	.
DNC014002	1-(1,2,4-Oxadiazol-3-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014003	1-(1,2,4-Oxadiazol-5-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014004	1-(1,3,4-Oxadiazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014005	7-phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one	Discovery agent	.	.
DNC014006	7-Phenyl-1-(2H-tetrazol-5-yl)-heptan-1-one	Discovery agent	.	.
DNC014007	NSC-270718	Discovery agent	.	.
DNC014008	L-162313	Discovery agent	.	.
DNC014009	L-162782	Discovery agent	.	.
DNC014010	3-hydroxy-N,N,N-trimethylbenzenaminium iodide	Discovery agent	.	.
DNC014011	BW-28C51	Discovery agent	.	.
DNC014012	1-(4-bromooxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014013	1-(4-chlorooxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014014	1-(4-iodooxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014015	1-(4-methyloxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014016	2-(7-phenylheptanoyl)oxazole-4-carbaldehyde	Discovery agent	.	.
DNC014017	Methyl 2-(7-phenylheptanoyl)oxazole-4-carboxylate	Discovery agent	.	.
DNC014018	7-phenyl-1-(4-phenyloxazol-2-yl)heptan-1-one	Discovery agent	.	.
DNC014019	2-(7-phenylheptanoyl)oxazole-4-carboxylic acid	Discovery agent	.	.
DNC014020	2-(7-phenylheptanoyl)oxazole-4-carboxamide	Discovery agent	.	.
DNC014021	2-(7-phenylheptanoyl)oxazole-4-carbonitrile	Discovery agent	.	.
DNC014022	1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014023	1-(4-acetyloxazol-2-yl)-7-phenylheptan-1-one	Discovery agent	.	.
DNC014024	Isopropyl dodecylfluorophosphonate	Discovery agent	.	.
DNC014025	Methyl icosylphosphonofluoridate	Discovery agent	.	.
DNC014026	4-cyanophenyl ethyl dodecylphosphonate	Discovery agent	.	.
DNC014027	Isopropyl 4-nitrophenyl dodecylphosphonate	Discovery agent	.	.
DNC014028	Chlorphrifos oxon	Discovery agent	.	.
DNC014029	Dodecane-1-sulfonyl fluoride	Discovery agent	.	.
DNC014030	Octane-1-sulfonyl fluoride	Discovery agent	.	.
DNC014031	2-tosylbenzene-1,4-diol	Discovery agent	.	.
DNC014032	2-tosylnaphthalene	Discovery agent	.	.
DNC014033	2-(p-tolylthio)naphthalene-1,4-dione	Discovery agent	.	.
DNC014034	D-237	Discovery agent	.	.
DNC014035	PERILLALDEHYDE	Discovery agent	.	.
DNC014036	1,3-dibenzyl urea	Discovery agent	.	.
DNC014037	1-(1-Naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014038	1-(2-Naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014039	(6-Methoxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014040	(6-Ethoxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014041	(6-Propoxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014042	(6-Butoxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014043	(6-Benzyloxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014044	(6-methylthio-2-naphthyl)isopropylamine	Discovery agent	.	.
DNC014045	N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014046	N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane	Discovery agent	.	.
DNC014047	Beta-methoxyamphetamine	Discovery agent	.	.
DNC014048	1-(4-ethoxyphenyl)propan-2-amine	Discovery agent	.	.
DNC014049	1-(4-propoxyphenyl)propan-2-amine	Discovery agent	.	.
DNC014050	1-(4-butoxyphenyl)propan-2-amine	Discovery agent	.	.
DNC014051	1-(4-(benzyloxy)phenyl)propan-2-amine	Discovery agent	.	.
DNC014052	SA-6541	Discovery agent	.	.
DNC014052	SA-6541	Inflammatory diseases	.	.
DNC014053	2-p-tolyl-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014054	2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014055	2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014056	Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate	Discovery agent	.	.
DNC014057	2-(4-chlorophenyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014058	2-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014059	2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014060	2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole	Discovery agent	.	.
DNC014061	2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	Discovery agent	.	.
DNC014062	(4-Quinolin-2-ylpiperazin-1-yl)acetic Acid	Discovery agent	.	.
DNC014063	3-[(6-Methylpyridin-2-yl)ethynyl]benzonitrile	Discovery agent	.	.
DNC014064	N-(6-methylpyridin-2-yl)biphenyl-3-carboxamide	Discovery agent	.	.
DNC014065	N-(6-methylpyridin-2-yl)-6-phenylnicotinamide	Discovery agent	.	.
DNC014066	2-Phenyl-5-(2-methylthiazol-4ylethynyl)pyridine	Discovery agent	.	.
DNC014067	N-methyl-2-(pyridin-2-yl)ethanamine	Discovery agent	.	.
DNC014068	PD-174265	Discovery agent	.	.
DNC014069	PF-915275	Discovery agent	.	.
DNC014069	PF-915275	Non-insulin dependent diabetes	.	E11.9
DNC014070	Triethyl 2-aminopropane-1,2,3-tricarboxylate	Discovery agent	.	.
DNC014071	Tribenzyl 2-aminopropane-1,2,3-tricarboxylate	Discovery agent	.	.
DNC014072	3-Amino-3-(methoxycarbonyl)-1,5-pentandioic acid	Discovery agent	.	.
DNC014073	3-ethoxycarbonylpyroglutamate	Discovery agent	.	.
DNC014074	1-Aminopropane-1,2,3-tricarboxylic acid	Discovery agent	.	.
DNC014075	7-Oxo-7H-dibenzo[de,g]quinoline	Discovery agent	.	.
DNC014076	9-amino-7H-dibenzo[de,h]quinolin-7-one	Discovery agent	.	.
DNC014077	4-(4-(4-Nitrophenyl)thiazol-2-ylamino)phenol	Discovery agent	.	.
DNC014078	3-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol	Discovery agent	.	.
DNC014079	2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol	Discovery agent	.	.
DNC014080	4-(2-Aminothiazol-4-yl)phenol	Discovery agent	.	.
DNC014081	(Z)-2'-des-methyl sulindac sulfide	Discovery agent	.	.
DNC014082	S-p-bromobenzyl glutatione	Discovery agent	.	.
DNC014083	SN-11	Discovery agent	.	.
DNC014084	SN-23	Discovery agent	.	.
DNC014085	SN-28	Discovery agent	.	.
DNC014086	4-(4,5-dihydrothiazol-2-yl)phenyl butylcarbamate	Discovery agent	.	.
DNC014087	4-(1,2,3-thiadiazol-4-yl)phenyl butylcarbamate	Discovery agent	.	.
DNC014088	4-(1,2,3-thiadiazol-4-yl)phenyl hexylcarbamate	Discovery agent	.	.
DNC014089	Cyclohexyl biphenyl-4-ylcarbamate	Discovery agent	.	.
DNC014090	N-alpha-methylhistamine	Discovery agent	.	.
DNC014091	N-Ethyl-2-methylnorapomorphine hydrochloride	Discovery agent	.	.
DNC014092	N-Ethyl-2-phenylnorapomorphine hydrochloride	Discovery agent	.	.
DNC014093	N-Propyl-2-methylnorapomorphine hydrochloride	Discovery agent	.	.
DNC014094	N-Propyl-2-phenylnorapomorphine hydrochloride	Discovery agent	.	.
DNC014095	2,4'-Dimethoxy-5,3'-dipropyl-biphenyl	Discovery agent	.	.
DNC014096	(S)-3-(azetidin-2-ylmethoxy)-2-fluoropyridine	Discovery agent	.	.
DNC014097	SPIROINDANYLOXYMORPHONE	Discovery agent	.	.
DNC014098	EUSYNSTYELAMIDE B	Discovery agent	.	.
DNC014099	Eusynstyelamide C	Discovery agent	.	.
DNC014100	NVP-AEW541	Discovery agent	.	.
DNC014101	(E)-4,4-Dimethyl-1-quinolin-3-yl-pent-1-en-3-one	Discovery agent	.	.
DNC014102	(E)-1-Adamantan-1-yl-3-quinolin-3-yl-propenone	Discovery agent	.	.
DNC014103	(3,4-dimethylphenyl)(4-phenoxyphenyl)methanone	Discovery agent	.	.
DNC014104	FGGFTGARKSARKWRNQ	Discovery agent	.	.
DNC014105	FGGFTGARKSARKWKNQ	Discovery agent	.	.
DNC014106	FGGFTGARKSARKRWNQ	Discovery agent	.	.
DNC014107	FGGFTGARKSARKKWNQ	Discovery agent	.	.
DNC014108	FENBUFEN	Arthritis	710-719	M00-M25
DNC014108	FENBUFEN	Discovery agent	.	.
DNC014109	2beta,3alpha-dihydroxyurs-12-en-28-oic acid	Discovery agent	.	.
DNC014110	2beta,3alpha-dihydroxyolean-12-en-28-oic acid	Discovery agent	.	.
DNC014111	3-(benzo[d]oxazol-2-yl)phenyl propylcarbamate	Discovery agent	.	.
DNC014112	3-(4,5-Dihydrooxazol-2-yl)phenyl propylcarbamate	Discovery agent	.	.
DNC014113	Kojic acid-phenylalanine amide	Discovery agent	.	.
DNC014114	Dimethyl 2,2,2-trifluoro-1-phenylethyl phosphate	Discovery agent	.	.
DNC014115	Diethyl 2,2,2-trifluoro-1-phenylethyl phosphate	Discovery agent	.	.
DNC014116	Dibutyl 2,2,2-trifluoro-1-phenylethyl phosphate	Discovery agent	.	.
DNC014117	5-boronothiophene-2-carboxylic acid	Discovery agent	.	.
DNC014118	Benzo[c][1,2]oxaborol-1(3H)-ol	Discovery agent	.	.
DNC014119	3-boronobenzoic acid	Discovery agent	.	.
DNC014120	Tyr-D-Ala-Gly-NMePhe	Discovery agent	.	.
DNC014121	Beta-funaltrexamine	Discovery agent	.	.
DNC014122	N-(cis-9-cis-12-octadecadienyl)sulfamide	Discovery agent	.	.
DNC014123	{[(9Z)-octadec-9-en-1-yl]sulfamoyl}amine	Discovery agent	.	.
DNC014124	N-octadecyl-N'-propylsulfamide	Discovery agent	.	.
DNC014125	N-(2-adamantyl)-N'-propylsulfamide	Discovery agent	.	.
DNC014126	N-(1-adamantyl)-N'-propylsulfamide	Discovery agent	.	.
DNC014127	H-2',6'-dimethyltyrosine-Tic-Phe-Phe-OH	Discovery agent	.	.
DNC014128	H-Tyr-Tic-Phe-Phe-OH	Discovery agent	.	.
DNC014129	H-2',6'-dimethyltyrosine-Tic-OH	Discovery agent	.	.
DNC014130	H-Tyr-Tic-OH	Discovery agent	.	.
DNC014131	(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine	Discovery agent	.	.
DNC014132	HTyr-Gly-Gly-Phe-Leu-Arg-Arg-lle-Arg-Pro-LysNH2	Discovery agent	.	.
DNC014133	ZYKLOPHIN	Discovery agent	.	.
DNC014134	KATSUMADAIN A	Discovery agent	.	.
DNC014135	(S)-1,7-Diphenyl-6(E)-hepten-3-ol	Discovery agent	.	.
DNC014136	(E,E)-1,7-Diphenyl-4,6-heptadien-3-one	Discovery agent	.	.
DNC014137	(E,E)-5-Hydroxy-1,7-diphenyl-4,6-heptadien-3-one	Discovery agent	.	.
DNC014138	4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one	Discovery agent	.	.
DNC014139	(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile	Discovery agent	.	.
DNC014140	2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide	Discovery agent	.	.
DNC014141	2'-epi-guianin	Discovery agent	.	.
DNC014142	Nectamazin C	Discovery agent	.	.
DNC014143	NEOLIGNAN 9-NOR-7,8-DEHYDRO-ISOLICARIN B	Discovery agent	.	.
DNC014144	OCOPHYLLALS A	Discovery agent	.	.
DNC014145	OCOPHYLLALS B	Discovery agent	.	.
DNC014146	3-Phenyl-2-nortropene	Discovery agent	.	.
DNC014147	3-(4-Fluorophenyl)-2-nortropene	Discovery agent	.	.
DNC014148	3-(4-Chlorophenyl)-2-nortropene	Discovery agent	.	.
DNC014149	3-(4-Trifluoromethylphenyl)-2-nortropene	Discovery agent	.	.
DNC014150	3-(3,4-dichlorophenyl)-2-nortropene	Discovery agent	.	.
DNC014151	3-alpha-Phenylmethoxy-3-beta-phenyl-nortropane	Discovery agent	.	.
DNC014152	2,6-diamino-5-nitrosopyrimidin-4(3H)-one	Discovery agent	.	.
DNC014153	2,6-diamino-5-nitropyrimidin-4(3H)-one	Discovery agent	.	.
DNC014154	2-amino-8-methyl-7,8-dihydropteridin-4(3H)-one	Discovery agent	.	.
DNC014155	5-methoxy-2-(4-(methylsulfonyl)phenyl)-1H-indole	Discovery agent	.	.
DNC014156	3,4-dihydroxybenzaldehyde-O-ethyloxime	Discovery agent	.	.
DNC014157	SRI-224	Discovery agent	.	.
DNC014158	2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide	Discovery agent	.	.
DNC014159	(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine	Discovery agent	.	.
DNC014160	(2R,3S)-2-[(3-Iodophenoxy)phenylmethyl]morpholine	Discovery agent	.	.
DNC014161	(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine	Discovery agent	.	.
DNC014162	S-ATPO	Discovery agent	.	.
DNC014163	4,5,6,7-tetrafluoro-3-methyl-1H-indazole	Discovery agent	.	.
DNC014164	4,5,6,7-tetrafluoro-3-perfluorophenyl-1H-indazole	Discovery agent	.	.
DNC014165	2-Cinnamamido-N4-hexyl-N1-hydroxysuccinamide	Discovery agent	.	.
DNC014166	2-Cinnamamido-N1-hydroxy-N4-octylsuccinamide	Discovery agent	.	.
DNC014167	2-Cinnamamido-N1-hydroxy-N4-pentylsuccinamide	Discovery agent	.	.
DNC014168	N4-Butyl-2-cinnamamido-N1-hydroxysuccinamide	Discovery agent	.	.
DNC014169	Physostigmine salicylate	Discovery agent	.	.
DNC014170	3alpha-(2'-Indolecarbonyloxy)-nortropane	Discovery agent	.	.
DNC014171	3alpha-(1'-Methyl-2'-Indolecarbonyloxy)-tropane	Discovery agent	.	.
DNC014172	RHODIOLININ	Discovery agent	.	.
DNC014173	HERBACETIN	Discovery agent	.	.
DNC014174	KNT-62	Discovery agent	.	.
DNC014175	KNT-63	Discovery agent	.	.
DNC014176	PIPERINE	Discovery agent	.	.
DNC014176	PIPERINE	Vitiligo	709.01	L80
DNC014177	Methyl piperate	Discovery agent	.	.
DNC014178	MF-438	Discovery agent	.	.
DNC014178	MF-438	Metabolic disorders	.	E70-E90
DNC014179	7,8,4'-trihydroxyisoflavone	Discovery agent	.	.
DNC014180	7,3',4'-trihydroxyisoflavone	Discovery agent	.	.
DNC014181	4-Benzoxazo-2-yl-1,4-diazabicyclo[3.2.2]nonane	Discovery agent	.	.
DNC014182	2-(4-(methylsulfonyl)phenyl)-3-phenylquinoline	Discovery agent	.	.
DNC014183	4-Nitrophenyl 4-Benzylpiperazine-1-carboxylate	Discovery agent	.	.
DNC014184	1-[(Furan-2(5H)-one)-4-methyl]-desloratadine	Discovery agent	.	.
DNC014185	4-(2,6-diamino-9H-purin-8-yl)-2,6-dimethoxyphenol	Discovery agent	.	.
DNC014186	9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide	Discovery agent	.	.
DNC014187	9-O-[3-(Phenylol-1-yloxy)propyl]berberine bromide	Discovery agent	.	.
DNC014188	9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide	Discovery agent	.	.
DNC014189	9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide	Discovery agent	.	.
DNC014190	9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide	Discovery agent	.	.
DNC014191	KNT-5	Discovery agent	.	.
DNC014192	Isosorbide-di-(4-nitrophenyl carbamate)	Discovery agent	.	.
DNC014193	Isosorbide-di-phenylcarbamate	Discovery agent	.	.
DNC014194	DAEDALIN A	Discovery agent	.	.
DNC014195	(+/-)-Daedalin A	Discovery agent	.	.
DNC014196	LM-4108	Discovery agent	.	.
DNC014197	2-(Biphenyl-3-ylthio)-N,N-dimethylethanamine	Discovery agent	.	.
DNC014198	2-(3-Bromophenylthio)-N,N-dimethylethanamine	Discovery agent	.	.
DNC014199	SC-558	Discovery agent	.	.
DNC014200	IODOSUPROFEN	Discovery agent	.	.
DNC014201	IODOINDOMETHACIN	Discovery agent	.	.
DNC014202	3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid	Discovery agent	.	.
DNC014203	4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid	Discovery agent	.	.
DNC014204	2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid	Discovery agent	.	.
DNC014205	PSB-0952	Discovery agent	.	.
DNC014206	2-Chloro-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014207	2-Bromo-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014208	4-Chloro-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014209	6-Fluoro-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014210	6-Chloro-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014211	6-Hydroxy-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014212	5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide	Discovery agent	.	.
DNC014213	2-Chloro-N-(3-morpholinopropyl)nicotinamide	Discovery agent	.	.
DNC014214	4-Chloro-N-(3-morpholinopropyl)nicotinamide	Discovery agent	.	.
DNC014215	6-Chloro-N-(3-morpholinopropyl)nicotinamide	Discovery agent	.	.
DNC014216	5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide	Discovery agent	.	.
DNC014217	2-Bromo-N-(3-morpholinopropyl)nicotinamide	Discovery agent	.	.
DNC014218	(+/-)-2-Phenylthiomorpholine	Discovery agent	.	.
DNC014219	(+/-)-2-Phenylthiomorpholin-5-one	Discovery agent	.	.
DNC014220	(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one	Discovery agent	.	.
DNC014221	INFRACTOPICRIN	Discovery agent	.	.
DNC014222	10-Hydroxy-infractopicrin	Discovery agent	.	.
DNC014223	H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-OH	Discovery agent	.	.
DNC014224	H-Ala-Pro-Phe-Phe-NH2	Discovery agent	.	.
DNC014225	H-Tyr-Ala-Phe-Phe-NH2	Discovery agent	.	.
DNC014226	H-Tyr-Pro-Phe-Ala-NH2	Discovery agent	.	.
DNC014227	H-Tyr-Pro-Phe-Phe-OH	Discovery agent	.	.
DNC014228	H-Pro-Phe-Phe-NH2	Discovery agent	.	.
DNC014229	H-Phe-Phe-NH2	Discovery agent	.	.
DNC014230	H-Phe-NH2	Discovery agent	.	.
DNC014231	Ac-Phe-Phe-NH2	Discovery agent	.	.
DNC014232	(L)-Phe-(D)-Phe-NH2	Discovery agent	.	.
DNC014233	(D)-Phe-(D)-Phe-NH2	Discovery agent	.	.
DNC014234	(D)-Phe-(L)-Phe-NH2	Discovery agent	.	.
DNC014235	H-Leu-Phe-NH2	Discovery agent	.	.
DNC014236	H-Tyr(OMe)-Phe(2-Me)-NH2	Discovery agent	.	.
DNC014237	(-)-Discorhabdin Z	Discovery agent	.	.
DNC014238	N-(3-(3-cyanobenzamido)phenyl)-2-methoxybenzamide	Discovery agent	.	.
DNC014239	2-chloro-N-(3-(3-chlorobenzamido)phenyl)benzamide	Discovery agent	.	.
DNC014240	3-chloro-N-(3-isobutyramidophenyl)benzamide	Discovery agent	.	.
DNC014241	N-(3-acetamidophenyl)-3-chlorobenzamide	Discovery agent	.	.
DNC014242	MOLASSAMIDE	Discovery agent	.	.
DNC014243	Lithospermic acid	Discovery agent	.	.
DNC014244	Clinopodic acid C	Discovery agent	.	.
DNC014245	2-N-Methylamino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC014246	2-N-Ethylamino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC014247	2-N-Allylamino-1-(4-methylthiophenyl)propan	Discovery agent	.	.
DNC014248	2-N-Propargylamino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC014249	2-N,N-Dimethylamino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC014250	2-N-Hydroxyamino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC014251	2-N-Methoxyamino-1-(4-methylthiophenyl)propane	Discovery agent	.	.
DNC014252	2-Amino-1-(4-ethylthiophenyl)propane	Discovery agent	.	.
DNC014253	1-(4-Benzylsulfanyl-phenyl)-propylamine	Discovery agent	.	.
DNC014254	1-Methyl-2-(4-phenylsulfanyl-phenyl)-ethylamine	Discovery agent	.	.
DNC014255	2-N-Methylamino-1-(4-ethylthiophenyl)propane	Discovery agent	.	.
DNC014256	2-N-Ethylamino-1-(4-ethylthiophenyl)propane	Discovery agent	.	.
DNC014257	2-N-Hydroxyamino-1-(4-ethylthiophenyl)propane	Discovery agent	.	.
DNC014258	2-Amino-1-(4-ethylthiophenyl)butane	Discovery agent	.	.
DNC014259	2-N-Ethylamino-1-(4-ethylthiophenyl)butane	Discovery agent	.	.
DNC014260	2-N-Hydroxyamino-1-(4-ethylthiophenyl)butane	Discovery agent	.	.
DNC014261	2-Amino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014262	2-N-Methylamino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014263	2-N-Ethylamino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014264	2-N-(n-Propyl)amino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014265	2-N-(Isopropyl)amino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014266	2-N-Cyclopropylamino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014267	2-N-Propargylamino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014268	2-N-Hydroxyamino-1-(4-methylthiophenyl)butane	Discovery agent	.	.
DNC014269	LOMERIZINE	Discovery agent	.	.
DNC014270	1-benzhydryl-4-(3,3-diphenylpropyl)piperazine	Discovery agent	.	.
DNC014271	1-benzhydryl-4-(4,4-diphenylbutyl)piperazine	Discovery agent	.	.
DNC014272	NP-118809	Discovery agent	.	.
DNC014272	NP-118809	Pain	338,780	R52, G89
DNC014273	N,4-dibenzhydrylpiperazine-1-carboxamide	Discovery agent	.	.
DNC014274	3-(6-fluoroquinazolin-4-ylamino)benzonitrile	Discovery agent	.	.
DNC014275	6-fluoro-N-m-tolylquinazolin-4-amine	Discovery agent	.	.
DNC014276	N-(3-bromophenyl)-6-fluoroquinazolin-4-amine	Discovery agent	.	.
DNC014277	4-(3-bromophenoxy)-6-chloroquinazoline	Discovery agent	.	.
DNC014278	7-bromo-N-(3-bromophenyl)isoquinolin-1-amine	Discovery agent	.	.
DNC014279	N-(3-bromophenyl)-6-chloroquinazolin-4-amine	Discovery agent	.	.
DNC014280	N-(3-chlorophenyl)-6-methoxyquinazolin-4-amine	Discovery agent	.	.
DNC014281	N-(3-chlorophenyl)-6-nitroquinazolin-4-amine	Discovery agent	.	.
DNC014282	N-(3-chlorophenyl)-6-fluoroquinazolin-4-amine	Discovery agent	.	.
DNC014283	6-bromo-N-m-tolylquinazolin-4-amine	Discovery agent	.	.
DNC014284	6-bromo-N-(3-bromophenyl)quinazolin-4-amine	Discovery agent	.	.
DNC014285	6-bromo-N-(3-fluorophenyl)quinazolin-4-amine	Discovery agent	.	.
DNC014286	6-bromo-N-(3-chlorophenyl)quinazolin-4-amine	Discovery agent	.	.
DNC014287	2-isooleanolic acid	Discovery agent	.	.
DNC014288	2-isoursolic acid	Discovery agent	.	.
DNC014289	2-Oxoolean-12-en-28-oic acid	Discovery agent	.	.
DNC014290	Benzyl 2-hydroxyiminoolean-12-en-28-oate	Discovery agent	.	.
DNC014291	2-Hydroxyiminoolean-12-en-28-oic acid	Discovery agent	.	.
DNC014292	2-Hydroxyiminours-12-en-28-oic acid	Discovery agent	.	.
DNC014293	2alpha-Hydroxyolean-12-en-28-oic acid	Discovery agent	.	.
DNC014294	2alpha-Hydroxyurs-12-en-28-oic acid	Discovery agent	.	.
DNC014295	Ethyl 2beta-hydroxyolean-12-en-28-oate	Discovery agent	.	.
DNC014296	N-Butyl 2beta-hydroxyolean-12-en-28-oate	Discovery agent	.	.
DNC014297	PALBINONE	Discovery agent	.	.
DNC014298	(-)-uniflorine A	Discovery agent	.	.
DNC014299	UNIFLORINE B	Discovery agent	.	.
DNC014300	3,5-di(pyridin-4-yl)-1H-1,2,4-triazole	Discovery agent	.	.
DNC014301	3,4'-(1H-1,2,4-triazole-3,5-diyl)dipyridine	Discovery agent	.	.
DNC014302	3,5-bis(2-methylpyridin-4-yl)-1H-1,2,4-triazole	Discovery agent	.	.
DNC014303	1-aminobutylphosphonic acid	Discovery agent	.	.
DNC014304	1-aminohexylphosphonic acid	Discovery agent	.	.
DNC014305	1-aminopentylphosphonic acid monophenyl ester	Discovery agent	.	.
DNC014306	1-aminohexylphosphonic acid monophenyl ester	Discovery agent	.	.
DNC014307	3-Benzyl-2-ethylthio-6-nitro-quinazolin-4(3H)-one	Discovery agent	.	.
DNC014308	3-benzyl-2-mercapto-6-nitroquinazolin-4(3H)-one	Discovery agent	.	.
DNC014309	[Leu5]enkephalin	Discovery agent	.	.
DNC014310	3-(2-Diethylamino-acetamino)-rutaecarpine	Discovery agent	.	.
DNC014311	3-(2-N-Pyrrolyl-acetamino)-rutaecarpine	Discovery agent	.	.
DNC014312	3-(2-N-Piperidyl-acetamino)-rutaecarpine	Discovery agent	.	.
DNC014313	3-(2-Diethylamino-propionamino)-rutaecarpine	Discovery agent	.	.
DNC014314	3-(2-N-Pyrrolyl-propionamino)-rutaecarpine	Discovery agent	.	.
DNC014315	3-(2-N-Piperidyl-propionamino)-rutaecarpine	Discovery agent	.	.
DNC014316	N-(4-hydroxyphenylpropanyl)-spermine	Discovery agent	.	.
DNC014317	Philanthotoxin-343	Discovery agent	.	.
DNC014318	Argiotoxin-636	Discovery agent	.	.
DNC014319	ERITADENINE	Discovery agent	.	.
DNC014320	Y-29794	Discovery agent	.	.
DNC014321	9-Ethyl-beta-carboline	Discovery agent	.	.
DNC014322	2-Propyl-beta-carboline-2-ium iodide	Discovery agent	.	.
DNC014323	9-Ethyl-2-methyl-beta-carboline-2-ium iodide	Discovery agent	.	.
DNC014324	9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline	Discovery agent	.	.
DNC014325	9-[5-(beta-Carboline-9-yl)pentyl]-beta-carboline	Discovery agent	.	.
DNC014326	4',4-Dihydroxychalcone	Discovery agent	.	.
DNC014327	4'-Amino-4-hydroxychalcone	Discovery agent	.	.
DNC014328	4'-(4-Nitrobenzensulfonamide)-4-hydroxychalcone	Discovery agent	.	.
DNC014329	4'-(p-Toluenesulfonamide)-4-hydroxychalcone	Discovery agent	.	.
DNC014330	4'-(Benzensulfonamide)-4-hydroxychalcone	Discovery agent	.	.
DNC014331	4'-(4-Aminobenzensulfonamide)-4-hydroxychalcone	Discovery agent	.	.
DNC014332	4'-(4-Fluorobenzensulfonamide)-4-hydroxychalcone	Discovery agent	.	.
DNC014333	2-AMINO-3-(4-HYDROXY-1,2,5-OXADIAZOL-3-YL)PROPIONIC ACID (STRUCTURAL MIX)	Discovery agent	.	.
DNC014334	O7-Nitrooxyethyl chrysin	Discovery agent	.	.
DNC014335	O5-Acetyl-O7-nitrooxyethyl chrysin	Discovery agent	.	.
DNC014336	6-Benzylthioinosine	Discovery agent	.	.
DNC014337	MEBUDIPINE	Discovery agent	.	.
DNC014338	DEMETHYLMEDICARPIN	Discovery agent	.	.
DNC014339	ISONEORAUTENOL	Discovery agent	.	.
DNC014340	Eryvarin D	Discovery agent	.	.
DNC014341	Erythribyssin O	Discovery agent	.	.
DNC014342	CALOPOCARPIN	Discovery agent	.	.
DNC014343	Erythribyssin L	Discovery agent	.	.
DNC014344	Cristacarpin	Discovery agent	.	.
DNC014345	PHASEOLLIDIN	Discovery agent	.	.
DNC014346	ERYSTAGALLIN A	Discovery agent	.	.
DNC014347	2-Benzoxy-5-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC014348	5-Chloro-2-(2-methylquinolin-7-yl)benzonitrile	Discovery agent	.	.
DNC014349	5-(2-Methylquinolin-7-yl)-2-phenylbenzonitrile	Discovery agent	.	.
DNC014350	5-((6-Methylpyridin-2-yl)ethynyl)nicotinonitrile	Discovery agent	.	.
DNC014351	5-(2-Methylquinolin-7-yl)-2-phenylnicotinonitrile	Discovery agent	.	.
DNC014352	2-Chloro-5-(2-methylquinolin-7-yl)nicotinonitrile	Discovery agent	.	.
DNC014353	PHASEOLIN	Discovery agent	.	.
DNC014354	Erysubin D	Discovery agent	.	.
DNC014355	Erythribyssin D	Discovery agent	.	.
DNC014356	Erythribyssin M	Discovery agent	.	.
DNC014357	1-D-glucopyranosyl uracil	Discovery agent	.	.
DNC014358	1-D-glucopyranosyl cytosine	Discovery agent	.	.
DNC014359	(+/-)-2-Amino-1,2,3,4-tetrahydro-2-naphthoic acid	Discovery agent	.	.
DNC014360	(+/-)-2-Aminoindane-2-carboxylic acid	Discovery agent	.	.
DNC014361	N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine	Discovery agent	.	.
DNC014362	N-benzyl-2-morpholinopyrimidin-4-amine	Discovery agent	.	.
DNC014363	N-benzyl-2-thiomorpholinopyrimidin-4-amine	Discovery agent	.	.
DNC014364	N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine	Discovery agent	.	.
DNC014365	2-morpholino-N-phenethylpyrimidin-4-amine	Discovery agent	.	.
DNC014366	9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide	Discovery agent	.	.
DNC014367	9-O-[3-(4-Nitro-phenoxyl)butyl]-berberine bromide	Discovery agent	.	.
DNC014368	9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide	Discovery agent	.	.
DNC014369	9-O-[3-(Phenylamino)propyl]-berberine bromide	Discovery agent	.	.
DNC014370	1,2-Di(berberine-9-O-yl)ethane dibromide	Discovery agent	.	.
DNC014371	1,3-Di(berberine-9-O-yl)ethane dibromide	Discovery agent	.	.
DNC014372	1,4-Di(berberine-9-O-yl)ethane dibromide	Discovery agent	.	.
DNC014373	Ac-[CFWKYC]-NH2	Discovery agent	.	.
DNC014374	Ac-SFWKYS-NH2	Discovery agent	.	.
DNC014375	Ac-FWKY-NH2	Discovery agent	.	.
DNC014376	Ac-WKY-NH2	Discovery agent	.	.
DNC014377	Ac-[CfWKYC]-NH2	Discovery agent	.	.
DNC014378	Ac-[CFwKYC]-NH2	Discovery agent	.	.
DNC014379	Ac-[CFWkYC]-NH2	Discovery agent	.	.
DNC014380	Ac-[CFWKyC]-NH2	Discovery agent	.	.
DNC014381	Ac-[CFWKFC]-NH2	Discovery agent	.	.
DNC014382	AGTAD[CFWKYC]V	Discovery agent	.	.
DNC014383	NSC-40331	Discovery agent	.	.
DNC014384	NSC-89508	Discovery agent	.	.
DNC014385	SOPHORICOSIDE	Discovery agent	.	.
DNC014386	5,5'-methylenebis(1,3,4-thiadiazole-2(3H)-thione)	Discovery agent	.	.
DNC014387	5-phenyl-1,3,4-thiadiazole-2(3H)-thione	Discovery agent	.	.
DNC014388	5-(pyridin-4-yl)-1,3,4-thiadiazole-2(3H)-thione	Discovery agent	.	.
DNC014389	2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione	Discovery agent	.	.
DNC014390	5-benzhydryl-1,3,4-thiadiazole-2(3H)-thione	Discovery agent	.	.
DNC014391	5-(4-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014392	5-benzyl-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014393	5,5'-methylenebis(1,3,4-oxadiazole-2(3H)-thione)	Discovery agent	.	.
DNC014394	5-cyclohexyl-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014395	5-phenyl-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014396	5-benzhydryl-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014397	5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014398	5-(3-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione	Discovery agent	.	.
DNC014399	2-mercaptophenylphosphonic acid	Discovery agent	.	.
DNC014400	Diisopropyl 2-(sulfanylmethyl)phenylphosphonate	Discovery agent	.	.
DNC014401	2-(Sulfanylmethyl)phenylphosphonic acid	Discovery agent	.	.
DNC014402	Diisopropyl 1-mercaptopropylphosphonate	Discovery agent	.	.
DNC014403	Alpha-Sulfanylpropylphosphonic acid	Discovery agent	.	.
DNC014404	Diisopropyl mercapto(phenyl)methylphosphonate	Discovery agent	.	.
DNC014405	Alpha-Sulfanylbenzylphosphonic acid	Discovery agent	.	.
DNC014406	Alpha-Sulfanyl(2,4-dichlorobenzyl)phosphonic acid	Discovery agent	.	.
DNC014407	Alpha-Sulfanyl(2-methoxybenzyl)phosphonic acid	Discovery agent	.	.
DNC014408	Alpha-Sulfanyl(4-bromobenzyl)phosphonic acid	Discovery agent	.	.
DNC014409	Alpha-Sulfanyl(4-fluorobenzyl)phosphonic acid	Discovery agent	.	.
DNC014410	4-phospho-D-erythronate	Discovery agent	.	.
DNC014411	1,6-bis(4-(pyridin-2-yl)piperazin-1-yl)hexane	Discovery agent	.	.
DNC014412	3-cyano-N-(3-ethylphenyl)-5-fluorobenzamide	Discovery agent	.	.
DNC014413	3-cyano-N-(3-ethynylphenyl)-5-fluorobenzamide	Discovery agent	.	.
DNC014414	3-cyano-N-(3-cyanophenyl)-5-fluorobenzamide	Discovery agent	.	.
DNC014415	3-cyano-5-fluoro-N-m-tolylbenzamide	Discovery agent	.	.
DNC014416	N-(3-chlorophenyl)-3-cyano-5-fluorobenzamide	Discovery agent	.	.
DNC014417	3-cyano-5-fluoro-N-(3-fluorophenyl)benzamide	Discovery agent	.	.
DNC014418	3-cyano-5-fluoro-N-phenylbenzamide	Discovery agent	.	.
DNC014419	3-cyano-N-(6-ethylpyridin-2-yl)-5-fluorobenzamide	Discovery agent	.	.
DNC014420	3-cyano-5-fluoro-N-(pyridin-2-yl)benzamide	Discovery agent	.	.
DNC014421	3-(Aminooxy)propan-1-amine hydrochloride	Discovery agent	.	.
DNC014422	1-Amino-3-(aminoxy)-2-propanol Dihydrochloride	Discovery agent	.	.
DNC014423	VU10007	Discovery agent	.	.
DNC014424	VU10010	Discovery agent	.	.
DNC014425	HELENAQUINONE	Discovery agent	.	.
DNC014426	SMEATHXANTHONE A	Discovery agent	.	.
DNC014427	GARTANIN	Discovery agent	.	.
DNC014428	MANGOSTENONE G	Discovery agent	.	.
DNC014429	MANGOSTIN	Discovery agent	.	.
DNC014430	MANGOSTANIN	Discovery agent	.	.
DNC014431	MANGOSTANOL	Discovery agent	.	.
DNC014432	8-DEOXYGARTANIN	Discovery agent	.	.
DNC014433	MANGOSTENONE F	Discovery agent	.	.
DNC014434	NALFURAFINE	Discovery agent	.	.
DNC014435	ALLICIN	Discovery agent	.	.
DNC014436	S-propyl propane-1-sulfinothioate	Discovery agent	.	.
DNC014437	S-benzyl phenylmethanesulfinothioate	Discovery agent	.	.
DNC014438	S-isopentyl 3-methylbutane-1-sulfinothioate	Discovery agent	.	.
DNC014439	S-hexyl hexane-1-sulfinothioate	Discovery agent	.	.
DNC014440	Ethyl octylfluorophosphonate	Discovery agent	.	.
DNC014441	1-(4-(methylsulfonyl)phenyl)-1H-indole	Discovery agent	.	.
DNC014442	1-(4-(methylsulfonyl)phenyl)-1H-pyrrole	Discovery agent	.	.
DNC014443	4-fluoro-N-(4-(methylsulfonyl)phenyl)aniline	Discovery agent	.	.
DNC014444	2-(4-(methylsulfonyl)phenyl)pyridine	Discovery agent	.	.
DNC014445	Furan-3-yl(4-(methylsulfonyl)phenyl)methanone	Discovery agent	.	.
DNC014446	2-(p-Methylsulfonylbenzoyl)furan	Discovery agent	.	.
DNC014447	TWS-119	Discovery agent	.	.
DNC014448	(+/-)-threo-N-(3-Phenylpropyl)ritalinol	Discovery agent	.	.
DNC014449	(+/-)-threo-N-Propargylmethylphenidate	Discovery agent	.	.
DNC014450	(+/-)-threo-N-(4-Phenylbutyl)ritalinol	Discovery agent	.	.
DNC014451	(+/-)-threo-N-(2-Phenylethyl)ritalinol	Discovery agent	.	.
DNC014452	(+/-)-threo-N-(3-Phenylpropyl)methylphenidate	Discovery agent	.	.
DNC014453	(+/-)-threo-N-(3-Chlorobenzyl)methylphenidate	Discovery agent	.	.
DNC014454	(+/-)-threo-N-(2-Phenylethyl)methylphenidate	Discovery agent	.	.
DNC014455	(+/-)-threo-N-(4-Phenylbutyl)methylphenidate	Discovery agent	.	.
DNC014456	(+/-)-threo-N-(5-Phenylpentyl)methylphenidate	Discovery agent	.	.
DNC014457	(+/-)-threo-N-(6-Phenylhexyl)methylphenidate	Discovery agent	.	.
DNC014458	(+/-)-threo-N-(2-Chlorobenzyl)methylphenidate	Discovery agent	.	.
DNC014459	(+/-)-threo-N-Allylmethylphenidate	Discovery agent	.	.
DNC014460	(+/-)-threo-N-(4-Chlorobenzyl)methylphenidate	Discovery agent	.	.
DNC014461	(+/-)-threo-N-(4-Nitrobenzyl)methylphenidate	Discovery agent	.	.
DNC014462	(+/-)-threo-N-(4-Methoxybenzyl)methylphenidate	Discovery agent	.	.
DNC014463	(+/-)-threo-N-(2-Methylpyridine)methylphenidate	Discovery agent	.	.
DNC014464	(+/-)-threo-N-(3-Methylpyridine)methylphenidate	Discovery agent	.	.
DNC014465	(+/-)-threo-N-(4-Methylpyridine)methylphenidate	Discovery agent	.	.
DNC014466	(+/-)-threo-N-(2-Methylfuran)methylphenidate	Discovery agent	.	.
DNC014467	(+/-)-threo-N-(3-Methylthiopene)methylphenidate	Discovery agent	.	.
DNC014468	(+/-)-threo-N-(2-Methylthiopene)methylphenidate	Discovery agent	.	.
DNC014469	(+/-)-threo-N-(3-Methylfuran)methylphenidate	Discovery agent	.	.
DNC014470	(+/-)-threo-N-Ethylritalinol	Discovery agent	.	.
DNC014471	(+/-)-threo-3',5'-Dimethylmethylphenidate	Discovery agent	.	.
DNC014472	(+/-)-threo-3',5'-Dichloromethylphenidate	Discovery agent	.	.
DNC014473	(+/-)-threo-N-3-Chlorobenzylmethylphenidate	Discovery agent	.	.
DNC014474	N-Benzylmethylphenidate	Discovery agent	.	.
DNC014475	(+/-)-threo-Ritalinol	Discovery agent	.	.
DNC014476	DEXMETHYLPHENIDATE	Discovery agent	.	.
DNC014477	(+/-)-threo-3-Fluororitalinol	Discovery agent	.	.
DNC014478	(+/-)-threo-3',4'-Dichlororitalinol	Discovery agent	.	.
DNC014479	(+/-)-threo-3',4'-Dichlororitalinol methyl ether	Discovery agent	.	.
DNC014480	(+/-)-threo-N-Benzyl-3'-chloromethylphenidate	Discovery agent	.	.
DNC014481	(+/-)-threo-N-Benzylmethylphenidate amide	Discovery agent	.	.
DNC014482	(+/-)-threo-Ritalinol methyl ether	Discovery agent	.	.
DNC014483	(+/-)-threo-N-Benzyl-3',4'-dichlororitalinol	Discovery agent	.	.
DNC014484	(+/-)-threo-3',4'-Dichloromethylphenidate amide	Discovery agent	.	.
DNC014485	(+/-)-threo-N-Methyl-30-methylmethylphenidate	Discovery agent	.	.
DNC014486	(+/-)-threo-Benzylphenidate	Discovery agent	.	.
DNC014487	(+/-)-threo-Ritalinol acetate	Discovery agent	.	.
DNC014488	(+/-)-threo-Methylphenidate amide	Discovery agent	.	.
DNC014489	(+/-)-threo-4'-Ethylmethylphenidate	Discovery agent	.	.
DNC014490	ACULEACIN A	Discovery agent	.	.
DNC014491	CORONARIDINE	Discovery agent	.	.
DNC014492	VOACANGINE	Discovery agent	.	.
DNC014493	Pseudocolumbamine trifluoroacetate	Discovery agent	.	.
DNC014494	Palmatine trifluoroacetate	Discovery agent	.	.
DNC014495	Pseudopalmatine trifluoroacetate	Discovery agent	.	.
DNC014496	LYSICAMINE	Discovery agent	.	.
DNC014497	2-(ethylthiomethyl)-5-hydroxy-4H-pyran-4-one	Discovery agent	.	.
DNC014498	5-hydroxy-2-(propylthiomethyl)-4H-pyran-4-one	Discovery agent	.	.
DNC014499	2-(butylthiomethyl)-5-hydroxy-4H-pyran-4-one	Discovery agent	.	.
DNC014500	5-hydroxy-2-(pentylthiomethyl)-4H-pyran-4-one	Discovery agent	.	.
DNC014501	2-(hexylthiomethyl)-5-hydroxy-4H-pyran-4-one	Discovery agent	.	.
DNC014502	2-(heptylthiomethyl)-5-hydroxy-4H-pyran-4-one	Discovery agent	.	.
DNC014503	2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one	Discovery agent	.	.
DNC014504	5,5'-methylenebis(3,4-dibromobenzene-1,2-diol)	Discovery agent	.	.
DNC014505	Bis(2,3-dibromo-4,5-dihydroxyphenyl)ether	Discovery agent	.	.
DNC014506	Bis(3-bromo-4,5-dihydroxyphenyl)methanone	Discovery agent	.	.
DNC014507	2,2',3-Tribromo-4,4',5,5'-tetrahydroxybibenzyl	Discovery agent	.	.
DNC014508	N-Phenylbenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014509	N-(4-Ethylphenyl)benzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014510	5-Chloro-N-phenylbenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014511	5-Chloro-N-(4-ethylphenyl)benzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014512	5-Methyl-N-phenylbenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014513	N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014514	N-(2-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014515	5-Methoxy-N-phenylbenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014516	N-(3-Bromophenyl)-5-methoxybenzo[d]oxazol-2-amine	Discovery agent	.	.
DNC014517	N-(3-(aminomethyl)-benzyl)acetamidine	Discovery agent	.	.
DNC014518	4-[(2-Methyl-1H-imidazol-1-yl)methyl]pyridine	Discovery agent	.	.
DNC014519	(+/-)-2-Methyl-1-(1-phenylethyl)-1H-imidazole	Discovery agent	.	.
DNC014520	1-Benzyl-2-methyl-1H-imidazole	Discovery agent	.	.
DNC014521	1-[(3-Methoxybenzyl)amino]ethaniminium chloride	Discovery agent	.	.
DNC014522	1-(Benzhydrylamino)ethaniminium bromide	Discovery agent	.	.
DNC014523	OSELTAMIVIR ACID	Discovery agent	.	.
DNC014524	ACH-702	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNC014524	ACH-702	Discovery agent	.	.
DNC014525	2-hydroxy-3-isopropyl-2,4,6-cycloheptatrien-1-one	Discovery agent	.	.
DNC014526	HINOKITIOL	Discovery agent	.	.
DNC014527	2-hydroxy-5-isopropyl-2,4,6-cycloheptatrien-1-one	Discovery agent	.	.
DNC014528	2-(Phenylsulfonamido)acetic Acid	Discovery agent	.	.
DNC014529	MESUAGENIN A	Discovery agent	.	.
DNC014530	MESUAGENIN B	Discovery agent	.	.
DNC014531	Mesuagenin D	Discovery agent	.	.
DNC014532	FLUOXETINE HYDROCHLORIDE	Discovery agent	.	.
DNC014533	TENIDAP	Discovery agent	.	.
DNC014533	TENIDAP	Rheumatold arthritis	.	M05-M06
DNC014534	(E)-2-(4-(methylsulfonyl)styryl)furan	Discovery agent	.	.
DNC014535	(E)-2-(4-(methylsulfonyl)styryl)thiophene	Discovery agent	.	.
DNC014536	(E)-3-(4-(methylsulfonyl)styryl)thiophene	Discovery agent	.	.
DNC014537	(E)-4-(2-(furan-2-yl)vinyl)benzenesulfonamide	Discovery agent	.	.
DNC014538	(E)-4-(2-(thiophen-2-yl)vinyl)benzenesulfonamide	Discovery agent	.	.
DNC014539	(E)-4-(2-(thiophen-3-yl)vinyl)benzenesulfonamide	Discovery agent	.	.
DNC014540	GNF-PF-1399	Discovery agent	.	.
DNC014541	EUPAFOLIN	Discovery agent	.	.
DNC014542	THIOCOLCHICINE	Discovery agent	.	.
DNC014543	PITRAZEPINE	Discovery agent	.	.
DNC014544	2-(2-Iodo-phenyl)-benzo[d][1,3]oxazin-4-one	Discovery agent	.	.
DNC014545	2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol	Discovery agent	.	.
DNC014546	L-708474	Discovery agent	.	.
DNC014547	(3-Amino-1-hydroxy-propyl)-methyl-phosphinic acid	Discovery agent	.	.
DNC014548	CR-1795	Discovery agent	.	.
DNC014549	CGP-35582	Discovery agent	.	.
DNC014550	CGP-36216	Discovery agent	.	.
DNC014551	(R)-4-Amino-3-(4-chloro-phenyl)-butyric acid	Discovery agent	.	.
DNC014552	CR-2345	Discovery agent	.	.
DNC014553	((Z)-3-Amino-propenyl)-methyl-phosphinic acid	Discovery agent	.	.
DNC014554	CGP-34938	Discovery agent	.	.
DNC014555	CGP-35024	Discovery agent	.	.
DNC014556	(3-Amino-propyl)-phosphonic acid	Discovery agent	.	.
DNC014557	(3-Amino-1-ethyl-propyl)-methyl-phosphinic acid	Discovery agent	.	.
DNC014558	((E)-3-Amino-propenyl)-methyl-phosphinic acid	Discovery agent	.	.
DNC014559	(3-Amino-propyl)-hydroxymethyl-phosphinic acid	Discovery agent	.	.
DNC014560	(3-Amino-propyl)-difluoromethyl-phosphinic acid	Discovery agent	.	.
DNC014561	N,N'-Di-acenaphthen-5-yl-guanidine	Discovery agent	.	.
DNC014562	L-740093	Discovery agent	.	.
DNC014563	3,3-Dimethyl-dihydro-furan-2-one	Discovery agent	.	.
DNC014564	N-(5-Hydroxycarbamoyl-pentyl)-4-methoxy-benzamide	Discovery agent	.	.
DNC014565	DEOXYADENOSINE	Discovery agent	.	.
DNC014566	MYOSEVERIN	Discovery agent	.	.
DNC014567	N-(5-Hydroxycarbamoyl-pentyl)-benzamide	Discovery agent	.	.
DNC014568	Ro-15-3505	Discovery agent	.	.
DNC014569	1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione	Discovery agent	.	.
DNC014570	2-(4-Methoxy-phenyl)-1H-indole-3-carbaldehyde	Discovery agent	.	.
DNC014571	6-Benzylamino-5-bromo-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014572	6-p-Tolylamino-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014573	5-Bromo-6-p-tolylamino-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014574	N*4*-Benzyl-6-chloro-pyrimidine-2,4-diamine	Discovery agent	.	.
DNC014575	1,3-Dibenzyl-[1,3]diazetidine-2,4-dione	Discovery agent	.	.
DNC014576	6-Benzylamino-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014577	6-(Indan-5-ylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014578	6-Benzylamino-5-iodo-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014579	2-Amino-6-(indan-5-ylamino)-3H-pyrimidin-4-one	Discovery agent	.	.
DNC014580	TAUTOMYCIN	Discovery agent	.	.
DNC014581	MICROCYSTIN-LR	Discovery agent	.	.
DNC014582	CANTHARIDIN	Discovery agent	.	.
DNC014582	CANTHARIDIN	Molluscum contagiosum infection	.	B08.1
DNC014583	PALASONIN	Discovery agent	.	.
DNC014584	CANTHARIDIC_ACID	Discovery agent	.	.
DNC014585	3-(1H-Pyrrol-3-yl)-propionamide	Discovery agent	.	.
DNC014586	NORCANTHARIDIN	Discovery agent	.	.
DNC014587	BMY-44621	Discovery agent	.	.
DNC014588	ZK-807834	Discovery agent	.	.
DNC014588	ZK-807834	Thrombosis	.	I80-I82
DNC014589	YM-60828	Discovery agent	.	.
DNC014590	3-Amino-propane-1-sulfonic acid	Discovery agent	.	.
DNC014591	CGP-35348	Discovery agent	.	.
DNC014591	CGP-35348	Epilepsy	.	G40
DNC014592	(3-Amino-propyl)-hexyl-phosphinic acid	Discovery agent	.	.
DNC014593	1,4-dideoxy-1,4-imino-D-arabinito	Discovery agent	.	.
DNC014594	DEOXYURIDINE	Discovery agent	.	.
DNC014595	DEOXYCYTIDINE	Discovery agent	.	.
DNC014596	COMBETASTATIN	Discovery agent	.	.
DNC014597	Peptide boronate	Discovery agent	.	.
DNC014598	Peptide boronate	Discovery agent	.	.
DNC014599	Peptide boronate	Discovery agent	.	.
DNC014600	Peptide boronate	Discovery agent	.	.
DNC014601	Peptide boronate	Discovery agent	.	.
DNC014602	Peptide boronate	Discovery agent	.	.
DNC014603	Peptide boronate	Discovery agent	.	.
DNC014604	CVS-2139	Discovery agent	.	.
DNC014605	Peptide boronate	Discovery agent	.	.
DNC014606	CVS-2359	Discovery agent	.	.
DNC014607	Peptide boronate	Discovery agent	.	.
DNC014608	Peptide boronate	Discovery agent	.	.
DNC014609	2-Propionyl-1H-indole-6-carboxamidine	Discovery agent	.	.
DNC014610	4-(5-Nitro-indol-1-ylmethyl)-benzamidine	Discovery agent	.	.
DNC014611	1-(3-Amino-benzyl)-1H-indole-5-carboxamidine	Discovery agent	.	.
DNC014612	4-Indol-1-ylmethyl-benzamidine	Discovery agent	.	.
DNC014613	1-(3-Nitro-benzyl)-1H-indole-5-carboxamidine	Discovery agent	.	.
DNC014614	1-Benzyl-1H-indole-5-carboxamidine	Discovery agent	.	.
DNC014615	PIRINIXIC ACID	Discovery agent	.	.
DNC014616	(3-Amino-phenyl)-phosphonic acid diphenyl ester	Discovery agent	.	.
DNC014617	Piperidine-1-carboxamidine	Discovery agent	.	.
DNC014618	3-Hydroxy-piperidine-4-carboxylic acid	Discovery agent	.	.
DNC014619	Piperidine-4-carboxylic acid	Discovery agent	.	.
DNC014620	4-Amino-3-benzofuran-2-yl-butyric acid	Discovery agent	.	.
DNC014621	SCH-48375	Discovery agent	.	.
DNC014622	1-(4-Chloro-phenyl)-3-(3-pentyl-oct-2-enyl)-urea	Discovery agent	.	.
DNC014623	3,4-Dichloro-N-(3,3-diphenyl-allyl)-benzamide	Discovery agent	.	.
DNC014624	7-Diazonium-naphthalene-1-sulfonic acid anion	Discovery agent	.	.
DNC014625	Toluene-1-diazonium-3-sulfonic acid anion	Discovery agent	.	.
DNC014626	8-Diazonium-naphthalene-1-sulfonic acid anion	Discovery agent	.	.
DNC014627	2-Methoxy-5-(5,6,7-trimethoxy-indan-1-yl)-phenol	Discovery agent	.	.
DNC014628	1-(4-Chloro-phenyl)-3-(3,3-diphenyl-allyl)-urea	Discovery agent	.	.
DNC014629	1-(3,3-Diphenyl-allyl)-3-m-tolyl-urea	Discovery agent	.	.
DNC014630	ZK-200775	Coronary artery disease	.	I20-I25
DNC014630	ZK-200775	Discovery agent	.	.
DNC014631	6-Thiophen-3-yl-imidazo[2,1-b]thiazole	Discovery agent	.	.
DNC014632	AFLATREME	Discovery agent	.	.
DNC014633	6-Thiophen-2-yl-imidazo[2,1-b]thiazole	Discovery agent	.	.
DNC014634	GNF-PF-117	Discovery agent	.	.
DNC014635	Tert-butyloxy carbonyl-D-Phe-pro-Arg-H	Discovery agent	.	.
DNC014636	(R)-5-Amino-3-(4-chloro-phenyl)-pentanoic acid	Discovery agent	.	.
DNC014637	4-Methyl-5-piperidin-4-yl-isoxazol-3-ol	Discovery agent	.	.
DNC014638	6-(Naphthalen-2-ylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014639	6-(3-Ethyl-phenylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014640	6-(4-Bromo-phenylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014641	6-(3-Bromo-phenylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014642	6-(3-Iodo-phenylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014643	6-(4-Chloro-phenylamino)-1H-pyrimidine-2,4-dione	Discovery agent	.	.
DNC014644	4-Ethyl-5-piperidin-4-yl-isoxazol-3-ol	Discovery agent	.	.
DNC014645	2-Furan-2-yl-7-methyl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014646	L-371912	Discovery agent	.	.
DNC014647	L-370518	Discovery agent	.	.
DNC014647	L-370518	Myocardial infarction	.	I21-I22
DNC014648	NSC-664171	Discovery agent	.	.
DNC014649	NSC-679036	Discovery agent	.	.
DNC014650	2-Aminomethyl-pyrrolidine-3,4-diol	Discovery agent	.	.
DNC014651	2-Cyclopentylaminomethyl-pyrrolidine-3,4-diol	Discovery agent	.	.
DNC014652	BRL-54504AX	Discovery agent	.	.
DNC014653	N-methyl ryanodine-succinamidate	Discovery agent	.	.
DNC014654	(O10eq)-Benzyloxycarbonyl-beta-alanylryanodine	Discovery agent	.	.
DNC014655	ANHYDRORYANIDINE	Discovery agent	.	.
DNC014656	(O10eq)-beta-guanidinopropionylryanodine	Discovery agent	.	.
DNC014657	2-Methoxy-5-(3,4,5-trimethoxy-phenoxy)-phenol	Discovery agent	.	.
DNC014658	GLYCYLRYANODINE	Discovery agent	.	.
DNC014659	(O10eq)-beta-alanylryanodine	Discovery agent	.	.
DNC014660	Benzyloxycarbonyl-glycylryanodine	Discovery agent	.	.
DNC014661	(O10eq)-beta-alanyl-anhydro-ryanodine	Discovery agent	.	.
DNC014662	ABT-751	Discovery agent	.	.
DNC014662	ABT-751	Solid tumours	.	C00-C75,C7A,C7B
DNC014663	Di-Benzyloxycarbonyl-guanidino acetylryanodine	Discovery agent	.	.
DNC014664	(O10eq)-guanidino acetylryanodine	Discovery agent	.	.
DNC014665	HMR-1556	Discovery agent	.	.
DNC014666	AdcAhxArg4NH(CH2)6NH2	Discovery agent	.	.
DNC014667	AdcAhxArg4Lys(biotin)-PEG-OMe	Discovery agent	.	.
DNC014668	AdcAhxArg6	Discovery agent	.	.
DNC014669	AdcAhxArg4Lys-PEGOMe	Discovery agent	.	.
DNC014670	CENTAUREIDIN	Discovery agent	.	.
DNC014671	PHENSTATIN	Discovery agent	.	.
DNC014672	NSC-106970	Discovery agent	.	.
DNC014673	AdoC(beta-Ala)Arg6	Discovery agent	.	.
DNC014674	AdoC(GABA)Arg6	Discovery agent	.	.
DNC014675	7-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014676	2-Naphthalen-1-yl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014677	N-(1-Benzyl-2-oxo-ethyl)-benzamide	Discovery agent	.	.
DNC014678	6-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014679	AdoC(Aun)Arg6	Discovery agent	.	.
DNC014680	AdoC(Dpr)2AlaArg6	Discovery agent	.	.
DNC014681	AdoC(Aoc)Arg6	Discovery agent	.	.
DNC014682	AdoC(Ahx)Arg6	Discovery agent	.	.
DNC014683	AdoCGlyArg6	Discovery agent	.	.
DNC014684	2-m-Tolyl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014685	2-(3-Chloro-phenyl)-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014686	AdoC(betaAsp)2AlaArg6	Discovery agent	.	.
DNC014687	5,7-Dimethyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014688	(1-Benzyl-2-oxo-ethyl)-carbamic acid benzyl ester	Discovery agent	.	.
DNC014689	5-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014690	AdoC(beta-Ala)2AlaArg6	Discovery agent	.	.
DNC014691	2-Naphthalen-2-yl-1H-[1,8]naphthyridin-4-one	Discovery agent	.	.
DNC014692	4-Amino-3-(2-chloro-phenyl)-butyric acid	Discovery agent	.	.
DNC014693	4-Amino-3-(5-chloro-thiophen-2-yl)-butyric acid	Discovery agent	.	.
DNC014694	4-Amino-3-(5-methyl-thiophen-2-yl)-butyric acid	Discovery agent	.	.
DNC014695	4-Amino-3-(4-fluoro-phenyl)-butyric acid	Discovery agent	.	.
DNC014696	DIAZEPAM HYDROCHLORIDE	Discovery agent	.	.
DNC014697	4-Amino-3-thiophen-2-yl-butyric acid	Discovery agent	.	.
DNC014698	4-Amino-3-(5-bromo-thiophen-2-yl)-butyric acid	Discovery agent	.	.
DNC014699	Benzamidrazone analogue	Discovery agent	.	.
DNC014700	MR-22388	Discovery agent	.	.
DNC014701	Benzamidrazone analogue	Discovery agent	.	.
DNC014702	P1 argininal derivative	Discovery agent	.	.
DNC014703	3-ammoniopropane-1-sulfinate	Discovery agent	.	.
DNC014704	Benzamidrazone analogue	Discovery agent	.	.
DNC014705	Benzamidrazone analogue	Discovery agent	.	.
DNC014706	P1 argininal derivative	Discovery agent	.	.
DNC014707	Benzamidrazone analogue	Discovery agent	.	.
DNC014708	Benzamidrazone analogue	Discovery agent	.	.
DNC014709	Benzamidrazone analogue	Discovery agent	.	.
DNC014710	6-Methyl-2-p-tolyl-chromen-4-one	Discovery agent	.	.
DNC014711	6-Ethyl-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC014712	2-(2-Amino-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014713	2-(3-Amino-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014714	Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC014715	2-(3-Bromo-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014716	6-Methyl-2-pyridin-3-yl-chromen-4-one	Discovery agent	.	.
DNC014717	5-Aminomethyl-4,5-dihydro-isoxazol-3-ol	Discovery agent	.	.
DNC014718	5-Aminomethyl-4,5-dihydro-isoxazol-3-ol	Discovery agent	.	.
DNC014719	2-(3-Hydroxy-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014720	2-(2-Methoxy-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014721	2-(2-Hydroxy-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014722	ORG-25543	Discovery agent	.	.
DNC014722	ORG-25543	Pain	338,780	R52, G89
DNC014723	2-(4-Amino-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014724	2-(3-Methoxy-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014725	Boc-cyclo-(Glu-Tyr-Nle-D-Lys)-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC014726	2-Phenyl-6-propyl-chromen-4-one	Discovery agent	.	.
DNC014727	6-Amino-2-(1H-imidazol-4-yl)-hexanoic acid	Discovery agent	.	.
DNC014728	4-Amino-3-hydroxy-butyric acid	Discovery agent	.	.
DNC014729	Boc-D-Glu-Tyr(SO3H)-Nle-D-Lys-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC014730	Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2	Discovery agent	.	.
DNC014731	4-Methyl-3-(2-oxo-azetidin-1-yl)-benzoic acid	Discovery agent	.	.
DNC014732	4-Amino-3-hydroxy-butyric acid	Discovery agent	.	.
DNC014733	RWJ-56423	Asthma	.	J45
DNC014733	RWJ-56423	Discovery agent	.	.
DNC014734	Boc-Glu-Tyr(SO3H)-Nle-D-Lys-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC014735	5-Aminomethyl-4,5-dihydro-isoxazol-3-ol	Discovery agent	.	.
DNC014736	6-Methyl-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC014737	Ro-16-6028	Anxiety disorder	.	F40-F42
DNC014737	Ro-16-6028	Discovery agent	.	.
DNC014738	6-Isopropyl-2-phenyl-chromen-4-one	Discovery agent	.	.
DNC014739	2-(3-Butoxy-phenyl)-6-methyl-chromen-4-one	Discovery agent	.	.
DNC014740	Boc-D-Glu-Tyr(SO3H)-Nle-D-Nle-Trp-Nle-Asp-Phe-NH2	Discovery agent	.	.
DNC014741	WEDELOLACTONE	Discovery agent	.	.
DNC014742	5-tert-Butyl-2-(4-fluoro-phenyl)-[1,3]dithiane	Discovery agent	.	.
DNC014743	5-tert-Butyl-2-(4-ethynyl-phenyl)-[1,3]dithiane	Discovery agent	.	.
DNC014744	4-(5-tert-Butyl-[1,3]dithian-2-yl)-benzonitrile	Discovery agent	.	.
DNC014745	FR-175985	Discovery agent	.	.
DNC014746	4-Chloro-2,6-diisopropyl-phenol	Discovery agent	.	.
DNC014747	Pranazepide	Discovery agent	.	.
DNC014747	Pranazepide	Pancreatic disease	.	K85-K86
DNC014748	Benzoic acid 2,6-diisopropyl-phenyl ester	Discovery agent	.	.
DNC014749	2,6-Diisopropyl-4-nitro-phenol	Discovery agent	.	.
DNC014750	Acetic acid 2,6-diisopropyl-phenyl ester	Discovery agent	.	.
DNC014751	ALFAXALONE	Discovery agent	.	.
DNC014752	4-Bromo-2,6-diisopropyl-phenol	Discovery agent	.	.
DNC014753	4-Iodo-2,6-diisopropyl-phenol	Discovery agent	.	.
DNC014754	4-Dimethylamino-2,6-diisopropyl-phenol	Discovery agent	.	.
DNC014755	4-Hydroxy-3,5-diisopropyl-benzaldehyde	Discovery agent	.	.
DNC014756	L-655240	Discovery agent	.	.
DNC014757	(E)-Octadec-9-enoic acid phenylamide	Discovery agent	.	.
DNC014758	DEOXYGALACTONOJIRIMYCIN	Discovery agent	.	.
DNC014759	MDL-28170	Alzheimer's disease	.	G30,F00
DNC014759	MDL-28170	Discovery agent	.	.
DNC014760	4'-(p-toluenesulfonamide)-3,4-dihydroxy chalcone	Discovery agent	.	.
DNC014761	PHOSPHOGLYCOLOHYDROXAMATE	Discovery agent	.	.
DNC014762	SM-32504	Arteriosclerosis	.	I70
DNC014762	SM-32504	Discovery agent	.	.
DNC014763	(R)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid	Discovery agent	.	.
DNC014764	(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid	Discovery agent	.	.
DNC014765	3-(aminomethyl)-4-(furan-3-yl)butanoic acid	Discovery agent	.	.
DNC014766	3-(aminomethyl)-4-(furan-2-yl)butanoic acid	Discovery agent	.	.
DNC014767	3-(aminomethyl)-4-(thiophen-3-yl)butanoic acid	Discovery agent	.	.
DNC014768	3-(aminomethyl)-4-(thiophen-2-yl)butanoic acid	Discovery agent	.	.
DNC014769	(+)-5-deoxyadeenophorine	Discovery agent	.	.
DNC014770	SNJ-1715	Cataract	366	H25-H26, H28, Q12.0
DNC014770	SNJ-1715	Discovery agent	.	.
DNC014771	SJA-6017	Discovery agent	.	.
DNC014772	ETIOCHOLANOLONE	Discovery agent	.	.
DNC014773	ANDROSTERONE	Discovery agent	.	.
DNC014774	RHIZOXIN	Breast cancer	174, 175, 217	C50, D24
DNC014774	RHIZOXIN	Discovery agent	.	.
DNC014775	D-myo-inositol 1,4,5-trisphosphate	Discovery agent	.	.
DNC014776	5'-Deoxy-5'-phenyladenophostin A	Discovery agent	.	.
DNC014777	ADENOPHOSTIN A	Discovery agent	.	.
DNC014778	5,6,8-trichloroquinoline-4-one-3-carboxylic acid	Discovery agent	.	.
DNC014779	7,8-dichloroquinoline-4-one-3-carboxylic acid	Discovery agent	.	.
DNC014780	Ac-HSDAVFTDQYTRLRKQVAAKKYLQSIKQKRYC	Discovery agent	.	.
DNC014781	1-[2-(2-triphenylmethoxyethoxy)ethyl]thymine	Discovery agent	.	.
DNC014782	1-[7-(triphenylmethoxy)heptyl]thymine	Discovery agent	.	.
DNC014783	N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide	Discovery agent	.	.
DNC014784	N-(4-bromo-2-methylphenyl)-2-naphthamide	Discovery agent	.	.
DNC014785	5-(4'-benzoylbiphenyl-4-yl)-2-furoic acid	Discovery agent	.	.
DNC014786	Ceftazidime BATSI	Discovery agent	.	.
DNC014787	ISOLONGIFOLOL	Discovery agent	.	.
DNC014788	VL-0494	Discovery agent	.	.
DNC014789	4-amino-3-fluoro-5-iodobenzenesulfonamide	Discovery agent	.	.
DNC014790	4-amino-3,5-dibromobenzenesulfonamide	Discovery agent	.	.
DNC014791	5-methyl-benzo[b]thiophen-2-ylboronic acid	Discovery agent	.	.
DNC014792	Thiophene-2-ylboronic acid	Discovery agent	.	.
DNC014793	5-hydroxymethylbenzo[b]thiophen-2-ylboronic acid	Discovery agent	.	.
DNC014794	SQ-14603	Discovery agent	.	.
DNC014795	IK-682	Discovery agent	.	.
DNC014796	IM-491	Discovery agent	.	.
DNC014797	(R)-4-amino-2-methylbutanoic acid	Discovery agent	.	.
DNC014798	3-(4-(4-hydroxyphenyl)phthalazin-1-ylamino)phenol	Discovery agent	.	.
DNC014799	TALAROFLAVONE	Discovery agent	.	.
DNC014800	PROTOSTEMODIOL	Discovery agent	.	.
DNC014801	3,5-difluorophenol	Discovery agent	.	.
DNC014802	(24E)-3beta-hydroxy-7,24-euphadien-26-oic acid	Discovery agent	.	.
DNC014803	PICROTIN	Discovery agent	.	.
DNC014804	PROTIRELIN	Alzheimer's disease	.	G30,F00
DNC014804	PROTIRELIN	Discovery agent	.	.
DNC014805	S-methyl 4-methyl-4-morpholinopent-2-ynethioate	Discovery agent	.	.
DNC014806	ARC-1028	Discovery agent	.	.
DNC014807	IM-491	Discovery agent	.	.
DNC014808	Gallic acid 5,6-dihydroxy-3-carboxyphenylester	Discovery agent	.	.
DNC014809	2,5-Dideoxy-2,5-imino-D-mannitol	Discovery agent	.	.
DNC014810	(+)-Myristinin A	Discovery agent	.	.
DNC014811	(+)-Myristinin D	Discovery agent	.	.
DNC014812	FITC-LMNNAEHINQFYMFI	Discovery agent	.	.
DNC014813	GNF-PF-85	Discovery agent	.	.
DNC014814	CORYMBONE B	Discovery agent	.	.
DNC014815	Ac-His-DPhe(pBr)-Arg-Trp-NH2	Discovery agent	.	.
DNC014816	Ac-His-DPhe(pI)-Arg-Trp-NH2	Discovery agent	.	.
DNC014817	Ac-His-DPhe(pCF3)-Arg-Trp-NH2	Discovery agent	.	.
DNC014818	Ac-His-DNal(2)-Arg-Trp-NH2	Discovery agent	.	.
DNC014819	Ac-His-DPhe(3,4-diCl)-Arg-Trp-NH2	Discovery agent	.	.
DNC014820	NCI-58425	Discovery agent	.	.
DNC014821	BENZYL BENZOATE	Discovery agent	.	.
DNC014822	OXYBENZONE	Discovery agent	.	.
DNC014823	ETHIOFENCARB	Discovery agent	.	.
DNC014824	BIFENOX	Discovery agent	.	.
DNC014825	2-(3-methoxybenzylthio)-2-phenylacetic acid	Discovery agent	.	.
DNC014826	NCI-159878	Discovery agent	.	.
DNC014827	Alpha,beta-methylene-dATP	Discovery agent	.	.
DNC014828	Alpha,beta-methylene-dGTP	Discovery agent	.	.
DNC014829	Alpha,beta-methylene-dTTP	Discovery agent	.	.
DNC014830	Alpha,beta-methylene-dCTP	Discovery agent	.	.
DNC014831	(Z)-5-Benzylidene-2-thioxothiazolidin-4-one	Discovery agent	.	.
DNC014832	(Z)-5-Butylidene-2-thioxothiazolidin-4-one	Discovery agent	.	.
DNC014833	(Z)-5-Hexylidene-2-thioxothiazolidin-4-one	Discovery agent	.	.
DNC014834	(Z)-5-Octylidene-2-thioxothiazolidin-4-one	Discovery agent	.	.
DNC014835	(Z)-5-Decylidene-2-thioxothiazolidin-4-one	Discovery agent	.	.
DNC014836	CALYSTEGINE B2	Discovery agent	.	.
DNC014837	Aloe-emodin	Discovery agent	.	.
DNC014838	3-(2-propyn-1-yl)thymidine	Discovery agent	.	.
DNC014839	1-hydroxy-2-dodecyl-4(1H)quinolone	Discovery agent	.	.
DNC014840	3alpha-O-trans-p-coumaroyl-7-labden-15-oic acid	Discovery agent	.	.
DNC014841	3-Oximo-olean-12-en-29-oic acid	Discovery agent	.	.
DNC014842	HYRTIOSULAWESINE	Discovery agent	.	.
DNC014843	2-methoxy-3,4-methylenedioxybenzophenone	Discovery agent	.	.
DNC014844	DdCTP SODIUM	Discovery agent	.	.
DNC014845	Mahureone D	Discovery agent	.	.
DNC014846	3beta-hydroxyrus-12,19(29)-dien-28-oic acid	Discovery agent	.	.
DNC014847	3beta-hydroxyrus-18,20(30)-dien-28-oic acid	Discovery agent	.	.
DNC014848	BETULINIC ACID	Melanoma	172	C43
DNC014848	BETULINIC ACID	Viral infections	042-075	A80-A99, B00-B34
DNC014849	3-cis-p-coumaroyl maslinic acid	Discovery agent	.	.
DNC014850	3-trans-p-coumaroyl maslinic acid	Discovery agent	.	.
DNC014851	5-(methylthio)thiophene-2-carboxylic acid	Discovery agent	.	.
DNC014852	(2-hydroxyphenyl)(4-hydroxyphenyl)methanone	Discovery agent	.	.
DNC014853	7-(4-methoxyphenyl)pteridine-2,4-diol	Discovery agent	.	.
DNC014854	3-amino-2-(benzylideneamino)-5-mercaptophenol	Discovery agent	.	.
DNC014855	2,3-dioxoindoline-7-carboxylic acid	Discovery agent	.	.
DNC014856	2-hydroxy-17beta-estradiol	Discovery agent	.	.
DNC014857	2,5-didesoxy-3-ATP	Discovery agent	.	.
DNC014858	2,5-difluorophenol	Discovery agent	.	.
DNC014859	PENICILLIOL A	Discovery agent	.	.
DNC014860	4,5,6,7-tetrabromo-1H-benzimidazole	Discovery agent	.	.
DNC014861	5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole	Discovery agent	.	.
DNC014862	CGP-029482	Discovery agent	.	.
DNC014863	EMODIN	Discovery agent	.	.
DNC014864	2-hydroxyisoquinoline-1,3(2H,4H)-dione	Discovery agent	.	.
DNC014865	3-hydroxyquinazoline-2,4(1H,3H)-dione	Discovery agent	.	.
DNC014866	DL-guanidinoethylmercaptosuccinic acid	Discovery agent	.	.
DNC014867	2-(4-benzoylpiperidine-1-carbonyl)benzoic acid	Discovery agent	.	.
DNC014868	ST-5732	Discovery agent	.	.
DNC014869	5-(2-methylpiperazin-1-ylsulfonyl)isoquinoline	Discovery agent	.	.
DNC014870	BMS-754807	Discovery agent	.	.
DNC014871	3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide	Discovery agent	.	.
DNC014872	Ethyl 2-amino-4,5-diphenylthiophene-3-carboxylate	Discovery agent	.	.
DNC014873	SB-258585	Discovery agent	.	.
DNC014873	SB-258585	Psychotic disorders	.	F20-F29
DNC014874	5-phenyl-1H-1,2,3-triazole	Discovery agent	.	.
DNC014875	Gababutin	Discovery agent	.	.
DNC014876	2-(1-(aminomethyl)-3-ethylcyclopentyl)acetic acid	Discovery agent	.	.
DNC014877	2-(1-(aminomethyl)-3-butylcyclopentyl)acetic acid	Discovery agent	.	.
DNC014878	Trans-dimethyl gababutin	Discovery agent	.	.
DNC014879	SNX-2112	Discovery agent	.	.
DNC014880	17-desmethoxy-17-aminogeldanamycin	Discovery agent	.	.
DNC014881	(12E,20Z,18S)-8-hydroxyvariabilin	Discovery agent	.	.
DNC014882	3'-(1,2,3-Triazol-1-yl)-3'-deoxy-beta-D-thymidine	Discovery agent	.	.
DNC014883	NSC-527035	Discovery agent	.	.
DNC014884	POLYSIN	Discovery agent	.	.
DNC014885	Beta-1-C-butenyl-1-deoxygalactonojirimycin	Discovery agent	.	.
DNC014886	5-Fluoro-2-sulfanyl-phenylphosphonic acid	Discovery agent	.	.
DNC014887	Alpha-Sulfanyl(4-chlorobenzyl)phosphonic acid	Discovery agent	.	.
DNC014888	MYRIOCIN	Discovery agent	.	.
DNC014889	THAPSIGARGIN	Discovery agent	.	.
DNC014890	4-(3-bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol	Discovery agent	.	.
DNC014891	DORSOMORPHIN	Discovery agent	.	.
DNC014892	NSC-119910	Discovery agent	.	.
DNC014893	DIHYDROXANTHOHUMOL	Discovery agent	.	.
DNC014894	GNF-PF-4453	Discovery agent	.	.
DNC014895	AW-00430	Discovery agent	.	.
DNC014896	DEMETHYL-CANTHARIDIN	Discovery agent	.	.
DNC014897	AT1001	Autoimmune diseases	.	D84.9
DNC014897	AT1001	Discovery agent	.	.
DNC014898	TLN-4601	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DNC014898	TLN-4601	Discovery agent	.	.
DNC014899	GW274150	Asthma	.	J45
DNC014899	GW274150	Discovery agent	.	.
DNC014900	Mogamulizumab	Discovery agent	.	.
DNC014901	AZ-11557272	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNC014901	AZ-11557272	Discovery agent	.	.
DNC014902	ABT-737	Cancer	140-229	C00-C96
DNC014902	ABT-737	Discovery agent	.	.
DNC014903	AMG102	Colorectal cancer	153, 154	C18-C21
DNC014903	AMG102	Non-small cell lung cancer	.	C33-C34
DNC014904	4-aminobenzoic acid hydrazide	Discovery agent	.	.
DNC014905	RC-3095	Discovery agent	.	.
DNC014905	RC-3095	Solid tumours	.	C00-C75,C7A,C7B
DNC014906	Phlorizin	Discovery agent	.	.
DNC014907	ABT-594	Discovery agent	.	.
DNC014907	ABT-594	Neuropathic pain	338,780	R52, G89
DNC014908	TW-37	Discovery agent	.	.
DNCL001563	Y-90 Clivatuzumab	Pancreatic cancer	140-229, 157	C00-C96, C25
DNCL001563	Y-90 Clivatuzumab	Pancreatic cancer	157	C25
DNCL001564	Veltuzumab	Autoimmune diseases	.	D84.9
DNCL001564	Veltuzumab	Chronic lymphocytic leukemia	204.1	C91.1
DNCL001564	Veltuzumab	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL001564	Veltuzumab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL001564	Veltuzumab	Rheumatold arthritis	714	M05-M06
DNCL001564	Veltuzumab	Systemic lupus erythematosus	710	M32
DNCL001565	Sc Veltuzumab	Idiopathic thrombocytopenic purpura	287.31	D69.3
DNCL001565	Sc Veltuzumab	Pheumatoid arthritis	710-719	M00-M25
DNCL001565	Sc Veltuzumab	Rheumatold arthritis	714	M05-M06
DNCL001566	Milatuzumab-Dox	Multiple myeloma	203	C90.0
DNCL001567	Milatuzumab	Chronic lymphocytic leukaemia	.	C91.1
DNCL001567	Milatuzumab	Chronic lymphocytic leukemia	204.1	C91.1
DNCL001567	Milatuzumab	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 203.0, 208.9	C81, C81-C96, C82-C85, C90.0, C91-C95
DNCL001567	Milatuzumab	Recurrent multiple myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL001568	Vmab + Y-90 Emab	Diffuse large B-cell lymphoma	200	C83.3
DNCL001569	Pretargeting TF2	Colorectal cancer	153, 154	C18-C21
DNCL001570	Labetuzumab-SN-38	Cancer	140-229	C00-C96
DNCL001570	Labetuzumab-SN-38	Colorectal cancer	153, 154	C18-C21
DNCL001571	Gevokizumab	Behcet's syndrome	136.1	M35.2
DNCL001571	Gevokizumab	Rheumatold arthritis	714	M05-M06
DNCL001571	Gevokizumab	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL001572	Interferon-alpha lozenge	Behcet's syndrome	136.1	M35.2
DNCL001572	Interferon-alpha lozenge	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL001572	Interferon-alpha lozenge	Fibromyalgia	729.1	M79.7
DNCL001573	ACE-031	Duchenne muscular dystrophy	.	G71.0
DNCL001573	ACE-031	Duchenne muscular dystrophy	359.1	G71.0
DNCL001574	Ataluren	Duchenne muscular dystrophy	359.1	G71.0
DNCL001574	Ataluren	Systemic lupus erythematosus	710	M32
DNCL001575	Eteplirsen	Duchenne muscular dystrophy	.	G71.0
DNCL001575	Eteplirsen	Duchenne muscular dystrophy	359.1	G71.0
DNCL001576	GSK2402968	Duchenne muscular dystrophy	.	G71.0
DNCL001576	GSK2402968	Duchenne muscular dystrophy	359.1	G71.0
DNCL001577	Muscular dystrophy gene therapy	Duchenne muscular dystrophy	359.1	G71.0
DNCL001578	Fibroblast growth factor-18	Acute cartilage injury of the knee	836	S83
DNCL001578	Fibroblast growth factor-18	Cartilage injury	.	S83
DNCL001578	Fibroblast growth factor-18	Osteoarthritis	715	M15-M19, M47
DNCL001579	Tissue repair stem cell therapy implant	Alveolar bone loss; Non-union fracture; Vertebral fracture	523.5, 733.0, 733.13, 805-806	K05.4, M48.4, M48.5, M80, M80-M81, M84, S12
DNCL001579	Tissue repair stem cell therapy implant	Osteonecrosis	733.4	M87
DNCL001580	Secukinumab	Ankylosing spondylitis	720	M08.1, M45
DNCL001580	Secukinumab	Psoriatic arthritis	696	L40.5, M07
DNCL001580	Secukinumab	Rheumatold arthritis	714	M05-M06
DNCL001581	Chondrocyte tissue grafts	Back pain	724.5,338,780	M54, G89, R52
DNCL001581	Chondrocyte tissue grafts	Pain	.	G89
DNCL001582	Fulranumab	Arthralgia	.	M25.5
DNCL001582	Fulranumab	Back pain	724.5,338,780	M54, G89, R52
DNCL001582	Fulranumab	Cancer pain	140-229, 338,780	C00-C96, R52, G89
DNCL001583	Oxycodone/ naloxone controlled release	Back pain	724.5,338,780	M54, G89, R52
DNCL001584	ZX002	Back pain	724.5,338,780	M54, G89, R52
DNCL001585	AC-100	Arthritis	710-719	M00-M25
DNCL001585	AC-100	Bone disorders; Cartilage disorders	710-739	M00-M99
DNCL001586	Juvenile chondrocyte grafts	Cartilage disorders	718	M24
DNCL001586	Juvenile chondrocyte grafts	Contraception	.	Z30
DNCL001587	Autologous chondrocyte implantation	Cartilage disorders	718	M24
DNCL001587	Autologous chondrocyte implantation	Primary biliary cirrhosis	.	K74.3
DNCL001588	Autologous cartilage system	Cartilage lesions of the knee	836	S83
DNCL001589	AMG 785	Fracture healing	.	S00-T88
DNCL001589	AMG 785	Postmenopausal osteoporosis	733	M80-M81
DNCL001590	RQ-00000005	Frailty	.	R54
DNCL001591	A-0001	Cataract	366	H25-H26, H28, Q12.0
DNCL001591	A-0001	Friedreich's ataxia	334	G11.1
DNCL001592	Collagenase injection	Frozen shoulder	726	M75.0
DNCL001592	Collagenase injection	Tendon injuries	.	S56
DNCL001593	CG-100649	Arthritis	.	M00-M25
DNCL001593	CG-100649	Inflammation associated with osteoarthritis	715	M15-M19, M47
DNCL001594	Chondroitinase	Intervertebral disc displacement	722.0-722.2	M51.2
DNCL001595	Oral human gammaglobulin	Clostridium difficile infection	001-139	A00-B99
DNCL001595	Oral human gammaglobulin	Juvenile rheumatoid arthritis	710-719, 714, 714.3	M00-M25, M05-M06, M08.0
DNCL001596	OTI-030	Knee injuries	.	S80-S89
DNCL001597	CK-2017357	Muscle fatigue	780.7	R53
DNCL001598	Arbaclofen placarbil	Gastroesophageal reflux disease	.	K21
DNCL001598	Arbaclofen placarbil	Muscle spasticity	781	R25.2
DNCL001599	Nabiximols	Cancer pain	140-229, 338,780	C00-C96, R52, G89
DNCL001599	Nabiximols	Muscle spasticity	781	R25.2
DNCL001600	AMG 745	Muscular atrophy	728.2	M62.5
DNCL001601	GTx-024	Muscular atrophy	728.2	M62.5
DNCL001602	LY2495655	Cachexia	.	R64
DNCL001602	LY2495655	Disuse muscle atrophy; Cancercachexia	140-229, 799.4	C00-C96, R64
DNCL001602	LY2495655	Muscular atrophy	728.2	M62.5
DNCL001603	LGD-4033	Musculoskeletal disorders	.	M00-M99
DNCL001604	Musculoskeletal mAb therapeutic	Musculoskeletal disorders	.	M00-M99
DNCL001605	ABT-652	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL001605	ABT-652	Excessive daytime sleepiness	291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54	F51.1, G47.1
DNCL001605	ABT-652	Musculoskeletal pain	338,780	R52, G89
DNCL001606	Diclofenac transdermal second-generation	Musculoskeletal pain	338,780	R52, G89
DNCL001607	FX005	Malignant melanoma	172	C43
DNCL001607	FX005	Musculoskeletal pain	338,780	R52, G89
DNCL001608	JNJ-39439335	Musculoskeletal pain	338,780	R52, G89
DNCL001608	JNJ-39439335	Pain	.	G89
DNCL001609	SAR114137	Osteoarthritic pain	338,780	R52, G89
DNCL001610	SAR292833	Neuropathic pain; Osteoarthritic pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
DNCL001610	SAR292833	Osteoarthritic pain	338,780	R52, G89
DNCL001610	SAR292833	Pain	.	G89
DNCL001611	Ilaris canakinumab	Osteoarthritis	715	M15-M19, M47
DNCL001612	Prednisone/ dipyridamole	Osteoarthritis	715	M15-M19, M47
DNCL001612	Prednisone/ dipyridamole	Rheumatold arthritis	714	M05-M06
DNCL001613	Ampion	Bronchiectasis	.	J47
DNCL001613	Ampion	Osteoarthritis	715	M15-M19, M47
DNCL001614	BI 113823	Osteoarthritis	715	M15-M19, M47
DNCL001615	IP-880	Osteoarthritis	715	M15-M19, M47
DNCL001616	IP-889	Osteoarthritis	715	M15-M19, M47
DNCL001617	LT-NS001	Ankylosing spondylitis	720	M08.1, M45
DNCL001617	LT-NS001	Osteoarthritis	715	M15-M19, M47
DNCL001618	Osteoarthritis compound	Osteoarthritis	715	M15-M19, M47
DNCL001619	SAR113945	Osteoarthritis	715	M15-M19, M47
DNCL001620	SD-6010	Osteoarthritis	715	M15-M19, M47
DNCL001621	TG-C	Arthritis	.	M00-M25
DNCL001621	TG-C	Osteoarthritis	715	M15-M19, M47
DNCL001622	AMG 167	Bone-related conditions	710-739	M00-M99
DNCL001622	AMG 167	Osteopenia	.	M85.8
DNCL001622	AMG 167	Osteopenia	733.9	M85.8
DNCL001623	BA-058	Osteoporosis	.	M80-M81
DNCL001623	BA-058	Osteoporosis	733	M80-M81
DNCL001624	AUS-131	Hot flashes	.	N95.1
DNCL001624	AUS-131	Osteoporosis	733	M80-M81
DNCL001625	DP-001	Osteoporosis	733	M80-M81
DNCL001626	MK-5442	Osteoporosis	733	M80-M81
DNCL001627	Osteoporosis compound	Osteoporosis	.	M80-M81
DNCL001627	Osteoporosis compound	Osteoporosis	733	M80-M81
DNCL001628	Teriparatide intranasal	Osteoporosis	733	M80-M81
DNCL001629	Teriparatide transdermal	Osteoporosis	.	M80-M81
DNCL001629	Teriparatide transdermal	Osteoporosis	733	M80-M81
DNCL001630	PF-04840082	Osteoporosis	733	M80-M81
DNCL001631	IBU-PC	Pain; Inflammation associated with osteoarthritis	338, 715,780	M15-M19, M47, R52, G89
DNCL001632	GSK768974	Postmenopausal osteoporosis	733	M80-M81
DNCL001633	Bazedoxifene/ conjugated estrogens	Postmenopausal osteoporosis	627.2, 733.0	M80-M81, N95.0
DNCL001634	Calcitonin oral	Pain	.	G89
DNCL001634	Calcitonin oral	Postmenopausal osteoporosis	627.2, 733.0	M80-M81, N95.0
DNCL001635	RG4934	Psoriatic arthritis	696	L40.5, M07
DNCL001636	RO5310074	Psoriatic arthritis	696	L40.5, M07
DNCL001637	PF-00489791	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL001637	PF-00489791	Raynaud's disease	443	I73.0
DNCL001638	SLX-2101	Erectile dysfunction	.	F52.2,N48.4
DNCL001638	SLX-2101	Hypertension	401	I10, I11, I12, I13, I15
DNCL001638	SLX-2101	Raynaud's disease	443	I73.0
DNCL001639	BAFF antibody	Rheumatold arthritis	714	M05-M06
DNCL001639	BAFF antibody	Systemic lupus erythematosus	710	M32
DNCL001640	CNTO-136	Cutaneous lupus erythematosus	.	L93
DNCL001640	CNTO-136	Lupus	710	M32
DNCL001640	CNTO-136	Rheumatold arthritis	714	M05-M06
DNCL001641	Olokizumab	Rheumatold arthritis	714	M05-M06
DNCL001642	PF-04236921	Lupus	710	M32
DNCL001642	PF-04236921	Rheumatold arthritis	714	M05-M06
DNCL001642	PF-04236921	Systemic lupus erythematosus	710	M32
DNCL001643	SBI-087	Multiple sclerosis	.	G35
DNCL001643	SBI-087	Rheumatold arthritis	714	M05-M06
DNCL001643	SBI-087	Systemic lupus erythematosus	710	M32
DNCL001644	RG7416	Glioblastoma multiforme	.	C71
DNCL001644	RG7416	Rheumatold arthritis	714	M05-M06
DNCL001645	BIIB 023	Rheumatold arthritis	.	M05-M06
DNCL001645	BIIB 023	Rheumatold arthritis	714	M05-M06
DNCL001646	ARG301	Rheumatold arthritis	714	M05-M06
DNCL001647	ASP2408	Rheumatold arthritis	714	M05-M06
DNCL001648	AVL-292	Autoimmune diseases	279.4	D84.9, M35.9
DNCL001648	AVL-292	Cancer	140-229	C00-C96
DNCL001648	AVL-292	Chronic lymphocytic leukemia	204.1	C91.1
DNCL001648	AVL-292	Lymphoma	202.8	C81-C96
DNCL001648	AVL-292	Non-Hodgkin's lymphoma	202.8	C81-C96
DNCL001648	AVL-292	Rheumatold arthritis	714	M05-M06
DNCL001649	BG-12	Rheumatold arthritis	714	M05-M06
DNCL001650	BMS-817399	Rheumatold arthritis	714	M05-M06
DNCL001651	BMS-945429	Rheumatold arthritis	714	M05-M06
DNCL001652	CCX354	Rheumatold arthritis	714	M05-M06
DNCL001653	Cenplacel-L	Rheumatold arthritis	714	M05-M06
DNCL001654	CH-4051	Immune disorder	.	D80-D89
DNCL001654	CH-4051	Rheumatold arthritis	714	M05-M06
DNCL001655	EVT 401	Rheumatold arthritis	714	M05-M06
DNCL001656	Fezakinumabx	Rheumatold arthritis	714	M05-M06
DNCL001657	Fostamatinib	Haematological malignancies	200-209	C81-C96
DNCL001657	Fostamatinib	Hematological malignancies	200-209	C81-C96
DNCL001657	Fostamatinib	Rheumatold arthritis	714	M05-M06
DNCL001658	GSK315234	Rheumatold arthritis	714	M05-M06
DNCL001659	HE3286	Rheumatold arthritis	714	M05-M06
DNCL001659	HE3286	Type 2 diabetes	250.00, 250.02	E11
DNCL001660	IL-17 antibody	Ankylosing spondylitis	.	M08.1,M45
DNCL001660	IL-17 antibody	Rheumatold arthritis	714	M05-M06
DNCL001662	JNJ-40346527	Hodgkin's lymphoma	.	C81
DNCL001662	JNJ-40346527	Hodgkin's lymphoma	201	C81
DNCL001662	JNJ-40346527	Rheumatold arthritis	714	M05-M06
DNCL001663	KB002/003	Rheumatold arthritis	714	M05-M06
DNCL001664	LX2931	Autoimmune diseases	.	D84.9
DNCL001664	LX2931	Rheumatold arthritis	714	M05-M06
DNCL001665	Methotrexate subcutaneous auto-injection	Rheumatold arthritis	714	M05-M06
DNCL001666	NN8209	Rheumatoid arthritis	714	M05-M06
DNCL001666	NN8209	Rheumatold arthritis	714	M05-M06
DNCL001667	NN8226	Rheumatoid arthritis	714	M05-M06
DNCL001667	NN8226	Rheumatold arthritis	.	M05-M06
DNCL001667	NN8226	Rheumatold arthritis	714	M05-M06
DNCL001668	NN8555	Rheumatold arthritis	714	M05-M06
DNCL001669	NN8828	Crohn's disease	555	K50
DNCL001669	NN8828	Rheumatoid arthritis	714	M05-M06
DNCL001669	NN8828	Rheumatold arthritis	.	M05-M06
DNCL001669	NN8828	Rheumatold arthritis	714	M05-M06
DNCL001669	NN8828	Systemic lupus erythematosus	710	M32
DNCL001670	Ozoralizumab	Ankylosing spondylitis	.	M08.1,M45
DNCL001670	Ozoralizumab	Rheumatold arthritis	714	M05-M06
DNCL001671	PF-04171327	Rheumatold arthritis	.	M05-M06
DNCL001671	PF-04171327	Rheumatold arthritis	714	M05-M06
DNCL001672	PF-05230905	Rheumatold arthritis	714	M05-M06
DNCL001673	PLX3397	Acute myeloid leukemia	202.8	C81-C96
DNCL001673	PLX3397	Acute myeloid leukemia	205	C92.0
DNCL001673	PLX3397	Glioblastoma	.	C71
DNCL001673	PLX3397	Glioblastoma	191	C71
DNCL001673	PLX3397	Hodgkin's lymphoma	201	C81
DNCL001673	PLX3397	Metastatic breast cancer	174, 175	C50
DNCL001673	PLX3397	Metastatic prostate cancer	185	C61
DNCL001673	PLX3397	Metastatic solid tumors	140-199, 202.8, 208.9, 210-229	C00-C75, C7A, C7B, C81-C96, C91-C95, D10-D36, D3A
DNCL001673	PLX3397	Prostate cancer	185	C61
DNCL001673	PLX3397	Recurrent glioblastoma	140-199, 191, 202.8, 208.9, 210-229	C00-C75, C71, C7A, C7B, C81-C96, C91-C95, D10-D36, D3A
DNCL001673	PLX3397	Recurrent or refractory Hodgkin's disease	201	C81
DNCL001673	PLX3397	Recurrent or refractory acute myeloid leukemia	140-199, 202.8, 205.0, 210-229	C00-C75, C7A, C7B, C81-C96, C92.0, D10-D36, D3A
DNCL001673	PLX3397	Rheumatold arthritis	714	M05-M06
DNCL001674	PLX5622	Alzheimer's disease; Multiple sclerosis	331.0, 340	G30, G35
DNCL001674	PLX5622	Rheumatold arthritis	714	M05-M06
DNCL001675	PMI-001	Lupus nephritis	583.81	M32.1, N08.5
DNCL001675	PMI-001	Rheumatold arthritis	714	M05-M06
DNCL001676	PRO-515	Rheumatold arthritis	714	M05-M06
DNCL001677	PRTX-100	Active rheumatoid arthritis	714	M05, M06
DNCL001677	PRTX-100	Rheumatold arthritis	714	M05-M06
DNCL001678	RPI-78	Rheumatold arthritis	714	M05-M06
DNCL001679	RX-10001	Asthma	493	J45
DNCL001679	RX-10001	Cardiovascular disease	390-459	I00-I99
DNCL001679	RX-10001	Rheumatold arthritis	714	M05-M06
DNCL001680	SAN-300	Rheumatold arthritis	714	M05-M06
DNCL001681	SCH-900117	Rheumatold arthritis	714	M05-M06
DNCL001682	VGX-1027	Rheumatold arthritis	714	M05-M06
DNCL001683	VX-509	Rheumatold arthritis	714	M05-M06
DNCL001684	MEDI-546	Ovarian cancer	.	C56
DNCL001684	MEDI-546	Scleroderma	701.0710.1	L94.0-L94.1, M34
DNCL001684	MEDI-546	Systemic lupus erythematosus	710	M32
DNCL001685	Mesenchymal stem cell therapy	Angina	413	I20
DNCL001685	Mesenchymal stem cell therapy	Bone marrow regeneration	279.5, 996	D89.8, T86
DNCL001685	Mesenchymal stem cell therapy	Heart failure	410, 428	I21, I22, I50
DNCL001685	Mesenchymal stem cell therapy	Spinal fusion	952	S14, S24, S34
DNCL001686	ARG201	Diffuse systemic sclerosis	.	M34
DNCL001686	ARG201	Systemic scleroderma	710.1	M34
DNCL001687	CC-10015	Systemic scleroderma	710.1	M34
DNCL001688	BMP-655	Tendon injuries	.	S56
DNCL001689	AGN-XX/YY	Diabetic nephropathy	.	E11.40
DNCL001689	AGN-XX/YY	Fibromyalgia	729.1	M79.7
DNCL001690	Flupirtine	Cancer pain	338,780	R52, G89
DNCL001690	Flupirtine	Fibromyalgia	729.1	M79.7
DNCL001691	TNX-102	Fibromyalgia syndrome	729.1	M79.7
DNCL001692	Lesinurad	Gout	274.00274.1274.8274.9	M10
DNCL001692	Lesinurad	Hyperuricaemia	790.6	E79.0
DNCL001693	MBX-102	Gout	274.00274.1274.8274.9	M10
DNCL001694	Pegadricase	Gout	274.00274.1274.8274.9	M10
DNCL001695	Atacicept EMD Serono	Lupus nephritis	583.81	M32.1, N08.5
DNCL001696	A-623	Systemic lupus erythematosus	710	M32
DNCL001697	AGS-009	Lupus	.	M32
DNCL001697	AGS-009	Lupus	710	M32
DNCL001697	AGS-009	Systemic lupus erythematosus	710	M32
DNCL001698	AMG 557	Lupus	.	M32
DNCL001698	AMG 557	Systemic lupus erythematosus	710	M32
DNCL001699	AMG 811	Discoid lupus erythematosus	.	L93.0
DNCL001699	AMG 811	Systemic lupus erythematosus	710	M32
DNCL001700	CDP-7657	Systemic lupus erythematosus	710	M32
DNCL001701	DV-1179	Systemic lupus erythematosus	710	M32
DNCL001702	Forigerimod	Systemic lupus erythematosus	710	M32
DNCL001703	Laquinimod	Lupus nephritis	583.81	M32.1, N08.5
DNCL001703	Laquinimod	Systemic lupus erythematosus	710	M32
DNCL001704	MEDI-545	Systemic lupus erythematosus	710	M32
DNCL001705	MEDI-570	Systemic lupus erythematosus	710	M32
DNCL001706	KRN23	X-linked hypophosphatemia	599.89	N39.8
DNCL001707	AMG 145	Hypercholesterolaemia	.	E78.0
DNCL001707	AMG 145	Hyperlipidemia	272.0-272.4	E78
DNCL001708	Adenosine triphosphate injection	Bradycardia	427.81, 659.7, 779.81, 785.9	R00.1
DNCL001708	Adenosine triphosphate injection	Paroxysmal supraventricular tachycardia	427, 427.0, 427.1, 427.89, 785.0	I47-I49, I47.1, I47.2, R00.0
DNCL001709	CU-2010	Bleeding	.	R58
DNCL001709	CU-2010	Blood loss during cardiac surgery	.	R58
DNCL001710	CCX140	Diabetes mellitus type 2	.	E11
DNCL001710	CCX140	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL001710	CCX140	Type 2 diabetes	250.00, 250.02	E11
DNCL001710	CCX140	Vascular restinosis following angioplasty or stenting	.	E11
DNCL001711	Adult stem cell therapy	Chronic myocardial ischemia	459.89	I99.8
DNCL001711	Adult stem cell therapy	Critical limb ischemia	459.89	I99.8
DNCL001711	Adult stem cell therapy	Stroke	434.91	I61-I63
DNCL001712	Cell therapy	Cancer	140-229	C00-C96
DNCL001712	Cell therapy	Peripheral arterial disorders	.	I73.9
DNCL001712	Cell therapy	Peripheral vascular disorders	.	I73.9
DNCL001713	Aliskiren/valsartan	Acutecoronary syndrome	411.1	I20.0
DNCL001714	AP214	Kidney disorders in cardiac surgery	.	N00-N99
DNCL001715	RFXIII	Post-operative hemorrhage in cardiac surgery	.	.
DNCL001716	RVX-208	Acutecoronary syndrome	411.1	I20.0
DNCL001716	RVX-208	Alzheimer's disease	.	G30,F00
DNCL001716	RVX-208	Alzheimer's disease	331	G30
DNCL001716	RVX-208	Atherosclerosis	411.1, 414.0, 440	I20.0, I70
DNCL001717	VIA-2291	Acutecoronary syndrome	411.1	I20.0
DNCL001717	VIA-2291	Atherosclerosis	411.1, 414.0, 440	I20.0, I70
DNCL001718	Taberminogene vadenovec	Vascular restinosis following vascular graft surgery	.	.
DNCL001719	Aspirin/ esomeprazole fixed-dose combination	Cardiovascular disease	.	.
DNCL001720	Myolimus	Coronary artery restenosis	.	I20-I25
DNCL001721	Aspirin/lisinopril/ lovastatin fixed-dose combination	Cardiovascular disease	390-459	I00-I99
DNCL001722	AMT-011	Blood forming organ disorders	.	D75.9
DNCL001722	AMT-011	Hyperlipoproteinemia type I	272.0-272.4	E78
DNCL001723	ETC-1002	Dyslipidemia	272	E78
DNCL001724	Neu2000	Myocardial infarction	410, 434.91	I21, I22, I61-I63
DNCL001724	Neu2000	Stroke	.	I61-I63
DNCL001724	Neu2000	Stroke	410, 434.91	I21, I22, I61-I63
DNCL001725	PLX-PAD	Critical limb ischemia	459.89	I99.8
DNCL001725	PLX-PAD	Peripheral vascular disorders	.	I73.9
DNCL001726	TS-011	Stroke	434.91	I61-I63
DNCL001727	VM-202	Angina	.	I20
DNCL001727	VM-202	Myocardial ischemia	325, 430-459, 443.9, 459.89	G45-G46, I60-I95, I73.9, I99.8
DNCL001727	VM-202	Peripheral arterial disease	443.9	I73.9
DNCL001728	APN01	Heart failure	428	I50
DNCL001728	APN01	Hypertension	401, 410, 428	I10, I11, I12, I13, I15, I21, I22, I50
DNCL001728	APN01	Lung injury	.	S00-T98
DNCL001728	APN01	Myocardial infarction	401, 410, 428	I10, I11, I12, I13, I15, I21, I22, I50
DNCL001729	Epicardial angiogenesis patch	Heart failure	.	I50
DNCL001729	Epicardial angiogenesis patch	Heart failure	428	I50
DNCL001729	Epicardial angiogenesis patch	Ischemic heart diseases	390-429, 410-414, 428	I00-I52, I20-I25, I50
DNCL001730	AMR-001	Heart failure	.	I50
DNCL001730	AMR-001	Myocardial infarction	410	I21, I22
DNCL001731	BMS-394136	Arrhythmia	427	I47-I49
DNCL001732	BMS-914392	Atrial fibrillation	427.31	I48
DNCL001733	VTP-27999	Hypertension	401	I10, I11, I12, I13, I15
DNCL001734	Stem cell therapy	AIDS-related lymphoma	202	C81-C96
DNCL001734	Stem cell therapy	Graft-versus-host disease	279.5	T86.0
DNCL001734	Stem cell therapy	Spinal cord injuries	.	S14,S24,S34
DNCL001734	Stem cell therapy	Stroke	410, 434.91	I21, I22, I61-I63
DNCL001735	SDF-1	Heart failure	.	I50
DNCL001735	SDF-1	Heart failure	428	I50
DNCL001736	ALO 212	Critical limb ischemia	459.89	I99.8
DNCL001737	Thymosin beta-4	Alopecia	.	L65.9
DNCL001737	Thymosin beta-4	Myocardial infarction	410	I21, I22
DNCL001738	SPI-017	Lumbar spinal stenosis	.	M48.06
DNCL001738	SPI-017	Peripheral arterial disorders	.	I73.9
DNCL001739	Myoblast cell transplantation therapy	Congestive heart failure	428	I50
DNCL001740	K-604	Arteriosclerosis	.	I70
DNCL001740	K-604	Atherosclerosis	414.0, 440	I70
DNCL001741	HPP-593	Diabetes mellitus	250	E08-E13
DNCL001741	HPP-593	Dyslipidemia	272	E78
DNCL001742	NA-1 neuroprotectant	Stroke	434.91	I61-I63
DNCL001743	INT0001/2004	Hypertension	401	I10, I11, I12, I13, I15
DNCL001744	TKM-ApoB	Hypercholesterolemia	272	E78.0
DNCL001745	NX-CP-105	Myocardial infarction	410	I21, I22
DNCL001746	Angiotensin inhibitor therapeutic vaccine	Hypertension	401	I10, I11, I12, I13, I15
DNCL001747	TRV120027	Acute heart failure	428	I50
DNCL001747	TRV120027	Heart failure	.	I50
DNCL001748	CSL112	Acute coronary syndrome	411.1	I20.0
DNCL001749	Cardiac PET imaging agent	Diagnosis of coronary artery disease	410-414, 429.2	I20-I25
DNCL001750	Myocardial perfusion imaging agent	Diagnosis of coronary disorders	410-414, 429.2	I20-I25
DNCL001751	ANGX-1039	Intermittent claudication	440.21	I73.9
DNCL001752	Cardiovascular therapeutic	Cardiovascular disease	390-459	I00-I99
DNCL001753	Hydralazine hydrochloride/ isosorbide dinitrate	Heart failure	428	I50
DNCL001754	NU-172	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001755	CER-001	Acute coronary syndrome	.	I24.9
DNCL001755	CER-001	Post-acute coronary syndrome	.	I24.9
DNCL001756	CER-002	Cardiovascular disease	.	I00-I99
DNCL001756	CER-002	Dyslipidemia	272	E78
DNCL001757	CER-627	Dyslipidemia	272	E78
DNCL001758	Sobetirome	Dyslipidemia	272	E78
DNCL001759	ISIS 353512	Cardiovascular disease	390-459	I00-I99
DNCL001760	ISIS-APOCIIIRx	Coronary artery disease	410-414, 429.2	I20-I25
DNCL001760	ISIS-APOCIIIRx	Hypertriglyceridemia	.	E78.1,E78.2,E78.3
DNCL001760	ISIS-APOCIIIRx	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DNCL001760	ISIS-APOCIIIRx	Severe hypertriglyceridemia	.	I20-I25
DNCL001761	Nitrite inhalation	Hypertension	.	I10-I15
DNCL001761	Nitrite inhalation	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001762	BIBT986	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001763	LMI1195	Diagnosis of heart failure	428	I50
DNCL001763	LMI1195	Heart failure	.	I50
DNCL001764	GS 9667	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DNCL001765	Autologous cell therapy	Ischemic heart diseases	410-414	I20-I25
DNCL001766	RG7418	Arteriosclerosis	.	I70
DNCL001766	RG7418	Atherosclerosis	414.0, 440	I70
DNCL001766	RG7418	Cardiovascular disease	444	I74
DNCL001767	SAR104772	Stroke	434.91	I61-I63
DNCL001768	MK-3614	Hypertension	401	I10, I11, I12, I13, I15
DNCL001769	MK-5478	Hypertension	401	I10, I11, I12, I13, I15
DNCL001770	MK-8266	Essential hypertension	401	I10, I11, I12, I13, I15
DNCL001771	RWJ-676070	Congestive heart failure	428, 428.0	I50
DNCL001771	RWJ-676070	Hyponatremia	276.1, 428	E87.1, I50
DNCL001772	SPD 535	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001773	SLV338	Cardiometabolic disorders	.	E88.9
DNCL001774	APD811	Hypertension	.	I10-I15
DNCL001774	APD811	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001775	BVI-007	Myocardial infarction	410, 434.91	I21, I22, I61-I63
DNCL001775	BVI-007	Thrombotic stroke	410, 434.91	I21, I22, I61-I63
DNCL001776	Adipose stem cell therapy	Myocardial infarction	.	I21-I22
DNCL001776	Adipose stem cell therapy	Myocardial infarction	410	I21, I22
DNCL001776	Adipose stem cell therapy	Myocardial ischemia	410, 459.89	I21, I22, I99.8
DNCL001777	MB-07811	Hyperlipidemia	272.0-272.4	E78
DNCL001778	ILS920	Stroke	434.91	I61-I63
DNCL001779	PF-04950615	Hypercholesterolemia	272	E78.0
DNCL001779	PF-04950615	Hyperlipidemia	272.0-272.4	E78
DNCL001780	PSI-697	Atherosclerosis	414.0, 437.6, 440, 453, 671.5, 671.9	I70, I80-I82
DNCL001780	PSI-697	Thrombosis	.	I80-I82
DNCL001780	PSI-697	Thrombosis	414.0, 437.6, 440, 453, 671.5, 671.9	I70, I80-I82
DNCL001781	Turofexorate isopropyl	Hyperlipidemia	272.0-272.4	E78
DNCL001782	LU AA24493	Stroke	434.91	I61-I63
DNCL001783	Resten-MP	Coronary artery restenosis	.	I20-I25
DNCL001784	Ularitide	Acute decompensated heart failure	428	I50
DNCL001784	Ularitide	Heart failure	.	I50
DNCL001785	GSK2190914	Asthma	493	J45
DNCL001785	GSK2190914	Cardiovascular disease	.	I00-I99
DNCL001785	GSK2190914	Cardiovascular disease	390-459	I00-I99
DNCL001786	GSK568859	Atherosclerosis	414.0, 440	I70
DNCL001787	GSK813893	Stroke in atrial fibrillation	427.31, 434.91	I48, I61-I63
DNCL001788	BR-4628	Congestive heart failure	428	I50
DNCL001788	BR-4628	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DNCL001789	Thrombosis inhibitor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001790	MTR105	Cardiac surgery-related hypotension	458, 796.3	I95
DNCL001790	MTR105	Hypotension	458, 796.3	I95
DNCL001791	REG2	Venous thrombosis	.	I82
DNCL001791	REG2	Venous thrombosis	453	I80-I82
DNCL001792	MP-124	Acute ischemic stroke	434.91	I61-I63
DNCL001792	MP-124	Stroke	434.91	I61-I63
DNCL001793	RBx10558	Hyperlipidemia	272.0-272.4	E78
DNCL001794	MER-102	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001795	SAR236553	Hypercholesterolaemia	.	E78.0
DNCL001795	SAR236553	Hypercholesterolemia	272	E78.0
DNCL001796	GGF	Congestive heart failure	428	I50
DNCL001797	PA08140	Cardiovascular disease	390-459	I00-I99
DNCL001798	RG1512	Acute coronary syndrome	390-459, 411.1	I00-I99, I20.0
DNCL001798	RG1512	Peripheral vascular disease	443.9	I73.9
DNCL001799	RG7232	Dyslipidemia	272	E78
DNCL001800	RO-4905417	Acute coronary syndrome	.	I24.9
DNCL001800	RO-4905417	Peripheral arterial disease	443.9	I73.9
DNCL001801	Beperminogene perplasmid	Heart disease	.	I00-I52
DNCL001801	Beperminogene perplasmid	Ischemic heart diseases	325, 390-429, 410-414, 430-459, 443.9	G45-G46, I00-I52, I20-I25, I60-I95, I73.9
DNCL001801	Beperminogene perplasmid	Peripheral arterial disease	443.9	I73.9
DNCL001802	DB-772d	Cardiovascular disease	390-459	I00-I99
DNCL001803	BMS-779788	Atherosclerosis	414.0, 440	I70
DNCL001804	ACY001	Chronic ischemia	459.89	I99.8
DNCL001804	ACY001	Coronary ischemia	.	I25
DNCL001805	Danegaptide	Atrial fibrillation	427.31	I48
DNCL001806	PF-3049423	Ischemic stroke	434.91	I61-I63
DNCL001806	PF-3049423	Stroke	434.91	I61-I63
DNCL001807	ALD-201	Ischemic heart failure	428	I50
DNCL001808	MultiGeneAngio cell therapy	Vascular systems peripheral arterial disorders	447	I77
DNCL001809	B-type natriuretic peptide	Chronic heart failure	428	I50
DNCL001809	B-type natriuretic peptide	Heart disease	390-429	I00-I52
DNCL001810	VMD-30283	Myocardial infarction	410	I21, I22
DNCL001811	PVS-10200	Peripheral arterial disorders	.	I73.9
DNCL001811	PVS-10200	Restenosis	.	I51.89
DNCL001812	LT-1951	Coronary artery disease	.	I20-I25
DNCL001812	LT-1951	Coronary artery restenosis	.	I20-I25
DNCL001813	PL2100	Stroke	410, 434.91	I21, I22, I61-I63
DNCL001814	PRT-201	Peripheral arterial occlusive disease	.	I73.9
DNCL001814	PRT-201	Vascular access for hemodialysis	.	I73.9
DNCL001815	AAV1/SERCA2a gene therapy	Advanced heart failure	428	I50
DNCL001815	AAV1/SERCA2a gene therapy	Heart failure	.	I50
DNCL001816	Saratin	Inflammatory diseases	.	.
DNCL001816	Saratin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001817	LCQ908	Familial chylomicronemia syndrome	.	J10, J11
DNCL001817	LCQ908	Hepatitis C virus infection	.	B17.1,B18.2
DNCL001817	LCQ908	Hyperlipoproteinemia type I; Hyperlipoproteinemia type V	272.0-272.4	E78
DNCL001817	LCQ908	Type 2 diabetes	250.00, 250.02	E11
DNCL001818	Eicosapentaenoic acid/docosa-hexaenoic acid	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DNCL001819	TAL-0500018	Peripheral arterial occlusive disorder	434.91	I61-I63
DNCL001819	TAL-0500018	Stroke	325, 430-459, 434.91, 443.9	G45-G46, I60-I95, I61-I63, I73.9
DNCL001820	ALD-301	Critical limb ischemia	459.89	I99.8
DNCL001820	ALD-301	Ischemia	459.89	I99.8
DNCL001821	Hypoxia therapeutic	Hypoxia	799.02	R09.02
DNCL001821	Hypoxia therapeutic	Hypoxia associated with intermittent claudication	440.21, 443.9, 799.02	I73.9, R09.02
DNCL001822	AMG 423	Angina pectoris; cardiomyopathies	413, 428	I20, I50
DNCL001822	AMG 423	Heart disease	.	I00-I52
DNCL001822	AMG 423	Heart failure	428	I50
DNCL001823	BAY 60-4552	Heart failure	428	I50
DNCL001824	BMS-180431	Hyperlipidemia	272.0-272.4	E78
DNCL001825	BMS-582949	Atherosclerosis	414.0, 440	I70
DNCL001825	BMS-582949	Psoriasis	696	L40
DNCL001826	BMS-770767	Hypercholesterolemia	272	E78.0
DNCL001827	BMS-823778	Hypercholesterolemia	272	E78.0
DNCL001828	NTC-801	Atrial fibrillation	.	I48
DNCL001828	NTC-801	Atrial fibrillation; Atrial flutter	427.31, 427.32, 487, 488	I48, J10, J11
DNCL001829	KAI-9803/ BMS-875944	Reperfusion injury following acute myocardial infarction	410	I21, I21-I22, I22
DNCL001830	GP-531	Myocardial ischemia	459.89	I99.8
DNCL001831	Revascor	Myocardial infarction	410, 428	I21, I22, I50
DNCL001832	MultiStem	Myocardial infarction	410, 434.91	I21, I22, I61-I63
DNCL001832	MultiStem	Stroke	.	I61-I63
DNCL001833	Beraprost modified release	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001834	Aviptadil	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001835	Cell-based gene therapy	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001836	Nitric oxide synthase gene therapy	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001837	K-134	Arteriosclerosis	440	I70
DNCL001838	NTx-265	Stroke	434.91	I61-I63
DNCL001839	Prochymal	Repair of heart tissue following myocardial infarction	410	I21, I22
DNCL001840	XOMA 052	Cardiovascular disease	390-459	I00-I99
DNCL001840	XOMA 052	Diabetes mellitus type 2	.	E11
DNCL001841	AR9281	Hypertension	401	I10, I11, I12, I13, I15
DNCL001842	BB3	Cerebrovascular ischaemia	.	G45.9,I67.8
DNCL001842	BB3	Congestive heart failure	428, 428.0	I50
DNCL001843	PL-3994	Asthma	.	J45
DNCL001843	PL-3994	Congestive heart failure	401, 428, 428.0	I10, I11, I12, I13, I15, I50
DNCL001843	PL-3994	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
DNCL001844	Bendavia	Acute myocardial infarction	410	I21-I22
DNCL001844	Bendavia	Chronic heart failure	428	I50
DNCL001845	HIF-1 alpha gene therapy	Occlusive arterial disease	.	I73.9
DNCL001846	M118	Acute coronary syndrome	411.1	I20.0
DNCL001847	Ferumoxytol	Diagnosis of peripheral arterial disorders	.	I73.9
DNCL001848	Egaptivon pegol	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001849	MD-0727	Hypercholesterolemia	272	E78.0
DNCL001850	SLx-4090	Diabetes mellitus	250	E08-E13
DNCL001850	SLx-4090	Dyslipidemia	272	E78
DNCL001850	SLx-4090	Hyperlipidemia	.	E78.5
DNCL001851	Coronary artery disease gene therapy	Coronary artery disease	.	I20-I25
DNCL001851	Coronary artery disease gene therapy	Coronary artery disease	410-414, 429.2	I20-I25
DNCL001852	ACT-280778	Essential hypertension	401	I10, I11, I12, I13, I15
DNCL001852	ACT-280778	Hypertension	401	I10, I11, I12, I13, I15
DNCL001853	Tezosentan	Cardiotonic	.	I50
DNCL001853	Tezosentan	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001854	YSPSL	Anemia	.	D50-D64
DNCL001854	YSPSL	Myocardial reperfusion injury associated with liver transplantation	996.82	T86.4
DNCL001855	Tissue repair stem cell therapy	Dilated cardiomyopathy	359.4-359.9, 425.4, 728-728	G71-G72, I42.0, M60-M63
DNCL001855	Tissue repair stem cell therapy	Peripheral ischemia	459.89	I99.8
DNCL001856	ART-123	Disseminated intravascular coagulation	286.6	D65
DNCL001857	Vernakalant	Atrial fibrillation	427.31	I48
DNCL001858	18F-flurpiridaz	Diagnosis of coronary disorders	410-414, 429.2	I20-I25
DNCL001859	Cangrelor	Coronary thrombosis	414.8, 437.6, 453, 671.5, 671.9	I24.0, I80-I82
DNCL001859	Cangrelor	Ischemic heart disorders	437.6, 453, 671.5, 671.9	I80-I82
DNCL001859	Cangrelor	Thrombosis	.	I80-I82
DNCL001860	MDCO-216	Acute coronary syndrome	411.1, 414.0, 440	I20.0, I70
DNCL001860	MDCO-216	Atherosclerosis	411.1, 414.0, 440	I20.0, I70
DNCL001860	MDCO-216	Coronary artery disease	.	I20-I25
DNCL001861	Icodextrin solution	Congestive heart failure	428	I50
DNCL001862	Cicletanine	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001863	LY2484595	Hypercholesterolaemia	.	E78.0
DNCL001863	LY2484595	Hypercholesterolemia	272	E78.0
DNCL001864	Celivarone	Ventricular arrhythmias	427	I47-I49
DNCL001865	Lercanidipine MR	Hypertension	401	I10, I11, I12, I13, I15
DNCL001866	JNJ-39588146	Heart failure	428	I50
DNCL001867	K201	Atrial fibrillation	427.31	I48
DNCL001868	DCCR	Dyslipidemia	272	E78
DNCL001869	PF-489791	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNCL001869	PF-489791	Raynaud's disease	443	I73.0
DNCL001870	Terguride	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001871	Resten-NG	Cancer	.	C00-C97
DNCL001871	Resten-NG	Coronary artery restenosis	.	I20-I25
DNCL001872	E5555	Acute coronary syndrome	411.1	I20.0
DNCL001873	Elinogrel	Acute coronary syndrome	410, 411.1	I20.0, I21, I22
DNCL001873	Elinogrel	Cardiovascular disease	.	I00-I99
DNCL001873	Elinogrel	Myocardial infarction	410, 411.1	I20.0, I21, I22
DNCL001874	LCI699	Cushing's disease	.	E24.0
DNCL001874	LCI699	Cushing's disease	255	E24.0
DNCL001874	LCI699	Heart failure	401, 428	I10, I11, I12, I13, I15, I50
DNCL001874	LCI699	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
DNCL001874	LCI699	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL001875	LCZ696	Heart failure	.	I50
DNCL001875	LCZ696	Heart failure	401, 428	I10, I11, I12, I13, I15, I50
DNCL001875	LCZ696	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
DNCL001876	GSK249320	Stroke	434.91	I61-I63
DNCL001877	Sodelglitazar	Hyperlipidemia	272.0-272.4	E78
DNCL001878	MTR107	Intradialytic hypotension	458	I95
DNCL001879	IK-5001	Congestive heart failure following acute myocardial infarction	410, 428, 428.0	I21, I21-I22, I22, I50
DNCL001880	REG1	Acute coronary syndrome	411.1	I20.0
DNCL001881	CXL-1020	Acute decompensated heart failure	428	I50
DNCL001881	CXL-1020	Chronic heart failure	428	I50
DNCL001882	CMX-2043	Myocardial reperfusion injury	.	T86.4
DNCL001883	ATI-2042	Atrial fibrillation	427.31	I48
DNCL001884	Iodofiltic acid I-123	Diagnosis of myocardial ischemia	459.89	I99.8
DNCL001884	Iodofiltic acid I-123	Myocardial disease	.	I21-I22,I40-I42
DNCL001885	Micardis telmisartan	Hypertension	401	I10, I11, I12, I13, I15
DNCL001886	SCH-900271	Acute ischemic stroke	434.91	I61-I63
DNCL001886	SCH-900271	Hyperlipidemia	272.0-272.4	E78
DNCL001887	Diannexin	Myocardial reperfusion injury	.	T86.4
DNCL001888	Human hemoglobin	Blood transfusion	.	D50-D89
DNCL001888	Human hemoglobin	Ischemia	459.89	I99.8
DNCL001889	Capadenoson	Atrial fibrillation	427.31	I48
DNCL001890	INOmax nitric oxide inhalation	Congestive heart failure	428, 428.0	I50
DNCL001891	V10153	Ischemic stroke	434.91	I61-I63
DNCL001892	1-MNA	Hyperlipidemia	272.0-272.4	E78
DNCL001892	1-MNA	Lipid metabolism disorder	.	E75-E78
DNCL001893	Novolimus	Coronary artery restenosis	.	I51.89
DNCL001893	Novolimus	Restenosis	.	I51.89
DNCL001894	Tecarfarin	Cerebrovascular ischaemia	.	G45.9,I67.8
DNCL001894	Tecarfarin	Thromboembolism	444.9	I74, I82, O88, T79.0-T79.1
DNCL001895	Darexaban maleate	Acute coronary syndrome	.	I24.9
DNCL001895	Darexaban maleate	Venous thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL001896	Cell-based heart damage therapy	Congestive heart failure	428	I50
DNCL001897	DP-b99	Stroke	434.91	I61-I63
DNCL001898	Ivabradine	Angina	413	I20
DNCL001898	Ivabradine	Coronary artery disease	410-414, 428.0, 429.2	I20-I25, I50
DNCL001899	Terutroban sodium	Thromboembolism	.	I80-I82
DNCL001900	Desmoteplase	Ischemic stroke	434.91	I61-I63
DNCL001900	Desmoteplase	Stroke	.	I61-I63
DNCL001901	INDI-702	Intermittent claudication	440.21	I73.9
DNCL001902	Tafamidis meglumine	Transthyretin familial amyloid cardiomyopathy	.	I42
DNCL001903	Clazosentan	Vasospasm following subarachnoid hemorrhage	430, 728.85, 852.0, 852.1	I60, P10.3, R25.2, S06.6
DNCL001904	Macitentan	Cardiovascular disease	.	I00-I99
DNCL001904	Macitentan	Glioblastoma	191	C71
DNCL001904	Macitentan	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001905	Selexipag	Pulmonary arterial hypertension	416	I27.0, I27.2
DNCL001905	Selexipag	Thrombosis	.	I80-I82
DNCL001906	Riferminogene pecaplasmid	Critical limb ischemia	459.89	I99.8
DNCL001907	Atorvastatin/ ezetimibe	Hypercholesterolemia	272	E78.0
DNCL001908	Laropiprant/niacin/ simvastatin combination	Hyperlipidemia	272.0-272.4	E78
DNCL001909	Fenofibrate/ simvastatin	Hyperlipidemia	272.0-272.4	E78
DNCL001910	Alferminogene tadenovec	Heart disease	.	I00-I52
DNCL001910	Alferminogene tadenovec	Myocardial ischemia	459.89	I99.8
DNCL001911	AMR101	Hypertriglyceridemia	272.1	E78.1, E78.2, E78.3
DNCL001912	Apadenoson	Diagnosis of coronary disorders	410-414, 429.2	I20-I25
DNCL001913	Recombinant relaxin	Acute heart failure	428	I50
DNCL001913	Recombinant relaxin	Heart failure	.	I50
DNCL001914	Mega-3-acid ethyl esters	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
DNCL001915	Riociguat	Chronic thromboembolic pulmonary hypertension	401, 416.0	I10, I11, I12, I13, I15, I27.0, I27.2
DNCL001915	Riociguat	Pulmonary arterial hypertension	.	I27.0,I27.2
DNCL001915	Riociguat	Pulmonary hypertension	416	I27.0, I27.2
DNCL001916	Edoxaban tosylate	Embolism; Venous thromboembolism	434.91, 444.9, 453	I61-I63, I74, I80-I82, I82, O88, T79.0-T79.1
DNCL001916	Edoxaban tosylate	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
DNCL001917	Irbesartan/ trichlormethiazide fixed-dose combination	Hypertension	401	I10, I11, I12, I13, I15
DNCL001918	Iobenguane I 123 injection	Diagnosis of heart failure	428	I50
DNCL001919	Amlodipine/ irbesartan fixed-dose combination	Hypertension	401	I10, I11, I12, I13, I15
DNCL001920	Omega-3 acid ethyl esters	Atrial fibrillation	272, 427.31	E78, I48
DNCL001920	Omega-3 acid ethyl esters	Hypertriglyceridemia	.	E78.1
DNCL001921	Clonidine controlled-release	Hypertension	401	I10, I11, I12, I13, I15
DNCL001922	AAB-002	Alzheimer's disease	331	G30
DNCL001923	ACC-002	Alzheimer's disease	331	G30
DNCL001924	LMTX	Acute myeloid leukemia	205	C92.0
DNCL001924	LMTX	Mild to moderate alzheimer's disease	331	G30
DNCL001925	MCD-386/glycopyrrolate	Autosomal dominant alzheimer's disease	331	G30
DNCL001926	BCI-632	Alzheimer's disease	331	G30
DNCL001926	BCI-632	Cognitive impairment	.	F06.7
DNCL001926	BCI-632	Major depressive disorder	296.2, 296.3	F32, F33
DNCL001927	BCI-838	Alzheimer's disease	331	G30
DNCL001927	BCI-838	Major depressive disorder	296.2, 296.3	F32, F33
DNCL001928	BIIB037	Alzheimer's disease	.	G30,F00
DNCL001928	BIIB037	Alzheimer's disease	331	G30
DNCL001929	Bisnorcymserine	Alzheimer's disease	.	G30,F00
DNCL001929	Bisnorcymserine	Alzheimer's disease	331	G30
DNCL001930	BMS-241027	Alzheimer's disease	.	G30,F00
DNCL001930	BMS-241027	Alzheimer's disease; Tauopathies	290-294, 294.0, 331.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, G30, R41.3
DNCL001931	BMS-932481	Alzheimer's disease	.	G30,F00
DNCL001931	BMS-932481	Alzheimer's disease	331	G30
DNCL001932	BMS-933043	Cognitive impairment	331.83	G31.84
DNCL001932	BMS-933043	Psychiatric disorders	.	F99
DNCL001932	BMS-933043	Psychiatric disorders	290-319	F01-F99
DNCL001933	DSP-8658	Alzheimer's disease	331	G30
DNCL001933	DSP-8658	Type 2 diabetes	250.00, 250.02	E11
DNCL001934	E2212	Alzheimer's disease	331	G30
DNCL001935	E2609	Alzheimer's disease	.	G30,F00
DNCL001935	E2609	Alzheimer's disease	331	G30
DNCL001936	EVP-0962	Alzheimer's disease	.	G30,F00
DNCL001936	EVP-0962	Alzheimer's disease	331	G30
DNCL001937	Exebryl-1	Alzheimer's disease	331	G30
DNCL001938	HPP-854	Alzheimer's disease	.	G30,F00
DNCL001938	HPP-854	Alzheimer's disease	331	G30
DNCL001939	Irdabisant	Cognition disorders	295	F20
DNCL001939	Irdabisant	Cognitive dysfunction	331	G30
DNCL001939	Irdabisant	Cognitive impairment	.	F06.7
DNCL001940	MK-8931	Alzheimer's disease	.	G30,F00
DNCL001940	MK-8931	Alzheimer's disease	331	G30
DNCL001941	PF-05212377	Alzheimer's disease	.	G30,F00
DNCL001941	PF-05212377	Alzheimer's disease	331	G30
DNCL001942	Pioglitazone companion diagnostic	Alzheimer's disease	331	G30
DNCL001942	Pioglitazone companion diagnostic	Major depressive disorder	.	F32,F33
DNCL001943	RG1662	Cognitive disorders	290-294, 294.0, 758.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, Q90, R41.3
DNCL001943	RG1662	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DNCL001943	RG1662	Cognitive impairment	.	F06.7
DNCL001944	RG7129	Alzheimer's disease	.	G30,F00
DNCL001944	RG7129	Alzheimer's disease	331	G30
DNCL001945	SAR228810	Alzheimer's disease	331	G30
DNCL001946	SGC-1061	Alzheimer's disease	331	G30
DNCL001947	TD-8954	Alzheimer's disease	.	G30,F00
DNCL001947	TD-8954	Alzheimer's disease	331.0, 331.83	G30, G31.84
DNCL001947	TD-8954	GI motility dysfunction	.	K55-K64
DNCL001948	UB-311	Alzheimer's disease	.	G30,F00
DNCL001948	UB-311	Alzheimer's disease	331	G30
DNCL001948	UB-311	Mild to moderate alzheimer's disease	331	G30
DNCL001949	V950	Alzheimer's disease	331	G30
DNCL001950	XEL 001HP	Alzheimer's disease	331	G30
DNCL001951	AAB-003/PF-05236812	Alzheimer's disease	331	G30
DNCL001952	ABT-126	Alzheimer's disease	.	G30,F00
DNCL001952	ABT-126	Alzheimer's disease	331	G30
DNCL001952	ABT-126	Mild to moderate alzheimer's disease	331	G30
DNCL001952	ABT-126	Schizophrenia	295	F20
DNCL001953	ABT-560	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
DNCL001954	ABT-957	Alzheimer's disease	.	G30,F00
DNCL001954	ABT-957	Alzheimer's disease	331	G30
DNCL001955	AD03 vaccine	Alzheimer's disease	331	G30
DNCL001956	ARC029	Mild to moderate alzheimer's disease	331	G30
DNCL001957	ARC031	Alzheimer's disease	.	G30,F00
DNCL001957	ARC031	Alzheimer's disease	331	G30
DNCL001958	ASP0777	Alzheimer's disease	331	G30
DNCL001958	ASP0777	Dementia	290-294, 331.0	F01-F07, G30
DNCL001959	AVN 322	Alzheimer's disease	.	G30,F00
DNCL001959	AVN 322	Alzheimer's disease	331	G30
DNCL001960	BAN2401	Alzheimer's disease	.	G30,F00
DNCL001960	BAN2401	Alzheimer's disease	331	G30
DNCL001960	BAN2401	Mild to moderate alzheimer's disease	331	G30
DNCL001961	GSK933776A	Alzheimer's disease	.	G30,F00
DNCL001961	GSK933776A	Alzheimer's disease	331	G30
DNCL001962	LNK-754	Bladder cancer	.	C67
DNCL001962	LNK-754	Mild alzheimer's disease	331	G30
DNCL001963	MK-3134	Dementia	290-294	F01-F07
DNCL001964	MK-3328	Alzheimer's disease	.	G30,F00
DNCL001964	MK-3328	Alzheimer's disease	331	G30
DNCL001965	SYN-120	Alzheimer's disease	331	G30
DNCL001965	SYN-120	Cognition disorders	295	F20
DNCL001965	SYN-120	Cognitive disorders	290-294, 294.0, 331.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, G30, R41.3
DNCL001966	APH-0703	Alzheimer's disease	331	G30
DNCL001966	APH-0703	Alzheimer's disease; Cognitive disorders	290-294, 294.0, 331.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, G30, R41.3
DNCL001967	Secretase inhibitor	Alzheimer's disease	331	G30
DNCL001968	Bapineuzumab subcutaneous	Alzheimer's disease	331	G30
DNCL001969	BMS-708163	Alzheimer's disease	.	G30,F00
DNCL001969	BMS-708163	Alzheimer's disease	331	G30
DNCL001970	CERE-110	Alzheimer's disease	.	G30,F00
DNCL001970	CERE-110	Alzheimer's disease	331	G30
DNCL001971	CHF-5074	Alzheimer's disease	331	G30
DNCL001971	CHF-5074	Mild cognitive impairment	331.83	F06.7
DNCL001972	Crenezumab	Alzheimer's disease	.	G30,F00
DNCL001972	Crenezumab	Alzheimer's disease	331	G30
DNCL001973	Davunetide intranasal	Alzheimer's disease; Mild cognitive impairment	331.0, 331.83	F06.7, G30, G31.84
DNCL001973	Davunetide intranasal	Mild cognitive impairment associated with schizophrenia	295, 331.83	F06.7, F20, G31.84
DNCL001974	ELND005	Alzheimer's disease	.	G30,F00
DNCL001974	ELND005	Mild to moderate alzheimer's disease	331	G30
DNCL001975	EVP-6124	Mild to moderate alzheimer's disease	331	G30
DNCL001975	EVP-6124	Neurological disease	.	G00-G99
DNCL001975	EVP-6124	Schizophrenia	295	F20
DNCL001976	LU AE58054	Alzheimer's disease	331	G30
DNCL001976	LU AE58054	Schizophrenia	.	F20
DNCL001976	LU AE58054	Schizophrenia	295, 331.83	F20, G31.84
DNCL001977	MSDC-0160	Alzheimer's disease	331	G30
DNCL001978	NIC5-15	Alzheimer's disease	.	G30,F00
DNCL001978	NIC5-15	Alzheimer's disease	331	G30
DNCL001979	R-phenserine	Alzheimer's disease	.	G30,F00
DNCL001979	R-phenserine	Alzheimer's disease; Mild cognitive impairment	331.0, 331.83	F06.7, G30, G31.84
DNCL001980	PRX-3140	Alzheimer's disease	.	G30,F00
DNCL001980	PRX-3140	Alzheimer's disease	331	G30
DNCL001980	PRX-3140	Post-traumatic stress disorder	309.81	F43.1
DNCL001981	RG1577	Alzheimer's disease	.	G30,F00
DNCL001981	RG1577	Alzheimer's disease	331	G30
DNCL001982	ST-101	Alzheimer's disease	331	G30
DNCL001982	ST-101	Anxiety disorder	.	F40-F42
DNCL001983	TTP-448	Alzheimer's disease	.	G30,F00
DNCL001983	TTP-448	Alzheimer's disease	331	G30
DNCL001984	Vanutide cridificar	Alzheimer's disease	.	G30,F00
DNCL001984	Vanutide cridificar	Alzheimer's disease	331	G30
DNCL001985	VI-1121	Alzheimer's disease	331	G30
DNCL001986	ABT-288	Alzheimer's disease	.	G30,F00
DNCL001986	ABT-288	Alzheimer's disease	331	G30
DNCL001986	ABT-288	Schizophrenia	295	F20
DNCL001987	ABT-384	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL001987	ABT-384	Mild to moderate alzheimer's disease	331	G30
DNCL001988	AD02 vaccine	Alzheimer's disease	331	G30
DNCL001989	AVN 101	Alzheimer's disease	.	G30,F00
DNCL001989	AVN 101	Alzheimer's disease	331	G30
DNCL001989	AVN 101	Anxiety disorder	300	F40-F42
DNCL001990	AVN 397	Alzheimer's disease	331	G30
DNCL001990	AVN 397	Anxiety disorder	300	F40-F42
DNCL001991	AZD4694	Alzheimer's disease	331	G30
DNCL001992	AZD5213	Alzheimer's disease	.	G30,F00
DNCL001992	AZD5213	Alzheimer's disease	331	G30
DNCL001992	AZD5213	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL001993	CAD106	Alzheimer's disease	.	G30,F00
DNCL001993	CAD106	Alzheimer's disease	331	G30
DNCL001994	T-817MA	Alzheimer's disease	331	G30
DNCL001994	T-817MA	Mild to moderate alzheimer's disease	331	G30
DNCL001995	Immune globulin	Alzheimer's disease	331	G30
DNCL001996	Gantenerumab	Alzheimer's disease	.	G30,F00
DNCL001996	Gantenerumab	Alzheimer's disease	331	G30
DNCL001997	F18-florbetaben	Alzheimer's disease	331	G30
DNCL001998	F18-flutemetamol	Alzheimer's disease	.	G30,F00
DNCL001998	F18-flutemetamol	Alzheimer's disease	331	G30
DNCL001999	Human immunoglobulin	Alzheimer's disease	331	G30
DNCL002000	Solanezumab	Alzheimer's disease	.	G30,F00
DNCL002000	Solanezumab	Alzheimer's disease	331	G30
DNCL002001	Formoterol/fluticasone propionate	Asthma	493	J45
DNCL002002	ABT-308	Asthma	493	J45
DNCL002003	RG7185	Asthma	493	J45
DNCL002004	OPK-0018	Asthma	493	J45
DNCL002005	ONO-6950	Asthma	493	J45
DNCL002006	PUR003	Asthma	493	J45
DNCL002006	PUR003	Infectious disease	001-139	A00-B99
DNCL002007	BI-144807	Asthma	493	J45
DNCL002008	CNTO 3157	Asthma	493	J45
DNCL002009	CNTO 5825	Allergic asthma	493	J45
DNCL002010	MK-1029	Asthma	493	J45
DNCL002010	MK-1029	Mild to moderate asthma	493	J45
DNCL002011	AMG 157	Asthma	.	J45
DNCL002011	AMG 157	Asthma	493	J45
DNCL002012	ARRY-502	Allergic asthma	493	J45
DNCL002013	R zileuton	Asthma	493	J45
DNCL002014	QGE031	Allergic diseases	995.3	T78.4
DNCL002014	QGE031	Asthma	493	J45
DNCL002015	GSK2239633	Asthma	493	J45
DNCL002016	GSK2269557	Asthma	.	J45
DNCL002016	GSK2269557	Asthma	493	J45
DNCL002017	AM211	Asthma	493	J45
DNCL002017	AM211	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNCL002017	AM211	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002018	GSK1440115	Asthma	493	J45
DNCL002019	N6022	Acute asthma	493	J45
DNCL002019	N6022	Asthma	.	J45
DNCL002020	RNS60	Asthma	493	J45
DNCL002021	TC-6987	Asthma	493	J45
DNCL002022	ASM8	Allergic asthma	493	J45
DNCL002022	ASM8	Asthma	493	J45
DNCL002023	Syk kinase silencer	Asthma	.	J45
DNCL002023	Syk kinase silencer	Asthma	493	J45
DNCL002024	Setipiprant	Asthma	493	J45
DNCL002025	BI-54903	Asthma	493	J45
DNCL002026	BI-54903/olodaterol fixed-dose combination	Asthma	493	J45
DNCL002027	BI-671800	Asthma	493	J45
DNCL002028	Olodaterol	Asthma	493	J45
DNCL002028	Olodaterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002029	JNJ-40929837	Asthma	493	J45
DNCL002030	Lebrikizumab	Allergic asthma	493, 995.3	J45, T78.4
DNCL002030	Lebrikizumab	Severe asthma	493	J45
DNCL002031	RG7449	Allergic asthma	493	J45
DNCL002031	RG7449	Asthma	.	J45
DNCL002031	RG7449	Asthma	493	J45
DNCL002032	House dust mite allergy vaccine tablet	Allergic asthma	493	J45
DNCL002033	Montelukast/mometasone	Asthma	493	J45
DNCL002034	LAS 100977	Asthma	.	J45
DNCL002034	LAS 100977	Asthma	493	J45
DNCL002034	LAS 100977	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002035	AMG 827	Asthma	493	J45
DNCL002036	MN-221	Aging skin	.	L00-L99
DNCL002036	MN-221	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002036	MN-221	Exacerbations of acute asthma	493	J45
DNCL002037	Indacaterol/mometasone	Asthma	493	J45
DNCL002038	QAV680	Asthma	493	J45
DNCL002039	QAW039	Asthma	493	J45
DNCL002040	QAX576	Asthma	.	J45
DNCL002040	QAX576	Asthma	493	J45
DNCL002041	GSK870086	Asthma	493	J45
DNCL002042	GW766994	Asthma	493	J45
DNCL002043	SAR231893	Asthma	.	J45
DNCL002043	SAR231893	Asthma	493	J45
DNCL002043	SAR231893	Asthma; Atopic dermatitis	493, 691.8, 692.9	J45, L20, L20-L30
DNCL002044	JNJ-39758979	Asthma	493	J45
DNCL002045	GSK679586	Asthma	493	J45
DNCL002046	VR506	Asthma	493	J45
DNCL002047	Vilanterol	Asthma	493	J45
DNCL002047	Vilanterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002048	Reslizumab	Asthma	.	J45
DNCL002048	Reslizumab	Eosinophilic asthma	493	J45
DNCL002049	Formoterol/budesonide	Asthma	493	J45
DNCL002050	E004	Asthma	493	J45
DNCL002051	AMG 853	Asthma	493	J45
DNCL002052	Fluticasone furoate/ fluticasone propionate	Asthma	493	J45
DNCL002053	Salbutamol dry-powder inhalation	Asthma	493	J45
DNCL002054	Masitinib	Asthma	493	J45
DNCL002054	Masitinib	Gastrointestinal stromal tumor	150-159	C15-C26
DNCL002054	Masitinib	Pancreatic cancer	157	C25
DNCL002055	Mometasone furoate/ formoterol fumarate	Allergic asthma	493, 995.3	J45, T78.4
DNCL002055	Mometasone furoate/ formoterol fumarate	Asthma	493	J45
DNCL002056	Vinanterol inhalation/ fluticasone furoate powder	Asthma	493	J45
DNCL002057	Histamine dihydrochloride	Acute myeloid leukemia	205	C92.0
DNCL002058	Omacetaxine	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
DNCL002058	Omacetaxine	Chronic myelogenous leukemia	205.1	C92.1
DNCL002058	Omacetaxine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002059	Melphalan drug delivery system	Inoperable/unresectable liver cancer	140-229, 155	C00-C96, C22.0
DNCL002060	Bendamustine	Acute lymphoblastic leukemia; Acute myeloid leukemia	202.8, 203.0, 204.0, 205.0	C81-C96, C90.0, C91.0, C92.0
DNCL002060	Bendamustine	Children ALL	204.0, 205.0	C91.0, C92.0
DNCL002060	Bendamustine	Indolent B-cell non-hodgkin's lymphoma	200, 201, 202, 202.8, 203.0, 208.9	C81, C81-C96, C82-C85, C90.0, C91-C95
DNCL002060	Bendamustine	Mantle cell lymphoma	200.4, 202.8	C81-C96, C85.7
DNCL002060	Bendamustine	Multiple myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL002060	Bendamustine	Myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL002060	Bendamustine	Non-hodgkin's lymphoma	200, 201, 202, 202.8, 203.0, 208.9	C81, C81-C96, C82-C85, C90.0, C91-C95
DNCL002061	Tc-99m tilmanocept	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002061	Tc-99m tilmanocept	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
DNCL002061	Tc-99m tilmanocept	Malignant melanoma	172	C43
DNCL002061	Tc-99m tilmanocept	Melanoma	172	C43
DNCL002062	Rituxan rituxumab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002063	Tumor-specific, radio-labeled monoclonal antibody targeting agent	Metastatic colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002064	Radium-223 chloride	Bone metastases	198.5	C79.51
DNCL002064	Radium-223 chloride	Bone metastases in prostate cancer	140-199, 140-229, 185, 198.5, 210-229	C00-C75, C00-C96, C61, C79.51, C7A, C7B, D10-D36, D3A
DNCL002065	Pomalidomide	Multiple myeloma	172.9	C43
DNCL002065	Pomalidomide	Myelofibrosis	289.83	C94.4, D47.1
DNCL002065	Pomalidomide	Pancreatic cancer	157	C25
DNCL002065	Pomalidomide	Recurrent multiple myeloma	202.8, 203.0	C81-C96, C90.0
DNCL002065	Pomalidomide	Small-cell lung cancer	140-229, 162	C00-C96, C33-C34
DNCL002065	Pomalidomide	Systemic sclerosis	710.1	M34
DNCL002065	Pomalidomide	Waldenstrom's macroglobulinemia	273.3	C88.0
DNCL002066	Maraciclatide	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002067	AFX-9154	Leukemia	208.9	C91-C95
DNCL002068	AFX-9901	Cancer	140-229	C00-C96
DNCL002069	IMC-gp100	Malignant melanoma	172	C43
DNCL002069	IMC-gp100	Melanoma	.	C43
DNCL002070	SR13668	Cancer	140-229	C00-C96
DNCL002071	OBP-301	Breast cancer	174, 175	C50
DNCL002071	OBP-301	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002071	OBP-301	Liver cancer	.	C22
DNCL002071	OBP-301	Liver cancer	155	C22.0
DNCL002071	OBP-301	Mesothelioma	163	C45
DNCL002072	KRN-330	Colorectal cancer	.	C18-C20,C21
DNCL002072	KRN-330	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002073	GL-0810	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002073	GL-0810	Squamous cell carcinoma of the head and neck	199	C44
DNCL002074	Anti-CD22/CD19 mAb-toxin conjugate	Acute lymphoblastic leukemia	204	C91.0
DNCL002075	Plitidepsin	Lymphoma	202.8	C81-C96
DNCL002075	Plitidepsin	Multiple myeloma	203	C90.0
DNCL002075	Plitidepsin	Myeloma	203	C90.0
DNCL002075	Plitidepsin	Solid tumours	.	C00-C75,C7A,C7B
DNCL002075	Plitidepsin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002076	SHP-141	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DNCL002077	IMP321	Pancreatic cancer	157	C25
DNCL002078	Tasquinimod	Metastatic prostate cancer	140-229, 185	C00-C96, C61
DNCL002078	Tasquinimod	Metastatic prostate cancer	185	C61
DNCL002078	Tasquinimod	Prostate cancer	.	C61
DNCL002079	CBP-501	Mesothelioma	.	C45
DNCL002079	CBP-501	Mesothelioma	163	C45
DNCL002079	CBP-501	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002080	EC17	Kidney cancer	140-229	C00-C96
DNCL002080	EC17	Renal cancer	189	C64
DNCL002080	EC17	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002081	Paclitaxel liposomal	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002082	PG11047	Lymphoma	.	C81-C96
DNCL002082	PG11047	Lymphoma	202.8	C81-C96
DNCL002082	PG11047	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002083	Purine nucleoside phosphorylase gene therapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002084	VGX-100	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002085	EC0225	Cancer	140-229	C00-C96
DNCL002086	HBI-8000	Cancer	.	C00-C97
DNCL002086	HBI-8000	Cancer	140-229	C00-C96
DNCL002086	HBI-8000	Lymphoma	202.8	C81-C96
DNCL002087	GL-0817	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002087	GL-0817	Multiple myeloma	203	C90.0
DNCL002087	GL-0817	Myeloma	203	C90.0
DNCL002088	ALB-109564a	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002089	EC0489	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002090	P28 peptide	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002091	PRI-724	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1	C92.0, C92.1
DNCL002091	PRI-724	Cancer	.	C00-C97
DNCL002091	PRI-724	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002092	PWT33597	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002093	AG103	Oral mucositis associated with cancertreatment	140-229, 528.0	C00-C96, K12.3
DNCL002094	ARC-100	Alzheimer's disease	331	G30
DNCL002094	ARC-100	Breast cancer	174, 175	C50
DNCL002094	ARC-100	Glioblastoma	191	C71
DNCL002094	ARC-100	Hormone-refractory prostate cancer	140-229, 185	C00-C96, C61
DNCL002094	ARC-100	Malignant melanoma	172	C43
DNCL002094	ARC-100	Medulloblastoma	191	C71
DNCL002094	ARC-100	Neuroblastoma	194	C74.9
DNCL002095	Gene therapy	Adjuvant prostate cancer	140-229, 185	C00-C96, C61
DNCL002095	Gene therapy	Brain cancer	.	C71
DNCL002095	Gene therapy	Brain cancer	140-229, 191	C00-C96, C71
DNCL002095	Gene therapy	Glioma	191	C71
DNCL002095	Gene therapy	Pancreatic cancer	157	C25
DNCL002096	Belagenpumatucel-L	Glioma	191	C71
DNCL002096	Belagenpumatucel-L	Non-small-cell lung carcinoma	162	C33, C34
DNCL002096	Belagenpumatucel-L	Small-cell lung cancer	162	C33, C34
DNCL002097	AC480	Breast cancer	174, 175	C50
DNCL002097	AC480	Glioma	191	C71
DNCL002097	AC480	Non-small-cell lung carcinoma	162	C33, C34
DNCL002098	BZL-101	Breast cancer	174, 175	C50
DNCL002098	BZL-101	Breast cancer	174, 175, 217	C50, D24
DNCL002099	Breast cancer vaccine	Breast cancer	174, 175	C50
DNCL002100	MM-302	Breast cancer	174, 175	C50
DNCL002100	MM-302	Cancer	.	C00-C97
DNCL002101	NPC-1C	Colorectal cancer	153, 154	C18-C21
DNCL002101	NPC-1C	Late-stage metastatic pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002101	NPC-1C	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002102	Reovirus	Colorectal cancer	153, 154	C18-C21
DNCL002102	Reovirus	Fallopian tube cancer	.	C57.0,D28.2
DNCL002102	Reovirus	Glioma	140-199, 183, 191, 210-229	C00-C75, C56, C71, C7A, C7B, D10-D36, D3A
DNCL002102	Reovirus	Malignant melanoma	140-199, 172, 183, 210-229	C00-C75, C43, C56, C7A, C7B, D10-D36, D3A
DNCL002102	Reovirus	Metastatic head and neck cancer	140-149, 140-199, 140-229, 183, 210-229	C00-C75, C00-C96, C07-C14, C32-C33, C56, C7A, C7B, D10-D36, D3A
DNCL002102	Reovirus	Non-small-cell lung carcinoma	162	C33, C34
DNCL002102	Reovirus	Ovarian cancer	140-199, 140-229, 183, 210-229	C00-C75, C00-C96, C56, C7A, C7B, D10-D36, D3A
DNCL002102	Reovirus	Ovarian cancer	140-229, 183	C00-C96, C56
DNCL002102	Reovirus	Pancreatic cancer	140-199, 140-229, 157, 183, 210-229	C00-C75, C00-C96, C25, C56, C7A, C7B, D10-D36, D3A
DNCL002102	Reovirus	Sarcoma	.	D69.3
DNCL002102	Reovirus	Solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
DNCL002103	TAS-102	Colorectal cancer	153, 154	C18-C21
DNCL002104	TF2	Colorectal cancer	153, 154	C18-C21
DNCL002105	HF-10	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002105	HF-10	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002106	AMG 172	Cancers	140-239	C00-C96
DNCL002106	AMG 172	Renal cancer	.	C64
DNCL002106	AMG 172	Renal cancer	189	C64
DNCL002107	Tivozanib	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002107	Tivozanib	Colorectal cancer	153, 154	C18-C21
DNCL002107	Tivozanib	Renal cancer	140-229, 189	C00-C96, C64
DNCL002107	Tivozanib	Renal cancer	189	C64
DNCL002108	Veglin	Kaposi's sarcoma	176	C46
DNCL002108	Veglin	Mesothelioma	163	C45
DNCL002108	Veglin	Renal cancer	189	C64
DNCL002108	Veglin	Solid tumours	.	C00-C75,C7A,C7B
DNCL002109	AC220	Acute lymphoblastic leukemia	204	C91.0
DNCL002109	AC220	Acute myeloid leukemia	205, 205.0, 208.9	C91-C95, C92, C92.0
DNCL002109	AC220	Leukaemia	.	C91-C95
DNCL002109	AC220	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002110	AC430	Leukemia	208.9	C91-C95
DNCL002111	AZD1208	Acute myeloid leukemia	205	C92.0
DNCL002111	AZD1208	Haematological malignancies	200-209	C81-C96
DNCL002111	AZD1208	Hematological malignancies	200-209	C81-C96
DNCL002111	AZD1208	Solid tumours	.	C00-C75,C7A,C7B
DNCL002112	Bafetinib	Acute lymphoblastic leukemia; Chronic myelogenous leukemia	204.0, 205.1	C91.0, C92.1
DNCL002112	Bafetinib	Bone disease	.	M00-M99
DNCL002112	Bafetinib	Brain cancer	140-229, 191, 208.9	C00-C96, C71, C91-C95
DNCL002112	Bafetinib	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002112	Bafetinib	Metastatic hormone refractory prostate cancer	.	M00-M99
DNCL002113	ABT-199/GDC-0199	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002114	BI-836826	Chronic lymphocytic leukaemia	.	C91.1
DNCL002114	BI-836826	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002115	CNDO-109	Acute myeloid leukemia	205	C92.0
DNCL002115	CNDO-109	Cancer	.	C00-C97
DNCL002116	CWP232291	Acute myeloid leukemia	205	C92.0
DNCL002117	DCC-2036	Acute lymphoblastic leukemia	.	C91.0
DNCL002117	DCC-2036	Acute lymphoblastic leukemia; Chronic myelogenous leukemia	204.0, 205.1	C91.0, C92.1
DNCL002117	DCC-2036	Acute myeloid leukemia	205	C92.0
DNCL002118	DCDS-4501A	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002118	DCDS-4501A	Hematologic malignancies	200-209	C81-C96
DNCL002118	DCDS-4501A	Hematological malignancies	.	C81-C96
DNCL002118	DCDS-4501A	Hematological malignancies	140-239, 200-209, 202.8	C00-C96, C81-C96
DNCL002118	DCDS-4501A	Non-Hodgkin's lymphoma; Diffuse large B-cell lymphoma	200, 200.0, 202	C82-C85, C83.3
DNCL002119	DCDT-2980S	Hematologic malignancies	200-209	C81-C96
DNCL002119	DCDT-2980S	Hematological malignancies	.	C81-C96
DNCL002119	DCDT-2980S	Hematological malignancies	140-239, 200-209, 202.8	C00-C96, C81-C96
DNCL002119	DCDT-2980S	Non-Hodgkin's lymphoma; Diffuse large B-cell lymphoma	200, 200.0, 202	C82-C85, C83.3
DNCL002119	DCDT-2980S	Recurrent chronic lymphocytic leukemia	204.1	C91.1
DNCL002120	GNKG-168	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002121	HuM195-Ac-225	Acute myeloid leukemia	205	C92.0
DNCL002122	LDE225	Basal cell cancer	173	C44
DNCL002122	LDE225	Basal cell carcinoma	140-199, 173, 210-229	C00-C75, C44, C7A, C7B, D10-D36, D3A
DNCL002122	LDE225	Chronic myelogenous leukemia	205.1	C92.1
DNCL002122	LDE225	Neoadjuvant pancreatic cancer	140-199, 140-229, 157, 208.9, 210-229	C00-C75, C00-C96, C25, C7A, C7B, C91-C95, D10-D36, D3A
DNCL002122	LDE225	Skin cancers	.	C43-C44
DNCL002122	LDE225	Solid tumours	140-199, 208.9, 210-229	C00-C75, C7A, C7B, C91-C95, D10-D36, D3A
DNCL002123	LG740	Acute lymphoblastic leukemia; B-cell prolymphocytic leukemia	204.0, 208.9	C91-C95, C91.0
DNCL002123	LG740	Diffuse large B-cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma	200.0, 202.0, 202.8, 208.9	C81-C96, C82, C83.3, C85.1, C91-C95
DNCL002123	LG740	Diffuse large b-cell lymphoma	200	C83.3
DNCL002124	LOR-2040	Acute myeloid leukemia	205	C92.0
DNCL002124	LOR-2040	Chronic myelogenous leukemia; Myelodysplastic syndromes	205.1, 238.7	C92.1, D46
DNCL002124	LOR-2040	Metastatic breast cancer	140-229, 174, 175, 208.9	C00-C96, C50, C91-C95
DNCL002124	LOR-2040	Metastatic colorectal cancer	140-229, 153, 154, 208.9	C00-C96, C18-C21, C20, C91-C95
DNCL002124	LOR-2040	Metastatic prostate cancer	140-229, 185, 208.9	C00-C96, C61, C91-C95
DNCL002124	LOR-2040	Metastatic renal cancer	140-229, 189, 208.9	C00-C96, C64, C91-C95
DNCL002124	LOR-2040	Solid tumours	.	C00-C75,C7A,C7B
DNCL002125	Lurbinectedin	Leukaemia	.	C91-C95
DNCL002125	Lurbinectedin	Leukemia	208.9	C91-C95
DNCL002125	Lurbinectedin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002126	MK-8242	Acute myeloid leukemia	205	C92.0
DNCL002126	MK-8242	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002127	ON 013105	Acute lymphoblastic leukemia	204	C91.0
DNCL002127	ON 013105	Hematological malignancies	.	C81-C96
DNCL002127	ON 013105	Lymphoma	202.8	C81-C96
DNCL002127	ON 013105	Refractory lymphoma	202.8	C81-C96
DNCL002128	Oral azacitidine	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1	C92.0, C92.1
DNCL002128	Oral azacitidine	Lymphoma	202.8	C81-C96
DNCL002128	Oral azacitidine	Myelodysplastic syndromes	238.7	D46
DNCL002128	Oral azacitidine	Myelodysplastic syndromes	758.33	Q93.88
DNCL002128	Oral azacitidine	Non-small-cell lung carcinoma	140-199, 162, 202.8, 208.9, 210-229	C00-C75, C33, C34, C7A, C7B, C81-C96, C91-C95, D10-D36, D3A
DNCL002128	Oral azacitidine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002129	MOR208	B-Cell malignancies	202.8	C85.1
DNCL002129	MOR208	Chronic lymphocytic leukaemia	.	C91.1
DNCL002129	MOR208	Recurrent chronic lymphocytic leukemia	204.1	C91.1
DNCL002130	Tivantinib	Liver cancer	140-229, 155	C00-C96, C22.0
DNCL002130	Tivantinib	Solid tumours	.	C00-C75,C7A,C7B
DNCL002131	AP26113	Cancer	.	C00-C97
DNCL002131	AP26113	Non-small-cell lung carcinoma	162	C33, C34
DNCL002132	GI-4000	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002132	GI-4000	Colorectal cancer	153, 154	C18-C21
DNCL002132	GI-4000	Colorectal cancer; Non-small-cell lung cancer	140-229, 153, 154, 162	C00-C96, C18-C21, C20, C33, C34
DNCL002132	GI-4000	Colorectal cancer; pancreatic cancer	153, 154, 157	C18-C21, C25
DNCL002132	GI-4000	Non-small-cell lung carcinoma	162	C33, C34
DNCL002132	GI-4000	Pancreatic cancer	157	C25
DNCL002133	JNJ-26854165	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002133	JNJ-26854165	Non-small cell lung cancer	.	C33-C34
DNCL002133	JNJ-26854165	Non-small-cell lung carcinoma	162	C33, C34
DNCL002133	JNJ-26854165	Prostate cancer	185	C61
DNCL002134	PRAME antigen-specific cancer immunotherapeutic	Malignant melanoma	172	C43
DNCL002134	PRAME antigen-specific cancer immunotherapeutic	Metastatic malignant melanoma	172	C43
DNCL002134	PRAME antigen-specific cancer immunotherapeutic	Metastatic melanoma; Non-small cell lung cancer	162, 172	C33, C34, C43
DNCL002134	PRAME antigen-specific cancer immunotherapeutic	Non-small-cell lung carcinoma	162	C33, C34
DNCL002134	PRAME antigen-specific cancer immunotherapeutic	Resectable non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
DNCL002135	RG7599	Non-small cell lung cancer; Ovarian cancer	140-229, 162, 183, 204.0	C00-C96, C33, C33-C34, C34, C56, C91.0
DNCL002135	RG7599	Non-small-cell lung carcinoma	162	C33, C34
DNCL002135	RG7599	Ovarian cancer	.	C56
DNCL002135	RG7599	Ovarian cancer	183	C56
DNCL002136	AEZS-112	Lung cancer	162	C33-C34
DNCL002136	AEZS-112	Lymphoma	202.8	C81-C96
DNCL002136	AEZS-112	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002137	AFM13	Hodgkin's disease	201	C81
DNCL002137	AFM13	Hodgkin's lymphoma	.	C81
DNCL002137	AFM13	Hodgkin's lymphoma	201	C81
DNCL002138	Vinorelbine liposomal	Lymphoma	.	C81-C96
DNCL002138	Vinorelbine liposomal	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002138	Vinorelbine liposomal	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002139	Autologous cancer vaccine	Lymphoma	202	C82
DNCL002140	Bcl-2 inhibitor	Cancer	.	C00-C97
DNCL002140	Bcl-2 inhibitor	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002141	CC-115	Cancer	.	C00-C97
DNCL002141	CC-115	Multiple myeloma	203	C90.0
DNCL002141	CC-115	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002141	CC-115	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002142	CC-223	Cancer	.	C00-C97
DNCL002142	CC-223	Multiple myeloma	203	C90.0
DNCL002142	CC-223	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002142	CC-223	Non-small-cell lung carcinoma	162, 202.8, 203.0	C33, C34, C81-C96, C90.0
DNCL002142	CC-223	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002143	CEP-9722	Cerebrovascular ischaemia	.	G45.9,I67.8
DNCL002143	CEP-9722	Mantle cell lymphoma	200.4	C85.7
DNCL002143	CEP-9722	Mantle cell lymphoma	200.4, 202.8	C81-C96, C85.7
DNCL002143	CEP-9722	Non-small-cell lung carcinoma	162	C33, C34
DNCL002144	ONO-4059	B-cell lymphoma	.	C85.1
DNCL002144	ONO-4059	B-cell lymphoma	202.8	C85.1
DNCL002145	RG7598	Multiple myeloma	203	C90.0
DNCL002145	RG7598	Myeloma	203	C90.0
DNCL002146	RG7458	Ovarian cancer	.	C56
DNCL002146	RG7458	Ovarian cancer	183	C56
DNCL002147	GV1001	Pancreatic cancer	157	C25
DNCL002148	AZD3514	Prostate cancer	185	C61
DNCL002149	CYT-500	Prostate cancer	185	C61
DNCL002150	DPX-0907	Breast cancer	174, 175	C50
DNCL002150	DPX-0907	Breast cancer; Ovarian cancer; Prostate cancer	140-229, 174, 175, 183, 185	C00-C96, C50, C56, C61
DNCL002150	DPX-0907	Ovarian cancer	183	C56
DNCL002150	DPX-0907	Prostate cancer	185	C61
DNCL002151	MER-104	Prostate cancer	185	C61
DNCL002152	TeloB-Vax	Cancer	.	C00-C97
DNCL002152	TeloB-Vax	Prostate cancer	185	C61
DNCL002153	Iofolastat I-124	Prostate cancer	.	C61
DNCL002153	Iofolastat I-124	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002154	Ad-IL-12 DNA therapeutic	Malignant melanoma	172	C43
DNCL002155	AbGn-7	Cancer	140-229	C00-C96
DNCL002155	AbGn-7	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002156	ABI-009	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002157	AZD1480	Myeloproliferative disorder	.	D47.1
DNCL002157	AZD1480	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002158	AZD2014	Cancer	.	C00-C97
DNCL002158	AZD2014	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL002158	AZD2014	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002159	AZD5363	Cancer	.	C00-C97
DNCL002159	AZD5363	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL002159	AZD5363	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002160	BGJ398	Cancer	.	C00-C97
DNCL002160	BGJ398	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002161	EMD-1214063	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002162	Enavatuzumab	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002163	LP-261	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DNCL002163	LP-261	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002164	ME-143	Refractory solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002165	MEDI-565	Solid tumours	.	C00-C75,C7A,C7B
DNCL002165	MEDI-565	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL002165	MEDI-565	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002166	MEDI0639	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL002166	MEDI0639	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002167	MG-1102	Cancer	140-229	C00-C96
DNCL002167	MG-1102	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002168	MGA271	Refractory metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002168	MGA271	Solid tumours	.	C00-C75,C7A,C7B
DNCL002169	MGAH22	Solid tumours	.	C00-C75,C7A,C7B
DNCL002169	MGAH22	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002170	MINT1526A	Cancer	140-229	C00-C96
DNCL002170	MINT1526A	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002171	MSC2015103B	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002172	MTKi-328	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002173	NKP-1339	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002174	NMS-1286937	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002175	OMP-21M18	Solid tumours	.	C00-C75,C7A,C7B
DNCL002175	OMP-21M18	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002176	OMP-59R5	Pancreatic cancer	157	C25
DNCL002176	OMP-59R5	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002177	PM-060184	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002177	PM-060184	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002178	RRx-001	Lymphoma	202.8	C81-C96
DNCL002178	RRx-001	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002179	SAR125844	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002180	SAR153192	Solid tumours	.	C00-C75,C7A,C7B
DNCL002180	SAR153192	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002181	SCH-900353	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002182	TAG vaccine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002183	TAK-441	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002184	TAK-733	Cancer	.	C00-C97
DNCL002184	TAK-733	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002185	TAK-960	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002186	TRC102	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002187	V935	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002188	T-cell replacement therapy	Graft-versus-host disease	279.5	T86.0
DNCL002189	MLN0128	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002189	MLN0128	Hematological malignancies	200-209	C81-C96
DNCL002189	MLN0128	Multiple myeloma	.	C90.0
DNCL002189	MLN0128	Multiple myeloma; Waldenstrom's macroglobulinemia	203.0, 273.3	C88.0, C90.0
DNCL002189	MLN0128	Myeloma	203	C90.0
DNCL002189	MLN0128	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002190	NTX-010	Neuroendocrine tumors	140-199, 209, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002190	NTX-010	Small-cell lung cancer	162	C33, C34
DNCL002191	TG02	Cancer	.	C00-C97
DNCL002191	TG02	Chronic lymphocytic leukemia	203.0, 204.1, 208.9	C90.0, C91-C95, C91.1
DNCL002191	TG02	Hematological malignancies	200-209	C81-C96
DNCL002191	TG02	Myeloma	203.0, 208.9	C90.0, C91-C95
DNCL002192	CBLB502	Cancer	.	C00-C97
DNCL002192	CBLB502	Cancer	140-229	C00-C96
DNCL002193	Fenretinide intravenous	Cancer	140-229	C00-C96
DNCL002194	PF-03084014	Alzheimer's disease	.	G30,F00
DNCL002194	PF-03084014	Cancer	140-229	C00-C96
DNCL002195	PF-04449913	Acute myeloid leukemia	205	C92.0
DNCL002195	PF-04449913	Cancer	.	C00-C97
DNCL002195	PF-04449913	Cancer	140-229	C00-C96
DNCL002196	PF-05082566	Cancer	.	C00-C97
DNCL002196	PF-05082566	Cancer	140-229	C00-C96
DNCL002196	PF-05082566	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002197	SB1578	Cancer	140-229	C00-C96
DNCL002198	IMC-3C5	Cancer	140-229	C00-C96
DNCL002198	IMC-3C5	Solid tumours	.	C00-C75,C7A,C7B
DNCL002199	Anti-cancer mAb	Cancer	140-229	C00-C96
DNCL002200	TST-10088	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002201	VTX-2337	Allergy	.	T78.4
DNCL002201	VTX-2337	B-cell lymphoma	202.8	C85.1
DNCL002201	VTX-2337	Lymphoma	202.8	C81-C96
DNCL002201	VTX-2337	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002202	ONT-10	Solid tumours	.	C00-C75,C7A,C7B
DNCL002202	ONT-10	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002203	ETBX-011	Glaucoma	365	H40-H42
DNCL002203	ETBX-011	Late-stage metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002203	ETBX-011	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002204	ATI-1123	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002205	G-202	Solid tumours	.	C00-C75,C7A,C7B
DNCL002205	G-202	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002206	BNP1350	Solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
DNCL002207	L-MDAM	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002208	OVI-123	Acute lymphoblastic leukemia	204	C91.0
DNCL002208	OVI-123	TdT-positive leukemia	208.9	C91-C95
DNCL002209	PBI-05204	Cancer	.	C00-C97
DNCL002209	PBI-05204	Cancer	140-229	C00-C96
DNCL002210	Carboxyamidotriazole orotate	Cancer	140-229	C00-C96
DNCL002210	Carboxyamidotriazole orotate	Glioblastoma	.	C71
DNCL002211	StMN1 Lp	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002212	IMT-1012	Breast cancer	174, 175	C50
DNCL002212	IMT-1012	Breast cancer; Ovarian cancer	140-229, 174, 175, 183	C00-C96, C50, C56
DNCL002212	IMT-1012	Ovarian cancer	183	C56
DNCL002213	EP-100	Cancer	140-229	C00-C96
DNCL002213	EP-100	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002214	GGTI-2418	Cancer	.	C00-C97
DNCL002214	GGTI-2418	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002215	Ovarian dendritic cell-based vaccine	Ovarian cancer	183	C56
DNCL002215	Ovarian dendritic cell-based vaccine	Ovarian cancer; Peritoneal cancer	140-229, 158, 183	C00-C96, C48.1-C48.2, C56
DNCL002216	Curmucin	Cancer	140-229	C00-C96
DNCL002217	PNT2258	B-cell lymphoma	.	C85.1
DNCL002217	PNT2258	B-cell lymphoma	202.8	C85.1
DNCL002217	PNT2258	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002218	CYT107	HIV infections	42	B20
DNCL002218	CYT107	Human immunodeficiency virus infection	.	B20
DNCL002218	CYT107	Malignant melanoma	172	C43
DNCL002218	CYT107	Renal cancer	189	C64
DNCL002219	AMP-224	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002220	LG631	Chemoprotection	191	C71
DNCL002220	LG631	Glioblastoma	191	C71
DNCL002221	8H9 I-131 mAb	Peritoneal cancer	.	C48.1-C48.2
DNCL002221	8H9 I-131 mAb	Peritoneal cancer	140-229, 158	C00-C96, C48.1-C48.2
DNCL002221	8H9 I-131 mAb	Soft tissue sarcoma	171	C49
DNCL002222	Zanolimumab	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DNCL002222	Zanolimumab	Lymphoma	.	C81-C96
DNCL002222	Zanolimumab	Peripheral T-cell lymphoma	202.7	C84.4
DNCL002223	CYT-6091	Cancer	.	C00-C97
DNCL002223	CYT-6091	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002224	GI-6301	Solid tumours	.	C00-C75,C7A,C7B
DNCL002224	GI-6301	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002225	GI-6207	Cancer	.	C00-C97
DNCL002225	GI-6207	Cancer	140-229	C00-C96
DNCL002225	GI-6207	Metastatic cancer	140-229	C00-C96
DNCL002225	GI-6207	Metastatic medullary thyroid cancer	193	C73
DNCL002226	INNO-305	Acute myeloid leukemia	140-199, 205.0, 210-229, 238.7	C00-C75, C7A, C7B, C92.0, D10-D36, D3A, D46
DNCL002226	INNO-305	Lung cancer	.	C33-C34
DNCL002226	INNO-305	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002227	JX-929	Solid tumours	.	C00-C75,C7A,C7B
DNCL002227	JX-929	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002228	FP-1039/HGS1036	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002229	NKTR-105	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002230	BMN-673	Hematological malignancies	200-209	C81-C96
DNCL002230	BMN-673	Psoriatic arthritis	696	L40.5, M07
DNCL002230	BMN-673	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002231	LOR 253	Cancer	.	C00-C97
DNCL002231	LOR 253	Metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002232	PB-357	Cancer	140-229	C00-C96
DNCL002233	DM-CHOC-PEN	Brain cancer	191, 225.0	C71, D33
DNCL002233	DM-CHOC-PEN	Cancer	140-229	C00-C96
DNCL002234	AE37	Breast cancer	174, 175	C50
DNCL002234	AE37	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
DNCL002234	AE37	Ovarian cancer	183	C56
DNCL002235	SB-313-xTZ	Glioblastoma	.	C71
DNCL002235	SB-313-xTZ	Glioblastoma	191	C71
DNCL002236	CA-18C3	Cancer-related cachexia	140-199, 210-229, 799.4	C00-C75, C7A, C7B, D10-D36, D3A, R64
DNCL002236	CA-18C3	Diabetes mellitus type 2	.	E11
DNCL002236	CA-18C3	Hematological malignancies	140-199, 140-229, 140-239, 200-209, 210-229	C00-C75, C00-C96, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002236	CA-18C3	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002236	CA-18C3	Type 2 diabetes	250.00, 250.02	E11
DNCL002237	TUSC2/FUS1 gene therapy	Non-small-cell lung carcinoma	162	C33, C34
DNCL002238	D-1MT	Cancer	.	C00-C97
DNCL002238	D-1MT	Metastatic breast cancer	140-199, 140-229, 174, 175, 210-229	C00-C75, C00-C96, C50, C7A, C7B, D10-D36, D3A
DNCL002238	D-1MT	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002239	X-82	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DNCL002239	X-82	Macular degeneration	.	H35.3
DNCL002240	VX15	Solid tumours	.	C00-C75,C7A,C7B
DNCL002240	VX15	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002241	Cintredekin besudotox	Brain cancer	.	C71
DNCL002241	Cintredekin besudotox	Glioma	191	C71
DNCL002242	TKM-PLK1	Lymphoma	202.8	C81-C96
DNCL002242	TKM-PLK1	Solid tumours	.	C00-C75,C7A,C7B
DNCL002242	TKM-PLK1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002243	QBI-139	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002244	CPI-613	Combination therapy	.	C81-C96
DNCL002244	CPI-613	Hematological malignancies	.	C81-C96
DNCL002244	CPI-613	Hematological malignancies	140-239, 200-209	C00-C96, C81-C96
DNCL002245	KHK-2866	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
DNCL002245	KHK-2866	Ovarian cancer	.	C56
DNCL002245	KHK-2866	Ovarian cancer	140-199, 140-229, 183, 210-229	C00-C75, C00-C96, C56, C7A, C7B, D10-D36, D3A
DNCL002246	Teglarinad	Lymphoma	.	C81-C96
DNCL002246	Teglarinad	Lymphoma	202.8	C81-C96
DNCL002246	Teglarinad	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002247	AT-406/Debio-1143	Acute myeloid leukemia	205	C92.0
DNCL002247	AT-406/Debio-1143	Lymphoma	202.8, 208.9	C81-C96, C91-C95
DNCL002248	Cancer vaccine	Breast cancer	174, 175	C50
DNCL002248	Cancer vaccine	Cancer	140-229	C00-C96
DNCL002248	Cancer vaccine	Glioblastoma	191	C71
DNCL002248	Cancer vaccine	Lymphoma	202.0, 202.8	C81-C96, C82
DNCL002248	Cancer vaccine	Metastatic renal cancer	140-229, 189	C00-C96, C64
DNCL002248	Cancer vaccine	Ovarian cancer	183	C56
DNCL002248	Cancer vaccine	Sarcoma	.	D69.3
DNCL002249	BTSCAN	Acute coronary syndrome	.	I24.9
DNCL002249	BTSCAN	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002250	TOK-001	Castration-resistant prostate cancer	185	C61
DNCL002250	TOK-001	Prostate cancer	.	C61
DNCL002251	Oral clofaribine	Myelodysplastic syndromes	238.7	D46
DNCL002252	Ficlatuzumab	Multiple myeloma	.	C90.0
DNCL002252	Ficlatuzumab	Non-small-cell lung carcinoma	162	C33, C34
DNCL002252	Ficlatuzumab	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002253	MM-151	Cancer	.	C00-C97
DNCL002253	MM-151	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002254	IPI-145	Arthritis	.	M00-M25
DNCL002254	IPI-145	Hematological malignancies	200-209	C81-C96
DNCL002255	BIND-014	Cancer	.	C00-C97
DNCL002255	BIND-014	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002256	99mTc-MIP-1405	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002257	XMT-1001	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002258	XMT-1107	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002259	CUDC-101	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002260	AI-850	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002261	XmAb2513	Hodgkin's disease; T-cell lymphoma	201, 202.8	C81, C81-C96
DNCL002261	XmAb2513	Hodgkin's lymphoma	.	C81
DNCL002261	XmAb2513	Hodgkin's lymphoma	201	C81
DNCL002262	CALAA 01	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002263	Palifosfamide	Sarcoma	.	C00-C75
DNCL002263	Palifosfamide	Small-cell lung cancer	140-199, 162, 210-229	C00-C75, C33, C34, C7A, C7B, D10-D36, D3A
DNCL002263	Palifosfamide	Soft tissue sarcoma	171	C49
DNCL002263	Palifosfamide	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002264	DC-IL-12 DNA therapeutic	Malignant melanoma	172	C43
DNCL002264	DC-IL-12 DNA therapeutic	Solid tumours	.	C00-C75,C7A,C7B
DNCL002265	Darinaparsin	Hematological malignancies	140-239, 200-209, 202.8, 203.0	C00-C96, C81-C96, C90.0
DNCL002265	Darinaparsin	Liver cancer	155	C22.0
DNCL002265	Darinaparsin	Lymphoma	202.8	C81-C96
DNCL002265	Darinaparsin	Multiple myeloma	203	C90.0
DNCL002265	Darinaparsin	Myeloma	202.8, 203.0	C81-C96, C90.0
DNCL002265	Darinaparsin	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 203.0	C81, C81-C96, C82-C85, C90.0
DNCL002265	Darinaparsin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002266	CLT-008	Blood transfusion	.	D50-D89
DNCL002266	CLT-008	Chemotherapy-related neutropenia	288	D70
DNCL002266	CLT-008	Hematological malignancies	140-229, 140-239, 200-209	C00-C96, C00-C96, C81-C96
DNCL002267	KB004	Hematological malignancies	.	C81-C96
DNCL002267	KB004	Hematological malignancies	200-209	C81-C96
DNCL002268	ONX-0801	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002269	Oprozomib	Hematological malignancies	200-209	C81-C96
DNCL002269	Oprozomib	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002270	JVRS-100	Leukaemia	.	C91-C95
DNCL002270	JVRS-100	Leukemia	208.9	C91-C95
DNCL002271	TH-302	Advanced leukemia	203.0, 208.9	C90.0, C91-C95
DNCL002271	TH-302	Astrocytoma	191	C71
DNCL002271	TH-302	Leukemia	208.9	C91-C95
DNCL002271	TH-302	Multiple myeloma	203	C90.0
DNCL002271	TH-302	Myeloma	203.0, 208.9	C90.0, C91-C95
DNCL002271	TH-302	Pancreatic cancer	157	C25
DNCL002271	TH-302	Soft tissue sarcoma	171	C49
DNCL002271	TH-302	Solid tumours	.	C00-C75,C7A,C7B
DNCL002272	Topotecan liposomes injection	Ovarian cancer	183	C56
DNCL002272	Topotecan liposomes injection	Small-cell lung cancer	162	C33, C34
DNCL002273	OXi4503	Acute myeloid leukemia	205	C92.0
DNCL002273	OXi4503	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
DNCL002273	OXi4503	Refractory acute myeloid leukemia	205	C92.0
DNCL002274	HeR2	Breast cancer	174, 175	C50
DNCL002275	SB989	Hematological malignancies	140-199, 140-239, 200-209, 208.9, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, C91-C95, D10-D36, D3A
DNCL002275	SB989	Late-stage solid tumors	140-199, 208.9, 210-229	C00-C75, C7A, C7B, C91-C95, D10-D36, D3A
DNCL002275	SB989	Leukemia	208.9	C91-C95
DNCL002275	SB989	Myelodysplastic syndromes	140-199, 210-229, 238.7	C00-C75, C7A, C7B, D10-D36, D3A, D46
DNCL002276	Omtriptolide	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002277	TLC-388	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002278	Imprime pGG	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002278	Imprime pGG	Colorectal cancer	153, 154	C18-C21
DNCL002278	Imprime pGG	Malignant melanoma	172, 208.9	C43, C91-C95
DNCL002278	Imprime pGG	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
DNCL002278	Imprime pGG	Solid tumours	.	C00-C75,C7A,C7B
DNCL002279	MTRN-2696	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002280	Cytotropic heterogeneous molecular lipids	Cancer	140-229	C00-C96
DNCL002281	AP1903	Graft-versus-host disease	279.5	T86.0
DNCL002281	AP1903	Prostate cancer	185	C61
DNCL002281	AP1903	Transplant rejection	.	T86
DNCL002282	B7-2/GM-CSF	Cancer	140-229	C00-C96
DNCL002283	KX2-391	Acute myeloid leukemia	205	C92.0
DNCL002283	KX2-391	Prostate cancer	185	C61
DNCL002284	Elesclomol	Acute myeloid leukemia	183, 205.0	C56, C92.0
DNCL002284	Elesclomol	Acute myeloid leukemia	205	C92.0
DNCL002284	Elesclomol	Non-small-cell lung carcinoma	162, 183, 208.9	C33, C34, C56, C91-C95
DNCL002284	Elesclomol	Ovarian cancer	183	C56
DNCL002285	Ganetespib	Acute lymphoblastic leukemia; Acute myeloid leukemia; Chronic myelogenous leukemia	203.0, 204.0, 205.0, 205.1	C90.0, C91.0, C92.0, C92.1
DNCL002285	Ganetespib	Breast cancer	174, 175	C50
DNCL002285	Ganetespib	Esophageal cancer; Gastric cancer	140-229, 150, 151	C00-C96, C15, C16
DNCL002285	Ganetespib	Hormone-refractory prostate cancer; Leukemia; Liver cancer	140-229, 185, 203.0, 208.9	C00-C96, C61, C90.0, C91-C95
DNCL002285	Ganetespib	Liver cancer	155	C22.0
DNCL002285	Ganetespib	Malignant melanoma	172, 203.0, 208.9	C43, C90.0, C91-C95
DNCL002285	Ganetespib	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
DNCL002285	Ganetespib	Myelodysplastic syndromes	238.7	D46
DNCL002285	Ganetespib	Non-small-cell lung carcinoma	162, 203.0, 208.9	C33, C34, C90.0, C91-C95
DNCL002285	Ganetespib	Pancreatic cancer	157	C25
DNCL002285	Ganetespib	Refractory/metastatic colorectal	.	D46
DNCL002285	Ganetespib	Small-cell lung cancer	162	C33, C34
DNCL002286	BBI503	Cholangiocarcinoma; Hepatocellular carcinoma; Ovarian cancer	.	C22.1,C22.0,C56
DNCL002286	BBI503	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002287	BBI608	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002287	BBI608	Ovarian cancer	.	C56
DNCL002288	CDX-1127	Cancer	.	C00-C97
DNCL002288	CDX-1127	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002288	CDX-1127	Lymphoma; Leukemia; Solid tumors	140-199, 202, 204-208	C00-C75, C7A, C7B, C81-C96
DNCL002288	CDX-1127	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002289	CDX-301	Cancer	.	C00-C97
DNCL002289	CDX-301	Cancer	140-229	C00-C96
DNCL002289	CDX-301	Hematopoietic stem cell transplantation	.	Z00-Z99
DNCL002290	PRT6207	Cancer	140-229	C00-C96
DNCL002291	Dendritic cancer cell vaccine	Malignant melanoma	172	C43
DNCL002292	IMGN529	Metastatic non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
DNCL002292	IMGN529	Non-Hodgkin's lymphoma	.	C85.9
DNCL002292	IMGN529	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002293	Lorvotuzumab mertansine	Multiple myeloma	203	C90.0
DNCL002293	Lorvotuzumab mertansine	Small-cell lung cancer	162	C33, C34
DNCL002294	IMGN388	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002295	ARQ 621	Cancer	.	C00-C97
DNCL002295	ARQ 621	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002295	ARQ 621	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002296	ARQ 736	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002297	ARQ 761	Solid tumours	.	C00-C75,C7A,C7B
DNCL002297	ARQ 761	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002298	ARQ 092	Inoperable/unresectable late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002298	ARQ 092	Solid tumours	.	C00-C75,C7A,C7B
DNCL002299	Brostallicin	Breast cancer	174, 175, 217	C50, D24
DNCL002299	Brostallicin	Triple-negative breast cancer	174, 175	C50
DNCL002300	BI-811283	Acute myeloid leukemia	.	C92.0
DNCL002300	BI-811283	Acute myeloid leukemia	205	C92.0
DNCL002300	BI-811283	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002301	BI-831266	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002302	BI-836845	Cancer	.	C00-C97
DNCL002302	BI-836845	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002303	BI-847325	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002304	BI-853520	Cancer	.	C00-C97
DNCL002304	BI-853520	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002305	Anti-CD137	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002306	Anti-PD-L1	HIV-1 infections	42	B20
DNCL002306	Anti-PD-L1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002307	BMS-936561	Hematological malignancies	200-209	C81-C96
DNCL002308	BMS-936564	Acute myeloid leukemia; B-cell chronic lymphocytic leukemia	202.8, 203.0, 204.1, 205.0, 208.9	C81-C96, C90.0, C91-C95, C91.1, C92.0
DNCL002308	BMS-936564	Cancer	.	C00-C97
DNCL002308	BMS-936564	Hematological malignancies	200-209	C81-C96
DNCL002308	BMS-936564	Lymphoma	202.0, 202.8, 203.0, 208.9	C81-C96, C82, C90.0, C91-C95
DNCL002308	BMS-936564	Relapsed/refractory myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL002309	BMS-986015	Cancer	.	C00-C97
DNCL002309	BMS-986015	Cancer	140-229	C00-C96
DNCL002310	BMS-986016	Cancer	140-229	C00-C96
DNCL002311	EGFR/IGFR tandem adnectin	Cancer	140-229	C00-C96
DNCL002312	IL-21	Cancer	140-229	C00-C96
DNCL002312	IL-21	Colorectal cancer	.	C18-C20,C21
DNCL002313	BMS-906024	Cancer	140-229	C00-C96
DNCL002313	BMS-906024	Lymphoma	202.8	C81-C96
DNCL002313	BMS-906024	T-cell acute lymphocytic leukemia	204.0-208.9	C83-C88
DNCL002313	BMS-906024	T-cell lymphoblastic lymphoma	204.0-208.9	C84
DNCL002314	MLN9708	Cancer	.	C00-C97
DNCL002314	MLN9708	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002314	MLN9708	Hematological malignancies	140-239, 200-209, 203.0	C00-C96, C81-C96, C90.0
DNCL002314	MLN9708	Lymphoma; Waldenstrm's macroglobulinemia	140-199, 202.8, 203.0, 210-229	C00-C75, C7A, C7B, C81-C96, C90.0, D10-D36, D3A
DNCL002314	MLN9708	Multiple myeloma	140-199, 202.8, 203.0, 210-229	C00-C75, C7A, C7B, C81-C96, C90.0, D10-D36, D3A
DNCL002314	MLN9708	Multiple myeloma	203	C90.0
DNCL002314	MLN9708	Relapsed/refractory myeloma	203	C90.0
DNCL002314	MLN9708	Relapsed/refractory myeloma	203.0, 277.3	C90.0, E85
DNCL002314	MLN9708	Relapsed/refractory primary amyloidosis	277.3	E85
DNCL002314	MLN9708	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002315	MLN1117	Solid tumours	.	C00-C75,C7A,C7B
DNCL002315	MLN1117	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002316	MLN2480	Malignancies	140-239	C00-C96
DNCL002316	MLN2480	Melanoma	.	C43
DNCL002316	MLN2480	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002317	Siltuximab	Anemia	.	D50-D64
DNCL002317	Siltuximab	Giant lymph node hyperplasia	203	C90.0
DNCL002317	Siltuximab	Hormone-refractory prostate cancer	140-229, 185, 203.0	C00-C96, C61, C90.0
DNCL002317	Siltuximab	Multiple myeloma	203	C90.0
DNCL002317	Siltuximab	Myeloma	203	C90.0
DNCL002318	Ferroportin mAb	Anemia	140-229, 280-285	C00-C96, D50-D64
DNCL002318	Ferroportin mAb	Anemia	280-285	D50-D64
DNCL002319	Hepcidin mAb	Anemia	140-229, 280-285	C00-C96, D50-D64
DNCL002319	Hepcidin mAb	Anemia	280-285	D50-D64
DNCL002320	Chk1 inhibitor	Cancer	140-229	C00-C96
DNCL002321	C-Met inhibitor	Cancer	140-229	C00-C96
DNCL002322	IMC-CS4	Cancer	.	C00-C97
DNCL002322	IMC-CS4	Cancer	140-229	C00-C96
DNCL002323	FGF receptor inhibitor	Cancer	.	C00-C97
DNCL002323	FGF receptor inhibitor	Cancer	140-229	C00-C96
DNCL002324	Gemcitabine prodrug	Cancer	140-229	C00-C96
DNCL002325	JAK2 inhibitor	Cancer	140-229	C00-C96
DNCL002326	LY2603618	Non-small cell lung cancer	.	C33-C34
DNCL002326	LY2603618	Pancreatic cancer	157	C25
DNCL002327	Notch inhibitor	Cancer	140-229	C00-C96
DNCL002328	P38 MAP inhibitor	Cancer	140-229	C00-C96
DNCL002329	P70/AKT inhibitor	Cancer	140-229	C00-C96
DNCL002330	RON mAb	Cancer	140-229	C00-C96
DNCL002331	OPB-51602	Cancer	.	C00-C97
DNCL002331	OPB-51602	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002332	OPB-31121	Cancer	140-229	C00-C96
DNCL002332	OPB-31121	Hepatocellular carcinoma	.	C22.0
DNCL002333	GDC-0349	Cancer	.	C00-C97
DNCL002333	GDC-0349	Non-Hodgkin's lymphoma	140-199, 200, 201, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81, C81-C96, C82-C85, D10-D36, D3A
DNCL002333	GDC-0349	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002334	GDC-0425	Lymphoma	202.8	C81-C96
DNCL002334	GDC-0425	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002334	GDC-0425	Solid tumours; Lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DNCL002335	GDC-0575	Lymphoma	.	C81-C96
DNCL002335	GDC-0575	Lymphoma	202.8	C81-C96
DNCL002335	GDC-0575	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002335	GDC-0575	Solid tumours; Lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DNCL002336	GDC-0917	Lymphoma	.	C81-C96
DNCL002336	GDC-0917	Lymphoma	202.8	C81-C96
DNCL002336	GDC-0917	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002337	RG7602	Lymphoma	202.8	C81-C96
DNCL002337	RG7602	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002337	RG7602	Solid tumours; Lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DNCL002338	DFRF-4539A	Myeloma	203	C90.0
DNCL002338	DFRF-4539A	Refractory metastatic multiple myeloma	203	C90.0
DNCL002339	RG7444	Refractory metastatic multiple myeloma	140-199, 203.0, 210-229	C00-C75, C7A, C7B, C90.0, D10-D36, D3A
DNCL002339	RG7444	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002340	DMUC-5754A	Fallopian tube cancer; Peritoneal cancer	140-229, 158, 183, 183.2, 221.0	C00-C96, C48.1-C48.2, C56, C57, D28
DNCL002340	DMUC-5754A	Ovarian cancer	.	C56
DNCL002340	DMUC-5754A	Ovarian cancer	140-229, 183	C00-C96, C56
DNCL002341	RG7600	Ovarian cancer	183	C56
DNCL002341	RG7600	Pancreatic and ovarian cancers	140-229, 183	C00-C96, C56
DNCL002341	RG7600	Platinum-resistant ovarian cancer	140-229, 183	C00-C96, C56
DNCL002341	RG7600	Platinum-resistant pancreatic cancer	140-229, 157, 183	C00-C96, C25, C56
DNCL002342	DSTP-3086S	Metastatic hormone-refractory prostate cancer	140-229, 185	C00-C96, C61
DNCL002342	DSTP-3086S	Prostate cancer	.	C61
DNCL002342	DSTP-3086S	Prostate cancer	185	C61
DNCL002343	DEDN-6526A	Malignant melanoma	172	C43
DNCL002344	RG7636	Malignant melanoma	172	C43
DNCL002344	RG7636	Melanoma	.	C43
DNCL002344	RG7636	Metastatic melanoma	172	C43
DNCL002345	Anti-IGF-1R mAb	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002346	GDC-0032	Metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002346	GDC-0032	Solid tumours	.	C00-C75,C7A,C7B
DNCL002346	GDC-0032	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002347	MPDL-3280A	Metastatic melanoma	172	C43
DNCL002347	MPDL-3280A	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002348	RG7446	Solid tumours	.	C00-C75,C7A,C7B
DNCL002348	RG7446	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002349	RG7594	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DNCL002350	Solid tumor immunotherapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002351	RG7596	Hematological malignancies	.	C81-C96
DNCL002351	RG7596	Hematological malignancies	200-209	C81-C96
DNCL002352	RG7347	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002353	MK-8808	Late-stage follicular lymphoma	202.0, 202.8	C81-C96, C82
DNCL002353	MK-8808	Lymphoma	202	C82
DNCL002353	MK-8808	Rheumatold arthritis	.	M05-M06
DNCL002354	MK-3475	Melanoma	.	C43
DNCL002354	MK-3475	Melanoma	172	C43
DNCL002354	MK-3475	Metastatic Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002355	Robatumumab	Colorectal cancer	153, 154	C18-C21
DNCL002355	Robatumumab	Osteosarcoma	170	C40-C41
DNCL002355	Robatumumab	Osteosarcoma; Sarcoma	170	C40-C41
DNCL002355	Robatumumab	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002356	HTERT plasmid DNA cancer vaccine	Cancer	140-229	C00-C96
DNCL002357	MK-5108/VX-689	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002358	V930/V932	Cancer	140-229	C00-C96
DNCL002359	ISIS-STAT3Rx	Cancer	140-229	C00-C96
DNCL002360	ASP3026	Cancer	140-229	C00-C96
DNCL002360	ASP3026	Late-stage B-cell lymphoma	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C85.1, D10-D36, D3A
DNCL002360	ASP3026	Late-stage B-cell lymphoma	202.8	C81-C96, C85.1
DNCL002360	ASP3026	Late-stage solid tumors	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002361	AGS-6MF	Cancer	140-229	C00-C96
DNCL002362	AGS-16M8F	Cancer	140-229	C00-C96
DNCL002362	AGS-16M8F	Renal cancer	.	C64
DNCL002363	AMG 208	Cancer	140-229	C00-C96
DNCL002363	AMG 208	Cancers	140-239	C00-C96
DNCL002363	AMG 208	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002364	AMG 337	Cancer	.	C00-C97
DNCL002364	AMG 337	Cancers	140-239	C00-C96
DNCL002364	AMG 337	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002365	AMG 780	Cancer	.	C00-C97
DNCL002365	AMG 780	Cancers	140-239	C00-C96
DNCL002365	AMG 780	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002366	AMG 820	Cancer	.	C00-C97
DNCL002366	AMG 820	Cancers	140-239	C00-C96
DNCL002366	AMG 820	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002367	AMG 900	Cancers	140-239	C00-C96
DNCL002367	AMG 900	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002367	AMG 900	Solid tumours	.	C00-C75,C7A,C7B
DNCL002367	AMG 900	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002368	AMG 319	Hematologic malignancies	200-209	C81-C96
DNCL002368	AMG 319	Hematological malignancies	200-209	C81-C96
DNCL002368	AMG 319	Myeloid leukemia	.	C92
DNCL002369	U3-1565	Cancer	.	C00-C97
DNCL002369	U3-1565	Solid cancer	140-199	C00-C75, C7A, C7B
DNCL002369	U3-1565	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002370	JNJ-26481585	Cancer	.	C00-C97
DNCL002370	JNJ-26481585	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DNCL002370	JNJ-26481585	Cutaneous T-cell lymphoma	202.1, 202.2, 202.8, 208.9	C81-C96, C84.0, C84.1, C91-C95
DNCL002370	JNJ-26481585	Myelodysplastic syndromes; Metastatic leukemia	202.8, 208.9, 238.7	C81-C96, C91-C95, D46
DNCL002371	OPR-003	Hematological malignancies	200-209	C81-C96
DNCL002372	Anti-OX40 mAb	Prostate cancer	185	C61
DNCL002373	SAR256212	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002373	SAR256212	Breast cancer	174, 175	C50
DNCL002373	SAR256212	Non-small-cell lung carcinoma	162, 183	C33, C34, C56
DNCL002373	SAR256212	Ovarian cancer	183	C56
DNCL002374	Genz644282	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002375	SAR245408/MSC1936369B combination therapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002376	SAR245409/MSC1936369B combination therapy	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002377	SAR566658	DS6-positive solid tumors	140-199	C00-C75, C7A, C7B
DNCL002378	SAR650984	Hematological malignancies	.	C81-C96
DNCL002378	SAR650984	Hematological malignancies	200-209	C81-C96
DNCL002379	BP-100-1-01	Acute lymphoblastic leukemia	.	C91.0
DNCL002379	BP-100-1-01	Acute lymphoblastic leukemia; Acute myeloid leukemia; Chronic myelogenous leukemia	204.0, 205.0, 205.1, 238.7	C91.0, C92.0, C92.1, D46
DNCL002379	BP-100-1-01	Hematological malignancies	200-209	C81-C96
DNCL002379	BP-100-1-01	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
DNCL002380	Oncolytic virus	Prostate cancer	185	C61
DNCL002381	ABC294640	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DNCL002381	ABC294640	Cancer	140-229	C00-C96
DNCL002382	Colorectal cancer vaccine	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002382	Colorectal cancer vaccine	Colorectal cancer	153, 154	C18-C21
DNCL002382	Colorectal cancer vaccine	Stage III colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002383	GO-203-2c	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002384	ABT-348	Cancer	.	C00-C97
DNCL002384	ABT-348	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002384	ABT-348	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002385	ABT-700	Advanced solid tumours	140-199	C00-C75, C7A, C7B
DNCL002385	ABT-700	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002386	ABT-767	Solid tumours	.	C00-C75,C7A,C7B
DNCL002386	ABT-767	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002387	ABT-806	Cancer	140-229	C00-C96
DNCL002387	ABT-806	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002388	Indium-111	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002389	Etirinotecan pegol	Colorectal cancer	153, 154	C18-C21
DNCL002389	Etirinotecan pegol	Combination therapy	183	C56
DNCL002389	Etirinotecan pegol	Metastatic breast cancer	140-199, 140-229, 174, 175, 183, 210-229	C00-C75, C00-C96, C50, C56, C7A, C7B, D10-D36, D3A
DNCL002389	Etirinotecan pegol	Platinum-resistant ovarian cancer	140-199, 140-229, 183, 210-229	C00-C75, C00-C96, C56, C7A, C7B, D10-D36, D3A
DNCL002390	Folate binding protein vaccine	Breast cancer	174, 175	C50
DNCL002390	Folate binding protein vaccine	Endometrial cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
DNCL002390	Folate binding protein vaccine	Ovarian cancer	183	C56
DNCL002391	Unknown6	Gynecological cancer	140-229, 183	C00-C96, C56
DNCL002392	PEG arginine deiminase	Hepatocellular carcinoma	155	C22.0
DNCL002392	PEG arginine deiminase	Metastatic malignant melanoma	172	C43
DNCL002392	PEG arginine deiminase	Pediatric cancer	140-229	C00-C96
DNCL002392	PEG arginine deiminase	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002393	GL-ONC1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002394	HuM195/rGel	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1, 238.7	C92.0, C92.1, D46
DNCL002394	HuM195/rGel	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
DNCL002395	Melanoma DNA vaccine	Malignant melanoma	172	C43
DNCL002396	NPI-0052	Lymphoma	202.8	C81-C96
DNCL002396	NPI-0052	Multiple myeloma	203	C90.0
DNCL002396	NPI-0052	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002397	Sonepcizumab	Macular degeneration	.	H35.3
DNCL002397	Sonepcizumab	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002398	INK1117	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002399	CX-4945	Cancer	.	C00-C97
DNCL002399	CX-4945	Multiple myeloma	203	C90.0
DNCL002399	CX-4945	Myeloma	203	C90.0
DNCL002399	CX-4945	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002400	Inotuzumab ozogamicin	Acute lymphoblastic leukemia	204	C91.0
DNCL002400	Inotuzumab ozogamicin	Aggressive non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL002400	Inotuzumab ozogamicin	Cancer	.	C00-C97
DNCL002400	Inotuzumab ozogamicin	Diffuse large B-cell lymphoma; indolent non-Hodgkin's lymphoma	200, 200.0, 202, 202.8	C81-C96, C82-C85, C83.3, C85.1
DNCL002401	PF-03446962	Cancer	.	C00-C97
DNCL002401	PF-03446962	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002402	PF-04605412	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002403	PF-04691502	Cancer	.	C00-C97
DNCL002403	PF-04691502	Endometrial cancer	182	C54.1
DNCL002403	PF-04691502	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002404	PF-05212384	Cancer	.	C00-C97
DNCL002404	PF-05212384	Endometrial cancer	182	C54.1
DNCL002404	PF-05212384	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002405	AR-12	Cancer	.	C00-C97
DNCL002405	AR-12	Lymphoma	202.8	C81-C96
DNCL002405	AR-12	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002406	AR-67	Glioblastoma	.	C71
DNCL002406	AR-67	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
DNCL002406	AR-67	Myelodysplastic syndromes	140-199, 210-229, 238.7	C00-C75, C7A, C7B, D10-D36, D3A, D46
DNCL002406	AR-67	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002407	Fluorapacin	Cancer	140-229	C00-C96
DNCL002408	PV-10	Liver cancer; liver metastases	140-229, 155	C00-C96, C22.0
DNCL002408	PV-10	Malignant melanoma	172	C43
DNCL002409	Simotaxel IV	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002410	D-3263	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002411	ARRY-380	Breast cancer	174, 175	C50
DNCL002411	ARRY-380	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DNCL002412	ARRY-162	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002412	ARRY-162	Malignant melanoma	140-199, 172, 210-229	C00-C75, C43, C7A, C7B, D10-D36, D3A
DNCL002413	ARRY-300	Cancer	140-229	C00-C96
DNCL002414	ARRY-382	Cancer	140-229	C00-C96
DNCL002415	Golnerminogene pradenovec	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002415	Golnerminogene pradenovec	Malignant melanoma	172	C43
DNCL002415	Golnerminogene pradenovec	Prostate cancer	185	C61
DNCL002415	Golnerminogene pradenovec	Sarcoma	.	C00-C75
DNCL002416	LGK974	Breast cancer	174, 175	C50
DNCL002416	LGK974	Cancer	.	C00-C97
DNCL002416	LGK974	Malignant melanoma	172	C43
DNCL002417	LGX818	Melanoma	.	C43
DNCL002417	LGX818	Melanoma	172	C43
DNCL002417	LGX818	Metastatic colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002417	LGX818	Metastatic malignant melanoma	172	C43
DNCL002418	LEE011	Lymphoma	202.8	C81-C96
DNCL002418	LEE011	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002419	Lucatumumab	Lymphoma	.	C81-C96
DNCL002419	Lucatumumab	Lymphoma	202	C82
DNCL002419	Lucatumumab	Lymphoma	202.8	C81-C96
DNCL002420	Sotrastaurin	Diffuse large b-cell lymphoma	200	C83.3
DNCL002421	RAF265	Malignant melanoma	140-199, 172, 210-229	C00-C75, C43, C7A, C7B, D10-D36, D3A
DNCL002421	RAF265	Melanoma	.	C43
DNCL002421	RAF265	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002422	BHQ880	Multiple myeloma	203	C90.0
DNCL002422	BHQ880	Myeloma	203	C90.0
DNCL002422	BHQ880	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002423	BQS481	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002424	BYL719	Cancer	.	C00-C97
DNCL002424	BYL719	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002424	BYL719	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002425	HSP990	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002426	LCL161	Breast cancer	174, 175	C50
DNCL002426	LCL161	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002427	LDK378	Non-small cell lung cancer	.	C33-C34
DNCL002427	LDK378	Non-small cell lung cancer	162	C33, C34
DNCL002427	LDK378	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002428	LEQ506	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002429	GSK2126458	Lymphoma	.	C81-C96
DNCL002429	GSK2126458	Lymphoma	202.8	C81-C96
DNCL002429	GSK2126458	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002430	GSK2141795	Colorectal cancer	.	C18-C20,C21
DNCL002430	GSK2141795	Lymphoma	202.8	C81-C96
DNCL002430	GSK2141795	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002431	Trametinib	KRAS mutant non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
DNCL002431	Trametinib	Lymphoma	202.8	C81-C96
DNCL002431	Trametinib	Malignant melanoma	172	C43
DNCL002431	Trametinib	Malignant melanoma	172, 202.8, 203.0, 208.9	C43, C81-C96, C90.0, C91-C95
DNCL002431	Trametinib	Melanoma	.	C43
DNCL002431	Trametinib	Metastatic melanoma	172	C43
DNCL002431	Trametinib	Multiple myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL002431	Trametinib	Non-small-cell lung carcinoma	162	C33, C34
DNCL002431	Trametinib	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
DNCL002431	Trametinib	Relapsed/refractory leukemia	208.9	C91-C95
DNCL002432	GSK2241658A	Metastatic malignant melanoma	172	C43
DNCL002432	GSK2241658A	Metastatic melanoma	172	C43
DNCL002433	GSK2302025A	Metastatic malignant melanoma	172	C43
DNCL002434	GSK1070916A	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002435	GSK2256098	Solid tumours	.	C00-C75,C7A,C7B
DNCL002435	GSK2256098	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002436	GSK2636771	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002437	OMP-18R5	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002438	BAY 1000394	Cancer	140-229	C00-C96
DNCL002438	BAY 1000394	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002439	BAY 79-4620	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002440	BAY 80-6946	Cancer	.	C00-C97
DNCL002440	BAY 80-6946	Cancer	140-229	C00-C96
DNCL002440	BAY 80-6946	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002440	BAY 80-6946	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002441	BAY 87-2243	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002442	BAY 94-9343	Cancer	.	C00-C97
DNCL002442	BAY 94-9343	Cancer	140-229	C00-C96
DNCL002442	BAY 94-9343	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002443	BAY 10-02670	Symptomatic uterine fibroids	218.9	D25
DNCL002443	BAY 10-02670	Uterine leiomyoma	218.9	D25
DNCL002444	BAY 94-9392	Cancer	140-229	C00-C96
DNCL002445	DPX-survivac cancer vaccine	Ovarian cancer	183	C56
DNCL002446	Sapacitabine	Acute myeloid leukemia	140-199, 205.0, 210-229	C00-C75, C7A, C7B, C92.0, D10-D36, D3A
DNCL002446	Sapacitabine	Acute myeloid leukemia	205	C92.0
DNCL002446	Sapacitabine	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002446	Sapacitabine	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
DNCL002446	Sapacitabine	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
DNCL002446	Sapacitabine	Non-small-cell lung carcinoma	140-199, 162, 208.9, 210-229	C00-C75, C33, C34, C7A, C7B, C91-C95, D10-D36, D3A
DNCL002446	Sapacitabine	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002447	ABI-011	Cancer	140-229	C00-C96
DNCL002447	ABI-011	Solid tumours	.	C00-C75,C7A,C7B
DNCL002448	UNBS-5162	Lymphoma	202.8	C81-C96
DNCL002448	UNBS-5162	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002449	SAR307746	Solid tumours	.	C00-C75,C7A,C7B
DNCL002449	SAR307746	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002450	PSMA ADC	Prostate cancer	185	C61
DNCL002451	PSMA protein vaccine	Prostate cancer	185	C61
DNCL002452	PSMA VRP therapeutic vaccine	Prostate cancer	185	C61
DNCL002453	HS-110	Late-stage non-small cell lung cancer	162	C33, C34
DNCL002453	HS-110	Non-small cell lung cancer	.	C33-C34
DNCL002453	HS-110	Non-small-cell lung carcinoma	162	C33, C34
DNCL002454	ALD-151	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002454	ALD-151	Leukemia	.	C91-C95
DNCL002455	RG7256	Malignant melanoma	172	C43
DNCL002456	RG7112	Hematological malignancies	.	C81-C96
DNCL002456	RG7112	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002456	RG7112	Hematological malignancies	200-209	C81-C96
DNCL002456	RG7112	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002456	RG7112	Solid tumours; Hematological tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002457	RG7116	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002458	RG7155	Solid tumours	.	C00-C75,C7A,C7B
DNCL002458	RG7155	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002459	RG7167	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002460	RG7304	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002461	RG7356	Acute myeloid leukemia	.	C92.0
DNCL002461	RG7356	Acute myeloid leukemia	205	C92.0
DNCL002461	RG7356	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002462	RG7388	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002462	RG7388	Hematological malignancies	200-209	C81-C96
DNCL002462	RG7388	Solid tumours	.	C00-C75,C7A,C7B
DNCL002462	RG7388	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002462	RG7388	Solid tumours; Hematological tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002463	RG7593	Hematological malignancies	200-209	C81-C96
DNCL002463	RG7593	Solid tumours	.	C00-C75,C7A,C7B
DNCL002464	Tigatuzumab	Breast cancer	174, 175	C50
DNCL002464	Tigatuzumab	Colorectal cancer	.	C18-C20,C21
DNCL002464	Tigatuzumab	Colorectal cancer	153, 154	C18-C21
DNCL002464	Tigatuzumab	Liver cancer	155	C22.0
DNCL002464	Tigatuzumab	Lymphoma	202.8	C81-C96
DNCL002464	Tigatuzumab	Ovarian cancer	183	C56
DNCL002464	Tigatuzumab	Pancreatic cancer	157	C25
DNCL002465	DS-2248	Solid cancer	140-199	C00-C75, C7A, C7B
DNCL002465	DS-2248	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002466	DS-7423	Cancer	.	C00-C97
DNCL002466	DS-7423	Solid cancer	140-199	C00-C75, C7A, C7B
DNCL002466	DS-7423	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002467	EZN-2208	Combination therapy	.	C81-C96
DNCL002467	EZN-2208	Metastatic breast cancer	174, 175	C50
DNCL002467	EZN-2208	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002467	EZN-2208	Solid tumours	.	C00-C75,C7A,C7B
DNCL002467	EZN-2208	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002468	Naptumomab estafenatox	Non-small-cell lung carcinoma	162	C33, C34
DNCL002468	Naptumomab estafenatox	Pancreatic cancer	157	C25
DNCL002468	Naptumomab estafenatox	Renal cancer	189	C64
DNCL002468	Naptumomab estafenatox	Solid tumours	.	C00-C75,C7A,C7B
DNCL002469	GRN1005	Brain metastases	198.3	C79.31
DNCL002469	GRN1005	Glioma	191	C71
DNCL002470	Verpasep caltespen	Cervical intraepithelial neoplasia	.	D06,N87
DNCL002470	Verpasep caltespen	Cervical intraepithelial neoplasia	233.1, 622.10	D06, N87
DNCL002471	BIIB 022	Hepatocellular carcinoma	.	C22.0
DNCL002471	BIIB 022	Liver cancer	155	C22.0
DNCL002471	BIIB 022	Non-small-cell lung carcinoma	162	C33, C34
DNCL002472	P2045	NSCLC; Small-cell lung carcinoma	162	C33, C34
DNCL002472	P2045	Non-small-cell lung carcinoma	162	C33, C34
DNCL002473	MK-1496	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002474	PTI-188	Malignant melanoma	172	C43
DNCL002475	Obatoclax	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002475	Obatoclax	Lymphoma	202.0, 202.8, 203.0, 208.9	C81-C96, C82, C90.0, C91-C95
DNCL002475	Obatoclax	Mantle cell lymphoma	200.4	C85.7
DNCL002475	Obatoclax	Multiple myeloma	203	C90.0
DNCL002475	Obatoclax	Small-cell lung cancer	162, 202.8, 203.0, 208.9	C33, C34, C81-C96, C90.0, C91-C95
DNCL002475	Obatoclax	Solid tumours	.	C00-C75,C7A,C7B
DNCL002476	CEP-11981	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002477	Galiximab	Lymphoma	.	C81-C96
DNCL002477	Galiximab	Non-Hodgkin's lymphoma	200, 201, 202, 202.8	C81, C81-C96, C82-C85
DNCL002477	Galiximab	Non-hodgkin's lymphoma	200, 201, 202, 202.8	C81, C81-C96, C82-C85
DNCL002478	BIIB 015	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002479	BIIB 028	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002480	V934/V935	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002481	TRC093	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002482	PF-00337210	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002483	Iboctadekin	Non-Hodgkin's lymphoma	183, 200, 201, 202, 202.8	C56, C81, C81-C96, C82-C85
DNCL002483	Iboctadekin	Ovarian cancer	.	C56
DNCL002483	Iboctadekin	Ovarian cancer	183	C56
DNCL002484	BI-505	Late-stage multiple myeloma	203	C90.0
DNCL002484	BI-505	Multiple myeloma	.	C90.0
DNCL002484	BI-505	Myeloma	203	C90.0
DNCL002485	IMF-001	NY-ESO-1 antigen-expressing solid tumors	140-199	C00-C75, C7A, C7B
DNCL002485	IMF-001	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002486	In-111-DAC imaging agent	Cancer	140-229	C00-C96
DNCL002487	REIC gene therapy	Cancer	.	C00-C97
DNCL002487	REIC gene therapy	Prostate cancer	185	C61
DNCL002488	WX-UK1	Solid tumours	.	C00-C75,C7A,C7B
DNCL002488	WX-UK1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002489	CB3304	Cancer	.	C00-C97
DNCL002489	CB3304	Hematological malignancies	200-209	C81-C96
DNCL002489	CB3304	Multiple myeloma	203	C90.0
DNCL002490	Indatuximab ravtansine	Relapsed/refractory multiple myeloma	203	C90.0
DNCL002491	IPH-2101	Multiple myeloma	.	C90.0
DNCL002491	IPH-2101	Multiple myeloma	203	C90.0
DNCL002492	BC-819	Bladder cancer	188	C67
DNCL002492	BC-819	Late-stage ovarian cancer	140-229, 183, 188	C00-C96, C56, C67
DNCL002492	BC-819	Late-stage pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002493	AlloStim	Cancer	140-229	C00-C96
DNCL002493	AlloStim	Hematological malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL002493	AlloStim	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002494	E7050	Gastric cancer	140-229, 151	C00-C96, C16
DNCL002494	E7050	Glioblastoma	191	C71
DNCL002494	E7050	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002494	E7050	Late-stage malignant melanoma	140-199, 172, 210-229	C00-C75, C43, C7A, C7B, D10-D36, D3A
DNCL002494	E7050	Liver cancer	.	C22
DNCL002494	E7050	Liver cancer	155	C22.0
DNCL002494	E7050	Metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002495	Toca 511/Toca FC	Glioblastoma	191	C71
DNCL002496	Trans-sodium crocetinate	Glioblastoma	.	C71
DNCL002496	Trans-sodium crocetinate	Glioblastoma	191	C71
DNCL002497	VAL-083	Acute myeloid leukemia	.	C92.0
DNCL002497	VAL-083	Grade IV malignant glioma	191	C71
DNCL002498	VB-111	Glioblastoma	.	C71
DNCL002498	VB-111	Glioblastoma	191	C71
DNCL002498	VB-111	Thyroid cancer	193	C73
DNCL002499	SF1	Advanced breast cancer	174, 175	C50
DNCL002500	AVX-701	Cancer	140-229	C00-C96
DNCL002500	AVX-701	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21
DNCL002500	AVX-701	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002501	EGEN-001	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002501	EGEN-001	Fallopian tube cancer; Peritoneal cancer	140-229, 158, 183, 183.2, 221.0	C00-C96, C48.1-C48.2, C56, C57, D28
DNCL002501	EGEN-001	Ovarian cancer	.	C56
DNCL002501	EGEN-001	Ovarian cancer	183	C56
DNCL002502	Active specific immunotherapy	Colorectal cancer	153, 154	C18-C21
DNCL002503	PHY906	Chemotherapy-induced gastrointestinal disorders	530-558	K20-K64
DNCL002503	PHY906	Colorectal cancer	153, 154	C18-C21
DNCL002503	PHY906	Liver cancer	155	C22.0
DNCL002503	PHY906	Pancreatic cancer	157	C25
DNCL002504	TL-32711	Acute myeloid leukemia	205	C92.0
DNCL002504	TL-32711	Cancer	140-229	C00-C96
DNCL002504	TL-32711	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002505	Abexinostat	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DNCL002505	Abexinostat	Lymphoma	202.8	C81-C96
DNCL002505	Abexinostat	Lymphoma; Mantle cell lymphoma	200.4, 202.0, 202.8	C81-C96, C82, C85.7
DNCL002505	Abexinostat	Sarcoma	202.8	C81-C96
DNCL002506	Anti-MUC1 mAb	Pancreatic cancer	157	C25
DNCL002507	BAY 86-9766	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DNCL002507	BAY 86-9766	Liver cancer	140-229, 155	C00-C96, C22.0
DNCL002507	BAY 86-9766	Pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002508	BPX-101	Prostate cancer	.	C61
DNCL002508	BPX-101	Prostate cancer	185	C61
DNCL002509	VT-464	Prostate cancer	185	C61
DNCL002510	Samarium SM-153 lexidronam	Bone metastases	198.5	C79.51
DNCL002510	Samarium SM-153 lexidronam	Breast cancer	174, 175	C50
DNCL002510	Samarium SM-153 lexidronam	Osteosarcoma	170	C40-C41
DNCL002511	TH-9402	Graft-versus host disease	.	T86.0
DNCL002511	TH-9402	Graft-versus-host disease	279.5	T86.0
DNCL002512	MSC1936369B	Colorectal cancer	.	C18-C20,C21
DNCL002512	MSC1936369B	Hematological malignancies	200-209	C81-C96
DNCL002513	Umbilical cord blood stem cell therapy	Hematological malignancies	200-209	C81-C96
DNCL002513	Umbilical cord blood stem cell therapy	Sickle-cell anemia	280-285	D50-D64
DNCL002514	Telapristone	Endometriosis	.	N80
DNCL002514	Telapristone	Uterine leiomyoma	218.9	D25
DNCL002515	SL-701	Adult high-grade glioma	191	C71
DNCL002515	SL-701	Glioma	191	C71
DNCL002515	SL-701	Pediatric malignant glioma	191	C71
DNCL002516	Autologous cell vaccine	Malignant melanoma	172	C43
DNCL002516	Autologous cell vaccine	Non-small-cell lung carcinoma	162	C33, C34
DNCL002516	Autologous cell vaccine	Ovarian cancer	183	C56
DNCL002517	Thiarabine	Acute myeloid leukemia	205	C92.0
DNCL002517	Thiarabine	Lymphoma	202.8	C81-C96
DNCL002517	Thiarabine	Solid tumours	.	C00-C75,C7A,C7B
DNCL002518	Rintatolimod	Cancer	140-229	C00-C96
DNCL002518	Rintatolimod	Human immunodeficiency virus infection	.	B20
DNCL002519	Rigosertib	Acute myeloid leukemia	205	C92.0
DNCL002519	Rigosertib	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002519	Rigosertib	Lymphoma	202.8	C81-C96
DNCL002519	Rigosertib	Myelodysplastic syndromes	183, 202.8, 238.7	C56, C81-C96, D46
DNCL002519	Rigosertib	Myelodysplastic syndromes	238.7	D46
DNCL002519	Rigosertib	Ovarian cancer	183	C56
DNCL002519	Rigosertib	Pancreatic cancer	157	C25
DNCL002519	Rigosertib	Solid tumours	.	C00-C75,C7A,C7B
DNCL002520	TRU-016	Autoimmune diseases	.	D84.9
DNCL002520	TRU-016	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002520	TRU-016	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL002521	CLL immunotherapeutic vaccine	Chronic lymphocytic leukaemia	204.1, 208.9	C91-C95, C91.1
DNCL002521	CLL immunotherapeutic vaccine	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002522	CO-1686	Non-small cell lung cancer	.	C33-C34
DNCL002522	CO-1686	Non-small-cell lung carcinoma	162	C33, C34
DNCL002523	INNO-206	Pancreatic ductal adenocarcinoma	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002523	INNO-206	Soft tissue sarcoma	171	C49
DNCL002523	INNO-206	Solid tumours	.	C00-C75,C7A,C7B
DNCL002523	INNO-206	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002524	JX-594	Colorectal cancer	.	C18-C20,C21
DNCL002524	JX-594	Colorectal cancer	153, 154	C18-C21
DNCL002524	JX-594	Liver cancer	155	C22.0
DNCL002525	MGCD265	Non-small cell lung cancer	.	C33-C34
DNCL002525	MGCD265	Non-small-cell lung carcinoma	162	C33, C34
DNCL002526	Norepinephrine topical	Alopecia	.	L65.9
DNCL002526	Norepinephrine topical	Oral mucositis; Radiation-induced skin damage	528	K12.3
DNCL002527	CLR1404-I-124	Brain cancer	191	C71
DNCL002527	CLR1404-I-124	Non-small-cell lung carcinoma	162	C33, C34
DNCL002528	CLR1404-I-131	Non-small-cell lung carcinoma	162	C33, C34
DNCL002529	Daratumumab	Multiple myeloma	.	C90.0
DNCL002529	Daratumumab	Multiple myeloma	203	C90.0
DNCL002529	Daratumumab	Myeloma	203	C90.0
DNCL002530	SGX201	Cancer	005, 008, 009, 140-229, 555-558	A02-A09, C00-C96, K50-K55
DNCL002531	KW-2450	Breast cancer	.	C50
DNCL002531	KW-2450	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002532	BIW-8962	Multiple myeloma	.	C90.0
DNCL002532	BIW-8962	Multiple myeloma	203	C90.0
DNCL002532	BIW-8962	Myeloma	203	C90.0
DNCL002533	KW-2478	Cancer	.	C00-C97
DNCL002533	KW-2478	Multiple myeloma	203	C90.0
DNCL002533	KW-2478	Myeloma	203	C90.0
DNCL002534	JI-101	Solid tumours	.	C00-C75,C7A,C7B
DNCL002534	JI-101	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002535	ACY-1215	Autoimmune diseases	.	D84.9
DNCL002535	ACY-1215	Multiple myeloma	203	C90.0
DNCL002535	ACY-1215	Myeloma	203	C90.0
DNCL002536	M402	Metastatic pancreatic cancer	157	C25
DNCL002537	CRLX101	Late-stage solid tumors	140-199	C00-C75, C7A, C7B
DNCL002537	CRLX101	Solid tumours	.	C00-C75,C7A,C7B
DNCL002538	Prostate cancer vaccine	Colorectal cancer	.	C18-C20,C21
DNCL002538	Prostate cancer vaccine	Metastatic prostate cancer	140-229, 185	C00-C96, C61
DNCL002538	Prostate cancer vaccine	Prostate cancer	185	C61
DNCL002539	Ascorbic acid/menadione	Prostate cancer	185	C61
DNCL002540	Personalized cancer vaccine	Breast cancer	174, 175	C50
DNCL002541	SL-401	Acute myeloid leukemia	205	C92.0
DNCL002541	SL-401	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
DNCL002541	SL-401	Blastic plasmacytoid dendritic cell neoplasm	.	Q93.88
DNCL002541	SL-401	Multiple myeloma	203	C90.0
DNCL002541	SL-401	Myelodysplastic syndrome	758.33	Q93.88
DNCL002541	SL-401	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
DNCL002541	SL-401	Relapsed or refractory IL-3R+ cancers	140-229	C00-C96
DNCL002541	SL-401	Relapsed/refractory blastic plasmacytoid dendritic cell neoplasm	140-239, 205.0, 238.7	C00-C96, C92.0, D46
DNCL002542	Imetelstat	Chronic lymphocytic leukemia	203.0, 204.1	C90.0, C91.1
DNCL002542	Imetelstat	Essential thrombocythemia	203.0, 238.71, 289.9	C90.0, D47.3, D75.2, D75.8
DNCL002542	Imetelstat	Late-stage non-small cell lung cancer	162, 203.0, 208.9	C33, C34, C90.0, C91-C95
DNCL002542	Imetelstat	Metastatic breast cancer	174, 175	C50
DNCL002542	Imetelstat	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
DNCL002542	Imetelstat	Myeloma	203	C90.0
DNCL002543	GRNVAC1	Acute myeloid leukemia	.	C92.0
DNCL002543	GRNVAC1	Acute myeloid leukemia	205	C92.0
DNCL002543	GRNVAC1	Prostate cancer	185	C61
DNCL002544	PRo antigen cancer vaccine	HIV infections	.	B20
DNCL002544	PRo antigen cancer vaccine	Prostate cancer	185	C61
DNCL002545	SB1518	Myelodysplastic syndromes	238.7	D46
DNCL002545	SB1518	Myeloid leukemia	205	C92
DNCL002546	Bavituximab	Asthma	493	J45
DNCL002546	Bavituximab	Liver cancer	155	C22.0
DNCL002546	Bavituximab	Non-small-cell lung cancer	162	C33, C34
DNCL002546	Bavituximab	Pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002547	Oregovomab	Ovarian cancer	.	C56
DNCL002547	Oregovomab	Ovarian cancer	183	C56
DNCL002548	CDX-1401	Multiple solid tumors	140-199	C00-C75, C7A, C7B
DNCL002548	CDX-1401	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002549	Intetumumab	Malignant melanoma	172	C43
DNCL002549	Intetumumab	Prostate cancer	.	C61
DNCL002549	Intetumumab	Prostate cancer	185	C61
DNCL002550	Ibrutinib	Chronic lymphocytic leukemia	202.8, 203.0, 204.1	C81-C96, C90.0, C91.1
DNCL002550	Ibrutinib	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002550	Ibrutinib	Chronic lymphocytic leukemia	204.1, 208.9	C91-C95, C91.1
DNCL002550	Ibrutinib	Diffuse large B-cell lymphoma; Mantle cell lymphoma	200.0, 200.4, 202.8, 203.0, 208.9	C81-C96, C83.3, C85.1, C85.7, C90.0, C91-C95
DNCL002550	Ibrutinib	Diffuse large b-cell lymphoma	200	C83.3
DNCL002550	Ibrutinib	Lymphoma	202	C82
DNCL002550	Ibrutinib	Mantle cell lymphoma	200.4, 202.8, 203.0, 208.9	C81-C96, C85.7, C90.0, C91-C95
DNCL002550	Ibrutinib	Multiple myeloma	203	C90.0
DNCL002550	Ibrutinib	Myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL002550	Ibrutinib	Refractory/relapsed mantle cell lymphoma	200.4	C85.7
DNCL002551	Samarium SM-153 lexidronam injection	Multiple myeloma	203	C90.0
DNCL002551	Samarium SM-153 lexidronam injection	Prostate cancer	185	C61
DNCL002552	Cancer vaccine E75	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002552	Cancer vaccine E75	Prostate cancer	185	C61
DNCL002553	ARN-509	Hormone-refractory prostate cancer	185	C61
DNCL002553	ARN-509	Prostate cancer	.	C61
DNCL002554	TRC 105	Breast cancer	174, 175	C50
DNCL002554	TRC 105	Fallopian tube cancer; Peritoneal cancer	140-229, 183.2, 221.0	C00-C96, C57, D28
DNCL002554	TRC 105	Macular degeneration	.	H35.3
DNCL002554	TRC 105	Ovarian cancer	183	C56
DNCL002554	TRC 105	Prostate cancer	185	C61
DNCL002555	HE3235	Breast cancer	174, 175, 217	C50, D24
DNCL002555	HE3235	Hormone-refractory prostate cancer	185	C61
DNCL002556	PR104	Acute myeloid leukemia	205	C92.0
DNCL002557	PEGPH20	Pancreatic cancer	.	C25
DNCL002557	PEGPH20	Pancreatic cancer	157	C25
DNCL002558	AR-42	Chronic lymphocytic leukemia	202.8, 203.0, 204.1	C81-C96, C90.0, C91.1
DNCL002558	AR-42	Hematological malignancies	200-209	C81-C96
DNCL002558	AR-42	Lymphoma	202.8	C81-C96
DNCL002558	AR-42	Multiple myeloma	203	C90.0
DNCL002559	INC280	Solid tumours	.	C00-C75,C7A,C7B
DNCL002559	INC280	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002560	GSK2302024A	Neoadjuvant breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002561	GSK2110183	Leukemia	208.9	C91-C95
DNCL002561	GSK2110183	Multiple myeloma	203	C90.0
DNCL002561	GSK2110183	Myeloma	203	C90.0
DNCL002562	Amrubicin	Late-stage breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002562	Amrubicin	Small-cell lung cancer	162	C33, C34
DNCL002563	SNS01-T	Diffuse large B-cell lymphoma; Mantle cell lymphoma	200.0, 200.4, 202.8, 203.0	C81-C96, C83.3, C85.1, C85.7, C90.0
DNCL002563	SNS01-T	Multiple myeloma	.	C90.0
DNCL002563	SNS01-T	Multiple myeloma	203	C90.0
DNCL002563	SNS01-T	Myeloma	202.8, 203.0	C81-C96, C90.0
DNCL002564	Crolibulin	Solid tumours	.	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002564	Crolibulin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002565	AGS-005	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002566	SGI110	Acute myeloid leukemia	.	C92.0
DNCL002566	SGI110	Acute myeloid leukemia	205	C92.0
DNCL002566	SGI110	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
DNCL002566	SGI110	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
DNCL002567	ALT-801	Malignant melanoma	172	C43
DNCL002567	ALT-801	Melanoma	.	C43
DNCL002567	ALT-801	Myeloma	203	C90.0
DNCL002567	ALT-801	Urogenital cancer	140-229	C00-C96
DNCL002568	ALT-836	Adult respiratory distress syndrome	.	J80
DNCL002568	ALT-836	Cancer	140-229	C00-C96
DNCL002569	HuM195-Bi-213	Acute myeloid leukemia	205	C92.0
DNCL002570	Efatutazone	Colorectal cancer	.	C18-C20,C21
DNCL002570	Efatutazone	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002570	Efatutazone	Non-small-cell lung carcinoma	162	C33, C34
DNCL002570	Efatutazone	Thyroid cancer	140-229, 193	C00-C96, C73
DNCL002571	NV-1020	Liver cancer	155	C22.0
DNCL002572	ALXN6000	Chronic lymphocytic leukaemia	.	C91.1
DNCL002572	ALXN6000	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002572	ALXN6000	Multiple myeloma	203	C90.0
DNCL002573	KD032	Non-small-cell lung carcinoma	162	C33, C34
DNCL002573	KD032	Pancreatic cancer	157	C25
DNCL002574	MB07133	Hepatocellular carcinoma	155	C22.0
DNCL002574	MB07133	Inoperable/unresectable liver cancer	140-229, 155	C00-C96, C22.0
DNCL002575	SBG	Breast cancer	174, 175, 217	C50, D24
DNCL002575	SBG	Neuroblastoma	194	C74.9
DNCL002576	RGI-2001	Graft-versus-host disease	.	D89.811
DNCL002576	RGI-2001	Graft-versus-host disease	279.5	T86.0
DNCL002577	Poly-ICLC	Anaplastic astrocytoma	191	C71
DNCL002577	Poly-ICLC	Glioblastoma multiforme	.	C71
DNCL002578	Upamostat	Breast cancer	174, 175	C50
DNCL002579	Sym004	Colorectal cancer	.	C18-C20,C21
DNCL002579	Sym004	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002580	Irinotecan eluting beads	Liver metastases from colorectal cancer	140-229, 153, 154	C00-C96, C18-C21
DNCL002581	EC145	Non-small cell lung cancer	.	C33-C34
DNCL002581	EC145	Non-small-cell lung carcinoma	162	C33, C34
DNCL002581	EC145	Platinum-resistant ovarian cancer	140-229, 183	C00-C96, C56
DNCL002582	Interleukin-12 gene therapy	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
DNCL002582	Interleukin-12 gene therapy	Cutaneous T-cell lymphoma	202.1, 202.2, 202.8	C81-C96, C84.0, C84.1
DNCL002582	Interleukin-12 gene therapy	Malignant melanoma; Merkel cell carcinoma	172, 202.8, 209.31-209.36	C43, C44, C81-C96
DNCL002583	Coxsackievirus A21	Glioblastoma	.	C71
DNCL002583	Coxsackievirus A21	Malignant melanoma	172	C43
DNCL002584	CB-10-01	Malignant melanoma	172	C43
DNCL002584	CB-10-01	Melanoma	.	C43
DNCL002585	EC20	Non-small-cell lung carcinoma	162	C33, C34
DNCL002585	EC20	Ovarian cancer	.	C56
DNCL002585	EC20	Ovarian cancer	140-229, 183	C00-C96, C56
DNCL002586	Melphalan intravenous	Multiple myeloma	.	C90.0
DNCL002586	Melphalan intravenous	Multiple myeloma	203	C90.0
DNCL002586	Melphalan intravenous	Myeloma	203	C90.0
DNCL002587	Onyvax-105 anti-idiotype cancer vaccine 105AD7	Prostate cancer	185	C61
DNCL002588	PHA848125	Solid tumours	.	C00-C75,C7A,C7B
DNCL002588	PHA848125	Thymoma	164.0, 212.6	C37, D15.0
DNCL002589	CEN-109	Cancer	140-229	C00-C96
DNCL002590	AEZS-108	Acute lymphoblastic leukemia	.	C91.0
DNCL002590	AEZS-108	Late-stage endometrial cancer	140-229, 182.0, 183, 188	C00-C96, C54.1, C56, C67
DNCL002590	AEZS-108	Ovarian cancer	183	C56
DNCL002590	AEZS-108	Prostate cancer	185	C61
DNCL002591	Tesetaxel	Bladder cancer	140-229, 188	C00-C96, C67
DNCL002591	Tesetaxel	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002591	Tesetaxel	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
DNCL002591	Tesetaxel	Malignant melanoma	172, 188	C43, C67
DNCL002591	Tesetaxel	Prostate cancer	185	C61
DNCL002592	VB4-845	Head and neck cancer	.	C07-C14,C32-C33
DNCL002592	VB4-845	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002593	DCVax	Colorectal cancer	.	C18-C20,C21
DNCL002593	DCVax	Glioblastoma	191	C71
DNCL002593	DCVax	Late-stage prostate cancer	140-229, 185	C00-C96, C61
DNCL002593	DCVax	Prostate cancer	185	C61
DNCL002594	G-100 prophage cancer vaccine	Erkel cell carcinoma	.	C4A
DNCL002594	G-100 prophage cancer vaccine	Glioma	191	C71
DNCL002595	G-200 prophage cancer vaccine	Recurrent glioma	191	C71
DNCL002596	GMB-Vax	Glioblastoma	191	C71
DNCL002597	ICT-107	Brain cancer	.	C71
DNCL002597	ICT-107	Glioblastoma	191	C71
DNCL002598	Olaratumab	Glioblastoma	191	C71
DNCL002598	Olaratumab	Non-small cell lung cancer	162	C33, C34
DNCL002598	Olaratumab	Ovarian cancer	183	C56
DNCL002598	Olaratumab	Solid tumours	.	C00-C75,C7A,C7B
DNCL002599	Paclitaxel poliglumex	Fallopian tube cancer; Peritoneal cancer	140-229, 158, 183, 183.2, 221.0	C00-C96, C48.1-C48.2, C56, C57, D28
DNCL002599	Paclitaxel poliglumex	Glioma; Glioblastoma	191	C71
DNCL002599	Paclitaxel poliglumex	Non-small-cell lung carcinoma	162, 183	C33, C34, C56
DNCL002599	Paclitaxel poliglumex	Ovarian cancer	183	C56
DNCL002599	Paclitaxel poliglumex	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002600	TVI-Brain-1	Glioma	191	C71
DNCL002600	TVI-Brain-1	Pneumococcal infections	.	J13
DNCL002601	18F-fluorothymidine	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002602	Acolbifene	Breast cancer	174, 175	C50
DNCL002602	Acolbifene	Breast cancer	174, 175, 217	C50, D24
DNCL002603	AFP464	Breast cancer	174, 175	C50
DNCL002604	Dalotuzumab	Breast cancer	.	C50
DNCL002604	Dalotuzumab	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002605	Onartuzumab	Avastin-nave recurrent glioblastoma	191	C71
DNCL002605	Onartuzumab	Breast cancer	.	C50
DNCL002605	Onartuzumab	Colorectal cancer	153, 154	C18-C21
DNCL002605	Onartuzumab	Metastatic HER2-negative gastric cancer	140-229, 151	C00-C96, C16
DNCL002605	Onartuzumab	Metastatic breast cancer	174, 175	C50
DNCL002605	Onartuzumab	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002605	Onartuzumab	Metastatic non-small cell lung cancer	162	C33, C34
DNCL002605	Onartuzumab	Non-squamous non-small cell lung cancer	162	C33, C34
DNCL002605	Onartuzumab	Squamous non-small cell lung cancer	162	C33, C34
DNCL002605	Onartuzumab	Triple-negative metastatic breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002606	Rucaparib	Breast cancer	174, 175	C50
DNCL002606	Rucaparib	Ovarian cancer	183	C56
DNCL002607	SR 16234	Breast cancer	174, 175	C50
DNCL002608	Varlitinib	Breast cancer	174, 175	C50
DNCL002609	ADXS-HPV	Cancer	.	C00-C97
DNCL002609	ADXS-HPV	Cervical cancer	140-229, 180	C00-C96, C53
DNCL002609	ADXS-HPV	Recurrent cervical cancer; Cervical intraepithelial neoplasia	140-229, 180, 233.1, 622.10	C00-C96, C53, D06, N87
DNCL002610	PM-00104	Cervical cancer	180	C53
DNCL002610	PM-00104	Endometrial cancer	182	C54.1
DNCL002610	PM-00104	Ewing's sarcoma	170	C41
DNCL002610	PM-00104	Solid tumours	.	C00-C75,C7A,C7B
DNCL002611	PV701	Cervical cancer	180	C53
DNCL002611	PV701	Colorectal cancer	153, 154	C18-C21
DNCL002612	VGX-3100	Cervical intraepithelial neoplasia	001-139, 233.1, 622.10	A00-B99, D06, N87
DNCL002612	VGX-3100	Cervical intraepithelial neoplasia	233.1, 622.10	D06, N87
DNCL002612	VGX-3100	Human papillomavirus infections	001-139, 042-075, 140-229	A00-B99, A80-A99, B00-B34, C00-C96
DNCL002612	VGX-3100	Papillomavirus infections	.	A00-B99
DNCL002613	Brivanib	Breast cancer	.	C50
DNCL002613	Brivanib	Liver cancer	140-229, 155	C00-C96, C22.0
DNCL002613	Brivanib	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002613	Brivanib	Sarcoma	.	D69.3
DNCL002614	CT-011	Acute myeloid leukemia	205	C92.0
DNCL002614	CT-011	Metastatic colorectal cancer	140-229, 153, 154	C00-C96, C18-C21
DNCL002615	E7820	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002615	E7820	Colorectal cancer	153, 154	C18-C21
DNCL002615	E7820	Solid tumours	.	C00-C75,C7A,C7B
DNCL002616	Encapsulated cell therapy	Colorectal cancer	153, 154	C18-C21
DNCL002616	Encapsulated cell therapy	Refractory metastatic colorectal cancer	.	C18-C21
DNCL002616	Encapsulated cell therapy	Refractory metastatic pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002616	Encapsulated cell therapy	Refractory metastatic prostate cancer	140-229, 185	C00-C96, C61
DNCL002617	Autologous tumor cell vaccine	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002617	Autologous tumor cell vaccine	Ovarian cancer	183	C56
DNCL002618	Picoplatin	Colorectal cancer	153, 154	C18-C21
DNCL002618	Picoplatin	Ovarian cancer	183	C56
DNCL002618	Picoplatin	Prostate cancer	185	C61
DNCL002618	Picoplatin	Small-cell lung cancer	162	C33, C34
DNCL002619	Polyclonal antibody stimulator	Colorectal cancer	153, 154	C18-C21
DNCL002619	Polyclonal antibody stimulator	Gastric cancer	151	C16
DNCL002619	Polyclonal antibody stimulator	Gastric cancer; Pancreatic cancer	140-229, 151, 157	C00-C96, C16, C25
DNCL002619	Polyclonal antibody stimulator	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
DNCL002619	Polyclonal antibody stimulator	Pancreatic cancer	157	C25
DNCL002619	Polyclonal antibody stimulator	Prostate cancer	185	C61
DNCL002620	RG7160	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002620	RG7160	Solid tumours	.	C00-C75,C7A,C7B
DNCL002620	RG7160	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002621	RG7597	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002621	RG7597	Metastatic epithelial tumors	140-199	C00-C75, C7A, C7B
DNCL002622	TAS-106	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002623	AGS-003	Kidney cancer	140-229	C00-C96
DNCL002623	AGS-003	Metastatic kidney cancer	140-229	C00-C96
DNCL002623	AGS-003	Metastatic renal cancer	140-229, 189	C00-C96, C64
DNCL002623	AGS-003	Metastatic renal cell carcer	189	C64
DNCL002623	AGS-003	Migraine	346	G43
DNCL002623	AGS-003	Renal cancer	140-229, 189	C00-C96, C64
DNCL002624	Anti-PD1	Melanoma	172	C43
DNCL002624	Anti-PD1	Renal cell carcinoma	189	C64
DNCL002625	ABIO-0501	Chronic myeloid leukemia	205.1	C92.1
DNCL002626	GSK2130579A	Acute myeloid leukemia	205	C92.0
DNCL002627	Leukemia DNA vaccine	Acute myeloid leukemia	205	C92.0
DNCL002627	Leukemia DNA vaccine	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1	C92.0, C92.1
DNCL002628	Treosulfan	Acute lymphoblastic leukemia; Acute myeloid leukemia	204.0, 205.0, 238.7	C91.0, C92.0, D46
DNCL002628	Treosulfan	Melanoma	.	C43
DNCL002629	RG7686	Hepatocellular carcinoma	.	C22.0
DNCL002629	RG7686	Metastatic liver cancer	140-229, 155	C00-C96, C22.0
DNCL002630	LY2157299	Arteriosclerosis	.	I70
DNCL002630	LY2157299	Liver cancer	155	C22.0
DNCL002630	LY2157299	Liver cancer; Brain cancer	140-229, 155, 191	C00-C96, C22.0, C71
DNCL002631	AMG888/U3-1287	Non-small-cell lung carcinoma	162	C33, C34
DNCL002632	BMS-936558	Lung cancer	162	C33-C34
DNCL002632	BMS-936558	Non-small cell lung cancer	.	C33-C34
DNCL002633	Apricoxib	Non-small-cell lung carcinoma	162	C33, C34
DNCL002633	Apricoxib	Pancreatic cancer	.	M05-M06
DNCL002633	Apricoxib	Rheumatold arthritis	.	M05-M06
DNCL002634	Custirsen	Cancer	140-229	C00-C96
DNCL002634	Custirsen	Non-small-cell lung cancer	162	C33, C34
DNCL002634	Custirsen	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002635	Karenitecin	Advanced ovarian cancer	183	C56
DNCL002635	Karenitecin	Lung cancer	.	C33-C34
DNCL002635	Karenitecin	Non-small-cell lung carcinoma	162	C33, C34
DNCL002636	MORAb-009	Mesothelioma	163	C45
DNCL002636	MORAb-009	Solid tumours	.	C00-C75,C7A,C7B
DNCL002637	Pegdinetanib	Non-small-cell lung carcinoma	162	C33, C34
DNCL002638	Plinabulin	Non-small-cell lung carcinoma	162	C33, C34
DNCL002639	PT107	Non-small-cell lung carcinoma	162	C33, C34
DNCL002639	PT107	Sarcoma	.	C00-C75
DNCL002640	Ranpirnase	Lung cancer	162	C33-C34
DNCL002640	Ranpirnase	Non-small-cell lung carcinoma	162	C33, C34
DNCL002641	Retaspimycin	Non-small-cell lung carcinoma	162	C33, C34
DNCL002642	RG7414	Colorectal cancer	.	C18-C20,C21
DNCL002642	RG7414	Colorectal cancer	153, 154	C18-C21
DNCL002642	RG7414	Non-small-cell lung carcinoma	162	C33, C34
DNCL002642	RG7414	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002643	Volociximab	Non-small-cell lung carcinoma	162	C33, C34
DNCL002644	B-cell lymphoma vaccine	Indolent follicular lymphoma	202	C82
DNCL002644	B-cell lymphoma vaccine	Indolent follicular lymphoma	202.0, 202.8	C81-C96, C82
DNCL002644	B-cell lymphoma vaccine	Lymphoma	.	C81-C96
DNCL002644	B-cell lymphoma vaccine	Mantle cell lymphoma	200.4	C85.7
DNCL002644	B-cell lymphoma vaccine	Mantle cell lymphoma	202.8	C81-C96
DNCL002645	Ombrabulin	Non-small-cell lung cancer	162, 183	C33, C34, C56
DNCL002645	Ombrabulin	Ovarian cancer	140-229, 183	C00-C96, C56
DNCL002645	Ombrabulin	Sarcoma	.	C00-C75
DNCL002645	Ombrabulin	Sarcoma	.	D69.3
DNCL002646	Anti-PSCA mAb	Metastatic pancreatic cancer	157	C25
DNCL002646	Anti-PSCA mAb	Solid tumours	.	C00-C75,C7A,C7B
DNCL002647	CO-101	Metastatic pancreatic	.	C25.9
DNCL002648	Onyvax-P	Prostate cancer	185	C61
DNCL002649	TroVax	Colorectal cancer	.	C18-C20,C21
DNCL002649	TroVax	Hormone-refractory prostate cancer	185	C61
DNCL002650	Saridegib	Chondrosarcoma	170.9	C41.9
DNCL002651	Trabectedin	Metastatic breast cancer	174, 175	C50
DNCL002651	Trabectedin	Ovarian cancer	140-229, 183	C00-C96, C56
DNCL002651	Trabectedin	Prostate cancer	185	C61
DNCL002651	Trabectedin	Relapsed ovarian cancer	183	C56
DNCL002651	Trabectedin	Soft tissue sarcoma	171	C49
DNCL002652	NX-101	Dermal neurofibromatoses	.	Q85.00
DNCL002653	AZD4547	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL002653	AZD4547	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002654	Belotecan	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002655	Tremelimumab	Solid tumours	.	C00-C75,C7A,C7B
DNCL002655	Tremelimumab	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL002655	Tremelimumab	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002656	TXA127	Chemotherapy-induced emesis	.	C81-C96
DNCL002656	TXA127	Lymphoma	202.8	C81-C96
DNCL002657	XEN-2174	Cancer pain	338,780	R52, G89
DNCL002658	MER-101	Bone metastases	198.5	C79.51
DNCL002659	Volasertib	Acute myeloid leukemia	.	C92.0
DNCL002659	Volasertib	Acute myeloid leukemia	205	C92.0
DNCL002659	Volasertib	Cancers	140-239	C00-C96
DNCL002659	Volasertib	Urogenital cancer	140-229	C00-C96
DNCL002660	SCH-900776	Cancer	140-229	C00-C96
DNCL002661	Ecromeximab	Malignant melanoma	172	C43
DNCL002661	Ecromeximab	Metastatic melanoma	172	C43
DNCL002662	CG201	Solid tumours	.	C00-C75,C7A,C7B
DNCL002662	CG201	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002663	J 591 Lu-177	Metastatic prostate cancer; Non-metastatic prostate cancer	140-229, 185	C00-C96, C61
DNCL002663	J 591 Lu-177	Prostate cancer	185	C61
DNCL002664	IRX-2	Acute myeloid leukemia	205	C92.0
DNCL002664	IRX-2	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002665	Squalamine	Cancer	.	C00-C97
DNCL002665	Squalamine	Resistant ovarian cancer	140-229, 183	C00-C96, C56
DNCL002666	Tigapotide	Hormone-refractory prostate cancer	185	C61
DNCL002667	Vaccine autologous tumor cell vaccine	Adjuvant ovarian cancer	140-229, 183	C00-C96, C56
DNCL002667	Vaccine autologous tumor cell vaccine	Malignant melanoma	172, 183	C43, C56
DNCL002668	AP5346	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL002669	Uridine triacetate	Diabetes mellitus	250	E08-E13
DNCL002669	Uridine triacetate	Gastric cancer	140-229, 151	C00-C96, C16
DNCL002669	Uridine triacetate	Pancreatic cancer	157	C25
DNCL002670	Fluciclatide F-18	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002671	Mapatumumab	Advanced hepatocellular carcinoma	155	C22.0
DNCL002671	Mapatumumab	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
DNCL002671	Mapatumumab	Multiple myeloma	203	C90.0
DNCL002671	Mapatumumab	Myeloma	203	C90.0
DNCL002671	Mapatumumab	Non-small-cell lung carcinoma	162, 203.0	C33, C34, C90.0
DNCL002671	Mapatumumab	Solid tumours	.	C00-C75,C7A,C7B
DNCL002672	PCI-27483	Metastatic pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002672	PCI-27483	Pancreatic cancer	.	C25
DNCL002673	NP-2 gene therapy	Cancer pain	338,780	R52, G89
DNCL002674	Morphine intranasal	Cancer pain	338,780	R52, G89
DNCL002675	CRS-207	Mesothelioma	.	C45
DNCL002675	CRS-207	Metastatic pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002676	Lung cancer immunotherapy	Malignant melanoma	172	C43
DNCL002676	Lung cancer immunotherapy	Metastatic non-small cell lung cancer	162	C33, C34
DNCL002676	Lung cancer immunotherapy	Non-small-cell lung carcinoma	162	C33, C34
DNCL002677	Melanoma melanoma vaccine	Malignant melanoma	172	C43
DNCL002678	Imexon	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
DNCL002679	Liposome encapsulated paclitaxel	Breast cancer	174, 175	C50
DNCL002680	LE-DT	Pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002681	Amonafide	Breast cancer	174, 175	C50
DNCL002681	Amonafide	Ovarian cancer	183	C56
DNCL002681	Amonafide	Prostate cancer	185	C61
DNCL002682	CP-18770	Multiple myeloma	.	C90.0
DNCL002682	CP-18770	Multiple myeloma	203	C90.0
DNCL002683	C31510	Basal cell cancer	.	C44
DNCL002683	C31510	Basal cell cancer; Squamous call cancer	140-229, 173, 204.0	C00-C96, C44, C91.0
DNCL002684	MM-398	Metastatic pancreatic cancer	157	C25
DNCL002685	Metaiodobenzylguanidine I-131	Cancer	.	C00-C97
DNCL002685	Metaiodobenzylguanidine I-131	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
DNCL002686	GM-CT-01	Cancer	.	C00-C97
DNCL002686	GM-CT-01	Colorectal cancer	140-229, 153, 154	C00-C96, C18-C21, C20
DNCL002687	ARX-02	Cancer pain	140-229, 338,780	C00-C96, R52, G89
DNCL002687	ARX-02	Pain	.	G89
DNCL002688	Fosbretabulin	Non-small-cell lung cancer	162, 183	C33, C34, C56
DNCL002688	Fosbretabulin	Ovarian cancer	183	C56
DNCL002688	Fosbretabulin	Rheumatold arthritis	.	M05-M06
DNCL002689	CV-301	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002689	CV-301	Metastatic breast cancer	174, 175	C50
DNCL002690	Telcyta canfosfamide	Diffuse large B-cell lymphoma; Mantle cell lymphoma; Non-Hodgkin's lymphoma	183, 200, 200.0, 200.4, 201, 202, 202.8	C56, C81, C81-C96, C82-C85, C83.3, C85.1, C85.7
DNCL002690	Telcyta canfosfamide	Diffuse large b-cell lymphoma	200	C83.3
DNCL002691	Ibritumomab tiuxetan	Mantle cell lymphoma	200.4	C85.7
DNCL002692	Afimoxifene	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002693	Monoclonal antibody TNT-1	Recurrent glioblastoma	191	C71
DNCL002694	Rindopepimut	Brain cancer	.	C71
DNCL002694	Rindopepimut	Glioblastoma	191	C71
DNCL002694	Rindopepimut	Recurrent glioblastoma	191	C71
DNCL002695	CDX-011	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002695	CDX-011	Breast cancer	174, 175	C50
DNCL002695	CDX-011	Lymphoma	.	C81-C96
DNCL002695	CDX-011	Malignant melanoma	172	C43
DNCL002696	Vitespen	Renal cell carcinoma	189	C64
DNCL002697	Pixantrone	Breast cancer	140-229, 174, 175, 202.8	C00-C96, C50, C81-C96
DNCL002697	Pixantrone	Diffuse large B-cell lymphoma; Follicular lymphoma	200.0, 202.0, 202.8	C81-C96, C82, C83.3, C85.1
DNCL002697	Pixantrone	Diffuse large b-cell lymphoma	200	C83.3
DNCL002697	Pixantrone	Multiple sclerosis	.	G35
DNCL002698	Emepepimut-S	Lung cancer	.	C33-C34
DNCL002698	Emepepimut-S	Non-small-cell lung carcinoma	162	C33, C34
DNCL002698	Emepepimut-S	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002698	Emepepimut-S	Prostate cancer	185	C61
DNCL002699	TAK-700	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
DNCL002699	TAK-700	Non-metastatic castration-resistant prostate cancer	185	C61
DNCL002699	TAK-700	Prostate cancer	.	C61
DNCL002699	TAK-700	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002699	TAK-700	Prostate cancer	185	C61
DNCL002700	GS-6624	Colorectal cancer	.	C18-C20,C21
DNCL002700	GS-6624	Colorectal cancer	153, 154	C18-C21
DNCL002700	GS-6624	Pancreatic cancer	157	C25
DNCL002701	GS-1101	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002701	GS-1101	Indolent non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL002702	ODM-201	Castration-resistant prostate cancer	185	C61
DNCL002702	ODM-201	Prostate cancer	.	C61
DNCL002703	Icrucumab	Colorectal cancer	153, 154	C18-C21
DNCL002703	Icrucumab	Metastatic breast cancer	140-229, 174, 175, 188	C00-C96, C50, C67
DNCL002704	Litronesib	Metastatic breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002704	Litronesib	Non-small-cell lung carcinoma	162	C33, C34
DNCL002705	Cixutumumab	Liver cancer	155	C22.0
DNCL002705	Cixutumumab	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
DNCL002705	Cixutumumab	Non-small-cell lung carcinoma	162	C33, C34
DNCL002706	LY2603618	Ancreatic cancerand non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
DNCL002706	LY2603618	Non-small-cell lung carcinoma	162	C33, C34
DNCL002707	LY2835219	Cancer	.	C00-C97
DNCL002707	LY2835219	Cancer	140-229	C00-C96
DNCL002708	LY2875358	Cancer	140-229	C00-C96
DNCL002709	LY2510924	Cancer	.	C00-C97
DNCL002709	LY2510924	Cancer	140-229	C00-C96
DNCL002710	LY2090314	Acute myeloid leukemia	.	C92.0
DNCL002710	LY2090314	Acute myeloid leukemia; Acute promyelocytic leukemia	205.0, 208.9	C91-C95, C92.0, C92.4
DNCL002710	LY2090314	Cancer	140-229	C00-C96
DNCL002711	LY2940680	Cancer	.	C00-C97
DNCL002711	LY2940680	Cancer	140-229	C00-C96
DNCL002712	RG7321	Breast cancer	.	C50
DNCL002712	RG7321	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002713	ISIS-EIF4ERx	Cancer	140-229	C00-C96
DNCL002713	ISIS-EIF4ERx	Late-stage non-small cell lung cancer	162	C33, C34
DNCL002713	ISIS-EIF4ERx	Non-small-cell lung carcinoma	162	C33, C34
DNCL002713	ISIS-EIF4ERx	Prostate cancer	140-229, 185	C00-C96, C61
DNCL002714	YM155	Breast cancer	174, 175	C50
DNCL002714	YM155	Non-Hodgkin's lymphoma	200, 201, 202, 202.8	C81, C81-C96, C82-C85
DNCL002714	YM155	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002715	NX-1207	Hepatocellular carcinoma	155	C22.0
DNCL002715	NX-1207	Prostate cancer	185	C61
DNCL002716	SAR256212 companion diagnostic	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002717	SAR245409	Cancer	140-199, 140-229, 210-229	C00-C75, C00-C96, C7A, C7B, D10-D36, D3A
DNCL002717	SAR245409	Non-Hodgkin's lymphoma	200, 201, 202, 202.8	C81, C81-C96, C82-C85
DNCL002718	Leukemia cancer vaccine	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1	C92.0, C92.1
DNCL002719	Myeloma cancer vaccine	Multiple myeloma	203	C90.0
DNCL002720	Pancreatic cancer vaccine	Pancreatic cancer	157	C25
DNCL002721	Elagolix	Uterine leiomyoma	218.9	D25
DNCL002722	IDM-2101	Colorectal cancer	.	C18-C20,C21
DNCL002722	IDM-2101	Non-small-cell lung carcinoma	162	C33, C34
DNCL002723	ISF35	Chronic lymphocytic leukaemia	.	C91.1
DNCL002723	ISF35	Chronic lymphocytic leukemia	200, 202, 202.8, 204.1	C81-C96, C82-C85, C91.1
DNCL002723	ISF35	Chronic lymphocytic leukemia	204.1	C91.1
DNCL002723	ISF35	Mantle cell lymphoma; Small lymphocytic lymphoma	200.0, 200.4, 202.0, 202.8, 204.0, 204.1V10.60, 208.9	C81-C96, C82, C83.3, C85.7, C91-C95, C91.0, C91.1
DNCL002723	ISF35	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL002723	ISF35	Refractory metastatic chronic lymphocytic leukemia	204.1	C91.1
DNCL002724	PRX-302	Prostate cancer	185	C61
DNCL002725	Dacomitinib	Non-small-cell lung carcinoma	162	C33, C34
DNCL002725	Dacomitinib	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL002726	Tanezumab	Cancer pain	140-229, 338,780	C00-C96, R52, G89
DNCL002727	DN24-02	Breast cancer; Colorectal cancer; Ovarian cancer	140-229, 153, 154, 174, 175, 183	C00-C96, C18-C21, C50, C56
DNCL002727	DN24-02	Colorectal cancer	.	C18-C20,C21
DNCL002727	DN24-02	HER2-positive urogenital cancer	140-229, 179-186	C00-C96, C50-C68
DNCL002727	DN24-02	HER2-positive urogenital cancer	179-186	C50-C68
DNCL002728	Golnerminogene pradenovac	Esophageal cancer	140-229, 150	C00-C96, C15
DNCL002729	E7850	Hormone-refractory prostate cancer	140-229, 183, 185	C00-C96, C56, C61
DNCL002729	E7850	Ovarian cancer	183	C56
DNCL002729	E7850	Solid tumours	.	C00-C75,C7A,C7B
DNCL002729	E7850	Thyroid cancer	140-229, 183, 193	C00-C96, C56, C73
DNCL002730	MORAb-004	Colorectal cancer	.	C18-C20,C21
DNCL002730	MORAb-004	Colorectal cancer	153, 154	C18-C21
DNCL002730	MORAb-004	Malignant melanoma	172	C43
DNCL002730	MORAb-004	Melanoma	172	C43
DNCL002730	MORAb-004	Sarcoma	.	D69.3
DNCL002731	SOM230	Meningioma; Neuroendocrine tumors	140-199, 209, 210-229, 225.2	C00-C75, C70, C7A, C7B, D10-D36, D32, D3A
DNCL002732	HER2 antigen-specific cancer immunotherapeutic	Breast cancer	174, 175	C50
DNCL002733	Doxorubicin-eluting beads	Liver cancer	155	C22.0
DNCL002734	GTx-758	Advanced prostate cancer	140-229, 185	C00-C96, C61
DNCL002734	GTx-758	Prostate cancer	.	C61
DNCL002735	Eniluracil	Hyperlipidemia	272.0-272.4	E78
DNCL002735	Eniluracil	Metastatic breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002736	Autologous stem cell therapy	Malignant melanoma	172	C43
DNCL002736	Autologous stem cell therapy	Spinal cord injuries	952	S14, S24, S34
DNCL002737	Labetuzumab I-131	Colorectal cancer	153, 154	C18-C21
DNCL002738	APN301	Cancer	140-229	C00-C96
DNCL002738	APN301	Malignant melanoma	172	C43
DNCL002738	APN301	Neuroblastoma	194	C74.9
DNCL002739	Sagopilone	Breast cancer	174, 175	C50
DNCL002739	Sagopilone	Ovarian cancer	183	C56
DNCL002739	Sagopilone	Prostate cancer	185	C61
DNCL002740	V505	Cervical cancer	001-139, 140-229, 180	A00-B99, C00-C96, C53
DNCL002740	V505	Cervical cancer	140-229, 180	C00-C96, C53
DNCL002740	V505	Human papillomavirus infections	001-139, 042-075, 140-229	A00-B99, A80-A99, B00-B34, C00-C96
DNCL002741	TVI-Kidney-1	Carcinoma	.	D07.30
DNCL002741	TVI-Kidney-1	Renal cell carcinoma	189	C64
DNCL002742	Cenersen	Acute myeloid leukemia	205	C92.0
DNCL002743	BIIB 2024	Breast cancer	174, 175	C50
DNCL002743	BIIB 2024	Gastrointestinal stromal tumor	150-159	C15-C26
DNCL002744	AME-133v	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL002745	BAY 86-5044	Metastatic breast cancer	174, 175	C50
DNCL002746	IRX4204	Prostate cancer	185	C61
DNCL002747	Paclitaxel polymeric micelle formulation	Late-stage pancreatic cancer	140-229, 157	C00-C96, C25
DNCL002747	Paclitaxel polymeric micelle formulation	Pancreatic cancer	157	C25
DNCL002748	SG2000	Ovarian cancer	183	C56
DNCL002749	MUC-1 cancer vaccine	Ovarian cancer	183	C56
DNCL002750	Thymalfasin alfa 1	Liver cancer	155	C22.0
DNCL002750	Thymalfasin alfa 1	Malignant melanoma	172	C43
DNCL002751	Tc-99m ethylenedicysteine glucosamine	Non-small-cell lung carcinoma	162	C33, C34
DNCL002752	Fentanyl inhalation	Cancer pain	338,780	R52, G89
DNCL002753	EMD-525797	Colorectal cancer	.	C18-C20,C21
DNCL002753	EMD-525797	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
DNCL002754	OPT-822/OPT-821	Breast cancer	174, 175	C50
DNCL002754	OPT-822/OPT-821	Breast cancer	174, 175, 217	C50, D24
DNCL002755	RP101	Infections disease	.	A00-B99
DNCL002755	RP101	Pancreatic cancer	157	C25
DNCL002756	Pertuzumab companion diagnostic	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002757	IMA901	Kidney cancer	140-229	C00-C96
DNCL002757	IMA901	Renal cancer	189	C64
DNCL002758	Elacytarabine	AML	205	C92.0
DNCL002758	Elacytarabine	Late-stage acute myeloid leukemia	205	C92.0
DNCL002759	NGR-hTNF	Mesothelioma	163	C45
DNCL002760	Abagovomab	Ovarian cancer	.	C56
DNCL002760	Abagovomab	Ovarian cancer	183	C56
DNCL002761	EN3488	Bladder cancer	188	C67
DNCL002761	EN3488	Non-muscle invasive bladder cancer	188	C67, C67.9
DNCL002762	Companion diagnostic test EGFR-TKI	Advanced breast cancer	174, 175	C50
DNCL002763	V503	Cervical cancer	140-229, 180	C00-C96, C53
DNCL002763	V503	Cervical cancer; vulvovaginal cancer	001-139, 140-229, 180	A00-B99, C00-C96, C53
DNCL002763	V503	HPV-related cancers	078.1079.4	B97.7
DNCL002763	V503	Human papillomavirus infections	001-139, 042-075, 140-229	A00-B99, A80-A99, B00-B34, C00-C96
DNCL002764	Talaporfin	Breast cancer	174, 175, 217	C50, D24
DNCL002764	Talaporfin	Metastatic colorectal cancer	153, 154	C18-C21
DNCL002765	Ramucirumab	Colorectal cancer	153, 154	C18-C21
DNCL002765	Ramucirumab	Gastric cancer	151	C16
DNCL002765	Ramucirumab	Metastatic breast cancer	140-229, 174, 175	C00-C96, C50
DNCL002765	Ramucirumab	Metastatic breast cancer; Colorectal cancer; Gastric cancer	140-229, 151	C00-C96, C16
DNCL002766	Leukocyte interleukin	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
DNCL002766	Leukocyte interleukin	Human immunodeficiency virus infection	.	B20
DNCL002767	Girentuximab	Clear cell renal cell carcinoma	189	C64
DNCL002768	Obinutuzumab	Chronic Lymphocytic Leukemia	202.8, 204.1	C81-C96, C91.1
DNCL002768	Obinutuzumab	Chronic Lymphocytic Leukemia	204.1	C91.1
DNCL002768	Obinutuzumab	Chronic lymphocytic leukaemia	.	C91.1
DNCL002768	Obinutuzumab	Diffuse large B-cell lymphoma; Non-Hodgkin's lymphoma	200, 200.0, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C83.3, C85.1, C91-C95
DNCL002768	Obinutuzumab	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
DNCL002769	Astuprotimut-R	Adjuvant non-small-cell lung carcinoma	162	C33, C34
DNCL002769	Astuprotimut-R	Bladder cancer	188	C67
DNCL002769	Astuprotimut-R	Inoperable/unresectable malignant melanoma	172	C43
DNCL002769	Astuprotimut-R	Lung cancer	.	C33-C34
DNCL002769	Astuprotimut-R	Malignant melanoma	172	C43
DNCL002769	Astuprotimut-R	Malignant melanoma; Non-small-cell lung cancer	140-229, 162, 172	C00-C96, C33, C33-C34, C34, C43
DNCL002770	Virulizin	Breast cancer	174, 175, 217	C50, D24
DNCL002770	Virulizin	Prostate cancer	185	C61
DNCL002771	Velimogene aliplasmid	Malignant melanoma	172	C43
DNCL002771	Velimogene aliplasmid	Melanoma	.	C43
DNCL002772	S-1	Gastric cancer	151	C16
DNCL002773	E6014	Oral mucositis	528	K12.3
DNCL002774	Carlecortemcel-L	Hematological malignancies	200-209	C81-C96
DNCL002774	Carlecortemcel-L	Skin and lung infections	162, 680-709	C33-C34, L00-L99
DNCL002775	Dimesna	Chemoprotection	.	E10.2, E11.2, E13.2
DNCL002775	Dimesna	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002775	Dimesna	Lung cancer	162	C33-C34
DNCL002776	Melanoma vaccine	Malignant melanoma	172	C43
DNCL002776	Melanoma vaccine	Ovarian cancer	183	C56
DNCL002777	Ch14.18 mAb	Diabetic foot ulcer	707	L88-L89
DNCL002777	Ch14.18 mAb	Neuroblastoma	194	C74.9
DNCL002778	Rolapitant	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DNCL002779	Remestemcel-L	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002779	Remestemcel-L	Graft-versus-host disease	279.5	T86.0
DNCL002779	Remestemcel-L	Type 1 diabetes	250.01	E10
DNCL002780	Pancreas algenpantucel-L	Pancreatic cancer	157	C25
DNCL002781	Dronabinol oral solution	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DNCL002782	Rilimogene galvacirepvec	Castration-resistant prostate cancer	140-229, 185	C00-C96, C61
DNCL002782	Rilimogene galvacirepvec	Prostate cancer	.	C61
DNCL002783	KD019	Late-stage non-small cell lung cancer	162	C33, C34
DNCL002784	M-200 prophage cancer vaccine	Metastatic melanoma	172	C43
DNCL002784	M-200 prophage cancer vaccine	Seizures	.	G40
DNCL002785	Intedanib	Colorectal cancer	.	C18-C20,C21
DNCL002785	Intedanib	Late-stage non-small-cell lung carcinoma	162, 183	C33, C34, C56
DNCL002785	Intedanib	Late-stage ovarian cancer	140-229, 183	C00-C96, C56
DNCL002786	Elotuzumab	Multiple myeloma	.	C90.0
DNCL002786	Elotuzumab	Multiple myeloma	203	C90.0
DNCL002786	Elotuzumab	Myeloma	203	C90.0
DNCL002787	Necitumumab	Colorectal cancer	.	C18-C20,C21
DNCL002787	Necitumumab	Non-small-cell lung carcinoma	162	C33, C34
DNCL002787	Necitumumab	Squamous non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
DNCL002788	Talminogene laherparepvec	Malignant melanoma	172	C43
DNCL002788	Talminogene laherparepvec	Solid tumours	.	C00-C75,C7A,C7B
DNCL002789	POL-103A	Malignant melanoma	172	C43
DNCL002790	Netupitant/palonosetron	Chemotherapy-induced nausea and vomiting	787, 787.0	R11
DNCL002791	Girentuximab I-124	Renal cancer	.	C64
DNCL002791	Girentuximab I-124	Renal cancer	140-229, 189	C00-C96, C64
DNCL002792	Canfosfamide	Non-small-cell lung carcinoma	162, 183, 202.8	C33, C34, C56, C81-C96
DNCL002792	Canfosfamide	Ovarian cancer	183	C56
DNCL002792	Canfosfamide	Solid tumours	.	C00-C75,C7A,C7B
DNCL002793	Aclidinium	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002794	Aclidinium/formoterol	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002795	AZD2115	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002796	AZD2423	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002797	AZD3199	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002798	AZD5069	Asthma	493	J45
DNCL002798	AZD5069	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNCL002798	AZD5069	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002799	AZD5423	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002800	AZD8683	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002801	BCT197	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002802	BI-137882	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002803	BIO-11006	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002804	EP-101	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002805	EP-102	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002806	EPI-12323	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002807	GSK1325756	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002808	Levosalbutamol/ipratropium	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002809	MEDI-2338	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002810	MEDI8968	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002811	O-desulfated heparin	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002812	Olodaterol/tiotropium bromide	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002813	Paclitaxel-loaded stent	Emphysema	492	J43
DNCL002814	PF-03715455	Chronic obstructive pulmonary disease	.	J44.9
DNCL002814	PF-03715455	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002815	PH-797804	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002816	PT003	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002817	PT005	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002818	PUR118	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002819	Relovair	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002820	RV568	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002821	TD-4208	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002822	Tetomilast	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNCL002822	Tetomilast	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL002823	11-HSD inhibitor	Diabetes mellitus	250	E08-E13
DNCL002824	AC 165198	Diabetes mellitus	250	E08-E13
DNCL002825	Afrezza	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002826	Alogliptin/metformin	Type 2 diabetes	250.00, 250.02	E11
DNCL002827	Alogliptin/pioglitazone	Type 2 diabetes	250.00, 250.02	E11
DNCL002828	Alogliptin/roflumilast	Type 2 diabetes	250.00, 250.02	E11
DNCL002829	AMG 151	Type 2 diabetes	250.00, 250.02	E11
DNCL002830	AMG 876	Type 2 diabetes	250.00, 250.02	E11
DNCL002831	Anagliptin	Diabetes mellitus type 2	.	E11
DNCL002831	Anagliptin	Type 2 diabetes	250.00, 250.02	E11
DNCL002832	Analog insulin-PH20	Type 1 diabetes	250.01	E10
DNCL002832	Analog insulin-PH20	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002833	ARI-2243	Type 2 diabetes	250.00, 250.02	E11
DNCL002834	ASP1941	Liver disease	.	K70-K77
DNCL002834	ASP1941	Type 2 diabetes	250.00, 250.02	E11
DNCL002835	AV 133	Alzheimer's disease	.	G30,F00
DNCL002835	AV 133	Diabetes mellitus	250	E08-E13
DNCL002836	BGP-15	Type 2 diabetes	250.00, 250.02	E11
DNCL002837	BI-135585	Type 2 diabetes	250.00, 250.02	E11
DNCL002838	BIOD-123	Diabetes mellitus type 1	.	E10
DNCL002838	BIOD-123	Type 1 diabetes	250.01	E10
DNCL002839	Canagliflozin/metformin	Type 2 diabetes	250.00, 250.02	E11
DNCL002840	CAT 1004	Type 2 diabetes	250.00, 250.02	E11
DNCL002841	CJC-1134-PC	Diabetes mellitus type 2	.	E11
DNCL002841	CJC-1134-PC	Type 2 diabetes	250.00, 250.02	E11
DNCL002842	CVX 096	Diabetes mellitus type 2	.	E11
DNCL002842	CVX 096	Type 2 diabetes	250.00, 250.02	E11
DNCL002843	Dapagliflozin/metformin	Type 2 diabetes	250, 250.00, 250.02	E08-E13, E11
DNCL002843	Dapagliflozin/metformin	Type 2 diabetes	250.00, 250.02	E11
DNCL002844	DB 959	Type 2 diabetes	250.00, 250.02	E11
DNCL002845	DC9703	Type 2 diabetes	250.00, 250.02	E11
DNCL002846	Diabetes compound	Diabetes mellitus	250	E08-E13
DNCL002847	Dulaglutide	Diabetes mellitus type 2	.	E11
DNCL002847	Dulaglutide	Type 2 diabetes	250.00, 250.02	E11
DNCL002848	EGT-0001442	Type 2 diabetes	250.00, 250.02	E11
DNCL002849	EGT-0001474	Type 2 diabetes	250.00, 250.02	E11
DNCL002850	Empagliflozin	Diabetes mellitus type 1	.	E10
DNCL002850	Empagliflozin	Diabetes mellitus type 2	250	E11
DNCL002850	Empagliflozin	Type 2 diabetes	250	E08-E13
DNCL002850	Empagliflozin	Type 2 diabetes	250.00, 250.02	E11
DNCL002851	Empagliflozin/linagliptin	Type 2 diabetes	250.00, 250.02	E11
DNCL002852	Empagliflozin/metformin	Type 2 diabetes	250.00, 250.02	E11
DNCL002853	Emricasan	Hepatic fibrosis	.	K74.0
DNCL002853	Emricasan	Type 1 diabetes	250, 250.01	E08-E13, E10
DNCL002854	Encapsulated islet cell transplantation therapy	Type 1 diabetes	250.01	E10
DNCL002855	Ertugliflozin/PF-04971729	Type 2 diabetes	250.00, 250.02	E11
DNCL002856	GK1-399	Diabetes mellitus	.	E10-E14
DNCL002856	GK1-399	Type 2 diabetes	250.00, 250.02	E11
DNCL002857	GPR 119 agonist	Diabetes mellitus	250	E08-E13
DNCL002858	GSK1070806	Type 2 diabetes	250.00, 250.02	E11
DNCL002859	GSK2330672	Type 2 diabetes	250.00, 250.02	E11
DNCL002860	HDV-insulin	Type 2 diabetes	250.00, 250.02	E11
DNCL002861	HIP-2B	Diabetes mellitus type 2	.	E11
DNCL002861	HIP-2B	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002862	IBC-VS01	Diabetes mellitus type 1	.	E10
DNCL002862	IBC-VS01	Type 1 diabetes	250.01	E10
DNCL002863	Indeglitazar	Type 2 diabetes	250.00, 250.02	E11
DNCL002864	INGAP peptide	Type 1 diabetes	250.01	E10
DNCL002864	INGAP peptide	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002865	Insulin adjustable basal	Diabetes mellitus	250	E08-E13
DNCL002866	Insulin oral sublingual	Type 1 diabetes	250.01	E10
DNCL002867	Insulin transdermal	Diabetes mellitus type 2	.	E11
DNCL002867	Insulin transdermal	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002868	INT131	Type 2 diabetes	250.00, 250.02	E11
DNCL002869	ISIS-GCCRrx	Cushing's disease	255	E24
DNCL002869	ISIS-GCCRrx	Diabetes mellitus	.	E10-E14
DNCL002869	ISIS-GCCRrx	Diabetes mellitus	250	E08-E13
DNCL002869	ISIS-GCCRrx	Type 2 diabetes	250.00, 250.02	E11
DNCL002870	ISIS-GCGRrx	Diabetes mellitus	.	E10-E14
DNCL002870	ISIS-GCGRrx	Diabetes mellitus	250	E08-E13
DNCL002870	ISIS-GCGRrx	Type 2 diabetes	250.00, 250.02	E11
DNCL002871	ISIS-PTP1Brx	Diabetes mellitus	250	E08-E13
DNCL002871	ISIS-PTP1Brx	Type 2 diabetes	250.00, 250.02	E11
DNCL002872	ISIS-SGLT2rx	Type 2 diabetes	250.00, 250.02	E11
DNCL002873	ITCA 650	Type 2 diabetes	250.00, 250.02	E11
DNCL002874	JNJ-16269110	Type 2 diabetes	250.00, 250.02	E11
DNCL002875	JNJ-41443532	Type 2 diabetes	250.00, 250.02	E11
DNCL002876	KRP-104	Type 2 diabetes	250.00, 250.02	E11
DNCL002877	LEZ763	Peripheral arterial disease	443.9	I73.9
DNCL002877	LEZ763	Type 2 diabetes	250.00, 250.02	E11
DNCL002878	LIK066	Type 2 diabetes	250.00, 250.02	E11
DNCL002879	LIM-0705	Insulin resistance	.	E00-E90
DNCL002879	LIM-0705	Type 2 diabetes	250.00, 250.02	E11
DNCL002880	Linagliptin/pioglitazone	Type 2 diabetes	250.00, 250.02	E11
DNCL002881	Lisofylline	Type 1 diabetes	250.01	E10
DNCL002882	LX-4211	Diabetes mellitus type 2	.	E11
DNCL002882	LX-4211	Type 2 diabetes	250.00, 250.02	E11
DNCL002883	LY2409021	Type 2 diabetes	250.00, 250.02	E11
DNCL002884	LY2523199	Type 2 diabetes	250.00, 250.02	E11
DNCL002885	LY2605541	Diabetes mellitus	.	E10-E14
DNCL002885	LY2605541	Type 1/2 diabetes	250	E08-E13
DNCL002885	LY2605541	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002886	LY2963016	Diabetes mellitus	.	E10-E14
DNCL002886	LY2963016	Type 1/2 diabetes	250	E08-E13
DNCL002886	LY2963016	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002887	MBX-2982	Type 2 diabetes	250.00, 250.02	E11
DNCL002888	Mesenchymal precursor cell	Type 2 diabetes	250.00, 250.02	E11
DNCL002889	Metformin delayed-release formulation	Type 2 diabetes	250.00, 250.02	E11
DNCL002890	Metreleptin	Diabetes mellitus; Hypertriglyceridemia	250, 272.1, 272.6	E08-E13, E78.1, E78.2, E78.3, E88.1
DNCL002890	Metreleptin	Lipodystrophy	272.6	E88.1
DNCL002890	Metreleptin	Type 1 diabetes	250.01	E10
DNCL002891	Mitoglitazone	Type 2 diabetes	250.00, 250.02	E11
DNCL002892	MK-3102	Diabetes mellitus	250	E08-E13
DNCL002892	MK-3102	Diabetes mellitus type 2	.	E11
DNCL002892	MK-3102	Type 2 diabetes	250.00, 250.02	E11
DNCL002893	MK-5823	Type 2 diabetes	250.00, 250.02	E11
DNCL002894	MSDC-0602	Type 2 diabetes	250.00, 250.02	E11
DNCL002895	NN1218	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002895	NN1218	Type 2 diabetes	250.00, 250.02	E11
DNCL002896	NN1953	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002897	NN1954	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002898	NN9068	Type 2 diabetes	250.00, 250.02	E11
DNCL002899	NN9924	Type 2 diabetes	250.00, 250.02	E11
DNCL002900	NN9926	Type 2 diabetes	250.00, 250.02	E11
DNCL002901	NP-500	Diabetes mellitus type 2	.	E11
DNCL002901	NP-500	Metabolic syndrome X	277.7	E88.81
DNCL002901	NP-500	Type 2 diabetes	250.00, 250.02	E11
DNCL002902	OAP-189	Type 2 diabetes	250.00, 250.02	E11
DNCL002903	Oral-lyn	Type 1 diabetes	250.01	E10
DNCL002904	Oxyntomodulin	Diabetes mellitus type 2	.	E11
DNCL002904	Oxyntomodulin	Type 2 diabetes	250.00, 250.02	E11
DNCL002905	PAZ-320	Diabetes mellitus	.	E10-E14
DNCL002905	PAZ-320	Type 2 diabetes	250.00, 250.02	E11
DNCL002906	PB-1023	Diabetes mellitus type 2	.	E11
DNCL002906	PB-1023	Type 2 diabetes	250.00, 250.02	E11
DNCL002907	PEG-FGF-21	Diabetes mellitus	250	E08-E13
DNCL002907	PEG-FGF-21	Type 2 diabetes	250.00, 250.02	E11
DNCL002908	Peptide p277	Grass pollen hypersensitivity	.	J30.1
DNCL002908	Peptide p277	Type 1 diabetes	250, 250.01	E08-E13, E10
DNCL002909	PF-04937319	Diabetes mellitus type 2	.	E11
DNCL002909	PF-04937319	Type 2 diabetes	250.00, 250.02	E11
DNCL002910	PF-05175157	Type 2 diabetes	250.00, 250.02	E11
DNCL002911	PF-05231023	Diabetes mellitus type 2	.	E11
DNCL002911	PF-05231023	Type 2 diabetes	250.00, 250.02	E11
DNCL002912	RG4929	Type 2 diabetes	250.00, 250.02	E11
DNCL002913	RG7201	Type 2 diabetes	250.00, 250.02	E11
DNCL002914	RG7426	Diabetes mellitus type 1	.	E10
DNCL002914	RG7426	Type 1 diabetes	250.01	E10
DNCL002915	RG7685	Type 2 diabetes	250.00, 250.02	E11
DNCL002916	Ryzodeg	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002917	S-707106	Diabetes mellitus type 2	.	E11
DNCL002917	S-707106	Type 2 diabetes	250.00, 250.02	E11
DNCL002918	Semaglutide	Type 2 diabetes	250.00, 250.02	E11
DNCL002919	Sitagliptin/atovastatin	Type 2 diabetes	250.00, 250.02	E11
DNCL002920	SRT2104	Psoriasis	696	L40
DNCL002920	SRT2104	Type 2 diabetes	250.00, 250.02	E11
DNCL002921	SRT2379	Diabetes mellitus type 2	.	E11
DNCL002921	SRT2379	Type 2 diabetes	250.00, 250.02	E11
DNCL002922	SRT3025	Diabetes mellitus type 2	.	E11
DNCL002922	SRT3025	Type 2 diabetes	250.00, 250.02	E11
DNCL002923	T2 18C3	Type 2 diabetes	250.00, 250.02	E11
DNCL002924	TAK-329	Diabetes mellitus	.	E10-E14
DNCL002924	TAK-329	Diabetes mellitus	250	E08-E13
DNCL002924	TAK-329	Type 1 diabetes	250.01	E10
DNCL002925	TAK-472	Type 2 diabetes	250.00, 250.02	E11
DNCL002926	TAK-875	Diabetes mellitus	.	E10-E14
DNCL002926	TAK-875	Diabetes mellitus	250	E08-E13
DNCL002926	TAK-875	Type 2 diabetes	250.00, 250.02	E11
DNCL002927	Teneligliptin	Type 2 diabetes	250.00, 250.02	E11
DNCL002928	Teplizumab	Melanoma	.	C43
DNCL002928	Teplizumab	Type 1 diabetes	250.01	E10
DNCL002929	Insulin degludec	Type 1 diabetes	250, 250.01	E08-E13, E10
DNCL002929	Insulin degludec	Type 1/2 diabetes	250	E08-E13
DNCL002929	Insulin degludec	Type 1/2 diabetes	250, 250.00, 250.01, 250.02	E08-E13, E10, E11
DNCL002930	TT-401	Type 2 diabetes	250.00, 250.02	E11
DNCL002931	TTP054	Type 2 diabetes	250.00, 250.02	E11
DNCL002932	TTP355	Type 2 diabetes	250.00, 250.02	E11
DNCL002933	Vildagliptin/metformin	Type 2 diabetes	250.00, 250.02	E11
DNCL002934	VRS-859	Type 2 diabetes	250.00, 250.02	E11
DNCL002935	VVP808	Type 2 diabetes	250.00, 250.02	E11
DNCL002936	ABT-335	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002937	ABT-639	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002937	ABT-639	Pain	.	G89
DNCL002938	ACT-1 topical gel	Diabetic foot ulcer	707	L88-L89
DNCL002939	AKB-9778	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002939	AKB-9778	Peripheral arterial disease	.	I73.9
DNCL002940	ALG-1001	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002941	ARA 290	Depression	311	F32
DNCL002941	ARA 290	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002941	ARA 290	Mood disorder	.	F30-F39
DNCL002942	ARC-4558	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002942	ARC-4558	Hypertension	401	I10, I11, I12, I13, I15
DNCL002943	Baricitinib	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002943	Baricitinib	Psoriasis	696	L40
DNCL002943	Baricitinib	Rheumatold arthritis	714	M05-M06
DNCL002943	Baricitinib	Rheumatold arthritis; Psoriasis; Diabetic nephropathy	250, 250.4, 580-599, 696, 710-719, 714	E08-E13, E10.2, E11.2, E13.2, L40, M00-M25, M05-M06, N00-N29
DNCL002944	BVS857	Insulin resistance	.	E00-E90
DNCL002945	C-peptide long-acting	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
DNCL002946	Gentamicin-collagen sponge	Diabetic foot ulcer	707	L88-L89
DNCL002946	Gentamicin-collagen sponge	Multiples Myelom	.	C90.0
DNCL002947	CORT001	Metabolic syndrome X	277.7	E88.81
DNCL002948	CTP-499	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002948	CTP-499	Renal disease	.	N00-N29
DNCL002949	DSC-127	Diabetic foot ulcer	.	E08-E13
DNCL002949	DSC-127	Diabetic foot ulcer	707	L88-L89
DNCL002950	EVK-001	Diabetic gastroparesis	250, 536.3	E08-E13, K31.8
DNCL002951	Afilibercept	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002951	Afilibercept	Diabetic retinopathy	.	E10.3,E11.3,E13.3
DNCL002952	GRT 6005/06	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002953	HO-0303	Diabetic foot ulcer	707	L88-L89
DNCL002954	Iroxanadine	Atherosclerosis	414.0, 440	I70
DNCL002954	Iroxanadine	Diabetic foot ulcer; Diabetic neuropathy	250, 250.6, 356.0, 356.8, 707	E08-E13, E10.4, E11.4, E13.4, G64, G90.0, L88-L89
DNCL002955	Losartan/thioctic acid	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002956	LY2382770	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002957	LY2623091	Chronic kidney disease	250, 403, 580-589, 585.1-585.5, 585.9	E08-E13, N00-N29, N18
DNCL002957	LY2623091	Diabetes mellitus	.	E10-E14
DNCL002957	LY2623091	Renal disease associated with diabetes	250	E08-E13
DNCL002958	MK-6096	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002958	MK-6096	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNCL002959	Modified hepatocyte growth factor gene therapy	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002960	Doxycycline topical gel	Diabetic foot ulcer	707	L88-L89
DNCL002961	Nemonoxacin	Infections associated with diabetic foot ulcers	001-139, 250, 707	A00-B99, E08-E13, L88-L89
DNCL002962	Antisense oligonucleotide Nexagon	Diabetic foot ulcer	707	L88-L89
DNCL002963	Nova63035	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002964	Pexiganan	Diabetic foot ulcer	707	L88-L89
DNCL002965	PF-655	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002965	PF-655	Macular degeneration	.	H35.3
DNCL002966	Pyridoxamine	Diabetic kidney disease	.	E11.22
DNCL002966	Pyridoxamine	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
DNCL002967	Ranirestat	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002968	RM-131	Cachexia	.	R64
DNCL002968	RM-131	Diabetic gastroparesis	250, 536.3	E08-E13, K31.8
DNCL002969	Safotibant	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DNCL002970	SAR164653	Cardiovascular disease	250	E08-E13
DNCL002970	SAR164653	Cardiovascular disease 	250	E08-E13
DNCL002970	SAR164653	Diabetic complication	.	E08-E13
DNCL002971	Sirolimus ophthalmic	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
DNCL002972	SKL-NP	Diabetic neuropathic pain	250, 338, 356.0, 356.8,780	E08-E13, G64, G90.0, R52, G89
DNCL002972	SKL-NP	Pain	.	G89
DNCL002973	TAK-428	Diabetic nephropathy	.	E11.40
DNCL002973	TAK-428	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL002974	TTPABC	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL002975	TV1001	Diabetic angiopathy	250.7	E10.5, E11.5, E13.5
DNCL002976	TZP-102	Diabetic gastroparesis	250, 536.3	E08-E13, K31.8
DNCL002977	White blood cell therapy	Diabetic foot ulcer	707	L88-L89
DNCL002978	Abacavir/dolutegravir/lamivudine	HIV infections	42	B20
DNCL002979	BI-224436	HIV infections	42	B20
DNCL002980	CB1922	HIV infections	42	B20
DNCL002981	Cenicriviroc	HIV-1 infections	42	B20
DNCL002981	Cenicriviroc	Human immunodeficiency virus infection	.	B20
DNCL002982	CMX157	HIV infections	42	B20
DNCL002983	Cobicistat	HIV infections	42	B20
DNCL002984	Cobicistat/darunavir	HIV infections	42	B20
DNCL002985	Cobicistat/darunavir/emtricitabine/GS-7340	HIV-1 infections	42	B20
DNCL002986	Cobicistat/elvitegravir/emtricitabine/GS-7340	HIV-1 infections	42	B20
DNCL002987	Dolutegravir	HIV infections	42	B20
DNCL002987	Dolutegravir	HIV-1 infections	42	B20
DNCL002987	Dolutegravir	Human immunodeficiency virus infection	.	B20
DNCL002988	Efavirenz/lamivudine/tenofovir fumarate	HIV-1 infections	42	B20
DNCL002989	GS-7340	HIV infections	42	B20
DNCL002989	GS-7340	Human immunodeficiency virus infection	.	B20
DNCL002990	HIV attachment inhibitor	HIV infections	42	B20
DNCL002991	HIV maturation inhibitor	HIV infections	42	B20
DNCL002992	Ibalizumab	HIV-1 infections	42	B20
DNCL002993	KD-247	Acquired immune deficiency syndrome	42	B20
DNCL002993	KD-247	HIV-1 infections	42	B20
DNCL002994	KP-1461	HIV infections	42	B20
DNCL002994	KP-1461	Pneumococcal infections	.	J13
DNCL002995	Lamivudine /lopinavir/ritonavir fixed-dose combination	HIV-1 infections	42	B20
DNCL002996	Lamivudine /maraviroc/zidovudine fixed-dose combination	HIV infections	42	B20
DNCL002997	Lersivirine	HIV infections	42	B20
DNCL002998	MK-1439	HIV infections	42	B20
DNCL002998	MK-1439	HIV-1 infections	42	B20
DNCL002998	MK-1439	Human immunodeficiency virus infection	.	B20
DNCL002999	NRT inhibitor	HIV infections	42	B20
DNCL003000	CCR5 receptor antagonist	Cancers	.	B20
DNCL003000	CCR5 receptor antagonist	HIV infections	42	B20
DNCL003001	RAP101	HIV infections	42	B20
DNCL003002	RPI-MN	HIV infections	42	B20
DNCL003003	S/GSK1265744	HIV infections	42	B20
DNCL003003	S/GSK1265744	Human immunodeficiency virus infection	.	B20
DNCL003004	SPL-7013	HIV infections	42	B20
DNCL003005	Tenofovir vaginal gel	HIV infections	42	B20
DNCL003006	TMC310911	HIV infections	42	B20
DNCL003007	UB-421	HIV-1 infections	42	B20
DNCL003008	VRX806	HIV infections	42	B20
DNCL003009	HIV gene therapy	HIV infections	42	B20
DNCL003010	Lexgenleucel-T	HIV infections	42	B20
DNCL003011	SB-728-T	HIV infections	42	B20
DNCL003011	SB-728-T	Human immunodeficiency virus infection	.	B20
DNCL003012	AMZ0026	HIV infections	42	B20
DNCL003013	Cytolin	HIV infections	42	B20
DNCL003014	IRT-103	HIV infections	42	B20
DNCL003015	ADVAX	Diabetes mellitus	.	E10-E14
DNCL003015	ADVAX	HIV infections	42	B20
DNCL003016	AGS-004	HIV infections	42	B20
DNCL003016	AGS-004	HIV-1 infections	42	B20
DNCL003017	AVX-101	HIV-1 infection	001-139, 042	A00-B99, B20
DNCL003017	AVX-101	HIV-1 infections	001-139, 042	A00-B99, B20
DNCL003017	AVX-101	HIV-1 infections	42	B20
DNCL003018	DCVax-001	HIV infections	.	B20
DNCL003018	DCVax-001	HIV infections	001-139, 042	A00-B99, B20
DNCL003018	DCVax-001	HIV infections	42	B20
DNCL003019	DermaVir patch	HIV-1 infections	42	B20
DNCL003020	HIV gp41 vaccine	HIV infections	42	B20
DNCL003021	HIV recombinant vaccine	HIV infection	001-139, 042	A00-B99, B20
DNCL003021	HIV recombinant vaccine	HIV-1 infections	001-139, 042	A00-B99, B20
DNCL003021	HIV recombinant vaccine	HIV-1 infections	42	B20
DNCL003022	HIV vaccine	HIV infection	001-139, 042	A00-B99, B20
DNCL003022	HIV vaccine	HIV infections	001-139, 042	A00-B99, B20
DNCL003022	HIV vaccine	HIV infections	42	B20
DNCL003022	HIV vaccine	HIV-1 infections	42	B20
DNCL003022	HIV vaccine	HIV-2 infections	79.53	B97.35
DNCL003023	HIVAX	HIV-1 infections	42	B20
DNCL003024	ITV-1	HIV infections	42	B20
DNCL003024	ITV-1	Human immunodeficiency virus infection	.	B20
DNCL003025	Pennvax-B DNA vaccine	HIV infections	001-139, 042	A00-B99, B20
DNCL003025	Pennvax-B DNA vaccine	HIV infections	42	B20
DNCL003025	Pennvax-B DNA vaccine	Human immunodeficiency virus infection	.	B20
DNCL003026	Pennvax-G DNA vaccine	HIV infections	001-139, 042	A00-B99, B20
DNCL003026	Pennvax-G DNA vaccine	HIV infections	42	B20
DNCL003026	Pennvax-G DNA vaccine	Human immunodeficiency virus infection	.	B20
DNCL003027	TUTI-16	HIV-1 infections	42	B20
DNCL003028	Vacc-4x	HIV-1 infections	42	B20
DNCL003028	Vacc-4x	Human immunodeficiency virus infection	.	B20
DNCL003029	VRC-HIVADV014-00-VP	HIV infections	001-139, 042	A00-B99, B20
DNCL003029	VRC-HIVADV014-00-VP	HIV infections	42	B20
DNCL003029	VRC-HIVADV014-00-VP	Lateral sclerosis	.	G12.2
DNCL003030	VRC-HIVADV027-00-VP	HIV infections	001-139, 042	A00-B99, B20
DNCL003030	VRC-HIVADV027-00-VP	HIV infections	42	B20
DNCL003031	VRC-HIVDNA016-00-VP	HIV infection	001-139, 042	A00-B99, B20
DNCL003031	VRC-HIVDNA016-00-VP	HIV infections	001-139, 042	A00-B99, B20
DNCL003031	VRC-HIVDNA016-00-VP	HIV infections	42	B20
DNCL003032	ALKS33	Alcohol use disorders	303	F10.2
DNCL003032	ALKS33	Drug dependence	303-304	F10.2-F19.2
DNCL003033	ALKS5461	Cocaine dependence	.	F14.2
DNCL003033	ALKS5461	Cocaine dependence	304.2, 311	F14.2, F32
DNCL003033	ALKS5461	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003034	ARD-1600	Smoking dependence	292	F17.2
DNCL003035	Buprenorphine/naloxone	Opioid dependence	304	F11.2
DNCL003036	EMB-001	Cocaine dependence	304.2	F14.2
DNCL003037	INT-0003/2005	Nicotine dependence	305.1	F17
DNCL003038	KRL-901	Alcohol use disorders	303	F10.2
DNCL003039	MT-7716	Alcohol use disorders	303	F10.2
DNCL003040	Neboglamine	Cocaine dependence	304.2	F14.2
DNCL003041	Nepicastat oral	Cocaine dependence	.	F14.2
DNCL003041	Nepicastat oral	Cocaine dependence	300, 304.2	F14.2, F40-F42
DNCL003041	Nepicastat oral	Post-traumatic stress disorder	309.81	F43.1
DNCL003042	NIC002	Nicotine dependence	305.1	F17
DNCL003042	NIC002	Smoking cessation	292	F17.2
DNCL003042	NIC002	Smoking withdrawl syndrom	292	F17.2
DNCL003043	NicVAX	Nicotine dependence	305.1	F17
DNCL003043	NicVAX	Smoking cessation	292	F17.2
DNCL003044	OMS-403	Nicotine dependence	305.1	F17
DNCL003044	OMS-403	Nicotine dependence; opioid dependence	304.0, 305.1	F11.2, F17
DNCL003045	SEL-068	Smoking cessation	292	F17.2
DNCL003045	SEL-068	Smoking dependence	292	F17.2
DNCL003046	TA-CD	Cocaine addiction	304.2	F14.2
DNCL003046	TA-CD	Cocaine dependence	304.2	F14.2
DNCL003046	TA-CD	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL003047	X-22	Myocardial infarction	410	I21, I22
DNCL003047	X-22	Smoking dependence	292	F17.2
DNCL003048	ABT-436	Anxiety disorder	.	F40-F42
DNCL003048	ABT-436	Anxiety disorder	300, 311	F32, F40-F42
DNCL003048	ABT-436	Major depressive disorder	296.2, 296.3, 300	F32, F33, F40-F42
DNCL003049	Alprazolam sublingual	Anxiety disorder	300	F40-F42
DNCL003050	Alprazolam transdermal	Panic disorder	300.01, 300.21	F41.0
DNCL003051	BNC210	Anxiety disorder	300	F40-F42
DNCL003052	CX157	Anxiety disorder	300, 311	F32, F40-F42
DNCL003052	CX157	Mood disorder	.	F30-F39
DNCL003052	CX157	Treatment-resistant depression	300, 311	F32, F40-F42
DNCL003053	CXB722	Anxiety disorder	300, 311	F32, F40-F42
DNCL003053	CXB722	Depressive disorders	296, 300	F30-F39, F40-F42
DNCL003054	KRL-104	Generalized anxiety disorder	300.02	F41.1
DNCL003055	PH94B	Generalized social phobia	300.23	F40.1, F93.2
DNCL003056	SPN-805	Anxiety disorder	300	F40-F42
DNCL003057	SPN-808	Anxiety disorder	300	F40-F42
DNCL003058	SRX246	Post-traumatic stress disorder	.	F43.1
DNCL003058	SRX246	Traumatic stress disorder	.	F43.1
DNCL003059	Tedatioxetine	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
DNCL003059	Tedatioxetine	Major depressive disorder	296.2, 296.3, 300	F32, F33, F40-F42
DNCL003060	TGFK08AA	Generalized anxiety disorder	300.02	F41.1
DNCL003061	TGWOOAA	Anxiety disorder	.	F40-F42
DNCL003061	TGWOOAA	Generalized anxiety disorder; Social phobia	300, 300.02, 300.23	F40-F42, F40.1, F41.1, F93.2
DNCL003062	Vortioxetine	Anxiety disorder	300	F40-F42
DNCL003062	Vortioxetine	Depressive disorders	296	F30-F39
DNCL003062	Vortioxetine	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
DNCL003062	Vortioxetine	Generalized anxiety disorder	300.02	F41.1
DNCL003062	Vortioxetine	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003062	Vortioxetine	Major depressive disorder	296.2, 296.3, 300	F32, F33, F40-F42
DNCL003063	YKP-3089	Anxiety disorder	300, 311	F32, F40-F42
DNCL003063	YKP-3089	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
DNCL003063	YKP-3089	Epilepsy	.	G40
DNCL003064	Amfetamine transdermal	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003065	Bavisant	Attention deficit hyperactivity disorder	.	F90
DNCL003065	Bavisant	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003066	COL-171	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003067	CX1739	Attention deficit hyperactivity disorder	.	F90
DNCL003067	CX1739	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003068	EB-1020	Attention deficit hyperactivity disorder	.	F90
DNCL003068	EB-1020	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003069	Edivoxetine	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003069	Edivoxetine	Major depressive disorder	296.2, 296.3, 314.00, 314.01	F32, F33, F90
DNCL003069	Edivoxetine	Major depressive disorder; Pediatric attention deficit hyperactivity disorder	296.2, 296.3, 314.0, 314.00, 314.01	F32, F33, F90
DNCL003070	KP106	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003071	KRL-401	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003072	Methylphenidate extended-release	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003073	NWP06	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003074	NWP09	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003074	NWP09	Pain	.	G89
DNCL003075	OPC-34712	Attention deficit hyperactivity disorder	295, 311, 314.00, 314.01	F20, F32, F90
DNCL003075	OPC-34712	Major depressive disorder	295, 296.2, 296.3, 314.00, 314.01	F20, F32, F33, F90
DNCL003075	OPC-34712	Renal cancer	.	C64
DNCL003075	OPC-34712	Schizophrenia	295, 311, 314.00, 314.01	F20, F32, F90
DNCL003076	ORADUR-ADHD	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003077	Sofinicline	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003078	SPN-811	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003079	SPN-812	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003079	SPN-812	Factor IX deficiency	.	D67
DNCL003080	TD-9855	ADHD; Fibromyalgia	314.00, 314.01, 729.1	F90, M79.7
DNCL003080	TD-9855	Attention deficit hyperactivity disorder	314.00, 314.01	F90
DNCL003080	TD-9855	Pain	.	G89
DNCL003081	AMG 747	Cognitive impairment	.	F06.7
DNCL003081	AMG 747	Schizophrenia	295	F20
DNCL003082	AQW051	Cognition disorders	295	F20
DNCL003082	AQW051	Cognitive impairment	.	F06.7
DNCL003083	AV965	Cognition impairment	331.83	G31.84
DNCL003084	ADX N05	Depressive disorders	296, 710.0	F30-F39, M32
DNCL003084	ADX N05	Excessive daytime sleepiness	291.82, 292.85, 307.43-307.44, 311, 327.1, 710.0, 780.53-780.54	F32, F51.1, G47.1, M32
DNCL003084	ADX N05	Mood disorder	.	F30-F39
DNCL003085	Amitifadine	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003085	Amitifadine	Obesity	.	E66
DNCL003086	Aripiprazole/escitalopram fixed-dose combination	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003087	Armodafinil	Binge-eating disorder	307.5, 311	F32, F50
DNCL003087	Armodafinil	Bipolar depression	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 311	F31, F32
DNCL003087	Armodafinil	Pediatric cancer	.	.
DNCL003088	BCI-952	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003089	Bipolar disorder NCE	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DNCL003090	BMS-820836	Major depressive disorder	.	F32,F33
DNCL003090	BMS-820836	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003091	Cariprazine	Bipolar depression; Major depressive disorder	296.0, 296.1, 296.2, 296.3, 296.4, 296.5, 296.6, 296.7, 296.8, 311	F31, F32, F33
DNCL003091	Cariprazine	Bipolar disorder	.	F31
DNCL003091	Cariprazine	Bipolar disorder	295, 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F20, F31
DNCL003091	Cariprazine	Schizophrenia	295, 311	F20, F32
DNCL003092	Depression NCE	Depression	311	F32
DNCL003093	DSP-1053	Major depressive disorder	.	F32,F33
DNCL003093	DSP-1053	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003094	Elpetrigine	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DNCL003095	GLYX-13	Major depressive disorder	.	F32,F33
DNCL003095	GLYX-13	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003096	HT-2157	Cognitive impairment	.	F06.7
DNCL003096	HT-2157	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003097	Levomilnacipran	Fibromyalgia	729.1	M79.7
DNCL003097	Levomilnacipran	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003098	Nefiracetam	Alzheimer's disease	.	G30,F00
DNCL003098	Nefiracetam	Major depressive disorder post stroke	296.2, 296.3, 434.91	F32, F33, I61-I63
DNCL003099	Nemifitide	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003100	NSI-189	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003101	RG1578	Depression	311	F32
DNCL003101	RG1578	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003101	RG1578	Mood disorder	.	F30-F39
DNCL003102	RG7090	Fragile X syndrome	.	Q99.2
DNCL003102	RG7090	Fragile X syndrome	311, 759.83	F32, Q99.2
DNCL003102	RG7090	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003102	RG7090	Treatment-resistant depression	311	F32
DNCL003103	RO4995819	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003104	SEP-228432	Depressive disorders	296	F30-F39
DNCL003104	SEP-228432	Neuropathic pain	338,780	R52, G89
DNCL003105	SKL-10406	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003106	SPN-802	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
DNCL003107	Tasimelteon	Insomnia	307.41, 307.42, 311, 327.0, 780.51, 780.52	F32, F51.0, G47.0
DNCL003107	Tasimelteon	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
DNCL003108	AFQ056	Anxiety disorder	.	F40-F42
DNCL003108	AFQ056	Fragile X syndrome	299.00, 759.83	F84.0, Q99.2
DNCL003108	AFQ056	Fragile X syndrome	332, 759.83	F02.3, G20, Q99.2
DNCL003109	AT001	Autism	299	F84.0
DNCL003109	AT001	Rheumatold arthritis	714	M05-M06
DNCL003110	CM-AT	Attention deficit hyperactivity disorder	.	F90
DNCL003110	CM-AT	Autism	299	F84.0
DNCL003111	CYP2001	Autism	299	F84.0
DNCL003112	RG7314	Autism	.	F84.0
DNCL003112	RG7314	Autism	299	F84.0
DNCL003113	STX107	Fragile X syndrome	759.83	Q99.2
DNCL003114	STX209	Autism	299	F84.0
DNCL003114	STX209	Fragile X syndrome	759.83	Q99.2
DNCL003115	ALKS9070/ALKS9072	Schizophrenia	295	F20
DNCL003116	AM-831	Schizophrenia	295	F20
DNCL003117	AMG 579	Schizoaffective disorder; Schizophrenia	295, 295.70	F20, F25
DNCL003117	AMG 579	Schizophrenia	.	F20
DNCL003118	ATON-005	Psychotic disorders	290-299	F20-F29
DNCL003119	AVN 211	Schizophrenia	295	F20
DNCL003120	CM-2395	Schizophrenia	295	F20
DNCL003121	DCCCyB	Schizophrenia	295	F20
DNCL003122	ITI-007	Schizophrenia	.	F20
DNCL003122	ITI-007	Schizophrenia	295, 710.0	F20, M32
DNCL003122	ITI-007	Sleep maintenance insomnia	295, 307.41, 307.42, 327.0, 780.51, 780.52	F20, F51.0, G47.0
DNCL003123	JNJ-17305600	Schizophrenia	295	F20
DNCL003124	JNJ-37822681	Schizophrenia	295	F20
DNCL003125	MK-2637	Schizophrenia	295	F20
DNCL003126	MK-8998	Schizophrenia	295	F20
DNCL003127	PF-02545920	Schizophrenia	.	F20
DNCL003127	PF-02545920	Schizophrenia	295	F20
DNCL003128	PF-04958242	Schizophrenia	295	F20
DNCL003129	PF-05180999	Schizophrenia	295	F20
DNCL003130	Pitolisant	Schizophrenia	295	F20
DNCL003131	Pomaglumetad	Schizophrenia	.	F20
DNCL003131	Pomaglumetad	Schizophrenia	295	F20
DNCL003132	RP5063	Schizoaffective disorder; Schizophrenia	295, 295.70	F20, F25
DNCL003132	RP5063	Schizophrenia	.	F20
DNCL003133	SB773812	Schizophrenia	295	F20
DNCL003134	SLV 354	Schizophrenia	295	F20
DNCL003135	TGOF02N	Schizophrenia	295	F20
DNCL003136	Zicronapine	Schizophrenia	.	F20
DNCL003136	Zicronapine	Schizophrenia	295	F20
DNCL003137	E2006	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNCL003138	GSK649868	Insomnia	.	F51.0,G47.0
DNCL003138	GSK649868	Sleep disorders	307.4, 327, 780.5	F51, G47
DNCL003139	KRL-103	Sleep disorders	307.4, 327, 780.5	F51, G47
DNCL003140	Melatonin controlled-release	Sleep disorders	307.4, 327, 780.5	F51, G47
DNCL003141	MK-3697	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNCL003142	MK-7288	Excessive daytime sleepiness	291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54	F51.1, G47.1
DNCL003143	Neu-P11	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNCL003144	Zaleplon controlled-release	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNCL003145	Zolpidem buccal spray	Sleep maintenance insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
DNCL003146	ADX71149	Psychiatric disorders	.	F99
DNCL003146	ADX71149	Psychiatric disorders	290-319	F01-F99
DNCL003147	BI-409306	Psychiatric disorders	.	F99
DNCL003147	BI-409306	Psychiatric disorders	290-319	F01-F99
DNCL003148	CORT-108297	Abnormal weight gain	.	R63.5
DNCL003148	CORT-108297	Psychiatric disorders	290-319	F01-F99
DNCL003148	CORT-108297	Weight gain associated with antipsychotics	.	R63.5
DNCL003149	PH80	Premenstrual dysphoric disorder; Premenstrual syndrome	.	F38.8,N94.3
DNCL003149	PH80	Premenstrual dysphoric disorder; Premenstrual syndrome	625.4	N94.3
DNCL003150	Cat allergy vaccine	Non-cystic fibrosis bronchiectasis	494	J47
DNCL003150	Cat allergy vaccine	Perennial allergic rhinitis	204.0, 472.0, 477, 995.3	C91.0, J00, J30, J31.0, T78.4
DNCL003151	Food allergy epicutaneous immunotherapy	Peanut hypersensitivity	995.3, 995.61, V15.01	T78.4
DNCL003151	Food allergy epicutaneous immunotherapy	Peanut hypersensitivity	995.61, V15.01	T78.4
DNCL003152	Grass pollen allergy vaccine tablet	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DNCL003153	Grass pollen extract sublingual vaccine	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DNCL003154	House dust mite allergy sublingual vaccine	Allergic rhinitis	477	J30
DNCL003155	Peanut allergy vaccine	Peanut hypersensitivity	995.61, V15.01	T78.4
DNCL003156	Quattro	Grass pollen hypersensitivity; Ragweed hypersensitivity allergic diseases	204.0, 995.3	C91.0, T78.4
DNCL003156	Quattro	Tree pollen hypersensitivity	995.3	T78.4
DNCL003157	Ragweed allergy vaccine	Leukemia	.	C91-C95
DNCL003157	Ragweed allergy vaccine	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
DNCL003158	Immunotherapeutic vaccine	Acute myeloid leukemia; Chronic myeloid leukemia	205, 205.0, 205.1, 208.9	C91-C95, C92, C92.0, C92.1
DNCL003158	Immunotherapeutic vaccine	Atherosclerosis	414.0, 440	I70
DNCL003158	Immunotherapeutic vaccine	Breast cancer	174, 175	C50
DNCL003158	Immunotherapeutic vaccine	Chronic Lymphocytic Leukemia	202.8, 204.1	C81-C96, C91.1
DNCL003158	Immunotherapeutic vaccine	Colorectal cancer	153, 154	C18-C21
DNCL003158	Immunotherapeutic vaccine	Hematological malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL003158	Immunotherapeutic vaccine	Multiple myeloma	203	C90.0
DNCL003158	Immunotherapeutic vaccine	Pancreatic cancer	157	C25
DNCL003158	Immunotherapeutic vaccine	Prostate cancer	140-229, 185	C00-C96, C61
DNCL003159	Anti-GnRH vaccine	Prostate cancer	185	C61
DNCL003160	Brain dendritic cell-based vaccine	Glioblastoma	191	C71
DNCL003161	Prostate dendritic cell-based vaccine	Prostate cancer	185	C61
DNCL003162	Dendritic cell cancer vaccine	Malignant melanoma	172	C43
DNCL003163	FANG vaccine	Malignant melanoma; Ovarian cancer	140-229, 172, 183	C00-C96, C43, C56
DNCL003163	FANG vaccine	Ovarian cancer	.	C56
DNCL003164	FBP vaccine	Breast cancer	174, 175	C50
DNCL003164	FBP vaccine	Endometrial cancer	182	C54.1
DNCL003164	FBP vaccine	Endometrial cancer; Ovarian cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
DNCL003165	HTERT vaccine	Cancer	140-229	C00-C96
DNCL003166	Algenpantucel-L	Diabetes mellitus	250	E08-E13
DNCL003166	Algenpantucel-L	Pancreatic cancer	157	C25
DNCL003167	HER-2/neu-based modified vaccinia ankara vaccine	Breast cancer	174, 175	C50
DNCL003168	MVA-BN Breast	Prostate cancer	185	C61
DNCL003169	E75 cancer vaccine	Breast cancer	.	C50
DNCL003169	E75 cancer vaccine	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL003169	E75 cancer vaccine	Prostate cancer	185	C61
DNCL003170	OPT-822	Breast cancer	174, 175	C50
DNCL003171	Oral peptide cancer vaccine	Cancer	140-229	C00-C96
DNCL003172	Recombinant soluble PSMA protein vaccine	Prostate cancer	185	C61
DNCL003173	Tipapkinogene sovacivec	Cervical intraepithelial neoplasia	233.1, 622.10	D06, N87
DNCL003174	Tumor-associated antigen vaccine	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
DNCL003175	WT1 immunotherapeutic	Acute myeloid leukemia	205	C92.0
DNCL003175	WT1 immunotherapeutic	Breast cancer	140-229, 174, 175	C00-C96, C50
DNCL003175	WT1 immunotherapeutic	Breast cancer	174, 175	C50
DNCL003176	ACAM-Cdiff	Clostridium difficile infection	8.45	A04.7
DNCL003176	ACAM-Cdiff	Indolent non-hodgkin's lymphoma	200, 202	C82-C85
DNCL003177	ACE527	Escherichia coli infection	.	A00-B99
DNCL003177	ACE527	Traveler's diarrhea	001-139, 787.91	A00-B99, A09, K59.1
DNCL003178	Ad26.ENVA.01 HIV-1 recombinant vaccine	HIV infection	001-139, 042	A00-B99, B20
DNCL003178	Ad26.ENVA.01 HIV-1 recombinant vaccine	HIV infections	001-139, 042	A00-B99, B20
DNCL003179	Influenza A virus H5N1 vaccine	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003180	AG-707	Herpes simplex virus infection	.	A60,B00
DNCL003180	AG-707	Herpes simplex virus infections	001-139, 042-075, 054, 054.0, 054.1, 054.2, 054.3, 771.2	A00-B99, A60, A80-A99, B00, B00-B34, G05.1, P35.2
DNCL003181	Anthrax transdermal vaccine	Anthrax	22	A22
DNCL003182	ANZ-521	Hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DNCL003183	AV-7909	Anthrax	22	A22
DNCL003184	AVX-502	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003184	AVX-502	Influenza virus infections	487	J10, J11
DNCL003185	Biothrax anthrax vaccine adsorbed	Anthrax	22	A22
DNCL003185	Biothrax anthrax vaccine adsorbed	Bacillus anthracis infection	.	A22
DNCL003186	Botulinum toxin recombinant vaccine	Botulism	005.1, 040.41, 040.42	A05.1
DNCL003187	Chikungunya virus vaccine	Chikungunya virus infection	.	A92.0
DNCL003187	Chikungunya virus vaccine	Chikungunya virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
DNCL003188	CholeraGarde cholera vaccine live attenuated	Cholera	1	A00
DNCL003189	ChronVac-C hepatitis C DNA vaccine	Hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DNCL003189	ChronVac-C hepatitis C DNA vaccine	Hepatitis C virus infection	.	B18.2
DNCL003190	Cytomegalovirus vaccine	Cytomegalovirus	78.5	B25.8, H30.9
DNCL003190	Cytomegalovirus vaccine	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
DNCL003191	Dengue	Dengue fever	061, 780.6	A90, R50
DNCL003191	Dengue	Mild-to-severe dengue fever	061, 780.6	A90, R50
DNCL003191	Dengue	Mild-to-severe dengue fever	61	A90
DNCL003191	Dengue	Spasticity 	.	G80.1
DNCL003192	Tetravalent hybrid dengue virus vaccine	Dengue	61	A90
DNCL003193	DNA topical patch vaccine	HIV infection	001-139, 042	A00-B99, B20
DNCL003194	DTP-HepB-Polio-Hib	Diphtheria; Tetanus; Pertussis	032, 033, 037, 771.3	A33-A35, A36, A37
DNCL003194	DTP-HepB-Polio-Hib	Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus influenzae type b	032, 033, 037, 041.5, 045, 070.2, 070.3, 138, 487, 488, 573.3, 771.3	A33-A35, A36, A37, A49.2, A80, B16, B18.0, B18.1, B91, J10, J11, K75.9
DNCL003194	DTP-HepB-Polio-Hib	Hepatitis B virus infection	.	B16
DNCL003194	DTP-HepB-Polio-Hib	Hepatitis B virus infection; Poliomyelitis; Haemophilus influenzae type B	041.5, 045, 070.2, 070.3, 138, 487, 488, 573.3	A49.2, A80, B16, B18.0, B18.1, B91, J10, J11, K75.9
DNCL003194	DTP-HepB-Polio-Hib	Pediatric hexavalent	.	B16
DNCL003195	DV-601	Hepatitis B	070.2, 070.3, 573.3	B16, B18.0, B18.1, K75.9
DNCL003196	Ebola vaccine	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
DNCL003196	Ebola vaccine	Ebola virus infection	65.8	A98.4
DNCL003196	Ebola vaccine	Parasitic infection	.	B89
DNCL003197	EP1043	HIV-1 infections	001-139, 042	A00-B99, B20
DNCL003198	EP1090	HIV-1 infections	001-139, 042	A00-B99, B20
DNCL003199	EP1300	Malaria	84	B50-B54
DNCL003200	ETEC vaccine	Cholera; Escherichia coli infections	001, 001-139	A00, A00-B99
DNCL003200	ETEC vaccine	Diarrhea	.	A09,K59.1
DNCL003201	FluBlok influenza virus vaccine	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003201	FluBlok influenza virus vaccine	Influenza virus infections	487	J10, J11
DNCL003202	FluLaval FluLaval	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003202	FluLaval FluLaval	Influenza virus infections	487	J10, J11
DNCL003203	Fluvirin influenza A virus H1N1 vaccine	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003203	Fluvirin influenza A virus H1N1 vaccine	Influenza virus infections	487	J10, J11
DNCL003204	GelVac H5N1 influenza virus vaccine intranasal	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003204	GelVac H5N1 influenza virus vaccine intranasal	Influenza virus infections	487	J10, J11
DNCL003205	GI-5005	Anthrax	22	A22
DNCL003205	GI-5005	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DNCL003206	GSK1437173A	Varicella zoster virus infections	001-139, 042-075, 052, 053	B01, B02, A00-B99, A80-A99, B00-B34
DNCL003207	GSK1492903A	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
DNCL003208	GSK2189242A	Pneumococcal infections	001-139	A00-B99
DNCL003209	GSK2254232A	Haemophilus infections; Pneumococcal infections	001-139	A00-B99
DNCL003210	GSK2254233A	Haemophilus infections; Pneumococcal infections	001-139	A00-B99
DNCL003210	GSK2254233A	Pneumococcal infections	.	J13
DNCL003211	GSK2282512A	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003212	GSK2321138A	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003213	GSK2340273A	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003214	GSK2340274A	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003214	GSK2340274A	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003215	GSK2392102A	Staphylococcal infections	001-139	A00-B99
DNCL003216	GSK2830930A	Pneumococcal infections	.	J13
DNCL003216	GSK2830930A	Pneumococcal infections	001-139	A00-B99
DNCL003217	H5N1 influenza virus vaccine	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003218	H5N1 pandemic influenza virus vaccine	Influenza A virus H5N1 infections	.	J11.1
DNCL003218	H5N1 pandemic influenza virus vaccine	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003219	HBV-002	West Nile virus infection	.	A92
DNCL003219	HBV-002	West Nile virus infection	001-139, 042-075, 066.4	A00-B99, A80-A99, A92.3, B00-B34
DNCL003220	Helicobacter pylori vaccine	Helicobacter infections	41.86	B96.81
DNCL003221	Hepatitis B DNA vaccine	Hepatitis B virus infection	.	B16
DNCL003221	Hepatitis B DNA vaccine	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DNCL003222	Hepatitis B vaccine	Hepatitis B virus infection	.	B16
DNCL003222	Hepatitis B vaccine	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DNCL003223	Hepatitis C vaccine	Hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DNCL003223	Hepatitis C vaccine	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DNCL003223	Hepatitis C vaccine	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DNCL003224	Hepatitis B vaccine 1018-ISS conjugate	Hepatitis B virus infection	.	B16
DNCL003224	Hepatitis B vaccine 1018-ISS conjugate	Hepatitis B virus infection	070.2, 070.3, 573.3	B16, B18.0, B18.1, K75.9
DNCL003225	Herpes simplex DNA vaccine	Herpes simplex virus infections	001-139, 042-075, 054, 054.0, 054.1, 054.2, 054.3, 771.2	A00-B99, A60, A80-A99, B00, B00-B34, G05.1, P35.2
DNCL003226	Herpes simplex vaccine	Genital herpes	.	B00-B09
DNCL003226	Herpes simplex vaccine	Herpes simplex virus infection	.	B00-B09
DNCL003227	Replication-defective HIV-1 vaccine	HIV-1 infections	42	B20
DNCL003228	Imvamune smallpox vaccine	Smallpox	50	B03
DNCL003228	Imvamune smallpox vaccine	Virus infection	.	B03
DNCL003229	Influenza A virus H1N1 vaccine	Familial chylomicronemia syndrome	.	J10, J11
DNCL003229	Influenza A virus H1N1 vaccine	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003230	Influenza A virus vaccine H1N1	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003230	Influenza A virus vaccine H1N1	Influenza A virus H1N1 subtype	487, 488	J10, J11
DNCL003231	Influenza A virus vaccine H5N1	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003232	Influenza A virus vaccine H9N2	Influenza A virus H9N2 infections	487, 488	J10, J11
DNCL003232	Influenza A virus vaccine H9N2	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003233	Influenza virus DNA vaccine	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003233	Influenza virus DNA vaccine	Influenza A virus H1N1 subtype	487, 488	J10, J11
DNCL003234	Influenza virus vaccine	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003234	Influenza virus vaccine	Influenza virus infections	487	J10, J11
DNCL003235	Influvac tC cell culture-derived influenza vaccine	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003236	INO-3510	Influenza A virus H1N1 infections; Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003236	INO-3510	Influenza virus infections	.	J10-J11
DNCL003237	Japanese encephalitis vaccine	Japanese encephalitis virus infection	.	A83.0
DNCL003237	Japanese encephalitis vaccine	Japanese encephalitis virus infection	323	A83-A86, B94.1, G05
DNCL003238	Ii-Key hybrid peptide vaccine	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003239	LIQ-001	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003239	LIQ-001	Influenza virus infections	487	J10, J11
DNCL003240	Lyme disease vaccine	Lyme disease	88.81	A69.2
DNCL003241	Malaria DNA vaccine	Malaria	84	B50-B54
DNCL003241	Malaria DNA vaccine	Plasmodium infection	.	B54
DNCL003242	Malaria vaccine	Malaria	84	B50-B54
DNCL003242	Malaria vaccine	Plasmodium infection	.	B54
DNCL003243	Marburg virus DNA vaccine	Marburg virus disease	78.89	A98.3
DNCL003244	MEDI-534	Parainfluenza and respiratory syncytial virus infections	001-139, 042-075, 079.6, 487, 488	A00-B99, A80-A99, B00-B34, B97.4, J10, J11
DNCL003244	MEDI-534	Respiratory syncytial virus 	.	B97.4
DNCL003245	MenABCWY	Meningococcal groups A B C Y and W-135 infections	001-139	A00-B99
DNCL003245	MenABCWY	Psoriasis	.	L40
DNCL003246	Hib-MenCY-TT conjugated vaccine	Neisseria meningitidis infection	001-139, 041.5, 487, 488	A00-B99, A49.2, J10, J11
DNCL003247	Meninge ACYW	Meningococcal	36.9	A39
DNCL003247	Meninge ACYW	Meningococcal infections	36.9	A39
DNCL003247	Meninge ACYW	Rheumatold arthritis	714	M05-M06
DNCL003248	Meningococcal vaccine group B quadrivalent recombinant vaccine	Meningococcal group B infections	001-139	A00-B99
DNCL003248	Meningococcal vaccine group B quadrivalent recombinant vaccine	Neisseria meningitidis infection	.	A87
DNCL003249	MMR	Measles, mumps, rubella prophylaxis	055, 056, 072	B05, B06, B26
DNCL003250	Mosquirix malaria recombinant vaccine	Malaria	84	B50-B54
DNCL003250	Mosquirix malaria recombinant vaccine	Parkinson's disease	.	G20
DNCL003251	HIV multiantigen vaccine	HIV-1 infections	001-139, 042	A00-B99, B20
DNCL003252	MVA-BN polytope HIV vaccine	HIV infection	001-139, 042	A00-B99, B20
DNCL003252	MVA-BN polytope HIV vaccine	HIV infections	001-139, 042	A00-B99, B20
DNCL003253	NB-1008	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003253	NB-1008	Prophylaxis of seasonal influenza	487	J09
DNCL003254	NDV-3	Candidiasis infection	.	B37.0
DNCL003254	NDV-3	Candidiasis infection	001-139, 112	A00-B99, B37
DNCL003255	MenACWY-TT conjugated vaccine	Meningococcal groups A C Y and W-135 infections	001-139	A00-B99
DNCL003255	MenACWY-TT conjugated vaccine	Neisseria meningitis prophylaxis	.	A87
DNCL003256	NmVac	Meningococcal groups	.	A00-B99
DNCL003256	NmVac	Meningococcal groups infections	.	A00-B99
DNCL003257	Norovirus bivalent vaccine	Norovirus infections	001-139	A00-B99
DNCL003258	Norovirus monovalent vaccine	Norovirus infections	001-139	A00-B99
DNCL003259	PanBlok influenza A virus H5N1 vaccine	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003259	PanBlok influenza A virus H5N1 vaccine	Influenza virus infections	487	J10, J11
DNCL003260	Parvovirus B19 vaccine	Parvovirus infections	001-139	A00-B99
DNCL003261	PER.C-flu vaccine	Colorectal cancer	.	C18-C20,C21
DNCL003261	PER.C-flu vaccine	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003262	PF-05212366	Adolescent meningitis	320-322	G00-G03
DNCL003263	PF-05212367	Infant meningitis	320-322	G00-G03
DNCL003264	PF-06290510	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003264	PF-06290510	Staphylococcal infections	001-139	A00-B99
DNCL003265	Plague vaccine injectable	Leukemia	.	C91-C95
DNCL003265	Plague vaccine injectable	Yersinia infections	20	A20
DNCL003266	Seasonal influenza virus vaccine	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003266	Seasonal influenza virus vaccine	Influenza virus infections	487	J10, J11
DNCL003267	Pseudomonas aeruginosa antibody fragment product	Ventilator-associated pneumonia	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
DNCL003268	PXVX-0103	Influenza A virus H5N1 infections	001-139, 487, 488	A00-B99, J10, J11
DNCL003268	PXVX-0103	Influenza virus infections	487	J10, J11
DNCL003269	Q-LAIV	Seasonal influenza	487, 488	J10, J11
DNCL003270	Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed combined with inactivated poliomyelitis vaccine	Diphtheria; Tetanus; Pertussis; Polio	032, 033, 037, 045, 138, 771.3	A33-A35, A36, A37, A80, B91
DNCL003271	Diphtheria and tetanus toxoids	Polio vaccine	045, 138	A80, B91
DNCL003272	Rabies VRVg	Rabies virus infection	.	A82
DNCL003272	Rabies VRVg	Rabies virus infection	001-139	A00-B99
DNCL003273	Respiratory syncytial virus VLPvaccine	Respiratory syncytial virus 	001-139, 079.6	A00-B99, B97.4
DNCL003273	Respiratory syncytial virus VLPvaccine	Respiratory syncytial virus infections	001-139, 079.6	A00-B99, B97.4
DNCL003274	RiVax ricin vaccine	Ricin poisoning	.	T36-T65
DNCL003275	Rotavirus vaccine	Pediatric cancer	.	.
DNCL003275	Rotavirus vaccine	Rotavirus infections	001-139	A00-B99
DNCL003276	Rotavirus vaccine I321	Rotavirus infections	001-139	A00-B99
DNCL003277	RPA-102	Anthrax	22	A22
DNCL003277	RPA-102	Cancer	140-229	C00-C96
DNCL003278	Shigella vaccine	Shigella infections	001-139	A00-B99
DNCL003279	SparVax recombinant protective antigen anthrax vaccine	Anthrax	22	A22
DNCL003279	SparVax recombinant protective antigen anthrax vaccine	Depression	311	F32
DNCL003280	Staphylococcus aureus vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003280	Staphylococcus aureus vaccine	Staphylococcal infections	001-139	A00-B99
DNCL003281	Staphylococcus aureus vaccine conjugate pentavalent	Staphylococcal infection	001-139	A00-B99
DNCL003281	Staphylococcus aureus vaccine conjugate pentavalent	Staphylococcal infections	001-139	A00-B99
DNCL003282	Streptococcal B vaccine	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003282	Streptococcal B vaccine	Streptococcal infections	001-139	A00-B99
DNCL003283	Streptococcal B vaccine conjugate	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003283	Streptococcal B vaccine conjugate	Streptococcal infections	001-139	A00-B99
DNCL003284	Streptococcus pneumoniae vaccine	Meningitis	.	G03.9
DNCL003284	Streptococcus pneumoniae vaccine	Meningitis and penumonia	320-322	G00-G03
DNCL003285	TCN-032	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003285	TCN-032	Influenza virus infections	.	J10-J11
DNCL003286	TG-4040	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003287	Cytomegalovirus DNA vaccine	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
DNCL003287	Cytomegalovirus DNA vaccine	Systemic lupus erythematosus	710	M32
DNCL003288	Tuberculosis recombinant subunit vaccine	Tuberculosis	010-018	A15-A19
DNCL003289	Tuberculosis vaccine	Tuberculosis	010-018	A15-A19
DNCL003290	Tularemia vaccine	Tularemia	.	A21
DNCL003291	Typhella typhoid vaccine oral	Salmonella infection	.	A02.9
DNCL003291	Typhella typhoid vaccine oral	Typhoid	.	A15-A19
DNCL003292	Typhoid vaccine	Mycobacterium tuberculosis infection	.	A15-A19
DNCL003292	Typhoid vaccine	Typhoid	.	A15-A19
DNCL003293	V114	Pneumococcal infections	001-139	A00-B99
DNCL003294	V212	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL003294	V212	Herpes varicella zoster	.	B02
DNCL003294	V212	Herpes zoster	53	B02
DNCL003295	V502	Human papillomavirus infections	001-139	A00-B99
DNCL003296	V520/V526 combination vaccine	HIV infections	42	B20
DNCL003297	VAX-102	Influenza A virus infections	.	J10-J11
DNCL003297	VAX-102	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003298	VAX-125	HIV infections	.	B20
DNCL003298	VAX-125	Influenza A virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003299	VAX-128	Influenza A virus H1N1 infections	487, 488	J10, J11
DNCL003299	VAX-128	Influenza virus infections	.	J10-J11
DNCL003300	VGX-3400	Influenza A virus H5N1 infections	487, 488	J10, J11
DNCL003300	VGX-3400	Influenza virus infections	.	J10-J11
DNCL003301	Visceral leishmaniasis vaccine	Visceral leishmaniasis	85	B55.0
DNCL003302	VLP-based influenza vaccine	Influenza virus infections	001-139, 042-075, 487, 488	A00-B99, A80-A99, B00-B34, J10, J11
DNCL003303	VRC-EBOADV018-00-VP	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
DNCL003303	VRC-EBOADV018-00-VP	Ebola virus infections	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
DNCL003304	XRX-001	Yellow fever	780.6	R50
DNCL003304	XRX-001	Yellow fever virus infection	780.6	R50
DNCL003305	Zoster	Herpes varicella zoster	.	B02
DNCL003305	Zoster	Herpes zoster prophylaxis	53	B02
DNCL003305	Zoster	Type 2 diabetes	250.00, 250.02	E11
DNCL003306	BHT-3009	Multiple sclerosis	.	G35
DNCL003306	BHT-3009	Multiple sclerosis	340	G35
DNCL003307	BHT-3021	Type 1 diabetes	250.01	E10
DNCL003308	Insulin B-chain vaccine	Diabetes mellitus	.	E10-E14
DNCL003308	Insulin B-chain vaccine	Type 1 diabetes	250.01	E10
DNCL003309	PEG-SN38	Metastatic breast cancer	174, 175	C50
DNCL003309	PEG-SN38	Metastatic colorectal cancer	153, 154	C18-C21
DNCL003309	PEG-SN38	Pediatric solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003309	PEG-SN38	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003310	AMG 110	Cancer	.	C00-C97
DNCL003310	AMG 110	Cancers	140-239	C00-C96
DNCL003311	AMG 139	Inflammatory diseases	.	.
DNCL003312	AMG 232	Cancer	.	C00-C97
DNCL003312	AMG 232	Cancers	140-239	C00-C96
DNCL003313	AMG 334	Migraine	.	G43
DNCL003313	AMG 334	Migraine	346	G43
DNCL003314	AMG 357	Autoimmune diseases	.	D84.9
DNCL003314	AMG 357	Autoimmune diseases	279.4	D84.9, M35.9
DNCL003315	AMG 595	Glioblastoma	.	C71
DNCL003315	AMG 595	Glioblastoma	191	C71
DNCL003316	AMG 729	Autoimmune diseases	.	D84.9
DNCL003316	AMG 729	Autoimmune diseases	279.4	D84.9, M35.9
DNCL003317	AMG 181	Inflammatory bowel disease	555, 556	K50, K51
DNCL003318	AMG 416	Hyperparathyroidism in chronic kidney disease	252.02, 403, 585.1-585.5, 585.9, 588.81	E21.1, N18
DNCL003318	AMG 416	Myelodysplastic syndromes	238.7	D46
DNCL003319	Blinatumomab	Acute lymphoblastic leukemia	.	C91.0
DNCL003319	Blinatumomab	Acute lymphoblastic leukemia	204	C91.0
DNCL003319	Blinatumomab	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL003319	Blinatumomab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003320	Brodalumab	Asthma	.	J45
DNCL003320	Brodalumab	Inflammatory diseases	.	.
DNCL003320	Brodalumab	Psoriasis	696	L40
DNCL003321	Omecamtiv mecarbil	Heart failure	428	I50
DNCL003322	Romosozumab	Osteoporosis	.	M80-M81
DNCL003322	Romosozumab	Postmenopausal osteoporosis	733	M80-M81
DNCL003323	Talimogene	Melanoma	172	C43
DNCL003324	XGEVA	Bone metastases	.	C79.51
DNCL003324	XGEVA	Prostate cancer	185	C61
DNCL003325	MDV3100	Metastatic castration-resistant prostate cancer	185	C61
DNCL003325	MDV3100	Prostate cancer	185	C61
DNCL003326	MDV3101	Breast cancer	174, 175	C50
DNCL003326	MDV3101	Prostate cancer	.	C61
DNCL003327	ASP4130	Advanced renal cell carcinoma	189	C64
DNCL003327	ASP4130	Solid tumours	.	C00-C75,C7A,C7B
DNCL003328	ASP4131	Colorectal cancer	153, 154	C18-C21
DNCL003328	ASP4131	Colorectal cancer; Breast cancer	140-229, 153, 154, 174, 175	C00-C96, C18-C21, C50
DNCL003329	Isavuconazole	Candidemia; Invasive candidiasis	112	B37
DNCL003329	Isavuconazole	Fungal infection	.	B35-B49
DNCL003329	Isavuconazole	Invasive aspergillosis	117.3	B44
DNCL003330	ASP0113	Cytomegalovirus infection	001-139, 042-075, 078.5, 279.5, 996	A00-B99, A80-A99, B00-B34, B25, D89.8, T86
DNCL003330	ASP0113	Cytomegalovirus reactivation in hematopoietic cell transplant recipients	78.5	B25
DNCL003331	ASP015K	Psoriasis	696	L40
DNCL003331	ASP015K	Rheumatold arthritis	714	M05-M06
DNCL003332	ASKP1240	Organ transplant rejection	996.8	T86
DNCL003333	ASP3652	Bladder pain syndrome; Interstitial cystitis	595.1,338,780	N30.1, G89, R52
DNCL003333	ASP3652	Chronic prostatitis; Chronic pelvic pain syndrome	601.1,338,780	N41.1, G89, R52
DNCL003334	ASP1707	Endometriosis	617	N80
DNCL003334	ASP1707	Prostate cancer	185	C61
DNCL003335	YM060	Diarrhea-predominant IBS	564.1	K58
DNCL003335	YM060	Irritable bowel syndrome	564.1	K58
DNCL003336	YM533	Chronic renal failure	584, 585, 585.9585.1-585.5403	N17, N18, N19
DNCL003337	FK949E	Alcohol use disorders	303	F10.2
DNCL003337	FK949E	Major depressive disorder	296.2, 296.3	F32, F33
DNCL003338	ASP1585	Hyperphosphatemia	275.3	E22.1
DNCL003339	ASP3550	Prostate cancer	185	C61
DNCL003340	ASP7374	Influenza virus infections	487, 488	J10, J11
DNCL003340	ASP7374	Prophylaxis of seasonal influenza	487	J09
DNCL003341	ASP7373	Prophylaxis of H5N1 influenza	487	J09
DNCL003342	ASP0306	Lower urinary tract symptoms	600	N40
DNCL003343	ASP4901	Lower urinary tract symptoms	600	N40
DNCL003344	ASP8477	Neuropathic pain	338,780	R52, G89
DNCL003345	ASP9226	Neuropathic pain	338,780	R52, G89
DNCL003346	ASP7991	Hyperparathyroidism	252.02, 588.81	E21.1
DNCL003347	ASP2409	Organ transplant rejection	996.8	T86
DNCL003348	ASP6432	Lower urinary tract symptoms	600	N40
DNCL003349	ASP9853	Cancer	140-229	C00-C96
DNCL003350	ASP8232	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL003351	ASP3662	Alzheimer's disease	331	G30
DNCL003352	Axanum	Low dose aspirin associated peptic ulcer	531-534, 531-534	K25-K27, K25-K27
DNCL003353	Brilinta/Brilique	Arterial thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DNCL003353	Brilinta/Brilique	Myocardial infarction	.	I80-I82
DNCL003353	Brilinta/Brilique	Peripheral artery disease	.	I80-I82
DNCL003354	Bydureon Dual Chamber Pen	Diabetes mellitus	.	E10-E14
DNCL003354	Bydureon Dual Chamber Pen	Diabetes mellitus	250	E08-E13
DNCL003355	Kombiglyze XR/Komboglyze FDC	Diabetes mellitus	250	E08-E13
DNCL003356	SaxaDapa FDC	Diabetes mellitus	250	E08-E13
DNCL003357	Symbicort	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003357	Symbicort	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003357	Symbicort	SMART syndrome	.	J40-J44, J47
DNCL003358	CAZ AVI	Infections disease	.	A00-B99
DNCL003358	CAZ AVI	Serious infections	001-139	A00-B99
DNCL003359	Zinforo	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNCL003359	Zinforo	Pneumonia/skin infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
DNCL003360	Naloxegol	Opioid-induced constipation	564	K59.0
DNCL003361	AZD1722	End stage renal disease; Chronic kidney disorder	.	N18
DNCL003361	AZD1722	Renal disease	.	N00-N29
DNCL003362	Tralokinumab	Asthma; Idiopathic pulmonary fibrosis	493	J45
DNCL003362	Tralokinumab	Ulcerative colitis	556	K51
DNCL003363	AZD5847	Tuberculosis	010-018	A15-A19
DNCL003364	CXL	MRSA infection	41.12	A49.02
DNCL003364	CXL	Methicillin-resistant staphylococcus aureus	.	B95.62
DNCL003365	ATM AVI	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003365	ATM AVI	Bacterial infections	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003366	MEDI-550	HIV infection	001-139, 042	A00-B99, B20
DNCL003366	MEDI-550	Pandemic influenza prophylaxis	487, 488	J10, J11
DNCL003367	MEDI-557	Respiratory syncytial virus infection	79.6	B97.4
DNCL003368	MEDI-559	Respiratory syncytial virus 	79.6	B97.4
DNCL003368	MEDI-559	Respiratory syncytial virus infection	79.6	B97.4
DNCL003369	AZD3293	Alzheimer's disease	.	G30,F00
DNCL003369	AZD3293	Alzheimer's disease	331	G30
DNCL003370	MEDI5117	Rheumatold arthritis	714	M05-M06
DNCL003371	AZD9150	Haematological malignancies	200-209	C81-C96
DNCL003371	AZD9150	Hematological malignancies	.	C81-C96
DNCL003371	AZD9150	Hematological malignancies	200-209	C81-C96
DNCL003372	MEDI4736	Solid tumours	.	C00-C75,C7A,C7B
DNCL003372	MEDI4736	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL003373	MEDI6469	Solid tumours	.	C00-C75,C7A,C7B
DNCL003373	MEDI6469	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL003374	Moxetumomab	Haematological malignancies	200-209	C81-C96
DNCL003374	Moxetumomab	Hematological malignancies	200-209	C81-C96
DNCL003375	Volitinib	Solid tumours	.	C00-C75,C7A,C7B
DNCL003375	Volitinib	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL003376	Benralizumab	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003377	MEDI7183	Crohn's disease	.	K50
DNCL003377	MEDI7183	Crohn's disease; Ulcerative colitis	555, 556	K50, K51
DNCL003378	AZD8848	Asthma	493	J45
DNCL003379	AZD7594	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003379	AZD7594	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003380	MEDI2070	Crohn's disease	555	K50
DNCL003381	MEDI4212	Asthma	.	J45
DNCL003381	MEDI4212	Asthma	493	J45
DNCL003382	MEDI5872	Systemic lupus erythematosus	710	M32
DNCL003383	MEDI7814	Chronic obstructive pulmonary disease	.	J40-J44,J47
DNCL003383	MEDI7814	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003384	MEDI9929	Asthma	493	J45
DNCL003385	RDEA3170	Hyperuricaemia	.	E79.0
DNCL003385	RDEA3170	Hyperuricaemia	274, 274.00274.1274.8274.9, 790.6	E79.0, M10
DNCL003386	FluMist/Fluenz	Influenza virus infections	487, 488	J10, J11
DNCL003387	BAY 2010112	Cancer	140-229	C00-C96
DNCL003388	BAY 1082439	Cancer	.	C00-C97
DNCL003388	BAY 1082439	Cancer	140-229	C00-C96
DNCL003389	BAY 1067197	Heart failure	.	I50
DNCL003389	BAY 1067197	Heart failure	428	I50
DNCL003390	BAY 86-8050	Heart failure	.	I50
DNCL003390	BAY 86-8050	Heart failure	428	I50
DNCL003391	BAY 1021189	Heart failure	.	I50
DNCL003391	BAY 1021189	Heart failure	428	I50
DNCL003392	BAY 85-3934	Anemia	.	D50-D64
DNCL003392	BAY 85-3934	Anemia	280-285	D50-D64
DNCL003393	BAY 85-8501	Bronchiectasis	.	J47
DNCL003393	BAY 85-8501	Bronchiectasis	494, 748.61	J47, Q33.4
DNCL003394	BAY 1026153	Endometriosis	617	N80
DNCL003395	MEK-Inhibitor	Cancer	140-229	C00-C96
DNCL003396	Radium-223-Dichloride	Cancer	140-229	C00-C96
DNCL003396	Radium-223-Dichloride	Castration-resistant prostate cancer	185	C61
DNCL003397	BAY 94-8862	Congestive heart failure	428	I50
DNCL003398	Amikacin Inhale	Gram-negative pneumonia	482.83	J15.6
DNCL003398	Amikacin Inhale	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
DNCL003399	BAY 94-9027	Hemophilia	286	D66-D68
DNCL003399	BAY 94-9027	Stroke	.	I61-I63
DNCL003400	BAY 86-6150	Hemophilia	286	D66-D68
DNCL003401	LCS 16	Alzheimer's disease	331	G30
DNCL003401	LCS 16	Contraception	.	Z30
DNCL003402	ATX-101	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003402	ATX-101	Submental fat removal	.	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003403	Cipro Inhale	Lung infection	162	C33-C34
DNCL003404	Tedizolid	Skin and lung infections	162, 680-709	C33-C34, L00-L99
DNCL003404	Tedizolid	Skin infections	.	L00-L99
DNCL003405	FUMADERM	Psoriasis	696	L40
DNCL003406	TECFIDERA	Multiple Sclerosis; Relapsing forms	340	G35
DNCL003406	TECFIDERA	Multiple sclerosis	.	G35
DNCL003407	Recombinant factor IX Fc	Hemophilia B	286.1	D67
DNCL003408	Recombinant factor VIII Fc	Hemophilia A	286	D66
DNCL003409	PLEGRIDY	Multiple Sclerosis; Relapsing forms	340	G35
DNCL003409	PLEGRIDY	Multiple sclerosis	.	G35
DNCL003410	ANTI-TWEAK	Lupus nephritis	583.81	M32.1, N08.5
DNCL003411	Anti-LINGO	Multiple sclerosis	340	G35
DNCL003412	STX-100	Idiopathic pulmonary fibrosis	516.3	J84.1
DNCL003413	Neublastin	Neuropathic pain	338,780	R52, G89
DNCL003413	Neublastin	Pain	.	G89
DNCL003414	CD40L	Esophagus cancer	.	C15.9
DNCL003414	CD40L	Systemic lupus erythematosus	710	M32
DNCL003415	SMNrx	Spinal muscular atrophy	.	G12.0-G12.1
DNCL003415	SMNrx	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DNCL003416	Nintedanib	Idiopathic pulmonary fibrosis	516.3	J84.1
DNCL003416	Nintedanib	Non-small cell lung cancer	162	C33, C34
DNCL003416	Nintedanib	Ovarian cancer	183	C56
DNCL003417	ACE-536	Anemia	238.7, 280-285	D46, D50-D64
DNCL003417	ACE-536	Anemia	280-285	D50-D64
DNCL003418	CC-930	Discoid lupus erythematosus	.	L93.0
DNCL003418	CC-930	Discoid lupus erythematosus	695.4	L93.0
DNCL003418	CC-930	Idiopathic pulmonary fibrosis	516.3	J84.1
DNCL003419	CC-11050	Cutaneous lupus erythematosus	710	M32
DNCL003420	PDA-001	Crohn's disease	555	K50
DNCL003420	PDA-001	Multiple sclerosis	340	G35
DNCL003420	PDA-001	Rheumatold arthritis	714	M05-M06
DNCL003420	PDA-001	Sarcoidosis	135	D86
DNCL003421	CYT-609	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003422	DU-176b	Atrial fibrillation	427.31	I48
DNCL003423	DE-766	Esophageal cancer	150	C15
DNCL003423	DE-766	Gastric cancer	151	C16
DNCL003423	DE-766	Non-small cell lung cancer	162	C33, C34
DNCL003424	CS-3150	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DNCL003424	CS-3150	Hypertension	.	I10-I15
DNCL003424	CS-3150	Hypertension	401	I10, I11, I12, I13, I15
DNCL003425	DS-7250	Diabetes mellitus	.	E10-E14
DNCL003425	DS-7250	Diabetes mellitus	250	E08-E13
DNCL003425	DS-7250	Diabetes mellitus; Obesity	250, 278	E08-E13, E66
DNCL003426	CS-1008	Hepatocellular carcinoma	155	C22.0
DNCL003427	CS-7017	Colorectal cancer	153, 154	C18-C21
DNCL003427	CS-7017	Non-small cell lung cancer	162	C33, C34
DNCL003428	U3-1287	Breast cancer	174, 175	C50
DNCL003428	U3-1287	Non-small cell lung cancer	162	C33, C34
DNCL003428	U3-1287	Non-small-cell lung cancer	162	C33, C34
DNCL003430	DS-5565	Chronic pain	338.2,780	R52.1-R52.2, G89
DNCL003431	SUN13837	Spinal cord injuries	952	S14, S24, S34
DNCL003432	ASB17061	Atopic dermatitis	691.8	L20
DNCL003433	DS-7309	Diabetes mellitus	.	E10-E14
DNCL003433	DS-7309	Diabetes mellitus	250	E08-E13
DNCL003434	DS-6930	Diabetes mellitus	250	E08-E13
DNCL003435	DS-8500	Diabetes mellitus	250	E08-E13
DNCL003436	DS-1442	Dyslipidemia	272	E78
DNCL003437	DS-1040	Acute ischemic stroke	434.91	I61-I63
DNCL003437	DS-1040	Stroke	.	I61-I63
DNCL003438	DS-3078	Lymphoma	.	C81-C96
DNCL003438	DS-3078	Lymphoma	202.8	C81-C96
DNCL003438	DS-3078	Solid cancer; Lymphoma	140-199, 140-229, 202.8	C00-C75, C00-C96, C7A, C7B, C81-C96
DNCL003439	DS-8587	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003440	CS-4771	Sepsis	995.91	A40, A41
DNCL003441	CS-0777	Immuno-modulator	.	D80-D89
DNCL003442	GS-9973	B-Cell malignancies	202.8	C85.1
DNCL003442	GS-9973	B-cell hematological malignancies	200-209	C81-C96
DNCL003442	GS-9973	B-cell lymphoma	.	C85.1
DNCL003443	Nivolumab	Hematological malignancies	200-209	C81-C96
DNCL003444	SAR405838	Hematological malignancies	200-209	C81-C96
DNCL003444	SAR405838	Solid tumours	.	C00-C75,C7A,C7B
DNCL003444	SAR405838	Solid tumours; Hematological malignancies	140-199, 200-209	C00-C75, C7A, C7B, C81-C96
DNCL003445	ABT-199/GDC-0199/RG7601	Myeloma	202.8, 203.0, 208.9	C81-C96, C90.0, C91-C95
DNCL003445	ABT-199/GDC-0199/RG7601	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 203.0, 208.9	C81, C81-C96, C82-C85, C90.0, C91-C95
DNCL003445	ABT-199/GDC-0199/RG7601	Relapsed/refractory chronic lymphocytic leukemia	202.8, 203.0, 204.1, 208.9	C81-C96, C90.0, C91-C95, C91.1
DNCL003446	Lintuzumab Ac-225	Acute myeloid leukemia	205	C92.0
DNCL003447	AT-406	Acute myeloid leukemia	205	C92.0
DNCL003448	BI-836858	Acute myeloid leukemia	205	C92.0
DNCL003449	Birinapant	Acute myeloid leukemia	205	C92.0
DNCL003449	Birinapant	Lymphoma	.	C81-C96
DNCL003449	Birinapant	Lymphoma	202.8, 208.9	C81-C96, C91-C95
DNCL003450	Lintuzumab Bi-213	Acute myeloid leukemia	205	C92.0
DNCL003451	Calaspargase pegol	Acute lymphoblastic leukemia	.	C91.0
DNCL003451	Calaspargase pegol	Adolescents and children ALL	204	C91.0
DNCL003452	CC-292	Chronic lymphocytic leukaemia	.	C91.1
DNCL003452	CC-292	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003452	CC-292	Lymphoma	202.8, 208.9	C81-C96, C91-C95
DNCL003453	CC-486	Lower-risk myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
DNCL003453	CC-486	Myelodysplastic syndromes	.	D46
DNCL003453	CC-486	Post-induction AML maintenance	205.0, 238.7	C92.0, D46
DNCL003454	CTL019	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003454	CTL019	Leukaemia	.	C91-C95
DNCL003454	CTL019	Leukemia	208.9	C91-C95
DNCL003455	DFP-10917	Acute lymphoblastic leukemia	204	C91.0
DNCL003455	DFP-10917	Acute lymphoblastic leukemia; Acute myeloid leukemia	204.0, 205.0	C91.0, C92.0
DNCL003456	EPZ-5676	Leukaemia	.	C91-C95
DNCL003456	EPZ-5676	Leukemia	208.9	C91-C95
DNCL003457	Asparaginase Erwinia	Acute lymphoblastic leukemia	204	C91.0
DNCL003458	GS-9820	Chronic lymphocytic leukaemia	.	C91.1
DNCL003458	GS-9820	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003458	GS-9820	Lymphoid malignancies	202	C81-C96
DNCL003458	GS-9820	Lymphoma	202.8, 208.9	C81-C96, C91-C95
DNCL003459	HTERT RNA vaccine	Acute myeloid leukemia	205	C92.0
DNCL003460	Ibrutinib companion diagnostic	Chronic lymphocytic leukaemia	.	C91.1
DNCL003460	Ibrutinib companion diagnostic	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003461	Idelalisib	Chronic lymphocytic leukaemia	.	C91.1
DNCL003461	Idelalisib	Chronic lymphocytic leukaemia	204.1	C91.1
DNCL003461	Idelalisib	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003461	Idelalisib	Indolent non-hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL003461	Idelalisib	Indolent non-hodgkin's lymphoma	200, 202	C82-C85
DNCL003462	Iomab-B	Acute myeloid leukemia	.	C92.0
DNCL003462	Iomab-B	Acute myeloid leukemia	205	C92.0
DNCL003463	KX01	Acute myeloid leukemia	205	C92.0
DNCL003463	KX01	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1	C92.0, C92.1
DNCL003464	Lirilumab	Acute myeloid leukemia	205	C92.0
DNCL003465	PM01183	Leukemia	.	C91-C95
DNCL003465	PM01183	Leukemia	208.9	C91-C95
DNCL003466	Quizartinib	Acute myeloid leukemia	205	C92.0
DNCL003466	Quizartinib	Relapsed/refractory acute myeloid leukemia	205	C92.0
DNCL003467	SGN-CD19A	Acute lymphoblastic leukemia	.	C91.0
DNCL003467	SGN-CD19A	Acute lymphoblastic leukemia	204	C91.0
DNCL003467	SGN-CD19A	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL003468	TCN-P	Acute myeloid leukemia	205	C92.0
DNCL003469	Ublituximab	Chronic lymphocytic leukaemia	.	C91.1
DNCL003469	Ublituximab	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003469	Ublituximab	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL003470	VAY736	Chronic lymphocytic leukaemia	.	C91.1
DNCL003470	VAY736	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003471	XmAb 5574/MOR208	Cancer	140-229	C00-C96
DNCL003471	XmAb 5574/MOR208	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003472	AEB071	Diffuse large b-cell lymphoma	200	C83.3
DNCL003472	AEB071	Psoriasis	696	L40
DNCL003473	Anti-CD79b antibody-drug conjugate	Diffuse large B-cell lymphoma; Non-Hodgkin's lymphoma	200, 200.0, 201, 202, 202.8	C81, C81-C96, C82-C85, C83.3, C85.1
DNCL003474	Autologous idiotypic cancer vaccin	Lymphoma	202	C82
DNCL003475	BI-695500	Diabetes mellitus	250	E08-E13
DNCL003475	BI-695500	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003476	CGC-11047	Lymphoma	202.8	C81-C96
DNCL003476	CGC-11047	Solid tumours	.	C00-C75,C7A,C7B
DNCL003477	CUDC-427	Lymphoma	202.8	C81-C96
DNCL003478	CUDC-907	Cancer	.	C00-C97
DNCL003478	CUDC-907	Diffuse large B-cell lymphoma	200.0, 202.8, 203.0	C81-C96, C83.3, C85.1, C90.0
DNCL003478	CUDC-907	Myeloma	202.8, 203.0	C81-C96, C90.0
DNCL003479	Delanzomib	Myeloma	202.8, 203.0	C81-C96, C90.0
DNCL003479	Delanzomib	Non-Hodgkin's lymphoma	200, 201, 202, 202.8, 203.0	C81, C81-C96, C82-C85, C90.0
DNCL003480	DI-Leu16-IL2	B-cell lymphoma	.	C85.1
DNCL003480	DI-Leu16-IL2	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003481	Epratuzumab Y-90	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003482	GDC-0980/RG7422	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003483	Imprime PGG immunotherapeutic	Advanced indolent non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
DNCL003484	JNJ-42756493	Lymphoma	202.8	C81-C96
DNCL003485	LY3039478	Lymphoma	.	C81-C96
DNCL003485	LY3039478	Lymphoma	202.8	C81-C96
DNCL003486	Marizomib	Lymphoma	202.8, 203.0	C81-C96, C90.0
DNCL003486	Marizomib	Myeloma	202.8, 203.0	C81-C96, C90.0
DNCL003486	Marizomib	Solid tumours	.	C00-C75,C7A,C7B
DNCL003487	Mechlorethamine gel	Mycosis fungoides	202.1, 202.8	C81-C96, C84.0
DNCL003488	Ocaratuzumab	Lymphoma	.	C81-C96
DNCL003488	Ocaratuzumab	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003489	Pacritinib	Hematological malignancies	.	C81-C96
DNCL003489	Pacritinib	Myelofibrosis	202.8, 289.83, 709.2	C81-C96, C94.4, D47.1, L90.5
DNCL003489	Pacritinib	Relapsed lymphoma	202.8	C81-C96
DNCL003490	Pidilizumab	Cancer	.	C00-C97
DNCL003490	Pidilizumab	Diffuse large b-cell lymphoma	200	C83.3
DNCL003492	Sepantronium bromide	Non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003493	Urelumab	Cancer	.	C00-C97
DNCL003493	Urelumab	Relapsed/refractory B-cell non-Hodgkin lymphoma	200, 202, 202.8	C81-C96, C82-C85
DNCL003494	Veltuzumab/epratuzumab Y-90	Diffuse large b-cell lymphoma	200	C83.3
DNCL003495	ARRY-614	Arthritis	.	M00-M25
DNCL003495	ARRY-614	Myelodysplastic syndromes	238.7	D46
DNCL003496	Pracinostat	Myelodysplastic syndromes	238.7	D46
DNCL003496	Pracinostat	Myelofibrosis	208.9, 289.83, 709.2	C91-C95, C94.4, D47.1, L90.5
DNCL003497	Ezatiostat	Myelodysplastic syndromes	.	D46
DNCL003497	Ezatiostat	Myelodysplastic syndromes	238.7	D46
DNCL003498	Antibody-drug conjugate	Melanoma	172	C43
DNCL003498	Antibody-drug conjugate	Multiple myeloma	203	C90.0
DNCL003498	Antibody-drug conjugate	Myeloma	203	C90.0
DNCL003498	Antibody-drug conjugate	Non-small cell lung cancer; ovarian cancer	162, 183	C33, C34, C56
DNCL003498	Antibody-drug conjugate	Ovarian cancer	183	C56
DNCL003498	Antibody-drug conjugate	Pancreatic and ovarian cancers	157, 183	C25, C56
DNCL003499	BT-062	Multiple myeloma	.	C90.0
DNCL003499	BT-062	Myeloma	203	C90.0
DNCL003500	DKN-01	Multiple myeloma	.	C90.0
DNCL003500	DKN-01	Myeloma	203	C90.0
DNCL003501	IMGN901	Myeloma	203	C90.0
DNCL003501	IMGN901	Solid tumours	.	C00-C75,C7A,C7B
DNCL003502	LGH447	Multiple myeloma	.	C90.0
DNCL003502	LGH447	Myeloma	203	C90.0
DNCL003503	MFGR-1877S	Multiple myeloma	.	C90.0
DNCL003503	MFGR-1877S	Myeloma	203	C90.0
DNCL003504	Milatuzumab-doxorubicin conjugate	Myeloma	203	C90.0
DNCL003505	PVX-410	Cancer	.	C00-C97
DNCL003505	PVX-410	Smoldering myeloma	203	C90.0
DNCL003506	Tabalumab	Lupus; Multiple myeloma	203.0, 710.0	C90.0, M32
DNCL003506	Tabalumab	Multiple myeloma	.	C90.0
DNCL003506	Tabalumab	Myeloma	203	C90.0
DNCL003507	BMS-911543	Myelofibrosis	289.83	C94.4, D47.1
DNCL003508	INCB39110	Myelofibrosis	.	C94.4,D47.1
DNCL003508	INCB39110	Myelofibrosis	289.83	C94.4, D47.1
DNCL003508	INCB39110	Psoriasis	696	L40
DNCL003508	INCB39110	Rheumatold arthritis	714	M05-M06
DNCL003509	Ruxolitinib	Essential thrombocythemia	238.71	D47.3, D75.2
DNCL003509	Ruxolitinib	Essential thrombocythemia	238.71, 289.9	D47.3, D75.2, D75.8
DNCL003509	Ruxolitinib	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
DNCL003509	Ruxolitinib	Pancreatic cancer	157	C25
DNCL003509	Ruxolitinib	Polycythemia vera	238.4	D45
DNCL003510	LY2784544	Breast cancer	.	C50
DNCL003510	LY2784544	Myeloproliferative disorders	205.1, 238.4, 289.89, 289.9	D47.1
DNCL003510	LY2784544	Myeloproliferative neoplasms	205.1, 238.4, 289.89, 289.9	D47.1
DNCL003511	Momelotinib	Myelofibrosis	.	C94.4,D47.1
DNCL003511	Momelotinib	Myelofibrosis	289.83	C94.4, D47.1
DNCL003512	NS-018	Myelofibrosis	289.83	C94.4, D47.1
DNCL003513	PRM-151	Macular degeneration	.	H35.3
DNCL003513	PRM-151	Myelofibrosis	289.83	C94.4, D47.1
DNCL003514	SAR302503	Myelofibrosis	289.83	C94.4, D47.1
DNCL003514	SAR302503	Polycythemia vera; Myelofibrosis	238.4, 289.0, 289.83, 709.2, 776.4	C94.4, D45, D47.1, D75.1, L90.5, P61.1
DNCL003515	Simtuzumab	Colorectal cancer	153, 154	C18-C21
DNCL003515	Simtuzumab	Idiopathic pulmonary fibrosis	516.3	J84.1
DNCL003515	Simtuzumab	Liver fibrosis due to non-alcoholic	571	K70.3, K71.7, K74
DNCL003515	Simtuzumab	Myelofibrosis	289.83	C94.4, D47.1
DNCL003515	Simtuzumab	Pancreatic cancer	157	C25
DNCL003516	DC Bead	Liver cancer	155	C22.0
DNCL003516	DC Bead	Transcatheter arterial embolization of hepatocellular carcinoma	155	C22.0
DNCL003516	DC Bead	Transcatheter arterial embolization of hypervascular tumors	140-229	C00-D48
DNCL003517	Careram	Rheumatold arthritis	714	M05-M06
DNCL003518	Cinitapride	Functional dyspepsia	536.8	K30
DNCL003519	E5501	Idiopathic thrombocytopenic purpura	287.31	D69.3
DNCL003519	E5501	Thrombocytopenia	.	D69.6
DNCL003519	E5501	Thrombocytopenia during interferon therapy	287.3, 287.4, 287.5	D69.6, P61.0
DNCL003519	E5501	Thrombocytopenia in chronic liver disease	287.3, 287.4, 287.5, 570-574	D69.6, K70-K77, P61.0
DNCL003520	MORAb-003	Platinum-sensitive ovarian cancer	183	C56
DNCL003521	Inovelon/Banzel	Pediatric Lennox-Gastaut syndrome	345	G40.4
DNCL003522	AS-3201	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DNCL003522	AS-3201	Neuropathy	.	G64,G90.0
DNCL003523	E6005	Atopic dermatitis	.	L20
DNCL003523	E6005	Atopic dermatitis	691.8	L20
DNCL003524	E6201	Breast cancer	.	C50
DNCL003524	E6201	Psoriasis	696	L40
DNCL003525	E7016	Malignant melanoma	172	C43
DNCL003525	E7016	Melanoma	172	C43
DNCL003526	Ontak	Alopecia	.	L65.9
DNCL003526	Ontak	Melanoma	172	C43
DNCL003527	Eluxadoline	Diarrhea-predominant IBS	564.1	K58
DNCL003528	Avarofloxacin	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003528	Avarofloxacin	Bacterial pneumonia infection	.	J13,J15
DNCL003529	Dapoxetine	Premature ejaculation	302.75	F52.4
DNCL003530	MEGF0444A	Colorectal cancer	.	C18-C20,C21
DNCL003530	MEGF0444A	Metastatic colorectal cancer	153, 154	C18-C21
DNCL003530	MEGF0444A	Non-small cell lung cancer	162	C33, C34
DNCL003531	MEHD7945A	Colorectal cancer	153, 154	C18-C21
DNCL003531	MEHD7945A	Head and neck cancer	.	C07-C14,C32-C33
DNCL003531	MEHD7945A	Head and neck cancer	140-149	C07-C14, C32-C33
DNCL003531	MEHD7945A	Metastatic epithelial tumors	140-199	C00-C75, C7A, C7B
DNCL003532	GDC-0199	Cancer	.	C00-C97
DNCL003532	GDC-0199	Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma	200, 202, 204.1	C82-C85, C91.1
DNCL003533	C-0084	Glioma	191	C71
DNCL003534	Trastuzumab emtansine	Breast cancer	.	C50
DNCL003534	Trastuzumab emtansine	HER2-positive metastatic breast cancer	174, 175	C50
DNCL003535	FCFD4514S	Geographic atrophy associated with AMD	362.5	H35.3
DNCL003536	MCAF5352A	Autoimmune diseases	279.4	D84.9, M35.9
DNCL003537	Etrolizumab	Ulcerative colitis	556	K51
DNCL003538	MEMP1972A	Asthma	493	J45
DNCL003539	Sodium Hyaluronate	Enthesopathy	726	M76-M77.9
DNCL003540	Arbaclofen	Fragile X syndrome	759.83	Q99.2
DNCL003541	MPSK3169A	Cardiovascular disease	390-459	I00-I99
DNCL003541	MPSK3169A	Metabolic disorders	.	E70-E90
DNCL003542	Tofogliflozin	Diabetes mellitus type 2	.	E11
DNCL003542	Tofogliflozin	Type 2 diabetes	250.00, 250.02	E11
DNCL003543	Eliglustat tartrate	Gaucher disease	272.7	E75.2
DNCL003543	Eliglustat tartrate	Metabolic disorders	.	E70-E90
DNCL003544	Acid sphingomyelinase	Niemann-Pick disease type B	272.7	E75.241
DNCL003545	AAV-hAADC gene therapy	Parkinson's disease	332	F02.3, G20
DNCL003546	AAV-sFLT gene therapy	Age-related macular degeneration	362.5	H35.3
DNCL003546	AAV-sFLT gene therapy	Macular degeneration	.	H35.3
DNCL003547	Single Tablet Regimen	HIV infections	42	B20
DNCL003548	Single Tablet Regimen of sofosbuvir and ledipasvir (	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003549	GS-9451	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003549	GS-9451	Hepatitis C virus infection	.	B17.1,B18.2
DNCL003550	GS-9669	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003550	GS-9669	Hepatitis C virus infection	.	B17.1,B18.2
DNCL003551	GS-5816	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003551	GS-5816	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003552	GS-9620	Chronic HBV infection	070.2-070.3	B16, B18.0, B18.1
DNCL003552	GS-9620	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003552	GS-9620	Hepatitis B virus infection	.	B16
DNCL003553	Tenofovir Alafenamide	Chronic HBV infection	070.2-070.3	B16, B18.0, B18.1
DNCL003554	GS-4774	Chronic HBV infection	070.2-070.3	B16, B18.0, B18.1
DNCL003554	GS-4774	Non-small-cell lung carcinoma	162	C33, C34
DNCL003555	GS-5745	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003555	GS-5745	Ulcerative colitis	.	K51
DNCL003555	GS-5745	Ulcerative colitis	556	K51
DNCL003556	Ranolazine/Dronedarone Fixed-Dose Combination	Paroxysmal atrial fibrillation	427.31	I48
DNCL003557	GS-6615	Ischemic heart diseases	.	I20-I25
DNCL003557	GS-6615	Ischemic heart diseases; Arrhythmias	390-429	I00-I52
DNCL003558	GS-9268	Non-cystic fibrosis bronchiectasis	494	J47
DNCL003559	GS-5806	Respiratory syncytial virus 	.	B97.4
DNCL003559	GS-5806	Respiratory syncytial virus 	79.6	B97.4
DNCL003560	GI-13020	HBV infection	070.2-070.3	B16, B18.0, B18.1
DNCL003561	GI-5005-02	Chronic hepatitis C	001-139, 070.4, 070.5, 070.70, 573.3	A00-B99, B17.1, B18.2, K75.9
DNCL003562	GI-4000 in combination with gemcitabine	Ras mutation positive pancreas cancer	157.0-157.9	C25
DNCL003563	GSK1995057	Acute lung injury	518	J80
DNCL003564	GSK2374697	Obesity	278	E66
DNCL003565	GSK2661380	Solid tumours	140-199	C00-C75, C7A, C7B
DNCL003566	GSK3052230	Cancer	.	C00-C97
DNCL003566	GSK3052230	Cancer	140-229	C00-C96
DNCL003567	GSK249320	Stroke	434.91	I61-I63
DNCL003568	GSK2586881	Acute lung injury	518	J80
DNCL003568	GSK2586881	Asthma	.	J45
DNCL003569	GSK933776	Geographic retinal atrophy	.	H35.3
DNCL003569	GSK933776	Macular degeneration	.	H35.3
DNCL003570	GSK1070806	Diabetes mellitus type 2	.	E11
DNCL003570	GSK1070806	Type 2 diabetes	250.00, 250.02	E11
DNCL003571	Ozanezumab	Amyotrophic lateral sclerosis	335.2	G12.2
DNCL003571	Ozanezumab	Lateral sclerosis	.	G12.2
DNCL003572	Sirukumab	Rheumatold arthritis	714	M05-M06
DNCL003573	1614235 + 2330672	Type 2 diabetes	250.00, 250.02	E11
DNCL003574	GSK2849466	Heart failure	428	I50
DNCL003575	GSK2890457	Obesity	278	E66
DNCL003576	GSK1278863	Anaemia	280-285, 585.9585.1-585.5403	D50-D64, N18
DNCL003576	GSK1278863	Wound healing	.	S91.3
DNCL003577	Camicinal	Delayed gastric emptying	536.3	K31.8
DNCL003577	Camicinal	Gastroparesis	.	K31.8
DNCL003578	Retosiban	Threatened pre-term labour	.	O60.1,P07.3
DNCL003579	GSK2245840	Psoriasis	696	L40
DNCL003580	GSK2586184	Lupus	.	M32
DNCL003580	GSK2586184	Systemic lupus erythematosus	695, 696, 710.0	L40, L51-L54, M32
DNCL003581	GSK2941266	Rheumatold arthritis	714	M05-M06
DNCL003582	Vercirnon	Crohn's disease	.	K50
DNCL003582	Vercirnon	Crohn's disease	555	K50
DNCL003583	GSK2140944	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNCL003583	GSK2140944	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003584	GSK2696266	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003585	GSK1322322	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNCL003585	GSK1322322	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003586	GSK2336805	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003587	Tafenoquine	Malaria	.	B50-B54
DNCL003587	Tafenoquine	Plasmodium vivax malaria	84	B50-B54
DNCL003588	GSK356278	Huntington's disease	294.1, 333.4	F02.2, G10
DNCL003589	GSK2647544	Alzheimer's disease	.	G30,F00
DNCL003589	GSK2647544	Alzheimer's disease	331	G30
DNCL003590	GSK239512	Alzheimer's disease	.	G30,F00
DNCL003590	GSK239512	Multiple sclerosis	340	G35
DNCL003591	GSK742457	Dementia	290-294	F01-F07
DNCL003592	Patrome	Parkinson's disease	.	G20
DNCL003592	Patrome	Parkinson's disease	332	F02.3, G20
DNCL003593	GSK525762	Cancer	.	C00-C97
DNCL003593	GSK525762	NUT gene midline carcinoma	.	C00-D48
DNCL003594	GSK2110183	Hematological malignancies	.	C81-C96
DNCL003594	GSK2110183	Langerhan cell histiocytosis	.	C90.0
DNCL003594	GSK2110183	Multiple myeloma	203	C90.0
DNCL003594	GSK2110183	Ovarian cancer	183	C56
DNCL003595	GSK2256098	Cancer	140-229	C00-C96
DNCL003596	GSK2636771	Cancer	140-229	C00-C96
DNCL003596	GSK2636771	Solid tumours	.	C00-C75,C7A,C7B
DNCL003597	Trametinib + 2141795	Cancer	140-229	C00-C96
DNCL003598	Dabrafenib	Melanoma	.	C43
DNCL003598	Dabrafenib	Metastatic melanoma	172	C43
DNCL003598	Dabrafenib	Non-small cell lung cancer	162	C33, C34
DNCL003599	Trametinib + dabrafenib	Colorectal cancer	153, 154	C18-C21
DNCL003599	Trametinib + dabrafenib	Metastatic melanoma	172	C43
DNCL003600	GSK1325756	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003601	GSK2256294	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003602	GSK2269557	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003603	GSK2339345	Cough	786.2	R05
DNCL003604	GSK961081	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003605	GSK2190915	Asthma	493	J45
DNCL003606	GSK2245035	Asthma	493	J45
DNCL003607	Relvar/Breo	Asthma	493	J45
DNCL003607	Relvar/Breo	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003608	Umeclidinium	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003609	Anoro	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003610	S. pneumoniae paediatric next generation	Streptococcus pneumoniae infection	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
DNCL003611	Mosquirix	Malaria prophylaxis	84	B50-B54
DNCL003612	HIV	HIV disease immunotherapy	42	B20
DNCL003612	HIV	HIV disease prophylaxis	42	B20
DNCL003613	NTHi	Haemophilus influenzae prophylaxis	487, 488	J10, J11
DNCL003614	Staphylococcus Aureus	Staphylococcus aureus infection	001-139	A00-B99
DNCL003615	Tuberculosis	Tuberculosis prophylaxis	010-018	A15-A19
DNCL003616	Flu	Pre-pandemic and pandemic influenza prophylaxis	487, 488	J10, J11
DNCL003617	MAGE-A3 immunotherapeutic	Bladder cancer	140-229, 188	C00-C96, C67
DNCL003617	MAGE-A3 immunotherapeutic	Melanoma	172.9	C43
DNCL003617	MAGE-A3 immunotherapeutic	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
DNCL003617	MAGE-A3 immunotherapeutic	Type 2 diabetes	250.00, 250.02	E11
DNCL003618	Migalastat HCl + ERT	Fabry disease	272.7	E75.2
DNCL003619	Drisapersen	Duchenne muscular dystrophy	.	G71.0
DNCL003619	Drisapersen	Duchenne muscular dystrophy	359.1	G71.0
DNCL003620	GSK2696273	Immune deficiency	279.2	D81.3
DNCL003620	GSK2696273	Type 1 diabetes	250.01	E10
DNCL003621	Migalastat HCl	Fabry disease	272.7	E75.2
DNCL003622	GSK2894512	Atopic dermatitis	691.8	L20
DNCL003623	Duac low dose	Acne vulgaris	706.1	L70.0
DNCL003624	GSK1265744	HIV infections	42	B20
DNCL003625	Dolutegravir + abacavir sulphate + lamivudine	HIV infections	42	B20
DNCL003626	IDX719	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003626	IDX719	Hepatitis C virus infection	.	B17.1,B18.2
DNCL003627	INCB28060	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003628	KYNAMRO	Cardiovascular disease	390-459	I00-I99
DNCL003628	KYNAMRO	Familial hypercholesterolemia	.	I00-I99
DNCL003629	ISIS-CRPRx	Coronary artery disease	410-414, 429.2	I20-I25
DNCL003629	ISIS-CRPRx	Inflammation	.	I20-I25
DNCL003630	ISIS-FXIRx	Clotting disorders	286	D65-D69
DNCL003631	ISIS-APOARx	Coronary artery disease	.	I20-I25
DNCL003631	ISIS-APOARx	Coronary artery disease	410-414, 429.2	I20-I25
DNCL003632	ISIS-TTRRx	Amyloidosis	.	E85
DNCL003632	ISIS-TTRRx	TTR amyloidosis	277.3	E85
DNCL003633	ISIS-SMNRx	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
DNCL003634	ISIS-FGFR4Rx	Obesity	278	E66
DNCL003635	Plazomicin	Pancreatic cancer	157	C25
DNCL003635	Plazomicin	Severe bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003636	Darunavir and cobicistat	HIV infections	42	B20
DNCL003637	Simeprevir	Chronic hepatitis C	001-139, 070.4, 070.5, 070.70, 573.3	A00-B99, B17.1, B18.2, K75.9
DNCL003638	Paliperidone palmitate IM long acting injectable	Schizophrenia	295	F20
DNCL003639	KX01 and paclitaxel	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003640	Oraxol	Gastric cancer	151	C16
DNCL003641	Oratecan	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003642	SGN-35	Hodgkin's lymphoma	201	C81
DNCL003642	SGN-35	Hodgkin's lymphoma; Cutaneous T-Cell lymphoma	201, 202.1, 202.2, 202.8	C81, C81-C96, C84.0, C84.1
DNCL003642	SGN-35	Mature T-cell lymphoma	204.0-208.9	C83-C88
DNCL003642	SGN-35	Post-ASCT Hodgkin's lymphoma	201	C81
DNCL003642	SGN-35	Relapsed cutaneous T-cell lymphoma	202	C84
DNCL003642	SGN-35	Relapsed/refractory Hodgkin's lymphoma	201	C81
DNCL003642	SGN-35	Relapsed/refractory systemic anaplastic large cell lymphoma	200.6	C84.6, C84.7
DNCL003643	MLN0264	Advanced gastrointestinal cancer	150-159	C15-C26
DNCL003643	MLN0264	Gastrointestinal cancer	.	C15-C26
DNCL003643	MLN0264	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003644	HyperAcute Pancreas	Surgically-resected pancreatic cancer	157	C25
DNCL003645	HyperAcute Lung	Advanced non-Small cell lung cancer	162	C33, C34
DNCL003646	HyperAcute Melanoma	Advanced melanoma	172	C43
DNCL003646	HyperAcute Melanoma	Diabetes mellitus	250	E08-E13
DNCL003647	NLG8189	Metastatic solid tumors	140-199	C00-C75, C7A, C7B
DNCL003648	ATI355	Spinal cord injuries	.	S14,S24,S34
DNCL003648	ATI355	Spinal cord injuries	952	S14, S24, S34
DNCL003649	BAF312	Hepatocellular carcinoma	.	C22.0
DNCL003649	BAF312	Multiple sclerosis	340	G35
DNCL003650	BGS649	Obese hypogonadotropic hypogonadism	257.2	E23.0, E28.3, E29.1
DNCL003651	BYM338	Acute myeloid leukemia	205	C92.0
DNCL003651	BYM338	Sporadic inclusion body myositis	729.1	M60
DNCL003652	DEB025	Chronic hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
DNCL003653	Exjade	Iron overload	.	R79.0
DNCL003653	Exjade	Non-transfusion dependent thalassemia	282.4	D56
DNCL003654	KAE609	Malaria	84	B50-B54
DNCL003655	LFF571	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNCL003655	LFF571	Clostridium difficile infection	001-139	A00-B99
DNCL003656	MEK162	Melanoma	.	C43
DNCL003656	MEK162	Melanoma	172	C43
DNCL003657	QMF149	Asthma; Chronic obstructive pulmonary disease	460-519, 493	J00-J99, J45
DNCL003658	RLX030	Acute heart failure	428	I50
DNCL003659	NN5401	Diabetes mellitus	.	E10-E14
DNCL003659	NN5401	Type 1/2 diabetes	250	E08-E13
DNCL003660	NN1841	FXIII congenital deficiency	286.3	D68.2
DNCL003660	NN1841	Hemophilia	.	D66-D68
DNCL003661	Turoctocog alfa	Haemophilia A	286	D66
DNCL003661	Turoctocog alfa	Hemophilia A	286	D66
DNCL003662	IDegLira	Type 2 diabetes	250.00, 250.02	E11
DNCL003663	N8-GP	Factor VIII deficiency	.	D66
DNCL003663	N8-GP	Haemophilia A	286	D66
DNCL003664	N9-GP	Factor IX deficiency	.	D67
DNCL003664	N9-GP	Haemophilia B	286.1	D67
DNCL003665	NN8717	Graft-versus host disease	.	T86.0
DNCL003665	NN8717	Ulcerative colitis	556	K51
DNCL003666	LATIN T1D	Diabetes mellitus type 1	.	E10
DNCL003666	LATIN T1D	Type 1 diabetes	250.01	E10
DNCL003667	OI338GT	Diabetes mellitus type 2	.	E11
DNCL003667	OI338GT	Type 1/2 diabetes	250	E08-E13
DNCL003668	OI362GT	Diabetes mellitus type 2	.	E11
DNCL003668	OI362GT	Type 1/2 diabetes	250	E08-E13
DNCL003669	OI287GT	Diabetes mellitus type 2	.	E11
DNCL003669	OI287GT	Type 1/2 diabetes	250	E08-E13
DNCL003670	OG217SC	Diabetes mellitus type 2	.	E11
DNCL003670	OG217SC	Type 2 diabetes	250.00, 250.02	E11
DNCL003671	OG987GT	Diabetes mellitus type 2	.	E11
DNCL003671	OG987GT	Type 2 diabetes	250.00, 250.02	E11
DNCL003672	OG987SC	Type 2 diabetes	250.00, 250.02	E11
DNCL003673	FIAsp	Type 1/2 diabetes	250	E08-E13
DNCL003674	LAI287	Type 1/2 diabetes	250	E08-E13
DNCL003674	LAI287	Type 2 diabetes	250.00, 250.02	E11
DNCL003675	NN7415	Haemophilia A; Haemophilia B	286.0, 286.1	D66, D67
DNCL003676	NN8640	Growth disorder	.	E23.0
DNCL003677	NN8210	Rheumatoid arthritis	714	M05-M06
DNCL003677	NN8210	Rheumatold arthritis	714	M05-M06
DNCL003678	NN8765	Autoimmune diseases	.	D84.9
DNCL003678	NN8765	Rheumatoid arthritis	714	M05-M06
DNCL003679	Prochyma	Acute myocardial infarction	410	I21-I22
DNCL003679	Prochyma	Acute radiation syndrome	990	T66
DNCL003679	Prochyma	Crohn's disease	555	K50
DNCL003679	Prochyma	Graft-versus-host disease	279.5	T86.0
DNCL003679	Prochyma	Pulmonary disease	460-519	J00-J99
DNCL003679	Prochyma	Type 2 diabetes	250.01	E10
DNCL003680	ChondrogenTM	Arthritis	710-719	M00-M25
DNCL003681	Osteocel-XCTM	Focal bone regeneration	.	M00-M99
DNCL003682	AN2728	Atopic dermatitis	.	L20
DNCL003682	AN2728	Psoriasis	696	L40
DNCL003683	AS101	Psoriasis	696	L40
DNCL003684	CT 327	Psoriasis	696	L40
DNCL003685	DPIV/CD26	Acne vulgaris	.	L70.0
DNCL003685	DPIV/CD26	Psoriasis	696	L40
DNCL003686	LAS41004	Psoriasis	696	L40
DNCL003687	LEO 80185	Psoriasis	696	L40
DNCL003688	LEO 90100	Psoriasis	696	L40
DNCL003689	M518101	Psoriasis	696	L40
DNCL003690	PH-10	Psoriasis	696	L40
DNCL003691	WBI-1001	Psoriasis	696	L40
DNCL003692	ACT-128800	Psoriasis	696	L40
DNCL003693	Apo805K1	Psoriasis	696	L40
DNCL003694	FP187	Psoriasis	696	L40
DNCL003695	LEO 22811	Psoriasis	696	L40
DNCL003696	VB-201	Atherosclerosis	414.0, 440	I70
DNCL003696	VB-201	Psoriasis	696	L40
DNCL003697	Ixekizumab	Psoriasis	696	L40
DNCL003697	Ixekizumab	Psoriatic arthritis	696, 696.0	L40, L40.5, M07
DNCL003698	MK-3222/SCH 900222	Psoriasis	696	L40
DNCL003699	BT-061	Asthma	.	J45
DNCL003699	BT-061	Psoriasis	696	L40
DNCL003700	CHU	Atopic dermatitis	691.8	L20
DNCL003700	CHU	Cancers	140-229	C00-C96
DNCL003700	CHU	Enthesopathy	726	M76-M77.9
DNCL003700	CHU	Hemophilia A	286	D66
DNCL003700	CHU	Rheumatold arthritis	714	M05-M06
DNCL003700	CHU	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003700	CHU	Type 2 diabetes	250.00, 250.02	E11
DNCL003702	RG7212	Cancer	140-229	C00-C96
DNCL003702	RG7212	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003703	RG7221	Cancers	140-229	C00-C96
DNCL003703	RG7221	Colorectal cancer	153, 154	C18-C21
DNCL003704	RG7420	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003705	RG7440	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003706	RG7450	Prostate cancer	185	C61
DNCL003707	RG7601	Chronic lymphocytic leukaemia	.	C91.1
DNCL003707	RG7601	Relapsed/refractory chronic lymphocytic leukaemia	204.1	C91.1
DNCL003708	RG7604	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003709	RG7666	Glioblastoma multiforme	.	C71
DNCL003709	RG7666	Progressive or recurrent high-grade glioma	191	C71
DNCL003710	RG7741	Solid tumours; Lymphoma	140-199, 202.8	C00-C75, C7A, C7B, C81-C96
DNCL003711	RG7853	Non-small cell lung cancer	162	C33, C34
DNCL003712	RG3616	Advanced basal cell carcinoma	173	C44
DNCL003712	RG3616	Operable basal cell carcinoma	173	C44
DNCL003713	RG3638	Avastin-nave recurrent glioblastoma	191	C71
DNCL003713	RG3638	Metastatic HER2-negative gastric cancer	140-229, 151	C00-C96, C16
DNCL003713	RG3638	Metastatic colorectal cancer	153, 154	C18-C21
DNCL003713	RG3638	Metastatic non-small cell lung cancer	162	C33, C34
DNCL003713	RG3638	Non-squamous non-small cell lung cancer	162	C33, C34
DNCL003713	RG3638	Squamous non-small cell lung cancer	162	C33, C34
DNCL003713	RG3638	Triple-negative metastatic breast cancer	140-229, 174, 175	C00-C96, C50
DNCL003714	RG7422	Breast cancer	.	C50
DNCL003714	RG7422	Solid tumours; non-Hodgkin's lymphoma	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C82-C85, D10-D36, D3A
DNCL003715	RG1273	HER2-positive breast cancer	174, 175	C50
DNCL003715	RG1273	Lung cancer	.	C33-C34
DNCL003716	RG3502	HER2-positive metastatic breast cancer	174, 175	C50
DNCL003717	RG7159	Chronic lymphocytic leukemia	204.1	C91.1
DNCL003717	RG7159	Diffuse large b-cell lymphoma	200	C83.3
DNCL003717	RG7159	Non-hodgkin's lymphoma	200, 202	C82-C85
DNCL003717	RG7159	Refractory indolent non-Hodgkin's lymphoma	200, 202	C82-C85
DNCL003718	RG7421+RG7204	BRAF mutation positive metastatic melanoma	172	C43
DNCL003719	RG7624	Autoimmune diseases	279.4	D84.9, M35.9
DNCL003720	RG7413	Inflammatory bowel disease	.	K50,K51
DNCL003720	RG7413	Ulcerative colitis	556	K51
DNCL003721	RG3637	Cancer	.	C00-C97
DNCL003721	RG3637	Severe asthma	493	J45
DNCL003722	RG3806	Acromegaly	253	E22.0
DNCL003723	RG7417	Geographic atrophy associated with AMD	.	H35.3
DNCL003723	RG7417	Macular degeneration	.	H35.3
DNCL003724	RG7667	Cytomegalovirus infection 	.	B25.9
DNCL003724	RG7667	Cytomegalovirus infection 	78.5	B25
DNCL003725	RG7697	Diabetes mellitus type 2	.	E11
DNCL003725	RG7697	Type 2 diabetes	250.00, 250.02	E11
DNCL003726	RG7652	Metabolic disease	270-279	E70-E89
DNCL003727	RG7203	Schizophrenia	.	F20
DNCL003727	RG7203	Schizophrenia	295	F20
DNCL003728	RG1450	Alzheimer's disease	331	G30
DNCL003729	RG7412	Alzheimer's disease	331	G30
DNCL003730	SSTarbaclofen	Autism	.	F84.0
DNCL003730	SSTarbaclofen	Autism	299	F84.0
DNCL003730	SSTarbaclofen	Fragile X syndrome	759.83	Q99.2
DNCL003731	GZ402674	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003732	Combinations SAR245409 / MSC1936369B SAR245408/SAR256212	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003733	SAR260301	PTEN-deficient tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DNCL003733	SAR260301	Solid tumours	.	C00-C75,C7A,C7B
DNCL003734	SAR127963	Traumatic brain injury	800, 801, 803, 804, 850-854	S06
DNCL003734	SAR127963	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
DNCL003735	GZ404477	Parkinson's disease	332	F02.3, G20
DNCL003736	SAR391786	Muscle atrophy	.	M62.5
DNCL003736	SAR391786	Muscular atrophy	728.2	M62.5
DNCL003737	SAR399063	Pre-sarcopenia	.	M62
DNCL003738	SAR404460	Pre-sarcopenia	.	M62
DNCL003739	SAR126119	Acute ischemic stroke	434.91	I61-I63
DNCL003740	SAR252067	Crohn's disease; Ulcerative colitis	555, 556, 556.9	K50, K50-K52, K51
DNCL003741	SAR113244	Lupus	.	M32
DNCL003741	SAR113244	Systemic lupus erythematosus	710	M32
DNCL003742	Lixisenatide + Lantus	Type 2 diabetes	250.00, 250.02	E11
DNCL003743	GZ402665	Niemann-Pick disease	.	E75.249
DNCL003743	GZ402665	Niemann-Pick disease type B	272.7	E75.241
DNCL003744	GZ402671	Fabry disease	272.7	E75.2
DNCL003745	FOV1101	Allergic conjunctivitis	204.0, 372.0, 372.14, 995.3	C91.0, H10, H10.45, T78.4
DNCL003745	FOV1101	Allergic conjunctivitis	372.14	H10.45
DNCL003746	Ferroquine	Malaria	84	B50-B54
DNCL003747	Fresolimumab	Fibrosis	709.2	L90.5
DNCL003747	Fresolimumab	Focal segmental glomerulosclerosis	.	N00-N08
DNCL003748	SAR97276	Malaria	84	B50-B54
DNCL003749	SAR279356	Infections disease	.	A00-B99
DNCL003749	SAR279356	Serious infections	001-139	A00-B99
DNCL003750	SAR339658	Inflammatory bowel disease	555, 556	K50, K51
DNCL003751	SAR156597	Idiopathic pulmonary fibrosis	.	J84.1
DNCL003751	SAR156597	Idiopathic pulmonary fibrosis	516.3	J84.1
DNCL003752	SYNVISC-ONE	Pain	715,338,780	M16.9, G89, R52
DNCL003753	MACI	Articular cartilage defects	733	M94
DNCL003753	MACI	Leukemia	208.9	C91-C95
DNCL003754	Quadracel	Diphtheria; Tetanus; Pertussis; Polio	032, 033, 037, 045, 138, 771.3	A33-A35, A36, A37, A80, B91
DNCL003754	Quadracel	Leukemia	.	C91-C95
DNCL003755	VaxiGrip QIV IM	Quadrivalent inactivated influenza	487, 488	J10, J11
DNCL003756	Fluzone QIV ID	Quadrivalent inactivated influenza	487, 488	J10, J11
DNCL003757	New hexavalent vaccine (DTP-HepB-Polio-Hib vaccine)	DTP-hepb-polio-hib	.	N17-N19
DNCL003757	New hexavalent vaccine (DTP-HepB-Polio-Hib vaccine)	Renal failure	.	N17-N19
DNCL003758	Fluzone QIV IM	Quadrivalent inactivated influenza	487, 488	J10, J11
DNCL003759	Lixisenatide	Type 2 diabetes	250.00, 250.02	E11
DNCL003760	SI-6603	Lumber disk herniation	722.0-722.2	M51.2
DNCL003761	Condoliase	Lumber disk herniation	722.0-722.2	M51.2
DNCL003762	SI-657	Alzheimer's disease	726	M76-M77.9
DNCL003762	SI-657	Cancer	140-229	C00-C96
DNCL003763	SI-613	Knee osteoarthritis	715	M15-M19, M47
DNCL003764	SI-614	Dry eye disease	370.33	H16.229
DNCL003764	SI-614	Mild to moderate alzheimer's disease	331	G30
DNCL003765	Levoleucovorin	Advanced metastatic colorectal cancer	153, 154	C18-C21
DNCL003765	Levoleucovorin	Anemia	.	D50-D64
DNCL003765	Levoleucovorin	Mucositis mitigation following folotyn	528.00-528.01	J34, K12.3, K12.30, K12.31, K12.32, K12.33, K12.39, K92.81, N76.81
DNCL003765	Levoleucovorin	Osteosarcoma	170	C40-C41
DNCL003766	Captisol-enabled Melphalan	Multiple Myeloma; Autologous Stem Cell Transplant	203	C90.0
DNCL003767	Apaziquone/EOquin	Non-muscle invasive bladder cancer	188	C67, C67.9
DNCL003768	SPI-2012	Neutropenia	.	D70
DNCL003768	SPI-2012	Neutropenia; Breast cancer	174, 175	C50
DNCL003769	Renazorb	Hyperphosphatemia	275.3	E22.1
DNCL003770	SPI-205	Neuropathy	356.0, 356.8	G64, G90.0
DNCL003770	SPI-205	Parkinson's disease	.	G20
DNCL003771	CT-064	Osteoporosis	733	M80-M81
DNCL003772	TS-071	Type 2 diabetes	250.00, 250.02	E11
DNCL003773	TT-063	Osteoarthritis; Scapulohumeral periarthritis; Myalgia	715, 729.1	M15-M19, M47, M79.1
DNCL003774	NT-702	Asthma	493	J45
DNCL003774	NT-702	Intermittent claudication caused by ASO	440.21	I73.9
DNCL003775	Palux	Intermittent claudication caused by SCS	440.21	I73.9
DNCL003776	TS-091	Hypersomnia	.	G47.1
DNCL003776	TS-091	Sleep disorders	307.4, 327, 780.5	F51, G47
DNCL003777	TS-111	Depression	311	F32
DNCL003778	MLN0002	Crohn's disease	.	K50
DNCL003778	MLN0002	Crohn's disease	555	K50
DNCL003778	MLN0002	Ulcerative colitis	556	K51
DNCL003779	Peginesatide	Anaemia	280-285, 403, 580-589, 585.1-585.5, 585.9	D50-D64, N00-N29, N18
DNCL003779	Peginesatide	Anemia	280-285	D50-D64
DNCL003780	BLB-750	Influenza virus infections	487	J10, J11
DNCL003780	BLB-750	Pandemic influenza	487, 488	J10, J11
DNCL003781	TAK-438	Acid-related diseases	531-534	K25-K27
DNCL003781	TAK-438	Gastroesophageal reflux disease	.	K21
DNCL003782	TAK-816	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003782	TAK-816	Haemophilus influenza type b infection	001-139	A00-B99
DNCL003783	TAK-361S	Diphtheria, pertussis, tetanus, polio infection	001-139, 032, 033, 037, 045, 138, 771.3	A00-B99, A33-A35, A36, A37, A80, B91
DNCL003783	TAK-361S	Infectious and parasitic disease	.	A00-B99
DNCL003784	Norovirus vaccine	Acute gastroenteritis caused by norovirus	008.8009.0, 009.1, 558	A02.0, A08, A09, J10.8, J11.8, K52
DNCL003784	Norovirus vaccine	Gastroenteritis	.	K52.9
DNCL003785	TAK-272	Hypertension	401	I10, I11, I12, I13, I15
DNCL003786	TAK-063	Schizophrenia	295	F20
DNCL003787	MT203	Autoimmune diseases	.	D84.9
DNCL003787	MT203	Rheumatold arthritis	714	M05-M06
DNCL003788	Lu AA24530	Major depressive disorder	.	F32,F33
DNCL003788	Lu AA24530	Major depressive; Generalized anxiety disorders	296.2, 296.3, 300	F32, F33, F40-F42
DNCL003789	AMG 403	Pain	338,780	R52, G89
DNCL003790	ITI-214	Cognitive impairment	.	F06.7
DNCL003790	ITI-214	Schizophrenia	295, 331.83	F20, G31.84
DNCL003791	RELVARTM or BREOTM ELLIPTATM	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003792	ANORATM ELLIPTATM	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003793	TD-1607	Serious Gram+ Infections	001-139	A00-B99
DNCL003794	TD-1211	Constipation	.	K59.0
DNCL003794	TD-1211	Opioid-induced constipation	564	K59.0
DNCL003795	VR315	Asthma	493	J45
DNCL003795	VR315	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003796	VR632	Asthma	493	J45
DNCL003796	VR632	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
DNCL003797	VR496	Cystic fibrosis	277	E84
DNCL003798	XmAb 5871	Autoimmune diseases	.	D84.9
DNCL003798	XmAb 5871	Autoimmune diseases	279.4	D84.9, M35.9
DNCL003799	PF-4605412	Cancers	140-229	C00-C96
DNCL003800	Undisclosed	Cancers	140-229	C00-C96
DNCL003801	Liprotamase	Cystic fibrosis	.	E84
DNCL003801	Liprotamase	Exocrine pancreatic enzyme insufficiency	277.0, 709.2	E84, L90.5
DNCL003802	Evacetrapib	Cardiovascular disease	325, 430-459	G45-G46, I60-I95
DNCL003803	Blosozumab	Osteoporosis	733	M80-M81
DNCL003804	LY2886721	Alzheimer's disease	.	G30,F00
DNCL003804	LY2886721	Alzheimer's disease	331	G30
DNCL003805	LY2951742	Migraine	.	G43
DNCL003805	LY2951742	Prophylaxis of migraine	346	G43
DNCL003806	LY2801653	Cancer	.	C00-C97
DNCL003806	LY2801653	Cancer	140-229	C00-C96
DNCL003807	LY2812176	Cancer	140-229	C00-C96
DNCL003808	LY2606368	Cancer	.	C00-C97
DNCL003808	LY2606368	Cancer	140-229	C00-C96
DNCL003809	LY2874455	Cancer	140-229	C00-C96
DNCL003810	LY3012212	Arteriosclerosis	.	I70
DNCL003810	LY3012212	Bladder cancer	188	C67
DNCL003811	LY2523355	Acute myeloid leukemia	.	C92.0
DNCL003811	LY2523355	Cancers	140-229	C00-C96
DNCL003812	IL-1 Monoclonal Antibody	Cardiovascular disease	390-459	I00-I99
DNCL003813	CSF-1R Monoclonal Antibody	Cancer	.	C00-C97
DNCL003813	CSF-1R Monoclonal Antibody	Cancer	140-229	C00-C96
DNCL003814	Ferroportin Monoclonal Antibody	Anemia	280-285	D50-D64
DNCL003815	PI3 Kinase/mTOR Inhibitor	Cancer	140-229	C00-C96
DNCL003816	P38 MAP Kinase Inhibitor	Cancer	140-229	C00-C96
DNCL003817	P70 S6 Kinase/AKT Dual Inhibitor	Cancer	140-229	C00-C96
DNCL003818	RON Monoclonal Antibody	Cancer	140-229	C00-C96
DNCL003819	VEGFR3 Monoclonal Antibody	Cancer	.	C00-C97
DNCL003819	VEGFR3 Monoclonal Antibody	Cancer	140-229	C00-C96
DNCL003820	MK-7655	Bacterial infection	.	A00-A09,A15-A19,A20-A28,A30-A49,A65-A69,A70-A74,A75-A79
DNCL003820	MK-7655	Bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
DNCL003821	MK-8228	Cytomegalovirus infection	.	B25
DNCL003821	MK-8228	Cytomegalovirus infection 	78.5	B25
DNCL003822	MK-8342	Contraception	.	Z30
DNCL003823	MK-8175A	Contraception	.	Z30
DNCL003824	MK-8342B	Contraception	.	Z30
DNCL003825	MK-8835	Diabetes mellitus	250	E08-E13
DNCL003826	MK-8742	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DNCL003827	MK-1602	Migraine	346	G43
DNCL003828	MK-4618	Overactive bladder disorder	596.51	N32.81
DNCL003829	MK-8457	Rheumatold arthritis	714	M05-M06
DNCL003830	MK-3415A	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
DNCL003830	MK-3415A	Malaria	.	B50-B54
DNCL003831	MK-8962	Fertility	.	N00-N99
DNCL003832	V419	Hepatitis B virus infection	070.2, 070.3	B16, B18.0, B18.1
DNCL003833	MK-8109	Platinum-resistant ovarian cancer	183	C56
DNCL003834	MK-3222	Hairy cell leukemia	.	C91.40
DNCL003834	MK-3222	Psoriasis	696	L40
DNCL003835	MK-08887A	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DNCL003836	MK-8616	Neuromuscular disease	.	T36-T50
DNCL003836	MK-8616	Poison intoxication	.	T36-T50
DNCL003837	Budesonide foam	Ulcerative colitis	556	K51
DND000001	XL-888	Cancer	.	C00-C97
DND000001	XL-888	Cancer	140-229	C00-C96
DND000002	XL-228	Leukaemia	.	C91-C95
DND000002	XL-228	Leukaemia	204	C91.0
DND000003	TRX-518 (GITR antibody)	Melanoma	172	C43
DND000004	SSR-97225	Cancer	140-229	C00-C96
DND000005	PF-562271	Pancreatic cancer	157	C25
DND000005	PF-562271	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DND000006	PF-4217903	Cancer	140-229	C00-C96
DND000007	PF-3758309	Cancer	140-229	C00-C96
DND000008	PF-3732010	Cancer	140-229	C00-C96
DND000009	Paclitaxel	Oesophageal cancer	.	C15.9
DND000010	MGN-1706	Cancer	140-229	C00-C96
DND000010	MGN-1706	Prostate cancer	185	C61
DND000011	MEDI-547	Ovarian cancer	183	C56
DND000011	MEDI-547	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DND000012	IPH-1101	Lymphoma	.	C81-C96
DND000012	IPH-1101	Lymphoma	202.8	C81-C96
DND000013	IMC-EB10	Acute myeloid leukemia	.	C92.0
DND000013	IMC-EB10	Leukaemia	204	C91.0
DND000014	Goserelin	Prostate cancer	185	C61
DND000015	EMD-1204831	Cancer	140-229	C00-C96
DND000015	EMD-1204831	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DND000016	CVX-241	Cancer	140-229	C00-C96
DND000017	AZD-2461	Cancer	140-229	C00-C96
DND000017	AZD-2461	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
DND000018	Amonafide malate	Leukaemia	204	C91.0
DND000019	Amolimogene	Dysplasia	.	C92.A2
DND000020	AGS-8M4	Cancer	.	C00-C97
DND000020	AGS-8M4	Ovarian cancer	183	C56
DND000021	AGS-16 MAb,	Cancer	.	C00-C97
DND000021	AGS-16 MAb,	Renal cancer	189	C64
DND000022	5-FU, Galectin	Colorectal cancer	153, 154	C18-C21
DND000023	Zalutumumab	Head and neck cancer	.	C07-C14,C32-C33
DND000023	Zalutumumab	Squamous cell carcinoma of the head and neck	199	C44
DND000024	Uterine fibroids therapy	Fibrosis	709.2	L90.5
DND000024	Uterine fibroids therapy	Uterine fibroids	.	D25
DND000025	TTP-488 PF-04494700	Alzheimer's disease	331	G30
DND000026	TRX-4	Rheumatold arthritis	714	M05-M06
DND000027	TRX-1	Autoimmune diseases	.	D84.9
DND000027	TRX-1	Lupus erythematosus	.	L93
DND000028	MTRX-1011A	Autoimmune diseases	.	D84.9
DND000028	MTRX-1011A	Rheumatold arthritis	714	M05-M06
DND000029	PMI-001 TwHF extract	Rheumatold arthritis	714	M05-M06
DND000030	JTS-653	Overactive bladder disorder	.	N32.81
DND000030	JTS-653	Pain	338,780	R52, G89
DND000031	ILV-095	Psoriasis	696	L40
DND000031	ILV-095	Rheumatold arthritis	714	M05-M06
DND000032	Fezakinumab	Psoriasis	.	L40
DND000032	Fezakinumab	Rheumatold arthritis	714	M05-M06
DND000033	GLPG-0259	Inflammatory diseases	.	.
DND000033	GLPG-0259	Rheumatold arthritis	714	M05-M06
DND000034	AT-001 dnaJ peptide dnaJP1 rheumatoid arthritis therapy	Rheumatold arthritis	714	M05-M06
DND000035	Amolimogene bepiplasmid Biotope-CD Biotope-diabetes	Dysplasia	.	C92.A2
DND000036	AGG-523	Osteoarthritis	715	M15-M19, M47
DND000036	AGG-523	Rheumatold arthritis	714	M05-M06
DND000037	ADL-5859	Pain	.	G89
DND000037	ADL-5859	Pain	338,780	R52, G89
DND000038	ADL-5747	Pain	.	G89
DND000038	ADL-5747	Pain	338,780	R52, G89
DND000039	PF-4967544	Renal failure	584, 585	N17, N18, N19
DND000040	BMS-844421	Cardiovascular disease	390-459	I00-I99
DND000041	Antihypertensives, NicOx-1	Cardiovascular disease	390-459	I00-I99
DND000042	Antihypertensives, NicOx-2	Cardiovascular disease	390-459	I00-I99
DND000043	SB-509	Cardiovascular disease	390-459	I00-I99
DND000043	SB-509	Diabetes mellitus	250	E08-E13
DND000043	SB-509	Neuropathy	.	G64,G90.0
DND000044	Flovagatran	Cardiovascular disease	390-459	I00-I99
DND000044	Flovagatran	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
DND000045	OBE-101	Cardiovascular disease	390-459	I00-I99
DND000045	OBE-101	Obesity	.	E66
DND000045	OBE-101	Obesity	278	E66
DND000046	Sirolimus stent	Cardiovascular disease	390-459	I00-I99
DND000047	Avotermin	Cardiovascular disease	390-459	I00-I99
DND000047	Avotermin	Scar tissue	.	L80-L99
DND000048	RG-7273	Cardiovascular disease	390-459	I00-I99
DND000048	RG-7273	Lipid metabolism disorder	.	E75-E78
DND000049	RG-7236	Cardiovascular disease	390-459	I00-I99
DND000050	REGN-728	Cardiovascular disease	390-459	I00-I99
DND000051	NCX-6560	Cardiovascular disease	390-459	I00-I99
DND000052	MP-136	Cardiovascular disease	390-459	I00-I99
DND000052	MP-136	Lipid metabolism disorder	.	E75-E78
DND000053	GED-aPC	Cardiovascular disease	.	I00-I99
DND000053	GED-aPC	Cardiovascular disease	390-459	I00-I99
DND000054	TB-402	Atrial fibrillation	.	I48
DND000054	TB-402	Cardiovascular disease	390-459	I00-I99
DND000055	Tagatose	Cardiovascular disease	390-459	I00-I99
DND000056	Granotapide	Cardiovascular disease	390-459	I00-I99
DND000057	AZD-2927	Atrial fibrillation	427.31	I48
DND000057	AZD-2927	Cardiovascular disease	390-459	I00-I99
DND000058	LCP-AtorFen	Cardiovascular disease	390-459	I00-I99
DND000059	TC-5214	Cardiovascular disease	390-459	I00-I99
DND000060	Sitagliptin + atorvastatin	Cardiovascular disease	390-459	I00-I99
DND000061	Rusalatide acetate	Cardiovascular disease	390-459	I00-I99
DND000061	Rusalatide acetate	Diabetic foot ulcer	.	E08-E13
DND000062	Iferanserin-Ventrus	Cardiovascular disease	390-459	I00-I99
DND000062	Iferanserin-Ventrus	Hemorrhoids	.	I84
DND000063	Eprotirome	Cardiovascular disease	390-459	I00-I99
DND000064	NN-9925	Diabetes mellitus	250	E08-E13
DND000064	NN-9925	Non-insulin dependent diabetes	.	E11.9
DND000065	DSP-7238	Diabetes mellitus	250	E08-E13
DND000066	DMG-221	Diabetes mellitus	250	E08-E13
DND000067	AZD-6714	Diabetes mellitus	250	E08-E13
DND000067	AZD-6714	Diabetes mellitus type 2	.	E11
DND000068	PF-0516704	Diabetes mellitus	250	E08-E13
DND000069	PMI-004	Diabetes mellitus	250	E08-E13
DND000069	PMI-004	Diabetic neuropathy	250.6	E10.4, E11.4, E13.4
DND000070	ISIS-1133715	Diabetes mellitus	250	E08-E13
DND000071	MK-0431C	Diabetes mellitus	250	E08-E13
DND000072	GAD antigen	Diabetes mellitus	250	E08-E13
DND000073	TT488	Diabetes mellitus	250	E08-E13
DND000074	Vitreosolve	Diabetes mellitus	250	E08-E13
DND000074	Vitreosolve	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
DND000075	P57	Eating disorder	307.5	F50
DND000075	P57	Obesity	278	E66
DND000076	NN-9161	Obesity	278	E66
DND000077	AC 137-164594	Obesity	278	E66
DND000078	ASP-9831	Non-alcoholic steatohepatitis	.	K75.81
DND000078	ASP-9831	Steatohepatitis	.	K70.1,K76.0
DND000079	AJD-101	Diabetes mellitus	250	E08-E13
DND000079	AJD-101	Type 2 diabetes	250.00, 250.02	E11
DND000080	ASP-4178	Non-insulin dependent diabetes	.	E11.9
DND000080	ASP-4178	Type 2 diabetes	250.00, 250.02	E11
DND000081	ASP-5034	Non-insulin dependent diabetes	.	E11.9
DND000081	ASP-5034	Type 2 diabetes	250.00, 250.02	E11
DND000082	NN9223	Type 2 diabetes	250.00, 250.02	E11
DND000083	PF-04991532	Diabetes mellitus	.	E10-E14
DND000083	PF-04991532	Type 2 diabetes	250.00, 250.02	E11
DND000084	PF-50190457	Type 2 diabetes	250.00, 250.02	E11
DND000085	Tagatose	Atherosclerosis	414.0, 440	I70
DND000085	Tagatose	Type 2 diabetes	250.00, 250.02	E11
DND000086	Metformin gum	Type 2 diabetes	250.00, 250.02	E11
DND000087	SAR101099	Diabetes mellitus	250	E08-E13
DND000087	SAR101099	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DND000088	FOV-2304	Diabetes mellitus	250	E08-E13
DND000088	FOV-2304	Diabetic macular edema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
DND000089	TP-508	Diabetes mellitus	250	E08-E13
DND000090	Placulumab	Diabetes mellitus	250	E08-E13
DND000090	Placulumab	Sciatica	.	M54.3-M54.4
DND000091	PF-04634817	Diabetes mellitus	250	E08-E13
DND000091	PF-04634817	Diabetic nephropathy	.	E10.2,E11.2,E13.2
DND000092	PF-4136309	Diabetes mellitus	250	E08-E13
DND000092	PF-4136309	Hepatitis C virus infection	.	B17.1,B18.2
DND000093	SPD-556	Diabetes mellitus	250	E08-E13
DND000093	SPD-556	Heart failure	.	I50
DND000094	AZ-2066	Diabetes mellitus	250	E08-E13
DND000095	AGI-006 arbaclofen	Diabetes mellitus	250	E08-E13
DND000096	TZP-101 ulimorelin	Postoperative ileus	537.2, 560.1, 560.31, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, P76.1
DND000097	PF-05212389	Obesity	278	E66
DND000098	Neurogenix	Obesity	278	E66
DND000099	WAY-162545	Anxiety disorder	300	F40-F42
DND000099	WAY-162545	Diabetes mellitus	250	E08-E13
DND000100	NME Lilly 5	Diabetes mellitus	250	E08-E13
DND000101	KB-141	Diabetes mellitus	250	E08-E13
DND000101	KB-141	Obesity	.	E66
DND000102	MK-0431 combo	Diabetes mellitus	250	E08-E13
DND000103	CRx-102	Inflammatory disorders	.	.
DND000104	NN-8555	Autoimmune diseases	.	D84.9
DND000104	NN-8555	Inflammatory disorders	.	.
DND000105	SCV-07	Inflammatory disorders	.	.
DND000106	G-100192	Inflammatory disorders	.	.
DND000107	KRP-110	Inflammatory disorders	.	.
DND000108	ALKS-37	Inflammatory disorders	.	.
DPR000001	GSK683699	Crohn's disease; Inflammatory bowel disease	555, 556	K50, K51
DPR000002	(S)-amisulpride	Schizophrenia	295	F20
DPR000003	1192U90	Psychotic disorders	.	F20-F29
DPR000003	1192U90	Schizophrenia	295	F20
DPR000004	5-HT2C agonist	Schizophrenia	295	F20
DPR000005	A-71378	Obesity	278	E66
DPR000006	A-74498	Obesity	278	E66
DPR000007	A-837093	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DPR000007	A-837093	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DPR000008	AC-162352	Obesity	278	E66
DPR000009	Adenosine A(2A) receptor antagonist	Parkinson's disease	332	F02.3, G20
DPR000010	ADX-2 series	Anxiety disorder	.	F40-F42
DPR000010	ADX-2 series	Schizophrenia	295	F20
DPR000011	AG-021541	Hepatitis C virus infection	001-139, 042-075, 070.4, 070.5, 070.70, 573.3	A00-B99, A80-A99, B00-B34, B17.1, B18.2, K75.9
DPR000011	AG-021541	Hepatitis C virus infection	070.4, 070.5, 070.70	B17.1, B18.2
DPR000012	ALN-PCS01	Dyslipidemia	272	E78
DPR000012	ALN-PCS01	Hypercholesterolaemia	.	E78.0
DPR000013	AMG 714	Psoriasis	696	L40
DPR000014	Apafant	Ocular allergy	360-379	H00-H59
DPR000015	AR-R-1589	Obesity; Eating disorders	278, 307.5	E66, F50
DPR000016	ATI-17000	Irritable bowel syndrome	564.1	K58
DPR000017	ATL-1103	Acromegaly	.	E22.0
DPR000017	ATL-1103	Acromegaly	253	E22.0
DPR000018	AZ-40140	Obesity; Type 2 diabetes	250, 250.00, 250.02, 278	E08-E13, E11, E66
DPR000019	Belaperidone	Psychotic disorders	.	F20-F29
DPR000019	Belaperidone	Schizophrenia	295	F20
DPR000020	BIBO-3304	Obesity	278	E66
DPR000021	BIO-306	Acute migraine	205	C92.0
DPR000022	Bisquaternary salt	Fungal diseases	110-118	B35-B49
DPR000023	BL-1020	Schizophrenia	295	F20
DPR000024	BMS-192548	Obesity	278	E66
DPR000025	BMS-433771	Respiratory syncytial virus 	79.6	B97.4
DPR000026	BVT-A	Acromegaly	253	E22.0
DPR000027	CB1 antagonist	Diabetes mellitus	.	E10-E14
DPR000027	CB1 antagonist	Obesity	278	E66
DPR000028	Celastrol	Motor neurone disease; Amyotropic lateral sclerosis	335.2	G12.2
DPR000029	CHIR-01020	Obesity	278	E66
DPR000030	Chitin synthase inhibitor	Fungal diseases	110-118	B35-B49
DPR000031	CL-314698	Obesity; Type 2 diabetes	250, 250.00, 250.02, 278	E08-E13, E11, E66
DPR000032	CP-114271	Obesity	.	E66
DPR000032	CP-114271	Obesity	278	E66
DPR000033	Cruentaren	Fungal diseases	110-118	B35-B49
DPR000034	CYT-009-GhrQb	Obesity	278	E66
DPR000035	D1 agonist D2 antagonist	Schizophrenia	295	F20
DPR000036	Dianicline	Nicotine dependence	.	F17
DPR000036	Dianicline	Tobacco dependence	305.1	F17
DPR000037	Dianicline+rimonabant	Tobacco dependence	305.1	F17
DPR000038	DPC-333	Inflammatory bowel disease	.	K50,K51
DPR000038	DPC-333	Inflammatory bowel disease; Rheumatoid arthritis	555, 556, 710-719, 714	K50, K51, M00-M25, M05-M06
DPR000039	DX-890	Acute lung injury; Acute respiratory distress syndrome; cystic fibrosis	277.0, 518.5, 518.82, 709.2	E84, J80, L90.5
DPR000039	DX-890	Cystic fibrosis	277	E84
DPR000040	E-6276	Schizophrenia	295	F20
DPR000041	EP-01492	Obesity	278	E66
DPR000042	Estrogen and selective estrogen receptor modulators	Parkinson's disease	332	F02.3, G20
DPR000043	Fananserin	Psychotic disorders	.	F20-F29
DPR000043	Fananserin	Schizophrenia	295	F20
DPR000044	FAS1	Fungal diseases	110-118	B35-B49
DPR000045	FK778	Kidney transplant rejection; Heart transplant rejection	996	T86
DPR000045	FK778	Transplant rejection	.	T86
DPR000046	FPL-14294	Obesity	278	E66
DPR000047	FR-79620	Eating disorder; Obesity; Diabetes	250, 278, 307.5	E08-E13, E66, F50
DPR000048	FSA2	Fungal diseases	110-118	B35-B49
DPR000049	GCR-1087	Obesity; Type 2 diabetes	250, 250.00, 250.02, 278	E08-E13, E11, E66
DPR000050	Genz29155	Heart transplant rejection	996	T86
DPR000050	Genz29155	Multiple sclerosis	340	G35
DPR000051	GG-8573	Gallstone prophylaxis; Obesity	278	E66
DPR000052	GI-264879A	Obesity	278	E66
DPR000053	GNTI	Obesity	278	E66
DPR000054	GSK-326416	Gastroparesis	536.3	K31.8
DPR000055	GW-3333	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DPR000056	GW-594884A	Obesity	278	E66
DPR000057	GYKI-47261	Parkinson's disease	332	F02.3, G20
DPR000058	HMG-CoA reductase inhibitor	Chemotherapy or radiotherapy-induced mucositis	528	K12.3
DPR000059	Icofungipen	Fungal diseases	110-118	B35-B49
DPR000059	Icofungipen	Fungal infections	110-118	B35-B49
DPR000060	IDDB-41331	Obesity	278	E66
DPR000061	IDDBCP-150101	Obesity; Sexual dysfunction	278, 302.7	E66, F52
DPR000062	Indol-3-carbinol	Fungal diseases	110-118	B35-B49
DPR000063	Iptakalim	Parkinson's disease	332	F02.3, G20
DPR000064	KD-3020	Non-alcoholic fatty liver disease	571.8	K76.0
DPR000064	KD-3020	Wound healing	.	S91.3
DPR000065	L-742791	Obesity	278	E66
DPR000066	L-751250	Obesity	278	E66
DPR000067	Laropiprant+niacin	Dyslipidemia	272	E78
DPR000068	LY-25582	Obesity	278	E66
DPR000069	LY-362884	Obesity; Type 2 diabetes	250, 250.00, 250.02, 278	E08-E13, E11, E66
DPR000070	MC-4 agonist	Obesity	278	E66
DPR000071	MCH antagonist	Obesity	278	E66
DPR000072	MCP-1	Rheumatold arthritis	714	M05-M06
DPR000073	Melanotetan II	Sexual dysfunction; Obesity; Type 2 diabetes	250, 250.00, 250.02, 278, 302.7	E08-E13, E11, E66, F52
DPR000074	MGluR2 agonist	Schizophrenia	295	F20
DPR000075	MGluRIII agonist and mGlu5 antagonist	Parkinson's disease	332	F02.3, G20
DPR000076	Miltefosine	Leishmaniasis	.	B55.0
DPR000076	Miltefosine	Visceral leishmaniasis	085.0, 110-118	B35-B49, B55.0
DPR000077	Mteron-F1	Chemotherapy-induced mucositis	528	K12.3
DPR000078	NAChRs agonist	Parkinson's disease	332	F02.3, G20
DPR000079	Nimesulide	Acute pain; fever; Osteoarthritis; Dysmenorrhea	338, 625.3, 715, 780.6	M15-M19, M47, N94.4-N94.6, R50, R52, G89
DPR000080	NOX-F37	Acute and chronic heart failure	428	I50
DPR000081	NPY antagonist	Obesity	278	E66
DPR000082	NPY5RA-972	Obesity	278	E66
DPR000083	ONO-5046	Community-acquired pneumonial; Acute lung injury	480-486, 518, 770.0	J12, J13, J14, J15, J16, J17, J18, J80, P23
DPR000084	Org-24461	Schizophrenia	295	F20
DPR000085	Organon	Schizophrenia	295	F20
DPR000086	Organon-2	Schizophrenia	295	F20
DPR000087	Organon-3	Schizophrenia	295	F20
DPR000088	Ostarine	Cancer	.	C00-C97
DPR000088	Ostarine	Hypogonadism	257.2	E23.0, E28.3, E29.1
DPR000089	PCSK9 inhibitor	Dyslipidemia	272	E78
DPR000090	PD-160170	Hypertension; Obesity; Heart disease	278, 390-429	E66, I00-I52
DPR000091	PD-170292	Obesity	278	E66
DPR000092	PF9601N	Parkinson's disease	332	F02.3, G20
DPR000093	PT-15	Diabetes mellitus	.	E10-E14
DPR000093	PT-15	Sexual dysfunction; Obesity	278, 302.7	E66, F52
DPR000094	RFI-641	Respiratory syncytial virus 	79.6	B97.4
DPR000095	RGH-1756	Schizophrenia	295	F20
DPR000096	Rhucin	Graft rejection in heart transplantation	996	T86
DPR000097	Rimcazole	Cancer	.	C00-C97
DPR000097	Rimcazole	Schizophrenia	295	F20
DPR000098	RMG-40083	Schizophrenia	295	F20
DPR000099	RO-26-2853	Cancers	.	.
DPR000100	Ro-27-3225	Obesity	278	E66
DPR000101	Rottlerin	Parkinson's disease	332	F02.3, G20
DPR000102	RS-504393	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
DPR000103	S32504	Major depressive disorder	.	F32,F33
DPR000103	S32504	Parkinson's disease	332	F02.3, G20
DPR000104	Scriptaid	Breast cancer	174, 175, 217	C50, D24
DPR000104	Scriptaid	Cancers	140-229	C00-C96
DPR000105	SDZ-HDC-912	Psychotic disorders	.	F20-F29
DPR000105	SDZ-HDC-912	Schizophrenia	295	F20
DPR000106	Sirna-027	Exudative age-related macular degeneration	362.5	H35.3
DPR000106	Sirna-027	Macular degeneration	362.5	H35.3
DPR000106	Sirna-027	Neovascular age-related macular degeneration	362.5	H35.3
DPR000107	SLV-332	Irritable bowel syndrome	564.1	K58
DPR000108	SMP-534	Diabetic nephropathy	250.4	E10.2, E11.2, E13.2
DPR000109	SNAP-7941	Obesity; Anxiety; Depression	278, 300, 311	E66, F32, F40-F42
DPR000110	Sonepiprazole	Psychotic disorders	.	F20-F29
DPR000110	Sonepiprazole	Schizophrenia	295	F20
DPR000111	SR-31742A	Psychotic disorders	.	F20-F29
DPR000111	SR-31742A	Schizophrenia	295	F20
DPR000112	SSR-103800	Schizophrenia	295	F20
DPR000113	SSR-504734	Cognitive impairment	.	F06.7
DPR000113	SSR-504734	Schizophrenia	295	F20
DPR000114	T-226293	Obesity	278	E66
DPR000115	T-226296	Obesity	278	E66
DPR000116	Tanaproget	Heart transplant rejection	996	T86
DPR000117	UCL-2000 and butabindide	Obesity	278	E66
DPR000118	VP-14637	Respiratory syncytial virus 	.	B97.4
DPR000118	VP-14637	Respiratory syncytial virus 	79.6	B97.4
DPR000119	VT-111	Acutecoronary syndrome	411.1	I20.0
DPR000119	VT-111	Graft rejection in heart transplantation	996	T86
DPR000120	YM-344031	Asthma	493	J45
DPR000121	YM-355179	Asthma	493	J45
DPR000122	Huntingtin gene antisense	Huntington's disease	294.1, 333.4	F02.2, G10
DPR000123	Gem 92	Acquired immune deficiency syndrome	42	B20
DPR000123	Gem 92	HIV-1 infections	42	B20
DPR000124	AG-024322	Advanced cancers	140-229	C00-C96
DPR000124	AG-024322	Cancer	140-229	C00-C96
DPR000125	TAK-779	HIV infections	42	B20
DPR000125	TAK-779	Transplant rejection	.	T86
DPR000126	Remacemide	Huntington's disease	294.1, 333.4	F02.2, G10
DPR000126	Remacemide	Pain	338	R52
DPR000126	Remacemide	Parkinson's disease	332	F02.3, G20
DPR000127	LY467711	Neuropathic pain; Migraine	338, 346,780	G43, R52, G89
DPR000128	LY525327	Neuropathic pain; Migraine	338, 346,780	G43, R52, G89
DPR000129	ASP8497	Type 2 diabetes	250.00, 250.02	E11
DPR000130	CCT-018159	Cancers	140-229	C00-C96
DPR000131	CHAP-15	Cancers	140-229	C00-C96
DPR000132	Chlamydocin	Cancers	140-229	C00-C96
DPR000133	Denagliptin	Diabetes mellitus type 2	.	E11
DPR000133	Denagliptin	Type 2 diabetes	250.00, 250.02	E11
DPR000134	Depudecin	Cancers	140-229	C00-C96
DPR000135	ER-319711-15	Type 2 diabetes	250.00, 250.02	E11
DPR000136	FFF1	Cancers	140-229	C00-C96
DPR000137	FFF2	Cancers	140-229	C00-C96
DPR000138	FFF3	Cancers	140-229	C00-C96
DPR000139	FFF4	Cancers	140-229	C00-C96
DPR000140	HC-Toxin	Cancers	140-229	C00-C96
DPR000141	HDAC-42	Cancer	.	C00-C97
DPR000141	HDAC-42	Cancers	140-229	C00-C96
DPR000142	Isoleucine thiazolidide DPP IV	Type 2 diabetes	250.00, 250.02	E11
DPR000143	JNS-16241199	Cancers	140-229	C00-C96
DPR000144	KRH-2731	HIV infections	42	B20
DPR000145	LY-2463665	Type 2 diabetes	250.00, 250.02	E11
DPR000146	LY367265	Depression	311	F32
DPR000147	M-carboxycinnamic acid bishydroxamide	Cancers	140-229	C00-C96
DPR000148	McN3377	Anxiety disorder	300	F40-F42
DPR000148	McN3377	Fragile X syndrome	759.83	Q99.2
DPR000149	NVP DPP728	Type 2 diabetes	250.00, 250.02	E11
DPR000150	Oxamflatin	Cancers	140-229	C00-C96
DPR000151	R-1438	Diabetes mellitus type 2	.	E11
DPR000151	R-1438	Type 2 diabetes	250.00, 250.02	E11
DPR000152	SB-623	Cerebrovascular ischaemia	.	G45.9,I67.8
DPR000152	SB-623	Stroke	434.91	I61-I63
DPR000153	SB-6241	Cancers	140-229	C00-C96
DPR000154	SB-639	Cancer	.	C00-C97
DPR000154	SB-639	Cancers	140-229	C00-C96
DPR000155	SCH-C	HIV infections	42	B20
DPR000156	SK-7041	Cancers	140-229	C00-C96
DPR000157	SK-7068	Cancers	140-229	C00-C96
DPR000158	Tak-220	HIV-1 infections	42	B20
DPR000159	TP-023	Anxiety disorder	300	F40-F42
DPR000160	TPT-43	Alzheimer's disease	331	G30
DPR000161	VER 49009	Cancers	140-229	C00-C96
DPR000162	YM-992	Depression	311	F32
DPR000163	Batimastat	Cancers	140-229	C00-C96
DPR000164	Metastat	Kaposi's sarcoma	176	C46
DPR000165	Galardin	Corneal ulcers	370	H16.0
DPR000166	4SC-202	Cancer	140-229	C00-C96
DPR000166	4SC-202	Hematological malignancies	.	C81-C96
DPR000167	AEZS-123	Alcohol use disorders	303	F10.2
DPR000168	ALN-HTT	Huntington's disease	.	F02.2,G10
DPR000168	ALN-HTT	Huntington's disease	294.1, 333.4	F02.2, G10
DPR000169	ALN-PCS	Hypercholesterolemia	272	E78.0
DPR000170	ANAVEX 1007	Melanoma; Prostate cancer; Pancreatic cancer	140-229, 157, 172, 185	C00-C96, C25, C43, C61
DPR000171	ANAVEX 1-41	Alzheimer's disease	331	G30
DPR000171	ANAVEX 1-41	Cerebrovascular ischaemia	.	G45.9,I67.8
DPR000172	AT008	Cervical cancer; Esophageal cancer	140-229, 150, 180	C00-C96, C15, C53
DPR000172	AT008	Multiple sclerosis	340	G35
DPR000173	BMS-PCSK9	Coronary artery disease	410-414, 429.2	I20-I25
DPR000174	CF502	Inflammation	.	I20-I25
DPR000175	CF602	Inflammation	.	I20-I25
DPR000175	CF602	Inflammatory diseases	.	.
DPR000176	IMO-2134	Asthma	493	J45
DPR000176	IMO-2134	Asthma; Allergy	204.0, 493, 995.3	C91.0, J45, T78.4
DPR000177	ISIS-FGFR4	Obesity	278	E66
DPR000178	ISIS-GCCR	Diabetes mellitus type 2	.	E11
DPR000178	ISIS-GCCR	Type 2 diabetes	250.00, 250.02	E11
DPR000179	ISIS-GCGR	Diabetes mellitus	250	E08-E13
DPR000179	ISIS-GCGR	Type 2 diabetes	250.00, 250.02	E11
DPR000180	ISIS-PTP1B	Diabetes mellitus type 2	.	E11
DPR000180	ISIS-PTP1B	Type 2 diabetes	250.00, 250.02	E11
DPR000181	ISIS-STAT3	Cancer	140-229	C00-C96
DPR000181	ISIS-STAT3	Cancers	140-229	C00-C96
DPR000182	JD-5037	Cardiovascular disease	390-459	I00-I99
DPR000182	JD-5037	Obesity; Diabetes	250, 278	E08-E13, E66
DPR000183	RG2833	Cancer	140-229	C00-C96
DPR000184	RM-493	Diabetes mellitus	250	E08-E13
DPR000184	RM-493	Obesity; Diabetes	250, 278	E08-E13, E66
DPR000185	SCY-641	Ocular infection	.	H00-H59
DPR000185	SCY-641	Ocular inflammatory	370.33	H16.229
DPR000186	SGN-19A	Cancer	.	C00-C97
DPR000186	SGN-19A	Hematologic malignancies	200-209	C81-C96
DPR000187	TZP-301	Metabolic disorders	270-279	E70-E89
DPR000187	TZP-301	Obesity	278	E66
DPR000188	XL475	Diabetes mellitus	250	E08-E13
DPR000188	XL475	Type 2 diabetes	250.00, 250.02	E11
DPR000189	ZP2929	Obesity; Diabetes	250, 278	E08-E13, E66
DPR000189	ZP2929	Type 2 diabetes	250.00, 250.02	E11